PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Waldetoft, KW; Svensson, L; Morgelin, M; Olin, AI; Nitsche-Schmitz, DP; Bjorck, L; Frick, IM				Waldetoft, Kristofer Wollein; Svensson, Lisbeth; Morgelin, Matthias; Olin, Anders I.; Nitsche-Schmitz, D. Patric; Bjorck, Lars; Frick, Inga-Maria			Streptococcal Surface Proteins Activate the Contact System and Control Its Antibacterial Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT KININOGEN; VIRULENCE MECHANISM; C STREPTOCOCCUS; INNATE IMMUNITY; HUMAN-PLASMA; COMPLEMENT; IGG; IDENTIFICATION; FOG; PATHOGENESIS	Group G streptococci (GGS) are important bacterial pathogens in humans. Here, we investigated the interactions between GGS and the contact system, a procoagulant and proinflammatory proteolytic cascade that, upon activation, also generates antibacterial peptides. Two surface proteins of GGS, protein FOG and protein G (PG), were found to bind contact system proteins. Experiments utilizing contact protein-deficient human plasma and isogenic GGS mutant strains lacking FOG or PG showed that FOG and PG both activate the procoagulant branch of the contact system. In contrast, only FOG induced cleavage of high molecular weight kininogen, generating the proinflammatory bradykinin peptide and additional high molecular weight kininogen fragments containing the antimicrobial peptide NAT-26. On the other hand, PG protected the bacteria against the antibacterial effect of NAT-26. These findings underline the significance of the contact system in innate immunity and demonstrate that GGS have evolved surface proteins to exploit and modulate its effects.	[Waldetoft, Kristofer Wollein; Svensson, Lisbeth; Morgelin, Matthias; Olin, Anders I.; Bjorck, Lars; Frick, Inga-Maria] Lund Univ, Div Infect Med, Dept Clin Sci, SE-22184 Lund, Sweden; [Nitsche-Schmitz, D. Patric] Helmholtz Ctr Infect Res HZI, Microbial Pathogenesis Res Grp, D-38124 Braunschweig, Germany	Lund University; Helmholtz Association; Helmholtz-Center for Infection Research	Waldetoft, KW (corresponding author), Lund Univ, Div Infect Med, Dept Clin Sci, BMC B14, SE-22184 Lund, Sweden.	kristofer.wollein_waldetoft@med.lu.se			Swedish Research Council [7480]; Swedish Government Funds for Clinical Research (ALF); Kock Foundation; Osterlund Foundation; Knut and Alice Wallenberg Foundation; Royal Physiographic Society; Hansa Medical AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Government Funds for Clinical Research (ALF); Kock Foundation; Osterlund Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Royal Physiographic Society; Hansa Medical AB	This work was supported by Swedish Research Council Project 7480, the Swedish Government Funds for Clinical Research (ALF), the Kock Foundation, the Osterlund Foundation, the Knut and Alice Wallenberg Foundation, the Royal Physiographic Society, and Hansa Medical AB.	Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; Akesson P, 2010, MICROBIOL-SGM, V156, P3660, DOI 10.1099/mic.0.039578-0; BJORCK L, 1987, MOL IMMUNOL, V24, P1113, DOI 10.1016/0161-5890(87)90080-0; BJORCK L, 1984, J IMMUNOL, V133, P969; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Bramhachari PV, 2010, J MED MICROBIOL, V59, P220, DOI 10.1099/jmm.0.015644-0; Brandt CM, 2009, CLIN INFECT DIS, V49, P766, DOI 10.1086/605085; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cohen-Poradosu R, 2004, EMERG INFECT DIS, V10, P1455, DOI 10.3201/eid1008.030840; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; della Vergiliana JFV, 2010, BIOL CHEM, V391, P1067, DOI 10.1515/BC.2010.102; Dinkla K, 2007, J BIOL CHEM, V282, P18686, DOI 10.1074/jbc.M701047200; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Frick IM, 2007, THROMB HAEMOSTASIS, V98, P497, DOI 10.1160/TH07-01-0051; Frick IM, 2011, J BIOL CHEM, V286, P1331, DOI 10.1074/jbc.M110.178350; GHEBREHIWET B, 1983, J CLIN INVEST, V71, P1450, DOI 10.1172/JCI110898; GUSS B, 1986, EMBO J, V5, P1567, DOI 10.1002/j.1460-2075.1986.tb04398.x; Hashikawa S, 2004, J CLIN MICROBIOL, V42, P186, DOI 10.1128/JCM.42.1.186-192.2004; HERWALD H, 1995, J BIOL CHEM, V270, P14634; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; Holm K, 2011, INFECT IMMUN, V79, P3284, DOI 10.1128/IAI.05264-11; Johansson HM, 2004, MICROBIOL-SGM, V150, P4211, DOI 10.1099/mic.0.27269-0; Joseph K, 2005, ADV IMMUNOL, V86, P159, DOI 10.1016/S0065-2776(04)86005-X; Linge HM, 2007, MICROBIOL-SGM, V153, P3800, DOI 10.1099/mic.0.2007/009647-0; MANDLE RJ, 1976, P NATL ACAD SCI USA, V73, P4179, DOI 10.1073/pnas.73.11.4179; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Murphy EC, 2011, MICROBIOL-SGM, V157, P2094, DOI 10.1099/mic.0.046862-0; NESBITT SA, 1992, ANAL BIOCHEM, V206, P267, DOI 10.1016/0003-2697(92)90365-E; Nitsche-Schmitz DP, 2007, J BIOL CHEM, V282, P17530, DOI 10.1074/jbc.M702612200; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Oehmcke S, 2010, J MOL MED, V88, P121, DOI 10.1007/s00109-009-0564-y; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; REIS KJ, 1984, J IMMUNOL, V132, P3091; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; SMITHERICHSEN N, 1982, CIRC SHOCK, V9, P491; Sylvetsky N, 2002, AM J MED, V112, P622, DOI 10.1016/S0002-9343(02)01117-8; Takahashi T, 2011, J INFECT CHEMOTHER, V17, P1, DOI 10.1007/s10156-010-0084-2; THOMPSON RE, 1977, J CLIN INVEST, V60, P1376, DOI 10.1172/JCI108898	40	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25010	25018		10.1074/jbc.M112.373217	http://dx.doi.org/10.1074/jbc.M112.373217			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22648411	Green Published, hybrid			2022-12-25	WOS:000306651700014
J	Chucair-Elliott, AJ; Elliott, MH; Wang, JG; Moiseyev, GP; Ma, JX; Politi, LE; Rotstein, NP; Akira, S; Uematsu, S; Ash, JD				Chucair-Elliott, Ana J.; Elliott, Michael H.; Wang, Jiangang; Moiseyev, Gennadiy P.; Ma, Jian-Xing; Politi, Luis E.; Rotstein, Nora P.; Akira, Shizuo; Uematsu, Satoshi; Ash, John D.			Leukemia Inhibitory Factor Coordinates the Down-regulation of the Visual Cycle in the Retina and Retinal-pigmented Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-INDUCED DEGENERATION; PRECONDITIONING-INDUCED PROTECTION; FIBROBLAST-GROWTH-FACTOR; MACULAR DEGENERATION; PHOTOTRANSDUCTION MACHINERY; DARK-ADAPTATION; OUTER SEGMENTS; GENE LEADS; RAT RETINA; RPE65	Leukemia inhibitory factor (LIF), an interleukin-6 family neurocytokine, is up-regulated in response to different types of retinal stress and has neuroprotective activity through activation of the gp130 receptor/STAT3 pathway. We observed that LIF induces rapid, robust, and sustained activation of STAT3 in both the retina and retinal pigmented epithelium (RPE). Here, we tested whether LIF-induced STAT3 activation within the RPE can down-regulate RPE65, the central enzyme in the visual cycle that provides the 11-cis-retinal chromophore to photoreceptors in vivo. We generated conditional knock-out mice to specifically delete STAT3 or gp130 in RPE, retina, or both RPE and retina. After intravitreal injection of LIF, we analyzed the expression levels of visual cycle genes and proteins, isomerase activity of RPE65, levels of rhodopsin protein, and the rates of dark adaptation and rhodopsin regeneration. We found that RPE65 protein levels and isomerase activity were reduced and recovery of bleachable rhodopsin was delayed in LIF-injected eyes. In mice with functional gp130/STAT3 signaling in the retina, rhodopsin protein was also reduced by LIF. However, the LIF-induced down-regulation of RPE65 required a functional gp130/STAT3 cascade intrinsic to RPE. Our data demonstrate that a single cytokine, LIF, can simultaneously and independently affect both RPE and photoreceptors through the same signaling cascade to reduce the generation and utilization of 11-cis-retinal.	[Wang, Jiangang; Ash, John D.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Chucair-Elliott, Ana J.; Elliott, Michael H.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Moiseyev, Gennadiy P.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Moiseyev, Gennadiy P.; Ma, Jian-Xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Chucair-Elliott, Ana J.; Politi, Luis E.; Rotstein, Nora P.] Univ Nacl Sur, Dept Biol Bioquim & Farm, Inst Invest Bioquim Bahia Blanca, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Akira, Shizuo; Uematsu, Satoshi] Osaka Univ, Host Def Lab, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	State University System of Florida; University of Florida; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; National University of the South; Osaka University	Ash, JD (corresponding author), Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA.	jash@ufl.edu	Akira, Shizuo/C-3134-2009; wang, jian/GVS-0711-2022	Chucair-Elliott, Ana/0000-0002-0172-1876; Ash, John/0000-0002-8330-7301	National Institutes of Health [R01EY16459, R01EY012231, R01EY018659, R01EY019309, R01EY019494, EY012190, RR024215, RR017703]; Foundation Fighting Blindness; Research to Prevent Blindness, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215, P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019494, R01EY012231, R01EY016459, P30EY012190, R01EY018659, R01EY019309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY16459 (to J. D. A.), R01EY012231 (to J. X. M.), R01EY018659 (to J. X. M.), R01EY019309 (to J. X. M.), R01EY019494 (to M. H. E.), EY012190 (NEI core grant), and Grants RR024215 and RR017703 (Center of Biomedical Research Excellence). This work was also supported by Foundation Fighting Blindness and an unrestricted grant from Research to Prevent Blindness, Inc.	Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; BOK D, 1993, J CELL SCI, P189; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; BOSCH E, 1993, J HISTOCHEM CYTOCHEM, V41, P253, DOI 10.1177/41.2.8419462; Burgi S, 2009, MOL VIS, V15, P1631; CHAITIN MH, 1983, INVEST OPHTH VIS SCI, V24, P812; Chollangi S, 2009, NEUROBIOL DIS, V34, P535, DOI 10.1016/j.nbd.2009.03.012; Do Rhee K, 2007, INVEST OPHTH VIS SCI, V48, P1389, DOI 10.1167/iovs.06-0677; Driessen CAGG, 2000, MOL CELL BIOL, V20, P4275, DOI 10.1128/MCB.20.12.4275-4287.2000; Farjo KM, 2009, INVEST OPHTH VIS SCI, V50, P5089, DOI 10.1167/iovs.09-3797; Fasler-Kan E, 2005, OPHTHALMOLOGICA, V219, P214, DOI 10.1159/000085730; Franco LM, 2009, INVEST OPHTH VIS SCI, V50, P4004, DOI 10.1167/iovs.08-2898; GAO H, 1995, DEV BIOL, V169, P168, DOI 10.1006/dbio.1995.1135; Gao H, 1996, EXP EYE RES, V62, P181, DOI 10.1006/exer.1996.0022; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; Kubota R, 2012, RETINA-J RET VIT DIS, V32, P183, DOI 10.1097/IAE.0b013e318217369e; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; LAVAIL MM, 1976, EXP EYE RES, V23, P277, DOI 10.1016/0014-4835(76)90209-8; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; Li R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023148; Liu CD, 1998, J NEUROSCI, V18, P1337; LOPEZ PF, 1992, AUST NZ J OPHTHALMOL, V20, P163, DOI 10.1111/j.1442-9071.1992.tb00935.x; Mandal MNA, 2011, J BIOL CHEM, V286, P32491, DOI 10.1074/jbc.M111.255877; Marmorstein AD, 2001, TRAFFIC, V2, P867, DOI 10.1034/j.1600-0854.2001.21202.x; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Moiseyev G, 2008, J BIOL CHEM, V283, P8110, DOI 10.1074/jbc.M703654200; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; Ranchon I, 2003, J NEUROSCI, V23, P6050, DOI 10.1523/JNEUROSCI.23-14-06050.2003; Rattner A, 2008, J NEUROSCI, V28, P9880, DOI 10.1523/JNEUROSCI.2401-08.2008; Redmond TM, 2007, MOL VIS, V13, P1813; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Samardzija M, 2006, EUR J NEUROSCI, V23, P1028, DOI 10.1111/j.1460-9568.2006.04639.x; SHICHI H, 1969, J BIOL CHEM, V244, P529; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strick DJ, 2009, INVEST OPHTH VIS SCI, V50, P2427, DOI 10.1167/iovs.08-3058; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tanito M, 2009, J LIPID RES, V50, P807, DOI 10.1194/jlr.M800170-JLR200; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Ueki Y, 2010, ADV EXP MED BIOL, V664, P655, DOI 10.1007/978-1-4419-1399-9_75; Ueki Y, 2009, P NATL ACAD SCI USA, V106, P21389, DOI 10.1073/pnas.0906156106; WEN R, 1995, J NEUROSCI, V15, P7377; Wen R, 2008, ADV EXP MED BIOL, V613, P407, DOI 10.1007/978-0-387-74904-4_48; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2003, INVEST OPHTH VIS SCI, V44, P2798, DOI 10.1167/iovs.02-1134; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Yu DY, 2004, INVEST OPHTH VIS SCI, V45, P2013, DOI 10.1167/iovs.03-0845; Zarbin MA, 1998, EUR J OPHTHALMOL, V8, P199, DOI 10.1177/112067219800800401; Zhang SSM, 2003, EXP EYE RES, V76, P421, DOI 10.1016/S0014-4835(03)00002-2	60	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24092	24102		10.1074/jbc.M112.378240	http://dx.doi.org/10.1074/jbc.M112.378240			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645143	Green Published, hybrid			2022-12-25	WOS:000306651100004
J	Noguchi, TQP; Komori, T; Umeki, N; Demizu, N; Ito, K; Iwane, AH; Tokuraku, K; Yanagida, T; Uyeda, TQP				Noguchi, Taro Q. P.; Komori, Tomotaka; Umeki, Nobuhisa; Demizu, Noriyuki; Ito, Kohji; Iwane, Atsuko Hikikoshi; Tokuraku, Kiyotaka; Yanagida, Toshio; Uyeda, Taro Q. P.			G146V Mutation at the Hinge Region of Actin Reveals a Myosin Class-specific Requirement of Actin Conformations for Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; F-ACTIN; SLIDING MOVEMENT; ATP HYDROLYSIS; CROSS-LINKING; MOTOR DOMAIN; FILAMENTS; PHOSPHATE; BINDING; DICTYOSTELIUM	The G146V mutation in actin is dominant lethal in yeast. G146V actin filaments bind cofilin only minimally, presumably because cofilin binding requires the large and small actin domains to twist with respect to one another around the hinge region containing Gly-146, and the mutation inhibits that twisting motion. A number of studies have suggested that force generation by myosin also requires actin filaments to undergo conformational changes. This prompted us to examine the effects of the G146V mutation on myosin motility. When compared with wild-type actin filaments, G146V filaments showed a 78% slower gliding velocity and a 70% smaller stall force on surfaces coated with skeletal heavy meromyosin. In contrast, the G146V mutation had no effect on either gliding velocity or stall force on myosin V surfaces. Kinetic analyses of actin-myosin binding and ATPase activity indicated that the weaker affinity of actin filaments for myosin heads carrying ADP, as well as reduced actin-activated ATPase activity, are the cause of the diminished motility seen with skeletal myosin. Interestingly, the G146V mutation disrupted cooperative binding of myosin II heads to actin filaments. These data suggest that myosin-induced conformational changes in the actin filaments, presumably around the hinge region, are involved in mediating the motility of skeletal myosin but not myosin V and that the specific structural requirements for the actin subunits, and thus the mechanism of motility, differ among myosin classes.	[Demizu, Noriyuki; Tokuraku, Kiyotaka] Miyakonojo Natl Coll Technol, Dept Chem Sci & Engn, Miyazaki 8858567, Japan; [Noguchi, Taro Q. P.; Umeki, Nobuhisa; Uyeda, Taro Q. P.] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058562, Japan; [Noguchi, Taro Q. P.; Uyeda, Taro Q. P.] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058573, Japan; [Komori, Tomotaka; Iwane, Atsuko Hikikoshi; Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Nanobiol Labs, Suita, Osaka 5650871, Japan; [Ito, Kohji] Chiba Univ, Fac Sci, Dept Biol, Chiba 2638522, Japan; [Yanagida, Toshio] RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka 5650874, Japan; [Yanagida, Toshio] Ctr Informat & Neural Networks CiNet, Suita, Osaka 5650871, Japan; [Yanagida, Toshio] Osaka Univ, World Premier Int Res Ctr WPI, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Uyeda, Taro Q. P.] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo 1350064, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Osaka University; Chiba University; RIKEN; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; National Institute of Advanced Industrial Science & Technology (AIST)	Noguchi, TQP (corresponding author), Miyakonojo Natl Coll Technol, Dept Chem Sci & Engn, Yoshio Cho, Miyazaki 8858567, Japan.	t-noguchi@cc.miyakonojo-nct.ac.jp	Ito, Kohji/K-8441-2017; Tokuraku, Kiyotaka/D-4542-2014	Ito, Kohji/0000-0001-9573-432X; Tokuraku, Kiyotaka/0000-0002-7747-4808; Iwane, Atsuko/0000-0003-2641-2268	Ministry of Science, Culture, Sports and Technology; Grants-in-Aid for Scientific Research [23370072] Funding Source: KAKEN	Ministry of Science, Culture, Sports and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for scientific research from the Ministry of Science, Culture, Sports and Technology (to T. Q. P. U. and T. Q. P. N.).	Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Hachikubo Y, 2003, J BIOCHEM, V134, P165, DOI 10.1093/jb/mvg125; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kim E, 2002, BIOCHEMISTRY-US, V41, P86, DOI 10.1021/bi0113824; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Komori T, 2009, BIOPHYS J, V96, pL4, DOI 10.1016/j.bpj.2008.09.031; Kozuka J, 2006, NAT CHEM BIOL, V2, P83, DOI 10.1038/nchembio763; Kubota H, 2009, J BIOL CHEM, V284, P35251, DOI 10.1074/jbc.M109.013565; Kueh HY, 2008, P NATL ACAD SCI USA, V105, P16531, DOI 10.1073/pnas.0807394105; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MIKI M, 1982, BIOCHEMISTRY-US, V21, P3661, DOI 10.1021/bi00258a021; MILLAR NC, 1983, FEBS LETT, V160, P141, DOI 10.1016/0014-5793(83)80954-5; Miller CJ, 1996, BIOCHEMISTRY-US, V35, P3670, DOI 10.1021/bi952645v; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; Noguchi TQP, 2007, J BIOL CHEM, V282, P27721, DOI 10.1074/jbc.M703165200; Noguchi TQP, 2010, BIOCHEM BIOPH RES CO, V396, P1006, DOI 10.1016/j.bbrc.2010.05.047; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Okada T, 2007, BIOCHEM BIOPH RES CO, V354, P379, DOI 10.1016/j.bbrc.2006.12.200; Oosawa F., 1972, COLD SPRING HARB SYM, V37, P277; Orlova A, 1997, J MOL BIOL, V265, P469, DOI 10.1006/jmbi.1996.0761; Orlova A, 2004, P NATL ACAD SCI USA, V101, P17664, DOI 10.1073/pnas.0407525102; Orlova A, 2001, J MOL BIOL, V312, P95, DOI 10.1006/jmbi.2001.4945; Prochniewicz E, 2001, BIOCHEMISTRY-US, V40, P13933, DOI 10.1021/bi010893n; PROCHNIEWICZ E, 1990, J MOL BIOL, V216, P761, DOI 10.1016/0022-2836(90)90397-5; Prochniewicz E, 2010, J MOL BIOL, V396, P501, DOI 10.1016/j.jmb.2009.11.063; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Tokuraku K, 2009, J MOL BIOL, V386, P149, DOI 10.1016/j.jmb.2008.12.008; Uyeda TQP, 2002, BIOCHEMISTRY-US, V41, P9525, DOI 10.1021/bi026177i; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Volkmann N, 2003, P NATL ACAD SCI USA, V100, P3227, DOI 10.1073/pnas.0536510100; WARSHAW DM, 1990, J CELL BIOL, V111, P453, DOI 10.1083/jcb.111.2.453; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; YANAGIDA T, 1984, NATURE, V307, P58, DOI 10.1038/307058a0	41	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24339	24345		10.1074/jbc.M111.321752	http://dx.doi.org/10.1074/jbc.M111.321752			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637580	Green Published, hybrid			2022-12-25	WOS:000306651100028
J	Wang, B; Means, CK; Yang, YM; Mamonova, T; Bisello, A; Altschuler, DL; Scott, JD; Friedman, PA				Wang, Bin; Means, Chris K.; Yang, Yanmei; Mamonova, Tatyana; Bisello, Alessandro; Altschuler, Daniel L.; Scott, John D.; Friedman, Peter A.			Ezrin-anchored Protein Kinase A Coordinates Phosphorylation-dependent Disassembly of a NHERF1 Ternary Complex to Regulate Hormone-sensitive Phosphate Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; OPOSSUM KIDNEY-CELLS; PARATHYROID-HORMONE; PDZ DOMAIN; I COTRANSPORTER; DOWN-REGULATION; ERM PROTEINS; NAPI-IIA; MUTATIONS; ASSOCIATION	Congenital defects in the Na/H exchanger regulatory factor-1 (NHERF1) are linked to disordered phosphate homeostasis and skeletal abnormalities in humans. In the kidney, these mutations interrupt parathyroid hormone (PTH)-responsive sequestration of the renal phosphate transporter, Npt2a, with ensuing urinary phosphate wasting. We now report that NHERF1, a modular PDZ domain scaffolding protein, coordinates the assembly of an obligate ternary complex with Npt2a and the PKA-anchoring protein ezrin to facilitate PTH-responsive cAMP signaling events. Activation of ezrin-anchored PKA initiates NHERF1 phosphorylation to disassemble the ternary complex, release Npt2a, and thereby inhibit phosphate transport. Loss-of-function mutations stabilize an inactive NHERF1 conformation that we show is refractory to PKA phosphorylation and impairs assembly of the ternary complex. Compensatory mutations introduced in mutant NHERF1 re-establish the integrity of the ternary complex to permit phosphorylation of NHERF1 and rescue PTH action. These findings offer new insights into a novel macromolecular mechanism for the physiological action of a critical ternary complex, where anchored PKA coordinates the assembly and turnover of the Npt2a-NHERF1-ezrin complex.	[Wang, Bin; Yang, Yanmei; Mamonova, Tatyana; Bisello, Alessandro; Altschuler, Daniel L.; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab Prot Coupled Receptor Biol G, Pittsburgh, PA 15261 USA; [Means, Chris K.; Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab Prot Coupled Receptor Biol G, W1340 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	paf10@pitt.edu		Wang, Bin/0000-0002-5396-6111	National Institutes of Health [DK069998, DK071158, DK063069, GM048231]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071158, R01DK063069, R01DK069998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048231, R37GM048231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK069998 (to P. A. F.), DK071158 (to A. B.), DK063069 (to D. L. A.), GM048231 (to J. D. S.). This work was also supported by the Howard Hughes Medical Institute (to J. D. S.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alarcon-Riquelme ME, 2003, NAT GENET, V35, P299, DOI 10.1038/ng1203-299; Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Arola AM, 2007, MOL GENET METAB, V90, P435, DOI 10.1016/j.ymgme.2006.12.008; Ba JM, 2003, AM J PHYSIOL-RENAL, V285, pF1233, DOI 10.1152/ajprenal.00249.2003; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Bhattacharya S, 2010, J BIOL CHEM, V285, P9981, DOI 10.1074/jbc.M109.074005; BIBER J, 1990, METHOD ENZYMOL, V191, P494; CARR DW, 1992, J BIOL CHEM, V267, P13376; CARR DW, 1991, J BIOL CHEM, V266, P14188; Charizopoulou N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1200; Cheng H, 2009, STRUCTURE, V17, P660, DOI 10.1016/j.str.2009.03.009; COLE JA, 1987, AM J PHYSIOL, V253, pE221, DOI 10.1152/ajpendo.1987.253.2.E221; Courbebaisse M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034764; Cunningham R, 2009, AM J PHYSIOL-RENAL, V296, pF355, DOI 10.1152/ajprenal.90426.2008; Dai JL, 2004, ONCOGENE, V23, P8681, DOI 10.1038/sj.onc.1207962; de Azevedo WF, 2008, CURR DRUG TARGETS, V9, P1071, DOI 10.2174/138945008786949441; de Paula FJA, 2010, HORM METAB RES, V42, P299, DOI 10.1055/s-0030-1248255; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Ferrara AM, 2009, J ENDOCRINOL INVEST, V32, P238, DOI 10.1007/BF03346459; Forster IC, 1999, J PHYSIOL-LONDON, V517, P327, DOI 10.1111/j.1469-7793.1999.0327t.x; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Fouassier L, 2005, EXP CELL RES, V306, P264, DOI 10.1016/j.yexcr.2005.02.011; Friedman PA, 1996, ENDOCRINOLOGY, V137, P13, DOI 10.1210/en.137.1.13; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Hernando N, 2005, J PHYSIOL-LONDON, V567, P21, DOI 10.1113/jphysiol.2005.087049; Aparisi MJ, 2010, MOL VIS, V16, P2948; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Kawai M, 2011, NAT REV DRUG DISCOV, V10, P141, DOI 10.1038/nrd3299; Khundmiri SJ, 2003, J BIOL CHEM, V278, P10134, DOI 10.1074/jbc.M211775200; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Levi M, 2008, NEW ENGL J MED, V359, P1171, DOI 10.1056/NEJMe0805943; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Li JQ, 2009, J MOL BIOL, V392, P166, DOI 10.1016/j.jmb.2009.07.005; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mamonova T, 2012, BIOCHEMISTRY-US, V51, P3110, DOI 10.1021/bi201213w; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Murer H, 2010, J NEPHROL, V23, pS145; Nagai S, 2011, J BIOL CHEM, V286, P1618, DOI 10.1074/jbc.M110.198416; Nashiki K, 2005, KIDNEY INT, V68, P1137, DOI 10.1111/j.1523-1755.2005.00505.x; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shenolikar S, 2001, FEBS LETT, V489, P233, DOI 10.1016/S0014-5793(01)02109-3; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Stokka AJ, 2010, BIOCHEM J, V425, P381, DOI 10.1042/BJ20091136; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Tanimura A, 2011, J MED INVESTIG, V58, P140, DOI 10.2152/jmi.58.140; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2010, J BIOL CHEM, V285, P26976, DOI 10.1074/jbc.M110.147785; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2011, AM J PHYSIOL-RENAL, V300, pF231, DOI 10.1152/ajprenal.00532.2010; Weinman EJ, 2010, J BIOL CHEM, V285, P25134, DOI 10.1074/jbc.M110.132423; Weinman EJ, 2010, J BIOL CHEM, V285, P13454, DOI 10.1074/jbc.M109.094359; Weinman EJ, 1998, J CLIN INVEST, V101, P2199, DOI 10.1172/JCI204; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wozniak M, 1996, J BIOL CHEM, V271, P5017	73	32	33	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24148	24163		10.1074/jbc.M112.369405	http://dx.doi.org/10.1074/jbc.M112.369405			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22628548	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000306651100010
J	Eren, E; van den Berg, B				Eren, Elif; van den Berg, Bert			Structural Basis for Activation of an Integral Membrane Protease by Lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YERSINIA-PESTIS; ESCHERICHIA-COLI; PLASMINOGEN ACTIVATION; SURFACE PROTEASE; ACTIVE-SITE; OMPT; PLAGUE; FAMILY	Omptins constitute a unique family of outer membrane proteases that are widespread in Enterobacteriaceae. The plasminogen activator (Pla) of Yersinia pestis is an omptin family member that is very important for development of both bubonic and pneumonic plague. The physiological function of Pla is to cleave (activate) human plasminogen to form the plasma protease plasmin. Uniquely, lipopolysaccharide (LPS) is essential for the catalytic activity of all omptins, including Pla. Why omptins require LPS for enzymatic activity is unknown. Here, we report the co-crystal structure of LPS-free Pla in complex with the activation loop peptide of human plasminogen, its natural substrate. The structure shows that in the absence of LPS, the peptide substrate binds deep within the active site groove and displaces the nucleophilic water molecule, providing an explanation for the dependence of omptins on LPS for enzymatic activity.	[Eren, Elif; van den Berg, Bert] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	van den Berg, B (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	bert.vandenberg@umassmed.edu		van den Berg, Bert/0000-0003-1966-8804; Eren, Elif/0000-0002-7942-4943				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baaden M, 2004, BIOPHYS J, V87, P2942, DOI 10.1529/biophysj.104.046987; Coskun U, 2011, STRUCTURE, V19, P1543, DOI 10.1016/j.str.2011.10.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eren E, 2010, STRUCTURE, V18, P809, DOI 10.1016/j.str.2010.03.013; Haiko J, 2009, INNATE IMMUN-LONDON, V15, P67, DOI 10.1177/1753425909102559; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hritonenko V, 2007, MOL MEMBR BIOL, V24, P395, DOI 10.1080/09687680701443822; Kramer RA, 2002, EUR J BIOCHEM, V269, P1746, DOI 10.1046/j.1432-1327.2002.02820.x; Kramer RA, 2001, FEBS LETT, V505, P426, DOI 10.1016/S0014-5793(01)02863-0; Kukkonen M, 2004, INT J MED MICROBIOL, V294, P7, DOI 10.1016/j.ijmm.2004.01.003; Kukkonen M, 2004, MOL MICROBIOL, V51, P215, DOI 10.1046/j.1365-2958.2003.03817.x; Kukkonen M, 2001, MOL MICROBIOL, V40, P1097, DOI 10.1046/j.1365-2958.2001.02451.x; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Oates J, 2011, CURR OPIN STRUC BIOL, V21, P802, DOI 10.1016/j.sbi.2011.09.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plow Edward F., 1999, Thrombosis and Haemostasis, V82, P4; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033	23	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23971	23976		10.1074/jbc.M112.376418	http://dx.doi.org/10.1074/jbc.M112.376418			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22645135	Green Published, hybrid			2022-12-25	WOS:000306511300066
J	Kobayashi, M; Teramoto, W; Hidaka, S; Sugita, Y				Kobayashi, Maori; Teramoto, Wataru; Hidaka, Souta; Sugita, Yoichi			Sound Frequency and Aural Selectivity in Sound-Contingent Visual Motion Aftereffect	PLOS ONE			English	Article							TEMPORAL-ORDER; VENTRILOQUISM; ADAPTATION; PERCEPTION; RECALIBRATION; SIMULTANEITY; ATTENTION	Background: One possible strategy to evaluate whether signals in different modalities originate from a common external event or object is to form associations between inputs from different senses. This strategy would be quite effective because signals in different modalities from a common external event would then be aligned spatially and temporally. Indeed, it has been demonstrated that after adaptation to visual apparent motion paired with alternating auditory tones, the tones begin to trigger illusory motion perception to a static visual stimulus, where the perceived direction of visual lateral motion depends on the order in which the tones are replayed. The mechanisms underlying this phenomenon remain unclear. One important approach to understanding the mechanisms is to examine whether the effect has some selectivity in auditory processing. However, it has not yet been determined whether this aftereffect can be transferred across sound frequencies and between ears. Methodology/Principal Findings: Two circles placed side by side were presented in alternation, producing apparent motion perception, and each onset was accompanied by a tone burst of a specific and unique frequency. After exposure to this visual apparent motion with tones for a few minutes, the tones became drivers for illusory motion perception. However, the aftereffect was observed only when the adapter and test tones were presented at the same frequency and to the same ear. Conclusions/Significance: These findings suggest that the auditory processing underlying the establishment of novel audiovisual associations is selective, potentially but not necessarily indicating that this processing occurs at an early stage.	[Kobayashi, Maori; Teramoto, Wataru] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 980, Japan; [Teramoto, Wataru] Tohoku Univ, Dept Psychol, Grad Sch Arts & Letters, Sendai, Miyagi 980, Japan; [Hidaka, Souta] Rikkyo Univ, Dept Psychol, Niiza, Saitama, Japan; [Sugita, Yoichi] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki, Japan	Tohoku University; Tohoku University; Rikkyo University; National Institute of Advanced Industrial Science & Technology (AIST)	Kobayashi, M (corresponding author), Meiji Univ, Dept Sci & Technol, Kawasaki, Kanagawa, Japan.	te11001@meiji.ac.jp; y.sugita@waseda.jp	Hidaka, Souta/L-6393-2019	Hidaka, Souta/0000-0001-6727-5322	Ministry of Education, Science, and Culture, Japan [19001004]	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Specially Promoted Research (19001004) of the Ministry of Education, Science, and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arman AC, 2006, VISION RES, V46, P2968, DOI 10.1016/j.visres.2006.03.003; Canon KL, 1970, J EXP PSYCHOL, V84, P141; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Frissen I, 2005, ACTA PSYCHOL, V118, P93, DOI 10.1016/j.actpsy.2004.10.004; Frissen I, 2003, ACTA PSYCHOL, V113, P315, DOI 10.1016/S0001-6918(03)00043-X; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; HALL JW, 1983, J ACOUST SOC AM, V73, P894, DOI 10.1121/1.389013; Hidaka S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-44; Kashino M, 1998, J ACOUST SOC AM, V103, P3597, DOI 10.1121/1.423064; Lewald J, 2002, LEARN MEMORY, V9, P268, DOI 10.1101/lm.51402; Lovelace CT, 2003, COGNITIVE BRAIN RES, V17, P447, DOI 10.1016/S0926-6410(03)00160-5; MACLEOD A, 1990, British Journal of Audiology, V24, P29, DOI 10.3109/03005369009077840; RADEAU M, 1974, Q J EXP PSYCHOL, V26, P63, DOI 10.1080/14640747408400388; Recanzone GH, 1998, P NATL ACAD SCI USA, V95, P869, DOI 10.1073/pnas.95.3.869; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Stein BE., 1993, MERGING SENSES; Teramoto W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012255; Vatakis A, 2008, EXP BRAIN RES, V185, P521, DOI 10.1007/s00221-007-1168-9; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Welch R.B, 1986, HDB PERCEPTION HUMAN, V1; Xial LQ, 2008, CURR BIOL, V18, P1922; Yeh SL, 1996, J EXP PSYCHOL HUMAN, V22, P446, DOI 10.1037/0096-1523.22.2.446	23	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36803	10.1371/journal.pone.0036803	http://dx.doi.org/10.1371/journal.pone.0036803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649500	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335800017
J	Kyrylkova, K; Kyryachenko, S; Biehs, B; Klein, O; Kioussi, C; Leid, M				Kyrylkova, Kateryna; Kyryachenko, Sergiy; Biehs, Brian; Klein, Ophir; Kioussi, Chrissa; Leid, Mark			BCL11B Regulates Epithelial Proliferation and Asymmetric Development of the Mouse Mandibular Incisor	PLOS ONE			English	Article							STEM-CELL COMPARTMENT; AMELOBLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; TOOTH DEVELOPMENT; SIGNALING CENTER; DUAL ROLE; HEDGEHOG; FGF10; MORPHOGENESIS; EXPRESSION	Mouse incisors grow continuously throughout life with enamel deposition uniquely on the outer, or labial, side of the tooth. Asymmetric enamel deposition is due to the presence of enamel-secreting ameloblasts exclusively within the labial epithelium of the incisor. We have previously shown that mice lacking the transcription factor BCL11B/CTIP2 (BCL11B hereafter) exhibit severely disrupted ameloblast formation in the developing incisor. We now report that BCL11B is a key factor controlling epithelial proliferation and overall developmental asymmetry of the mouse incisor: BCL11B is necessary for proliferation of the labial epithelium and development of the epithelial stem cell niche, which gives rise to ameloblasts; conversely, BCL11B suppresses epithelial proliferation, and development of stem cells and ameloblasts on the inner, or lingual, side of the incisor. This bidirectional action of BCL11B in the incisor epithelia appears responsible for the asymmetry of ameloblast localization in developing incisor. Underlying these spatio-specific functions of BCL11B in incisor development is the regulation of a large gene network comprised of genes encoding several members of the FGF and TGF beta superfamilies, Sprouty proteins, and Sonic hedgehog. Our data integrate BCL11B into these pathways during incisor development and reveal the molecular mechanisms that underlie phenotypes of both Bcl11b(-/-) and Sprouty mutant mice.	[Kyrylkova, Kateryna; Kyryachenko, Sergiy; Kioussi, Chrissa; Leid, Mark] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Biehs, Brian; Klein, Ophir] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Biehs, Brian; Klein, Ophir] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Biehs, Brian; Klein, Ophir] Univ Calif San Francisco, Program Craniofacial & Mesenchymal Biol, San Francisco, CA USA	Oregon State University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kyrylkova, K (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	chrissa.kioussi@oregonstate.edu; mark.leid@oregonstate.edu		Klein, Ophir/0000-0002-6254-7082; Kioussi, Chrissa/0000-0001-8226-9908	NIH/NIDCR [DE021879]; NIH/NIAMS [AR054406]; CIRM New Faculty Award II; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R15DE021879] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); CIRM New Faculty Award II; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH/NIDCR (grant DE021879 to ML), NIH/NIAMS (grant AR054406 to CK), and by a CIRM New Faculty Award II to ODK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Bellusci S, 1996, DEVELOPMENT, V122, P1693; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Caton J, 2009, DEV BIOL, V328, P493, DOI 10.1016/j.ydbio.2009.02.014; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Golonzhka O, 2007, GENE EXPR PATTERNS, V7, P754, DOI 10.1016/j.modgep.2007.06.002; Golonzhka O, 2009, J INVEST DERMATOL, V129, P1459, DOI 10.1038/jid.2008.392; Golonzhka O, 2009, P NATL ACAD SCI USA, V106, P4278, DOI 10.1073/pnas.0900568106; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Harada H, 2002, DEVELOPMENT, V129, P1533; KERLEY M A, 1975, Proceedings of the Oklahoma Academy of Science, V55, P6; Kettunen P, 2000, DEV DYNAM, V219, P322, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1062>3.0.CO;2-J; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; LUMSDEN AGS, 1988, DEVELOPMENT, V103, P155; O'Hagan RC, 1998, ONCOGENE, V16, P301, DOI 10.1038/sj.onc.1201547; Peters H, 1999, TRENDS GENET, V15, P59, DOI 10.1016/S0168-9525(98)01662-X; Porntaveetus T, 2011, J ANAT; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Takahashi S, 2007, BIOCHEM BIOPH RES CO, V353, P405, DOI 10.1016/j.bbrc.2006.12.053; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tummers M, 2003, DEVELOPMENT, V130, P1049, DOI 10.1242/dev.00332; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Vaahtokari A, 1996, MECH DEVELOP, V54, P39, DOI 10.1016/0925-4773(95)00459-9; Vaahtokari A, 1996, DEVELOPMENT, V122, P121; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Wang XP, 2004, DEV CELL, V7, P719, DOI 10.1016/j.devcel.2004.09.012; Yokohama-Tamaki T, 2006, DEVELOPMENT, V133, P1359, DOI 10.1242/dev.02307; ZEICHNERDAVID M, 1995, INT J DEV BIOL, V39, P69; Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299; Zhang YD, 2000, DEVELOPMENT, V127, P1431	42	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37670	10.1371/journal.pone.0037670	http://dx.doi.org/10.1371/journal.pone.0037670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629441	gold, Green Published			2022-12-25	WOS:000305345300068
J	Wali, JA; de Boo, HA; Derraik, JGB; Phua, HH; Oliver, MH; Bloomfield, FH; Harding, JE				Wali, Jibran A.; de Boo, Hendrina A.; Derraik, Jose G. B.; Phua, Hui Hui; Oliver, Mark H.; Bloomfield, Frank H.; Harding, Jane E.			Weekly Intra-Amniotic IGF-1 Treatment Increases Growth of Growth-Restricted Ovine Fetuses and Up-Regulates Placental Amino Acid Transporters	PLOS ONE			English	Article							LATE-GESTATION; FACTOR-I; AMNIOTIC-FLUID; GLUCOSE TRANSPORTERS; MAMMALIAN TARGET; PLASMA-MEMBRANE; FETAL; EXPRESSION; PROTEIN; SYNCYTIOTROPHOBLAST	Frequent treatment of the growth-restricted (IUGR) ovine fetus with intra-amniotic IGF-1 increases fetal growth. We aimed to determine whether increased growth was maintained with an extended dosing interval and to examine possible mechanisms. Pregnant ewes were allocated to three groups: Control, and two IUGR groups (induced by placental embolization) treated with weekly intra-amniotic injections of either saline (IUGR) or 360 mg IGF-1 (IGF1). IUGR fetuses were hypoxic, hyperuremic, hypoglycemic, and grew more slowly than controls. Placental glucose uptake and SLC2A1 (GLUT2) mRNA levels decreased in IUGR fetuses, but SLC2A3 (GLUT3) and SLC2A4 (GLUT4) levels were unaffected. IGF-1 treatment increased fetal growth rate, did not alter uterine blood flow or placental glucose uptake, and increased placental SLC2A1 and SLC2A4 (but not SLC2A3) mRNA levels compared with saline-treated IUGR animals. Following IGF-1 treatment, placental mRNA levels of isoforms of the system A, y(+), and L amino acid transporters increased 1.3 to 5.0 fold, while the ratio of phosphorylated-mTOR to total mTOR also tended to increase. Weekly intra-amniotic IGF-1 treatment provides a promising avenue for intra-uterine treatment of IUGR babies, and may act via increased fetal substrate supply, up-regulating placental transporters for neutral, cationic, and branched-chain amino acids, possibly via increased activation of the mTOR pathway.	[Wali, Jibran A.; de Boo, Hendrina A.; Derraik, Jose G. B.; Phua, Hui Hui; Oliver, Mark H.; Bloomfield, Frank H.; Harding, Jane E.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	University of Auckland	Wali, JA (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	j.harding@auckland.ac.nz	Wali, Jibran/K-9843-2019; Derraik, José Guilherme Behrensdorf/A-1925-2008; Harding, Jane E/J-5853-2015	Wali, Jibran/0000-0002-8524-5773; Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956; Harding, Jane E/0000-0003-2697-1422; Bloomfield, Frank/0000-0001-6424-6577; Oliver, Mark/0000-0002-0359-2297	Health Research Council of New Zealand [HRC 05-193]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was funded by the Health Research Council of New Zealand (grant HRC 05-193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsson-Wikland K, 1998, HORM RES, V49, P7, DOI 10.1159/000053080; Arroyo JA, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.031; BATTAGLIA C, 1992, AM J OBSTET GYNECOL, V167, P430, DOI 10.1016/S0002-9378(11)91424-0; Bloomfield FH, 2002, REPROD FERT DEVELOP, V14, P393, DOI 10.1071/RD02022; Bloomfield FH, 2002, AM J PHYSIOL-ENDOC M, V282, pE259, DOI 10.1152/ajpendo.00200.2001; Bloomfield FH, 2002, J PEDIATR GASTR NUTR, V35, P287, DOI 10.1097/00005176-200209000-00010; Bloomfield FH, 2002, PEDIATR RES, V51, P361, DOI 10.1203/00006450-200203000-00016; Bloomfield FH, 1998, FETAL MAT MED REV, V10, P91, DOI DOI 10.1017/S0965539597000235; BREIER BH, 1991, J ENDOCRINOL, V128, P347, DOI 10.1677/joe.0.1280347; Cariappa R, 2003, PLACENTA, V24, P713, DOI 10.1016/S0143-4004(03)00085-7; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Crump C, 2011, AM J EPIDEMIOL, V173, P797, DOI 10.1093/aje/kwq440; Desforges M, 2006, AM J PHYSIOL-CELL PH, V290, pC305, DOI 10.1152/ajpcell.00258.2005; Eremia SC, 2007, ENDOCRINOLOGY, V148, P2963, DOI 10.1210/en.2006-1701; Ericsson A, 2005, HUM REPROD, V20, P521, DOI 10.1093/humrep/deh596; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Eriksson JG, 2002, DIABETOLOGIA, V45, P342, DOI 10.1007/s00125-001-0757-6; Fang J, 2006, GROWTH HORM IGF RES, V16, P318, DOI 10.1016/j.ghir.2006.08.002; Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004; GITLIN D, 1972, AM J OBSTET GYNECOL, V113, P632, DOI 10.1016/0002-9378(72)90632-1; Glazier JD, 1997, PEDIATR RES, V42, P514, DOI 10.1203/00006450-199710000-00016; Grillo MA, 2008, AMINO ACIDS, V34, P517, DOI 10.1007/s00726-007-0006-5; GULL I, 1993, AM J OBSTET GYNECOL, V168, P706, DOI 10.1016/0002-9378(93)90520-S; HARDING JE, 1994, ENDOCRINOLOGY, V134, P1509, DOI 10.1210/en.134.3.1509; Harding JE, 2001, LUNG BIOL HEALTH DIS, V151, P181; Harding JE, 1997, PRENAT NEONAT MED, V2, P300; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Jansson T, 2006, PLACENTA, V27, pS91, DOI 10.1016/j.placenta.2005.11.010; Jensen EC, 1999, J ENDOCRINOL, V161, P485, DOI 10.1677/joe.0.1610485; Kainulainen H, 1997, GYNECOL OBSTET INVES, V44, P89, DOI 10.1159/000291493; KARL PI, 1995, J CELL PHYSIOL, V165, P83, DOI 10.1002/jcp.1041650111; Kevorkova O, 2007, BIOL REPROD, V76, P487, DOI 10.1095/biolreprod.106.055285; KNISS DA, 1994, J REPROD MED, V39, P249; Korgun ET, 2001, BIOL REPROD, V65, P1364, DOI 10.1095/biolreprod65.5.1364; Koupil I, 2005, J EPIDEMIOL COMMUN H, V59, P473, DOI 10.1136/jech.2004.026518; Kramer MS, 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000032; LASSARRE C, 1991, PEDIATR RES, V29, P219, DOI 10.1203/00006450-199103000-00001; Lesage J, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740037; Miller SL, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.029; Owens J.A., 1989, ADV FETAL PHYSL, P263; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PIMENTEL G, 1986, AM J OBSTET GYNECOL, V155, P1181, DOI 10.1016/0002-9378(86)90141-9; PRITCHAR.JA, 1965, OBSTET GYNECOL, V25, P289; Roos S, 2009, AM J PHYSIOL-CELL PH, V297, pC723, DOI 10.1152/ajpcell.00191.2009; Roos S, 2009, AM J PHYSIOL-CELL PH, V296, pC142, DOI 10.1152/ajpcell.00330.2008; Roos S, 2007, J PHYSIOL-LONDON, V582, P449, DOI 10.1113/jphysiol.2007.129676; Roos S, 2009, BIOCHEM SOC T, V37, P295, DOI 10.1042/BST0370295; Rosario FJ, 2011, ENDOCRINOLOGY, V152, P1119, DOI 10.1210/en.2010-1153; Rosenberg A, 2008, SEMIN PERINATOL, V32, P219, DOI 10.1053/j.semperi.2007.11.003; Ross MG, 2008, SEMIN PERINATOL, V32, P213, DOI 10.1053/j.semperi.2007.11.005; Rumball CWH, 2008, ENDOCRINOLOGY, V149, P1163, DOI 10.1210/en.2007-1306; Schini-Kerth V. B., 1999, Journal of Endocrinological Investigation, V22, P82; Shaikh S, 2005, J ENDOCRINOL, V186, P145, DOI 10.1677/joe.1.06113; Van Bulck B, 2003, BJOG-INT J OBSTET GY, V110, P27; Winer N, 2009, CLIN NUTR, V28, P243, DOI 10.1016/j.clnu.2009.03.007; Wooding FBP, 2005, PLACENTA, V26, P626, DOI 10.1016/j.placenta.2004.09.013; YOUNG WP, 1974, J APPL PHYSIOL, V37, P620, DOI 10.1152/jappl.1974.37.4.620; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193; Zaitoun I, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-49; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	61	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37899	10.1371/journal.pone.0037899	http://dx.doi.org/10.1371/journal.pone.0037899			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629469	gold, Green Published			2022-12-25	WOS:000305345300083
J	Standl, M; Lattka, E; Stach, B; Koletzko, S; Bauer, CP; von Berg, A; Berdel, D; Kramer, U; Schaaf, B; Roder, S; Herbarth, O; Buyken, A; Drogies, T; Thiery, J; Koletzko, B; Heinrich, J				Standl, Marie; Lattka, Eva; Stach, Barbara; Koletzko, Sibylle; Bauer, Carl-Peter; von Berg, Andrea; Berdel, Dietrich; Kraemer, Ursula; Schaaf, Beate; Roeder, Stefan; Herbarth, Olf; Buyken, Anette; Drogies, Tim; Thiery, Joachim; Koletzko, Berthold; Heinrich, Joachim		GINIplus Study Grp; LISAplus Study Grp	FADS1 FADS2 Gene Cluster, PUFA Intake and Blood Lipids in Children: Results from the GINIplus and LISAplus Studies	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HIGH-DENSITY-LIPOPROTEIN; SINGLE-NUCLEOTIDE POLYMORPHISMS; PROLIFERATOR-ACTIVATED RECEPTOR; CARDIOVASCULAR RISK-FACTORS; FATTY-ACID-COMPOSITION; NUTRITIONAL INTERVENTION; VARIANTS; ASSOCIATION; ATHEROSCLEROSIS	Background: Elevated cholesterol levels in children can be a risk factor for cardiovascular diseases in later life. In adults, it has been shown that blood lipid levels are strongly influenced by polymorphisms in the fatty acid desaturase (FADS) gene cluster in addition to nutritional and other exogenous and endogenous determinants. Our aim was to investigate whether lipid levels are determined by the FADS genotype already in children and whether this association interacts with dietary intake of n-3 fatty acids. Methods: The analysis was based on data of 2006 children from two German prospective birth cohort studies. Total cholesterol, HDL, LDL and triglycerides were measured at 10 years of age. Six single nucleotide polymorphisms (SNPs) of the FADS gene cluster were genotyped. Dietary n-3 fatty acid intake was assessed by food frequency questionnaire. Linear regression modeling was used to assess the association between lipid levels, n-3 fatty acid intake and FADS genotype. Results: Individuals carrying the homozygous minor allele had lower levels of total cholesterol [means ratio (MR) ranging from 0.96 (p = 0.0093) to 0.98 (p = 0.2949), depending on SNPs] and LDL [MR between 0.94 (p = 0.0179) and 0.97 (p = 0.2963)] compared to homozygous major allele carriers. Carriers of the heterozygous allele showed lower HDL levels [beta between -0.04 (p = 0.0074) to -0.01 (p = 0.3318)] and higher triglyceride levels [MR ranging from 1.06 (p = 0.0065) to 1.07 (p = 0.0028)] compared to homozygous major allele carriers. A higher n-3 PUFA intake was associated with higher concentrations of total cholesterol, LDL, HDL and lower triglyceride levels, but these associations did not interact with the FADS1 FADS2 genotype. Conclusion: Total cholesterol, HDL, LDL and triglyceride concentrations may be influenced by the FADS1 FADS2 genotype already in 10 year old children. Genetically determined blood lipid levels during childhood might differentially predispose individuals to the development of cardiovascular diseases later in life.	[Standl, Marie; Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Lattka, Eva] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Stach, Barbara; Drogies, Tim; Thiery, Joachim] Univ Hosp Leipzig, Fac Med, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Koletzko, Sibylle; Koletzko, Berthold] Univ Munich, Dr von Hauner Childrens Hosp, Med Ctr, Munich, Germany; [Bauer, Carl-Peter] Tech Univ Munich, Dept Pediat, Munich, Germany; [von Berg, Andrea; Berdel, Dietrich] Marien Hosp Wesel, Dept Pediat, Wesel, Germany; [Kraemer, Ursula] Univ Dusseldorf, IUF, Leibniz Inst Umweltmed Forsch, D-40225 Dusseldorf, Germany; [Schaaf, Beate] Med Practice Pediat, Bad Honnef, Germany; [Roeder, Stefan] UFZ Helmholtz Ctr Environm Res, Helmholtz Ctr Environm Res, Dept Environm Immunol, Leipzig, Germany; [Herbarth, Olf] Univ Leipzig, Fac Med Environm Med & Hyg, Leipzig, Germany; [Buyken, Anette] Univ Bonn, Res Inst Child Nutr, Dortmund, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; University of Munich; Technical University of Munich; St. Marien Hospital; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; University of Bonn	Standl, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany.	heinrich@helmholtz-muenchen.de	Heinrich, Joachim/N-1720-2013; Reischl, Eva/B-9311-2013	Heinrich, Joachim/0000-0002-9620-1629; Reischl, Eva/0000-0003-4055-8060; Standl, Marie/0000-0002-5345-2049	"Kompetenznetz Adipositas" ("Competence Network Obesity"); German Federal Ministry of Education and Research [FKZ: 01GI0826]; Munich Center of Health Sciences (MCHEALTH); Federal Ministry for Education, Science, Research and Technology [01 EG 9705/2, 01EG9732]; Federal Ministry of Environment (IUF) [FKS 20462296]; Bristol-Myers Squibb Foundation, New York, NY, USA	"Kompetenznetz Adipositas" ("Competence Network Obesity"); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Munich Center of Health Sciences (MCHEALTH); Federal Ministry for Education, Science, Research and Technology; Federal Ministry of Environment (IUF); Bristol-Myers Squibb Foundation, New York, NY, USA(Bristol-Myers Squibb)	This work was supported financially in part by the "Kompetenznetz Adipositas" ("Competence Network Obesity") funded by the German Federal Ministry of Education and Research (FKZ: 01GI0826) and by the Munich Center of Health Sciences (MCHEALTH). The LISAplus study was funded by grants of the Federal Ministry for Education, Science, Research and Technology (Grant No. 01 EG 9705/2 and 01EG9732) and the 6 years follow-up of the LISAplus study was partly funded by the Federal Ministry of Environment (IUF, FKS 20462296). BK is the recipient of a Freedom to Discover Award of the Bristol-Myers Squibb Foundation, New York, NY, USA. The authors gratefully acknowledge partial financial support from the Commission of the European Communities, specific RTD Programme "Quality of Life and Management of Living Resources", within the 7th Framework Programme NUTRIMENTHE, FP7-212652. This manuscript does not necessarily reflect the views of the Commission and in no way anticipates the future policy in this area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Baylin A, 2007, AM J CLIN NUTR, V85, P554, DOI 10.1093/ajcn/85.2.554; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Calabresi L, 2004, METABOLISM, V53, P153, DOI 10.1016/j.metabol.2003.09.007; Caspi A, 2007, P NATL ACAD SCI USA, V104, P18860, DOI 10.1073/pnas.0704292104; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; De Silva NMG, 2011, DIABETES, V60, P1008, DOI 10.2337/db10-1317; Fruchart JC, 1999, CURR OPIN LIPIDOL, V10, P245, DOI 10.1097/00041433-199906000-00007; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hartmann B., 2005, BUNDESLEBENSMITTELSC; Heinrich J, 2002, EUR RESPIR J, V20, P617, DOI 10.1183/09031936.02.02322001; HERTZ R, 1995, J BIOL CHEM, V270, P13470, DOI 10.1074/jbc.270.22.13470; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kareinen A, 2001, ARTERIOSCL THROM VAS, V21, P1346, DOI 10.1161/hq0801.093655; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; Lattka E, 2011, AM J CLIN NUTR, V93, P382, DOI 10.3945/ajcn.110.004515; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Lu YC, 2010, AM J CLIN NUTR, V92, P258, DOI 10.3945/ajcn.2009.29130; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P1998, DOI 10.1161/01.ATV.20.8.1998; MILLER NE, 1975, LANCET, V1, P1033, DOI 10.1016/S0140-6736(75)91977-7; Molto-Puigmarti C, 2010, AM J CLIN NUTR, V91, P1368, DOI 10.3945/ajcn.2009.28789; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; PHILLIPSON BE, 1985, NEW ENGL J MED, V312, P1210, DOI 10.1056/NEJM198505093121902; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rzehak P, 2009, BRIT J NUTR, V101, P20, DOI 10.1017/S0007114508992564; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Stiegler P, 2010, PUBLIC HEALTH NUTR, V13, P38, DOI 10.1017/S1368980009005813; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; von Berg A, 2003, J ALLERGY CLIN IMMUN, V111, P533, DOI 10.1067/mai.2003.101; von Berg A, 2010, CLIN EXP ALLERGY, V40, P627, DOI 10.1111/j.1365-2222.2009.03444.x; VUDAC N, 1994, J BIOL CHEM, V269, P31012; VUDAC N, 1995, J CLIN INVEST, V96, P741, DOI 10.1172/JCI118118; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156	42	44	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37780	10.1371/journal.pone.0037780	http://dx.doi.org/10.1371/journal.pone.0037780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629455	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100050
J	Meng, FX; Sun, YN; Liu, XZ; Wang, JX; Xu, TJ; Wang, RX				Meng, Fanxing; Sun, Yuena; Liu, Xuezhu; Wang, Jianxin; Xu, Tianjun; Wang, Rixin			Analysis of C3 Suggests Three Periods of Positive Selection Events and Different Evolutionary Patterns between Fish and Mammals	PLOS ONE			English	Article							COMPLEMENT COMPONENT C3; MULTIPLE SEQUENCE ALIGNMENT; GENOME DUPLICATION; ACQUIRED-IMMUNITY; INNATE IMMUNITY; ANCIENT ORIGIN; SEA-ANEMONE; 2 PARTS; SYSTEM; ACTIVATION	Background: The third complement component (C3) is a central protein of the complement system conserved from fish to mammals. It also showed distinct characteristics in different animal groups. Striking features of the fish complement system were unveiled, including prominent levels of extrahepatic expression and isotypic diversity of the complement components. The evidences of the involvement of complement system in the enhancement of B and T cell responses found in mammals indicated that the complement system also serves as a bridge between the innate and adaptive responses. For the reasons mentioned above, it is interesting to explore the evolutionary process of C3 genes and to investigate whether the huge differences between aquatic and terrestrial environments affected the C3 evolution between fish and mammals. Methodology/Principal Findings: Analysis revealed that these two groups of animals had experienced different evolution patterns. The mammalian C3 genes were under purifying selection pressure while the positive selection pressure was detected in fish C3 genes. Three periods of positive selection events of C3 genes were also detected. Two happened on the ancestral lineages to all vertebrates and mammals, respectively, one happened on early period of fish evolutionary history. Conclusions/Significance: Three periods of positive selection events had happened on C3 genes during history and the fish and mammals C3 genes experience different evolutionary patterns for their distinct living environments.	[Meng, Fanxing; Sun, Yuena; Liu, Xuezhu; Wang, Jianxin; Xu, Tianjun; Wang, Rixin] Zhejiang Ocean Univ, Coll Marine Sci, Lab Marine Living Resources & Mol Engn, Zhoushan, Peoples R China	Zhejiang Ocean University	Meng, FX (corresponding author), Zhejiang Ocean Univ, Coll Marine Sci, Lab Marine Living Resources & Mol Engn, Zhoushan, Peoples R China.	tianjunxu@163.com; wangrixin1123@126.com	Meng, Fanxing/Q-8294-2017; Xu, Tianjun/G-2545-2013	Meng, Fanxing/0000-0003-3656-2905; 	National Nature Science Foundation of China [31001120]; Zhejiang Provincial Natural Science Foundation of China [Y3100013, Y12C030014]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported by National Nature Science Foundation of China (31001120) and Zhejiang Provincial Natural Science Foundation of China (Y3100013, Y12C030014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajees AA, 2006, NATURE, V444, P221, DOI 10.1038/nature05258; Al-Sharif WZ, 1998, J IMMUNOL, V160, P2983; Boshra H, 2006, FISH SHELLFISH IMMUN, V20, P239, DOI 10.1016/j.fsi.2005.04.004; Budd A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r38; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Castillo MG, 2009, DEV COMP IMMUNOL, V33, P69, DOI 10.1016/j.dci.2008.07.013; CHU CT, 1994, LAB INVEST, V71, P792; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Fujito NT, 2010, DEV COMP IMMUNOL, V34, P775, DOI 10.1016/j.dci.2010.02.011; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Holland MCH, 2002, FISH SHELLFISH IMMUN, V12, P399, DOI 10.1006/fsim.2001.0408; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Janssen BJC, 2007, MOL IMMUNOL, V44, P3, DOI 10.1016/j.molimm.2006.06.017; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kimura A, 2009, IMMUNOBIOLOGY, V214, P165, DOI 10.1016/j.imbio.2009.01.003; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Law SKA, 1997, PROTEIN SCI, V6, P263; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Liang YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004234; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Long MY, 2001, SCIENCE, V293, P1551; Marino R, 2002, IMMUNOGENETICS, V53, P1055, DOI 10.1007/s00251-001-0421-9; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Mollnes Tom E., 2002, Trends in Immunology, V23, P61, DOI 10.1016/S1471-4906(01)02129-9; Morgan BP, 2005, IMMUNOL LETT, V97, P171, DOI 10.1016/j.imlet.2004.11.010; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Nakao M, 2000, EUR J IMMUNOL, V30, P858, DOI 10.1002/1521-4141(200003)30:3&lt;858::AID-IMMU858&gt;3.0.CO;2-M; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen CH, 2002, J LEUKOCYTE BIOL, V72, P249; Nielsen R, 1998, GENETICS, V148, P929; Nonaka M, 2004, IMMUNOL REV, V198, P203, DOI 10.1111/j.0105-2896.2004.00118.x; Nonaka M, 2004, MOL IMMUNOL, V40, P897, DOI 10.1016/j.molimm.2003.10.009; Nonaka M, 2000, FISH SHELLFISH IMMUN, V10, P215, DOI 10.1006/fsim.1999.0252; Nonaka M, 1999, J IMMUNOL, V162, P387; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; Pinto MR, 2007, ADV EXP MED BIOL, V598, P372; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P305, DOI 10.1016/j.fsi.2008.11.015; Pride D.T., 2004, SWAPP 1 0 2 TOOL ANA; REID KBM, 1981, ANNU REV BIOCHEM, V50, P433, DOI 10.1146/annurev.bi.50.070181.002245; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Smith LC, 1999, IMMUNOPHARMACOLOGY, V42, P107, DOI 10.1016/S0162-3109(99)00009-0; Sunyer JO, 1998, IMMUNOL REV, V166, P39, DOI 10.1111/j.1600-065X.1998.tb01251.x; Sunyer JO, 1998, IMMUNOL TODAY, V19, P519; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Van de Peer Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-250; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Xu TJ, 2010, FISH SHELLFISH IMMUN, V29, P1099, DOI 10.1016/j.fsi.2010.08.013; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	61	10	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37489	10.1371/journal.pone.0037489	http://dx.doi.org/10.1371/journal.pone.0037489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624039	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343500124
J	Punj, V; Matta, H; Chaudhary, PM				Punj, Vasu; Matta, Hittu; Chaudhary, Preet M.			A Computational Profiling of Changes in Gene Expression and Transcription Factors Induced by vFLIP K13 in Primary Effusion Lymphoma	PLOS ONE			English	Article							NF-KAPPA-B; SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; ENDOTHELIAL-CELLS; REGULATORY MOTIFS; INDUCED APOPTOSIS; PROTEIN; ACTIVATION; INDUCTION; PATHWAYS	Infection with Kaposi's sarcoma associated herpesvirus (KSHV) has been linked to the development of primary effusion lymphoma (PEL), a rare lymphoproliferative disorder that is characterized by loss of expression of most B cell markers and effusions in the body cavities. This unique clinical presentation of PEL has been attributed to their distinctive plasmablastic gene expression profile that shows overexpression of genes involved in inflammation, adhesion and invasion. KSHV-encoded latent protein vFLIP K13 has been previously shown to promote the survival and proliferation of PEL cells. In this study, we employed gene array analysis to characterize the effect of K13 on global gene expression in PEL-derived BCBL1 cells, which express negligible K13 endogenously. We demonstrate that K13 upregulates the expression of a number of NF-kappa B responsive genes involved in cytokine signaling, cell death, adhesion, inflammation and immune response, including two NF-kappa B subunits involved in the alternate NF-kappa B pathway, RELB and NFKB2. In contrast, CD19, a B cell marker, was one of the genes downregulated by K13. A comparison with K13-induced genes in human vascular endothelial cells revealed that although there was a considerable overlap among the genes induced by K13 in the two cell types, chemokines genes were preferentially induced in HUVEC with few exceptions, such as RANTES/CCL5, which was induced in both cell types. Functional studies confirmed that K13 activated the RANTES/CCL5 promoter through the NF-kappa B pathway. Taken collectively, our results suggest that K13 may contribute to the unique gene expression profile, immunophenotype and clinical presentation that are characteristics of KSHV-associated PEL.	[Punj, Vasu; Matta, Hittu; Chaudhary, Preet M.] Univ So Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Los Angeles, CA 90033 USA; [Punj, Vasu; Matta, Hittu; Chaudhary, Preet M.] Univ So Calif, Keck Sch Med, Ctr Study Blood Dis, Los Angeles, CA 90033 USA; [Punj, Vasu] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Bioinformat Core,USC Epigenome Ctr, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California	Punj, V (corresponding author), Univ So Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Los Angeles, CA 90033 USA.	preet.chaudhary@med.usc.edu	Chaudhary, Preet/E-1970-2018		United States National Institutes of Health [DE019811, CA139119]; NATIONAL CANCER INSTITUTE [R01CA139119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019811] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the United States National Institutes of Health (DE019811 and CA139119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Ballon G, 2011, J CLIN INVEST, V121, P1141, DOI 10.1172/JCI44417; Baxter A, 2004, BIOORG MED CHEM LETT, V14, P2817, DOI 10.1016/j.bmcl.2004.03.058; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Carbone A, 2009, HIV ASS LYMPHOMAS GA, P1213; Carbone A, 2007, ACTA HAEMATOL-BASEL, V117, P129, DOI 10.1159/000097459; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chaudhary Preet M., 2008, V1, P186, DOI 10.1159/000141519; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Crawford A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002098; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; Dittmer D, 1998, J VIROL, V72, P8309, DOI 10.1128/JVI.72.10.8309-8315.1998; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hengge UR, 2002, LANCET INFECT DIS, V2, P344, DOI 10.1016/S1473-3099(02)00288-8; Hestand MS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-495; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Jenner RG, 2003, P NATL ACAD SCI USA, V100, P10399, DOI 10.1073/pnas.1630810100; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Keller SA, 2000, BLOOD, V96, P2537; Kim SY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-330; Klein U, 2003, BLOOD, V101, P4115, DOI 10.1182/blood-2002-10-3090; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Matta H, 2008, ONCOGENE, V27, P5243, DOI 10.1038/onc.2008.150; Matta H, 2007, ONCOGENE, V26, P1656, DOI 10.1038/sj.onc.1209931; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Matta H, 2011, J BIOL CHEM, V286, P21555, DOI 10.1074/jbc.M111.224048; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; NORDAN RP, 1986, SCIENCE, V233, P566, DOI 10.1126/science.3726549; Pan XF, 2011, MOL IMMUNOL, V48, P1573, DOI 10.1016/j.molimm.2011.03.012; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Punj V, 2010, ONCOGENE, V29, P1835, DOI 10.1038/onc.2009.460; Punj V, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-50; Punj V, 2009, BLOOD, V113, P5660, DOI 10.1182/blood-2008-10-186403; Qi CF, 2007, CANCER RES, V67, P2439, DOI 10.1158/0008-5472.CAN-06-1561; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sinha S, 2008, GENOME RES, V18, P477, DOI 10.1101/gr.6828808; Smith AJ, 2011, J IMMUNOL, V186, P6576, DOI 10.4049/jimmunol.1100277; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suffee N, 2011, BIOCHEM SOC T, V39, P1649, DOI 10.1042/BST20110651; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Sun Q, 2003, BLOOD, V101, P1956, DOI 10.1182/blood-2002-07-2072; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tong H, 2010, IMMUNOL LETT, V128, P108, DOI 10.1016/j.imlet.2010.01.001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Warner JB, 2008, NAT METHODS, V5, P347, DOI [10.1038/NMETH.1188, 10.1038/nmeth.1188]; Wen KW, 2010, CANCER LETT, V289, P140, DOI 10.1016/j.canlet.2009.07.004; Xu YY, 2007, J GEN VIROL, V88, P46, DOI 10.1099/vir.0.82375-0; Yang YQ, 2011, J BIOL CHEM, V286, P27988, DOI 10.1074/jbc.M110.213363; Yin L, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12584; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225; Zhao JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001067	69	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37498	10.1371/journal.pone.0037498	http://dx.doi.org/10.1371/journal.pone.0037498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624040	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500125
J	Titulaer, M; Spoelstra, K; Lange, CYMJG; Visser, ME				Titulaer, Mieke; Spoelstra, Kamiel; Lange, Cynthia Y. M. J. G.; Visser, Marcel E.			Activity Patterns during Food Provisioning Are Affected by Artificial Light in Free Living Great Tits (Parus major)	PLOS ONE			English	Article							BIRDS; POLLUTION; PETRELS; CLUTCH; NIGHT	Artificial light may have severe ecological consequences but there is limited experimental work to assess these consequences. We carried out an experimental study on a wild population of great tits (Parus major) to assess the impact of light pollution on daily activity patterns during the chick provisioning period. Pairs that were provided with a small light outside their nest box did not alter the onset, cessation or duration of their working day. There was however a clear effect of artificial light on the feeding rate in the second half of the nestling period: when provided with artificial light females increased their feeding rate when the nestlings were between 9 and 16 days old. Artificial light is hypothesised to have affected the perceived photoperiod of either the parents or the offspring which in turn led to increased parental care. This may have negative fitness consequences for the parents, and light pollution may thus create an ecological trap for breeding birds.	[Titulaer, Mieke; Spoelstra, Kamiel; Lange, Cynthia Y. M. J. G.; Visser, Marcel E.] Netherlands Inst Ecol, Dept Anim Ecol, Wageningen, Netherlands; [Spoelstra, Kamiel] Wageningen Univ, Nat Conservat & Plant Ecol Dept, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research	Titulaer, M (corresponding author), Netherlands Inst Ecol, Dept Anim Ecol, Wageningen, Netherlands.	m.visser@nioo.knaw.nl	Spoelstra, Kamiel/B-4222-2015; Visser, Marcel E/A-9151-2009; KNAW, NIOO-KNAW/A-4320-2012	Spoelstra, Kamiel/0000-0001-8614-4387; Visser, Marcel E/0000-0002-1456-1939; KNAW, NIOO-KNAW/0000-0002-3835-159X	Dutch Technology Foundation STW, division of NWO; Ministry of Economic Affairs	Dutch Technology Foundation STW, division of NWO(Technologiestichting STW); Ministry of Economic Affairs	This research is supported by the Dutch Technology Foundation STW, which is the applied science division of NWO, and the Technology Programme of the Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cassone VM, 2009, GEN COMP ENDOCR, V163, P109, DOI 10.1016/j.ygcen.2009.01.003; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; De Molenaar JG, 2000, 064 ALT RES I GROEN; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; FOSTER RG, 2004, RHYTHMS LIFE BIOL CL; Husby A, 2009, P ROY SOC B-BIOL SCI, V276, P1845, DOI 10.1098/rspb.2008.1937; Kempenaers B, 2010, CURR BIOL, V20, P1; Kumar V, 2010, PHYSIOL BIOCHEM ZOOL, V83, P827, DOI 10.1086/652243; Le Corre M, 2002, BIOL CONSERV, V105, P93, DOI 10.1016/S0006-3207(01)00207-5; Lebbin DJ, 2007, WILSON J ORNITHOL, V119, P506, DOI 10.1676/06-139.1; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.1890/1540-9295(2004)002[0191:ELP]2.0.CO;2; Miles W, 2010, BIRD STUDY, V57, P244, DOI 10.1080/00063651003605064; Miller MW, 2006, CONDOR, V108, P130, DOI 10.1650/0010-5422(2006)108[0130:AEOLPO]2.0.CO;2; PERRINS CM, 1965, J ANIM ECOL, V34, P601, DOI 10.2307/2453; Poot H, 2008, ECOL SOC, V13; Santos CD, 2010, ACTA OECOL, V36, P166, DOI 10.1016/j.actao.2009.11.008; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; Verhulst S, 1998, FUNCT ECOL, V12, P132, DOI 10.1046/j.1365-2435.1998.00165.x	19	70	71	4	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37377	10.1371/journal.pone.0037377	http://dx.doi.org/10.1371/journal.pone.0037377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624023	Green Published, gold			2022-12-25	WOS:000305343500107
J	Wang, YX; Xu, L; Sun, XY; Zou, Y; Zhang, HT; Jonas, JB				Wang, Ya Xing; Xu, Liang; Sun, Xiu Ying; Zou, Yang; Zhang, Hai Tao; Jonas, Jost B.			Five Year Incidence of Visual Field Loss in Adult Chinese. The Beijing Eye Study	PLOS ONE			English	Article							FREQUENCY-DOUBLING PERIMETRY; LOW-VISION; TECHNOLOGY PERIMETRY; PREVALENCE; POPULATION; IMPAIRMENT; GLAUCOMA; BLINDNESS; CHINA; URBAN	Purpose: To describe the cumulative 5 year incidence of visual field loss in adult Chinese in Greater Beijing. Methods: The Beijing Eye Study 2006 included 3251 subjects (mean age 60.4 +/- 10.1 years) who had participated in the Beijing Eye Study 2001 and returned for re-examination. All participants underwent a comprehensive eye examination, including visual field test by frequency doubling threshold perimetry. An abnormal visual field was defined as reduced sensitivity in at least one test location. Incident visual field loss was defined as a change in visual field from normal at baseline to abnormal at follow-up. Results: An incident visual field loss was detected in 273 eyes ( 4.3 +/- 0.5%) /235 subjects (7.3 +/- 0.5%). It was significantly associated with higher age (P = 0.001), higher intraocular pressure (P < 0.001), and higher fasting blood glucose concentration (P = 0.019). Considering only eyes (n = 140) with a detected cause for visual field loss, the most frequent causes were cataract (68 (48.6%) eyes) followed by glaucoma (23 (16.4%) eyes), diabetic retinopathy (13 (9.3%) eyes), age-related macular degeneration (10 (7.1%) eyes), and myopic degenerative retinopathy (9 (6.4%) eyes). For 133 (48.7%) eyes with a visual field loss, the cause for the VFL remained unclear. Conclusions: The 5-year incidence of visual field loss was 4.3 +/- 0.5% per eye or 7.3 +/- 0.5% per subject. It increased significantly with age, intraocular pressure, and fasting blood glucose level. Major causes for the incidence of visual field loss were cataract, glaucoma and diabetic retinopathy.	[Wang, Ya Xing; Xu, Liang; Sun, Xiu Ying; Zou, Yang; Zhang, Hai Tao; Jonas, Jost B.] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Wang, YX (corresponding author), Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China.	xlbio1@gmail.com; Jost.Jonas@augen.ma.uni-heidelberg.de	wang, YA XING/K-9671-2016	wang, YA XING/0000-0003-2749-7793	National Key Laboratory Fund, Beijing, China; Beijing Natural Science Foundation, Beijing, China	National Key Laboratory Fund, Beijing, China; Beijing Natural Science Foundation, Beijing, China(Beijing Natural Science Foundation)	Supported by the National Key Laboratory Fund, Beijing, China, and the Beijing Natural Science Foundation, Beijing, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Ophthalmology, V98, P786; Czudowska MA, 2010, OPHTHALMOLOGY, V117, P1705, DOI 10.1016/j.ophtha.2010.01.034; Dimitrov PN, 2003, INVEST OPHTH VIS SCI, V44, P5075, DOI 10.1167/iovs.02-0457; Foran S, 2003, OPHTHALMOLOGY, V110, P41, DOI 10.1016/S0161-6420(02)01295-2; Gunnlaugsdottir E, 2010, ACTA OPHTHALMOL, V88, P358, DOI 10.1111/j.1755-3768.2008.01445.x; Hennis AJ, 2009, OPHTHALMOLOGY, V116, P1461, DOI 10.1016/j.ophtha.2009.02.017; Huang SS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1362, DOI 10.1001/archophthalmol.2009.138; Hyman L, 2010, ARCH OPHTHALMOL-CHIC, V128, P601, DOI 10.1001/archophthalmol.2010.78; Iester M, 2000, AM J OPHTHALMOL, V130, P160, DOI 10.1016/S0002-9394(00)00464-5; Iwasaki A, 2002, AM J OPHTHALMOL, V134, P529, DOI 10.1016/S0002-9394(02)01684-7; Iwase A, 2007, OPHTHALMOLOGY, V114, P27, DOI 10.1016/j.ophtha.2006.06.041; JOHNSON CA, 1983, ARCH OPHTHALMOL-CHIC, V101, P371; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P2942; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P505, DOI 10.1007/BF00181769; Kassoff A, 2001, AM J OPHTHALMOL, V131, P167; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Klein R, 2006, AM J OPHTHALMOL, V142, P539, DOI 10.1016/j.ajo.2006.06.015; Kogure S, 2003, BRIT J OPHTHALMOL, V87, P604, DOI 10.1136/bjo.87.5.604; Leske MC, 2007, OPHTHALMOLOGY, V114, P1058, DOI 10.1016/j.ophtha.2006.08.051; Li YB, 2008, AM J OPHTHALMOL, V146, P329, DOI 10.1016/j.ajo.2008.04.015; Liang YB, 2008, OPHTHALMOLOGY, V115, P1965, DOI 10.1016/j.ophtha.2008.05.030; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; Liu WW, 2007, OPHTHALMOLOGY, V114, P1795, DOI 10.1016/j.ophtha.2007.03.010; Mansberger SL, 2007, J GLAUCOMA, V16, P73, DOI 10.1097/01.ijg.0000243481.75155.97; McKean-Cowdin R, 2007, AM J OPHTHALMOL, V143, P1013, DOI 10.1016/j.ajo.2007.02.022; PandaJonas S, 1996, AM J OPHTHALMOL, V121, P181, DOI 10.1016/S0002-9394(14)70583-5; PandaJonas S, 1995, OPHTHALMOLOGY, V102, P1853, DOI 10.1016/S0161-6420(95)30784-1; Ramrattan RS, 2001, ARCH OPHTHALMOL-CHIC, V119, P1788, DOI 10.1001/archopht.119.12.1788; Realini T, 2004, OPHTHALMOLOGY, V111, P2133, DOI 10.1016/j.ophtha.2004.05.024; Roy MS, 2007, ARCH OPHTHALMOL-CHIC, V125, P1061, DOI 10.1001/archopht.125.8.1061; Saw SM, 2004, OPHTHALMOLOGY, V111, P1161, DOI 10.1016/j.ophtha.2003.09.040; Skenduli-Bala E, 2005, ARCH OPHTHALMOL-CHIC, V123, P233, DOI 10.1001/archopht.123.2.233; Thomas D, 2001, AM J OPHTHALMOL, V131, P734, DOI 10.1016/S0002-9394(01)00837-6; Topouzis F, 2004, AM J OPHTHALMOL, V137, P420, DOI 10.1016/j.ajo.2003.09.045; Varma R, 2010, AM J OPHTHALMOL, V149, P713, DOI 10.1016/j.ajo.2009.12.011; Wang YX, 2007, ARCH OPHTHALMOL-CHIC, V125, P1402, DOI 10.1001/archopht.125.10.1402; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wang YX, 2006, AM J OPHTHALMOL, V141, P1078, DOI 10.1016/j.ajo.2006.01.023; Wong TY, 2008, ARCH OPHTHALMOL-CHIC, V126, P1091, DOI 10.1001/archopht.126.8.1091; Xu L, 2006, AM J OPHTHALMOL, V141, P591, DOI 10.1016/j.ajo.2005.10.018; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Zhang JS, 2011, OPHTHALMOLOGY, V118, P711, DOI 10.1016/j.ophtha.2010.08.021; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023	44	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37232	10.1371/journal.pone.0037232	http://dx.doi.org/10.1371/journal.pone.0037232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624000	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343500082
J	Zhou, DX; Bennett, SW; Keller, AA				Zhou, Dongxu; Bennett, Samuel W.; Keller, Arturo A.			Increased Mobility of Metal Oxide Nanoparticles Due to Photo and Thermal Induced Disagglomeration	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; AGGREGATION KINETICS; ENVIRONMENTAL IMPLICATIONS; DIVALENT ELECTROLYTES; SILVER NANOPARTICLES; ZNO NANOPARTICLES; IONIC-STRENGTH; DLVO THEORY; TIO2; STABILITY	Significant advances have been made on our understanding of the fate and transport of engineered nanomaterials. One unexplored aspect of nanoparticle aggregation is how environmental stimuli such as light exposure and temperature variations affect the mobility of engineered nanoparticles. In this study, TiO2, ZnO, and CeO2 were chosen as model materials for investigating the mobility of nanoparticles under three external stimuli: heat, light and sonication. Sunlight and high power sonication were able to partially disagglomerate metal oxide clusters, but primary particles bonded by solid state necks were left intact. A cycle of temperature increase from 25 degrees C to 65 degrees C and then decrease back was found to disagglomerate the compact clusters in the heating phase and reagglomerate them as more open fractal structures during the cooling phase. A fractal model summing the pair-wise DLVO interactions between primary particles within two fractal agglomerates predicts weak attractions on the order of a few kT. Our study shows that common environmental stimuli such as light exposure or temperature variation can disagglomerate nanoparticle clusters and enhance their mobility in open waters. This phenomenon warrants attention since it is likely that metal oxide nanoparticles will experience these natural stimuli during their transport in the environment.	[Zhou, Dongxu] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Ctr Environm Implicat Nanotechnol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Zhou, DX (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	keller@bren.ucsb.edu	Zhou, Dongxu/C-1255-2013		National Science Foundation; U.S. Environmental Protection Agency [DBI-0830117]	National Science Foundation(National Science Foundation (NSF)); U.S. Environmental Protection Agency(United States Environmental Protection Agency)	This work was supported by the National Science Foundation and the U.S. Environmental Protection Agency under Cooperative Agreement Number DBI-0830117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of NSF or USEPA. This work has not been subjected to USEPA review and no official endorsement should be inferred.	AKRATOPULU KC, 1990, J CHEM SOC FARADAY T, V86, P3437, DOI 10.1039/ft9908603437; Bennett SW, 2012, PLOS ONE IN PRESS; Bian SW, 2011, LANGMUIR, V27, P6059, DOI 10.1021/la200570n; Brasil AM, 2001, J AEROSOL SCI, V32, P489, DOI 10.1016/S0021-8502(00)00097-5; Buettner KM, 2010, COLLOID SURFACE A, V366, P74, DOI 10.1016/j.colsurfa.2010.05.024; Chen KL, 2006, ENVIRON SCI TECHNOL, V40, P1516, DOI 10.1021/es0518068; Chowdhury I, 2010, COLLOID SURFACE A, V368, P91, DOI 10.1016/j.colsurfa.2010.07.019; Croll S, 2002, PROG ORG COAT, V44, P131, DOI 10.1016/S0300-9440(01)00261-2; Domingos RF, 2009, ENVIRON SCI TECHNOL, V43, P1282, DOI 10.1021/es8023594; Elimelech M., 1995, PARTICLE DEPOSITION, DOI [10.1016/B978-0-7506-7024-1.X5000-6, DOI 10.1016/B978-0-7506-7024-1.X5000-6]; Findlay AD, 1996, COLLOID SURFACE A, V118, P97, DOI 10.1016/0927-7757(96)03708-9; French RA, 2009, ENVIRON SCI TECHNOL, V43, P1354, DOI 10.1021/es802628n; Godwin HA, 2009, ENVIRON SCI TECHNOL, V43, P6453, DOI 10.1021/es8034544; Grass RN, 2006, AICHE J, V52, P1318, DOI 10.1002/aic.10739; Horst AM, 2010, APPL ENVIRON MICROB, V76, P7292, DOI 10.1128/AEM.00324-10; Hotze EM, 2010, J ENVIRON QUAL, V39, P1909, DOI 10.2134/jeq2009.0462; Hunter R. J., 1981, ZETA POTENTIAL COLLO, DOI 10.1016/B978-0-12-361961-7.50006-7; Huynh KA, 2011, ENVIRON SCI TECHNOL, V45, P5564, DOI 10.1021/es200157h; Ji ZX, 2010, ENVIRON SCI TECHNOL, V44, P7309, DOI 10.1021/es100417s; KAJIHARA M, 1971, Journal of the Oceanographical Society of Japan, V27, P158, DOI 10.1007/BF02109135; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kim AY, 2000, LANGMUIR, V16, P2101, DOI 10.1021/la990841n; Kim T, 2008, J COLLOID INTERF SCI, V318, P238, DOI 10.1016/j.jcis.2007.10.029; Lattuada M, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061404; Li XA, 2010, LANGMUIR, V26, P16690, DOI 10.1021/la101768n; Liu HH, 2011, ENVIRON SCI TECHNOL, V45, P9284, DOI 10.1021/es202134p; Mandzy N, 2005, POWDER TECHNOL, V160, P121, DOI 10.1016/j.powtec.2005.08.020; Peralta-Videa JR, 2011, J HAZARD MATER, V186, P1, DOI 10.1016/j.jhazmat.2010.11.020; Petosa AR, 2010, ENVIRON SCI TECHNOL, V44, P6532, DOI 10.1021/es100598h; Saleh NB, 2008, ENVIRON SCI TECHNOL, V42, P7963, DOI 10.1021/es801251c; Teleki A, 2008, POWDER TECHNOL, V181, P292, DOI 10.1016/j.powtec.2007.05.016; Thio BJR, 2011, J HAZARD MATER, V189, P556, DOI 10.1016/j.jhazmat.2011.02.072; WARREN PB, 1994, NUOVO CIMENTO D, V16, P1231, DOI 10.1007/BF02458805; Wiesner MR, 2006, ENVIRON SCI TECHNOL, V40, P4336, DOI 10.1021/es062726m; YOTSUMOTO H, 1993, J COLLOID INTERF SCI, V157, P426, DOI 10.1006/jcis.1993.1205; Zhang Y, 2009, WATER RES, V43, P4249, DOI 10.1016/j.watres.2009.06.005; Zhou DX, 2010, WATER RES, V44, P2948, DOI 10.1016/j.watres.2010.02.025	37	49	50	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37363	10.1371/journal.pone.0037363	http://dx.doi.org/10.1371/journal.pone.0037363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624021	Green Published, gold			2022-12-25	WOS:000305343500105
J	Garrido-Gomez, T; Dominguez, F; Quinonero, A; Estella, C; Vilella, F; Pellicer, A; Simon, C				Garrido-Gomez, Tamara; Dominguez, Francisco; Quinonero, Alicia; Estella, Carlos; Vilella, Felipe; Pellicer, Antonio; Simon, Carlos			Annexin A2 is critical for embryo adhesiveness to the human endometrium by RhoA activation through F-actin regulation	FASEB JOURNAL			English	Article						cytoskeleton; implantation; receptivity; epithelial cells	EPITHELIAL RL95-2 CELLS; UTERINE RECEPTIVITY; LIPID RAFTS; TROPHOBLAST; IMPLANTATION; DYNAMICS; BINDING; CYTOSKELETON; MIGRATION; MEMBRANE	Annexin A2 (ANXA2) is present in vivo in the mid-and late-secretory endometria and is mainly localized in the luminal epithelium. Our aim was to evaluate its function in regulating the human implantation process. With an in vitro adhesion model, constructed to evaluate how the mouse embryo and JEG-3 spheroids attach to human endometrial epithelial cells, we demonstrated that ANXA2 inhibition significantly diminishes embryo adhesiveness. ANXA2 is also implicated in endometrial epithelial cell migration and trophoblast outgrowth. ANXA2 was seen to be linked to the RhoA/ROCK pathway and to regulate cell adhesion. We noted that ANXA2 inhibition significantly reduces active RhoA, although RhoA inactivation does not alter the ANXA2 levels. RhoA inactivation and ROCK inhibition also moderate embryo adhesiveness to endometrial epithelial cells. We corroborated that the induction of constitutively active RhoA partially reverses the effects of ANXA2 inhibition on endometrial adhesiveness. These molecules colocalize on the plasma membrane of endometrial epithelial cells, and a large proportion of ANXA2 and RhoA are colocalized in the F-actin networks. The functional effects of ANXA2 inhibition and RhoA/ROCK inactivation are associated with significant alterations in F-actin organization and its depolymerization. ANXA2 may act upstream of the RhoA/ROCK pathway by regulating F-actin remodeling and is a key factor in human endometrial adhesiveness.-Garrido-Gomez, T., Dominguez, F., Quinonero, A., Estella, C., Vilella, F., Pellicer, A., Simon, C. Annexin A2 is critical for embryo adhesiveness to the human endometrium by RhoA activation through F-actin regulation. FASEB J. 26, 3715-3727 (2012). www.fasebj.org	[Garrido-Gomez, Tamara; Dominguez, Francisco; Quinonero, Alicia; Estella, Carlos; Vilella, Felipe; Pellicer, Antonio; Simon, Carlos] Univ Valencia, Fdn Invest Clin Valencia Inst Invest Sanitaria IN, Inst Univ IVI, Fdn IVI, Valencia, Spain	University of Valencia	Simon, C (corresponding author), Univ Valencia, Inst Univ IVI, Fdn IVI, C Catedrat Agustin Escardino 9, Paterna 46980, Valencia, Spain.	carlos.simon@ivi.es	MARTINEZ, ANTONIO PELLICER/C-4832-2015; Simon, Carlos/G-2186-2014; Gomez, Tamara Garrido/B-6551-2017; Pellicer, Antonio/AAA-6005-2020; Dominguez, Francisco/AAA-7260-2020; Vilella, Felipe/C-2970-2018; Estella, Carlos/L-2097-2014	Simon, Carlos/0000-0003-0902-9531; Pellicer, Antonio/0000-0002-8254-863X; Dominguez, Francisco/0000-0002-7620-8081; Estella, Carlos/0000-0003-1551-2327; GARRIDO, TAMARA/0000-0002-6584-4832; Vilella, Felipe/0000-0002-0039-9846				Aplin J D, 2007, Reprod Biomed Online, V14 Spec No 1, P49, DOI 10.1016/S1472-6483(10)61458-7; Babbin BA, 2007, AM J PATHOL, V170, P951, DOI 10.2353/ajpath.2007.060647; Babiychuk EB, 2002, FASEB J, V16, DOI 10.1096/fj.02-0070com; Burkart A, 2003, J BIOL CHEM, V278, P18360, DOI 10.1074/jbc.M210701200; Dominguez F, 2005, FASEB J, V19, P1056, DOI 10.1096/fj.05-3781hyp; Dominguez F, 2009, HUM REPROD, V24, P2607, DOI 10.1093/humrep/dep230; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Filipenko NR, 2001, J BIOL CHEM, V276, P5310, DOI 10.1074/jbc.M009710200; Fowler PA, 2007, PROTEOMICS, V7, P130, DOI 10.1002/pmic.200600469; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Gerke V, 1997, BBA-MOL CELL RES, V1357, P129, DOI 10.1016/S0167-4889(97)00038-4; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; Hansen MDH, 2002, J BIOL CHEM, V277, P45371, DOI 10.1074/jbc.M207747200; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Heneweer C, 2003, CELLS TISSUES ORGANS, V175, P1, DOI 10.1159/000073432; Heneweer C, 2002, MOL HUM REPROD, V8, P1014, DOI 10.1093/molehr/8.11.1014; HENEWEER C, 2005, J EXP CLIN ASSIST RE, V9, P2; HITT AL, 1994, CURR OPIN CELL BIOL, V6, P120, DOI 10.1016/0955-0674(94)90125-2; Horcajadas JA, 2008, J CLIN ENDOCR METAB, V93, P4500, DOI 10.1210/jc.2008-0588; Ihnatovych I, 2009, BIOL REPROD, V81, P222, DOI 10.1095/biolreprod.108.074666; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; JOHN NJ, 1993, IN VITRO CELL DEV-AN, V29A, P461, DOI 10.1007/BF02639380; LINDENBERG S, 1991, DAN MED BULL, V38, P371; Lock FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031423; Martin JC, 2000, BIOL REPROD, V63, P1370, DOI 10.1095/biolreprod63.5.1370; Mercader A, 2006, METHOD ENZYMOL, V420, P3, DOI 10.1016/S0076-6879(06)20001-6; Murphy CR, 1995, HUM REPROD UPDATE, V1, P567, DOI 10.1093/humupd/1.6.567; Murphy CR, 2000, J REPROD FERTIL, P23; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; PSYCHOYOS A, 1986, ANN NY ACAD SCI, V476, P36, DOI 10.1111/j.1749-6632.1986.tb20920.x; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Shiokawa S, 2002, J CLIN ENDOCR METAB, V87, P5808, DOI 10.1210/jc.2002-020376; Simon C, 1999, J CLIN ENDOCR METAB, V84, P2638, DOI 10.1210/jc.84.8.2638; Simon C, 2003, TRENDS ENDOCRIN MET, V14, P197, DOI 10.1016/S1043-2760(03)00084-5; Simon C, 2000, J REPROD FERTIL, P43; Simon C, 1999, FERTIL STERIL, V72, P1061, DOI 10.1016/S0015-0282(99)00408-2; Thie M, 1997, MOL HUM REPROD, V3, P275, DOI 10.1093/molehr/3.4.275; THIE M, 1995, EUR J CELL BIOL, V66, P180; VANBLERKOM J, 1981, AM J ANAT, V162, P143, DOI 10.1002/aja.1001620206; Wang DS, 2004, WORLD J GASTROENTERO, V10, P299; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Xu BY, 2012, J CELL PHYSIOL, V227, P2722, DOI 10.1002/jcp.23016	47	44	46	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3715	3727		10.1096/fj.12-204008	http://dx.doi.org/10.1096/fj.12-204008			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22645245				2022-12-25	WOS:000308391600013
J	Otero, A; de la Vega, MR; Tanco, S; Lorenzo, J; Aviles, FX; Reverter, D				Otero, Anabel; Rodriguez de la Vega, Monica; Tanco, Sebastian; Lorenzo, Julia; Aviles, Francesc X.; Reverter, David			The novel structure of a cytosolic M14 metallocarboxypeptidase (CCP) from Pseudomonas aeruginosa: a model for mammalian CCPs	FASEB JOURNAL			English	Article						metalloprotease; crystal structure; inhibitor; tubulin	CRYSTAL-STRUCTURE; PROTEIN-STRUCTURE; INHIBITOR; SEQUENCE; COMPLEX; FAMILY	M14 family from Pseudomonas aeruginosa, which belongs to a bacterial clade of carboxypeptidases that are homologous to the recently discovered M14D subfamily of human nonsecretory cytosolic carboxypeptidases (CCPs). CCPs are intracellular peptidases involved, among other roles, in the post-translational modifications of tubulin. Here we report the crystal structure of PaCCP at high resolution (1.6 angstrom). Its 375 residues are folded in a novel beta-sandwich N-terminal domain followed by the classical carboxypeptidase alpha/beta-hydrolase domain, this one in a shorter and more compact form. The former is unique in the whole family and does not have sequential or structural homology with other domains that are usually flanking the latter, like the prodomain of the M14A subfamily or the C-terminal transthyretin/prealbumin-like domains of the M14B subfamily. PaCCP does not display activity against small carboxypeptidase substrates, so in this form it might constitute an inactive precursor of the protease. Structural results derived from cocrystallization with well-known inhibitors of MCPs indicate that the enzyme might only possess C-terminal hydrolase activity against cellular substrates of particular specificity and/or when undergoes structural rearrangements. The derived PaCCP structure allows a first structural insight into the more complex and largely unknown mammalian CCP subfamily.-Otero, A., Rodriguez de la Vega, M., Tanco, S., Lorenzo, J., Aviles, F. X., Reverter, D. The novel structure of a cytosolic M14 metallocarboxypeptidase (CCP) from Pseudomonas aeruginosa: a model for mammalian CCPs. FASEB J. 26, 3754-3764 (2012). www.fasebj.org	[Aviles, Francesc X.] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Aviles, FX (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.	francescxavier.aviles@uab.es; david.reverter@uab.cat	Lorenzo, Julia/E-9015-2011; Aviles, Francesc Xavier/F-3482-2019; Rodriguez de la Vega Otazo, Monica Margarita/H-7008-2015; Tanco, Sebastian Martin/R-2528-2016; Avilés, Francesc Xavier/A-2664-2015; Reverter, David/H-5360-2015	Lorenzo, Julia/0000-0001-5659-6008; Aviles, Francesc Xavier/0000-0002-1399-6789; Rodriguez de la Vega Otazo, Monica Margarita/0000-0002-1061-3471; Tanco, Sebastian Martin/0000-0003-2130-4401; Avilés, Francesc Xavier/0000-0002-1399-6789; Reverter, David/0000-0002-5347-0992	Ministerio de Ciencia e Innovacion (MICINN) of Spain [BFU2008-0364, BIO2010-22321-C02]; European Commission [MIRG-CT-2007-200346, LIVIMODE 241919]	Ministerio de Ciencia e Innovacion (MICINN) of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (MICINN) of Spain, BFU2008-0364, BIO2010-22321-C02; and by grants from the European Commission, MIRG-CT-2007-200346 and LIVIMODE 241919 (FP7-Health-2009). D. R. acknowledges the Ramon y Cajal program of MICINN.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aloy P, 2001, J BIOL CHEM, V276, P16177, DOI 10.1074/jbc.M011457200; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Berezniuk I, 2012, J BIOL CHEM, V287, P6503, DOI 10.1074/jbc.M111.309138; Berezniuk I, 2010, FASEB J, V24, P1813, DOI 10.1096/fj.09-147942; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia-Saez I, 1997, EMBO J, V16, P6906, DOI 10.1093/emboj/16.23.6906; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; Hsieh JM, 2010, P NATL ACAD SCI USA, V107, P17962, DOI 10.1073/pnas.1006687107; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Keil C, 2007, J MOL BIOL, V366, P504, DOI 10.1016/j.jmb.2006.11.025; KIM H, 1990, BIOCHEMISTRY-US, V29, P5546, DOI 10.1021/bi00475a019; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Lindner HA, 2003, J BIOL CHEM, V278, P44496, DOI 10.1074/jbc.M304233200; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Sahab ZJ, 2011, CANCER RES, V71, P1219, DOI 10.1158/0008-5472.CAN-10-2294; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanglas L, 2008, MOL CELL, V31, P598, DOI 10.1016/j.molcel.2008.05.031; Schrodinger L., 2020, PYMOL; Shaya D, 2010, J BIOL CHEM, V285, P20051, DOI 10.1074/jbc.M110.101071; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan FL, 1997, BIOCHEM J, V327, P81, DOI 10.1042/bj3270081; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Zuckerkandl E, 1965, EVOLUTIONARY DIVERGE	33	12	12	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3754	3764		10.1096/fj.12-209601	http://dx.doi.org/10.1096/fj.12-209601			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22645247				2022-12-25	WOS:000308391600016
J	Yegutkin, GG; Wieringa, B; Robson, SC; Jalkanen, S				Yegutkin, Gennady G.; Wieringa, Be; Robson, Simon C.; Jalkanen, Sirpa			Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities	FASEB JOURNAL			English	Article						purinergic signaling; human and murine serum; intravascular nucleotide homeostasis; purinergic signaling	EXTRACELLULAR NUCLEOTIDE-METABOLISM; ECTO-ATPASE; ADENOSINE-DIPHOSPHATE; ENDOTHELIAL-CELLS; CD39; PLASMA; ECTONUCLEOTIDASES; INHIBITOR; RECEPTORS; ADENINE	Extracellular ATP and ADP trigger inflammatory, vasodilatatory, and prothrombotic signaling events in the vasculature, and their turnover is governed by networks of membrane-associated enzymes. The contribution of soluble activities to intravascular nucleotide homeostasis remains controversial. By using thin-layer chromatographic assays, we revealed transphosphorylation of [gamma-P-32]ATP and AMP by human and murine sera, which was progressively inhibited by specific adenylate kinase (AK) inhibitor Ap(5)A. This phosphotransfer reaction was diminished markedly in serum from knockout mice lacking the major AK isoform, AK1, and in human serum immunodepleted of AK1. We also showed that similar to 75% ADP in cell-free serum is metabolized via reversible AK1 reaction 2ADP <-> ATP + AMP. The generated ATP and AMP are then metabolized through the coupled nucleotide pyrophosphatase/phosphodiesterase and 5'-nucleotidase/CD73 reactions, respectively. Constitutive presence of another nucleotide-converting enzyme, nucleoside triphosphate diphosphohydrolase-1 (NTPDase1, known as CD39), was ascertained by the relative deficiency of serum from CD39-null mice to dephosphorylate [H-3]ADP and [gamma-P-32]ATP, and also by diminished [H-3]ADP hydrolysis by human serum pretreated with NTPDase1 inhibitors, POM-1 and ARL-67156. In summary, we have identified hitherto unrecognized soluble forms of AK1 and NTPDase1/CD39 that contribute in the active cycling between the principal platelet-recruiting agent ADP and other circulating nucleotides.-Yegutkin, G. G., Wieringa, B., Robson, S. C., Jalkanen, S. Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities FASEB J. 26, 3875-3883 (2012). www.fasebj.org	[Yegutkin, Gennady G.; Jalkanen, Sirpa] Univ Turku, MediCity Res Lab, FIN-20520 Turku, Finland; [Yegutkin, Gennady G.; Jalkanen, Sirpa] Univ Turku, Dept Med Microbiol, FIN-20520 Turku, Finland; [Wieringa, Be] Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands; [Robson, Simon C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Gastroenterol, Boston, MA 02215 USA	University of Turku; University of Turku; Radboud University Nijmegen; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Yegutkin, GG (corresponding author), Univ Turku, MediCity Res Lab, Tykistokatu 6A, FIN-20520 Turku, Finland.	genyeg@utu.fi	Yegutkin, Gennady G./K-3815-2014; Robson, Simon C./AAA-8537-2021; Wieringa, Berend/A-5346-2011	Yegutkin, Gennady G./0000-0001-6684-7982; Wieringa, Berend/0000-0001-9192-8020	Academy of Finland; Sigrid Juselius Foundation; U.S. National Institutes of Health	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the Academy of Finland and the Sigrid Juselius Foundation (G.G.Y. and S.J.) and the U.S. National Institutes of Health (S. C. R.). The authors are grateful to Frank Oerlemans for help in collecting the tissues from AK <SUP>/</SUP> and wild-type AK<SUP>+/+</SUP> mice and to Drs. Keiichi Enjyoji and Guido Beldi (Harvard Medical School, Boston, MA, USA) for supplying plasma samples from CD39-null mice. The authors also thank Sari Maki for technical assistance and Anne Sovikoski-Georgieva for secretarial help.	Banz Y, 2008, BRIT J HAEMATOL, V142, P627, DOI 10.1111/j.1365-2141.2008.07230.x; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Buergler JM, 2005, J THROMB THROMBOLYS, V19, P115, DOI 10.1007/s11239-005-1381-y; Cauwenberghs S, 2006, TRANSFUSION, V46, P1018, DOI 10.1111/j.1537-2995.2006.00837.x; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Chen BC, 1996, BRIT J PHARMACOL, V119, P1628, DOI 10.1111/j.1476-5381.1996.tb16082.x; Choo HJ, 2008, EXP MOL MED, V40, P220, DOI 10.3858/emm.2008.40.2.220; COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531; Collavin L, 1999, ONCOGENE, V18, P5879, DOI 10.1038/sj.onc.1202970; CRACK BE, 1995, BRIT J PHARMACOL, V114, P475, DOI 10.1111/j.1476-5381.1995.tb13251.x; Donaldson SH, 2002, AM J RESP CELL MOL, V26, P209, DOI 10.1165/ajrcmb.26.2.4650; Dwyer KM, 2004, J CLIN INVEST, V113, P1440, DOI 10.1172/JCI200419560; Dzeja PP, 2007, MOL SYSTEM BIOENERGE, P265; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Eltzschig HK, 2009, BLOOD, V113, P224, DOI 10.1182/blood-2008-06-165746; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Esch JSA, 1999, BIOCHEMISTRY-US, V38, P2248, DOI 10.1021/bi982426k; Gachet C, 2006, ANNU REV PHARMACOL, V46, P277, DOI 10.1146/annurev.pharmtox.46.120604.141207; Gayle RB, 1998, J CLIN INVEST, V101, P1851, DOI 10.1172/JCI1753; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Hart ML, 2010, J IMMUNOL, V184, P4017, DOI 10.4049/jimmunol.0901851; HASLAM RJ, 1967, BIOCHEM J, V103, P773, DOI 10.1042/bj1030773; IRELAND DM, 1966, BIOCHEM J, V99, P283, DOI 10.1042/bj0990283; Janssen E, 2000, EMBO J, V19, P6371, DOI 10.1093/emboj/19.23.6371; Janssen E, 2004, MOL CELL BIOCHEM, V256, P59, DOI 10.1023/B:MCBI.0000009859.15267.db; JORGENSEN S, 1956, ACTA PHARMACOL TOX, V12, P294; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Knowles AF, 2011, PURINERG SIGNAL, V7, P21, DOI 10.1007/s11302-010-9214-7; Levesque SA, 2007, BRIT J PHARMACOL, V152, P141, DOI 10.1038/sj.bjp.0707361; Marcus AJ, 2003, J PHARMACOL EXP THER, V305, P9, DOI 10.1124/jpet.102.043729; Mercier N, 2012, AM J PATHOL, V180, P419, DOI 10.1016/j.ajpath.2011.10.002; Muller CE, 2006, BIOORG MED CHEM LETT, V16, P5943, DOI 10.1016/j.bmcl.2006.09.003; Noma T, 2005, J MED INVESTIG, V52, P127, DOI 10.2152/jmi.52.127; Park W, 1996, J RHEUMATOL, V23, P1233; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Ralevic V, 1998, PHARMACOL REV, V50, P413; Robson SC, 2005, SEMIN THROMB HEMOST, V31, P217, DOI 10.1055/s-2005-869527; Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Sorensen CE, 2003, J PHYSIOL-LONDON, V551, P881, DOI 10.1113/jphysiol.2003.049411; Straub A, 2011, ARTERIOSCL THROM VAS, V31, P1607, DOI 10.1161/ATVBAHA.111.226373; SUNDERMAN FW, 1990, ANN CLIN LAB SCI, V20, P123; Todorov LD, 1997, NATURE, V387, P76, DOI 10.1038/387076a0; Wheeler DG, 2012, J MOL CELL CARDIOL, V52, P958, DOI 10.1016/j.yjmcc.2012.01.002; Yan HG, 1999, ADV ENZYMOL RAMB, V73, P103, DOI 10.1002/9780470123195.ch4; Yegutkin G, 2000, BRIT J PHARMACOL, V129, P921, DOI 10.1038/sj.bjp.0703136; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yegutkin GG, 2007, J PHYSIOL-LONDON, V579, P553, DOI 10.1113/jphysiol.2006.119453; Yegutkin GG, 2006, J BIOL CHEM, V281, P29441, DOI 10.1074/jbc.M602480200; Yegutkin GG, 2011, ANGIOGENESIS, V14, P503, DOI 10.1007/s10456-011-9234-0; Yegutkin GG, 2001, FASEB J, V15, P251, DOI 10.1096/fj.00-0268com; Yegutkin GG, 2003, FASEB J, V17, P1328, DOI 10.1096/fj.02-1136fje; Yegutkin GG, 2000, BBA-BIOMEMBRANES, V1466, P234, DOI 10.1016/S0005-2736(00)00165-6	55	46	46	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3875	3883		10.1096/fj.12-205658	http://dx.doi.org/10.1096/fj.12-205658			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22637533	Green Published			2022-12-25	WOS:000308391600027
J	Glembotski, CC; Thuerauf, DJ; Huang, CQ; Vekich, JA; Gottlieb, RA; Doroudgar, S				Glembotski, Christopher C.; Thuerauf, Donna J.; Huang, Chengqun; Vekich, John A.; Gottlieb, Roberta A.; Doroudgar, Shirin			Mesencephalic Astrocyte-derived Neurotrophic Factor Protects the Heart from Ischemic Damage and Is Selectively Secreted upon Sarco/endoplasmic Reticulum Calcium Depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; ENDOPLASMIC-RETICULUM; ER STRESS; SARCOPLASMIC-RETICULUM; MYOCARDIAL-INFARCTION; MOLECULAR CHAPERONES; CA2+ RELEASE; HELA-CELLS; PROTEINS; ATF6	The endoplasmic reticulum (ER) stress protein mesencephalic astrocyte-derived neurotrophic factor (MANF) has been reported to protect cells from stress-induced cell death before and after its secretion; however, the conditions under which it is secreted are not known. Accordingly, we examined the mechanism of MANF release from cultured ventricular myocytes and HeLa cells, both of which secrete proteins via the constitutive pathway. Although the secretion of proteins via the constitutive pathway is not known to increase upon changes in intracellular calcium, MANF secretion was increased within 30 min of treating cells with compounds that deplete sarcoplasmic reticulum (SR)/ER calcium. In contrast, secretion of atrial natriuretic factor from ventricular myocytes was not increased by SR/ER calcium depletion, suggesting that not all secreted proteins exhibit the same characteristics as MANF. We postulated that SR/ER calcium depletion triggered MANF secretion by decreasing its retention. Consistent with this were co-immunoprecipitation and live cell, zero distance, photo affinity cross-linking, demonstrating that, in part, MANF was retained in the SR/ER via its calcium-dependent interaction with the SR/ER-resident protein, GRP78 (glucose-regulated protein 78 kDa). This unusual mechanism of regulating secretion from the constitutive secretory pathway provides a potentially missing link in the mechanism by which extracellular MANF protects cells from stresses that deplete SR/ER calcium. Consistent with this was our finding that administration of recombinant MANF to mice decreased tissue damage in an in vivo model of myocardial infarction, a condition during which ER calcium is known to be dysregulated, and MANF expression is induced.	[Glembotski, Christopher C.] San Diego State Univ, SDSU Heart Inst, San Diego, CA 92182 USA; [Glembotski, Christopher C.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Glembotski, CC (corresponding author), San Diego State Univ, SDSU Heart Inst, 5500 Campanile Dr, San Diego, CA 92182 USA.	cglembotski@sciences.sdsu.edu			National Institutes of Health [PO1 HL085577, RO1 HL75573, RO1 HL104535, RO3 EB011698, R01HL060590, RO1AG033283]; Rees-Stealy Research Foundation; San Diego Chapter of the Achievement Rewards for College Scientists Foundation; American Heart Association [10PRE3410005]; Inamori Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104535, P01HL085577, R01HL060590, R01HL075573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB011698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rees-Stealy Research Foundation; San Diego Chapter of the Achievement Rewards for College Scientists Foundation; American Heart Association(American Heart Association); Inamori Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL085577, RO1 HL75573, RO1 HL104535, and RO3 EB011698 (to C. C. G.), and R01HL060590, and RO1AG033283 (to R. A. G.). This work was also supported by grants and fellowships from the Rees-Stealy Research Foundation, the San Diego Chapter of the Achievement Rewards for College Scientists Foundation, the American Heart Association (Predoctoral Fellowship 10PRE3410005), and the Inamori Foundation (to S. D.).	Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; Amodio G, 2009, INT J BIOCHEM CELL B, V41, P2511, DOI 10.1016/j.biocel.2009.08.006; Andon NL, 2002, PROTEOMICS, V2, P1156, DOI 10.1002/1615-9861(200209)2:9<1156::AID-PROT1156>3.0.CO;2-4; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Bhogal MS, 1998, P NATL ACAD SCI USA, V95, P1484, DOI 10.1073/pnas.95.4.1484; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Castellano J, 2011, J MOL CELL CARDIOL, V50, P894, DOI 10.1016/j.yjmcc.2011.02.002; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; DEYOUNG MB, 1994, CIRC RES, V74, P33, DOI 10.1161/01.RES.74.1.33; DiJeso B, 1997, BIOCHEM BIOPH RES CO, V234, P133, DOI 10.1006/bbrc.1997.6601; DORNER AJ, 1994, BIOLOGICALS, V22, P103, DOI 10.1006/biol.1994.1016; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; Doroudgar S, 2011, TRENDS MOL MED, V17, P207, DOI 10.1016/j.molmed.2010.12.003; Doroudgar S, 2009, J BIOL CHEM, V284, P29735, DOI 10.1074/jbc.M109.018036; Eaddy AC, 2011, BIOCHEM BIOPH RES CO, V404, P424, DOI 10.1016/j.bbrc.2010.11.137; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Glembotski CC, 2011, J MOL CELL CARDIOL, V51, P512, DOI 10.1016/j.yjmcc.2010.10.008; Guo YR, 1998, AM J PHYSIOL-HEART C, V275, pH1375; HALBAN PA, 1994, BIOCHEM J, V299, P1; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; JAMSA E, 1994, YEAST, V10, P355, DOI 10.1002/yea.320100308; Kato T, 2005, J CLIN INVEST, V115, P2716, DOI 10.1172/JCI24280; KIM NN, 1995, AM J PHYSIOL-ENDOC M, V269, pE426, DOI 10.1152/ajpendo.1995.269.3.E426; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Kuznetsov G, 1997, J BIOL CHEM, V272, P3057, DOI 10.1074/jbc.272.5.3057; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; LODISH HF, 1990, J BIOL CHEM, V265, P10893; LODISH HF, 1992, J BIOL CHEM, V267, P12753; Louch WE, 2006, J PHYSIOL-LONDON, V574, P519, DOI 10.1113/jphysiol.2006.107227; Lu FH, 2010, BASIC CLIN PHARMACOL, V106, P396, DOI 10.1111/j.1742-7843.2009.00502.x; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Martindale JJ, 2005, J BIOL CHEM, V280, P669, DOI 10.1074/jbc.M406690200; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Missiaen L, 2004, CELL CALCIUM, V36, P479, DOI 10.1016/j.ceca.2004.04.007; Miyamoto S, 2010, CIRC RES, V107, P476, DOI 10.1161/CIRCRESAHA.109.215020; Molinari A, 2005, CURR TOP MICROBIOL, V300, P1; Montero M, 1997, FASEB J, V11, P881, DOI 10.1096/fasebj.11.11.9285486; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Muresan Z, 1998, MOL ENDOCRINOL, V12, P458, DOI 10.1210/me.12.3.458; OLDEN K, 1979, P NATL ACAD SCI USA, V76, P791, DOI 10.1073/pnas.76.2.791; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Paula S, 2009, BIOORGAN MED CHEM, V17, P6613, DOI 10.1016/j.bmc.2009.07.075; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; Pelham HRB, 1999, PHILOS T ROY SOC B, V354, P1471, DOI 10.1098/rstb.1999.0491; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Santhamma KR, 2000, J BIOL CHEM, V275, P23253, DOI 10.1074/jbc.M000593200; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; Temsah RM, 2002, AM J PHYSIOL-CELL PH, V283, pC1306, DOI 10.1152/ajpcell.00138.2002; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Treiman M, 2002, TRENDS CARDIOVAS MED, V12, P57, DOI 10.1016/S1050-1738(01)00147-5; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu XL, 2008, PHARMACOLOGY, V81, P325, DOI 10.1159/000121335; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yu YQ, 2010, J CEREBR BLOOD F MET, V30, P79, DOI 10.1038/jcbfm.2009.181; Zhang JY, 2003, J BIOL CHEM, V278, P7459, DOI 10.1074/jbc.M207976200; Zhou CY, 2006, NEUROREPORT, V17, P293, DOI 10.1097/01.wnr.0000201504.23255.bc	71	132	139	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25893	25904		10.1074/jbc.M112.356345	http://dx.doi.org/10.1074/jbc.M112.356345			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22637475	hybrid, Green Published			2022-12-25	WOS:000306916300018
J	Gonzalez-Paez, GE; Wolan, DW				Gonzalez-Paez, Gonzalo E.; Wolan, Dennis W.			Ultrahigh and High Resolution Structures and Mutational Analysis of Monomeric Streptococcus pyogenes SpeB Reveal a Functional Role for the Glycine-rich C-terminal Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR CYSTEINE PROTEASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; PROTEINASE; ZYMOGEN; PAPAIN; INHIBITORS; MECHANISM; SEQUENCE; FIBRONECTIN	Cysteine protease SpeB is secreted from Streptococcus pyogenes and has been studied as a potential virulence factor since its identification almost 70 years ago. Here, we report the crystal structures of apo mature SpeB to 1.06 angstrom resolution as well as complexes with the general cysteine protease inhibitor trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane and a novel substrate mimetic peptide inhibitor. These structures uncover conformational changes associated with maturation of SpeB from the inactive zymogen to its active form and identify the residues required for substrate binding. With the use of a newly developed fluorogenic tripeptide substrate to measure SpeB activity, we determined IC50 values for trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane and our new peptide inhibitor and the effects of mutations within the C-terminal active site loop. The structures and mutational analysis suggest that the conformational movements of the glycine-rich C-terminal loop are important for the recognition and recruitment of biological substrates and release of hydrolyzed products.	[Wolan, Dennis W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wolan, DW (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, MEM L43,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wolan@scripps.edu		Wolan, Dennis/0000-0001-9879-8353; Gonzalez-Paez, Gonzalo/0000-0003-4708-5753				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albericio F, 2004, CURR OPIN CHEM BIOL, V8, P211, DOI 10.1016/j.cbpa.2004.03.002; Alphey MS, 2006, ACTA CRYSTALLOGR F, V62, P504, DOI 10.1107/S1744309106014849; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; BOSSEMEYER D, 1994, TRENDS BIOCHEM SCI, V19, P201, DOI 10.1016/0968-0004(94)90022-1; Brak K, 2010, J MED CHEM, V53, P1763, DOI 10.1021/jm901633v; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Collin M, 2003, INFECT IMMUN, V71, P2983, DOI 10.1128/IAI.71.6.2983-2992.2003; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Dardenne LE, 2003, PROTEINS, V52, P236, DOI 10.1002/prot.10368; Doran JD, 1999, EUR J BIOCHEM, V263, P145, DOI 10.1046/j.1432-1327.1999.00473.x; Doran JD, 1996, BIOCHEMISTRY-US, V35, P12495, DOI 10.1021/bi960649+; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; GERWIN BI, 1966, J BIOL CHEM, V241, P3331; Ghosh R, 2008, FEBS J, V275, P421, DOI 10.1111/j.1742-4658.2007.06211.x; Gubba S, 1998, INFECT IMMUN, V66, P765, DOI 10.1128/IAI.66.2.765-770.1998; Guncar G, 2000, STRUCTURE, V8, P305, DOI 10.1016/S0969-2126(00)00108-8; HAUSER AR, 1990, J BACTERIOL, V172, P4536, DOI 10.1128/jb.172.8.4536-4542.1990; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; Hoffman B., 1993, ACTA CRYSTALLOGR S, P102; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Imamura T, 2005, J EXP MED, V201, P1669, DOI 10.1084/jem.20042041; Kagawa TF, 2000, P NATL ACAD SCI USA, V97, P2235, DOI 10.1073/pnas.040549997; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; KAPUR V, 1993, P NATL ACAD SCI USA, V90, P7676, DOI 10.1073/pnas.90.16.7676; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIU TY, 1965, NATURE, V206, P33, DOI 10.1038/206033a0; Mallorqui-Fernandez N, 2008, J BIOL CHEM, V283, P2871, DOI 10.1074/jbc.M708481200; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Musser JM, 2005, AM J PATHOL, V167, P1461, DOI 10.1016/S0002-9440(10)61232-1; Musser JM, 1996, INFECT IMMUN, V64, P1913, DOI 10.1128/IAI.64.6.1913-1917.1996; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P4868, DOI 10.1021/bi982632s; Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]; Nomizu M, 2001, J BIOL CHEM, V276, P44551, DOI 10.1074/jbc.M106306200; Olsen JG, 2009, J MOL BIOL, V393, P693, DOI 10.1016/j.jmb.2009.08.046; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potempa J, 2005, MOL MICROBIOL, V57, P605, DOI 10.1111/j.1365-2958.2005.04714.x; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; RODRIGUEZ M, 1991, TETRAHEDRON LETT, V32, P923, DOI 10.1016/S0040-4039(00)92121-X; Vedadi M, 2010, J STRUCT BIOL, V172, P107, DOI 10.1016/j.jsb.2010.05.005; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Wang CC, 2009, J BIOL CHEM, V284, P10957, DOI 10.1074/jbc.M807624200; YU CE, 1991, INFECT IMMUN, V59, P211, DOI 10.1128/IAI.59.1.211-215.1991	56	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24412	24426		10.1074/jbc.M112.361576	http://dx.doi.org/10.1074/jbc.M112.361576			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645124	Green Published, hybrid			2022-12-25	WOS:000306651100035
J	Faria, LCB; Rocha, ASL; Kleinschmidt, JH; Silva-Filho, MC; Bim, E; Herai, RH; Yamagishi, MEB; Palazzo, R				Faria, Luzinete C. B.; Rocha, Andrea S. L.; Kleinschmidt, Joao H.; Silva-Filho, Marcio C.; Bim, Edson; Herai, Roberto H.; Yamagishi, Michel E. B.; Palazzo, Reginaldo, Jr.			Is a Genome a Codeword of an Error-Correcting Code?	PLOS ONE			English	Article							BCH CODES	Since a genome is a discrete sequence, the elements of which belong to a set of four letters, the question as to whether or not there is an error-correcting code underlying DNA sequences is unavoidable. The most common approach to answering this question is to propose a methodology to verify the existence of such a code. However, none of the methodologies proposed so far, although quite clever, has achieved that goal. In a recent work, we showed that DNA sequences can be identified as codewords in a class of cyclic error-correcting codes known as Hamming codes. In this paper, we show that a complete intron-exon gene, and even a plasmid genome, can be identified as a Hamming code codeword as well. Although this does not constitute a definitive proof that there is an error-correcting code underlying DNA sequences, it is the first evidence in this direction.	[Faria, Luzinete C. B.; Rocha, Andrea S. L.; Palazzo, Reginaldo, Jr.] Univ Estadual Campinas, Dept Telemat, Sao Paulo, Brazil; [Kleinschmidt, Joao H.] Univ Fed ABC, Ctr Engn Modelagem & Ciencias Sociais Aplicadas, Sao Paulo, Brazil; [Silva-Filho, Marcio C.] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz Queiroz, Sao Paulo, Brazil; [Bim, Edson] Univ Estadual Campinas, Dept Sistema Controle Energia, Sao Paulo, Brazil; [Herai, Roberto H.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Yamagishi, Michel E. B.] Embrapa Informat Agropecuaria, Lab Bioinforma Aplicada, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade Estadual de Campinas; University of California System; University of California San Diego; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Faria, LCB (corresponding author), Univ Estadual Campinas, Dept Telemat, Sao Paulo, Brazil.	luzinete@dt.fee.unicamp.br; andrea@dt.fee.unicamp.br	Herai, Roberto/HII-2648-2022; Kleinschmidt, João Henrique/E-9372-2012; Bim, Edson/AAQ-8069-2020; Yamagishi, Michel Eduardo Beleza/B-7902-2012; Silva-Filho, Marcio/F-2639-2012	Herai, Roberto/0000-0001-9885-2735; Kleinschmidt, João Henrique/0000-0001-6706-455X; Yamagishi, Michel Eduardo Beleza/0000-0001-7109-3038; Silva-Filho, Marcio/0000-0003-2129-0388	Brazilian agencies FAPESP; CNPq; CAPES	Brazilian agencies FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank the Brazilian agencies FAPESP, CNPq and CAPES for the financial support during the period of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade AA, 2003, COMPUT APPL MATH, V22, P233, DOI 10.1590/S1807-03022003000200005; Bose R.C., 1960, INFORM CONTR, V3, P68, DOI DOI 10.1016/S0019-9958(60)90287-4; de Andrade AA, 1999, LINEAR ALGEBRA APPL, V286, P69, DOI 10.1016/S0024-3795(98)10163-5; Elia M., 2000, J DISCRETE MATH SCI, V3, P41; Faria LCB, 2010, ELECTRON LETT, V46, P202, DOI 10.1049/el.2010.3397; FORSDYKE DR, 1981, J THEOR BIOL, V93, P861, DOI 10.1016/0022-5193(81)90344-1; Hocquenghem A., 1959, CHIFFRES, P147; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huffman W., 2003, FUNDAMENTALS ERROR C; Interlando JC, 1997, IEEE T INFORM THEORY, V43, P1013, DOI 10.1109/18.568713; Kumar RP, 2010, BIOESSAYS, V32, P165, DOI 10.1002/bies.200900111; Rocha ASL, 2010, IEEE INT SYMP INFO, P1320, DOI 10.1109/ISIT.2010.5513747; Liebovitch LS, 1996, BIOPHYS J, V71, P1539, DOI 10.1016/S0006-3495(96)79356-6; McWilliams FJ., 1977, THEORY ERROR CORRECT; Ozturk S, 2011, HISTOL HISTOPATHOL, V26, P505, DOI 10.14670/HH-26.505; Peterson W., 1972, ERROR CORRECTING COD, V2nd ed.; Pless VS, 1996, IEEE T INFORM THEORY, V42, P1594, DOI 10.1109/18.532906; Rosen GL, 2006, IEEE ENG MED BIOL, V25, P62, DOI 10.1109/MEMB.2006.1578665; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; SHANKAR P, 1979, IEEE T INFORM THEORY, V25, P480, DOI 10.1109/TIT.1979.1056063	20	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36644	10.1371/journal.pone.0036644	http://dx.doi.org/10.1371/journal.pone.0036644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649495	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800012
J	Fontaine, B; van Achterberg, K; Alonso-Zarazaga, MA; Araujo, R; Asche, M; Aspock, H; Aspock, U; Audisio, P; Aukema, B; Bailly, N; Balsamo, M; Bank, RA; Belfiore, C; Bogdanowicz, W; Boxshall, G; Burckhardt, D; Chylarecki, P; Deharveng, L; Dubois, A; Enghoff, H; Fochetti, R; Fontaine, C; Gargominy, O; Lopez, MSG; Goujet, D; Harvey, MS; Heller, KG; van Helsdingen, P; Hoch, H; De Jong, Y; Karsholt, O; Los, W; Magowski, W; Massard, JA; McInnes, SJ; Mendes, LF; Mey, E; Michelsen, V; Minelli, A; Nafria, JMN; van Nieukerken, EJ; Pape, T; De Prins, W; Ramos, M; Ricci, C; Roselaar, C; Rota, E; Segers, H; Timm, T; van Tol, J; Bouchet, P				Fontaine, Benoit; van Achterberg, Kees; Angel Alonso-Zarazaga, Miguel; Araujo, Rafael; Asche, Manfred; Aspoeck, Horst; Aspoeck, Ulrike; Audisio, Paolo; Aukema, Berend; Bailly, Nicolas; Balsamo, Maria; Bank, Ruud A.; Belfiore, Carlo; Bogdanowicz, Wieslaw; Boxshall, Geoffrey; Burckhardt, Daniel; Chylarecki, Przemyslaw; Deharveng, Louis; Dubois, Alain; Enghoff, Henrik; Fochetti, Romolo; Fontaine, Colin; Gargominy, Olivier; Gomez Lopez, Maria Soledad; Goujet, Daniel; Harvey, Mark S.; Heller, Klaus-Gerhard; van Helsdingen, Peter; Hoch, Hannelore; De Jong, Yde; Karsholt, Ole; Los, Wouter; Magowski, Wojciech; Massard, Jos A.; McInnes, Sandra J.; Mendes, Luis F.; Mey, Eberhard; Michelsen, Verner; Minelli, Alessandro; Nieto Nafria, Juan M.; van Nieukerken, Erik J.; Pape, Thomas; De Prins, Willy; Ramos, Marian; Ricci, Claudia; Roselaar, Cees; Rota, Emilia; Segers, Hendrik; Timm, Tarmo; van Tol, Jan; Bouchet, Philippe			New Species in the Old World: Europe as a Frontier in Biodiversity Exploration, a Test Bed for 21st Century Taxonomy	PLOS ONE			English	Article							ASTRONOMY; AMATEURS	The number of described species on the planet is about 1.9 million, with ca. 17,000 new species described annually, mostly from the tropics. However, taxonomy is usually described as a science in crisis, lacking manpower and funding, a politically acknowledged problem known as the Taxonomic Impediment. Using data from the Fauna Europaea database and the Zoological Record, we show that contrary to general belief, developed and heavily-studied parts of the world are important reservoirs of unknown species. In Europe, new species of multicellular terrestrial and freshwater animals are being discovered and named at an unprecedented rate: since the 1950s, more than 770 new species are on average described each year from Europe, which add to the 125,000 terrestrial and freshwater multicellular species already known in this region. There is no sign of having reached a plateau that would allow for the assessment of the magnitude of European biodiversity. More remarkably, over 60% of these new species are described by non-professional taxonomists. Amateurs are recognized as an essential part of the workforce in ecology and astronomy, but the magnitude of non-professional taxonomist contributions to alpha-taxonomy has not been fully realized until now. Our results stress the importance of developing a system that better supports and guides this formidable workforce, as we seek to overcome the Taxonomic Impediment and speed up the process of describing the planetary biodiversity before it is too late.	[Fontaine, Benoit; Fontaine, Colin] Museum Natl Hist Nat, UMR 7204, F-75231 Paris, France; [van Achterberg, Kees; van Nieukerken, Erik J.; van Tol, Jan] NCB Nat, Leiden, Netherlands; [Angel Alonso-Zarazaga, Miguel; Araujo, Rafael; Ramos, Marian] CSIC, Museo Nacl Ciencias Nat, Depto Biodiversidad & Biol Evolut, E-28006 Madrid, Spain; [Asche, Manfred; Hoch, Hannelore] Humboldt Univ, Museum Nat Kunde, Leibniz Inst Evolut & Biodiversitatsforsch, D-10099 Berlin, Germany; [Aspoeck, Horst] Med Univ Vienna, Dept Med Parasitol, Vienna, Austria; [Aspoeck, Ulrike] Univ Vienna, Nat Hist Museum Wien, Vienna, Austria; [Audisio, Paolo] Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, Rome, Italy; [Bailly, Nicolas] WorldFish Ctr, Laguna, Philippines; [Balsamo, Maria] Univ Urbino Carlo Bo, Dipartimento Sci Uomo Ambiente & Nat, Urbino, Italy; [Belfiore, Carlo] Univ Tuscia, Dipartimento Sci Ecol & Biol, Viterbo, Italy; [Bogdanowicz, Wieslaw; Chylarecki, Przemyslaw] Polish Acad Sci, Museum & Inst Zool, Warsaw, Poland; [Boxshall, Geoffrey] Nat Hist Museum, Dept Zool, London SW7 5BD, England; [Burckhardt, Daniel] Nat Hist Museum, Basel, Switzerland; [Deharveng, Louis; Dubois, Alain; Bouchet, Philippe] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France; [Enghoff, Henrik; Karsholt, Ole; Michelsen, Verner; Pape, Thomas] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark; [Fochetti, Romolo] Univ Tuscia, Dipartimento Sci Ambientali, Viterbo, Italy; [Gargominy, Olivier] Museum Natl Hist Nat, Serv Patrimoine Nat, F-75231 Paris, France; [Gomez Lopez, Maria Soledad] Univ Barcelona, Parasitol Lab, Barcelona, Spain; [Goujet, Daniel] Museum Natl Hist Nat, Dept Hist Terre, F-75231 Paris, France; [Harvey, Mark S.] Western Australian Museum, Dept Terr Zool, Welshpool, WA, Australia; [Heller, Klaus-Gerhard] Univ Erlangen Nurnberg, Inst Zool, D-91054 Erlangen, Germany; [van Helsdingen, Peter] European Invertebrate Survey, Natl Nat Hist Museum Nat, Leiden, Netherlands; [De Jong, Yde; Los, Wouter] Univ Amsterdam, Zool Museum, Amsterdam, Netherlands; [Magowski, Wojciech] Adam Mickiewicz Univ, Dept Anim Taxon & Ecol, Poznan, Poland; [McInnes, Sandra J.] British Antarctic Survey, Cambridge, England; [Mendes, Luis F.] Ctr Zool, Inst Invest Cient Trop, Lisbon, Portugal; [Mey, Eberhard] Nat Hist Museum Thuringer Landesmuseum, Rudolstadt, Germany; [Minelli, Alessandro] Univ Padua, Dept Biol, Padua, Italy; [Nieto Nafria, Juan M.] Univ Leon, Dept Biodiversidad & Gest Ambiental, E-24071 Leon, Spain; [De Prins, Willy] Flemish Entomol Soc, Leefdaal, Belgium; [Ricci, Claudia] Univ Milan, Dipartimento Protez Sistemi Agroalimentare & Urba, Milan, Italy; [Roselaar, Cees] NCB Nat, Amsterdam, Netherlands; [Rota, Emilia] Univ Siena, Dipartimento Sci Ambientali, Sez Sistemat Ecol Anim & Vegetale, I-53100 Siena, Italy; [Segers, Hendrik] Royal Belgian Inst Nat Sci, Freshwater Lab, Brussels, Belgium; [Timm, Tarmo] Estonian Univ Life Sci, Inst Agr & Environm Sci, Tartumaa, Estonia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Medical University of Vienna; University of Vienna; Sapienza University Rome; CGIAR; Worldfish; University of Urbino; Tuscia University; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; Natural History Museum London; Museum National d'Histoire Naturelle (MNHN); University of Copenhagen; Tuscia University; Museum National d'Histoire Naturelle (MNHN); University of Barcelona; Museum National d'Histoire Naturelle (MNHN); Western Australian Museum; University of Erlangen Nuremberg; University of Amsterdam; Adam Mickiewicz University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Padua; Universidad de Leon; University of Milan; University of Siena; Royal Belgian Institute of Natural Sciences; Estonian University of Life Sciences	Fontaine, B (corresponding author), Museum Natl Hist Nat, UMR 7204, F-75231 Paris, France.	fontaine@mnhn.fr	van Achterberg, Kees/AFV-5150-2022; van Nieukerken, Erik/B-4512-2012; Fontaine, Colin/N-6469-2015; McInnes, Sandra/AAN-4773-2020; Dubois, Arnaud/C-1791-2014; Bailly, Nicolas/AID-4444-2022; Pape, Thomas/E-7520-2011; Balsamo, Maria/AAW-3205-2020; Ramos, Maria Angeles/E-5536-2013; Harvey, Mark/P-4265-2019; Mendes, Luis/N-3140-2013; Aspöck, Horst/O-1990-2017; Chylarecki, Przemysław/B-7696-2013; Segers, Hendrik/C-4101-2009; Harvey, Mark S/L-1177-2013; Enghoff, Henrik/A-5796-2013	van Nieukerken, Erik/0000-0002-5721-1840; Fontaine, Colin/0000-0001-5367-5675; Pape, Thomas/0000-0001-6609-0609; Balsamo, Maria/0000-0002-7947-0632; Ramos, Maria Angeles/0000-0001-5224-5665; Harvey, Mark/0000-0003-1482-0109; Mendes, Luis/0000-0002-2873-6066; Aspöck, Horst/0000-0001-9407-3566; Chylarecki, Przemysław/0000-0001-6863-4294; Segers, Hendrik/0000-0001-5399-3657; Harvey, Mark S/0000-0003-1482-0109; AUDISIO, Paolo Aldo/0000-0002-7990-6934; Gargominy, Olivier/0000-0001-7807-944X; BELFIORE, Carlo/0000-0002-0061-8658; Burckhardt, Daniel/0000-0001-8368-5268; Bogdanowicz, Wieslaw/0000-0003-1196-2494; Magowski, Wojciech/0000-0003-2521-9458; Boxshall, Geoffrey/0000-0001-8170-7734; Rota, Emilia/0000-0002-8235-6419; Minelli, Alessandro/0000-0003-3387-1489; Los, Wouter/0000-0001-7433-4431	European Commission [EVR1-CT-1999-20001]; Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Fauna Europaea project was supported by the European Commission under contract no. EVR1-CT-1999-20001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2007, SYST BIOL, V56, P531, DOI 10.1080/10635150701424546; [Anonymous], 2010, SOS STATE OBSERVED S; Bebber DP, 2007, P R SOC B, V274, P1651, DOI 10.1098/rspb.2007.0464; Boero F., 2010, BIODIVERSITY, V2, P115; Bohannon J, 2007, SCIENCE, V318, P192, DOI 10.1126/science.318.5848.192; Bouchet P, 1997, VELIGER, V40, P1; Bouchet Philippe, 1999, Bulletin of Zoological Nomenclature, V56, P6; Bouchet Philippe, 2009, Vita Malacologica, V8, P1; CHAPMAN AD, 2009, NUMBERS LIVING SPECI; Cotterill FPD, 2010, BIODIVERS CONSERV, V19, P291, DOI 10.1007/s10531-009-9721-4; DAVIES RB, 1987, BIOMETRIKA, V74, P33, DOI 10.1093/biomet/74.1.33; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; EDIT, 2010, EDIT EP7 APPL TAX CO; Fauna_Europaea, 2004, FAUN EUR DAT; Foissner W, 2004, ACTA PROTOZOOL, V43, P3; Fontaine B, 2007, BIOL CONSERV, V139, P167, DOI 10.1016/j.biocon.2007.06.012; Fontaine B, 2010, NATURE, V468, P377, DOI 10.1038/468377a; GASTON KJ, 1992, NATURE, V356, P281, DOI 10.1038/356281a0; Green SV, 1998, J INSECT CONSERV, V2, P151, DOI 10.1023/A:1009633811789; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; IBOL, 2009, LEP BARC LIF SPHING; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Joppa LN, 2011, TRENDS ECOL EVOL, V26, P551, DOI 10.1016/j.tree.2011.07.010; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Mace G.M., 2005, ECOSYSTEMS HUMAN WEL, P77; Martinez SI, 2010, CURR OPIN ENV SUST, V2, P27, DOI 10.1016/j.cosust.2010.03.004; May RM, 2004, PHILOS T ROY SOC B, V359, P733, DOI 10.1098/rstb.2003.1455; MAY RM, 1995, NATURE, V378, P447, DOI 10.1038/378447a0; Minelli A, 2003, TRENDS ECOL EVOL, V18, P75, DOI 10.1016/S0169-5347(02)00051-4; Morchio R, 2000, RIV BIOL-BIOL FORUM, V93, P373; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; NEW TR, 1995, INTRO INVERTEBRATE C; Novotny V, 2000, OIKOS, V89, P564, DOI 10.1034/j.1600-0706.2000.890316.x; Pearson DL, 2011, BIOSCIENCE, V61, P58, DOI 10.1525/bio.2011.61.1.11; Reaka-Kudla Marjorie L., 1997, P83; SCBD (Secretariat of the Convention on Biological Diversity), 2010, WHAT IS PROBL TAX IM; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Wheeler QD, 2004, PHILOS T R SOC B, V359, P571, DOI 10.1098/rstb.2003.1452	38	77	88	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36881	10.1371/journal.pone.0036881	http://dx.doi.org/10.1371/journal.pone.0036881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649502	gold, Green Published, Green Accepted			2022-12-25	WOS:000305335800020
J	Gosoniu, L; Msengwa, A; Lengeler, C; Vounatsou, P				Gosoniu, Laura; Msengwa, Amina; Lengeler, Christian; Vounatsou, Penelope			Spatially Explicit Burden Estimates of Malaria in Tanzania: Bayesian Geostatistical Modeling of the Malaria Indicator Survey Data	PLOS ONE			English	Article							TRANSMISSION	A national HIV/AIDS and malaria parasitological survey was carried out in Tanzania in 2007-2008. In this study the parasitological data were analyzed: i) to identify climatic/environmental, socio-economic and interventions factors associated with child malaria risk and ii) to produce a contemporary, high spatial resolution parasitaemia risk map of the country. Bayesian geostatistical models were fitted to assess the association between parasitaemia risk and its determinants. Bayesian kriging was employed to predict malaria risk at unsampled locations across Tanzania and to obtain the uncertainty associated with the predictions. Markov chain Monte Carlo (MCMC) simulation methods were employed for model fit and prediction. Parasitaemia risk estimates were linked to population data and the number of infected children at province level was calculated. Model validation indicated a high predictive ability of the geostatistical model, with 60.00% of the test locations within the 95% credible interval. The results indicate that older children are significantly more likely to test positive for malaria compared with younger children and living in urban areas and better-off households reduces the risk of infection. However, none of the environmental and climatic proxies or the intervention measures were significantly associated with the risk of parasitaemia. Low levels of malaria prevalence were estimated for Zanzibar island. The population-adjusted prevalence ranges from 0.29% in Kaskazini province (Zanzibar island) to 18.65% in Mtwara region. The pattern of predicted malaria risk is similar with the previous maps based on historical data, although the estimates are lower. The predicted maps could be used by decision-makers to allocate resources and target interventions in the regions with highest burden of malaria in order to reduce the disease transmission in the country.	[Gosoniu, Laura; Lengeler, Christian; Vounatsou, Penelope] Univ Basel, Swiss Trop & Publ Hlth Inst, Dept Publ Hlth & Epidemiol, CH-4003 Basel, Switzerland; [Msengwa, Amina] Univ Dar Es Salaam, Dept Stat, Dar Es Salaam, Tanzania	University of Basel; Swiss Tropical & Public Health Institute; University of Dar es Salaam	Gosoniu, L (corresponding author), Univ Basel, Swiss Trop & Publ Hlth Inst, Dept Publ Hlth & Epidemiol, CH-4003 Basel, Switzerland.	penelope.vounatsou@unibas.ch		Vounatsou, Penelope/0000-0002-4904-5352	Swiss National Science Foundation [IZLSZ3 122926]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This investigation received financial support from the Swiss National Science Foundation Project No. IZLSZ3 122926). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NAT MAL MED TERM STR; [Anonymous], TANZ HIV AIDS MAL IN; [Anonymous], 2004, COCHRANE DB SYST REV; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Gemperli A, 2006, TROP MED INT HEALTH, V11, P1032, DOI 10.1111/j.1365-3156.2006.01640.x; Gosoniu L, 2007, THESIS U BASEL; Gosoniu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009322; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Le Sueur D, 1998, ATLAS MALARIA AFRICA, V19, p[1998, 23]; MARA/ARMA, 1998, 1 MARA ARMA COLL; Ministry of Health and Social Welfare, 2006, ZANZ MAL CONTR PROGR; Msengwa A, 2010, THESIS U DAR ES SALA; Smithson P, 2009, BUT NOT OUT IMPACT M; World Health Organization, GLOB MAL CONTR EL RE	16	34	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e23966	10.1371/journal.pone.0023966	http://dx.doi.org/10.1371/journal.pone.0023966			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649486	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305335800002
J	Liu, YG; Bridges, R; Wortham, A; Kulesz-Martin, M				Liu, Yuangang; Bridges, Rebecca; Wortham, Aaron; Kulesz-Martin, Molly			NF-kappa B Repression by PIAS3 Mediated RelA SUMOylation	PLOS ONE			English	Article							GENE-ACTIVATION; SUMO-1 MODIFICATION; TEMPORAL CONTROL; DNA-BINDING; ALPHA; TRANSCRIPTION; PROTEINS; MOTIF; COMPLEXES; RECEPTOR	Negative regulation of the NF-kappa B transcription factor is essential for tissue homeostasis in response to stress and inflammation. NF-kappa B activity is regulated by a variety of biochemical mechanisms including phosphorylation, acetylation, and ubiquitination. In this study, we provide the first experimental evidence that NF-kappa B is regulated by SUMOylation, where the RelA subunit of NF-kappa B is SUMOylated by PIAS3, a member of the PIAS (protein inhibitor of activated STAT) protein family with E3 SUMO ligase activity. PIAS3-mediated NF-kappa B repression was compromised by either RelA mutant resistant to SUMOylation or PIAS3 mutant defective in SUMOylation. PIAS3-mediated SUMOylation of endogenous RelA was induced by NF-kappa B activation thus forming a negative regulatory loop. The SUMOylation of endogenous RelA was enhanced in IkB alpha null as compared with wild type fibroblasts. The RelA SUMOylation was induced by TNF alpha but not leptomycin B mediated RelA nuclear translocation. Furthermore, RelA mutants defective in DNA binding were not SUMOylated by PIAS3, suggesting that RelA DNA binding is a signal for PIAS3-mediated SUMOylation. These results support a novel negative feedback mechanism for NF-kappa B regulation by PIAS3-mediated RelA SUMOylation.	[Liu, Yuangang; Bridges, Rebecca; Wortham, Aaron; Kulesz-Martin, Molly] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA	Oregon Health & Science University	Liu, YG (corresponding author), Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA.	liuy@ohsu.edu; kuleszma@ohsu.edu			National Institutes of Health (NIH) [CA098577, NIH AR55651]; OHSU Knight Cancer Institute [CA69533]; National Psoriasis Foundation; NATIONAL CANCER INSTITUTE [R01CA098577, P30CA069533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OHSU Knight Cancer Institute; National Psoriasis Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health (NIH) CA098577 and NIH AR55651 (http://www.nih.gov/), OHSU Knight Cancer Institute CA69533 (www.ohsu.edu), and the National Psoriasis Foundation (http://www.psoriasis.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Hari KL, 2001, GENE DEV, V15, P1334, DOI 10.1101/gad.877901; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Jang HD, 2004, J BIOL CHEM, V279, P24873, DOI 10.1074/jbc.M313018200; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005; Liu B, 2010, SCIENCE, V330, P521, DOI 10.1126/science.1193787; Liu YG, 2001, CANCER RES, V61, P5402; Liu YG, 2007, CANCER RES, V67, P10711, DOI 10.1158/0008-5472.CAN-07-1968; Liu YG, 2010, J INVEST DERMATOL, V130, P1384, DOI 10.1038/jid.2009.416; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; SCHNEIDER BL, 1993, J INVEST DERMATOL, V101, P595, DOI 10.1111/1523-1747.ep12366051; Shin JA, 2005, MOL CELL, V19, P817, DOI 10.1016/j.molcel.2005.08.021; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wissink S, 1997, J BIOL CHEM, V272, P22278, DOI 10.1074/jbc.272.35.22278; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P	38	42	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37636	10.1371/journal.pone.0037636	http://dx.doi.org/10.1371/journal.pone.0037636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649547	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800066
J	Lesscher, HMB; Houthuijzen, JM; Koerkamp, MJG; Holstege, FCP; Vanderschuren, LJMJ				Lesscher, Heidi M. B.; Houthuijzen, Julia M.; Koerkamp, Marian J. Groot; Holstege, Frank C. P.; Vanderschuren, Louk J. M. J.			Amygdala 14-3-3 zeta as a Novel Modulator of Escalating Alcohol Intake in Mice	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; GAMMA-AMINOBUTYRIC-ACID; VENTRAL TEGMENTAL AREA; PARKINSONS-DISEASE; DRUG-ADDICTION; C57BL/6J MICE; NUCLEUS-ACCUMBENS; EXTENDED AMYGDALA; ETHANOL DRINKING; GENE-EXPRESSION	Alcoholism is a devastating brain disorder that affects millions of people worldwide. The development of alcoholism is caused by alcohol-induced maladaptive changes in neural circuits involved in emotions, motivation, and decision-making. Because of its involvement in these processes, the amygdala is thought to be a key neural structure involved in alcohol addiction. However, the molecular mechanisms that govern the development of alcoholism are incompletely understood. We have previously shown that in a limited access choice paradigm, C57BL/6J mice progressively escalate their alcohol intake and display important behavioral characteristic of alcohol addiction, in that they become insensitive to quinine-induced adulteration of alcohol. This study used the limited access choice paradigm to study gene expression changes in the amygdala during the escalation to high alcohol consumption in C57BL/6J mice. Microarray analysis revealed that changes in gene expression occurred predominantly after one week, i.e. during the initial escalation of alcohol intake. One gene that stood out from our analysis was the adapter protein 14-3-3 zeta, which was up-regulated during the transition from low to high alcohol intake. Independent qPCR analysis confirmed the up-regulation of amygdala 14-3-3 zeta during the escalation of alcohol intake. Subsequently, we found that local knockdown of 14-3-3 zeta in the amygdala, using RNA interference, dramatically augmented alcohol intake. In addition, knockdown of amygdala 14-3-3 zeta promoted the development of inflexible alcohol drinking, as apparent from insensitivity to quinine adulteration of alcohol. This study identifies amygdala 14-3-3 zeta as a novel key modulator that is engaged during escalation of alcohol use.	[Lesscher, Heidi M. B.; Houthuijzen, Julia M.; Vanderschuren, Louk J. M. J.] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Lesscher, Heidi M. B.; Vanderschuren, Louk J. M. J.] Univ Utrecht, Fac Vet Med, Dept Anim Sci & Soc, Div Behav Neurosci, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	Lesscher, HMB (corresponding author), Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	h.m.b.lesscher@uu.nl	Holstege, Frank/AAM-9944-2021; Vanderschuren, Louk/AAS-4391-2020	Vanderschuren, Louk/0000-0002-5379-0363; Groot Koerkamp, Marian JA/0000-0002-0867-0821; Houthuijzen, Julia/0000-0003-0404-1961	Brain Foundation of the Netherlands [H06.08]; Netherlands organization for health research and development (ZonMw) [91679134]	Brain Foundation of the Netherlands; Netherlands organization for health research and development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by a Fellowship from the Brain Foundation of the Netherlands, grant H06.08, and a VENI grant from the Netherlands organization for health research and development (ZonMw), grant 91679134, to H.M.B.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2012, NEUROSCIENCE, V211, P107, DOI 10.1016/j.neuroscience.2011.08.014; Altar CA, 2009, NEUROPSYCHOPHARMACOL, V34, P18, DOI 10.1038/npp.2008.172; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson NJ, 2007, ALCOHOL CLIN EXP RES, V31, P1061, DOI 10.1111/j.1530-0277.2007.00394.x; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bell RL, 2006, ALCOHOL, V40, P3, DOI 10.1016/j.alcohol.2006.10.001; Bergamaschi A, 2012, ONCOGENE, V31, P39, DOI 10.1038/onc.2011.223; BREESE CR, 1995, BRAIN RES, V674, P82, DOI 10.1016/0006-8993(94)01384-T; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Choi DS, 2008, J NEUROSCI, V28, P11890, DOI 10.1523/JNEUROSCI.3156-08.2008; Contet C, 2011, ADDICT BIOL, V16, P615, DOI 10.1111/j.1369-1600.2010.00304.x; Couve A, 2001, MOL CELL NEUROSCI, V17, P317, DOI 10.1006/mcne.2000.0938; Covault J, 2004, AM J MED GENET B, V129B, P104, DOI 10.1002/ajmg.b.30091; Dai JG, 2003, J NEUROCHEM, V84, P23, DOI 10.1046/j.1471-4159.2003.01254.x; de Backer MWA, 2011, INT J OBESITY, V35, P629, DOI 10.1038/ijo.2010.169; Dick DM, 2006, ALCOHOL CLIN EXP RES, V30, P1101, DOI 10.1111/j.1530-0277.2006.00136.x; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Ford MM, 2008, ALCOHOL CLIN EXP RES, V32, P1408, DOI 10.1111/j.1530-0277.2008.00718.x; Geisler S, 2005, J COMP NEUROL, V490, P270, DOI 10.1002/cne.20668; Haugbol SR, 2005, ALCOHOL ALCOHOLISM, V40, P89, DOI 10.1093/alcalc/agh117; Heilig M, 2007, TRENDS NEUROSCI, V30, P399, DOI 10.1016/j.tins.2007.06.006; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; HYYTIA P, 1995, EUR J PHARMACOL, V283, P151, DOI 10.1016/0014-2999(95)00314-B; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Koob GF, 2009, NAT REV DRUG DISCOV, V8, P500, DOI 10.1038/nrd2828; Koob GF, 2003, EUR NEUROPSYCHOPHARM, V13, P442, DOI 10.1016/j.euroneuro.2003.08.005; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Lancien M, 2006, PLANT CELL ENVIRON, V29, P1430, DOI 10.1111/j.1365-3040.2006.01526.x; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Lesscher HMB, 2009, GENES BRAIN BEHAV, V8, P493, DOI 10.1111/j.1601-183X.2009.00485.x; Lesscher HMB, 2010, ALCOHOL CLIN EXP RES, V34, P1219, DOI 10.1111/j.1530-0277.2010.01199.x; Lesscher HMB, 2009, PHARMACOGENET GENOM, V19, P719, DOI 10.1097/FPC.0b013e3283311320; Macha MA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-655; MacKay RK, 2011, ALCOHOL CLIN EXP RES, V35, P1041, DOI 10.1111/j.1530-0277.2011.01436.x; Makris N, 2008, BIOL PSYCHIAT, V64, P192, DOI 10.1016/j.biopsych.2008.01.018; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Noble EP, 1998, PSYCHIAT RES, V81, P133, DOI 10.1016/S0165-1781(98)00084-5; O'Brien CP, 2008, PHILOS T R SOC B, V363, P3277, DOI 10.1098/rstb.2008.0105; Olive MF, 2000, EUR J NEUROSCI, V12, P4131, DOI 10.1046/j.1460-9568.2000.00297.x; Park CS, 2006, J KOREAN MED SCI, V21, P533, DOI 10.3346/jkms.2006.21.3.533; Paul G, 2009, GENOMICS, V94, P287, DOI 10.1016/j.ygeno.2009.07.004; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perry JL, 2008, PSYCHOPHARMACOLOGY, V200, P1, DOI 10.1007/s00213-008-1173-0; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Phillips AG, 2003, NEUROSCI BIOBEHAV R, V27, P543, DOI 10.1016/j.neubiorev.2003.09.002; Phillips Jennifer, 1996, Methods (Orlando), V10, P283, DOI 10.1006/meth.1996.0104; Qian Z, 2012, NEUROSCIENCE, V201, P34, DOI 10.1016/j.neuroscience.2011.11.021; Radel M, 2005, ARCH GEN PSYCHIAT, V62, P47, DOI 10.1001/archpsyc.62.1.47; Ravindran CRM, 2006, NEUROCHEM RES, V31, P1111, DOI 10.1007/s11064-006-9124-9; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Roberto M, 2004, J NEUROSCI, V24, P10159, DOI 10.1523/JNEUROSCI.3004-04.2004; Roberto M, 2003, P NATL ACAD SCI USA, V100, P2053, DOI 10.1073/pnas.0437926100; Roberto M, 2010, BIOL PSYCHIAT, V67, P831, DOI 10.1016/j.biopsych.2009.11.007; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Rodaros D, 2007, NEUROSCIENCE, V150, P8, DOI 10.1016/j.neuroscience.2007.09.043; Rodd ZA, 2008, PHARMACOL BIOCHEM BE, V89, P481, DOI 10.1016/j.pbb.2008.01.023; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Rose R, 2010, ANGEW CHEM INT EDIT, V49, P4129, DOI 10.1002/anie.200907203; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sanchis-Segura C, 2006, J NEUROSCI, V26, P1231, DOI 10.1523/JNEUROSCI.4237-05.2006; Sander T, 1999, ALCOHOL CLIN EXP RES, V23, P427, DOI 10.1097/00000374-199903000-00007; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider F, 2001, AM J PSYCHIAT, V158, P1075, DOI 10.1176/appi.ajp.158.7.1075; SCHULTEIS G, 1995, P NATL ACAD SCI USA, V92, P5880, DOI 10.1073/pnas.92.13.5880; See RE, 2005, EUR J PHARMACOL, V526, P140, DOI 10.1016/j.ejphar.2005.09.034; Soo Hoo Guy W, 2003, J Intensive Care Med, V18, P150; TOKER A, 1990, EUR J BIOCHEM, V191, P421, DOI 10.1111/j.1432-1033.1990.tb19138.x; Ubl A, 2002, MOL BRAIN RES, V108, P33, DOI 10.1016/S0169-328X(02)00510-7; van den Brink W, 2012, CURR DRUG ABUSE REV, DOI [10.2174/1874212221267084737, DOI 10.2174/1874212221267084737]; Vanderschuren LJMJ, 2005, EUR J PHARMACOL, V526, P77, DOI 10.1016/j.ejphar.2005.09.037; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; WHO, 2004, GLOB STAT REP ALC; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Wu H, 2010, ANGEW CHEM INT EDIT, V49, P6528, DOI 10.1002/anie.201003257; Yacoubian TA, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.4; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	83	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37999	10.1371/journal.pone.0037999	http://dx.doi.org/10.1371/journal.pone.0037999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629472	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300086
J	Wang, X; Li, GZ				Wang, Xiao; Li, Guo-Zheng			A Multi-Label Predictor for Identifying the Subcellular Locations of Singleplex and Multiplex Eukaryotic Proteins	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SUPPORT VECTOR MACHINES; COUPLED RECEPTOR CLASSES; GRAM-NEGATIVE-BACTERIA; TOP-DOWN APPROACH; ENSEMBLE CLASSIFIER; APPROXIMATE ENTROPY; APOPTOSIS PROTEINS; FUSION CLASSIFIER; WAVELET TRANSFORM	Subcellular locations of proteins are important functional attributes. An effective and efficient subcellular localization predictor is necessary for rapidly and reliably annotating subcellular locations of proteins. Most of existing subcellular localization methods are only used to deal with single-location proteins. Actually, proteins may simultaneously exist at, or move between, two or more different subcellular locations. To better reflect characteristics of multiplex proteins, it is highly desired to develop new methods for dealing with them. In this paper, a new predictor, called Euk-ECC-mPLoc, by introducing a powerful multi-label learning approach which exploits correlations between subcellular locations and hybridizing gene ontology with dipeptide composition information, has been developed that can be used to deal with systems containing both singleplex and multiplex eukaryotic proteins. It can be utilized to identify eukaryotic proteins among the following 22 locations: (1) acrosome, (2) cell membrane, (3) cell wall, (4) centrosome, (5) chloroplast, (6) cyanelle, (7) cytoplasm, (8) cytoskeleton, (9) endoplasmic reticulum, (10) endosome, (11) extracellular, (12) Golgi apparatus, (13) hydrogenosome, (14) lysosome, (15) melanosome, (16) microsome, (17) mitochondrion, (18) nucleus, (19) peroxisome, (20) spindle pole body, (21) synapse, and (22) vacuole. Experimental results on a stringent benchmark dataset of eukaryotic proteins by jackknife cross validation test show that the average success rate and overall success rate obtained by Euk-ECC-mPLoc were 69.70% and 81.54%, respectively, indicating that our approach is quite promising. Particularly, the success rates achieved by Euk-ECC-mPLoc for small subsets were remarkably improved, indicating that it holds a high potential for simulating the development of the area. As a user-friendly web-server, Euk-ECC-mPLoc is freely accessible to the public at the website http://levis.tongji.edu.cn:8080/bioinfo/Euk-ECC-mPLoc/. We believe that Euk-ECC-mPLoc may become a useful high-throughput tool, or at least play a complementary role to the existing predictors in identifying subcellular locations of eukaryotic proteins.	[Wang, Xiao; Li, Guo-Zheng] Tongji Univ, Dept Control Sci & Engn, MOE Key Lab Embedded Syst & Serv Comp, Shanghai 200092, Peoples R China	Tongji University	Wang, X (corresponding author), Tongji Univ, Dept Control Sci & Engn, MOE Key Lab Embedded Syst & Serv Comp, Shanghai 200092, Peoples R China.	gzli@tongji.edu.cn	Li, Guo-Zheng/D-5744-2011	Li, Guo-Zheng/0000-0001-5568-0347	Natural Science Foundation of China [61005006]; Fundamental Research Funds for the Central Universities	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Natural Science Foundation of China under grant no. 61005006, and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2009, NATURAL SCI, V1, P6392; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2006, BIOCHEM BIOPH RES CO, V347, P150, DOI 10.1016/j.bbrc.2006.06.059; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Ding H, 2011, PROTEIN PEPTIDE LETT, V18, P58, DOI 10.2174/092986611794328708; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Ding YS, 2008, PATTERN RECOGN LETT, V29, P1887, DOI 10.1016/j.patrec.2008.06.007; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gerstein M, 2001, CURR OPIN STRUC BIOL, V11, P327, DOI 10.1016/S0959-440X(00)00209-8; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Guo JX, 2011, J COMPUT CHEM, V32, P1612, DOI 10.1002/jcc.21740; Hu LL, 2011, PROTEIN PEPTIDE LETT, V18, P552, DOI 10.2174/092986611795222795; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Huang Y, 2004, BIOINFORMATICS, V20, P21, DOI 10.1093/bioinformatics/btg366; Jiang XY, 2008, AMINO ACIDS, V34, P669, DOI 10.1007/s00726-008-0034-9; Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443; Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P1473; Khan A, 2011, COMPUT BIOL CHEM, V35, P218, DOI 10.1016/j.compbiolchem.2011.05.003; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Li ZC, 2009, AMINO ACIDS, V37, P415, DOI 10.1007/s00726-008-0170-2; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; Lin J, 2011, AFR J BIOTECHNOL, V10, P16963, DOI 10.5897/AJB11.429; Lin J, 2011, PROTEIN PEPTIDE LETT, V18, P1219, DOI 10.2174/092986611797642797; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Millar AH, 2009, PLANT CELL, V21, P1625, DOI 10.1105/tpc.109.066019; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Nakai K, 2000, ADV PROTEIN CHEM, V54, P277, DOI 10.1016/S0065-3233(00)54009-1; Nanni L, 2011, IEEE ACM T COMPUTATI; Nanni L, 2008, AMINO ACIDS, V34, P653, DOI 10.1007/s00726-007-0018-1; Niu B, 2008, MOL DIVERS, V12, P41, DOI 10.1007/s11030-008-9073-0; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Qiu JD, 2011, J MOL GRAPH MODEL, V30, P129, DOI 10.1016/j.jmgm.2011.06.014; Qiu JD, 2010, PROTEIN PEPTIDE LETT, V17, P715, DOI 10.2174/092986610791190372; Qiu JD, 2009, ANAL BIOCHEM, V390, P68, DOI 10.1016/j.ab.2009.04.009; Read J, 2009, LECT NOTES ARTIF INT, V5782, P254, DOI 10.1007/978-3-642-04174-7_17; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shen HB, 2007, AMINO ACIDS, V33, P57, DOI 10.1007/s00726-006-0478-8; Shen HB, 2007, BIOCHEM BIOPH RES CO, V355, P1006, DOI 10.1016/j.bbrc.2007.02.071; Shen HB, 2010, J BIOMOL STRUCT DYN, V28, P175, DOI 10.1080/07391102.2010.10507351; Shen HB, 2010, J THEOR BIOL, V264, P326, DOI 10.1016/j.jtbi.2010.01.018; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Shen HB, 2009, PROTEIN PEPTIDE LETT, V16, P1478, DOI 10.2174/092986609789839322; SMITH C, 2008, SUBCELLULAR TARGETIN; Tsoumakas G, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P667, DOI 10.1007/978-0-387-09823-4_34; Wang JR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-174; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Wang YC, 2010, PROTEIN PEPTIDE LETT, V17, P1441, DOI 10.2174/0929866511009011441; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu LZ, 2010, J THEOR BIOL, V267, P1, DOI 10.1016/j.jtbi.2010.08.001; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhang GY, 2008, PROTEIN PEPTIDE LETT, V15, P1132, DOI 10.2174/092986608786071184; Zhang GY, 2008, J THEOR BIOL, V253, P310, DOI 10.1016/j.jtbi.2008.03.015; Zhang SW, 2008, AMINO ACIDS, V35, P591, DOI 10.1007/s00726-008-0086-x; Zhang SW, 2008, AMINO ACIDS, V34, P565, DOI 10.1007/s00726-007-0010-9; Zhang S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-127; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001; Zou DS, 2011, J COMPUT CHEM, V32, P271, DOI 10.1002/jcc.21616	90	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36317	10.1371/journal.pone.0036317	http://dx.doi.org/10.1371/journal.pone.0036317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629314	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345300007
J	Golias, J; Schwarzer, M; Wallner, M; Kverka, M; Kozakova, H; Srutkova, D; Klimesova, K; Sotkovsky, P; Palova-Jelinkova, L; Ferreira, F; Tuckova, L				Golias, Jaroslav; Schwarzer, Martin; Wallner, Michael; Kverka, Miloslav; Kozakova, Hana; Srutkova, Dagmar; Klimesova, Klara; Sotkovsky, Petr; Palova-Jelinkova, Lenka; Ferreira, Fatima; Tuckova, Ludmila			Heat-Induced Structural Changes Affect OVA-Antigen Processing and Reduce Allergic Response in Mouse Model of Food Allergy	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANES; BIRCH POLLEN ALLERGEN; MURINE MODEL; ORAL TOLERANCE; EGG ALLERGY; ALKALINE-PHOSPHATASE; DENDRITIC CELLS; CELIAC-DISEASE; MICE; SENSITIZATION	Background and Aims: The egg protein ovalbumin (OVA) belongs to six most frequent food allergens. We investigated how thermal processing influences its ability to induce allergic symptoms and immune responses in mouse model of food allergy. Methodology/Principal Findings: Effect of increased temperature (70 degrees C and 95 degrees C) on OVA secondary structure was characterized by circular dichroism and by the kinetics of pepsin digestion with subsequent HPLC. BALB/c mice were sensitized intraperitoneally and challenged with repeated gavages of OVA or OVA heated to 70 degrees C (h-OVA). Levels of allergen-specific serum antibodies were determined by ELISA (IgA and IgGs) or by beta-hexosaminidase release test (IgE). Specific activities of digestive enzymes were determined in brush border membrane vesicles of jejunal enterocytes. Cytokine production and changes in regulatory T cells in mesenteric lymph nodes and spleen were assessed by ELISA and FACS. Heating of OVA to 70 degrees C caused mild irreversible changes in secondary structure compared to boiling to 95 degrees C (b-OVA), but both OVA treatments led to markedly different digestion kinetics and Tregs induction ability in vitro, compared to native OVA. Heating of OVA significantly decreased clinical symptoms (allergic diarrhea) and immune allergic response on the level of IgE, IL-4, IL-5, IL-13. Furthermore, h-OVA induced lower activities of serum mast cell protease-1 and enterocyte brush border membrane alkaline phosphatase as compared to native OVA. On the other hand h-OVA stimulated higher IgG2a in sera and IFN-gamma secretion by splenocytes. Conclusions: Minor irreversible changes in OVA secondary structure caused by thermal processing changes both its digestion and antigenic epitopes formation, which leads to activation of different T cell subpopulations, induces shift towards Th1 response and ultimately reduces its allergenicity.	[Golias, Jaroslav; Kverka, Miloslav; Klimesova, Klara; Sotkovsky, Petr; Palova-Jelinkova, Lenka; Tuckova, Ludmila] Acad Sci Czech Republic, Inst Microbiol, Dept Immunol & Gnotobiol, Vvi, Prague, Czech Republic; [Schwarzer, Martin; Kozakova, Hana; Srutkova, Dagmar] Acad Sci Czech Republic, Inst Microbiol, Dept Immunol & Gnotobiol, Vvi, Novy Hradek, Czech Republic; [Wallner, Michael; Ferreira, Fatima] Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Salzburg University	Golias, J (corresponding author), Acad Sci Czech Republic, Inst Microbiol, Dept Immunol & Gnotobiol, Vvi, Prague, Czech Republic.	schwarzer@biomed.cas.cz	Wallner, Michael/L-5437-2015; Šrůtková, Dagmar/H-8511-2014; Goliáš, Jaroslav/J-6896-2014; Ferreira, Fatima/E-4889-2011; Ferreira, Fatima/AAB-4321-2019; Schwarzer, Martin/P-9871-2017; Kozakova, Hana/I-1153-2014; Kverka, Miloslav/H-2507-2014; Kostovcikova, Klara/J-6851-2014	Wallner, Michael/0000-0001-6568-7892; Šrůtková, Dagmar/0000-0003-0054-5396; Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Schwarzer, Martin/0000-0002-1401-6578; Kozakova, Hana/0000-0001-7352-5922; Kverka, Miloslav/0000-0002-1335-5252; Kostovcikova, Klara/0000-0003-1821-398X	Czech Science Foundation [GA310/07/0414, 310/08/H077]; Synlab; Academy of Sciences of the Czech Republic [IAA500200801, IAA500200710, KJB500200904]; Czech Ministry of Education, Youth and Sports [2B06155, LC07017]; Institutional Research Concept [AV0Z50200510]	Czech Science Foundation(Grant Agency of the Czech Republic); Synlab; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Institutional Research Concept	This work was supported by grants from the Czech Science Foundation (GA310/07/0414, 310/08/H077 and 310/08/H077), http://www.gacr.cz/; Synlab (http:www.synlab.cz), the Academy of Sciences of the Czech Republic (IAA500200801, IAA500200710 and KJB500200904), http://www.gaav.cz/; the Czech Ministry of Education, Youth and Sports (2B06155 and LC07017), http://www.msmt.cz; and by Institutional Research Concept Grant AV0Z50200510, http://www.isvav.cz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Brandt EB, 2009, J ALLERGY CLIN IMMUN, V123, P53, DOI 10.1016/j.jaci.2008.10.001; Brunner R, 2009, ALLERGY, V64, P890, DOI 10.1111/j.1398-9995.2008.01933.x; Dearman RJ, 2007, METHODS, V41, P91, DOI 10.1016/j.ymeth.2006.07.008; Detel D, 2007, J PEDIATR GASTR NUTR, V45, P65, DOI 10.1097/MPG.0b013e318054b085; Diesner SC, 2008, IMMUNOL LETT, V121, P45, DOI 10.1016/j.imlet.2008.08.006; Harada T, 2003, AM J PHYSIOL-GASTR L, V284, pG255, DOI 10.1152/ajpgi.00244.2002; Herouet-Guicheney C, 2009, J APPL TOXICOL, V29, P141, DOI 10.1002/jat.1391; Himly M, 2009, ALLERGY, V64, P1038, DOI 10.1111/j.1398-9995.2009.01957.x; Hudcovic T, 2009, PHYSIOL RES, V58, P101, DOI 10.33549/physiolres.931340; Huntington JA, 2001, J CHROMATOGR B, V756, P189, DOI 10.1016/S0378-4347(01)00108-6; Johansen P, 2005, EUR J IMMUNOL, V35, P3591, DOI 10.1002/eji.200535076; KESSLER M, 1978, BIOCHIM BIOPHYS ACTA, V506, P136, DOI 10.1016/0005-2736(78)90440-6; Kozakova H, 2001, FOLIA MICROBIOL, V46, P573, DOI 10.1007/BF02818005; Kozakova H, 2006, MICROBES INFECT, V8, P2629, DOI 10.1016/j.micinf.2006.07.008; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; Lee SY, 2001, CLIN IMMUNOL, V101, P220, DOI 10.1006/clim.2001.5122; Lehrer SB, 2004, J IMMUNOL METHODS, V284, P1, DOI 10.1016/j.jim.2003.08.017; Lemon-Mule H, 2008, J ALLERGY CLIN IMMUN, V122, P977, DOI 10.1016/j.jaci.2008.09.007; Li XM, 1999, J ALLERGY CLIN IMMUN, V103, P206, DOI 10.1016/S0091-6749(99)70492-6; Lied GA, 2011, INT J GEN MED, V4, P389, DOI 10.2147/IJGM.S17655; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynes MD, 2011, LIFE SCI, V88, P384, DOI 10.1016/j.lfs.2010.12.015; Martos G, 2011, J ALLERGY CLIN IMMUN, V127, P990, DOI 10.1016/j.jaci.2011.01.057; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mine Y, 2007, BBA-PROTEINS PROTEOM, V1774, P200, DOI 10.1016/j.bbapap.2006.12.003; Nowak-Wegrzyn A, 2011, J ALLERGY CLIN IMMUN, V127, P558, DOI 10.1016/j.jaci.2010.12.1098; Pali-Scholl I, 2010, CLIN EXP ALLERGY, V40, P1091, DOI 10.1111/j.1365-2222.2010.03468.x; Perrier C, 2010, CLIN EXP ALLERGY, V40, P153, DOI 10.1111/j.1365-2222.2009.03329.x; Repa A, 2008, IMMUNOL LETT, V117, P50, DOI 10.1016/j.imlet.2007.11.025; Roth-Walter F, 2008, ALLERGY, V63, P882, DOI 10.1111/j.1398-9995.2008.01673.x; Saldanha JCS, 2004, BRAZ J MED BIOL RES, V37, P809, DOI 10.1590/S0100-879X2004000600005; Savage JH, 2007, J ALLERGY CLIN IMMUN, V120, P1413, DOI 10.1016/j.jaci.2007.09.040; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1077, DOI 10.1016/j.jaci.2010.02.038; SIMON PM, 1979, BIOCHEM J, V178, P407, DOI 10.1042/bj1780407; SMITH MW, 1990, EXP PHYSIOL, V75, P613, DOI 10.1113/expphysiol.1990.sp003439; Tuckova L, 2002, J LEUKOCYTE BIOL, V71, P625; Vaali K, 2006, SCAND J GASTROENTERO, V41, P1405, DOI 10.1080/00365520600815639; van der Ventel ML, 2011, MOL IMMUNOL, V48, P637, DOI 10.1016/j.molimm.2010.11.001; Viney JL, 1998, J IMMUNOL, V160, P5815; WHITACRE CC, 1991, J IMMUNOL, V147, P2155; Wiedermann U, 1999, J ALLERGY CLIN IMMUN, V103, P1202, DOI 10.1016/S0091-6749(99)70200-9; Yang M, 2010, CLIN EXP ALLERGY, V40, P668, DOI 10.1111/j.1365-2222.2009.03442.x	44	40	45	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37156	10.1371/journal.pone.0037156	http://dx.doi.org/10.1371/journal.pone.0037156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629361	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100015
J	Hure, AJ; Powers, JR; Mishra, GD; Herbert, DL; Byles, JE; Loxton, D				Hure, Alexis J.; Powers, Jennifer R.; Mishra, Gita D.; Herbert, Danielle L.; Byles, Julie E.; Loxton, Deborah			Miscarriage, Preterm Delivery, and Stillbirth: Large Variations in Rates within a Cohort of Australian Women	PLOS ONE			English	Article							RISK-FACTORS; PREGNANCY; BIRTH	Objectives: We aimed to use simple clinical questions to group women and provide their specific rates of miscarriage, preterm delivery, and stillbirth for reference. Further, our purpose was to describe who has experienced particularly low or high rates of each event. Methods: Data were collected as part of the Australian Longitudinal Study on Women's Health, a national prospective cohort. Reproductive histories were obtained from 5806 women aged 31-36 years in 2009, who had self-reported an outcome for one or more pregnancy. Age at first birth, number of live births, smoking status, fertility problems, use of in vitro fertilisation (IVF), education and physical activity were the variables that best separated women into groups for calculating the rates of miscarriage, preterm delivery, and stillbirth. Results: Women reported 10,247 live births, 2544 miscarriages, 1113 preterm deliveries, and 113 stillbirths. Miscarriage was correlated with stillbirth (r = 0.09, P<0.001). The calculable rate of miscarriage ranged from 11.3 to 86.5 miscarriages per 100 live births. Women who had high rates of miscarriage typically had fewer live births, were more likely to smoke and were more likely to have tried unsuccessfully to conceive for >= 12 months. The highest proportion of live preterm delivery (32.2%) occurred in women who had one live birth, had tried unsuccessfully to conceive for >= 12 months, had used IVF, and had 12 years education or equivalent. Women aged 14-19.99 years at their first birth and reported low physical activity had 38.9 stillbirths per 1000 live births, compared to the lowest rate at 5.5 per 1000 live births. Conclusion: Different groups of women experience vastly different rates of each adverse pregnancy event. We have used simple questions and established reference data that will stratify women into low-and high-rate groups, which may be useful in counselling those who have experienced miscarriage, preterm delivery, or stillbirth, plus women with fertility intent.	[Hure, Alexis J.; Powers, Jennifer R.; Byles, Julie E.; Loxton, Deborah] Univ Newcastle, Res Ctr Gender Hlth & Ageing, Callaghan, NSW 2308, Australia; [Mishra, Gita D.; Herbert, Danielle L.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia	University of Newcastle; University of Queensland	Hure, AJ (corresponding author), Univ Newcastle, Res Ctr Gender Hlth & Ageing, Callaghan, NSW 2308, Australia.	alexis.hure@newcastle.edu.au	Powers, Jennifer R/A-8108-2011; Herbert, Danielle/A-1685-2010; Byles, Julie E/C-5062-2008	Herbert, Danielle/0000-0001-5133-9731; Byles, Julie E/0000-0002-3984-6877; Hure, Alexis/0000-0003-2225-0986	Department of Health and Ageing [G0189875]; National Health and Medical Research Council [APP1000986]	Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The Australian Longitudinal Study on Women's Health was funded by the Department of Health and Ageing (G0189875), http://www.health.gov.au/. This work was undertaken as part of the Centre for Research Excellence in Women's Health in the 21st Century (CREWH21), funded by the National Health and Medical Research Council (APP1000986), http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen K, 2004, AM J EPIDEMIOL, V159, P155, DOI 10.1093/aje/kwh034; [Anonymous], 2008, FERTIL STERIL, V89, P1603, DOI 10.1016/j.fertnstert.2008.03.002; Australian Government, 2012, FAM ASS GUID VERS 11; Australian Institute of Health and Welfare, 2000, NAT HLTH DAT DICT VE; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; BOUE J, 1975, TERATOLOGY, V12, P11, DOI 10.1002/tera.1420120103; Brown WJ, 1998, WOMEN HEALTH, V28, P23; Brown WJBL, 1996, J WOMENS HEALTH, V5, P467, DOI DOI 10.1089/JWH.1996.5.467; de La Rochebrochard E, 2002, HUM REPROD, V17, P1649, DOI 10.1093/humrep/17.6.1649; El-Sayed MM, 2009, J OBSTET GYNAECOL, V29, P681, DOI 10.3109/01443610903215399; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Forbes LS, 1997, TRENDS ECOL EVOL, V12, P446, DOI 10.1016/S0169-5347(97)01179-8; George L, 2006, PAEDIATR PERINAT EP, V20, P119, DOI 10.1111/j.1365-3016.2006.00703.x; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Gray RH, 2000, AM J PUBLIC HEALTH, V90, P1452, DOI 10.2105/AJPH.90.9.1452; GUERNERI S, 1987, HUM REPROD, V2, P735, DOI 10.1093/oxfordjournals.humrep.a136623; Herbert D, 2009, WOMEN HEALTH ISS, V19, P21, DOI 10.1016/j.whi.2008.08.007; JOFFE M, 1994, FERTIL STERIL, V62, P71; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Li Z, 2011, AUSTRALIAS MOTHERS B; Miranda ML, 2011, PUBLIC HEALTH REP, V126, P797, DOI 10.1177/003335491112600605; MORRISON J, 1989, BRIT J OBSTET GYNAEC, V96, P298, DOI 10.1111/j.1471-0528.1989.tb02389.x; National Health and Medical Research Council, 2001, AUSTR AL GUID HLTH R; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Reddy UM, 2009, OBSTET GYNECOL, V114, P901, DOI 10.1097/AOG.0b013e3181b8f6e4; Simmons RK, 2006, SOC SCI MED, V63, P1934, DOI 10.1016/j.socscimed.2006.04.024; Tulandi T., 2011, UPTODATE; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; World Health Organization, 2006, GLOB DAT BOD MASS IN	33	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37109	10.1371/journal.pone.0037109	http://dx.doi.org/10.1371/journal.pone.0037109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VD	22629355	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100012
J	Phillips, HM; Papoutsi, T; Soenen, H; Ybot-Gonzalez, P; Henderson, DJ; Chaudhry, B				Phillips, Helen M.; Papoutsi, Tania; Soenen, Helena; Ybot-Gonzalez, Patricia; Henderson, Deborah J.; Chaudhry, Bill			Neural Crest Cell Survival Is Dependent on Rho Kinase and Is Required for Development of the Mid Face in Mouse Embryos	PLOS ONE			English	Article							VENTRAL BODY-WALL; FRONTONASAL DYSPLASIA; ROCK-I; MIGRATION; ACTIVATION; GTPASES; CLOSURE; ROLES; ACTIN	Neural crest cells (NCC) give rise to much of the tissue that forms the vertebrate head and face, including cartilage and bone, cranial ganglia and teeth. In this study we show that conditional expression of a dominant-negative (DN) form of Rho kinase (Rock) in mouse NCC results in severe hypoplasia of the frontonasal processes and first pharyngeal arch, ultimately resulting in reduction of the maxilla and nasal bones and severe craniofacial clefting affecting the nose, palate and lip. These defects resemble frontonasal dysplasia in humans. Disruption of the actin cytoskeleton, which leads to abnormalities in cell-matrix attachment, is seen in the RockDN;Wnt1-cre mutant embryos. This leads to elevated cell death, resulting in NCC deficiency and hypoplastic NCC-derived craniofacial structures. Rock is thus essential for survival of NCC that form the craniofacial region. We propose that reduced NCC numbers in the frontonasal processes and first pharyngeal arch, resulting from exacerbated cell death, may be the common mechanism underlying frontonasal dysplasia.	[Phillips, Helen M.; Papoutsi, Tania; Soenen, Helena; Henderson, Deborah J.; Chaudhry, Bill] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ybot-Gonzalez, Patricia] Hosp Infantil Virgen del Rocio, Dept Pediat, Seville, Spain	Newcastle University - UK; Virgen del Rocio University Hospital	Phillips, HM (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	deborah.henderson@ncl.ac.uk	IBIS, INMUNODEFICIEN/C-1245-2016; Papoutsi, Tania/F-2324-2016; Ybot-González, Patricia/D-6947-2014; IBIS, NEUROCIENCIA APLICAD/C-2516-2016; ybot-gonzalez, patricia/C-9625-2016	Papoutsi, Tania/0000-0001-6393-7253; Ybot-González, Patricia/0000-0001-7836-2659; Phillips, Helen Margaret/0000-0003-4513-9148; Henderson, Deborah/0000-0002-2705-5998	British Heart Foundation [BS/05/003, RG/07/007]; British Heart Foundation [RG/07/007/23635, FS/11/20/28857] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	Funding provided by British Heart Foundation (grants BS/05/003 and RG/07/007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Beverdam A, 2001, DEVELOPMENT, V128, P3975; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Cordero DR, 2011, AM J MED GENET A, V155A, P270, DOI 10.1002/ajmg.a.33702; Daley WP, 2012, DEVELOPMENT, V139, P411, DOI 10.1242/dev.075366; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Fogelgren B, 2008, DEV DYNAM, V237, P1767, DOI 10.1002/dvdy.21587; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Groysman M, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-27; Hildreth V, 2009, J ANAT, V214, P894, DOI 10.1111/j.1469-7580.2009.01087.x; Iwao K, 2008, GRAEF ARCH CLIN EXP, V246, P1117, DOI 10.1007/s00417-008-0845-0; Knight RD, 2006, ADV EXP MED BIOL, V589, P120; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Ma WB, 1999, CLIN ANAT, V12, P315, DOI 10.1002/(SICI)1098-2353(1999)12:5<315::AID-CA2>3.0.CO;2-2; McBratney BM, 2003, ANAT REC PART A, V271A, P291, DOI 10.1002/ar.a.10034; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Qu SM, 1999, DEVELOPMENT, V126, P359; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Thomas PS, 2010, DEV BIOL, V340, P613, DOI 10.1016/j.ydbio.2010.02.021; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Thumkeo D, 2003, MOL CELL BIOL, V23, P5043, DOI 10.1128/MCB.23.14.5043-5055.2003; Twigg SRF, 2009, AM J HUM GENET, V84, P698, DOI 10.1016/j.ajhg.2009.04.009; Wei L, 2001, DEVELOPMENT, V128, P2953; Wiradjaja F, 2010, BIRTH DEFECTS RES C, V90, P8, DOI 10.1002/bdrc.20172	36	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37685	10.1371/journal.pone.0037685	http://dx.doi.org/10.1371/journal.pone.0037685			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629443	Green Published, gold			2022-12-25	WOS:000305343100046
J	Zimmer, SL; McEvoy, SM; Menon, S; Read, LK				Zimmer, Sara L.; McEvoy, Sarah M.; Menon, Sarita; Read, Laurie K.			Additive and Transcript-Specific Effects of KPAP1 and TbRND Activities on 3 ' Non-Encoded Tail Characteristics and mRNA Stability in Trypanosoma brucei	PLOS ONE			English	Article							INDUCIBLE EXPRESSION SYSTEM; DEVELOPMENTAL REGULATION; MITOCHONDRIAL RNAS; NADH DEHYDROGENASE; APOCYTOCHROME-B; POLYADENYLATION; COMPLEX; ENDONUCLEASE; INFORMATION; METABOLISM	Short, non-encoded oligo(A), oligo(U), or A/U tails can impact mRNA stability in kinetoplastid mitochondria. However, a comprehensive picture of the relative effects of these modifications in RNA stability is lacking. Furthermore, while the U-preferring exoribonuclease TbRND acts on U-tailed gRNAs, its role in decay of uridylated mRNAs has only been cursorily investigated. Here, we analyzed the roles of mRNA 3' tail composition and TbRND in RNA decay using cells harbouring single or double knockdown of TbRND and the KPAP1 poly(A) polymerase. Analysis of mRNA abundance and tail composition reveals dramatic and transcript-specific effects of adenylation and uridylation on mitochondrial RNAs. Oligo(A) and A-rich tails can stabilize a proportion of edited and never-edited RNAs. However, non-tailed RNAs are not inherently unstable, implicating additional stability determinants and/or spatial segregation of sub-populations of a given RNA in regulation of RNA decay. Oligo(U) tails, which have been shown to contribute to decay of some never-edited RNAs, are not universally destabilizing. We also show that RNAs display very different susceptibility to uridylation in the absence of KPAP1, a factor that may contribute to regulation of decay. Finally, 3' tail composition apparently impacts the ability of an RNA to be edited.	[Zimmer, Sara L.; McEvoy, Sarah M.; Menon, Sarita; Read, Laurie K.] SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zimmer, SL (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14260 USA.	lread@buffalo.edu		Menon, Sarita/0000-0001-9548-149X; Zimmer, Sara/0000-0002-1707-1839	National Institutes of Health [R01 AI077520, F32 AI092902]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077520, F32AI092902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the National Institutes of Health (R01 AI077520 to LKR; F32 AI092902 to SLZ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; Aphasizhev R, 2011, WIRES RNA, V2, P669, DOI 10.1002/wrna.82; Aphasizhev R, 2011, RES MICROBIOL, V162, P655, DOI 10.1016/j.resmic.2011.04.015; Aphasizheva I, 2011, MOL CELL, V42, P106, DOI 10.1016/j.molcel.2011.02.021; Aphasizheva I, 2010, MOL CELL BIOL, V30, P1555, DOI 10.1128/MCB.01281-09; Aphasizheva I, 2009, RNA, V15, P1322, DOI 10.1261/rna.1538809; BHAT GJ, 1992, MOL BIOCHEM PARASIT, V52, P231, DOI 10.1016/0166-6851(92)90055-O; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DECKER CJ, 1990, CELL, V61, P1001, DOI 10.1016/0092-8674(90)90065-M; Etheridge RD, 2008, EMBO J, V27, P1596, DOI 10.1038/emboj.2008.87; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FEAGIN JE, 1985, NUCLEIC ACIDS RES, V13, P4577, DOI 10.1093/nar/13.12.4577; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Kao CY, 2007, MOL BIOCHEM PARASIT, V154, P158, DOI 10.1016/j.molbiopara.2007.04.014; Kao CY, 2005, MOL CELL BIOL, V25, P1634, DOI 10.1128/MCB.25.5.1634-1644.2005; Koslowsky DJ, 1997, MOL BIOCHEM PARASIT, V90, P81, DOI 10.1016/S0166-6851(97)00133-3; KOSLOWSKY DJ, 1990, CELL, V62, P901, DOI 10.1016/0092-8674(90)90265-G; Lisitsky I, 1996, P NATL ACAD SCI USA, V93, P13398, DOI 10.1073/pnas.93.23.13398; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Mattiacio JL, 2008, NUCLEIC ACIDS RES, V36, P319, DOI 10.1093/nar/gkm690; MICHELOTTI EF, 1992, MOL BIOCHEM PARASIT, V54, P31, DOI 10.1016/0166-6851(92)90092-X; Osato D, 2009, RNA, V15, P1338, DOI 10.1261/rna.1642809; Panigrahi AK, 2006, RNA, V12, P1038, DOI 10.1261/rna.45506; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Penschow JL, 2004, EUKARYOT CELL, V3, P1206, DOI 10.1128/EC.3.5.1206-1216.2004; READ LK, 1992, J BIOL CHEM, V267, P1123; RILEY GR, 1995, NUCLEIC ACIDS RES, V23, P708, DOI 10.1093/nar/23.4.708; Ryan CM, 2003, J BIOL CHEM, V278, P32753, DOI 10.1074/jbc.M303552200; Schnaufer A, 2002, INT J PARASITOL, V32, P1071, DOI 10.1016/S0020-7519(02)00020-6; Schnaufer A, 2010, J BIOL CHEM, V285, P5282, DOI 10.1074/jbc.M109.059378; SEIWERT SD, 1994, SCIENCE, V266, P114, DOI 10.1126/science.7524149; SOUZA AE, 1992, MOL CELL BIOL, V12, P2100, DOI 10.1128/MCB.12.5.2100; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Williams S, 2008, EXP PARASITOL, V118, P420, DOI 10.1016/j.exppara.2007.10.008; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zimmer SL, 2011, J BIOL CHEM, V286, P10329, DOI 10.1074/jbc.M110.152439	40	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37639	10.1371/journal.pone.0037639	http://dx.doi.org/10.1371/journal.pone.0037639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629436	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343100043
J	Kratzat, S; Nikolova, V; Miething, C; Hoellein, A; Schoeffmann, S; Gorka, O; Pietschmann, E; Illert, AL; Ruland, J; Peschel, C; Nilsson, J; Duyster, J; Keller, U				Kratzat, Susanne; Nikolova, Viktoriya; Miething, Cornelius; Hoellein, Alexander; Schoeffmann, Stephanie; Gorka, Oliver; Pietschmann, Elke; Illert, Anna-Lena; Ruland, Juergen; Peschel, Christian; Nilsson, Jonas; Duyster, Justus; Keller, Ulrich			Cks1 Is Required for Tumor Cell Proliferation but Not Sufficient to Induce Hematopoietic Malignancies	PLOS ONE			English	Article							CDK INHIBITOR P27; RETRACTED ARTICLE. SEE; BOX PROTEIN SKP2; BREAST-CANCER; MICE LACKING; P27(KIP1); EXPRESSION; SURVIVAL; LYMPHOMAGENESIS; TUMORIGENESIS	The Cks1 component of the SCFSkp2 complex is necessary for p27(Kip1) ubiquitylation and degradation. Cks1 expression is elevated in various B cell malignancies including Burkitt lymphoma and multiple myeloma. We have previously shown that loss of Cks1 results in elevated p27(Kip1) levels and delayed tumor development in a mouse model of Myc-induced B cell lymphoma. Surprisingly, loss of Skp2 in the same mouse model also resulted in elevated p27(Kip1) levels but exhibited no impact on tumor onset. This raises the possibility that Cks1 could have other oncogenic activities than suppressing p27(Kip1). To challenge this notion we have targeted overexpression of Cks1 to B cells using a conditional retroviral bone marrow transduction-transplantation system. Despite potent ectopic overexpression, Cks1 was unable to promote B cell hyperproliferation or B cell malignancies, indicating that Cks1 is not oncogenic when overexpressed in B cells. Since Skp2 overexpression can drive T-cell tumorigenesis or other cancers we also widened the quest for oncogenic activity of Cks1 by ubiquitously expressing Cks1 in hematopoetic progenitors. At variance with c-Myc overexpression, which caused acute myeloid leukemia, Cks1 overexpression did not induce myeloproliferation or leukemia. Therefore, despite being associated with a poor prognosis in various malignancies, sole Cks1 expression is insufficient to induce lymphoma or a myeloproliferative disease in vivo.	[Kratzat, Susanne; Nikolova, Viktoriya; Miething, Cornelius; Hoellein, Alexander; Schoeffmann, Stephanie; Pietschmann, Elke; Illert, Anna-Lena; Peschel, Christian; Duyster, Justus; Keller, Ulrich] Tech Univ Munich, Dept Med 3, Munich, Germany; [Gorka, Oliver; Ruland, Juergen] Tech Univ Munich, Inst Clin Chem & Biochem, Munich, Germany; [Nilsson, Jonas] Univ Gothenburg, Sahlgrenska Canc Ctr, Gothenburg, Sweden	Technical University of Munich; Technical University of Munich; University of Gothenburg	Kratzat, S (corresponding author), Tech Univ Munich, Dept Med 3, Munich, Germany.	ulrich.keller@lrz.tum.de	Miething, Cornelius/F-9498-2014; Illert, Anna L/G-8127-2019; Gorka, Oliver/AAF-1633-2020; Ruland, Jürgen/Q-6680-2018; Nilsson, Jonas/E-5346-2013	Miething, Cornelius/0000-0003-4699-3805; Ruland, Jürgen/0000-0002-8381-3597; Gorka, Oliver/0000-0002-8245-3008; Nilsson, Jonas/0000-0003-0346-6837; Hollein, Alexander/0000-0002-9799-7809	Deutsche Forschungsgemeinschaft (German Research Foundation) [SFB-TRR54]; Deutsche Jose Carreras Leukamie Stiftung (Jose Carreras International Leukemia Foundation) (DJCLS) [R11/18]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Deutsche Jose Carreras Leukamie Stiftung (Jose Carreras International Leukemia Foundation) (DJCLS)	This work was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation) (SFB-TRR54) and the Deutsche Jose Carreras Leukamie Stiftung (Jose Carreras International Leukemia Foundation) (DJCLS, R11/18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Bourne Y, 1996, CELL, V84, P863, DOI 10.1016/S0092-8674(00)81065-X; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chang H, 2006, BRIT J HAEMATOL, V135, P486, DOI 10.1111/j.1365-2141.2006.06325.x; Chang H, 2010, HAEMATOL-HEMATOL J, V95, P1542, DOI 10.3324/haematol.2010.022210; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Coats S, 1999, CURR BIOL, V9, P163, DOI 10.1016/S0960-9822(99)80086-4; den Hollander J, 2010, BLOOD; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Inui N, 2003, BIOCHEM BIOPH RES CO, V303, P978, DOI 10.1016/S0006-291X(03)00469-8; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Krek W, 1998, CURR OPIN GENET DEV, V8, P36, DOI 10.1016/S0959-437X(98)80059-2; Lan YS, 2008, INT J CANCER, V123, P543, DOI 10.1002/ijc.23548; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Li MH, 2004, INT J ONCOL, V24, P305; Liberal V, 2011, P NATL ACAD SCI US; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; Miething C, 2006, LEUKEMIA, V20, P650, DOI 10.1038/sj.leu.2404151; Morris MC, 1998, BIOCHEMISTRY-US, V37, P14257, DOI 10.1021/bi980913u; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Old JB, 2010, MOL CANCER RES, V8, P353, DOI 10.1158/1541-7786.MCR-09-0232; Oostendorp RAJ, 2002, BLOOD, V99, P1183, DOI 10.1182/blood.V99.4.1183; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shim EH, 2003, CANCER RES, V63, P1583; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Slotky M, 2005, BREAST CANCER RES, V7, pR737, DOI 10.1186/bcr1278; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Su AI, 2001, CANCER RES, V61, P7388; Supriatno, 2003, ONCOL REP, V10, P527; Wang XC, 2009, J CANCER RES CLIN, V135, P1393, DOI 10.1007/s00432-009-0582-8; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Wong YF, 2006, INT J CANCER, V118, P2461, DOI 10.1002/ijc.21660	41	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37433	10.1371/journal.pone.0037433	http://dx.doi.org/10.1371/journal.pone.0037433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624029	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500114
J	Liu, XY; Ren, BA; Gao, H; Liu, M; Dai, HQ; Song, FH; Yu, ZY; Wang, SJ; Hu, JC; Kokare, CR; Zhang, LX				Liu, Xiangyang; Ren, Biao; Gao, Hong; Liu, Mei; Dai, Huanqin; Song, Fuhang; Yu, Zhenyan; Wang, Shujin; Hu, Jiangchun; Kokare, Chandrakant R.; Zhang, Lixin			Optimization for the Production of Surfactin with a New Synergistic Antifungal Activity	PLOS ONE			English	Article							BACILLUS-NATTO TK-1; LIPOPEPTIDE BIOSURFACTANT; MICROBIAL SURFACTANTS; SUBTILIS; INHIBITION; ISOFORMS; MODELS	Background: Two of our long term efforts are to discover compounds with synergistic antifungal activity from metabolites of marine derived microbes and to optimize the production of the interesting compounds produced by microorganisms. In this respect, new applications or mechanisms of already known compounds with a high production yield could be continually identified. Surfactin is a well-known lipopeptide biosurfactant with a broad spectrum of antimicrobial and antiviral activity; however, there is less knowledge on surfactin's antifungal activity. In this study, we investigated the synergistic antifungal activity of C-15-surfactin and the optimization of its production by the response surface method. Methodology/Principal Findings: Using a synergistic antifungal screening model, we found that the combination of C-15-surfactin and ketoconazole (KTC) showed synergistic antifungal effect on Candida albicans SC5314 when the concentrations of C-15-surfactin and KTC were 6.25 mu g/mL and 0.004 mu g/mL, respectively. These concentrations were lower than their own efficient antifungal concentrations, which are >100 mu g/mL and 0.016 mu g/mL, respectively. The production of C-15-surfactin from Bacillus amyloliquefaciens was optimized by the response surface methodology in shaker flask cultivation. The Plackett-Burman design found sucrose, ammonium nitrate and NaH2PO4 center dot 2H(2)O to have significant effects on C-15-surfactin production. The optimum values of the tested variables were 21.17 g/L sucrose, 2.50 g/L ammonium nitrate and 11.56 g/L NaH2PO4 center dot 2H(2)O. A production of 134.2 mg/L, which were in agreement with the prediction, was observed in a verification experiment. In comparison to the production of original level (88.6 mg/L), a 1.52-fold increase had been obtained. Conclusion/Significance: This work first found that C-15-surfactin was an efficient synergistic antifungal agent, and demonstrated that response surface methodology was an effective method to improve the production of C-15-surfactin.	[Liu, Xiangyang; Ren, Biao; Gao, Hong; Liu, Mei; Dai, Huanqin; Song, Fuhang; Zhang, Lixin] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Wang, Shujin; Hu, Jiangchun] Chinese Acad Sci, Inst Appl Ecol, Shenyang, Peoples R China; [Yu, Zhenyan] Shengli Oilfield Xinhai Xingda Ind Grp Co Ltd, Dongying, Shandong, Peoples R China; [Ren, Biao; Zhang, Lixin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Kokare, Chandrakant R.] Bharati Vidyapeeth Univ, Pune, Maharashtra, India	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Bharati Vidyapeeth Deemed University	Liu, XY (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	Zhanglixin@im.ac.cn	Ren, Biao/P-1067-2015; Kokare, Chandrakant/ADT-7205-2022	Ren, Biao/0000-0003-4215-2873; Zhang, Lixin/0000-0003-0894-9520; Gao, Hong/0000-0002-8544-7826	National Natural Science Foundation of China [30973665, 30901849, 30873129, 30911120483, 30911120484, 81011120046, 81102356, 31100075, 81102369, 81102362, 31170095, 31000004]; CAS Pillar Program [XDA04074000]; Ministry of Science and Technology of China [2007DFB31620, 2011ZX11102]; National Distinguished Young Scholar Program in China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Pillar Program; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Distinguished Young Scholar Program in China	This work was supported in part by grants from National Natural Science Foundation of China (30973665, 30901849, 30873129, 30911120483, 30911120484, 81011120046, 81102356, 31100075, 81102369, 81102362, 31170095, and 31000004), the CAS Pillar Program (XDA04074000) and the Ministry of Science and Technology of China (2007DFB31620, 2011ZX11102). L. Z. is an Awardee for National Distinguished Young Scholar Program in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortolato M, 1997, BIOTECHNOL LETT, V19, P433, DOI 10.1023/A:1018387909310; Cao XH, 2010, CHEM-BIOL INTERACT, V183, P357, DOI 10.1016/j.cbi.2009.11.027; Cao XH, 2009, BRAZ J MICROBIOL, V40, P373, DOI 10.1590/S1517-838220090002000030; Cao XH, 2009, BIOTECHNOL APPL BIOC, V52, P97, DOI 10.1042/BA20070227; Cao XH, 2009, CELL BIOCHEM BIOPHYS, V55, P163, DOI 10.1007/s12013-009-9065-4; Carrillo C, 2003, BBA-BIOMEMBRANES, V1611, P91, DOI 10.1016/S0005-2736(03)00029-4; Chakraborty S, 2011, J MOL CATAL B-ENZYM, V68, P52, DOI 10.1016/j.molcatb.2010.09.009; Chen XH, 2009, J BIOTECHNOL, V140, P27, DOI 10.1016/j.jbiotec.2008.10.011; Christofi N, 2002, J APPL MICROBIOL, V93, P915, DOI 10.1046/j.1365-2672.2002.01774.x; Deleu M, 2003, LANGMUIR, V19, P3377, DOI 10.1021/la026543z; Eeman M, 2006, LANGMUIR, V22, P11337, DOI 10.1021/la061969p; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fonseca RR, 2007, APPL BIOCHEM BIOTECH, V137, P471, DOI 10.1007/s12010-007-9073-z; Gheshlaghi R, 2005, BIOTECHNOL BIOENG, V90, P754, DOI 10.1002/bit.20474; Grau A, 1999, BBA-BIOMEMBRANES, V1418, P307, DOI 10.1016/S0005-2736(99)00039-5; Haddad NIA, 2008, PROTEIN PEPTIDE LETT, V15, P265, DOI 10.2174/092986608783744225; Hwang YH, 2007, EUR J PHARMACOL, V556, P166, DOI 10.1016/j.ejphar.2006.10.031; Jacques P, 1999, APPL BIOCHEM BIOTECH, V77-9, P223, DOI 10.1385/ABAB:77:1-3:223; Keenan B, 2011, BACTERIAL PRODUCTION, P158; Khopade A, 2012, J COLLOID INTERF SCI, V367, P311, DOI 10.1016/j.jcis.2011.11.009; KIM J, 1993, EVOLUTION, V47, P471, DOI 10.1111/j.1558-5646.1993.tb02107.x; Kim SY, 2007, FEBS LETT, V581, P865, DOI 10.1016/j.febslet.2007.01.059; Kiran GS, 2010, COLLOID SURFACE B, V78, P8, DOI 10.1016/j.colsurfb.2010.01.028; Kracht M, 1999, J ANTIBIOT, V52, P613, DOI 10.7164/antibiotics.52.613; Liu XY, 2008, J PEPT SCI, V14, P864, DOI 10.1002/psc.1017; Liu XY, 2010, APPL MICROBIOL BIOT, V87, P1881, DOI 10.1007/s00253-010-2653-9; MAGETDANA R, 1995, BIOPHYS J, V68, P1937, DOI 10.1016/S0006-3495(95)80370-X; MAGETDANA R, 1992, BIOCHIMIE, V74, P1047, DOI 10.1016/0300-9084(92)90002-V; Razafindralambo H, 2004, J SURFACTANTS DETERG, V7, P41, DOI 10.1007/s11743-004-0286-x; Seydlova G, 2008, CENT EUR J MED, V3, P123, DOI 10.2478/s11536-008-0002-5; Singh P, 2004, TRENDS BIOTECHNOL, V22, P142, DOI 10.1016/j.tibtech.2004.01.010; Takahashi T, 2006, J ANTIBIOT, V59, P35, DOI 10.1038/ja.2006.6; Tang JS, 2007, MAGN RESON CHEM, V45, P792, DOI 10.1002/mrc.2048; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yoneda T, 2001, J COSMET SCI, V52, P153; Zhang LX, 2007, P NATL ACAD SCI USA, V104, P4606, DOI 10.1073/pnas.0609370104	36	75	87	6	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e34430	10.1371/journal.pone.0034430	http://dx.doi.org/10.1371/journal.pone.0034430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629294	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500001
J	Pistritto, G; Papaleo, V; Sanchez, P; Ceci, C; Barbaccia, ML				Pistritto, Giuseppa; Papaleo, Veruska; Sanchez, Pilar; Ceci, Claudia; Barbaccia, Maria Luisa			Divergent Modulation of Neuronal Differentiation by Caspase-2 and-9	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ICE/CED-3 PROTEASE; EXPRESSION; INHIBITION; TERATOCARCINOMA; ACTIVATION; MATURATION; SYSTEM; ROLES; LINE	Human Ntera2/cl.D1 (NT2) cells treated with retinoic acid (RA) differentiate towards a well characterized neuronal phenotype sharing many features with human fetal neurons. In view of the emerging role of caspases in murine stem cell/neural precursor differentiation, caspases activity was evaluated during RA differentiation. Caspase-2, -3 and -9 activity was transiently and selectively increased in differentiating and non-apoptotic NT2-cells. SiRNA-mediated selective silencing of either caspase-2 (si-Casp2) or -9 (si-Casp9) was implemented in order to dissect the role of distinct caspases. The RA-induced expression of neuronal markers, i.e. neural cell adhesion molecule (NCAM), microtubule associated protein-2 (MAP2) and tyrosine hydroxylase (TH) mRNAs and proteins, was decreased in si-Casp9, but markedly increased in si-Casp2 cells. During RA-induced NT2 differentiation, the class III histone deacetylase Sirt1, a putative caspase substrate implicated in the regulation of the proneural bHLH MASH1 gene expression, was cleaved to a similar to 100 kDa fragment. Sirt1 cleavage was markedly reduced in si-Casp9 cells, even though caspase-3 was normally activated, but was not affected (still cleaved) in si-Casp2 cells, despite a marked reduction of caspase-3 activity. The expression of MASH1 mRNA was higher and occurred earlier in si-Casp2 cells, while was reduced at early time points during differentiation in si-Casp9 cells. Thus, caspase-2 and -9 may perform opposite functions during RA-induced NT2 neuronal differentiation. While caspase-9 activation is relevant for proper neuronal differentiation, likely through the fine tuning of Sirt1 function, caspase-2 activation appears to hinder the RA-induced neuronal differentiation of NT2 cells.	[Pistritto, Giuseppa; Papaleo, Veruska; Ceci, Claudia; Barbaccia, Maria Luisa] Univ Roma Tor Vergata, Sch Med, Dept Neurosci, Rome, Italy; [Sanchez, Pilar] Univ Granada, Dept Biochem & Mol Biol, Fac Med, E-18071 Granada, Spain	University of Rome Tor Vergata; University of Granada	Pistritto, G (corresponding author), Univ Roma Tor Vergata, Sch Med, Dept Neurosci, Rome, Italy.	pistritto@med.uniroma2.it		BARBACCIA, MARIA LUISA/0000-0002-5378-3972; Ceci, Claudia/0000-0002-5958-7497	Regione Calabria-Italy [212413102008]; Tor Vergata University, Rome, Italy	Regione Calabria-Italy; Tor Vergata University, Rome, Italy	This work was partially supported by a grant (n. 212413102008) from Regione Calabria-Italy and from the Research Fund of Tor Vergata University, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.54; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Aranha MM, 2009, J CELL BIOCHEM, V107, P748, DOI 10.1002/jcb.22172; Autiero I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007350; Baratchi S, 2010, CRIT REV BIOCHEM MOL, V45, P535, DOI 10.3109/10409238.2010.516740; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Carlsson Y, 2011, ANN NEUROL, V70, P781, DOI 10.1002/ana.22431; Chauvier D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.87; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; DINSMORE JH, 1991, CELL, V64, P817, DOI 10.1016/0092-8674(91)90510-6; Dorstyn Loretta, 2009, F1000 Biol Rep, V1, P96, DOI 10.3410/B1-96; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Guillemain I, 2003, J NEUROSCI RES, V71, P38, DOI 10.1002/jnr.10458; Hara K, 2008, PROG NEUROBIOL, V85, P318, DOI 10.1016/j.pneurobio.2008.04.005; Ishizaki Y, 1998, J CELL BIOL, V140, P153, DOI 10.1083/jcb.140.1.153; Kim MJ, 2009, FEBS LETT, V583, P1183, DOI 10.1016/j.febslet.2009.03.007; Krumschnabel G, 2009, CELL DEATH DIFFER, V16, P195, DOI 10.1038/cdd.2008.170; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Kurinaga E, 2009, TRENDS CELL BIOL, V17, P135; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Megiorni F, 2005, NEUROSCI LETT, V373, P105, DOI 10.1016/j.neulet.2004.09.070; Musch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010726; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Ohsawa S, 2006, FEBS LETT, V580, P5875, DOI 10.1016/j.febslet.2006.09.051; Ohsawa S, 2010, P NATL ACAD SCI USA, V107, P13366, DOI 10.1073/pnas.0910488107; Oomman S, 2006, BRAIN RES, V1078, P19, DOI 10.1016/j.brainres.2006.01.041; Paquet-Durand F, 2003, DEV BRAIN RES, V142, P161, DOI 10.1016/S0165-3806(03)00065-8; Pistritto G, 2009, EXP NEUROL, V217, P302, DOI 10.1016/j.expneurol.2009.03.008; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; POLLERBERG EG, 1985, J CELL BIOL, V101, P1921, DOI 10.1083/jcb.101.5.1921; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwartz CM, 2005, STEM CELLS DEV, V14, P517, DOI 10.1089/scd.2005.14.517; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Smidt MP, 2004, CELL TISSUE RES, V318, P35, DOI 10.1007/s00441-004-0943-1; Srinivasula SM, 2001, METHOD CELL BIOL, V66, P1; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Zhang Y, 2011, BIOCHEM BIOPH RES CO, V404, P610, DOI 10.1016/j.bbrc.2010.12.014; Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593	50	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36002	10.1371/journal.pone.0036002	http://dx.doi.org/10.1371/journal.pone.0036002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629307	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343500008
J	An, JY; Kim, E; Zakrzewska, A; Yoo, YD; Jang, JM; Han, DH; Lee, MJ; Seo, JW; Lee, YJ; Kim, TY; de Rooij, DG; Kim, BY; Kwon, YT				An, Jee Young; Kim, Euna; Zakrzewska, Adriana; Yoo, Young Dong; Jang, Jun Min; Han, Dong Hoon; Lee, Min Jae; Seo, Jai Wha; Lee, Yong Jun; Kim, Tae-You; de Rooij, Dirk G.; Kim, Bo Yeon; Kwon, Yong Tae			UBR2 of the N-End Rule Pathway Is Required for Chromosome Stability via Histone Ubiquitylation in Spermatocytes and Somatic Cells	PLOS ONE			English	Article							E3 UBIQUITIN LIGASES; DOUBLE-STRAND BREAKS; PROPHASE-I; MOLECULAR PRINCIPLES; MEIOTIC CHROMOSOMES; SEX-CHROMOSOMES; CROSSING-OVER; X-CHROMOSOME; MOUSE; MICE	The N-end rule pathway is a proteolytic system in which its recognition components (N-recognins) recognize destabilizing N-terminal residues of short-lived proteins as an essential element of specific degrons, called N-degrons. The RING E3 ligases UBR2 and UBR1 are major N-recognins that share size (200 kDa), conserved domains and substrate specificities to N-degrons. Despite the known function of the N-end rule pathway in degradation of cytosolic proteins, the major phenotype of UBR2-deficient male mice is infertility caused by arrest of spermatocytes at meiotic prophase I. UBR2-deficient spermatocytes are impaired in transcriptional silencing of sex chromosome-linked genes and ubiquitylation of histone H2A. In this study we show that the recruitment of UBR2 to meiotic chromosomes spatiotemporally correlates to the induction of chromatin-associated ubiquitylation, which is significantly impaired in UBR2-deficient spermatocytes. UBR2 functions as a scaffold E3 that promotes HR6B/UbcH2-dependent ubiquitylation of H2A and H2B but not H3 and H4, through a mechanism distinct from typical polyubiquitylation. The E3 activity of UBR2 in histone ubiquitylation is allosterically activated by dipeptides bearing destabilizing N-terminal residues. Insufficient monoubiquitylation and polyubiquitylation on UBR2-deficient meiotic chromosomes correlate to defects in double strand break (DSB) repair and other meiotic processes, resulting in pachytene arrest at stage IV and apoptosis. Some of these functions of UBR2 are observed in somatic cells, in which UBR2 is a chromatin-binding protein involved in chromatin-associated ubiquitylation upon DNA damage. UBR2-deficient somatic cells show an array of chromosomal abnormalities, including hyperproliferation, chromosome instability, and hypersensitivity to DNA damage-inducing reagents. UBR2-deficient mice enriched in C57 background die upon birth with defects in lung expansion and neural development. Thus, UBR2, known as the recognition component of a major cellular proteolytic system, is associated with chromatin and controls chromatin dynamics and gene expression in both germ cells and somatic cells.	[An, Jee Young; Zakrzewska, Adriana; Seo, Jai Wha; Kwon, Yong Tae] Univ Pittsburgh, Sch Pharm, Ctr Pharmacogenet, Pittsburgh, PA 15260 USA; [An, Jee Young; Zakrzewska, Adriana; Seo, Jai Wha; Kwon, Yong Tae] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA USA; [Kim, Euna; Yoo, Young Dong; Jang, Jun Min; Han, Dong Hoon; Kim, Tae-You; Kwon, Yong Tae] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, World Class Univ WCU Program, Seoul, South Korea; [Kim, Euna; Yoo, Young Dong; Jang, Jun Min; Han, Dong Hoon; Kim, Tae-You] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Lee, Min Jae] Kyung Hee Univ, Coll Appl Sci, Dept Appl Chem, Yongin, South Korea; [Lee, Yong Jun] Univ Pittsburgh, Sch Med, Dept Surg & Pharmacol, Hillman Canc Ctr, Pittsburgh, PA USA; [Kim, Tae-You] Seoul Natl Univ, Canc Hosp, Seoul, South Korea; [Kim, Tae-You] Seoul Natl Univ, Coll Med, Seoul, South Korea; [de Rooij, Dirk G.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, Reprod Biol Lab,Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol, Chem Biol Res Ctr, World Class Inst, Ochang, Cheongwon, South Korea	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Seoul National University (SNU); Seoul National University (SNU); University of Amsterdam; Academic Medical Center Amsterdam; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	An, JY (corresponding author), Univ Pittsburgh, Sch Pharm, Ctr Pharmacogenet, Pittsburgh, PA 15260 USA.	bykim@kribb.re.kr; yok5@pitt.edu	Kim, Tae-You/J-2750-2012; de Rooij, D.G./AAW-1195-2021; han, donghoon/AAU-8725-2021; Lee, Min Jae/C-9814-2015	Lee, Min Jae/0000-0002-3252-6467; de Rooij, Dirk/0000-0003-3932-4419	NIH [HL083365]; World Class University [R31-2008-000-10103-0]; World Class Institute; Basic Science Research programs through the National Research Foundation [2011-0007990]; Ministry of Education, Science and Technology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083365] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class University; World Class Institute; Basic Science Research programs through the National Research Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH grant HL083365 (to Y.T.K.) and World Class University (R31-2008-000-10103-0 to Y.T.K. and T.Y.K.), World Class Institute (to B.Y.K.), and Basic Science Research programs (2011-0007990 to M.J.L.) through the National Research Foundation funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JY, 2010, P NATL ACAD SCI USA, V107, P1912, DOI 10.1073/pnas.0910267107; Baarends WM, 2007, J CELL SCI, V120, P1841, DOI 10.1242/jcs.03451; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Baarends WM, 1999, DEV BIOL, V207, P322, DOI 10.1006/dbio.1998.9155; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow C, 1998, DEVELOPMENT, V125, P4007; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kneitz B, 2000, GENE DEV, V14, P1085; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Lee MJ, 2008, P NATL ACAD SCI USA, V105, P100, DOI 10.1073/pnas.0708465105; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Moens PB, 2002, J CELL SCI, V115, P1611; MONESI V, 1965, CHROMOSOMA, V17, P11, DOI 10.1007/BF00285153; Perry J, 2001, GENOME RES, V11, P1826, DOI 10.1101/gr.203001; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; RAMAN R, 1991, SOMAT CELL MOLEC GEN, V17, P429, DOI 10.1007/BF01233166; Roest HP, 1996, CELL, V86, P799, DOI 10.1016/S0092-8674(00)80154-3; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Schimenti J, 2005, NAT GENET, V37, P11, DOI 10.1038/ng0105-11; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Sriram SM, 2010, NAT STRUCT MOL BIOL, V17, P1164, DOI 10.1038/nsmb1010-1164; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2012, ANN REV BIO IN PRESS; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2007, J BIOL CHEM, V282, P18510, DOI 10.1074/jbc.M701894200; Tasaki T, 2009, J BIOL CHEM, V284, P1884, DOI 10.1074/jbc.M803641200; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Wiltshire T, 1998, MOL REPROD DEV, V49, P70, DOI 10.1002/(SICI)1098-2795(199801)49:1&lt;70::AID-MRD8&gt;3.0.CO;2-L; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Xu XL, 2003, DEVELOPMENT, V130, P2001, DOI 10.1242/dev.00410; Yan OY, 2006, MUTAT RES-FUND MOL M, V596, P64, DOI 10.1016/j.mrfmmm.2005.12.016; Yang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014017; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2	61	24	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37414	10.1371/journal.pone.0037414	http://dx.doi.org/10.1371/journal.pone.0037414			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22616001	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000305341200073
J	Moreau, M; Le Tortorec, A; Deleage, C; Brown, C; Denis, H; Satie, AP; Bourry, O; Deureuddre-Bosquet, N; Roques, P; Le Grand, R; Dejucq-Rainsford, N				Moreau, Marina; Le Tortorec, Anna; Deleage, Claire; Brown, Charles; Denis, Helene; Satie, Anne-Pascale; Bourry, Olivier; Deureuddre-Bosquet, Nathalie; Roques, Pierre; Le Grand, Roger; Dejucq-Rainsford, Nathalie			Impact of Short-Term HAART Initiated during the Chronic Stage or Shortly Post-Exposure on SIV Infection of Male Genital Organs	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; SEMEN-PRODUCING ORGANS; HIV RNA; SEXUAL TRANSMISSION; REPRODUCTIVE-TRACT; T-LYMPHOCYTES; SEMINAL CELLS; MACAQUES; BLOOD	Background: The male genital tract is suspected to constitute a viral sanctuary as persistent HIV shedding is found in the semen of a subset of HIV-infected men receiving effective antiretroviral therapy (HAART). The origin of this persistent shedding is currently unknown. Phylogenetic studies indicated that HIV in semen from untreated men arises from local sources and/or passive diffusion from the blood. We previously demonstrated in human and macaque low levels and localized infection of several semen-producing organs by HIV/SIV. Using a macaque model, this study investigates the impact of short term HAART (2-4 weeks) initiated either during the asymptomatic chronic stage or 4 h post-intravenous inoculation of SIVmac251 on the infection of male genital organs. Methodology/Principal Findings: Short term HAART during the chronic stage decreased blood viral load. No major impact of HAART was observed on SIV DNA levels in male genital organs using a sensitive nested PCR assay. Using in situ hybridization, SIV RNA+ cells were detected in all male genital tract organs from untreated and treated animals with undetectable blood viral load following HAART. Infected CD68+ myeloid cells and CD3+ T lymphocytes were detected pre-and post-HAART. In contrast, short term HAART initiated 4 h post-SIV exposure led to a drastic decrease of the male genital tissues infection, although it failed to prevent systemic infection. In both cases, HAART tended to decrease the number of CD3+ T cells in the male organs. Conclusions: Our results indicate that the established infection of male genital organs is not greatly impacted by short term HAART, whereas the same treatment during pre-acute phase of the infection efficiently impairs viral dissemination to the male genital tract. Further investigations are now needed to determine whether infection of male genital organs is responsible for long term persistent HIV shedding in semen despite HAART.	[Moreau, Marina; Le Tortorec, Anna; Deleage, Claire; Denis, Helene; Satie, Anne-Pascale; Dejucq-Rainsford, Nathalie] Univ Rennes 1, INSERM, IRSET U1085, Inst Federatif Rech 140, Rennes, France; [Bourry, Olivier; Deureuddre-Bosquet, Nathalie; Roques, Pierre; Le Grand, Roger] CEA, DSV, Inst Emerging Dis & Innovat Therapies, Div Immunovirol, Fontenay Aux Roses, France; [Brown, Charles] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Bourry, Olivier; Deureuddre-Bosquet, Nathalie; Roques, Pierre; Le Grand, Roger] Univ Paris 11, UMR E1, Orsay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CEA; UDICE-French Research Universities; Universite Paris Saclay; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); UDICE-French Research Universities; Universite Paris Saclay	Moreau, M (corresponding author), Univ Rennes 1, INSERM, IRSET U1085, Inst Federatif Rech 140, Rennes, France.	nathalie.dejucq-rainsford@inserm.fr	Le Tortorec, Anna/J-5291-2015; Roques, Pierre/M-2212-2013; DEJUCQ-RAINSFORD, Nathalie/I-2571-2015	Roques, Pierre/0000-0003-1825-1054; 	ANRS; Sidaction; Inserm; Region Bretagne	ANRS(ANRSFrench National Research Agency (ANR)); Sidaction; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Bretagne(Region Bretagne)	This work was funded by ANRS, Sidaction, Inserm and Region Bretagne. Marina Moreau is the recipient of stipends from Region Bretagne and Sidaction. Claire Deleage and Helene Denis are supported by ANRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001053; Annamalai L, 2010, AM J PATHOL, V177, P777, DOI 10.2353/ajpath.2010.091248; Aquaro S, 2006, J LEUKOCYTE BIOL, V80, P1103, DOI 10.1189/jlb.0606376; Barroso PF, 2000, ANN INTERN MED, V133, P280, DOI 10.7326/0003-4819-133-4-200008150-00012; BASKERVILLE A, 1992, J COMP PATHOL, V107, P49, DOI 10.1016/0021-9975(92)90095-C; Benito JM, 2004, AIDS RES HUM RETROV, V20, P227, DOI 10.1089/088922204773004950; Benlhassan-Chahour K, 2003, J VIROL, V77, P12479, DOI 10.1128/JVI.77.23.12479-12493.2003; Bourry O, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-78; Bourry O, 2009, AIDS, V23, P447, DOI 10.1097/QAD.0b013e328321302d; Brown CR, 2007, J VIROL, V81, P5594, DOI 10.1128/JVI.00202-07; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Caufour P, 2001, MICROBES INFECT, V3, P181, DOI 10.1016/S1286-4579(01)01370-3; Choo EF, 2000, DRUG METAB DISPOS, V28, P655; Clay CC, 2005, J VIROL, V79, P13759, DOI 10.1128/JVI.79.21.13759-13768.2005; Crowe S, 2003, J LEUKOCYTE BIOL, V74, P635, DOI 10.1189/jlb.0503204; Deleage C, 2011, AM J PATHOL, V179, P2397, DOI 10.1016/j.ajpath.2011.08.005; Dioszeghy V, 2006, J VIROL, V80, P236, DOI 10.1128/JVI.80.1.236-245.2006; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Ghosn J, 2004, AIDS, V18, P447, DOI 10.1097/00002030-200402200-00011; Gunthard HF, 2001, J INFECT DIS, V183, P1318, DOI 10.1086/319864; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Halfon P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010569; Hirsch V, 1997, J VIROL, V71, P1608, DOI 10.1128/JVI.71.2.1608-1620.1997; HIRSCH VM, 1995, J VIROL, V69, P955, DOI 10.1128/JVI.69.2.955-967.1995; Kotler DP, 1998, AIDS, V12, P597, DOI 10.1097/00002030-199806000-00008; Kwa S, 2011, BLOOD, V118, P2763, DOI 10.1182/blood-2011-02-339515; Lambert-Niclot S, 2010, ANTIMICROB AGENTS CH, V54, P4910, DOI 10.1128/AAC.00725-10; Le Grand R, 2000, AIDS, V14, P1864; Le Tortorec A, 2010, INT J ANDROL, V33, pE98, DOI 10.1111/j.1365-2605.2009.00973.x; Le Tortorec A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001792; Le Tortorec A, 2010, M S-MED SCI, V26, P861, DOI 10.1051/medsci/20102610861; Le Tortorec A, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-119; Leruez-Ville M, 2002, AIDS, V16, P486, DOI 10.1097/00002030-200202150-00023; Livni E, 2004, NUCL MED BIOL, V31, P613, DOI 10.1016/j.nucmedbio.2003.11.006; Marcelin AG, 2008, AIDS, V22, P1677, DOI 10.1097/QAD.0b013e32830abdc8; Mayer KH, 1999, CLIN INFECT DIS, V28, P1252, DOI 10.1086/514775; MILLER CJ, 1994, LAB INVEST, V70, P255; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Nunnari G, 2002, AIDS, V16, P39, DOI 10.1097/00002030-200201040-00006; Paranjpe S, 2002, AIDS RES HUM RETROV, V18, P1271, DOI 10.1089/088922202320886316; Pasquier C, 2012, ANTIVIRAL T IN PRESS; Pasquier C, 2009, J CLIN MICROBIOL, V47, P2883, DOI 10.1128/JCM.02131-08; Pasquier CJM, 2008, AIDS, V22, P1894, DOI 10.1097/QAD.0b013e3283101281; Pasternak AO, 2008, J CLIN MICROBIOL, V46, P2206, DOI 10.1128/JCM.00055-08; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005; Puaux AL, 2004, VACCINE, V22, P3535, DOI 10.1016/j.vaccine.2004.03.044; PUDNEY J, 1991, AM J PATHOL, V139, P149; Roulet V, 2006, AM J PATHOL, V169, P2094, DOI 10.2353/ajpath.2006.060191; Sellier P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010570; Shehu-Xhilaga M, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-7; Shen CL, 2010, VIROLOGY, V401, P190, DOI 10.1016/j.virol.2010.01.033; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; Stuart JWTC, 2000, J ACQ IMMUN DEF SYND, V25, P203, DOI 10.1097/00126334-200011010-00001; Taylor S, 2010, CURR OPIN HIV AIDS, V5, P335, DOI 10.1097/COH.0b013e32833a0b69; Thiebot H, 2005, BLOOD, V105, P2403, DOI 10.1182/blood-2004-01-0025; Thiebot H, 2001, J VIROL, V75, P11594, DOI 10.1128/JVI.75.23.11594-11602.2001; Wang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027207; Whitney JB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001293; Willey S, 2003, AIDS, V17, P183, DOI 10.1097/00002030-200301240-00007; Yeni P, 2008, PRISE CHARGE MED PER; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502; Zhou SH, 2004, J VIROL, V78, P3578, DOI 10.1128/JVI.78.7.3578-3600.2004	65	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37348	10.1371/journal.pone.0037348	http://dx.doi.org/10.1371/journal.pone.0037348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615988	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200066
J	Karki, S; Li, MMH; Schoggins, JW; Tian, SY; Rice, CM; MacDonald, MR				Karki, Sophiya; Li, Melody M. H.; Schoggins, John W.; Tian, Suyan; Rice, Charles M.; MacDonald, Margaret R.			Multiple Interferon Stimulated Genes Synergize with the Zinc Finger Antiviral Protein to Mediate Anti-Alphavirus Activity	PLOS ONE			English	Article							SINDBIS VIRUS-INFECTION; RNA HELICASE; CELL LINES; REPLICATION; INDUCTION; LAMBDA; IDENTIFICATION; RECOGNITION; INHIBITION; PROTECTION	The zinc finger antiviral protein (ZAP) is a host factor that mediates inhibition of viruses in the Filoviridae, Retroviridae and Togaviridae families. We previously demonstrated that ZAP blocks replication of Sindbis virus (SINV), the prototype Alphavirus in the Togaviridae family at an early step prior to translation of the incoming genome and that synergy between ZAP and one or more interferon stimulated genes (ISGs) resulted in maximal inhibitory activity. The present study aimed to identify those ISGs that synergize with ZAP to mediate Alphavirus inhibition. Using a library of lentiviruses individually expressing more than 350 ISGs, we screened for inhibitory activity in interferon defective cells with or without ZAP overexpression. Confirmatory tests of the 23 ISGs demonstrating the largest infection reduction in combination with ZAP revealed that 16 were synergistic. Confirmatory tests of all potentially synergistic ISGs revealed 15 additional ISGs with a statistically significant synergistic effect in combination with ZAP. These 31 ISGs are candidates for further mechanistic studies. The number and diversity of the identified ZAP-synergistic ISGs lead us to speculate that ZAP may play an important role in priming the cell for optimal ISG function.	[Karki, Sophiya; Li, Melody M. H.; Schoggins, John W.; Rice, Charles M.; MacDonald, Margaret R.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10021 USA; [Tian, Suyan] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Karki, S (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.	macdonm@rockefeller.edu	Li, Melody/AAV-1802-2021; Tian, Suyan/W-3273-2019	Tian, Suyan/0000-0002-5942-1542	grants from the National Institutes of Health [AI057905, AI091707]; Northeast Biodefense Center [U54-AI057158-Lipkin]; Center for Clinical and Translational Science Award (CTSA) from the National Center for Research Resources [UL1 RR024143]; Irma T. Hirschl/Monique Weill-Caulier Trust; Greenberg Medical Research Institute; Starr Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057905, R01AI091707, U54AI057158] Funding Source: NIH RePORTER	grants from the National Institutes of Health; Northeast Biodefense Center; Center for Clinical and Translational Science Award (CTSA) from the National Center for Research Resources; Irma T. Hirschl/Monique Weill-Caulier Trust; Greenberg Medical Research Institute; Starr Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by grants from the National Institutes of Health including grant AI057905 to M. R. M., grant AI091707 to C. M. R., grant U54-AI057158-Lipkin from the Northeast Biodefense Center, and Center for Clinical and Translational Science Award (CTSA) UL1 RR024143 (to the Rockefeller University) from the National Center for Research Resources. The work was also supported in part by the Irma T. Hirschl/Monique Weill-Caulier Trust, the Greenberg Medical Research Institute and the Starr Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDZHAPARIDZE OG, 1981, J VIROL, V37, P1; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Chan YL, 2008, J VIROL, V82, P10455, DOI 10.1128/JVI.00438-08; Chen GF, 2008, P NATL ACAD SCI USA, V105, P4352, DOI 10.1073/pnas.0712276105; CLARKE JB, 1983, VET MICROBIOL, V8, P259, DOI 10.1016/0378-1135(83)90078-0; Cristea IM, 2010, J VIROL, V84, P6720, DOI 10.1128/JVI.01983-09; DeFilippis VR, 2006, J VIROL, V80, P1032, DOI 10.1128/JVI.80.2.1032-1037.2006; Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Giannakopoulos NV, 2009, J VIROL, V83, P1602, DOI 10.1128/JVI.01590-08; Grieder FB, 1999, VIROLOGY, V257, P106, DOI 10.1006/viro.1999.9662; Griffin DE, 2007, FIELDS VIROLOGY, V1, P1023; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; Huang Z, 2010, PROTEIN CELL, V1, P752, DOI 10.1007/s13238-010-0096-9; Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Law LMJ, 2010, J VIROL, V84, P4504, DOI 10.1128/JVI.02018-09; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; MacDonald MR, 2007, J VIROL, V81, P13509, DOI 10.1128/JVI.00402-07; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Muller S, 2007, J VIROL, V81, P2391, DOI 10.1128/JVI.01601-06; OTSUKI K, 1979, ARCH VIROL, V60, P249, DOI 10.1007/BF01317496; Ryman KD, 2005, J VIROL, V79, P1487, DOI 10.1128/JVI.79.3.1487-1499.2005; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; STANWICK TL, 1974, INFECT IMMUN, V10, P810, DOI 10.1128/IAI.10.4.810-815.1974; TRUANT AL, 1977, J MED VIROL, V1, P49, DOI 10.1002/jmv.1890010108; Wang N, 2010, J BIOL CHEM, V285, P6080, DOI 10.1074/jbc.M109.054486; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Ye PY, 2010, PROTEIN CELL, V1, P956, DOI 10.1007/s13238-010-0117-8; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07	39	53	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37398	10.1371/journal.pone.0037398	http://dx.doi.org/10.1371/journal.pone.0037398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615998	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300110
J	Mackintosh, C; Garcia-Dominguez, DJ; Ordonez, JL; Ginel-Picardo, A; Smith, PG; Sacristan, MP; de Alava, E				Mackintosh, C.; Garcia-Dominguez, D. J.; Ordonez, J. L.; Ginel-Picardo, A.; Smith, P. G.; Sacristan, M. P.; de Alava, E.			WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells	ONCOGENE			English	Article						MLN4924; Ewing sarcoma; WEE1; cyclin A; cyclin E; P27	NEDD8-ACTIVATING ENZYME-INHIBITOR; UBIQUITIN LIGASE; BETA-TRCP; CANCER-CELLS; DEGRADATION; PHOSPHORYLATION; P27(KIP1); KINASES; P27; COMPLEX	Ewing sarcoma (ES) is an aggressive bone and soft tissue tumor of children and young adults in which finding effective new targeted therapies is imperative. Here, we report an in-depth preclinical study of the investigational cullin-RING ubiquitin ligase (CRL) inhibitor MLN4924 in ES, as we have recently demonstrated the implication of a CRL component in the ES pathogenesis. First, our results support a high sensitivity of ES cells to MLN4924 growth inhibition both in vitro (14 ES cell lines tested, median IC50 = 81 nM) and in tumor xenografts (tumor regression achieved with 60 mg/kg BID, subcutaneously, n = 9). Second, we report a dual mechanism of action of MLN4924 in ES cells: while a wide range of MLN4924 concentrations (similar to 30-300 nM) trigger a G2 arrest that can only be rescued by WEE1 kinase inhibition or depletion, saturating doses of the drug (>300 nM) cause a delay in S-phase progression concomitant with unbalanced CDK2-Cyclin E and CDK2-Cyclin A relative levels (accumulation of the first and depletion of the latter). The aberrant presence of CDC6 in the nucleus at late S-phase cell cycle stage confirmed the loss of CDK2-Cyclin A-specific functions. Remarkably, other mechanisms explored (P27 accumulation and DNA damage signaling pathways) were found unable to explain MLN4924 effects, strengthening the specificity of our findings and suggesting the absence of functionality of some CRL substrates accumulated in response to MLN4924. This study renders a rationale for clinical trials and contributes molecular mechanisms for a better understanding of this promising antitumoral agent. Oncogene (2013) 32, 1441-1451; doi:10.1038/onc.2012.153; published online 28 May 2012	[Mackintosh, C.; Garcia-Dominguez, D. J.; Ordonez, J. L.; de Alava, E.] IBSAL Ctr Invest Canc IBMCC USAL CSIC, Mol Pathol Program, Salamanca 37007, Spain; [Ginel-Picardo, A.] Ctr Invest Canc IBMCC USAL CSIC, Lab 1, Salamanca, Spain; [Smith, P. G.] Millennium Pharmaceut Inc, Discovery, Cambridge, MA USA; [Sacristan, M. P.] Ctr Invest Canc IBMCC USAL CSIC, Dept Mol & Genet, Salamanca 37007, Spain; [de Alava, E.] IBSAL Univ Hosp Salamanca, Dept Pathol, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	Mackintosh, C (corresponding author), IBSAL Ctr Invest Canc IBMCC USAL CSIC, Mol Pathol Program, Campus Miguel de Unamuno S-N, Salamanca 37007, Spain.	cmackintosh@usal.es; edealava@usal.es	Sacristan, Maria/Y-4923-2019; Garcia, Daniel Jose/B-5366-2016; de Alava, Enrique/GOH-0368-2022; Garcia, Daniel Jose/X-6857-2019; Sacristán, María P/A-9587-2016; IBIS, SARCOMAS/O-1893-2015; Ordóñez, José Luis/B-6069-2017	Sacristan, Maria/0000-0003-2314-8430; Garcia, Daniel Jose/0000-0001-8150-2747; de Alava, Enrique/0000-0001-8400-046X; Sacristán, María P/0000-0003-2314-8430; Ordóñez, José Luis/0000-0002-3791-4215; Mackintosh, Carlos/0000-0002-6786-9558	Maria Garcia Estrada Foundation; Ministry of Economy and Competitiveness of Spain-FEDER [PI081828, RD06/0020/0059, PI1100018]; Ministry of Economy and Competitiveness of Spain-FEDER (ISCIII_postdoc grant) [CD06/00001]; European Commission [278742 EUROSARC]	Maria Garcia Estrada Foundation; Ministry of Economy and Competitiveness of Spain-FEDER; Ministry of Economy and Competitiveness of Spain-FEDER (ISCIII_postdoc grant); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank Cristina Teodosio and Martin Perez de Andres for their kind help in flow cytometry studies. Daniel J Garcia-Dominguez is supported by a grant from the Maria Garcia Estrada Foundation. Research in Enrique de Alava's lab is also supported by the Ministry of Economy and Competitiveness of Spain-FEDER (PI081828, RD06/0020/0059, PI1100018, ISCIII_postdoc grant CD06/00001) and the European Commission (FP7-HEALTH-2011-two-stage, Project ID 278742 EUROSARC).	Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Bernstein M, 2006, ONCOLOGIST, V11, P503, DOI 10.1634/theoncologist.11-5-503; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Haeusler J, 2010, CANCER-AM CANCER SOC, V116, P443, DOI 10.1002/cncr.24740; Jia LJ, 2011, NEOPLASIA, V13, P561, DOI 10.1593/neo.11420; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Liao H, 2011, MOL CELL PROTEOMICS, DOI [10.1074/mcp.M111.009183, DOI 10.1074/mcp.M111.009183]; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Mackintosh C, 2012, ONCOGENE, V31, P1287, DOI 10.1038/onc.2011.317; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Smith MA, 2012, PEDIATR BLOOD CANCER, V59, P246, DOI 10.1002/pbc.23357; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Susaki E, 2007, CELL CYCLE, V6, P3015, DOI 10.4161/cc.6.24.5087; Swords RT, 2010, BLOOD, V115, P3796, DOI 10.1182/blood-2009-11-254862; Syljuasen RG, 2006, CANCER RES, V66, P10253, DOI 10.1158/0008-5472.CAN-06-2144; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Wei DP, 2012, CANCER RES, V72, P282, DOI 10.1158/0008-5472.CAN-11-2866; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324	40	52	53	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 14	2013	32	11					1441	1451		10.1038/onc.2012.153	http://dx.doi.org/10.1038/onc.2012.153			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OZ	22641220				2022-12-25	WOS:000316455600010
J	Lisciandro, JG; Prescott, SL; Nadal-Sims, MG; Devitt, CJ; Pomat, W; Siba, PM; Tulic, MC; Holt, PG; Strickland, D; van den Biggelaar, AHJ				Lisciandro, Joanne G.; Prescott, Susan L.; Nadal-Sims, Marie G.; Devitt, Catherine J.; Pomat, William; Siba, Peter M.; Tulic, Meri C.; Holt, Patrick G.; Strickland, Deborah; van den Biggelaar, Anita H. J.			Ontogeny of Toll-Like and NOD-Like Receptor-Mediated Innate Immune Responses in Papua New Guinean Infants	PLOS ONE			English	Article							CYTOKINE RESPONSES; VACCINATION; INFLAMMASOME; POPULATION; MECHANISMS; INDUCTION; PROFILES; NEWBORN; NLRP3; ALUM	Studies addressing the ontogeny of the innate immune system in early life have reported mainly on Toll-like receptor (TLR) responses in infants living in high-income countries, with little or even no information on other pattern recognition receptors or on early life innate immune responses in children living under very different environmental conditions in less-developed parts of the world. In this study, we describe whole blood innate immune responses to both Toll-like and nucleotide-binding oligomerization domain (NOD)-like receptor agonists including the widely used vaccine adjuvant 'alum' in a group of Papua New Guinean infants aged 1-3 (n = 18), 4-6 (n = 18), 7-12 (n = 21) and 13-18 (n = 10) months old. Depending on the ligands and cytokines studied, different age-related patterns were found: alum-induced IL-1 beta and CXCL8 responses were found to significantly decline with increasing age; inflammatory (IL-6, IL-1 beta, IFN-gamma) responses to TLR2 and TLR3 agonists increased; and IL-10 responses remained constant or increased during infancy, while TNF-alpha responses either declined or remained the same. We report for the first time that whole blood innate immune responses to the vaccine adjuvant alum decrease with age in infancy; a finding that may imply that the adjuvant effect of alum in pediatric vaccines could be age-related. Our findings further suggest that patterns of innate immune development may vary between geographically diverse populations, which in line with the 'hygiene hypothesis' particularly involves persistence of innate IL-10 responses in populations experiencing higher infectious pressure.	[Lisciandro, Joanne G.; Nadal-Sims, Marie G.; Devitt, Catherine J.; Holt, Patrick G.; Strickland, Deborah; van den Biggelaar, Anita H. J.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Lisciandro, Joanne G.; Prescott, Susan L.; Tulic, Meri C.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Pomat, William; Siba, Peter M.] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea	Telethon Kids Institute; University of Western Australia; University of Western Australia; PNG Institute Of Medical Research	Lisciandro, JG (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia.	joannel@ichr.uwa.edu.au	strickland, deborah/K-4597-2019; Prescott, Susan/H-5665-2014; Strickland, Deborah/AGV-6937-2022; Tulic, Meri/P-6613-2016; Tulic, Meri K/ABB-5138-2020; Holt, Patrick/H-1548-2011	Strickland, Deborah/0000-0003-0114-4201; Tulic, Meri/0000-0002-2661-2369; Tulic, Meri K/0000-0002-2661-2369; Holt, Patrick/0000-0003-1193-0935	Australian National Health and Medical Research Council (NHMRC) [513836]; University of Western Australia Research Grants Scheme; Australian Postgraduate Award; Stan and Jean Perron Award; NHMRC R Douglas Wright Biomedical Career Development [458780]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Western Australia Research Grants Scheme; Australian Postgraduate Award(Australian Government); Stan and Jean Perron Award; NHMRC R Douglas Wright Biomedical Career Development(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian National Health and Medical Research Council (NHMRC) Project Grant (513836) and a University of Western Australia Research Grants Scheme. JL received an Australian Postgraduate Award and a Stan and Jean Perron Award, and AB received a NHMRC R Douglas Wright Biomedical Career Development Grant (458780). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins Becky, 2003, Clin Dev Immunol, V10, P43, DOI 10.1080/10446670310001598474; Aimanianda V, 2009, TRENDS PHARMACOL SCI, V30, P287, DOI 10.1016/j.tips.2009.03.005; Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1367; Atkinson W, 2011, EP PREV VACC PREV DI; Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003; Blimkie D, 2011, J IMMUNOL METHODS, V366, P89, DOI 10.1016/j.jim.2011.01.009; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Burl S, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012287, 10.1371/journal.pone.0018185]; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; De Gregorio E, 2009, CURR OPIN IMMUNOL, V21, P339, DOI 10.1016/j.coi.2009.05.003; De Wit D, 2003, J AUTOIMMUN, V21, P277, DOI 10.1016/j.jaut.2003.08.003; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Fleer A, 2007, NEONATOLOGY, V92, P145, DOI 10.1159/000102054; Goriely S, 2001, J IMMUNOL, V166, P2141, DOI 10.4049/jimmunol.166.3.2141; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Herbert OC, 2009, WORLD ALLERGY ORGAN, V2, P130, DOI 10.1097/WOX.0b013e3181accf27; Higgins Sarah C, 2010, Curr Infect Dis Rep, V12, P4, DOI 10.1007/s11908-009-0080-9; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Lalor MK, 2011, J INFECT DIS, V204, P1075, DOI 10.1093/infdis/jir515; Lalor MK, 2009, J INFECT DIS, V199, P795, DOI 10.1086/597069; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, BLOOD, V108, P1284, DOI 10.1182/blood-2005-12-4821; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Lisciandro JG, 2010, CLIN EXP ALLERGY, V40, P1719, DOI 10.1111/j.1365-2222.2010.03629.x; Mutapi F, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-139; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; Philbin VJ, 2009, PEDIATR RES, V65, p98R, DOI 10.1203/PDR.0b013e31819f195d; Prescott SL, 2003, CLIN EXP ALLERGY, V33, P566, DOI 10.1046/j.1365-2222.2003.01659.x; Prescott SL, 2008, J ALLERGY CLIN IMMUN, V122, P391, DOI 10.1016/j.jaci.2008.04.042; Roduit C, 2011, J ALLERGY CLIN IMMUN, V127, P179, DOI 10.1016/j.jaci.2010.10.010; Spreafico R, 2010, EUR J IMMUNOL, V40, P638, DOI 10.1002/eji.200940039; Tulic MK, 2011, J ALLERGY CLIN IMMUN, V127, P470, DOI 10.1016/j.jaci.2010.09.020; van den Biggelaar AHJ, 2010, CLIN EXP IMMUNOL, V160, P42, DOI 10.1111/j.1365-2249.2010.04137.x; van den Biggelaar AHJ, 2011, VACCINE, V29, P5414, DOI 10.1016/j.vaccine.2011.05.065; van den Biggelaar AHJ, 2009, J ALLERGY CLIN IMMUN, V124, P544, DOI 10.1016/j.jaci.2009.03.040; Yerkovich ST, 2007, PEDIATR RES, V62, P547, DOI 10.1203/PDR.0b013e3181568105	43	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36793	10.1371/journal.pone.0036793	http://dx.doi.org/10.1371/journal.pone.0036793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649499	gold, Green Submitted, Green Published			2022-12-25	WOS:000305335800016
J	Menendez, R; Torres, A; Reyes, S; Zalacain, R; Capelastegui, A; Rajas, O; Borderias, L; Martin-Villasclaras, JJ; Bello, S; Alfageme, I; de Castro, FR; Rello, J; Molinos, L; Ruiz-Manzano, J				Menendez, Rosario; Torres, Antoni; Reyes, Soledad; Zalacain, Rafael; Capelastegui, Alberto; Rajas, Olga; Borderias, Luis; Martin-Villasclaras, Juan J.; Bello, Salvador; Alfageme, Inmaculada; Rodriguez de Castro, Felipe; Rello, Jordi; Molinos, Luis; Ruiz-Manzano, Juan			Compliance with Guidelines-Recommended Processes in Pneumonia: Impact of Health Status and Initial Signs	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; QUALITY-OF-CARE; ANTIMICROBIAL THERAPY; ANTIBIOTIC DELIVERY; MEDICARE PATIENTS; ELDERLY-PATIENTS; OUTCOMES; MORTALITY; ADHERENCE; PATIENT	Initial care has been associated with improved survival of community-acquired pneumonia (CAP). We aimed to investigate patient comorbidities and health status measured by the Charlson index and clinical signs at diagnosis associated with adherence to recommended processes of care in CAP. We studied 3844 patients hospitalized with CAP. The evaluated recommendations were antibiotic adherence to Spanish guidelines, first antibiotic dose,6 hours and oxygen assessment. Antibiotic adherence was 72.6%, first dose <6 h was 73.4% and oxygen assessment was 90.2%. Antibiotic adherence was negatively associated with a high Charlson score (Odds ratio [OR], 0.91), confusion (OR, 0.66) and tachycardia >= 100 bpm (OR, 0.77). Delayed first dose was significantly lower in those with tachycardia (OR, 0.75). Initial oxygen assessment was negatively associated with fever (OR, 0.61), whereas tachypnea >= 30 (OR, 1.58), tachycardia (OR, 1.39), age >65 (OR, 1.51) and COPD (OR, 1.80) were protective factors. The combination of antibiotic adherence and timing <6 hours was negatively associated with confusion (OR, 0.69) and a high Charlson score (OR, 0.92) adjusting for severity and hospital effect, whereas age was not an independent factor. Deficient health status and confusion, rather than age, are associated with lower compliance with antibiotic therapy recommendations and timing, thus identifying a subpopulation more prone to receiving lower quality care.	[Menendez, Rosario; Reyes, Soledad] Univ Hosp, Serv Neumol, Valencia, Spain; [Torres, Antoni] Univ Barcelona, CIBERES, IDIBAPS, Inst Clin Torax,Serv Pneumol, Barcelona, Spain; [Zalacain, Rafael] Hosp Cruces, Serv Neumol, Bilbao, Spain; [Capelastegui, Alberto] Hosp Galdakao, Serv Neumol, Galdakao, Spain; [Rajas, Olga] Hosp Princesa, Serv Neumol, Madrid, Spain; [Borderias, Luis] Hosp San Jorge, Serv Neumol, Huesca, Spain; [Martin-Villasclaras, Juan J.] Hosp Carlos Haya, Serv Neumol, Malaga, Spain; [Bello, Salvador] Hosp Miguel Servet, Serv Neumol, Zaragoza, Spain; [Alfageme, Inmaculada] Hosp Valme, Serv Neumol, Seville, Spain; [Rodriguez de Castro, Felipe] Hosp Dr Negrin, Serv Neumol, Las Palmas Gran Canaria, Spain; [Rello, Jordi] Hosp Valle De Hebron, Inst Recerca Vall Hebron UAB, CIBERES, Barcelona, Spain; [Molinos, Luis] Univ Oviedo, Hosp Cent Asturias, Serv Neumol, E-33080 Oviedo, Spain; [Ruiz-Manzano, Juan] Hosp Badalona Germans Trias & Pujol, Serv Neumol, Badalona, Spain; [Menendez, Rosario; Reyes, Soledad] Politecn La Fe, CIBERES, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Universitario Cruces; Galdakao Hospital; Hospital de La Princesa; Hospital Universidad San Jorge; Hospital Carlos Haya; Miguel Servet University Hospital; Hospital Valme; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Central University Hospital Asturias; University of Oviedo; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Menendez, R (corresponding author), Univ Hosp, Serv Neumol, Valencia, Spain.	rosmenend@gmail.com	Alfageme, Inmaculada/K-2092-2014; Menéndez, Rosario/G-9723-2016; de Castro, Felipe Rodriguez/R-8416-2019; Zalacain, Rafael/E-2972-2012; Rello, Jordi/P-2402-2019; Torres, Antoni/H-6128-2017; , Ivan/D-6804-2012	Alfageme, Inmaculada/0000-0002-5106-1669; Menéndez, Rosario/0000-0002-3592-3839; Rello, Jordi/0000-0003-0676-6210; Torres, Antoni/0000-0002-8643-2167; Rodriguez de Castro, Felipe/0000-0002-6812-2739; , Ivan/0000-0002-3108-058X; Borderias, Luis/0000-0003-3296-9644	CIBERES (Centro de investigacion en red de enfermedades respiratorias) an initiative of ISCIII (Instituto de Salud Carlos III); Beca Fis [PI 041150]; Beca SEPAR (Sociedad Espanola de Neumologia y Cirugia toracica) [2006/0237]; Beca de la Conselleria Sanitat Comunidad Valenciana [2007/0059]; PII (Programme of research of SEPAR) in respiratory infections	CIBERES (Centro de investigacion en red de enfermedades respiratorias) an initiative of ISCIII (Instituto de Salud Carlos III); Beca Fis; Beca SEPAR (Sociedad Espanola de Neumologia y Cirugia toracica); Beca de la Conselleria Sanitat Comunidad Valenciana; PII (Programme of research of SEPAR) in respiratory infections	This work was supported by CIBERES (Centro de investigacion en red de enfermedades respiratorias) an initiative of ISCIII (Instituto de Salud Carlos III); Beca Fis (PI 041150); Beca SEPAR (Sociedad Espanola de Neumologia y Cirugia toracica) (2006/0237); Beca de la Conselleria Sanitat Comunidad Valenciana (2007/0059) and PII (Programme of research of SEPAR) in respiratory infections. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfageme I, 2005, ARCH BRONCONEUMOL, V41, P272; Battleman DS, 2002, ARCH INTERN MED, V162, P682, DOI 10.1001/archinte.162.6.682; Blasi F, 2008, EUR RESPIR J, V32, P902, DOI 10.1183/09031936.00092607; Blot SI, 2007, CRIT CARE MED, V35, P2509, DOI 10.1097/01.CCM.0000287587.43801.9C; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Capelastegui A, 2004, CLIN INFECT DIS, V39, P955, DOI 10.1086/423960; Caterino JM, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dambrava PG, 2008, EUR RESPIR J, V32, P892, DOI 10.1183/09031936.00163407; Dean NC, 2006, CHEST, V130, P794, DOI 10.1378/chest.130.3.794; Ewig S, 2010, LANCET INFECT DIS, V10, P279, DOI 10.1016/S1473-3099(10)70032-3; Feagan BG, 2000, CAN MED ASSOC J, V162, P1415; Ferrer R, 2009, AM J RESP CRIT CARE, V180, P861, DOI 10.1164/rccm.200812-1912OC; Fine JM, 2002, ARCH INTERN MED, V162, P827, DOI 10.1001/archinte.162.7.827; Frei CR, 2010, CLIN THER, V32, P293, DOI 10.1016/j.clinthera.2010.02.006; Halm EA, 2000, ARCH INTERN MED, V160, P98, DOI 10.1001/archinte.160.1.98; HOSMER DW, 1989, APPL LOGISTIC REGRES; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Landon BE, 2006, ARCH INTERN MED, V166, P2511, DOI 10.1001/archinte.166.22.2511; Marras Theodore K, 2004, Can Respir J, V11, P131; McCabe C, 2009, ARCH INTERN MED, V169, P1525, DOI 10.1001/archinternmed.2009.259; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Menendez R, 2005, AM J RESP CRIT CARE, V172, P757, DOI 10.1164/rccm.200411-1444OC; Menendez R, 2012, EUR RESPIR J, V39, P156, DOI 10.1183/09031936.00188710; Metersky ML, 2006, CHEST, V130, P16, DOI 10.1378/chest.130.1.16; Mortensen EM, 2004, AM J MED, V117, P726, DOI 10.1016/j.amjmed.2004.06.028; Mortensen EM, 2006, AM J MED, V119, P859, DOI 10.1016/j.amjmed.2006.04.017; Pines JM, 2009, J EMERG MED, V37, P335, DOI 10.1016/j.jemermed.2009.06.127; Reid RO, 2010, ARCH INTERN MED, V170, P1442, DOI 10.1001/archinternmed.2010.307; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	32	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37570	10.1371/journal.pone.0037570	http://dx.doi.org/10.1371/journal.pone.0037570			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629420	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300052
J	Lockwood, WW; Wilson, IM; Coe, BP; Chari, R; Pikor, LA; Thu, KL; Solis, LM; Nunez, MI; Behrens, C; Yee, J; English, J; Murray, N; Tsao, MS; Minna, JD; Gazdar, AF; Wistuba, II; MacAulay, CE; Lam, S; Lam, WL				Lockwood, William W.; Wilson, Ian M.; Coe, Bradley P.; Chari, Raj; Pikor, Larissa A.; Thu, Kelsie L.; Solis, Luisa M.; Nunez, Maria I.; Behrens, Carmen; Yee, John; English, John; Murray, Nevin; Tsao, Ming-Sound; Minna, John D.; Gazdar, Adi F.; Wistuba, Ignacio I.; MacAulay, Calum E.; Lam, Stephen; Lam, Wan L.			Divergent Genomic and Epigenomic Landscapes of Lung Cancer Subtypes Underscore the Selection of Different Oncogenic Pathways during Tumor Development	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DNA METHYLATION PROFILES; GENE-EXPRESSION; MOLECULAR-ORIGINS; TRANSCRIPTION FACTORS; DOWN-REGULATION; STEM-CELLS; FHIT GENE; SURVIVAL; ASSOCIATION	For therapeutic purposes, non-small cell lung cancer (NSCLC) has traditionally been regarded as a single disease. However, recent evidence suggest that the two major subtypes of NSCLC, adenocarcinoma (AC) and squamous cell carcinoma (SqCC) respond differently to both molecular targeted and new generation chemotherapies. Therefore, identifying the molecular differences between these tumor types may impact novel treatment strategy. We performed the first large-scale analysis of 261 primary NSCLC tumors (169 AC and 92 SqCC), integrating genome-wide DNA copy number, methylation and gene expression profiles to identify subtype-specific molecular alterations relevant to new agent design and choice of therapy. Comparison of AC and SqCC genomic and epigenomic landscapes revealed 778 altered genes with corresponding expression changes that are selected during tumor development in a subtype-specific manner. Analysis of >200 additional NSCLCs confirmed that these genes are responsible for driving the differential development and resulting phenotypes of AC and SqCC. Importantly, we identified key oncogenic pathways disrupted in each subtype that likely serve as the basis for their differential tumor biology and clinical outcomes. Downregulation of HNF4 alpha target genes was the most common pathway specific to AC, while SqCC demonstrated disruption of numerous histone modifying enzymes as well as the transcription factor E2F1. In silico screening of candidate therapeutic compounds using subtype-specific pathway components identified HDAC and PI3K inhibitors as potential treatments tailored to lung SqCC. Together, our findings suggest that AC and SqCC develop through distinct pathogenetic pathways that have significant implication in our approach to the clinical management of NSCLC.	[Lockwood, William W.; Wilson, Ian M.; Coe, Bradley P.; Chari, Raj; Pikor, Larissa A.; Thu, Kelsie L.; MacAulay, Calum E.; Lam, Stephen; Lam, Wan L.] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada; [Solis, Luisa M.; Behrens, Carmen; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Nunez, Maria I.; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Yee, John] Vancouver Gen Hosp, Dept Surg, Vancouver, BC, Canada; [English, John] Vancouver Gen Hosp, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Murray, Nevin] British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC V5Z 4E6, Canada; [Tsao, Ming-Sound] Univ Toronto, Ontario Canc Inst, Toronto, ON, Canada; [Tsao, Ming-Sound] Univ Toronto, Dept Pathol, Univ Hlth Network Princess Margaret Hosp, Toronto, ON, Canada; [Minna, John D.; Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA	British Columbia Cancer Agency; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lockwood, WW (corresponding author), NHGRI, Canc Biol & Genet Sect, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	william.lockwood@nih.gov	Chari, Raj/G-3285-2019; Coe, Bradley/A-2878-2009; Tsao, Ming-Sound/M-3503-2017; Lockwood, William W/A-2879-2009; MacAulay, Calum/K-1795-2016; Tsao, Ming Sound/AFQ-7332-2022	Tsao, Ming Sound/0000-0002-9160-5405; Coe, Bradley/0000-0001-8471-4016; MacAulay, Calum/0000-0003-4440-2792; Thu, Kelsie/0000-0001-9262-7238	Canadian Institutes for Health Research (CIHR) [MOP-86731, MOP-77903, MOP-110949]; Canadian Cancer Society [CCS20485]; NCI Early Detection Research Network; Department of Defence [CDMRP W81XWH-10-1-0634]; CIHR; NSERC (Natural Sciences and Engineering Research Council); CIHR Jean-Francois Saint Denis Fellowship in Cancer Research; Banting Postdoctoral Fellowship; Vanier Canada Graduate Scholarships; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); NCI Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defence; CIHR(Canadian Institutes of Health Research (CIHR)); NSERC (Natural Sciences and Engineering Research Council)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Jean-Francois Saint Denis Fellowship in Cancer Research(Canadian Institutes of Health Research (CIHR)); Banting Postdoctoral Fellowship; Vanier Canada Graduate Scholarships; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Canadian Institutes for Health Research (CIHR) (MOP-86731, MOP-77903, MOP-110949), Canadian Cancer Society (CCS20485), NCI Early Detection Research Network, and Department of Defence (CDMRP W81XWH-10-1-0634). W. W. L., I. M. W., B. P. C., R. C., K. L. T. and L. A. P. were supported by scholarships from CIHR and NSERC (Natural Sciences and Engineering Research Council), and W. W. L. by a CIHR Jean-Francois Saint Denis Fellowship in Cancer Research, R. C. by a Banting Postdoctoral Fellowship, K. L. T. and L. A. P. by Vanier Canada Graduate Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin C, 2005, CANCER RES, V65, P7561, DOI 10.1158/0008-5472.CAN-05-1513; Bardelli A, 2001, P NATL ACAD SCI USA, V98, P5770, DOI 10.1073/pnas.081082898; Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Broet P, 2009, CANCER RES, V69, P1055, DOI 10.1158/0008-5472.CAN-08-1116; Chari R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-297; Cheng L, 2000, CARCINOGENESIS, V21, P1527, DOI 10.1093/carcin/21.8.1527; Chi B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-13; Chi B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-243; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Coe BP, 2006, BRIT J CANCER, V94, P1927, DOI 10.1038/sj.bjc.6603167; Coe BP, 2008, J CELL PHYSIOL, V217, P590, DOI 10.1002/jcp.21554; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Dang TP, 2003, ONCOGENE, V22, P1988, DOI 10.1038/sj.onc.1206230; de Fraipont F, 2005, LUNG CANCER, V50, P199, DOI 10.1016/j.lungcan.2005.05.019; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Eymin B, 2001, ONCOGENE, V20, P1678, DOI 10.1038/sj.onc.1204242; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Felip E, 2007, EXPERT REV MOL DIAGN, V7, P261, DOI 10.1586/14737159.7.3.261; Garnis C, 2005, ONCOGENE, V24, P4806, DOI 10.1038/sj.onc.1208643; Garraway LA, 2006, CANCER RES, V66, P2506, DOI 10.1158/0008-5472.CAN-05-4604; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Geradts J, 2000, BRIT J CANCER, V82, P1191, DOI 10.1054/bjoc.1999.1062; Giangreco A, 2007, AM J RESP CRIT CARE, V175, P547, DOI 10.1164/rccm.200607-984PP; Gollob JA, 2006, SEMIN ONCOL, V33, P392, DOI 10.1053/j.seminoncol.2006.04.002; Grigo K, 2008, BIOL CHEM, V389, P179, DOI 10.1515/BC.2008.011; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; HIGASHIYAMA M, 1995, CANCER RES, V55, P6040; Hillemacher T, 2008, EUR NEUROPSYCHOPHARM, V18, P295, DOI 10.1016/j.euroneuro.2007.12.005; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Hyman E, 2002, CANCER RES, V62, P6240; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jong K, 2004, BIOINFORMATICS, V20, P3636, DOI 10.1093/bioinformatics/bth355; Khojasteh M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-274; Kim H, 2004, J CLIN ONCOL, V22, P2363, DOI 10.1200/JCO.2004.10.077; Kim JS, 2004, CARCINOGENESIS, V25, P2165, DOI 10.1093/carcin/bgh217; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Langer CJ, 2010, J CLIN ONCOL, V28, P5311, DOI 10.1200/JCO.2010.28.8126; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lazarevich NL, 2008, BIOCHEMISTRY-MOSCOW+, V73, P573, DOI 10.1134/S0006297908050106; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Lockwood WW, 2008, ONCOGENE, V27, P4615, DOI 10.1038/onc.2008.98; Lockwood WW, 2007, INT J CANCER, V120, P436, DOI 10.1002/ijc.22335; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; Lucas B, 2005, ONCOGENE, V24, P6418, DOI 10.1038/sj.onc.1208794; Luk C, 2001, CANCER GENET CYTOGEN, V125, P87, DOI 10.1016/S0165-4608(00)00363-0; Maruyama R, 2004, CANCER-AM CANCER SOC, V100, P1472, DOI 10.1002/cncr.20144; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Olaussen KA, 2007, CURR OPIN PULM MED, V13, P284, DOI 10.1097/MCP.0b013e32816b5c63; ORZAN F, 2010, NEUROPATHOL APPL NEU; Pei JM, 2001, GENE CHROMOSOME CANC, V31, P282, DOI 10.1002/gcc.1145; Petersen I, 1997, CANCER RES, V57, P2331; Petersen I, 2009, LUNG CANCER, V65, P312, DOI 10.1016/j.lungcan.2008.12.013; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Sel S, 1996, CANCER LETT, V101, P205, DOI 10.1016/0304-3835(96)04136-5; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Sozzi G, 1997, CANCER RES, V57, P2121; Sozzi G, 1998, CANCER RES, V58, P5032; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Sy SMH, 2004, EUR J CANCER, V40, P1082, DOI 10.1016/j.ejca.2004.01.012; Thomas RK, 2006, CLIN CANCER RES, V12, p4384S, DOI 10.1158/1078-0432.CCR-06-0098; Tomizawa Y, 1998, CANCER RES, V58, P5478; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Toyooka S, 2001, MOL CANCER THER, V1, P61; Toyooka S, 2003, INT J CANCER, V103, P153, DOI 10.1002/ijc.10787; Travis W, 2004, WHO CLASSIFICATION T; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Vaissiere T, 2009, CANCER RES, V69, P243, DOI 10.1158/0008-5472.CAN-08-2489; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Vilmar A, 2009, LUNG CANCER, V64, P131, DOI 10.1016/j.lungcan.2008.08.006; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Watson SK, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-6; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Wu ZL, 2009, CELL DEATH DIFFER; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yang HH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009355; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102	96	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37775	10.1371/journal.pone.0037775	http://dx.doi.org/10.1371/journal.pone.0037775			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629454	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343100049
J	Maron, JL; Johnson, KL; Dietz, JA; Chen, MHL; Bianchi, DW				Maron, Jill L.; Johnson, Kirby L.; Dietz, Jessica A.; Chen, Minghua L.; Bianchi, Diana W.			Neuropeptide Y2 Receptor (NPY2R) Expression in Saliva Predicts Feeding Immaturity in the Premature Neonate	PLOS ONE			English	Article							BODY-WEIGHT; BEHAVIOR; NPYY2; GENE	Background: The current practice in newborn medicine is to subjectively assess when a premature infant is ready to feed by mouth. When the assessment is inaccurate, the resulting feeding morbidities may be significant, resulting in long-term health consequences and millions of health care dollars annually. We hypothesized that the developmental maturation of hypothalamic regulation of feeding behavior is a predictor of successful oral feeding in the premature infant. To test this hypothesis, we analyzed the gene expression of neuropeptide Y2 receptor (NPY2R), a known hypothalamic regulator of feeding behavior, in neonatal saliva to determine its role as a biomarker in predicting oral feeding success in the neonate. Methodology/Principal Findings: Salivary samples (n = 116), were prospectively collected from 63 preterm and 13 term neonates (post-conceptual age (PCA) 26 4/7 to 41 4/7 weeks) from five predefined feeding stages. Expression of NPY2R in neonatal saliva was determined by multiplex RT-qPCR amplification. Expression results were retrospectively correlated with feeding status at time of sample collection. Statistical analysis revealed that expression of NPY2R had a 95% positive predictive value for feeding immaturity. NPY2R expression statistically significantly decreased with advancing PCA (Wilcoxon test p value<0.01), and was associated with feeding status (chi square p value = 0.013). Conclusions/Significance: Developmental maturation of hypothalamic regulation of feeding behavior is an essential component of oral feeding success in the newborn. NPY2R expression in neonatal saliva is predictive of an immature feeding pattern. It is a clinically relevant biomarker that may be monitored in saliva to improve clinical care and reduce significant feeding-associated morbidities that affect the premature neonate.	[Maron, Jill L.; Dietz, Jessica A.; Chen, Minghua L.] Tufts Med Ctr, Floating Hosp Children, Dept Pediat, Div Newborn Med, Boston, MA 02111 USA; [Johnson, Kirby L.; Bianchi, Diana W.] Tufts Med Ctr, Floating Hosp Children, Dept Pediat, Div Genet, Boston, MA USA; [Maron, Jill L.; Johnson, Kirby L.; Bianchi, Diana W.] Tufts Med Ctr, Mother Infant Res Inst, Boston, MA USA	Floating Hospital For Children; Tufts Medical Center; Floating Hospital For Children; Tufts Medical Center; Tufts Medical Center	Maron, JL (corresponding author), Tufts Med Ctr, Floating Hosp Children, Dept Pediat, Div Newborn Med, Boston, MA 02111 USA.	jmaron@tuftsmedicalcenter.org		Daley, Jessica/0000-0001-5133-448X	NICHD [K08 HD 059819-03]; Charles H. Hood Foundation; Richard Saltonstall Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD059819] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Charles H. Hood Foundation; Richard Saltonstall Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	NICHD K08 HD 059819-03, the Charles H. Hood Foundation (www.hria.org/tmfservices/tmfgrants/hood.html), and the Richard Saltonstall Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaizu N, 2008, ACTA PAEDIATR, V97, P61, DOI 10.1111/j.1651-2227.2007.00548.x; Barlow SM, 2009, CURR OPIN OTOLARYNGO, V17, P187, DOI 10.1097/MOO.0b013e32832b312a; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butler A A, 2001, Trends Genet, V17, pS50, DOI 10.1016/S0168-9525(01)02481-7; Campbell CD, 2007, DIABETES, V56, P1460, DOI 10.2337/db06-1051; Delaney AL, 2008, DEV DISABIL RES REV, V14, P105, DOI 10.1002/ddrr.16; Dietz JA, 2012, NEONATOLOGY, V101, P55, DOI 10.1159/000328026; Huang XF, 2008, NEUROCHEM RES, V33, P1881, DOI 10.1007/s11064-008-9661-5; Kamiji MM, 2007, CURR TOP MED CHEM, V7, P1734, DOI 10.2174/156802607782340957; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Lau C., 2006, NEOREVIEWS, V7, P19, DOI [10.1542/neo.7-1-e19, DOI 10.1542/neo.7-1-e19, DOI 10.1542/NEO.7-1-E19]; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Maron JL, 2010, CLIN CHEM, V56, P409, DOI 10.1373/clinchem.2009.136234; Mizuno K, 2005, DEV MED CHILD NEUROL, V47, P299, DOI 10.1017/S0012162205000587; Naveilhan P, 1999, NAT MED, V5, P1188, DOI 10.1038/13514; PANKSEPP J, 1974, FED PROC, V33, P1150; Samara M, 2010, DEV MED CHILD NEUROL, V52, pe16, DOI 10.1111/j.1469-8749.2009.03512.x; Sato N, 2009, EXPERT OPIN THER PAT, V19, P1401, DOI 10.1517/13543770903251722; Shi YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011361; Takiguchi E, 2010, METABOLISM, V59, P1591, DOI 10.1016/j.metabol.2010.02.014; Uddman R, 2002, PEPTIDES, V23, P927, DOI 10.1016/S0196-9781(02)00003-7; Wang LX, 2010, AM J PHYSIOL-GASTR L, V298, pG45, DOI 10.1152/ajpgi.00349.2009; Yoo SB, 2011, NEUROPEPTIDES, V45, P343, DOI 10.1016/j.npep.2011.07.005; Zimmermann BG, 2007, ANN NY ACAD SCI, V1098, P184, DOI 10.1196/annals.1384.002	24	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37870	10.1371/journal.pone.0037870	http://dx.doi.org/10.1371/journal.pone.0037870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629465	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343100056
J	Su, CH; Wang, JT; Hsiung, CA; Chien, LJ; Chi, CL; Yu, HT; Chang, FY; Chang, SC				Su, Chiu-Hsia; Wang, Jann-Tay; Hsiung, Chao A.; Chien, Li-Jung; Chi, Cheng-Liang; Yu, Hui-Tzu; Chang, Feng-Yee; Chang, Shan-Chwen			Increase of Carbapenem-Resistant Acinetobacter baumannii Infection in Acute Care Hospitals in Taiwan: Association with Hospital Antimicrobial Usage	PLOS ONE			English	Article							RISK-FACTORS; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC USAGE; OUTBREAK; COLONIZATION; EMERGENCE; SPREAD; ACQUISITION; BACTEREMIA; PROGNOSIS	Objective: Carbapenem-resistant Acinetobacter baumannii (CRAB) has emerged as an important pathogen causing healthcare-associated infections (HAIs) in Taiwan. The present study is aimed to investigate the epidemiology of HAIs caused by CRAB and the association of CRAB infection and hospital usage of different antimicrobials. Methods: Two nationwide databases in the period 2003 to 2008, the Taiwan Nosocomial Infection Surveillance System and National Health Insurance claim data, were used for analysis. A total of 13,811 healthcare-associated A. baumannii infections and antimicrobial usage data from 121 hospitals were analyzed. Results: There was a significant increase in the proportion of number of HAIs caused by CRAB over that by all A. baumannii (CRABpAB), from 14% in 2003 to 46% in 2008 (P<0.0001). The greatest increase was in central Taiwan, from 4% in 2003 to 62% in 2008 (P<0.0001). Use of anti-pseudomonal carbapenems, but not other classes of antibiotics, was significantly correlated with the increase of CRABpAB (r = 0.86, P<0.0001). Conclusions: We suggested that dedicated use of anti-pseudomonal carbapenems would be an important intervention to control the increase of CRABpAB.	[Su, Chiu-Hsia; Chien, Li-Jung; Chang, Feng-Yee] Ctr Dis Control Taiwan, Taipei, Taiwan; [Su, Chiu-Hsia] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Wang, Jann-Tay; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Hsiung, Chao A.; Chi, Cheng-Liang; Yu, Hui-Tzu] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Coll Med, Grad Inst Pharm, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital	Su, CH (corresponding author), Ctr Dis Control Taiwan, Taipei, Taiwan.	changsc@ntu.edu.tw	Hsiung, Chao Agnes/E-3994-2010	CHANG, SHAN-CHWEN/0000-0001-6505-4139; WANG, JANN-TAY/0000-0002-0924-3469				Akinci E, 2005, J HOSP INFECT, V59, P317, DOI 10.1016/j.jhin.2004.09.030; Baran G, 2008, INT J INFECT DIS, V12, P16, DOI 10.1016/j.ijid.2007.03.005; Bureau of National Health Insurance, 2009, INTR NAT HLTH INS TA; *CDC TAIW, 2009, STAT COMM DIS SURV R; Centers for Disease Control of Taiwan, 2004, STAT COMM DIS SURV R; Chen CM, 2009, DIAGN MICR INFEC DIS, V63, P394, DOI 10.1016/j.diagmicrobio.2008.12.011; Chen TL, 2010, ANTIMICROB AGENTS CH, V54, P4575, DOI 10.1128/AAC.00764-10; Cisneros JM, 2002, CLIN MICROBIOL INFEC, V8, P687, DOI 10.1046/j.1469-0691.2002.00487.x; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Corbella X, 2000, J CLIN MICROBIOL, V38, P4086, DOI 10.1128/JCM.38.11.4086-4095.2000; Romanelli RMD, 2009, BRAZ J INFECT DIS, V13, P341, DOI 10.1590/S1413-86702009000500005; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; HICPAC, 2006, MAN MULT RES ORG HEA; Karageorgopoulos DE, 2008, J ANTIMICROB CHEMOTH, V62, P45, DOI 10.1093/jac/dkn165; Katragkou A, 2006, INTENS CARE MED, V32, P1384, DOI 10.1007/s00134-006-0239-x; Kim YA, 2008, SCAND J INFECT DIS, V40, P234, DOI 10.1080/00365540701633004; Kuo HY, 2010, DIAGN MICR INFEC DIS, V66, P195, DOI 10.1016/j.diagmicrobio.2009.09.013; Lee SO, 2004, ANTIMICROB AGENTS CH, V48, P224, DOI 10.1128/AAC.48.1.224-228.2004; Lee TM, 2010, INFECT CONTROL J, V20, P107; Lee YT, 2012, J MICROBIOL IMMUNOL, V45, P43, DOI 10.1016/j.jmii.2011.09.020; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Lu PL, 2009, J ANTIMICROB CHEMOTH, V63, P641, DOI 10.1093/jac/dkn553; Manikal VM, 2000, CLIN INFECT DIS, V31, P101, DOI 10.1086/313902; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Paterson DL, 2006, CLIN INFECT DIS, V43, pS43, DOI 10.1086/504476; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Schreckenberg PC, 2003, MANUAL CLIN MICROBIO, P749; Smolyakova R, 2003, J HOSP INFECT, V54, P32, DOI 10.1016/S0195-6701(03)00046-X; Tomas MD, 2005, CLIN MICROBIOL INFEC, V11, P540, DOI 10.1111/j.1469-0691.2005.01184.x; Tsai HT, 2008, DIAGN MICR INFEC DIS, V62, P298, DOI 10.1016/j.diagmicrobio.2008.06.017; Tseng YC, 2007, DIAGN MICR INFEC DIS, V59, P181, DOI 10.1016/j.diagmicrobio.2007.04.024; Unal S, 2005, DIAGN MICR INFEC DIS, V53, P265, DOI 10.1016/j.diagmicrobio.2005.10.002; Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205; Williams VR, 2009, AM J INFECT CONTROL, V37, P106, DOI 10.1016/j.ajic.2008.05.007; World Health Organization: Geneva (WHO), 2007, COLL CTR DRUG STAT M	36	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37788	10.1371/journal.pone.0037788	http://dx.doi.org/10.1371/journal.pone.0037788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629456	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343100051
J	Awoniyi, M; Miller, SI; Wilson, CB; Hajjar, AM; Smith, KD				Awoniyi, Muyiwa; Miller, Samuel I.; Wilson, Christopher B.; Hajjar, Adeline M.; Smith, Kelly D.			Homeostatic Regulation of Salmonella-Induced Mucosal Inflammation and Injury by IL-23	PLOS ONE			English	Article							ENTERICA SEROVAR ENTERITIDIS; IMMUNE-RESPONSE; INTESTINAL INFLAMMATION; BACTERIAL-INFECTION; BARRIER SURFACES; GAMMA-INTERFERON; IL-17 PRODUCTION; HOST-DEFENSE; INNATE; MICE	IL-12 and IL-23 regulate innate and adaptive immunity to microbial pathogens through influencing the expression of IFN-gamma, IL-17, and IL-22. Herein we define the roles of IL-12 and IL-23 in regulating host resistance and intestinal inflammation during acute Salmonella infection. We find that IL-23 alone is dispensable for protection against systemic spread of bacteria, but synergizes with IL-12 for optimal protection. IL-12 promotes the production of IFN-gamma by NK cells, which is required for resistance against Salmonella and also for induction of intestinal inflammation and epithelial injury. In contrast, IL-23 controls the severity of inflammation by inhibiting IL-12A expression, reducing IFN-gamma and preventing excessive mucosal injury. Our studies demonstrate that IL-23 is a homeostatic regulator of IL-12-dependent, IFN-gamma-mediated intestinal inflammation.	[Awoniyi, Muyiwa; Smith, Kelly D.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Awoniyi, Muyiwa; Smith, Kelly D.] Univ Washington, Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Wilson, Christopher B.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Hajjar, Adeline M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Awoniyi, M (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kelsmith@uw.edu		Hajjar, Adeline/0000-0002-4838-8070	National Institutes of Health [R01AI062859, R21AI083558, F31AI083042, U54AI057141]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI083042, R01AI062859, R21AI083558, U54AI057141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01AI062859 and R21AI083558 (K.D.S.), F31AI083042 (M.A.) and U54AI057141 (S.I.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2007, J ALLERGY CLIN IMMUN, V120, P916, DOI 10.1016/j.jaci.2007.05.023; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; de Jong R, 1998, SCIENCE, V280, P1435; Dubin Patricia J, 2007, Expert Rev Respir Med, V1, P121, DOI 10.1586/17476348.1.1.121; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Harrington L, 2007, FEMS IMMUNOL MED MIC, V51, P372, DOI 10.1111/j.1574-695X.2007.00313.x; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Holscher C, 2004, MED MICROBIOL IMMUN, V193, P1, DOI 10.1007/s00430-003-0186-x; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2011, CURR OPIN MICROBIOL, V14, P106, DOI 10.1016/j.mib.2010.12.003; Kirby AC, 2002, J IMMUNOL, V169, P4450, DOI 10.4049/jimmunol.169.8.4450; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Lehmann J, 2001, J IMMUNOL, V167, P5304, DOI 10.4049/jimmunol.167.9.5304; Lugering A, 2003, J IMMUNOL, V171, P2208, DOI 10.4049/jimmunol.171.5.2208; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Mastroeni P, 1998, INFECT IMMUN, V66, P4767, DOI 10.1128/IAI.66.10.4767-4776.1998; MCGOVERN VJ, 1979, AM J SURG PATHOL, V3, P483, DOI 10.1097/00000478-197912000-00001; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Metzger DW, 2010, CYTOKINE, V52, P102, DOI 10.1016/j.cyto.2010.06.011; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; Schulz SM, 2008, J IMMUNOL, V181, P7891, DOI 10.4049/jimmunol.181.11.7891; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Siegemund S, 2009, INT IMMUNOL, V21, P555, DOI 10.1093/intimm/dxp025; Sieve AN, 2010, EUR J IMMUNOL, V40, P2236, DOI 10.1002/eji.200939759; Songhet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022459; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wallis TS, 2000, MOL MICROBIOL, V36, P997, DOI 10.1046/j.1365-2958.2000.01892.x; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Zhang XY, 2009, J IMMUNOL, V183, P1291, DOI 10.4049/jimmunol.0803075; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	45	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37311	10.1371/journal.pone.0037311	http://dx.doi.org/10.1371/journal.pone.0037311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624013	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343500096
J	Chu, YZ; Yao, JZ; Guo, H				Chu, Yuzhuo; Yao, Jianzhuang; Guo, Hong			QM/MM MD and Free Energy Simulations of G9a-Like Protein (GLP) and Its Mutants: Understanding the Factors that Determine the Product Specificity	PLOS ONE			English	Article							LYSINE METHYLTRANSFERASE SET7/9; MOLECULAR-DYNAMICS SIMULATIONS; HISTONE MODIFICATIONS; CATALYTIC MECHANISM; METHYLATION; BINDING; CHROMATIN; INSIGHTS; REVEAL; WATER	Certain lysine residues on histone tails could be methylated by protein lysine methyltransferases (PKMTs) using S-adenosyl-L-methionine (AdoMet) as the methyl donor. Since the methylation states of the target lysines play a fundamental role in the regulation of chromatin structure and gene expression, it is important to study the property of PKMTs that allows a specific number of methyl groups (one, two or three) to be added (termed as product specificity). It has been shown that the product specificity of PKMTs may be controlled in part by the existence of specific residues at the active site. One of the best examples is a Phe/Tyr switch found in many PKMTs. Here quantum mechanical/molecular mechanical (QM/MM) molecular dynamics (MD) and free energy simulations are performed on wild type G9a-like protein (GLP) and its F1209Y and Y1124F mutants for understanding the energetic origin of the product specificity and the reasons for the change of product specificity as a result of single-residue mutations at the Phe/Tyr switch as well as other positions. The free energy barriers of the methyl transfer processes calculated from our simulations are consistent with experimental data, supporting the suggestion that the relative free energy barriers may determine, at least in part, the product specificity of PKMTs. The changes of the free energy barriers as a result of the mutations are also discussed based on the structural information obtained from the simulations. The results suggest that the space and active-site interactions around the e-amino group of the target lysine available for methyl addition appear to among the key structural factors in controlling the product specificity and activity of PKMTs.	[Chu, Yuzhuo; Yao, Jianzhuang; Guo, Hong] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37920 USA; [Chu, Yuzhuo] Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN USA; [Guo, Hong] Univ Tennessee, Oak Ridge Natl Lab, Ctr Biophys Mol, Oak Ridge, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Chu, YZ (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37920 USA.	hguo1@utk.edu	Guo, Hong/E-6357-2010		National Science Foundation Award [0817940]; National Institute for Mathematical and Biological Synthesis (NIMBioS) at University of Tennessee; National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF Award [EF-0832858]	National Science Foundation Award(National Science Foundation (NSF)); National Institute for Mathematical and Biological Synthesis (NIMBioS) at University of Tennessee(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF Award	This work is supported in part by the National Science Foundation Award (Grant number: 0817940 to HG) and NSF TeraGrid resources provided by University of Texas at Austin. YZC is supported by a fellowship from the National Institute for Mathematical and Biological Synthesis (NIMBioS) at University of Tennessee sponsored by the National Science Foundation, the U.S. Department of Homeland Security and the U.S. Department of Agriculture through NSF Award #EF-0832858. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bai QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019856; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROOKS CL, 1985, BIOPOLYMERS, V24, P843, DOI 10.1002/bip.360240509; Chu YZ, 2010, J CHEM THEORY COMPUT, V6, P1380, DOI 10.1021/ct9006458; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Cui Q, 2001, J PHYS CHEM B, V105, P569, DOI 10.1021/jp0029109; Del Rizzo PA, 2010, J BIOL CHEM, V285, P31849, DOI 10.1074/jbc.M110.114587; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Glowacki DR, 2009, J PHYS CHEM B, V113, P16603, DOI 10.1021/jp9074898; Guo HB, 2007, P NATL ACAD SCI USA, V104, P8797, DOI 10.1073/pnas.0702981104; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Hu P, 2008, J AM CHEM SOC, V130, P3806, DOI 10.1021/ja075896n; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lall S, 2007, NAT STRUCT MOL BIOL, V14, P1110, DOI 10.1038/nsmb1107-1110; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Ricchiuto P, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3624928; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; TORRIE GM, 1974, CHEM PHYS LETT, V28, P578, DOI 10.1016/0009-2614(74)80109-0; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; Wang SL, 2007, J PHYS CHEM B, V111, P3758, DOI 10.1021/jp067147i; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Xu Q, 2009, CHEM-EUR J, V15, P12596, DOI 10.1002/chem.200902297; Xu ST, 2011, NUCLEIC ACIDS RES, V39, P4438, DOI 10.1093/nar/gkr019; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhang XD, 2008, BIOCHEMISTRY-US, V47, P6671, DOI 10.1021/bi800244s; Zhang X, 2008, P NATL ACAD SCI USA, V105, P5728, DOI 10.1073/pnas.0801788105	38	15	16	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37674	10.1371/journal.pone.0037674	http://dx.doi.org/10.1371/journal.pone.0037674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624060	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343500149
J	Krause, MA; Diakite, SAS; Lopera-Mesa, TM; Amaratunga, C; Arie, T; Traore, K; Doumbia, S; Konate, D; Keefer, JR; Diakite, M; Fairhurst, RM				Krause, Michael A.; Diakite, Seidina A. S.; Lopera-Mesa, Tatiana M.; Amaratunga, Chanaki; Arie, Takayuki; Traore, Karim; Doumbia, Saibou; Konate, Drissa; Keefer, Jeffrey R.; Diakite, Mahamadou; Fairhurst, Rick M.			alpha-Thalassemia Impairs the Cytoadherence of Plasmodium falciparum- Infected Erythrocytes	PLOS ONE			English	Article							HUMAN CEREBRAL MALARIA; ALPHA(+)-THALASSEMIA PROTECTS; HEMOGLOBIN-E; RED-CELLS; CHILDREN; SURFACE; PHAGOCYTOSIS; EXPRESSION; SEVERITY; GROWTH	Background: alpha-thalassemia results from decreased production of alpha-globin chains that make up part of hemoglobin tetramers (Hb; alpha(2)beta(2)) and affects up to 50% of individuals in some regions of sub-Saharan Africa. Heterozygous (-alpha/alpha alpha) and homozygous (-alpha/-alpha) genotypes are associated with reduced risk of severe Plasmodium falciparum malaria, but the mechanism of this protection remains obscure. We hypothesized that alpha-thalassemia impairs the adherence of parasitized red blood cells (RBCs) to microvascular endothelial cells (MVECs) and monocytes - two interactions that are centrally involved in the pathogenesis of severe disease. Methods and Findings: We obtained P. falciparum isolates directly from Malian children with malaria and used them to infect alpha alpha/alpha alpha (normal), -alpha/alpha alpha and -alpha/-alpha RBCs. We also used laboratory-adapted P. falciparum clones to infect -/-alpha RBCs obtained from patients with HbH disease. Following a single cycle of parasite invasion and maturation to the trophozoite stage, we tested the ability of parasitized RBCs to bind MVECs and monocytes. Compared to parasitized alpha alpha/alpha alpha RBCs, we found that parasitized -alpha/alpha alpha, -alpha/-alpha and -/-alpha RBCs showed, respectively, 22%, 43% and 63% reductions in binding to MVECs and 13%, 33% and 63% reductions in binding to monocytes. alpha-thalassemia was associated with abnormal display of P. falciparum erythrocyte membrane protein 1 (PfEMP1), the parasite's main cytoadherence ligand and virulence factor, on the surface of parasitized RBCs. Conclusions: Parasitized alpha-thalassemic RBCs show PfEMP1 display abnormalities that are reminiscent of those on the surface of parasitized sickle HbS and HbC RBCs. Our data suggest a model of malaria protection in which alpha-thalassemia ameliorates the pro-inflammatory effects of cytoadherence. Our findings also raise the possibility that other unstable hemoglobins such as HbE and unpaired alpha-globin chains (in the case of beta-thalassemia) protect against life-threatening malaria by a similar mechanism.	[Krause, Michael A.; Lopera-Mesa, Tatiana M.; Amaratunga, Chanaki; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Diakite, Seidina A. S.; Traore, Karim; Doumbia, Saibou; Konate, Drissa; Diakite, Mahamadou] Univ Bamako, Malaria Res & Training Ctr, Fac Med Pharm & Odontostomatol, Bamako, Mali; [Arie, Takayuki] Osaka Prefecture Univ, Dept Phys & Elect, Sch Engn, Osaka, Japan; [Keefer, Jeffrey R.] Johns Hopkins Sch Med, Div Pediat Hematol, Dept Pediat, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bamako; Osaka Metropolitan University; Johns Hopkins University; Johns Hopkins Medicine	Krause, MA (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rfairhurst@niaid.nih.gov		Diakite, Seidina A. S./0000-0003-1193-6501	Intramural Research Program of the NIAID; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001062, ZIAAI001000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Intramural Research Program of the NIAID, NIH. The authors wish to acknowledge Jennifer M. Anderson, Steve Beaudry, Mory Doumbia, Seydou Doumbia, Robert W. Gwadz, Carole A. Long, Sam Moretz, Dick Sakai, Cheick Traore, and Thomas E. Wellems for their efforts in support of this work.; This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; ALLEN SJ, 1993, T ROY SOC TROP MED H, V87, P282, DOI 10.1016/0035-9203(93)90129-E; Arie T, 2005, J STRUCT BIOL, V150, P163, DOI 10.1016/j.jsb.2005.02.008; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BROWN AE, 1990, EUR J HAEMATOL, V45, P120; CAMPWALA HQ, 1982, J LAB CLIN MED, V99, P25; CARLSON J, 1994, BLOOD, V84, P3909, DOI 10.1182/blood.V84.11.3909.bloodjournal84113909; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Chakravorty SJ, 2008, BIOCHEM SOC T, V36, P221, DOI 10.1042/BST0360221; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Enevold A, 2008, AM J TROP MED HYG, V78, P714, DOI 10.4269/ajtmh.2008.78.714; Fowkes FJI, 2008, PLOS MED, V5, P494, DOI 10.1371/journal.pmed.0050056; Giribaldi G, 2001, BRIT J HAEMATOL, V113, P492, DOI 10.1046/j.1365-2141.2001.02707.x; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; HEBBEL RP, 1982, J CLIN INVEST, V70, P1253, DOI 10.1172/JCI110724; HEBBEL RP, 1985, CLIN HAEMATOL, V14, P129; Horrocks P, 2005, J CELL SCI, V118, P2507, DOI 10.1242/jcs.02381; Imrie H, 2006, AM J TROP MED HYG, V74, P965, DOI 10.4269/ajtmh.2006.74.965; Jenkins N, 2007, J INFECT DIS, V196, P321, DOI 10.1086/518795; KITAYAPORN D, 1992, T ROY SOC TROP MED H, V86, P240, DOI 10.1016/0035-9203(92)90292-K; LUZZI GA, 1991, J EXP MED, V173, P785, DOI 10.1084/jem.173.4.785; MACDONALD VW, 1982, BIOCHIM BIOPHYS ACTA, V701, P39, DOI 10.1016/0167-4838(82)90309-0; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mockenhaupt FP, 1999, J INFECT DIS, V180, P925, DOI 10.1086/314959; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Mockenhaupt FP, 1999, TROP MED INT HEALTH, V4, P302, DOI 10.1046/j.1365-3156.1999.00386.x; Mockenhaupt FP, 2001, TROP MED INT HEALTH, V6, P102, DOI 10.1046/j.1365-3156.2001.00688.x; OCKENHOUSE CF, 1989, J CLIN INVEST, V84, P468, DOI 10.1172/JCI114188; Oo M, 1995, B WORLD HEALTH ORGAN, V73, P659; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; Pattanapanyasat K, 1999, BLOOD, V93, P3116; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TURNER GDH, 1994, AM J PATHOL, V145, P1057; UDOMSANGPETCH R, 1993, BLOOD, V82, P3752; Veenemans J, 2008, J INFECT DIS, V198, P401, DOI 10.1086/589884; Wambua S, 2006, PLOS MED, V3, P643, DOI 10.1371/journal.pmed.0030158; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Williams TN, 2002, BRIT J HAEMATOL, V118, P663, DOI 10.1046/j.1365-2141.2002.03610.x; YUTHAVONG Y, 1988, AM J CLIN PATHOL, V89, P521, DOI 10.1093/ajcp/89.4.521	52	36	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37214	10.1371/journal.pone.0037214	http://dx.doi.org/10.1371/journal.pone.0037214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623996	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500076
J	Mohler, E; Frei, P; Frolich, J; Braun-Fahrlander, C; Roosli, M				Mohler, Evelyn; Frei, Patrizia; Froehlich, Juerg; Braun-Fahrlaender, Charlotte; Roeoesli, Martin		QUALIFEX-Team	Exposure to Radiofrequency Electromagnetic Fields and Sleep Quality: A Prospective Cohort Study	PLOS ONE			English	Article							PHONE BASE STATIONS; DOUBLE-BLIND; PERSONAL EXPOSURE; MOBILE PHONES; SYMPTOMS; HEALTH; PREVALENCE; SIGNALS	Background: There is persistent public concern about sleep disturbances due to radiofrequency electromagnetic field (RF-EMF) exposure. The aim of this prospective cohort study was to investigate whether sleep quality is affected by mobile phone use or by other RF-EMF sources in the everyday environment. Methods: We conducted a prospective cohort study with 955 study participants aged between 30 and 60 years. Sleep quality and daytime sleepiness was assessed by means of standardized questionnaires in May 2008 (baseline) and May 2009 (follow-up). We also asked about mobile and cordless phone use and asked study participants for consent to obtain their mobile phone connection data from the mobile phone operators. Exposure to environmental RF-EMF was computed for each study participant using a previously developed and validated prediction model. In a nested sample of 119 study participants, RF-EMF exposure was measured in the bedroom and data on sleep behavior was collected by means of actigraphy during two weeks. Data were analyzed using multivariable regression models adjusted for relevant confounders. Results: In the longitudinal analyses neither operator-recorded nor self-reported mobile phone use was associated with sleep disturbances or daytime sleepiness. Also, exposure to environmental RF-EMF did not affect self-reported sleep quality. The results from the longitudinal analyses were confirmed in the nested sleep study with objectively recorded exposure and measured sleep behavior data. Conclusions: We did not find evidence for adverse effects on sleep quality from RF-EMF exposure in our everyday environment.	[Mohler, Evelyn; Frei, Patrizia; Braun-Fahrlaender, Charlotte; Roeoesli, Martin] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Mohler, Evelyn; Frei, Patrizia; Braun-Fahrlaender, Charlotte; Roeoesli, Martin] Univ Basel, Basel, Switzerland; [Froehlich, Juerg] ETH, Lab Electromagnet Fields & Microwave Elect, Zurich, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich	Mohler, E (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	martin.roosli@unibas.ch	Röösli, Martin/A-2658-2008	Röösli, Martin/0000-0002-7475-1531; Frohlich, Jurg/0000-0002-5923-3410	Swiss National Science Foundation [405740-113595]; Swiss School of Public Health+ (SSPH+)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss School of Public Health+ (SSPH+)	The study was funded by the Swiss National Science Foundation (Grant 405740-113595, www.snf.ch). Martin Roosli is supported by the Swiss School of Public Health+ (SSPH+, http://www.ssphplus.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Berg-Beckhoff G, 2009, OCCUP ENVIRON MED, V66, P124, DOI 10.1136/oem.2008.039834; Blettner M, 2009, OCCUP ENVIRON MED, V66, P118, DOI 10.1136/oem.2007.037721; Borbely AA, 1999, NEUROSCI LETT, V275, P207, DOI 10.1016/S0304-3940(99)00770-3; Burgi A, 2010, BIOELECTROMAGNETICS, V31, P226, DOI 10.1002/bem.20552; Danker-Hopfe H, 2010, AM J HUM BIOL, V22, P613, DOI 10.1002/ajhb.21053; Eltiti S, 2007, ENVIRON HEALTH PERSP, V115, P1603, DOI 10.1289/ehp.10286; Frei P, 2010, ENVIRON INT, V36, P714, DOI 10.1016/j.envint.2010.05.005; Frei P, 2009, SCI TOTAL ENVIRON, V408, P102, DOI 10.1016/j.scitotenv.2009.09.023; Frei P, 2009, ENVIRON RES, V109, P779, DOI 10.1016/j.envres.2009.04.015; Hinrichs H, 2005, SOMNOLOGY, V9, P185, DOI [10.1111/j.1439-054X.2005.00069.x, DOI 10.1111/J.1439-054X.2005.00069.X]; Huber R, 2002, J SLEEP RES, V11, P289, DOI 10.1046/j.1365-2869.2002.00314.x; Huss A, 2004, INT J HYG ENVIR HEAL, V207, P245, DOI 10.1078/1438-4639-00286; Hutter HP, 2006, OCCUP ENVIRON MED, V63, P307, DOI 10.1136/oem.2005.020784; Infas, 2010, ERM BEF ANGST BREIT; Jean-Louis G, 2000, SLEEP, V23, P1115; Johns M, 1997, SLEEP, V20, P844, DOI 10.1093/sleep/20.10.844; Loughran SP, 2005, NEUROREPORT, V16, P1973, DOI 10.1097/01.wnr.0000186593.79705.3c; Lowden A, 2011, BIOELECTROMAGNETICS, V32, P4, DOI 10.1002/bem.20609; Mohler E, 2010, RADIAT RES, V174, P347, DOI 10.1667/RR2153.1; Neubauer G, 2007, BIOELECTROMAGNETICS, V28, P224, DOI 10.1002/bem.20298; Oftedal G, 2007, CEPHALALGIA, V27, P447, DOI 10.1111/j.1468-2982.2007.01336.x; Oftedal G, 2000, OCCUP MED-OXFORD, V50, P237, DOI 10.1093/occmed/50.4.237; Regel SJ, 2007, J SLEEP RES, V16, P253, DOI 10.1111/j.1365-2869.2007.00603.x; Roosli M, 2008, BIOELECTROMAGNETICS, V29, P471, DOI 10.1002/bem.20417; Roosli M, 2010, CR PHYS, V11, P576, DOI 10.1016/j.crhy.2010.10.007; Roosli M, 2010, B WORLD HEALTH ORGAN, V88, P887, DOI 10.2471/BLT.09.071852; Roosli M, 2004, INT J HYG ENVIR HEAL, V207, P141, DOI 10.1078/1438-4639-00269; Rubin GJ, 2010, BIOELECTROMAGNETICS, V31, P1, DOI 10.1002/bem.20536; Schmitt BE, 2000, SCHWEIZ MED WSCHR, V130, P772; Schreier N, 2006, SOZ PRAVENTIV MED, V51, P202, DOI 10.1007/s00038-006-5061-2; Thomas S, 2008, BIOELECTROMAGNETICS, V29, P463, DOI 10.1002/bem.20414; Wallace D, 2010, ENVIRON HEALTH PERSP, V118, P735, DOI 10.1289/ehp.0901416	33	35	35	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37455	10.1371/journal.pone.0037455	http://dx.doi.org/10.1371/journal.pone.0037455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624036	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000305343500121
J	Wang, ZQ; Liang, PP; Jia, XQ; Jin, GW; Song, HQ; Han, Y; Lu, J; Li, KC				Wang, Zhiqun; Liang, Peipeng; Jia, Xiuqin; Jin, Guangwei; Song, Haiqing; Han, Ying; Lu, Jie; Li, Kuncheng			The Baseline and Longitudinal Changes of PCC Connectivity in Mild Cognitive Impairment: A Combined Structure and Resting-State fMRI Study	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; ALZHEIMERS-DISEASE; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; MRI; DEMENTIA; CORTEX; MEMORY	The baseline and longitudinal changes of the posterior cingulate cortex (PCC) connectivity were assessed in order to clarify the neural mechanism of mild cognitive impairment (MCI). Twenty-eight right-handed subjects (14 MCI patients and 14 healthy elders) participated in this study. Clinical and neuropsychological examinations were performed on all the subjects. PCC functional connectivity was studied by examining the correlation between low frequency fMRI signal fluctuations in the PCC and those in all the other brain regions. Additionally, we traced all the MCI patients and compared their PCC connectivity in the initial stage and that in 3 years later. We also explored the relationship between the PCC functional connectivity strength and cognitive performances. Our results are as follows: Functional connectivity between the PCC and a set of regions is decreased in MCI patients. Most of these regions are within the default mode network (DMN). Three years later, the regions of superior frontal gyrus (SFG) and middle frontal gyrus (MFG) presented further decreased connectivity to the PCC in MCI. In addition, we also find enhanced functional connectivity between PCC and medial prefrontal cortex (MPFC), PCC and anterior cingulate cortex (ACC) in MCI patients. At last, our research also shows that the PCC connectivity with some regions significantly correlates with the cognitive performances of patients as measured by mini-mental state examination (MMSE), and California verbal learning test (CVLT) scores. The baseline and longitudinal changes of the PCC connectivity in our study suggest that impairment and compensation coexist in the disease progress of MCI patients.	[Wang, Zhiqun; Liang, Peipeng; Jia, Xiuqin; Jin, Guangwei; Lu, Jie; Li, Kuncheng] Capital Med Univ, Dept Radiol, Xuanwu Hosp, Beijing, Peoples R China; [Song, Haiqing; Han, Ying] Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing, Peoples R China; [Li, Kuncheng] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Wang, ZQ (corresponding author), Capital Med Univ, Dept Radiol, Xuanwu Hosp, Beijing, Peoples R China.	likuncheng@xwh.ccmu.edu.cn	Lu, Jie/GNW-3367-2022; Liang, Peipeng/A-9502-2015; Han, Ying/H-7111-2017; , xiuqin/T-8052-2018	Liang, Peipeng/0000-0003-3795-4134; , xiuqin/0000-0003-3920-2884	Natural Science Foundation of China [81000606, 61105118, 81141018]; State Key Laboratory of Cognitive Neuroscience and Learning [CNKOPZD1001]; CAS Key Laboratory of Brain Function and Disease; Key Work of Special Project [Z101107052210002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Cognitive Neuroscience and Learning; CAS Key Laboratory of Brain Function and Disease; Key Work of Special Project	This work was supported by the Natural Science Foundation of China (Grant Nos. 81000606, 61105118, 81141018), Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning (No.CNKOPZD1001), Open Research Fund of CAS Key Laboratory of Brain Function and Disease, and Key Work of Special Project (Z101107052210002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2011, NEUROBIOL AGING; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Binnewijzend M.A., 2011, NEUROBIOL AGING; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Liang PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022153; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; Mevel K, 2011, INT J ALZHEIMERS DIS, V2011; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rombouts SARB, 2009, HUM BRAIN MAPP, V30, P256, DOI 10.1002/hbm.20505; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang Z, 2010, EUR J RADIOL; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	37	53	60	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36838	10.1371/journal.pone.0036838	http://dx.doi.org/10.1371/journal.pone.0036838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629335	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500030
J	Yokoyama, M; Naganawa, S; Yoshimura, K; Matsushita, S; Sato, H				Yokoyama, Masaru; Naganawa, Satoshi; Yoshimura, Kazuhisa; Matsushita, Shuzo; Sato, Hironori			Structural Dynamics of HIV-1 Envelope Gp120 Outer Domain with V3 Loop	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; AMINO-ACID SUBSTITUTIONS; CORECEPTOR USAGE; NEUTRALIZATION EPITOPE; EXTERNAL GLYCOPROTEIN; MONOCLONAL-ANTIBODY; CHEMOKINE RECEPTORS; MOLECULAR-DYNAMICS; CRYPTIC NATURE; FORCE-FIELDS	Background: The net charge of the hypervariable V3 loop on the HIV-1 envelope gp120 outer domain plays a key role in modulating viral phenotype. However, the molecular mechanisms underlying the modulation remain poorly understood. Methodology/Principal Findings: By combining computational and experimental approaches, we examined how V3 net charge could influence the phenotype of the gp120 interaction surface. Molecular dynamics simulations of the identical gp120 outer domain, carrying a V3 loop with net charge of +3 or +7, showed that the V3 change alone could induce global changes in fluctuation and conformation of the loops involved in binding to CD4, coreceptor and antibodies. A neutralization study using the V3 recombinant HIV-1 infectious clones showed that the virus carrying the gp120 with +3 V3, but not with +7 V3, was resistant to neutralization by anti-CD4 binding site monoclonal antibodies. An information entropy study shows that otherwise variable surface of the gp120 outer domain, such as V3 and a region around the CD4 binding loop, are less heterogeneous in the gp120 subpopulation with +3 V3. Conclusions/Significance: These results suggest that the HIV-1 gp120 V3 loop acts as an electrostatic modulator that influences the global structure and diversity of the interaction surface of the gp120 outer domain. Our findings will provide a novel structural basis to understand how HIV-1 adjusts relative replication fitness by V3 mutations.	[Yokoyama, Masaru; Sato, Hironori] Natl Inst Infect Dis, Lab Viral Genom, Pathogen Genom Ctr, Musashimurayama, Tokyo, Japan; [Naganawa, Satoshi] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 113, Japan; [Yoshimura, Kazuhisa; Matsushita, Shuzo] Kumamoto Univ, Ctr AIDS Res, Div Clin Retrovirol & Infect Dis, Kumamoto, Japan	National Institute of Infectious Diseases (NIID); Tokyo Metropolitan Institute of Medical Science; Kumamoto University	Yokoyama, M (corresponding author), Natl Inst Infect Dis, Lab Viral Genom, Pathogen Genom Ctr, 4-7-1 Gakuen, Musashimurayama, Tokyo, Japan.	yokoyama@nih.go.jp; hirosato@nih.go.jp	Matsushita, Shuzo/F-5782-2013; Naganawa, Shinji/I-1572-2012	Naganawa, Shinji/0000-0002-0214-613X	Ministry of Health, Labor and Welfare, Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants-in-aid from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; BONHOEFFER S, 1995, NATURE, V376, P125, DOI 10.1038/376125a0; BOUHABIB DC, 1994, J VIROL, V68, P6006, DOI 10.1128/JVI.68.9.6006-6013.1994; Brown LS, 1997, P NATL ACAD SCI USA, V94, P5040, DOI 10.1073/pnas.94.10.5040; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Burns D P, 1994, Curr Top Microbiol Immunol, V188, P185; Case D, 2006, AMBER 9; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cavacini LA, 2002, AIDS, V16, P2409, DOI 10.1097/00002030-200212060-00005; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Cho MW, 1998, J VIROL, V72, P2509, DOI 10.1128/JVI.72.3.2509-2515.1998; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; GOUDSMIT J, 1988, P NATL ACAD SCI USA, V85, P4478, DOI 10.1073/pnas.85.12.4478; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu GQ, 2011, J VIROL, V85, P2741, DOI 10.1128/JVI.01612-10; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; HWANG SS, 1992, SCIENCE, V257, P535, DOI 10.1126/science.1636088; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kato K, 1999, J VIROL, V73, P5520, DOI 10.1128/JVI.73.7.5520-5526.1999; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; LUKASHOV VV, 1995, J VIROL, V69, P6911, DOI 10.1128/JVI.69.11.6911-6916.1995; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MATSUSHITA S, 1988, J VIROL, V62, P2107, DOI 10.1128/JVI.62.6.2107-2114.1988; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Milich L, 1997, VIROLOGY, V239, P108, DOI 10.1006/viro.1997.8821; MILICH L, 1993, J VIROL, V67, P5623, DOI 10.1128/JVI.67.9.5623-5634.1993; Miyamoto T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022779; Motomura K, 2008, J VIROL, V82, P11247, DOI 10.1128/JVI.00897-08; Naganawa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003206; Ode H, 2011, J MOL MODEL, V17, P391, DOI 10.1007/s00894-010-0739-z; Ogert RA, 2001, J VIROL, V75, P5998, DOI 10.1128/JVI.75.13.5998-6006.2001; Oka T, 2009, VIROLOGY, V394, P119, DOI 10.1016/j.virol.2009.08.018; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; RUSCHE JR, 1988, P NATL ACAD SCI USA, V85, P3198, DOI 10.1073/pnas.85.9.3198; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanchez R, 2000, NAT STRUCT BIOL, V7, P986, DOI 10.1038/80776; Sato H, 1999, VIROLOGY, V257, P491, DOI 10.1006/viro.1999.9670; Shannon CE, 1997, M D COMPUT, V14, P306; Shibata J, 2007, J VIROL, V81, P3757, DOI 10.1128/JVI.01544-06; Shiino T, 2000, J VIROL, V74, P1069, DOI 10.1128/JVI.74.3.1069-1078.2000; SHIODA T, 1994, J VIROL, V68, P7689, DOI 10.1128/JVI.68.12.7689-7696.1994; SIMMONDS P, 1990, J VIROL, V64, P5840, DOI 10.1128/JVI.64.12.5840-5850.1990; Speck RF, 1997, J VIROL, V71, P7136, DOI 10.1128/JVI.71.9.7136-7139.1997; Thorpe IF, 2007, P NATL ACAD SCI USA, V104, P8821, DOI 10.1073/pnas.0610064104; VERONESE FD, 1992, AIDS RES HUM RETROV, V8, P1125, DOI 10.1089/aid.1992.8.1125; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; WILLEY RL, 1994, J VIROL, V68, P1029, DOI 10.1128/JVI.68.2.1029-1039.1994; WILLEY RL, 1994, J VIROL, V68, P4409, DOI 10.1128/JVI.68.7.4409-4419.1994; Wu SR, 2010, P NATL ACAD SCI USA, V107, P18844, DOI 10.1073/pnas.1007227107; Xiao LH, 1998, VIROLOGY, V240, P83, DOI 10.1006/viro.1997.8924; Yoshimura K, 2010, J VIROL	63	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37530	10.1371/journal.pone.0037530	http://dx.doi.org/10.1371/journal.pone.0037530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624045	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500132
J	Pavlovski, D; Thundyil, J; Monk, PN; Wetsel, RA; Taylor, SM; Woodruff, TM				Pavlovski, Dale; Thundyil, John; Monk, Peter N.; Wetsel, Rick A.; Taylor, Stephen M.; Woodruff, Trent M.			Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis	FASEB JOURNAL			English	Article						neuroinflammation; stroke; cell death; innate immune system; neurodegeneration	DECAY-ACCELERATING FACTOR; CENTRAL-NERVOUS-SYSTEM; CELL-DEATH; RAT MODEL; RECEPTOR ANTAGONIST; ALZHEIMERS-DISEASE; IN-VITRO; STROKE; EXPRESSION; BRAIN	C5a receptors are found in the central nervous system (CNS), on both neurons and glia. However, the origin of the C5a, which activates these receptors, is unclear. In the present study, we show that primary cultured mouse cortical neurons constitutively express C5, the precursor of C5a, and express the classical receptor for C5a, CD88. With cell ischemia caused by 12 h glucose deprivation, or oxygen-glucose deprivation (OGD), neurons demonstrated increased apoptosis, up-regulation of CD88, and increased levels of C5a in the media. Exogenous murine C5a (100 nM) added to the neuronal cultures resulted in apoptosis, without affecting cell necrosis. Pretreatment of the cells with the specific CD88 receptor antagonist PMX53 (100 nM) significantly blocked ischemia-induced apoptosis (similar to 50%), and neurons from CD88(-/-) mice were similarly protected. In a murine model of stroke, using middle cerebral artery occlusion (MCAO), we found that C5a levels in the brain increased; this also occurred in cerebral slice cultures exposed to OGD. CD88(-/-) mice subjected to MCAO had significantly reduced infarct volumes and improved neurological scores. Taken together, our results demonstrate that neurons in the CNS have the capability to generate C5a following ischemic stress, and this has the potential to activate their C5a receptors, with deleterious consequences.-Pavlovski, D., Thundyil, J., Monk, P. N., Wetsel, R. A., Taylor, S. M., Woodruff, T. M. Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis. FASEB J. 26, 3680-3690 (2012). www.fasebj.org	[Pavlovski, Dale; Thundyil, John; Taylor, Stephen M.; Woodruff, Trent M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Monk, Peter N.] Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Wetsel, Rick A.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Res Ctr Immunol & Autoimmune Dis, Houston, TX USA	University of Queensland; University of Sheffield; University of Texas System; University of Texas Health Science Center Houston	Woodruff, TM (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	t.woodruff@uq.edu.au	Woodruff, Trent/AAS-4629-2020; Woodruff, Trent M/B-4861-2009; Monk, Peter/C-6155-2008	Woodruff, Trent/0000-0003-1382-911X; Woodruff, Trent M/0000-0003-1382-911X; Monk, Peter/0000-0003-4637-3059	National Health and Medical Research Council of Australia [APP1004455, APP1021413]; Australian Research Council [FT110100332]; British Heart Foundation [PG/09/018/25279] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); British Heart Foundation(British Heart Foundation)	The authors thank Dr. Thiruma Arumugam for his contribution to this study. This study was funded through the support of the National Health and Medical Research Council of Australia (project grants APP1004455 and APP1021413) and the Australian Research Council (Future Fellowship FT110100332 to T. M. W.).	Adams HR, 2003, J HYPERTENS, V21, pS3, DOI 10.1097/00004872-200306005-00002; Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; Arumugam TV, 2009, NEUROSCIENCE, V158, P1074, DOI 10.1016/j.neuroscience.2008.07.015; Arumugam TV, 2007, P NATL ACAD SCI USA, V104, P14104, DOI 10.1073/pnas.0700506104; Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Benard M, 2004, J BIOL CHEM, V279, P43487, DOI 10.1074/jbc.M404124200; Benard M, 2008, MOL IMMUNOL, V45, P3767, DOI 10.1016/j.molimm.2008.05.027; Crane JW, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-34; D'Ambrosio AL, 2001, MOL MED, V7, P367, DOI 10.1007/BF03402183; Farkas I, 1998, NEUROSCIENCE, V86, P903, DOI 10.1016/S0306-4522(98)00108-0; Farkas I, 2003, J IMMUNOL, V170, P5764, DOI 10.4049/jimmunol.170.11.5764; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Fujita H, 1996, GLIA, V18, P269, DOI 10.1002/(SICI)1098-1136(199612)18:4<269::AID-GLIA2>3.0.CO;2-T; Gasque P, 1997, AM J PATHOL, V150, P31; Hollmann TJ, 2008, MOL IMMUNOL, V45, P1907, DOI 10.1016/j.molimm.2007.10.037; Huber-Lang M, 2002, AM J PATHOL, V161, P1849, DOI 10.1016/S0002-9440(10)64461-6; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Humayun S, 2009, J NEUROIMMUNOL, V210, P52, DOI 10.1016/j.jneuroim.2009.01.028; Jacob A, 2010, J NEUROIMMUNOL, V221, P46, DOI 10.1016/j.jneuroim.2010.02.011; Kim DD, 2008, BLOOD, V112, P1109, DOI 10.1182/blood-2008-01-134304; Kim GH, 2008, NEUROSURGERY, V63, P122, DOI 10.1227/01.NEU.0000335079.70222.8D; Malagelada C, 2005, NEUROBIOL DIS, V20, P27, DOI 10.1016/j.nbd.2005.01.028; Manthey HD, 2011, FASEB J, V25, P2447, DOI 10.1096/fj.10-174284; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; Mocco J, 2006, NEUROSURGERY, V59, P28, DOI [10.1227/01.NEU.0000219221.14280.65, 10.1227/01.neu.0000243280.75920.f4]; Nishiura H, 2009, LAB INVEST, V89, P676, DOI 10.1038/labinvest.2009.27; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; O'Barr SA, 2001, J IMMUNOL, V166, P4154, DOI 10.4049/jimmunol.166.6.4154; Okun E, 2007, J NEUROCHEM, V102, P1232, DOI 10.1111/j.1471-4159.2007.04615.x; Osaka H, 1999, NEUROSCIENCE, V88, P1073, DOI 10.1016/S0306-4522(98)00372-8; Osaka H, 1999, J CELL BIOCHEM, V73, P303, DOI 10.1002/(SICI)1097-4644(19990601)73:3<303::AID-JCB2>3.0.CO;2-2; Pedersen ED, 2009, SCAND J IMMUNOL, V69, P555, DOI 10.1111/j.1365-3083.2009.02253.x; Ramaglia V, 2009, PROG BRAIN RES, V175, P95, DOI 10.1016/S0079-6123(09)17507-6; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Stahel PF, 1997, AM J PATHOL, V151, P897; Stahel PF, 1997, IMMUNOPHARMACOLOGY, V38, P65, DOI 10.1016/S0162-3109(97)80150-6; Stahel PF, 2000, J NEUROIMMUNOL, V109, P164, DOI 10.1016/S0165-5728(00)00304-0; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Thomas A, 2000, INT IMMUNOL, V12, P1015, DOI 10.1093/intimm/12.7.1015; Van Beek J, 2000, EXP NEUROL, V161, P373, DOI 10.1006/exnr.1999.7273; Wang Y, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-24; Woehrl B, 2011, J CLIN INVEST, V121, P3943, DOI 10.1172/JCI57522; Woodruff TM, 2005, J PHARMACOL EXP THER, V314, P811, DOI 10.1124/jpet.105.086835; Woodruff TM, 2006, FASEB J, V20, P1407, DOI 10.1096/fj.05-5814com; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; Woodruff TM, 2010, NEUROMOL MED, V12, P179, DOI 10.1007/s12017-009-8085-y; Woodruff TM, 2008, J IMMUNOL, V181, P8727, DOI 10.4049/jimmunol.181.12.8727; World Health Organization, WHO GLOB INF	50	73	76	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2012	26	9					3680	3690		10.1096/fj.11-202382	http://dx.doi.org/10.1096/fj.11-202382			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22651932				2022-12-25	WOS:000308391600010
J	Xu, YC; Brown, KM; Wang, ZA; van der Wel, H; Teygong, C; Zhang, DM; Blader, IJ; West, CM				Xu, Yuechi; Brown, Kevin M.; Wang, Zhuo A.; van der Wel, Hanke; Teygong, Crystal; Zhang, Dongmei; Blader, Ira J.; West, Christopher M.			The Skp1 Protein from Toxoplasma Is Modified by a Cytoplasmic Prolyl 4-Hydroxylase Associated with Oxygen Sensing in the Social Amoeba Dictyostelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; HYDROXYLASE DOMAIN; GONDII; HIF; GLYCOSYLATION; CYCLE; HYDROXYPROLINE; STABILIZATION; BRADYZOITES; INHIBITION	In diverse types of organisms, cellular hypoxic responses are mediated by prolyl 4-hydroxylases that use O-2 and alpha-ketoglutarate as substrates to hydroxylate conserved proline residues in target proteins. Whereas in metazoans these enzymes control the stability of the HIF alpha family of transcription factor subunits, the Dictyostelium enzyme (DdPhyA) contributes to O-2 regulation of development by a divergent mechanism involving hydroxylation and subsequent glycosylation of DdSkp1, an adaptor subunit in E3(SCF) ubiquitin ligases. Sequences related to DdPhyA, DdSkp1, and the glycosyltransferases that cap Skp1 hydroxyproline occur also in the genomes of Toxoplasma and other protists, suggesting that this O-2 sensing mechanism may be widespread. Here we show by disruption of the TgphyA locus that this enzyme is required for Skp1 glycosylation in Toxoplasma and that disrupted parasites grow slowly at physiological O-2 levels. Conservation of cellular function was tested by expression of TgPhyA in DdphyA-null cells. Simple gene replacement did not rescue Skp1 glycosylation, whereas overexpression not only corrected Skp1 modification but also restored the O-2 requirement to a level comparable to that of overexpressed DdPhyA. Bacterially expressed TgPhyA protein can prolyl hydroxylate both Toxoplasma and Dictyostelium Skp1s. Kinetic analyses showed that TgPhyA has similar properties to DdPhyA, including a superimposable dependence on the concentration of its co-substrate alpha-ketoglutarate. Remarkably, however, TgPhyA had a significantly higher apparent affinity for O-2. The findings suggest that Skp1 hydroxylation by PhyA is a conserved process among protists and that this biochemical pathway may indirectly sense O-2 by detecting the levels of O-2-regulated metabolites such as alpha-ketoglutarate.	[Xu, Yuechi; Wang, Zhuo A.; van der Wel, Hanke; Zhang, Dongmei; West, Christopher M.] OUHSC, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA; [Brown, Kevin M.; Teygong, Crystal; Blader, Ira J.] OUHSC, Dept Microbiol & Immunol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA; [Blader, Ira J.] OUHSC, Dept Ophthalmol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	West, CM (corresponding author), OUHSC, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, 975 NE 10th St,BRC 417, Oklahoma City, OK 73104 USA.	Cwest2@ouhsc.edu	zhang, dongmei/B-8011-2013; Wang, Zhuo/L-6912-2019; xu, yuechi/G-5353-2012	Wang, Zhuo/0000-0002-4707-036X; Xu, yuechi/0000-0003-0030-4111	National Institutes of Health [R01-GM084383, R01-GM037539, R01-AI069986]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084383, R01GM037539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM084383, R01-GM037539, and R01-AI069986.	Anderson K, 2011, J BIOL CHEM, V286, P42027, DOI 10.1074/jbc.M111.303222; Asif MH, 2009, FUNCT INTEGR GENOMIC, V9, P525, DOI 10.1007/s10142-009-0118-y; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Chowdhury R, 2011, J MOL BIOL, V410, P268, DOI 10.1016/j.jmb.2011.04.075; Chua YL, 2010, J BIOL CHEM, V285, P31277, DOI 10.1074/jbc.M110.158485; Culpepper MA, 2010, BIOCHEMISTRY-US, V49, P124, DOI 10.1021/bi901771z; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Ercan A, 2006, J BIOL CHEM, V281, P12713, DOI 10.1074/jbc.M513664200; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Hewitson KS, 2007, J BIOL CHEM, V282, P3293, DOI 10.1074/jbc.M608337200; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KIM K, 1993, SCIENCE, V262, P911, DOI 10.1126/science.8235614; Kimmel Alan R., 2006, V346, P187; Knauer SH, 2012, FEBS J, V279, P816, DOI 10.1111/j.1742-4658.2012.08473.x; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; KOZAROV E, 1995, J BIOL CHEM, V270, P3022, DOI 10.1074/jbc.270.7.3022; Leite RB, 2008, PROTIST, V159, P355, DOI 10.1016/j.protis.2008.03.002; Lyons RE, 2002, TRENDS PARASITOL, V18, P198, DOI 10.1016/S1471-4922(02)02248-1; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; McInerney JO, 1998, BIOINFORMATICS, V14, P372, DOI 10.1093/bioinformatics/14.4.372; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Ponts N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002386; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Sakadzic S, 2010, NAT METHODS, V7, P755, DOI 10.1038/nmeth.1490; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Spear W, 2006, CELL MICROBIOL, V8, P339, DOI 10.1111/j.1462-5822.2005.00628.x; van der Wel H, 2005, J BIOL CHEM, V280, P14645, DOI 10.1074/jbc.M500600200; van der Wel H, 2002, J BIOL CHEM, V277, P46527, DOI 10.1074/jbc.M208824200; van der Wel H, 2002, J BIOL CHEM, V277, P46328, DOI 10.1074/jbc.M208024200; van der Wel H, 2011, BIOCHEMISTRY-US, V50, P1700, DOI 10.1021/bi101977w; Wang ZA, 2011, DEV BIOL, V349, P283, DOI 10.1016/j.ydbio.2010.10.013; Wang ZA, 2009, J BIOL CHEM, V284, P28896, DOI 10.1074/jbc.M109.022574; Weiss LM, 2000, FRONT BIOSCI-LANDMRK, V5, pD391, DOI 10.2741/Weiss; West CM, 2006, METHOD ENZYMOL, V417, P389, DOI 10.1016/S0076-6879(06)17023-8; West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893; West CM, 2010, BBA-GEN SUBJECTS, V1800, P160, DOI 10.1016/j.bbagen.2009.11.006; West CM, 2004, BBA-GEN SUBJECTS, V1673, P29, DOI 10.1016/j.bbagen.2004.04.007; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Zhang DM, 2012, J BIOL CHEM, V287, P2006, DOI 10.1074/jbc.M111.314021	43	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25098	25110		10.1074/jbc.M112.355446	http://dx.doi.org/10.1074/jbc.M112.355446			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22648409	hybrid, Green Published			2022-12-25	WOS:000306651700022
J	Sato, S; Kawamoto, J; Sato, SB; Watanabe, B; Hiratake, J; Esaki, N; Kurihara, T				Sato, Sho; Kawamoto, Jun; Sato, Satoshi B.; Watanabe, Bunta; Hiratake, Jun; Esaki, Nobuyoshi; Kurihara, Tatsuo			Occurrence of a Bacterial Membrane Microdomain at the Cell Division Site Enriched in Phospholipids with Polyunsaturated Hydrocarbon Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHEWANELLA-LIVINGSTONENSIS AC10; COLD-ADAPTED BACTERIUM; FATTY-ACIDS; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC-ACID; OUTER-MEMBRANE; IN-VIVO; LIPIDS; PROTEIN; RHODOPSIN	In this study, we found that phospholipids containing an eicosapentaenyl group form a novel membrane microdomain at the cell division site of a Gram-negative bacterium, Shewanella livingstonensis Ac10, using chemically synthesized fluorescent probes. The occurrence of membrane microdomains in eukaryotes and prokaryotes has been demonstrated with various imaging tools for phospholipids with different polar head-groups. However, few studies have focused on the hydrocarbon chain-dependent localization of membrane-resident phospholipids in vivo. We previously found that lack of eicosapentaenoic acid (EPA), a polyunsaturated fatty acid found at the sn-2 position of glycerophospholipids, causes a defect in cell division after DNA replication of S. livingstonensis Ac10. Here, we synthesized phospholipid probes labeled with a fluorescent 7-nitro-2,1,3-benzoxadiazol-4-yl (NBD) group to study the localization of EPA-containing phospholipids by fluorescence microscopy. A fluorescent probe in which EPA was bound to the glycerol backbone via an ester bond was found to be unsuitable for imaging because EPA was released from the probe by in vivo hydrolysis. To overcome this problem, we synthesized hydrolysis-resistant ether-type phospholipid probes. Using these probes, we found that the fluorescence localized between two nucleoids at the cell center during cell division when the cells were grown in the presence of the eicosapentaenyl group-containing probe (N-NBD-1-oleoyl-2-eicosapentaenyl-sn-glycero-3-phosphoethanolamine), whereas this localization was not observed with the oleyl group-containing control probe (N-NBD-1-oleoyl-2-oleyl-sn-glycero-3-phosphoethanolamine). Thus, phospholipids containing an eicosapentaenyl group are specifically enriched at the cell division site. Formation of a membrane microdomain enriched in EPA-containing phospholipids at the nucleoid occlusion site probably facilitates cell division.	[Sato, Sho; Kawamoto, Jun; Watanabe, Bunta; Hiratake, Jun; Esaki, Nobuyoshi; Kurihara, Tatsuo] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Sato, Satoshi B.] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Kurihara, T (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	kurihara@scl.kyoto-u.ac.jp		Kawamoto, Jun/0000-0002-5025-5613; Watanabe, Bunta/0000-0003-3645-5712	Japan Society for the Promotion of Science [20360372, 22404021]; Institute for Fermentation (Osaka) [22658028]; Japan Foundation for Applied Enzymology; Japan Science and Technology Agency [10-041]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute for Fermentation (Osaka)(Institute for Fermentation (IFO)); Japan Foundation for Applied Enzymology; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by Grants-in-aid for Scientific Research (B) 20360372 and 22404021 from the Japan Society for the Promotion of Science, Grant-in-aid for Challenging Exploratory Research 22658028, and grants from the Institute for Fermentation (Osaka) and the Japan Foundation for Applied Enzymology (to T. K.); by Grant for Research for Promoting Technological Seeds 10-041 from the Japan Science and Technology Agency (to J. K.); and by Japan Society for the Promotion of Science research fellowships for young scientists (to S. S.).	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carrillo-Tripp M, 2005, BIOCHEMISTRY-US, V44, P10164, DOI 10.1021/bi050822e; Dekker N, 2000, MOL MICROBIOL, V35, P711, DOI 10.1046/j.1365-2958.2000.01775.x; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Feller SE, 2008, CHEM PHYS LIPIDS, V153, P76, DOI 10.1016/j.chemphyslip.2008.02.013; Feller SE, 2005, CURR OPIN STRUC BIOL, V15, P416, DOI 10.1016/j.sbi.2005.07.002; Grossfield A, 2006, P NATL ACAD SCI USA, V103, P4888, DOI 10.1073/pnas.0508352103; Harvat EM, 2005, J BIOL CHEM, V280, P12028, DOI 10.1074/jbc.M414368200; HSU L, 1991, J BIOL CHEM, V266, P13783; Jao CY, 2009, P NATL ACAD SCI USA, V106, P15332, DOI 10.1073/pnas.0907864106; Kawamoto J, 2007, EXTREMOPHILES, V11, P819, DOI 10.1007/s00792-007-0098-6; Kawamoto J, 2011, ENVIRON MICROBIOL, V13, P2293, DOI 10.1111/j.1462-2920.2011.02487.x; Kawamoto J, 2009, J BACTERIOL, V191, P632, DOI 10.1128/JB.00881-08; Kuerschner L, 2005, NAT METHODS, V2, P39, DOI 10.1038/NMETH728; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Miyake R, 2007, APPL ENVIRON MICROB, V73, P4849, DOI 10.1128/AEM.00824-07; Neef AB, 2009, ANGEW CHEM INT EDIT, V48, P1498, DOI 10.1002/anie.200805507; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Reutelingsperger CPM, 2002, J IMMUNOL METHODS, V265, P123, DOI 10.1016/S0022-1759(02)00075-3; Sato SB, 2011, PROSTAG LEUKOTR ESS, V84, P31, DOI 10.1016/j.plefa.2010.09.006; Sato S, 2008, EXTREMOPHILES, V12, P753, DOI 10.1007/s00792-008-0182-6; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Watts GF, 2011, CURR OPIN LIPIDOL, V22, P70, DOI 10.1097/MOL.0b013e328342b10f; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300	32	15	16	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24113	24121		10.1074/jbc.M111.318311	http://dx.doi.org/10.1074/jbc.M111.318311			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22648406	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000306651100006
J	Mulepati, S; Orr, A; Bailey, S				Mulepati, Sabin; Orr, Amberly; Bailey, Scott			Crystal Structure of the Largest Subunit of a Bacterial RNA-guided Immune Complex and Its Role in DNA Target Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRISPR RNA; ANTIVIRAL DEFENSE; RECOGNITION; SYSTEM; RESISTANCE; NUCLEASE; PROTEIN; ENDORIBONUCLEASE; INTERFERENCE; MATURATION	Prokaryotes make use of small RNAs encoded by CRISPR (clustered regularly interspaced short palindromic repeat) loci to provide immunity against bacteriophage or plasmid invasion. In Escherichia coli, the CRISPR-associated complex for antiviral defense (Cascade) utilizes these RNAs to target foreign DNA for destruction. CasA, the largest subunit of Cascade, is essential for its function. Here we report the crystal structure of Thermus thermophilus CasA. The structure is composed of two domains that are arranged in a chair-like conformation with a novel fold forming the larger N-terminal domain. Docking of the crystal structure into cryo-electron microscopy maps reveals two loops in CasA that likely have important functions in DNA target binding. Finally, DNA binding experiments show that CasA is essential for binding of Cascade to DNA target.	[Mulepati, Sabin; Orr, Amberly; Bailey, Scott] Johns Hopkins Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bailey, S (corresponding author), Johns Hopkins Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St,W8704, Baltimore, MD 21205 USA.	scbailey@jhsph.edu	Bailey, Scott/N-7248-2019		National Institutes of Health [R01 GM097330]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM097330 (to S. B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agari Y, 2008, PROTEINS, V73, P1063, DOI 10.1002/prot.22224; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2011, EMBO J, V30, P4616, DOI 10.1038/emboj.2011.377; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mulepati S, 2011, J BIOL CHEM, V286, P31896, DOI 10.1074/jbc.M111.270017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Sashital D. G., 2012, MOL CELL IN PRESS; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108	36	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22445	22449		10.1074/jbc.C112.379503	http://dx.doi.org/10.1074/jbc.C112.379503			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22621933	hybrid, Green Published			2022-12-25	WOS:000306495000004
J	Kidd, C; Piantadosi, ST; Aslin, RN				Kidd, Celeste; Piantadosi, Steven T.; Aslin, Richard N.			The Goldilocks Effect: Human Infants Allocate Attention to Visual Sequences That Are Neither Too Simple Nor Too Complex	PLOS ONE			English	Article							PREFERENCES; INFORMATION; NOVELTY; FAMILIARITY; REDUNDANCY	Human infants, like immature members of any species, must be highly selective in sampling information from their environment to learn efficiently. Failure to be selective would waste precious computational resources on material that is already known (too simple) or unknowable (too complex). In two experiments with 7- and 8-month-olds, we measure infants' visual attention to sequences of events varying in complexity, as determined by an ideal learner model. Infants' probability of looking away was greatest on stimulus items whose complexity (negative log probability) according to the model was either very low or very high. These results suggest a principle of infant attention that may have broad applicability: infants implicitly seek to maintain intermediate rates of information absorption and avoid wasting cognitive resources on overly simple or overly complex events.	[Kidd, Celeste; Aslin, Richard N.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA	University of Rochester	Kidd, C (corresponding author), Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA.	ckidd@bcs.rochester.edu			National Science Foundation; National Institutes of Health [HD-37082]; J.S. McDonnell Foundation [220020096]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037082] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001319] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J.S. McDonnell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	CK and STP were supported by Graduate Research Fellowships from the National Science Foundation (www.nsf.gov). The research was supported by grants from the National Institutes of Health (HD-37082, www.nih.gov) and the J.S. McDonnell Foundation (220020096, www.jsmf.org) to RNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aslin RN, 2007, DEVELOPMENTAL SCI, V10, P48, DOI 10.1111/j.1467-7687.2007.00563.x; Berlyne DE, 1960, CONFLICT AROUSAL CUR, V331; Civan A, 2005, INFANCY, V7, P111, DOI 10.1207/s15327078in0702_1; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; DEMBER WN, 1957, PSYCHOL REV, V64, P91, DOI 10.1037/h0046861; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; Fiser J, 2002, P NATL ACAD SCI USA, V99, P15822, DOI 10.1073/pnas.232472899; Genzel D, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P199; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Hunter M.A., 1988, ADV INFANCY RES, V5, P69, DOI DOI 10.1037/0012-1649.19.3.338; Jaeger TF, 2010, COGNITIVE PSYCHOL, V61, P23, DOI 10.1016/j.cogpsych.2010.02.002; James W., 1890, PRINCIPLES PSYCHOL; Kaldy Z, 2006, DEVELOPMENTAL SCI, V9, P482, DOI 10.1111/j.1467-7687.2006.00515.x; KINNEY DK, 1976, CHILD DEV, V47, P155; Kirkham NZ, 2002, COGNITION, V83, pB35, DOI 10.1016/S0010-0277(02)00004-5; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Levy R., 2007, ADV NEURAL INFORM PR, V19, P849; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Piaget J., 1970, STRUCTURALISM; Piantadosi ST, R RICH METH IN PRESS; Piantadosi ST, 2011, P NATL ACAD SCI USA, V108, P3526, DOI 10.1073/pnas.1012551108; Roder BJ, 2000, INFANCY, V1, P491, DOI 10.1207/S15327078IN0104_9; ROSE SA, 1982, DEV PSYCHOL, V18, P704, DOI 10.1037/0012-1649.18.5.704; ROVEECOLLIER CK, 1980, SCIENCE, V208, P1159, DOI 10.1126/science.7375924; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Saylor MM, 2007, J COGN DEV, V8, P113, DOI 10.1207/s15327647jcd0801_6; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SIQUELAND ER, 1969, SCIENCE, V165, P1144, DOI 10.1126/science.165.3898.1144; Sokolov E.N., 1963, PERCEPTION CONDITION; Stevenson H. W., 1972, CHILDRENS LEARNING; Teglas E, 2011, SCIENCE, V332, P1054, DOI 10.1126/science.1196404; Tribus M., 1961, THERMOSTATICS THERMO; Turk-Browne NB, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.016.2008; Wagner S.H., 1986, ADV INFANCY RES, V4, P240; Xu F, 2008, P NATL ACAD SCI USA, V105, P5012, DOI 10.1073/pnas.0704450105; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	40	279	280	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36399	10.1371/journal.pone.0036399	http://dx.doi.org/10.1371/journal.pone.0036399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649492	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800009
J	Lima, JC; Rodrigues-da-Silva, RN; Banic, DM; Jiang, JL; Singh, B; Fabricio-Silva, GM; Porto, LCS; Meyer, EVS; Moreno, A; Rodrigues, MM; Barnwell, JW; Galinski, MR; de Oliveira-Ferreira, J				Lima-Junior, Josue C.; Rodrigues-da-Silva, Rodrigo N.; Banic, Dalma M.; Jiang, Jianlin; Singh, Balwan; Fabricio-Silva, Gustavo M.; Porto, Luis C. S.; Meyer, Esmeralda V. S.; Moreno, Alberto; Rodrigues, Mauricio M.; Barnwell, John W.; Galinski, Mary R.; de Oliveira-Ferreira, Joseli			Influence of HLA-DRB1 and HLA-DQB1 Alleles on IgG Antibody Response to the P. vivax MSP-1, MSP-3 alpha and MSP-9 in Individuals from Brazilian Endemic Area	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; HLA CLASS-II; C-TERMINAL REGIONS; PLASMODIUM-VIVAX; IMMUNE-RESPONSES; CIRCUMSPOROZOITE PROTEIN; IMMUNOGENIC PROPERTIES; MALARIA PARASITES; FALCIPARUM; VACCINE	Background: The antibody response generated during malaria infections is of particular interest, since the production of specific IgG antibodies is required for acquisition of clinical immunity. However, variations in antibody responses could result from genetic polymorphism of the HLA class II genes. Given the increasing focus on the development of subunit vaccines, studies of the influence of class II alleles on the immune response in ethnically diverse populations is important, prior to the implementation of vaccine trials. Methods and Findings: In this study, we evaluated the influence of HLA-DRB1* and -DQB1* allelic groups on the naturally acquired humoral response from Brazilian Amazon individuals (n = 276) against P. vivax Merozoite Surface Protein-1 (MSP-1), MSP-3 alpha and MSP-9 recombinant proteins. Our results provide information concerning these three P. vivax antigens, relevant for their role as immunogenic surface proteins and vaccine candidates. Firstly, the studied population was heterogeneous presenting 13 HLA-DRB1* and 5 DQB1* allelic groups with a higher frequency of HLA-DRB1*04 and HLA-DQB1*03. The proteins studied were broadly immunogenic in a naturally exposed population with high frequency of IgG antibodies against PvMSP1-19 (86.7%), PvMSP-3 (77%) and PvMSP-9 (76%). Moreover, HLA-DRB1*04 and HLA-DQB1*03 alleles were associated with a higher frequency of IgG immune responses against five out of nine antigens tested, while HLA-DRB1* 01 was associated with a high frequency of non-responders to repetitive regions of PvMSP-9, and the DRB1*16 allelic group with the low frequency of responders to PvMSP3 full length recombinant protein. Conclusions: HLA-DRB1*04 alleles were associated with high frequency of antibody responses to five out of nine recombinant proteins tested in Rondonia State, Brazil. These features could increase the success rate of future clinical trials based on these vaccine candidates.	[Lima-Junior, Josue C.; de Oliveira-Ferreira, Joseli] Inst Oswaldo Cruz, Lab Immunoparasitol, BR-20001 Rio De Janeiro, Brazil; [Lima-Junior, Josue C.; Rodrigues-da-Silva, Rodrigo N.] Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, Brazil; [Banic, Dalma M.; Meyer, Esmeralda V. S.] Inst Oswaldo Cruz, Lab Simulideos & Oncocercose, BR-20001 Rio De Janeiro, Brazil; [Jiang, Jianlin; Singh, Balwan; Meyer, Esmeralda V. S.; Moreno, Alberto; Galinski, Mary R.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Fabricio-Silva, Gustavo M.; Porto, Luis C. S.] Univ Estado Rio De Janeiro, Histocompatibil & Cryopreservat Lab, Rio De Janeiro, Brazil; [Rodrigues, Mauricio M.] Univ Fed Sao Paulo, Ctr Terapia Celular & Mol CTCMol, Escola Paulista Med, Sao Paulo, Brazil; [Moreno, Alberto; Galinski, Mary R.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA; [Barnwell, John W.] CDC Natl Ctr Infect Dis, Div Parasit Dis, Atlanta, GA USA	Fundacao Oswaldo Cruz; Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Emory University; Universidade do Estado do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); Emory University; Centers for Disease Control & Prevention - USA	Lima, JC (corresponding author), Inst Oswaldo Cruz, Lab Immunoparasitol, BR-20001 Rio De Janeiro, Brazil.	lila@ioc.fiocruz.br	da Costa Lima-Junior, Josue/AAI-4746-2021; Lima-Junior, Josué C/B-1361-2014; Oliveira-Ferreira, Joseli/E-7942-2014; Rodrigues, Mauricio M./B-8512-2012; Porto, Luis Cristovao/U-6499-2019; Porto, Luis Cristovao M S/I-2984-2013	da Costa Lima-Junior, Josue/0000-0002-5848-404X; Lima-Junior, Josué C/0000-0002-5848-404X; Oliveira-Ferreira, Joseli/0000-0002-6063-465X; Porto, Luis Cristovao/0000-0003-1499-1821; Porto, Luis Cristovao M S/0000-0003-1499-1821; Banic, Dalma Maria/0000-0003-1619-3794; Rodrigues-da-Silva, Rodrigo Nunes/0000-0002-9772-849X; Moreno, Alberto/0000-0002-3031-7194	Brazilian National Research Council - CNPq/ (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) Fiocruz; FAPESP (Foundation for Research Support of the State of Sao Paulo) [2009/15132-4]; INCTV-CNPq, (The National Institute for Vaccine Technology) National Institute of Health; Yerkes National Primate Research Center Base [RR00165]; National Center for Research Resources of the National Institutes of Health; NIH [RO1 AI0555994]; CAPES/Fiocruz; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER	Brazilian National Research Council - CNPq/ (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) Fiocruz; FAPESP (Foundation for Research Support of the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INCTV-CNPq, (The National Institute for Vaccine Technology) National Institute of Health; Yerkes National Primate Research Center Base; National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES/Fiocruz(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Brazilian National Research Council - CNPq/PAPES, (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Apoio Pesquisa Estrategica em Sade) Fiocruz, FAPESP (Foundation for Research Support of the State of Sao Paulo) 2009/15132-4 and INCTV-CNPq, (The National Institute for Vaccine Technology) National Institute of Health, the Yerkes National Primate Research Center Base Grant # RR00165 awarded by the National Center for Research Resources of the National Institutes of Health, and NIH Grants # RO1 AI0555994. Josue da Costa Lima Junior was the recipient of a CAPES/Fiocruz Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banic DM, 2002, AM J TROP MED HYG, V66, P509, DOI 10.4269/ajtmh.2002.66.509; Barnwell JW, 1999, EXP PARASITOL, V91, P238, DOI 10.1006/expr.1998.4372; Bastos MS, 2007, CLIN VACCINE IMMUNOL, V14, P1249, DOI 10.1128/CVI.00243-07; BECK HP, 1995, AM J TROP MED HYG, V53, P284; Buhler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014643; Chauhan VS, 2010, HUM VACCIN, V6; Cowan GJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026616; Cunha MG, 2001, VACCINE, V20, P385, DOI 10.1016/S0264-410X(01)00359-0; Davenport MP, 1996, MOL MED TODAY, V2, P38, DOI 10.1016/1357-4310(96)88757-0; de Oliveira CI, 1999, VACCINE, V17, P2959, DOI 10.1016/S0264-410X(99)00176-0; DELPORTILLO HA, 1991, P NATL ACAD SCI USA, V88, P4030, DOI 10.1073/pnas.88.9.4030; Dias S, 2011, VACCINE, V29, P7491, DOI 10.1016/j.vaccine.2011.07.029; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Galinski MR, 1999, MOL BIOCHEM PARASIT, V101, P131, DOI 10.1016/S0166-6851(99)00063-8; Galinski MR, 2001, MOL BIOCHEM PARASIT, V115, P41, DOI 10.1016/S0166-6851(01)00267-5; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Herrera S, 2007, TRENDS PARASITOL, V23, P122, DOI 10.1016/j.pt.2007.01.008; Higgs ES, 2005, AM J TROP MED HYG, V73, P1; Iriemenam NC, 2009, VACCINE, V27, P62, DOI 10.1016/j.vaccine.2008.10.025; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Jepson A, 1997, INFECT IMMUN, V65, P872, DOI 10.1128/IAI.65.3.872-876.1997; Johnson A, 2000, INFECT IMMUN, V68, P2231, DOI 10.1128/IAI.68.4.2231-2236.2000; Johnson AH, 2004, INFECT IMMUN, V72, P2762, DOI 10.1128/IAI.72.5.2762-2771.2004; Lima JC, 2010, VACCINE, V28, P3185, DOI 10.1016/j.vaccine.2010.02.046; Lima-Junior JC, 2008, VACCINE, V26, P6645, DOI 10.1016/j.vaccine.2008.09.029; Lima-Junior JC, 2011, VACCINE; MCCUTCHAN TF, 1985, SCIENCE, V230, P1381, DOI 10.1126/science.2416057; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Modiano D, 1999, AM J TROP MED HYG, V61, P663, DOI 10.4269/ajtmh.1999.61.663; Modiano D, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P193; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; OEUVRAY C, 1994, BLOOD, V84, P1594; Oliveira-Ferreira J, 2004, ACTA TROP, V92, P63, DOI 10.1016/j.actatropica.2004.02.011; Oliveira-Ferreira J, 2004, VACCINE, V22, P2023, DOI 10.1016/j.vaccine.2003.07.021; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; PATARROYO ME, 1991, PARASITE IMMUNOL, V13, P509, DOI 10.1111/j.1365-3024.1991.tb00547.x; Pratt-Riccio LR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-144; Pratt-Riccio LR, 2005, AM J TROP MED HYG, V73, P1096, DOI 10.4269/ajtmh.2005.73.1096; Ribeiro RS, 2011, MEM I OSWALDO CRUZ, V106, P27, DOI 10.1590/S0074-02762011000900004; RILEY E, 1992, IMMUNOL TODAY, V13, P333, DOI 10.1016/0167-5699(92)90165-4; RILEY EM, 1992, INT IMMUNOL, V4, P1055, DOI 10.1093/intimm/4.9.1055; SINIGAGLIA F, 1990, IMMUNOL LETT, V25, P265, DOI 10.1016/0165-2478(90)90125-A; Soares IS, 2002, PARASITOLOGY, V124, P237, DOI 10.1017/S003118200100110X; Soares IS, 1999, AM J TROP MED HYG, V60, P357, DOI 10.4269/ajtmh.1999.60.357; Soares IS, 1997, INFECT IMMUN, V65, P1606, DOI 10.1128/IAI.65.5.1606-1614.1997; STEPHENS HAF, 1995, EUR J IMMUNOL, V25, P3142, DOI 10.1002/eji.1830251123; Stern LJ, 2009, CURR PHARM DESIGN, V15, P3249, DOI 10.2174/138161209789105171; Suh KN, 2004, CAN MED ASSOC J, V170, P1693, DOI 10.1503/cmaj.1030418; SVS SdVeS-, 2011, SIST INF GER DIV SIG; van Lith M, 2010, J BIOL CHEM, V285, P40800, DOI 10.1074/jbc.M110.148155; Vargas-Serrato E, 2002, MOL BIOCHEM PARASIT, V120, P41, DOI 10.1016/S0166-6851(01)00433-9; Volpini WMG, 2001, HUM IMMUNOL, V62, P1226, DOI 10.1016/S0198-8859(01)00323-8; *WHO, 2005, WORLD MAL REP; Yang CF, 1999, INFECT IMMUN, V67, P342, DOI 10.1128/IAI.67.1.342-349.1999; Zhang QF, 2009, J CLIN IMMUNOL, V29, P454, DOI 10.1007/s10875-009-9281-0	59	38	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36419	10.1371/journal.pone.0036419	http://dx.doi.org/10.1371/journal.pone.0036419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649493	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335800010
J	Lou, YF; Wang, MY; Mao, WL				Lou, YuFeng; Wang, ManYi; Mao, WeiLin			Clinical Usefulness of Measuring Red Blood Cell Distribution Width in Patients with Hepatitis B	PLOS ONE			English	Article							STAGE LIVER-DISEASE; HEART-FAILURE; ACUTE EXACERBATION; PROGNOSTIC MARKER; SCORING SYSTEM; ENDEMIC AREA; C VIRUS; ANEMIA; VOLUME; RISK	Background: Red blood cell distribution width (RDW), an automated measure of red blood cell size heterogeneity (e. g., anisocytosis) that is largely overlooked, is a newly recognized risk marker in patients with cardiovascular diseases, but its role in persistent viral infection has not been well-defined. The present study was designed to investigate the association between RDW values and different disease states in hepatitis B virus (HBV)-infected patients. In addition, we analyzed whether RDW is associated with mortality in the HBV-infected patients. Methodology/Principal Findings: One hundred and twenty-three patients, including 16 with acute hepatitis B (AHB), 61 with chronic hepatitis B (CHB), and 46 with chronic severe hepatitis B (CSHB), and 48 healthy controls were enrolled. In all subjects, a blood sample was collected at admission to examine liver function, renal function, international normalized ratio and routine hematological testing. All patients were followed up for at least 4 months. A total of 10 clinical chemistry, hematology, and biochemical variables were analyzed for possible association with outcomes by using Cox proportional hazards and multiple regression models. RDW values at admission in patients with CSHB (18.30 +/- 3.11%, P<0.001), CHB (16.37 +/- 2.43%, P<0.001) and AHB (14.38 +/- 1.72%, P<0.05) were significantly higher than those in healthy controls (13.03 +/- 1.33%). Increased RDW values were clinically associated with severe liver disease and increased 3-month mortality rate. Multivariate analysis demonstrated that RDW values and the model for end-stage liver disease score were independent predictors for mortality (both P<0.001). Conclusion: RDW values are significantly increased in patients with hepatitis B and associated with its severity. Moreover, RDW values are an independent predicting factor for the 3-month mortality rate in patients with hepatitis B.	[Lou, YuFeng; Wang, ManYi; Mao, WeiLin] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Mao, WL (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China.	mao_wei_lin@163.com			Health Department of Zhejiang Province [2011KYA058]	Health Department of Zhejiang Province	The work was supported by grants from Health Department of Zhejiang Province (2011KYA058). URL http://www.zjwst.gov.cn/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ani C, 2009, J NEUROL SCI, V277, P103, DOI 10.1016/j.jns.2008.10.024; Asahina Y, 1996, J HEPATOL, V25, P787, DOI 10.1016/S0168-8278(96)80280-7; Aslan D, 2002, AM J HEMATOL, V69, P31, DOI 10.1002/ajh.10011; Bertoletti A, 1997, GASTROENTEROLOGY, V112, P193, DOI 10.1016/S0016-5085(97)70235-X; BESSMAN JD, 1983, CYTOMETRY, V3, P292, DOI 10.1002/cyto.990030411; BINGHAM J, 1960, BLOOD, V15, P244, DOI 10.1182/blood.V15.2.244.244; Bramhall SR, 2001, WORLD J GASTROENTERO, V7, P602; Chen PC, 2010, AM J EPIDEMIOL, V171, P214, DOI 10.1093/aje/kwp360; Chinese Association of Infectious Diseases and Parasitology Hepatology, 2000, CHINESE J HEPATOLOGY, V6, P324; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Chu CM, 1999, J MED VIROL, V58, P154, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;154::AID-JMV9&gt;3.0.CO;2-E; Coursaget P, 1998, AM J TROP MED HYG, V58, P330, DOI 10.4269/ajtmh.1998.58.330; Dabbah S, 2010, AM J CARDIOL, V105, P312, DOI 10.1016/j.amjcard.2009.09.027; Demir A, 2002, PEDIATR INT, V44, P612, DOI 10.1046/j.1442-200X.2002.01636.x; DOUGLAS SW, 1975, BLOOD, V45, P55; ENGLAND JM, 1974, LANCET, V1, P701; EVANS T C, 1991, Journal of Emergency Medicine, V9, P71, DOI 10.1016/0736-4679(91)90592-4; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Freeman RB, 2002, LIVER TRANSPLANT, V8, P851, DOI 10.1053/jlts.2002.35927; Hampole CV, 2009, AM J CARDIOL, V104, P868, DOI 10.1016/j.amjcard.2009.05.016; HORNEY JT, 1977, GASTROENTEROLOGY, V73, P639; Huo TI, 2006, LIVER TRANSPLANT, V12, P65, DOI 10.1002/lt.20560; Huo TI, 2005, J HEPATOL, V42, P826, DOI 10.1016/j.jhep.2005.01.019; Imperial JC, 1999, J GASTROEN HEPATOL, V14, pS1, DOI 10.1046/j.1440-1746.1999.01903.x; Jalan R, 2002, BLOOD PURIFICAT, V20, P252, DOI 10.1159/000047017; KARNAD A, 1985, ARCH INTERN MED, V145, P1270, DOI 10.1001/archinte.145.7.1270; KATZ R, 1964, GASTROENTEROLOGY, V46, P399; Lai YC, 2002, WORLD J GASTROENTERO, V8, P567, DOI 10.3748/wjg.v8.i3.567; LIEBERMAN FL, 1967, J CLIN INVEST, V46, P1297, DOI 10.1172/JCI105622; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; Mao WL, 2011, J CLIN GASTROENTEROL, V45, P551, DOI 10.1097/MCG.0b013e3181faefa3; Mao WL, 2010, ASAIO J, V56, P475, DOI 10.1097/MAT.0b013e3181e6bf13; Maruyama S, 2001, J LAB CLIN MED, V138, P332, DOI 10.1067/mlc.2001.119106; NUNNALLY RM, 1961, AM J MED, V30, P972, DOI 10.1016/0002-9343(61)90185-1; Okumura A, 2001, J GASTROENTEROL, V36, P103, DOI 10.1007/s005350170138; Pascual-Figal DA, 2009, EUR J HEART FAIL, V11, P840, DOI 10.1093/eurjhf/hfp109; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Perkins SL., 2003, WINTROBES CLIN HEMAT, P5; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Shakil AO, 2000, LIVER TRANSPLANT, V6, P163, DOI 10.1016/S1527-6465(00)80005-2; Shiota G, 2000, LIVER, V20, P415, DOI 10.1034/j.1600-0676.2000.020005415.x; Summerfield JA, 2000, J ROY COLL PHYS LOND, V34, P381; Tang ZY, 2001, WORLD J GASTROENTERO, V7, P445; THOMPSON WG, 1988, ARCH INTERN MED, V148, P2128, DOI 10.1001/archinte.148.10.2128; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Xess A, 2001, Indian J Pathol Microbiol, V44, P253; Xue YL, 2001, WORLD J GASTROENTERO, V7, P826, DOI 10.3748/wjg.v7.i6.826	49	90	93	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37644	10.1371/journal.pone.0037644	http://dx.doi.org/10.1371/journal.pone.0037644			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649548	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800067
J	Xu, WH; Liu, ZB; Yang, C; Qin, W; Shao, ZM				Xu, Wen-Huan; Liu, Zhe-Bin; Yang, Chen; Qin, Wenxin; Shao, Zhi-Ming			Expression of Dickkopf-1 and Beta-Catenin Related to the Prognosis of Breast Cancer Patients with Triple Negative Phenotype	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; HEPATOCELLULAR CARCINOMAS; TUMORS; PROTEIN; PATTERNS; CELLS; GENE; ACCUMULATION; METASTASIS; INHIBITOR	Background and Aim: We investigated the prognostic importance of dickkopf-1(DKK1) and beta-catenin expression in triple negative breast cancers. Methods: The expression of DKK1 and beta-catenin was evaluated in breast cell lines using RT-PCR and western blot. Immunohistochemistry was used to characterize the expression pattern of DKK1 and beta-catenin in 85 triple negative breast cancers and prognostic significance was assessed by Kaplan-Meier analysis and Cox proportional hazards regression modeling. Results: The expression of DKK1 was confirmed in hormone-resistant breast cell lines MDA-MB-231, MDA-MB-231-HM and MDA-MB-435. Expression of DKK1 in triple negative breast cancers correlated with cytoplasmic/ nuclear beta-catenin (p=0.000). Elevated expression of DKK1 and cytoplasmic/nuclear beta-catenin in triple negative cancers indicate poor outcome of patients. DKK1 was also a prognostic factor for patients with earlier stage or no lymph node metastasis. Conclusion: DKK1 together with beta-catenin might be important prognostic factors in triple negative breast carcinoma. DKK1 might be a valuable biomarker in predicting the prognosis of patients with earlier stage or no lymph node metastasis. It is possible that through further understanding of the role of Wnt/beta-catenin pathway activation, beta-catenin would be a potential therapeutic target for the triple negative breast cancer.	[Xu, Wen-Huan; Liu, Zhe-Bin; Yang, Chen; Shao, Zhi-Ming] Fudan Univ, Canc Hosp, Breast Canc Inst, Dept Breast Surg, Shanghai 200433, Peoples R China; [Xu, Wen-Huan; Liu, Zhe-Bin; Yang, Chen; Shao, Zhi-Ming] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Xu, Wen-Huan; Liu, Zhe-Bin; Yang, Chen; Shao, Zhi-Ming] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Qin, Wenxin] Shanghai Jiao Tong Univ, WHO Collaborating Ctr Res Canc, Shanghai Canc Inst, Natl Lab Oncogenes & Related Genes,Sch Med, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University	Xu, WH (corresponding author), Fudan Univ, Canc Hosp, Breast Canc Inst, Dept Breast Surg, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com			National Natural Science Foundation of China [30971143, 30972936, 81072165, 81001169]; Shanghai United Developing Technology Project of Municipal Hospitals [SHDC12010116]; Ministry of Health	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai United Developing Technology Project of Municipal Hospitals; Ministry of Health	This research is supported by grants from the National Natural Science Foundation of China (30971143, 30972936, 81072165, 81001169), the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), and the Key Clinical Program of the Ministry of Health (2010-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Karayiannakis AJ, 2001, EUR J SURG ONCOL, V27, P31, DOI 10.1053/ejso.1999.1017; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Li DQ, 2006, PROTEOMICS, V6, P3352, DOI 10.1002/pmic.200500617; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prasad CP, 2007, ONCOLOGY-BASEL, V73, P112, DOI 10.1159/000120999; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Terris B, 1999, ONCOGENE, V18, P6583, DOI 10.1038/sj.onc.1203051; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Tulac S, 2006, J CLIN ENDOCR METAB, V91, P1453, DOI 10.1210/jc.2005-0769; Wirths O, 2003, LAB INVEST, V83, P429, DOI 10.1097/01.LAB.0000059926.66359.BD; Wong SCC, 2002, J PATHOL, V196, P145, DOI 10.1002/path.1035; Yamabuki T, 2007, CANCER RES, V67, P2517, DOI 10.1158/0008-5472.CAN-06-3369; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020	26	52	57	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37624	10.1371/journal.pone.0037624	http://dx.doi.org/10.1371/journal.pone.0037624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649545	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335800064
J	McDonald, AT				McDonald, Andrew T.			Phylogeny of Basal Iguanodonts (Dinosauria: Ornithischia): An Update	PLOS ONE			English	Article							KHOK KRUAT FORMATION; HADROSAUROID DINOSAUR; NORTHEASTERN THAILAND; SOUTHERN ENGLAND; INCOMPLETE TAXA; NORTH-AMERICA; MISSING DATA; ORNITHOPODA; CHINA; CHARACTERS	The precise phylogenetic relationships of many non-hadrosaurid members of Iguanodontia, i.e., basal iguanodonts, have been unclear. Therefore, to investigate the global phylogeny of basal iguanodonts a comprehensive data matrix was assembled, including nearly every valid taxon of basal iguanodont. The matrix was analyzed in the program TNT, and the maximum agreement subtree of the resulting most parsimonious trees was then calculated in PAUP. Ordering certain multistate characters and omitting taxa through safe taxonomic reduction did not markedly improve resolution. The results provide some new information on the phylogeny of basal iguanodonts, pertaining especially to obscure or recently described taxa, and support some recent taxonomic revisions, such as the splitting of traditional "Camptosaurus'' and "Iguanodon''. The maximum agreement subtree also shows a close relationship between the Asian Probactrosaurus gobiensis and the North American Eolambia, supporting the previous hypothesis of faunal interchange between Asia and North America in the early Late Cretaceous. Nevertheless, the phylogenetic relationships of many basal iguanodonts remain ambiguous due to the high number of taxa removed from the maximum agreement subtree and poor resolution of consensus trees.	Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	McDonald, AT (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	mcandr@sas.upenn.edu			Jurassic Foundation; Evolving Earth Foundation; University of Pennsylvania Paleobiology Summer Stipend; Utah Friends of Paleontology	Jurassic Foundation; Evolving Earth Foundation; University of Pennsylvania Paleobiology Summer Stipend; Utah Friends of Paleontology	This research was supported by funds from the Jurassic Foundation (http://jurassicfoundation.org), Evolving Earth Foundation (http://www.evolvingearth.org), University of Pennsylvania Paleobiology Summer Stipend (http://www.sas.upenn.edu/earth/), and Utah Friends of Paleontology (http://www.utahpaleo.org/greatbasin.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ramirez-Velasco AA, 2012, CAN J EARTH SCI, V49, P379, DOI 10.1139/E11-062; Barrett PM, 2011, SPEC PAP PALAEONTOL, P131, DOI 10.1111/j.1475-4983.2011.01076.x; Buffetaut E, 2011, ANN PALEONTOL, V97, P51, DOI 10.1016/j.annpal.2011.08.001; Butler RJ, 2007, J VERTEBR PALEONTOL, V27, P253, DOI 10.1671/0272-4634(2007)27[253:HITATP]2.0.CO;2; Carpenter K, 2010, J IBER GEOL, V36, P145, DOI 10.5209/rev_JIGE.2010.v36.n2.3; Cifelli RL, 1997, P NATL ACAD SCI USA, V94, P11163, DOI 10.1073/pnas.94.21.11163; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; Godefroit Pascal, 2004, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V74, P139; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Head JJ, 1998, J VERTEBR PALEONTOL, V18, P718, DOI 10.1080/02724634.1998.10011101; Kearney M, 2003, J VERTEBR PALEONTOL, V23, P263, DOI 10.1671/0272-4634(2003)023[0263:PDTMDI]2.0.CO;2; Kobayashi Y, 2003, J VERTEBR PALEONTOL, V23, P166, DOI 10.1671/0272-4634(2003)23[166:ANIDOF]2.0.CO;2; Mantell GA., 1825, PHILOS T ROY SOC LON, VCXV, P179, DOI DOI 10.1098/RSTL.1825.0010; Mcdonald AT, 2011, ZOOTAXA, P52, DOI 10.11646/zootaxa.2783.1.4; Mcdonald AT, 2010, ZOOTAXA, P1; McDonald AT, 2012, CRETACEOUS RES, V33, P1, DOI 10.1016/j.cretres.2011.03.002; McDonald AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014075; Mcdonald AT, 2010, J VERTEBR PALEONTOL, V30, P799, DOI 10.1080/02724631003763516; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P413; Norman DB, 2010, ZOOTAXA, P47; Norman DB, 2011, SPEC PAP PALAEONTOL, P165, DOI 10.1111/j.1475-4983.2011.01082.x; Norman DB, 2002, ZOOL J LINN SOC-LOND, V136, P113, DOI 10.1046/j.1096-3642.2002.00027.x; Paul G., 2006, HORNS BEAKS, P69; Prieto-Marquez A, 2010, ZOOTAXA, P1; Prieto-Marquez A, 2010, AM MUS NOVIT, P1, DOI 10.1206/3694.2; Ruiz-Ome?aca JI., 2006, HORNS BEAKS CERATOPS, P3; Ruiz-Omenaca JI, 2011, ESTUD GEOL-MADRID, V67, P83, DOI 10.3989/egeol.40276.124; Sereno P. C, 2005, STEM ARCHOSAURIA VER; Shibata M, 2011, ACTA GEOL SIN-ENGL, V85, P969, DOI 10.1111/j.1755-6724.2011.00230.x; Sues HD, 2009, P R SOC B, V276, P2549, DOI 10.1098/rspb.2009.0229; Swofford DL, 2005, PAUP PHYLOGENETIC AN; Walker J. D., 2009, GSA TODAY, V19, P60, DOI DOI 10.1130/2009.CTS004R2C; Wang XL, 2010, EARTH ENV SCI T R SO, V101, P135, DOI 10.1017/S1755691010009266; Weishampel David B., 2003, Journal of Systematic Palaeontology, V1, P65, DOI 10.1017/S1477201903001032; Wiens JJ, 2003, J VERTEBR PALEONTOL, V23, P297, DOI 10.1671/0272-4634(2003)023[0297:ITICAP]2.0.CO;2; WILKINSON M, 1992, CLADISTICS, V8, P375, DOI 10.1111/j.1096-0031.1992.tb00079.x; Wilkinson M, 2001, TAXEQ3 SOFTWARE DOCU; Wu W.H., 2010, GEOLOGY RESOURCES, V19, P127; You H, 2011, ACTA GEOL SIN-ENGL, V85, P51, DOI 10.1111/j.1755-6724.2011.00377.x; You HL, 2003, CRETACEOUS RES, V24, P347, DOI 10.1016/S0195-6671(03)00048-X	40	54	57	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36745	10.1371/journal.pone.0036745	http://dx.doi.org/10.1371/journal.pone.0036745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629328	Green Published, gold			2022-12-25	WOS:000305345300012
J	Pawelczyk, S; Scott, KA; Hamer, R; Blades, G; Deane, CM; Wadhams, GH				Pawelczyk, Sonja; Scott, Kathryn A.; Hamer, Rebecca; Blades, Gareth; Deane, Charlotte M.; Wadhams, George H.			Predicting Inter-Species Cross-Talk in Two-Component Signalling Systems	PLOS ONE			English	Article							RHODOBACTER-SPHAEROIDES; PHOSPHORYLATION SITE; RESPONSE REGULATOR; PROTEIN; TRANSDUCTION; KINASE; SPECIFICITY; CHEMOTAXIS; OMPR; PHOSPHOTRANSFER	Phosphosignalling pathways are an attractive option for the synthetic biologist looking for a wide repertoire of modular components from which to build. We demonstrate that two-component systems can be used in synthetic biology. However, their potential is limited by the fact that host cells contain many of their own phosphosignalling pathways and these may interact with, and cross-talk to, the introduced synthetic components. In this paper we also demonstrate a simple bioinformatic tool that can help predict whether interspecies cross-talk between introduced and native two-component signalling pathways will occur and show both in vitro and in vivo that the predicted interactions do take place. The ability to predict potential cross-talk prior to designing and constructing novel pathways or choosing a host organism is essential for the promise that phosphosignalling components hold for synthetic biology to be realised.	[Pawelczyk, Sonja; Scott, Kathryn A.; Hamer, Rebecca; Blades, Gareth; Deane, Charlotte M.; Wadhams, George H.] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England; [Hamer, Rebecca; Deane, Charlotte M.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford; University of Oxford	Pawelczyk, S (corresponding author), Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England.	george.wadhams@bioch.ox.ac.uk		Scott, Kathryn/0000-0003-3395-9210; Deane, Charlotte/0000-0003-1388-2252	BBSRC (Biotechnology and Biological Sciences Research Council); EPSRC (Engineering and Physical Sciences Research Council) [BB/D020190/I]	BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the BBSRC (Biotechnology and Biological Sciences Research Council) and EPSRC (Engineering and Physical Sciences Research Council) grant (BB/D020190/I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antunes MS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.28; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bashor CJ, 2010, ANNU REV BIOPHYS, V39, P515, DOI 10.1146/annurev.biophys.050708.133652; DELGADO J, 1993, MOL MICROBIOL, V10, P1037, DOI 10.1111/j.1365-2958.1993.tb00974.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FISHER SL, 1995, J BIOL CHEM, V270, P23143, DOI 10.1074/jbc.270.39.23143; FORST SA, 1994, RES MICROBIOL, V145, P363, DOI 10.1016/0923-2508(94)90083-3; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Hamer R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-3; Ind AC, 2009, APPL ENVIRON MICROB, V75, P6613, DOI 10.1128/AEM.01587-09; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; JIN T, 1993, J MOL BIOL, V232, P484, DOI 10.1006/jmbi.1993.1404; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Martin AC, 2001, MOL MICROBIOL, V40, P1261, DOI 10.1046/j.1365-2958.2001.02468.x; Mattison K, 2002, J MOL BIOL, V315, P497, DOI 10.1006/jmbi.2001.5222; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Ninfa AJ, 2007, METHOD ENZYMOL, V422, P488, DOI 10.1016/S0076-6879(06)22025-1; Ohta N, 2003, J BACTERIOL, V185, P4424, DOI 10.1128/JB.185.15.4424-4431.2003; PENFOLD RJ, 1992, GENE, V118, P145, DOI 10.1016/0378-1119(92)90263-O; Porter SL, 2002, J MOL BIOL, V324, P35, DOI 10.1016/S0022-2836(02)01031-8; Porter SL, 2011, J BACTERIOL; Porter SL, 2008, TRENDS MICROBIOL, V16, P251, DOI 10.1016/j.tim.2008.02.006; Pratt L., 1995, 2 COMPONENT SIGNAL T, P105; RUSSO FD, 1991, J MOL BIOL, V222, P567, DOI 10.1016/0022-2836(91)90497-T; Saito H, 2010, CURR OPIN MICROBIOL, V13, P677, DOI 10.1016/j.mib.2010.09.001; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Scott KA, 2010, MOL MICROBIOL, V76, P318, DOI 10.1111/j.1365-2958.2010.07095.x; Shah DSH, 2000, MOL MICROBIOL, V35, P101, DOI 10.1046/j.1365-2958.2000.01680.x; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Szurmant H, 2010, CURR OPIN MICROBIOL, V13, P190, DOI 10.1016/j.mib.2010.01.007; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; UTSUMI R, 1989, SCIENCE, V245, P1246, DOI 10.1126/science.2476847; Verhamme DT, 2002, MICROBIOL-SGM, V148, P69, DOI 10.1099/00221287-148-1-69; Wadhams GH, 2002, MOL MICROBIOL, V46, P1211, DOI 10.1046/j.1365-2958.2002.03252.x; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011; Yoshida T, 2002, MOL MICROBIOL, V46, P1273, DOI 10.1046/j.1365-2958.2002.03239.x; Yoshida T, 2007, METHOD ENZYMOL, V423, P166, DOI 10.1016/S0076-6879(07)23007-1	48	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37737	10.1371/journal.pone.0037737	http://dx.doi.org/10.1371/journal.pone.0037737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629451	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300074
J	Rubinger, D; Backenroth, R; Sapoznikov, D				Rubinger, Dvora; Backenroth, Rebecca; Sapoznikov, Dan			Sympathetic Activation and Baroreflex Function during Intradialytic Hypertensive Episodes	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ALTERED NOREPINEPHRINE TURNOVER; BLOOD-PRESSURE; NERVE ACTIVITY; NITRIC-OXIDE; SENSITIVITY; HEMODIALYSIS; ASSOCIATION; CALCIUM; VOLUME	Background: The mechanisms of intradialytic increases in blood pressure are not well defined. The present study was undertaken to assess the role of autonomic nervous system activation during intradialytic hypertensive episodes. Methodology/Principal Findings: Continuous interbeat intervals (IBI) and systolic blood pressure (SBP) were monitored during hemodialysis in 108 chronic patients. Intradialytic hypertensive episodes defined as a period of at least 10 mmHg increase in SBP between the beginning and the end of a dialysis session or hypertension resistant to ultrafiltration occurring during or immediately after the dialysis procedure, were detected in 62 out of 113 hemodialysis sessions. SBP variability, IBI variability and baroreceptor sensitivity (BRS) in the low (LF) and high (HF) frequency ranges were assessed using the complex demodulation technique (CDM). Intradialytic hypertensive episodes were associated with an increased (n = 45) or decreased (n = 17) heart rate. The maximal blood pressure was similar in both groups. In patients with increased heart rate the increase in blood pressure was associated with marked increases in SBP and IBI variability, with suppressed BRS indices and enhanced sympatho-vagal balance. In contrast, in those with decreased heart rate, there were no significant changes in the above parameters. End-of-dialysis blood pressure in all sessions associated with hypertensive episode was significantly higher than in those without such episodes. In logistic regression analysis, predialysis BRS in the low frequency range was found to be the main predictor of intradialytic hypertension. Conclusion/Significance: Our data point to sympathetic overactivity with feed-forward blood pressure enhancement as an important mechanism of intradialytic hypertension in a significant proportion of patients. The triggers of increased sympathetic activity during hemodialysis remain to be determined. Intradialytic hypertensive episodes are associated with higher end-of-dialysis blood pressure, suggesting that intradialytic hypertension may play a role in generation of interdialytic hypertension.	[Rubinger, Dvora] Hadassah Univ Med Ctr, Dept Med, Serv Nephrol, Jerusalem, Israel; Hadassah Univ Med Ctr, Dept Med, Hypertens Serv, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Rubinger, D (corresponding author), Hadassah Univ Med Ctr, Dept Med, Serv Nephrol, Jerusalem, Israel.	rdvora@hadassah.org.il						Agarwal R, 2010, NEPHROL DIAL TRANSPL, V25, P3355, DOI 10.1093/ndt/gfq210; Amerling R., 1995, CLIN DIALYSIS, P235; Augustyniak RA, 2002, J HYPERTENS, V20, P3, DOI 10.1097/00004872-200201000-00002; BERNTSON GG, 1991, PSYCHOL REV, V98, P459, DOI 10.1037/0033-295X.98.4.459; BIGAZZI R, 1994, J AM SOC NEPHROL, V4, P1896; BIGAZZI R, 1994, J AM SOC NEPHROL, V4, P1901; Boulanger CM, 2007, HYPERTENSION, V49, P902, DOI 10.1161/01.HYP.0000259667.22309.df; Brychta RJ, 2007, AM J PHYSIOL-HEART C, V292, pH1193, DOI 10.1152/ajpheart.00645.2006; Camm AJ, 1996, CIRCULATION, V93, P1043; Campese VM, 2002, HYPERTENSION, V39, P519, DOI 10.1161/hy0202.102815; Castiglioni P, 2011, J ELECTROCARDIOL, V44, P391, DOI 10.1016/j.jelectrocard.2011.01.006; Chazot C, 2010, NEPHRON CLIN PRACT, V115, pC182, DOI 10.1159/000313031; Chen J, 2006, SEMIN DIALYSIS, V19, P141, DOI 10.1111/j.1525-139X.2006.00140.x; Chern CM, 2006, J CARDIOVASC PHARM, V47, P169, DOI 10.1097/01.fjc.0000199225.17928.f5; Chou KJ, 2006, KIDNEY INT, V69, P1833, DOI 10.1038/sj.ki.5000266; CONVERSE RL, 1992, NEW ENGL J MED, V327, P1912, DOI 10.1056/NEJM199212313272704; CONVERSE RL, 1992, J CLIN INVEST, V90, P1657, DOI 10.1172/JCI116037; Desir GV, 2011, CURR OPIN NEPHROL HY, V20, P31, DOI 10.1097/MNH.0b013e3283412721; Ding YF, 2011, J PHYSIOL-LONDON, V589, P245, DOI 10.1113/jphysiol.2010.200584; DOLSON GM, 1995, AM J KIDNEY DIS, V26, P321, DOI 10.1016/0272-6386(95)90652-5; Dubin R, 2011, HEMODIAL INT, V15, P350, DOI 10.1111/j.1542-4758.2011.00560.x; Eguchi K, 2007, J CARDIOVASC PHARM, V49, P394, DOI 10.1097/FJC.0b013e31804d1cf1; Eisenhofer G, 2005, KIDNEY INT, V67, P668, DOI 10.1111/j.1523-1755.2005.67123.x; Elghozi JL, 2007, FUND CLIN PHARMACOL, V21, P337, DOI 10.1111/j.1472-8206.2007.00502.x; Gori T, 2002, J AM COLL CARDIOL, V40, P2000, DOI 10.1016/S0735-1097(02)02532-9; Grassi G, 2003, HYPERTENSION, V41, P558, DOI 10.1161/01.HYP.0000058003.27729.5A; Grassi G, 2011, HYPERTENSION, V57, P846, DOI 10.1161/HYPERTENSIONAHA.110.164780; Grassi G, 2009, HYPERTENSION, V54, P690, DOI 10.1161/HYPERTENSIONAHA.108.119883; Hart EC, 2011, J PHYSIOL-LONDON, V589, P3395, DOI 10.1113/jphysiol.2011.208538; HAYANO J, 1994, J APPL PHYSIOL, V77, P2879, DOI 10.1152/jappl.1994.77.6.2879; HEGBRANT J, 1993, NEPHRON, V63, P303, DOI 10.1159/000187214; Hering D, 2007, J HYPERTENS, V25, P157, DOI 10.1097/HJH.0b013e3280102d92; Horl MP, 2002, AM J KIDNEY DIS, V39, P227, DOI 10.1053/ajkd.2002.30542; Huang BS, 2011, CURR HYPERTENS REP, V13, P214, DOI 10.1007/s11906-011-0192-0; Inrig JK, 2007, KIDNEY INT, V71, P454, DOI 10.1038/sj.ki.5002077; Inrig JK, 2011, CLIN J AM SOC NEPHRO, V6, P2016, DOI 10.2215/CJN.11351210; Inrig JK, 2010, AM J KIDNEY DIS, V55, P580, DOI 10.1053/j.ajkd.2009.08.013; Inrig JK, 2009, AM J KIDNEY DIS, V54, P881, DOI 10.1053/j.ajkd.2009.05.012; Kara T, 2003, ACTA PHYSIOL SCAND, V177, P377, DOI 10.1046/j.1365-201X.2003.01083.x; Katzarski KS, 1999, CLIN NEPHROL, V52, P304; Klein IHHT, 2003, J AM SOC NEPHROL, V14, P3239, DOI 10.1097/01.ASN.0000098687.01005.A5; La Rovere MT, 1998, LANCET, V351, P478; LAROVERE MT, 1995, J CARDIOVASC ELECTR, V6, P761; Legramante JM, 1999, CIRCULATION, V99, P1760, DOI 10.1161/01.CIR.99.13.1760; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1058, DOI 10.1093/ndt/gfh103; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670; Matzke GR, 2011, KIDNEY INT, V80, P1122, DOI 10.1038/ki.2011.322; Michael F, 2004, SEMIN DIALYSIS, V17, P279, DOI 10.1111/j.0894-0959.2004.17327.x; Munakata M, 2003, CLIN EXP HYPERTENS, V25, P169, DOI 10.1081/CEH-120019149; Munger MA, 2000, AM J KIDNEY DIS, V36, P130, DOI 10.1053/ajkd.2000.8285; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Norton MR, 2005, J APPL PHYSIOL, V98, P2298, DOI 10.1152/japplphysiol.00772.2004; Pagani M, 1997, CIRCULATION, V95, P1441; Parati G, 2000, J HYPERTENS, V18, P7, DOI 10.1097/00004872-200018010-00003; PARATI G, 1995, HYPERTENSION, V25, P1276, DOI 10.1161/01.HYP.25.6.1276; Penaz, 1973, P 10 INT C MED BIOL; Pitzalis MV, 1998, CHEST, V114, P185, DOI 10.1378/chest.114.1.185; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; Raj DSC, 2002, KIDNEY INT, V61, P697, DOI 10.1046/j.1523-1755.2002.00150.x; Rubinger D, 2008, J AM SOC NEPHROL, V19, p725A; Rubinger D, 2009, NEPHROL DIAL TRANSPL, V24, P1305, DOI 10.1093/ndt/gfn732; Sajadieh A, 2004, EUR HEART J, V25, P363, DOI 10.1016/j.ehj.2003.12.003; Sapoznikov D, 2010, J HYPERTENS, V28, P314, DOI 10.1097/HJH.0b013e328332b7af; Schlaich MP, 2009, J AM SOC NEPHROL, V20, P933, DOI 10.1681/ASN.2008040402; Stauss HM, 2007, CLIN EXP PHARMACOL P, V34, P362, DOI 10.1111/j.1440-1681.2007.04588.x; Stocker SD, 2010, PHYSIOL BEHAV, V100, P519, DOI 10.1016/j.physbeh.2010.04.024; Van Buren PN, 2011, CLIN J AM SOC NEPHRO, V6, P1684, DOI 10.2215/CJN.11041210; vanKuijk WHM, 1997, CLIN NEPHROL, V47, P190; WESSELING KH, 1995, HOMEOSTASIS HLTH DIS, V36, P67; Ylitalo A, 2000, J AM COLL CARDIOL, V35, P194, DOI 10.1016/S0735-1097(99)00506-9	71	29	30	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36943	10.1371/journal.pone.0036943	http://dx.doi.org/10.1371/journal.pone.0036943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629345	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300016
J	Wei, W; Gai, ZC; Ai, H; Wu, WX; Yang, YB; Peng, JX; Hong, HZ; Li, Y; Liu, KY				Wei, Wei; Gai, Zhongchao; Ai, Hui; Wu, Wenxian; Yang, Yongbo; Peng, Jianxin; Hong, Huazhu; Li, Yi; Liu, Kaiyu			Baculovirus Infection Triggers a Shift from Amino Acid Starvation-Induced Autophagy to Apoptosis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; VIRUS; EXPRESSION; REPLICATION; SUBVERSION; SILKWORM; PREVENTS; PROTECTS; CLEAVAGE	Autophagy plays a central role in regulating important cellular functions such as cell survival during starvation and control of infectious pathogens. On the other hand, many pathogens have evolved mechanisms of inhibition of autophagy such as blockage of the formation of autophagosomes or the fusion of autophagosomes with lysosomes. Baculoviruses are important insect pathogens for pest control, and autophagy activity increases significantly during insect metamorphosis. However, it is not clear whether baculovirus infection has effects on the increased autophagy. In the present study, we investigated the effects of the Autographa californica nucleopolyhedrovirus (AcMNPV) infection on autophagy in SL-HP cell line from Spodoptera litura induced under amino acid deprivation. The results revealed that AcMNPV infection did not inhibit autophagy but triggered apoptosis under starvation pressure. In the early stage of infection under starvation, mitochondrial dysfunction was detected, suggesting the organelles might be involved in cell apoptosis. The semi-quantitative PCR assay revealed that the expression of both p35 and ie-1 genes of AcMNPV had no significant difference between the starved and unstarved SL-HP cells. The western blot analysis showed that no cleavage of endogenous Atg6 occurred during the process of apoptosis in SL-HP cells. These data demonstrated that some permissive insect cells may defend baculovirus infection via apoptosis under starvation and apoptosis is independent of the cleavage of Atg6 in SL-HP cells.	[Wei, Wei; Gai, Zhongchao; Ai, Hui; Wu, Wenxian; Yang, Yongbo; Peng, Jianxin; Hong, Huazhu; Li, Yi; Liu, Kaiyu] Cent China Normal Univ, Coll Life Sci, Wuhan, Peoples R China	Central China Normal University	Wei, W (corresponding author), Cent China Normal Univ, Coll Life Sci, Wuhan, Peoples R China.	liyi@mail.ccnu.edu.cn; liukaiyu@mail.ccnu.edu.cn	Gai, Zhongchao/GON-5469-2022; Wu, Wenxian/AAG-9752-2019	Gai, Zhongchao/0000-0003-3367-3378; Wu, Wenxian/0000-0003-4059-5945	Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [230594]; Hubei Province Natural Science Foundation [2007ABA160]; National Natural Science Foundation of China [30470073, 30970136]	Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Hubei Province Natural Science Foundation(Natural Science Foundation of Hubei Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project-sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (230594), Hubei Province Natural Science Foundation (2007ABA160) and the National Natural Science Foundation of China (30470073; 30970136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DE, 2008, AUTOPHAGY, V4, P101, DOI 10.4161/auto.5222; Barth JMI, 2011, CELL DEATH DIFFER, V18, P915, DOI 10.1038/cdd.2010.157; Betin VMS, 2009, J CELL SCI, V122, P2554, DOI 10.1242/jcs.046250; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Cho DH, 2009, CANCER LETT, V274, P95, DOI 10.1016/j.canlet.2008.09.004; Gannage M, 2010, AUTOPHAGY, V6, P166, DOI 10.4161/auto.6.1.10624; Ghadimi D, 2010, INT IMMUNOPHARMACOL, V10, P694, DOI 10.1016/j.intimp.2010.03.014; Goncu E, 2008, AUTOPHAGY, V4, P1069, DOI 10.4161/auto.6953; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hisahara S, 2000, EMBO J, V19, P341, DOI 10.1093/emboj/19.3.341; Kang KD, 2011, J INVERTEBR PATHOL, V106, P205, DOI 10.1016/j.jip.2010.09.005; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Liu KY, 2012, INSECT SCI, V19, P30, DOI 10.1111/j.1744-7917.2011.01431.x; Liu KY, 2011, J VIROL, V85, P10069, DOI 10.1128/JVI.00625-11; Liu LJ, 2007, CELL BIOL INT, V31, P996, DOI 10.1016/j.cellbi.2007.03.011; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mpakou VE, 2008, AUTOPHAGY, V4, P97, DOI 10.4161/auto.5205; Munafo DB, 2001, J CELL SCI, V114, P3619; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Rossman JS, 2009, CELL HOST MICROBE, V6, P299, DOI 10.1016/j.chom.2009.09.009; Schultz KLW, 2009, J VIROL, V83, P262, DOI 10.1128/JVI.01827-08; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Wu WX, 2011, J INSECT PHYSIOL, V57, P723, DOI 10.1016/j.jinsphys.2011.02.008; Wu YL, 2008, VIRUS RES, V135, P247, DOI 10.1016/j.virusres.2008.04.001; XIE W, 1988, ACTA SCI NATURALISM, V4, P113; Zeng XD, 2009, SCI CHINA SER C, V52, P761, DOI 10.1007/s11427-009-0105-5; Zhang X, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-50; Zhang XP, 2008, CYTOTECHNOLOGY, V57, P233, DOI 10.1007/s10616-008-9158-8	35	15	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37457	10.1371/journal.pone.0037457	http://dx.doi.org/10.1371/journal.pone.0037457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629397	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343100029
J	Francey, D; Bergmuller, R				Francey, Damien; Bergmueller, Ralph			Images of Eyes Enhance Investments in a Real-Life Public Good	PLOS ONE			English	Article							INDIRECT RECIPROCITY; COMPETITIVE ALTRUISM; PARTNER CHOICE; COOPERATION; TRAGEDY; COMMONS; CUES; PUNISHMENT; EVOLUTION; CLIMATE	A key issue in cooperation research is to determine the conditions under which individuals invest in a public good. Here, we tested whether cues of being watched increase investments in an anonymous public good situation in real life. We examined whether individuals would invest more by removing experimentally placed garbage (paper and plastic bottles) from bus stop benches in Geneva in the presence of images of eyes compared to controls (images of flowers). We provided separate bins for each of both types of garbage to investigate whether individuals would deposit more items into the appropriate bin in the presence of eyes. The treatment had no effect on the likelihood that individuals present at the bus stop would remove garbage. However, those individuals that engaged in garbage clearing, and were thus likely affected by the treatment, invested more time to do so in the presence of eyes. Images of eyes had a direct effect on behaviour, rather than merely enhancing attention towards a symbolic sign requesting removal of garbage. These findings show that simple images of eyes can trigger reputational effects that significantly enhance on non-monetary investments in anonymous public goods under real life conditions. We discuss our results in the light of previous findings and suggest that human social behaviour may often be shaped by relatively simple and potentially unconscious mechanisms instead of very complex cognitive capacities.	[Francey, Damien; Bergmueller, Ralph] Univ Neuchatel, Dept Ecoethol, CH-2000 Neuchatel, Switzerland	University of Neuchatel	Francey, D (corresponding author), Univ Neuchatel, Dept Ecoethol, CH-2000 Neuchatel, Switzerland.	ralph.bergmueller@unine.ch						Alexander R., 2008, ESSAYS PEDAGOGY; Barclay P, 2007, P ROY SOC B-BIOL SCI, V274, P749, DOI 10.1098/rspb.2006.0209; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Bergmuller R, 2007, BEHAV PROCESS, V76, P170, DOI 10.1016/j.beproc.2007.06.013; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Bshary A, 2010, CURR BIOL, V20, P2032, DOI 10.1016/j.cub.2010.10.027; Burnham TC, 2007, HUM NATURE-INT BIOS, V18, P88, DOI 10.1007/s12110-007-9012-2; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Colander D, 2009, CRIT REV, V21, P249, DOI 10.1080/08913810902934109; CONNOR RC, 1995, TRENDS ECOL EVOL, V10, P84, DOI 10.1016/S0169-5347(00)88988-0; Coulson A., 1995, INT J BANK MARK, V13, P22, DOI DOI 10.1108/02652329510078668; Ernest-Jones M, 2011, EVOL HUM BEHAV, V32, P172, DOI 10.1016/j.evolhumbehav.2010.10.006; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2010, P ROY SOC B-BIOL SCI, V277, P1315, DOI 10.1098/rspb.2009.1900; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Jensen K, 2010, PHILOS T R SOC B, V365, P2635, DOI 10.1098/rstb.2010.0146; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Kurzban R, 2001, J NONVERBAL BEHAV, V25, P241, DOI 10.1023/A:1012563421824; Lamba S, 2010, EVOL HUM BEHAV, V31, P271, DOI 10.1016/j.evolhumbehav.2010.02.002; Mifune N, 2010, EVOL HUM BEHAV, V31, P109, DOI 10.1016/j.evolhumbehav.2009.09.004; Milinski M, 2006, P NATL ACAD SCI USA, V103, P3994, DOI 10.1073/pnas.0504902103; Milinski M, 2002, P ROY SOC B-BIOL SCI, V269, P881, DOI 10.1098/rspb.2002.1964; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Olson M., 1965, LOGIC COLLECTIVE ACT; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Pinto A, 2011, CURR BIOL, V21, P1140, DOI 10.1016/j.cub.2011.05.021; Raihani NJ, 2010, OIKOS, V119, P1391, DOI 10.1111/j.1600-0706.2010.18279.x; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Rankin DJ, 2011, TRENDS ECOL EVOL, V26, P1, DOI 10.1016/j.tree.2010.10.005; Rigdon M, 2009, J ECON PSYCHOL, V30, P358, DOI 10.1016/j.joep.2009.02.002; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Sherratt TN, 2009, FRONT BIOSCI-LANDMRK, V14, P4557, DOI 10.2741/3548; Shettleworth SJ, 2010, TRENDS COGN SCI, V14, P477, DOI 10.1016/j.tics.2010.07.002; Sylwester K, 2010, BIOL LETTERS, V6, P659, DOI 10.1098/rsbl.2010.0209; TESSMAN I, 1995, OIKOS, V74, P157, DOI 10.2307/3545685; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Vugt M, 2009, CURR DIR PSYCHOL SCI, V18, P169, DOI 10.1111/j.1467-8721.2009.01630.x; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850	46	49	50	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37397	10.1371/journal.pone.0037397	http://dx.doi.org/10.1371/journal.pone.0037397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22624026	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500111
J	Liu, QZ; Han, LZ; Li, B; Sun, JY; Ni, YX				Liu, Qingzhong; Han, Lizhong; Li, Bin; Sun, Jingyong; Ni, Yuxing			Virulence Characteristic and MLST-agr Genetic Background of High-Level Mupirocin-Resistant, MRSA Isolates from Shanghai and Wenzhou, China	PLOS ONE			English	Article							SENSITIVE STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; MOLECULAR CHARACTERIZATION; ENTEROTOXIN GENE; BINDING PROTEIN; CLONAL DISTRIBUTION; SUPERANTIGEN GENES; SLIME PRODUCTION; TOXIN GENES	The emergence and prevalence of high-level mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MuH MRSA) is challenging the eradication of MRSA nasal carriage and the treatment of skin and soft tissue infections. To understand the potentially pathogenetic capacity and the genetic basis of MuH MRSA, it is important to have a detailed knowledge of the molecular traits of this organism. Fifty three MuH MRSA isolates were gathered from Shanghai (28 isolates) and Wenzhou (25 isolates) in China. These isolates, consisting of 27 different PFGE-SCCmec-spa patterns, were examined by PCR for 35 virulence genes and further typed using agr (accessory gene regulator) typing and MLST (multilocus sequence typing). All 53 strains were positive for the genes hlg/hlg variant and icaD, and negative for seb, sed, see, seh, eta, etb, hld, cap-5, and ACME-arcA. Compared with Wenzhou isolates, Shanghai isolates were more likely to carry seg (P = 0.002) and several other genes which were not found in Wenzhou strains such as sec, sei, tst (P < 0.001 each), and pvl (P = 0.012), and less likely to contain sea (P < 0.001), cna (P = 0.031), and efb (P = 0.045). MLST and agr typing showed that ST239-agr1, ST5-agr1, and ST239-agr2 were the common lineages in MuH MRSA isolates from these two different regions. Our results indicated that MuH MRSA strains from two different geographic regions of China have differences in distribution of some virulence genes, while their major MLST-agr genetic backgrounds were accordant.	[Liu, Qingzhong] Shanghai Jiao Tong Univ, Dept Clin Lab, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [Han, Lizhong; Li, Bin; Sun, Jingyong; Ni, Yuxing] Ruijin Hosp, Sch Med, Dept Clin Microbiol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, QZ (corresponding author), Shanghai Jiao Tong Univ, Dept Clin Lab, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China.	yuxinni53@yahoo.com.cn			Shanghai First People's Hospital [10B10]; Natural Science Foundation; Science and Technology Commission of Shanghai [09ZR1419200]; Ministry of Health and Public Welfare Industry Research Fund, China [200802107]	Shanghai First People's Hospital; Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Health and Public Welfare Industry Research Fund, China	This work was supported by grants from Shanghai First People's Hospital Research Fund (No. 10B10), Natural Science Foundation, Science and Technology Commission of Shanghai (No. 09ZR1419200), and the Ministry of Health and Public Welfare Industry Research Fund, China (No. 200802107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciola CR, 2001, J CLIN MICROBIOL, V39, P2151, DOI 10.1128/JCM.39.6.2151-2156.2001; Atkins KL, 2008, MOL IMMUNOL, V45, P1600, DOI 10.1016/j.molimm.2007.10.021; Ben Nejma M, 2006, DIAGN MICR INFEC DIS, V55, P21, DOI 10.1016/j.diagmicrobio.2005.10.017; Bokarewa MI, 2006, INT J BIOCHEM CELL B, V38, P504, DOI 10.1016/j.biocel.2005.07.005; Cafiso V, 2007, FEMS IMMUNOL MED MIC, V51, P220, DOI 10.1111/j.1574-695X.2007.00298.x; Chien YT, 1999, J BIOL CHEM, V274, P37169, DOI 10.1074/jbc.274.52.37169; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Downer R, 2002, J BIOL CHEM, V277, P243, DOI 10.1074/jbc.M107621200; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Ferry T, 2005, CLIN INFECT DIS, V41, P771, DOI 10.1086/432798; Ghebremedhin B, 2007, J MED MICROBIOL, V56, P365, DOI 10.1099/jmm.0.46883-0; Goerke C, 2006, ANTIMICROB AGENTS CH, V50, P171, DOI 10.1128/AAC.50.1.171-177.2006; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Harraghy N, 2003, MICROBIOL-SGM, V149, P2701, DOI 10.1099/mic.0.26465-0; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; Holtfreter S, 2004, INFECT IMMUN, V72, P4061, DOI 10.1128/IAI.72.7.4061-4071.2004; Hudson MC, 1999, FEMS MICROBIOL LETT, V173, P279, DOI 10.1016/S0378-1097(99)00079-8; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Jarraud S, 2001, J IMMUNOL, V166, P669, DOI 10.4049/jimmunol.166.1.669; Lee LY, 2002, J CLIN INVEST, V110, P1461, DOI 10.1172/JC1200216318; Liu M, 2010, CURR MICROBIOL, V61, P435, DOI 10.1007/s00284-010-9635-0; Liu QZ, 2010, INT J ANTIMICROB AG, V35, P114, DOI 10.1016/j.ijantimicag.2009.09.018; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; Monday SR, 1999, J CLIN MICROBIOL, V37, P3411, DOI 10.1128/JCM.37.10.3411-3414.1999; Moore PCL, 2001, J CLIN MICROBIOL, V39, P2760, DOI 10.1128/JCM.39.8.2760-2767.2001; Morgan WR, 2007, J CLIN MICROBIOL, V45, P668, DOI 10.1128/JCM.01657-06; Murray CK, 2009, BURNS, V35, P1112, DOI 10.1016/j.burns.2009.02.013; Palma M, 1996, INFECT IMMUN, V64, P5284, DOI 10.1128/IAI.64.12.5284-5289.1996; PATTI JM, 1992, J BIOL CHEM, V267, P4766; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Perez-Roth E, 2006, ANTIMICROB AGENTS CH, V50, P3207, DOI 10.1128/AAC.00059-06; Rice K, 2001, INFECT IMMUN, V69, P159, DOI 10.1128/IAI.69.1.159-169.2001; Salasia Siti Isrina Oktavia, 2004, J Vet Sci, V5, P103; Tung HS, 2000, BIOCHEM J, V345, P611, DOI 10.1042/0264-6021:3450611; van Belkum A, 2006, J CLIN MICROBIOL, V44, P1555, DOI 10.1128/JCM.44.4.1555-1557.2006; van Leeuwen W, 2000, J BACTERIOL, V182, P5721, DOI 10.1128/JB.182.20.5721-5729.2000; Verdier I, 2007, J CLIN MICROBIOL, V45, P725, DOI 10.1128/JCM.01572-06; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Yao D, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-133; Yu F, 2008, CLIN MICROBIOL INFEC, V14, P381, DOI 10.1111/j.1469-0691.2007.01927.x; Zhang SP, 1998, FEMS MICROBIOL LETT, V168, P227, DOI 10.1111/j.1574-6968.1998.tb13278.x; Zmantar T, 2008, J BASIC MICROB, V48, P308, DOI 10.1002/jobm.200700289	44	18	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37005	10.1371/journal.pone.0037005	http://dx.doi.org/10.1371/journal.pone.0037005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623969	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500046
J	Jiang, WL; Xie, H; Ghoorah, D; Shang, YL; Shi, HJ; Liu, F; Yang, XL; Xu, HB				Jiang, Weili; Xie, Hui; Ghoorah, Devina; Shang, Yalei; Shi, Haojun; Liu, Fang; Yang, Xiangliang; Xu, Haibo			Conjugation of Functionalized SPIONs with Transferrin for Targeting and Imaging Brain Glial Tumors in Rat Model	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; MAGNETIC-RESONANCE DETECTION; IN-VIVO; DRUG-DELIVERY; CONTRAST AGENTS; RECEPTOR; BARRIER; CANCER; TISSUE; FERUMOXTRAN-10	Currently, effective and specific diagnostic imaging of brain glioma is a major challenge. Nanomedicine plays an essential role by delivering the contrast agent in a targeted manner to specific tumor cells, leading to improvement in accurate diagnosis by good visualization and specific demonstration of tumor cells. This study investigated the preparation and characterization of a targeted MR contrast agent, transferrin-conjugated superparamagnetic iron oxide nanoparticles (Tf-SPIONs), for brain glioma detection. MR imaging showed the obvious contrast change of brain glioma before and after administration of Tf-SPIONs in C6 glioma rat model in vivo on T2 weighted imaging. Significant contrast enhancement of brain glioma could still be clearly seen even 48 h post injection, due to the retention of Tf-SPIONs in cytoplasm of tumor cells which was proved by Prussian blue staining. Thus, these results suggest that Tf-SPIONs could be a potential targeting MR contrast agent for the brain glioma.	[Jiang, Weili; Ghoorah, Devina; Shang, Yalei; Shi, Haojun; Liu, Fang; Xu, Haibo] Huazhong Univ Sci & Technol, Dept Radiol, Union Hosp, Wuhan 430074, Hubei, Peoples R China; [Xie, Hui] China Patent Informat Ctr, Dept Informat Proc, Wuhan, Peoples R China; [Yang, Xiangliang] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Jiang, WL (corresponding author), Huazhong Univ Sci & Technol, Dept Radiol, Union Hosp, Wuhan 430074, Hubei, Peoples R China.	nanomedicine@mail.hust.edu.cn; xuhaibo1120@hotmail.com			National 973 Projection of China [2011CB933103]; National Natural Science Foundation in China [81171386, 30770623]; Hubei Key Laboratory Foundation of Molecular Imaging [2008-69]; Hubei Natural Science Foundation [2009CDB008]	National 973 Projection of China(National Basic Research Program of China); National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); Hubei Key Laboratory Foundation of Molecular Imaging; Hubei Natural Science Foundation(Natural Science Foundation of Hubei Province)	This work was supported by National 973 Projection of China (grant number: 2011CB933103), National Natural Science Foundation in China (grant number: 81171386 and 30770623), Hubei Key Laboratory Foundation of Molecular Imaging (grant number: 2008-69), as well as Hubei Natural Science Foundation (grant number: 2009CDB008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Bourrinet P, 2006, INVEST RADIOL, V41, P313, DOI 10.1097/01.rli.0000197669.80475.dd; Burtea Carmen, 2008, V185, P135, DOI 10.1007/978-3-540-72718-7_7; Cao Y, 2006, J CLIN ONCOL, V24, P1228, DOI 10.1200/JCO.2005.04.7233; Chertok B, 2008, BIOMATERIALS, V29, P487, DOI 10.1016/j.biomaterials.2007.08.050; Chirasani SR, 2009, J MOL MED, V87, P153, DOI 10.1007/s00109-008-0414-3; Corot C, 2006, ADV DRUG DELIVER REV, V58, P1471, DOI 10.1016/j.addr.2006.09.013; Descamps L, 1996, AM J PHYSIOL-HEART C, V270, pH1149, DOI 10.1152/ajpheart.1996.270.4.H1149; Gao HL, 2010, ACTA PHARMACOL SIN, V31, P237, DOI 10.1038/aps.2009.199; High WA, 2007, J AM ACAD DERMATOL, V56, P21, DOI 10.1016/j.jaad.2006.10.047; Hu FQ, 2006, ADV MATER, V18, P2553, DOI 10.1002/adma.200600385; Huh YM, 2005, J AM CHEM SOC, V127, P12387, DOI 10.1021/ja052337c; INOUE T, 1993, J CELL PHYSIOL, V156, P212, DOI 10.1002/jcp.1041560128; JUNG CW, 1995, MAGN RESON IMAGING, V13, P661, DOI 10.1016/0730-725X(95)00024-B; Koo YEL, 2006, ADV DRUG DELIVER REV, V58, P1556, DOI 10.1016/j.addr.2006.09.012; Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8; Moore A, 2000, RADIOLOGY, V214, P568, DOI 10.1148/radiology.214.2.r00fe19568; Muldoon LL, 1999, AM J NEURORADIOL, V20, P217; Muldoon LL, 2005, NEUROSURGERY, V57, P785, DOI 10.1227/01.NEU.0000175731.25414.4c; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; RECHT L, 1990, J NEUROSURG, V72, P941, DOI 10.3171/jns.1990.72.6.0941; Rees J, 2003, CURR OPIN NEUROL, V16, P643, DOI 10.1097/00019052-200312000-00001; Sun C, 2008, SMALL, V4, P372, DOI 10.1002/smll.200700784; Ulbrich K, 2009, EUR J PHARM BIOPHARM, V71, P251, DOI 10.1016/j.ejpb.2008.08.021; Varallyay P, 2002, AM J NEURORADIOL, V23, P510; Xia Q., 2009, J CHIN PHARM SCI, V18, P7; Xie H, 2011, BIOMATERIALS, V32, P495, DOI 10.1016/j.biomaterials.2010.09.024; Yoon DJ, 2010, CANCER RES, V70, P4520, DOI 10.1158/0008-5472.CAN-09-4311	28	53	57	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37376	10.1371/journal.pone.0037376	http://dx.doi.org/10.1371/journal.pone.0037376			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615995	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200070
J	Jin, W; Wu, K; Li, YZ; Yang, WT; Zou, B; Zhang, F; Zhang, J; Wang, KK				Jin, W.; Wu, K.; Li, Y-Z; Yang, W-T; Zou, B.; Zhang, F.; Zhang, J.; Wang, K-K			AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia	ONCOGENE			English	Article						cathepsin G; AML1-ETO; t(8;21) AML	FUSION PROTEIN; NEUTROPHIL ELASTASE; GENE-EXPRESSION; EMBRYONIC LETHALITY; TRANSCRIPTION; DIFFERENTIATION; APOPTOSIS; CELLS; PU.1; PROMOTER	Although the significance of cathepsin G (CTSG) in host defense has been intensively investigated, little is known about its potential roles in granulopoiesis or leukemogenesis. We report here that CTSG is directly targeted and suppressed by AML1-ETO in t(8;21) acute myeloid leukemia (AML). Luciferase assays demonstrate that the CTSG promoter is strongly transactivated by AML1 and the AML1-dependent transactivation is suppressed by AML1-ETO. We also define a novel regulatory mechanism by which AML1-ETO-mediated transrepression requires both AML1-ETO and AML1 binding at adjacent sites, instead of the replacement of AML1 by AML1-ETO, and wild-type AML1 binding is a prerequisite for the repressive effect caused by AML1-ETO. Further evidence shows that CTSG, as a hematopoietic serine protease, can degrade AML1-ETO both in vitro and in vivo. Restoration of CTSG induces partial differentiation, growth inhibition and apoptosis in AML1-ETO-positive cells. In addition to t(8; 21) AML, CTSG downregulation is observed in AML patients with other cytogenetic/genetic abnormalities that potentially interrupt normal AML1 function, that is, inv(16) and EVI1 overexpression. Thus, the targeting and suppression of CTSG by AML1-ETO in t(8; 21) AML may provide a mechanism for leukemia cells to escape from the intracellular surveillance system by preventing degradation of foreign proteins. Oncogene (2013) 32, 1978-1987; doi:10.1038/onc.2012.204; published online 28 May 2012	[Jin, W.; Wu, K.; Li, Y-Z; Yang, W-T; Zou, B.; Zhang, F.; Zhang, J.; Wang, K-K] SJTU SM, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200025, Peoples R China; [Jin, W.; Wu, K.; Li, Y-Z; Yang, W-T; Zou, B.; Zhang, F.; Zhang, J.; Wang, K-K] SJTU SM, Ruijin Hosp, Shanghai Inst Hematol, Shanghai 200025, Peoples R China; [Zhang, J.] Chinese Acad Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zhang, J.] SJTU SM, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Wang, KK (corresponding author), SJTU SM, Ruijin Hosp, State Key Lab Med Genom, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China.	kankanwang@shsmu.edu.cn		Wu, Kang/0000-0002-9024-795X	Ministry of Science and Technology Grants of China [2009CB825607, 2012AA02A211, 2011CB910202]; National Natural Science Foundation Grants of China [31171257, 90919059, 30971623]	Ministry of Science and Technology Grants of China; National Natural Science Foundation Grants of China(National Natural Science Foundation of China (NSFC))	We thank Dr Lubbert M for providing the AML1-ETO-inducible cell line, U937-A/E9/14/18. This work was supported in part by the Ministry of Science and Technology Grants of China (2009CB825607, 2012AA02A211 and 2011CB910202) and National Natural Science Foundation Grants of China (31171257, 90919059 and 30971623).	Biggs JR, 2001, P NATL ACAD SCI USA, V98, P3814, DOI 10.1073/pnas.071057398; BITTER MA, 1987, HUM PATHOL, V18, P211, DOI 10.1016/S0046-8177(87)80002-3; Corsello SM, 2009, BLOOD, V113, P6193, DOI 10.1182/blood-2008-07-166090; DENGLER R, 1995, BRIT J HAEMATOL, V89, P250, DOI 10.1111/j.1365-2141.1995.tb03297.x; Dunne J, 2006, ONCOGENE, V25, P6067, DOI 10.1038/sj.onc.1209638; Fliegauf M, 2004, ONCOGENE, V23, P9070, DOI 10.1038/sj.onc.1208042; Frank R, 1995, ONCOGENE, V11, P2667; Gardini A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000275; Garwicz D, 1998, BLOOD, V92, P1415, DOI 10.1182/blood.V92.4.1415.416k28_1415_1422; Heidenreich O, 2003, BLOOD, V101, P3157, DOI 10.1182/blood-2002-05-1589; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Howcroft TK, 2005, J IMMUNOL, V174, P2106, DOI 10.4049/jimmunol.174.4.2106; Hug BA, 2004, ONCOGENE, V23, P4270, DOI 10.1038/sj.onc.1207674; Igney FH, 2002, J LEUKOCYTE BIOL, V71, P907; Jiang Y, 2005, LEUKEMIA, V19, P1239, DOI 10.1038/sj.leu.2403734; Kadkol SS, 2004, J MOL DIAGN, V6, P22, DOI 10.1016/S1525-1578(10)60487-4; Kitareewan S, 2007, J NATL CANCER I, V99, P41, DOI 10.1093/jnci/djk004; Klampfer L, 1996, P NATL ACAD SCI USA, V93, P14059, DOI 10.1073/pnas.93.24.14059; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Lane AA, 2003, CELL, V115, P305, DOI 10.1016/S0092-8674(03)00852-3; Laricchia-Robbio L, 2009, CANCER RES, V69, P1633, DOI 10.1158/0008-5472.CAN-08-2562; Lausen J, 2006, ONCOGENE, V25, P1349, DOI 10.1038/sj.onc.1209181; Lennartsson A, 2005, GENE, V356, P193, DOI 10.1016/j.gene.2005.05.004; Licht JD, 2001, ONCOGENE, V20, P5660, DOI 10.1038/sj.onc.1204593; Linggi B, 2002, NAT MED, V8, P743, DOI 10.1038/nm726; McGhee L, 2003, J CELL BIOCHEM, V89, P1005, DOI 10.1002/jcb.10548; Mulloy JC, 2005, P NATL ACAD SCI USA, V102, P4016, DOI 10.1073/pnas.0404701102; Mulloy JC, 2003, BLOOD, V102, P4369, DOI 10.1182/blood-2003-05-1762; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; Okuda T, 1998, BLOOD, V91, P3134, DOI 10.1182/blood.V91.9.3134.3134_3134_3143; Okumura AJ, 2008, BLOOD, V112, P1392, DOI 10.1182/blood-2007-11-124735; Peterson LF, 2004, ONCOGENE, V23, P4255, DOI 10.1038/sj.onc.1207727; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Piazza F, 2000, BLOOD, V96, P1358, DOI 10.1182/blood.V96.4.1358.h8001358_1358_1365; Puissant A, 2010, LEUKEMIA, V24, P115, DOI 10.1038/leu.2009.233; Senyuk V, 2007, CANCER RES, V67, P5658, DOI 10.1158/0008-5472.CAN-06-3962; Shimada H, 2002, LEUKEMIA, V16, P874, DOI 10.1038/sj.leu.2402465; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7; Uchida H, 1997, J IMMUNOL, V158, P2251; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Vangala RK, 2003, BLOOD, V101, P270, DOI 10.1182/blood-2002-04-1288; Wang KK, 2010, CANCER CELL, V17, P186, DOI 10.1016/j.ccr.2009.12.045; Wang L, 2007, CELL DEATH DIFFER, V14, P306, DOI 10.1038/sj.cdd.4401996; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Yang G, 2007, ONCOGENE, V26, P91, DOI 10.1038/sj.onc.1209760; Yergeau DA, 1997, NAT GENET, V15, P303, DOI 10.1038/ng0397-303; Zhou GB, 2007, BLOOD, V109, P3441, DOI 10.1182/blood-2006-06-032250	51	20	22	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2013	32	15					1978	1987		10.1038/onc.2012.204	http://dx.doi.org/10.1038/onc.2012.204			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	126GB	22641217				2022-12-25	WOS:000317599900012
J	Huang, SK; Scruggs, AM; Donaghy, J; McEachin, RC; Fisher, AS; Richardson, BC; Peters-Golden, M				Huang, Steven K.; Scruggs, Anne M.; Donaghy, Jake; McEachin, Richard C.; Fisher, Aaron S.; Richardson, Bruce C.; Peters-Golden, Marc			Prostaglandin E-2 increases fibroblast gene-specific and global DNA methylation via increased DNA methyltransferase expression	FASEB JOURNAL			English	Article						epigenetics; eicosanoids; macrophage	RECEPTOR-MEDIATED INCREASE; LUNG FIBROBLASTS; E-PROSTANOID-2 RECEPTOR; DE-NOVO; TRANSCRIPTIONAL REGULATION; INHIBITS FIBROBLAST; MAMMALIAN-CELLS; CANCER; GROWTH; CYCLOOXYGENASE-2	Although alterations in DNA methylation patterns have been associated with specific diseases and environmental exposures, the mediators and signaling pathways that direct these changes remain understudied. The bioactive lipid mediator prostaglandin E-2 (PGE(2)) has been shown to exert a myriad of effects on cell survival, proliferation, and differentiation. Here, we report that PGE(2) also signals to increase global DNA methylation and DNA methylation machinery in fibroblasts. HumanMethylation27 BeadChip array analysis of primary fetal (IMR-90) and adult lung fibroblasts identified multiple genes that were hypermethylated in response to PGE(2). PGE(2), compared with nontreated controls, increased expression and activity (EC50 similar to 10(7) M) of one specific isoform of DNA methyltransferase, DNMT3a. Silencing of DNMT3a negated the ability of PGE(2) to increase DNMT activity. The increase in DNMT3a expression was mediated by PGE(2) signaling via its E prostanoid 2 receptor and the second messenger cAMP. PGE(2), compared with the untreated control, increased the expression and activity of Sp1 and Sp3 (EC50 similar to 3 x 10(7) M), transcription factors known to increase DNMT3a expression, and inhibition of these transcription factors abrogated the PGE(2) increase of DNMT3a expression. These findings were specific to fibroblasts, as PGE(2) decreased DNMT1 and DNMT3a expression in RAW macrophages. Taken together, these findings establish that DNA methylation is regulated by a ubiquitous bioactive endogenous mediator. Given that PGE(2) biosynthesis is modulated by environmental toxins, various disease states, and commonly used pharmacological agents, these findings uncover a novel mechanism by which alterations in DNA methylation patterns may arise in association with disease and certain environmental exposures.-Huang, S. K., Scruggs, A. M., Donaghy, J., McEachin, R. C., Fisher, A. S., Richardson, B. C., Peters-Golden, M. Prostaglandin E-2 increases fibroblast gene-specific and global DNA methylation via increased DNA methyltransferase expression. FASEB J. 26, 3703-3714 (2012). www.fasebj.org	[Huang, Steven K.; Scruggs, Anne M.; Donaghy, Jake; Fisher, Aaron S.; Peters-Golden, Marc] Univ Michigan, Sch Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [McEachin, Richard C.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI USA; [Richardson, Bruce C.] Univ Michigan, Sch Med, Div Rheumatol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Huang, SK (corresponding author), 6301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	stehuang@umich.edu			American Thoracic Society Coalition for Pulmonary Fibrosis Foundation; U.S. National Institutes of Health [HL094657, HL094311, AG013283, P30 ES017885]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL094657, R01HL094311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES017885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	American Thoracic Society Coalition for Pulmonary Fibrosis Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Drs. Robert Lyons and Susan L. Dagenais for their assistance with the HumanMethylation27 CpG array. This work was funded by a grant from the American Thoracic Society Coalition for Pulmonary Fibrosis Foundation and by grants HL094657 (to S. K. H.), HL094311 (to M.P.-G.), AG013283, and P30 ES017885 from the U.S. National Institutes of Health.	Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Balana C, 2003, CLIN CANCER RES, V9, P1461; Ballestar E, 2006, J IMMUNOL, V176, P7143, DOI 10.4049/jimmunol.176.12.7143; BOROK Z, 1991, AM REV RESPIR DIS, V144, P1080, DOI 10.1164/ajrccm/144.5.1080; Bradbury D, 2005, J BIOL CHEM, V280, P29993, DOI 10.1074/jbc.M414530200; Choung J, 1998, J CELL BIOCHEM, V71, P254, DOI 10.1002/(SICI)1097-4644(19981101)71:2<254::AID-JCB10>3.3.CO;2-L; DIBONA GF, 1986, AM J MED, V80, P12, DOI 10.1016/0002-9343(86)90928-9; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2002, SEMIN CANCER BIOL, V12, P389, DOI 10.1016/S1044-579X(02)00059-7; FINE A, 1989, J BIOL CHEM, V264, P16988; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hagood JS, 2005, AM J PATHOL, V167, P365, DOI 10.1016/S0002-9440(10)62982-3; Hata K, 2002, DEVELOPMENT, V129, P1983; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Huang SK, 2008, AM J RESP CELL MOL, V39, P482, DOI 10.1165/rcmb.2008-0080OC; Huang SK, 2008, AM J RESP CRIT CARE, V177, P66, DOI 10.1164/rccm.200706-963OC; Huang SK, 2010, AM J PATHOL, V177, P2245, DOI 10.2353/ajpath.2010.100446; Huang SK, 2009, FASEB J, V23, P4317, DOI 10.1096/fj.08-128801; Jiang GF, 2008, TOXICOLOGY, V244, P49, DOI 10.1016/j.tox.2007.10.028; Jinawath A, 2005, BIOCHEM J, V385, P557, DOI 10.1042/BJ20040684; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; KOCHANEK S, 1993, EMBO J, V12, P1141, DOI 10.1002/j.1460-2075.1993.tb05755.x; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Kristensen DM, 2011, ENVIRON HEALTH PERSP, V119, P534, DOI 10.1289/ehp.1002635; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li YP, 2010, EXP GERONTOL, V45, P312, DOI 10.1016/j.exger.2009.12.008; Liu C, 2004, EXP CELL RES, V297, P61, DOI 10.1016/j.yexcr.2004.02.014; Liu H, 2007, ONCOGENE, V26, P5900, DOI 10.1038/sj.onc.1210400; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; North ML, 2011, ANN ALLERG ASTHMA IM, V106, P355, DOI 10.1016/j.anai.2011.02.008; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 2006, IMMUNOLOGY, V118, P343, DOI 10.1111/j.1365-2567.2006.02376.x; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; ROBERT A, 1979, GASTROENTEROLOGY, V77, P433; Sartor MA, 2010, BIOINFORMATICS, V26, P456, DOI 10.1093/bioinformatics/btp683; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Szczeklik W, 2004, J ALLERGY CLIN IMMUN, V114, P248, DOI 10.1016/j.jaci.2004.05.030; Toyota M, 2000, CANCER RES, V60, P4044; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weisenberger DJ, 2002, GENE, V298, P91, DOI 10.1016/S0378-1119(02)00976-9; White ES, 2005, AM J RESP CELL MOL, V32, P135, DOI 10.1165/rcmb.2004-0126OC; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Xia DR, 2012, NAT MED, V18, P224, DOI 10.1038/nm.2608; Zheng Y, 2009, CANCER RES, V69, P896, DOI 10.1158/0008-5472.CAN-08-2677	53	43	44	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2012	26	9					3703	3714		10.1096/fj.11-203323	http://dx.doi.org/10.1096/fj.11-203323			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22645246	Green Published, Green Submitted			2022-12-25	WOS:000308391600012
J	Tong, Q; Wang, F; Zhou, HZ; Sun, HL; Song, H; Shu, YY; Gong, Y; Zhang, WT; Cai, TX; Yang, FQ; Tang, J; Jiang, T				Tong, Qiong; Wang, Feng; Zhou, Hong-Zhe; Sun, Han-Li; Song, Hui; Shu, Yu-Yan; Gong, Yong; Zhang, Wen-Ting; Cai, Tan-xi; Yang, Fu-Quan; Tang, Jie; Jiang, Tao			Structural and functional insights into lipid-bound nerve growth factors	FASEB JOURNAL			English	Article						cobra NGF; mouse NGF; lyso-PS; crystal structure	CRYSTAL-STRUCTURE; MAST-CELLS; NEUROTROPHIN RECEPTOR; TRK PROTOONCOGENE; MEMBRANE-BINDING; NGF; ACTIVATION; COMPLEX; SPECIFICITY; EXPRESSION	Nerve growth factor (NGF) is a dimeric molecule that modulates the survival, proliferation, and differentiation of nervous cells and is also known to act on cells of the immune system and endocrine system. NGFs extracted from mouse submaxillary gland and cobra venom have different immunological behaviors, yet the underlying mechanism remains unclear. Here we report the crystal structure of the NGF purified from Chinese cobra Naja naja atra (cNGF), which unexpectedly reveals a 2-tailed lipid molecule that is embedded between the two protomers of the NGF homodimer. In addition, crystallographic analysis indicated that the purified mouse NGF(mNGF) is free from lipid but can bind lysophosphatidylserine (lyso-PS) in the same pocket as cNGF. Bioassays indicated that the binding of lipid molecules to cNGF and mNGF are essential for their mast cell activation activity and abates their p75(NTR) binding capacity. Taken together, these results suggest a new mechanism for the regulation of the function of NGF.-Tong, Q., Wang, F., Zhou, H.-Z., Sun, H.-L., Song, H., Shu, Y.-Y., Gong, Y., Zhang, W.-T., Cai, T.-X., Yang, F.-Q., Tang, J., Jiang, T. Structural and functional insights into lipid-bound nerve growth factors. FASEB J. 26, 3811-3821 (2012). www.fasebj.org	[Tong, Qiong; Wang, Feng; Zhou, Hong-Zhe; Sun, Han-Li; Gong, Yong; Zhang, Wen-Ting; Cai, Tan-xi; Yang, Fu-Quan; Tang, Jie; Jiang, Tao] Inst Biophys, Natl Key Lab Biomacro Mol, Beijing 100101, Peoples R China; [Wang, Feng; Song, Hui] Guangxi Univ Tradit Chinese Med, Nanning, Peoples R China; [Shu, Yu-Yan] Guangxi Univ Tradit Chinese Med, Snake Venom Res Inst, Nanning, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Guangxi University of Chinese Medicine; Guangxi University of Chinese Medicine	Jiang, T (corresponding author), Inst Biophys, Natl Key Lab Biomacro Mol, 15 Datun Rd, Beijing 100101, Peoples R China.	tjiang@ibp.ac.cn			National Natural Science Foundation of China [31021062, 31025009]; National High Technology Research and Development Program of China [2006AA02A319]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The authors thank Z.-J. Lin for assistance with the design of the project and helpful comments on the manuscript, staff of the Shanghai Synchrotron Radiation Facility (SSRF; Shanghai, China), Beijing Synchrotron Radiation Facility (BSRF; Beijing, China), Super Photon Ring-8 GeV (Spring-8; Koto, Japan) and Diamond Light Source (Chilton, UK) for assistance in data collection, and Y-Y. Chen for assistance with the BIAcore analysis. This research was supported financially by the National Natural Science Foundation of China (grants 31021062, 31025009), and the National High Technology Research and Development Program of China (grant 2006AA02A319).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALOE L, 1977, BRAIN RES, V133, P358, DOI 10.1016/0006-8993(77)90772-7; ANGELETTI RH, 1970, P NATL ACAD SCI USA, V65, P668, DOI 10.1073/pnas.65.3.668; Aurikko JP, 2005, J BIOL CHEM, V280, P33453, DOI 10.1074/jbc.M503189200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banfield MJ, 2001, STRUCTURE, V9, P1191, DOI 10.1016/S0969-2126(01)00681-5; BANKS BEC, 1973, NATURE, V246, P503, DOI 10.1038/246503a0; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; Bax B, 1997, STRUCTURE, V5, P1275, DOI 10.1016/S0969-2126(97)00280-3; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bonini S, 2003, INT ARCH ALLERGY IMM, V131, P80, DOI 10.1159/000070922; BRUNI A, 1982, FEBS LETT, V138, P190, DOI 10.1016/0014-5793(82)80438-9; Burgi B, 1996, J IMMUNOL, V157, P5582; Butte MJ, 1998, BIOCHEMISTRY-US, V37, P16846, DOI 10.1021/bi981254o; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; COHEN S, 1954, P NATL ACAD SCI USA, V40, P1014, DOI 10.1073/pnas.40.10.1014; EHLERS MD, 1995, J CELL BIOL, V130, P149, DOI 10.1083/jcb.130.1.149; EHRHARD PB, 1993, P NATL ACAD SCI USA, V90, P5423, DOI 10.1073/pnas.90.12.5423; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freund-Michel V, 2008, PHARMACOL THERAPEUT, V117, P52, DOI 10.1016/j.pharmthera.2007.07.003; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; Hamanoue M, 1999, MOL CELL NEUROSCI, V14, P28, DOI 10.1006/mcne.1999.0770; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HEFTI F, 1986, ANN NEUROL, V20, P275, DOI 10.1002/ana.410200302; HORIGOME K, 1993, J BIOL CHEM, V268, P14881; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang MD, 2003, NAT STRUCT BIOL, V10, P751, DOI 10.1038/nsb971; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; Levi-Montalcini R., 1997, SAGA NERVE GROWTH FA, P399; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; MATSUDA H, 1988, P NATL ACAD SCI USA, V85, P6508, DOI 10.1073/pnas.85.17.6508; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEARCE FL, 1986, J PHYSIOL-LONDON, V372, P379, DOI 10.1113/jphysiol.1986.sp016014; ROBINSON RC, 1995, BIOCHEMISTRY-US, V34, P4139, DOI 10.1021/bi00013a001; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; Tabellini G, 2004, CELL SIGNAL, V16, P1263, DOI 10.1016/j.cellsig.2004.03.018; THORPE LW, 1987, J NEUROSCI RES, V18, P134, DOI 10.1002/jnr.490180120; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Watanabe H, 2004, J BIOL CHEM, V279, P37870, DOI 10.1074/jbc.M402610200; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Welker P, 1998, IMMUNOLOGY, V94, P310; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; YANKNER BA, 1990, P NATL ACAD SCI USA, V87, P9020, DOI 10.1073/pnas.87.22.9020; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	54	16	16	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3811	3821		10.1096/fj.12-207316	http://dx.doi.org/10.1096/fj.12-207316			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22649032				2022-12-25	WOS:000308391600021
J	Bier, C; Knauer, SK; Wunsch, D; Kunst, L; Scheiding, S; Kaiser, M; Ottmann, C; Kramer, OH; Stauber, RH				Bier, Carolin; Knauer, Shirley K.; Wuensch, Desiree; Kunst, Lena; Scheiding, Sabine; Kaiser, Markus; Ottmann, Christian; Kraemer, Oliver H.; Stauber, Roland H.			Allosteric inhibition of Taspase1's pathobiological activity by enforced dimerization in vivo	FASEB JOURNAL			English	Article						protein complex stabilizer; chemical biology; protease; dominant negative; protein interaction; threonine aspartase-1	PROTEIN-PROTEIN INTERACTIONS; STABILIZATION; PROTEASES; SURVIVIN; MLL	Taspase1 mediates cleavage of the mixed lineage leukemia (MLL) protein and leukemia-provoking MLL fusions and promotes solid malignancies. Currently, no effective and specific Taspase1 inhibitors are available, precluding its therapeutic exploitation. As the Taspase1 proenzyme is autoproteolytically cleaved and assumed to assemble into an active alpha beta beta alpha heterodimer, we attempted to interfere with its activity by targeting Taspase1's dimerization. Notably, enforced expression of inactive Taspase1 mutants, aiming to inhibit formation of active protease dimers, was not inhibitory. Immunoprecipitation, gel filtration, and in vivo protein interaction assays revealed that active Taspase1 exists predominantly as an alpha beta monomer in living cells, providing an explanation why overexpression of inactive mutants was not trans-dominant. To alternatively test the biological consequences of enforced dimerization, we engineered Taspase1 variants containing the Jun/Fos dimerization motif. In absence of the respective interaction partners, the protease fusions were fully active, while enforcing dimerization by coexpression significantly inhibited processing of several target proteins in living cells. Our study provides the first evidence that Taspase1 is already active as an alpha beta monomer, arguing against heterocomplex formation being required for its pathobiological activity. Thus, it clearly supports strategies aiming to inhibit the cancer-promoting activity of Taspase1 by the identification of chemical decoys enforcing its dimerization.-Bier, C., Knauer, S. K., Wunsch, D., Kunst, L., Scheiding, S., Kaiser, M., Ottmann, C., Kramer, O. H., Stauber, R. H. Allosteric inhibition of Taspase1's pathobiological activity by enforced dimerization in vivo. FASEB J. 26, 3421-3429 (2012). www.fasebj.org	[Bier, Carolin; Wuensch, Desiree; Stauber, Roland H.] Univ Med Ctr Mainz, Mainz Screening Ctr, D-55101 Mainz, Germany; [Knauer, Shirley K.; Kunst, Lena] Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Inst Mol Biol, D-45117 Essen, Germany; [Kaiser, Markus] Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Inst Biol Chem, Essen, Germany; [Scheiding, Sabine; Kraemer, Oliver H.] Univ Jena, Ctr Mol Biomed, Inst Biochem & Biophys, Jena, Germany; [Ottmann, Christian] Max Planck Gesell, Chem Genom Ctr, Dortmund, Germany	Johannes Gutenberg University of Mainz; University of Duisburg Essen; University of Duisburg Essen; Friedrich Schiller University of Jena; Max Planck Society	Stauber, RH (corresponding author), Univ Med Ctr Mainz, Mainz Screening Ctr, Langenbeckstr 1, D-55101 Mainz, Germany.	shirley.knauer@uni-due.de; rstauber@uni-mainz.de	Krämer, Oliver H/L-9266-2015; Gül, Désirée/AAB-5965-2022; Knauer, Shirley K/E-7931-2012	Krämer, Oliver H/0000-0003-3973-045X; Knauer, Shirley K/0000-0003-4321-0924; Stauber, Roland/0000-0002-1341-4523; Guel, Desiree/0000-0002-2446-5756	German Cancer Aid [FKZ102362]; Fritz Thyssen Foundation; Head and Neck Cancer Foundation; Deutsche Forschungsgemeinschaft [DFG INST371/5-1FUGG]; Inneruniversity and MAIFOR Mainz Support Program	German Cancer Aid(Deutsche Krebshilfe); Fritz Thyssen Foundation; Head and Neck Cancer Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Inneruniversity and MAIFOR Mainz Support Program	The authors thank Sandra Friedl for excellent technical assistance. This study was supported by grants from German Cancer Aid (FKZ102362), the Fritz Thyssen Foundation, the Head and Neck Cancer Foundation, Deutsche Forschungsgemeinschaft (DFG INST371/5-1FUGG), and the Inneruniversity and MAIFOR Mainz Support Program. The authors declare no conflicts of interest.	Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Bier C., 2012, CANCER RES, DOI [10.1158/0008-5472.CAN-12-0150, DOI 10.1158/0008-5472.CAN-12-0150]; Bier C, 2011, TRAFFIC, V12, P703, DOI 10.1111/j.1600-0854.2011.01191.x; Bier C, 2011, J BIOL CHEM, V286, P3007, DOI 10.1074/jbc.M110.161646; Chen DY, 2012, CANCER RES, V72, P736, DOI 10.1158/0008-5472.CAN-11-2584; Chen DY, 2010, CANCER RES, V70, P5358, DOI 10.1158/0008-5472.CAN-10-0027; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Engels K, 2007, J PATHOL, V211, P532, DOI 10.1002/path.2134; Ginter T, 2012, CELL SIGNAL, V24, P1453, DOI 10.1016/j.cellsig.2012.02.018; Hauske P, 2008, CHEMBIOCHEM, V9, P2920, DOI 10.1002/cbic.200800528; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Khan JA, 2005, STRUCTURE, V13, P1443, DOI 10.1016/j.str.2005.07.006; Knauer SK, 2007, CELL CYCLE, V6, P1502; Knauer SK, 2006, EMBO REP, V7, P1259, DOI 10.1038/sj.embor.7400824; Knauer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018253; Knauer SK, 2005, ANAL CHEM, V77, P4815, DOI 10.1021/ac050413o; Knauer SK, 2005, TRAFFIC, V6, P594, DOI 10.1111/j.1600-0854.2005.00298.x; Knauer SK, 2005, MOL CELL BIOL, V25, P2573, DOI 10.1128/MCB.25.7.2573-2582.2005; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Labisso WL, 2012, CELL CYCLE, V11, P1593, DOI 10.4161/cc.20008; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; Mitternacht S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002148; Molzan M, 2010, MOL CELL BIOL, V30, P4698, DOI 10.1128/MCB.01636-09; Ordonez Gonzalo R., 2009, V539, P33, DOI 10.1007/978-1-60327-003-8_2; Ottmann C, 2009, J MOL BIOL, V386, P913, DOI 10.1016/j.jmb.2009.01.005; Pless B, 2011, LEUKEMIA, V25, P663, DOI 10.1038/leu.2010.308; Rose R, 2010, ANGEW CHEM INT EDIT, V49, P4129, DOI 10.1002/anie.200907203; Saunders LP, 2008, MOL CANCER THER, V7, P3352, DOI 10.1158/1535-7163.MCT-08-0463; Schumacher B, 2010, FEBS LETT, V584, P1443, DOI 10.1016/j.febslet.2010.02.065; Shen XY, 2008, P NATL ACAD SCI USA, V105, P18788, DOI 10.1073/pnas.0810104105; Simard JR, 2009, J AM CHEM SOC, V131, P18478, DOI 10.1021/ja907795q; Sperandio O, 2010, DRUG DISCOV TODAY, V15, P220, DOI 10.1016/j.drudis.2009.11.007; Stauber RH, 2012, ONCOTARGET, V3, P31; Tanaka T, 2008, CELL CYCLE, V7, P1569, DOI 10.4161/cc.7.11.6061; Tenzer S, 2011, ACS NANO, V5, P7155, DOI 10.1021/nn201950e; Thiel P, 2012, ANGEW CHEM INT EDIT, V51, P2012, DOI 10.1002/anie.201107616; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Weber L, 2010, EXPERT OPIN THER PAT, V20, P179, DOI 10.1517/13543770903514129; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006; Zinzalla G, 2009, FUTURE MED CHEM, V1, P65, DOI [10.4155/fmc.09.12, 10.4155/FMC.09.12]; Zudaire E, 2011, United States patent US, Patent No. [WO2011/014825 A2, 2011014825]	44	18	18	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3421	3429		10.1096/fj.11-202432	http://dx.doi.org/10.1096/fj.11-202432			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22623586				2022-12-25	WOS:000307162800029
J	Meech, R; Rogers, A; Zhuang, LZ; Lewis, BC; Miners, JO; Mackenzie, PI				Meech, Robyn; Rogers, Anne; Zhuang, Lizhe; Lewis, Benjamin C.; Miners, John O.; Mackenzie, Peter I.			Identification of Residues That Confer Sugar Selectivity to UDP-Glycosyltransferase 3A (UGT3A) Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LIVER-MICROSOMES; GLUCURONOSYLTRANSFERASE 2B7; NOMENCLATURE UPDATE; CRYSTAL-STRUCTURE; GENE SUPERFAMILY; GLUCURONIC ACID; HUMAN BILIRUBIN; GLUCOSIDATION; SPECIFICITY; METABOLISM	Recent studies in this laboratory characterized the UGT3A family enzymes, UGT3A1 and UGT3A2, and showed that neither uses the traditional UDP-glycosyltransferase UGT co-substrate UDP-glucuronic acid. Rather, UGT3A1 uses GlcNAc as preferred sugar donor and UGT3A2 uses UDP-Glc. The enzymatic characterization of UGT3A mutants, structural modeling, and multispecies gene analysis have now been employed to identify a residue within the active site of these enzymes that confers their unique sugar preferences. An asparagine (Asn-391) in the UGT signature sequence of UGT3A1 is necessary for utilization of UDP-GlcNAc. Conversely, a phenylalanine (Phe-391) in UGT3A2 favors UDP-Glc use. Mutation of Asn-391 to Phe in UGT3A1 enhances its ability to utilize UDP-Glc and completely inhibits its ability to use UDP-GlcNAc. An analysis of homology models docked with UDP-sugar donors indicates that Asn-391 in UGT3A1 is able to accommodate the N-acetyl group on C2 of UDP-GlcNAc so that the anomeric carbon atom (C1) is optimally situated for catalysis involving His-35. Replacement of Asn with Phe at position 391 disrupts this catalytically productive orientation of UDP-GlcNAc but allows a more optimal alignment of UDP-Glc for sugar donation. Multispecies sequence analysis reveals that only primates possess UGT3A sequences containing Asn-391, suggesting that other mammals may not have the capacity to N-acetylglucosaminidate small molecules. In support of this hypothesis, Asn-391-containing UGT3A forms from two non-human primates were found to use UDP-GlcNAc, whereas UGT3A isoforms from non-primates could not use this sugar donor. This work gives new insight into the residues that confer sugar specificity to UGT family members and suggests a primate-specific innovation in glycosidation of small molecules.	[Meech, Robyn] Flinders Univ S Australia, Flinders Med Ctr, Sch Med, Dept Clin Pharmacol, Bedford Pk, SA 5042, Australia	Flinders Medical Centre; Flinders University South Australia	Meech, R (corresponding author), Flinders Univ S Australia, Flinders Med Ctr, Sch Med, Dept Clin Pharmacol, Bedford Pk, SA 5042, Australia.	robyn.meech@flinders.edu.au		Meech, Robyn/0000-0002-6831-0801; Lewis, Benjamin/0000-0002-3714-9381; Mackenzie, Peter/0000-0002-0697-6878; miners, john/0000-0001-9555-9453	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia.	Battaglia E, 1998, DRUG METAB DISPOS, V26, P812; Bosio A, 1996, GENOMICS, V34, P69, DOI 10.1006/geno.1996.0242; Bowalgaha K, 2005, BRIT J CLIN PHARMACO, V60, P423, DOI 10.1111/j.1365-2125.2005.02446.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Kubo A, 2004, ARCH BIOCHEM BIOPHYS, V429, P198, DOI 10.1016/j.abb.2004.06.021; Mackenzie P, 2003, BIOCHEM PHARMACOL, V65, P417, DOI 10.1016/S0006-2952(02)01522-8; MacKenzie PI, 2011, MOL PHARMACOL, V79, P472, DOI 10.1124/mol.110.069336; Mackenzie PI, 2008, J BIOL CHEM, V283, P36205, DOI 10.1074/jbc.M807961200; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Meech R, 1997, CLIN EXP PHARMACOL P, V24, P907, DOI 10.1111/j.1440-1681.1997.tb02718.x; Meech R, 2010, DRUG METAB REV, V42, P45, DOI 10.3109/03602530903205823; Miley MJ, 2007, J MOL BIOL, V369, P498, DOI 10.1016/j.jmb.2007.03.066; MINERS JO, 1991, PHARMACOL THERAPEUT, V51, P347, DOI 10.1016/0163-7258(91)90065-T; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Osmani SA, 2008, PLANT PHYSIOL, V148, P1295, DOI 10.1104/pp.108.128256; Patana AS, 2007, MOL PHARMACOL, V72, P604, DOI 10.1124/mol.107.036871; POWELL MJD, 1977, MATH PROGRAM, V12, P241, DOI 10.1007/BF01593790; Radominska-Pandya A, 1999, DRUG METAB REV, V31, P817, DOI 10.1081/DMR-100101944; Radominska-Pandya A, 2010, DRUG METAB REV, V42, P133, DOI 10.3109/03602530903209049; RITTER JK, 1992, J BIOL CHEM, V267, P3257; SENAFI SB, 1994, BIOCHEM J, V303, P233, DOI 10.1042/bj3030233; Tang CY, 2003, DRUG METAB DISPOS, V31, P37, DOI 10.1124/dmd.31.1.37; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Udomuksorn W, 2007, PHARMACOGENET GENOM, V17, P1017, DOI 10.1097/FPC.0b013e328256b1b6; Xiong Y, 2008, DRUG METAB DISPOS, V36, P517, DOI 10.1124/dmd.107.016469	28	24	24	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24122	24130		10.1074/jbc.M112.343608	http://dx.doi.org/10.1074/jbc.M112.343608			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22621930	hybrid, Green Published			2022-12-25	WOS:000306651100007
J	Nottingham, RM; Pusapati, GV; Ganley, IG; Barr, FA; Lambright, DG; Pfeffer, SR				Nottingham, Ryan M.; Pusapati, Ganesh V.; Ganley, Ian G.; Barr, Francis A.; Lambright, David G.; Pfeffer, Suzanne R.			RUTBC2 Protein, a Rab9A Effector and GTPase-activating Protein for Rab36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; HUMAN-CELLS; ENDOSOMES; FAMILY; DOMAIN; IDENTIFICATION; HYDROLYSIS; PATHWAY; COMPLEX; ATPASE	Rab GTPases regulate vesicle budding, motility, docking, and fusion. In cells, their cycling between active, GTP-bound states and inactive, GDP-bound states is regulated by the action of opposing enzymes called guanine nucleotide exchange factors and GTPase-activating proteins (GAPs). The substrates for most RabGAPs are unknown, and the potential for cross-talk between different membrane trafficking pathways remains uncharted territory. Rab9A and its effectors regulate recycling of mannose 6-phosphate receptors from late endosomes to the trans Golgi network. We show here that RUTBC2 is a TBC domain-containing protein that binds to Rab9A specifically both in vitro and in cultured cells but is not a GAP for Rab9A. Biochemical screening of Rab protein substrates for RUTBC2 revealed highest GAP activity toward Rab34 and Rab36. In cells, membrane-associated RUTBC2 co-localizes with Rab36, and expression of wild type RUTBC2, but not the catalytically inactive, RUTBC2 R829A mutant, decreases the amount of membrane-associated Rab36 protein. These data show that RUTBC2 can act as a Rab36 GAP in cells and suggest that RUTBC2 links Rab9A function to Rab36 function in the endosomal system.	[Nottingham, Ryan M.; Pusapati, Ganesh V.; Ganley, Ian G.; Pfeffer, Suzanne R.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Barr, Francis A.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Lambright, David G.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Stanford University; University of Oxford; University of Massachusetts System; University of Massachusetts Worcester	Pfeffer, SR (corresponding author), Stanford Univ, Dept Biochem, Sch Med, 279 Campus Dr,B400, Stanford, CA 94305 USA.	pfeffer@stanford.edu		Pusapati, Ganesh/0000-0002-1406-2566; Barr, Francis/0000-0001-7518-253X; Ganley, Ian/0000-0003-1481-9407	National Institutes of Health [DK37332, GM007276]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037332, R01DK037332, R37DK037332] Funding Source: NIH RePORTER; MRC [MC_UP_A500_1019] Funding Source: UKRI; Medical Research Council [MC_UP_A500_1019] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DK37332 (to S. R. P.).; Supported in part by National Institutes of Health Training Grant GM007276.	Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; Ausseil K, 2006, MOL GENET METAB, V87, P22, DOI 10.1016/j.ymgme.2005.09.021; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Callebaut I, 2001, TRENDS BIOCHEM SCI, V26, P79, DOI 10.1016/S0968-0004(00)01730-8; Chen L, 2010, MOL MEMBR BIOL, V27, P23, DOI 10.3109/09687680903417470; Diaz E, 1997, J CELL BIOL, V138, P283, DOI 10.1083/jcb.138.2.283; Espinosa EJ, 2009, CELL, V137, P938, DOI 10.1016/j.cell.2009.03.043; Federoff HJ, 2009, NEUROTOX RES, V16, P261, DOI 10.1007/s12640-009-9056-7; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Goldenberg NM, 2007, MOL BIOL CELL, V18, P4762, DOI 10.1091/mbc.E06-11-0991; Goldenberg NM, 2009, AM J PHYSIOL-CELL PH, V297, pC1053, DOI 10.1152/ajpcell.00286.2009; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Janoueix-Lerosey I, 1998, EUR J BIOCHEM, V252, P290, DOI 10.1046/j.1432-1327.1998.2520290.x; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Luo Y, 2008, J NEUROSCI, V28, P9277, DOI 10.1523/JNEUROSCI.3021-08.2008; Mori T, 1999, BIOCHEM BIOPH RES CO, V254, P594, DOI 10.1006/bbrc.1998.9968; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P243, DOI 10.1016/S0968-0004(97)01073-6; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; Nottingham RM, 2011, J BIOL CHEM, V286, P33213, DOI 10.1074/jbc.M111.261115; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Shutes A, 2005, METHODS, V37, P183, DOI 10.1016/j.ymeth.2005.05.019; Speight P, 2005, TRAFFIC, V6, P858, DOI 10.1111/j.1600-0854.2005.00321.x; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Wang TL, 2002, MOL BIOL CELL, V13, P4317, DOI 10.1091/mbc.E02-05-0280; Yang H, 2007, GENOMICS, V90, P249, DOI 10.1016/j.ygeno.2007.03.013; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047	37	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22740	22748		10.1074/jbc.M112.362558	http://dx.doi.org/10.1074/jbc.M112.362558			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22637480	Green Published, hybrid			2022-12-25	WOS:000306495000031
J	Blumenthal, A; Nagalingam, G; Huch, JH; Walker, L; Guillemin, GJ; Smythe, GA; Ehrt, S; Britton, WJ; Saunders, BM				Blumenthal, Antje; Nagalingam, Gayathri; Huch, Jennifer H.; Walker, Lara; Guillemin, Gilles J.; Smythe, George A.; Ehrt, Sabine; Britton, Warwick J.; Saunders, Bernadette M.			M-tuberculosis Induces Potent Activation of IDO-1, but This Is Not Essential for the Immunological Control of Infection	PLOS ONE			English	Article							REGULATORY T-CELLS; INTERFERON-GAMMA; INDOLEAMINE 2,3-DIOXYGENASE; PICOLINIC-ACID; ANTIMICROBIAL ACTIVITY; MACROPHAGE ACTIVATION; IMMUNE-RESPONSE; TRYPTOPHAN; INHIBITION; KYNURENINE	Indoleamine 2,3-dioxygenesae-1 (IDO-1) catalyses the initial, rate-limiting step in tryptophan metabolism, thereby regulating tryptophan availability and the formation of downstream metabolites, including picolinic and quinolinic acid. We found that Mycobacterium tuberculosis infection induced marked upregulation of IDO-1 expression in both human and murine macrophages in vitro and in the lungs of mice following aerosol challenge with M. tuberculosis. The absence of IDO-1 in dendritic cells enhanced the activation of mycobacteria-specific T cells in vitro. Interestingly, IDO-1-deficiency during M. tuberculosis infection in mice was not associated with altered mycobacteria-specific T cell responses in vivo. The bacterial burden of infected organs, pulmonary inflammatory responses, and survival were also comparable in M. tuberculosis-infected IDO-1 deficient and wild type animals. Tryptophan is metabolised into either picolinic acid or quinolinic acid, but only picolinic acid inhibited the growth of M. tuberculosis in vitro. By contrast macrophages infected with pathogenic mycobacteria, produced quinolinic, rather than picolinic acid, which did not reduce M. tuberculosis growth in vitro. Therefore, although M. tuberculosis induces robust expression of IDO-1 and activation of tryptophan metabolism, IDO-1-deficiency fails to impact on the immune control and the outcome of the infection in the mouse model of tuberculosis.	[Blumenthal, Antje; Ehrt, Sabine] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Blumenthal, Antje; Britton, Warwick J.; Saunders, Bernadette M.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Nagalingam, Gayathri; Huch, Jennifer H.; Walker, Lara] Centenary Inst Sydney, Mycobacterial Res Program, Sydney, NSW, Australia; [Guillemin, Gilles J.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW, Australia; [Smythe, George A.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Ehrt, Sabine] Cornell Univ, Program Immunol & Microbial Pathogenesis, Weill Grad Sch Med Sci, New York, NY 10021 USA; [Britton, Warwick J.; Saunders, Bernadette M.] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia	Cornell University; University of Queensland; University of Sydney; Centenary Institute; University of New South Wales Sydney; University of New South Wales Sydney; Cornell University; University of Sydney	Blumenthal, A (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA.	a.blumenthal@uq.edu.au; b.saunders@centenary.org.au	Guillemin, Gilles J/C-3878-2015; Blumenthal, Antje/A-3608-2011; Ehrt, Sabine/AAU-6449-2020	Guillemin, Gilles J/0000-0001-8105-4470; Blumenthal, Antje/0000-0003-3673-7015; Saunders, Bernadette/0000-0003-0540-4445; Britton, Warwick/0000-0001-6721-9646	Australian National Health and Medical Research Council; NSW state government; Australian Postgraduate Award; National Institutes of Health [HL68525]; I.T. Hirschl Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068525] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NSW state government; Australian Postgraduate Award(Australian Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); I.T. Hirschl Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Australian National Health and Medical Research Council and the NSW state government through its infrastructure grant to the Centenary 1 Institute. GN is a recipient of an Australian Postgraduate Award. This work was supported in part by National Institutes of Health grant HL68525 (to SE) and the I.T. Hirschl Trust (to SE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AS, 2009, J IMMUNOL, V183, P718, DOI 10.4049/jimmunol.0801212; Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; Ball HJ, 2009, INT J BIOCHEM CELL B, V41, P467, DOI 10.1016/j.biocel.2008.01.005; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; Blumenthal A, 2009, CELL HOST MICROBE, V5, P35, DOI 10.1016/j.chom.2008.12.002; Cai S, 2006, J ANTIMICROB CHEMOTH, V57, P85, DOI 10.1093/jac/dki418; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Cheng SC, 2010, J IMMUNOL, V185, P2450, DOI 10.4049/jimmunol.1000756; Clark CJ, 2005, INFECT IMMUN, V73, P5249, DOI 10.1128/IAI.73.8.5249-5251.2005; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Davies NWS, 2010, INT J TRYPTOPHAN RES, V3, P121; Demangel C, 1999, EUR J IMMUNOL, V29, P1972, DOI 10.1002/(SICI)1521-4141(199906)29:06<1972::AID-IMMU1972>3.0.CO;2-1; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Heller MC, 2010, VET IMMUNOL IMMUNOP, V138, P174, DOI 10.1016/j.vetimm.2010.07.013; JOHNSON GS, 1979, J BIOL CHEM, V254, P5483; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Li Q, 2011, IMMUNOL LETT, V138, P113, DOI 10.1016/j.imlet.2011.03.008; Li Q, 2011, CELL MOL IMMUNOL, V8, P172, DOI 10.1038/cmi.2010.80; MacKenzie CR, 1999, EUR J IMMUNOL, V29, P3254, DOI 10.1002/(SICI)1521-4141(199910)29:10&lt;3254::AID-IMMU3254&gt;3.0.CO;2-0; Maneglier B, 2009, FUND CLIN PHARMACOL, V23, P573, DOI 10.1111/j.1472-8206.2009.00703.x; Medana IM, 2002, J INFECT DIS, V185, P650, DOI 10.1086/339009; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Moreau M, 2005, J INFECT DIS, V192, P537, DOI 10.1086/431603; Muller A, 2009, J CELL MOL MED, V13, P1125, DOI 10.1111/j.1582-4934.2008.00542.x; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; MURRAY HW, 1989, INFECT IMMUN, V57, P845, DOI 10.1128/IAI.57.3.845-849.1989; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Narui K, 2009, BIOL PHARM BULL, V32, P41, DOI 10.1248/bpb.32.41; Ozeki Y, 2010, INT IMMUNOL, V22, P179, DOI 10.1093/intimm/dxp126; Pais TF, 2000, J IMMUNOL, V164, P389, DOI 10.4049/jimmunol.164.1.389; Pais TF, 2004, MICROBIOL-SGM, V150, P1507, DOI 10.1099/mic.0.26815-0; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Romani L, 2008, J IMMUNOL, V180, P5157, DOI 10.4049/jimmunol.180.8.5157; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Saunders BM, 2003, J IMMUNOL, V171, P5442, DOI 10.4049/jimmunol.171.10.5442; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Schroecksnadel K, 2003, J RHEUMATOL, V30, P1935; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; Smythe GA, 2002, ANAL BIOCHEM, V301, P21, DOI 10.1006/abio.2001.5490; Suzuki Y, 2012, CLIN VACCINE IMMUNOL, V19, P436, DOI 10.1128/CVI.05402-11; Tamura T, 2004, INT IMMUNOL, V16, P1691, DOI 10.1093/intimm/dxh170; VARESIO L, 1990, J IMMUNOL, V145, P4265; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Wozniak TM, 2010, INFECT IMMUN, V78, P4187, DOI 10.1128/IAI.01392-09	54	58	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37314	10.1371/journal.pone.0037314	http://dx.doi.org/10.1371/journal.pone.0037314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649518	Green Submitted, gold, Green Published			2022-12-25	WOS:000305335800036
J	Brown, J; Gedeon, T				Brown, Jacob; Gedeon, Tomas			Structure of the Afferent Terminals in Terminal Ganglion of a Cricket and Persistent Homology	PLOS ONE			English	Article							NEURAL MAP	We use topological data analysis to investigate the three dimensional spatial structure of the locus of afferent neuron terminals in crickets Acheta domesticus. Each afferent neuron innervates a filiform hair positioned on a cercus: a protruding appendage at the rear of the animal. The hairs transduce air motion to the neuron signal that is used by a cricket to respond to the environment. We stratify the hairs (and the corresponding afferent terminals) into classes depending on hair length, along with position. Our analysis uncovers significant structure in the relative position of these terminal classes and suggests the functional relevance of this structure. Our method is very robust to the presence of significant experimental and developmental noise. It can be used to analyze a wide range of other point cloud data sets.	[Brown, Jacob; Gedeon, Tomas] Montana State Univ, Dept Math Sci, Ctr Computat Biol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Brown, J (corresponding author), Montana State Univ, Dept Math Sci, Ctr Computat Biol, Bozeman, MT 59717 USA.	gedeon@math.montana.edu			NSF (National Science Foundation) [DMS-081878, CMMI-0849433]; Defense Advanced Research Project Agency (DARPA) [00001741/HR0011-09-1-0055]; Division Of Mathematical Sciences [0818785] Funding Source: National Science Foundation	NSF (National Science Foundation)(National Science Foundation (NSF)); Defense Advanced Research Project Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work has been partially supported by NSF (National Science Foundation) grants DMS-081878 and CMMI-0849433, and a Defense Advanced Research Project Agency (DARPA) grant 00001741/HR0011-09-1-0055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Edelsbrunner H, 2000, ANN IEEE SYMP FOUND, P454; Goodman JE, 2008, CONT MATH, V453, P257; Jacobs GA, 1996, J NEUROSCI, V16, P769; Jacobs GA, 2000, J NEUROSCI, V20, P2934; Kaczynski T., 2004, APPL MATH SCI; Lee AB, 2003, INT J COMPUT VISION, V54, P83, DOI 10.1023/A:1023705401078; Miller J., COMMUNICATION; Mrozek M, 2006, HOMOLOGY SOFTWARE WE; Mrozek M, 2010, COMPUTER MATH APPL, V60; Mrozek M, 2009, DISCRETE COMPUT GEOM, V41, P96, DOI 10.1007/s00454-008-9073-y; Mulder-Rosi J, 2010, J NEUROPHYSIOL, V103, P1823, DOI 10.1152/jn.00875.2009; Munkres J. R., 1984, ELEMENTS ALGEBRAIC T; Paydar S, 1999, J NEUROSCI, V19, P1771; Silverman BW., 1986, DENSITY ESTIMATION S, V26, DOI 10.1201/9781315140919; Storjohann A., 1996, ISSAC 96. Proceedings of the 1996 International Symposium on Symbolic and Algebraic Computation, P267, DOI 10.1145/236869.237084	16	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37278	10.1371/journal.pone.0037278	http://dx.doi.org/10.1371/journal.pone.0037278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649516	Green Published, gold			2022-12-25	WOS:000305335800034
J	El Helou, N; Tafflet, M; Berthelot, G; Tolaini, J; Marc, A; Guillaume, M; Hausswirth, C; Toussaint, JF				El Helou, Nour; Tafflet, Muriel; Berthelot, Geoffroy; Tolaini, Julien; Marc, Andy; Guillaume, Marion; Hausswirth, Christophe; Toussaint, Jean-Francois			Impact of Environmental Parameters on Marathon Running Performance	PLOS ONE			English	Article							ATHLETIC PERFORMANCE; EXERCISE PERFORMANCE; AIR-POLLUTION; ANTICIPATORY REDUCTION; AMBIENT-TEMPERATURE; HEAT; RUNNERS; COLD; DOMINANCE; TIME	Purpose: The objectives of this study were to describe the distribution of all runners' performances in the largest marathons worldwide and to determine which environmental parameters have the maximal impact. Methods: We analysed the results of six European (Paris, London, Berlin) and American (Boston, Chicago, New York) marathon races from 2001 to 2010 through 1,791,972 participants' performances (all finishers per year and race). Four environmental factors were gathered for each of the 60 races: temperature (degrees C), humidity (%), dew point (degrees C), and the atmospheric pressure at sea level (hPA); as well as the concentrations of four atmospheric pollutants: NO2 - SO2 - O-3 and PM10 (mu g.m(-3)). Results: All performances per year and race are normally distributed with distribution parameters (mean and standard deviation) that differ according to environmental factors. Air temperature and performance are significantly correlated through a quadratic model. The optimal temperatures for maximal mean speed of all runners vary depending on the performance level. When temperature increases above these optima, running speed decreases and withdrawal rates increase. Ozone also impacts performance but its effect might be linked to temperature. The other environmental parameters do not have any significant impact. Conclusions: The large amount of data analyzed and the model developed in this study highlight the major influence of air temperature above all other climatic parameter on human running capacity and adaptation to race conditions.	[El Helou, Nour; Tafflet, Muriel; Berthelot, Geoffroy; Tolaini, Julien; Marc, Andy; Guillaume, Marion; Toussaint, Jean-Francois] INSEP, IRMES, BioMed Res Inst Sports Epidemiol, Paris, France; [El Helou, Nour; Berthelot, Geoffroy; Marc, Andy; Toussaint, Jean-Francois] Univ Paris 05, Paris, France; [El Helou, Nour] Univ St Joseph, Fac Pharm, Dept Nutr, Beirut, Lebanon; [Tafflet, Muriel] Paris Cardiovasc Res Ctr PARCC, INSERM, U970, Paris, France; [Hausswirth, Christophe] INSEP, Res Dept, Paris, France; [Toussaint, Jean-Francois] Hop Hotel Dieu, AP HP, CIMS, F-75181 Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Saint Joseph University Beirut; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	El Helou, N (corresponding author), INSEP, IRMES, BioMed Res Inst Sports Epidemiol, Paris, France.	nour.elhelou@insep.fr	Helou, Nour El/AAH-6490-2021	Helou, Nour El/0000-0002-6012-0042				AirParif website, 2009, AIR POLL DAT PAR; Alvarez-Ramirez J, 2007, PHYSICA A, V380, P447, DOI 10.1016/j.physa.2007.03.008; Alvarez-Ramirez J, 2006, PHYSICA A, V365, P509, DOI 10.1016/j.physa.2005.09.066; Armstrong LE, 1996, MED SCI SPORT EXER, V28, pR1; Baker J, 2003, BRIT J SPORT MED, V37, P553, DOI 10.1136/bjsm.37.6.553; Beis LY, 2012, CLIN J SPORT MED, V22, P254, DOI 10.1097/JSM.0b013e31824a55d7; Berthelot G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008800; BUONCRISTIANI JF, 1983, CHANCE, V6, P24; Cheuvront SN, 2001, SPORTS MED, V31, P743, DOI 10.2165/00007256-200131100-00004; Chimenti L, 2009, J SPORT SCI, V27, P925, DOI 10.1080/02640410902946493; Coyle EF, 2007, SPORTS MED, V37, P306, DOI 10.2165/00007256-200737040-00009; Dawson NJ, 1987, T MENZIES FDN, V14, P41; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Ely MR, 2008, MED SCI SPORT EXER, V40, P1675, DOI 10.1249/MSS.0b013e3181788da9; Ely MR, 2007, MED SCI SPORT EXER, V39, P2029, DOI 10.1249/mss.0b013e318149f2c3; Ely MR, 2007, MED SCI SPORT EXER, V39, P487, DOI 10.1249/mss.0b013e31802d3aba; Galloway SDR, 1997, MED SCI SPORT EXER, V29, P1240, DOI 10.1097/00005768-199709000-00018; Gonzalez-Alonso J, 2007, SPORTS MED, V37, P371, DOI 10.2165/00007256-200737040-00025; Goulet EDB, 2011, BRIT J SPORT MED, V45, P1149, DOI 10.1136/bjsm.2010.077966; Hamilton B, 2000, BRIT J SPORT MED, V34, P391, DOI 10.1136/bjsm.34.5.391; Hargreaves M, 2008, J SCI MED SPORT, V11, P66, DOI 10.1016/j.jsams.2007.07.002; Kenefick RW, 2007, SPORTS MED, V37, P312, DOI 10.2165/00007256-200737040-00010; Kirschbaum MUF, 2011, FOREST ECOL MANAG, V262, P1008, DOI 10.1016/j.foreco.2011.05.036; Korrick SA, 1998, ENVIRON HEALTH PERSP, V106, P93, DOI 10.2307/3433784; Laaidi M, 2006, INT J BIOMETEOROL, V51, P145, DOI 10.1007/s00484-006-0045-8; Larsen HB, 2003, COMP BIOCHEM PHYS A, V136, P161, DOI 10.1016/S1095-6433(03)00227-7; Lippi G, 2008, INT J SPORTS MED, V29, P696, DOI 10.1055/s-2008-1038684; Lippi G, 2008, J PHYSIOL-LONDON, V586, P3017, DOI 10.1113/jphysiol.2008.155887; LondonAir website, 2009, AIR POLL DAT LOND; MacArthur D, 2005, HUM GENET, V116, P331, DOI 10.1007/s00439-005-1261-8; Marino FE, 2004, J APPL PHYSIOL, V96, P124, DOI 10.1152/japplphysiol.00582.2003; Marino FE, 2000, PFLUG ARCH EUR J PHY, V441, P359, DOI 10.1007/s004240000432; Marr LC, 2010, MED SCI SPORT EXER, V42, P585, DOI 10.1249/MSS.0b013e3181b84a85; Martin DE, 1999, CHANCE, V12, P20, DOI DOI 10.1080/09332480.1999.10542170; Maughan RJ, 2007, SPORTS MED, V37, P396, DOI 10.2165/00007256-200737040-00032; Montain SJ, 2007, SPORTS MED, V37, P320, DOI 10.2165/00007256-200737040-00012; Nimmo M, 2004, J SPORT SCI, V22, P898, DOI 10.1080/0264041400005883; Online worldwide athletic results database website, MAR RAC RES; Roberts WO, 2010, MED SCI SPORT EXER, V42, P226, DOI 10.1249/MSS.0b013e3181b1cdcf; Rundell KW, 2012, BR J SPORTS MED; Sawka MN, 2006, AM COLL SPORTS MED A; SHEPHARD RJ, 1984, CAN MED ASSOC J, V131, P105; Station Database of the Environmental Agency, 2009, AIR POLL BERL; Thibault V, 2010, J SPORT SCI MED, V9, P214; TRAPASSO LM, 1989, INT J BIOMETEOROL, V33, P233, DOI 10.1007/BF01051083; Tucker R, 2004, PFLUG ARCH EUR J PHY, V448, P422, DOI 10.1007/s00424-004-1267-4; Tucker R, 2006, J PHYSIOL-LONDON, V574, P905, DOI 10.1113/jphysiol.2005.101733; Vihma T, 2010, INT J BIOMETEOROL, V54, P297, DOI 10.1007/s00484-009-0280-x; Walters TJ, 2000, J APPL PHYSIOL, V89, P799, DOI 10.1152/jappl.2000.89.2.799; Weller AS, 1997, AM J PHYSIOL-REG I, V272, pR226, DOI 10.1152/ajpregu.1997.272.1.R226; Zeng LQ, 2009, COMP BIOCHEM PHYS A, V153, P125, DOI 10.1016/j.cbpa.2009.01.013; ZHANG SP, 1992, INT J BIOMETEOROL, V36, P63; Zouhal H, 2009, INT J SPORTS MED, V30, P516, DOI 10.1055/s-0029-1202350; Zouhal H, 2011, BRIT J SPORT MED, V45, P1101, DOI 10.1136/bjsm.2010.074641	54	96	101	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37407	10.1371/journal.pone.0037407	http://dx.doi.org/10.1371/journal.pone.0037407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649525	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800043
J	Hotte, NSC; Salim, SY; Tso, RH; Albert, EJ; Bach, P; Walker, J; Dieleman, LA; Fedorak, RN; Madsen, KL				Hotte, Naomi S. C.; Salim, Saad Y.; Tso, Robert H.; Albert, Eric J.; Bach, Phil; Walker, John; Dieleman, Levinus A.; Fedorak, Richard N.; Madsen, Karen L.			Patients with Inflammatory Bowel Disease Exhibit Dysregulated Responses to Microbial DNA	PLOS ONE			English	Article							TLR9 POLYMORPHISMS; CROHNS-DISEASE; RECEPTOR 9; MUCOSA; PROBIOTICS; COLITIS; MURINE; GENE	Background: A critical role for the gut epithelium lies in its ability to discriminate between pathogens and commensals and respond appropriately. Dysfunctional interactions between microbes and epithelia are believed to have a role in inflammatory bowel disease (IBD). In this study, we analyzed microbiota and gene expression in IBD patients and examined responses of mucosal biopsies to bacterial DNA. Methods: Biopsies were taken from non-inflamed areas of the colon in healthy controls (HC) and Crohn's disease (CD) and ulcerative colitis (UC) patients in remission. Biopsies were snap-frozen or cultured with DNA from Lactobacillus plantarum (LP) or Salmonella dublin (SD). Gene expression was analyzed under basal conditions and in response to DNA. Gene networks were analyzed using Ingenuity Pathways software. Mucosal-associated microbiota was analyzed using terminal restriction fragment length polymorphism. Frequency of single nucleotide polymorphisms in NOD2 and TLR9 was assessed. Results: Patients with IBD had altered microbiota, enhanced expression of inflammatory genes, and increased correlations between specific gene expression and microbes. Principle component analysis showed CD and UC patients to cluster independently from healthy controls in both gene expression and microbial analysis. DNA from LP stimulated anti-inflammatory pathways in controls and UC patients, but induced an upregulation of IL17A in CD patients. There were no differences in SNP frequencies of TLR9 or NOD2 in the groups. Conclusions: Patients with Crohn's disease exhibit altered responses to bacterial DNA. These findings suggest that the gut response to bacterial DNA may depend not only on the specific type of bacterial DNA, but also on the host.	[Hotte, Naomi S. C.; Salim, Saad Y.; Tso, Robert H.; Albert, Eric J.; Bach, Phil; Walker, John; Dieleman, Levinus A.; Fedorak, Richard N.; Madsen, Karen L.] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Alberta	Hotte, NSC (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	karen.madsen@ualberta.ca	Salim, Saad/C-6470-2013; Madsen, Karen L/H-5898-2011; Dieleman, Levinus/AAT-8198-2021	Salim, Saad/0000-0002-6036-3589; Fedorak, Richard/0000-0002-7382-0080; Dieleman, Levinus/0000-0001-7852-2122	Canadian Institutes for Health Research; Crohns and Colitis Foundation of Canada; Alberta Innovates; Alberta IBD Consortium	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Crohns and Colitis Foundation of Canada; Alberta Innovates; Alberta IBD Consortium	Canadian Institutes for Health Research, http://www.cihr-irsc.gc.ca; Crohns and Colitis Foundation of Canada, http://www.ccfc.ca; Alberta Innovates, http://www.albertainnovates.ca; Alberta IBD Consortium, http://albertaibdconsortium.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Campeau J, 2010, GASTROENTEROLOGY; Chen GY, 2011, GASTROENTEROLOGY; Chen KH, 2011, BRIT J SURG, V98, P1252, DOI 10.1002/bjs.7532; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Hedin C, 2007, P NUTR SOC, V66, P307, DOI 10.1017/S0029665107005563; Hong J, 2007, J GASTROEN HEPATOL, V22, P1760, DOI 10.1111/j.1440-1746.2006.04727.x; Jijon H, 2004, GASTROENTEROLOGY, V126, P1358, DOI 10.1053/j.gastro.2004.02.003; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319; Kingma SDK, 2011, J NUTR, V141, P1023, DOI 10.3945/jn.110.135517; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Nishikawa J, 2009, SCAND J GASTROENTERO, V44, P180, DOI 10.1080/00365520802433231; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Sam-Agudu NA, 2010, AM J TROP MED HYG, V82, P548, DOI 10.4269/ajtmh.2010.09-0467; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Torok P, 2009, AM J GASTROENTEROL, V104, P1723, DOI 10.1038/ajg.2009.184; Torok HP, 2004, CLIN IMMUNOL, V112, P85, DOI 10.1016/j.clim.2004.03.002; Torok HP, 2004, GASTROENTEROLOGY, V127, P365, DOI 10.1053/j.gastro.2004.05.051; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	24	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37932	10.1371/journal.pone.0037932	http://dx.doi.org/10.1371/journal.pone.0037932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649567	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335800087
J	Koide, T; Banno, M; Aleksic, B; Yamashita, S; Kikuchi, T; Kohmura, K; Adachi, Y; Kawano, N; Kushima, I; Nakamura, Y; Okada, T; Ikeda, M; Ohi, K; Yasuda, Y; Hashimoto, R; Inada, T; Ujike, H; Iidaka, T; Suzuki, M; Takeda, M; Iwata, N; Ozaki, N				Koide, Takayoshi; Banno, Masahiro; Aleksic, Branko; Yamashita, Saori; Kikuchi, Tsutomu; Kohmura, Kunihiro; Adachi, Yasunori; Kawano, Naoko; Kushima, Itaru; Nakamura, Yukako; Okada, Takashi; Ikeda, Masashi; Ohi, Kazutaka; Yasuda, Yuka; Hashimoto, Ryota; Inada, Toshiya; Ujike, Hiroshi; Iidaka, Tetsuya; Suzuki, Michio; Takeda, Masatoshi; Iwata, Nakao; Ozaki, Norio			Common Variants in MAGI2 Gene Are Associated with Increased Risk for Cognitive Impairment in Schizophrenic Patients	PLOS ONE			English	Article							CARD SORTING TEST; BIPOLAR DISORDER; HERITABILITY; POPULATION; LINKAGE; LOCALIZATION; PLASTICITY; PROTEINS; ABILITY; GWAS	Schizophrenia is a complex psychiatric disorder characterized by positive symptoms, negative symptoms, and cognitive impairment. MAGI2, a relatively large gene (similar to 1.5 Mbps) that maps to chromosome 7q21, is involved in recruitment of neurotransmitter receptors such as AMPA- and NMDA-type glutamate receptors. A genetic association study designed to evaluate the association between MAGI2 and cognitive performance or schizophrenia has not been conducted. In this case-control study, we examined the relationship of single nucleotide polymorphism (SNP) variations in MAGI2 and risk for schizophrenia in a large Japanese sample and explored the potential relationships between variations in MAGI2 and aspects of human cognitive function related to glutamate activity. Based on the result of first schizophrenia genome-wide association study in a Japanese population (JGWAS), we selected four independent SNPs and performed an association study using a large independent Japanese sample set (cases 1624, controls 1621). Wisconsin Card Sorting Test (WCST) was used to evaluate executive function in 114 cases and 91 controls. We found suggestive evidence for genetic association of common SNPs within MAGI2 locus and schizophrenia in Japanese population. Furthermore in terms of association between MAGI2 and cognitive performance, we observed that genotype effect of rs2190665 on WCST score was significant (p = 0.034) and rs4729938 trended toward significance (p = 0.08). In conclusion, although we could not detect strong genetic evidence for association of common variants in MAGI2 and increased schizophrenia risk in a Japanese population, these SNPs may increase risk of cognitive impairment in schizophrenic patients.	[Koide, Takayoshi; Banno, Masahiro; Aleksic, Branko; Yamashita, Saori; Kikuchi, Tsutomu; Kohmura, Kunihiro; Adachi, Yasunori; Kawano, Naoko; Kushima, Itaru; Nakamura, Yukako; Okada, Takashi; Iidaka, Tetsuya; Ozaki, Norio] Nagoya Univ, Dept Psychiat, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan; [Ohi, Kazutaka; Yasuda, Yuka; Hashimoto, Ryota; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan; [Hashimoto, Ryota; Takeda, Masatoshi] Kanazawa Univ, Mol Res Ctr Childrens Mental Dev, United Grad Sch Child Dev, Osaka Univ, Osaka, Japan; [Hashimoto, Ryota; Takeda, Masatoshi] Hamamatsu Univ Grad Sch Med, Osaka, Japan; [Inada, Toshiya] Seiwa Hosp, Inst Neuropsychiat, Dept Psychiat, Tokyo, Japan; [Ujike, Hiroshi] Okayama Univ, Grad Sch Med & Dent, Dept Neuropsychiat, Okayama, Japan; [Suzuki, Michio] Toyama Univ, Dept Neuropsychiat, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Koide, Takayoshi; Banno, Masahiro; Aleksic, Branko; Yamashita, Saori; Kikuchi, Tsutomu; Kohmura, Kunihiro; Adachi, Yasunori; Kawano, Naoko; Kushima, Itaru; Nakamura, Yukako; Okada, Takashi; Ohi, Kazutaka; Yasuda, Yuka; Hashimoto, Ryota; Iidaka, Tetsuya; Iwata, Nakao; Ozaki, Norio] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Nagoya University; Fujita Health University; Osaka University; Kanazawa University; Osaka University; Okayama University; University of Toyama; Japan Science & Technology Agency (JST)	Koide, T (corresponding author), Nagoya Univ, Dept Psychiat, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	branko@med.nagoya-u.ac.jp	Banno, Masahiro/E-5341-2010; nakamura, yukako/M-8889-2014; Aleksic, Branko/G-1540-2011; Iidaka, Tetsuya/M-8847-2014; Hashimoto, Ryota/AAE-3200-2019; Ohi, Kazutaka/J-7851-2019; Ozaki, Norio/M-8908-2014; Hashimoto, Ryota/P-8572-2014; KUSHIMA, Itaru/M-8872-2014; Aleksic, Branko/L-7851-2019; OKADA, Takashi/M-8902-2014	Banno, Masahiro/0000-0002-2539-1031; nakamura, yukako/0000-0002-3306-7127; Aleksic, Branko/0000-0001-8982-4580; Iidaka, Tetsuya/0000-0002-6199-8711; Hashimoto, Ryota/0000-0002-5941-4238; Ohi, Kazutaka/0000-0001-9577-9640; Ozaki, Norio/0000-0002-7360-4898; Hashimoto, Ryota/0000-0002-5941-4238; Aleksic, Branko/0000-0001-8982-4580; Ikeda, Masashi/0000-0001-6237-2449; Inada, Toshiya/0000-0002-8427-5639; OKADA, Takashi/0000-0001-5580-9913; Kushima, Itaru/0000-0002-0018-5178	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Science, Sports and Culture of Japan; Comparative Cognitive Science Institutes; Core Research for Evolutional Science and Technology; Grants-in-Aid for Scientific Research [22390225] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Comparative Cognitive Science Institutes; Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding for this study was provided by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/english/); The Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/english/); Grant-in-Aid for "Integrated research on neuropsychiatric disorder'' carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://brainprogram.mext.go.jp/); Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan (https://www.hokatsu-nou.nips.ac.jp/); The Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes (http://www.meijo-u.ac.jp/sougou/gakujutsu/hitech.html); and the Core Research for Evolutional Science and Technology (http://www.jst.go.jp/kisoken/crest/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksic B, 2010, SCHIZOPHR RES, V118, P113, DOI 10.1016/j.schres.2010.01.014; Anderson CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000580; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Burdick KE, 2010, AM J PSYCHIAT, V167, P436, DOI 10.1176/appi.ajp.2009.09050615; Burdick KE, 2006, HUM MOL GENET, V15, P1563, DOI 10.1093/hmg/ddi481; Chou LN, 2010, BEHAV GENET, V40, P22, DOI 10.1007/s10519-009-9299-3; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Emtage L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004613; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; GOLDBERG TE, 1990, ARCH GEN PSYCHIAT, V47, P1066; Green MF, 2006, J CLIN PSYCHIAT, V67, P3, DOI 10.4088/JCP.1006e12; Heaton, 1981, WISCONSIN CARD SORTI; Heaton R.K., 1993, WISCONSIN CARD SORTI; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hori H, 2006, SCHIZOPHR RES, V86, P138, DOI 10.1016/j.schres.2006.05.004; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Inagaki A, 2010, JPN J CLIN PSYCHOPHA, V13, P1349; Inagaki A, 2008, JPN J CLIN PSYCHOPHA, V11, P887; Kashima H, 1987, NEUROPSYCHOLOGICAL I; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kremen WS, 2007, AM J MED GENET B, V144B, P403, DOI 10.1002/ajmg.b.30527; Krystal JH, 2002, ARCH GEN PSYCHIAT, V59, P663, DOI 10.1001/archpsyc.59.7.663; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Sassoe-Pognetto M, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00004; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stetak A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006019; Suzuki H, 2011, PROG NEURO-PSYCHOPH, V35, P161, DOI 10.1016/j.pnpbp.2010.10.021; Taylor J, 2007, TWIN RES HUM GENET, V10, P829, DOI 10.1375/twin.10.6.829; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yamada A, 2003, GENES CELLS, V8, P985, DOI 10.1046/j.1356-9597.2003.00690.x	40	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36836	10.1371/journal.pone.0036836	http://dx.doi.org/10.1371/journal.pone.0036836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649501	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335800018
J	Sibole, SC; Erdemir, A				Sibole, Scott C.; Erdemir, Ahmet			Chondrocyte Deformations as a Function of Tibiofemoral Joint Loading Predicted by a Generalized High-Throughput Pipeline of Multi-Scale Simulations	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; HUMAN ARTICULAR-CARTILAGE; CELL-MATRIX INTERACTIONS; PERICELLULAR MATRIX; MECHANICAL-PROPERTIES; KNEE-JOINT; BEHAVIOR; STRESS; STRAIN; AGE	Cells of the musculoskeletal system are known to respond to mechanical loading and chondrocytes within the cartilage are not an exception. However, understanding how joint level loads relate to cell level deformations, e. g. in the cartilage, is not a straightforward task. In this study, a multi-scale analysis pipeline was implemented to post-process the results of a macro-scale finite element (FE) tibiofemoral joint model to provide joint mechanics based displacement boundary conditions to micro-scale cellular FE models of the cartilage, for the purpose of characterizing chondrocyte deformations in relation to tibiofemoral joint loading. It was possible to identify the load distribution within the knee among its tissue structures and ultimately within the cartilage among its extracellular matrix, pericellular environment and resident chondrocytes. Various cellular deformation metrics (aspect ratio change, volumetric strain, cellular effective strain and maximum shear strain) were calculated. To illustrate further utility of this multi-scale modeling pipeline, two micro-scale cartilage constructs were considered: an idealized single cell at the centroid of a 100 x 100 x 100 mm block commonly used in past research studies, and an anatomically based (11 cell model of the same volume) representation of the middle zone of tibiofemoral cartilage. In both cases, chondrocytes experienced amplified deformations compared to those at the macro-scale, predicted by simulating one body weight compressive loading on the tibiofemoral joint. In the 11 cell case, all cells experienced less deformation than the single cell case, and also exhibited a larger variance in deformation compared to other cells residing in the same block. The coupling method proved to be highly scalable due to micro-scale model independence that allowed for exploitation of distributed memory computing architecture. The method's generalized nature also allows for substitution of any macro-scale and/or micro-scale model providing application for other multi-scale continuum mechanics problems.	[Sibole, Scott C.] Cleveland Clin, Computat Biomodeling CoBi Core, Lerner Res Inst, Cleveland, OH 44106 USA; Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sibole, SC (corresponding author), Cleveland Clin, Computat Biomodeling CoBi Core, Lerner Res Inst, Cleveland, OH 44106 USA.	erdemira@ccf.org		Erdemir, Ahmet/0000-0002-4629-8055; Sibole, Scott/0000-0003-2260-8167	National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health [R01EB009643]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009643] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the grant R01EB009643 provided by the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health (http://www.nibib.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusara Z, 2011, J BIOMECH, V44, P930, DOI 10.1016/j.jbiomech.2010.11.031; Alexopoulos LG, 2005, ACTA BIOMATER, V1, P317, DOI 10.1016/j.actbio.2005.02.001; Alexopoulos LG, 2003, J BIOMECH ENG-T ASME, V125, P323, DOI 10.1115/1.1579047; Barela AMF, 2008, J ELECTROMYOGR KINES, V18, P446, DOI 10.1016/j.jelekin.2006.10.008; Breuls RGM, 2002, J BIOMECH ENG-T ASME, V124, P198, DOI 10.1115/1.1449492; BUTLER DL, 1990, J BIOMECH ENG-T ASME, V112, P38, DOI 10.1115/1.2891124; Cao L, 2009, CELL MOL BIOENG, V2, P306, DOI 10.1007/s12195-009-0081-7; Charlebois M, 2004, J BIOMECH ENG-T ASME, V126, P129, DOI 10.1115/1.1688771; Chen CS, 1999, OSTEOARTHR CARTILAGE, V7, P81, DOI 10.1053/joca.1998.0164; Donahue TLH, 2002, J BIOMECH ENG-T ASME, V124, P273, DOI 10.1115/1.1470171; Donkelaar CC, 2011, BIOMECHANIC IN PRESS; Erdemir A, 2011, 23 C INT SOC BIOM BR; Erdemir A, OPEN KNEE 3 DIMENSIO; FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19; Gardiner JC, 2003, J ORTHOP RES, V21, P1098, DOI 10.1016/S0736-0266(03)00113-X; Guilak F, 2005, ANN BIOMED ENG, V33, P1312, DOI 10.1007/s10439-005-4479-7; Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6; Guillen T, 2011, J MECH BEHAV BIOMED, V4, P1452, DOI 10.1016/j.jmbbm.2011.05.015; Halloran JP, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005333; Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198; Herzog W, 2006, BIOMECH MODEL MECHAN, V5, P64, DOI 10.1007/s10237-006-0029-y; Hofer JK, 2011, J ARTHROPLA IN PRESS; Hsieh CH, 2008, OSTEOARTHR CARTILAGE, V16, P480, DOI 10.1016/j.joca.2007.08.004; Hudelmaier M, 2001, ARTHRITIS RHEUM, V44, P2556, DOI 10.1002/1529-0131(200111)44:11<2556::AID-ART436>3.0.CO;2-U; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814; Karamanidis K, 2009, ANN BIOMED ENG, V37, P467, DOI 10.1007/s10439-008-9624-7; Kazemi M, 2011, J MECH BEHAV BIOMED, V4, P1351, DOI 10.1016/j.jmbbm.2011.05.004; Kim HA, 2000, J RHEUMATOL, V27, P455; Kolahi KS, 2010, WIRES SYST BIOL MED, V2, P625, DOI 10.1002/wsbm.79; Korhonen Rami K., 2010, Molecular & Cellular Biomechanics, V7, P125; Kouznetsova VG, 2004, COMPUT METHOD APPL M, V193, P5525, DOI 10.1016/j.cma.2003.12.073; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Maas S, 2010, FEBIO THEORY MANUAL; Maas S, 2009, COMP FEBIO ABAQUS NI; Mackerle Jaroslav, 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P149, DOI 10.1080/10255840600751523; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; MEACHIM G, 1962, ANN RHEUM DIS, V21, P45, DOI 10.1136/ard.21.1.45; MESSIER SP, 1994, MED SCI SPORT EXER, V26, P1446; Michalek AJ, 2007, J BIOMECH, V40, P1405, DOI 10.1016/j.jbiomech.2006.05.025; Peeters EAG, 2004, ANN BIOMED ENG, V32, P1443, DOI 10.1114/B:ABME.0000042231.59230.72; Pena E, 2006, J BIOMECH, V39, P1686, DOI 10.1016/j.jbiomech.2005.04.030; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Ramage L, 2009, SCAND J MED SCI SPOR, V19, P457, DOI 10.1111/j.1600-0838.2009.00912.x; RYU J, 1984, ARTHRITIS RHEUM, V27, P49, DOI 10.1002/art.1780270109; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Shepherd DET, 1999, RHEUMATOLOGY, V38, P124, DOI 10.1093/rheumatology/38.2.124; SOKABE M, 1991, BIOPHYS J, V59, P722, DOI 10.1016/S0006-3495(91)82285-8; Temple MM, 2007, OSTEOARTHR CARTILAGE, V15, P1042, DOI 10.1016/j.joca.2007.03.005; Tetsunaga T, 2011, OSTEOARTHR CARTILAGE, V19, P222, DOI 10.1016/j.joca.2010.11.004; TISSAKHT M, 1995, J BIOMECH, V28, P411, DOI 10.1016/0021-9290(94)00081-E; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wang P, 2011, FASEB J, V25, P3401, DOI 10.1096/fj.11-184861; Weiss JA, 1996, COMPUT METHOD APPL M, V135, P107, DOI 10.1016/0045-7825(96)01035-3; Wilson W, 2005, MED ENG PHYS, V27, P810, DOI 10.1016/j.medengphy.2005.03.004; Worsley P, 2011, GAIT POSTURE, V33, P268, DOI 10.1016/j.gaitpost.2010.11.018; Yang NH, 2010, J ORTHOP RES, V28, P1539, DOI 10.1002/jor.21174; Yao J, 2006, J BIOMECH ENG-T ASME, V128, P135, DOI 10.1115/1.2132373; Yutani Yasutaka, 1996, Osaka City Medical Journal, V42, P37	58	34	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37538	10.1371/journal.pone.0037538	http://dx.doi.org/10.1371/journal.pone.0037538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649535	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800054
J	Tomotani, BM; Flores, DEFL; Tachinardi, P; Paliza, JD; Oda, GA; Valentinuzzi, VS				Tomotani, Barbara M.; Flores, Danilo E. F. L.; Tachinardi, Patricia; Paliza, Jose D.; Oda, Gisele A.; Valentinuzzi, Veronica S.			Field and Laboratory Studies Provide Insights into the Meaning of Day-Time Activity in a Subterranean Rodent (Ctenomys aff. knighti), the Tuco-Tuco	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; LOCOMOTOR-ACTIVITY; MOLE-RATS; BEHAVIORAL ACTIVITY; ACTIVITY PATTERNS; TALARUM RODENTIA; MONTE DESERT; TEMPERATURE; ENTRAINMENT; MASKING	South American subterranean rodents (Ctenomys aff. knighti), commonly known as tuco-tucos, display nocturnal, wheel-running behavior under light-dark (LD) conditions, and free-running periods >24 h in constant darkness (DD). However, several reports in the field suggested that a substantial amount of activity occurs during daylight hours, leading us to question whether circadian entrainment in the laboratory accurately reflects behavior in natural conditions. We compared circadian patterns of locomotor activity in DD of animals previously entrained to full laboratory LD cycles (LD12:12) with those of animals that were trapped directly from the field. In both cases, activity onsets in DD immediately reflected the previous dark onset or sundown. Furthermore, freerunning periods upon release into DD were close to 24 h indicating aftereffects of prior entrainment, similarly in both conditions. No difference was detected in the phase of activity measured with and without access to a running wheel. However, when individuals were observed continuously during daylight hours in a semi-natural enclosure, they emerged above-ground on a daily basis. These day-time activities consisted of foraging and burrow maintenance, suggesting that the designation of this species as nocturnal might be inaccurate in the field. Our study of a solitary subterranean species suggests that the circadian clock is entrained similarly under field and laboratory conditions and that day-time activity expressed only in the field is required for foraging and may not be time-dictated by the circadian pacemaker.	[Tomotani, Barbara M.; Flores, Danilo E. F. L.; Tachinardi, Patricia; Oda, Gisele A.] Univ Sao Paulo, Dept Fisiol, Inst Biociencias, Sao Paulo, Brazil; [Paliza, Jose D.; Valentinuzzi, Veronica S.] Ctr Reg Invest Cient & Transferencia Tecnol CRILA, Anillaco, La Rioja, Argentina	Universidade de Sao Paulo	Tomotani, BM (corresponding author), Univ Sao Paulo, Dept Fisiol, Inst Biociencias, Sao Paulo, Brazil.	gaoda@ib.usp.br; vvalentinuzzi@crilar-conicet.gob.ar	Mizumo Tomotani, Barbara/A-5600-2013; oda, gisele a/F-4283-2012	Mizumo Tomotani, Barbara/0000-0002-8855-4803; oda, gisele a/0000-0001-7776-5368; Eugenio de Franca Laurindo Flores, Danilo/0000-0003-1770-3581	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) [PIP-11420090100252]; CRILAR (Centro Regional de Investigaciones Cientificas y Transferencia Tecnologica); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2008/55035-5, 2010/502221]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [130021/2009-1]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CRILAR (Centro Regional de Investigaciones Cientificas y Transferencia Tecnologica); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas, grant PIP-11420090100252), CRILAR (Centro Regional de Investigaciones Cientificas y Transferencia Tecnologica), FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grants 2008/55035-5, 2010/502221), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, 130021/2009-1) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2009, J ARID ENVIRON, V73, P144, DOI 10.1016/j.jaridenv.2008.09.028; Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Aton SJ, 2004, J BIOL RHYTHM, V19, P198, DOI 10.1177/0748730404264156; Beaule C, 2011, J BIOL RHYTHM, V26, P561, DOI 10.1177/0748730411416329; Bidau C, 2006, MAMIFEROS ARGENTINA, P219; Blanchong JA, 1999, J BIOL RHYTHM, V14, P364, DOI 10.1177/074873099129000777; Buffenstein R, 2000, LIFE UNDERGROUND BIO, P183; Burda H, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P21, DOI 10.1007/978-3-540-69276-8_3; Busch C, 2000, LIFE UNDERGROUND, P183; Cohen R, 2010, J BIOL RHYTHM, V25, P47, DOI 10.1177/0748730409351672; Cook JA, 1998, EVOLUTION, V52, P1521, DOI 10.1111/j.1558-5646.1998.tb02035.x; Cutrera AP, 2006, J MAMMAL, V87, P1183, DOI 10.1644/05-MAMM-A-386R1.1; Daan S., 1981, HDB BEHAVIOURAL NEUR, P275, DOI DOI 10.1007/978-1-4615-6552-9_15; Daan S, 2011, J BIOL RHYTHM, V26, P118, DOI 10.1177/0748730410397645; DECOURSEY PJ, 1986, J COMP PHYSIOL A, V159, P161, DOI 10.1007/BF00612299; Erkert HG, 2006, FOLIA PRIMATOL, V77, P87, DOI 10.1159/000089697; Fracchia S, 2011, J ARID ENVIRON, V75, P1016, DOI 10.1016/j.jaridenv.2011.04.034; Goldman BD, 1997, J BIOL RHYTHM, V12, P348, DOI 10.1177/074873049701200407; Gritton HJ, 2009, BEHAV NEUROSCI, V123, P937, DOI 10.1037/a0017128; Houben T, 2009, J BIOL RHYTHM, V24, P477, DOI 10.1177/0748730409349895; Hut RA, 1999, J BIOL RHYTHM, V14, P290, DOI 10.1177/074873099129000704; Hut RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017527; Chiesa JJ, 2010, J BIOL RHYTHM, V25, P277, DOI 10.1177/0748730410376159; Kas MJH, 1999, J NEUROSCI, V19, P328, DOI 10.1523/JNEUROSCI.19-01-00328.1999; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Kronfeld-Schor N, 2008, BIOL RHYTHM RES, V39, P193, DOI 10.1080/09291010701683268; Levy O, 2007, CHRONOBIOL INT, V24, P599, DOI 10.1080/07420520701534640; Luna F, 2002, CAN J ZOOL, V80, P2144, DOI 10.1139/Z02-201; Luna F, 2006, CAN J ZOOL, V84, P661, DOI 10.1139/Z06-040; MARIMUTHU G, 1981, BEHAV ECOL SOCIOBIOL, V8, P147, DOI 10.1007/BF00300827; MARQUES MD, 1994, CHRONOBIOL INT, V11, P146, DOI 10.3109/07420529409057234; MOORE RY, 1983, FED PROC, V42, P2783; Mrosovsky N, 2005, J COMP PHYSIOL A, V191, P1011, DOI 10.1007/s00359-005-0017-1; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Oosthuizen MK, 2003, J BIOL RHYTHM, V18, P481, DOI 10.1177/0748730403259109; Page TL, 1997, J BIOL RHYTHM, V12, P218, DOI 10.1177/074873049701200303; Pittendrigh C.S., 1981, BIOL CLOCKS SEASONAL, P1; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Rezende EL, 2003, J ARID ENVIRON, V55, P63, DOI 10.1016/S0140-1963(02)00259-8; Riccio AP, 2000, PHYSIOL BEHAV, V71, P1, DOI 10.1016/S0031-9384(00)00281-X; Valentinuzzi VS, 2009, CHRONOBIOL INT, V26, P14, DOI 10.1080/07420520802686331; Schleich CE, 2007, ETHOLOGY, V113, P573, DOI 10.1111/j.1439-0310.2007.01352.x; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smale L, 2003, J BIOL RHYTHM, V18, P356, DOI 10.1177/0748730403256651; VASSALLO AI, 1994, J MAMMAL, V75, P725, DOI 10.2307/1382522; Vivanco P, 2010, CHRONOBIOL INT, V27, P517, DOI 10.3109/07420521003743660	47	44	49	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37918	10.1371/journal.pone.0037918	http://dx.doi.org/10.1371/journal.pone.0037918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649565	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800085
J	Macanas-Pirard, P; Leisewitz, A; Broekhuizen, R; Cautivo, K; Barriga, FM; Leisewitz, F; Gidi, V; Riquelme, E; Montecinos, VP; Swett, P; Besa, P; Ramirez, P; Ocqueteau, M; Kalergis, AM; Holt, M; Rettig, M; DiPersio, JF; Nervi, B				Macanas-Pirard, Patricia; Leisewitz, Andrea; Broekhuizen, Richard; Cautivo, Kelly; Barriga, Francisco M.; Leisewitz, Francisco; Gidi, Victoria; Riquelme, Erick; Montecinos, Viviana P.; Swett, Pilar; Besa, Pelayo; Ramirez, Pablo; Ocqueteau, Mauricio; Kalergis, Alexis M.; Holt, Matthew; Rettig, Michael; DiPersio, John F.; Nervi, Bruno			Bone Marrow Stromal Cells Modulate Mouse ENT1 Activity and Protect Leukemia Cells from Cytarabine Induced Apoptosis	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; MULTIDRUG-RESISTANCE PROTEIN-1; ACUTE MYELOGENOUS LEUKEMIA; HEMATOPOIETIC STEM-CELLS; ARA-C; DEOXYCYTIDINE KINASE; CYTOSINE-ARABINOSIDE; DRUG-RESISTANCE; CXCR4; MICROENVIRONMENT	Background: Despite a high response rate to chemotherapy, the majority of patients with acute myeloid leukemia (AML) are destined to relapse due to residual disease in the bone marrow (BM). The tumor microenvironment is increasingly being recognized as a critical factor in mediating cancer cell survival and drug resistance. In this study, we propose to identify mechanisms involved in the chemoprotection conferred by the BM stroma to leukemia cells. Methods: Using a leukemia mouse model and a human leukemia cell line, we studied the interaction of leukemia cells with the BM microenvironment. We evaluated in vivo and in vitro leukemia cell chemoprotection to different cytotoxic agents mediated by the BM stroma. Leukemia cell apoptosis was assessed by flow cytometry and western blotting. The activity of the equilibrative nucleoside transporter 1 (ENT1), responsible for cytarabine cell incorporation, was investigated by measuring transport and intracellular accumulation of H-3-adenosine. Results: Leukemia cell mobilization from the bone marrow into peripheral blood in vivo using a CXCR4 inhibitor induced chemo-sensitization of leukemia cells to cytarabine, which translated into a prolonged survival advantage in our mouse leukemia model. In vitro, the BM stromal cells secreted a soluble factor that mediated significant chemoprotection to leukemia cells from cytarabine induced apoptosis. Furthermore, the BM stromal cell supernatant induced a 50% reduction of the ENT1 activity in leukemia cells, reducing the incorporation of cytarabine. No protection was observed when radiation or other cytotoxic agents such as etoposide, cisplatin and 5-fluorouracil were used. Conclusion: The BM stroma secretes a soluble factor that significantly protects leukemia cells from cytarabine-induced apoptosis and blocks ENT1 activity. Strategies that modify the chemo-protective effects mediated by the BM microenvironment may enhance the benefit of conventional chemotherapy for patients with AML.	[Macanas-Pirard, Patricia; Leisewitz, Andrea; Broekhuizen, Richard; Leisewitz, Francisco; Gidi, Victoria; Montecinos, Viviana P.; Swett, Pilar; Besa, Pelayo; Ramirez, Pablo; Ocqueteau, Mauricio; Nervi, Bruno] Pontificia Univ Catolica Chile, Dept Hematol & Oncol, Fac Med, Santiago, Chile; [Kalergis, Alexis M.] Pontificia Univ Catolica Chile, Dept Reumatol, Fac Med, Santiago, Chile; [Cautivo, Kelly; Barriga, Francisco M.; Riquelme, Erick; Kalergis, Alexis M.] Pontificia Univ Catolica Chile, Dept Genet Mol & Microbiol, Fac Ciencias Biol, Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Holt, Matthew; Rettig, Michael; DiPersio, John F.] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Washington University (WUSTL)	Macanas-Pirard, P (corresponding author), Pontificia Univ Catolica Chile, Dept Hematol & Oncol, Fac Med, Alameda 340, Santiago, Chile.	bnervi@med.puc.cl	Macanas-Pirard, Patricia/HCI-9651-2022; Nervi, Bruno/L-7470-2014; RIQUELME, ERICK/AAA-6191-2022	Macanas-Pirard, Patricia/0000-0003-2631-8618; Nervi, Bruno/0000-0002-3016-7261; Cautivo, Kelly/0000-0003-4434-2814; Kalergis, Alexis/0000-0001-7622-5263; ramirez, pablo/0000-0003-0593-7161; Rettig, Michael/0000-0002-1091-0564	Chilean National Commission for Scientific Research and Technology CONICYT (FONDECYT) [11085015, 1110319, 11080206]; Millennium Institute on Immunology and Immunotherapy [P07/088-F]	Chilean National Commission for Scientific Research and Technology CONICYT (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Institute on Immunology and Immunotherapy	This work was supported by grants from the Chilean National Commission for Scientific Research and Technology CONICYT (FONDECYT #11085015, #1110319 and #11080206) and by the Millennium Institute on Immunology and Immunotherapy (P07/088-F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Cashen Amanda F, 2007, Future Oncol, V3, P19, DOI 10.2217/14796694.3.1.19; Cass CE, 1998, BIOCHEM CELL BIOL, V76, P761, DOI 10.1139/bcb-76-5-761; Clarke Marilyn L, 2002, Cancer Treat Res, V112, P27; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Galmarini CM, 2003, INT J CANCER, V107, P149, DOI 10.1002/ijc.11339; Galmarini CM, 2003, LEUKEMIA LYMPHOMA, V44, P1105, DOI 10.1080/1042819031000077142; Galmarini CM, 2002, BRIT J HAEMATOL, V117, P860, DOI 10.1046/j.1365-2141.2002.03538.x; Galmarini CM, 2002, LEUKEMIA RES, V26, P621, DOI 10.1016/S0145-2126(01)00184-9; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Gazitt Y, 2004, LEUKEMIA, V18, P1, DOI 10.1038/sj.leu.2403173; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Jin GL, 2009, BIOCHEM BIOPH RES CO, V390, P1001, DOI 10.1016/j.bbrc.2009.10.094; Kanno SI, 2007, CLIN CHIM ACTA, V377, P144, DOI 10.1016/j.cca.2006.09.014; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Leisewitz AV, 2011, BIOCHEM BIOPH RES CO, V404, P370, DOI 10.1016/j.bbrc.2010.11.125; Leslie EM, 2001, TOXICOLOGY, V167, P3, DOI 10.1016/S0300-483X(01)00454-1; Leslie EM, 2001, MOL PHARMACOL, V59, P1171, DOI 10.1124/mol.59.5.1171; Mackey JR, 1998, DRUG RESIST UPDATE, V1, P310, DOI 10.1016/S1368-7646(98)80047-2; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Molina-Arcas M, 2005, LEUKEMIA, V19, P64, DOI 10.1038/sj.leu.2403582; Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Rettig MP, 2009, METHOD ENZYMOL, V460, P57, DOI 10.1016/S0076-6879(09)05203-3; Ryningen A, 2005, LEUKEMIA RES, V29, P185, DOI 10.1016/j.leukres.2004.06.008; SHEWACH DS, 1992, MOL PHARMACOL, V42, P518; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Spiegel A, 2004, BLOOD, V103, P2900, DOI 10.1182/blood-2003-06-1891; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; Taichman RS, 2002, CANCER RES, V62, P1832; Takagaki K, 2004, J BIOCHEM, V136, P733, DOI 10.1093/jb/mvh180; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; TATTERSALL MH, 1974, BRIT J HAEMATOL, V27, P39, DOI 10.1111/j.1365-2141.1974.tb06772.x; Veuger MJT, 2000, BLOOD, V96, P1517, DOI 10.1182/blood.V96.4.1517.h8001517_1517_1524; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yoon Y, 2007, CANCER RES, V67, P7518, DOI 10.1158/0008-5472.CAN-06-2263; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311	42	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37203	10.1371/journal.pone.0037203	http://dx.doi.org/10.1371/journal.pone.0037203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629369	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345300026
J	Ferrer, P; Tripathi, AK; Clark, MA; Hand, CC; Rienhoff, HY; Sullivan, DJ				Ferrer, Patricia; Tripathi, Abhai K.; Clark, Martha A.; Hand, Carla Cerami; Rienhoff, Hugh Young, Jr.; Sullivan, David J., Jr.			Antimalarial Iron Chelator, FBS0701, Shows Asexual and Gametocyte Plasmodium falciparum Activity and Single Oral Dose Cure in a Murine Malaria Model	PLOS ONE			English	Article							CELLS; POOL; FLUORESCENCE; PARASITEMIA; ARTEMISININ; OVERLOAD; THERAPY; YOELII	Iron chelators for the treatment of malaria have proven therapeutic activity in vitro and in vivo in both humans and mice, but their clinical use is limited by the unsuitable absorption and pharmacokinetic properties of the few available iron chelators. FBS0701, (S)3 ''-(HO)-desazadesferrithiocin-polyether [DADFT-PE], is an oral iron chelator currently in Phase 2 human studies for the treatment of transfusional iron overload. The drug has very favorable absorption and pharmacokinetic properties allowing for once-daily use to deplete circulating free iron with human plasma concentrations in the high mu M range. Here we show that FBS0701 has inhibition concentration 50% (IC50) of 6 mu M for Plasmodium falciparum in contrast to the IC50 for deferiprone and deferoxamine at 15 and 30 mu M respectively. In combination, FBS0701 interfered with artemisinin parasite inhibition and was additive with chloroquine or quinine parasite inhibition. FBS0701 killed early stage P. falciparum gametocytes. In the P. berghei Thompson suppression test, a single dose of 100 mg/kg reduced day three parasitemia and prolonged survival, but did not cure mice. Treatment with a single oral dose of 100 mg/kg one day after infection with 10 million lethal P. yoelii 17XL cured all the mice. Pretreatment of mice with a single oral dose of FBS0701 seven days or one day before resulted in the cure of some mice. Plasma exposures and other pharmacokinetics parameters in mice of the 100 mg/kg dose are similar to a 3 mg/kg dose in humans. In conclusion, FBS0701 demonstrates a single oral dose cure of the lethal P. yoelii model. Significantly, this effect persists after the chelator has cleared from plasma. FBS0701 was demonstrated to remove labile iron from erythrocytes as well as enter erythrocytes to chelate iron. FBS0701 may find clinically utility as monotherapy, a malarial prophylactic or, more likely, in combination with other antimalarials.	[Ferrer, Patricia; Tripathi, Abhai K.; Sullivan, David J., Jr.] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Clark, Martha A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Hand, Carla Cerami] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Rienhoff, Hugh Young, Jr.] FerroKin BioSci Inc, San Carlos, CA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ferrer, P (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	dsulliva@jhsph.edu		Tripathi, Abhai/0000-0001-9848-0142; Cerami, Carla/0000-0002-7634-0955	Bloomberg Foundation via the Johns Hopkins Malaria Research Institute; National Institutes of Health [5U01 HD061241-03]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD061241] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD061235] Funding Source: NIH RePORTER	Bloomberg Foundation via the Johns Hopkins Malaria Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors acknowledge partial support by the Bloomberg Foundation via the Johns Hopkins Malaria Research Institute and partial support by the National Institutes of Health 5U01 HD061241-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell A, 2005, FEMS MICROBIOL LETT, V253, P171, DOI 10.1016/j.femsle.2005.09.035; Bennett TN, 2004, ANTIMICROB AGENTS CH, V48, P1807, DOI 10.1128/AAC.48.5.1807-1810.2004; Bergeron RJ, 2008, J MED CHEM, V51, P3913, DOI 10.1021/jm800154m; Bergeron RJ, 2011, BIOMETALS, V24, P239, DOI 10.1007/s10534-010-9389-y; Buchholz K, 2011, J INFECT DIS, V203, P1445, DOI 10.1093/infdis/jir037; Darbari D, 2003, BLOOD, V102, P357, DOI 10.1182/blood-2002-03-0914; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; ELION GB, 1954, J BIOL CHEM, V208, P477; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Goma J, 1996, PARASITOLOGY, V112, P165, DOI 10.1017/S0031182000084729; GORDEUK V, 1992, NEW ENGL J MED, V327, P1473, DOI 10.1056/NEJM199211193272101; GORDEUK VR, 1992, BLOOD, V79, P308; HORKY J, 1978, PHYSIOL BOHEMOSLOV, V27, P209; Loyevsky M, 1999, MOL BIOCHEM PARASIT, V101, P43, DOI 10.1016/S0166-6851(99)00053-5; Mabeza GF, 1999, PHARMACOL THERAPEUT, V81, P53, DOI 10.1016/S0163-7258(98)00037-0; MESHNICK SR, 1993, ANTIMICROB AGENTS CH, V37, P1108, DOI 10.1128/AAC.37.5.1108; O'Neill PM, 2004, J MED CHEM, V47, P2945, DOI 10.1021/jm030571c; Petritus PM, 2008, J IMMUNOL, V180, P444, DOI 10.4049/jimmunol.180.1.444; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Prus E, 2008, BRIT J HAEMATOL, V142, P301, DOI 10.1111/j.1365-2141.2008.07192.x; Prus E, 2008, CYTOM PART A, V73A, P22, DOI 10.1002/cyto.a.20491; Rienhoff HY, 2011, HAEMATOL-HEMATOL J, V96, P521, DOI 10.3324/haematol.2010.034405; Shvartsman M, 2010, BIOCHEM J, V429, P185, DOI 10.1042/BJ20100213; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Thuma PE, 1998, AM J TROP MED HYG, V58, P358, DOI 10.4269/ajtmh.1998.58.358; WALKER WS, 1984, BRIT J HAEMATOL, V58, P259, DOI 10.1111/j.1365-2141.1984.tb06084.x; Wang J, 2010, PLOS ONE, V5, pA158, DOI 10.1371/journal.pone.0009582	27	31	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37171	10.1371/journal.pone.0037171	http://dx.doi.org/10.1371/journal.pone.0037171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629364	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343100016
J	Jonas, JB; Hayreh, SS; Tao, Y; Papastathopoulos, KI; Rensch, F				Jonas, Jost B.; Hayreh, Sohan Singh; Tao, Yong; Papastathopoulos, Konstantinos I.; Rensch, Florian			Optic Nerve Head Change in Non-Arteritic Anterior Ischemic Optic Neuropathy and Its Influence on Visual Outcome	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; DISC MORPHOLOGY; BEIJING EYE; PARAPAPILLARY ATROPHY; COHERENCE TOMOGRAPHY; ADULT CHINESE; FIBER LAYER; PATHOGENESIS; RATIO; CUP	Purpose: To evaluate changes in cup/disc (C/D) diameter ratios and parapapillary atrophy in patients with non-arteritic anterior ischemic optic neuropathy (NA-AION), using morphometric methods. Methods: The clinical non-interventional study included 157 patients with unilateral or bilateral NA-AION. Optic disc photographs taken from both eyes at the end of follow-up were morphometrically examined. Results: Follow-up was 86.3 +/- 70.3 months. Horizontal and vertical disc diameters (P = 0.30; P = 0.61, respectively), horizontal and vertical C/D ratios (P = 0.47; P = 0.19, resp.), and size of alpha zone and beta zone of parapapillary atrophy (P = 0.27; P = 0.32, resp.) did not differ significantly between affected eyes and contralateral normal eyes in patients with unilateral NA-AION. Similarly, horizontal and vertical disc diameters, horizontal and vertical C/D ratios, and size of alpha zone and beta zone did not vary significantly (all P>0.05) between the unaffected eyes of patients with unilateral NA-AION and the eyes of patients with bilateral NA-AION. Optic disc diameters, C/D ratios, size of alpha zone or beta zone of parapapillary atrophy were not significantly associated with final visual outcome in the eyes affected with NA-AION (all P>0.20) nor with the difference in final visual acuity between affected eyes and unaffected eyes in patients with unilateral NA-AION (all P>0.25). Conclusions: NA-AION did not affect C/D ratios nor alpha zone and beta zone of parapapillary atrophy. Optic disc size was not related to the final visual acuity outcome in NA-AION.	[Jonas, Jost B.; Papastathopoulos, Konstantinos I.; Rensch, Florian] Univ Heidelberg, Dept Ophthalmol, Med Fac Mannheim, D-6800 Mannheim, Germany; [Hayreh, Sohan Singh] Univ Iowa, Coll Med, Dept Ophthalmol, Iowa City, IA 52242 USA; [Hayreh, Sohan Singh] Univ Iowa, Coll Med, Dept Visual Sci, Iowa City, IA USA; [Tao, Yong] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China	Ruprecht Karls University Heidelberg; University of Iowa; University of Iowa; Peking University	Jonas, JB (corresponding author), Univ Heidelberg, Dept Ophthalmol, Med Fac Mannheim, D-6800 Mannheim, Germany.	Jost.Jonas@augen.ma.uni-heidelberg.de	Hayreh, Sohan Singh/AFU-1623-2022	Hayreh, Sohan/0000-0002-0709-886X	U.S. National Institutes of Health [EY-1576]; Research to Prevent Blindness, Incorporated, New York, United States of America; NATIONAL EYE INSTITUTE [R01EY001576] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Incorporated, New York, United States of America; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Dr. S. S. Hayreh's grant EY-1576 from the U.S. National Institutes of Health, and in part by unrestricted grants from Research to Prevent Blindness, Incorporated, New York, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK RW, 1984, OPHTHALMOLOGY, V91, P1334; BECK RW, 1987, OPHTHALMOLOGY, V94, P1503; BURDE RM, 1993, AM J OPHTHALMOL, V116, P759, DOI 10.1016/S0002-9394(14)73478-6; Chan CKM, 2009, BRIT J OPHTHALMOL, V93, P731, DOI 10.1136/bjo.2008.143297; Contreras I, 2007, INVEST OPHTH VIS SCI, V48, P4087, DOI 10.1167/iovs.07-0171; Danesh-Meyer H, 2005, OPHTHALMOLOGY, V112, P1104, DOI 10.1016/j.ophtha.2004.12.041; Danesh-Meyer HV, 2010, INVEST OPHTH VIS SCI, V51, P2003, DOI 10.1167/iovs.09-3492; Danesh-Meyer HV, 2001, OPHTHALMOLOGY, V108, P593, DOI 10.1016/S0161-6420(00)00602-3; DICKERSIN K, 1995, JAMA-J AM MED ASSOC, V273, P625, DOI 10.1001/jama.1995.03520320035038; DORO S, 1985, ARCH OPHTHALMOL-CHIC, V103, P1143; FEIT RH, 1984, AM J OPHTHALMOL, V98, P105, DOI 10.1016/0002-9394(84)90196-X; Hattenhauer MG, 1997, AM J OPHTHALMOL, V123, P103, DOI 10.1016/S0002-9394(14)70999-7; Hayreh SS, 2008, OPHTHALMOLOGY, V115, P298, DOI 10.1016/j.ophtha.2007.05.027; Hayreh SS, 2007, GRAEF ARCH CLIN EXP, V245, P1107, DOI 10.1007/s00417-006-0494-0; Hayreh SS, 2009, PROG RETIN EYE RES, V28, P34, DOI 10.1016/j.preteyeres.2008.11.002; Hayreh SS, 2008, OPHTHALMOLOGY, V115, P2275, DOI 10.1016/j.ophtha.2008.08.007; HAYREH SS, 1972, BRIT J OPHTHALMOL, V56, P175, DOI 10.1136/bjo.56.3.175; HAYREH SS, 1972, BRIT J OPHTHALMOL, V56, P736, DOI 10.1136/bjo.56.10.736; Hayreh SS, 2001, OPHTHALMOLOGY, V108, P1586, DOI 10.1016/S0161-6420(01)00649-2; HAYREH SS, 1970, BRIT J OPHTHALMOL, V54, P461, DOI 10.1136/bjo.54.7.461; HAYREH SS, 1974, BRIT J OPHTHALMOL, V58, P863, DOI 10.1136/bjo.58.10.863; Hayreh SS, 2011, ISCHEMIC OPTIC NEURO, P298; Hayreh SS, 1994, CURR OPIN OPHTHALMOL, V5II, P26; Hayreh SS, 1976, T AM ACAD OPHTHALMOL, V81; JOHNSON LN, 1994, J NEURO-OPHTHALMOL, V14, P38; JONAS JB, 1993, INVEST OPHTH VIS SCI, V34, P2260; Jonas JB, 1999, AM J OPHTHALMOL, V127, P523, DOI 10.1016/S0002-9394(99)00030-6; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P2942; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; Jonas JB, 2001, OPHTHALMOLOGY, V108, P1059, DOI 10.1016/S0161-6420(01)00571-1; JONAS JB, 1988, INT OPHTHALMOL, V12, P119, DOI 10.1007/BF00137137; Jonas JB, 2000, INVEST OPHTH VIS SCI, V41, P1764; QUIGLEY H, 1977, T AM ACAD OPHTHALMOL, V83, P755; Ramrattan RS, 1999, OPHTHALMOLOGY, V106, P1588, DOI 10.1016/S0161-6420(99)90457-8; Saito H, 2008, OPHTHALMOLOGY, V115, P1585, DOI 10.1016/j.ophtha.2008.01.012; Saito H, 2006, OPHTHALMOLOGY, V113, P1340, DOI 10.1016/j.ophtha.2006.01.072; Suh MH, 2011, AM J OPHTHALMOL, V151, P277, DOI 10.1016/j.ajo.2010.08.033; Wang YX, 2007, BRIT J OPHTHALMOL, V91, P401, DOI 10.1136/bjo.2006.103788; Xu L, 2007, EUR J OPHTHALMOL, V17, P459, DOI 10.1177/112067210701700335; You QS, 2009, ACTA OPHTHALMOL, V87, P354, DOI 10.1111/j.1755-3768.2008.01426.x	40	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37499	10.1371/journal.pone.0037499	http://dx.doi.org/10.1371/journal.pone.0037499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629408	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100036
J	Niki, Y; Takeuchi, T; Nakayama, M; Nagasawa, H; Kurasawa, T; Yamada, H; Toyama, Y; Miyamoto, T				Niki, Yasuo; Takeuchi, Tsutomu; Nakayama, Masanori; Nagasawa, Hayato; Kurasawa, Takahiko; Yamada, Harumoto; Toyama, Yoshiaki; Miyamoto, Takeshi			Clinical Significance of Cartilage Biomarkers for Monitoring Structural Joint Damage in Rheumatoid Arthritis Patients Treated with Anti-TNF Therapy	PLOS ONE			English	Article							PREDICT RADIOGRAPHIC PROGRESSION; SERUM KERATAN SULFATE; MATRIX PROTEIN COMP; KNEE OSTEOARTHRITIS; DISEASE-ACTIVITY; BIOCHEMICAL MARKERS; DESTRUCTION; ETANERCEPT; METABOLISM; INFLIXIMAB	Purpose: With the current use of biologics in rheumatoid arthritis (RA), there is a need to monitor ongoing structural joint damage due to the dissociation of articular cartilage damage from disease activity of RA. This study longitudinally analyzed levels of serum cartilage biomarkers during 54 weeks of infliximab therapy, to evaluate the feasibility of biomarkers for monitoring structural joint damage. Methods: Subjects comprised 33 patients with early RA and 33 patients with established RA. All patients received 3 mg/kg of infliximab and methotrexate for 54 weeks. Levels of the following serum cartilage markers were measured at baseline and at weeks 14, 22, and 54: hyaluronan (HA); cartilage oligometric matrix protein (COMP); type II collagen (CII)-related neoepitope (C2C); type II procollagen carboxy-propeptide (CPII); and keratin sulfate (KS). Time courses for each biomarker were assessed, and relationships between these biomarkers and clinical or radiographic parameters generally used for RA were investigated. Results: Levels of CRP, MMP-3, DAS28-CRP, and annual progression of TSS were improved to similar degrees in both groups at week 54. HA and C2C/CPII were significantly decreased compared to baseline in the early RA group (p<0.001), whereas HA and COMP, but not C2C/CPII, were decreased in the established RA group. Strikingly, serum C2C/CPII levels were universally improved in early RA, regardless of EULAR response grade. Both Delta HA and Delta C2C/CPII from baseline to week 54 correlated significantly with not only Delta CRP, but also Delta DAS28 in early RA. Interestingly, when partial correlation coefficients were calculated by standardizing CRP levels, the significant correlation of Delta HA to Delta DAS28 disappeared, whereas correlations of Delta C2C/CPII to Delta DAS28, Delta JNS, and Delta HAQ remained significant. These results suggest a role of Delta C2C/CPII as a marker of ongoing structural joint damage with the least association with CRP, and that irreversible cartilage damage in established RA limits restoration of the C2C/CPII level, even with tight control of joint inflammation. Conclusion: The temporal course of C2C/CPII level during anti-TNF therapy indicates that CII turnover shifts toward CII synthesis in early RA, but not in established RA, potentially due to irreversible cartilage damage. Delta C2C/CPII appears to offer a useful marker reflecting ongoing structural joint damage, dissociated from inflammatory indices such as CRP and MMP-3.	[Niki, Yasuo; Nakayama, Masanori; Toyama, Yoshiaki; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Takeuchi, Tsutomu] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan; [Takeuchi, Tsutomu; Nagasawa, Hayato; Kurasawa, Takahiko] Saitama Med Ctr, Div Rheumatol & Clin Immunol, Saitama, Japan; [Yamada, Harumoto] Fujita Hlth Univ, Dept Orthopaed Surg, Nagoya, Aichi, Japan	Keio University; Keio University; Fujita Health University	Niki, Y (corresponding author), Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan.	y-niki@a8.keio.jp	Toyama, Yoshiaki/K-5743-2013; Kurasawa, Takahiko/L-2905-2013; Takeuchi, Tsutomu/L-2327-2013; Takeuchi, Tsutomu/AFM-8316-2022	Takeuchi, Tsutomu/0000-0003-1111-8218; 				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; Cahue S, 2007, OSTEOARTHR CARTILAGE, V15, P819, DOI 10.1016/j.joca.2007.01.016; Crnkic M, 2003, ARTHRITIS RES THER, V5, pR181, DOI 10.1186/ar760; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Garnero P, 2001, ANN RHEUM DIS, V60, P619, DOI 10.1136/ard.60.6.619; Gordon CD, 2008, CLIN CHIM ACTA, V398, P21, DOI 10.1016/j.cca.2008.07.031; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Karsdal MA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2434; Kim TH, 2005, ARTHRITIS RHEUM-US, V52, P885, DOI 10.1002/art.20870; Kong SY, 2006, ARTHRITIS RHEUM-US, V54, P2496, DOI 10.1002/art.21977; Lamers RJAN, 2005, OSTEOARTHR CARTILAGE, V13, P762, DOI 10.1016/j.joca.2005.04.005; Landewe R, 2006, ARTHRITIS RHEUM-US, V54, P3119, DOI 10.1002/art.22143; MANSSON B, 1995, J CLIN INVEST, V95, P1071, DOI 10.1172/JCI117753; Morozzi G, 2007, CLIN RHEUMATOL, V26, P1335, DOI 10.1007/s10067-006-0520-y; Mullan RH, 2007, ARTHRITIS RHEUM, V56, P2919, DOI 10.1002/art.22843; Mundermann A, 2005, OSTEOARTHR CARTILAGE, V13, P34, DOI 10.1016/j.joca.2004.09.007; POOLE AR, 1995, MECH MODELS RHEUMATO, P163; POOLE AR, 1993, ARTHRITIS ALLIED CON, P279; RIZKALLA G, 1992, J CLIN INVEST, V90, P2268, DOI 10.1172/JCI116113; ROOS H, 1995, OSTEOARTHR CARTILAGE, V3, P7, DOI 10.1016/S1063-4584(05)80033-0; Takeuchi T, 2008, MOD RHEUMATOL, V18, P447, DOI 10.1007/s10165-008-0077-5; THONAR EJMA, 1992, CLIN BIOCHEM, V25, P175, DOI 10.1016/0009-9120(92)90263-R; Tomatsu S, 2005, J INHERIT METAB DIS, V28, P187, DOI 10.1007/s10545-005-5673-3; van den Broek M, 2011, ANN RHEUM DIS, V70, P1389, DOI 10.1136/ard.2010.147751; van Meurs JBJ, 1999, ARTHRITIS RHEUM, V42, P1128, DOI 10.1002/1529-0131(199906)42:6<1128::AID-ANR9>3.0.CO;2-2; Vignon E, 2001, OSTEOARTHR CARTILAGE, V9, P289, DOI 10.1053/joca.2000.0387; Wakitani S, 2007, RHEUMATOLOGY, V46, P1652, DOI 10.1093/rheumatology/kem220; Young-Min S, 2007, ARTHRITIS RHEUM-US, V56, P3236, DOI 10.1002/art.22923	29	17	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37447	10.1371/journal.pone.0037447	http://dx.doi.org/10.1371/journal.pone.0037447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629396	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343100028
J	van der Lelie, D; Taghavi, S; McCorkle, SM; Li, LL; Malfatti, SA; Monteleone, D; Donohoe, BS; Ding, SY; Adney, WS; Himmel, ME; Tringe, SG				van der Lelie, Daniel; Taghavi, Safiyh; McCorkle, Sean M.; Li, Luen-Luen; Malfatti, Stephanie A.; Monteleone, Denise; Donohoe, Bryon S.; Ding, Shi-You; Adney, William S.; Himmel, Michael E.; Tringe, Susannah G.			The Metagenome of an Anaerobic Microbial Community Decomposing Poplar Wood Chips	PLOS ONE			English	Article							AROMATIC-COMPOUNDS; GLYCOSIDE HYDROLASES; CELLOBIOSE DEHYDROGENASE; HIGHER TERMITES; LIGNIN DEGRADATION; GUT MICROBIOME; BIOMASS; GENOMES; POLYSACCHARIDES; CELLULOSOMES	This study describes the composition and metabolic potential of a lignocellulosic biomass degrading community that decays poplar wood chips under anaerobic conditions. We examined the community that developed on poplar biomass in a non-aerated bioreactor over the course of a year, with no microbial inoculation other than the naturally occurring organisms on the woody material. The composition of this community contrasts in important ways with biomass-degrading communities associated with higher organisms, which have evolved over millions of years into a symbiotic relationship. Both mammalian and insect hosts provide partial size reduction, chemical treatments (low or high pH environments), and complex enzymatic 'secretomes' that improve microbial access to cell wall polymers. We hypothesized that in order to efficiently degrade coarse untreated biomass, a spontaneously assembled free-living community must both employ alternative strategies, such as enzymatic lignin depolymerization, for accessing hemicellulose and cellulose and have a much broader metabolic potential than host-associated communities. This would suggest that such a community would make a valuable resource for finding new catalytic functions involved in biomass decomposition and gaining new insight into the poorly understood process of anaerobic lignin depolymerization. Therefore, in addition to determining the major players in this community, our work specifically aimed at identifying functions potentially involved in the depolymerization of cellulose, hemicelluloses, and lignin, and to assign specific roles to the prevalent community members in the collaborative process of biomass decomposition. A bacterium similar to Magnetospirillum was identified among the dominant community members, which could play a key role in the anaerobic breakdown of aromatic compounds. We suggest that these compounds are released from the lignin fraction in poplar hardwood during the decay process, which would point to lignin-modification or depolymerization under anaerobic conditions.	[van der Lelie, Daniel; Taghavi, Safiyh; McCorkle, Sean M.; Li, Luen-Luen; Monteleone, Denise] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [van der Lelie, Daniel; Taghavi, Safiyh; McCorkle, Sean M.; Li, Luen-Luen; Monteleone, Denise; Donohoe, Bryon S.; Ding, Shi-You; Adney, William S.; Himmel, Michael E.] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN USA; [van der Lelie, Daniel; Taghavi, Safiyh; Adney, William S.] RTI Int, Ctr Agr & Environm Biotechnol, Res Triangle Pk, NC USA; [Malfatti, Stephanie A.; Tringe, Susannah G.] DOE Joint Genome Inst, Walnut Creek, CA USA; [Donohoe, Bryon S.; Ding, Shi-You; Adney, William S.; Himmel, Michael E.] Natl Renewable Energy Lab, Golden, CO USA	United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); Research Triangle Institute; United States Department of Energy (DOE); United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	van der Lelie, D (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.	vdlelied@rti.org	Tringe, Susannah Green/T-9431-2019; Ding, Shi-You/O-1209-2013; DING, SHIYOU/ABD-8519-2021	Tringe, Susannah Green/0000-0001-6479-8427; DING, SHIYOU/0000-0002-1102-1507; Malfatti, Stephanie/0000-0003-4225-9857	United States Department of Energy's Office of Science, Biological and Environmental Research Program; University of California; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; BioEnergy Science Center (BESC); Office of Biological and Environmental Research in the DOE Office of Science; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]	United States Department of Energy's Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); BioEnergy Science Center (BESC)(United States Department of Energy (DOE)); Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	Metagenome sequencing of poplar biomass decaying community was performed at the Joint Genome Institute (JGI) under the auspices of the United States Department of Energy's Office of Science, Biological and Environmental Research Program; and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, the Lawrence Livermore National Laboratory under Contract No. DE-AC52-07NA27344, and the Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. The BioEnergy Science Center (BESC) funded the microbial/biochemical aspects of this work. BESC is a United States Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Amann R.J., 1990, APPL ENVIRON MICROB, V56, P1910; Barragan MJL, 2004, MICROBIOL-SGM, V150, P2018, DOI 10.1099/mic.0.27186-0; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; BIGNELL DE, 1995, INSECT SOC, V42, P57, DOI 10.1007/BF01245699; BRON S, 1972, MUTAT RES, V15, P395, DOI 10.1016/0027-5107(72)90004-8; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681, DOI 10.1128/AEM.61.7.2681-2687.1995; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Decou R, 2009, PHYTOCHEMISTRY, V70, P163, DOI 10.1016/j.phytochem.2008.12.019; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Erb A, 2009, PHYTOCHEMISTRY, V70, P1812, DOI 10.1016/j.phytochem.2009.05.019; Geelhoed JS, 2009, FEMS MICROBIOL ECOL, V70, P54, DOI 10.1111/j.1574-6941.2009.00739.x; Geib SM, 2008, P NATL ACAD SCI USA, V105, P12932, DOI 10.1073/pnas.0805257105; Gilbert JA, 2011, ANNU REV MAR SCI, V3, P347, DOI 10.1146/annurev-marine-120709-142811; Gilbert JA, 2011, ISME J, V5, P777, DOI 10.1038/ismej.2010.178; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Harvey AJ, 2000, PROTEINS, V41, P257, DOI 10.1002/1097-0134(20001101)41:2<257::AID-PROT100>3.0.CO;2-C; Heidelberg KB, 2010, MICROB BIOTECHNOL, V3, P531, DOI 10.1111/j.1751-7915.2010.00193.x; Henriksson G, 2000, BBA-PROTEIN STRUCT M, V1480, P83, DOI 10.1016/S0167-4838(00)00096-0; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hilden L, 2000, FEBS LETT, V477, P79, DOI 10.1016/S0014-5793(00)01757-9; Himmel M. E., 2008, BIOMASS RECALCITRANC; Himmel ME, 1997, ACS SYM SER, V666, P2; Huang DL, 2010, BIORESOURCE TECHNOL, V101, P4062, DOI 10.1016/j.biortech.2009.12.145; Juarez JF, 2010, APPL ENVIRON MICROB, V76, P383, DOI 10.1128/AEM.02255-09; Kshattriya S, 1996, ECOPRINT, V3, P41; Kunin V, 2010, OPEN J, V1; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee RC, 2003, J BIOL CHEM, V278, P5377, DOI 10.1074/jbc.M210627200; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Li LL, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-23; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Lorenz P, 2005, NAT REV MICROBIOL, V3, P510, DOI 10.1038/nrmicro1161; Mansfield SD, 1997, APPL ENVIRON MICROB, V63, P3804, DOI 10.1128/AEM.63.10.3804-3809.1997; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mratyunjay Majumder, 2008, Communications in Biometry and Crop Science, V3, P45; Pati A, 2011, STAND GENOMIC SCI, V5, P248, DOI 10.4056/sigs.2075298; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramsak A, 2000, FEMS MICROBIOL ECOL, V33, P69, DOI 10.1111/j.1574-6941.2000.tb00728.x; Saar BG, 2010, ANGEW CHEM INT EDIT, V49, P5476, DOI 10.1002/anie.201000900; Schluter A, 2008, J BIOTECHNOL, V136, P77, DOI 10.1016/j.jbiotec.2008.05.008; Shinoda Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1483, DOI 10.1271/bbb.69.1483; Shinoda Y, 2000, APPL ENVIRON MICROB, V66, P1286, DOI 10.1128/AEM.66.4.1286-1291.2000; Sjostrom J, 1993, WOOD CHEM FUNDAMENTA; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Thongaram T, 2005, EXTREMOPHILES, V9, P229, DOI 10.1007/s00792-005-0440-9; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WEIMER PJ, 1977, APPL ENVIRON MICROB, V33, P289, DOI 10.1128/AEM.33.2.289-297.1977; Wymelenberg AV, 2011, APPL ENVIRON MICROB, V77, P4499, DOI 10.1128/AEM.00508-11; Yu H, 2007, BIODEGRADATION, V18, P793, DOI 10.1007/s10532-007-9108-8; Molina MTZ, 2009, NEW BIOTECHNOL, V25, pS100, DOI 10.1016/j.nbt.2009.06.685; Zeng YN, 2010, BIOENERG RES, V3, P272, DOI 10.1007/s12155-010-9079-1	68	77	78	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e36740	10.1371/journal.pone.0036740	http://dx.doi.org/10.1371/journal.pone.0036740			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629327	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343100007
J	Avanzini, P; Fabbri-Destro, M; Dalla Volta, R; Daprati, E; Rizzolatti, G; Cantalupo, G				Avanzini, Pietro; Fabbri-Destro, Maddalena; Dalla Volta, Riccardo; Daprati, Elena; Rizzolatti, Giacomo; Cantalupo, Gaetano			The Dynamics of Sensorimotor Cortical Oscillations during the Observation of Hand Movements: An EEG Study	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; PRIMARY MOTOR CORTEX; SELF-PACED MOVEMENT; HIGH-RESOLUTION EEG; PREMOTOR CORTEX; MU-RHYTHM; VOLUNTARY MOVEMENT; INFERIOR PARIETAL; PRECISION GRIP; HUMAN BRAIN	Background: The observation of action done by others determines a desynchronization of the rhythms recorded from cortical central regions. Here, we examined whether the observation of different types of hand movements (target directed, non-target directed, cyclic and non-cyclic) elicits different EEG cortical temporal patterns. Methodology: Video-clips of four types of hand movements were shown to right-handed healthy participants. Two were target directed (grasping and pointing) motor acts; two were non-target directed (supinating and clenching) movements. Grasping and supinating were performed once, while pointing and clenching twice (cyclic movements). High-density EEG was recorded and analyzed by means of wavelet transform, subdividing the time course in time bins of 200 ms. The observation of all presented movements produced a desynchronization of alpha and beta rhythms in central and parietal regions. The rhythms desynchronized as soon as the hand movement started, the nadir being reached around 700 ms after movement onset. At the end of the movement, a large power rebound occurred for all bands. Target and non-target directed movements produced an alpha band desynchronization in the central electrodes at the same time, but with a stronger desynchronization and a prolonged rebound for target directed motor acts. Most interestingly, there was a clear correlation between the velocity profile of the observed movements and beta band modulation. Significance: Our data show that the observation of motor acts determines a modulation of cortical rhythm analogous to that occurring during motor act execution. In particular, the cortical motor system closely follows the velocity of the observed movements. This finding provides strong evidence for the presence in humans of a mechanism (mirror mechanism) mapping action observation on action execution motor programs.	[Avanzini, Pietro; Dalla Volta, Riccardo; Rizzolatti, Giacomo] Univ Parma, Dipartimento Neurosci Sez Fisiol, I-43100 Parma, Italy; [Fabbri-Destro, Maddalena; Rizzolatti, Giacomo] Italian Inst Technol, Brain Ctr Motor & Social Cognit, Parma, Italy; [Dalla Volta, Riccardo] Magna Graecia Univ Catanzaro, Dipartimento Sci Med & Chirurg, Catanzaro, Italy; [Daprati, Elena] Univ Roma Tor Vergata, Dipartimento Neurosci, Rome, Italy; [Daprati, Elena] Univ Roma Tor Vergata, Ctr Biomed Spaziale, Rome, Italy; [Cantalupo, Gaetano] Univ Parma, Dipartimento Neurosci Neuropsichiat Infantile, I-43100 Parma, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT; Magna Graecia University of Catanzaro; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Parma	Avanzini, P (corresponding author), Univ Parma, Dipartimento Neurosci Sez Fisiol, I-43100 Parma, Italy.	pietro.avanzini@unipr.it	daprati, elena/AAA-2224-2019; Cantalupo, Gaetano/N-8617-2019; Cantalupo, Gaetano/A-4231-2010; Fabbri-Destro, Maddalena/J-4988-2018	Cantalupo, Gaetano/0000-0003-1343-8434; Cantalupo, Gaetano/0000-0003-1343-8434; DALLA VOLTA, Riccardo/0000-0002-2621-4459; Fabbri Destro, Maddalena/0000-0001-8321-4634; Avanzini, Pietro/0000-0001-9371-451X	Fondo Regionale per le Neuroscienze; Compagnia di San Paolo (Neuroscience Program); European Union grant "Cogsystem"	Fondo Regionale per le Neuroscienze; Compagnia di San Paolo (Neuroscience Program)(Compagnia di San Paolo); European Union grant "Cogsystem"	This study was supported by Fondo Regionale per le Neuroscienze, by Compagnia di San Paolo (Neuroscience Program), and by European Union grant "Cogsystem" to GR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHULER EL, 1997, 27 ANN M SOC NEUR NE; [Anonymous], 1974, Electroencephalogr Clin Neurophysiol, V37, P538; Arnstein D, 2011, J NEUROSCI, V31, P14243, DOI 10.1523/JNEUROSCI.0963-11.2011; Babiloni C, 1999, NEUROIMAGE, V10, P658, DOI 10.1006/nimg.1999.0504; Babiloni C, 2002, NEUROIMAGE, V17, P559, DOI 10.1006/nimg.2002.1192; Caetano G, 2007, P NATL ACAD SCI USA, V104, P9058, DOI 10.1073/pnas.0702453104; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; CHATRIAN GE, 1959, ELECTROEN CLIN NEURO, V11, P497, DOI 10.1016/0013-4694(59)90048-3; Cochin S, 1998, ELECTROEN CLIN NEURO, V107, P287, DOI 10.1016/S0013-4694(98)00071-6; Cochin S, 1999, EUR J NEUROSCI, V11, P1839, DOI 10.1046/j.1460-9568.1999.00598.x; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fischer T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012514; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; GASTAUT H, 1952, Mars Med, V89, P296; GASTAUT HJ, 1954, ELECTROEN CLIN NEURO, V6, P433, DOI 10.1016/0013-4694(54)90058-9; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hari R, 2006, PROG BRAIN RES, V159, P253, DOI 10.1016/S0079-6123(06)59017-X; HYVARINEN J, 1982, PHYSIOL REV, V62, P1060, DOI 10.1152/physrev.1982.62.3.1060; Jastorff J, 2010, J NEUROPHYSIOL, V104, P128, DOI 10.1152/jn.00254.2010; Kilavik B.E., 2011, CEREB CORTEX; Kilner JM, 2003, NEUROIMAGE, V18, P67, DOI 10.1006/nimg.2002.1322; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Muthukumaraswamy SD, 2004, CLIN NEUROPHYSIOL, V115, P1760, DOI 10.1016/j.clinph.2004.03.004; Muthukumaraswamy SD, 2004, PSYCHOPHYSIOLOGY, V41, P152, DOI 10.1046/j.1469-8986.2003.00129.x; Nam CS, 2011, CLIN NEUROPHYSIOL, V122, P567, DOI 10.1016/j.clinph.2010.08.002; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; Nunez PL, 2006, CLIN NEUROPHYSIOL, V117, P2424, DOI 10.1016/j.clinph.2006.06.754; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perry A, 2010, NEUROREPORT, V21, P1050, DOI 10.1097/WNR.0b013e32833fcb71; Perry A, 2009, BRAIN RES, V1282, P126, DOI 10.1016/j.brainres.2009.05.059; Pfurtscheller G, 2005, NEUROSCI LETT, V378, P156, DOI 10.1016/j.neulet.2004.12.034; Pfurtscheller G, 1997, ELECTROEN CLIN NEURO, V102, P316, DOI 10.1016/S0013-4694(96)96612-2; PFURTSCHELLER G, 1989, ELECTROEN CLIN NEURO, V72, P250, DOI 10.1016/0013-4694(89)90250-2; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Press C, 2011, J NEUROSCI, V31, P2792, DOI 10.1523/JNEUROSCI.1595-10.2011; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Salenius S, 1997, NEUROIMAGE, V5, P221, DOI 10.1006/nimg.1997.0261; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Stancak A, 1997, ELECTROEN CLIN NEURO, V102, P495, DOI 10.1016/S0013-4694(96)96623-0; Streltsova A, 2010, EXP BRAIN RES, V205, P363, DOI 10.1007/s00221-010-2371-7; TIIHONEN J, 1989, NEUROSCIENCE, V32, P793, DOI 10.1016/0306-4522(89)90299-6; TORO C, 1994, ELECTROEN CLIN NEURO, V93, P380, DOI 10.1016/0168-5597(94)90126-0; Yuan H, 2010, IEEE ENG MED BIO, P142, DOI 10.1109/IEMBS.2010.5627414; Yuan H, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026001	61	115	118	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37534	10.1371/journal.pone.0037534	http://dx.doi.org/10.1371/journal.pone.0037534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624046	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500133
J	Lyng, MB; Laenkholm, AV; Sokilde, R; Gravgaard, KH; Litman, T; Ditzel, HJ				Lyng, Maria B.; Laenkholm, Anne-Vibeke; Sokilde, Rolf; Gravgaard, Karina H.; Litman, Thomas; Ditzel, Henrik J.			Global MicroRNA Expression Profiling of High-Risk ER plus Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GROWTH-FACTOR RECEPTOR; RESISTANCE; TARGETS; TUMORS; DEREGULATION; GUIDELINES; EXPERIENCE; DATABASE; PATHWAY	Purpose: Despite the benefits of estrogen receptor (ER)-targeted endocrine therapies in breast cancer, many tumors develop resistance. MicroRNAs (miRNAs) have been suggested as promising biomarkers and we here evaluated whether a miRNA profile could be identified, sub-grouping ER+ breast cancer patients treated with adjuvant Tamoxifen with regards to probability of recurrence. Experimental Design: Global miRNA analysis was performed on 152 ER+ primary tumors from high-risk breast cancer patients with an initial discovery set of 52 patients, followed by two independent test sets (N = 60 and N = 40). All patients had received adjuvant Tamoxifen as mono-therapy (median clinical follow-up: 4.6 years) and half had developed distant recurrence (median time-to-recurrence: 3.5 years). MiRNA expression was examined by unsupervised hierarchical clustering and supervised analysis, including clinical parameters as co-variables. Results: The discovery set identified 10 highly significant miRNAs that discriminated between the patient samples according to outcome. However, the subsequent two independent test sets did not confirm the predictive potential of these miRNAs. A significant correlation was identified between miR-7 and the tumor grade. Investigation of the microRNAs with the most variable expression between patients in different runs yielded a list of 31 microRNAs, eight of which are associated with stem cell characteristics. Conclusions: Based on the large sample size, our data strongly suggests that there is no single miRNA profile predictive of outcome following adjuvant Tamoxifen treatment in a broad cohort of ER+ breast cancer patients. We identified a subgroup of Tamoxifen-treated breast cancer patients with miRNA-expressing tumors associated with cancer stem cell characteristics.	[Lyng, Maria B.; Gravgaard, Karina H.; Ditzel, Henrik J.] Univ So Denmark, Inst Mol Med, Odense, Denmark; [Laenkholm, Anne-Vibeke] Slagelse Hosp, Dept Pathol, Slagelse, Denmark; [Sokilde, Rolf; Litman, Thomas] Exiqon AS, Dept Biomarker Discovery, Vedbaek, Denmark; [Ditzel, Henrik J.] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark	University of Southern Denmark; Exiqon; University of Southern Denmark; Odense University Hospital	Lyng, MB (corresponding author), Univ So Denmark, Inst Mol Med, Odense, Denmark.	mlyng@health.sdu.dk; hditzel@health.sdu.dk	Søkilde, Rolf/F-5138-2015	Søkilde, Rolf/0000-0003-3010-3599; Gravgaard Thomsen, Karina/0000-0002-9593-7239; Litman, Thomas/0000-0002-6068-901X; Laenkholm, Anne-Vibeke/0000-0003-2166-8686; Ditzel, Henrik J./0000-0003-3927-5135	Danish Cancer Society; Danish Cancer Research Foundation; Danish Research Council; Danish Strategic Research Council; A Race Against Breast Cancer; Sino-Danish Breast Cancer Research Centre; NanoCAN Lundbeck Center of Excellence; Region of Southern Denmark Research Foundation; Danish Center for Translational Breast Cancer research (DCTB)	Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation; Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); A Race Against Breast Cancer; Sino-Danish Breast Cancer Research Centre; NanoCAN Lundbeck Center of Excellence; Region of Southern Denmark Research Foundation; Danish Center for Translational Breast Cancer research (DCTB)	This work was supported in part by the Danish Cancer Society, the Danish Cancer Research Foundation, the Danish Research Council, the Danish Strategic Research Council, A Race Against Breast Cancer, Sino-Danish Breast Cancer Research Centre, NanoCAN Lundbeck Center of Excellence, Region of Southern Denmark Research Foundation, and Danish Center for Translational Breast Cancer research (DCTB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Andersen J, 2008, ACTA ONCOL, V47, P718, DOI 10.1080/02841860802014882; Baum M, 2002, LANCET, V359, P2131; Blamey RW, 2002, EUR J CANCER, V38, P615, DOI 10.1016/S0959-8049(02)00011-4; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cittelly DM, 2010, CARCINOGENESIS, V31, P2049, DOI 10.1093/carcin/bgq192; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Elston C W, 2002, Histopathology, V41, P154; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Frogne T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2230; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Lyng MB, 2011, PREDICTION OUT UNPUB; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Masri S, 2010, BREAST CANCER RES TR, V124, P89, DOI 10.1007/s10549-009-0716-3; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; MOURIDSEN HT, 2008, BIG 1 98 RANDOMIZED; O'Brien CS, 2009, J MAMMARY GLAND BIOL, V14, P45, DOI 10.1007/s10911-009-9115-y; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006; Rodriguez-Gonzalez FG, 2010, BREAST CANC RES TREA; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Sachdeva M, 2011, ONCOGENE, V30, P822, DOI 10.1038/onc.2010.463; Tessel MA, 2010, CURR OPIN ONCOL; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200	33	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36170	10.1371/journal.pone.0036170	http://dx.doi.org/10.1371/journal.pone.0036170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623953	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500012
J	Schulz, TC; Young, HY; Agulnick, AD; Babin, MJ; Baetge, EE; Bang, AG; Bhoumik, A; Cepa, I; Cesario, RM; Haakmeester, C; Kadoya, K; Kelly, JR; Kerr, J; Martinson, LA; McLean, AB; Moorman, MA; Payne, JK; Richardson, M; Ross, KG; Sherrer, ES; Song, XH; Wilson, AZ; Brandon, EP; Green, CE; Kroon, EJ; Kelly, OG; D'Amour, KA; Robins, AJ				Schulz, Thomas C.; Young, Holly Y.; Agulnick, Alan D.; Babin, M. Josephine; Baetge, Emmanuel E.; Bang, Anne G.; Bhoumik, Anindita; Cepa, Igor; Cesario, Rosemary M.; Haakmeester, Carl; Kadoya, Kuniko; Kelly, Jonathan R.; Kerr, Justin; Martinson, Laura A.; McLean, Amanda B.; Moorman, Mark A.; Payne, Janice K.; Richardson, Mike; Ross, Kelly G.; Sherrer, Eric S.; Song, Xuehong; Wilson, Alistair Z.; Brandon, Eugene P.; Green, Chad E.; Kroon, Evert J.; Kelly, Olivia G.; D'Amour, Kevin A.; Robins, Allan J.			A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem Cells	PLOS ONE			English	Article							SUSPENSION-CULTURE; GENE-EXPRESSION; DIFFERENTIATION; EXPANSION; ENDODERM; TRANSPLANTATION; GROWTH; COLONY	Development of a human embryonic stem cell (hESC)-based therapy for type 1 diabetes will require the translation of proof-of-principle concepts into a scalable, controlled, and regulated cell manufacturing process. We have previously demonstrated that hESC can be directed to differentiate into pancreatic progenitors that mature into functional glucose-responsive, insulin-secreting cells in vivo. In this study we describe hESC expansion and banking methods and a suspension-based differentiation system, which together underpin an integrated scalable manufacturing process for producing pancreatic progenitors. This system has been optimized for the CyT49 cell line. Accordingly, qualified large-scale single-cell master and working cGMP cell banks of CyT49 have been generated to provide a virtually unlimited starting resource for manufacturing. Upon thaw from these banks, we expanded CyT49 for two weeks in an adherent culture format that achieves 50-100 fold expansion per week. Undifferentiated CyT49 were then aggregated into clusters in dynamic rotational suspension culture, followed by differentiation en masse for two weeks with a four-stage protocol. Numerous scaled differentiation runs generated reproducible and defined population compositions highly enriched for pancreatic cell lineages, as shown by examining mRNA expression at each stage of differentiation and flow cytometry of the final population. Islet-like tissue containing glucose-responsive, insulin-secreting cells was generated upon implantation into mice. By four- to five-months post-engraftment, mature neo-pancreatic tissue was sufficient to protect against streptozotocin (STZ)-induced hyperglycemia. In summary, we have developed a tractable manufacturing process for the generation of functional pancreatic progenitors from hESC on a scale amenable to clinical entry.	[Schulz, Thomas C.; Sherrer, Eric S.; Song, Xuehong; Robins, Allan J.] Viacyte Inc, Athens, GA USA; [Young, Holly Y.; Agulnick, Alan D.; Babin, M. Josephine; Baetge, Emmanuel E.; Bang, Anne G.; Bhoumik, Anindita; Cepa, Igor; Cesario, Rosemary M.; Haakmeester, Carl; Kadoya, Kuniko; Kelly, Jonathan R.; Kerr, Justin; Martinson, Laura A.; Moorman, Mark A.; Payne, Janice K.; Richardson, Mike; Ross, Kelly G.; Wilson, Alistair Z.; Brandon, Eugene P.; Green, Chad E.; Kroon, Evert J.; Kelly, Olivia G.; D'Amour, Kevin A.; Robins, Allan J.] Viacyte Inc, San Diego, CA USA; [McLean, Amanda B.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Schulz, TC (corresponding author), Viacyte Inc, Athens, GA USA.	tschulz@viacyte.com		KROON, EVERT/0000-0002-4069-3644	California Institute for Regenerative Medicine [DR1-01423, TR1-01215]; National Institutes of Health (NIGMS) [5P01GM085354-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Studies were performed in part with funding derived from the California Institute for Regenerative Medicine (DR1-01423, TR1-01215), and the National Institutes of Health (NIGMS, 5P01GM085354-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amit M, 2010, STEM CELL REV REP, V6, P248, DOI 10.1007/s12015-010-9149-y; Barbaric I, 2011, CRYOBIOLOGY, V63, P298, DOI 10.1016/j.cryobiol.2011.10.002; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Cai J, 2010, J MOL CELL BIOL, V2, P50, DOI 10.1093/jmcb/mjp037; Chen XL, 2010, STEM CELLS DEV, V19, P1781, DOI 10.1089/scd.2010.0077; Clark GO, 2007, BIOCHEM BIOPH RES CO, V356, P587, DOI 10.1016/j.bbrc.2007.03.017; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dominguez-Bendala J, 2011, CURR OPIN ORGAN TRAN, V16, P76, DOI 10.1097/MOT.0b013e32834252b5; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; Fortina P, 2008, NAT BIOTECHNOL, V26, P293, DOI 10.1038/nbt0308-293; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hosokawa M, 2001, BIOCHEM BIOPH RES CO, V289, P1114, DOI 10.1006/bbrc.2001.6145; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Johannesson M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004794; Kehoe DE, 2010, TISSUE ENG PT A, V16, P405, DOI [10.1089/ten.tea.2009.0454, 10.1089/ten.TEA.2009.0454]; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; LEY K, 1989, BLOOD, V73, P1324; Li L, 2010, BIOPHYS J, V98, P2442, DOI 10.1016/j.bpj.2010.02.029; Lock LT, 2009, TISSUE ENG PT A, V15, P2051, DOI 10.1089/ten.tea.2008.0455; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Matsumoto S, 2011, DIABETES METAB J, V35, P199, DOI 10.4093/dmj.2011.35.3.199; McCall MD, 2010, CLIN SCI, V118, P87, DOI 10.1042/CS20090072; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005; OKAMOTO H, 1985, BIOMED BIOCHIM ACTA, V44, P15; Olariu V, 2010, STEM CELL RES, V4, P50, DOI 10.1016/j.scr.2009.09.001; Olmer R, 2010, STEM CELL RES, V5, P51, DOI 10.1016/j.scr.2010.03.005; Phillips BW, 2008, J BIOTECHNOL, V138, P24, DOI 10.1016/j.jbiotec.2008.07.1997; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Schulz TC, 2009, EMERGING TECHNOLOGY, P251; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shim JH, 2007, DIABETOLOGIA, V50, P1228, DOI 10.1007/s00125-007-0634-z; Singh H, 2010, STEM CELL RES, V4, P165, DOI 10.1016/j.scr.2010.03.001; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Ungrin MD, 2012, BIOTECHNOL BIOENG, V109, P853, DOI 10.1002/bit.24375; Van Winkle AP, 2012, CELLS TISSUES ORGANS, V196, P34, DOI 10.1159/000330691; Verdier C, 2009, J MATH BIOL, V58, P235, DOI 10.1007/s00285-008-0164-4; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wquimby F, 2007, MOUSE BIOMEDICAL RES, P171, DOI DOI 10.1016/B978-012369454-6/50060-1; Young H, 2009, ESSENTIALS OF STEM CELL BIOLOGY, 2ND EDITION, P397, DOI 10.1016/B978-0-12-374729-7.00044-5	47	290	329	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37004	10.1371/journal.pone.0037004	http://dx.doi.org/10.1371/journal.pone.0037004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623968	gold, Green Published			2022-12-25	WOS:000305343500045
J	Tovilla-Zarate, C; Juarez-Rojop, I; Jimenez, YP; Jimenez, MA; Vazquez, S; Bermudez-Ocana, D; Ramon-Frias, T; Mendoza, ADG; Garcia, SP; Narvaez, LL				Tovilla-Zarate, Carlos; Juarez-Rojop, Isela; Peralta Jimenez, Yesenia; Antonia Jimenez, Maria; Vazquez, Silvia; Bermudez-Ocana, Deysi; Ramon-Frias, Teresa; Genis Mendoza, Alma D.; Pool Garcia, Sherezada; Lopez Narvaez, Lilia			Prevalence of Anxiety and Depression among Outpatients with Type 2 Diabetes in the Mexican Population	PLOS ONE			English	Article							RISK-FACTORS; COMORBID DEPRESSION; RATING-SCALE; COMPLICATIONS; ASSOCIATION; DISORDERS; DISEASES; HEALTH; STATES; WORLD	Background: Depression and anxiety are common in diabetic patients; however, in recent years the frequency of these symptoms has markedly increased worldwide. Therefore, it is necessary to establish the frequency and factors associated with depression and anxiety, since they can be responsible for premature morbidity, mortality, risk of developing comorbidities, complications, suffering of patients, as well as escalation of costs. We studied the frequency of depression and anxiety in Mexican outpatients with type 2 diabetes and identified the risk factors for depression and anxiety. Methods and Findings: We performed a study in 820 patients with type 2 diabetes. The prevalence of depression and anxiety was estimated using the Hamilton Depression Rating Scale and the Hamilton Anxiety Rating Scale, respectively. We calculated the proportions for depression and anxiety and, after adjusting for confounding variables, we performed multivariate analysis using multiple logistic regressions to evaluate the combined effect of the various factors associated with anxiety and depression among persons with type 2 diabetes. The rates for depression and anxiety were 48.27% (95% CI: 44.48-52.06) and 55.10% (95% CI: 51.44-58.93), respectively. Occupation and complications in diabetes were the factors associated with anxiety, whereas glucose level and complications in diabetes were associated with depression. Complications in diabetes was a factor common to depression and anxiety (p < 0.0001; OR 1.79, 95% CI 1.29-2.4). Conclusions: Our findings demonstrate that a large proportion of diabetic patients present depression and/or anxiety. We also identified a significant association between complications in diabetes with depression and anxiety. Interventions are necessary to hinder the appearance of complications in diabetes and in consequence prevent depression and anxiety.	[Tovilla-Zarate, Carlos; Peralta Jimenez, Yesenia; Antonia Jimenez, Maria; Vazquez, Silvia; Bermudez-Ocana, Deysi; Ramon-Frias, Teresa] Univ Juarez Autonoma Tabasco, Div Acad Multidisciplinaria Comalcalco, Comalcalco, Tabasco, Mexico; [Juarez-Rojop, Isela] Univ Juarez Autonoma Tabasco, Div Acad Ciencias Salud, Villahermosa, Tabasco, Mexico; [Genis Mendoza, Alma D.] Serv Atenc Psiquiatr, Secretaria Salud, Mexico City, DF, Mexico; [Pool Garcia, Sherezada] Hosp Gen Comalcalco, Tabasco Secretaria Salud, Comalcalco, Tabasco, Mexico; [Tovilla-Zarate, Carlos; Lopez Narvaez, Lilia] Ctr Invest Genom, Comalcalco, Tabasco, Mexico	Universidad Juarez Autonoma de Tabasco; Universidad Juarez Autonoma de Tabasco	Tovilla-Zarate, C (corresponding author), Univ Juarez Autonoma Tabasco, Div Acad Multidisciplinaria Comalcalco, Comalcalco, Tabasco, Mexico.	alfonso_tovillaz@yahoo.com.mx	Juarez Rojop, Isela Esther/G-4832-2016; Tovilla-Zárate, Carlos Alfonso/AAC-3260-2021	Juarez Rojop, Isela Esther/0000-0003-3760-7394; Tovilla-Zárate, Carlos Alfonso/0000-0001-8170-8171; Genis-Mendoza, Alma/0000-0001-8180-477X; Bermudez-Ocana, Deysi/0000-0002-9750-7670	Universidad Juarez Autonoma de Tabasco P.O.A. [20111282]	Universidad Juarez Autonoma de Tabasco P.O.A.	This study was supported by Universidad Juarez Autonoma de Tabasco P.O.A. 20111282. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almawi W, 2008, J ENDOCRINOL INVEST, V31, P1020, DOI 10.1007/BF03345642; Balhara Yatan Pal Singh, 2011, Indian J Endocrinol Metab, V15, pS50, DOI 10.4103/2230-8210.83057; Bouwman V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009971; Castro-Ake Gilberto Alejandro, 2009, Rev Med Inst Mex Seguro Soc, V47, P377; Champaneri S, 2010, CURR DIABETES REP, V10, P396, DOI 10.1007/s11892-010-0148-9; Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x; Colunga-Rodríguez Cecilia, 2008, Rev. salud pública, V10, P137, DOI 10.1590/S0124-00642008000100013; Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214; Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464; Furuya M, 2010, ACTA DIABETOLOGICA; Garduno-Espinosa J, 1998, REV INVEST CLIN, V50, P287; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Iype T, 2009, ANN INDIAN ACAD NEUR, V12, P25, DOI 10.4103/0972-2327.48848; JoaquIn Z, 2007, SALUD MENT, V30, P4; Katon W, 2010, DEPRESS ANXIETY, V27, P19, DOI 10.1002/da.20613; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Khuwaja AK, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-72; Khuwaja AK, 2010, CHRONIC ILLN, V6, P163, DOI 10.1177/1742395309352255; Kim TS, 2011, PSYCHIAT INVEST, V8, P1, DOI 10.4306/pi.2011.8.1.1; Kummer A, 2010, ARQ NEURO-PSIQUIAT, V68, P495, DOI 10.1590/S0004-282X2010000400005; Lin EHB, 2009, ANN FAM MED, V7, P414, DOI 10.1370/afm.998; Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068; Maharaj RG, 2005, W INDIAN MED J, V54, P369; McDade-Montez EA, 2011, ANN BEHAV MED PUBLIC; Medina-Mora ME, 2003, SALUD MENT, V26, P1; Mirza I, 2004, BMJ-BRIT MED J, V328, P794, DOI 10.1136/bmj.328.7443.794; Mosaku K, 2008, J NATL MED ASSOC, V100, P73, DOI 10.1016/S0027-9684(15)31178-0; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Olaiz G, 2006, ENCUESTA NACL SALUD; Pulido-Criollo F, 2009, REV PANAM SALUD PUBL, V26, P209, DOI 10.1590/S1020-49892009000900004; Shear MK, 2001, DEPRESS ANXIETY, V13, P166, DOI 10.1002/da.1033; Stein DJ, 2004, LANCET, V364, P233, DOI 10.1016/S0140-6736(04)16693-2; Trento M, 2011, CROSS SECTIONAL SURV; Vogelzangs N, 2007, PSYCHONEUROENDOCRINO, V32, P151, DOI 10.1016/j.psyneuen.2006.11.009	36	69	73	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36887	10.1371/journal.pone.0036887	http://dx.doi.org/10.1371/journal.pone.0036887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629339	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500034
J	Yang, Y; Shi, ZY; Reheman, A; Jin, JW; Li, CL; Wang, YM; Andrews, MC; Chen, PG; Zhu, GH; Ling, WH; Ni, HY				Yang, Yan; Shi, Zhenyin; Reheman, Adili; Jin, Joseph W.; Li, Conglei; Wang, Yiming; Andrews, Marc C.; Chen, Pingguo; Zhu, Guangheng; Ling, Wenhua; Ni, Heyu			Plant Food Delphinidin-3-Glucoside Significantly Inhibits Platelet Activation and Thrombosis: Novel Protective Roles against Cardiovascular Diseases	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; PROTEIN-KINASE; DIETARY POLYPHENOLS; SIGNALING PATHWAY; ALPHA-GRANULES; GRAPE JUICE; IN-VITRO; ANTHOCYANINS; SUPPLEMENTATION; FIBRINOGEN	Delphinidin-3-glucoside (Dp-3-g) is one of the predominant bioactive compounds of anthocyanins in many plant foods. Although several anthocyanin compounds have been reported to be protective against cardiovascular diseases (CVDs), the direct effect of anthocyanins on platelets, the key players in atherothrombosis, has not been studied. The roles of Dp-3-g in platelet function are completely unknown. The present study investigated the effects of Dp-3-g on platelet activation and several thrombosis models in vitro and in vivo. We found that Dp-3-g significantly inhibited human and murine platelet aggregation in both platelet-rich plasma and purified platelets. It also markedly reduced thrombus growth in human and murine blood in perfusion chambers at both low and high shear rates. Using intravital microscopy, we observed that Dp-3-g decreased platelet deposition, destabilized thrombi, and prolonged the time required for vessel occlusion. Dp-3-g also significantly inhibited thrombus growth in a carotid artery thrombosis model. To elucidate the mechanisms, we examined platelet activation markers via flow cytometry and found that Dp-3-g significantly inhibited the expression of P-selectin, CD63, CD40L, which reflect platelet alpha- and delta-granule release, and cytosol protein secretion, respectively. We further demonstrated that Dp-3-g downregulated the expression of active integrin alpha IIb beta 3 on platelets, and attenuated fibrinogen binding to platelets following agonist treatment, without interfering with the direct interaction between fibrinogen and integrin alpha IIb beta 3. We found that Dp-3-g reduced phosphorylation of adenosine monophosphate-activated protein kinase, which may contribute to the observed inhibitory effects on platelet activation. Thus, Dp-3-g significantly inhibits platelet activation and attenuates thrombus growth at both arterial and venous shear stresses, which likely contributes to its protective roles against thrombosis and CVDs.	[Yang, Yan; Jin, Joseph W.; Wang, Yiming; Chen, Pingguo; Ni, Heyu] Canadian Blood Serv, Toronto, ON, Canada; [Yang, Yan; Shi, Zhenyin; Ling, Wenhua; Ni, Heyu] Sun Yat Sen Univ, Dept Nutr, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Yan; Reheman, Adili; Jin, Joseph W.; Li, Conglei; Wang, Yiming; Andrews, Marc C.; Chen, Pingguo; Zhu, Guangheng; Ni, Heyu] St Michaels Hosp, Toronto Platelet Immunobiol Grp, Dept Lab Med, Toronto, ON M5B 1W8, Canada; [Yang, Yan; Reheman, Adili; Jin, Joseph W.; Li, Conglei; Wang, Yiming; Andrews, Marc C.; Chen, Pingguo; Zhu, Guangheng; Ni, Heyu] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Yang, Yan; Li, Conglei; Wang, Yiming; Ni, Heyu] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Andrews, Marc C.; Ni, Heyu] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Ni, Heyu] Univ Toronto, Dept Med, Toronto, ON, Canada	Canadian Blood Services; Sun Yat Sen University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto	Yang, Y (corresponding author), Canadian Blood Serv, Toronto, ON, Canada.	yangyan3@mail.sysu.edu.cn; Nih@smh.ca		Ni, Heyu/0000-0002-7621-2945; Wang, Yiming/0000-0001-8031-6184; Yang, Yan/0000-0002-5662-4600	Canadian Institutes of Health Research; National Natural Science Foundation of China (China-Canada Joint Health Research Initiative Program); Heart and Stroke Foundation of Canada (Ontario); National Natural Science Foundation of China Research [30972481]; St. Michael's Hospital, Canadian Blood Services; Canada Foundation for Innovation; Canadian Blood Services postdoctoral fellowship award; Ph.D. Graduate Fellowship from Canadian Blood Services; Connaught Scholarships, University of Toronto; Heart and Stroke Foundation of Canada postdoctoral fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China (China-Canada Joint Health Research Initiative Program); Heart and Stroke Foundation of Canada (Ontario)(Heart & Stroke Foundation of Canada); National Natural Science Foundation of China Research(National Natural Science Foundation of China (NSFC)); St. Michael's Hospital, Canadian Blood Services; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Blood Services postdoctoral fellowship award; Ph.D. Graduate Fellowship from Canadian Blood Services; Connaught Scholarships, University of Toronto; Heart and Stroke Foundation of Canada postdoctoral fellowship(Heart & Stroke Foundation of Canada)	This work was supported by Canadian Institutes of Health Research and National Natural Science Foundation of China (China-Canada Joint Health Research Initiative Program), Heart and Stroke Foundation of Canada (Ontario), and National Natural Science Foundation of China Research Grants (No. 30972481). Equipment Funds from St. Michael's Hospital, Canadian Blood Services and Canada Foundation for Innovation. YY is a recipient of the Canadian Blood Services postdoctoral fellowship award. YW is a recipient of a Ph.D. Graduate Fellowship from Canadian Blood Services. CL is a recipient of Connaught Scholarships, University of Toronto. JWJ is a recipient of the Canadian Blood Services postdoctoral fellowship award, and the Heart and Stroke Foundation of Canada postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdel-Aal ESM, 2008, J AGR FOOD CHEM, V56, P11171, DOI 10.1021/jf802168c; Auger C, 2010, MOL NUTR FOOD RES, V54, pS171, DOI 10.1002/mnfr.200900602; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Bishayee A, 2010, NAT PROD COMMUN, V5, P1613; Bitsch R, 2004, J BIOMED BIOTECHNOL, P293, DOI 10.1155/S1110724304403106; Bouaziz A, 2007, ARCH BIOCHEM BIOPHYS, V457, P235, DOI 10.1016/j.abb.2006.10.020; Chang H, 2010, NUTR CANCER, V62, P1128, DOI 10.1080/01635581.2010.494821; Chun OK, 2007, J NUTR, V137, P1244, DOI 10.1093/jn/137.5.1244; COLLER BS, 1989, CIRCULATION, V80, P1766, DOI 10.1161/01.CIR.80.6.1766; Conquer JA, 1998, J NUTR, V128, P593, DOI 10.1093/jn/128.3.593; DEMROW HS, 1995, CIRCULATION, V91, P1182, DOI 10.1161/01.CIR.91.4.1182; Freedman JE, 2001, CIRCULATION, V103, P2792, DOI 10.1161/01.CIR.103.23.2792; Garcia-Alonso M, 2009, J NUTR BIOCHEM, V20, P521, DOI 10.1016/j.jnutbio.2008.05.011; Griep LMO, 2011, BRIT J NUTR, V106, P1562, DOI 10.1017/S0007114511001942; Guerrero JA, 2007, BRIT J CLIN PHARMACO, V64, P133, DOI 10.1111/j.1365-2125.2007.02881.x; Guo HH, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-10; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Hosseinian FS, 2007, J AGR FOOD CHEM, V55, P10832, DOI 10.1021/jf072529m; Hubbard GP, 2004, J THROMB HAEMOST, V2, P2138, DOI 10.1111/j.1538-7836.2004.01067.x; Hubbard GP, 2003, P NUTR SOC, V62, P469, DOI 10.1079/PNS2003253; Hwang YP, 2011, NUTR RES, V31, P896, DOI 10.1016/j.nutres.2011.09.026; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Janssen PLTMK, 1998, AM J CLIN NUTR, V67, P255, DOI 10.1093/ajcn/67.2.255; Jirouskova M, 2004, BLOOD, V103, P1995, DOI 10.1182/blood-2003-10-3401; Lamy S, 2008, CARCINOGENESIS, V29, P1033, DOI 10.1093/carcin/bgn070; Langer HF, 2008, THROMB HAEMOSTASIS, V99, P480, DOI 10.1160/TH07-11-0685; Li CL, 2011, J CLIN INVEST, V121, P4537, DOI 10.1172/JCI57850; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Murphy KJ, 2003, AM J CLIN NUTR, V77, P1466, DOI 10.1093/ajcn/77.6.1466; Navarro-Nunez L, 2009, BRIT J PHARMACOL, V158, P1548, DOI 10.1111/j.1476-5381.2009.00440.x; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Ni HY, 2003, BLOOD, V102, P3609, DOI 10.1182/blood-2003-03-0850; Ni HY, 2003, TRANSFUS APHER SCI, V28, P257, DOI 10.1016/S1473-0502(03)00044-2; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; Ostertag LM, 2011, MOL NUTR FOOD RES, V55, P1624, DOI 10.1002/mnfr.201100135; Ostertag LM, 2010, MOL NUTR FOOD RES, V54, P60, DOI 10.1002/mnfr.200900172; Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814; Randriamboavonjy V, 2010, BLOOD, V116, P2134, DOI 10.1182/blood-2010-04-279612; Rechner AR, 2005, THROMB RES, V116, P327, DOI 10.1016/j.thromres.2005.01.002; Reheman A, 2005, J THROMB HAEMOST, V3, P875, DOI 10.1111/j.1538-7836.2005.01217.x; Reheman A, 2010, THROMB RES, V125, pE177, DOI 10.1016/j.thromres.2010.01.009; Reheman A, 2009, BLOOD, V113, P1809, DOI 10.1182/blood-2008-04-148361; Rein D, 2000, J NUTR, V130, p2120S, DOI 10.1093/jn/130.8.2120S; Rein D, 2000, AM J CLIN NUTR, V72, P30; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Wallace TC, 2011, ADV NUTR, V2, P1, DOI 10.3945/an.110.000042; Wang Q, 2007, ASIA PAC J CLIN NUTR, V16, P295; Wei XY, 2011, J SCI FOOD AGR, V91, P1006, DOI 10.1002/jsfa.4275; Xia M, 2007, ARTERIOSCL THROM VAS, V27, P519, DOI 10.1161/01.ATV.0000254672.04573.2d; Xia M, 2009, ATHEROSCLEROSIS, V202, P41, DOI 10.1016/j.atherosclerosis.2008.04.005; Yamamoto J, 2006, PLATELETS, V17, P555, DOI 10.1080/09537100600759295; Yang CS, 2008, MOL NUTR FOOD RES, V52, pS139, DOI 10.1002/mnfr.200700234; Yang H, 2006, J THROMB HAEMOST, V4, P2230, DOI 10.1111/j.1538-7836.2006.02116.x; Yang H, 2009, BLOOD, V114, P425, DOI 10.1182/blood-2008-03-145821; Yang Y, 2011, J AGR FOOD CHEM, V59, P6759, DOI 10.1021/jf201079h; Zamora-Ros R, 2011, BRIT J NUTR, V106, P1090, DOI [10.1017/S0007114511006386, 10.1017/S0007114511001437]; Zhang YH, 2010, INFLAMM RES, V59, P723, DOI 10.1007/s00011-010-0183-7; Zhu YN, 2011, CLIN CHEM, V57, P1524, DOI 10.1373/clinchem.2011.167361; Zimmerman GA, 2008, ARTERIOSCL THROM VAS, V28, pS17, DOI 10.1161/ATVBAHA.107.160218	60	63	69	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37323	10.1371/journal.pone.0037323	http://dx.doi.org/10.1371/journal.pone.0037323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624015	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500098
J	Zhu, HP; Xia, X; Xiang, HY; Yu, CH; Du, YK				Zhu, Hui-ping; Xia, Xin; Xiang, Hui-yun; Yu, Chuan-hua; Du, Yu-kai			Disability, Home Physical Environment and Non-Fatal Injuries among Young Children in China	PLOS ONE			English	Article							UNINTENTIONAL INJURY; PUBLIC-HEALTH; US CHILDREN; RISK; PREVALENCE; COUNTRIES; MOTHERS; RECALL; PEOPLE; ADULTS	Objectives: We compared the patterns of medically attended injuries between children with and without disabilities and explored the residential environment risks in five counties of Hubei Province in the People's Republic of China by a 1: 1 matched case-control study based on the biopsychosocial model of the International Classification of Functioning, Disability and Health - ICF. Methods: 1201 children aged 1-14 with disabilities and 1201 their healthy counterparts matched as having the same gender, same age, and lived in the same neighborhood were recruited in our study. Characteristics of injuries in the past 12 months were compared between children with and without disabilities. The associations among disability status, home environment factors and injuries were examined in logistic regression analysis taking into account sociodemographic factors. Results: Children with disabilities had a significantly higher prevalence of injury than children without disabilities (10.2% vs. 4.4%; P<.001). The two groups differed significantly in terms of number of injury episodes, injury place and activity at time of injury. Falls were the leading mechanism of injury regardless of disability status. Most of the injury events happened inside the home and leisure activities were the most reported activity when injured for both groups. The univariate OR for injury was 4.46 (2.57-7.74) for the disabled children compared with the non-disabled children. Disabled children whose family raised cat/dog(s) were 76% more likely to be injured during the last 12 months (OR = 1.76; 95% CI = 1.02, 3.02), comparing with those whose family did not have any cat/dog. And for children without disabilities, those whose family had cat/dog(s) were over 3 times more likely to having injuries comparing with those whose family did not have any cat/dog. Conclusions: Children with disabilities had a significantly increased risk for injury. Interventions to prevent residential injury are an important public health priority in children with disabilities.	[Zhu, Hui-ping; Du, Yu-kai] Huazhong Univ Sci & Technol, Dept Maternal & Child Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Xia, Xin] Wuhan Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan 430072, Peoples R China; [Xiang, Hui-yun] Ohio State Univ, Res Inst, Ctr Injury Res & Policy, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Yu, Chuan-hua] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Wuhan 430072, Peoples R China	Huazhong University of Science & Technology; Wuhan University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Wuhan University	Zhu, HP (corresponding author), Huazhong Univ Sci & Technol, Dept Maternal & Child Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China.	birdping@163.com	Xiang, Huiyun/E-4335-2011		USA-China Agricultural Injury Research Training Project; National Institutes of Health Fogarty International Center [1D43TW007257-01A2]; FOGARTY INTERNATIONAL CENTER [D43TW007257] Funding Source: NIH RePORTER	USA-China Agricultural Injury Research Training Project; National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	HYX's effort in this project was supported by the USA-China Agricultural Injury Research Training Project, funded by the National Institutes of Health Fogarty International Center (Grant #: 1D43TW007257-01A2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahmed MK, 1999, INT J EPIDEMIOL, V28, P306, DOI 10.1093/ije/28.2.306; Bang RL, 1997, EUR J EPIDEMIOL, V13, P33, DOI 10.1023/A:1007368014623; Bartlett SN, 2002, HEALTH POLICY PLANN, V17, P1, DOI 10.1093/heapol/17.1.1; Gauchard GC, 2006, NEUROEPIDEMIOLOGY, V26, P108, DOI 10.1159/000090445; Gottlieb CA, 2009, LANCET, V374, P1831, DOI 10.1016/S0140-6736(09)61871-7; HAREL Y, 1994, AM J PUBLIC HEALTH, V84, P599, DOI 10.2105/AJPH.84.4.599; Hawkins ER, 2007, PEDIATR EMERG CARE, V23, P790, DOI 10.1097/PEC.0b013e318159ffd9; Hsieh K, 2001, J INTELL DISABIL RES, V45, P76, DOI 10.1046/j.1365-2788.2001.00277.x; Jette AM, 2009, J GERONTOL A-BIOL, V64, P1165, DOI 10.1093/gerona/glp093; Jin HQ, 1999, CHIN J ERGONOMICS, V1, P1; Kinne S, 2004, AM J PUBLIC HEALTH, V94, P443, DOI 10.2105/AJPH.94.3.443; LANDEN DD, 1995, PUBLIC HEALTH REP, V110, P350; LeBlanc JC, 2006, CAN MED ASSOC J, V175, P883, DOI 10.1503/cmaj.050592; Lee LC, 2008, RES DEV DISABIL, V29, P247, DOI 10.1016/j.ridd.2007.05.002; Leff M, 2010, INJURY PREV, V16, DOI 10.1136/ip.2010.028522; Legood R, 2002, INJ PREV, V8, P155, DOI 10.1136/ip.8.2.155; Limbos MAP, 2004, ARCH PEDIAT ADOL MED, V158, P1057, DOI 10.1001/archpedi.158.11.1057; Lollar DJ, 2002, PUBLIC HEALTH REP, V117, P131, DOI 10.1093/phr/117.2.131; Lyons RA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003600.pub2; Mehta A, 1996, J Indian Med Assoc, V94, P219; Mull DS, 2001, SOC SCI MED, V52, P1081, DOI 10.1016/S0277-9536(00)00215-X; National Bureau of Statistics of China and China Disabled Person's Federation, MAJ DAT COMM 2 2 NAT; Petridou E, 2003, INJURY PREV, V9, P226, DOI 10.1136/ip.9.3.226; Qiu HX, 1998, CHIN J EPIDEMIOL, V4, P211; Ramirez M, 2010, ACAD PEDIATR, V10, P317, DOI 10.1016/j.acap.2010.06.003; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Schwebel DC, 2006, J SAFETY RES, V37, P167, DOI 10.1016/j.jsr.2005.11.004; Schwebel David C, 2009, Int Emerg Nurs, V17, P47, DOI 10.1016/j.ienj.2008.07.003; Sherrard J, 2001, Inj Prev, V7, P56; Sherrard J, 2002, J INTELL DISABIL RES, V46, P6, DOI 10.1046/j.1365-2788.2002.00346.x; Sinclair SA, 2008, AM J PUBLIC HEALTH, V98, P1510, DOI 10.2105/AJPH.2006.097097; Slayter EM, 2006, MENT RETARD, V44, P212, DOI 10.1352/0047-6765(2006)44[212:IPACAA]2.0.CO;2; Soubhi H, 2004, AM J HEALTH BEHAV, V28, P397; UN Enable, FREQ ASK QUEST REG C; United Nations Children's Fund. Early Child Development Unit, PROGR EXP EARL CHILD; Wang SY, 1998, LIT INFORMATION PREV, V4, P299; Wilber N, 2002, MILBANK Q, V80, P393, DOI 10.1111/1468-0009.00009; World Health Organization, 2002, COMMON LANGUAGE FUNC; World Health Organization. Disability and Rehabilitation Team, WORLD REP DIS REH; Xiang H, 2005, INJURY PREV, V11, P157, DOI 10.1136/ip.2004.006429; Xiang HY, 2005, AM J PUBLIC HEALTH, V95, P1970, DOI 10.2105/AJPH.2004.057505	42	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37766	10.1371/journal.pone.0037766	http://dx.doi.org/10.1371/journal.pone.0037766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22624063	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343500152
J	Kang, SO; Wright, JO; Tesorero, RA; Lee, H; Beall, B; Cho, KH				Kang, Song Ok; Wright, Jordan O.; Tesorero, Rafael A.; Lee, Hyunwoo; Beall, Bernard; Cho, Kyu Hong			Thermoregulation of Capsule Production by Streptococcus pyogenes	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; HYALURONIC-ACID CAPSULE; VIRULENCE GENE-EXPRESSION; LISTERIA-MONOCYTOGENES; H-NS; MOLECULAR CHARACTERIZATION; M-PROTEIN; SHIGELLA-FLEXNERI; BACILLUS-SUBTILIS; TRANSCRIPTIONAL CONTROL	The capsule of Streptococcus pyogenes serves as an adhesin as well as an anti-phagocytic factor by binding to CD44 on keratinocytes of the pharyngeal mucosa and the skin, the main entry sites of the pathogen. We discovered that S. pyogenes HSC5 and MGAS315 strains are further thermoregulated for capsule production at a post-transcriptional level in addition to the transcriptional regulation by the CovRS two-component regulatory system. When the transcription of the hasABC capsular biosynthetic locus was de-repressed through mutation of the covRS system, the two strains, which have been used for pathogenesis studies in the laboratory, exhibited markedly increased capsule production at sub-body temperature. Employing transposon mutagenesis, we found that CvfA, a previously identified membrane-associated endoribonuclease, is required for the thermoregulation of capsule synthesis. The mutation of the cvfA gene conferred increased capsule production regardless of temperature. However, the amount of the capsule transcript was not changed by the mutation, indicating that a post-transcriptional regulator mediates between CvfA and thermoregulated capsule production. When we tested naturally occurring invasive mucoid strains, a high percentage (11/53, 21%) of the strains exhibited thermoregulated capsule production. As expected, the mucoid phenotype of these strains at sub-body temperature was due to mutations within the chromosomal covRS genes. Capsule thermoregulation that exhibits high capsule production at lower temperatures that occur on the skin or mucosal surface potentially confers better capability of adhesion and invasion when S. pyogenes penetrates the epithelial surface.	[Kang, Song Ok; Wright, Jordan O.; Tesorero, Rafael A.; Cho, Kyu Hong] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA; [Lee, Hyunwoo] Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL USA; [Beall, Bernard] Ctr Dis Control & Prevent, Streptococcus Lab, Atlanta, GA USA	Southern Illinois University System; Southern Illinois University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Centers for Disease Control & Prevention - USA	Kang, SO (corresponding author), So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.	cho@micro.siu.edu		Tesorero, Rafael/0000-0002-1636-0954	Scientist Development Grant from the American Heart Association [11SDG7440083]	Scientist Development Grant from the American Heart Association(American Heart Association)	This work was supported by Scientist Development Grant 11SDG7440083 from the American Heart Association. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Alverson J, 2003, MOL MICROBIOL, V48, P1665, DOI 10.1046/j.1365-2958.2003.03537.x; Ashbaugh CD, 1998, J BACTERIOL, V180, P4955, DOI 10.1128/JB.180.18.4955-4959.1998; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BENCHETRIT LC, 1977, ANAL BIOCHEM, V79, P431, DOI 10.1016/0003-2697(77)90418-3; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Bernish B, 1999, J BIOL CHEM, V274, P4786, DOI 10.1074/jbc.274.8.4786; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Cho KH, 2008, INFECT IMMUN, V76, P3176, DOI 10.1128/IAI.01721-07; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; CRATER DL, 1995, J BIOL CHEM, V270, P18452, DOI 10.1074/jbc.270.31.18452; CRATER DL, 1995, J BIOL CHEM, V270, P28676, DOI 10.1074/jbc.270.48.28676; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; DONS L, 1992, MOL MICROBIOL, V6, P2919, DOI 10.1111/j.1365-2958.1992.tb01751.x; DONS L, 1994, DNA SEQUENCE, V4, P301, DOI 10.3109/10425179409020856; Dorman CJ, 1998, MOL MICROBIOL, V29, P677, DOI 10.1046/j.1365-2958.1998.00902.x; DOUGHERTY BA, 1994, J BIOL CHEM, V269, P169; DOUGHERTY BA, 1993, J BIOL CHEM, V268, P7118; DOUGHERTY BA, 1992, J EXP MED, V175, P1291, DOI 10.1084/jem.175.5.1291; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Federle MJ, 2002, MOL MICROBIOL, V43, P1161, DOI 10.1046/j.1365-2958.2002.02810.x; Froehlich BJ, 2009, J BACTERIOL, V191, P673, DOI 10.1128/JB.01256-08; Ghosh J, 2006, MOL MICROBIOL, V62, P1203, DOI 10.1111/j.1365-2958.2006.05430.x; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Granok AB, 2000, J BACTERIOL, V182, P1529, DOI 10.1128/JB.182.6.1529-1540.2000; Grundling A, 2004, P NATL ACAD SCI USA, V101, P12318, DOI 10.1073/pnas.0404924101; Gryllos I, 2008, P NATL ACAD SCI USA, V105, P16755, DOI 10.1073/pnas.0803815105; Gryllos I, 2007, MOL MICROBIOL, V65, P671, DOI 10.1111/j.1365-2958.2007.05818.x; HANSKI E, 1992, INFECT IMMUN, V60, P5119, DOI 10.1128/IAI.60.12.5119-5125.1992; HOE NP, 1993, J BACTERIOL, V175, P7901, DOI 10.1128/JB.175.24.7901-7909.1993; HULTON CSJ, 1990, CELL, V63, P631, DOI 10.1016/0092-8674(90)90458-Q; Hurme R, 1997, CELL, V90, P55, DOI 10.1016/S0092-8674(00)80313-X; Husmann LK, 1997, INFECT IMMUN, V65, P1422, DOI 10.1128/IAI.65.4.1422-1430.1997; Hynes WL, 2000, FEMS MICROBIOL LETT, V184, P109, DOI 10.1016/S0378-1097(00)00029-X; HYNES WL, 1995, INFECT IMMUN, V63, P3015, DOI 10.1128/IAI.63.8.3015-3020.1995; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Kang SO, 2010, INFECT IMMUN, V78, P2754, DOI 10.1128/IAI.01370-09; Kass EH, 1944, J EXP MED, V79, P319, DOI 10.1084/jem.79.3.319; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Lambers H., 2006, International Journal of Cosmetic Science, V28, P359, DOI 10.1111/j.1467-2494.2006.00344.x; Lehnik-Habrink M, 2010, MOL MICROBIOL, V77, P958, DOI 10.1111/j.1365-2958.2010.07264.x; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Los DA, 2004, CELL MOL BIOL, V50, P605; Loughman JA, 2006, J BACTERIOL, V188, P399, DOI 10.1128/JB.188.2.399-408.2006; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; Lyon WR, 2001, MOL MICROBIOL, V42, P145, DOI 10.1046/j.1365-2958.2001.02616.x; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Neely MN, 2003, J BACTERIOL, V185, P5166, DOI 10.1128/JB.185.17.5166-5174.2003; OKADA N, 1993, MOL MICROBIOL, V7, P893, DOI 10.1111/j.1365-2958.1993.tb01180.x; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; PEREZCASAL J, 1991, J BACTERIOL, V173, P2617, DOI 10.1128/jb.173.8.2617-2624.1991; PORTER ME, 1994, J BACTERIOL, V176, P4187, DOI 10.1128/JB.176.13.4187-4191.1994; Rohde JR, 1999, J BACTERIOL, V181, P4198, DOI 10.1128/JB.181.14.4198-4204.1999; Schmidt KH, 1996, MED MICROBIOL IMMUN, V184, P169, DOI 10.1007/PL00008248; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Schrager HM, 1996, J CLIN INVEST, V98, P1954, DOI 10.1172/JCI118998; SCOTT JR, 1974, VIROLOGY, V62, P344, DOI 10.1016/0042-6822(74)90397-3; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Shen A, 2006, PLOS PATHOG, V2, P282, DOI 10.1371/journal.ppat.0020030; SMITH RF, 1968, APPL MICROBIOL, V16, P1434, DOI 10.1128/AEM.16.9.1434-1436.1968; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Starr CR, 2006, INFECT IMMUN, V74, P40, DOI 10.1128/IAI.74.1.40-48.2006; TOBE T, 1995, J BACTERIOL, V177, P1094, DOI 10.1128/jb.177.4.1094-1097.1995; TOBE T, 1993, J BACTERIOL, V175, P6142, DOI 10.1128/JB.175.19.6142-6149.1993; WEISS AA, 1983, INFECT IMMUN, V42, P33, DOI 10.1128/IAI.42.1.33-41.1983; WESSELS MR, 1994, P NATL ACAD SCI USA, V91, P12238, DOI 10.1073/pnas.91.25.12238; WESSELS MR, 1994, INFECT IMMUN, V62, P433, DOI 10.1128/IAI.62.2.433-441.1994	78	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37367	10.1371/journal.pone.0037367	http://dx.doi.org/10.1371/journal.pone.0037367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615992	Green Published, gold			2022-12-25	WOS:000305341200069
J	Hatori, Y; Clasen, S; Hasan, NM; Barry, AN; Lutsenko, S				Hatori, Yuta; Clasen, Sara; Hasan, Nesrin M.; Barry, Amanda N.; Lutsenko, Svetlana			Functional Partnership of the Copper Export Machinery and Glutathione Balance in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL HOMEOSTASIS; ESCHERICHIA-COLI; WILSONS-DISEASE; CHAPERONE CCS; PROTEIN; REDOX; OXYGEN; THIOREDOXIN; METABOLISM; ATOX1	Cells use the redox properties of copper in numerous physiologic processes, including antioxidant defense, neurotransmitter biosynthesis, and angiogenesis. Copper delivery to the secretory pathway is an essential step in copper utilization and homeostatic maintenance. We demonstrate that the glutathione/glutathione disulfide (GSH/GSSG) pair controls the copper transport pathway by regulating the redox state of a copper chaperone Atox1. GSSG oxidizes copper-coordinating cysteines of Atox1 with the formation of an intramolecular disulfide. GSH alone is sufficient to reduce the disulfide, restoring the ability of Atox1 to bind copper; glutaredoxin 1 facilitates this reaction when GSH is low. In cells, high GSH both reduces Atox1 and is required for cell viability in the absence of Atox1. In turn, Atox1, which has a redox potential similar to that of glutaredoxin, becomes essential for cell survival when GSH levels decrease. Atox1(+/+) cells resist short term glutathione depletion, whereas Atox1(-/-) cells under the same conditions are not viable. We conclude that GSH balance and copper homeostasis are functionally linked and jointly maintain conditions for copper secretion and cell proliferation.	[Hatori, Yuta; Clasen, Sara; Hasan, Nesrin M.; Barry, Amanda N.; Lutsenko, Svetlana] Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Lutsenko, S (corresponding author), Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA.	lutsenko@jhmi.edu		Barry, Amanda/0000-0002-7992-0322	National Institutes of Health [R01 DK071865]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK071865 (to S. L.).	Anastassopoulou I, 2004, BIOCHEMISTRY-US, V43, P13046, DOI 10.1021/bi0487591; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Badarau A, 2011, J AM CHEM SOC, V133, P2983, DOI 10.1021/ja1091547; Banci L, 2008, P NATL ACAD SCI USA, V105, P6803, DOI 10.1073/pnas.0800019105; Barry AN, 2010, J BIOL INORG CHEM, V15, P47, DOI 10.1007/s00775-009-0595-4; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Boal AK, 2009, J AM CHEM SOC, V131, P14196, DOI 10.1021/ja906363t; Burkhead JL, 2011, J MOL BIOL, V406, P44, DOI 10.1016/j.jmb.2010.12.001; Culotta VC, 1999, ADV EXP MED BIOL, V448, P247; Filomeni G, 2006, ANTIOXID REDOX SIGN, V8, P2187, DOI 10.1089/ars.2006.8.2187; FREEDMAN JH, 1989, J BIOL CHEM, V264, P5598; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Gupta A, 2011, P NATL ACAD SCI USA, V108, P5390, DOI 10.1073/pnas.1014959108; Hamza I, 2001, P NATL ACAD SCI USA, V98, P6848, DOI 10.1073/pnas.111058498; Helbig K, 2008, J BACTERIOL, V190, P5431, DOI 10.1128/JB.00271-08; Hussain F, 2008, P NATL ACAD SCI USA, V105, P11158, DOI 10.1073/pnas.0802928105; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Huster D, 2007, MOL BIOSYST, V3, P816, DOI 10.1039/b711118p; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Kelner GS, 2000, J BIOL CHEM, V275, P580, DOI 10.1074/jbc.275.1.580; Kirlin WG, 1999, FREE RADICAL BIO MED, V27, P1208, DOI 10.1016/S0891-5849(99)00145-8; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Leitch JM, 2009, J BIOL CHEM, V284, P21863, DOI 10.1074/jbc.M109.000489; LeShane ES, 2010, J BIOL CHEM, V285, P6327, DOI 10.1074/jbc.M109.074633; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; LIZARD G, 1995, CYTOMETRY, V21, P275, DOI 10.1002/cyto.990210308; Lutsenko S, 2008, ARCH BIOCHEM BIOPHYS, V476, P22, DOI 10.1016/j.abb.2008.05.005; Mitozo PA, 2011, FREE RADICAL BIO MED, V51, P69, DOI 10.1016/j.freeradbiomed.2011.03.017; Miyayama T, 2009, TOXICOL APPL PHARM, V237, P205, DOI 10.1016/j.taap.2009.03.024; Mossner E, 1999, J BIOL CHEM, V274, P25254, DOI 10.1074/jbc.274.36.25254; NARTEY NO, 1987, LAB INVEST, V57, P397; Nkabyo YS, 2002, AM J PHYSIOL-GASTR L, V283, pG1352, DOI 10.1152/ajpgi.00183.2002; Ogra Y, 2010, J INORG BIOCHEM, V104, P858, DOI 10.1016/j.jinorgbio.2010.04.001; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Satoh T, 1996, BRAIN RES, V733, P9, DOI 10.1016/0006-8993(96)00527-6; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Singleton WCJ, 2010, J BIOL CHEM, V285, P27111, DOI 10.1074/jbc.M110.154468; Steveson TC, 2003, ENDOCRINOLOGY, V144, P188, DOI 10.1210/en.2002-220716; Suzuki KT, 2002, J INORG BIOCHEM, V88, P173, DOI 10.1016/S0162-0134(01)00376-2; Tapryal N, 2010, FREE RADICAL BIO MED, V48, P1492, DOI 10.1016/j.freeradbiomed.2010.02.029; WALKER FJ, 1990, J BIOL CHEM, V265, P1834	44	60	61	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26678	26687		10.1074/jbc.M112.381178	http://dx.doi.org/10.1074/jbc.M112.381178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22648419	hybrid, Green Published			2022-12-25	WOS:000307386000019
J	Whitcomb, SJ; Fierz, B; McGinty, RK; Holt, M; Ito, T; Muir, TW; Allis, CD				Whitcomb, Sarah J.; Fierz, Beat; McGinty, Robert K.; Holt, Matthew; Ito, Takashi; Muir, Tom W.; Allis, C. David			Histone Monoubiquitylation Position Determines Specificity and Direction of Enzymatic Cross-talk with Histone Methyltransferases Dot1L and PRC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CHROMATIN-STRUCTURE; H2B UBIQUITYLATION; TRANSCRIPTIONAL ACTIVATION; PROTEOLYTIC DIGESTION; UBIQUITIN LIGASE; GENE-EXPRESSION; H3 METHYLATION; ACTIVE GENES; HUMAN-CELLS	It is well established that chromatin is a destination for signal transduction, affecting many DNA-templated processes. Histone proteins in particular are extensively post-translationally modified. We are interested in how the complex repertoire of histone modifications is coordinately regulated to generate meaningful combinations of "marks" at physiologically relevant genomic locations. One important mechanism is "cross-talk" between pre-existing histone post-translational modifications and enzymes that subsequently add or remove modifications on chromatin. Here, we use chemically defined "designer" nucleosomes to investigate novel enzymatic cross-talk relationships between the most abundant histone ubiquitylation sites, H2AK119ub and H2BK120ub, and two important histone methyltransferases, Dot1L and PRC2. Although the presence of H2Bub in nucleosomes greatly stimulated Dot1L methylation of H3K79, we found that H2Aub did not influence Dot1L activity. In contrast, we show that H2Aub inhibited PRC2 methylation of H3K27, but H2Bub did not influence PRC2 activity. Taken together, these results highlight how the position of nucleosome monoubiquitylation affects the specificity and direction of cross-talk with enzymatic activities on chromatin.	[Whitcomb, Sarah J.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Holt, Matthew] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10065 USA; [Fierz, Beat; Muir, Tom W.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [McGinty, Robert K.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Ito, Takashi] Nagasaki Univ, Sch Med, Nagasaki 8528523, Japan	Rockefeller University; Rockefeller University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Nagasaki University	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, 1230 York Ave, New York, NY 10065 USA.	alliscd@rockefeller.edu	Muir, Tom/AHD-0860-2022; Fierz, Beat/H-3143-2012	Muir, Tom/0000-0001-9635-0344; Fierz, Beat/0000-0002-2991-3044; Whitcomb, Sarah/0000-0002-1392-1496	National Institutes of Health [2R01 GM040922-27]; Swiss National Science Foundation [PP00P3_133680]; The Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, R01GM107047, R01GM040922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); The Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01 GM040922-27. This work was also supported by Swiss National Science Foundation Grant PP00P3_133680 and The Rockefeller University.	Allis CD, 2011, CHEMBIOCHEM, V12, P264, DOI 10.1002/cbic.201000761; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BOHM L, 1980, EUR J BIOCHEM, V106, P525, DOI 10.1111/j.1432-1033.1980.tb04599.x; BOHM L, 1982, EUR J BIOCHEM, V123, P299, DOI 10.1111/j.1432-1033.1982.tb19767.x; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chatterjee C, 2010, J BIOL CHEM, V285, P11045, DOI 10.1074/jbc.R109.080291; Chatterjee C, 2010, NAT CHEM BIOL, V6, P267, DOI [10.1038/NCHEMBIO.315, 10.1038/nchembio.315]; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; McGinty RK, 2009, ACS CHEM BIOL, V4, P958, DOI 10.1021/cb9002255; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Richly H, 2010, NATURE, V468, P1124, DOI 10.1038/nature09574; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; VANHOLDE KE, 1980, BIOPHYS J, V32, P271, DOI 10.1016/S0006-3495(80)84956-3; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; WEST MHP, 1980, NUCLEIC ACIDS RES, V8, P4671, DOI 10.1093/nar/8.20.4671; Wu LP, 2011, MOL CELL, V43, P132, DOI 10.1016/j.molcel.2011.05.015; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005	45	29	30	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23718	23725		10.1074/jbc.M112.361824	http://dx.doi.org/10.1074/jbc.M112.361824			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22619169	Green Published, hybrid			2022-12-25	WOS:000306511300042
J	Lu, CM; Xie, G; Liu, MY; Zhu, H; Lei, BF				Lu, Chunmei; Xie, Gang; Liu, Mengyao; Zhu, Hui; Lei, Benfang			Direct Heme Transfer Reactions in the Group A Streptococcus Heme Acquisition Pathway	PLOS ONE			English	Article							CELL-SURFACE PROTEIN; BINDING PROTEIN; IRON; IDENTIFICATION; HTSA; HEMOGLOBIN; SYSTEM; SHP; TRANSPORT; DOMAIN	The heme acquisition machinery in Group A Streptococcus (GAS) consists of the surface proteins Shr and Shp and ATP-binding cassette transporter HtsABC. Shp cannot directly acquire heme from methemoglobin (metHb) but directly transfers its heme to HtsA. It has not been previously determined whether Shr directly relays heme from metHb to Shp. Thus, the complete pathway for heme acquisition from metHb by the GAS heme acquisition machinery has remained unclear. In this study, the metHb-to-Shr and Shr-to-Shp heme transfer reactions were characterized by spectroscopy, kinetics and protein-protein interaction analyses. Heme is efficiently transferred from the beta and alpha subunits of metHb to Shr with rates that are 7 and 60 times greater than those of the passive heme release from metHb, indicating that Shr directly acquires heme from metHb. The rapid heme transfer from Shr to Shp involves an initial heme donor/acceptor complex and a spectrally and kinetically detectable transfer intermediate, implying that heme is directly channeled from Shr to Shp. The present results show that Shr speeds up heme transfer from metHb to Shp, whereas Shp speeds up heme transfer from Shr to HtsA. Furthermore, the findings demonstrate that Shr can interact with metHb and Shp but not HtsA. Taken together with our published results on the Shp/HtsA reaction, these findings establish a model of the heme acquisition pathway in GAS in which Shr directly extracts heme from metHb and Shp relays it from Shr to HtsA.	[Lu, Chunmei; Zhu, Hui] Harbin Med Univ, Dept Physiol, Harbin, Peoples R China; [Xie, Gang; Liu, Mengyao; Zhu, Hui; Lei, Benfang] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA	Harbin Medical University; Montana State University System; Montana State University Bozeman	Lu, CM (corresponding author), Harbin Med Univ, Dept Physiol, Harbin, Peoples R China.	dzhuhui@yahoo.com.cn; blei@montana.edu		Lei, Benfang Lei/0000-0001-8133-6021	National Institutes of Health [AI095704, P20 RR-020185, GM103500-09]; Montana State University Agricultural Experimental Station; Scientific Research Foundation for the Returned Overseas Chinese Scholars; State of Education Ministry; Natural Science Foundation of Heilongjiang Province, China [LC2011C02]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montana State University Agricultural Experimental Station; Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State of Education Ministry; Natural Science Foundation of Heilongjiang Province, China(Natural Science Foundation of Heilongjiang Province); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health grants AI095704, P20 RR-020185, and GM103500-09, and the Montana State University Agricultural Experimental Station. The work done at Harbin Medical University was supported by a grant from the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State of Education Ministry and grant LC2011C02 from Natural Science Foundation of Heilongjiang Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2002, GENOME BIOL, V3; Ascoli F, 1981, Methods Enzymol, V76, P72; Bates CS, 2003, INFECT IMMUN, V71, P1042, DOI 10.1128/IAI.71.3.1042-1055.2003; Burkhard KA, 2007, J BIOL CHEM, V282, P15126, DOI 10.1074/jbc.M611121200; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Eichenbaum Z, 1996, INFECT IMMUN, V64, P5428, DOI 10.1128/IAI.64.12.5428-5429.1996; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Fuhrhop JH, PORPHYRINS METALLOPO, P804; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; KLEBBA PE, 1993, J BIOENERG BIOMEMBR, V25, P603; Lei BF, 2003, INFECT IMMUN, V71, P5962, DOI 10.1128/IAI.71.10.5962-5969.2003; Lei BF, 2002, INFECT IMMUN, V70, P4494, DOI 10.1128/IAI.70.8.4494-4500.2002; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Liu MY, 2005, INFECT IMMUN, V73, P5086, DOI 10.1128/IAI.73.8.5086-5092.2005; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nygaard TK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-82; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Ran YC, 2007, J BIOL CHEM, V282, P31380, DOI 10.1074/jbc.M705967200; Ran YC, 2010, BIOCHEMISTRY-US, V49, P2834, DOI 10.1021/bi901987h; Sook BR, 2008, BIOCHEMISTRY-US, V47, P2678, DOI 10.1021/bi701604y; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	31	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37556	10.1371/journal.pone.0037556	http://dx.doi.org/10.1371/journal.pone.0037556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649539	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335800058
J	Reilly, EC; Thompson, EA; Aspeslagh, S; Wands, JR; Elewaut, D; Brossay, L				Reilly, Emma C.; Thompson, Elizabeth A.; Aspeslagh, Sandrine; Wands, Jack R.; Elewaut, Dirk; Brossay, Laurent			Activated iNKT Cells Promote Memory CD8(+) T Cell Differentiation during Viral Infection	PLOS ONE			English	Article							INVARIANT NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; IMMUNE-RESPONSES; CUTTING EDGE; CYTOMEGALOVIRUS-INFECTION; PROTECTIVE IMMUNITY; INFLUENZA-VIRUS; KILLER; ANTIGEN; VACCINE	alpha-galactosylceramide (alpha-GalCer) is the prototypical lipid ligand for invariant NKT cells. Recent studies have proposed that alpha-GalCer is an effective adjuvant in vaccination against a range of immune challenges, however its mechanism of action has not been completely elucidated. A variety of delivery methods have been examined including pulsing dendritic cells with alpha-GalCer to optimize the potential of alpha-GalCer. These methods are currently being used in a variety of clinical trials in patients with advanced cancer but cannot be used in the context of vaccine development against pathogens due to their complexity. Using a simple delivery method, we evaluated alpha-GalCer adjuvant properties, using the mouse model for cytomegalovirus (MCMV). We measured several key parameters of the immune response to MCMV, including inflammation, effector, and central memory CD8(+) T cell responses. We found that alpha-GalCer injection at the time of the infection decreases viral titers, alters the kinetics of the inflammatory response, and promotes both increased frequencies and numbers of virus-specific memory CD8(+) T cells. Overall, our data suggest that iNKT cell activation by alpha-GalCer promotes the development of long-term protective immunity through increased fitness of central memory CD8(+) T cells, as a consequence of reduced inflammation.	[Reilly, Emma C.; Thompson, Elizabeth A.; Wands, Jack R.; Brossay, Laurent] Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Reilly, Emma C.; Thompson, Elizabeth A.; Wands, Jack R.; Brossay, Laurent] Brown Univ, Grad Program Pathobiol, Providence, RI 02912 USA; [Aspeslagh, Sandrine; Elewaut, Dirk] Univ Ghent, Fac Med & Hlth Sci, Dept Rheumatol, Lab Mol Immunol & Inflammat, B-9000 Ghent, Belgium	Brown University; Brown University; Ghent University	Reilly, EC (corresponding author), Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.	Laurent_Brossay@brown.edu	Thompson, Elizabeth A/M-4898-2017; Elewaut, Dirk/K-6831-2014	Thompson, Elizabeth A/0000-0001-8464-9904; Elewaut, Dirk/0000-0002-7468-974X; Brossay, Laurent/0000-0002-7497-8488	National Institutes of Health [AI46709, T32 5T32DK060415]; NCCR [1S10RR021051]; FWO; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046709, R21AI046709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCR(Swiss National Science Foundation (SNSF)); FWO(FWO); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health research grant AI46709 and an NCCR equipment grant 1S10RR021051 to LB. NIH T32 5T32DK060415 Training Program in Gastroenterology to ER. SA was supported by a FWO Flanders pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Butler NS, 2011, CELL MICROBIOL, V13, P925, DOI 10.1111/j.1462-5822.2011.01594.x; Carnaud C, 1999, J IMMUNOL, V163, P4647; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Dhodapkar MV, 2011, CLIN IMMUNOL, V140, P160, DOI 10.1016/j.clim.2010.12.010; Dubensky TW, 2010, SEMIN IMMUNOL, V22, P155, DOI 10.1016/j.smim.2010.04.007; Eberl G, 2000, EUR J IMMUNOL, V30, P985, DOI 10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E; Exley MA, 2001, J LEUKOCYTE BIOL, V69, P713; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889; Guillonneau C, 2009, P NATL ACAD SCI USA, V106, P3330, DOI 10.1073/pnas.0813309106; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; HENSON D, 1972, AM J PATHOL, V68, P183; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Ho LP, 2008, EUR J IMMUNOL, V38, P1913, DOI 10.1002/eji.200738017; Huang YX, 2008, VACCINE, V26, P1807, DOI 10.1016/j.vaccine.2008.02.002; Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002; JONJIC S, 1989, J EXP MED, V169, P1199, DOI 10.1084/jem.169.4.1199; JORDAN MC, 1977, J GEN VIROL, V37, P419, DOI 10.1099/0022-1317-37-2-419; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kamijuku, 2008, MUCOSAL IMMUNOLOGY; Kim S, 2008, J CLIN INVEST, V118, P2301, DOI [10.1172/JC133071, 10.1172/JCI33071]; Ko SY, 2005, J IMMUNOL, V175, P3309, DOI 10.4049/jimmunol.175.5.3309; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lefrancois L, 2010, IMMUNOL REV, V235, P206, DOI 10.1111/j.0105-2896.2010.00895.x; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; Nolz JC, 2011, ADV EXP MED BIOL, V780, P69, DOI 10.1007/978-1-4419-5632-3_7; Oki S, 2004, J CLIN INVEST, V113, P1631, DOI 10.1172/JCI200420862; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Polic B, 1998, J EXP MED, V188, P1047, DOI 10.1084/jem.188.6.1047; Renneson J, 2011, AM J PATHOL, V179, P1872, DOI 10.1016/j.ajpath.2011.06.023; Robbins SH, 2002, J IMMUNOL, V168, P2585, DOI 10.4049/jimmunol.168.6.2585; Sarkar S, 2007, J IMMUNOL, V179, P6704, DOI 10.4049/jimmunol.179.10.6704; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Schneiders FL, 2011, CLIN IMMUNOL, V140, P130, DOI 10.1016/j.clim.2010.11.010; Sierro S, 2005, EUR J IMMUNOL, V35, P1113, DOI 10.1002/eji.200425534; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; van Dommelen SLH, 2003, J VIROL, V77, P1877, DOI 10.1128/JVI.77.3.1877-1884.2003; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Wesley JD, 2005, J IMMUNOL, V174, P3864, DOI 10.4049/jimmunol.174.7.3864; Wesley JD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000106; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wiesel M, 2011, EUR J IMMUNOL; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Youn HJ, 2007, VACCINE, V25, P5189, DOI 10.1016/j.vaccine.2007.04.081; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	55	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37991	10.1371/journal.pone.0037991	http://dx.doi.org/10.1371/journal.pone.0037991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649570	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800090
J	Silva, LM; van Rossem, L; Jansen, PW; Hokken-Koelega, ACS; Moll, HA; Hofman, A; Mackenbach, JP; Jaddoe, VWV; Raat, H				Silva, Lindsay M.; van Rossem, Lenie; Jansen, Pauline W.; Hokken-Koelega, Anita C. S.; Moll, Henriette A.; Hofman, Albert; Mackenbach, Johan P.; Jaddoe, Vincent W. V.; Raat, Hein			Children of Low Socioeconomic Status Show Accelerated Linear Growth in Early Childhood; Results from the Generation R Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; MIDDLE-AGED MEN; BIRTH COHORT; FOLLOW-UP; MATERNAL SMOKING; GESTATIONAL-AGE; EARLY ADULTHOOD; BLOOD-PRESSURE; 1ST YEAR	Objective: People of low socioeconomic status are shorter than those of high socioeconomic status. The first two years of life being critical for height development, we hypothesized that a low socioeconomic status is associated with a slower linear growth in early childhood. We studied maternal educational level (high, mid-high, mid-low, and low) as a measure of socioeconomic status and its association with repeatedly measured height in children aged 0-2 years, and also examined to what extent known determinants of postnatal growth contribute to this association. Methods: This study was based on data from 2972 mothers with a Dutch ethnicity, and their children participating in The Generation R Study, a population-based cohort study in Rotterdam, the Netherlands (participation rate 61%). All children were born between April 2002 and January 2006. Height was measured at 2 months (mid-90% range 1.0-3.9), 6 months (mid-90% range 5.6-11.4), 14 months (mid-90% range 13.7-17.9) and 25 months of age (mid-90% range 23.6-29.6). Results: At 2 months, children in the lowest educational subgroup were shorter than those in the highest (difference: -0.87 cm; 95% CI: -1.16, -0.58). Between 1 and 18 months, they grew faster than their counterparts. By 14 months, children in the lowest educational subgroup were taller than those in the highest (difference at 14 months: 0.40 cm; 95% CI: 0.08,0.72). Adjustment for other determinants of postnatal growth did not explain the taller height. On the contrary, the differences became even larger (difference at 14 months: 0.61 cm; 95% CI: 0.26,0.95; and at 25 months: 1.00 cm; 95% CI: 0.57,1.43) Conclusions: Compared with children of high socioeconomic status, those of low socioeconomic status show an accelerated linear growth until the 18th month of life, leading to an overcompensation of their initial height deficit. The long-term consequences of these findings remain unclear and require further study.	[Silva, Lindsay M.; van Rossem, Lenie; Jansen, Pauline W.; Jaddoe, Vincent W. V.] Univ Med Ctr Rotterdam, Generat Study Grp R, Erasmus MC, Rotterdam, Netherlands; [Silva, Lindsay M.; Hokken-Koelega, Anita C. S.; Moll, Henriette A.; Jaddoe, Vincent W. V.] Univ Med Ctr Rotterdam, Dept Pediat, Erasmus MC, Rotterdam, Netherlands; [van Rossem, Lenie] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Jansen, Pauline W.] Univ Med Ctr Rotterdam, Dept Child & Adolescent Psychiat, Erasmus MC, Rotterdam, Netherlands; [Hofman, Albert] Univ Med Ctr Rotterdam, Dept Epidemiol, Erasmus MC, Rotterdam, Netherlands; [Mackenbach, Johan P.; Raat, Hein] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Silva, LM (corresponding author), Univ Med Ctr Rotterdam, Generat Study Grp R, Erasmus MC, Rotterdam, Netherlands.	l.silva@erasmusmc.nl	van Rossem, Lenie/GXH-0118-2022	Jansen, Pauline/0000-0001-7747-5803	Erasmus MC, University Medical Centre Rotterdam, Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw); Netherlands Organization for Scientific Research (NWO) [017.002.107]	Erasmus MC, University Medical Centre Rotterdam, Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Erasmus MC, University Medical Centre Rotterdam, Erasmus University Rotterdam, the Netherlands Organization for Health Research and Development (ZonMw), and the Netherlands Organization for Scientific Research (NWO) (017.002.107 to LMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, STAT NETHERLANDSALLO; [Anonymous], 2003, STAT NETHERLANDSSTAN; Botton J, 2008, AM J CLIN NUTR, V87, P1760, DOI 10.1093/ajcn/87.6.1760; Braveman P, 2001, PUBLIC HEALTH REP, V116, P449, DOI 10.1093/phr/116.5.449; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Cavelaars AEJM, 2000, ANN HUM BIOL, V27, P407, DOI 10.1080/03014460050044883; Colhoun HM, 1998, J HUM HYPERTENS, V12, P91, DOI 10.1038/sj.jhh.1000558; Spyrides MHC, 2008, J PEDIAT-BRAZIL, V84, P237, DOI [10.2223/JPED.1797, 10.1590/S0021-75572008000300009]; de Menezes RC, 2012, REV SAUDE PUBL, V45, P1079; Dewey KG, 2005, MATERN CHILD NUTR, V1, P11, DOI 10.1111/j.1740-8709.2004.00004.x; Dewey Kathryn G, 2003, J Hum Lact, V19, P9; Dowd JB, 2009, SOC SCI MED, V68, P699, DOI 10.1016/j.socscimed.2008.12.010; DRACHLER M. L., 2002, CENT EUR J PUBL HEAL, V10, P135; du Prel X, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-312; Dubois L, 2003, PUBLIC HEALTH NUTR, V6, P773, DOI 10.1079/PHN2003497; Fewtrell MS, 2000, DIABETOLOGIA, V43, P714, DOI 10.1007/s001250051368; Finch BK, 2011, ECON HUM BIOL, V9, P272, DOI 10.1016/j.ehb.2011.02.005; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Fredriks AM, 2003, EUR J PEDIATR, V162, P788, DOI 10.1007/s00431-003-1292-x; Fredriks AM, ACTA PAEDIAT, V93, P817; FREDRIKS AM, 2001, NED TIJDSCHR GENEES, V145, P1308; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; HEINIG MJ, 1993, AM J CLIN NUTR, V58, P152, DOI 10.1093/ajcn/58.2.152; HERNGREEN WP, 1994, ANN HUM BIOL, V21, P449, DOI 10.1080/03014469400003472; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Howe LD, 2012, J EPIDEMIOL COMMUN H, V66, P143, DOI 10.1136/jech.2010.113068; Jaddoe VWV, 2007, EUR J EPIDEMIOL, V22, P917, DOI 10.1007/s10654-007-9209-z; Jaddoe VWV, 2008, EUR J EPIDEMIOL, V23, P801, DOI 10.1007/s10654-008-9309-4; Jousilahti P, 2000, AM J EPIDEMIOL, V151, P1112, DOI 10.1093/oxfordjournals.aje.a010155; Kramer MS, 2004, J PEDIATR-US, V145, P600, DOI 10.1016/j.jpeds.2004.06.069; Laaksonen M, 2008, EUR J PUBLIC HEALTH, V18, P38, DOI 10.1093/eurpub/ckm051; Langenberg C, 2005, AM J PUBLIC HEALTH, V95, P628, DOI 10.2105/2004.046219; Langenberg C, 2003, J EPIDEMIOL COMMUN H, V57, P816, DOI 10.1136/jech.57.10.816; Law CM, 2002, CIRCULATION, V105, P1088, DOI 10.1161/hc0902.104677; Lawson DW, 2008, INT J EPIDEMIOL, V37, P1408, DOI 10.1093/ije/dyn116; Leunissen RWJ, 2008, J CLIN ENDOCR METAB, V93, P445, DOI 10.1210/jc.2007-1543; Li L, 2004, AM J CLIN NUTR, V80, P185; Lynch JW., 2000, SOCIAL EPIDEMIOLOGY, P13; Manor O, 2004, ANN EPIDEMIOL, V14, P453, DOI 10.1016/j.annepidem.2003.10.011; McNamee R, 2003, OCCUP ENVIRON MED, V60, P227, DOI 10.1136/oem.60.3.227; Mortensen LH, 2008, J EPIDEMIOL COMMUN H, V62, P325, DOI 10.1136/jech.2007.061473; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Parsons TJ, 2001, BRIT MED J, V323, P1331, DOI 10.1136/bmj.323.7325.1331; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Rubin DB, 2004, MULTIPLE IMPUTATION; Seguin L, 2005, J EPIDEMIOL COMMUN H, V59, P42, DOI 10.1136/jech.2004.020438; Silventoinen K, 2006, AM J EPIDEMIOL, V163, P615, DOI 10.1093/aje/kwj081; Singhal A, 2004, CIRCULATION, V109, P1108, DOI 10.1161/01.CIR.0000118500.23649.DF; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Spencer N, 2005, J EPIDEMIOL COMMUN H, V59, P842, DOI 10.1136/jech.2005.036301; TANNER JM, 1992, HORM RES, V38, P106, DOI 10.1159/000182580; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; Thrane N, 2005, EUR J EPIDEMIOL, V20, P467, DOI 10.1007/s10654-005-0719-2; van Rossem L, 2010, J PEDIATR-US, V157, P929, DOI 10.1016/j.jpeds.2010.06.008; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WATERLOW JC, 1994, EUR J CLIN NUTR, V48, pS72; Waterlow JC, 1994, EUR J CLIN NUTR S1, V48, pS73; WHINCUP PH, 1988, BMJ-BRIT MED J, V297, P980, DOI 10.1136/bmj.297.6654.980-c	61	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37356	10.1371/journal.pone.0037356	http://dx.doi.org/10.1371/journal.pone.0037356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TH	22649522	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335800040
J	Yang, LL; Wei, Y; Yang, J; Sun, Y; Shi, WM; Li, M				Yang Lili; Wei Yi; Yang Ji; Sun Yue; Shi Weimin; Li Ming			Global Activation of CD8(+) Cytotoxic T Lymphocytes Correlates with an Impairment in Regulatory T Cells in Patients with Generalized Vitiligo	PLOS ONE			English	Article							DISEASE-ACTIVITY; IFN-GAMMA; CD4(+); FOXP3; EFFECTOR	Melanocyte-specific CD8(+) cytotoxic T lymphocytes (CTLs) play a pivotal role in vitiligo-induced depigmentation. Yet, the mechanisms underlying the high frequency of generalized autoimmune disorders associated with generalized vitiligo (GV) are unknown. We hypothesized that an imbalance between activated CD8(+) CTLs and regulatory T cells (Tregs) exists in patients with GV. Assessment of the circulating CD8(+) CTLs and Tregs by flow cytometric analysis revealed an obvious expansion of CD8(+) CTLs and a concomitant decrease in Treg cells in GV patients. The percentages of skin infiltrating CD8(+) CTLs and Tregs were evaluated by immunohistochemistry and revealed dramatically increased numbers of both CD8(+) CTLs and Tregs in the perilesional skin of GV patients. However, peripheral Tregs were impaired in their ability to suppress the proliferation and cytolytic capacity of autologous CD8(+) T cells, suggesting that a functional failure of Tregs and the hyperactivation of CD8(+) CTLs may contribute to progressive GV. Our data indicate that reduced numbers and impaired function of natural Tregs fail to control the widespread activation of CD8(+) CTLs, which leads to the destruction of melanocytes and contributes to the elevated frequency of various associated autoimmune diseases. This knowledge furthers our understanding of the mechanisms of immune tolerance that are impaired in GV patients and may aid in the future development of effective immunotherapy for GV patients.	[Yang Lili; Wei Yi; Yang Ji; Li Ming] Fudan Univ, Dept Dermatol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Sun Yue; Shi Weimin] Shanghai Jiao Tong Univ, Dept Dermatol, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China	Fudan University; Shanghai Jiao Tong University	Yang, LL (corresponding author), Fudan Univ, Dept Dermatol, Zhongshan Hosp, Shanghai 200433, Peoples R China.	li.ming@zs-hospital.sh.cn		Yang, Lili/0000-0003-4560-0248	Innovation Fund; Fudan University	Innovation Fund; Fudan University	This work was supported by the Innovation Fund granted by Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Antiga E, 2010, J AUTOIMMUN, V35, P342, DOI 10.1016/j.jaut.2010.07.006; Ben Ahmed M, 2011, PIGMENT CELL MELANOM; Blanco P, 2005, ARTHRITIS RHEUM, V52, P201, DOI 10.1002/art.20745; Breathnach CC, 2005, VET IMMUNOL IMMUNOP, V103, P207, DOI 10.1016/j.vetimm.2004.09.024; Chi LJ, 2008, J PERIPHER NERV SYST, V13, P54, DOI 10.1111/j.1529-8027.2008.00158.x; CUNLIFFE WJ, 1968, BRIT J DERMATOL, V80, P135, DOI 10.1111/j.1365-2133.1968.tb12282.x; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Giovanni F, 2011, J NEUROIMMUNOL, V240, P137, DOI 10.1016/j.jneuroim.2011.09.002; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Klarquist J, 2010, PIGM CELL MELANOMA R, V23, P276, DOI 10.1111/j.1755-148X.2010.00688.x; Liblau RS, 2002, IMMUNITY, V17, P1, DOI 10.1016/S1074-7613(02)00338-2; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Malyguine Anatoli, 2003, European Cytokine Network, V14, P36; Miyara M, 2005, J IMMUNOL, V175, P8392, DOI 10.4049/jimmunol.175.12.8392; Ogg GS, 1998, J EXP MED, V188, P1203, DOI 10.1084/jem.188.6.1203; Oyarbide-Valencia K, 2006, AUTOIMMUN REV, V5, P486, DOI 10.1016/j.autrev.2006.03.012; Palermo B, 2001, J INVEST DERMATOL, V117, P326, DOI 10.1046/j.1523-1747.2001.01408.x; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SCHALLREUTER KU, 1994, DERMATOLOGY, V188, P269, DOI 10.1159/000247164; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Taieb A, 2007, PIGM CELL RES, V20, P27, DOI 10.1111/j.1600-0749.2006.00355.x; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Walter U, 2005, CURR OPIN IMMUNOL, V17, P624, DOI 10.1016/j.coi.2005.09.014; Wankowicz-Kalinska A, 2003, LAB INVEST, V83, P683, DOI 10.1097/01.LAB.0000069521.42488.1B; Westerhof W, 2007, PIGM CELL RES, V20, P345, DOI 10.1111/j.1600-0749.2007.00399.x; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165	30	35	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37513	10.1371/journal.pone.0037513	http://dx.doi.org/10.1371/journal.pone.0037513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649532	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800051
J	Munro, KM; Perreau, VM; Turnley, AM				Munro, Kathryn M.; Perreau, Victoria M.; Turnley, Ann M.			Differential Gene Expression in the EphA4 Knockout Spinal Cord and Analysis of the Inflammatory Response Following Spinal Cord Injury	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; ASTROCYTIC GLIOSIS; IMMUNE-RESPONSES; UP-REGULATION; REGENERATION; MICROGLIA; ARGINASE; CELLS; MICE; IDENTIFICATION	Mice lacking the axon guidance molecule EphA4 have been shown to exhibit extensive axonal regeneration and functional recovery following spinal cord injury. To assess mechanisms by which EphA4 may modify the response to neural injury a microarray was performed on spinal cord tissue from mice with spinal cord injury and sham injured controls. RNA was purified from spinal cords of adult EphA4 knockout and wild-type mice four days following lumbar spinal cord hemisection or laminectomy only and was hybridised to Affymetrix All-Exon Array 1.0 GeneChips (TM). While subsequent analyses indicated that several pathways were altered in EphA4 knockout mice, of particular interest was the attenuated expression of a number of inflammatory genes, including Arginase 1, expression of which was lower in injured EphA4 knockout compared to wild-type mice. Immunohistological analyses of different cellular components of the immune response were then performed in injured EphA4 knockout and wildtype spinal cords. While numbers of infiltrating CD3+ T cells were low in the hemisection model, a robust CD11b+ macrophage/microglial response was observed post-injury. There was no difference in the overall number or spread of macrophages/activated microglia in injured EphA4 knockout compared to wild-type spinal cords at 2, 4 or 14 days post-injury, however a lower proportion of Arginase-1 immunoreactive macrophages/activated microglia was observed in EphA4 knockout spinal cords at 4 days post-injury. Subtle alterations in the neuroinflammatory response in injured EphA4 knockout spinal cords may contribute to the regeneration and recovery observed in these mice following injury.	[Munro, Kathryn M.; Perreau, Victoria M.; Turnley, Ann M.] Univ Melbourne, Dept Anat & Neurosci, Ctr Neurosci Res, Parkville, Vic 3052, Australia	University of Melbourne	Munro, KM (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Ctr Neurosci Res, Parkville, Vic 3052, Australia.	vperreau@unimelb.edu.au		Turnley, Ann/0000-0002-8442-127X; Perreau, Victoria/0000-0002-0773-7246	Australian Postgraduate Award; National Health and Medical Research Council (NHMRC) Fellowship	Australian Postgraduate Award(Australian Government); National Health and Medical Research Council (NHMRC) Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	K.M.M. was supported by an Australian Postgraduate Award and A. M. T. is supported by a National Health and Medical Research Council (NHMRC) Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aasheim HC, 1997, BLOOD, V90, P3613, DOI 10.1182/blood.V90.9.3613; Aasheim HC, 2005, BLOOD, V105, P2869, DOI 10.1182/blood-2004-08-2981; Alonso CL, 2008, LEUK RES; Canty AJ, 2006, P NATL ACAD SCI USA, V103, P15629, DOI 10.1073/pnas.0607350103; Choi KM, 2010, GASTROENTEROLOGY, V138, P2399, DOI 10.1053/j.gastro.2010.02.014; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cruz-Orengo L, 2006, EXP NEUROL, V202, P421, DOI 10.1016/j.expneurol.2006.07.005; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Fabes J, 2006, EUR J NEUROSCI, V23, P1721, DOI 10.1111/j.1460-9568.2006.04704.x; Ghasemlou N, 2010, J NEUROSCI, V30, P13750, DOI 10.1523/JNEUROSCI.2998-10.2010; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2006, J COMP NEUROL, V497, P864, DOI 10.1002/cne.21029; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Goldshmit Y, 2010, J NEUROTRAUM, V27, P1321, DOI 10.1089/neu.2010.1294; Gundra UM, 2011, INFECT IMMUN, V79, P2586, DOI 10.1128/IAI.00920-10; Hawthorne AL, 2011, NEUROTHERAPEUTICS; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Ho Victor W. H., 2009, V531, P173, DOI 10.1007/978-1-59745-396-7_12; Holen HL, 2010, J LEUKOCYTE BIOL, V87, P1059, DOI 10.1189/jlb.0709497; Ivanov AI, 2006, IUBMB LIFE, V58, P389, DOI 10.1080/15216540600756004; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Kigerl KA, 2006, J COMP NEUROL, V494, P578, DOI 10.1002/cne.20827; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Martone ME, 1997, BRAIN RES, V771, P238, DOI 10.1016/S0006-8993(97)00792-0; Mukaino M, 2010, EXP NEUROL, V224, P403, DOI 10.1016/j.expneurol.2010.04.020; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Munoz JJ, 2006, J IMMUNOL, V177, P804, DOI 10.4049/jimmunol.177.2.804; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Parmentier-Batteur S, 2011, J NEUROCHEM, V118, P1016, DOI 10.1111/j.1471-4159.2011.07375.x; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Prevost N, 2002, P NATL ACAD SCI USA, V99, P9219, DOI 10.1073/pnas.142053899; Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102; Prokop S, 2011, AM J PATHOL, V178, P1279, DOI 10.1016/j.ajpath.2010.11.065; Puschmann TB, 2010, J NEUROCHEM, V113, P881, DOI 10.1111/j.1471-4159.2010.06655.x; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Sharfe N, 2008, MOL IMMUNOL, V45, P1208, DOI 10.1016/j.molimm.2007.09.019; Siegenthaler MM, 2007, J NEUROTRAUM, V24, P1631, DOI 10.1089/neu.2007.0302; Sobel RA, 2005, BRAIN PATHOL, V15, P35; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Yu H, 2001, J NEUROSCI RES, V66, P406, DOI 10.1002/jnr.1233; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	48	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37635	10.1371/journal.pone.0037635	http://dx.doi.org/10.1371/journal.pone.0037635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629434	Green Published, gold			2022-12-25	WOS:000305345300064
J	Swapna, LS; Srikeerthana, K; Srinivasan, N				Swapna, Lakshmipuram Seshadri; Srikeerthana, Kuchi; Srinivasan, Narayanaswamy			Extent of Structural Asymmetry in Homodimeric Proteins: Prevalence and Relevance	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; CRYSTAL-STRUCTURE; DNA RECOGNITION; EVOLUTIONARY CONSERVATION; COMPLEX REVEALS; BINDING MOAD; SYMMETRY; SEQUENCE; CHIP; IDENTIFICATION	Most homodimeric proteins have symmetric structure. Although symmetry is known to confer structural and functional advantage, asymmetric organization is also observed. Using a non-redundant dataset of 223 high-resolution crystal structures of biologically relevant homodimers, we address questions on the prevalence and significance of asymmetry. We used two measures to quantify global and interface asymmetry, and assess the correlation of several molecular and structural parameters with asymmetry. We have identified rare cases (11/223) of biologically relevant homodimers with pronounced global asymmetry. Asymmetry serves as a means to bring about 2:1 binding between the homodimer and another molecule; it also enables cellular signalling arising from asymmetric macromolecular ligands such as DNA. Analysis of these cases reveals two possible mechanisms by which possible infinite array formation is prevented. In case of homodimers associating via non-topologically equivalent surfaces in their tertiary structures, ligand-dependent mechanisms are used. For stable dimers binding via large surfaces, ligand-dependent structural change regulates polymerisation/depolymerisation; for unstable dimers binding via smaller surfaces that are not evolutionarily well conserved, dimerisation occurs only in the presence of the ligand. In case of homodimers associating via interaction surfaces with parts of the surfaces topologically equivalent in the tertiary structures, steric hindrance serves as the preventive mechanism of infinite array. We also find that homodimers exhibiting grossly symmetric organization rarely exhibit either perfect local symmetry or high local asymmetry. Binding of small ligands at the interface does not cause any significant variation in interface asymmetry. However, identification of biologically relevant interface asymmetry in grossly symmetric homodimers is confounded by the presence of similar small magnitude changes caused due to artefacts of crystallisation. Our study provides new insights regarding accommodation of asymmetry in homodimers.	[Swapna, Lakshmipuram Seshadri; Srikeerthana, Kuchi; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Swapna, LS (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	ns@mbu.iisc.ernet.in		Kuchi, Srikeerthana/0000-0003-3265-9355; Seshadri, Swapna/0000-0001-5906-7574	Department of Biotechnology, New Delhi; Mathematical Biology Programme; Department of Science and Technology (DST), New Delhi; Mathematical Biology Programme, DST	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Mathematical Biology Programme; Department of Science and Technology (DST), New Delhi(Department of Science & Technology (India)); Mathematical Biology Programme, DST	This research is supported by the Department of Biotechnology, New Delhi and the Mathematical Biology Programme sponsored by the Department of Science and Technology (DST), New Delhi. LSS is supported by the Mathematical Biology Programme, DST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AL, 2009, J MOL BIOL, V394, P522, DOI 10.1016/j.jmb.2009.09.031; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andre I, 2008, P NATL ACAD SCI USA, V105, P16148, DOI 10.1073/pnas.0807576105; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Benson ML, 2008, NUCLEIC ACIDS RES, V36, pD674, DOI 10.1093/nar/gkm911; Birck C, 2003, J BACTERIOL, V185, P254, DOI 10.1128/JB.185.1.254-261.2003; Blundell TL, 1996, P NATL ACAD SCI USA, V93, P14243, DOI 10.1073/pnas.93.25.14243; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; Brown JH, 2010, PROTEIN SCI, V19, P1366, DOI 10.1002/pro.415; Brown JH, 2006, PROTEIN SCI, V15, P1, DOI 10.1110/ps.051658406; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0; Dayhoff JE, 2010, J MOL BIOL, V395, P860, DOI 10.1016/j.jmb.2009.10.052; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeLuca HF, 1998, NUTR REV, V56, pS4; Deo RC, 2002, CELL, V108, P71, DOI 10.1016/S0092-8674(01)00632-8; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Erickson HP, 1997, TRENDS CELL BIOL, V7, P362, DOI 10.1016/S0962-8924(97)01108-2; Etienne-Manneville S, 2010, CURR OPIN CELL BIOL, V22, P104, DOI 10.1016/j.ceb.2009.11.008; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Ha N, 1996, NUCLEIC ACIDS RES, V24, P1453, DOI 10.1093/nar/24.8.1453; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Henrick K, 2008, NUCLEIC ACIDS RES, V36, pD426, DOI 10.1093/nar/gkm937; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu LG, 2005, PROTEINS, V60, P333, DOI 10.1002/prot.20512; Ispolatov I, 2005, NUCLEIC ACIDS RES, V33, P3629, DOI 10.1093/nar/gki678; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kanellopoulos PN, 1996, J MOL BIOL, V257, P1, DOI 10.1006/jmbi.1996.0141; Keskin O, 2004, PROTEIN SCI, V13, P1043, DOI 10.1110/ps.03484604; Khare SD, 2007, CURR PROTEIN PEPT SC, V8, P573, DOI 10.2174/138920307783018703; King DA, 1999, NAT STRUCT BIOL, V6, P64; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee SH, 2010, MOL CELLS, V29, P311, DOI 10.1007/s10059-010-0053-8; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Leung AKW, 2004, J MOL BIOL, V342, P953, DOI 10.1016/j.jmb.2004.07.061; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Levy ED, 2007, STRUCTURE, V15, P1364, DOI 10.1016/j.str.2007.09.019; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; LODI T, 1991, MOL CELL BIOL, V11, P3762, DOI 10.1128/MCB.11.7.3762; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Lukatsky DB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.178101; Lukatsky DB, 2007, J MOL BIOL, V365, P1596, DOI 10.1016/j.jmb.2006.11.020; Madrazo J, 2001, P NATL ACAD SCI USA, V98, P11967, DOI 10.1073/pnas.211439798; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; MARMORSTEIN R, 1994, GENE DEV, V8, P2504, DOI 10.1101/gad.8.20.2504; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagradova NK, 2001, FEBS LETT, V487, P327, DOI 10.1016/S0014-5793(00)02338-3; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Pednekar D, 2010, PROTEINS, V78, P3048, DOI 10.1002/prot.22828; Pereira-Leal JB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r51; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; Piron M, 1999, J VIROL, V73, P5411, DOI 10.1128/JVI.73.7.5411-5421.1999; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Shaffer PL, 2002, EMBO J, V21, P2242, DOI 10.1093/emboj/21.9.2242; Soding J, 2003, BIOESSAYS, V25, P837, DOI 10.1002/bies.10321; Stricker J, 2003, J BACTERIOL, V185, P4796, DOI 10.1128/JB.185.16.4796-4805.2003; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Swaminathan K, 1997, NAT STRUCT BIOL, V4, P751, DOI 10.1038/nsb0997-751; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TUCKER PA, 1994, EMBO J, V13, P2994, DOI 10.1002/j.1460-2075.1994.tb06598.x; Vende P, 2000, J VIROL, V74, P7064, DOI 10.1128/JVI.74.15.7064-7071.2000; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; WINKLER H, 1988, EMBO J, V7, P1799, DOI 10.1002/j.1460-2075.1988.tb03011.x; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Yuan Z, 2003, PROTEIN ENG, V16, P109, DOI 10.1093/proeng/gzg014; Zhang L, 1996, EMBO J, V15, P4676, DOI 10.1002/j.1460-2075.1996.tb00844.x; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhao H, 2002, STRUCTURE, V10, P1041, DOI 10.1016/S0969-2126(02)00803-1; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2; ZITOMER RS, 1987, MOL CELL BIOL, V7, P2212, DOI 10.1128/MCB.7.6.2212	77	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36688	10.1371/journal.pone.0036688	http://dx.doi.org/10.1371/journal.pone.0036688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629324	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000305345300011
J	Zaarour, RF; Chirivino, D; Del Maestro, L; Daviet, L; Atfi, A; Louvard, D; Arpin, M				Zaarour, Rania F.; Chirivino, Dafne; Del Maestro, Laurence; Daviet, Laurent; Atfi, Azeddine; Louvard, Daniel; Arpin, Monique			Ezrin Ubiquitylation by the E3 Ubiquitin Ligase, WWP1, and Consequent Regulation of Hepatocyte Growth Factor Receptor Activity	PLOS ONE			English	Article							DOMAIN BINDING-SITE; PLASMA-MEMBRANE; MET RECEPTOR; EPITHELIAL-CELLS; BREAST-CANCER; 1 TARGETS; PROTEIN; DEGRADATION; PHOSPHORYLATION; ACTIVATION	The membrane cytoskeleton linker ezrin participates in several functions downstream of the receptor Met in response to Hepatocyte Growth Factor (HGF) stimulation. Here we report a novel interaction of ezrin with a HECT E3 ubiquitin ligase, WWP1/Aip5/Tiul1, a potential oncogene that undergoes genomic amplification and overexpression in human breast and prostate cancers. We show that ezrin binds to the WW domains of WWP1 via the consensus motif PPVY477 present in ezrin's C-terminus. This association results in the ubiquitylation of ezrin, a process that requires an intact PPVY477 motif. Interestingly ezrin ubiquitylation does not target the protein for degradation by the proteasome. We find that ezrin ubiquitylation by WWP1 in epithelial cells leads to the upregulation of Met level in absence of HGF stimulation and increases the response of Met to HGF stimulation as measured by the ability of the cells to heal a wound. Interestingly this effect requires ubiquitylated ezrin since it can be rescued, after depletion of endogenous ezrin, by wild type ezrin but not by a mutant of ezrin that cannot be ubiquitylated. Taken together our data reveal a new role for ezrin in Met receptor stability and activity through its association with the E3 ubiquitin ligase WWP1. Given the role of Met in cell proliferation and tumorigenesis, our results may provide a mechanistic basis for understanding the role of ezrin in tumor progression.	[Zaarour, Rania F.; Chirivino, Dafne; Del Maestro, Laurence; Louvard, Daniel; Arpin, Monique] Ctr Natl Rech Sci, Unite Mixte Rech, Inst Curie, Paris, France; [Daviet, Laurent] Hybrigenics, Paris, France; [Atfi, Azeddine] Hop St Antoine, INSERM U, F-75571 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Zaarour, RF (corresponding author), Univ Sharjah, Coll Med, Sharjah Inst Med Res, Sharjah, U Arab Emirates.	marpin@curie.fr		Zaarour, Rania/0000-0001-9132-5940	Association pour la Recherche sur le Cancer ARC [3267, 4823]; Agence Nationale de la Recherche (ANR) [05BLAN033001]; GenHomme Network Grant [02490-6088]; Institut Curie; ANR [05BLAN033001]	Association pour la Recherche sur le Cancer ARC(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); GenHomme Network Grant; Institut Curie; ANR(French National Research Agency (ANR))	This work was supported by grants from Association pour la Recherche sur le Cancer ARC (3267, 4823), Agence Nationale de la Recherche (ANR 05BLAN033001) by a GenHomme Network Grant (02490-6088) to Hybrigenics and Institut Curie. Rania Zaarour was a recipient of fellowships from Institut Curie and ANR (05BLAN033001). Dafne Chirivino was a recipient of fellowship for PhD students from Institut Curie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; ANDREOLI C, 1994, J CELL SCI, V107, P2509; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen C, 2008, ONCOGENE, V27, P6845, DOI 10.1038/onc.2008.288; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Derivery E, 2009, CELL MOTIL CYTOSKEL, V66, P777, DOI 10.1002/cm.20342; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Elliott BE, 2004, J CELL BIOCHEM, V92, P16, DOI 10.1002/jcb.20033; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Heiska L, 2005, J BIOL CHEM, V280, P10244, DOI 10.1074/jbc.M411353200; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Li Y, 2009, ONCOGENE, V28, P2948, DOI 10.1038/onc.2009.162; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Naba A, 2008, EMBO J, V27, P38, DOI 10.1038/sj.emboj.7601943; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Peschard P, 2004, J BIOL CHEM, V279, P29565, DOI 10.1074/jbc.M403954200; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhang XL, 2004, BIOCHEM BIOPH RES CO, V316, P139, DOI 10.1016/j.bbrc.2004.02.033	39	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37490	10.1371/journal.pone.0037490	http://dx.doi.org/10.1371/journal.pone.0037490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629406	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300045
J	Burgers, P; Alexander, DE				Burgers, Phillip; Alexander, David E.			Normalized Lift: An Energy Interpretation of the Lift Coefficient Simplifies Comparisons of the Lifting Ability of Rotating and Flapping Surfaces	PLOS ONE			English	Article								For a century, researchers have used the standard lift coefficient C-L to evaluate the lift, L, generated by fixed wings over an area S against dynamic pressure, 1/2 rho v2, where v is the effective velocity of the wing. Because the lift coefficient was developed initially for fixed wings in steady flow, its application to other lifting systems requires either simplifying assumptions or complex adjustments as is the case for flapping wings and rotating cylinders. This paper interprets the standard lift coefficient of a fixed wing slightly differently, as the work exerted by the wing on the surrounding flow field (L/rho.S), compared against the total kinetic energy required for generating said lift, 1/2v(2). This reinterpreted coefficient, the normalized lift, is derived from the work-energy theorem and compares the lifting capabilities of dissimilar lift systems on a similar energy footing. The normalized lift is the same as the standard lift coefficient for fixed wings, but differs for wings with more complex motions; it also accounts for such complex motions explicitly and without complex modifications or adjustments. We compare the normalized lift with the previously-reported values of lift coefficient for a rotating cylinder in Magnus effect, a bat during hovering and forward flight, and a hovering dipteran. The maximum standard lift coefficient for a fixed wing without flaps in steady flow is around 1.5, yet for a rotating cylinder it may exceed 9.0, a value that implies that a rotating cylinder generates nearly 6 times the maximum lift of a wing. The maximum normalized lift for a rotating cylinder is 1.5. We suggest that the normalized lift can be used to evaluate propellers, rotors, flapping wings of animals and micro air vehicles, and underwater thrust-generating fins in the same way the lift coefficient is currently used to evaluate fixed wings.	[Burgers, Phillip] Embry Riddle Aeronaut Univ, Dept Arts & Sci, San Diego, CA USA; [Alexander, David E.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	Embry-Riddle Aeronautical University; University of Kansas	Burgers, P (corresponding author), Embry Riddle Aeronaut Univ, Dept Arts & Sci, San Diego, CA USA.	philburgers@yahoo.com							0	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e36732	10.1371/journal.pone.0036732	http://dx.doi.org/10.1371/journal.pone.0036732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629326	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343100006
J	Rhyne, AL; Tlusty, MF; Schofield, PJ; Kaufman, L; Morris, JA; Bruckner, AW				Rhyne, Andrew L.; Tlusty, Michael F.; Schofield, Pamela J.; Kaufman, Les; Morris, James A., Jr.; Bruckner, Andrew W.			Revealing the Appetite of the Marine Aquarium Fish Trade: The Volume and Biodiversity of Fish Imported into the United States	PLOS ONE			English	Article							PROPAGULE PRESSURE; RISKS	The aquarium trade and other wildlife consumers are at a crossroads forced by threats from global climate change and other anthropogenic stressors that have weakened coastal ecosystems. While the wildlife trade may put additional stress on coral reefs, it brings income into impoverished parts of the world and may stimulate interest in marine conservation. To better understand the influence of the trade, we must first be able to quantify coral reef fauna moving through it. Herein, we discuss the lack of a data system for monitoring the wildlife aquarium trade and analyze problems that arise when trying to monitor the trade using a system not specifically designed for this purpose. To do this, we examined an entire year of import records of marine tropical fish entering the United States in detail, and discuss the relationship between trade volume, biodiversity and introduction of non-native marine fishes. Our analyses showed that biodiversity levels are higher than previous estimates. Additionally, more than half of government importation forms have numerical or other reporting discrepancies resulting in the overestimation of trade volumes by 27%. While some commonly imported species have been introduced into the coastal waters of the USA (as expected), we also found that some uncommon species in the trade have also been introduced. This is the first study of aquarium trade imports to compare commercial invoices to government forms and provides a means to, routinely and in real time, examine the biodiversity of the trade in coral reef wildlife species.	[Rhyne, Andrew L.; Tlusty, Michael F.; Kaufman, Les] New England Aquarium, Res Dept, Boston, MA USA; [Rhyne, Andrew L.] Roger Williams Univ, Dept Biol & Marine Biol, Bristol, RI 02809 USA; [Schofield, Pamela J.] United States Geol Survey, SE Ecol Sci Ctr, Gainesville, FL USA; [Kaufman, Les] Boston Univ, Dept Biol, Boston Univ Marine Program, Boston, MA 02215 USA; [Kaufman, Les] Conservat Int, Arlington, VA USA; [Morris, James A., Jr.] Natl Ocean & Atmospher Adm, Natl Ocean Serv, Natl Ctr Coastal Ocean Sci, Beaufort, NC USA; [Bruckner, Andrew W.] Khaled Bin Sultan Living Oceans Fdn, Landover, MD USA	United States Department of the Interior; United States Geological Survey; Boston University; Conservation International; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS)	Rhyne, AL (corresponding author), New England Aquarium, Res Dept, Boston, MA USA.	arhyne@rwu.edu	Tlusty, Michael/AAF-9635-2021	Tlusty, Michael/0000-0002-7493-2025; Rhyne, Andrew/0000-0001-7252-3431	Environmental Defense Fund (EDF) as part of the International Marine Conservation Congress workshop "International Trade in Coral Reef Species"; National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program [NA09NMF4000385]; EDF; NOAA	Environmental Defense Fund (EDF) as part of the International Marine Conservation Congress workshop "International Trade in Coral Reef Species"; National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); EDF(Electricite de France (EDF)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	Seed funds to initiate this work were from the Environmental Defense Fund (EDF) as part of the 2009 International Marine Conservation Congress workshop "International Trade in Coral Reef Species." A National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program NA09NMF4000385 to Rhyne provided funding for the project. Two authors of this work are employees of the United States Government, but neither they nor their respective offices had a role in the funding of the research beyond provision of salary. The funder EDF had no role in the study's design, data acquisition, data collection, analysis, decision to publish, or preparation of the manuscript. The funder NOAA Office of Habitat Conservation provided the data used in the study but had no role in the analysis, decision to publish, or preparation of the manuscript.	Appeltans W, 2011, WORLD REGISTER MARIN; Aronson RB, 2009, AIP CONF PROC, V1157, P48, DOI 10.1063/1.3208031; AZA, 2010, MAR FISH TAX ADV GRO; Barber CV, 1998, CORAL REEFS CHALLENG, P39; Bickford D, 2011, SCIENCE, V331, P857, DOI 10.1126/science.331.6019.857-c; Blundell AG, 2005, CONSERV BIOL, V19, P2020, DOI 10.1111/j.1523-1739.2005.00253.x; Breder CM., 1966, MODES REPROD FISHES; Bruckner AW, 2005, REV BIOL TROP, V53, P127; Burke L., 2011, REEFS RISK REVISITED; Cheung WWL, 2005, BIOL CONSERV, V124, P97, DOI 10.1016/j.biocon.2005.01.017; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Drew J, 2008, CONSERV BIOL, V22, P965, DOI 10.1111/j.1523-1739.2008.01011.x; Duggan IC, 2006, BIOL INVASIONS, V8, P377, DOI 10.1007/s10530-004-2310-2; Erdmann MV, 2001, CORAL REEFS, V20, P252, DOI 10.1007/s003380100174; GAO, 2010, LIV AN IMP AG NEED B; Gertzen E, 2008, CAN J FISH AQUAT SCI, V65, P1265, DOI 10.1139/F08-056; Ho L, 2011, PEPPERMINT ANGELFISH; Hoeksema Bert W., 2007, V29, P117; Jaremo J, 2011, ECOL MODEL, V222, P485, DOI 10.1016/j.ecolmodel.2010.11.012; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kolm N, 2003, CONSERV BIOL, V17, P910, DOI 10.1046/j.1523-1739.2003.01522.x; Liao YC, 2010, BIOL INVASIONS, V12, P1961, DOI 10.1007/s10530-009-9642-x; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lunn KE, 2004, CORAL REEFS, V23, P344, DOI 10.1007/s00338-004-0393-y; McClenachan L, 2012, CONSERV LETT, V5, P73, DOI 10.1111/j.1755-263X.2011.00206.x; Murray JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029543; Nagendra H, 2002, APPL GEOGR, V22, P175, DOI 10.1016/S0143-6228(02)00002-4; Nijman V, 2010, BIODIVERS CONSERV, V19, P1101, DOI 10.1007/s10531-009-9758-4; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Prosek J, 2010, NATL GEOGR, P120; Randall JE, 1987, B MAR SCI, V41, P13; Rhyne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008413; Schofield P.J., 2009, FIELD GUIDE NONINDIG; Schofield PJ, 2010, AQUAT INVASIONS, V5, pS117, DOI 10.3391/ai.2010.5.S1.024; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; Smith KF, 2008, CONSERV LETT, V1, P103, DOI 10.1111/j.1755-263X.2008.00014.x; Strecker AL, 2011, FISHERIES, V36, P74, DOI 10.1577/03632415.2011.10389070; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Teitelbaum A., 2010, SPC LIVE REEF FISH I, V19, P3; Thresher R. E., 1984, REPROD REEF FISHES; Tissot BN, 2003, CONSERV BIOL, V17, P1759, DOI 10.1111/j.1523-1739.2003.00379.x; Tissot BN, 2010, MAR POLICY, V34, P1385, DOI 10.1016/j.marpol.2010.06.002; Tlusty M, 2002, AQUACULTURE, V205, P203, DOI 10.1016/S0044-8486(01)00683-4; US Fish and Wildlife Service, 2003, US WILDL TRAD OV 199; Vagelli Alejandro A., 2008, SPC Live Reef Fish Information Bulletin, V18, P17; Wabnitz C, 2003, OCEAN AQUARIUM; Walsh W, 2000, AQUARIUM COLLECTING; Weber ES, 2009, J VET DIAGN INVEST, V21, P306, DOI 10.1177/104063870902100302; Wood E.M., 2001, AQUARIUM SCI CONSERV, V3, P65, DOI DOI 10.1023/A:1011391700880	49	172	183	0	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e35808	10.1371/journal.pone.0035808	http://dx.doi.org/10.1371/journal.pone.0035808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629303	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343100003
J	Docquier, A; Augereau, P; Lapierre, M; Harmand, PO; Badia, E; Annicotte, JS; Fajas, L; Cavailles, V				Docquier, Aurelie; Augereau, Patrick; Lapierre, Marion; Harmand, Pierre-Olivier; Badia, Eric; Annicotte, Jean-Sebastien; Fajas, Lluis; Cavailles, Vincent			The RIP140 Gene Is a Transcriptional Target of E2F1	PLOS ONE			English	Article							RECEPTOR COREPRESSOR RIP140; CELL-CYCLE CONTROL; CANCER-CELLS; INTERACTING PROTEIN-140; FAMILY-MEMBERS; EMERGING ROLES; SP1; ESTROGEN; ACTIVATION; EXPRESSION	RIP140 is a transcriptional coregulator involved in energy homeostasis and ovulation which is controlled at the transcriptional level by several nuclear receptors. We demonstrate here that RIP140 is a novel target gene of the E2F1 transcription factor. Bioinformatics analysis, gel shift assay, and chromatin immunoprecipitation demonstrate that the RIP140 promoter contains bona fide E2F response elements. In transiently transfected MCF-7 breast cancer cells, the RIP140 promoter is transactivated by overexpression of E2F1/DP1. Interestingly, RIP140 mRNA is finely regulated during cell cycle progression (5-fold increase at the G1/S and G2/M transitions). The positive regulation by E2F1 requires sequences located in the proximal region of the promoter (-73/+167), involves Sp1 transcription factors, and undergoes a negative feedback control by RIP140. Finally, we show that E2F1 participates in the induction of RIP140 expression during adipocyte differentiation. Altogether, this work identifies the RIP140 gene as a new transcriptional target of E2F1 which may explain some of the effect of E2F1 in both cancer and metabolic diseases.	[Docquier, Aurelie; Augereau, Patrick; Lapierre, Marion; Harmand, Pierre-Olivier; Badia, Eric; Annicotte, Jean-Sebastien; Fajas, Lluis; Cavailles, Vincent] IRCM, Montpellier, France; [Docquier, Aurelie; Augereau, Patrick; Lapierre, Marion; Harmand, Pierre-Olivier; Badia, Eric; Annicotte, Jean-Sebastien; Fajas, Lluis; Cavailles, Vincent] INSERM, U896, Montpellier, France; [Docquier, Aurelie; Augereau, Patrick; Lapierre, Marion; Harmand, Pierre-Olivier; Badia, Eric; Annicotte, Jean-Sebastien; Fajas, Lluis; Cavailles, Vincent] Univ Montpellier I, Montpellier, France; [Docquier, Aurelie; Augereau, Patrick; Lapierre, Marion; Harmand, Pierre-Olivier; Badia, Eric; Annicotte, Jean-Sebastien; Fajas, Lluis; Cavailles, Vincent] CRLC Ctr Reg Lutte Canc Val dAurelle Paul Lamarqu, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Docquier, A (corresponding author), IRCM, Montpellier, France.	vincent.cavailles@inserm.fr	Lapierre, Marion/AAB-2845-2020; Cavailles, Vincent/Y-5379-2019; cavailles, vincent/C-6277-2017; Annicotte, Jean-Sébastien/H-4641-2018; Coll, Lluis Fajas/C-8567-2014	Lapierre, Marion/0000-0002-4708-805X; Cavailles, Vincent/0000-0002-7160-3074; Annicotte, Jean-Sébastien/0000-0002-2109-4849; Fajas, Lluis/0000-0002-1283-9503; BADIA, Eric/0000-0002-8922-9834	Institut National de la Sante et de la Recherche Medicale; University of Montpellier 1; Association pour la Recherche sur le Cancer [3494, 3169]; Institut National du Cancer [610-3D1616]; Association Le cancer du sein, parlons-en!; Ligue Nationale contre le Cancer; Ministere de la Recherche et de l'Enseignement Superieur [26059-2007]	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier 1; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer(Institut National du Cancer (INCA) France); Association Le cancer du sein, parlons-en!; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Ministere de la Recherche et de l'Enseignement Superieur	This work was supported by the Institut National de la Sante et de la Recherche Medicale, the University of Montpellier 1, the Association pour la Recherche sur le Cancer [grant numbers 3494, 3169], the Institut National du Cancer [grant number 610-3D1616], the Association Le cancer du sein, parlons-en! [Pink Ribbon Prize 2009], the Ligue Nationale contre le Cancer [grant to POH], and the Ministere de la Recherche et de l'Enseignement Superieur [grant number 26059-2007 to AD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2003, ONCOGENE, V22, P7632, DOI 10.1038/sj.onc.1206840; Augereau P, 2006, MOL PHARMACOL, V69, P1338, DOI 10.1124/mol.105.017376; Augereau Patrick, 2006, Nucl Recept Signal, V4, pe024; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Blanchet E, 2009, CELL CYCLE, V8, P4029, DOI 10.4161/cc.8.24.10110; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Bourdeau V, 2008, NUCLEIC ACIDS RES, V36, P76, DOI 10.1093/nar/gkm945; Carascossa S, 2006, MOL ENDOCRINOL, V20, P1506, DOI 10.1210/me.2005-0286; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Christian M, 2006, TRENDS ENDOCRIN MET, V17, P243, DOI 10.1016/j.tem.2006.06.008; Datta A, 2002, MOL CELL BIOL, V22, P8398, DOI 10.1128/MCB.22.24.8398-8408.2002; DeGregori J, 2006, CURR MOL MED, V6, P739; Docquier A, 2010, CLIN CANCER RES, V16, P2959, DOI 10.1158/1078-0432.CCR-09-3153; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Hitchens MR, 2003, APOPTOSIS, V8, P461, DOI 10.1023/A:1025586207239; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Huq MDM, 2005, MOL CELL PROTEOMICS, V4, P975, DOI 10.1074/mcp.M500015-MCP200; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; Kerley JS, 2001, BIOCHEM BIOPH RES CO, V285, P969, DOI 10.1006/bbrc.2001.5274; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Liao L, 2002, J STEROID BIOCHEM, V83, P3, DOI 10.1016/S0960-0760(02)00254-6; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Maehara K, 2005, J CELL BIOL, V168, P553, DOI 10.1083/jcb.200411093; Mussi P, 2006, MOL ENDOCRINOL, V20, P3105, DOI 10.1210/me.2005-0522; Nichol D, 2006, J BIOL CHEM, V281, P32140, DOI 10.1074/jbc.M604803200; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Rotheneder H, 1999, J MOL BIOL, V293, P1005, DOI 10.1006/jmbi.1999.3213; Steel JH, 2005, J ENDOCRINOL, V185, P1, DOI 10.1677/joe.1.05896; Thenot S, 1999, MOL CELL ENDOCRINOL, V156, P85, DOI 10.1016/S0303-7207(99)00139-2; Tsantoulis PK, 2005, EUR J CANCER, V41, P2403, DOI 10.1016/j.ejca.2005.08.005; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Wu CL, 1996, MOL CELL BIOL, V16, P3698; Wu ZL, 2009, INT J BIOCHEM CELL B, V41, P2389, DOI 10.1016/j.biocel.2009.06.004; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	39	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e35839	10.1371/journal.pone.0035839	http://dx.doi.org/10.1371/journal.pone.0035839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629304	Green Published, gold			2022-12-25	WOS:000305343500007
J	Feng, B; Xu, JP; Wu, G; Zeng, NK; Li, YC; Tolgor, B; Kost, GW; Yang, ZL				Feng, Bang; Xu, Jianping; Wu, Gang; Zeng, Nian-Kai; Li, Yan-Chun; Tolgor, Bau; Kost, Gerhard W.; Yang, Zhu L.			DNA Sequence Analyses Reveal Abundant Diversity, Endemism and Evidence for Asian Origin of the Porcini Mushrooms	PLOS ONE			English	Article							BOLETUS-EDULIS; HISTORICAL BIOGEOGRAPHY; MAXIMUM-LIKELIHOOD; ECTOMYCORRHIZAL FUNGI; DIVERSIFICATION; EVOLUTION; PATTERNS; FORESTS; HOST; TOOL	The wild gourmet mushroom Boletus edulis and its close allies are of significant ecological and economic importance. They are found throughout the Northern Hemisphere, but despite their ubiquity there are still many unresolved issues with regard to the taxonomy, systematics and biogeography of this group of mushrooms. Most phylogenetic studies of Boletus so far have characterized samples from North America and Europe and little information is available on samples from other areas, including the ecologically and geographically diverse regions of China. Here we analyzed DNA sequence variation in three gene markers from samples of these mushrooms from across China and compared our findings with those from other representative regions. Our results revealed fifteen novel phylogenetic species (about one-third of the known species) and a newly identified lineage represented by Boletus sp. HKAS71346 from tropical Asia. The phylogenetic analyses support eastern Asia as the center of diversity for the porcini sensu stricto clade. Within this clade, B. edulis is the only known holarctic species. The majority of the other phylogenetic species are geographically restricted in their distributions. Furthermore, molecular dating and geological evidence suggest that this group of mushrooms originated during the Eocene in eastern Asia, followed by dispersal to and subsequent speciation in other parts of Asia, Europe, and the Americas from the middle Miocene through the early Pliocene. In contrast to the ancient dispersal of porcini in the strict sense in the Northern Hemisphere, the occurrence of B. reticulatus and B. edulis sensu lato in the Southern Hemisphere was probably due to recent human-mediated introductions.	[Feng, Bang; Wu, Gang; Zeng, Nian-Kai; Li, Yan-Chun; Yang, Zhu L.] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Xu, Jianping] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Tolgor, Bau] Jilin Agr Univ, Inst Mycol, Changchun, Jilin, Peoples R China; [Kost, Gerhard W.] Univ Marburg, Marburg, Germany; [Feng, Bang; Wu, Gang; Zeng, Nian-Kai] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; McMaster University; Jilin Agricultural University; Philipps University Marburg; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Feng, B (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China.	fungiamanita@gmail.com	Hosen, Md. Iqbal/I-6008-2013	Hosen, Md. Iqbal/0000-0003-2731-6841; Li, Yanchun/0000-0002-7109-9269; feng, bang/0000-0001-7237-2899	National Natural Science Foundation of China; Yunnan Provincial Government [U0836604]; National Basic Research Program of China [2009CB522300]; Research Fund for the Large-scale Scientific Facilities of the Chinese Academy of Sciences [2009-LSF-GBOWS-01]; CAS/SAFEA International Partnership Program for Creative Research Teams; Hundred Talents Program of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Government; National Basic Research Program of China(National Basic Research Program of China); Research Fund for the Large-scale Scientific Facilities of the Chinese Academy of Sciences; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the Joint Funds of the National Natural Science Foundation of China and Yunnan Provincial Government (No. U0836604), the National Basic Research Program of China (No. 2009CB522300), the Research Fund for the Large-scale Scientific Facilities of the Chinese Academy of Sciences (No. 2009-LSF-GBOWS-01), the CAS/SAFEA International Partnership Program for Creative Research Teams, and the Hundred Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora D, 2008, ECON BOT, V62, P356, DOI 10.1007/s12231-008-9050-7; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Beugelsdijk DCM, 2008, PERSOONIA, V20, P1, DOI 10.3767/003158508X283692; Binder M., 2002, Feddes Repertorium, V113, P30, DOI 10.1002/1522-239X(200205)113:1/2&lt;30::AID-FEDR30&gt;3.0.CO;2-D; Binder M, 2006, MYCOLOGIA, V98, P971, DOI 10.3852/mycologia.98.6.971; Bonito GM, 2010, MOL ECOL, V19, P4994, DOI 10.1111/j.1365-294X.2010.04855.x; Clayton JW, 2009, SYST BIOL, V58, P395, DOI 10.1093/sysbio/syp041; Dentinger BTM, 2010, MOL PHYLOGENET EVOL, V57, P1276, DOI 10.1016/j.ympev.2010.10.004; Donoghue MJ, 2004, PHILOS T R SOC B, V359, P1633, DOI 10.1098/rstb.2004.1538; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ducousso M, 2004, MOL ECOL, V13, P231, DOI 10.1046/j.1365-294X.2003.02032.x; Garnica S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-213; Geml J, 2006, MOL ECOL, V15, P225, DOI 10.1111/j.1365-294X.2005.02799.x; Geml J, 2008, MOL PHYLOGENET EVOL, V48, P694, DOI 10.1016/j.ympev.2008.04.029; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Hibbett DS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-13; Hibbett DS, 1997, AM J BOT, V84, P981, DOI 10.2307/2446289; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hosaka K, 2008, MYCOL RES, V112, P448, DOI 10.1016/j.mycres.2007.06.004; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes KW, 2009, NEW PHYTOL, V182, P795, DOI 10.1111/j.1469-8137.2009.02802.x; Jansen G, 2010, MOL PHYLOGENET EVOL, V56, P294, DOI 10.1016/j.ympev.2010.01.029; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Leonardi M, 2005, FEMS MICROBIOL LETT, V243, P411, DOI 10.1016/j.femsle.2005.01.003; Lian Bin, 2008, Electron. J. Biotechnol., V11, P102; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Magri D, 2007, MOL ECOL, V16, P5259, DOI 10.1111/j.1365-294X.2007.03587.x; Matheny PB, 2009, J BIOGEOGR, V36, P577, DOI 10.1111/j.1365-2699.2008.02055.x; Mello A, 2006, J BIOTECHNOL, V121, P318, DOI 10.1016/j.jbiotec.2005.08.022; Nilsson RH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-178; Nylander J, 2004, MRMODELTEST2 2 COMPU; Pound MJ, 2011, PALAEOGEOGR PALAEOCL, V300, P29, DOI 10.1016/j.palaeo.2010.11.029; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryberg M, 2009, NEW PHYTOL, V181, P471, DOI 10.1111/j.1469-8137.2008.02667.x; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Shi GL, 2010, REV PALAEOBOT PALYNO, V162, P599, DOI 10.1016/j.revpalbo.2010.08.001; Simberloff D, 2010, AUSTRAL ECOL, V35, P489, DOI 10.1111/j.1442-9993.2009.02058.x; Singer R, 1975, AGARICALES MODERN TA; Sitta N, 2008, ECON BOT, V62, P307, DOI 10.1007/s12231-008-9037-4; Skrede I, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-230; Smith ME, 2007, MYCORRHIZA, V18, P15, DOI 10.1007/s00572-007-0148-z; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Smith SY, 2004, MYCOLOGIA, V96, P180, DOI 10.2307/3762001; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Taylor TN, 2004, MYCOLOGIA, V96, P1403, DOI 10.2307/3762157; Tedersoo L, 2011, MOL ECOL, V20, P3071, DOI 10.1111/j.1365-294X.2011.05145.x; Vellinga EC, 2009, NEW PHYTOL, V181, P960, DOI 10.1111/j.1469-8137.2008.02728.x; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; WANG Y, 1995, NEW ZEAL J CROP HORT, V23, P227, DOI 10.1080/01140671.1995.9513892; WARING RH, 1979, SCIENCE, V204, P1380, DOI 10.1126/science.204.4400.1380; White T., 1990, PCR PROTOCOLS GUIDE, P315; Yan Jun, 2010, Acta Edulis Fungi, V17, P26; Yu Y., 2014, RASP RECONSTRUCT ANC; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zang M., 2006, FLORA FUNGORUM SINIC, V22; Zhao Yong-Chang, 2006, Acta Botanica Yunnanica, V28, P575	66	78	87	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37567	10.1371/journal.pone.0037567	http://dx.doi.org/10.1371/journal.pone.0037567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629418	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500137
J	Pincede, I; Pollin, B; Meert, T; Plaghki, L; Le Bars, D				Pincede, Ivanne; Pollin, Bernard; Meert, Theo; Plaghki, Leon; Le Bars, Daniel			Psychophysics of a Nociceptive Test in the Mouse: Ambient Temperature as a Key Factor for Variation	PLOS ONE			English	Article							SPINAL-CORD NEURONS; TAIL-FLICK; BODY-TEMPERATURE; ANIMAL-MODELS; DAILY TORPOR; BEHAVIORAL THERMOREGULATION; LABORATORY ENVIRONMENT; THERMAL INHIBITION; SKIN TEMPERATURE; NERVE-FIBERS	Background: The mouse is increasingly used in biomedical research, notably in behavioral neurosciences for the development of tests or models of pain. Our goal was to provide the scientific community with an outstanding tool that allows the determination of psychophysical descriptors of a nociceptive reaction, which are inaccessible with conventional methods: namely the true threshold, true latency, conduction velocity of the peripheral fibers that trigger the response and latency of the central decision-making process. Methodology/Principal Findings: Basically, the procedures involved heating of the tail with a CO2 laser, recording of tail temperature with an infrared camera and stopping the heating when the animal reacted. The method is based mainly on the measurement of three observable variables, namely the initial temperature, the heating rate and the temperature reached at the actual moment of the reaction following random variations in noxious radiant heat. The initial temperature of the tail, which itself depends on the ambient temperature, very markedly influenced the behavioral threshold, the behavioral latency and the conduction velocity of the peripheral fibers but not the latency of the central decision-making. Conclusions/Significance: We have validated a psychophysical approach to nociceptive reactions for the mouse, which has already been described for rats and Humans. It enables the determination of four variables, which contribute to the overall latency of the response. The usefulness of such an approach was demonstrated by providing new fundamental findings regarding the influence of ambient temperature on nociceptive processes. We conclude by challenging the validity of using as "pain index" the reaction time of a behavioral response to an increasing heat stimulus and emphasize the need for a very careful control of the ambient temperature, as a prevailing environmental source of variation, during any behavioral testing of mice.	[Pincede, Ivanne; Pollin, Bernard; Le Bars, Daniel] CNRS UMR 7225, INSERM UMRS 975, Team Pain, Paris, France; [Pincede, Ivanne; Pollin, Bernard; Le Bars, Daniel] Univ Paris 06, Fac Med, Paris, France; [Meert, Theo] Univ Louvain, Dept Psychol, Louvain, Belgium; [Plaghki, Leon] Catholic Univ Louvain, Unite READ, B-1200 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Catholique Louvain	Pincede, I (corresponding author), CNRS UMR 7225, INSERM UMRS 975, Team Pain, Paris, France.	daniel.le_bars@upmc.fr			l'Institut National de la Sante et de la Recherche Medicale; Institut UPSA de la Douleur	l'Institut National de la Sante et de la Recherche Medicale; Institut UPSA de la Douleur	This work was supported by "l'Institut National de la Sante et de la Recherche Medicale" (http://www.inserm.fr) and a grant from the "Institut UPSA de la Douleur" (www.institut-upsa-douleur.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, PAIN, V9, P141; Benoist JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003125; BERGE OG, 1994, PAIN, V57, P256, DOI 10.1016/0304-3959(94)90234-8; Bouwknecht JA, 2007, NEUROSCI BIOBEHAV R, V31, P41, DOI 10.1016/j.neubiorev.2006.02.002; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Carrive P, 2011, PAIN, V152, P676, DOI 10.1016/j.pain.2010.12.019; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Chesler EJ, 2002, NAT NEUROSCI, V5, P1101, DOI 10.1038/nn1102-1101; Chesler EJ, 2002, NEUROSCI BIOBEHAV R, V26, P907, DOI 10.1016/S0149-7634(02)00103-3; DANNEMAN PJ, 1994, PAIN, V58, P39, DOI 10.1016/0304-3959(94)90183-X; DEJESUS PV, 1973, NEUROLOGY, V23, P1182, DOI 10.1212/WNL.23.11.1182; DEVOR M, 1982, EXP NEUROL, V76, P483, DOI 10.1016/0014-4886(82)90118-2; Falmagne J.-C., 1985, ELEMENTS PSYCHOPHYSI; FRANZ DN, 1968, J PHYSIOL-LONDON, V199, P319, DOI 10.1113/jphysiol.1968.sp008656; Gaskill BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032799; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; GORDON CJ, 1985, PHYSIOL BEHAV, V34, P687, DOI 10.1016/0031-9384(85)90365-8; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; HAIMICOHEN R, 1983, J NEUROSCI METH, V8, P127, DOI 10.1016/0165-0270(83)90113-9; HANDWERKER HO, 1987, EXP BRAIN RES, V65, P493; HARDY JD, 1956, J APPL PHYSIOL, V9, P257, DOI 10.1152/jappl.1956.9.2.257; HARRIS LS, 1964, J PHARMACOL EXP THER, V143, P141; Hart JS, 1971, COMP PHYSL THERMOREG, P1; HOLE K, 1993, PAIN, V53, P247, DOI 10.1016/0304-3959(93)90220-J; HOLE K, 1990, PAIN, V43, P391, DOI 10.1016/0304-3959(90)90039-G; HUDSON JW, 1979, PHYSIOL ZOOL, V52, P205, DOI 10.1086/physzool.52.2.30152564; KANUI TI, 1985, PAIN, V21, P231, DOI 10.1016/0304-3959(85)90087-9; KANUI TI, 1987, BRAIN RES, V402, P160, DOI 10.1016/0006-8993(87)91060-2; Kirk J A, 1968, Ann Phys Med, V9, P270; Kumazawa T, 1998, NEUROSCI RES, V32, P9, DOI 10.1016/S0168-0102(98)00060-1; LAMOTTE RH, 1983, FED PROC, V42, P2548; LAMOTTE RH, 1982, J NEUROSCI, V2, P765; Le Bars D, 2001, PHARMACOL REV, V53, P597; Le Bars D, 2009, PHARM PAIN, P475; LICHTMAN AH, 1993, PAIN, V55, P283, DOI 10.1016/0304-3959(93)90003-8; Luce R, 1986, RESPONSE TIMES THEIR, DOI [10.1093/acprof:oso/9780195070019.001.0001, DOI 10.1093/ACPROF:OSO/9780195070019.001.0001]; Masuda A, 2005, PSYCHOTHER PSYCHOSOM, V74, P288, DOI 10.1159/000086319; MEYER RA, 1976, IEEE T BIO-MED ENG, V23, P54, DOI 10.1109/TBME.1976.324616; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; Nuhr M, 2004, SPINE, V29, P1499, DOI 10.1097/01.BRS.0000131439.87553.99; Ohsawa M, 2011, PAIN, V152, P114, DOI 10.1016/j.pain.2010.10.005; PAINTAL AS, 1967, J PHYSIOL-LONDON, V193, P523, DOI 10.1113/jphysiol.1967.sp008376; Paintal AS, 1973, PATHOLOGICAL CONDUCT, P19; Plaghki Leon, 2005, Curr Opin Investig Drugs, V6, P58; Plaghki L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010269; Qiu CS, 2011, ANTINOCICEPTIVE EFFE; REN MF, 1979, CHINESE MED J-PEKING, V92, P576; Schubert KA, 2010, BIOL LETTERS, V6, P132, DOI 10.1098/rsbl.2009.0569; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z; STOLL AM, 1959, J APPL PHYSIOL, V14, P373, DOI 10.1152/jappl.1959.14.3.373; STOLWIJK JA, 1965, J APPL PHYSIOL, V20, P1006, DOI 10.1152/jappl.1965.20.5.1006; Swoap SJ, 2008, BIOCHEM PHARMACOL, V76, P817, DOI 10.1016/j.bcp.2008.06.017; Swoap Steven J, 2009, Am J Physiol Regul Integr Comp Physiol, V297, pR769, DOI 10.1152/ajpregu.00131.2009; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P753, DOI 10.1113/jphysiol.1995.sp020766; Tjolsen A, 1997, HANDB EXP PHARM, V130, P1; Tomlinson S, 2007, COMP BIOCHEM PHYS A, V148, P645, DOI 10.1016/j.cbpa.2007.08.013; TREEDE RD, 1995, J PHYSIOL-LONDON, V483, P747, DOI 10.1113/jphysiol.1995.sp020619; Vianna DML, 2005, EUR J NEUROSCI, V21, P2505, DOI 10.1111/j.1460-9568.2005.04073.x; Vierck CJ, 2008, PAIN, V135, P7, DOI 10.1016/j.pain.2007.12.008; Vinkers CH, 2008, EUR J PHARMACOL, V585, P407, DOI 10.1016/j.ejphar.2008.02.097; WALTERS ET, 1994, INT REV NEUROBIOL, V36, P325, DOI 10.1016/S0074-7742(08)60307-4; Walters ET, 2008, PAIN, P175; Wilson SG, 2001, BEHAV BRAIN RES, V125, P65, DOI 10.1016/S0166-4328(01)00281-9; Yoda T, 2000, AM J PHYSIOL-REG I, V278, pR134, DOI 10.1152/ajpregu.2000.278.1.R134; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	66	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36699	10.1371/journal.pone.0036699	http://dx.doi.org/10.1371/journal.pone.0036699			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629325	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343500024
J	Robinson, BG; Khurana, S; Pohl, JB; Li, WK; Ghezzi, A; Cady, AM; Najjar, K; Hatch, MM; Shah, RR; Bhat, A; Hariri, O; Haroun, KB; Young, MC; Fife, K; Hooten, J; Tran, T; Goan, D; Desai, F; Husain, F; Godinez, RM; Sun, JC; Corpuz, J; Moran, J; Zhong, AC; Chen, WY; Atkinson, NS				Robinson, Brooks G.; Khurana, Sukant; Pohl, Jascha B.; Li, Wen-ke; Ghezzi, Alfredo; Cady, Amanda M.; Najjar, Kristina; Hatch, Michael M.; Shah, Ruchita R.; Bhat, Amar; Hariri, Omar; Haroun, Kareem B.; Young, Melvin C.; Fife, Kathryn; Hooten, Jeff; Tran, Tuan; Goan, Daniel; Desai, Foram; Husain, Farhan; Godinez, Ryan M.; Sun, Jeffrey C.; Corpuz, Jonathan; Moran, Jacxelyn; Zhong, Allen C.; Chen, William Y.; Atkinson, Nigel S.			A Low Concentration of Ethanol Impairs Learning but Not Motor and Sensory Behavior in Drosophila Larvae	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; ANIMAL-MODELS; ENVIRONMENTAL ETHANOL; MELANOGASTER LARVAE; ALCOHOL-DRINKING; HONEY-BEE; RESPONSES; DEHYDROGENASE; PERFORMANCE; TOLERANCE	Drosophila melanogaster has proven to be a useful model system for the genetic analysis of ethanol-associated behaviors. However, past studies have focused on the response of the adult fly to large, and often sedating, doses of ethanol. The pharmacological effects of low and moderate quantities of ethanol have remained understudied. In this study, we tested the acute effects of low doses of ethanol (similar to 7 mM internal concentration) on Drosophila larvae. While ethanol did not affect locomotion or the response to an odorant, we observed that ethanol impaired associative olfactory learning when the heat shock unconditioned stimulus (US) intensity was low but not when the heat shock US intensity was high. We determined that the reduction in learning at low US intensity was not a result of ethanol anesthesia since ethanol-treated larvae responded to the heat shock in the same manner as untreated animals. Instead, low doses of ethanol likely impair the neuronal plasticity that underlies olfactory associative learning. This impairment in learning was reversible indicating that exposure to low doses of ethanol does not leave any long lasting behavioral or physiological effects.	[Robinson, Brooks G.; Khurana, Sukant; Pohl, Jascha B.; Li, Wen-ke; Ghezzi, Alfredo; Cady, Amanda M.; Najjar, Kristina; Hatch, Michael M.; Shah, Ruchita R.; Bhat, Amar; Hariri, Omar; Haroun, Kareem B.; Young, Melvin C.; Fife, Kathryn; Hooten, Jeff; Tran, Tuan; Goan, Daniel; Desai, Foram; Husain, Farhan; Godinez, Ryan M.; Sun, Jeffrey C.; Corpuz, Jonathan; Moran, Jacxelyn; Zhong, Allen C.; Chen, William Y.; Atkinson, Nigel S.] Univ Texas Austin, Inst Neurosci, Neurobiol Sect, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Robinson, BG (corresponding author), Univ Texas Austin, Inst Neurosci, Neurobiol Sect, Austin, TX 78712 USA.	nigela@mail.utexas.edu	Ghezzi, Alfredo/I-4620-2012	Ghezzi, Alfredo/0000-0001-9176-1320; Robinson, Brooks/0000-0001-5020-531X; Zhong, Allen/0000-0002-8102-6696; Moran, Jacxelyn/0000-0002-3453-0566; Khurana, Sukant/0000-0002-6665-6892	NIH [R01 AA018037]; NSF [IOS-0641370]; NIH Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant [5T32AA007471]; The University of Texas Undergraduate Research Fellowship; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018037, T32AA007471] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The University of Texas Undergraduate Research Fellowship; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by NIH R01 AA018037 to NSA and NSF grant IOS-0641370 to NSA supported the undergraduate contribution. BGR and JBP were supported by the NIH Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant # 5T32AA007471. AC and RG received The University of Texas Undergraduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson CI, 2000, ALCOHOL CLIN EXP RES, V24, P1153, DOI 10.1111/j.1530-0277.2000.tb02078.x; Acheson SK, 1998, ALCOHOL CLIN EXP RES, V22, P1437, DOI 10.1111/j.1530-0277.1998.tb03932.x; Atkinson NS, 2009, J NEUROGENET, V23, P293, DOI 10.1080/01677060802572937; Barr CS, 2006, ADDICT BIOL, V11, P374, DOI 10.1111/j.1369-1600.2005.00034.x; Bell RL, 2006, ADDICT BIOL, V11, P270, DOI 10.1111/j.1369-1600.2005.00029.x; Lopez MAC, 2011, ACCIDENT ANAL PREV, V43, P1104, DOI 10.1016/j.aap.2010.12.019; Cowmeadow RB, 2005, ALCOHOL CLIN EXP RES, V29, P1777, DOI 10.1097/01.alc.0000183232.56788.62; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; DEPIEREUX E, 1985, BEHAV GENET, V15, P181, DOI 10.1007/BF01065898; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Fry JD, 2006, GENET RES, V87, P87, DOI 10.1017/S0016672306008032; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; GIBSON WE, 1985, PHYSIOL BEHAV, V35, P1003, DOI 10.1016/0031-9384(85)90273-2; GIVENS B, 1995, ALCOHOL CLIN EXP RES, V19, P763, DOI 10.1111/j.1530-0277.1995.tb01580.x; Givens B, 1997, BEHAV NEUROSCI, V111, P275; Givens B, 1996, NEUROSCIENCE, V71, P417, DOI 10.1016/0306-4522(95)00443-2; Heberlein U, 2000, ALCOHOL RES HEALTH, V24, P185; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Hunt PS, 2009, ALCOHOL, V43, P465, DOI 10.1016/j.alcohol.2009.08.004; Iyengar BG, 2006, J COMP NEUROL, V499, P583, DOI 10.1002/cne.21133; Jacobson SW, 2011, ALCOHOL CLIN EXP RES, V35, P250, DOI 10.1111/j.1530-0277.2010.01341.x; Khurana S, 2012, BEHAV GENET, V42, P151, DOI 10.1007/s10519-011-9487-9; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015259; Khurana S, 2009, J BIOSCIENCES, V34, P621, DOI 10.1007/s12038-009-0080-9; KOELEGA HS, 1995, PSYCHOPHARMACOLOGY, V118, P233, DOI 10.1007/BF02245951; Koob GF, 2000, ADDICTION, V95, pS73; LISTER RG, 1991, NEUROPSYCHOLOGIA, V29, P1205, DOI 10.1016/0028-3932(91)90034-6; Markwiese BJ, 1998, ALCOHOL CLIN EXP RES, V22, P416, DOI 10.1111/j.1530-0277.1998.tb03668.x; Matthews DB, 2004, NEUROBIOL LEARN MEM, V82, P299, DOI 10.1016/j.nlm.2004.06.007; McBride WJ, 1998, CRIT REV NEUROBIOL, V12, P339, DOI 10.1615/CritRevNeurobiol.v12.i4.40; McClure KD, 2011, DIS MODEL MECH, V4, P335, DOI 10.1242/dmm.006411; McIntire Steven L, 2010, WormBook, P1, DOI 10.1895/wormbook.1.40.1; MCKENZIE JA, 1979, OECOLOGIA, V40, P299, DOI 10.1007/BF00345326; MELCHIOR CL, 1993, ALCOHOL, V10, P491, DOI 10.1016/0741-8329(93)90071-U; MILLER ME, 1978, J EXP PSYCHOL-HUM L, V4, P246, DOI 10.1037/0278-7393.4.3.246; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Mustard JA, 2008, NEUROBIOL LEARN MEM, V90, P633, DOI 10.1016/j.nlm.2008.07.017; PARSONS PA, 1980, BEHAV GENET, V10, P183, DOI 10.1007/BF01066268; Pauls D, 2010, CHEM SENSES, V35, P335, DOI 10.1093/chemse/bjq023; Pecsenye K, 1997, MOL GEN GENET, V255, P258, DOI 10.1007/s004380050496; Phillips DP, 2011, ADDICTION, V106, P1614, DOI 10.1111/j.1360-0443.2011.03472.x; Rajamohan A, 2008, J INSECT PHYSIOL, V54, P708, DOI 10.1016/j.jinsphys.2008.01.011; RICHTER R, 1975, SCHWEIZ MED WSCHR, V105, P884; Rodan AR, 2010, INT REV NEUROBIOL, V91, P25, DOI 10.1016/S0074-7742(10)91002-7; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Schweizer TA, 2008, EXP CLIN PSYCHOPHARM, V16, P240, DOI 10.1037/1064-1297.16.3.240; VANDERZEL A, 1991, ARCH BIOCHEM BIOPHYS, V287, P121, DOI 10.1016/0003-9861(91)90396-Z; VIGUE CL, 1982, BIOCHEM GENET, V20, P681, DOI 10.1007/BF00483965; White AM, 1997, PSYCHOPHARMACOLOGY, V133, P256, DOI 10.1007/s002130050399; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166	51	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37394	10.1371/journal.pone.0037394	http://dx.doi.org/10.1371/journal.pone.0037394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624024	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500109
J	Sun, HF; Hou, HL; Lu, P; Zhang, LX; Zhao, FY; Ge, C; Wang, TP; Yao, M; Li, JJ				Sun, Hefen; Hou, Helei; Lu, Ping; Zhang, Lixing; Zhao, Fangyu; Ge, Chao; Wang, Tingpu; Yao, Ming; Li, Jinjun			Isocorydine Inhibits Cell Proliferation in Hepatocellular Carcinoma Cell Lines by Inducing G2/M Cell Cycle Arrest and Apoptosis	PLOS ONE			English	Article							CANCER STEM-CELLS; PHASE; DNA; CHECKPOINT; EXPRESSION; MECHANISM; PHOSPHORYLATION; INACTIVATION; ALKALOIDS; PATHWAYS	The treatment of human hepatocellular carcinoma (HCC) cell lines with (+)-isocorydine, which was isolated and purified from Papaveraceae sp. plants, resulted in a growth inhibitory effect caused by the induction of G2/M phase cell cycle arrest and apoptosis. We report that isocorydine induces G2/M phase arrest by increasing cyclin B1 and p-CDK1 expression levels, which was caused by decreasing the expression and inhibiting the activation of Cdc25C. The phosphorylation levels of Chk1 and Chk2 were increased after ICD treatment. Furthermore, G2/M arrest induced by ICD can be disrupted by Chk1 siRNA but not by Chk2 siRNA. In addition, isocorydine treatment led to a decrease in the percentage of CD133(+) PLC/PRF/5 cells. Interestingly, isocorydine treatment dramatically decreased the tumorigenicity of SMMC-7721 and Huh7 cells. These findings indicate that isocorydine might be a potential therapeutic drug for the chemotherapeutic treatment of HCC.	[Sun, Hefen; Hou, Helei; Lu, Ping; Zhang, Lixing; Ge, Chao; Li, Jinjun] Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China; [Zhao, Fangyu; Yao, Ming] Jiao Tong Univ, Sch Med, Expt Pathol Lab, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China; [Wang, Tingpu] Tianshui Normal Univ, Coll Life Sci & Chem, Tianshui, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tianshui Normal University	Sun, HF (corresponding author), Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China.	jjli@shsci.org			National Key Sci-Tech Special Project of China [2008ZX10002-022]; National Key Program for Basic Research of China (973) [2009CB521803]; Program Of Shanghai Subject Chief Scientist (A) [09XD1403600]	National Key Sci-Tech Special Project of China; National Key Program for Basic Research of China (973)(National Basic Research Program of China); Program Of Shanghai Subject Chief Scientist (A)	This work was supported in part by grants from the National Key Sci-Tech Special Project of China (2008ZX10002-022), the National Key Program for Basic Research of China (973) (2009CB521803), the Program Of Shanghai Subject Chief Scientist (A) (09XD1403600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand S, 2006, J CELL BIOCHEM, V97, P709, DOI 10.1002/jcb.20672; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Cummings M, 2002, BRIT J HAEMATOL, V116, P421, DOI 10.1046/j.1365-2141.2002.03262.x; Dang Y, 2009, CHINESE CHEM LETT, V20, P1218, DOI 10.1016/j.cclet.2009.05.020; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hoet S, 2004, PLANTA MED, V70, P407, DOI 10.1055/s-2004-818967; HOFFMAN RM, 1980, P NATL ACAD SCI-BIOL, V77, P7306, DOI 10.1073/pnas.77.12.7306; HOFFMAN RM, 1983, BIOCHIM BIOPHYS ACTA, V738, P49, DOI 10.1016/0304-419X(84)90019-2; Huang WW, 2011, INT J ONCOL, V38, P1067, DOI 10.3892/ijo.2011.922; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Ruiz EJ, 2010, CURR BIOL, V20, P717, DOI 10.1016/j.cub.2010.02.050; Lee TKW, 2009, LIVER INT, V29, P955, DOI 10.1111/j.1478-3231.2009.02040.x; Li J, 2005, J BIOL CHEM, V280, P12041, DOI 10.1074/jbc.M412445200; Luo Y, 2001, NEOPLASIA, V3, P411, DOI 10.1038/sj.neo.7900175; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Moon DO, 2010, ONCOL REP, V24, P271, DOI 10.3892/or_00000856; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Ruo X, 1981, CHINESE PHARMACOL B, V16, P118; Saito H, 1998, HEPATOLOGY, V27, P1233, DOI 10.1002/hep.510270508; Scovassi AI, 1998, EUR J HISTOCHEM, V42, P251; Simbulan-Rosenthal CM, 1999, MOL CELL BIOCHEM, V193, P137, DOI 10.1023/A:1006988832729; Sotnikova R, 1997, METHOD FIND EXP CLIN, V19, P589; STERN PH, 1986, J NATL CANCER I, V76, P629, DOI 10.1093/jnci/76.4.629; Stewart ZA, 2003, TRENDS PHARMACOL SCI, V24, P139, DOI 10.1016/S0165-6147(03)00026-9; Visanji JM, 2006, CANCER LETT, V237, P130, DOI 10.1016/j.canlet.2005.05.045; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; YANG L, 1990, Yaoxue Xuebao, V25, P859; Yang Yue, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P686, DOI 10.3760/cma.j.issn.1007-3418.2011.09.013; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zhang W, 2010, NAT SCI, V2, P457, DOI [DOI 10.4236/NS.2010.25056, 10.4236/ns.2010.25056]; ZHAO YQ, 1991, ACTA PHARM SINIC, V12, P324	36	45	52	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36808	10.1371/journal.pone.0036808	http://dx.doi.org/10.1371/journal.pone.0036808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623962	Green Published, gold			2022-12-25	WOS:000305343500029
J	Wan, CH; Fu, J; Wang, Y; Miao, SY; Song, W; Wang, LF				Wan, Chunhua; Fu, Jun; Wang, Yong; Miao, Shiying; Song, Wei; Wang, Linfang			Exosome-Related Multi-Pass Transmembrane Protein TSAP6 Is a Target of Rhomboid Protease RHBDD1-Induced Proteolysis	PLOS ONE			English	Article							MEMBRANE-VESICLES; INTRAMEMBRANE PROTEOLYSIS; DIRECT STIMULATION; CELL-DEATH; T-CELLS; SECRETION; MICROVESICLES; ACTIVATION; APOPTOSIS; RELEASE	We have previously reported that rhomboid domain containing 1 (RHBDD1), a mammalian rhomboid protease highly expressed in the testis, can cleave the Bcl-2 protein Bik. In this study, we identified a multi-pass transmembrane protein, tumor suppressor activated pathway-6 (TSAP6) as a potential substrate of RHBDD1. RHBDD1 was found to induce the proteolysis of TSAP6 in a dose- and activity-dependent manner. The cleavage of TSAP6 was not restricted to its glycosylated form and occurred in three different regions. In addition, mass spectrometry and mutagenesis analyses both indicated that the major cleavage site laid in the C-terminal of the third transmembrane domain of TSAP6. A somatic cell knock-in approach was used to genetically inactivate the endogenous RHBDD1 in HCT116 and RKO colon cancer cells. Exosome secretion was significantly elevated when RHBDD1 was inactivated in the two cells lines. The increased exosome secretion was verfied through the detection of certain exosomal components, including Tsg101, Tf-R, FasL and Trail. In addition, the elevation of exosome secretion by RHBDD1 inactivation was reduced when TSAP6 was knocked down, indicating that the role of RHBDD1 in regulating exosomal trafficking is very likely to be TSAP6-dependent. We found that the increase in FasL and Trail increased exosome-induced apoptosis in Jurkat cells. Taken together, our findings suggest that RHBDD1 is involved in the regulation of a nonclassical exosomal secretion pathway through the restriction of TSAP6.	[Wan, Chunhua; Fu, Jun; Wang, Yong; Miao, Shiying; Song, Wei; Wang, Linfang] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing, Peoples R China; [Wan, Chunhua] Nantong Univ, Sch Publ Hlth, Nantong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Nantong University	Wan, CH (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing, Peoples R China.	roy_sw0925@yahoo.com.cn; wang.linfang@imicams.ac.cn			National Important Research Plan of China [2011CB944302]; National Natural Science Foundation of China [81101855]; State Key Laboratory Special fund from the Ministry of Science [2060204]; Research Fund for the Doctoral Program of High Education [20111106110023]	National Important Research Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory Special fund from the Ministry of Science; Research Fund for the Doctoral Program of High Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by grants from the National Important Research Plan of China (2011CB944302), grant for the youth (81101855) from the National Natural Science Foundation of China, the State Key Laboratory Special fund (2060204) from the Ministry of Science, and the Research Fund for the Doctoral Program of High Education (20111106110023). The experimental study was performed in compliance with the laws of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Alonso R, 2005, J BIOL CHEM, V280, P28439, DOI 10.1074/jbc.M501112200; Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Erez E, 2009, BIOCHEMISTRY-US, V48, P12314, DOI 10.1021/bi901648g; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Hirata R, 2002, NAT BIOTECHNOL, V20, P735, DOI 10.1038/nbt0702-735; Huber V, 2005, GASTROENTEROLOGY, V128, P1796, DOI 10.1053/j.gastro.2005.03.045; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kovar M, 2006, P NATL ACAD SCI USA, V103, P11671, DOI 10.1073/pnas.0603466103; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lespagnol A, 2008, CELL DEATH DIFFER, V15, P1723, DOI 10.1038/cdd.2008.104; Li XB, 2006, J CELL MOL MED, V10, P364, DOI 10.1111/j.1582-4934.2006.tb00405.x; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Lohi O, 2004, CURR BIOL, V14, P236, DOI 10.1016/j.cub.2004.01.025; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pascall JC, 2004, BIOCHEM BIOPH RES CO, V317, P244, DOI 10.1016/j.bbrc.2004.03.039; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Sanchez-Pulido L, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-98; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Szajnik M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011469; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tsruya R, 2007, EMBO J, V26, P1211, DOI 10.1038/sj.emboj.7601581; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; Urban S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-231; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; Wang Y, 2008, CELL MOL LIFE SCI, V65, P3822, DOI 10.1007/s00018-008-8452-0; Wang Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-25; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	44	27	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37452	10.1371/journal.pone.0037452	http://dx.doi.org/10.1371/journal.pone.0037452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624035	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343500120
J	Funamizu, N; Lacy, CR; Fujita, K; Furukawa, K; Misawa, T; Yanaga, K; Manome, Y				Funamizu, Naotake; Lacy, Curtis Ray; Fujita, Kaori; Furukawa, Kenei; Misawa, Takeyuki; Yanaga, Katsuhiko; Manome, Yoshinobu			Tetrahydrouridine Inhibits Cell Proliferation through Cell Cycle Regulation Regardless of Cytidine Deaminase Expression Levels	PLOS ONE			English	Article							JAPANESE CANCER-PATIENTS; CYTOSINE-ARABINOSIDE; PANCREATIC-CANCER; PLASMA PHARMACOKINETICS; DEOXYCYTIDINE KINASE; ORAL BIOAVAILABILITY; FORCED EXPRESSION; SOLID TUMORS; LUNG-CANCER; PHASE-II	Tetrahydrouridine (THU) is a well characterized and potent inhibitor of cytidine deaminase (CDA). Highly expressed CDA catalyzes and inactivates cytidine analogues, ultimately contributing to increased gemcitabine resistance. Therefore, a combination therapy of THU and gemcitabine is considered to be a potential and promising treatment for tumors with highly expressed CDA. In this study, we found that THU has an alternative mechanism for inhibiting cell growth which is independent of CDA expression. Three different carcinoma cell lines (MIAPaCa-2, H441, and H1299) exhibited decreased cell proliferation after sole administration of THU, while being unaffected by knocking down CDA. To investigate the mechanism of THU-induced cell growth inhibition, cell cycle analysis using flow cytometry was performed. This analysis revealed that THU caused an increased rate of G1-phase occurrence while S-phase occurrence was diminished. Similarly, Ki-67 staining further supported that THU reduces cell proliferation. We also found that THU regulates cell cycle progression at the G1/S checkpoint by suppressing E2F1. As a result, a combination regimen of THU and gemcitabine might be a more effective therapy than previously believed for pancreatic carcinoma since THU works as a CDA inhibitor, as well as an inhibitor of cell growth in some types of pancreatic carcinoma cells.	[Funamizu, Naotake; Manome, Yoshinobu] Jikei Univ, Dept Mol Cell Biol, Inst DNA Med, Sch Med, Tokyo, Japan; [Lacy, Curtis Ray] Univ Calif Irvine, Irvine, CA USA; [Fujita, Kaori] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Funamizu, Naotake; Furukawa, Kenei; Misawa, Takeyuki; Yanaga, Katsuhiko] Jikei Univ, Dept Surg, Sch Med, Tokyo, Japan	Jikei University; University of California System; University of California Irvine; Kyoto University; Jikei University	Funamizu, N (corresponding author), Jikei Univ, Dept Mol Cell Biol, Inst DNA Med, Sch Med, Tokyo, Japan.	funamizujikei@yahoo.co.jp	Yanaga, Katsuhiko/Y-6290-2019	Yanaga, Katsuhiko/0000-0001-8918-4720; Manome, Yoshinobu/0000-0002-8755-8976				Bardenheuer W, 2005, LEUKEMIA, V19, P2281, DOI 10.1038/sj.leu.2403977; Besnard T, 2008, J CHROMATOGR B, V870, P117, DOI 10.1016/j.jchromb.2008.05.040; Beumer JH, 2008, CANCER CHEMOTH PHARM, V62, P457, DOI 10.1007/s00280-007-0625-2; Beumer JH, 2008, CLIN CANCER RES, V14, P3529, DOI 10.1158/1078-0432.CCR-07-4885; Beumer JH, 2011, CANCER CHEMOTH PHARM, V67, P421, DOI 10.1007/s00280-010-1337-6; BOUFFARD DY, 1993, BIOCHEM PHARMACOL, V45, P1857, DOI 10.1016/0006-2952(93)90444-2; CAMIENER GW, 1968, BIOCHEM PHARMACOL, V17, P1981, DOI 10.1016/0006-2952(68)90114-7; COHEN RM, 1971, J BIOL CHEM, V246, P7561; Eliopoulos N, 1998, CANCER CHEMOTH PHARM, V42, P373, DOI 10.1007/s002800050832; Funamizu N, 2011, PANCREAS        0907; Funamizu N, 2010, ONCOL REP, V23, P471, DOI 10.3892/or_00000657; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Giovannetti E, 2007, PHARMACOL RES, V55, P343, DOI 10.1016/j.phrs.2007.01.003; Gourdeau H, 2001, CANCER CHEMOTH PHARM, V47, P236, DOI 10.1007/s002800000223; Guo DL, 2010, AAPS PHARMSCITECH, V11, P247, DOI 10.1208/s12249-010-9383-2; Gusella M, 2011, BRIT J CLIN PHARMACO, V71, P437, DOI 10.1111/j.1365-2125.2010.03838.x; Herbst RS, 2002, J CLIN ONCOL, V20, P3815, DOI 10.1200/JCO.2002.03.038; Hilger R A, 2002, Int J Clin Pharmacol Ther, V40, P567; HO DHW, 1977, CANCER TREAT REP, V61, P717; Horn T, 1998, NOTES UNDERGR, V37, P1; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kanai M, 2011, CANCER CHEMOTH PHARM, V68, P157, DOI 10.1007/s00280-010-1470-2; Kanno SI, 2007, CLIN CHIM ACTA, V377, P144, DOI 10.1016/j.cca.2006.09.014; Kaubisch A, 2004, CANCER CHEMOTH PHARM, V53, P337, DOI 10.1007/s00280-003-0727-4; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Ludovini V, 2011, J THORAC ONCOL, V6, P2018, DOI 10.1097/JTO.0b013e3182307e1f; Morita T, 2003, ONCOLOGY-BASEL, V65, P267, DOI 10.1159/000074480; Navarra P, 1999, CRIT REV ONCOL HEMAT, V29, P249, DOI 10.1016/S1040-8428(98)00032-8; Neff T, 1996, EXP HEMATOL, V24, P1340; Ng SSW, 2002, MOL CANCER THER, V1, P777; O'Byrne KJ, 1999, ANN ONCOL, V10, P981, DOI 10.1023/A:1008330302535; Ohta T, 2004, ONCOL REP, V12, P1115; Picot J, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15410; Schroder JK, 1998, BRIT J HAEMATOL, V103, P1096, DOI 10.1046/j.1365-2141.1998.01084.x; Spratlin J, 2004, CLIN CANCER RES, V10, P6956, DOI 10.1158/1078-0432.CCR-04-0224; STOLLER RG, 1978, BIOCHEM PHARMACOL, V27, P53, DOI 10.1016/0006-2952(78)90256-3; Sugiyama E, 2010, CLIN PHARMACOKINET, V49, P549, DOI 10.2165/11532970-000000000-00000; Tibaldi C, 2011, ANN ONCOL       0607; Ueno H, 2009, BRIT J CANCER, V100, P870, DOI 10.1038/sj.bjc.6604971; Un F, 2006, ANTICANCER RES, V26, P2761; WONG PP, 1979, CANCER TREAT REP, V63, P1245	42	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37424	10.1371/journal.pone.0037424	http://dx.doi.org/10.1371/journal.pone.0037424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22616006	Green Published, gold			2022-12-25	WOS:000305341300113
J	Kim, J; Tooker, JF; Luthe, DS; De Moraes, CM; Felton, GW				Kim, Jinwon; Tooker, John F.; Luthe, Dawn S.; De Moraes, Consuelo M.; Felton, Gary W.			Insect Eggs Can Enhance Wound Response in Plants: A Study System of Tomato Solanum lycopersicum L. and Helicoverpa zea Boddie	PLOS ONE			English	Article							PIERID BUTTERFLIES; INDUCED RESISTANCE; DEFENSE; OVIPOSITION; DEPOSITION; HERBIVORE; HYPERSENSITIVITY; TEMPERATURE; INDUCTION; MECHANISM	Insect oviposition on plants frequently precedes herbivory. Accumulating evidence indicates that plants recognize insect oviposition and elicit direct or indirect defenses to reduce the pressure of future herbivory. Most of the oviposition-triggered plant defenses described thus far remove eggs or keep them away from the host plant or their desirable feeding sites. Here, we report induction of antiherbivore defense by insect oviposition which targets newly hatched larvae, not the eggs, in the system of tomato Solanum lycopersicum L., and tomato fruitworm moth Helicoverpa zea Boddie. When tomato plants were oviposited by H. zea moths, pin2, a highly inducible gene encoding protease inhibitor2, which is a representative defense protein against herbivorous arthropods, was expressed at significantly higher level at the oviposition site than surrounding tissues, and expression decreased with distance away from the site of oviposition. Moreover, more eggs resulted in higher pin2 expression in leaves, and both fertilized and unfertilized eggs induced pin2 expression. Notably, when quantified daily following deposition of eggs, pin2 expression at the oviposition site was highest just before the emergence of larvae. Furthermore, H. zea oviposition primed the wound-induced increase of pin2 transcription and a burst of jasmonic acid (JA); tomato plants previously exposed to H. zea oviposition showed significantly stronger induction of pin2 and higher production of JA upon subsequent simulated herbivory than without oviposition. Our results suggest that tomato plants recognize H. zea oviposition as a signal of impending future herbivory and induce defenses to prepare for this herbivory by newly hatched neonate larvae.	[Kim, Jinwon; Tooker, John F.; De Moraes, Consuelo M.; Felton, Gary W.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Luthe, Dawn S.] Penn State Univ, Dept Soil & Crop Sci, University Pk, PA 16802 USA; [Kim, Jinwon; Tooker, John F.; Luthe, Dawn S.; De Moraes, Consuelo M.; Felton, Gary W.] Penn State Univ, Ctr Chem Ecol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kim, J (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	gwf10@psu.edu	Tooker, John/P-6421-2014; Felton, Gary W./E-8575-2013	Tooker, John/0000-0002-9303-6699; 	United States Department of Agriculture's USDA-NRI [2007-35302-18218]; David and Lucile Packard Foundation	United States Department of Agriculture's USDA-NRI; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was supported by the United States Department of Agriculture's USDA-NRI Grant 2007-35302-18218 (http://www.csrees.usda.gov/funding/nri/nri.html), which contributed to all of the study design, data collection and analysis, decision to publish, and preparation of the manuscript. It was also supported by the the David and Lucile Packard Foundation, which had no role in study design, data collection and decision to publish.	ADLER PH, 1991, ENTOMOL EXP APPL, V58, P159, DOI 10.1007/BF00164940; Agrawal AA, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P45; Andersson J, 2003, J CHEM ECOL, V29, P1489, DOI 10.1023/A:1024277823101; Balbyshev NF, 1997, J ECON ENTOMOL, V90, P652, DOI 10.1093/jee/90.2.652; Bernays EA, 1997, ECOL ENTOMOL, V22, P121, DOI 10.1046/j.1365-2311.1997.00042.x; Beyaert I, 2012, P ROY SOC B-BIOL SCI, V279, P101, DOI 10.1098/rspb.2011.0468; Bown AW, 2002, PLANT PHYSIOL, V129, P1430, DOI 10.1104/pp.006114; Bruessow F, 2010, PLANT J, V62, P876, DOI 10.1111/j.1365-313X.2010.04200.x; CHIPPENDALE GM, 1970, J INSECT PHYSIOL, V16, P1057, DOI 10.1016/0022-1910(70)90198-8; Colazza S, 2004, J EXP BIOL, V207, P47, DOI 10.1242/jeb.00732; Davidson J, 1944, J ANIM ECOL, V13, P26, DOI 10.2307/1326; De Puysseleyr V, 2011, ARTHROPOD-PLANT INTE, V5, P71, DOI 10.1007/s11829-010-9117-0; Desurmont GA, 2011, ECOL ENTOMOL, V36, P335, DOI 10.1111/j.1365-2311.2011.01277.x; Doss RP, 2000, P NATL ACAD SCI USA, V97, P6218, DOI 10.1073/pnas.110054697; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Farmer EE, 2009, P NATL ACAD SCI USA, V106, P935, DOI 10.1073/pnas.0812182106; Fatouros NE, 2008, P NATL ACAD SCI USA, V105, P10033, DOI 10.1073/pnas.0707809105; Felton GW, 2008, CURR OPIN PLANT BIOL, V11, P457, DOI 10.1016/j.pbi.2008.07.001; Fowler JH, 2009, PLANT CELL, V21, P1239, DOI 10.1105/tpc.108.065029; Frost CJ, 2008, PLANT PHYSIOL, V146, P818, DOI 10.1104/pp.107.113027; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Hilker M, 2002, J EXP BIOL, V205, P455; Hilker M, 2011, PHYTOCHEMISTRY, V72, P1612, DOI 10.1016/j.phytochem.2011.02.018; Hilker M, 2010, BIOL REV, V85, P267, DOI 10.1111/j.1469-185X.2009.00100.x; Hilker M, 2006, J CHEM ECOL, V32, P1379, DOI 10.1007/s10886-006-9057-4; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; HOWE RW, 1967, ANNU REV ENTOMOL, V12, P15, DOI 10.1146/annurev.en.12.010167.000311; Karban R, 2002, ECOLOGY, V83, P1209, DOI 10.1890/0012-9658(2002)083[1209:TFCOIE]2.0.CO;2; Karban R, 2011, FUNCT ECOL, V25, P339, DOI 10.1111/j.1365-2435.2010.01789.x; Kim J, 2011, PHYTOCHEMISTRY, V72, P1624, DOI 10.1016/j.phytochem.2011.03.026; Little D, 2007, PLANT PHYSIOL, V143, P784, DOI 10.1104/pp.106.090837; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Orozco-Cardenas ML, 2001, PLANT CELL, V13, P179, DOI 10.1105/tpc.13.1.179; Peiffer M, 2009, NEW PHYTOL, V184, P644, DOI 10.1111/j.1469-8137.2009.03002.x; Petzold-Maxwell J, 2011, ECOL ENTOMOL, V36, P700, DOI 10.1111/j.1365-2311.2011.01315.x; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Rhainds M, 2010, ENTOMOL EXP APPL, V136, P211, DOI 10.1111/j.1570-7458.2010.01032.x; Rotenberg D, 2006, J VIROL METHODS, V138, P49, DOI 10.1016/j.jviromet.2006.07.017; Seino Y, 1996, APPL ENTOMOL ZOOL, V31, P467, DOI 10.1303/aez.31.467; SHAPIRO AM, 1987, OECOLOGIA, V71, P631, DOI 10.1007/BF00379310; Tamiru A, 2011, ECOL LETT, V14, P1075, DOI 10.1111/j.1461-0248.2011.01674.x; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Tooker JF, 2005, J CHEM ECOL, V31, P2753, DOI 10.1007/s10886-005-8553-2; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; Videla M, 2007, INT J PEST MANAGE, V53, P259, DOI 10.1080/09670870701439594; Wasternack C, 2006, J PLANT PHYSIOL, V163, P297, DOI 10.1016/j.jplph.2005.10.014; Zalucki MP, 2002, ANNU REV ENTOMOL, V47, P361, DOI 10.1146/annurev.ento.47.091201.145220; Zheng SJ, 2008, PLANT PHYSIOL, V146, P812, DOI 10.1104/pp.107.111542; Zhu-Salzman K, 2008, PLANT PHYSIOL, V146, P852, DOI 10.1104/pp.107.112177	52	49	50	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37420	10.1371/journal.pone.0037420	http://dx.doi.org/10.1371/journal.pone.0037420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22616005	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300094
J	Wang, WN; Wu, EY; Hellinga, HW; Beese, LS				Wang, Weina; Wu, Eugene Y.; Hellinga, Homme W.; Beese, Lorena S.			Structural Factors That Determine Selectivity of a High Fidelity DNA Polymerase for Deoxy-, Dideoxy-, and Ribonucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I KLENOW FRAGMENT; TRANSLESION SYNTHESIS; ALLOSTERIC REGULATION; CRYSTAL-STRUCTURE; SINGLE RESIDUE; ACTIVE-SITE; REPLICATION; MECHANISM; FAMILY; SUGAR	In addition to discriminating against base pair mismatches, DNA polymerases exhibit a high degree of selectivity for deoxy-ribonucleotides over ribo- or dideoxynucleotides. It has been proposed that a single active site residue (steric gate) blocks productive binding of nucleotides containing 2'-hydroxyls. Although this steric gate plays a role in sugar moiety discrimination, its interactions do not account fully for the observed behavior of mutants. Here we present 10 high resolution crystal structures and enzyme kinetic analyses of Bacillus DNA polymerase I large fragment variants complexed with deoxy-, ribo-, and dideoxynucleotides and a DNA substrate. Taken together, these data present a more nuanced and general mechanism for nucleotide discrimination in which ensembles of intermediate conformations in the active site trap non-cognate substrates. It is known that the active site O-helix transitions from an open state in the absence of nucleotide substrates to a ternary complex closed state in which the reactive groups are aligned for catalysis. Substrate misalignment in the closed state plays a fundamental part in preventing non-cognate nucleotide misincorpation. The structures presented here show that additional O-helix conformations intermediate between the open and closed state extremes create an ensemble of binding sites that trap and misalign non-cognate nucleotides. Water-mediated interactions, absent in the fully closed state, play an important role in formation of these binding sites and can be remodeled to accommodate different non-cognate substrates. This mechanism may extend also to base pair discrimination.	[Wang, Weina; Wu, Eugene Y.; Hellinga, Homme W.; Beese, Lorena S.] DUMC, Dept Biochem, Durham, NC 27710 USA	Duke University	Beese, LS (corresponding author), DUMC, Dept Biochem, Box 3711, Durham, NC 27710 USA.	lb12@duke.edu	Wu, Eugene Y/K-5677-2015; Classen, Scott/AAY-8176-2020	Wu, Eugene Y/0000-0002-5189-7036; 	National Institutes of Health [P01 CA092584, R01 GM091487]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Department of Energy program Integrated Diffraction Analysis Technologies [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM091487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy program Integrated Diffraction Analysis Technologies(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 CA092584 and R01 GM091487 (to L. S. B.). Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. Use of the SIBYLS beamline at the Advanced Light Source, Lawrence Berkeley National Laboratory, was supported in part by the Department of Energy program Integrated Diffraction Analysis Technologies under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Astatke M, 1998, J MOL BIOL, V278, P147, DOI 10.1006/jmbi.1998.1672; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Brown JA, 2010, J MOL BIOL, V395, P282, DOI 10.1016/j.jmb.2009.11.003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cases-Gonzalez CE, 2000, J BIOL CHEM, V275, P19759, DOI 10.1074/jbc.M910361199; Cavanaugh NA, 2011, J BIOL CHEM, V286, P31650, DOI 10.1074/jbc.M111.253401; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLucia AM, 2003, NUCLEIC ACIDS RES, V31, P4129, DOI 10.1093/nar/gkg417; DIEKMANN S, 1989, J MOL BIOL, V205, P787, DOI 10.1016/0022-2836(89)90324-0; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans RJ, 2008, P NATL ACAD SCI USA, V105, P20695, DOI 10.1073/pnas.0809989106; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Henry AA, 2005, CURR OPIN BIOTECH, V16, P370, DOI 10.1016/j.copbio.2005.06.008; Holmberg RC, 2005, BIOMOL ENG, V22, P39, DOI 10.1016/j.bioeng.2004.12.001; Hsu GW, 2005, J BIOL CHEM, V280, P3764, DOI 10.1074/jbc.M411276200; Hsu GW, 2004, J BIOL CHEM, V279, P50280, DOI 10.1074/jbc.M409224200; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kiefer JR, 1997, STRUCTURE, V5, P95, DOI 10.1016/S0969-2126(97)00169-X; Kirouac KN, 2011, J MOL BIOL, V407, P382, DOI 10.1016/j.jmb.2011.01.037; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lansdon EB, 2010, J MOL BIOL, V397, P967, DOI 10.1016/j.jmb.2010.02.019; Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel PH, 2000, J BIOL CHEM, V275, P40266, DOI 10.1074/jbc.M005757200; PETRUSKA J, 1986, P NATL ACAD SCI USA, V83, P1559, DOI 10.1073/pnas.83.6.1559; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Sherrer SM, 2010, BIOCHEMISTRY-US, V49, P10179, DOI 10.1021/bi101465n; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Steitz TA, 2004, PHILOS T R SOC B, V359, P17, DOI 10.1098/rstb.2003.1374; TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VANDESANDE JH, 1972, J BIOL CHEM, V247, P6140; Wang MN, 2011, BIOCHEMISTRY-US, V50, P581, DOI 10.1021/bi101192f; Wang WN, 2011, P NATL ACAD SCI USA, V108, P17644, DOI 10.1073/pnas.1114496108; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171	67	43	43	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28215	28226		10.1074/jbc.M112.366609	http://dx.doi.org/10.1074/jbc.M112.366609			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22648417	hybrid, Green Published			2022-12-25	WOS:000308074600002
J	Kim, KS; Choi, YR; Park, JY; Lee, JH; Kim, DK; Lee, SJ; Paik, SR; Jou, I; Park, SM				Kim, Kwang Soo; Choi, Yu Ree; Park, Ji-Young; Lee, Jung-Ho; Kim, Dong Kyu; Lee, Seung-Jae; Paik, Seung R.; Jou, Ilo; Park, Sang Myun			Proteolytic Cleavage of Extracellular alpha-Synuclein by Plasmin IMPLICATIONS FOR PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA DEGRADATION; ALZHEIMERS-DISEASE; MATRIX METALLOPROTEINASES; NEURODEGENERATIVE DISEASES; ACTIVATOR INHIBITOR-1; LOCUS TRIPLICATION; FIBRIL FORMATION; IN-VITRO; AGGREGATION; MICROGLIA	Parkinson disease (PD) is the second most common neurodegenerative disease characterized by a progressive dopaminergic neuronal loss in association with Lewy body inclusions. Gathering evidence indicates that alpha-synuclein (alpha-syn), a major component of the Lewy body, plays an important role in the pathogenesis of PD. Although alpha-syn is considered to be a cytoplasmic protein, it has been detected in extracellular biological fluids, including human cerebrospinal fluid and blood plasma of healthy and diseased individuals. In addition, a prion-like spread of alpha-syn aggregates has been recently proposed to contribute to the propagation of Lewy bodies throughout the nervous system during progression of PD, suggesting that the metabolism of extracellular alpha-syn might play a key role in the pathogenesis of PD. In the present study, we found that plasmin cleaved and degraded extracellular alpha-syn specifically in a dose- and time-dependent manner. Aggregated forms of alpha-syn as well as monomeric alpha-syn were also cleaved by plasmin. Plasmin cleaved mainly the N-terminal region of alpha-syn and also inhibited the translocation of extracellular alpha-syn into the neighboring cells in addition to the activation of microglia and astrocytes by extracellular alpha-syn. Further, extracellular alpha-syn regulated the plasmin system through up-regulation of plasminogen activator inhibitor-1 (PAI-1) expression. These findings help to understand the molecular mechanism of PD and develop new therapeutic targets for PD.	[Kim, Kwang Soo; Choi, Yu Ree; Jou, Ilo; Park, Sang Myun] Ajou Univ, Dept Pharmacol, Sch Med, Suwon 442721, South Korea; [Choi, Yu Ree; Jou, Ilo; Park, Sang Myun] Ajou Univ, Neurosci Grad Program, Sch Med, Suwon 442721, South Korea; [Kim, Kwang Soo; Choi, Yu Ree; Park, Ji-Young; Jou, Ilo; Park, Sang Myun] Ajou Univ, Chron Inflammatory Dis Res Ctr, Sch Med, Suwon 442721, South Korea; [Lee, Jung-Ho; Paik, Seung R.] Seoul Natl Univ, Sch Chem & Biol Engn, Coll Engn, Seoul 151744, South Korea; [Kim, Dong Kyu; Lee, Seung-Jae] Konkuk Univ, Dept Biomed Sci & Technol, Seoul 143701, South Korea	Ajou University; Ajou University; Ajou University; Seoul National University (SNU); Konkuk University	Park, SM (corresponding author), Ajou Univ, Dept Pharmacol, Sch Med, San 5, Suwon 442721, South Korea.	sangmyun@ajou.ac.kr		Lee, Seung-Jae/0000-0002-5155-5335	Basic Science Research Program [2010-0003623]; Mid-career Researcher Program [2011-0016603]; MRC program through the National Research Foundation of Korea (NRF) [R13-2003-019]; Ministry of Education, Science, and Technology	Basic Science Research Program; Mid-career Researcher Program; MRC program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported in part by Basic Science Research Program (2010-0003623), Mid-career Researcher Program (2011-0016603), and MRC program (R13-2003-019) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology.	Ahn KJ, 2006, J NEUROCHEM, V97, P265, DOI 10.1111/j.1471-4159.2006.03731.x; Alvarez-Erviti L, 2011, NEUROSCI RES, V69, P337, DOI 10.1016/j.neures.2010.12.020; Barker R, 2010, BRAIN RES, V1355, P7, DOI 10.1016/j.brainres.2010.08.025; Bhak G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004177; Cacquevel M, 2007, NEUROBIOL DIS, V27, P164, DOI 10.1016/j.nbd.2007.04.004; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dotti CG, 2004, NEURODEGENER DIS, V1, P205, DOI 10.1159/000080987; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Iwata A, 2003, HUM MOL GENET, V12, P2625, DOI 10.1093/hmg/ddg283; Jang A, 2010, J NEUROCHEM, V113, P1263, DOI 10.1111/j.1471-4159.2010.06695.x; Joo SH, 2010, NEUROSCI LETT, V469, P352, DOI 10.1016/j.neulet.2009.12.026; Kasai T, 2008, NEUROSCI LETT, V436, P52, DOI 10.1016/j.neulet.2008.02.057; Kim KS, 2010, J BIOL CHEM, V285, P21416, DOI 10.1074/jbc.M110.103499; Kim KS, 2009, J LEUKOCYTE BIOL, V86, P349, DOI 10.1189/jlb.1008659; Klegeris A, 2006, FASEB J, V20, P2000, DOI 10.1096/fj.06-6183com; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kornblatt JA, 2003, BIOCHEM BIOPH RES CO, V305, P518, DOI 10.1016/S0006-291X(03)00804-0; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Ledesma MD, 2000, EMBO REP, V1, P530; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee JH, 2009, MOL CELL, V35, P806, DOI 10.1016/j.molcel.2009.07.021; Lee SB, 2009, BIOCHEM BIOPH RES CO, V381, P39, DOI 10.1016/j.bbrc.2009.02.002; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Levin J, 2009, EXP NEUROL, V215, P201, DOI 10.1016/j.expneurol.2008.10.010; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Liu RM, 2011, NEUROBIOL AGING, V32, P1079, DOI 10.1016/j.neurobiolaging.2009.06.003; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Melchor JP, 2003, J NEUROSCI, V23, P8867; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Miller G, 2009, SCIENCE, V326, P1337, DOI 10.1126/science.326.5958.1338; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Park JY, 2008, GLIA, V56, P1215, DOI 10.1002/glia.20691; Park JY, 2009, J NEUROCHEM, V110, P400, DOI 10.1111/j.1471-4159.2009.06150.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Roodveldt C, 2008, J CELL MOL MED, V12, P1820, DOI 10.1111/j.1582-4934.2008.00450.x; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schaller J, 2011, CELL MOL LIFE SCI, V68, P785, DOI 10.1007/s00018-010-0566-5; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Sheehan JJ, 2005, GLIA, V50, P340, DOI 10.1002/glia.20150; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; SUTTON R, 1994, BLOOD COAGUL FIBRIN, V5, P167, DOI 10.1097/00001721-199404000-00002; Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5; Tatebe H, 2010, NEUROSCI RES, V67, P341, DOI 10.1016/j.neures.2010.04.008; Tucker HM, 2000, J NEUROSCI, V20, P3937; Van Nostrand WE, 1999, BIOCHEMISTRY-US, V38, P11570, DOI 10.1021/bi990610f; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; WEINSTEI.MJ, 1972, BIOCHIM BIOPHYS ACTA, V258, P577, DOI 10.1016/0005-2744(72)90250-1; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	68	48	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24862	24872		10.1074/jbc.M112.348128	http://dx.doi.org/10.1074/jbc.M112.348128			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22619171	hybrid, Green Published			2022-12-25	WOS:000306651700001
J	Namiki, K; Matsunaga, H; Yoshioka, K; Tanaka, K; Murata, K; Ishida, J; Sakairi, A; Kim, J; Tokuhara, N; Shibakawa, N; Shimizu, M; Wada, Y; Tokunaga, Y; Shigetomi, M; Hagihara, M; Kimura, S; Sudo, T; Fukamizu, A; Kasuya, Y				Namiki, Kana; Matsunaga, Hirofumi; Yoshioka, Kento; Tanaka, Kensuke; Murata, Kazuya; Ishida, Junji; Sakairi, Akira; Kim, Jundal; Tokuhara, Naoki; Shibakawa, Nobuhiko; Shimizu, Motohisa; Wada, Yukinori; Tokunaga, Yasunori; Shigetomi, Manabu; Hagihara, Masahiko; Kimura, Sadao; Sudo, Tatsuhiko; Fukamizu, Akiyoshi; Kasuya, Yoshitoshi			Mechanism for p38 alpha-mediated Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MULTIPLE-SCLEROSIS; T-CELLS; MAP KINASE; MESSENGER-RNA; P38 MAPK; INFLAMMATION; EXPRESSION; GAMMA; GENE	One of the mitogen-activated protein kinases, p38, has been found to play a crucial role in various inflammatory responses. In this study, we analyzed the roles of p38 alpha in multiple sclerosis, using an animal model, experimental autoimmune encephalomyelitis (EAE). p38 alpha(+/-) mice (p38 alpha(-/-) showed embryonic lethality) showed less severe neurological signs than WT mice. Adoptive transfer of lymph node cells (LNC) from sensitized WT mice with MOG(35-55) to naive WT-induced EAE was much more severe compared with the case using LNC from sensitized p38 alpha(+/-) mice. Comprehensive analysis of cytokines from MOG(35-55)-challenged LNC by Western blot array revealed that production of IL-17 was significantly reduced by a single copy disruption of the p38 alpha gene or a p38 inhibitor. Likewise, by a luciferase reporter assay, an electrophoresis mobility shift assay, and characterization of the relationship between p38 activity and IL-17 mRNA expression, we confirmed that p38 positively regulates transcription of the Il17 gene. Furthermore, oral administration of a highly specific p38 alpha inhibitor (UR-5269) to WT mice at the onset of EAE markedly suppressed the progression of EAE compared with a vehicle group. These results suggest that p38 alpha participates in the pathogenesis of EAE through IL-17 induction.	[Kasuya, Yoshitoshi] Chiba Univ, Grad Sch Med, Dept Biochem & Mol Pharmacol, Chuo Ku, Chiba 2608670, Japan; [Matsunaga, Hirofumi; Shibakawa, Nobuhiko; Shimizu, Motohisa; Wada, Yukinori; Tokunaga, Yasunori; Shigetomi, Manabu; Hagihara, Masahiko] Ube Ind Ltd, Pharmaceut Res Lab, Ube, Yamaguchi 7558633, Japan; [Murata, Kazuya; Ishida, Junji; Sakairi, Akira; Kim, Jundal; Fukamizu, Akiyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba Adv Res Alliance, Life Sci Ctr, Tennoudai, Ibaraki 3058577, Japan; [Sudo, Tatsuhiko] RIKEN, Adv Sci Inst, Chem Biol Core Facil, Wako, Saitama 3510198, Japan; [Sudo, Tatsuhiko] RIKEN, Adv Sci Inst, Antibiot Lab, Wako, Saitama 3510198, Japan	Chiba University; Ube Industries Ltd.; University of Tsukuba; RIKEN; RIKEN	Kasuya, Y (corresponding author), Chiba Univ, Grad Sch Med, Dept Biochem & Mol Pharmacol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	kasuya@faculty.chiba-u.jp	Murata, Kazuya/GLR-2334-2022; Yoshioka, Kento/AAM-4454-2021; fukamizu, akiyoshi/J-5350-2012	Murata, Kazuya/0000-0002-3328-069X; Yoshioka, Kento/0000-0003-1701-3759; fukamizu, akiyoshi/0000-0002-8786-6020; Kasuya, Yoshitoshi/0000-0003-0614-5836; Kimura, Sadao/0000-0001-6768-7474; Jun-Dal, Kim/0000-0002-7361-0999	Ministry of Education, Science, Sports and Culture of Japan [21390172, 20790201]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research (B) 21390172 (to Y. K.) and Young Scientists (B) 20790201 (to K. N.) from the Ministry of Education, Science, Sports and Culture of Japan.	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Barone FC, 2001, J PHARMACOL EXP THER, V296, P312; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Commodaro AG, 2010, INVEST OPHTH VIS SCI, V51, P3567, DOI 10.1167/iovs.09-4393; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dodon MD, 2004, J GEN VIROL, V85, P1921, DOI 10.1099/vir.0.79921-0; Farooqi N, 2010, J NEUROCHEM, V115, P829, DOI 10.1111/j.1471-4159.2010.06982.x; Fassbender K, 1998, NEUROLOGY, V51, P753, DOI 10.1212/WNL.51.3.753; Ferber IA, 1996, J IMMUNOL, V156, P5; Feuerstein N, 1996, J IMMUNOL, V156, P4582; Gulen MF, 2010, IMMUNITY, V32, P54, DOI 10.1016/j.immuni.2009.12.003; Guo XL, 2010, EMBO MOL MED, V2, P504, DOI 10.1002/emmm.201000103; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hisahara S, 2001, J EXP MED, V193, P111, DOI 10.1084/jem.193.1.111; Hofstetter HH, 2005, J NEUROIMMUNOL, V170, P105, DOI 10.1016/j.jneuroim.2005.09.004; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Jirmanova L, 2011, BLOOD, V118, P3280, DOI 10.1182/blood-2011-01-333039; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korb A, 2006, ARTHRITIS RHEUM, V54, P2745, DOI 10.1002/art.22080; Krishnamoorthy G, 2009, NAT MED, V15, P626, DOI 10.1038/nm.1975; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; Matsuo Y, 2006, J BIOL CHEM, V281, P36767, DOI 10.1074/jbc.M604371200; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Merezak C, 2001, J VIROL, V75, P6977, DOI 10.1128/JVI.75.15.6977-6988.2001; Moldovan IR, 2003, J NEUROIMMUNOL, V141, P132, DOI 10.1016/S0165-5728(03)00221-2; Namiki K, 2007, J RECEPT SIG TRANSD, V27, P99, DOI 10.1080/10799890701357855; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; OFFNER H, 1994, J IMMUNOL, V153, P4988; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Otsu K, 2003, BIOCHEM BIOPH RES CO, V302, P56, DOI 10.1016/S0006-291X(03)00096-2; Patil C, 2004, IMMUNOL INVEST, V33, P213, DOI 10.1081/IMM-120034231; Sakurai K, 2004, J RECEPT SIG TRANSD, V24, P283, DOI 10.1081/RRS-200040324; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Takanami-Ohnishi Y, 2002, J BIOL CHEM, V277, P37896, DOI 10.1074/jbc.M207326200; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Taneja V, 2001, NAT IMMUNOL, V2, P781, DOI 10.1038/ni0901-781; Tokuhara N, 2010, J BIOL CHEM, V285, P33294, DOI 10.1074/jbc.M109.089805; Wang HH, 2011, J CLIN NEUROSCI, V18, P1313, DOI 10.1016/j.jocn.2011.01.031; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557	53	28	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24228	24238		10.1074/jbc.M111.338541	http://dx.doi.org/10.1074/jbc.M111.338541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637476	Green Published, hybrid			2022-12-25	WOS:000306651100017
J	Aguiar, ACC; Santos, RD; Figueiredo, FJB; Cortopassi, WA; Pimentel, AS; Franca, TCC; Meneghetti, MR; Krettli, AU				Campos Aguiar, Anna Caroline; Santos, Raquel de Meneses; Barbosa Figueiredo, Flavio Junior; Cortopassi, Wilian Augusto; Pimentel, Andre Silva; Costa Franca, Tanos Celmar; Meneghetti, Mario Roberto; Krettli, Antoniana Ursine			Antimalarial Activity and Mechanisms of Action of Two Novel 4-Aminoquinolines against Chloroquine-Resistant Parasites	PLOS ONE			English	Article							METAL-BASED CHEMOTHERAPY; ACTIVITY IN-VITRO; FALCIPARUM LACTATE-DEHYDROGENASE; PROTEIN DATA-BANK; PLASMODIUM-FALCIPARUM; TROPICAL DISEASES; DRUG DISCOVERY; HEMATIN POLYMERIZATION; COMPLEXES; MALARIA	Chloroquine (CQ) is a cost effective antimalarial drug with a relatively good safety profile (or therapeutic index). However, CQ is no longer used alone to treat patients with Plasmodium falciparum due to the emergence and spread of CQ-resistant strains, also reported for P. vivax. Despite CQ resistance, novel drug candidates based on the structure of CQ continue to be considered, as in the present work. One CQ analog was synthesized as monoquinoline (MAQ) and compared with a previously synthesized bisquinoline (BAQ), both tested against P. falciparum in vitro and against P. berghei in mice, then evaluated in vitro for their cytotoxicity and ability to inhibit hemozoin formation. Their interactions with residues present in the NADH binding site of P falciparum lactate dehydrogenase were evaluated using docking analysis software. Both compounds were active in the nanomolar range evaluated through the HRPII and hypoxanthine tests. MAQ and BAQ derivatives were not toxic, and both compounds significantly inhibited hemozoin formation, in a dose-dependent manner. MAQ had a higher selectivity index than BAQ and both compounds were weak PfLDH inhibitors, a result previously reported also for CQ. Taken together, the two CQ analogues represent promising molecules which seem to act in a crucial point for the parasite, inhibiting hemozoin formation.	[Campos Aguiar, Anna Caroline; Barbosa Figueiredo, Flavio Junior; Krettli, Antoniana Ursine] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Campos Aguiar, Anna Caroline; Krettli, Antoniana Ursine] Univ Fed Minas Gerais, Programa Pos Grad Med Mol, Fac Med, Belo Horizonte, MG, Brazil; [Santos, Raquel de Meneses; Meneghetti, Mario Roberto] Univ Fed Alagoas, Inst Quim & Biotecnol, Maceio, Alagoas, Brazil; [Cortopassi, Wilian Augusto; Costa Franca, Tanos Celmar] Inst Militar Engn, Lab Modelagem Mol Aplicada Defesa Quim & Biol LMD, Rio De Janeiro, Brazil; [Cortopassi, Wilian Augusto; Pimentel, Andre Silva] Pontificia Univ Catolica Rio de Janeiro, Dept Quim, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Federal de Alagoas; Instituto Militar de Engenharia (IME); Pontificia Universidade Catolica do Rio de Janeiro	Aguiar, ACC (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	tanos@ime.eb.br; mario.meneghetti@pq.cnpq.br; akrettli@cpqrr.fiocruz.br	Aguiar, Anna Caroline/J-6970-2015; Pimentel, Andre/B-1278-2010; Cortopassi, Wilian/P-3136-2014; Meneghetti, Mario Roberto/B-9336-2016; França, Tanos Celmar Costa/I-9519-2012	Aguiar, Anna Caroline/0000-0003-0139-8279; Pimentel, Andre/0000-0002-1301-0561; Cortopassi, Wilian/0000-0001-8038-7847; Meneghetti, Mario Roberto/0000-0002-0722-8599; França, Tanos Celmar Costa/0000-0002-6048-8103	MCT/CNPq/CT-Saude/MS/SCTIE/DECIT; FIOCRUZ-PAPES; FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro); CNPq (Conselho Nacional de Pesquisa)	MCT/CNPq/CT-Saude/MS/SCTIE/DECIT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIOCRUZ-PAPES; FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq (Conselho Nacional de Pesquisa)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Work supported from the Brazilian funding agencies MCT/CNPq/CT-Saude/MS/SCTIE/DECIT, FIOCRUZ-PAPES, FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais), FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro) and by CNPq (Conselho Nacional de Pesquisa) fellowships to AUK, ACCA, FJBF and WAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajibade PA, 2006, J COORD CHEM, V59, P1621, DOI 10.1080/00958970500537838; Andrade-Neto VF, 2004, PHYTOTHER RES, V18, P634, DOI 10.1002/ptr.1510; Andrews S, 2010, J MED CHEM, V53, P916, DOI 10.1021/jm900972u; [Anonymous], 2010, SCIENCE, V328, P846, DOI 10.1126/science.328.5980.846; [Anonymous], WHO WORLD MAL REP 20; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blackie MAL, 2010, BIOORG MED CHEM LETT, V20, P1078, DOI 10.1016/j.bmcl.2009.12.030; Borenfreunda E, 1987, TOXICOL IN VITRO, V2, P1; Carey FA, 1990, ADV ORGANIC CHEM B, P597; CARVALHO LH, 1991, BRAZ J MED BIOL RES, V24, P1113; Chellan P, 2010, J ORGANOMET CHEM, V695, P2225, DOI 10.1016/j.jorganchem.2010.06.010; Cortopassi WA, 2011, J BIOMOL STRUCT DYN, V29, P207, DOI 10.1080/07391102.2011.10507383; Cunico W, 2006, BIOORG MED CHEM LETT, V16, P649, DOI 10.1016/j.bmcl.2005.10.033; de Andrade-Neto VF, 2004, BIOORG MED CHEM LETT, V14, P1145, DOI 10.1016/j.bmcl.2003.12.069; de Madureira MD, 2002, J ETHNOPHARMACOL, V81, P23, DOI 10.1016/S0378-8741(02)00005-3; de Ridder S, 2008, J ETHNOPHARMACOL, V120, P302, DOI 10.1016/j.jep.2008.09.017; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Dios AC, 2004, INORG CHEM, V43, P8078; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dorn A, 1998, BIOCHEM PHARMACOL, V55, P727, DOI 10.1016/S0006-2952(97)00510-8; Ekoue-Kovi K, 2009, BIOORGAN MED CHEM, V17, P270, DOI 10.1016/j.bmc.2008.11.009; de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386; Frisch M.J., 2016, GAUSSIAN 16 REVISION; Gabbiani C, 2009, J INORG BIOCHEM, V103, P310, DOI 10.1016/j.jinorgbio.2008.10.004; Galanski M, 2005, CURR MED CHEM, V12, P2075, DOI 10.2174/0929867054637626; Gasser G, 2011, J MED CHEM, V54, P3, DOI 10.1021/jm100020w; Girault S, 2001, J MED CHEM, V44, P1658, DOI 10.1021/jm001096a; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Krettli AU, 2009, CURR DRUG TARGETS, V10, P261, DOI 10.2174/138945009787581203; Krettli AU, 2009, EXPERT OPIN DRUG DIS, V4, P95, DOI 10.1517/17530050802678127; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Leed A, 2002, BIOCHEMISTRY-US, V41, P10245, DOI 10.1021/bi020195i; Lin Jessica T, 2010, Curr Infect Dis Rep, V12, P165, DOI 10.1007/s11908-010-0099-y; Menting JG, 1997, MOL BIOCHEM PARASIT, V88, P215, DOI 10.1016/S0166-6851(97)00095-9; Musonda CC, 2006, BIOORGAN MED CHEM, V14, P5605, DOI 10.1016/j.bmc.2006.04.035; Navarro M, 2004, J MED CHEM, V47, P5204, DOI 10.1021/jm049792o; Navarro M, 1997, J MED CHEM, V40, P1937, DOI 10.1021/jm9607358; Ncokazi KK, 2005, ANAL BIOCHEM, V338, P306, DOI 10.1016/j.ab.2004.11.022; Penna-Coutinho J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021237; PETERS W, 1965, EXP PARASITOL, V17, P80, DOI 10.1016/0014-4894(65)90012-3; Portela C, 2003, FEBS LETT, V547, P217, DOI 10.1016/S0014-5793(03)00692-6; Read JA, 1999, J BIOL CHEM, V274, P10213, DOI 10.1074/jbc.274.15.10213; Rosenthal PJ, 2003, J EXP BIOL, V206, P3735, DOI 10.1242/jeb.00589; Ryckebusch A, 2005, BIOORG MED CHEM LETT, V15, P297, DOI 10.1016/j.bmcl.2004.10.080; SanchezDelgado RA, 1996, J MED CHEM, V39, P1095, DOI 10.1021/jm950729w; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Varotti FD, 2008, ANTIMICROB AGENTS CH, V52, P3868, DOI 10.1128/AAC.00510-08; Vippagunta SR, 1999, J MED CHEM, V42, P4630, DOI 10.1021/jm9902180; Wang C, 2010, BIOCHEM BIOPH RES CO, V402, P773, DOI 10.1016/j.bbrc.2010.10.108; Xu LL, 2005, EXP PARASITOL, V110, P80, DOI 10.1016/j.exppara.2005.02.004; Yearick K, 2008, J MED CHEM, V51, P1995, DOI 10.1021/jm800106u; Zhang HW, 2008, BIOMED PHARMACOTHER, V62, P65, DOI 10.1016/j.biopha.2007.04.007	57	37	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37259	10.1371/journal.pone.0037259	http://dx.doi.org/10.1371/journal.pone.0037259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649514	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335800032
J	Chafekar, SM; Duennwald, ML				Chafekar, Sidhartha M.; Duennwald, Martin L.			Impaired Heat Shock Response in Cells Expressing Full-Length Polyglutamine-Expanded Huntingtin	PLOS ONE			English	Article							MUTANT HUNTINGTIN; MOUSE MODELS; DISEASE; PROTEIN; STRESS; MECHANISMS; INDUCTION; PROTEOSTASIS; AGGREGATION; NEURONS	The molecular mechanisms by which polyglutamine (polyQ)-expanded huntingtin (Htt) causes neurodegeneration in Huntington's disease (HD) remain unclear. The malfunction of cellular proteostasis has been suggested as central in HD pathogenesis and also as a target of therapeutic interventions for the treatment of HD. We present results that offer a previously unexplored perspective regarding impaired proteostasis in HD. We find that, under non-stress conditions, the proteostatic capacity of cells expressing full length polyQ-expanded Htt is adequate. Yet, under stress conditions, the presence of polyQ-expanded Htt impairs the heat shock response, a key component of cellular proteostasis. This impaired heat shock response results in a reduced capacity to withstand the damage caused by cellular stress. We demonstrate that in cells expressing polyQ-expanded Htt the levels of heat shock transcription factor 1 (HSF1) are reduced, and, as a consequence, these cells have an impaired a heat shock response. Also, we found reduced HSF1 and HSP70 levels in the striata of HD knock-in mice when compared to wild-type mice. Our results suggests that full length, non-aggregated polyQ-expanded Htt blocks the effective induction of the heat shock response under stress conditions and may thus trigger the accumulation of cellular damage during the course of HD pathogenesis.	[Chafekar, Sidhartha M.; Duennwald, Martin L.] Boston Biomed Res Inst, Regenerat Biol Program, Watertown, MA USA	Boston Biomedical Research Institute	Chafekar, SM (corresponding author), Boston Biomed Res Inst, Regenerat Biol Program, Watertown, MA USA.	duennwald@bbri.org			Heredity Disease Foundation	Heredity Disease Foundation	This work was supported by a research grant from the Heredity Disease Foundation (to MLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BEERE HM, 1993, CANCER RES, V53, P3034; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bush KT, 1997, J BIOL CHEM, V272, P9086; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; CARR VM, 1994, J COMP NEUROL, V348, P150, DOI 10.1002/cne.903480109; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; Duennwald ML, 2011, PRION, V5, P285, DOI [10.4161/pri.5.4.18071, 10.4161/pri.18071]; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Finkbeiner S., 2011, COLD SPRING HARB PER, V3; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Gusella JF, 2006, TRENDS BIOCHEM SCI, V31, P533, DOI 10.1016/j.tibs.2006.06.009; GUSELLA JF, 1995, SEMIN CELL BIOL, V6, P21, DOI 10.1016/1043-4682(95)90011-X; Han I, 2010, J NEUROCHEM, V113, P1073, DOI 10.1111/j.1471-4159.2010.06672.x; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; MacDonald ME, 2003, NEUROMOL MED, V4, P7, DOI 10.1385/NMM:4:1-2:7; Mitra S, 2008, THESCIENTIFICWORLDJO, V8, P421, DOI 10.1100/tsw.2008.60; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Perez-Navarro E, 2006, HISTOL HISTOPATHOL, V21, P1217, DOI 10.14670/HH-21.1217; Persichetti F, 1999, NEUROBIOL DIS, V6, P364, DOI 10.1006/nbdi.1999.0260; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Sandqvist A, 2004, J CELL BIOL, V164, P15, DOI 10.1083/jcb.200311102; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Tagawa K, 2007, J NEUROSCI, V27, P868, DOI 10.1523/JNEUROSCI.4522-06.2007; Tebbenkamp ATN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013675; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Van Raamsdonk JM, 2007, BRAIN RES BULL, V72, P124, DOI 10.1016/j.brainresbull.2006.10.018; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; Wolfe KJ, 2011, SEMIN CELL DEV BIOL; Wyttenbach A, 2004, J MOL NEUROSCI, V23, P69, DOI 10.1385/JMN:23:1-2:069; Zhang L, 2006, MOL PHARMACEUT, V3, P62, DOI 10.1021/mp050095h; Zhang YQ, 2007, J MOL MED-JMM, V85, P1421, DOI 10.1007/s00109-007-0251-9; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	43	52	52	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37929	10.1371/journal.pone.0037929	http://dx.doi.org/10.1371/journal.pone.0037929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649566	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335800086
J	Verbeek, EC; Bakker, IMC; Bevova, MR; Bochdanovits, Z; Rizzu, P; Sondervan, D; Willemsen, G; de Geus, EJ; Smit, JH; Penninx, BW; Boomsma, DI; Hoogendijk, WJG; Heutink, P				Verbeek, Eva C.; Bakker, Ingrid M. C.; Bevova, Marianna R.; Bochdanovits, Zoltan; Rizzu, Patrizia; Sondervan, David; Willemsen, Gonneke; de Geus, Eco J.; Smit, Johannes H.; Penninx, Brenda W.; Boomsma, Dorret I.; Hoogendijk, Witte J. G.; Heutink, Peter			A Fine-Mapping Study of 7 Top Scoring Genes from a GWAS for Major Depressive Disorder	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PICCOLO; HYPOTHESIS; BEHAVIOR; NETWORK	Major depressive disorder (MDD) is a psychiatric disorder that is characterized -amongst others- by persistent depressed mood, loss of interest and pleasure and psychomotor retardation. Environmental circumstances have proven to influence the aetiology of the disease, but MDD also has an estimated 40% heritability, probably with a polygenic background. In 2009, a genome wide association study (GWAS) was performed on the Dutch GAIN-MDD cohort. A non-synonymous coding single nucleotide polymorphism (SNP) rs2522833 in the PCLO gene became only nominally significant after post-hoc analysis with an Australian cohort which used similar ascertainment. The absence of genome-wide significance may be caused by low SNP coverage of genes. To increase SNP coverage to 100% for common variants (m.a.f > 0.1, r(2)> 0.8), we selected seven genes from the GAIN-MDD GWAS: PCLO, GZMK, ANPEP, AFAP1L1, ST3GAL6, FGF14 and PTK2B. We genotyped 349 SNPs and obtained the lowest P-value for rs2715147 in PCLO at P=6.8E-7. We imputed, filling in missing genotypes, after which rs2715147 and rs2715148 showed the lowest P-value at P=1.2E-6. When we created a haplotype of these SNPs together with the non-synonymous coding SNP rs2522833, the P-value decreased to P=9.9E-7 but was not genome wide significant. Although our study did not identify a more strongly associated variant, the results for PCLO suggest that the causal variant is in high LD with rs2715147, rs2715148 and rs2522833.	[Verbeek, Eva C.; Bakker, Ingrid M. C.; Bevova, Marianna R.; Bochdanovits, Zoltan; Rizzu, Patrizia; Sondervan, David; Heutink, Peter] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Smit, Johannes H.; Penninx, Brenda W.; Hoogendijk, Witte J. G.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Willemsen, Gonneke; de Geus, Eco J.; Boomsma, Dorret I.] Vrije Univ Amsterdam Med Ctr, Dept Biol Psychol, Amsterdam, Netherlands; [Penninx, Brenda W.] Leiden Univ Med Ctr, Dept Psychiat, Leiden, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [Hoogendijk, Witte J. G.] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); University of Groningen; Erasmus University Rotterdam; Erasmus MC	Verbeek, EC (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands.	e.verbeek@vumc.nl	de Geus, Eco J.C./M-9318-2015; Boomsma, Dorret I/AAX-4470-2020; Penninx, Brenda WJH/S-7627-2017	de Geus, Eco J.C./0000-0001-6022-2666; Penninx, Brenda WJH/0000-0001-7779-9672; Willemsen, Gonneke/0000-0003-3755-0236; Heutink, Peter/0000-0001-5218-1737	Netherlands Scientific Organization [904-61-090, 904-61-193, 480-04-004, 400-05-717, 912-100-20]; Centre for Medical Systems Biology (NWO Genomics); Neuroscience Campus Amsterdam (NCA); EMGO+ Institute; ZonMW [10-000-1002]; National Institute of Mental Health (NIMH) [RO1 MH059160]; NESDA; NTR; Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health; NIMH [MH081802]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081802, R01MH059160] Funding Source: NIH RePORTER	Netherlands Scientific Organization; Centre for Medical Systems Biology (NWO Genomics); Neuroscience Campus Amsterdam (NCA); EMGO+ Institute; ZonMW(Netherlands Organization for Health Research and Development); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NESDA; NTR; Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding support for NESDA (Netherlands Study for Depression and Anxiety) and NTR (Netherlands Twin Registry) was provided by the Netherlands Scientific Organization (904-61-090, 904-61-193, 480-04-004, 400-05-717, 912-100-20) (http://www.nwo.nl/) Centre for Medical Systems Biology (NWO Genomics) (http://www.cmsb.nl/home/index.php), the Neuroscience Campus Amsterdam (NCA) (http://www.neurosciencecampus-amsterdam.nl/en/index.asp) and the EMGO+ Institute (http://www.emgo.nl/home/); ZonMW (Geestkracht program, 10-000-1002) (http://www.zonmw.nl/), National Institute of Mental Health (NIMH) (RO1 MH059160) and matching funds from participating institutes in NESDA and NTR. Genotyping was funded by the Genetic Association Information Network (GAIN)(http://www.genome.gov/19518664) of the Foundation for the US National Institutes of Health, and analysis was supported by grants from GAIN and the NIMH (MH081802) (http://www.nimh.nih.gov/index.shtml). Genotype data were obtained from dbGaP (http://www.ncbi.nlm.nih.gov/dbgap,accession number phs000020.v1.p1). The additional genotyping project was performed within the framework of the Center for Medical Systems Biology and TIPharma project T5-203 (http://www.tipharma.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bochdanovits Z, 2009, MOL PSYCHIATR, V14, P650, DOI 10.1038/mp.2009.37; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Bosker FJ, 2011, MOL PSYCHIATR, V16, P516, DOI 10.1038/mp.2010.38; Cen X, 2008, MOL PSYCHIATR, V13, P451, DOI 10.1038/sj.mp.4002132; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Furukawa-Hibi Y, 2010, NEUROREPORT, V21, P1177, DOI 10.1097/WNR.0b013e3283411685; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Kondaurova EM, 2011, J NEUROSCI RES, V89, P267, DOI 10.1002/jnr.22545; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Leal-Ortiz S, 2008, J CELL BIOL, V181, P831, DOI 10.1083/jcb.200711167; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lin DY, 2008, AM J HUM GENET, V82, P444, DOI 10.1016/j.ajhg.2007.11.004; Lips ES, 2011, MOL PSYCHIATR, P1; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; Pardo L, 2009, EUR J HUM GENET, V17, P802, DOI 10.1038/ejhg.2008.248; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reaux A, 1999, NEUROENDOCRINOLOGY, V69, P370, DOI 10.1159/000054439; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; Sheehan TP, 2003, BIOL PSYCHIAT, V54, P540, DOI 10.1016/S0006-3223(02)01815-2; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; van Rossum G., 1991, EUROPEN C P; Velders FP, 2011, PSYCHONEUROENDOCRINO, V36, P1053, DOI 10.1016/j.psyneuen.2011.01.003; Wall L., 2000, PROGRAMMING PERL	39	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37384	10.1371/journal.pone.0037384	http://dx.doi.org/10.1371/journal.pone.0037384			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649524	Green Published, gold			2022-12-25	WOS:000305335800042
J	Young, FB; Franciosi, S; Spreeuw, A; Deng, Y; Sanders, S; Tam, NCM; Huang, K; Singaraja, RR; Zhang, WN; Bissada, N; Kay, C; Hayden, MR				Young, Fiona B.; Franciosi, Sonia; Spreeuw, Amanda; Deng, Yu; Sanders, Shaun; Tam, Natalie C. M.; Huang, Kun; Singaraja, Roshni R.; Zhang, Weining; Bissada, Nagat; Kay, Chris; Hayden, Michael R.			Low Levels of Human HIP14 Are Sufficient to Rescue Neuropathological, Behavioural, and Enzymatic Defects Due to Loss of Murine HIP14 in Hip14-/- Mice	PLOS ONE			English	Article							YAC128 MOUSE MODEL; PROTEIN PALMITOYLATION; NEURONAL DEVELOPMENT; HUNTINGTONS-DISEASE; GENE; TRAFFICKING; EXPRESSION; TRANSMISSION; MUTATIONS; KNOCKOUT	Huntingtin Interacting Protein 14 (HIP14) is a palmitoyl acyl transferase (PAT) that was first identified due to altered interaction with mutant huntingtin, the protein responsible for Huntington Disease (HD). HIP14 palmitoylates a specific set of neuronal substrates critical at the synapse, and downregulation of HIP14 by siRNA in vitro results in increased cell death in neurons. We previously reported that mice lacking murine Hip14 (Hip14-/-) share features of HD. In the current study, we have generated human HIP14 BAC transgenic mice and crossed them to the Hip14-/- model in order to confirm that the defects seen in Hip14-/- mice are in fact due to loss of Hip14. In addition, we sought to determine whether human HIP14 can provide functional compensation for loss of murine Hip14. We demonstrate that despite a relative low level of expression, as assessed via Western blot, BAC-derived human HIP14 compensates for deficits in neuropathology, behavior, and PAT enzyme function seen in the Hip14-/- model. Our findings yield important insights into HIP14 function in vivo.	[Young, Fiona B.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Vancouver, BC, Canada	University of British Columbia; Child & Family Research Institute; University of British Columbia	Young, FB (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	mrh@cmmt.ubc.ca	Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Young, Fiona/0000-0002-3534-6875; Singaraja, Roshni/0000-0002-3418-3867	Canadian Institutes of Health Research-Institute of Genetics Walter; Jessie Boyd and Charles Scriver MD/PhD studentship [IMD 78843]; Michael Smith Foundation for Health Research as a Junior Trainee [ST-JGS-00607(06-1)]	Canadian Institutes of Health Research-Institute of Genetics Walter(Canadian Institutes of Health Research (CIHR)); Jessie Boyd and Charles Scriver MD/PhD studentship; Michael Smith Foundation for Health Research as a Junior Trainee	FBY is supported by the Canadian Institutes of Health Research-Institute of Genetics Walter and Jessie Boyd and Charles Scriver MD/PhD studentship (funding reference number IMD 78843; http://www.cihr-irsc.gc.ca). She has also received funding from the Michael Smith Foundation for Health Research as a Junior Trainee (Award Number: ST-JGS-00607(06-1) BM; http://www.msfhr.org/). MRH is a Killam University Professor and holds a Canada Research Chair in Human Genetics and Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2005, J NEUROSCI, V25, P6263, DOI 10.1523/JNEUROSCI.4757-04.2005; Bradley SV, 2007, HUM MOL GENET, V16, P1279, DOI 10.1093/hmg/ddm076; Chen JY, 2002, J BIOL CHEM, V277, P42588, DOI 10.1074/jbc.M205117200; Chen WY, 2004, HUM MOL GENET, V13, P2991, DOI 10.1093/hmg/ddh322; Cheung C, 2004, CANCER RES, V64, P3849, DOI 10.1158/0008-5472.CAN-04-0322; Coutinho JM, 2005, J LIPID RES, V46, P1113, DOI 10.1194/jlr.M400506-JLR200; Deng YP, 2004, J CHEM NEUROANAT, V27, P143, DOI 10.1016/j.jchemneu.2004.02.005; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gong S., 2005, CURRENT PROTOCOLS NE, P1; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hodgson JG, 1996, HUM MOL GENET, V5, P1875, DOI 10.1093/hmg/5.12.1875; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Lako M, 2000, Expert Rev Mol Med, V2, P1, DOI 10.1017/S1462399400001824; Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Manson AL, 1997, EMBO J, V16, P4238, DOI 10.1093/emboj/16.14.4238; Mansouri MR, 2005, EUR J HUM GENET, V13, P970, DOI 10.1038/sj.ejhg.5201445; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Osokine I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040034; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Roshon M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-2; Sarsero JP, 2004, MAMM GENOME, V15, P370, DOI 10.1007/s00335-004-3019-3; Sidera C, 2005, PROTEOMICS, V5, P1533, DOI 10.1002/pmic.200401185; Singaraja RR, 2011, HUM MOL GENET, V20, P3899, DOI 10.1093/hmg/ddr308; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Trimborn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009242; Van Raamsdonk JM, 2007, BRAIN RES BULL, V72, P124, DOI 10.1016/j.brainresbull.2006.10.018; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Voss AK, 1998, DEV DYNAM, V212, P171, DOI 10.1002/(SICI)1097-0177(199806)212:2<171::AID-AJA3>3.0.CO;2-E; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329	45	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36315	10.1371/journal.pone.0036315	http://dx.doi.org/10.1371/journal.pone.0036315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649491	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800008
J	Deakin, NO; Ballestrem, C; Turner, CE				Deakin, Nicholas O.; Ballestrem, Christoph; Turner, Christopher E.			Paxillin and Hic-5 Interaction with Vinculin Is Differentially Regulated by Rac1 and RhoA	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; PROTEIN-PROTEIN INTERACTIONS; FOCAL-ADHESION MATURATION; EARLY MOLECULAR EVENTS; CELL-MATRIX ADHESIONS; INTEGRIN ADHESOME; MIGRATING CELLS; PLASMA-MEMBRANE; TALIN BINDING	Cell migration is of paramount importance to organism development and maintenance as well as multiple pathological processes, including cancer metastasis. The RhoGTPases Rac1 and RhoA are indispensable for cell migration as they regulate cell protrusion, cell-extracellular matrix (ECM) interactions and force transduction. However, the consequences of their activity at a molecular level within the cell remain undetermined. Using a combination of FRET, FRAP and biochemical analyses we show that the interactions between the focal adhesion proteins vinculin and paxillin, as well as the closely related family member Hic-5 are spatially and reciprocally regulated by the activity of Rac1 and RhoA. Vinculin in its active conformation interacts with either paxillin or Hic-5 in adhesions in response to Rac1 and RhoA activation respectively, while inactive vinculin interacts with paxillin in the membrane following Rac1 inhibition. Additionally, Rac1 specifically regulates the dynamics of paxillin as well as its binding partner and F-actin interacting protein actopaxin (a-parvin) in adhesions. Furthermore, FRET analysis of protein: protein interactions within cell adhesions formed in 3D matrices revealed that, in contrast to 2D systems vinculin interacts preferentially with Hic-5. This study provides new insight into the complexity of cell-ECM adhesions in both 2D and 3D matrices by providing the first description of RhoGTPase-coordinated protein: protein interactions in a cellular microenvironment. These data identify discrete roles for paxillin and Hic-5 in Rac1 and RhoA-dependent cell adhesion formation and maturation; processes essential for productive cell migration.	[Deakin, Nicholas O.; Turner, Christopher E.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY USA; [Ballestrem, Christoph] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Manchester	Deakin, NO (corresponding author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY USA.	turnerce@upstate.edu		Ballestrem, Christoph/0000-0002-5375-7985	National Institutes of Health [R01 GM47607, HL070244]; Susan G. Komen for the Cure; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM47607 and HL070244 (C.E.T.) and Susan G. Komen for the Cure Postdoctoral Fellowship (N.O.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003234; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Ballestrem C, 2006, J CELL SCI, V119, P866, DOI 10.1242/jcs.02794; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Bastiaens PIH, 1996, P NATL ACAD SCI USA, V93, P8407, DOI 10.1073/pnas.93.16.8407; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Bristow JM, 2009, J CELL SCI, V122, P4535, DOI 10.1242/jcs.053728; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Clarke DM, 2004, J CELL BIOL, V166, P901, DOI 10.1083/jcb.200404024; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Deakin NO, 2009, J CELL SCI, V122, P1654, DOI 10.1242/jcs.049130; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEIGER B, 1979, CELL, V18, P193, DOI 10.1016/0092-8674(79)90368-4; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Golji J, 2011, BIOPHYS J, V100, P332, DOI 10.1016/j.bpj.2010.11.024; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Guignandon A, 2006, BIOCHEM BIOPH RES CO, V343, P407, DOI 10.1016/j.bbrc.2006.02.162; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Huang YL, 2011, J BIOL CHEM, V286, P3630, DOI 10.1074/jbc.M110.139923; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Huttelmaier S, 1997, EUR J BIOCHEM, V247, P1136, DOI 10.1111/j.1432-1033.1997.01136.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Johnson RP, 1998, BIOCHEMISTRY-US, V37, P10211, DOI 10.1021/bi9727242; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kim-Kaneyama J, 2005, J CELL SCI, V118, P937, DOI 10.1242/jcs.01683; Kim-Kaneyama J, 2011, J MOL CELL CARDIOL, V50, P77, DOI 10.1016/j.yjmcc.2010.09.024; Kotani H, 1997, ONCOGENE, V14, P1705, DOI 10.1038/sj.onc.1200998; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; LaLonde DP, 2006, CURR BIOL, V16, P1375, DOI 10.1016/j.cub.2006.05.057; Lele TP, 2008, BIOCHEM BIOPH RES CO, V369, P929, DOI 10.1016/j.bbrc.2008.02.137; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mierke CT, 2010, J BIOL CHEM; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nishiya N, 2002, J BIOCHEM, V132, P279, DOI 10.1093/oxfordjournals.jbchem.a003222; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Pignatelli J, 2012, JCB; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rooney C, 2010, EMBO REP, V11, P292, DOI 10.1038/embor.2010.10; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Shan YL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000116; Stanchi F, 2009, J CELL SCI, V122, P1800, DOI 10.1242/jcs.044602; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Sun YS, 2011, CHEMPHYSCHEM, V12, P462, DOI 10.1002/cphc.201000664; Thomas SM, 1999, J CELL SCI, V112, P181; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Webb DJ, 2003, CURR OPIN CELL BIOL, V15, P614, DOI 10.1016/S0955-0674(03)00105-4; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; WOOD CK, 1994, J CELL SCI, V107, P709; Wu CY, 2004, BBA-MOL CELL RES, V1692, P55, DOI 10.1016/j.bbamcr.2004.01.006; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 2001, J CELL SCI, V114, P3583; Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005	88	46	47	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37990	10.1371/journal.pone.0037990	http://dx.doi.org/10.1371/journal.pone.0037990			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629471	Green Published, gold			2022-12-25	WOS:000305345300085
J	Gagliano, M; Renton, M; Duvdevani, N; Timmins, M; Mancuso, S				Gagliano, Monica; Renton, Michael; Duvdevani, Nili; Timmins, Matthew; Mancuso, Stefano			Out of Sight but Not out of Mind: Alternative Means of Communication in Plants	PLOS ONE			English	Article							SELF/NON-SELF DISCRIMINATION; KIN RECOGNITION; BIOLOGICAL COMMUNICATION; COMPETITION; DEFENSE; PHYTOCHROME; GERMINATION; DISPERSAL; INTERPLAY; CAPSICUM	Current knowledge suggests that the mechanisms by which plants communicate information take numerous forms. Previous studies have focussed their attention on communication via chemicals, contact and light; other methods of interaction between plants have remained speculative. In this study we tested the ability of young chilli plants to sense their neighbours and identify their relatives using alternative mechanism(s) to recognised plant communication pathways. We found that the presence of a neighbouring plant had a significant influence on seed germination even when all known sources of communication signals were blocked. Furthermore, despite the signalling restriction, seedlings allocated energy to their stem and root systems differently depending on the identity of the neighbour. These results provide clear experimental evidence for the existence of communication channels between plants beyond those that have been recognized and studied thus far.	[Gagliano, Monica; Duvdevani, Nili] Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Crawley, Australia; [Gagliano, Monica] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Crawley, Australia; [Gagliano, Monica; Renton, Michael] Univ Western Australia, Sch Plant Biol, Crawley, Australia; [Renton, Michael] CSIRO Ecosyst Sci, Floreat, Australia; [Timmins, Matthew] Univ Western Australia, Autralian Res Ctr ARC Ctr Excellence, Crawley, Australia; [Mancuso, Stefano] Univ Florence, Int Lab Plant Neurobiol, Dept Plant Soil & Environm Sci, Sesto, Italy	University of Western Australia; University of Western Australia; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Florence	Gagliano, M (corresponding author), Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Crawley, Australia.	monica.gagliano@uwa.edu.au	Renton, Michael/A-9979-2011; Gagliano, Monica/A-3129-2012; Mancuso, Stefano/G-6515-2012	Renton, Michael/0000-0003-1316-0145; Gagliano, Monica/0000-0002-2414-6990; Mancuso, Stefano/0000-0003-1752-3986	UWA Postdoctoral Research Fellowship	UWA Postdoctoral Research Fellowship	This study was supported by a UWA Postdoctoral Research Fellowship to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aphalo PJ, 1999, J EXP BOT, V50, P1629, DOI 10.1093/jexbot/50.340.1629; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; Ballare CL, 1997, FUNCT ECOL, V11, P441, DOI 10.1046/j.1365-2435.1997.00108.x; BALLARE CL, 1991, OECOLOGIA, V86, P561, DOI 10.1007/BF00318323; BALUSKA F, 2005, COMMUNICATION PLANTS; Baluska F, 2007, PLANT SIGNAL BEHAV, V2, P205, DOI 10.4161/psb.2.4.4550; Bates D, LME4 LINEAR MIXED EF; Belyavskaya NA, 2004, ADV SPACE RES-SERIES, V34, P1566, DOI 10.1016/j.asr.2004.01.021; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carazo P, 2010, J EVOLUTION BIOL, V23, P661, DOI 10.1111/j.1420-9101.2010.01944.x; Collins B, 2000, ANN BOT-LONDON, V86, P739, DOI 10.1006/anbo.2000.1233; Dicke M, 2003, TRENDS PLANT SCI, V8, P403, DOI 10.1016/S1360-1385(03)00183-3; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Falik O, 2003, J ECOL, V91, P525, DOI 10.1046/j.1365-2745.2003.00795.x; Gagliano M, GREEN SYMPH IN PRESS; Gagliano M, 2012, TRENDS PLANT SCI, V17, P323, DOI 10.1016/j.tplants.2012.03.002; GEBER MA, 1989, ECOL MONOGR, V59, P267, DOI 10.2307/1942602; Gersani M, 2001, J ECOL, V89, P660, DOI 10.1046/j.0022-0477.2001.00609.x; Gregg RB, 1943, BIODYNAMICS, V3, P1; Gruntman M, 2004, P NATL ACAD SCI USA, V101, P3863, DOI 10.1073/pnas.0306604101; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Karban R, 2010, AM NAT, V176, P381, DOI 10.1086/655222; Karban R, 2009, ECOL LETT, V12, P502, DOI 10.1111/j.1461-0248.2009.01313.x; Kazan K, 2011, J EXP BOT, V62, P4087, DOI 10.1093/jxb/err142; Kelly JK, 1996, AM NAT, V147, P899, DOI 10.1086/285885; Murphy GP, 2007, J ECOL, V95, P261, DOI 10.1111/j.1365-2745.2007.01217.x; Murphy GP, 2009, AM J BOT, V96, P1990, DOI 10.3732/ajb.0900006; Orrock JL, 2010, AM J BOT, V97, P694, DOI 10.3732/ajb.0900051; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Perry L, 2007, SCIENCE, V315, P986, DOI 10.1126/science.1136914; PICKERSGILL B, 1971, EVOLUTION, V25, P683, DOI 10.1111/j.1558-5646.1971.tb01926.x; Scott-Phillips TC, 2008, J EVOLUTION BIOL, V21, P387, DOI 10.1111/j.1420-9101.2007.01497.x; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; SMITH H, 1995, ANNU REV PLANT PHYS, V46, P289, DOI 10.1146/annurev.pp.46.060195.001445; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Telewski FW, 2006, AM J BOT, V93, P1466, DOI 10.3732/ajb.93.10.1466; Tielborger K, 2009, OIKOS, V118, P792, DOI 10.1111/j.1600-0706.2008.17175.x; Trewavas A, 2003, ANN BOT-LONDON, V92, P1, DOI 10.1093/aob/mcg101; VENABLE DL, 1980, OECOLOGIA, V46, P272, DOI 10.1007/BF00540137; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; WALDMAN B, 1988, ANNU REV ECOL SYST, V19, P543	45	49	50	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37382	10.1371/journal.pone.0037382	http://dx.doi.org/10.1371/journal.pone.0037382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629387	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300036
J	Huang, WL; Lin, YH; Kuo, TBJ; Chang, LR; Chen, YZ; Yang, CCH				Huang, Wei-Lieh; Lin, Yu-Hsuan; Kuo, Terry B. J.; Chang, Li-Ren; Chen, Ying-Zai; Yang, Cheryl C. H.			Methadone-Mediated Autonomic Functioning of Male Patients with Heroin Dependence: The Influence of Borderline Personality Pattern	PLOS ONE			English	Article							OPIATE TREATMENT INDEX; POLYVAGAL THEORY; DISORDER; TEMPERAMENT; QUESTIONNAIRE; USERS; RISK; RELIABILITY; CHARACTER; OUTCOMES	Background: We hypothesize that the population with borderline personality shows different autonomic response to methadone compared to individuals with other personalities. This study applies heart rate variability (HRV) measurements and the Tridimensional Personality Questionnaire (TPQ) to examine this hypothesis. Methodology/Principal Findings: Forty-four male patients with heroin dependence were recruited from a methadone maintenance treatment program. Eight personality patterns were classified according to the TPQ norm used in Taiwan. The borderline pattern (BP, composed of high novelty seeking, high harm avoidance and low reward dependence) and the other personality patterns (OP) were separated into two groups. We compared the HRV profiles between the BP and OP groups. Correlation and regression analysis were performed to clarify relationship between HRV differences and the borderline index (BI, a new concept defined by us, which is calculated as novelty seeking + harm avoidance - reward dependence). The HRV targets investigated included low frequency (LF) power, high frequency (HF) power, total power (TP), normalized LF (LF%), and LF/HF. No baseline HRV parameters showed any inter-group difference. The BP group had a significantly lower Delta HF and a higher Delta LF/HF than the OP group. The personality dimension, reward dependence, showed a negative correlation with Delta LF/HF and Delta LF%. BI was negatively correlated with Delta HF and positively correlated with Delta LF/HF and Delta LF%. Conclusions/Significance: Borderline personality individuals show increased sympathetic activity and decreased parasympathetic activity compared to other personalities after taking methadone. The results support the hypothesis that there is an interaction between borderline personality and autonomic modulation.	[Huang, Wei-Lieh; Lin, Yu-Hsuan; Chang, Li-Ren; Chen, Ying-Zai] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Psychiat, Yunlin, Taiwan; [Huang, Wei-Lieh; Lin, Yu-Hsuan] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Huang, Wei-Lieh; Kuo, Terry B. J.; Yang, Cheryl C. H.] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Kuo, Terry B. J.; Yang, Cheryl C. H.] Natl Yang Ming Univ, Sleep Res Ctr, Taipei 112, Taiwan; [Kuo, Terry B. J.] Natl Cent Univ, Res Ctr Adapt Data Anal, Tao Yuan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Central University	Huang, WL (corresponding author), Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Psychiat, Yunlin, Taiwan.	cchyang@ym.edu.tw	Huang, Wei-Lieh/AAB-4851-2022	CHANG, LI-REN/0000-0003-0853-3904	National Taiwan University Hospital, Yun-Lin Branch [NTUHYL.99N015]; National Science Council (Taiwan) [NSC 100-2627-B-010-002]; Ministry of Education, Aim for the Top University Plan [100AC-B3]	National Taiwan University Hospital, Yun-Lin Branch; National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported by a grant (NTUHYL.99N015) from National Taiwan University Hospital, Yun-Lin Branch, and a grant (NSC 100-2627-B-010-002) from the National Science Council (Taiwan), and a grant (100AC-B3) from the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelekan M, 1996, DRUG ALCOHOL REV, V15, P261, DOI 10.1080/09595239600186001; Adelekan M, 1996, DRUG ALCOHOL REV, V15, P65, DOI 10.1080/09595239600185681; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Anthony James C., 1995, P361; Austin MA, 2007, BRAIN COGNITION, V65, P69, DOI 10.1016/j.bandc.2006.05.007; Barnow S, 2007, PSYCHOPATHOLOGY, V40, P369, DOI 10.1159/000106467; Bejerot S, 1998, ACTA PSYCHIAT SCAND, V98, P243, DOI 10.1111/j.1600-0447.1998.tb10075.x; Bleil ME, 2008, PSYCHOSOM MED, V70, P328, DOI 10.1097/PSY.0b013e31816baefa; Camm AJ, 1996, EUR HEART J, V17, P354; Chang LR, 2012, PROG NEURO-PSYCHOPH, V37, P188, DOI 10.1016/j.pnpbp.2012.01.006; Chen WJ, 2002, COMPR PSYCHIAT, V43, P158, DOI 10.1053/comp.2002.30797; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; CLONINGER CR, 1991, PSYCHOL REP, V69, P1047, DOI 10.2466/PR0.69.7.1047-1057; Darke S, 2005, ADDICTION, V100, P1121, DOI 10.1111/j.1360-0443.2005.01123.x; Darke S, 2004, DRUG ALCOHOL DEPEN, V74, P77, DOI 10.1016/j.drugalcdep.2003.12.002; Darke S, 2007, ADDICTION, V102, P1140, DOI 10.1111/j.1360-0443.2007.01876.x; Deering DEA, 1996, DRUG ALCOHOL REV, V15, P57, DOI 10.1080/09595239600185671; Dijkstra BAG, 2007, EUR ADDICT RES, V13, P81, DOI 10.1159/000097937; Dishman RK, 2000, INT J PSYCHOPHYSIOL, V37, P121, DOI 10.1016/S0167-8760(00)00085-4; Jariani M, 2010, PSYCHIAT DANUB, V22, P544; JENKINS WO, 1950, PSYCHOL BULL, V47, P193, DOI 10.1037/h0060772; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Lee TSH, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-6; Linehan M M, 1993, NIDA Res Monogr, V137, P201; Maggini C, 2000, COMPR PSYCHIAT, V41, P426, DOI 10.1053/comp.2000.16559; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Moldovanova I, 2008, HYPERTENSION, V51, P1203, DOI 10.1161/HYPERTENSIONAHA.107.107433; Moran P, 2007, J CLIN PSYCHIAT, V68, P69, DOI 10.4088/JCP.v68n0109; Ode S, 2010, EMOTION, V10, P536, DOI 10.1037/a0018698; Parker AG, 2006, PSYCHOL PSYCHOTHER-T, V79, P309, DOI 10.1348/147608305X70072; PORGES SW, 1995, PSYCHOPHYSIOLOGY, V32, P301, DOI 10.1111/j.1469-8986.1995.tb01213.x; Porges SW, 2003, PHYSIOL BEHAV, V79, P503, DOI 10.1016/S0031-9384(03)00156-2; Porges SW, 2001, INT J PSYCHOPHYSIOL, V42, P123, DOI 10.1016/S0167-8760(01)00162-3; Raby WN, 2006, DRUG ALCOHOL DEPEN, V81, P283, DOI 10.1016/j.drugalcdep.2005.07.008; Selby EA, 2009, REV GEN PSYCHOL, V13, P219, DOI 10.1037/a0015687; SHEK DTL, 1990, J CLIN PSYCHOL, V46, P35, DOI 10.1002/1097-4679(199001)46:1<35::AID-JCLP2270460106>3.0.CO;2-W; Stenbacka M, 2004, J PSYCHOACTIVE DRUGS, V36, P227, DOI 10.1080/02791072.2004.10399733; Svrakic DM, 2002, ACTA PSYCHIAT SCAND, V106, P189, DOI 10.1034/j.1600-0447.2002.02196.x; Weinberg A, 2009, BRAIN COGNITION, V71, P279, DOI 10.1016/j.bandc.2009.07.014; 1998, JAMA, V280, P1936, DOI DOI 10.1001/JAMA.280.22.1936	43	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37464	10.1371/journal.pone.0037464	http://dx.doi.org/10.1371/journal.pone.0037464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629400	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300043
J	Satti, H; McLaughlin, MM; Omotayo, DB; Keshavjee, S; Becerra, MC; Mukherjee, JS; Seung, KJ				Satti, Hind; McLaughlin, Megan M.; Omotayo, David B.; Keshavjee, Salmaan; Becerra, Mercedes C.; Mukherjee, Joia S.; Seung, Kwonjune J.			Outcomes of Comprehensive Care for Children Empirically Treated for Multidrug-Resistant Tuberculosis in a Setting of High HIV Prevalence	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RECONSTITUTION INFLAMMATORY SYNDROME; WESTERN CAPE PROVINCE; NEW-YORK-CITY; IMMUNE RECONSTITUTION; ANTIRETROVIRAL THERAPY; TUBERCLE-BACILLI; SOUTH-AFRICA; MDR-TB; OUTBREAK	Background: Few studies have examined outcomes for children treated for multidrug-resistant tuberculosis (MDR-TB), including those receiving concomitant treatment for MDR-TB and HIV co-infection. In Lesotho, where the adult HIV seroprevalence is estimated to be 24%, we sought to measure outcomes and adverse events in a cohort of children treated for MDR-TB using a community-based treatment delivery model. Methods: We reviewed retrospectively the clinical charts of children <= 15 years of age treated for culture-confirmed or suspected MDR-TB between July 2007 and January 2011. Results: Nineteen children, ages two to 15, received treatment. At baseline, 74% of patients were co-infected with HIV, 63% were malnourished, 84% had severe radiographic findings, and 21% had extrapulmonary disease. Five (26%) children had culture-confirmed MDR-TB, ten (53%) did not have culture results available, and four (21%) subsequently had results indicating drug-susceptible TB. All children with HIV co-infection who were not already on antiretroviral therapy (ART) were initiated on ART a median of two weeks after the start of the MDR-TB regimen. Among the 17 patients with final outcomes, 15 (88%) patients were cured or completed treatment, two (12%) patients died, and none defaulted or were lost to follow-up. The majority of patients (95%) experienced adverse events; only two required permanent discontinuation of the offending agent, and only one required suspension of MDR-TB treatment for more than one week. Conclusions: Pediatric MDR-TB and MDR-TB/HIV co-infection can be successfully treated using a combination of social support, close monitoring by community health workers and clinicians, and inpatient care when needed. In this cohort, adverse events were well tolerated and treatment outcomes were comparable to those reported in children with drug-susceptible TB and no HIV infection.	[Satti, Hind; McLaughlin, Megan M.; Omotayo, David B.; Keshavjee, Salmaan; Becerra, Mercedes C.; Mukherjee, Joia S.; Seung, Kwonjune J.] Partners Hlth, Maseru, Lesotho; [Satti, Hind; Keshavjee, Salmaan; Becerra, Mercedes C.; Mukherjee, Joia S.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [McLaughlin, Megan M.; Keshavjee, Salmaan; Becerra, Mercedes C.; Mukherjee, Joia S.; Seung, Kwonjune J.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Satti, H (corresponding author), Partners Hlth, Maseru, Lesotho.	hsatti@pih.org		Keshavjee, Salmaan/0000-0002-6967-3305				Al-Dabbagh M, 2011, PEDIATR INFECT DIS J, V30, P501, DOI 10.1097/INF.0b013e31820b583d; [Anonymous], 2008, GUID PROGR MAN DRUG; BLANC FX, 2010, 18 INT AIDS C VIENN; Boulware DR, 2008, CURR OPIN HIV AIDS, V3, P461, DOI 10.1097/COH.0b013e3282fe9693; Center for Disease Control and Prevention, 1998, MMWR MORB MORTAL WKL, V47, P1; Centers for Disease Control and Prevention, 1992, MMWR-MORBID MORTAL W, V41, P961; Centers for Disease Control and Prevention, 2002, VIT HLTH STAT; Cilliers K, 2010, ACTA PAEDIATR, V99, P705, DOI 10.1111/j.1651-2227.2010.01696.x; Cruz AT, 2007, PAEDIATR RESPIR REV, V8, P107, DOI 10.1016/j.prrv.2007.04.008; DEBRE R, 1959, AM REV RESPIR DIS, V80, P326; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; Drobac PC, 2006, PEDIATRICS, V117, P2022, DOI 10.1542/peds.2005-2235; Eamranond P, 2001, INT J TUBERC LUNG D, V5, P594; EDLIN BR, 1992, NEW ENGL J MED, V326, P1514, DOI 10.1056/NEJM199206043262302; Ettehad D, 2012, LANCET INFECT DIS; Fairlie L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-28; Feja K, 2008, PEDIATR INFECT DIS J, V27, P907, DOI 10.1097/INF.0b013e3181783aca; FISCHL MA, 1992, ANN INTERN MED, V117, P177, DOI 10.7326/0003-4819-117-3-177; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Graham SM, 2005, INT J TUBERC LUNG D, V9, P592; Graham SM, 2004, INT J TUBERC LUNG D, V8, P648; Graham SM, 2001, INT J TUBERC LUNG D, V5, P12; Hallbauer U. M., 2011, Southern African Journal of Epidemiology & Infection, V26, P161; Keshavjee S, 2010, NEW ENGL J MED, V363, P1781, DOI 10.1056/NEJMp1010023; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Ministry of Health and Social Welfare, 2009, DEM HLTH SURV; Moro ML, 1998, AIDS, V12, P1095, DOI 10.1097/00002030-199809000-00017; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Mukherjee JS, 2003, INT J TUBERC LUNG D, V7, P637; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Partners In Health, 2011, PARTN HLTH 2011 ANN; Pepper DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-83; Puthanakit T, 2006, PEDIATR INFECT DIS J, V25, P53, DOI 10.1097/01.inf.0000195618.55453.9a; Satti H, 2012, INT J TUBERC LUNG D, V16, P468, DOI 10.5588/ijtld.11.0615; Schaaf HS, 2011, PAEDIATR RESPIR REV, V12, P31, DOI 10.1016/j.prrv.2010.09.010; Schaaf HS, 2009, AM J PUBLIC HEALTH, V99, P1486, DOI 10.2105/AJPH.2008.143271; Schaaf HS, 2002, PEDIATRICS, V109, P765, DOI 10.1542/peds.109.5.765; Schaaf HS, 2006, ACTA PAEDIATR, V95, P523, DOI 10.1080/08035250600675741; Schaaf HS, 2003, ARCH DIS CHILD, V88, P1106, DOI 10.1136/adc.88.12.1106; Schaaf HS, 2000, INT J TUBERC LUNG D, V4, P1149; Schluger NW, 1996, PEDIATR PULM, V21, P138, DOI 10.1002/(SICI)1099-0496(199602)21:2<138::AID-PPUL9>3.0.CO;2-N; Seddon JA, 2012, CLIN INFECT DIS, V54, P157, DOI 10.1093/cid/cir772; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shenoi S, 2009, CURR OPIN INFECT DIS, V22, P11, DOI 10.1097/QCO.0b013e3283210020; Shin SY, 2004, CHEST, V125, P974, DOI 10.1378/chest.125.3.974; STEINER P, 1983, AM REV RESPIR DIS, V128, P425, DOI 10.1164/arrd.1983.128.3.425; Thee S, 2011, INT J TUBERC LUNG D, V15, P1191, DOI 10.5588/ijtld.10.0707; Thomas TA, 2010, INT J TUBERC LUNG D, V14, P1244; USAID TB Care II, 2011, COMM BAS CAR DRUG RE; Walters E, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-1; WHO, 2010, ANT THER HIV INF AD; WHO/IUATLD, 2010, GUID NAT TUB HIV PRO; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2011, TB DAT TUB COUNTR PR; Zampoli M, 2007, INT J TUBERC LUNG D, V11, P417	62	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37114	10.1371/journal.pone.0037114	http://dx.doi.org/10.1371/journal.pone.0037114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629356	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300021
J	Shao, J; Tian, LC; Lei, B; Wei, L; Yang, Y; Kijlstra, A; Yang, PZ				Shao, Ju; Tian, Lichun; Lei, Bo; Wei, Lin; Yang, Yan; Kijlstra, Aize; Yang, Peizeng			AAV2-Mediated Subretinal Gene Transfer of mIL-27p28 Attenuates Experimental Autoimmune Uveoretinitis in Mice	PLOS ONE			English	Article							VIRUS-INDUCED GENE-3; ADENOASSOCIATED VIRUS; CHRONIC UVEITIS; INTERLEUKIN-27; THERAPY; CELLS; IL-27; INFLAMMATION; INHIBITION; INFECTION	Background: Advances in gene transfer techniques have provided long-term, safe and stable transduction of retinal cells following subretinal injection with adeno-associated viral (AAV) vectors. In this study we investigated whether subretinal injection of AAV2-murine IL-27p28 vector was effective in inhibiting experimental autoimmune uveoretinitis (EAU) induced in B10RIII mice. Methodology/Principal Findings: An AAV2 vector encoding the murine IL-27p28 gene (rAAV2-CMV-mIL-27p28) was prepared and subretinally injected into B10RIII mice (4.35x10(8) vector genome (v. g.)). AAV2 vector mediating green fluorescent protein (rAAV2-CMV-GFP) served as a control (5x10(8) v.g.). The concentration of mIL-27p28 in homogenized eyes and serum was assayed by enzyme linked immunosorbent assay (ELISA) after subretinal injection. Human IRBP161-180 peptide and Complete Freund's Adjuvant were injected into mice receiving either the rAAV2-CMV-mIL-27p28 or rAAV2-CMV-GFP vector. EAU was evaluated clinically and pathologically. The level of IL-17 and IL-10 in homogenized eyes was measured on day 12 and day 21 following immunization. Delayed type hypersensitivity (DTH) and IRBP161-180-specific proliferation of lymphocytes from the spleen and lymph nodes were assayed to examine the influence of the subretinal delivery of rAAV2-CMV-mIL-27p28 on the systemic immune response. IL-27p28 was detectable by ELISA within the eyes from two weeks following subretinal injection of the rAAV2-CMV-mIL-27p28 vector and showed a sustained high expression from day 14 to 9 months with a highest expression at 5 months. Subretinal injection of the vector significantly attenuated the severity of EAU disease clinically and pathologically in association with a significantly decreased IL-17 expression and an increased IL-10 expression. The IL-27p28 vector did not affect the systemic immune response, as determined by DTH and IRBP161-180-specific lymphocyte proliferation. Conclusions/Significance: A high and stable expression of IL-27p28 was observed for at least 9 months following subretinal delivery of rAAV2-CMV-mIL-27p28. The amelioration of EAU disease severity was associated with a decreased IL-17 expression and an increased IL-10 expression.	[Shao, Ju; Tian, Lichun; Lei, Bo; Wei, Lin; Yang, Yan; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing Eye Inst, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Hosp Maastricht, Dept Ophthalmol, Eye Res Inst Maastricht, Maastricht, Netherlands	Chongqing Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing Eye Inst, Chongqing, Peoples R China.	peizengycmu@126.com	Yang, Peizeng/C-6336-2013	Lei, Bo/0000-0002-5497-0905	Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Key Project of Natural Science Foundation of Chongqing (CSTC) [2009BA5037]; National Natural Science Foundation Project [30973242]; National Natural Science Foundation of China [81070722]; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Fund for PAR-EU Scholars Program	Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); Key Project of Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation Project of CQ CSTC); National Natural Science Foundation Project(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Fund for PAR-EU Scholars Program	This work was supported by Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), http://www.ctin.ac.cn/View.aspx?id = 14380; Key Project of Natural Science Foundation of Chongqing (CSTC, 2009BA5037), http://www.ctin.ac.cn/Class.aspx?clsId = 226; National Natural Science Foundation Project (30973242), http://159.226.244.22/portal/proj_search.asp; National Natural Science Foundation of China (81070722), http://159.226.244.22/portal/proj_search.asp; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality, http://cqkjdj.cstc.gov.cn/View.aspx?id = 1000; Fund for PAR-EU Scholars Program, http://www.cqhrss.gov.cn/u/cqhrss/news_37398.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Annear MJ, 2011, GENE THER, V18, P53, DOI 10.1038/gt.2010.111; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Barker SE, 2009, J GENE MED, V11, P486, DOI 10.1002/jgm.1327; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Broderick CA, 2005, MOL THER, V12, P369, DOI 10.1016/j.ymthe.2005.03.018; Caspi Rachel R, 2003, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1506s53; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Colella P, 2009, TRENDS MOL MED, V15, P23, DOI 10.1016/j.molmed.2008.11.003; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Dick AD, 1997, BRIT J OPHTHALMOL, V81, P1107, DOI 10.1136/bjo.81.12.1107; Edelsten C, 2003, AM J OPHTHALMOL, V135, P676, DOI 10.1016/S0002-9394(02)02148-7; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Jankowski M, 2010, ARCH IMMUNOL THER EX, V58, P417, DOI 10.1007/s00005-010-0098-6; Lai YKY, 2002, GENE THER, V9, P804, DOI 10.1038/sj.gt.3301695; Lee YS, 2011, IMMUNOLOGY, V132, P492, DOI 10.1111/j.1365-2567.2010.03379.x; Lei B, 2009, MOL VIS, V15, P1374; Maaser C, 2004, IMMUNOLOGY, V112, P437, DOI 10.1111/j.1365-2567.2004.01895.x; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Niedbala W, 2008, ANN RHEUM DIS, V67, P1474, DOI 10.1136/ard.2007.083360; NUSSENBLATT RB, 1983, LANCET, V2, P235; Oh HM, 2011, J IMMUNOL, V187, P3338, DOI 10.4049/jimmunol.1004019; Pearl JE, 2004, J IMMUNOL, V173, P7490, DOI 10.4049/jimmunol.173.12.7490; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pot C, 2010, J INTERF CYTOK RES, V30, P381, DOI 10.1089/jir.2010.0047; Reeves SW, 2006, OPHTHALMOLOGY, V113, P302, DOI 10.1016/j.ophtha.2005.10.008; Rizzo LV, 1998, INT IMMUNOL, V10, P807, DOI 10.1093/intimm/10.6.807; Rosas LE, 2006, AM J PATHOL, V168, P158, DOI 10.2353/ajpath.2006.050013; Smith JR, 2005, HUM GENE THER, V16, P1037, DOI 10.1089/hum.2005.16.1037; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Tian LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019542; Yang JF, 2008, EUR J IMMUNOL, V38, P1204, DOI 10.1002/eji.200838145	38	6	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37773	10.1371/journal.pone.0037773	http://dx.doi.org/10.1371/journal.pone.0037773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629453	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300076
J	Graves, JA; Wang, YD; Sims-Lucas, S; Cherok, E; Rothermund, K; Branca, MF; Elster, J; Beer-Stolz, D; Van Houten, B; Vockley, J; Prochownik, EV				Graves, J. Anthony; Wang, Yudong; Sims-Lucas, Sunder; Cherok, Edward; Rothermund, Kristi; Branca, Maria F.; Elster, Jennifer; Beer-Stolz, Donna; Van Houten, Bennett; Vockley, Jerry; Prochownik, Edward V.			Mitochondrial Structure, Function and Dynamics Are Temporally Controlled by c-Myc	PLOS ONE			English	Article							TARGETED HOMOLOGOUS RECOMBINATION; CHLOROMETHYL-X-ROSAMINE; CELL-CYCLE ENTRY; MAMMALIAN-CELLS; IN-VIVO; GLUTAMATE EXCITOTOXICITY; PERMEABILITY TRANSITION; GENOMIC INSTABILITY; METABOLIC NETWORKS; PROTEIN DRP1	Although the c-Myc (Myc) oncoprotein controls mitochondrial biogenesis and multiple enzymes involved in oxidative phosphorylation (OXPHOS), the coordination of these events and the mechanistic underpinnings of their regulation remain largely unexplored. We show here that re-expression of Myc in myc-/- fibroblasts is accompanied by a gradual accumulation of mitochondrial biomass and by increases in membrane polarization and mitochondrial fusion. A correction of OXPHOS deficiency is also seen, although structural abnormalities in electron transport chain complexes (ETC) are not entirely normalized. Conversely, the down-regulation of Myc leads to a gradual decrease in mitochondrial mass and a more rapid loss of fusion and membrane potential. Increases in the levels of proteins specifically involved in mitochondrial fission and fusion support the idea that Myc affects mitochondrial mass by influencing both of these processes, albeit favoring the latter. The ETC defects that persist following Myc restoration may represent metabolic adaptations, as mitochondrial function is re-directed away from producing ATP to providing a source of metabolic precursors demanded by the transformed cell.	[Graves, J. Anthony; Cherok, Edward; Rothermund, Kristi; Elster, Jennifer; Prochownik, Edward V.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Hematol Oncol, Pittsburgh, PA 15213 USA; [Wang, Yudong; Vockley, Jerry] UPMC, Childrens Hosp Pittsburgh, Div Med Genet, Pittsburgh, PA USA; [Sims-Lucas, Sunder] UPMC, Childrens Hosp Pittsburgh, Div Nephrol, Pittsburgh, PA USA; [Branca, Maria F.] UPMC, Childrens Hosp Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Beer-Stolz, Donna] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA USA; [Beer-Stolz, Donna] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA USA; [Van Houten, Bennett; Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Van Houten, Bennett] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Vockley, Jerry] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Prochownik, Edward V.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Graves, JA (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Hematol Oncol, Pittsburgh, PA 15213 USA.	gravja@chp.edu	Van Houten, Bennett/K-2284-2019; Vockley, Jerry/B-5210-2016; Vockley, Jerry/AAF-8523-2020; Wang, Yudong/ABG-1086-2021	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457; Wang, Yudong/0000-0003-3224-4555; Sims-Lucas, Sunder/0000-0003-1908-4809	Harold Amos Medical Faculty Development Program; Robert Wood Johnson Foundation; Hyundai Hope on Wheels Scholarship; Public Health Service [R01 DYKE 8775]; University of Pittsburgh Cancer Institute; Commonwealth Universal Research Enhancement (C.U.R.E.) Program; Pennsylvania Settlement Fund; National Institutes of Health [CA140624, CA78259]; NATIONAL CANCER INSTITUTE [R01CA078259, R01CA140624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103529] Funding Source: NIH RePORTER	Harold Amos Medical Faculty Development Program; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Hyundai Hope on Wheels Scholarship; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Pittsburgh Cancer Institute; Commonwealth Universal Research Enhancement (C.U.R.E.) Program; Pennsylvania Settlement Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following: JAG was supported by the Harold Amos Medical Faculty Development Program sponsored by the Robert Wood Johnson Foundation and the Hyundai Hope on Wheels Scholarship, JV and YW were supported in part by Public Health Service grant R01 DYKE 8775, BVH was supported by The University of Pittsburgh Cancer Institute and Commonwealth Universal Research Enhancement (C.U.R.E.) Program, Pennsylvania Settlement Fund, and EVP was supported by National Institutes of Health grants CA140624 and CA78259. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Ahuja P, 2010, J CLIN INVEST, V120, P1494, DOI 10.1172/JCI38331; Benard G, 2010, BBA-BIOENERGETICS, V1797, P698, DOI 10.1016/j.bbabio.2010.02.030; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen H, 2010, ANN NY ACAD SCI, V1201, P21, DOI 10.1111/j.1749-6632.2010.05615.x; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chung HJ, 2005, MOL CELLS, V20, P157; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Fukazawa T, 2010, ANTICANCER RES, V30, P4193; Gilmore K, 1999, CYTOMETRY, V36, P355, DOI 10.1002/(SICI)1097-0320(19990801)36:4<355::AID-CYTO11>3.0.CO;2-9; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Graves JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013717; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Isenberg JS, 2000, TOXICOL SCI, V53, P340, DOI 10.1093/toxsci/53.2.340; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lenaz G, 2010, ANTIOXID REDOX SIGN, V12, P961, DOI 10.1089/ars.2009.2704; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li Y, 2008, ONCOGENE, V27, P1599, DOI 10.1038/sj.onc.1210794; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin CJ, 2009, CANCER RES, V69, P7491, DOI 10.1158/0008-5472.CAN-09-0813; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Macho A, 1996, CYTOMETRY, V25, P333, DOI 10.1002/(SICI)1097-0320(19961201)25:4<333::AID-CYTO4>3.0.CO;2-E; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nicholls DG, 2007, J NEUROSCI RES, V85, P3206, DOI 10.1002/jnr.21290; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Perl A, 2004, TRENDS IMMUNOL, V25, P360, DOI 10.1016/j.it.2004.05.001; Prachar J, 2003, GEN PHYSIOL BIOPHYS, V22, P525; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; PROUTY SM, 1993, ONCOGENE, V8, P899; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Rimbaud S, 2009, PHARMACOL REP, V61, P131, DOI 10.1016/S1734-1140(09)70015-5; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Sauvanet C, 2010, SEMIN CELL DEV BIOL, V21, P558, DOI 10.1016/j.semcdb.2009.12.006; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; SPIEGELMAN BM, 2007, FND S, V287, P60, DOI DOI 10.1002/9780470725207.CH5; SPIEGELMAN BM, 2007, FND S, V287, P63; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Takeda K, 2010, AUTOPHAGY, V6, P564, DOI 10.4161/auto.6.4.11948; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; WANG YD, 1995, BIOCHEMISTRY-US, V34, P7476, DOI 10.1021/bi00022a022; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang H, 1997, J BIOL CHEM, V272, P17416, DOI 10.1074/jbc.272.28.17416; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhang SXL, 2009, AM J RESP CELL MOL, V40, P332, DOI 10.1165/rcmb.2008-0003OC; Zinchuk Vadim, 2011, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s52; Zinchuk V, 2011, NAT PROTOC, V6, P1554, DOI 10.1038/nprot.2011.384; Zorzano A, 2010, SEMIN CELL DEV BIOL, V21, P566, DOI 10.1016/j.semcdb.2010.01.002	73	84	84	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37699	10.1371/journal.pone.0037699	http://dx.doi.org/10.1371/journal.pone.0037699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629444	Green Accepted, Green Published, gold			2022-12-25	WOS:000305343100047
J	Jarosinski, KW				Jarosinski, Keith W.			Dual Infection and Superinfection Inhibition of Epithelial Skin Cells by Two Alphaherpesviruses Co-Occur in the Natural Host	PLOS ONE			English	Article							MAREKS-DISEASE VIRUS; VARICELLA-ZOSTER-VIRUS; U(L)13 PROTEIN-KINASE; HERPES-SIMPLEX-VIRUS; SCID-HU MOUSE; PSEUDORABIES VIRUS; HORIZONTAL TRANSMISSION; GENETIC-RECOMBINATION; BOVINE HERPESVIRUS-1; VACCINE STRAINS	Hosts can be infected with multiple herpesviruses, known as superinfection; however, superinfection of cells is rare due to the phenomenon known as superinfection inhibition. It is believed that dual infection of cells occurs in nature, based on studies examining genetic exchange between homologous alphaherpesviruses in the host, but to date, this has not been directly shown in a natural model. In this report, gallid herpesvirus 2 (GaHV-2), better known as Marek's disease virus (MDV), was used in its natural host, the chicken, to determine whether two homologous alphaherpesviruses can infect the same cells in vivo. MDV shares close similarities with the human alphaherpesvirus, varicella zoster virus (VZV), with respect to replication in the skin and exit from the host. Recombinant MDVs were generated that express either the enhanced GFP (eGFP) or monomeric RFP (mRFP) fused to the UL47 (VP13/14) herpesvirus tegument protein. These viruses exhibited no alteration in pathogenic potential and expressed abundant UL47-eGFP or -mRFP in feather follicle epithelial cells in vivo. Using laser scanning confocal microscopy, it was evident that these two similar, but distinguishable, viruses were able to replicate within the same cells of their natural host. Evidence of superinfection inhibition was also observed. These results have important implications for two reasons. First, these results show that during natural infection, both dual infection of cells and superinfection inhibition can co-occur at the cellular level. Secondly, vaccination against MDV with homologous alphaherpesvirus like attenuated GaHV-2, or non-oncogenic GaHV-3 or meleagrid herpesvirus (MeHV-1) has driven the virus to greater virulence and these results implicate the potential for genetic exchange between homologous avian alphaherpesviruses that could drive increased virulence. Because the live attenuated varicella vaccine is currently being administered to children, who in turn could be superinfected by wild-type VZV, this could potentiate recombination events of VZV as well.	[Jarosinski, Keith W.] Cornell Univ, Dept Microbiol & Immunol, Ithaca, NY USA	Cornell University	Jarosinski, KW (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.	keith-jarosinski@uiowa.edu		Jarosinski, Keith/0000-0002-0391-9018	Public Health Service (PHS) [5RO1CA127238]; Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture [2010-65119-20493]; National Science Foundation (NSF) [NSF DBI-0618969]; TRIAD Foundation; NATIONAL CANCER INSTITUTE [R01CA127238] Funding Source: NIH RePORTER	Public Health Service (PHS)(United States Department of Health & Human ServicesUnited States Public Health Service); Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture; National Science Foundation (NSF)(National Science Foundation (NSF)); TRIAD Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This report was supported by Public Health Service (PHS) grant 5RO1CA127238 and Agriculture and Food Research Initiative Competitive Grant no. 2010-65119-20493 from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture. Dr. Jarosinski is grateful to the Plant Cell Imaging Center (PCIC) at the Boyce Thompson Institute for Plant Research for providing use of their Olympus SZX-12 Stereoscope that was purchased with an award from National Science Foundation (NSF) (NSF DBI-0618969). PCIC is supported by a grant from the TRIAD Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arvin AM, 2010, CURR TOP MICROBIOL, V342, P189, DOI 10.1007/82_2010_29; Baigent SJ, 2006, VET IMMUNOL IMMUNOP, V112, P78, DOI 10.1016/j.vetimm.2006.03.014; Banfield BW, 2003, J VIROL, V77, P10106, DOI 10.1128/JVI.77.18.10106-10112.2003; Breuer J, 2010, J GEN VIROL, V91, P821, DOI 10.1099/vir.0.017814-0; Calnek BW, 2001, CURR TOP MICROBIOL, V255, P25; Card JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021141; Chbab N, 2010, VET RES, V41, DOI 10.1051/vetres/2010026; CHRISTEN L, 1990, VIROLOGY, V174, P35, DOI 10.1016/0042-6822(90)90051-R; CHRISTENSEN LS, 1993, ARCH VIROL, V132, P37, DOI 10.1007/BF01309842; COCKLEY KD, 1988, J VIROL, V62, P188, DOI 10.1128/JVI.62.1.188-195.1988; DANGLER CA, 1993, AM J VET RES, V54, P540; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; DOHNER DE, 1988, J MED VIROL, V24, P329, DOI 10.1002/jmv.1890240310; Dunn JR, 2010, AVIAN DIS, V54, P1038, DOI 10.1637/9348-033010-Reg.1; EIDSON CS, 1971, J NATL CANCER I, V47, P113; Gershon AA, 2001, ARCH VIR S, V17, P1; Gimeno IM, 2008, VACCINE, V26, pC31, DOI 10.1016/j.vaccine.2008.04.009; GLAZENBURG KL, 1994, VIRUS RES, V34, P115, DOI 10.1016/0168-1702(94)90094-9; GLAZENBURG KL, 1995, ARCH VIROL, V140, P671, DOI 10.1007/BF01309957; Han MG, 2001, VET MICROBIOL, V83, P321, DOI 10.1016/S0378-1135(01)00423-0; HENDERSON LM, 1990, AM J VET RES, V51, P1656; HENDERSON LM, 1991, AM J VET RES, V52, P820; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; HUTCHISON CA, 1971, J VIROL, V8, P121, DOI 10.1128/JVI.8.1.121-124.1971; Jarosinski KW, 2007, J VIROL, V81, P10575, DOI 10.1128/JVI.01065-07; Jarosinski KW, 2006, EXPERT REV VACCINES, V5, P761, DOI 10.1586/14760584.5.6.761; Jarosinski KW, 2012, J VIROL, V86, P2428, DOI 10.1128/JVI.06719-11; Jarosinski KW, 2010, J VIROL, V84, P7911, DOI 10.1128/JVI.00433-10; Jarosinski KW, 2005, J VIROL, V79, P11647, DOI 10.1128/JVI.79.18.11647-11659.2005; JAVIER RT, 1986, SCIENCE, V234, P746, DOI 10.1126/science.3022376; Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997; Katz J B, 1990, J Vet Diagn Invest, V2, P135; Kaufer BB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002333; KLIEM M, 1989, VIROLOGY, V171, P350, DOI 10.1016/0042-6822(89)90602-8; Lee YM, 2005, J VIROL, V79, P3231, DOI 10.1128/JVI.79.6.3231-3242.2005; MCALLISTER WT, 1977, J VIROL, V24, P709, DOI 10.1128/JVI.24.2.709-711.1977; Meurens F, 2004, J VIROL, V78, P3872, DOI 10.1128/JVI.78.8.3872-3879.2004; Moffat JF, 1998, J VIROL, V72, P965, DOI 10.1128/JVI.72.2.965-974.1998; Moffat JF, 1998, P NATL ACAD SCI USA, V95, P11969, DOI 10.1073/pnas.95.20.11969; Muller T, 2011, ARCH VIROL, V156, P1691, DOI 10.1007/s00705-011-1080-2; NISHIYAMA Y, 1991, J VIROL, V65, P4520, DOI 10.1128/JVI.65.8.4520-4524.1991; Osterrieder N, 2006, NAT REV MICROBIOL, V4, P283, DOI 10.1038/nrmicro1382; Parcells MS, 1999, J VIROL, V73, P1362, DOI 10.1128/JVI.73.2.1362-1373.1999; Schat K.A., 2008, LAB MANUAL IDENTIFIC, V5th ed., P195; Schmidt-Chanasit J, 2011, INFECT GENET EVOL, V11, P1, DOI 10.1016/j.meegid.2010.08.014; Schumacher D, 2000, J VIROL, V74, P11088, DOI 10.1128/JVI.74.23.11088-11098.2000; Schynts F, 2003, J VIROL, V77, P12535, DOI 10.1128/JVI.77.23.12535-12542.2003; SHIRAKI K, 1991, J MED VIROL, V33, P128, DOI 10.1002/jmv.1890330212; SIMON KO, 1990, VIROLOGY, V177, P375, DOI 10.1016/0042-6822(90)90494-C; SUSSKIND MM, 1974, VIROLOGY, V62, P367, DOI 10.1016/0042-6822(74)90399-7; Thiry E, 2005, REV MED VIROL, V15, P89, DOI 10.1002/rmv.451; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; WITTER RL, 1971, AVIAN DIS, V15, P346, DOI 10.2307/1588707; Witter RL, 2001, CURR TOP MICROBIOL, V255, P57	56	20	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37428	10.1371/journal.pone.0037428	http://dx.doi.org/10.1371/journal.pone.0037428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629393	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343100027
J	Bi, W; Jing, XN; Zhu, LH; Liang, YR; Liu, J; Yang, LH; Xiao, SH; Xu, AD; Shi, QY; Tao, EX				Bi, Wei; Jing, Xiuna; Zhu, Lihong; Liang, Yanran; Liu, Jun; Yang, Lianhong; Xiao, Songhua; Xu, Anding; Shi, Qiaoyun; Tao, Enxiang			Inhibition of 26S Protease Regulatory Subunit 7 (MSS1) Suppresses Neuroinflammation	PLOS ONE			English	Article							NF-KAPPA-B; RAW 264.7 CELLS; TRANSCRIPTION FACTORS; RIFAMPICIN; EXPRESSION; DEGRADATION; RECEPTOR; INFLAMMATION; MICROGLIA; SURVIVAL	Recently, researchers have focused on immunosuppression induced by rifampicin. Our previous investigation found that rifampicin was neuroprotective by inhibiting the production of pro-inflammatory mediators, thereby suppressing microglial activation. In this study, using 2-dimensional gel electrophoresis (2-DE) and mass spectrometry (MS), we discovered that 26S protease regulatory subunit 7 (MSS1) was decreased in rifampicin-treated microglia. Western blot analysis verified the downregulation of MSS1 expression by rifampicin. As it is indicated that the modulation of the ubiquitin-26S proteasome system (UPS) with proteasome inhibitors is efficacious for the treatment of neuro-inflammatory disorders, we next hypothesized that silencing MSS1 gene expression might inhibit microglial inflammation. Using RNA interference (RNAi), we showed significant reduction of IkB alpha degradation and NF-kB activation. The production of lipopolysaccharides-induced pro-inflammatory mediators such as inducible nitric oxide synthase (iNOS), nitric oxide, cyclooxygenase-2, and prostaglandin E-2 were also reduced by MSS1 gene knockdown. Taken together, our findings suggested that rifampicin inhibited microglial inflammation by suppressing MSS1 protein production. Silencing MSS1 gene expression decreased neuroinflammation. We concluded that MSS1 inhibition, in addition to anti-inflammatory rifampicin, might represent a novel mechanism for the treatment of neuroinflammatory disorders.	[Bi, Wei; Jing, Xiuna; Liang, Yanran; Liu, Jun; Yang, Lianhong; Xiao, Songhua; Tao, Enxiang] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Bi, Wei; Xu, Anding] Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Zhu, Lihong] Jinan Univ, Joint Lab Brain Funct & Hlth, Guangzhou, Guangdong, Peoples R China; [Zhu, Lihong] Jinan Univ, Univ Hong Kong, Sch Med, Guangzhou, Guangdong, Peoples R China; [Shi, Qiaoyun] Stanford Univ, Sch Med, Div Cardiovasc Med, Ctr Inherited Cardiovasc Dis, Stanford, CA 94305 USA	Sun Yat Sen University; Jinan University; Jinan University; Jinan University; University of Hong Kong; Stanford University	Bi, W (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	tao_enxiang@yahoo.cn	Zhu, Li/GXH-9801-2022	Xu, An-Ding/0000-0003-3154-0985	Guangdong Provincial Department of Science and Technology [0400935505B33801003]; Ph.D. Programs Foundation of Ministry of Education of China [20070558257]; National Natural Science Foundation of China [81102449]	Guangdong Provincial Department of Science and Technology; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Guangdong Provincial Department of Science and Technology (0400935505B33801003), the Ph.D. Programs Foundation of Ministry of Education of China (No. 20070558257), and the National Natural Science Foundation of China (81102449). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An N, 2008, IMMUNOPHARM IMMUNOT, V30, P437, DOI 10.1080/08923970802135146; BELLAHSENE A, 1980, INFECT IMMUN, V27, P15; Bi W, 2011, BRAIN RES, V1395, P12, DOI 10.1016/j.brainres.2011.04.019; Blanchard JS, 1998, NAT MED, V4, P14, DOI 10.1038/nm0198-014; Brinkmann KC, 2005, PEDIATR RES, V57, P419, DOI 10.1203/01.PDR.0000153946.97159.79; Calleja C, 1998, NAT MED, V4, P92, DOI 10.1038/nm0198-092; Chen F, 1997, ARCH BIOCHEM BIOPHYS, V342, P383, DOI 10.1006/abbi.1997.0132; Dai JN, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021891, 10.1371/journal.pone.0028903]; DAJANI BM, 1972, LANCET, V2, P1094; De Mot R, 1999, TRENDS MICROBIOL, V7, P88, DOI 10.1016/S0966-842X(98)01432-2; Eikelenboom P, 2004, J NEURAL TRANSM, V111, P281, DOI 10.1007/s00702-003-0055-1; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jessie K, 2010, INT J MOL SCI, V11, P4488, DOI 10.3390/ijms11114488; Kim SK, 2009, KOREAN J PHYSIOL PHA, V13, P475, DOI 10.4196/kjpp.2009.13.6.475; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Koning N, 2007, ANN NEUROL, V62, P504, DOI 10.1002/ana.21220; KRAUSE DL, 2010, INT J ALZHEIMERS DIS, DOI DOI 10.4061/2010/732806VOL; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Mambo G, 2003, INT IMMUNOPHARMACOL, V3, P513, DOI 10.1016/S1567-5769(03)00022-5; Namazi H, 2008, J PAIN, V9, P380, DOI 10.1016/j.jpain.2008.01.325; Ozato K, 2002, BIOTECHNIQUES, P66; Qian L, 2010, J NEURAL TRANSM, V117, P971, DOI 10.1007/s00702-010-0428-1; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Sujashvili R., 2008, GEORGIAN MED NEWS, V161, P48; Tsankov N, 2006, J DERMATOL TREAT, V17, P18, DOI 10.1080/09546630500375643; Tsankov N, 2003, CLIN DERMATOL, V21, P50, DOI 10.1016/S0738-081X(02)00328-0; Tsikas D, 2007, J CHROMATOGR B, V851, P51, DOI 10.1016/j.jchromb.2006.07.054; Tsiskarishvili N V, 2009, Georgian Med News, P25; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang Y, 2006, PROTEOMICS, V6, P2422, DOI 10.1002/pmic.200500595; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024377; Williams AJ, 2006, NEUROCHEM INT, V49, P106, DOI 10.1016/j.neuint.2006.03.018; Woo MS, 2003, MOL BRAIN RES, V113, P86, DOI 10.1016/S0169-328X(03)00095-0; Xu J, 2007, BRAIN RES, V1139, P220, DOI 10.1016/j.brainres.2006.12.074; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yanagi S, 2000, BIOCHEM BIOPH RES CO, V279, P568, DOI 10.1006/bbrc.2000.3969; Zhang W, 2011, BIOCHEM BIOPH RES CO, V407, P668, DOI 10.1016/j.bbrc.2011.03.071	39	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36142	10.1371/journal.pone.0036142	http://dx.doi.org/10.1371/journal.pone.0036142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629310	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343500011
J	Cunningham, J; Estrella, V; Lloyd, M; Gillies, R; Frieden, BR; Gatenby, R				Cunningham, Jessica; Estrella, Veronica; Lloyd, Mark; Gillies, Robert; Frieden, B. Roy; Gatenby, Robert			Intracellular Electric Field and pH Optimize Protein Localization and Movement	PLOS ONE			English	Article							MEMBRANE; DYNAMICS; PATHWAY; TIME	Mammalian cell function requires timely and accurate transmission of information from the cell membrane (CM) to the nucleus (N). These pathways have been intensively investigated and many critical components and interactions have been identified. However, the physical forces that control movement of these proteins have received scant attention. Thus, transduction pathways are typically presented schematically with little regard to spatial constraints that might affect the underlying dynamics necessary for protein-protein interactions and molecular movement from the CM to the N. We propose messenger protein localization and movements are highly regulated and governed by Coulomb interactions between: 1. A recently discovered, radially directed E-field from the NM into the CM and 2. Net protein charge determined by its isoelectric point, phosphorylation state, and the cytosolic pH. These interactions, which are widely applied in elecrophoresis, provide a previously unknown mechanism for localization of messenger proteins within the cytoplasm as well as rapid shuttling between the CM and N. Here we show these dynamics optimize the speed, accuracy and efficiency of transduction pathways even allowing measurement of the location and timing of ligand binding at the CM -previously unknown components of intracellular information flow that are, nevertheless, likely necessary for detecting spatial gradients and temporal fluctuations in ligand concentrations within the environment. The model has been applied to the RAF-MEK-ERK pathway and scaffolding protein KSR1 using computer simulations and in-vitro experiments. The computer simulations predicted distinct distributions of phosphorylated and unphosphorylated components of this transduction pathway which were experimentally confirmed in normal breast epithelial cells (HMEC).	[Cunningham, Jessica; Estrella, Veronica; Gillies, Robert; Gatenby, Robert] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL USA; [Cunningham, Jessica; Gillies, Robert; Gatenby, Robert] H Lee Moffitt Canc Ctr & Res Inst, Dept Math Oncol, Tampa, FL USA; [Lloyd, Mark] H Lee Moffitt Canc Ctr & Res Inst, Dept Analyt Microscopy, Tampa, FL USA; [Frieden, B. Roy] Univ Arizona, Coll Opt Sci, Tucson, AZ USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of Arizona	Cunningham, J (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL USA.	Robert.Gatenby@Moffitt.org		Cunningham, Jessica/0000-0001-8704-8848	National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work is supported by a National Institutes of Health grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman D, 1995, HDB BIOL PHYS, V1, P612; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Bray D, 2008, CELL MOVEMENTS MOL M; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; Colwell LJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000747; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gagliardi LJ, 2005, J ELECTROSTAT, V63, P309, DOI 10.1016/j.elstat.2004.09.007; Gatenby RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012084; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; LOEWENSTEIN WR, 1963, J GEN PHYSIOL, V46, P1123, DOI 10.1085/jgp.46.6.1123; LOEWENSTEIN WR, 1962, NATURE, V195, P462, DOI 10.1038/195462a0; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MARTINEZZAGUILAN R, 1991, AM J PHYSIOL, V260, pC297, DOI 10.1152/ajpcell.1991.260.2.C297; Matheny SA, 2009, J BIOL CHEM, V284, P11007, DOI 10.1074/jbc.R800082200; Mazzanti M, 2001, PHYSIOL REV, V81, P1, DOI 10.1152/physrev.2001.81.1.1; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; MCLAUGHLIN S, 1988, J PHYSIOL-LONDON, V396, P189, DOI 10.1113/jphysiol.1988.sp016958; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Takeuchi A, 2009, CHANNELS, V3, P383, DOI 10.4161/chan.3.6.9775; Tuszynski JA, 2005, MATH COMPUT MODEL, V41, P1055, DOI 10.1016/j.mcm.2005.05.002; Tyner KM, 2007, BIOPHYS J, V93, P1163, DOI 10.1529/biophysj.106.092452; Vidal M, 2005, FEBS LETT, V579, P1834, DOI 10.1016/j.febslet.2005.02.030; Zhu L, 2007, BIOCHEM BIOPH RES CO, V356, P1038, DOI 10.1016/j.bbrc.2007.03.092	26	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36894	10.1371/journal.pone.0036894	http://dx.doi.org/10.1371/journal.pone.0036894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623963	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343500035
J	Pawar, SD; Tandale, BV; Raut, CG; Parkhi, SS; Barde, TD; Gurav, YK; Kode, SS; Mishra, AC				Pawar, Shailesh D.; Tandale, Babasaheb V.; Raut, Chandrashekhar G.; Parkhi, Saurabh S.; Barde, Tanaji D.; Gurav, Yogesh K.; Kode, Sadhana S.; Mishra, Akhilesh C.			Avian Influenza H9N2 Seroprevalence among Poultry Workers in Pune, India, 2010	PLOS ONE			English	Article							A H5N1 VIRUS; HUMAN INFECTION; HONG-KONG; TRANSMISSION; ANTIBODIES; CHINA	Avian influenza (AI) H9N2 has been reported from poultry in India. A seroepidemiological study was undertaken among poultry workers to understand the prevalence of antibodies against AI H9N2 in Pune, Maharashtra, India. A total of 338 poultry workers were sampled. Serum samples were tested for presence of antibodies against AI H9N2 virus by hemagglutination inhibition (HI) and microneutralization (MN) assays. A total of 249 baseline sera from general population from Pune were tested for antibodies against AI H9N2 and were negative by HI assay using >= 40 cut-off antibody titre. Overall 21 subjects (21/338 = 6.2%) were positive for antibodies against AI H9N2 by either HI or MN assays using >= 40 cut-off antibody titre. A total of 4.7% and 3.8% poultry workers were positive for antibodies against AI H9N2 by HI and MN assay respectively using 40 as cut-off antibody titre. This is the first report of seroprevalence of antibodies against AI H9N2 among poultry workers in India.	[Pawar, Shailesh D.; Tandale, Babasaheb V.; Raut, Chandrashekhar G.; Parkhi, Saurabh S.; Barde, Tanaji D.; Gurav, Yogesh K.; Kode, Sadhana S.; Mishra, Akhilesh C.] Natl Inst Virol, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Pawar, SD (corresponding author), Natl Inst Virol, Microbial Containment Complex, Pune, Maharashtra, India.	acm1750@rediffmail.com	Tandale, Babasaheb Vishwanath/AAT-7336-2021; Tandale, Babasaheb/K-8229-2018	Tandale, Babasaheb Vishwanath/0000-0003-0468-4879; Tandale, Babasaheb/0000-0003-0468-4879	Indian Council of Medical Research, India	Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	Financial support from the Indian Council of Medical Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; [Anonymous], 2011, FAOAIDE NEWS    0209; Butt AM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-319; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cameron KR, 2000, VIROLOGY, V278, P36, DOI 10.1006/viro.2000.0585; Chen Y, 2011, CLIN MICROBIOL INFEC, V17, P1347, DOI 10.1111/j.1469-0691.2011.03538.x; CIYONG L, 2008, CHIN MED J, V121, P2050; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; International Centre for Diarrhoeal Disease Research Bangladesh/Government of The People's Republic of Bangladesh, 2011, HSB (Health Science Bulletin), V9, P5; Jia N, 2009, J CLIN VIROL, V44, P225, DOI 10.1016/j.jcv.2008.12.014; Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Nagarajan S, 2009, VET MICROBIOL, V133, P154, DOI 10.1016/j.vetmic.2008.06.013; Naila Siddique, 2008, International Journal of Poultry Science, V7, P1122; Naing L, SAMPLE SIZE CALCULAT; Pawar SD, 2010, NATL I VIROLOGY ANN; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Reed L.J., 1938, SIMPLE METHOD ESTIMA, V27, P493, DOI [10.1093/oxfordjournals.aje.a118408, DOI 10.1093/OXFORDJOURNALS.AJE.A118408]; Riedel Stefan, 2006, Proc (Bayl Univ Med Cent), V19, P16; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; Schultsz C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007948; Shinde PV, 2012, AVIAN DIS, V56, P257, DOI 10.1637/9878-080511-Case.1; SHORTRIDGE KF, 1982, B WORLD HEALTH ORGAN, V60, P129; Tosh C, 2008, ARCH VIROL, V153, P1433, DOI 10.1007/s00705-008-0131-9; Uyeki TM, 2002, EMERG INFECT DIS, V8, P154, DOI 10.3201/eid0802.010148; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; WHO, 2002, 270 WHOCDSCSRNCS2002, V270	29	57	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36374	10.1371/journal.pone.0036374	http://dx.doi.org/10.1371/journal.pone.0036374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623954	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500014
J	Rascalou, G; Pontier, D; Menu, F; Gourbiere, S				Rascalou, Guilhem; Pontier, Dominique; Menu, Frederic; Gourbiere, Sebastien			Emergence and Prevalence of Human Vector-Borne Diseases in Sink Vector Populations	PLOS ONE			English	Article							DOMICILIATED TRIATOMA-DIMIDIATA; NEGLECTED TROPICAL DISEASES; ECOLOGICAL NICHE MODELS; CHAGAS-DISEASE; YUCATAN PENINSULA; CLIMATE-CHANGE; MALARIA TRANSMISSION; TRYPANOSOMA-CRUZI; JAPANESE ENCEPHALITIS; KALA-AZAR	Vector-borne diseases represent a major public health concern in most tropical and subtropical areas, and an emerging threat for more developed countries. Our understanding of the ecology, evolution and control of these diseases relies predominantly on theory and data on pathogen transmission in large self-sustaining 'source' populations of vectors representative of highly endemic areas. However, there are numerous places where environmental conditions are less favourable to vector populations, but where immigration allows them to persist. We built an epidemiological model to investigate the dynamics of six major human vector borne-diseases in such non self-sustaining 'sink' vector populations. The model was parameterized through a review of the literature, and we performed extensive sensitivity analysis to look at the emergence and prevalence of the pathogen that could be encountered in these populations. Despite the low vector abundance in typical sink populations, all six human diseases were able to spread in 15-55% of cases after accidental introduction. The rate of spread was much more strongly influenced by vector longevity, immigration and feeding rates, than by transmission and virulence of the pathogen. Prevalence in humans remained lower than 5% for dengue, leishmaniasis and Japanese encephalitis, but substantially higher for diseases with longer duration of infection; malaria and the American and African trypanosomiasis. Vector-related parameters were again the key factors, although their influence was lower than on pathogen emergence. Our results emphasize the need for ecology and evolution to be thought in the context of metapopulations made of a mosaic of sink and source habitats, and to design vector control program not only targeting areas of high vector density, but working at a larger spatial scale.	[Rascalou, Guilhem; Gourbiere, Sebastien] Univ Perpignan, UMR CNRS UPVD Ecol & Evolut Interact 5244, F-66025 Perpignan, France; [Pontier, Dominique; Menu, Frederic] Univ Lyon 1, UMR CNRS UCBL Lab Biometrie & Biol Evolut 5558, F-69622 Villeurbanne, France; [Gourbiere, Sebastien] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	Centre National de la Recherche Scientifique (CNRS); Universite Perpignan Via Domitia; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Sussex	Rascalou, G (corresponding author), Univ Perpignan, UMR CNRS UPVD Ecol & Evolut Interact 5244, Via Domitia, F-66025 Perpignan, France.	gourbiere@univ-perp.fr	Gourbière, Sébastien/C-4320-2011; MENU, Frédéric/C-3107-2016	Gourbiere, Sebastien/0000-0002-6701-4795; Pontier, Dominique/0000-0003-4700-3543	EU [253483]; French National Research Agency [ANR-08-MIE-007]	EU(European Commission); French National Research Agency(French National Research Agency (ANR))	This work has been supported by EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF) grant no. 253483, and by the French National Research Agency (grant reference "ANR-08-MIE-007"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000620; Akhwale WS, 2004, ACTA TROP, V91, P167, DOI 10.1016/j.actatropica.2004.02.010; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; [Anonymous], 2010, 1 WHO REP NEGL TROP; [Anonymous], VECT BORN HUM INF EU; ANTONOVICS J, 1995, AM NAT, V145, P661, DOI 10.1086/285761; Artzrouni M, 2001, IMA J MATH APPL MED, V18, P99; Artzrouni Marc, 1996, Journal of Biological Systems, V4, P459, DOI 10.1142/S0218339096000314; Baber I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010270; Barbu C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001045; Barbu C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000777; Barbu C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000416; Bellan SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010165; Bowman J, 2002, CONSERV ECOL, V6; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Carbajo AE, 2001, TROP MED INT HEALTH, V6, P170, DOI 10.1046/j.1365-3156.2001.00693.x; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Castellon TD, 2006, CONSERV BIOL, V20, P135, DOI 10.1111/j.1523-1739.2006.00332.x; Caswell H., 2006, MATRIX POPULATION MO; Cecere MC, 2006, EMERG INFECT DIS, V12, P1096; Coelho FC, 2008, CAD SAUDE PUBLICA, V24, P853, DOI 10.1590/S0102-311X2008000400016; Cohen JE, 2001, SCIENCE, V293, P694, DOI 10.1126/science.1060638; Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001; Devillers H, 2008, J THEOR BIOL, V255, P307, DOI 10.1016/j.jtbi.2008.08.023; Dias PC, 1996, TRENDS ECOL EVOL, V11, P326, DOI 10.1016/0169-5347(96)10037-9; Dieckmann U., 2002, ADAPTIVE DYNAMICS IN; Dumonteil E, 2004, AM J TROP MED HYG, V70, P514, DOI 10.4269/ajtmh.2004.70.514; Dumonteil E, 2002, AM J TROP MED HYG, V67, P176, DOI 10.4269/ajtmh.2002.67.176; Dumonteil E, 2009, J PARASITOL, V95, P469, DOI 10.1645/GE-1712.1; Edelstein-Keshet L., 1998, MATH MODELS BIOL; Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864; Esteva L, 1998, MATH BIOSCI, V150, P131, DOI 10.1016/S0025-5564(98)10003-2; Ewald PW, 2002, CA ST AD DY, V2, P10; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Farrell JP, 2002, LEISHMANIA; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Fox JW, 2007, AM NAT, V170, P396, DOI 10.1086/519855; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; GOMES AD, 1986, REV SAUDE PUBL, V20, P280, DOI 10.1590/S0034-89101986000400003; Gomulkiewicz R, 1999, THEOR POPUL BIOL, V55, P283, DOI 10.1006/tpbi.1998.1405; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Gourbiere S, 2012, HEREDITY, V108, P190, DOI 10.1038/hdy.2011.71; Gourbiere S, 2002, J THEOR BIOL, V217, P351, DOI 10.1006/jtbi.2002.3033; Gourbiere S, 2008, AM J TROP MED HYG, V78, P133, DOI 10.4269/ajtmh.2008.78.133; GOUTEUX JP, 1993, TROP MED PARASITOL, V44, P213; Gratz NG, 2006, VECTOR-AND RODENT-BORNE DISEASES OF EUROPE AND NORTH AMERICA: THEIR DISTRIBUTION AND PUBLIC HEALTH BURDEN, P1, DOI 10.2277/ 0521854474; Graves PM, 2009, T ROY SOC TROP MED H, V103, P1211, DOI 10.1016/j.trstmh.2008.11.016; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Gu WD, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-256; Gubler DJ, 1997, DENGUE DENGUE HEMORR; Gurtler RE, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000427; Guhl F, 2009, MEM I OSWALDO CRUZ, V104, P71, DOI 10.1590/S0074-02762009000900012; Gurtler RE, 2007, P NATL ACAD SCI USA, V104, P16194, DOI 10.1073/pnas.0700863104; Hanski I., 1999, METAPOPULATION ECOLO; Hargrove JW., 2003, TSETSE ERADICATION S; Hill CA, 2005, NAT REV MICROBIOL, V3, P262, DOI 10.1038/nrmicro1101; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000256; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Killeen GF, 2006, AM J TROP MED HYG, V75, P38, DOI 10.4269/ajtmh.2006.75.2_suppl.0750038; Killeen Gerry F, 2002, Malar J, V1, P8, DOI 10.1186/1475-2875-1-8; Killeen GF, 2003, LANCET INFECT DIS, V3, P297, DOI 10.1016/S1473-3099(03)00611-X; Kovats RS, 2001, PHILOS T R SOC B, V356, P1057, DOI 10.1098/rstb.2001.0894; Kumar V, 2009, MEM I OSWALDO CRUZ, V104, P1019, DOI 10.1590/S0074-02762009000700014; Lambrechts L, 2009, TROP MED INT HEALTH, V14, P1505, DOI 10.1111/j.1365-3156.2009.02401.x; Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002; Mackenzie JS, 2002, JAPANESE ENCEPHALITI, DOI 10.1007/978-3-642-59403-8; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Menu F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000691; MOLYNEUX DH, 1979, ACTA TROP, V36, P53; Mubayi A, 2010, J THEOR BIOL, V262, P177, DOI 10.1016/j.jtbi.2009.09.012; Norman FF, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000762; Nouvellet P, 2011, ESTIMATING UNO UNPUB; Nouvellet P, 2011, INFECT GENET EVOL, V11, P1243, DOI 10.1016/j.meegid.2011.04.008; Otto SP, 2007, BIOL GUIDE MATH MODE; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Paz-Bailey G, 2002, T ROY SOC TROP MED H, V96, P48, DOI 10.1016/S0035-9203(02)90236-1; Pedrini MRS, 2011, BIOTECHNOL PROGR, V27, P614, DOI 10.1002/btpr.602; Peterson AM, 2011, MALARIA ETIOLOGY PAT; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Pongsumpun P, 2008, TROP MED INT HEALTH, V13, P1180, DOI 10.1111/j.1365-3156.2008.02124.x; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rabinovich JE, 2004, AM J TROP MED HYG, V70, P373, DOI 10.4269/ajtmh.2004.70.373; RAWLINGS P, 1982, B ENTOMOL RES, V72, P139, DOI 10.1017/S0007485300050367; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; ROGERS DJ, 1984, B ENTOMOL RES, V74, P403, DOI 10.1017/S0007485300015674; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Rosenthal J, 2009, ECOHEALTH, V6, P489, DOI 10.1007/s10393-010-0314-1; Ross A, 2006, AM J TROP MED HYG, V75, P32, DOI 10.4269/ajtmh.2006.75.32; Ruiz D, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-66; Rutar T, 2004, AM J TROP MED HYG, V70, P15, DOI 10.4269/ajtmh.2004.70.15; Sanchez-Martin MJ, 2006, TROP MED INT HEALTH, V11, P1585, DOI 10.1111/j.1365-3156.2006.01717.x; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Seed JR, 2001, AFRICAN TRYPANOSOMES; Sepulveda AJ, 2011, OECOLOGIA, V166, P1043, DOI 10.1007/s00442-011-1935-y; Simpson JE, 2012, P ROY SOC B-BIOL SCI, V279, P925, DOI 10.1098/rspb.2011.1282; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; Sogoba N, 2007, AM J TROP MED HYG, V77, P82, DOI 10.4269/ajtmh.2007.77.82; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Stratton L, 2008, SOC SCI MED, V67, P854, DOI 10.1016/j.socscimed.2008.05.013; Takken W, 2007, ECOL CONT VECTOR-BOR, V1, P1; TAPASWI PK, 1995, ECOL MODEL, V83, P295, DOI 10.1016/0304-3800(94)00102-X; Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X; Telleria J, 2010, ELSEV INSIGHT, P1, DOI 10.1016/B978-0-12-384876-5.00021-6; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; Tittler R, 2006, ECOLOGY, V87, P3029, DOI 10.1890/0012-9658(2006)87[3029:EOLSDA]2.0.CO;2; van den Berg H, 2011, CIENC SAUDE COLETIVA, V16, P575, DOI 10.1590/S1413-81232011000200021; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785; Varmus H, 2003, SCIENCE, V302, P398, DOI 10.1126/science.1091769; Vazquez-Prokopec GM, 2005, J MED ENTOMOL, V42, P571, DOI 10.1603/0022-2585(2005)042[0571:SPORBT]2.0.CO;2; Vreysen M. J. B., 2007, AREA WIDE CONTROL IN; WHO, 2011, WORLD MALARIA REPORT 2011, P1; *WHO, 2005, WORLD MAL REP; Wolfram Research Inc., 2008, MATH VERS 7 0; Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x	123	43	45	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36858	10.1371/journal.pone.0036858	http://dx.doi.org/10.1371/journal.pone.0036858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629337	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500032
J	Robertson, HT; Allison, DB				Robertson, Henry T.; Allison, David B.			A Novel Generalized Normal Distribution for Human Longevity and other Negatively Skewed Data	PLOS ONE			English	Article							MORTALITY	Negatively skewed data arise occasionally in statistical practice; perhaps the most familiar example is the distribution of human longevity. Although other generalizations of the normal distribution exist, we demonstrate a new alternative that apparently fits human longevity data better. We propose an alternative approach of a normal distribution whose scale parameter is conditioned on attained age. This approach is consistent with previous findings that longevity conditioned on survival to the modal age behaves like a normal distribution. We derive such a distribution and demonstrate its accuracy in modeling human longevity data from life tables. The new distribution is characterized by 1. An intuitively straightforward genesis; 2. Closed forms for the pdf, cdf, mode, quantile, and hazard functions; and 3. Accessibility to non-statisticians, based on its close relationship to the normal distribution.	[Robertson, Henry T.; Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Robertson, HT (corresponding author), Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.	hrobertson@ms.soph.uab.edu		Allison, David/0000-0003-3566-9399	NIH [T32HL079888, T32HL072757, P30DK056336, R01DK076771]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072757, T32HL079888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336, R01DK076771] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The opinions expressed are those of the authors and not necessarily those of the National Institutes of Health (NIH) or any other organization with which the authors are affiliated. This research was supported by NIH grants T32HL079888, T32HL072757, P30DK056336, and R01DK076771. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias E, 2006, NATL VITAL STAT REPO, V58, P15; Azzalini A, 2005, SCAND J STAT, V32, P159, DOI 10.1111/j.1467-9469.2005.00426.x; Coles S, 2012, VALIDATED LIVING SUP; Cox C, 2007, STAT MED, V26, P4352, DOI 10.1002/sim.2836; Devlin B, 1997, NATURE, V388, P468, DOI 10.1038/41319; Douglas RJ, 2005, METROLOGIA, V42, pL35, DOI 10.1088/0026-1394/42/5/L03; Edwards RD, 2009, BERKELEY ELECT J MAC, V9; FOLKS JL, 1978, J ROY STAT SOC B MET, V40, P263; GEHAN EA, 1973, J AM STAT ASSOC, V68, P848, DOI 10.2307/2284511; Gompertz B, 1825, PHILOS T ROY SOC LON, V31, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; Horiuchi S, 1998, DEMOGRAPHY, V35, P391, DOI 10.2307/3004009; Hougaard, 2000, ANAL MULTIVARIATE SU; Ishwaran H, 2002, J AM STAT ASSOC, V97, P1154, DOI 10.1198/016214502388618951; JUCKETT DA, 1993, MECH AGEING DEV, V69, P1, DOI 10.1016/0047-6374(93)90068-3; Kannisto V, DEMOGRAPHIC RES, V3; Makeham W.M., 1860, J I ACTUAR, V8, P301, DOI DOI 10.1017/S204616580000126X; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; Nadarajah S, 2005, J APPL STAT, V32, P685, DOI 10.1080/02664760500079464; National Institute of Standards and Technology, 2011, MEAS SKEWN KURT; Plotnik R., 2013, INTRO PSYCHOL, V10th; Shkolnikov VM, 2011, HUMAN LIFE TABLE DAT; Teasdale TW, 2008, INTELLIGENCE, V36, P121, DOI 10.1016/j.intell.2007.01.007; van Dijk PC, 2008, KIDNEY INT, V74, P705, DOI 10.1038/ki.2008.294; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224	24	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37025	10.1371/journal.pone.0037025	http://dx.doi.org/10.1371/journal.pone.0037025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623974	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343500051
J	Zhang, H; Xu, LL; Zhang, RS; Hui, MQ; Long, ZY; Zhao, XJ; Yao, L				Zhang, Hang; Xu, Lele; Zhang, Rushao; Hui, Mingqi; Long, Zhiying; Zhao, Xiaojie; Yao, Li			Parallel Alterations of Functional Connectivity during Execution and Imagination after Motor Imagery Learning	PLOS ONE			English	Article							BRAIN ACTIVATION; PREMOTOR CORTEX; PARIETAL CORTEX; SCHEMA THEORY; MOVEMENTS; NETWORKS; CIRCUITS; AREAS; FMRI; MODULATION	Background: Neural substrates underlying motor learning have been widely investigated with neuroimaging technologies. Investigations have illustrated the critical regions of motor learning and further revealed parallel alterations of functional activation during imagination and execution after learning. However, little is known about the functional connectivity associated with motor learning, especially motor imagery learning, although benefits from functional connectivity analysis attract more attention to the related explorations. We explored whether motor imagery (MI) and motor execution (ME) shared parallel alterations of functional connectivity after MI learning. Methodology/Principal Findings: Graph theory analysis, which is widely used in functional connectivity exploration, was performed on the functional magnetic resonance imaging (fMRI) data of MI and ME tasks before and after 14 days of consecutive MI learning. The control group had no learning. Two measures, connectivity degree and interregional connectivity, were calculated and further assessed at a statistical level. Two interesting results were obtained: (1) The connectivity degree of the right posterior parietal lobe decreased in both MI and ME tasks after MI learning in the experimental group; (2) The parallel alterations of interregional connectivity related to the right posterior parietal lobe occurred in the supplementary motor area for both tasks. Conclusions/Significance: These computational results may provide the following insights: (1) The establishment of motor schema through MI learning may induce the significant decrease of connectivity degree in the posterior parietal lobe; (2) The decreased interregional connectivity between the supplementary motor area and the right posterior parietal lobe in post-test implicates the dissociation between motor learning and task performing. These findings and explanations further revealed the neural substrates underpinning MI learning and supported that the potential value of MI learning in motor function rehabilitation and motor skill learning deserves more attention and further investigation.	[Zhang, Hang] Peking Univ, Dept Biomed Engn, Beijing 100871, Peoples R China; [Xu, Lele; Zhang, Rushao; Zhao, Xiaojie; Yao, Li] Beijing Normal Univ, Sch Informat Sci & Technol, Beijing 100875, Peoples R China; [Zhang, Hang; Hui, Mingqi; Long, Zhiying; Yao, Li] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Peking University; Beijing Normal University; Beijing Normal University	Zhang, H (corresponding author), Peking Univ, Dept Biomed Engn, Beijing 100871, Peoples R China.	yaoli0316@gmail.com	Xu, Le/HDN-9623-2022		National Natural Science Foundation of China [60931003, 61075111, 61071178, 90820019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Program of National Natural Science Foundation of China (grant number 60931003) and National Natural Science Foundation of China (grant numbers 61075111, 61071178 and 90820019), URL:http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Arfanakis K, 2000, MAGN RESON IMAGING, V18, P921, DOI 10.1016/S0730-725X(00)00190-9; Argyelan M, 2008, J NEUROSCI, V28, P10687, DOI 10.1523/JNEUROSCI.2933-08.2008; Battaglia-Mayer A, 2002, BRAIN, V125, P225, DOI 10.1093/brain/awf034; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Buchel C, 2000, NEURAL NETWORKS, V13, P871, DOI 10.1016/S0893-6080(00)00066-6; Cauda F, 2011, HUM BRAIN MAPP, V32, P1566, DOI 10.1002/hbm.21132; Chafee MV, 2007, CEREB CORTEX, V17, P2914, DOI 10.1093/cercor/bhm017; Coynel D, 2010, NEUROIMAGE, V49, P759, DOI 10.1016/j.neuroimage.2009.08.048; Dechent P, 2004, COGNITIVE BRAIN RES, V19, P138, DOI 10.1016/j.cogbrainres.2003.11.012; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Fernandez-Ruiz J, 2007, CEREB CORTEX, V17, P2283, DOI 10.1093/cercor/bhl137; Fleming MK, 2010, EXP BRAIN RES, V201, P499, DOI 10.1007/s00221-009-2062-4; Fogassi L, 2005, CURR OPIN NEUROBIOL, V15, P626, DOI 10.1016/j.conb.2005.10.015; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Guillot A, 2008, NEUROIMAGE, V41, P1471, DOI 10.1016/j.neuroimage.2008.03.042; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Haslinger B, 2002, COGNITIVE BRAIN RES, V13, P159, DOI 10.1016/S0926-6410(01)00104-5; Hattori N, 2009, J NEUROPHYSIOL, V101, P1267, DOI 10.1152/jn.90249.2008; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Hoshi E, 2006, J NEUROPHYSIOL, V95, P3596, DOI 10.1152/jn.01126.2005; Isaac A.R., 1986, J MENT IMAG, V10, P23, DOI DOI 10.1037/T07980-000; Jackson PL, 2003, NEUROIMAGE, V20, P1171, DOI 10.1016/S1053-8119(03)00369-0; Jastorff J, 2010, J NEUROPHYSIOL, V104, P128, DOI 10.1152/jn.00254.2010; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Johansson RS, 2006, PLOS BIOL, V4, P1025, DOI 10.1371/journal.pbio.0040158; Kantak SS, 2012, NEUROREHAB NEURAL RE, V26, P282, DOI 10.1177/1545968311420845; Kasess CH, 2008, NEUROIMAGE, V40, P828, DOI 10.1016/j.neuroimage.2007.11.040; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Lafleur MF, 2002, NEUROIMAGE, V16, P142, DOI 10.1006/nimg.2001.1048; Lawrence AD, 1998, TRENDS COGN SCI, V2, P379, DOI 10.1016/S1364-6613(98)01231-5; Li CSR, 2000, NEUROSCI LETT, V287, P13, DOI 10.1016/S0304-3940(00)01164-2; Lopez L, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036107; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Luppino G, 2000, NEWS PHYSIOL SCI, V15, P219; Matelli M, 1998, J COMP NEUROL, V402, P327; Ogawa K, 2011, NEUROIMAGE, V56, P728, DOI 10.1016/j.neuroimage.2010.10.043; Parkinson A, 2010, NEUROPSYCHOLOGIA, V48, P3228, DOI 10.1016/j.neuropsychologia.2010.06.039; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Prabhu G, 2007, J PHYSIOL-LONDON, V581, P189, DOI 10.1113/jphysiol.2006.123356; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; Sakai K, 1998, J NEUROSCI, V18, P1827; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schmidt RA, 2003, RES Q EXERCISE SPORT, V74, P366, DOI 10.1080/02701367.2003.10609106; Seitz R J, 1990, Neuroreport, V1, P57, DOI 10.1097/00001756-199009000-00016; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Soliveri P, 1997, BRAIN, V120, P1325, DOI 10.1093/brain/120.8.1325; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Sun FT, 2007, CEREB CORTEX, V17, P1227, DOI 10.1093/cercor/bhl033; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Wenderoth N, 2006, NEUROIMAGE, V31, P264, DOI 10.1016/j.neuroimage.2005.11.033; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Zhang H, 2011, BRAIN RES, V1407, P38, DOI 10.1016/j.brainres.2011.06.038	62	20	21	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36052	10.1371/journal.pone.0036052	http://dx.doi.org/10.1371/journal.pone.0036052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629308	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500009
J	Chunta, JL; Vistisen, KS; Yazdi, Z; Braun, RD				Chunta, John L.; Vistisen, Kerry S.; Yazdi, Zeinab; Braun, Rod D.			Uptake Rate of Cationic Mitochondrial Inhibitor MKT-077 Determines Cellular Oxygen Consumption Change in Carcinoma Cells	PLOS ONE			English	Article							CANCER-CELLS; RHODACYANINE MKT-077; ANTITUMOR-ACTIVITY; LIPOPHILIC CATION; IN-VITRO; PHASE-I; MKT 077; TUMORS; RADIATION; TRANSPORT	Objective: Since tumor radiation response is oxygen-dependent, radiosensitivity can be enhanced by increasing tumor oxygenation. Theoretically, inhibiting cellular oxygen consumption is the most efficient way to increase oxygen levels. The cationic, rhodacyanine dye-analog MKT-077 inhibits mitochondrial respiration and could be an effective metabolic inhibitor. However, the relationship between cellular MKT-077 uptake and metabolic inhibition is unknown. We hypothesized that rat and human mammary carcinoma cells would take up MKT-077, causing a decrease in oxygen metabolism related to drug uptake. Methods: R3230Ac rat breast adenocarcinoma cells were exposed to MKT-077. Cellular MKT-077 concentration was quantified using spectroscopy, and oxygen consumption was measured using polarographic electrodes. MKT-077 uptake kinetics were modeled by accounting for uptake due to both the concentration and potential gradients across the plasma and mitochondrial membranes. These kinetic parameters were used to model the relationship between MKT-077 uptake and metabolic inhibition. MKT-077-induced changes in oxygen consumption were also characterized in MDA-MB231 human breast carcinoma cells. Results: Cells took up MKT-077 with a time constant of similar to 1 hr, and modeling showed that over 90% of intracellular MKT-077 was bound or sequestered, likely by the mitochondria. The uptake resulted in a rapid decrease in oxygen consumption, with a time constant of similar to 30 minutes. Surprisingly the change in oxygen consumption was proportional to uptake rate, not cellular concentration. MKT-077 proved a potent metabolic inhibitor, with dose-dependent decreases of 45-73% (p = 0.003). Conclusions: MKT-077 caused an uptake rate-dependent decrease in cellular metabolism, suggesting potential efficacy for increasing tumor oxygen levels and radiosensitivity in vivo.	[Chunta, John L.; Vistisen, Kerry S.; Yazdi, Zeinab; Braun, Rod D.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Chunta, John L.; Braun, Rod D.] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Detroit, MI USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Chunta, JL (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.	jchunta@molecularimaging.com		Yazdi, Zeinab/0000-0003-3533-912X	Department of Defense Breast Cancer Research Program [W81XWH-05-1-0264 (BC043817)]	Department of Defense Breast Cancer Research Program(United States Department of Defense)	This work was supported by the Department of Defense Breast Cancer Research Program W81XWH-05-1-0264 (BC043817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Britten CD, 2000, CLIN CANCER RES, V6, P42; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Chiba Y, 1998, ANTICANCER RES, V18, P1047; Chiba Y, 1998, J SURG ONCOL, V69, P105, DOI 10.1002/(SICI)1096-9098(199810)69:2<105::AID-JSO11>3.0.CO;2-0; Chiba Yohei, 1999, International Journal of Clinical Oncology, V4, P65, DOI 10.1007/s101470050028; Crokart N, 2007, CLIN CANCER RES, V13, P630, DOI 10.1158/1078-0432.CCR-06-0802; Deocaris CC, 2007, CANCER LETT, V252, P259, DOI 10.1016/j.canlet.2006.12.038; Emri M, 1998, EUR BIOPHYS J BIOPHY, V28, P78, DOI 10.1007/s002490050186; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Goldstick TK, 1973, ENG PRINCIPLES PHYSL, P257; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; HILF R, 1965, CANCER RES, V25, P286; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Kaul SC, 2001, NEOPLASIA, V3, P110, DOI 10.1038/sj.neo.7900139; Koya K, 1996, CANCER RES, V56, P538; Loetchutinat C, 2003, EUR J BIOCHEM, V270, P476, DOI 10.1046/j.1432-1033.2003.03403.x; Louis KS, 2011, METHODS MOL BIOL, V740, P7, DOI 10.1007/978-1-61779-108-6_2; Modica-Napolitano JS, 1998, CANCER RES, V58, P71; ModicaNapolitano JS, 1996, CANCER RES, V56, P544; Naasani I, 1999, CANCER RES, V59, P4004; Nuydens R, 1999, J NEUROSCI METH, V92, P153, DOI 10.1016/S0165-0270(99)00107-7; OKUNIEFF P, 1993, INT J RADIAT ONCOL, V26, P631, DOI 10.1016/0360-3016(93)90280-9; Okunieff P, 1996, BRIT J CANCER, V74, pS185; Overgaard J, 2007, J CLIN ONCOL, V25, P4066, DOI 10.1200/JCO.2007.12.7878; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; Propper DJ, 1999, ANN ONCOL, V10, P923, DOI 10.1023/A:1008336904585; Ran QT, 2000, BIOCHEM BIOPH RES CO, V275, P174, DOI 10.1006/bbrc.2000.3237; SCHUMACKER PT, 1993, AM J PHYSIOL, V265, pL395, DOI 10.1152/ajplung.1993.265.4.L395; SECOMB TW, 1995, ACTA ONCOL, V34, P313, DOI 10.3109/02841869509093981; SECOMB TW, 1993, INT J RADIAT ONCOL, V25, P481, DOI 10.1016/0360-3016(93)90070-C; Secomb TW, 1998, ADV EXP MED BIOL, V454, P629; Tatsuta N, 1999, CANCER CHEMOTH PHARM, V43, P295, DOI 10.1007/s002800050898; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Tikoo A, 2000, CANCER J, V6, P162; Wadhwa R, 2000, CANCER RES, V60, P6818; Weisberg EL, 1996, CANCER RES, V56, P551	37	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37471	10.1371/journal.pone.0037471	http://dx.doi.org/10.1371/journal.pone.0037471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22616013	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200078
J	Petit, G; Kornreich, C; Noel, X; Verbanck, P; Campanella, S				Petit, Geraldine; Kornreich, Charles; Noel, Xavier; Verbanck, Paul; Campanella, Salvatore			Alcohol-Related Context Modulates Performance of Social Drinkers in a Visual Go/No-Go Task: A Preliminary Assessment of Event-Related Potentials	PLOS ONE			English	Article							CUE-REACTIVITY; RESPONSE-INHIBITION; ADDICTIVE BEHAVIORS; ATTENTIONAL BIAS; USE DISORDERS; IMPULSIVITY; DRINKING; HEAVY; INDIVIDUALS; ACTIVATION	Background: Increased alcohol cue-reactivity and altered inhibitory processing have been reported in heavy social drinkers and alcohol-dependent patients, and are associated with relapse. In social drinkers, these two processes have been usually studied separately by recording event-related potentials (ERPs) during rapid picture presentation. The aim of our study was to confront social drinkers to a task triggering high alcohol cue-reactivity, to verify whether it specifically altered inhibitory performance, by using long-lasting background picture presentation. Methods: ERP were recorded during visual Go/No-Go tasks performed by social drinkers, in which a frequent Go signal (letter "M''), and a rare No-Go signal (letter "W'') were superimposed on three different types of background pictures: neutral (black background), alcohol-related and non alcohol-related. Results: Our data suggested that heavy social drinkers made more commission errors than light drinkers, but only in the alcohol-related context. Neurophysiologically, this was reflected by a delayed No-Go P3 component. Conclusions: Elevated alcohol cue-reactivity may lead to poorer inhibitory performance in heavy social drinkers, and may be considered as an important vulnerability factor in developing alcohol misuse. Prevention programs should be designed to decrease the high arousal of alcohol stimuli and strengthen cognitive control in young, at-risk individuals.	[Petit, Geraldine; Kornreich, Charles; Noel, Xavier; Verbanck, Paul; Campanella, Salvatore] Free Univ Brussels, Lab Psychol Med, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Petit, G (corresponding author), Free Univ Brussels, Lab Psychol Med, Brussels, Belgium.	salvatore.campanella@chu-brugmann.be		Kornreich, Charles/0000-0002-4898-5588	FNRS	FNRS(Fonds de la Recherche Scientifique - FNRS)	Geraldine Petit is Research Fellow, and Xavier Noel as well as Salvatore Campanella are Research Associates at the Belgian Fund of Scientific Research (FNRS). This study was financially supported by FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2010, NEUROIMAGE, V49, P914, DOI 10.1016/j.neuroimage.2009.08.045; Babor T, LEXICON ALCOHOL DRUG; Bartholow BD, 2007, PSYCHOL ADDICT BEHAV, V21, P555, DOI 10.1037/0893-164X.21.4.555; Bartholow BD, 2010, PSYCHOL ADDICT BEHAV, V24, P220, DOI 10.1037/a0017705; Beck AT., 1996, BECK DEPRESSION INVE; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; Beste C, 2008, NEUROPSYCHOLOGIA, V46, P1290, DOI 10.1016/j.neuropsychologia.2007.12.008; Bonomo YA, 2004, ADDICTION, V99, P1520, DOI 10.1111/j.1360-0443.2004.00846.x; Carretie L, 2006, EXP BRAIN RES, V174, P630, DOI 10.1007/s00221-006-0510-y; Chiu PH, 2008, NEUROIMAGE, V42, P988, DOI 10.1016/j.neuroimage.2008.04.248; Cirilli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026699; Cox WM, 1999, DRUG ALCOHOL DEPEN, V55, P85, DOI 10.1016/S0376-8716(98)00186-0; Crego A, 2009, BINGE DRINKING AFFEC; Dawe S, 2004, ADDICT BEHAV, V29, P1389, DOI 10.1016/j.addbeh.2004.06.004; Euser AS, 2012, PSYCHOPHARMACOLOGY, V222, P459, DOI 10.1007/s00213-012-2664-6; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Garland EL, 2012, PSYCHOPHARMACOLOGY, V222, P17, DOI 10.1007/s00213-011-2618-4; GREELEY JD, 1993, J STUD ALCOHOL, V54, P359, DOI 10.15288/jsa.1993.54.359; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; Herrmann MJ, 2000, ALCOHOL CLIN EXP RES, V24, P1724, DOI 10.1111/j.1530-0277.2000.tb01974.x; Herrmann MJ, 2001, ALCOHOL ALCOHOLISM, V36, P588, DOI 10.1093/alcalc/36.6.588; KAHLER CW, 1995, ADDICTION, V90, P1025, DOI 10.1046/j.1360-0443.1995.90810252.x; Kamarajan C, 2005, BIOL PSYCHOL, V69, P353, DOI 10.1016/j.biopsycho.2004.08.004; Kamarajan C, 2005, CLIN NEUROPHYSIOL, V116, P1049, DOI 10.1016/j.clinph.2004.12.015; Kiefer M, 1998, NEUROREPORT, V9, P765, DOI 10.1097/00001756-199803090-00037; Korpelainen JT, 2000, ACTA NEUROL SCAND, V101, P202, DOI 10.1034/j.1600-0404.2000.101003202.x; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Maurage P, 2007, CLIN NEUROPHYSIOL, V118, P633, DOI 10.1016/j.clinph.2006.11.007; Maurage P, 2009, J PSYCHIATR NEUROSCI, V34, P111; McKenzie M, 2011, MED J AUSTRALIA, V195, pS27; Mechtcheriakov S, 2007, J NEUROL NEUROSUR PS, V78, P610, DOI 10.1136/jnnp.2006.095869; Miller MA, 2011, DRUG ALCOHOL DEPEN, V117, P184, DOI 10.1016/j.drugalcdep.2011.01.016; Noel X, 2001, ARCH GEN PSYCHIAT, V58, P1152, DOI 10.1001/archpsyc.58.12.1152; Noel X, 2007, PSYCHOPHARMACOLOGY, V192, P291, DOI 10.1007/s00213-006-0695-6; Oddy BW, 2009, INT J PSYCHOPHYSIOL, V72, P323, DOI 10.1016/j.ijpsycho.2009.02.002; Pandey AK, 2012, BIOL PSYCHOL, V89, P170, DOI 10.1016/j.biopsycho.2011.10.009; Papachristou H, 2012, PSYCHOPHARMACOLOGY, V219, P511, DOI 10.1007/s00213-011-2240-5; Petit G, 2012, CLIN NEUROPHYSIOL, V123, P925, DOI 10.1016/j.clinph.2011.10.042; Ridderinkhof KR, 2002, SCIENCE, V298, P2209, DOI 10.1126/science.1076929; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Rugg M., 1995, ELECTROPHYSIOLOGY MI; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shin E, 2010, PSYCHOL ADDICT BEHAV, V24, P508, DOI 10.1037/a0019663; Smith JL, 2008, CLIN NEUROPHYSIOL, V119, P704, DOI 10.1016/j.clinph.2007.11.042; Smith LA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-51; Smolka MN, 2006, PSYCHOPHARMACOLOGY, V184, P577, DOI 10.1007/s00213-005-0080-x; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stacy AW, 2010, ANNU REV CLIN PSYCHO, V6, P551, DOI 10.1146/annurev.clinpsy.121208.131444; Thomas SE, 2005, J STUD ALCOHOL, V66, P354, DOI 10.15288/jsa.2005.66.354; Verdejo-Garcia A, 2010, PSYCHOPHARMACOLOGY, V210, P377, DOI 10.1007/s00213-010-1833-8; Vollstadt-Klein S, 2011, BIOL PSYCHIAT, V69, P1060, DOI 10.1016/j.biopsych.2010.12.016; Wessa M, 2007, AM J PSYCHIAT, V164, P638, DOI 10.1176/appi.ajp.164.4.638; Whiteside SP, 2003, EXP CLIN PSYCHOPHARM, V11, P210, DOI 10.1037/1064-1297.11.3.210; WHO, 2012, ICD 10 CLASS MENT BE; Wiers RW, 2007, PHARMACOL BIOCHEM BE, V86, P263, DOI 10.1016/j.pbb.2006.09.021; Wrase J, 2002, EUR PSYCHIAT, V17, P287, DOI 10.1016/S0924-9338(02)00676-4; YEE CM, 1994, J ABNORM PSYCHOL, V103, P625, DOI 10.1037/0021-843X.103.4.625; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x; Zhang WH, 2012, BIOL PSYCHOL, V89, P444, DOI 10.1016/j.biopsycho.2011.12.011; Zironi I, 2006, BEHAV BRAIN RES, V167, P150, DOI 10.1016/j.bbr.2005.09.007	61	80	84	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37466	10.1371/journal.pone.0037466	http://dx.doi.org/10.1371/journal.pone.0037466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UQ	22616012	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200077
J	Barrett, BT; Panesar, GK; Scally, AJ; Pacey, IE				Barrett, Brendan T.; Panesar, Gurvinder K.; Scally, Andrew J.; Pacey, Ian E.			A Limited Role for Suppression in the Central Field of Individuals with Strabismic Amblyopia	PLOS ONE			English	Article							BINOCULAR VIEWING CONDITIONS; PERIPHERAL VISUAL-FIELD; INTEROCULAR SUPPRESSION; ANISOMETROPIC AMBLYOPIA; PRIMARY MICROSTRABISMUS; RETINAL CORRESPONDENCE; CLINICAL SUPPRESSION; COMITANT STRABISMUS; PERIMETRIC ARTIFACT; AUTOMATED PERIMETRY	Background: Although their eyes are pointing in different directions, people with long-standing strabismic amblyopia typically do not experience double-vision or indeed any visual symptoms arising from their condition. It is generally believed that the phenomenon of suppression plays a major role in dealing with the consequences of amblyopia and strabismus, by preventing images from the weaker/deviating eye from reaching conscious awareness. Suppression is thus a highly sophisticated coping mechanism. Although suppression has been studied for over 100 years the literature is equivocal in relation to the extent of the retina that is suppressed, though the method used to investigate suppression is crucial to the outcome. There is growing evidence that some measurement methods lead to artefactual claims that suppression exists when it does not. Methodology/Results: Here we present the results of an experiment conducted with a new method to examine the prevalence, depth and extent of suppression in ten individuals with strabismic amblyopia. Seven subjects (70%) showed no evidence whatsoever for suppression and in the three individuals who did (30%), the depth and extent of suppression was small. Conclusions: Suppression may play a much smaller role in dealing with the negative consequences of strabismic amblyopia than previously thought. Whereas recent claims of this nature have been made only in those with micro-strabismus our results show extremely limited evidence for suppression across the central visual field in strabismic amblyopes more generally. Instead of suppressing the image from the weaker/deviating eye, we suggest the visual system of individuals with strabismic amblyopia may act to maximise the possibilities for binocular co-operation. This is consistent with recent evidence from strabismic and amblyopic individuals that their binocular mechanisms are intact, and that, just as in visual normals, performance with two eyes is better than with the better eye alone in these individuals.	[Barrett, Brendan T.; Panesar, Gurvinder K.; Pacey, Ian E.] Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England; [Scally, Andrew J.] Univ Bradford, Sch Hlth Studies, Bradford BD7 1DP, W Yorkshire, England	University of Bradford; University of Bradford	Barrett, BT (corresponding author), Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England.	i.pacey@bradford.ac.uk		Barrett, Brendan/0000-0003-4159-4223; Scally, Andy/0000-0002-6189-2247				Agrawal R, 2006, ARCH OPHTHALMOL-CHIC, V124, P844, DOI 10.1001/archopht.124.6.844; Baker DH, 2007, INVEST OPHTH VIS SCI, V48, P5332, DOI 10.1167/iovs.07-0194; BIRCH EE, 1985, INVEST OPHTH VIS SCI, V26, P1624; BOLANOWSKI SJ, 1987, VISION RES, V27, P967, DOI 10.1016/0042-6989(87)90012-5; BRADLEY A, 1986, INVEST OPHTH VIS SCI, V27, P1404; Bron AJ, 2000, OPHTHALMOLOGICA, V214, P86, DOI 10.1159/000027475; Buckley JG, 2010, INVEST OPHTH VIS SCI, V51, P2487, DOI 10.1167/iovs.09-3858; CAMPOS EC, 1983, DOC OPHTHALMOL, V55, P277, DOI 10.1007/BF00161285; CAMPOS EC, 1982, DOC OPHTHALMOL, V53, P249, DOI 10.1007/BF00140423; Ciuffreda KJ, 1990, AMBLYOPIA BASIC CLIN; Cleary M, 1998, BRIT J OPHTHALMOL, V82, P225, DOI 10.1136/bjo.82.3.225; Cooper J, 2000, Binocul Vis Strabismus Q, V15, P131; DEBELSUNCE S, 1991, INVEST OPHTH VIS SCI, V32, P2645; DENGLER B, 1993, GRAEF ARCH CLIN EXP, V231, P199, DOI 10.1007/BF00918841; Donahue SP, 1999, AM J OPHTHALMOL, V127, P312, DOI 10.1016/S0002-9394(98)90327-0; FLOM MC, 1985, AM J OPTOM PHYS OPT, V62, P153; Frandsen AD, 1960, ACTA OPHTHALMOL S, V62; Freeman AW, 1996, VISION RES, V36, P765, DOI 10.1016/0042-6989(95)00171-9; FREEMAN AW, 1994, VISION RES, V34, P2043, DOI 10.1016/0042-6989(94)90032-9; FUHR PS, 1990, ARCH OPHTHALMOL-CHIC, V108, P983, DOI 10.1001/archopht.1990.01070090085045; Grant S, 2007, INVEST OPHTH VIS SCI, V48, P1139, DOI 10.1167/iovs.06-0976; GRIFFIN JR, 1976, BINOCULAR ANOMALIES; Harrad R, 1996, EYE, V10, P270, DOI 10.1038/eye.1996.57; Harrad R, 1996, BRIT J OPHTHALMOL, V80, P373, DOI 10.1136/bjo.80.4.373; HARRAD RA, 1992, VISION RES, V32, P2135, DOI 10.1016/0042-6989(92)90075-T; Harwerth RS, 2003, INVEST OPHTH VIS SCI, V44, P4293, DOI 10.1167/iovs.03-0346; HESS RF, 1985, VISION RES, V25, P1577, DOI 10.1016/0042-6989(85)90128-2; Hess RF, 2010, J NEUROPHYSIOL, V104, P475, DOI 10.1152/jn.01060.2009; HOLOPIGIAN K, 1988, INVEST OPHTH VIS SCI, V29, P444; JAMPOLSKY A, 1955, ARCH OPHTHALMOL-CHIC, V54, P683; Joose M V, 2000, Strabismus, V8, P135, DOI 10.1076/0927-3972(200006)8:2;1-2;FT135; Joosse M V, 2000, Strabismus, V8, P233, DOI 10.1076/stra.8.4.233.686; Joosse MV, 1999, GRAEF ARCH CLIN EXP, V237, P535, DOI 10.1007/s004170050276; Joosse MV, 1997, VISION RES, V37, P2801, DOI 10.1016/S0042-6989(97)00067-9; Kilwinger S, 2002, VISION RES, V42, P2005, DOI 10.1016/S0042-6989(02)00095-0; KITAOJI H, 1987, INVEST OPHTH VIS SCI, V28, P1260; Leske DA, 2004, J AAPOS, V8, P28, DOI 10.1016/j.jaapos.2003.08.010; Li JR, 2011, INVEST OPHTH VIS SCI, V52, P4169, DOI 10.1167/iovs.11-7233; Maeda M, 1999, INVEST OPHTH VIS SCI, V28, P1260; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; MEHDORN E, 1989, DOC OPHTHALMOL, V71, P1, DOI 10.1007/BF00155128; Mullen KT, 1996, VISION RES, V36, P645, DOI 10.1016/0042-6989(95)00159-X; O'Connor AR, 2010, INVEST OPHTH VIS SCI, V51, P2019, DOI 10.1167/iovs.09-4434; Otto JMN, 2009, VISION RES, V49, P575, DOI 10.1016/j.visres.2009.01.007; PHILIPP W, 1989, GRAEF ARCH CLIN EXP, V227, P448, DOI 10.1007/BF02172897; PRATTJOHNSON JA, 1984, BRIT J OPHTHALMOL, V68, P174, DOI 10.1136/bjo.68.3.174; PRATTJOHNSON JA, 1983, ARCH OPHTHALMOL-CHIC, V101, P218; ROUSE MW, 1989, OPTOMETRY VISION SCI, V66, P355, DOI 10.1097/00006324-198906000-00004; Saladin J. J., 1998, BORISHS CLIN REFRACT, P724; Saladin JJ, 2005, OPTOMETRY VISION SCI, V82, P186, DOI 10.1097/01.OPX.0000156320.71949.9D; Selenow A., 1991, AMBLYOPIA BASIC CLIN; Sengpiel F, 1996, EYE, V10, P250, DOI 10.1038/eye.1996.54; Serrano-Pedraza I, 2011, INVEST OPHTH VIS SCI, V52, P2352, DOI 10.1167/iovs.10-6144; SIRETEANU R, 1989, INVEST OPHTH VIS SCI, V30, P2023; Sireteanu R, 1982, Hum Neurobiol, V1, P31; SIRETEANU R, 1981, VISION RES, V21, P1055, DOI 10.1016/0042-6989(81)90010-9; SIRETEANU R, 1981, VISION RES, V21, P1065, DOI 10.1016/0042-6989(81)90011-0; Tunnacliffe A. H., 1993, INTRO VISUAL OPTICS; von Graefe A., 1880, HDB GERAMMTEN AUGENH, V6; Von Noorden G. K., 2002, BINOCULAR VISION OCU, V6th; VONNOORDEN GK, 1985, INVEST OPHTH VIS SCI, V26, P1704; Watanabe Y, 2008, BRIT J OPHTHALMOL, V92, P47, DOI 10.1136/bjo.2007.117507; Wensveen JM, 2001, VISION RES, V41, P1593, DOI 10.1016/S0042-6989(00)00319-9; Wild JM, 2001, ACTA OPHTHALMOL SCAN, V79, P546, DOI 10.1034/j.1600-0420.2001.790602.x; Williams C, 2008, BRIT J OPHTHALMOL, V92, P959, DOI 10.1136/bjo.2007.134700	65	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36611	10.1371/journal.pone.0036611	http://dx.doi.org/10.1371/journal.pone.0036611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649494	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335800011
J	Dantes, R; Metcalfe, J; Kim, E; Kato-Maeda, M; Hopewell, PC; Kawamura, M; Nahid, P; Cattamanchi, A				Dantes, Raymund; Metcalfe, John; Kim, Elizabeth; Kato-Maeda, Midori; Hopewell, Philip C.; Kawamura, Masae; Nahid, Payam; Cattamanchi, Adithya			Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; GENOMIC DELETIONS; GENE; PEROXIDASE; CATALASE; STRAINS	Background: Specific isoniazid (INH) resistance conferring mutations have been shown to impact the likelihood of tuberculosis (TB) transmission. However, their role in the clinical presentation and outcomes of TB has not been evaluated. Methods: We included all cases of culture-confirmed, INH monoresistant tuberculosis reported to the San Francisco Department of Public Health Tuberculosis Control Section from October 1992 through October 2005. For cases with stored culture isolates, we used polymerase chain reaction (PCR) testing and gene sequencing to identify INH resistance-conferring mutations, and compared genotypic and phenotypic characteristics. Results: Among 101 consecutive cases of INH monoresistant TB in San Francisco 19 (19%) had isolates with a katG mutation other than S315T; 38 (38%) had isolates with the katG S315T mutation, 29 (29%) had isolates with a inhA-15;c-t promoter mutation, and 15 (15%) had isolates with other mutations. The katG S315T mutation was independently associated with high-level INH resistance (risk ratio [RR] 1.56, 95% confidence interval [CI] 1.07-2.27), and the inhA-15;c-t promoter mutation was inversely associated with high-level INH resistance ( RR 0.43, 95% CI 0.21-0.89). However, specific INH resistance-conferring mutations were not associated with the clinical severity or outcomes of INH monoresistant TB cases. Conclusion: These data suggest that INH resistance-conferring mutations do not impact the clinical presentation of TB.	[Dantes, Raymund; Metcalfe, John; Kim, Elizabeth; Kato-Maeda, Midori; Hopewell, Philip C.; Nahid, Payam; Cattamanchi, Adithya] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Metcalfe, John; Kato-Maeda, Midori; Hopewell, Philip C.; Nahid, Payam; Cattamanchi, Adithya] Univ Calif San Francisco, San Francisco Gen Hosp, Curry Int TB Ctr, San Francisco, CA USA; [Kawamura, Masae] Dept Publ Hlth, TB Control Sect, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Dantes, R (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	raydantes@gmail.com; acattamanchi@medsfgh.ucsf.edu		Nahid, Payam/0000-0003-2811-1311	National Institutes of Health [K23HL094141, K23HL092629, R01AI034238]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL092629, K23HL094141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funding from the National Institutes of Health (K23HL094141 [AC], K23HL092629 [PN], and R01AI034238 [PH]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 2008, 4 WHO; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Brassard P, 2006, CLIN INFECT DIS, V43, P717, DOI 10.1086/506935; Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324; Cattamanchi A, 2006, INT J TUBERC LUNG D, V10, P297; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Metcalfe JZ, 2010, EMERG INFECT DIS, V16, P1403, DOI 10.3201/eid1609.100253; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Telenti A, 1997, J CLIN MICROBIOL, V35, P719, DOI 10.1128/JCM.35.3.719-723.1997; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Walls RS, 2008, LANCET INFECT DIS, V8, P601, DOI 10.1016/S1473-3099(08)70227-5; *WHO, 2009, WHO REP 2009 GLOB TU; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	20	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37956	10.1371/journal.pone.0037956	http://dx.doi.org/10.1371/journal.pone.0037956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649569	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335800089
J	Orio, P; Soudry, D				Orio, Patricio; Soudry, Daniel			Simple, Fast and Accurate Implementation of the Diffusion Approximation Algorithm for Stochastic Ion Channels with Multiple States	PLOS ONE			English	Article							THRESHOLD FLUCTUATIONS; ACTION-POTENTIALS; GATING CURRENTS; NOISE; MODEL; SIMULATION; BEHAVIOR; SYSTEMS; OSCILLATIONS; INFORMATION	Background: The phenomena that emerge from the interaction of the stochastic opening and closing of ion channels (channel noise) with the nonlinear neural dynamics are essential to our understanding of the operation of the nervous system. The effects that channel noise can have on neural dynamics are generally studied using numerical simulations of stochastic models. Algorithms based on discrete Markov Chains (MC) seem to be the most reliable and trustworthy, but even optimized algorithms come with a nonnegligible computational cost. Diffusion Approximation (DA) methods use Stochastic Differential Equations (SDE) to approximate the behavior of a number of MCs, considerably speeding up simulation times. However, model comparisons have suggested that DA methods did not lead to the same results as in MC modeling in terms of channel noise statistics and effects on excitability. Recently, it was shown that the difference arose because MCs were modeled with coupled gating particles, while the DA was modeled using uncoupled gating particles. Implementations of DA with coupled particles, in the context of a specific kinetic scheme, yielded similar results to MC. However, it remained unclear how to generalize these implementations to different kinetic schemes, or whether they were faster than MC algorithms. Additionally, a steady state approximation was used for the stochastic terms, which, as we show here, can introduce significant inaccuracies. Main Contributions: We derived the SDE explicitly for any given ion channel kinetic scheme. The resulting generic equations were surprisingly simple and interpretable allowing an easy, transparent and efficient DA implementation, avoiding unnecessary approximations. The algorithm was tested in a voltage clamp simulation and in two different current clamp simulations, yielding the same results as MC modeling. Also, the simulation efficiency of this DA method demonstrated considerable superiority over MC methods, except when short time steps or low channel numbers were used.	[Orio, Patricio] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile; [Soudry, Daniel] Technion Israel Inst Technol, Dept Elect Engn, IL-32000 Haifa, Israel; [Soudry, Daniel] Technion Israel Inst Technol, Lab Network Biol, Haifa, Israel	Universidad de Valparaiso; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Orio, P (corresponding author), Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile.	patricio.orio@uv.cl	Orio, Patricio/F-6207-2010	Orio, Patricio/0000-0003-0332-8098	Fondecyt [11090308]; Millennium Science Institute (Ministerio de Economia, Chile) [P09-022-F]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Science Institute (Ministerio de Economia, Chile)	This work was supported by Fondecyt Grant 11090308 to PO (Conicyt, Chile). The Centro Interdisciplinario de Neurociencia de Valparaiso is funded by Grant P09-022-F of the Millennium Science Institute (Ministerio de Economia, Chile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Bhalla US, 2010, COMPUTATIONAL MODELI; Bruce IC, 2007, ANN BIOMED ENG, V35, P315, DOI 10.1007/s10439-006-9174-9; Bruce IC, 2009, ANN BIOMED ENG, V37, P824, DOI 10.1007/s10439-009-9635-z; Chow CC, 1996, BIOPHYS J, V71, P3013, DOI 10.1016/S0006-3495(96)79494-8; COLQUHOUN D, 1981, PROC R SOC SER B-BIO, V211, P205, DOI 10.1098/rspb.1981.0003; Dorval AD, 2005, J NEUROSCI, V25, P10025, DOI 10.1523/JNEUROSCI.3557-05.2005; Faisal A, 2010, STOCHASTIC METHODS N; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Faisal AA, 2007, PLOS COMPUT BIOL, V3, P783, DOI 10.1371/journal.pcbi.0030079; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; Fiete IR, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048104; FOX RF, 1994, PHYS REV E, V49, P3421, DOI 10.1103/PhysRevE.49.3421; Fox RF, 1997, BIOPHYS J, V72, P2068, DOI 10.1016/S0006-3495(97)78850-7; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gluckman BJ, 1996, PHYS REV LETT, V77, P4098, DOI 10.1103/PhysRevLett.77.4098; Godsil C.D., 2001, ALGEBRAIC GRAPH THEO; Goldwyn JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002247; Goldwyn JH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.041908; Golub G.H, 1996, J HOPKINS STUDIES MA; Haseltine EL, 2002, J CHEM PHYS, V117, P6959, DOI 10.1063/1.1505860; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Koch Christof, 1999, P1; LECAR H, 1971, BIOPHYS J, V11, P1068, DOI 10.1016/S0006-3495(71)86278-1; Linaro D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001102; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; MAURO A, 1970, J GEN PHYSIOL, V55, P497, DOI 10.1085/jgp.55.4.497; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Mino H, 2002, ANN BIOMED ENG, V30, P578, DOI 10.1114/1.1475343; MOLGEDEY L, 1992, PHYS REV LETT, V69, P3717, DOI 10.1103/PhysRevLett.69.3717; Motwani R, 1996, ACM COMPUT SURV, V28, P33, DOI 10.1145/234313.234327; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; Pakdaman K, 2010, ADV APPL PROBAB, V42, P761, DOI 10.1239/aap/1282924062; Rowat PF, 2004, J COMPUT NEUROSCI, V16, P87, DOI 10.1023/B:JCNS.0000014104.08299.8b; RUBINSTEIN JT, 1995, BIOPHYS J, V68, P779, DOI 10.1016/S0006-3495(95)80252-3; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SKAUGEN E, 1979, ACTA PHYSIOL SCAND, V107, P343, DOI 10.1111/j.1748-1716.1979.tb06486.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Steinmetz PN, 2000, J COMPUT NEUROSCI, V9, P133, DOI 10.1023/A:1008967807741; VANDENBERG CA, 1991, BIOPHYS J, V60, P1511, DOI 10.1016/S0006-3495(91)82186-5; White JA, 1998, J NEUROPHYSIOL, V80, P262, DOI 10.1152/jn.1998.80.1.262; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0	55	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36670	10.1371/journal.pone.0036670	http://dx.doi.org/10.1371/journal.pone.0036670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629320	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345300009
J	Wang, RR; Zhang, XG; Zhang, JX; Fan, YY; Shen, Y; Hu, WW; Chen, Z				Wang, Rongrong; Zhang, Xiangnan; Zhang, Jianxiang; Fan, Yanying; Shen, Yao; Hu, Weiwei; Chen, Zhong			Oxygen-Glucose Deprivation Induced Glial Scar-Like Change in Astrocytes	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCANS; CELL-CYCLE PROGRESSION; GROWTH-ASSOCIATED GENE; IN-VITRO MODEL; REACTIVE ASTROCYTES; AXONAL REGENERATION; RAT-BRAIN; EXPRESSION; NEUROCAN; STROKE	Background: It has been demonstrated that cerebral ischemia induces astrocyte reactivity, and subsequent glial scar formation inhibits axonal regeneration during the recovery phase. Investigating the mechanism of glial scar formation will facilitate the development of strategies to improve axonal regeneration. However, an in vitro model of ischemia-induced glial scar has not yet been systematically established. Methodology and Principal Findings: In the present study, we at the first time found that oxygen-glucose deprivation (OGD) in vitro can induce rat cortical astrocytes to present characteristics of glial scar. After OGD for 6 h, astrocytes showed a remarkable proliferation following 24 h reperfusion, evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and BrdU immunocytochemistry. Meanwhile, the expression of glial fibrillary acidic protein significantly increased, so did the expression of neurocan, which is a hallmark of the glial scar. In further experiments, neurons were co-cultured with astrocytes, which had been exposed to OGD, and then the immunostaining of class III beta-tubulin was carried out to assess the neurite growth. When the co-culture was performed at 48 h reperfusion of astrocytes, the neurite growth was obviously inhibited, and this inhibition could be reversed by chondroitinase ABC, which digests glycosaminoglycan chains on CSPGs, including neurocan. However, the processes of neurons were elongated, when the co-culture was performed immediately after OGD. Conclusions and Significance: Our results indicated that after conditioned OGD the astrocytes presented the characteristics of the glial scar, which are also comparable to the astrocytes in acute and chronic phases after cerebral ischemia in vivo. Therefore, the present system may be used as an in vitro model to explore the mechanisms underlying glial scar formation and the treatments to improve axonal regeneration after cerebral ischemia.	[Wang, Rongrong; Zhang, Xiangnan; Zhang, Jianxiang; Shen, Yao; Hu, Weiwei; Chen, Zhong] Zhejiang Univ, Coll Pharmaceut Sci,Dept Pharmacol, Sch Basic Med Sci,Key Lab Med Neurobiol, Zhejiang Prov Key Lab Neurobiol,Minist Hlth China, Hangzhou, Zhejiang, Peoples R China; [Fan, Yanying] Shanxi Med Univ, Dept Pharmacol, Taiyuan, Shanxi, Peoples R China; [Shen, Yao] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Zhejiang, Peoples R China	Zhejiang University; Shanxi Medical University; Wenzhou Medical University	Chen, Z (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci,Dept Pharmacol, Sch Basic Med Sci,Key Lab Med Neurobiol, Zhejiang Prov Key Lab Neurobiol,Minist Hlth China, Hangzhou, Zhejiang, Peoples R China.	huww@zju.edu.cn; chenzhong@zju.edu.cn	Zhang, xiangnan/C-9649-2010	Zhang, xiangnan/0000-0002-7603-7403	National Basic Research of China 973 Program [2011CB504403]; National Natural Science Foundation of China [81030061, 81173040, 81102429]	National Basic Research of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Basic Research of China 973 Program (2011CB504403, http://www.973.gov.cn), the National Natural Science Foundation of China (81030061, 81173040, 81102429; http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MF, 2003, NEUROCHEM RES, V28, P293, DOI 10.1023/A:1022385402197; Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7; Beck H, 2008, AM J PATHOL, V173, P77, DOI 10.2353/ajpath.2008.070648; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cheung NS, 1998, NEUROPHARMACOLOGY, V37, P1419, DOI 10.1016/S0028-3908(98)00123-3; Ciccarelli R, 2007, MOL PHARMACOL, V71, P1369, DOI 10.1124/mol.106.031617; Dai H, 2006, J NEUROCHEM, V96, P1390, DOI 10.1111/j.1471-4159.2005.03633.x; Deguchi K, 2005, BRAIN RES, V1037, P194, DOI 10.1016/j.brainres.2004.12.016; DOU CL, 1994, J NEUROSCI, V14, P7616; Gegg ME, 2005, BRAIN RES, V1036, P1, DOI 10.1016/j.brainres.2004.11.064; GRUMET M, 1994, J BIOL CHEM, V269, P12142; Huang XJ, 2008, GLIA, V56, P27, DOI 10.1002/glia.20588; Inatani M, 2000, INVEST OPHTH VIS SCI, V41, P2748; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Kalman M, 2004, ADV MOL CEL, P787; Komitova M, 2002, J CEREBR BLOOD F MET, V22, P852, DOI 10.1097/00004647-200207000-00010; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Li SL, 2006, NEUROBIOL DIS, V23, P362, DOI 10.1016/j.nbd.2006.03.011; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; LIUZZI FJ, 1987, SCIENCE, V237, P642, DOI 10.1126/science.3603044; Maeda N, 1996, DEVELOPMENT, V122, P647; Matsui F, 2005, J NEUROSCI RES, V81, P837, DOI 10.1002/jnr.20603; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; MILEV P, 1994, J CELL BIOL, V127, P1703, DOI 10.1083/jcb.127.6.1703; Moon LDF, 2001, EUR J NEUROSCI, V14, P1667, DOI 10.1046/j.0953-816x.2001.01795.x; Park LCH, 2001, MECH AGEING DEV, V123, P21, DOI 10.1016/S0047-6374(01)00336-0; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Polikov VS, 2006, BIOMATERIALS, V27, P5368, DOI 10.1016/j.biomaterials.2006.06.018; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Wang Y, 1997, J NEUROSCI, V17, P4341; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Yamada H, 1997, J NEUROSCI, V17, P7784; Yang Q, 2011, J NEUROCHEM, V119, P644, DOI 10.1111/j.1471-4159.2011.07446.x; Yao XH, 2003, BRAIN RES, V967, P11, DOI 10.1016/S0006-8993(02)04120-3; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	44	49	52	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37574	10.1371/journal.pone.0037574	http://dx.doi.org/10.1371/journal.pone.0037574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629422	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345300054
J	Zheng, WC; Reem, RE; Omarova, S; Huang, S; DiPatre, PL; Charvet, CD; Curcio, CA; Pikuleva, IA				Zheng, Wenchao; Reem, Rachel E.; Omarova, Saida; Huang, Suber; DiPatre, Pier Luigi; Charvet, Casey D.; Curcio, Christine A.; Pikuleva, Irina A.			Spatial Distribution of the Pathways of Cholesterol Homeostasis in Human Retina	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; OUTER SEGMENT MEMBRANES; AGE-RELATED MACULOPATHY; CENTRAL-NERVOUS-SYSTEM; SCAVENGER RECEPTOR BI; MACULAR DEGENERATION; IN-VIVO; VERTEBRATE RETINA; BRUCHS MEMBRANE; ACID SYNTHESIS	Background: The retina is a light-sensitive tissue lining the inner surface of the eye and one of the few human organs whose cholesterol maintenance is still poorly understood. Challenges in studies of the retina include its complex multicellular and multilayered structure; unique cell types and functions; and specific physico-chemical environment. Methodology/Principal Findings: We isolated specimens of the neural retina (NR) and underlying retinal pigment epithelium (RPE)/choroid from six deceased human donors and evaluated them for expression of genes and proteins representing the major pathways of cholesterol input, output and regulation. Eighty-four genes were studied by PCR array, 16 genes were assessed by quantitative real time PCR, and 13 proteins were characterized by immunohistochemistry. Cholesterol distribution among different retinal layers was analyzed as well by histochemical staining with filipin. Our major findings pertain to two adjacent retinal layers: the photoreceptor outer segments of NR and the RPE. We demonstrate that in the photoreceptor outer segments, cholesterol biosynthesis, catabolism and regulation via LXR and SREBP are weak or absent and cholesterol content is the lowest of all retinal layers. Cholesterol maintenance in the RPE is different, yet the gene expression also does not appear to be regulated by the SREBPs and varies significantly among different individuals. Conclusions/Significance: This comprehensive investigation provides important insights into the relationship and spatial distribution of different pathways of cholesterol input, output and regulation in the NR-RPE region. The data obtained are important for deciphering the putative link between cholesterol and age-related macular degeneration, a major cause of irreversible vision loss in the elderly.	[Zheng, Wenchao; Reem, Rachel E.; Omarova, Saida; Huang, Suber; Charvet, Casey D.; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Huang, Suber] Univ Hosp, Cleveland, OH USA; [DiPatre, Pier Luigi] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Curcio, Christine A.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA	Case Western Reserve University; University Hospitals of Cleveland; University of Texas System; University of Texas Medical Branch Galveston; University of Alabama System; University of Alabama Birmingham	Zheng, WC (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA.	iap8@case.edu		Pikuleva, Irina/0000-0001-9742-6232	National Institutes of Health [EY018383, AG024336, EY06109, T32 EY07157, P30 EY11373]; Research to Prevent Blindness Foundation; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [P30EY011373, R01EY018383, R01EY006109, T32EY007157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG024336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants EY018383 and AG024336 (IAP), EY06109 (CAC), T32 EY07157 (pre- and post-doctoral research training fellowships for CDC and RER, respectively), P30 EY11373 (to support the Visual Sciences Research Center Core Facilities), Jules and Doris Stein Professorship from the Research to Prevent Blindness Foundation (IAP), the Ohio Lions Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert AD, 2005, PROG LIPID RES, V44, P99, DOI 10.1016/j.plipres.2005.02.001; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Babiker A, 1997, J BIOL CHEM, V272, P26253, DOI 10.1074/jbc.272.42.26253; BOESZEBATTAGLIA K, 1989, J BIOL CHEM, V264, P8151; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P20727; Bojanic DD, 2010, J LIPID RES, V51, P169, DOI [10.1194/jlr.M900250-JLR200, 10.1194/M900250-JLR200]; Bonilha VL, 1997, J CELL SCI, V110, P1717; Bretillon L, 2008, INVEST OPHTH VIS SCI, V49, P1307, DOI 10.1167/iovs.07-0808; Bretillon L, 2007, CURR EYE RES, V32, P361, DOI 10.1080/02713680701231857; Bretillon L, 2008, EXP EYE RES, V87, P521, DOI 10.1016/j.exer.2008.08.010; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CASTANHO MARB, 1992, J BIOL CHEM, V267, P204; Cavelier C, 2006, BBA-MOL CELL BIOL L, V1761, P655, DOI 10.1016/j.bbalip.2006.04.012; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Claudepierre T, 2010, MOL CELL NEUROSCI, V43, P164, DOI 10.1016/j.mcn.2009.10.007; Curcio CA, 2005, EXP EYE RES, V81, P731, DOI 10.1016/j.exer.2005.04.012; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Curcio CA, 2010, J LIPID RES, V51, P451, DOI 10.1194/jlr.R002238; Curcio CA, 2009, METHODS MOL BIOL, V580, P267, DOI 10.1007/978-1-60761-325-1_15; Curcio CA, 2009, PROG RETIN EYE RES, V28, P393, DOI 10.1016/j.preteyeres.2009.08.001; de la Llera-Moya M, 2001, J LIPID RES, V42, P1969; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Dotti MT, 2001, J INHERIT METAB DIS, V24, P696, DOI 10.1023/A:1012981019336; Duncan KG, 2009, BRIT J OPHTHALMOL, V93, P1116, DOI 10.1136/bjo.2008.144006; Duncan KG, 2002, BIOCHEM BIOPH RES CO, V292, P1017, DOI 10.1006/bbrc.2002.6756; Dwyer MA, 2011, MOL ENDOCRINOL, V25, P360, DOI 10.1210/me.2010-0392; Elner Victor M, 2002, Trans Am Ophthalmol Soc, V100, P301; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; FLIESLER SJ, 1993, FEBS LETT, V335, P234, DOI 10.1016/0014-5793(93)80736-E; Fliesler SJ, 1997, INT J BIOCHEM CELL B, V29, P877, DOI 10.1016/S1357-2725(97)00018-6; FLIESLER SJ, 1982, BIOCHIM BIOPHYS ACTA, V711, P138, DOI 10.1016/0005-2760(82)90020-0; Fliesler SJ, 2010, J LIPID RES, V51, P3399, DOI 10.1194/jlr.R010538; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gordiyenko N, 2004, INVEST OPHTH VIS SCI, V45, P2822, DOI 10.1167/iovs.04-0074; GUARNERI P, 1994, J NEUROCHEM, V63, P86; Harris RBS, 1997, ANN NY ACAD SCI, V819, P155, DOI 10.1111/j.1749-6632.1997.tb51806.x; HAYES KC, 1989, INVEST OPHTH VIS SCI, V30, P225; Heo GY, 2011, J LIPID RES, V52, P1117, DOI 10.1194/jlr.M014217; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jaliffa CO, 2005, J NEUROCHEM, V94, P1666, DOI 10.1111/j.1471-4159.2005.03321.x; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Lee JW, 2006, EXP EYE RES, V83, P465, DOI 10.1016/j.exer.2005.11.018; Liao W-L, 2010, J PROTEOME RES; Liao WL, 2011, J PROTEOME RES, V10, P241, DOI 10.1021/pr1008898; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Mast N, 2011, INVEST OPHTH VIS SCI, V52, P594, DOI 10.1167/iovs.10-6021; Meaney S, 2002, J LIPID RES, V43, P2130, DOI 10.1194/jlr.M200293-JLR200; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Ohashi R, 2005, QJM-INT J MED, V98, P845, DOI 10.1093/qjmed/hci136; OMKUMAR RV, 1994, J BIOL CHEM, V269, P6810; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; Phillips SE, 2008, J NEUROSCI, V28, P6569, DOI 10.1523/JNEUROSCI.5529-07.2008; Pikuleva IA, 2006, DRUG METAB DISPOS, V34, P513, DOI 10.1124/dmd.105.008789; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Reynolds R, 2010, OPHTHALMOLOGY, V117, P1989, DOI 10.1016/j.ophtha.2010.07.009; Rudolf M, 2009, J HISTOCHEM CYTOCHEM, V57, P731, DOI 10.1369/jhc.2009.953448; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; RUSSELL DW, 2008, J LIPID RES, pS120; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Tserentsoodol N, 2006, MOL VIS, V12, P1319; Tserentsoodol N, 2006, MOL VIS, V12, P1306; Williams DL, 1999, CURR OPIN LIPIDOL, V10, P329, DOI 10.1097/00041433-199908000-00007; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	74	73	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37926	10.1371/journal.pone.0037926	http://dx.doi.org/10.1371/journal.pone.0037926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629470	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300084
J	Barclay, JL; Husse, J; Bode, B; Naujokat, N; Meyer-Kovac, J; Schmid, SM; Lehnert, H; Oster, H				Barclay, Johanna L.; Husse, Jana; Bode, Brid; Naujokat, Nadine; Meyer-Kovac, Judit; Schmid, Sebastian M.; Lehnert, Hendrik; Oster, Henrik			Circadian Desynchrony Promotes Metabolic Disruption in a Mouse Model of Shiftwork	PLOS ONE			English	Article							POSTPRANDIAL HORMONE; FOOD-INTAKE; BODY-MASS; RAT MODEL; WORK; SLEEP; NIGHT; GLUCOSE; OBESITY; CLOCK	Shiftwork is associated with adverse metabolic pathophysiology, and the rising incidence of shiftwork in modern societies is thought to contribute to the worldwide increase in obesity and metabolic syndrome. The underlying mechanisms are largely unknown, but may involve direct physiological effects of nocturnal light exposure, or indirect consequences of perturbed endogenous circadian clocks. This study employs a two-week paradigm in mice to model the early molecular and physiological effects of shiftwork. Two weeks of timed sleep restriction has moderate effects on diurnal activity patterns, feeding behavior, and clock gene regulation in the circadian pacemaker of the suprachiasmatic nucleus. In contrast, microarray analyses reveal global disruption of diurnal liver transcriptome rhythms, enriched for pathways involved in glucose and lipid metabolism and correlating with first indications of altered metabolism. Although altered food timing itself is not sufficient to provoke these effects, stabilizing peripheral clocks by timed food access can restore molecular rhythms and metabolic function under sleep restriction conditions. This study suggests that peripheral circadian desynchrony marks an early event in the metabolic disruption associated with chronic shiftwork. Thus, strengthening the peripheral circadian system by minimizing food intake during night shifts may counteract the adverse physiological consequences frequently observed in human shift workers.	[Barclay, Johanna L.; Husse, Jana; Bode, Brid; Naujokat, Nadine; Meyer-Kovac, Judit; Oster, Henrik] Max Planck Inst Biophys Chem, Gottingen, Germany; [Schmid, Sebastian M.; Lehnert, Hendrik; Oster, Henrik] Med Univ Lubeck, Dept Internal Med 1, D-23538 Lubeck, Germany	Max Planck Society; University of Lubeck	Barclay, JL (corresponding author), Max Planck Inst Biophys Chem, Gottingen, Germany.	henrik.oster@mpibpc.mpg.de	Oster, Henrik/O-4426-2019; Schmid, Sebastian M/E-5354-2015; Barclay, Johanna/G-6293-2012; Oster, Henrik/D-2335-2013	Oster, Henrik/0000-0002-1414-7068; Barclay, Johanna/0000-0001-5737-1775; Oster, Henrik/0000-0002-1414-7068; Meyhofer, Sebastian/0000-0003-2034-5922	German Research Foundation (DFG) [SFB 654]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a project grant (SFB 654) of the German Research Foundation (DFG) to HO and HL; HO is an Emmy Noether fellow of the DFG and a Lichtenberg fellow of the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Naimi S, 2004, CHRONOBIOL INT, V21, P937, DOI 10.1081/CBI-200037171; Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Arendt J, 2010, OCCUP MED-OXFORD, V60, P10, DOI 10.1093/occmed/kqp162; Baron KG, 2011, OBESITY, V19, P1374, DOI 10.1038/oby.2011.100; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Crispim CA, 2011, METABOLISM, V60, P1726, DOI 10.1016/j.metabol.2011.04.014; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Di Lorenzo L, 2003, INT J OBESITY, V27, P1353, DOI 10.1038/sj.ijo.0802419; Folkard S, 2008, CHRONOBIOL INT, V25, P215, DOI 10.1080/07420520802106835; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Gamble KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018395; Garaulet M, 2011, INT J OBES; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibbs M, 2007, J BIOL RHYTHM, V22, P368, DOI 10.1177/0748730407302843; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Hasan S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.010; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Korkmaz A, 2009, REV ENDOCR METAB DIS, V10, P261, DOI 10.1007/s11154-009-9117-5; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li Y, 2011, INT J OCCUP ENV HEAL, V17, P154, DOI 10.1179/oeh.2011.17.2.154; Lund J, 2001, J ENDOCRINOL, V171, P557, DOI 10.1677/joe.0.1710557; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Morikawa Y, 2008, J OCCUP HEALTH, V50, P270, DOI 10.1539/joh.L7116; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Oster H, 2003, GENE DEV, V17, P1366, DOI 10.1101/gad.256103; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Persson M, 2006, J Nurs Manag, V14, P414, DOI 10.1111/j.1365-2934.2006.00601.x; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rehman JU, 2010, EUR J ENDOCRINOL, V163, P383, DOI 10.1530/EJE-10-0297; Ribeiro DCO, 1998, J ENDOCRINOL, V158, P305, DOI 10.1677/joe.0.1580305; ROE JH, 1966, ANAL BIOCHEM, V15, P245, DOI 10.1016/0003-2697(66)90028-5; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Salgado-Delgado R, 2010, J BIOL RHYTHM, V25, P421, DOI 10.1177/0748730410383403; Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864; Sookoian S, 2007, J INTERN MED, V261, P285, DOI 10.1111/j.1365-2796.2007.01766.x; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; TOBLER I, 1983, NEUROSCI LETT, V42, P49, DOI 10.1016/0304-3940(83)90420-2; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Van Cauter E, 2008, EUR J ENDOCRINOL, V159, pS59, DOI 10.1530/EJE-08-0298; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wong H, 2010, INT J NURS STUD, V47, P1021, DOI 10.1016/j.ijnurstu.2010.01.001; Wu HJ, 2008, BRAIN RES BULL, V77, P241, DOI 10.1016/j.brainresbull.2008.07.013; Yamanaka Y, 2008, GENES CELLS, V13, P497, DOI 10.1111/j.1365-2443.2008.01183.x; Yang ST, 2009, ENDOCRINOLOGY, V150, P2153, DOI 10.1210/en.2008-0705; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	53	176	178	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37150	10.1371/journal.pone.0037150	http://dx.doi.org/10.1371/journal.pone.0037150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629359	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343100014
J	Jeker, LT; Zhou, XY; Gershberg, K; de Kouchkovsky, D; Morar, MM; Stadthagen, G; Lund, AH; Bluestone, JA				Jeker, Lukas T.; Zhou, Xuyu; Gershberg, Kseniya; de Kouchkovsky, Dimitri; Morar, Malika M.; Stadthagen, Gustavo; Lund, Anders H.; Bluestone, Jeffrey A.			MicroRNA 10a Marks Regulatory T Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; RETINOIC-ACID; REG-CELLS; IN-VIVO; DIFFERENTIATION; SPECIFICATION; GENERATION; RESPONSES; DICER; LEADS	MicroRNAs (miRNAs) are crucial for regulatory T cell (Treg) stability and function. We report that microRNA-10a (miR-10a) is expressed in Tregs but not in other T cells including individual thymocyte subsets. Expression profiling in inbred mouse strains demonstrated that non-obese diabetic (NOD) mice with a genetic susceptibility for autoimmune diabetes have lower Treg-specific miR-10a expression than C57BL/6J autoimmune resistant mice. Inhibition of miR-10a expression in vitro leads to reduced FoxP3 expression levels and miR-10a expression is lower in unstable "exFoxP3" T cells. Unstable in vitro TGF-beta-induced, iTregs do not express miR-10a unless cultured in the presence of retinoic acid (RA) which has been associated with increased stability of iTreg, suggesting that miR-10a might play a role in stabilizing Treg. However, genetic ablation of miR-10a neither affected the number and phenotype of natural Treg nor the capacity of conventional T cells to induce FoxP3 in response to TGF beta, RA, or a combination of the two. Thus, miR-10a is selectively expressed in Treg but inhibition by antagomiRs or genetic ablation resulted in discordant effects on FoxP3.	[Jeker, Lukas T.; Zhou, Xuyu; Gershberg, Kseniya; de Kouchkovsky, Dimitri; Morar, Malika M.; Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Jeker, Lukas T.; Zhou, Xuyu; Gershberg, Kseniya; de Kouchkovsky, Dimitri; Morar, Malika M.; Bluestone, Jeffrey A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Stadthagen, Gustavo; Lund, Anders H.] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Copenhagen	Jeker, LT (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	Jeff.bluestone@ucsf.edu	Lund, Anders H./F-4786-2014; Zhou, Xuyu/L-7422-2019	Lund, Anders H./0000-0002-7407-3398; Zhou, Xuyu/0000-0002-6626-0898; Jeker, Lukas/0000-0002-3359-8796; de Kouchkovsky, Dimitri/0000-0002-9609-3226	National Institutes of Health [P01 AI35297, U19 AI056388, P30 DK63720]; Juvenile Diabetes Research Foundation; Swiss National Science Foundation (SNSF) [PBBSB-118644]; Swiss Foundation for Grants in Biology and Medicine (SFGBM)/SNSF [PASMP3-124274/1]; Roche Research Foundation; Novartis Foundation; ADA Mentor-Based Award; Lundbeck Foundation [R31-2007-1447] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035297, U19AI056388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss Foundation for Grants in Biology and Medicine (SFGBM)/SNSF; Roche Research Foundation; Novartis Foundation(Novartis); ADA Mentor-Based Award; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants P01 AI35297 and U19 AI056388 (to JAB), P30 DK63720 (for core support; http://www.nih.gov), and a Scholar Award from the Juvenile Diabetes Research Foundation (to JAB; http://www.jdrf.org/). LTJ was supported by the Swiss National Science Foundation (SNSF) (PBBSB-118644), and the Swiss Foundation for Grants in Biology and Medicine (SFGBM)/SNSF (PASMP3-124274/1; http://www.snf.ch), the Roche Research Foundation (http://www.research-foundation.org), and the Novartis Foundation (formerly Ciba-Geigy Jubilee Foundation, http://www.jubilaeumsstiftung.novartis.com). XZ was supported by an ADA Mentor-Based Award (http://www.diabetes.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Jeker LT, 2010, J CLIN IMMUNOL, V30, P347, DOI 10.1007/s10875-010-9392-7; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Weiss FU, 2009, GASTROENTEROLOGY, V137, P2136, DOI 10.1053/j.gastro.2009.08.065; Zhou XH, 2010, J IMMUNOL, V185, P2675, DOI 10.4049/jimmunol.1000598; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	28	84	95	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36684	10.1371/journal.pone.0036684	http://dx.doi.org/10.1371/journal.pone.0036684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629323	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343500023
J	Ye, F; Cheng, Q; Hu, YT; Zhang, J; Chen, HZ				Ye, Feng; Cheng, Qi; Hu, Yuting; Zhang, Jing; Chen, Huaizeng			PARP-1 Val762Ala Polymorphism Is Associated with Risk of Cervical Carcinoma	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE-1; HPV VACCINATION; CANCER; REPAIR	PARP-1 is a nuclear enzyme that plays an important role in DNA repair, recombination, proliferation and the genome stability. The PARP-1 Val762Ala polymorphism has been associated with increased risk of developing cancers of the prostate, esophagus and lung. The aim of this study was to determine whether the PARP-1 Val762Ala polymorphism is associated with the risk of cervical carcinoma. MA-PCR was used to genotype the PARP-1 Val762Ala polymorphism in 539 women with cervical carcinoma, 480 women with CIN and 800 controls. The genotyping method was confirmed by the DNA sequencing analysis. The PARP-1 Val762Ala polymorphism was not associated with the risk of CIN. However, women carrying the PARP-1 Ala762Ala genotype were significantly susceptible to cervical carcinoma (OR: 2.70, 95% CI: 1.47-3.70), and the similar results were also found in squamous cell carcinoma (OR: 2.56, 95% CI: 1.47-3.70). In HPV positive population, the PARP-1 Ala762Ala genotype was also associated with increased risk of cervical carcinoma (OR: 5.56, 95% CI: 2.08-14.3). Our results indicate that the PARP-1 Ala762Ala genotype increases the risk of cervical carcinoma.	[Ye, Feng; Cheng, Qi; Hu, Yuting; Chen, Huaizeng] Zhejiang Univ, Sch Med, Womens Hosp, Womens Reprod Hlth Key Lab Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Jing] Zhejiang Univ, Sch Med, Womens Hosp, Dept Obstet & Gynecol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Ye, F (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Womens Reprod Hlth Key Lab Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China.	chenhz@zju.edu.cn			Zhejiang Natural Science Foundation of China [Y204049, Y207162, Y2110200]; Science and Technology Project of Zhejiang Province, China [2005C23003]; National Nature Science Foundation of China [30973380]	Zhejiang Natural Science Foundation of China; Science and Technology Project of Zhejiang Province, China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the Zhejiang Natural Science Foundation of China (Y204049, Y207162, Y2110200), from Science and Technology Project of Zhejiang Province, China (No. 2005C23003), and from National Nature Science Foundation of China (No. 30973380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu P, 2009, INDIAN J MED RES, V130, P241; Cottet F, 2000, J MOL MED, V78, P431, DOI 10.1007/s001090050488; Georgieva S, 2009, J BUON, V14, P391; Giuliano AR, 2002, J INFECT DIS, V186, P462, DOI 10.1086/341782; Hao BT, 2004, CANCER RES, V64, P4378, DOI 10.1158/0008-5472.CAN-04-0372; Heinen CD, 2002, CANCER BIOL THER, V1, P477, DOI 10.4161/cbt.1.5.160; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Iwashita A, 2005, FEBS LETT, V579, P1389, DOI 10.1016/j.febslet.2005.01.036; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kumari SR, 1998, CANCER RES, V58, P5075; Lazcano-Ponce E, 2009, ARCH MED RES, V40, P486, DOI 10.1016/j.arcmed.2009.07.007; Lockett KL, 2004, CANCER RES, V64, P6344, DOI 10.1158/0008-5472.CAN-04-0338; Magnusson PKE, 1999, NATURE, V400, P29, DOI 10.1038/21801; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peter M, 2010, J PATHOL, V221, P320, DOI 10.1002/path.2713; Saleem A, 2009, MINERVA MED, V100, P503; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shiokawa M, 2005, JPN J CLIN ONCOL, V35, P97, DOI 10.1093/jjco/hyi028; Silins I, 2004, GYNECOL ONCOL, V93, P484, DOI 10.1016/j.ygyno.2004.01.044; Tong WM, 2002, CANCER RES, V62, P6990; Waggoner SE, 2003, LANCET, V361, P2217, DOI 10.1016/S0140-6736(03)13778-6; Wang XG, 2007, BIOCHEM BIOPH RES CO, V354, P122, DOI 10.1016/j.bbrc.2006.12.162; Yoshida T, 2009, VIRCHOWS ARCH, V455, P253, DOI 10.1007/s00428-009-0823-x; Zhang QB, 2009, MOL BIOL REP, V36, P1461, DOI 10.1007/s11033-008-9336-y; Zhang XM, 2005, CANCER RES, V65, P722; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	26	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37446	10.1371/journal.pone.0037446	http://dx.doi.org/10.1371/journal.pone.0037446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624032	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500117
J	Ceh, J; Raina, JB; Soo, RM; van Keulen, M; Bourne, DG				Ceh, Janja; Raina, Jean-Baptiste; Soo, Rochelle M.; van Keulen, Mike; Bourne, David G.			Coral-Bacterial Communities before and after a Coral Mass Spawning Event on Ningaloo Reef	PLOS ONE			English	Article							GREAT-BARRIER-REEF; BIOGEOCHEMICAL RESPONSES; DIVERSITY; MUCUS	Bacteria associated with three coral species, Acropora tenuis, Pocillopora damicornis and Tubastrea faulkneri, were assessed before and after coral mass spawning on Ningaloo Reef in Western Australia. Two colonies of each species were sampled before and after the mass spawning event and two additional samples were collected for P. damicornis after planulation. A variable 470 bp region of the 16 S rRNA gene was selected for pyrosequencing to provide an understanding of potential variations in coral-associated bacterial diversity and community structure. Bacterial diversity increased for all coral species after spawning as assessed by Chao1 diversity indicators. Minimal changes in community structure were observed at the class level and data at the taxonomical level of genus incorporated into a PCA analysis indicated that despite bacterial diversity increasing after spawning, coral-associated community structure did not shift greatly with samples grouped according to species. However, interesting changes could be detected from the dataset; for example, a-Proteobacteria increased in relative abundance after coral spawning and particularly the Roseobacter clade was found to be prominent in all coral species, indicating that this group may be important in coral reproduction.	[Ceh, Janja; van Keulen, Mike] Murdoch Univ, Sch Biol Sci & Biotechnol, Perth, WA, Australia; [Ceh, Janja; Raina, Jean-Baptiste; Soo, Rochelle M.; Bourne, David G.] Australian Inst Marine Sci, Ctr Marine Microbiol & Genet Res, Townsville, Qld 4810, Australia; [Raina, Jean-Baptiste] James Cook Univ, JCU 3AIMS, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Raina, Jean-Baptiste] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	Murdoch University; Australian Institute of Marine Science; James Cook University; James Cook University	Ceh, J (corresponding author), Murdoch Univ, Sch Biol Sci & Biotechnol, Perth, WA, Australia.	J.Ceh@murdoch.edu.au	van Keulen, Mike/Q-9856-2019; Bourne, David G/B-5073-2008; Soo, Rochelle M/A-6505-2018	van Keulen, Mike/0000-0001-6235-5788; Bourne, David G/0000-0002-1492-8710; Soo, Rochelle M/0000-0002-8927-2066; Raina, Jean-Baptiste/0000-0002-7508-0004	Australian Institute for Marine Science; Murdoch University; Western Australian Marine Science Institute	Australian Institute for Marine Science; Murdoch University; Western Australian Marine Science Institute	Funding provided by Australian Institute for Marine Science, Murdoch University and Western Australian Marine Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Apprill A, 2009, ISME J, V3, P685, DOI 10.1038/ismej.2009.3; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Ceh J, 2011, FEMS MICROBIOL ECOL, V75, P134, DOI 10.1111/j.1574-6941.2010.00986.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar R.C., 2011, BIOINFORMATICS; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Glud RN, 2008, LIMNOL OCEANOGR, V53, P1014, DOI 10.4319/lo.2008.53.3.1014; Gower J.C., 2004, PROCRUSTES PROBLEMS; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hong MJ, 2009, APPL ENVIRON MICROB, V75, P7797, DOI 10.1128/AEM.01418-09; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; Nissimov J, 2009, FEMS MICROBIOL LETT, V292, P210, DOI 10.1111/j.1574-6968.2009.01490.x; Olson ND, 2009, J EXP MAR BIOL ECOL, V371, P140, DOI 10.1016/j.jembe.2009.01.012; Patten NL, 2008, AQUAT MICROB ECOL, V50, P209, DOI 10.3354/ame01179; Penesyan A, 2011, MAR DRUGS, V9, P1391, DOI 10.3390/md9081391; Piekarski T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-265; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Sharp KH, 2011, ISME J; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; SIMPSON CJ, 1993, CORAL REEFS, V12, P185, DOI 10.1007/BF00334478; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Vizcaino MI, 2010, MICROB ECOL, V59, P646, DOI 10.1007/s00248-010-9644-3; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Wild C, 2008, CORAL REEFS, V27, P123, DOI 10.1007/s00338-007-0298-7	35	49	50	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36920	10.1371/journal.pone.0036920	http://dx.doi.org/10.1371/journal.pone.0036920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22629343	Green Published, Green Accepted, gold			2022-12-25	WOS:000305341300043
J	Horvat, SJ; Deshpande, DA; Yan, HD; Panettieri, RA; Codina, J; DuBose, TD; Xin, WK; Rich, TC; Penn, RB				Horvat, Sarah J.; Deshpande, Deepak A.; Yan, Huandong; Panettieri, Reynold A.; Codina, Juan; DuBose, Thomas D., Jr.; Xin, Wenkuan; Rich, Thomas C.; Penn, Raymond B.			A-kinase anchoring proteins regulate compartmentalized cAMP signaling in airway smooth muscle	FASEB JOURNAL			English	Article						asthma; beta 2-adrenergic receptor; phosphodiesterase; gravin	NUCLEOTIDE-GATED CHANNELS; COUPLED RECEPTORS; ADENYLYL-CYCLASE; CELLS; PKA; PHOSPHODIESTERASE; PHOSPHORYLATION; ACTIVATION; STIMULATION; MECHANISMS	A-kinase anchoring proteins (AKAPs) have emerged as important regulatory molecules that can compartmentalize cAMP signaling transduced by beta 2-adrenergic receptors (beta(2)ARs); such compartmentalization ensures speed and fidelity of cAMP signaling and effects on cell function. This study aimed to assess the role of AKAPs in regulating global and compartmentalized beta(2)AR signaling in human airway smooth muscle (ASM). Transcriptome and proteomic analyses were used to characterize AKAP expression in ASM. Stable expression or injection of peptides AKAP-IS or Ht31 was used to disrupt AKAP-PKA interactions, and global and compartmentalized cAMP accumulation stimulated by beta-agonist was assessed by radioimmunoassay and membrane-delineated flow through cyclic nucleotide-gated channels, respectively. ASM expresses multiple AKAP family members, with gravin and ezrin among the most readily detected. AKAP-PKA disruption had minimal effects on whole-cell cAMP accumulation stimulated by beta-agonist (EC50 and B-max) concentrations, but significantly increased the duration of plasma membrane-delineated cAMP (tau=251 +/- 51 s for scrambled peptide control vs. 399 +/- 79 s for Ht31). Direct PKA inhibition eliminated decay of membrane-delineated cAMP levels. AKAPs coordinate compartmentalized cAMP signaling in ASM cells by regulating multiple elements of beta(2)AR-mediated cAMP accumulation, thereby representing a novel target for manipulating beta 2AR signaling and function in ASM.-Horvat, S. J., Deshpande, D. A., Yan, H., Panettieri, R. A., Codina, J., DuBose Jr., T. D., Xin, W., Rich, T. C., Penn, R. B. A-kinase anchoring proteins regulate compartmentalized cAMP signaling in airway smooth muscle. FASEB J. 26, 3670-3679 (2012). www.fasebj.org	[Horvat, Sarah J.; Deshpande, Deepak A.; Yan, Huandong; Penn, Raymond B.] Univ Maryland, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Panettieri, Reynold A.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Codina, Juan; DuBose, Thomas D., Jr.; Penn, Raymond B.] Wake Forest Univ Hlth Sci, Dept Internal Med, Winston Salem, NC USA; [Xin, Wenkuan; Rich, Thomas C.] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA; [Xin, Wenkuan; Rich, Thomas C.] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA	University System of Maryland; University of Maryland Baltimore; University of Pennsylvania; Wake Forest University; Wake Forest University School of Medicine; University of South Alabama; University of South Alabama	Penn, RB (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Pulm & Crit Care Med, 20 Penn St,HSF 2 Rm 147, Baltimore, MD 21201 USA.	trich@jaguar1.usouthal.edu; rpenn@medicine.umaryland.edu	panettieri, reynold/AAG-9485-2019		GlaxoSmithKline [P01 H066299, HL58506]; U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [T32 AR07592]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL058506, R01HL058506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041265] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study reflects equal contributions from the R. B. P. and T. C. R. laboratories and was funded in part by independent investigator grants from GlaxoSmithKline to R. B. P and T.C.R., P01 H066299 (T. C. R.), and HL58506 (R. B. P.). S.J.H. is supported by U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grant T32 AR07592. The authors thank Anna Misior for preliminary transcriptome and proteome analyses. The authors declare no other conflicts of interest.	Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Billington CK, 1999, AM J RESP CELL MOL, V21, P597, DOI 10.1165/ajrcmb.21.5.3759; Billington CK, 2005, BIOCHEMISTRY-US, V44, P14595, DOI 10.1021/bi0510734; Billington CK, 2003, RESP RES, V4; Brady JD, 2004, MOL PHARMACOL, V65, P503, DOI 10.1124/mol.65.3.503; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; CARR DW, 1991, J BIOL CHEM, V266, P14188; Chen MH, 2009, CELL SIGNAL, V21, P136, DOI 10.1016/j.cellsig.2008.09.019; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; Hewitt M, 2010, AM J RESP CELL MOL, V42, P243, DOI 10.1165/rcmb.2009-0038OC; Kong KC, 2008, BIOCHEMISTRY-US, V47, P9279, DOI 10.1021/bi801056w; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; Misior AM, 2008, MOL PHARMACOL, V73, P566, DOI 10.1124/mol.107.040519; Misior AM, 2009, AM J RESP CELL MOL, V41, P24, DOI 10.1165/rcmb.2008-0266OC; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Pascual RM, 2001, AM J PHYSIOL-LUNG C, V281, pL1425, DOI 10.1152/ajplung.2001.281.6.L1425; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Penn RB, 1999, J PHARMACOL EXP THER, V288, P428; Penn RB, 2001, J BIOL CHEM, V276, P32648, DOI 10.1074/jbc.M104143200; Piggott LA, 2006, J GEN PHYSIOL, V128, P3, DOI 10.1085/jgp.200509403; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; Rich TC, 2002, ANN BIOMED ENG, V30, P1088, DOI 10.1114/1.1511242; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Rich TC, 2007, AM J PHYSIOL-CELL PH, V292, pC319, DOI 10.1152/ajpcell.00121.2006; Sanderson JL, 2011, NEUROSCIENTIST, V17, P321, DOI 10.1177/1073858410384740; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; SETTE C, 1994, J BIOL CHEM, V269, P9245; Stangherlin A, 2011, J CARDIOVASC PHARM, V58, P345, DOI 10.1097/FJC.0b013e3182214f2b; Tao Jiangchuan, 2008, J Mol Signal, V3, P19, DOI 10.1186/1750-2187-3-19; Tasken K, 2006, FRONT BIOSCI-LANDMRK, V11, P2929, DOI 10.2741/2022; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Walker JKL, 2011, BRIT J PHARMACOL, V163, P18, DOI 10.1111/j.1476-5381.2010.01178.x; Wang WCH, 2009, P NATL ACAD SCI USA, V106, P15007, DOI 10.1073/pnas.0906034106; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Xin WK, 2008, J GEN PHYSIOL, V131, P349, DOI 10.1085/jgp.200709881	41	31	31	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3670	3679		10.1096/fj.11-201020	http://dx.doi.org/10.1096/fj.11-201020			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22649031	Green Published			2022-12-25	WOS:000308391600009
J	Kadiyala, CSR; Zheng, L; Du, YP; Yohannes, E; Kao, HY; Miyagi, M; Kern, TS				Kadiyala, Chandra Sekhar Rao; Zheng, Ling; Du, Yunpeng; Yohannes, Elizabeth; Kao, Hung-Ying; Miyagi, Masaru; Kern, Timothy S.			Acetylation of Retinal Histones in Diabetes Increases Inflammatory Proteins EFFECTS OF MINOCYCLINE AND MANIPULATION OF HISTONE ACETYLTRANSFERASE (HAT) AND HISTONE DEACETYLASE (HDAC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROINFLAMMATORY CYTOKINE; CHROMATIN MODIFICATION; ACTIVATION; GENES; CELLS; H3; DIMETHYLATION; EXPRESSION; INDUCTION	Histone acetylation was significantly increased in retinas from diabetic rats, and this acetylation was inhibited in diabetics treated with minocycline, a drug known to inhibit early diabetic retinopathy in animals. Histone acetylation and expression of inflammatory proteins that have been implicated in the pathogenesis of diabetic retinopathy were increased likewise in cultured retinal Muller glia grown in a diabetes-like concentration of glucose. Both the acetylation and induction of the inflammatory proteins in elevated glucose levels were significantly inhibited by inhibitors of histone acetyltransferase (garcinol and antisense against the histone acetylase, p300) or activators of histone deacetylase (theophylline and resveratrol) and were increased by the histone deacetylase inhibitor, suberolylanilide hydroxamic acid. We conclude that hyperglycemia causes acetylation of retinal histones (and probably other proteins) and that the acetylation contributes to the hyperglycemia-induced up-regulation of proinflammatory proteins and thereby to the development of diabetic retinopathy.	[Kadiyala, Chandra Sekhar Rao; Yohannes, Elizabeth; Miyagi, Masaru] Case Western Reserve Univ, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Du, Yunpeng; Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Kao, Hung-Ying; Miyagi, Masaru; Kern, Timothy S.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Miyagi, Masaru; Kern, Timothy S.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Kern, Timothy S.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Zheng, Ling] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Wuhan University	Miyagi, M (corresponding author), Case Western Reserve Univ, Case Ctr Prote & Bioinformat, 10900 Euclid Ave, Cleveland, OH 44106 USA.	masaru.miyagi@case.edu; tsk@case.edu		Zheng, Ling/0000-0002-6545-4180	National Institutes of Health [EY00300]; Veterans Affairs; Visual Sciences Research Center of Case Western Reserve University [P30EY-11373]; Case Western Reserve University; Cleveland Foundation; NATIONAL EYE INSTITUTE [R01EY000300, P30EY011373, R56EY000300] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); Visual Sciences Research Center of Case Western Reserve University; Case Western Reserve University; Cleveland Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant EY00300. This work was also supported by a merit grant from the Veterans Affairs (to T. S. K.), by Visual Sciences Research Center of Case Western Reserve University Grant P30EY-11373, and by funds from Case Western Reserve University and the Cleveland Foundation.	Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; Barnes PJ, 2011, J BIOL CHEM, V286, P32899, DOI 10.1074/jbc.R110.206466; Bhatt LK, 2010, AM J TRANSL RES, V2, P181; Blumenkranz MS, 2010, EYE, V24, P428, DOI 10.1038/eye.2009.335; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Chen HW, 2001, CURR OPIN CELL BIOL, V13, P218, DOI 10.1016/S0955-0674(00)00200-3; Chung S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023488; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Du YP, 2004, AM J PHYSIOL-REG I, V287, pR735, DOI 10.1152/ajpregu.00080.2003; Du YP, 2002, J NEUROCHEM, V80, P771, DOI 10.1046/j.0022-3042.2001.00737.x; Gaikwad AB, 2010, AM J PATHOL, V176, P1079, DOI 10.2353/ajpath.2010.090528; Guan KL, 2010, NAT PROTOC, V5, P1583, DOI 10.1038/nprot.2010.117; Huang CS, 1999, CARCINOGENESIS, V20, P237, DOI 10.1093/carcin/20.2.237; Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899; Ito T, 2000, GENE DEV, V14, P1899; Jeong JB, 2011, ARCH PHARM RES, V34, P2109, DOI 10.1007/s12272-011-1214-9; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; Miao F, 2008, DIABETES, V57, P3189, DOI 10.2337/db08-0645; Morinobu A, 2004, J BIOL CHEM, V279, P40640, DOI 10.1074/jbc.M407576200; Mukherji M, 2005, EXPERT REV PROTEOMIC, V2, P117, DOI 10.1586/14789450.2.1.117; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Perrone L, 2009, J CELL PHYSIOL, V221, P262, DOI 10.1002/jcp.21852; Rao KCS, 2005, MOL CELL PROTEOMICS, V4, P1550, DOI 10.1074/mcp.M500150-MCP200; Rodriguez-Collazo P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp273; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Saha RN, 2006, CELL DEATH DIFFER, V13, P539, DOI 10.1038/sj.cdd.4401769; Sarthy VP, 1998, INVEST OPHTH VIS SCI, V39, P212; Sayyed SG, 2010, NEPHROL DIAL TRANSPL, V25, P1811, DOI 10.1093/ndt/gfp730; Schwartz SG, 2011, CURR PHARM BIOTECHNO, V12, P347; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Shelton MD, 2007, J BIOL CHEM, V282, P12467, DOI 10.1074/jbc.M610863200; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Smith CM, 2003, ANAL BIOCHEM, V316, P23, DOI 10.1016/S0003-2697(03)00032-0; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tikoo K, 2008, BRIT J PHARMACOL, V153, P1225, DOI 10.1038/sj.bjp.0707666; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Wade PA, 2001, HUM MOL GENET, V10, P693, DOI 10.1093/hmg/10.7.693; Yang SR, 2008, AM J RESP CELL MOL, V38, P689, DOI 10.1165/rcmb.2007-0379OC; Yilmaz T, 2011, CURR PHARM BIOTECHNO, V12, P337, DOI 10.2174/138920111794480598; Yilmaz T, 2009, OPHTHALMOLOGY, V116, P902, DOI 10.1016/j.ophtha.2009.02.002; Yu ZT, 2002, J AM SOC NEPHROL, V13, P2009, DOI 10.1097/01.ASN.0000024253.59665.F1; Yun JM, 2011, J NUTR BIOCHEM, V22, P450, DOI 10.1016/j.jnutbio.2010.03.014; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Zheng L, 2007, DIABETES, V56, P337, DOI 10.2337/db06-0789; Zhong Q, 2010, J CELL BIOCHEM, V110, P1306, DOI 10.1002/jcb.22644	54	85	92	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25869	25880		10.1074/jbc.M112.375204	http://dx.doi.org/10.1074/jbc.M112.375204			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22648458	Green Published, hybrid			2022-12-25	WOS:000306916300016
J	Lei, IL; Gao, XL; Sham, MH; Wang, Z				Lei, Ienglam; Gao, Xiaolin; Sham, Mai Har; Wang, Zhong			SWI/SNF Protein Component BAF250a Regulates Cardiac Progenitor Cell Differentiation by Modulating Chromatin Accessibility during Second Heart Field Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REMODELING COMPLEX; NEUREGULIN RECEPTOR; MUSCLE DEVELOPMENT; OUTFLOW-TRACT; SUBUNIT; PLURIPOTENCY; REQUIREMENT; EXPRESSION; ORIGINS; DISEASE	ATP-dependent SWI/SNF chromatin remodeling complexes alter the structure of chromatin at specific loci and facilitate tissue-specific gene regulation during development. Several SWI/SNF subunits are required for cardiogenesis. However, the function and mechanisms of SWI/SNF in mediating cardiac progenitor cell (CPC) differentiation during cardiogenesis are not well understood. Our studies of the SWI/SNF chromatin remodeling complex identified that BAF250a, a regulatory subunit of the SWI/SNF, plays a key role in CPC differentiation. BAF250a ablation in mouse second heart field (SHF) led to trabeculation defects in the right ventricle, ventricular septal defect, persistent truncus arteriosus, reduced myocardial proliferation, and embryonic lethality around E13. Using an embryonic stem cell culture system that models the formation and differentiation of SHF CPCs in vivo, we have shown that BAF250a ablation in CPCs specifically inhibits cardiomyocyte formation. Moreover, BAF250a selectively regulates the expression of key cardiac factors Mef2c, Nkx2.5, and Bmp10 in SHF CPCs. Chromatin immunoprecipitation and DNase I digestion assays indicate that BAF250a regulates gene expression by binding selectively to its target gene promoters and recruiting Brg1, the catalytic subunit of SWI/SNF, to modulate chromatin accessibility. Our results thus identify BAF250a-mediated chromatin remodeling as an essential epigenetic mechanism mediating CPC differentiation.	[Lei, Ienglam; Sham, Mai Har] Univ Hong Kong, Dept Biochem, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Lei, Ienglam; Gao, Xiaolin; Wang, Zhong] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Lei, Ienglam; Gao, Xiaolin; Wang, Zhong] Harvard Stem Cell Inst, Boston, MA 02114 USA	University of Hong Kong; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Sham, MH (corresponding author), Univ Hong Kong, Dept Biochem, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.	mhsham@hku.hk; zhwang@partners.org	Sham, Mai Har/AAX-3781-2020; Lei, IENG LAM/AAT-8216-2020	Sham, Mai Har/0000-0003-1179-7839; Lei, IENG LAM/0000-0002-0248-6871	National Institutes of Health [R01 HL109054-01]; Harvard Stem Cell Institute; Massachusetts General Hospital; Stem Cell and Regenerative Medicine Consortium at Hong Kong University; Hong Kong University-Massachusetts General Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Massachusetts General Hospital(General Electric); Stem Cell and Regenerative Medicine Consortium at Hong Kong University; Hong Kong University-Massachusetts General Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL109054-01 (to Z. W.). This work was also supported by a seed grant from the Harvard Stem Cell Institute (to Z. W.), an internal grant from Massachusetts General Hospital (to Z. W.), and the Stem Cell and Regenerative Medicine Consortium at Hong Kong University (to M. H. S.).; Supported by a Hong Kong University-Massachusetts General Hospital joint Ph.D. studentship.	Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Black BL, 2007, SEMIN CELL DEV BIOL, V18, P67, DOI 10.1016/j.semcdb.2007.01.001; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Chen J, 1998, DEVELOPMENT, V125, P1943; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Huang XL, 2008, DEV BIOL, V319, P258, DOI 10.1016/j.ydbio.2008.04.020; Keppler BR, 2010, J BIOL CHEM, V285, P35665, DOI 10.1074/jbc.M110.173997; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Liu JD, 2010, DEVELOPMENT, V137, P3867, DOI 10.1242/dev.053736; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Lou X, 2011, DEVELOPMENT, V138, P3113, DOI 10.1242/dev.064279; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Takeuchi JK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1187; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Wurster AL, 2008, MOL CELL BIOL, V28, P7274, DOI 10.1128/MCB.00835-08	35	40	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24255	24262		10.1074/jbc.M112.365080	http://dx.doi.org/10.1074/jbc.M112.365080			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22621927	Green Published, hybrid			2022-12-25	WOS:000306651100019
J	Zeiger, AS; Loe, FC; Li, R; Raghunath, M; Van Vliet, KJ				Zeiger, Adam S.; Loe, Felicia C.; Li, Ran; Raghunath, Michael; Van Vliet, Krystyn J.			Macromolecular Crowding Directs Extracellular Matrix Organization and Mesenchymal Stem Cell Behavior	PLOS ONE			English	Article							MARROW STROMAL CELLS; IN-VITRO; INTERSTITIAL FLUID; EXCLUDED-VOLUME; CANCER; STABILITY; DEPOSITION; FILAMENTS; PROTEINS; LINEAGE	Microenvironments of biological cells are dominated in vivo by macromolecular crowding and resultant excluded volume effects. This feature is absent in dilute in vitro cell culture. Here, we induced macromolecular crowding in vitro by using synthetic macromolecular globules of nm-scale radius at physiological levels of fractional volume occupancy. We quantified the impact of induced crowding on the extracellular and intracellular protein organization of human mesenchymal stem cells (MSCs) via immunocytochemistry, atomic force microscopy (AFM), and AFM-enabled nanoindentation. Macromolecular crowding in extracellular culture media directly induced supramolecular assembly and alignment of extracellular matrix proteins deposited by cells, which in turn increased alignment of the intracellular actin cytoskeleton. The resulting cell-matrix reciprocity further affected adhesion, proliferation, and migration behavior of MSCs. Macromolecular crowding can thus aid the design of more physiologically relevant in vitro studies and devices for MSCs and other cells, by increasing the fidelity between materials synthesized by cells in vivo and in vitro.	[Zeiger, Adam S.; Van Vliet, Krystyn J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Zeiger, Adam S.; Loe, Felicia C.; Raghunath, Michael; Van Vliet, Krystyn J.] SMART, Biosyst & Micromech Interdisciplinary Res Grp Bio, Singapore, Singapore; [Loe, Felicia C.; Raghunath, Michael] Natl Univ Singapore, Fac Engn, Tissue Modulat Lab, Div Bioengn, Singapore 117548, Singapore; [Loe, Felicia C.] Natl Univ Singapore, Grad Programme Sci & Integrat Engn NGS, Singapore 117548, Singapore; [Li, Ran] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Raghunath, Michael] Yong Loo Ling Sch Med, Dept Biochem, Singapore, Singapore	Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT); National University of Singapore	Zeiger, AS (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	bierm@nus.edu.sg; krystyn@mit.edu	Raghunath, Michael/M-2727-2019; Raghunath, Michael/E-6483-2010	Raghunath, Michael/0000-0002-2138-6614	Singapore National Research Foundation through the Biosystems & Micromechanics (BioSyM) Interdisciplinary Research Group; United States National Science Foundation [CBET-0644846]; US National Defense Science & Engineering Graduate Fellowship program; NIH [5T32EB006348-05]; NSF MRSEC REU [DMR-0819762]; NUS Faculty Research Committee; NUS; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006348] Funding Source: NIH RePORTER	Singapore National Research Foundation through the Biosystems & Micromechanics (BioSyM) Interdisciplinary Research Group; United States National Science Foundation(National Science Foundation (NSF)); US National Defense Science & Engineering Graduate Fellowship program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF MRSEC REU(National Science Foundation (NSF)); NUS Faculty Research Committee; NUS(National University of Singapore); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research is supported by the Singapore National Research Foundation under the Singapore-MIT Alliance in Research & Technology (SMART) program, through the Biosystems & Micromechanics (BioSyM) Interdisciplinary Research Group (KJVV), as well as funding from the United States National Science Foundation CAREER Award, CBET-0644846 (KJVV), the US National Defense Science & Engineering Graduate Fellowship program and NIH Molecular, Cell, and Tissue Biomechanics Training Grant 5T32EB006348-05 (ASZ), and the NSF MRSEC REU program under DMR-0819762 (RL). FCL was a scholar of National University of Singapore (NUS) Graduate School for Integrative Sciences and Engineering, MR received funding from a NUS Faculty Research Committee Grant (Engineering in Medicine) and acknowledges the strong support of the NUS Tissue Engineering Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUKLAND K, 1984, AM J PHYSIOL, V247, pH74, DOI 10.1152/ajpheart.1984.247.1.H74; BATEMAN JF, 1986, J BIOL CHEM, V261, P4198; BATES DO, 1993, CLIN SCI, V85, P737, DOI 10.1042/cs0850737; Batra J, 2009, PROTEINS, V77, P133, DOI 10.1002/prot.22425; Beil M, 2005, J MICROSC-OXFORD, V220, P84, DOI 10.1111/j.1365-2818.2005.01505.x; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; Chen CZC, 2009, BRIT J PHARMACOL, V158, P1196, DOI 10.1111/j.1476-5381.2009.00387.x; Chen C, 2011, ADV DRUG DELIVER REV, V63, P277, DOI 10.1016/j.addr.2011.03.003; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; DRENCKHAHN D, 1986, J BIOL CHEM, V261, P2754; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; FOLKOW B, 1971, ACTA PHYSIOL SCAND, V83, P532, DOI 10.1111/j.1748-1716.1971.tb05111.x; Hancock R, 2004, BIOL CELL, V96, P595, DOI 10.1016/j.biolcel.2004.05.003; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; Homouz D, 2009, BIOPHYS J, V96, P671, DOI 10.1016/j.bpj.2008.10.014; Hu Y, 2007, NANO LETT, V7, P3056, DOI 10.1021/nl071542i; Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619; Iborra FJ, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-15; Ingber DE, 2008, SEMIN CANCER BIOL, V18, P356, DOI 10.1016/j.semcancer.2008.03.016; Jahne B., 2005, DIGITAL IMAGE PROCES; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/1066527041887258; Kulkarni AM, 2000, J CHEM PHYS, V113, P9863, DOI 10.1063/1.1321042; Lareu RR, 2007, FEBS LETT, V581, P2709, DOI 10.1016/j.febslet.2007.05.020; Lareu RR, 2007, BIOCHEM BIOPH RES CO, V363, P171, DOI 10.1016/j.bbrc.2007.08.156; Lareu RR, 2007, TISSUE ENG, V13, P385, DOI 10.1089/ten.2006.0224; LAURENT TC, 1995, BIOPHYS CHEM, V57, P7, DOI 10.1016/0301-4622(95)00048-3; Lode A, 2008, J TISSUE ENG REGEN M, V2, P400, DOI 10.1002/term.110; Loe F, 2011, UNPUB; MADDEN TL, 1993, BIOPHYS J, V65, P1147, DOI 10.1016/S0006-3495(93)81144-5; Maloney JM, 2010, BIOPHYS J, V99, P2479, DOI 10.1016/j.bpj.2010.08.052; McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Minton AP, 1997, CURR OPIN BIOTECH, V8, P65, DOI 10.1016/S0958-1669(97)80159-0; Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605; ONSAGER L, 1949, ANN NY ACAD SCI, V51, P627, DOI 10.1111/j.1749-6632.1949.tb27296.x; Oreffo ROC, 2005, STEM CELL REV, V1, P169, DOI 10.1385/SCR:1:2:169; PRICE PJ, 1982, IN VITRO CELL DEV B, V18, P576; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Richter K, 2008, BBA-MOL CELL RES, V1783, P2100, DOI 10.1016/j.bbamcr.2008.07.017; Rodriguez Luis G., 2004, V294, P23; Rodriguez-Almazan C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000497; Sasahara K, 2003, J MOL BIOL, V326, P1227, DOI 10.1016/S0022-2836(02)01443-2; Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008; Thompson MT, 2006, BIOMACROMOLECULES, V7, P1990, DOI 10.1021/bm060146b; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; WADSWORTH GR, 1953, BRIT MED J, V2, P1138, DOI 10.1136/bmj.2.4846.1138; WILF J, 1985, THROMB RES, V37, P681, DOI 10.1016/0049-3848(85)90197-5; Yeoman D, ANIMAL CELL TECHNOLO; Yow SZ, 2009, BIOMATERIALS, V30, P1133, DOI 10.1016/j.biomaterials.2008.11.003; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	55	140	141	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37904	10.1371/journal.pone.0037904	http://dx.doi.org/10.1371/journal.pone.0037904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649562	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800082
J	Ritchie, AJ; Kuldanek, K; Moodie, Z; Wang, ZM; Fox, J; Nsubuga, RN; Legg, K; Birabwa, EF; Kaleebu, P; McMichael, AJ; Watera, C; Goonetilleke, N; Fidler, S				Ritchie, Adam J.; Kuldanek, Kristin; Moodie, Zoe; Wang, Z. Maggie; Fox, Julie; Nsubuga, Rebecca N.; Legg, Kenneth; Birabwa, Esther F.; Kaleebu, Pontiano; McMichael, Andrew J.; Watera, Christine; Goonetilleke, Nilu; Fidler, Sarah			Comparison of Sexual Behavior and HIV Risk between Two HIV-1 Serodiscordant Couple Cohorts: The CHAVI 002 Study	PLOS ONE			English	Article							HETEROSEXUAL ANAL INTERCOURSE; EXPOSED-UNINFECTED INDIVIDUALS; RANDOMIZED CONTROLLED-TRIAL; DEVELOPING-COUNTRIES; HOMOSEXUAL-MEN; TRANSMISSION; INFECTION; METAANALYSIS; LYMPHOCYTES; PREVENTION	Background: The CHAVI002 study was designed to characterize immune responses, particularly HIV-specific T-cell responses, amongst 2 cohorts of HIV-exposed seronegative (HESN) individuals. The absence of a clear definition of HESNs has impaired comparison of research within and between such cohorts. This report describes two distinct HESN cohorts and attempts to quantify HIV exposure using a 'HIV risk index' (RI) model. Methods: HIV serodiscordant couples (UK; 24, Uganda; 72) and HIV unexposed seronegative (HUSN) controls (UK; 14, Uganda; 26 couples, 3 individuals) completed sexual behavior questionnaires every 3 months over a 9 month period. The two cohorts were heterogeneous, with most HESNs in the UK men who have sex with men (MSM), while all HESNs in Uganda were in heterosexual relationships. Concordance of responses between partners was determined. Each participant's sexual behavior score (SBS) was estimated based on the number and type of unprotected sex acts carried out in defined time periods. Independent HIV acquisition risk factors (partner plasma viral load, STIs, male circumcision, pregnancy) were integrated with the SBS, generating a RI for each HESN. Results: 96 HIV serodiscordant couples completed 929 SBQs. SBSs remained relatively stable amongst the UK cohort, whilst decreasing from Visit 1 to 2 in the Ugandan cohort. Compared to the Ugandan cohort, SBSs and RIs in the UK cohort were lower at visit 1, and generally higher at later visits. Differences between the cohorts, with lower rates of ART use in Uganda and higher risk per-act sex in the UK, had major impacts on the SBSs and RIs of each cohort. There was one HIV transmission event in the UK cohort. Conclusions: Employment of a risk quantification model facilitated quantification and comparison of HIV acquisition risk across two disparate HIV serodiscordant couple cohorts.	[Ritchie, Adam J.; McMichael, Andrew J.; Goonetilleke, Nilu] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Kuldanek, Kristin; Legg, Kenneth; Fidler, Sarah] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, HIV Clin Trials Ctr, London, England; [Moodie, Zoe; Wang, Z. Maggie] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Fox, Julie] Kings Coll London, Guy & St Thomas Hosp, Dept HIV, Fac Med, London WC2R 2LS, England; [Nsubuga, Rebecca N.; Birabwa, Esther F.; Kaleebu, Pontiano; Watera, Christine] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda	University of Oxford; Imperial College London; Fred Hutchinson Cancer Center; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Ritchie, AJ (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford, England.	adam.ritchie@imm.ox.ac.uk		Fidler, Sarah/0000-0003-1676-7583; fox, Julie/0000-0002-0583-8019	Center for HIV/AIDS Vaccine Immunology (National Institute of Allergy and Infectious Diseases) [A1067854]	Center for HIV/AIDS Vaccine Immunology (National Institute of Allergy and Infectious Diseases)	This work was supported by the Center for HIV/AIDS Vaccine Immunology (National Institute of Allergy and Infectious Diseases grant A1067854). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; BLASBAND D, 1985, ARCH SEX BEHAV, V14, P395, DOI 10.1007/BF01542001; Boily MC, 2009, SEX TRANSM INFECT, V85, P408, DOI 10.1136/sti.2009.037499; CLERICI M, 1992, J INFECT DIS, V165, P1012, DOI 10.1093/infdis/165.6.1012; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; del Romero J, 2002, AIDS, V16, P1296, DOI 10.1097/00002030-200206140-00017; Fox J, 2011, AIDS, V25, P1801, DOI 10.1097/QAD.0b013e32834a1cbb; Fox J, 2011, AIDS, V25, P1065, DOI 10.1097/QAD.0b013e328344fe4a; Fox J, 2010, ANTIVIR RES, V85, P276, DOI 10.1016/j.antiviral.2009.10.012; Gerberry DJ, 2011, AIDS, V25, P1119, DOI 10.1097/QAD.0b013e328346be41; Halperin DT, 1999, AIDS PATIENT CARE ST, V13, P717, DOI 10.1089/apc.1999.13.717; Hart GJ, 2010, CURR OPIN INFECT DIS, V23, P39, DOI 10.1097/QCO.0b013e328334feb1; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2010, CURR OPIN HIV AIDS, V5, P327, DOI 10.1097/COH.0b013e32833a0b9b; Khan A, 2008, SEX TRANSM INFECT, V84, P150, DOI 10.1136/sti.2007.028050; Kulkarni Prasad S., 2003, AIDS Reviews, V5, P87; Langhaug LF, 2010, TROP MED INT HEALTH, V15, P362, DOI 10.1111/j.1365-3156.2009.02464.x; Lopalco L, 1997, J BIOL REG HOMEOS AG, V11, P27; Mackesy-Amiti ME, 2010, SEX TRANSM DIS, V37, P346, DOI [10.1097/OLQ.0b013e3181c71d617, 10.1097/OLQ.0b013e3181c71d61]; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; McDaid LM, 2010, CURR OPIN HIV AIDS, V5, P311, DOI 10.1097/COH.0b013e32833a0b86; McGowan I, 2010, SEX TRANSM DIS, V37, P361, DOI 10.1097/OLQ.0b013e3181cd70c2; Mensch BS, 2008, INT FAM PLAN PERSPEC, V34, P169, DOI 10.1363/ifpp.34.169.08; Paxton WA, 1998, VIROLOGY, V244, P66, DOI 10.1006/viro.1998.9082; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; Perez CL, 2010, AIDS, V24, P969, DOI 10.1097/QAD.0b013e328337aff8; PINTO LA, 1995, J CLIN INVEST, V96, P867, DOI 10.1172/JCI118133; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Richens J, 2010, SEX TRANSM INFECT, V86, P310, DOI 10.1136/sti.2010.043422; Ritchie AJ, 2011, J VIROL, V85, P3507, DOI 10.1128/JVI.02444-10; Rosser BRS, 2010, J BEHAV MED, V33, P147, DOI 10.1007/s10865-009-9244-1; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; Roye CF, 2010, J ASSOC NURSE AIDS C, V21, P291, DOI 10.1016/j.jana.2009.12.002; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; VOELLER B, 1991, ARCH SEX BEHAV, V20, P233, DOI 10.1007/BF01541846	37	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37727	10.1371/journal.pone.0037727	http://dx.doi.org/10.1371/journal.pone.0037727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VQ	22629447	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345300070
J	Tezuka, T; Matsuo, C; Iizuka, T; Oda, M; Marubashi, W				Tezuka, Takahiro; Matsuo, Chihiro; Iizuka, Takahiro; Oda, Masayuki; Marubashi, Wataru			Identification of Nicotiana tabacum Linkage Group Corresponding to the Q Chromosome Gene(s) Involved in Hybrid Lethality	PLOS ONE			English	Article							INTERSPECIFIC HYBRIDIZATION; DNA MARKERS; CELL-DEATH; SOLANACEAE; TOBACCO; SUAVEOLENS; EXPRESSION; EVOLUTION; REGIONS; CROSSES	Background: A linkage map consisting of 24 linkage groups has been constructed using simple sequence repeat (SSR) markers in Nicotiana tabacum. However, chromosomal assignments of all linkage groups have not yet been made. The Q chromosome in N. tabacum encodes a gene or genes triggering hybrid lethality, a phenomenon that causes death of hybrids derived from some crosses. Methodology/Principal Findings: We identified a linkage group corresponding to the Q chromosome using an interspecific cross between an N. tabacum monosomic line lacking the Q chromosome and N. africana. N. ingulba yielded inviable hybrids after crossing with N. tabacum. SSR markers on the identified linkage group were used to analyze hybrid lethality in this cross. The results implied that one or more genes on the Q chromosome are responsible for hybrid lethality in this cross. Furthermore, the gene(s) responsible for hybrid lethality in the cross N. tabacum6N. africana appear to be on the region of the Q chromosome to which SSR markers PT30342 and PT30365 map. Conclusions/Significance: Linkage group 11 corresponded to the Q chromosome. We propose a new method to correlate linkage groups with chromosomes in N. tabacum.	[Tezuka, Takahiro; Iizuka, Takahiro; Oda, Masayuki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 591, Japan; [Matsuo, Chihiro] Osaka Prefecture Univ, Sch Life & Environm Sci, Sakai, Osaka 591, Japan; [Marubashi, Wataru] Meiji Univ, Sch Agr, Kawasaki, Kanagawa, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Meiji University	Tezuka, T (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 591, Japan.	tezuka@plant.osakafu-u.ac.jp	Tezuka, Takahiro/AAH-9589-2021	Tezuka, Takahiro/0000-0002-9203-1140	Japan Society for the Promotion of Science, Japan [20880024]	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Grant-in-Aid for Young Scientists (Start-up) No. 20880024 from the Japan Society for the Promotion of Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bindler G, 2007, THEOR APPL GENET, V114, P341, DOI 10.1007/s00122-006-0437-5; Bindler G, 2011, THEOR APPL GENET, V123, P219, DOI 10.1007/s00122-011-1578-8; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; BURK LG, 1979, SCIENCE, V206, P585, DOI 10.1126/science.206.4418.585; CAMERON DR, 1959, TOBACCO SCI, V3, P164; Chase MW, 2003, ANN BOT-LONDON, V92, P107, DOI 10.1093/aob/mcg087; Clarkson JJ, 2010, MOL PHYLOGENET EVOL, V55, P99, DOI 10.1016/j.ympev.2009.10.003; Clarkson JJ, 2004, MOL PHYLOGENET EVOL, V33, P75, DOI 10.1016/j.ympev.2004.05.002; Clausen RE, 1944, GENETICS, V29, P447; DANEHOWER DA, 1989, AGR BIOL CHEM TOKYO, V53, P2813, DOI 10.1080/00021369.1989.10869730; DEVERNA JW, 1987, THEOR APPL GENET, V73, P665, DOI 10.1007/BF00260773; Ichitani K, 2011, RICE, V4, P29, DOI 10.1007/s12284-011-9062-2; Iizuka T, 2012, EUPHYTICA IN PRESS, DOI [10.1007/s10681-011-0570-3, DOI 10.1007/S10681-011-0570-3]; Knapp S, 2004, TAXON, V53, P73, DOI 10.2307/4135490; KRAMER MG, 1988, J HERED, V79, P24, DOI 10.1093/oxfordjournals.jhered.a110439; KUBO T, 1982, TOBACCO SCI, V26, P126; Leitch IJ, 2008, ANN BOT-LONDON, V101, P805, DOI 10.1093/aob/mcm326; McNAUGHTON I. H., 1960, NEW PHYTOL, V59, P27, DOI 10.1111/j.1469-8137.1960.tb06198.x; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Mizuno N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011326; Moon HS, 2008, GENOME, V51, P547, DOI 10.1139/G08-039; Murad L, 2004, HEREDITY, V92, P352, DOI 10.1038/sj.hdy.6800431; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Olmo HP, 1935, GENETICS, V20, P0286; Song L, 2009, THEOR APPL GENET, V119, P33, DOI 10.1007/s00122-009-1014-5; Tezuka T, 2006, THEOR APPL GENET, V112, P1172, DOI 10.1007/s00122-006-0219-0; Tezuka T, 2004, PLANT CELL PHYSIOL, V45, P1863, DOI 10.1093/pcp/pch204; Tezuka T, 2004, BREEDING SCI, V54, P59, DOI 10.1270/jsbbs.54.59; Tezuka T, 2007, PLANTA, V226, P753, DOI 10.1007/s00425-007-0522-2; Tezuka T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036204; Tezuka T, 2010, ANN BOT-LONDON, V106, P267, DOI 10.1093/aob/mcq114; Vontimitta V, 2010, J AGR FOOD CHEM, V58, P294, DOI 10.1021/jf903256h; Yamada T, 1999, BREEDING SCI, V49, P203, DOI 10.1270/jsbbs.49.203	34	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37822	10.1371/journal.pone.0037822	http://dx.doi.org/10.1371/journal.pone.0037822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629459	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300078
J	Liu, GH; Young, DL				Liu, Guohong; Young, Dallan			Conserved Orb6 Phosphorylation Sites Are Essential for Polarized Cell Growth in Schizosaccharomyces pombe	PLOS ONE			English	Article							NDR-PROTEIN-KINASE; FISSION YEAST; SIGNALING PATHWAY; MORPHOGENESIS; FAMILY; CYCLE; INTERACTS; MAINTENANCE; NETWORK; NAK1	The Ndr-related Orb6 kinase is a key regulator of polarized cell growth in fission yeast, however the mechanism of Orb6 activation is unclear. Activation of other Ndr kinases involves both autophosphorylation and phosphorylation by an upstream kinase. Previous reports suggest that the Nak1 kinase functions upstream from Orb6. Supporting this model, we show that HA-Orb6 overexpression partially restored cell polarity in nak1 ts cells. We also demonstrated by coimmunoprecipitation and in vitro binding assays that Nak1 and Orb6 physically interact, and that the Nak1 C-terminal region is required forNak1/Orb6 complex formation in vivo. However, results from in vitro kinase assays did not show phosphorylation of recombinant Orb6 by HA-Nak1, suggesting that Orb6 activation may not involve direct phosphorylation by Nak1. To investigate the role of Orb6 phosphorylation and activity, we substituted Ala at the ATP-binding and conserved phosphorylation sites. Overexpression of kinase-dead HA-Orb6(K122A) in wild-type cells resulted in a loss of cell polarity, suggesting that it has a dominant-negative effect, and it failed to rescue the polarity defect of nak1 or orb6 ts mutants. Recombinant GST-Orb6(S291A) did not autophosphorylate in vitro suggesting that Ser291 is the primary autophosphorylation site. HA-Orb6(S291A) overexpression only partially rescued the orb6 polarity defect and failed to rescue the nak1 defect, suggesting that autophosphorylation is important for Orb6 function. GST-Orb6(T456A) autophosphorylated in vitro, indicating that the conserved phosphorylation site at Thr456 is not essential for kinase activity. However, HA-Orb6(T456A) overexpression had similar effects as overexpressing kinase-dead HA-Orb6(K122A), suggesting that Thr456 is essential for Orb6 function in vivo. Also, we found that both phosphorylation site mutations impaired the ability of Myc-Nak1 to coimmunoprecipitate with HA-Orb6. Together, our results suggest a model whereby autophosphorylation of Ser291 and phosphorylation of Thr456 by an upstream kinase promote Nak1/Orb6 complex formation and Orb6 activation.	[Liu, Guohong] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; Univ Calgary, Dept Oncol, Calgary, AB, Canada	University of Calgary; University of Calgary	Liu, GH (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	young@ucalgary.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	lThis research was funded by a grant from the Canadian Institutes of Health Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa C, 1993, EXPT FISSION YEAST L; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001347; Das M, 2009, CURR BIOL, V19, P1314, DOI 10.1016/j.cub.2009.06.057; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090; He Y, 2005, MOL BIOL CELL, V16, P689, DOI 10.1091/mbc.E04-09-0828; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2011, CELL SIGNAL, V23, P1433, DOI 10.1016/j.cellsig.2011.04.007; Hou MC, 2003, J CELL SCI, V116, P125, DOI 10.1242/jcs.00206; Huang TY, 2005, J CELL SCI, V118, P199, DOI 10.1242/jcs.01608; Huang TY, 2003, J BIOL CHEM, V278, P991, DOI 10.1074/jbc.M208993200; Jansen JM, 2006, J CELL BIOL, V175, P755, DOI 10.1083/jcb.200604107; Kanai M, 2005, EMBO J, V24, P3012, DOI 10.1038/sj.emboj.7600782; Leonhard K, 2005, J CELL SCI, V118, P1033, DOI 10.1242/jcs.01690; Loewith R, 2000, J CELL SCI, V113, P153; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; MILLWARD T, 1995, P NATL ACAD SCI USA, V92, P5022, DOI 10.1073/pnas.92.11.5022; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; MITCHISON JM, 1985, J CELL SCI, V75, P357; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; Piel M, 2009, CURR BIOL, V19, pR823, DOI 10.1016/j.cub.2009.08.012; Ray S, 2010, J CELL BIOL, V190, P793, DOI 10.1083/jcb.201002055; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Tamaskovic R, 2003, J BIOL CHEM, V278, P6710, DOI 10.1074/jbc.M210590200; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R; VERDE F, 1995, J CELL BIOL, V131, P1529, DOI 10.1083/jcb.131.6.1529; Verde F, 1998, P NATL ACAD SCI USA, V95, P7526, DOI 10.1073/pnas.95.13.7526; Wiley DJ, 2003, J BIOL CHEM, V278, P25256, DOI 10.1074/jbc.M209703200; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X	34	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37221	10.1371/journal.pone.0037221	http://dx.doi.org/10.1371/journal.pone.0037221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629372	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343100019
J	Petit, N; Pineyro, D; Lopez-Panades, E; Casacuberta, E; Navarro, A				Petit, Natalia; Pineyro, David; Lopez-Panades, Elisenda; Casacuberta, Elena; Navarro, Arcadi			HeT-A_pi1, a piRNA Target Sequence in the Drosophila Telomeric Retrotransposon HeT-A, Is Extremely Conserved across Copies and Species	PLOS ONE			English	Article							EVOLUTION; PIWI; ELEMENTS; MECHANISM; VIRILIS	The maintenance of the telomeres in Drosophila species depends on the transposition of the non-LTR retrotransposons HeT-A, TAHRE and TART. HeT-A and TART elements have been found in all studied species of Drosophila suggesting that their function has been maintained for more than 60 million years. Of the three elements, HeT-A is by far the main component of D. melanogaster telomeres and, unexpectedly for an element with an essential role in telomere elongation, the conservation of the nucleotide sequence of HeT-A is very low. In order to better understand the function of this telomeric retrotransposon, we studied the degree of conservation along HeT-A copies. We identified a small sequence within the 39 UTR of the element that is extremely conserved among copies of the element both, within D. melanogaster and related species from the melanogaster group. The sequence corresponds to a piRNA target in D. melanogaster that we named HeT-A_pi1. Comparison with piRNA target sequences from other Drosophila retrotransposons showed that HeT-A_pi1 is the piRNA target in the Drosophila genome with the highest degree of conservation among species from the melanogaster group. The high conservation of this piRNA target in contrast with the surrounding sequence, suggests an important function of the HeT-A_pi1 sequence in the co-evolution of the HeT-A retrotransposon and the Drosophila genome.	[Petit, Natalia; Navarro, Arcadi] Univ Pompeu Fabra, Dept Ciencies Expt & Salut DCEXS, Barcelona, Spain; [Petit, Natalia; Pineyro, David; Lopez-Panades, Elisenda; Casacuberta, Elena; Navarro, Arcadi] Inst Biol Evolut CSIC UPF, Barcelona, Spain; [Navarro, Arcadi] Univ Pompeu Fabra, INB, Barcelona, Spain; [Navarro, Arcadi] ICREA, Catalonia, Spain	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; ICREA	Petit, N (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut DCEXS, Barcelona, Spain.	elena.casacuberta@ibe.upf-csic.es; arcadi.navarro@upf.edu	Navarro, Arcadi/F-1592-2011; Marty, Natalia Petit/AAI-7449-2021	Navarro, Arcadi/0000-0003-2162-8246; Marty, Natalia Petit/0000-0002-3810-1152; Casacuberta, Elena/0000-0002-8203-8357; Pineyro, David/0000-0001-5633-3339	Spanish Ministry of Science and Innovation [BFU2009-08318/BMC, BFU2009-13409-C02-02]; Spanish National Institute for Bioinformatics; Consejo Superior de Investigaciones Cientificas (CSIC) [JAE-doc09_01394]; FEDER; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish National Institute for Bioinformatics; Consejo Superior de Investigaciones Cientificas (CSIC); FEDER(European Commission); ICREA(ICREA)	This work was supported by grants from the Spanish Ministry of Science and Innovation BFU2009-08318/BMC to EC and BFU2009-13409-C02-02 to AN. Funding was also provided by the Spanish National Institute for Bioinformatics (www.inb.org). NP is supported by JAE-doc09_01394 from Consejo Superior de Investigaciones Cientificas (CSIC) and FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; ASHBURNER M, 1994, DEVELOPMENT, V120, P2077; Blackburn, 2006, TELOMERES; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Casacuberta E, 2005, CYTOGENET GENOME RES, V110, P152, DOI 10.1159/000084947; Casacuberta E, 2003, P NATL ACAD SCI USA, V100, P14091, DOI 10.1073/pnas.1936193100; Casacuberta E, 2003, P NATL ACAD SCI USA, V100, P3363, DOI 10.1073/pnas.0230353100; Casacuberta E, 2002, GENETICS, V161, P1113; Collins K, 2000, CURR OPIN CELL BIOL, V12, P378, DOI 10.1016/S0955-0674(00)00103-4; Danilevskaya ON, 1998, GENETICS, V148, P233; Danilevskaya ON, 1998, P NATL ACAD SCI USA, V95, P3770, DOI 10.1073/pnas.95.7.3770; Danilevskaya ON, 1997, CELL, V88, P647, DOI 10.1016/S0092-8674(00)81907-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; George JA, 2006, GENOME RES, V16, P1231, DOI 10.1101/gr.5348806; Khurana JS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001246; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin H, 2008, COLD SH Q B, V73, P273, DOI 10.1101/sqb.2008.73.056; Lu J, 2010, GENOME RES, V20, P212, DOI 10.1101/gr.095406.109; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pardue ML, 2008, FLY, V2, P101, DOI 10.4161/fly.6393; Pardue ML, 1996, J MOL EVOL, V43, P572, DOI 10.1007/BF02202105; Pardue ML, 2005, CHROMOSOME RES, V13, P443, DOI 10.1007/s10577-005-0993-6; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; Pineyro D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-573; Shpiz S, 2009, NUCLEIC ACIDS RES, V37, P268, DOI 10.1093/nar/gkn960; Siomi H, 2008, CURR OPIN GENET DEV, V18, P181, DOI 10.1016/j.gde.2008.01.002; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zamore PD, 2010, EMBO J, V29, P3219, DOI 10.1038/emboj.2010.232; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37405	10.1371/journal.pone.0037405	http://dx.doi.org/10.1371/journal.pone.0037405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629389	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100025
J	Christie, DA; Kirchhof, MG; Vardhana, S; Dustin, ML; Madrenas, J				Christie, Darah A.; Kirchhof, Mark G.; Vardhana, Santosh; Dustin, Michael L.; Madrenas, Joaquin			Mitochondrial and Plasma Membrane Pools of Stomatin-Like Protein 2 Coalesce at the Immunological Synapse during T Cell Activation	PLOS ONE			English	Article							RAFT PROTEOME REVEALS; ATP SYNTHASE COMPLEX; LIPID RAFTS; ANTIGEN RECEPTOR; ASSOCIATION; PHOSPHORYLATION; PROHIBITINS; LIGATION; REQUIRES; SURFACE	Stomatin-like protein 2 (SLP-2) is a member of the stomatin - prohibitin - flotillin - HflC/K (SPFH) superfamily. Recent evidence indicates that SLP-2 is involved in the organization of cardiolipin-enriched microdomains in mitochondrial membranes and the regulation of mitochondrial biogenesis and function. In T cells, this role translates into enhanced T cell activation. Although the major pool of SLP-2 is associated with mitochondria, we show here that there is an additional pool of SLP-2 associated with the plasma membrane of T cells. Both plasma membrane-associated and mitochondria-associated pools of SLP-2 coalesce at the immunological synapse (IS) upon T cell activation. SLP-2 is not required for formation of IS nor for the re-localization of mitochondria to the IS because SLP-2-deficient T cells showed normal re-localization of these organelles in response to T cell activation. Interestingly, upon T cell activation, we found the surface pool of SLP-2 mostly excluded from the central supramolecular activation complex, and enriched in the peripheral area of the IS where signalling TCR microclusters are located. Based on these results, we propose that SLP-2 facilitates the compartmentalization not only of mitochondrial membranes but also of the plasma membrane into functional microdomains. In this latter location, SLP-2 may facilitate the optimal assembly of TCR signalosome components. Our data also suggest that there may be a net exchange of membrane material between mitochondria and plasma membrane, explaining the presence of some mitochondrial proteins in the plasma membrane.	[Christie, Darah A.; Kirchhof, Mark G.; Madrenas, Joaquin] Univ Western Ontario, Ctr Human Immunol, Robarts Res Inst, London, ON, Canada; [Christie, Darah A.; Kirchhof, Mark G.; Madrenas, Joaquin] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Christie, Darah A.; Kirchhof, Mark G.; Madrenas, Joaquin] Univ Western Ontario, Dept Med, London, ON, Canada; [Vardhana, Santosh; Dustin, Michael L.] Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY USA; [Madrenas, Joaquin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); McGill University	Christie, DA (corresponding author), Univ Western Ontario, Ctr Human Immunol, Robarts Res Inst, London, ON, Canada.	joaquin.madrenas@mcgill.ca	Madrenas, Quim/P-5008-2019; Dustin, Michael/AAM-4611-2020	Vardhana, Santosha/0000-0002-3100-1298; Dustin, Michael/0000-0003-4983-6389	CIHR [82794]; United States National Institutes of Health [AI43542]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043542, R37AI043542] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by grants from CIHR (82794) and the United States National Institutes of Health (AI43542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade-Navarro MA, 2009, CURR OPIN CELL BIOL, V21, P560, DOI 10.1016/j.ceb.2009.04.005; [Anonymous], 2008, REV CHILENA INFECT O, V25, P387; Apt W, 2008, REV CHIL INFECTOL, V25, P384, DOI /S0716-10182008000500013; Arp J, 2003, MOL CELL BIOL, V23, P8042, DOI 10.1128/MCB.23.22.8042-8057.2003; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Baroja ML, 1999, J IMMUNOL, V162, P2016; Bathori G, 1999, J BIOL CHEM, V274, P29607, DOI 10.1074/jbc.274.42.29607; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Chevallet M, 2006, ELECTROPHORESIS, V27, P1574, DOI 10.1002/elps.200500704; Christie DA, 2011, MOL CELL BIOL, V31, P3845, DOI 10.1128/MCB.05393-11; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Da Cruz S, 2010, CELL CALCIUM, V47, P11, DOI 10.1016/j.ceca.2009.10.005; Darlington PJ, 2002, J EXP MED, V195, P1337, DOI 10.1084/jem.20011868; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Gascoigne NRJ, 2004, CURR OPIN IMMUNOL, V16, P114, DOI 10.1016/j.coi.2003.11.008; Hajek P, 2007, J BIOL CHEM, V282, P5670, DOI 10.1074/jbc.M608168200; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kim BW, 2010, EXPERT REV PROTEOMIC, V7, P849, DOI 10.1586/EPR.10.87; Kim KB, 2006, PROTEOMICS, V6, P2444, DOI 10.1002/pmic.200500574; Kirchhof MG, 2008, J IMMUNOL, V181, P1927, DOI 10.4049/jimmunol.181.3.1927; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Mairhofer M, 2009, J BIOL CHEM, V284, P29218, DOI 10.1074/jbc.M109.014993; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Rezaul K, 2005, MOL CELL PROTEOMICS, V4, P169, DOI 10.1074/mcp.M400115-MCP200; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Snyers L, 1997, EUR J CELL BIOL, V73, P281; Snyers L, 1999, EUR J CELL BIOL, V78, P802, DOI 10.1016/S0171-9335(99)80031-4; Soubannier V, 2012, CURRENT BIOL CB; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Tomas EM, 2002, IMMUNOL LETT, V83, P143, DOI 10.1016/S0165-2478(02)00075-5; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wang YQ, 2009, CANCER BIOL THER, V8, P1658, DOI 10.4161/cbt.8.17.9283; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4	47	29	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37144	10.1371/journal.pone.0037144	http://dx.doi.org/10.1371/journal.pone.0037144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623988	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500065
J	McGuire, TF; Sajithlal, GB; Lu, J; Nicholls, RD; Prochownik, EV				McGuire, Terence F.; Sajithlal, Gangadharan B.; Lu, Jie; Nicholls, Robert D.; Prochownik, Edward V.			In Vivo Evolution of Tumor-Derived Endothelial Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENETIC ALTERATIONS; ARTERIAL DIFFERENTIATION; MOLECULAR-MECHANISMS; COPY-NUMBER; ANGIOGENESIS; BEVACIZUMAB; EXPRESSION; GROWTH; STROMA	The growth of a malignant tumor beyond a certain, limited size requires that it first develop an independent blood supply. In addition to providing metabolic support, this neovasculature also allows tumor cells to access the systemic circulation, thus facilitating metastatic dissemination. The neovasculature may originate either from normal blood vessels in close physical proximity to the tumor and/or from the recruitment of bone marrow-derived endothelial cell (EC) precursors. Recent studies have shown that human tumor vasculature ECs may also arise directly from tumor cells themselves and that the two populations have highly similar or identical karyotypes. We now show that, during the course of serial in vivo passage, these tumor-derived ECs (TDECs) progressively acquire more pronounced EC-like properties. These include higher-level expression of EC-specific genes and proteins, a greater capacity for EC-like behavior in vitro, and a markedly enhanced propensity to incorporate into the tumor vasculature. In addition, both vessel density and size are significantly increased in neoplasms derived from mixtures of tumor cells and serially passaged TDECs. A comparison of early-and late-passage TDECs using whole-genome single nucleotide polymorphism profiling showed the latter cells to have apparently evolved by a process of clonal expansion of a population with a distinct pattern of interstitial chromosomal gains and losses affecting a relatively small number of genes. The majority of these have established roles in vascular development, tumor suppression or epithelial-mesenchymal transition. These studies provide direct evidence that TDECs have a strong evolutionary capacity as a result of their inherent genomic instability. Consequently such cells might be capable of escaping anti-angiogenic cancer therapies by generating resistant populations.	[McGuire, Terence F.; Sajithlal, Gangadharan B.; Lu, Jie; Prochownik, Edward V.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Hematol Oncol, Pittsburgh, PA USA; [Nicholls, Robert D.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Birth Defect Labs,Div Genet, Pittsburgh, PA USA; [Nicholls, Robert D.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Prochownik, Edward V.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Nicholls, Robert D.; Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McGuire, TF (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Hematol Oncol, Pittsburgh, PA USA.	procev@chp.edu			National Institutes of Health [CA140624]; NATIONAL CANCER INSTITUTE [R01CA140624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a grant from National Institutes of Health to EVP (CA140624). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdelrahim M, 2010, INT J ONCOL, V36, P5, DOI 10.3892/ijo_00000470; Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Almog N, 2010, CANCER LETT, V294, P139, DOI 10.1016/j.canlet.2010.03.004; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Bochenek ML, 2010, J CELL SCI, V123, P1235, DOI 10.1242/jcs.061903; Bottos A, 2009, P NATL ACAD SCI USA, V106, P20782, DOI 10.1073/pnas.0809510106; Bussolati B, 2009, J CELL MOL MED, V13, P309, DOI 10.1111/j.1582-4934.2008.00338.x; Cao YH, 2009, FRONT BIOSCI-LANDMRK, V14, P3962, DOI [10.2741/3504, 10.2735/3504]; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chen D, 2011, J BIOL CHEM, V286, P13261, DOI 10.1074/jbc.M110.206771; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Davison EJ, 2005, GENE CHROMOSOME CANC, V44, P384, DOI 10.1002/gcc.20252; Dome B, 2008, CYTOM PART A, V73A, P186, DOI 10.1002/cyto.a.20480; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Haines BP, 2008, GENE EXPR PATTERNS, V8, P79, DOI 10.1016/j.modgep.2007.10.003; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jenab-Wolcott J, 2009, EXPERT OPIN BIOL TH, V9, P507, DOI [10.1517/14712590902817817, 10.1517/14712590902817817 ]; Johannsdottir HK, 2006, INT J CANCER, V119, P1052, DOI 10.1002/ijc.21934; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kolosionek E, 2009, MOL BIOL CELL, V20, P4751, DOI 10.1091/mbc.E09-01-0019; Kopp HG, 2006, CURR OPIN HEMATOL, V13, P175, DOI 10.1097/01.moh.0000219664.26528.da; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Larrivee B., 2007, V180, P89; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; LAWLEY TJ, 1989, J INVEST DERMATOL, V93, pS59, DOI 10.1111/1523-1747.ep12581070; Moinfar F, 2000, CANCER RES, V60, P2562; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; Pasic I, 2010, CANCER RES, V70, P160, DOI 10.1158/0008-5472.CAN-09-1902; Paterson RF, 2003, CANCER, V98, P1830, DOI 10.1002/cncr.11747; Paulis YWJ, 2010, BBA-REV CANCER, V1806, P18, DOI 10.1016/j.bbcan.2010.01.001; Pelham RJ, 2006, P NATL ACAD SCI USA, V103, P19848, DOI 10.1073/pnas.0609635104; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Sajithlal GB, 2010, INT J CANCER, V127, P2268, DOI 10.1002/ijc.25251; Schildkraut JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010061; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; SHAKADO S, 1995, HEPATOLOGY, V22, P969, DOI 10.1016/0270-9139(95)90322-4; Streubel B, 2004, NEW ENGL J MED, V351, P250, DOI 10.1056/NEJMoa033153; Suckow AT, 2008, ENDOCRINOLOGY, V149, P6006, DOI 10.1210/en.2008-0274; Tamura K, 2009, CANCER RES, V69, P8133, DOI 10.1158/0008-5472.CAN-09-0775; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tonra JR, 2007, IMMUNOL INVEST, V36, P3, DOI 10.1080/08820130600991794; Vinatzer U, 2008, CLIN CANCER RES, V14, P6426, DOI 10.1158/1078-0432.CCR-08-0702; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang DX, 2011, J BIOL CHEM, V286, P17746, DOI 10.1074/jbc.M110.206029; Zhou XH, 2003, GENE EXPR PATTERNS, V3, P397, DOI 10.1016/S1567-133X(03)00087-5	55	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37138	10.1371/journal.pone.0037138	http://dx.doi.org/10.1371/journal.pone.0037138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623986	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305343500063
J	Roscher, C; Schumacher, J; Gubsch, M; Lipowsky, A; Weigelt, A; Buchmann, N; Schmid, B; Schulze, ED				Roscher, Christiane; Schumacher, Jens; Gubsch, Marlen; Lipowsky, Annett; Weigelt, Alexandra; Buchmann, Nina; Schmid, Bernhard; Schulze, Ernst-Detlef			Using Plant Functional Traits to Explain Diversity-Productivity Relationships	PLOS ONE			English	Article							SPECIES-DIVERSITY; ECOSYSTEM FUNCTION; SEED SIZE; BIODIVERSITY; GRASSLAND; COMMUNITIES; ECOLOGY; COMPLEMENTARITY; MECHANISMS; SELECTION	Background: The different hypotheses proposed to explain positive species richness-productivity relationships, i.e. selection effect and complementarity effect, imply that plant functional characteristics are at the core of a mechanistic understanding of biodiversity effects. Methodology/Principal Findings: We used two community-wide measures of plant functional composition, (1) community-weighted means of trait values (CWM) and (2) functional trait diversity based on Rao's quadratic diversity (FDQ) to predict biomass production and measures of biodiversity effects in experimental grasslands (Jena Experiment) with different species richness (2, 4, 8, 16 and 60) and different functional group number and composition (1 to 4; legumes, grasses, small herbs, tall herbs) four years after establishment. Functional trait composition had a larger predictive power for community biomass and measures of biodiversitity effects (40-82% of explained variation) than species richness per se (<1-13% of explained variation). CWM explained a larger amount of variation in community biomass (80%) and net biodiversity effects (70%) than FDQ (36 and 38% of explained variation respectively). FDQ explained similar proportions of variation in complementarity effects (24%, positive relationship) and selection effects (28%, negative relationship) as CWM (27% of explained variation for both complementarity and selection effects), but for all response variables the combination of CWM and FDQ led to significant model improvement compared to a separate consideration of different components of functional trait composition. Effects of FDQ were mainly attributable to diversity in nutrient acquisition and life-history strategies. The large spectrum of traits contributing to positive effects of CWM on biomass production and net biodiversity effects indicated that effects of dominant species were associated with different trait combinations. Conclusions/Significance: Our results suggest that the identification of relevant traits and the relative impacts of functional identity of dominant species and functional diversity are essential for a mechanistic understanding of the role of plant diversity for ecosystem processes such as aboveground biomass production.	[Roscher, Christiane] UFZ Helmholtz Ctr Environm Res, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Schumacher, Jens] Univ Jena, Inst Stochast, Jena, Germany; [Gubsch, Marlen; Buchmann, Nina] Swiss Fed Inst Technol, Inst Agr Sci, Zurich, Switzerland; [Lipowsky, Annett; Schulze, Ernst-Detlef] Max Planck Inst Biogeochem, Jena, Germany; [Lipowsky, Annett; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Weigelt, Alexandra] Univ Leipzig, Inst Biol, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Friedrich Schiller University of Jena; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; University of Zurich; Leipzig University	Roscher, C (corresponding author), UFZ Helmholtz Ctr Environm Res, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany.	christiane.roscher@ufz.de	Buchmann, Nina/E-6095-2011; Schmid, Bernhard/C-8625-2009; Schulze, Ernst-Detlef/K-9627-2014	Buchmann, Nina/0000-0003-0826-2980; Schmid, Bernhard/0000-0002-8430-3214; 	German Science Foundation [FOR456, Ro2397/3-1]; University of Jena; Max Planck Society	German Science Foundation(German Research Foundation (DFG)); University of Jena; Max Planck Society(Max Planck SocietyFoundation CELLEX)	The Jena Experiment is funded by the German Science Foundation (FOR456) with additional support from the University of Jena and the Max Planck Society. CR was additionally supported by the German Science Foundation (Ro2397/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Ellenberg H., 1988, Vegetation ecology of Central Europe.; Eriksson O, 1998, J ECOL, V86, P922, DOI 10.1046/j.1365-2745.1998.00309.x; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jiang L, 2009, J ECOL, V97, P603, DOI 10.1111/j.1365-2745.2009.01503.x; Kluge G, 2000, BER DTSCH WETTERDIEN, V213, P1; Kutschera L., 1992, WURZELATLAS MITTELEU; Kutschera L., 1982, WURZELATLAS MITTELEU; LEISHMAN MR, 1995, J ECOL, V83, P517, DOI 10.2307/2261604; Leps J, 2004, BASIC APPL ECOL, V5, P529, DOI 10.1016/j.baae.2004.06.003; Leps J, 2006, PRESLIA, V78, P481; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lumley T., 2009, LEAPS REGRESSION SUB; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Mason NWH, 2003, J VEG SCI, V14, P571, DOI 10.1111/j.1654-1103.2003.tb02184.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2005, OECOLOGIA, V142, P353, DOI 10.1007/s00442-004-1744-7; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Ricotta C, 2005, BASIC APPL ECOL, V6, P479, DOI 10.1016/j.baae.2005.02.008; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rothmaler R, 2005, EXKURSIONSFLORA DEUT, V4; Schumacher J, 2009, OIKOS, V118, P1659, DOI 10.1111/j.1600-0706.2009.17711.x; Schwinning S, 1998, OECOLOGIA, V113, P447, DOI 10.1007/s004420050397; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Thompson K, 2005, FUNCT ECOL, V19, P355, DOI [10.1111/j.0269-8463.2005.00936.x, 10.1111/j.1365-2435.2005.00936.x]; Tilman D, 1997, OIKOS, V80, P185, DOI 10.2307/3546532; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tjoelker MG, 2005, NEW PHYTOL, V167, P493, DOI 10.1111/j.1469-8137.2005.01428.x; van Ruijven J, 2003, ECOL LETT, V6, P170, DOI 10.1046/j.1461-0248.2003.00427.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wacker L, 2009, ECOLOGY, V90, P637, DOI 10.1890/07-1946.1; Weigelt A., 2010, ECOLOGY, V91, P930, DOI DOI 10.1890/09-0863.1; Weiher E, 1998, OIKOS, V81, P309, DOI 10.2307/3547051; Weingessel A, 2011, QUADPROG FUNCTIONS S; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114	60	181	197	18	305	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36760	10.1371/journal.pone.0036760	http://dx.doi.org/10.1371/journal.pone.0036760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623961	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000305343500025
J	Corrales, RM; Molle, V; Leiba, J; Mourey, L; de Chastellier, C; Kremer, L				Corrales, Rosa Milagros; Molle, Virginie; Leiba, Jade; Mourey, Lionel; de Chastellier, Chantal; Kremer, Laurent			Phosphorylation of Mycobacterial PcaA Inhibits Mycolic Acid Cyclopropanation CONSEQUENCES FOR INTRACELLULAR SURVIVAL AND FOR PHAGOSOME MATURATION BLOCK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SER/THR PROTEIN-KINASES; STRUCTURAL-CHARACTERIZATION; PATHOGENIC MYCOBACTERIA; TUBERCULOSIS; MACROPHAGES; SYNTHASE; ARREST; FUSION; AVIUM; BIOSYNTHESIS	Pathogenic mycobacteria survive within macrophages by residing in phagosomes, which they prevent from maturing and fusing with lysosomes. Although several bacterial components were seen to modulate phagosome processing, the molecular regulatory mechanisms taking part in this process remain elusive. We investigated whether the phagosome maturation block (PMB) could be modulated by signaling through Ser/Thr phosphorylation. Here, we demonstrated that mycolic acid cyclopropane synthase PcaA, but not MmaA2, was phosphorylated by mycobacterial Ser/Thr kinases at Thr-168 and Thr-183 both in vitro and in mycobacteria. Phosphorylation of PcaA was associated with a significant decrease in the methyltransferase activity, in agreement with the strategic structural localization of these two phosphoacceptors. Using a BCG Delta pcaA mutant, we showed that PcaA was required for intracellular survival and prevention of phagosome maturation in human monocyte-derived macrophages. The physiological relevance of PcaA phosphorylation was further assessed by generating PcaA phosphoablative (T168A/T183A) or phosphomimetic (T168D/T183D) mutants. In contrast to the wild-type and phosphoablative pcaA alleles, introduction of the phosphomimetic pcaA allele in the Delta pcaA mutant failed to restore the parental mycolic acid profile and cording morphotype. Importantly, the PcaA phosphomimetic strain, as the Delta pcaA mutant, exhibited reduced survival in human macrophages and was unable to prevent phagosome maturation. Our results add new insight into the importance of mycolic acid cyclopropane rings in the PMB and provide the first evidence of a Ser/Thr kinase-dependent mechanism for modulating mycolic acid composition and PMB.	[de Chastellier, Chantal] Aix Marseille Univ, Ctr Immunol Marseille Luminy, UM 2, F-13288 Marseille, France; [Corrales, Rosa Milagros; Molle, Virginie; Leiba, Jade; Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Corrales, Rosa Milagros; Molle, Virginie; Leiba, Jade; Kremer, Laurent] Univ Montpellier I, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Mourey, Lionel] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Mourey, Lionel] Univ Toulouse 3, Univ Toulouse, IPBS, F-31077 Toulouse, France; [de Chastellier, Chantal] INSERM, U1104, F-13288 Marseille, France; [de Chastellier, Chantal] CNRS, UMR7280, F-13288 Marseille, France; [Kremer, Laurent] INSERM, DIMNP, F-34095 Montpellier 05, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	de Chastellier, C (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, UM 2, F-13288 Marseille, France.	dechastellier@ciml.univ-mrs.fr; laurent.kremer@univ-montp2.fr	Mourey, Lionel/B-5662-2009; MOLLE, Virginie/D-4050-2019; Kremer, Laurent/M-4935-2017	Mourey, Lionel/0000-0002-8259-1259; MOLLE, Virginie/0000-0002-6573-3411; Kremer, Laurent/0000-0002-6604-4458	French National Research Agency [ANR-09-MIEN-004]; Institut National de la Sante et de la Recherche Medicale (INSERM); InfectioPole Sud; Region Languedoc-Roussillon; University of Montpellier 1	French National Research Agency(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); InfectioPole Sud; Region Languedoc-Roussillon(Region Ile-de-FranceRegion Occitanie); University of Montpellier 1	This work was supported by grants from the French National Research Agency (ANR-09-MIEN-004) (to V. M. and L. K.) and funds from the Institut National de la Sante et de la Recherche Medicale (INSERM) (to C. dC.). This work was also supported by the InfectioPole Sud (to R. M. C.) and Region Languedoc-Roussillon and the University of Montpellier 1 (to J. L.).	Alibaud L, 2010, J BIOL CHEM, V285, P21698, DOI 10.1074/jbc.M110.125724; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Barkan D, 2009, CHEM BIOL, V16, P499, DOI 10.1016/j.chembiol.2009.04.001; Barthe P, 2009, STRUCTURE, V17, P568, DOI 10.1016/j.str.2009.02.012; Bessoles S, 2009, EUR J IMMUNOL, V39, P1025, DOI 10.1002/eji.200838929; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Canova MJ, 2008, PLASMID, V60, P149, DOI 10.1016/j.plasmid.2008.05.002; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Chua J, 2004, CURR OPIN MICROBIOL, V7, P71, DOI 10.1016/j.mib.2003.12.011; de Chastellier C, 2006, CELL MICROBIOL, V8, P242, DOI 10.1111/j.1462-5822.2005.00617.x; de Chastellier C, 2009, IMMUNOBIOLOGY, V214, P526, DOI 10.1016/j.imbio.2008.12.005; de Chastellier C, 2009, CELL MICROBIOL, V11, P1190, DOI 10.1111/j.1462-5822.2009.01324.x; DECHASTELLIER C, 1987, EUR J CELL BIOL, V44, P112; DECHASTELLIER C, 1993, INFECT IMMUN, V61, P3775, DOI 10.1128/IAI.61.9.3775-3784.1993; deChastellier C, 1997, EUR J CELL BIOL, V74, P49; DECHASTELLIER C, 1995, EUR J CELL BIOL, V68, P167; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; FREHEL C, 1986, INFECT IMMUN, V52, P252, DOI 10.1128/IAI.52.1.252-262.1986; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2003, J BIOL CHEM, V278, P7844, DOI 10.1074/jbc.M212458200; Huang CC, 2002, J BIOL CHEM, V277, P11559, DOI 10.1074/jbc.M111698200; Indrigo J, 2003, MICROBIOL-SGM, V149, P2049, DOI 10.1099/mic.0.26226-0; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Molle V, 2010, PROTEOMICS, V10, P3910, DOI 10.1002/pmic.201000316; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Slama N, 2011, BIOCHEM BIOPH RES CO, V412, P401, DOI 10.1016/j.bbrc.2011.07.051; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Zhang Y, 2006, DRUG DISCOV TODAY, V11, P21, DOI 10.1016/S1359-6446(05)03626-3	48	46	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26187	26199		10.1074/jbc.M112.373209	http://dx.doi.org/10.1074/jbc.M112.373209			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22621931	Green Published, hybrid			2022-12-25	WOS:000306916300046
J	Yang, J; Dolinger, M; Ritaccio, G; Mazurkiewicz, J; Conti, D; Zhu, XJ; Huang, YF				Yang, Jun; Dolinger, Michael; Ritaccio, Gabrielle; Mazurkiewicz, Joseph; Conti, David; Zhu, Xinjun; Huang, Yunfei			Leucine Stimulates Insulin Secretion via Down-regulation of Surface Expression of Adrenergic alpha 2A Receptor through the mTOR ( Mammalian Target of Rapamycin) Pathway IMPLICATION IN NEW-ONSET DIABETES IN RENAL TRANSPLANTATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; AMINO-ACIDS; KIDNEY-TRANSPLANT; GLUCOSE-HOMEOSTASIS; BLOOD-GLUCOSE; RISK-FACTORS; METABOLISM; ISLETS; INHIBITION; MELLITUS	The amino acid leucine is a potent secretagogue, capable of inducing insulin secretion. It also plays an important role in the regulation of mTOR activity, therefore, providing impetus to investigate if a leucine-sensing mechanism in the mTOR pathway is involved in insulin secretion. We found that leucine-induced insulin secretion was inhibited by both the mTOR inhibitor rapamycin as well as the adrenergic alpha 2 receptor agonist clonidine. We also demonstrated that leucine down-regulated the surface expression of adrenergic alpha 2A receptor via activation of the mTOR pathway. The leucine stimulatory effect on insulin secretion was attenuated in diabetic Goto-Kakizaki rats that overexpress adrenergic alpha 2A receptors, confirming the role of leucine in insulin secretion. Thus, our data demonstrate that leucine regulates insulin secretion by modulating adrenergic alpha 2 receptors through the mTOR pathway. The role of the mTOR pathway in metabolic homeostasis led us to a second important finding in this study; retrospective analysis of clinical data showed that co-administration of rapamycin and clonidine was associated with an increased incidence of new-onset diabetes in renal transplantation patients over those receiving rapamycin alone. We believe that inhibition of mTOR by rapamycin along with activation of adrenergic alpha 2 receptors by clonidine represents a double-hit to pancreatic islets that synergistically disturbs glucose homeostasis. This new insight may have important implications for the clinical management of renal transplant patients.	[Yang, Jun; Mazurkiewicz, Joseph; Huang, Yunfei] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Yang, Jun; Zhu, Xinjun] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Yang, Jun; Dolinger, Michael; Ritaccio, Gabrielle; Zhu, Xinjun] Albany Med Coll, Div Gastroenterol, Dept Internal Med, Albany, NY 12208 USA; [Conti, David] Albany Med Coll, Dept Transplant Surg, Albany, NY 12208 USA	Albany Medical College; Albany Medical College; Albany Medical College; Albany Medical College	Huang, YF (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	huangy@mail.amc.edu	Dolinger, Michael/AAU-4784-2021; huang, yunfei/HCH-7746-2022	Dolinger, Michael/0000-0002-9023-4948; 	National Institutes of Health [NS062068, K08DK088950]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK088950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS062068 (NINDS; to Y. H.) and K08DK088950 (NIDDK and The GI IBD Research Fund by Michael Kerr, to X. Z.).	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Bernard JR, 2011, AM J PHYSIOL-ENDOC M, V300, pE752, DOI 10.1152/ajpendo.00643.2010; Branstrom R, 1998, J BIOL CHEM, V273, P14113, DOI 10.1074/jbc.273.23.14113; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cottingham C, 2011, J BIOL CHEM, V286, P36063, DOI 10.1074/jbc.M111.261578; Devedjian JC, 2000, DIABETOLOGIA, V43, P899, DOI 10.1007/s001250051467; DITULLIO NW, 1984, J PHARMACOL EXP THER, V228, P168; Fagerholm V, 2011, BASIC CLIN PHARMACOL, V108, P365, DOI 10.1111/j.1742-7843.2011.00699.x; FLOYD JC, 1968, J CLIN ENDOCR METAB, V28, P266, DOI 10.1210/jcem-28-2-266; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; FRIEDMAN EA, 1985, AM J NEPHROL, V5, P196, DOI 10.1159/000166932; Gao Z, 2003, ENDOCRINOLOGY, V144, P1949, DOI 10.1210/en.2002-0072; Giroix MH, 1999, DIABETOLOGIA, V42, P965; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; GUTHRIE GP, 1983, CLIN PHARMACOL THER, V34, P713, DOI 10.1038/clpt.1983.239; Gyurus E, 2011, TRANSPL P, V43, P1583, DOI 10.1016/j.transproceed.2011.05.001; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; HUTTON JC, 1980, J BIOL CHEM, V255, P7340; Johnston O, 2008, J AM SOC NEPHROL, V19, P1411, DOI 10.1681/ASN.2007111202; Jonkers FC, 2001, DIABETES, V50, P540, DOI 10.2337/diabetes.50.3.540; Kalogeropoulo D, 2008, METABOLISM, V57, P1747, DOI 10.1016/j.metabol.2008.09.001; Kaposztas Z, 2011, TRANSPL P, V43, P1375, DOI 10.1016/j.transproceed.2011.04.008; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Kwon G, 2004, DIABETES, V53, pS225, DOI 10.2337/diabetes.53.suppl_3.S225; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; MACDONALD MJ, 1991, J BIOL CHEM, V266, P1335; MALAISSE WJ, 1980, DIABETES, V29, P431, DOI 10.2337/diabetes.29.6.431; Mangray M, 2011, AM J KIDNEY DIS, V57, P331, DOI 10.1053/j.ajkd.2010.10.048; MILNER RDG, 1970, J ENDOCRINOL, V47, P347, DOI 10.1677/joe.0.0470347; Peterhoff M, 2003, EUR J ENDOCRINOL, V149, P343, DOI 10.1530/eje.0.1490343; Reis MAB, 1997, J NUTR, V127, P403, DOI 10.1093/jn/127.3.403; Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Saunders C, 1999, PHARMACOL THERAPEUT, V84, P193, DOI 10.1016/S0163-7258(99)00032-7; Sharif A, 2010, NAT REV NEPHROL, V6, P415, DOI 10.1038/nrneph.2010.66; Shimodahira M, 2010, J ENDOCRINOL, V204, P37, DOI 10.1677/JOE-09-0216; Smith PA, 1997, J PHYSIOL-LONDON, V499, P625, DOI 10.1113/jphysiol.1997.sp021955; Stack JH, 1995, ANNU REV CELL DEV BI, V11, P1; van Loon LJC, 2000, AM J CLIN NUTR, V72, P96; Yang JC, 2010, NUTR REV, V68, P270, DOI 10.1111/j.1753-4887.2010.00282.x	42	44	45	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24795	24806		10.1074/jbc.M112.344259	http://dx.doi.org/10.1074/jbc.M112.344259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645144	Green Published, hybrid			2022-12-25	WOS:000306651100072
J	Chollangi, S; Thompson, JW; Ruiz, JC; Gardner, KH; Bruick, RK				Chollangi, Srinivas; Thompson, Joel W.; Ruiz, Julio C.; Gardner, Kevin H.; Bruick, Richard K.			Hemerythrin-like Domain within F-box and Leucine-rich Repeat Protein 5 (FBXL5) Communicates Cellular Iron and Oxygen Availability by Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PROTEIN-2; CYTOSOLIC ACONITASE; RESPONSIVE ELEMENT; MOLECULAR CONTROL; BINDING ACTIVITY; HOMEOSTASIS; METABOLISM; CELLS; DISEASE; LIGASE	Iron regulatory proteins play a principal role in maintaining cellular iron homeostasis by post-transcriptionally regulating factors responsible for iron uptake, utilization, and storage. An E3 ubiquitin ligase complex containing FBXL5 targets IRP2 for proteasomal degradation under iron- and oxygen-replete conditions, whereas FBXL5 itself is degraded when iron and oxygen availability decreases. FBXL5 contains a hemerythrin-like (Hr) domain at its N terminus that mediates its own differential stability. Here, we investigated the iron- and oxygen-dependent conformational changes within FBXL5-Hr that underlie its role as a cellular sensor. As predicted, FBXL5-Hr undergoes substantive structural changes when iron becomes limiting, accounting for its switch-like behavior. However, these same changes are not observed in response to oxygen depletion, indicating that this domain accommodates two distinct sensing mechanisms. Moreover, FBXL5-Hr does not behave as a dynamic sensor that continuously samples the cellular environment, assuming conformations in equilibrium with ever-changing cellular iron levels. Instead, the isolated domain appears competent to incorporate iron only at or near the time of its own synthesis. These observations have important implications for mechanisms by which these metabolites are sensed within mammalian cells.	[Chollangi, Srinivas; Thompson, Joel W.; Ruiz, Julio C.; Gardner, Kevin H.; Bruick, Richard K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bruick, RK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	richard.bruick@utsouthwestern.edu	Gardner, Kevin/K-5493-2019; Gardner, Kevin H./K-7802-2012	Gardner, Kevin H./0000-0002-8671-2556; Thompson, Joel/0000-0002-5131-3248	Graduate Programs Initiative from University of Texas Board of Regents; Sara and Frank McKnight graduate student fellowship; Burroughs Wellcome Fund; Robert A. Welch Foundation [I-1568]; National Institutes of Health [HL102481]; National Center for Research Resources, National Institutes of Health [C06 RR 15437-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102481] Funding Source: NIH RePORTER	Graduate Programs Initiative from University of Texas Board of Regents; Sara and Frank McKnight graduate student fellowship; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the Graduate Programs Initiative from the University of Texas Board of Regents.; Howard Hughes Medical Institute Scholar. Supported by a Sara and Frank McKnight graduate student fellowship.; Michael L. Rosenberg Scholar in Medical Research. Supported by a career award in the biomedical sciences from the Burroughs Wellcome Fund, Robert A. Welch Foundation Grant I-1568, and National Institutes of Health Grant HL102481. To whom correspondence should be addressed: University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390. Tel.: 214-648-6477; Fax: 214-648-0320; E-mail: richard. bruick@utsouthwestern.edu.; We thank Thomas Scheuermann (University of Texas Southwestern Medical Center) for assistance with the NMR studies. This work was conducted in a facility constructed with support from Research Facilities Improvement Program Grant C06 RR 15437-01 from the National Center for Research Resources, National Institutes of Health.	Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Beinert H, 1978, Methods Enzymol, V54, P435; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Chen HB, 2005, TOXICOL APPL PHARM, V206, P275, DOI 10.1016/j.taap.2004.11.011; Crooks DR, 2007, J NEUROSCI RES, V85, P1797, DOI 10.1002/jnr.21321; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FEIG AL, 1994, CHEM REV, V94, P759, DOI 10.1021/cr00027a011; Galaris D, 2008, CRIT REV CL LAB SCI, V45, P1, DOI [10.1080/10408360701713104, 10.1080/10408360701713104 ]; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Martelli A, 2004, J INORG BIOCHEM, V98, P1413, DOI 10.1016/j.jinorgbio.2004.04.011; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Niles BJ, 2008, J BIOL CHEM, V283, P5168, DOI 10.1074/jbc.M709043200; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; ROBBINS AH, 1989, PROTEINS, V5, P289, DOI 10.1002/prot.340050406; ROBBINS AH, 1985, J BIOL CHEM, V260, P2328; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Shu C, 2012, CHEMBIOCHEM, V13, P788, DOI 10.1002/cbic.201200043; SLATER ML, 1976, CELL, V7, P289, DOI 10.1016/0092-8674(76)90028-3; Thompson JW, 2012, J BIOL CHEM, V287, P7357, DOI 10.1074/jbc.M111.308684; Traverso ME, 2010, BIOCHEMISTRY-US, V49, P7060, DOI 10.1021/bi100866b; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; VUISTER GW, 1992, J BIOMOL NMR, V2, P401, DOI 10.1007/BF01874818; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; ZENG GC, 1984, MOL CELL BIOL, V4, P1815, DOI 10.1128/MCB.4.9.1815; ZHANG JH, 1992, P NATL ACAD SCI USA, V89, P7065, DOI 10.1073/pnas.89.15.7065	38	31	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23710	23717		10.1074/jbc.M112.360404	http://dx.doi.org/10.1074/jbc.M112.360404			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22648410	Green Published, hybrid			2022-12-25	WOS:000306511300041
J	Itan, E; Tannenbaum, E				Itan, Eran; Tannenbaum, Emmanuel			Effect of Chromosomal Instability on the Mutation-Selection Balance in Unicellular Populations	PLOS ONE			English	Article							GENETIC INSTABILITY; CANCER; DYNAMICS	This paper develops a mathematical model describing the evolutionary dynamics of a unicellular, asexually replicating population exhibiting chromosomal instability. Chromosomal instability is a form of genetic instability characterized by the gain or loss of entire chromosomes during cell division. We assume that the cellular genome is divided into several homologous groups of chromosomes, and that a single functional chromosome per homologous group is required for the cell to have the wild-type fitness. If the fitness is unaffected by the total number of chromosomes in the cell, our model is analytically solvable, and yields a mean fitness at mutation-selection balance that is identical to the mean fitness when there is no chromosomal instability. If this assumption is relaxed and the total number of chromosomes in the cell is not allowed to increase without bound, then chromosomal instability leads to a reduction in mean fitness. The results of this paper provide a useful baseline that can inform both future theoretial and experimental studies of chromosomal instability.	[Itan, Eran; Tannenbaum, Emmanuel] Ben Gurion Univ Negev, Dept Chem, Beer Sheva, Israel	Ben Gurion University	Itan, E (corresponding author), Ben Gurion Univ Negev, Dept Chem, Beer Sheva, Israel.	emmanuel.tannenbaum@gmail.com						Attolini CSO, 2009, ANN NY ACAD SCI, V1168, P23, DOI 10.1111/j.1749-6632.2009.04880.x; Brumer Y, 2006, J THEOR BIOL, V241, P216, DOI 10.1016/j.jtbi.2005.11.018; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Michor F, 2005, SEMIN CANCER BIOL, V15, P484, DOI 10.1016/j.semcancer.2005.06.005; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Nowak MA, 2006, J THEOR BIOL, V241, P26, DOI 10.1016/j.jtbi.2005.11.012	7	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e26513	10.1371/journal.pone.0026513	http://dx.doi.org/10.1371/journal.pone.0026513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649487	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335800003
J	Baba, K; Mazzoni, F; Owino, S; Contreras-Alcantara, S; Strettoi, E; Tosini, G				Baba, Kenkichi; Mazzoni, Francesca; Owino, Sharon; Contreras-Alcantara, Susana; Strettoi, Enrica; Tosini, Gianluca			Age-Related Changes in the Daily Rhythm of Photoreceptor Functioning and Circuitry in a Melatonin-Proficient Mouse Strain	PLOS ONE			English	Article							DEGENERATION; RETINA; EXPRESSION; RECEPTOR; CLOCK	Retinal melatonin is involved in the modulation of many important retinal functions. Our previous studies have shown that the viability of photoreceptors and ganglion cells is reduced during aging in mice that lack melatonin receptor type 1. This demonstrates that melatonin signaling is important for the survival of retinal neurons. In the present study, we investigate the effects of aging on photoreceptor physiology and retinal organization in CH3-f+/+ mice, a melatonin proficient mouse strain. Our data indicate that the amplitude of the a and b waves of the scotopic and photopic electroretinogram decreases with age. Moreover, the daily rhythm in the amplitude of the a- and b- waves is lost during the aging process. Similarly, the scotopic threshold response is significantly affected by aging, but only when it is measured during the night. Interestingly, the changes observed in the ERGs are not paralleled by relevant changes in retinal morphological features, and administration of exogenous melatonin does not affect the ERGs in C3H-f(+/+) at 12 months of age. This suggests that the responsiveness of the photoreceptors to exogenous melatonin is reduced during aging.	[Baba, Kenkichi; Owino, Sharon; Contreras-Alcantara, Susana; Tosini, Gianluca] CNR, Circadian Rhythms & Sleep Disorders Program, Inst Neurosci, Dept Anat & Neurobiol,Morehouse Sch Med, I-56100 Pisa, Italy; [Mazzoni, Francesca; Strettoi, Enrica] CNR, Italian Natl Res Council, Inst Neurosci, I-56100 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Baba, K (corresponding author), CNR, Circadian Rhythms & Sleep Disorders Program, Inst Neurosci, Dept Anat & Neurobiol,Morehouse Sch Med, I-56100 Pisa, Italy.	gtosini@msm.edu	Mazzoni, Francesca/T-9044-2019	tosini, gianluca/0000-0003-3645-4533; Strettoi, Enrica/0000-0002-6101-599X; Mazzoni, Francesca/0000-0002-7826-2786	National Institutes of Health [NS43459, EY28821, EY022216, 5S21MD000101, 5U54NS060659, S21MD000101, G12-RR03034]; Georgia Research Alliance [EY12654]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY020821, R01EY012654, R01EY022216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS043459, R01NS043459, U54NS060659] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health Grants NS43459, EY28821, EY022216; 5S21MD000101, 5U54NS060659, S21MD000101, G12-RR03034, the Georgia Research Alliance (to G.T.), and EY12654 (to E.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adi N, 2010, MED SCI MONITOR, V16, pBR61; Baba K, 2009, P NATL ACAD SCI USA, V106, P15043, DOI 10.1073/pnas.0904400106; BIRCH DG, 1992, ARCH OPHTHALMOL-CHIC, V110, P1571, DOI 10.1001/archopht.1992.01080230071024; Bubenik GA, 2011, J PHYSIOL PHARMACOL, V62, P13; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Fujieda H, 1999, NEUROSCIENCE, V93, P793, DOI 10.1016/S0306-4522(99)00111-6; Gagne Anne-Marie, 2009, J Circadian Rhythms, V7, P14, DOI 10.1186/1740-3391-7-14; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; GOTO M, 1989, J PINEAL RES, V7, P195, DOI 10.1111/j.1600-079X.1989.tb00667.x; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Li CB, 2001, OPTOMETRY VISION SCI, V78, P425, DOI 10.1097/00006324-200106000-00015; Liang FQ, 2001, NEUROREPORT, V12, P1011, DOI 10.1097/00001756-200104170-00029; Liets LC, 2006, P NATL ACAD SCI USA, V103, P12156, DOI 10.1073/pnas.0605211103; Meyer P, 2002, BRIT J OPHTHALMOL, V86, P1053, DOI 10.1136/bjo.86.9.1053; Peters JL, 2005, J PINEAL RES, V38, P209, DOI 10.1111/j.1600-079X.2004.00195.x; PULIDO O, 1986, EXP GERONTOL, V21, P23, DOI 10.1016/0531-5565(86)90014-8; Roseboom PH, 1998, MOL BRAIN RES, V63, P189, DOI 10.1016/S0169-328X(98)00273-3; Rosen R, 2009, MOL VIS, V15, P1673; Rufiange M, 2002, INVEST OPHTH VIS SCI, V43, P2491; Sanchez-Barcelo EJ, 2010, CURR MED CHEM, V17, P2070, DOI 10.2174/092986710791233689; Sengupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024483; Sugawara T, 1998, INVEST OPHTH VIS SCI, V39, P2458; Terzibasi E, 2009, NEUROBIOL AGING, V30, P819, DOI 10.1016/j.neurobiolaging.2007.08.017; Tosini G, 1998, BRAIN RES, V789, P221, DOI 10.1016/S0006-8993(97)01446-7; Tosini G, 2006, CHRONOBIOL INT, V23, P381, DOI 10.1080/07420520500482066; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Vivien-Roels B, 1998, J BIOL RHYTHM, V13, P403, DOI 10.1177/074873098129000228; Von Gall C, 2008, NEUROBIOL AGING, V29, P464, DOI 10.1016/j.neurobiolaging.2006.10.015; Wu YH, 2007, NEUROBIOL AGING, V28, P1239, DOI 10.1016/j.neurobiolaging.2006.06.002; Yi CX, 2005, ANN NY ACAD SCI, V1057, P384, DOI 10.1196/annals.1356.029	31	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37799	10.1371/journal.pone.0037799	http://dx.doi.org/10.1371/journal.pone.0037799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629458	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345300077
J	Gerena, Y; Skolasky, RL; Velez, JM; Toro-Nieves, D; Mayo, R; Nath, A; Wojna, V				Gerena, Yamil; Skolasky, Richard L.; Velez, Joyce M.; Toro-Nieves, Dianedis; Mayo, Raul; Nath, Avindra; Wojna, Valerie			Soluble and Cell-Associated Insulin Receptor Dysfunction Correlates with Severity of HAND in HIV-Infected Women	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; BECK DEPRESSION INVENTORY; MULTICENTER AIDS COHORT; COGNITIVE IMPAIRMENT; NEUROCOGNITIVE DISORDERS; DIABETES-MELLITUS; HIV-1-INFECTED PATIENTS; NEUROLOGIC DISEASE; GLUCOSE-METABOLISM	Background: Blood sugar metabolism abnormalities have been identified in HIV-infected individuals and associated with HIV-associated neurocognitive disorders (HAND). These abnormalities may occur as a result of chronic HIV infection, long-term use of combined antiretroviral treatment (CART), aging, genetic predisposition, or a combination of these factors, and may increase morbidity and mortality in this population. Objective: To determine if changes in soluble and cell-associated insulin receptor (IR) levels, IR substrate-1 (IRS-1) levels, and IRS-1 tyrosine phosphorylation are associated with the presence and severity of HAND in a cohort of HIV-seropositive women. Methods and Results: This is a retrospective cross-sectional study using patient database information and stored samples from 34 HIV-seropositive women and 10 controls without history of diabetes from the Hispanic-Latino Longitudinal Cohort of Women. Soluble IR subunits [sIR, ectodomain (a) and full-length or intact (ab)] were assayed in plasma and CSF samples by ELISA. Membrane IR levels, IRS-1 levels, and IRS-1 tyrosine phosphorylation were analyzed in CSF white cell pellets (WCP) using flow cytometry. HIV-seropositive women had significantly increased levels of intact or full-length sIR in plasma (p<0.001) and CSF (p<0.005) relative to controls. Stratified by HAND, increased levels of full-length sIR in plasma were associated with the presence (p<0.001) and severity (p<0.005) of HAND. A significant decrease in IRS-1 tyrosine-phosphorylation in the WCP was also associated with the presence (p<0.02) and severity (p<0.02) of HAND. Conclusions: This study provides evidence that IR secretion is increased in HIV-seropositive women, and increased IR secretion is associated with cognitive impairment in these women. Thus, IR dysfunction may have a role in the progression of HAND and could represent a biomarker for the presence and severity of HAND.	[Gerena, Yamil; Velez, Joyce M.; Toro-Nieves, Dianedis; Mayo, Raul; Wojna, Valerie] Univ Puerto Rico, NeuroAIDS Specialized Neurosci Res Program, San Juan, PR 00936 USA; [Gerena, Yamil] Univ Puerto Rico, Sch Pharm, San Juan, PR 00936 USA; [Skolasky, Richard L.] Johns Hopkins Univ, Dept Orthopaed Surg, Baltimore, MD USA; [Mayo, Raul] Univ Puerto Rico, Dept Phys Med, San Juan, PR 00936 USA; [Mayo, Raul] Univ Puerto Rico, Dept Rehabil, San Juan, PR 00936 USA; [Nath, Avindra] Natl Inst Neurol Disorders & Stroke, Sect Infect Nervous Syst, NIH, Bethesda, MD USA; [Wojna, Valerie] Univ Puerto Rico, Internal Med Neurol Div, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Johns Hopkins University; University of Puerto Rico; University of Puerto Rico; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Puerto Rico	Gerena, Y (corresponding author), Univ Puerto Rico, NeuroAIDS Specialized Neurosci Res Program, San Juan, PR 00936 USA.	valerie.wojna1@upr.edu		Gerena, Yamil/0000-0002-5324-109X; Wojna, Valerie/0000-0002-4014-9921; Skolasky, Richard/0000-0002-2598-4427	National Institutes of Health (NIH) [1R21MH095524-01, 5S11NS046278-07, 5U54NS043011-11, 1U54RR026139-01A1, 5G12RR003051-25]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026139, G12RR003051, P20RR011126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH080661, R21MH095524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003130, S11NS046278, U54NS043011] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by the National Institutes of Health (NIH) grants: 1R21MH095524-01, 5S11NS046278-07, 5U54NS043011-11, 1U54RR026139-01A1, and 5G12RR003051-25. Its contents are solely the responsibility of authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ances BM, 2009, NEUROLOGY, V73, P702, DOI 10.1212/WNL.0b013e3181b59a97; [Anonymous], 2006, AIDS READ; [Anonymous], 2006, AIDS READ; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bateman JM, 2006, CELL MOL LIFE SCI, V63, P1701, DOI 10.1007/s00018-006-6036-4; BERNAL G, 1995, REV LAT AM PSICOL, V27, P207; Bonilla J, 2004, J CLIN PSYCHOL, V60, P119, DOI 10.1002/jclp.10195; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7; Clifford DB, 2009, NEUROLOGY, V73, P1982, DOI 10.1212/WNL.0b013e3181c5b445; Cohen RA, 2010, NEUROLOGY, V75, P2052, DOI 10.1212/WNL.0b013e318200d833; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; Danoff A, 2005, JAIDS-J ACQ IMM DEF, V39, P55, DOI 10.1097/01.qai.0000147659.80642.5a; DAVIS TM, 1979, J CONSULT CLIN PSYCH, V47, P181, DOI 10.1037/0022-006X.47.1.181; Demsky YI, 1998, ASSESSMENT, V5, P25, DOI 10.1177/107319119800500105; Dube MP, 2000, CLIN INFECT DIS, V31, P1467, DOI 10.1086/317491; Ellis Ronald J, 2007, PLoS Clin Trials, V2, pe15, DOI 10.1371/journal.pctr.0020015; Genuth S, 2007, NEW ENGL J MED, V356, P1842; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Howard AA, 2005, CLIN INFECT DIS, V40, P1492, DOI 10.1086/429824; Huang Chiung-Chun, 2010, Chang Gung Med J, V33, P115; JANSSEN RS, 1991, NEUROLOGY, V41, P778; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Lee J, 2004, J PHARM PRACT, V17, P80; Letendre Scott L, 2010, Top HIV Med, V18, P45; Levine SJ, 2004, J IMMUNOL, V173, P5343, DOI 10.4049/jimmunol.173.9.5343; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Liner Kevin J 2nd, 2010, Curr HIV/AIDS Rep, V7, P85, DOI 10.1007/s11904-010-0042-8; Lo YC, 2009, HIV MED, V10, P302, DOI 10.1111/j.1468-1293.2008.00687.x; Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87; Maschke M, 2000, J NEUROL NEUROSUR PS, V69, P376, DOI 10.1136/jnnp.69.3.376; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; McArthur JC, 1999, SEMIN NEUROL, V19, P129, DOI 10.1055/s-2008-1040831; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; McArthur JC, 2010, AIDS, V24, P1367, DOI 10.1097/QAD.0b013e3283391d56; McGuire D, 2009, NEUROLOGY, V73, P1942, DOI 10.1212/WNL.0b013e3181c51a92; Nachega Jean B, 2009, Curr HIV/AIDS Rep, V6, P121, DOI 10.1007/s11904-009-0017-9; Nath A, 2006, CURR OPIN NEUROL, V19, P358, DOI 10.1097/01.wco.0000236614.51592.ca; Obata T, 2007, DIABETES, V56, P2028, DOI 10.2337/db07-0394; Panza F, 2010, J ALZHEIMERS DIS, V21, P691, DOI 10.3233/JAD-2010-091669; Perry SW, 2005, NEUROTOX RES, V8, P161, DOI 10.1007/BF03033827; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Price RW, 2007, NEUROLOGY, V69, P1781, DOI 10.1212/01.wnl.0000278457.55877.eb; Price RW, 2010, J NEUROVIROL, V16, P68; Ragin AB, 2004, NEUROLOGY, V63, P2293, DOI 10.1212/01.WNL.0000147477.44791.BD; Ronnemaa E, 2008, NEUROLOGY, V71, P1065, DOI 10.1212/01.wnl.0000310646.32212.3a; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Sacktor N, 2002, J NEUROVIROL, V8, P136, DOI 10.1080/13550280290049615; Schifitto G, 2009, NEUROLOGY, V73, P1975, DOI 10.1212/WNL.0b013e3181c51a48; Schulingkamp RJ, 2000, NEUROSCI BIOBEHAV R, V24, P855, DOI 10.1016/S0149-7634(00)00040-3; Schutzer SE, 2004, J NEUROIMMUNOL, V157, P120, DOI 10.1016/j.jneuroim.2004.08.024; Selnes OA, 2005, AIDS READ, V15, P294; Selnes Ola A, 2005, AIDS Read, V15, P289; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Sesti G, 2006, BEST PRACT RES CL EN, V20, P665, DOI 10.1016/j.beem.2006.09.007; Shapshak P, 2010, AIDS, V24, P1; Sobieszczyk ME, 2008, JAIDS-J ACQ IMM DEF, V48, P272, DOI 10.1097/QAI.0b013e31817af461; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tebas P, 2008, JAIDS-J ACQ IMM DEF, V49, pS86, DOI 10.1097/QAI.0b013e31818651e6; Tien PC, 2007, AIDS, V21, P1739, DOI 10.1097/QAD.0b013e32827038d0; Valcour VG, 2005, JAIDS-J ACQ IMM DEF, V38, P31, DOI 10.1097/00126334-200501010-00006; Valcour VG, 2006, JAIDS-J ACQ IMM DEF, V43, P405, DOI 10.1097/01.qai.0000243119.67529.f5; Wang TG, 2006, CLIN SCI, V110, P393, DOI 10.1042/CS20050278; Wojna V, 2007, AIDS PATIENT CARE ST, V21, P930, DOI 10.1089/apc.2006.0180; Wojna V., 2006, AIDS READ, V16, P629; Wojna Valerie, 2006, AIDS Read, V16, P615; Wojna V, 2006, J NEUROVIROL, V12, P356, DOI 10.1080/13550280600964576; Yaffe K, 2004, NEUROLOGY, V63, P658, DOI 10.1212/01.WNL.0000134666.64593.BA; Young SE, 2006, DIABETES CARE, V29, P2688, DOI 10.2337/dc06-0915	70	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37358	10.1371/journal.pone.0037358	http://dx.doi.org/10.1371/journal.pone.0037358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629383	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300034
J	Konopka, KH; Harbers, M; Houghton, A; Kortekaas, R; van Vliet, A; Timmerman, W; den Boer, JA; Struys, MMRF; van Wijhe, M				Konopka, Karl-Heinz; Harbers, Marten; Houghton, Andrea; Kortekaas, Rudie; van Vliet, Andre; Timmerman, Wia; den Boer, Johan A.; Struys, Michel M. R. F.; van Wijhe, Marten			Bilateral Sensory Abnormalities in Patients with Unilateral Neuropathic Pain; A Quantitative Sensory Testing (QST) Study	PLOS ONE			English	Article							HYPERALGESIA; MECHANISMS; INJURY; ACTIVATION; PROTOCOL; NEURONS; IMMUNE; SPREAD; MODEL	In patients who experience unilateral chronic pain, abnormal sensory perception at the non-painful side has been reported. Contralateral sensory changes in these patients have been given little attention, possibly because they are regarded as clinically irrelevant. Still, bilateral sensory changes in these patients could become clinically relevant if they challenge the correct identification of their sensory dysfunction in terms of hyperalgesia and allodynia. Therefore, we have used the standardized quantitative sensory testing (QST) protocol of the German Research Network on Neuropathic Pain (DFNS) to investigate somatosensory function at the painful side and the corresponding non-painful side in unilateral neuropathic pain patients using gender-and age-matched healthy volunteers as a reference cohort. Sensory abnormalities were observed across all QST parameters at the painful side, but also, to a lesser extent, at the contralateral, non-painful side. Similar relative distributions regarding sensory loss/gain for non-nociceptive and nociceptive stimuli were found for both sides. Once a sensory abnormality for a QST parameter at the affected side was observed, the prevalence of an abnormality for the same parameter at the non-affected side was as high as 57% (for Pressure Pain Threshold). Our results show that bilateral sensory dysfunction in patients with unilateral neuropathic pain is more rule than exception. Therefore, this phenomenon should be taken into account for appropriate diagnostic evaluation in clinical practice. This is particularly true for mechanical stimuli where the 95% Confidence Interval for the prevalence of sensory abnormalities at the non-painful side ranges between 33% and 50%.	[Konopka, Karl-Heinz; Struys, Michel M. R. F.; van Wijhe, Marten] Univ Groningen, Pain Management Unit, Dept Anesthesiol, Univ Med Ctr Groningen, Groningen, Netherlands; [Harbers, Marten; den Boer, Johan A.] Univ Groningen, Dept Psychiat, Univ Med Ctr Groningen, Groningen, Netherlands; [Houghton, Andrea] Merck & Co Inc, West Point, NY USA; [Kortekaas, Rudie] Univ Groningen, Dept Neurosci, Neuroimaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands; [van Vliet, Andre; Timmerman, Wia] PRA Int, Zuidlaren, Netherlands	University of Groningen; University of Groningen; Merck & Company; University of Groningen	Konopka, KH (corresponding author), Univ Groningen, Pain Management Unit, Dept Anesthesiol, Univ Med Ctr Groningen, Groningen, Netherlands.	k.h.konopka@umcg.nl		Struys, Michel/0000-0003-0421-536X; van Wijhe, Marten/0000-0001-6873-4092	Dutch Top Institute Pharma [T5-108]	Dutch Top Institute Pharma	This study was performed within the framework of Dutch Top Institute Pharma project T5-108. Partners in this project include Merck. Co., Inc., PRA International and UMC Groningen. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON R, 1994, NEUROSCI LETT, V165, P97, DOI 10.1016/0304-3940(94)90718-8; Baron R, 2000, CLIN J PAIN, V16, pS12, DOI 10.1097/00002508-200006001-00004; Baumgartner U, 2002, PAIN, V96, P141, DOI 10.1016/S0304-3959(01)00438-9; Chacur M, 2001, PAIN, V94, P231, DOI 10.1016/S0304-3959(01)00354-2; Felix ER, 2009, J REHABIL RES DEV, V46, P69, DOI 10.1682/JRRD.2008.04.0058; Fernandez-de-las-Penas C, 2009, BRAIN, V132, P1472, DOI 10.1093/brain/awp050; Freynhagen R, 2008, PAIN, V135, P65, DOI 10.1016/j.pain.2007.05.004; Gao YJ, 2010, PAIN, V148, P309, DOI 10.1016/j.pain.2009.11.017; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; Gierthmuhlen J, 2011, PAIN; Haanpaa M, 2010, PAIN; Haanpaa ML, 2009, AM J MED, V122, pS13, DOI 10.1016/j.amjmed.2009.04.006; Hansson E, 2006, ACTA PHYSIOL, V187, P321, DOI 10.1111/j.1748-1716.2006.01568.x; Hansson P, 2007, PAIN, V129, P256, DOI 10.1016/j.pain.2007.03.030; Hubbard RD, 2008, EXP NEUROL, V212, P482, DOI 10.1016/j.expneurol.2008.04.042; Huge V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002742; de la Llave-Rincon AI, 2009, EXP BRAIN RES, V198, P455, DOI 10.1007/s00221-009-1941-z; Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2; Liu XG, 2000, PAIN, V84, P309, DOI 10.1016/S0304-3959(99)00211-0; Maier C, 2010, PAIN; Maleki J, 2000, PAIN, V88, P259, DOI 10.1016/S0304-3959(00)00332-8; Milligan ED, 2003, J NEUROSCI, V23, P1026; Moore DS, 2003, INTRO PRACTICE STAT, Vxxv; Oaklander AL, 1998, ANN NEUROL, V44, P789, DOI 10.1002/ana.410440513; Ochoa JL, 2005, MUSCLE NERVE, V32, P459, DOI 10.1002/mus.20367; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Scholz J, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000047; Serra J, 2009, PAIN, V147, P46, DOI 10.1016/j.pain.2009.07.028; Shenker NG, 2008, RHEUMATOLOGY, V47, P1417, DOI 10.1093/rheumatology/ken251; Shy ME, 2003, NEUROLOGY, V60, P898, DOI 10.1212/01.WNL.0000058546.16985.11; Treede RD, 2002, PAIN, V98, P235, DOI 10.1016/S0304-3959(02)00203-8; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Veldman PHJM, 1996, PAIN, V64, P463, DOI 10.1016/0304-3959(95)00160-3; Walk D, 2009, CLIN J PAIN, V25, P632, DOI 10.1097/AJP.0b013e3181a68c64; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Watkins LR, 2002, PHYSIOL REV, V82, P981, DOI 10.1152/physrev.00011.2002	38	49	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37524	10.1371/journal.pone.0037524	http://dx.doi.org/10.1371/journal.pone.0037524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629414	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300049
J	Kravchenko, J; Akushevich, I; Abernethy, AP; Lyerly, HK				Kravchenko, Julia; Akushevich, Igor; Abernethy, Amy P.; Lyerly, H. Kim			Evaluating the Number of Stages in Development of Squamous Cell and Adenocarcinomas across Cancer Sites Using Human Population-Based Cancer Modeling	PLOS ONE			English	Article							STOCHASTIC CARCINOGENESIS MODEL; LUNG-CANCER; COLORECTAL-CANCER; MULTISTAGE CARCINOGENESIS; CERVICAL-CANCER; CARCINOMA; AGE; MORTALITY; RADIATION; TRENDS	Background: Adenocarcinomas (ACs) and squamous cell carcinomas (SCCs) differ by clinical and molecular characteristics. We evaluated the characteristics of carcinogenesis by modeling the age patterns of incidence rates of ACs and SCCs of various organs to test whether these characteristics differed between cancer subtypes. Methodology/Principal Findings: Histotype-specific incidence rates of 14 ACs and 12 SCCs from the SEER Registry (19732003) were analyzed by fitting several biologically motivated models to observed age patterns. A frailty model with the Weibull baseline was applied to each age pattern to provide the best fit for the majority of cancers. For each cancer, model parameters describing the underlying mechanisms of carcinogenesis including the number of stages occurring during an individual's life and leading to cancer (m-stages) were estimated. For sensitivity analysis, the age-period-cohort model was incorporated into the carcinogenesis model to test the stability of the estimates. For the majority of studied cancers, the numbers of m-stages were similar within each group (i.e., AC and SCC). When cancers of the same organs were compared (i.e., lung, esophagus, and cervix uteri), the number of m-stages were more strongly associated with the AC/SCC subtype than with the organ: 9.79+/-0.09, 9.93+/-0.19 and 8.80+/-0.10 for lung, esophagus, and cervical ACs, compared to 11.41+/-0.10, 12.86+/-0.34 and 12.01+/-0.51 for SCCs of the respective organs (p<0.05 between subtypes). Most SCCs had more than ten m-stages while ACs had fewer than ten m-stages. The sensitivity analyses of the model parameters demonstrated the stability of the obtained estimates. Conclusions/Significance: A model containing parameters capable of representing the number of stages of cancer development occurring during individual's life was applied to the large population data on incidence of ACs and SCCs. The model revealed that the number of m-stages differed by cancer subtype being more strongly associated with ACs/SCCs histotype than with organ/site.	[Kravchenko, Julia; Abernethy, Amy P.; Lyerly, H. Kim] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27706 USA; [Akushevich, Igor] Duke Univ, Med Ctr, Ctr Populat Hlth & Aging, Durham, NC USA; [Abernethy, Amy P.] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27710 USA; [Lyerly, H. Kim] Duke Univ, Med Ctr, Dept Surg, Div Gen Surg, Durham, NC 27710 USA; [Lyerly, H. Kim] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Kravchenko, J (corresponding author), Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27706 USA.	julia.krauchanka@duke.edu	Lyerly, Herbert K/B-6528-2014; Lyerly, Herbert Kim/AAX-4925-2020	Lyerly, Herbert K/0000-0002-0063-4770; Lyerly, Herbert Kim/0000-0002-0063-4770; Abernethy, Amy/0000-0001-6930-8722				Akushevich I, 2012, MATH BIOSCI, V236, P16, DOI 10.1016/j.mbs.2011.12.002; Akushevich IV, 2010, HEALTH PHYS, V99, P322, DOI 10.1097/HP.0b013e3181c61dc1; Areses K, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.e21087; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; ARMITAGE P, 1957, BRIT J CANCER, V11, P161, DOI 10.1038/bjc.1957.22; BLOT WJ, 2006, CANC EPIDEMIOLOGY PR, P697, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0036; BOFFETTA P, 2002, TXB CANC EPIDEMIOLOG, P248; Bonafe M, 2001, CRIT REV ONCOL HEMAT, V39, P227, DOI 10.1016/S1040-8428(01)00168-8; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Calabrese P, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-126; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; COOK GB, 1966, CANCER, V19, P959, DOI 10.1002/1097-0142(196607)19:7<959::AID-CNCR2820190709>3.0.CO;2-R; COY P, 1981, CHEST, V80, P453, DOI 10.1378/chest.80.4.453; de Rijke JM, 2000, CANCER, V89, P1121, DOI 10.1002/1097-0142(20000901)89:5<1121::AID-CNCR22>3.3.CO;2-7; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Forman D, 2002, EUR J GASTROEN HEPAT, V14, P99, DOI 10.1097/00042737-200202000-00001; GAIL MH, 1984, CANCER, V54, P1802, DOI 10.1002/1097-0142(19841101)54:9<1802::AID-CNCR2820540908>3.0.CO;2-4; Green J, 2003, BRIT J CANCER, V89, P2078, DOI 10.1038/sj.bjc.6601296; Grotmol T, 2011, CANCER EPIDEM BIOMAR, V20, P1350, DOI 10.1158/1055-9965.EPI-10-1014; Hassan KA, 2009, CLIN CANCER RES, V15, P6386, DOI 10.1158/1078-0432.CCR-09-1105; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Hazelton WD, 2005, CANCER EPIDEM BIOMAR, V14, P1171, DOI 10.1158/1055-9965.EPI-04-0756; Henson DE, 2009, ARCH PATHOL LAB MED, V133, P67, DOI 10.1043/1543-2165-133.1.67; Janssen-Heijnen MLG, 2001, LUNG CANCER, V31, P123, DOI 10.1016/S0169-5002(00)00197-5; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Karayi MK, 2004, PROSTATE CANCER P D, V7, P6, DOI 10.1038/sj.pcan.4500697; Kawase A, 2012, JPN J CLIN ONCOL, V42, P189, DOI 10.1093/jjco/hyr188; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kondo M, 2002, HEPATO-GASTROENTEROL, V49, P1230; Kravchenko J, 2011, BREAST CANCER RES TR, V128, P483, DOI 10.1007/s10549-011-1347-z; Lagergren J, 1999, ANN INTERN MED, V130, P883, DOI 10.7326/0003-4819-130-11-199906010-00003; Lindstrom AK, 2009, ANTICANCER RES, V29, P2577; Little MP, 2003, MATH BIOSCI, V183, P111, DOI 10.1016/S0025-5564(03)00040-3; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Manton K, 2009, CANC MORTALITY MORBI; Manton KG, 2008, MATH POPUL STUD, V15, P137, DOI 10.1080/08898480802221665; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Miyaishi O, 2000, MECH AGEING DEV, V117, P47, DOI 10.1016/S0047-6374(00)00136-6; MOOLGAVKAR SH, 1981, J NATL CANCER I, V66, P1037, DOI 10.1093/jnci/66.6.1037; MOOLGAVKAR SH, 1988, TOXICOL LETT, V43, P139, DOI 10.1016/0378-4274(88)90025-2; Moolgavkar SH, 2009, CANCER CAUSE CONTROL, V20, P935, DOI 10.1007/s10552-009-9328-9; OKAMOTO T, 1989, JPN J CANCER RES, V80, P191; PETERSON P, 2007, J THORAC ONCOL S4, V2, pS851, DOI DOI 10.1097/01.JTO.0000284677.33344.62; PIANTANELLI L, 1988, ANN NY ACAD SCI, V521, P99, DOI 10.1111/j.1749-6632.1988.tb35268.x; Pierce DA, 1999, RADIAT RES, V152, P642, DOI 10.2307/3580260; Rieker RJ, 2008, PATHOL ONCOL RES, V14, P199, DOI 10.1007/s12253-008-9050-z; ROSENTHAL SA, 1990, CANCER TREAT REV, V17, P409, DOI 10.1016/0305-7372(90)90082-Q; SATO S, 1994, CANCER RES, V54, P5652; Schiffman M, 2006, CANC EPIDEMIOLOGY PR, P1044; Schollnberger H, 2006, CARCINOGENESIS, V27, P1432, DOI 10.1093/carcin/bgi345; Schottenfeld D, 2006, CANC EPIDEMIOLOGY PR; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Smith DWE, 1999, LONGEVITY PARADOXES, P61; Stanta G, 1997, CLIN GERIATR MED, V13, P55; Tan W. Y., 1991, STOCHASTIC MODELS CA; Terry J, 2010, AM J SURG PATHOL, V34, P1805, DOI 10.1097/PAS.0b013e3181f7dae3; Thune I, 1997, INT J CANCER, V70, P57; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Veremeyeva G. A., 2010, International Journal of Low Radiation, V7, P53, DOI 10.1504/IJLR.2010.032771; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yashin AI, 2009, MATH BIOSCI, V218, P88, DOI 10.1016/j.mbs.2008.12.007; Yoshida H, 2003, ONCOL REP, V10, P45	65	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37430	10.1371/journal.pone.0037430	http://dx.doi.org/10.1371/journal.pone.0037430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629394	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300040
J	Lee, S; Han, MJ; Lee, KS; Back, SC; Hwang, D; Kim, HY; Shin, JH; Suh, SP; Ryang, DW; Kim, HR; Shin, MG				Lee, Soong; Han, Moon-Jong; Lee, Ki-Sang; Back, Seung-Chul; Hwang, David; Kim, Hwan-Young; Shin, Jong-Hee; Suh, Soon-Pal; Ryang, Dong-Wook; Kim, Hye-Ran; Shin, Myung-Geun			Frequent Occurrence of Mitochondrial DNA Mutations in Barrett's Metaplasia without the Presence of Dysplasia	PLOS ONE			English	Article							ESOPHAGEAL ADENOCARCINOMA; ATRIAL-FIBRILLATION; CANCER; PROGRESSION; TISSUE; MUSCLE	Background: Barrett's esophagus (BE) is one of the most common premalignant lesions and can progress to esophageal adenocarcinoma (EA). The numerous molecular events may play a role in the neoplastic transformation of Barrett's mucosa such as the change of DNA ploidy, p53 mutation and alteration of adhesion molecules. However, the molecular mechanism of the progression of BE to EA remains unclear and most studies of mitochondrial DNA (mtDNA) mutations in BE have performed on BE with the presence of dysplasia. Methods/Findings: Thus, the current study is to investigate new molecular events (Barrett's esophageal tissue-specific-mtDNA alterations/instabilities) in mitochondrial genome and causative factors for their alterations using the corresponding adjacent normal mucosal tissue (NT) and tissue (BT) from 34 patients having Barrett's metaplasia without the presence of dysplasia. Eighteen patients (53%) exhibited mtDNA mutations which were not found in adjacent NT. mtDNA copy number was about 3 times higher in BT than in adjacent NT. The activity of the mitochondrial respiratory chain enzyme complexes in tissues from Barrett's metaplasia without the presence of dysplasia was impaired. Reactive oxygen species (ROS) level in BT was significantly higher than those in corresponding samples. Conclusion/Significance: High ROS level in BT may contribute to the development of mtDNA mutations, which may play a crucial role in disease progression and tumorigenesis in BE.	[Lee, Soong; Han, Moon-Jong; Lee, Ki-Sang; Back, Seung-Chul; Hwang, David] Seonam Univ, Coll Med, Dept Internal Med, Namwon, South Korea; [Kim, Hwan-Young; Shin, Jong-Hee; Suh, Soon-Pal; Ryang, Dong-Wook; Shin, Myung-Geun] Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea; [Kim, Hwan-Young; Shin, Jong-Hee; Suh, Soon-Pal; Ryang, Dong-Wook; Shin, Myung-Geun] Chonnam Natl Univ, Dept Lab Med, Hwasun, South Korea; [Kim, Hye-Ran] Chonnam Natl Univ, Ctr Biomed Human Resources, Brain Korea Project 21, Kwangju, South Korea; [Kim, Hye-Ran; Shin, Myung-Geun] Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea; [Kim, Hye-Ran; Shin, Myung-Geun] Chonnam Natl Univ, Sch Med, Environm Hlth Ctr Childhood Leukemia & Canc, Hwasun, South Korea	Seonam University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University	Lee, S (corresponding author), Seonam Univ, Coll Med, Dept Internal Med, Namwon, South Korea.	KimHR@chonnam.ac.kr; mgshin@chonnam.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0024326]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2010-0024326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann S, 2006, INT J CANCER, V119, P264, DOI 10.1002/ijc.21848; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Flejou JF, 2005, GUT, V54, pI6, DOI 10.1136/gut.2004.041525; HAGGITT RC, 1994, HUM PATHOL, V25, P982, DOI 10.1016/0046-8177(94)90057-4; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jankowski JA, 2002, GASTROENTEROLOGY, V122, P588, DOI 10.1053/gast.2002.31599; Lee JS, 2001, MUTAT RES-FUND MOL M, V480, P189, DOI 10.1016/S0027-5107(01)00199-3; Lee S, 2007, CLIN CHEM, V53, P1390, DOI 10.1373/clinchem.2007.088047; Lin PH, 2003, FREE RADICAL BIO MED, V35, P1310, DOI 10.1016/j.freeradbiomed.2003.07.002; Nishikawa M, 2005, BRIT J CANCER, V93, P331, DOI 10.1038/sj.bjc.6602664; Park HW, 2007, J CLIN PATHOL, V60, P948, DOI 10.1136/jcp.2007.047134; Park SY, 2009, MITOCHONDRION, V9, P318, DOI 10.1016/j.mito.2009.04.006; PERA M, 1993, ANN THORAC SURG, V56, P1191, DOI 10.1016/0003-4975(95)90050-0; Sharma P, 2006, ENDOSCOPY, V38, P1206, DOI 10.1055/s-2006-944974; Shin MG, 2007, LEUKEMIA, V21, P369, DOI 10.1038/sj.leu.2404502; Shin MG, 2006, ELECTROPHORESIS, V27, P1331, DOI 10.1002/elps.200500551; Shin MG, 2004, BLOOD, V103, P553, DOI 10.1182/blood-2003-05-1724; Sommerer F, 2004, ONCOGENE, V23, P554, DOI 10.1038/sj.onc.1207189; Sui GP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-73; Tan BHL, 2009, EUR J CANCER, V45, P736, DOI 10.1016/j.ejca.2009.01.013; Tischoff Iris, 2008, Expert Rev Gastroenterol Hepatol, V2, P653, DOI 10.1586/17474124.2.5.653; Zagorowicz E, 2007, POSTGRAD MED J, V83, P529, DOI 10.1136/pgmj.2006.052910	23	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37571	10.1371/journal.pone.0037571	http://dx.doi.org/10.1371/journal.pone.0037571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629421	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345300053
J	Santos, MD; Mohammadi, MH; Yang, SG; Liang, CW; Kao, JPY; Alger, BE; Thompson, SM; Tang, CM				Santos, Mariton D.; Mohammadi, Michael H.; Yang, Sunggu; Liang, Conrad W.; Kao, Joseph P. Y.; Alger, Bradley E.; Thompson, Scott M.; Tang, Cha-Min			Dendritic Hold and Read: A Gated Mechanism for Short Term Information Storage and Retrieval	PLOS ONE			English	Article							MEMORY	Two contrasting theories have been proposed to explain the mechanistic basis of short term memory. One theory posits that short term memory is represented by persistent neural activity supported by reverberating feedback networks. An alternate, more recent theory posits that short term memory can be supported by feedforward networks. While feedback driven memory can be implemented by well described mechanisms of synaptic plasticity, little is known of possible molecular and cellular mechanisms that can implement feedforward driven memory. Here we report such a mechanism in which the memory trace exists in the form of glutamate-bound but Mg2+-blocked NMDA receptors on the thin terminal dendrites of CA1 pyramidal neurons. Because glutamate dissociates from subsets of NMDA receptors very slowly, excitatory synaptic transmission can leave a silent residual trace that outlasts the electrical activity by hundreds of milliseconds. Read-out of the memory trace is possible if a critical level of these bound-but-blocked receptors accumulates on a dendritic branch that will allow these quasi-stable receptors to sustain a regenerative depolarization when triggered by an independent gating signal. This process is referred to here as dendritic hold and read (DHR). Because the read-out of the input is not dependent on repetition of the input and information flows in a single-pass manner, DHR can potentially support a feedforward memory architecture.	[Santos, Mariton D.; Mohammadi, Michael H.; Yang, Sunggu; Liang, Conrad W.; Tang, Cha-Min] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Kao, Joseph P. Y.; Alger, Bradley E.; Thompson, Scott M.; Tang, Cha-Min] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Tang, Cha-Min] Baltimore Vet Adm Med Ctr, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Santos, MD (corresponding author), Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA.	ctang@som.umaryland.edu	Thompson, Scott M/K-8921-2015	Yang, Sunggu/0000-0002-7567-9949; Kao, Joseph/0000-0002-8875-2180	VA Merit Review; National Institutes of Health RO1; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065488] Funding Source: NIH RePORTER	VA Merit Review(US Department of Veterans Affairs); National Institutes of Health RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by VA Merit Review (CMT) and National Institutes of Health RO1 (JPYK, SMT, BEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	antos MD, 2009, SOC NEUR ABST, V718, P11; BEKKERS JM, 1990, COLD SH Q B, V55, P131; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hasselmo ME, 2005, NEURAL NETWORKS, V18, P1172, DOI 10.1016/j.neunet.2005.08.007; Liang CW, 2011, JOVE-J VIS EXP, DOI 10.3791/2003; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Polsky A, 2009, J NEUROSCI, V29, P11891, DOI 10.1523/JNEUROSCI.5250-08.2009; Santos MD, 2007, SOC NEUR ABST, V251; Santos MD, 2008, SOC NEUR ABST, V44; TANG CM, 2006, CURRENT PROTOCOLS NE; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; White OL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.148102; Yang SG, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046002; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	20	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37542	10.1371/journal.pone.0037542	http://dx.doi.org/10.1371/journal.pone.0037542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629416	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300051
J	Weisse, S; Heddergott, N; Heydt, M; Pflasterer, D; Maier, T; Haraszti, T; Grunze, M; Engstler, M; Rosenhahn, A				Weisse, Sebastian; Heddergott, Niko; Heydt, Matthias; Pflaesterer, Daniel; Maier, Timo; Haraszti, Tamas; Grunze, Michael; Engstler, Markus; Rosenhahn, Axel			A Quantitative 3D Motility Analysis of Trypanosoma brucei by Use of Digital In-line Holographic Microscopy	PLOS ONE			English	Article							AFRICAN TRYPANOSOMES; ACTIN CORTEX; FLAGELLUM; TRACKING; SURFACE; MODELS	We present a quantitative 3D analysis of the motility of the blood parasite Trypanosoma brucei. Digital in-line holographic microscopy has been used to track single cells with high temporal and spatial accuracy to obtain quantitative data on their behavior. Comparing bloodstream form and insect form trypanosomes as well as mutant and wildtype cells under varying external conditions we were able to derive a general two-state-run-and-tumble-model for trypanosome motility. Differences in the motility of distinct strains indicate that adaption of the trypanosomes to their natural environments involves a change in their mode of swimming.	[Weisse, Sebastian; Heydt, Matthias; Pflaesterer, Daniel; Maier, Timo; Haraszti, Tamas; Grunze, Michael; Rosenhahn, Axel] Univ Heidelberg, Heidelberg, Germany; [Weisse, Sebastian; Grunze, Michael; Rosenhahn, Axel] Karlsruhe Inst Technol, Inst Funct Interfaces, IFG, Karlsruhe, Germany; [Heddergott, Niko; Engstler, Markus] Univ Wurzburg, Dept Cell & Dev Biol, Bioctr, Wurzburg, Germany; [Maier, Timo; Haraszti, Tamas] Max Planck Inst Intelligent Syst, Stuttgart, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; University of Wurzburg; Max Planck Society	Weisse, S (corresponding author), Univ Heidelberg, Heidelberg, Germany.	axel.rosenhahn@urz.uni-heidelberg.de	Grunze, Michael H/H-1600-2013; Grunze, Michael/O-2912-2019; Rosenhahn, Axel/F-7319-2011; Pflästerer, Daniel/AAE-5052-2019	Rosenhahn, Axel/0000-0001-9393-7190; Haraszti, Tamas/0000-0002-7095-4358	"Optische Messtechniken fur die Charakterisierung von Transportprozessen an Grenzflachen" of the DFG [Graduiertenkolleg 1114]; Deutsche Forschungsgemeinschaft (DFG) [RO 2524/2-1]; Office of Naval Research [N00014-08-1-1116]; Helmholtz-programme Biointerfaces	"Optische Messtechniken fur die Charakterisierung von Transportprozessen an Grenzflachen" of the DFG; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Office of Naval Research(Office of Naval Research); Helmholtz-programme Biointerfaces	This work was funded by the Graduiertenkolleg 1114 "Optische Messtechniken fur die Charakterisierung von Transportprozessen an Grenzflachen" of the DFG. The authors acknowledge support by the Deutsche Forschungsgemeinschaft (DFG grant RO 2524/2-1), the Office of Naval Research (grant number N00014-08-1-1116), and the Helmholtz-programme Biointerfaces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron DM, 2007, J CELL SCI, V120, P1513, DOI 10.1242/jcs.004846; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; CROSS GAM, 1975, PARASITOLOGY, V71, P311, DOI 10.1017/S0031182000046758; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; Garcia-Sucerquia J, 2006, APPL OPTICS, V45, P836, DOI 10.1364/AO.45.000836; Haraszti T, 2009, CHEMPHYSCHEM, V10, P2777, DOI 10.1002/cphc.200900581; Haraszti Tamas, 2009, Biophysical Reviews and Letters, V4, P17, DOI 10.1142/S1793048009001009; Heydt M, 2007, J ADHESION, V83, P417, DOI 10.1080/00218460701377388; Heydt M, 2009, EUR PHYS J E, V30, P141, DOI 10.1140/epje/i2009-10459-9; Hill KL, 2010, CURR OPIN MICROBIOL, V13, P459, DOI 10.1016/j.mib.2010.05.015; Hill KL, 2003, EUKARYOT CELL, V2, P200, DOI 10.1128/EC.2.2.200-208.2003; Kreuzer HJ, 2001, J PHYS-CONDENS MAT, V13, P10729, DOI 10.1088/0953-8984/13/47/313; Kreuzer HJ, 2003, DIGITAL IN LINE HOLO, P299; Leal Taixe L, 2009, IEEE WORKSH MOT VID; Leal Taixe L, 2010, LNCS, V6376, P283; Legros D, 2002, LANCET INFECT DIS, V2, P437, DOI 10.1016/S1473-3099(02)00321-3; Lewis NI, 2006, PHYCOLOGIA, V45, P61, DOI 10.2216/04-59.1; Ralston KS, 2008, INT J PARASITOL, V38, P869, DOI 10.1016/j.ijpara.2008.03.003; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Rappaz B, 2005, OPT EXPRESS, V13, P9361, DOI 10.1364/OPEX.13.009361; Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106; Sheng J, 2007, P NATL ACAD SCI USA, V104, P17512, DOI 10.1073/pnas.0704658104; Sheng J, 2010, P NATL ACAD SCI USA, V107, P2082, DOI 10.1073/pnas.0912254107; Uppaluri S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002058; Wirtz E, 1998, NUCLEIC ACIDS RES, V26, P4626, DOI 10.1093/nar/26.20.4626; Xu W, 2003, OPT LETT, V28, P164, DOI 10.1364/OL.28.000164	33	27	27	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37296	10.1371/journal.pone.0037296	http://dx.doi.org/10.1371/journal.pone.0037296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629379	Green Published, gold			2022-12-25	WOS:000305345300032
J	Choi, J; Shin, D; Kim, M; Park, J; Lim, S; Ryu, S				Choi, Jeongjoon; Shin, Dongwoo; Kim, Minjeong; Park, Joowon; Lim, Sangyong; Ryu, Sangryeol			LsrR-Mediated Quorum Sensing Controls Invasiveness of Salmonella typhimurium by Regulating SPI-1 and Flagella Genes	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ENTEROHEMORRHAGIC ESCHERICHIA-COLI; CELL-CELL COMMUNICATION; III SECRETION SYSTEM; SPECIALIZED TRANSDUCTION; TETRACYCLINE RESISTANCE; PATHOGENICITY ISLAND-1; STREPTOCOCCUS-PYOGENES; SENSOR KINASE; LUXS GENE	Bacterial cell-to-cell communication, termed quorum sensing (QS), controls bacterial behavior by using various signal molecules. Despite the fact that the LuxS/autoinducer-2 (AI-2) QS system is necessary for normal expression of Salmonella pathogenicity island-1 (SPI-1), the mechanism remains unknown. Here, we report that the LsrR protein, a transcriptional regulator known to be involved in LuxS/AI-2-mediated QS, is also associated with the regulation of SPI-1-mediated Salmonella virulence. We determined that LsrR negatively controls SPI-1 and flagella gene expressions. As phosphorylated AI-2 binds to and inactivates LsrR, LsrR remains active and decreases expression of SPI-1 and flagella genes in the luxS mutant. The reduced expression of those genes resulted in impaired invasion of Salmonella into epithelial cells. Expression of SPI-1 and flagella genes was also reduced by overexpression of the LsrR regulator from a plasmid, but was relieved by exogenous AI-2, which binds to and inactivates LsrR. These results imply that LsrR plays an important role in selecting infectious niche of Salmonella in QS dependent mode.	[Choi, Jeongjoon; Park, Joowon; Ryu, Sangryeol] Seoul Natl Univ, Dept Food & Anim Biotechnol, Dept Agr Biotechnol, Ctr Agr Biomat, Seoul, South Korea; [Choi, Jeongjoon; Park, Joowon; Ryu, Sangryeol] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Shin, Dongwoo] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Samsung Biomed Res Inst, Suwon, South Korea; [Kim, Minjeong; Lim, Sangyong] Korea Atom Energy Res Inst, Radiat Res Div Biotechnol, Jeongeup, South Korea	Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Korea Atomic Energy Research Institute (KAERI)	Choi, J (corresponding author), Seoul Natl Univ, Dept Food & Anim Biotechnol, Dept Agr Biotechnol, Ctr Agr Biomat, Seoul, South Korea.	sangryu@snu.ac.kr	Choi, Jeongjoon/AAL-5387-2021	Choi, Jeongjoon/0000-0002-4137-6923	WCU (World Class University) program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [R32-2008-000-10183-0]; Ministry of Education, Science and Technology through the Brain Korea 21 Project	WCU (World Class University) program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science and Technology through the Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by WCU (World Class University) program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (R32-2008-000-10183-0). JP was the recipient of a graduate fellowship provided by the Ministry of Education, Science and Technology through the Brain Korea 21 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearson BL, 2008, MICROB PATHOGENESIS, V44, P271, DOI 10.1016/j.micpath.2007.10.001; Burgess NA, 2002, MICROBIOL-SGM, V148, P763, DOI 10.1099/00221287-148-3-763; CHAN RK, 1972, VIROLOGY, V50, P883, DOI 10.1016/0042-6822(72)90442-4; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Choi J, 2007, INFECT IMMUN, V75, P4885, DOI 10.1128/IAI.01942-06; Choi J, 2010, P NATL ACAD SCI USA, V107, P20506, DOI 10.1073/pnas.1000759107; Choi J, 2010, VACCINE, V28, P6436, DOI 10.1016/j.vaccine.2010.07.048; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Clarke MB, 2005, MOL MICROBIOL, V57, P1734, DOI 10.1111/j.1365-2958.2005.04792.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Dunny GM, 1997, ANNU REV MICROBIOL, V51, P527, DOI 10.1146/annurev.micro.51.1.527; Eichelberg K, 2000, INFECT IMMUN, V68, P2735, DOI 10.1128/IAI.68.5.2735-2743.2000; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; GALAN JE, 1990, INFECT IMMUN, V58, P1879; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Husseiny MI, 2005, VACCINE, V23, P2580, DOI 10.1016/j.vaccine.2004.11.035; Li J, 2007, J BACTERIOL, V189, P6011, DOI 10.1128/JB.00014-07; Lim S, 2007, NUCLEIC ACIDS RES, V35, P1822, DOI 10.1093/nar/gkm060; Lostroh CP, 2001, MICROBES INFECT, V3, P1281; Lucas RL, 2000, MOL MICROBIOL, V36, P1024, DOI 10.1046/j.1365-2958.2000.01961.x; Lyon WR, 2001, MOL MICROBIOL, V42, P145, DOI 10.1046/j.1365-2958.2001.02616.x; Marouni MJ, 2003, INFECT IMMUN, V71, P5633, DOI 10.1128/IAI.71.10.5633-5639.2003; Meijler MM, 2004, ANGEW CHEM INT EDIT, V43, P2106, DOI 10.1002/anie.200353150; Miller J.H., 1972, EXPT MOL GENETICS; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Perego M, 1996, P NATL ACAD SCI USA, V93, P1549, DOI 10.1073/pnas.93.4.1549; Perrett CA, 2009, J BACTERIOL, V191, P7253, DOI 10.1128/JB.00727-09; Rezzonico F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-154; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Sperandio V, 2001, J BACTERIOL, V183, P5187, DOI 10.1128/JB.183.17.5187-5197.2001; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Taga ME, 2003, MOL MICROBIOL, V50, P1411, DOI 10.1046/j.1365-2958.2003.03781.x; Thijs IM, 2010, CELL RES, V20, P966, DOI 10.1038/cr.2010.104; VanEngelenburg SB, 2008, CHEM BIOL, V15, P619, DOI 10.1016/j.chembiol.2008.04.014; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; WATANABE T, 1972, VIROLOGY, V50, P874, DOI 10.1016/0042-6822(72)90441-2; Winzer K, 2002, INFECT IMMUN, V70, P2245, DOI 10.1128/IAI.70.4.2245-2248.2002; Xavier KB, 2007, ACS CHEM BIOL, V2, P128, DOI 10.1021/cb600444h; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Xue T, 2009, CELL RES, V19, P1258, DOI 10.1038/cr.2009.91; Yoon H, 2003, FEMS MICROBIOL LETT, V226, P391, DOI 10.1016/S0378-1097(03)00641-4	45	37	41	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37059	10.1371/journal.pone.0037059	http://dx.doi.org/10.1371/journal.pone.0037059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623980	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343500057
J	Ibanez, A; Cetkovich, M; Petroni, A; Urquina, H; Baez, S; Gonzalez-Gadea, ML; Kamienkowski, JE; Torralva, T; Torrente, F; Strejilevich, S; Teitelbaum, J; Hurtado, E; Guex, R; Melloni, M; Lischinsky, A; Sigman, M; Manes, F				Ibanez, Agustin; Cetkovich, Marcelo; Petroni, Agustin; Urquina, Hugo; Baez, Sandra; Luz Gonzalez-Gadea, Maria; Esteban Kamienkowski, Juan; Torralva, Teresa; Torrente, Fernando; Strejilevich, Sergio; Teitelbaum, Julia; Hurtado, Esteban; Guex, Raphael; Melloni, Margherita; Lischinsky, Alicia; Sigman, Mariano; Manes, Facundo			The Neural Basis of Decision-Making and Reward Processing in Adults with Euthymic Bipolar Disorder or Attention-Deficit/Hyperactivity Disorder (ADHD)	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; MEDIAL FRONTAL-CORTEX; SUSTAINED ATTENTION; CINGULATE CORTEX; VALIDITY; BRAIN; NEUROECONOMICS; IMPULSIVITY; PERFORMANCE; IMPAIRMENT	Background: Attention-deficit/hyperactivity disorder (ADHD) and bipolar disorder (BD) share DSM-IV criteria in adults and cause problems in decision-making. Nevertheless, no previous report has assessed a decision-making task that includes the examination of the neural correlates of reward and gambling in adults with ADHD and those with BD. Methodology/Principal Findings: We used the Iowa gambling task (IGT), a task of rational decision-making under risk (RDMUR) and a rapid-decision gambling task (RDGT) which elicits behavioral measures as well as event-related potentials (ERPs: fERN and P3) in connection to the motivational impact of events. We did not observe between-group differences for decision-making under risk or ambiguity (RDMUR and IGT); however, there were significant differences for the ERP-assessed RDGT. Compared to controls, the ADHD group showed a pattern of impaired learning by feedback (fERN) and insensitivity to reward magnitude (P3). This ERP pattern (fERN and P3) was associated with impulsivity, hyperactivity, executive function and working memory. Compared to controls, the BD group showed fERN- and P3-enhanced responses to reward magnitude regardless of valence. This ERP pattern (fERN and P3) was associated with mood and inhibitory control. Consistent with the ERP findings, an analysis of source location revealed reduced responses of the cingulate cortex to the valence and magnitude of rewards in patients with ADHD and BD. Conclusions/Significance: Our data suggest that neurophysiological (ERPs) paradigms such as the RDGT are well suited to assess subclinical decision-making processes in patients with ADHD and BD as well as for linking the cingulate cortex with action monitoring systems.	[Ibanez, Agustin; Cetkovich, Marcelo; Urquina, Hugo; Luz Gonzalez-Gadea, Maria; Torralva, Teresa; Torrente, Fernando; Strejilevich, Sergio; Teitelbaum, Julia; Melloni, Margherita; Lischinsky, Alicia; Manes, Facundo] Favaloro Univ, Lab Expt Psychol & Neurosci, Inst Cognit Neurol, Buenos Aires, DF, Argentina; [Ibanez, Agustin; Cetkovich, Marcelo; Urquina, Hugo; Baez, Sandra; Luz Gonzalez-Gadea, Maria; Torralva, Teresa; Torrente, Fernando; Strejilevich, Sergio; Teitelbaum, Julia; Melloni, Margherita; Lischinsky, Alicia; Manes, Facundo] Favaloro Univ, Inst Neurosci, Buenos Aires, DF, Argentina; [Ibanez, Agustin; Petroni, Agustin; Baez, Sandra; Luz Gonzalez-Gadea, Maria; Sigman, Mariano] Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [Ibanez, Agustin; Hurtado, Esteban] Univ Diego Portales, Lab Cognit & Social Neurosci, Santiago, Chile; [Petroni, Agustin; Esteban Kamienkowski, Juan; Sigman, Mariano] Univ Buenos Aires, Integrat Neurosci Lab, Dept Phys, Buenos Aires, DF, Argentina; [Hurtado, Esteban] Pontificia Univ Catolica Chile, Santiago, Chile; [Baez, Sandra] Pontificia Univ Catolica Argentina, Buenos Aires, DF, Argentina; [Urquina, Hugo] Univ Surcolombiana, Neiva, Colombia; [Guex, Raphael] Univ Geneva, Lab Behav Neurol & Imaging Cognit, Geneva, Switzerland	University Diego Portales; University of Buenos Aires; Pontificia Universidad Catolica de Chile; Pontifical Catholic University of Argentina; University of Geneva	Ibanez, A (corresponding author), Favaloro Univ, Lab Expt Psychol & Neurosci, Inst Cognit Neurol, Buenos Aires, DF, Argentina.	aibanez@neurologiacognitiva.org	Ibanez, Agustin/H-7976-2015; Torrente, Fernando/AAD-7885-2022	Ibanez, Agustin/0000-0001-6758-5101; Torrente, Fernando/0000-0001-7470-6979; Kamienkowski, Juan Esteban/0000-0002-5725-6539; Baez, Sandra/0000-0003-0875-1709; Petroni, Agustin/0000-0001-7352-6300; melloni, margherita/0000-0003-0931-8640; Strejilevich, Sergio Adrian/0000-0001-8410-7187	Consejo Nacional de Investigaciones Cientificas y Tecnicas; Foundation Instituto de Neurologia Cognitiva and Human Frontiers Program	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Foundation Instituto de Neurologia Cognitiva and Human Frontiers Program	This study was supported by grants Consejo Nacional de Investigaciones Cientificas y Tecnicas, Foundation Instituto de Neurologia Cognitiva and Human Frontiers Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillet S, 1999, IEEE T BIO-MED ENG, V46, P522, DOI 10.1109/10.759053; Barkley R, 1998, GUILFORD PRESS; BARRATT ES, 1969, J MED EDUC, V44, P604; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Beck A.T., 1996, MANUAL BECK DEPRESSI; Benedetti F, 2007, ARCH GEN PSYCHIAT, V64, P179, DOI 10.1001/archpsyc.64.2.179; Biederman J, 2008, PSYCHOL MED, V38, P1045, DOI 10.1017/S0033291707001791; Brand M, 2006, NEURAL NETWORKS, V19, P1266, DOI 10.1016/j.neunet.2006.03.001; Brooks JO, 2006, BIPOLAR DISORD, V8, P248, DOI 10.1111/j.1399-5618.2006.00310.x; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Chandler RA, 2009, BIOL PSYCHIAT, V66, P840, DOI 10.1016/j.biopsych.2009.05.011; Chang Kiki D, 2010, J Clin Psychiatry, V71, pe05, DOI 10.4088/JCP.8125tx7c; Christodouiou T, 2006, EUR PSYCHIAT, V21, P270, DOI 10.1016/j.eurpsy.2006.04.006; Clark L, 2004, NEUROCASE, V10, P398, DOI 10.1080/13554790490882799; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Clark L, 2002, BRIT J PSYCHIAT, V180, P313, DOI 10.1192/bjp.180.4.313; Crone EA, 2003, J CHILD PSYCHOL PSYC, V44, P214, DOI 10.1111/1469-7610.00115; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Ernst M, 2003, AM J PSYCHIAT, V160, P1061, DOI 10.1176/appi.ajp.160.6.1061; Fernandez-Duque D, 2007, JUDGM DECIS MAK, V2, P1; Fountoulakis KN, 2008, BRAIN RES REV, V59, P9, DOI 10.1016/j.brainresrev.2008.04.005; Fujiwara J, 2009, J NEUROPHYSIOL, V101, P3284, DOI 10.1152/jn.90909.2008; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gleichgerrcht E, 2011, SOC NEUROSCI-UK, V6, P113, DOI 10.1080/17470919.2010.506751; Gleichgerrcht E, 2010, NAT REV NEUROL, V6, P611, DOI 10.1038/nrneurol.2010.148; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Hayden BY, 2008, NEURON, V60, P19, DOI 10.1016/j.neuron.2008.09.012; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Jameson TL, 2004, PSYCHON B REV, V11, P515, DOI 10.3758/BF03196604; Jollant F, 2007, EUR PSYCHIAT, V22, P455, DOI 10.1016/j.eurpsy.2007.06.001; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kaladjian A, 2009, PSYCHIAT RES-NEUROIM, V173, P45, DOI 10.1016/j.pscychresns.2008.08.003; Klassen LJ, 2010, J AFFECT DISORDERS, V124, P1, DOI 10.1016/j.jad.2009.06.036; Krain AL, 2006, NEUROIMAGE, V32, P477, DOI 10.1016/j.neuroimage.2006.02.047; Lee D, 2008, NAT NEUROSCI, V11, P404, DOI 10.1038/nn2065; Li XR, 2010, HUM BRAIN MAPP, V31, P410, DOI 10.1002/hbm.20875; Luman M, 2010, BIOL PSYCHIAT, V68, P337, DOI 10.1016/j.biopsych.2009.12.037; Malloy-Diniz L, 2007, J INT NEUROPSYCH SOC, V13, P693, DOI 10.1017/S1355617707070889; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Manes FF, 2010, NAT REV NEUROL, V6, P347, DOI 10.1038/nrneurol.2010.34; Mantyla T, 2012, J ATTEN DISORD, V16, P164, DOI 10.1177/1087054709360494; Martino DJ, 2011, PSYCHOL MED, V41, P1319, DOI 10.1017/S0033291710001832; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Murphy FC, 1999, PSYCHOL MED, V29, P1307, DOI 10.1017/S0033291799001233; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Partington J, 1949, PSYCHOL CTR B, V1; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Rangel A, 2008, NEURON, V59, P525, DOI 10.1016/j.neuron.2008.08.003; Rey A, 1941, PSYCHOLOGIE, V8; Roiser J, 2009, PSYCHOL MED, V39, P785, DOI 10.1017/S0033291708004200; Rubinsztein JS, 2000, PSYCHOL MED, V30, P1025, DOI 10.1017/S0033291799002664; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; San Martin R, 2010, NEUROIMAGE, V51, P1194, DOI 10.1016/j.neuroimage.2010.03.031; Schecklmann M, 2008, J PSYCHIATR RES, V43, P98, DOI 10.1016/j.jpsychires.2008.02.005; SLOVIC P, 1966, CHILD DEV, V37, P169, DOI 10.1111/j.1467-8624.1966.tb05377.x; Spielberg C, 1970, MANUAL STAIT TRAIT A; Taylor CT, 2008, J ANXIETY DISORD, V22, P868, DOI 10.1016/j.janxdis.2007.09.001; Torralva T, 2007, NEUROPSYCHOLOGIA, V45, P342, DOI 10.1016/j.neuropsychologia.2006.05.031; Torralva T, 2011, PSYCHIAT RES, V186, P261, DOI 10.1016/j.psychres.2010.08.007; Torralva T, 2009, J INT NEUROPSYCH SOC, V15, P777, DOI 10.1017/S1355617709990415; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Volkow ND, 2004, AM J PSYCHIAT, V161, P1173, DOI 10.1176/appi.ajp.161.7.1173; Weber BJ, 2008, BRAIN RES, V1234, P104, DOI 10.1016/j.brainres.2008.07.105; Wechsler D., 1997, WECHSLER ADULT INTEL; Wilbertz G, 2012, NEUROIMAGE, V60, P353, DOI 10.1016/j.neuroimage.2011.12.011; Wingo AP, 2007, J CLIN PSYCHIAT, V68, P1776, DOI 10.4088/JCP.v68n1118; Yechiam E, 2008, PSYCHIAT RES, V161, P142, DOI 10.1016/j.psychres.2007.07.001; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	71	67	67	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37306	10.1371/journal.pone.0037306	http://dx.doi.org/10.1371/journal.pone.0037306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22624011	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500094
J	Lin, WC; Hsu, TW; Chen, CL; Wu, CWW; Lu, CH; Chen, HL; Li, SH; Yeh, PY; Cheng, YF; Lin, CP				Lin, Wei-Che; Hsu, Tun-Wei; Chen, Chao-Long; Wu, Changwei W.; Lu, Cheng-Hsien; Chen, Hsiu-Ling; Li, Shau-Hsuan; Yeh, Pin-Yang; Cheng, Yu-Fan; Lin, Ching-Po			Connectivity of Default-Mode Network Is Associated with Cerebral Edema in Hepatic Encephalopathy	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; CHRONIC LIVER-DISEASE; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; FMRI; FLUCTUATIONS; CONSCIOUSNESS; ABNORMALITIES; EXPRESSION; CIRRHOSIS	Cerebral edema, a well-known feature of acute liver disease, can occur in cirrhotic patients regardless of hepatic encephalopathy (HE) and adversely affect prognosis. This study characterized and correlated functional HE abnormalities in the brain to cerebral edema using resting-state functional magnetic resonance imaging (rs-fMRI) and diffusion tensor imaging (DTI). Forty-one cirrhotic patients (16 without HE, 14 minimal HE, 11 overt HE) and 32 healthy controls were assessed. The HE grade in cirrhotic patients was evaluated by the West Haven criteria and neuro-psychological examinations. Functional connectivity correlation coefficient (fc-CC) of the default mode network (DMN) was determined by rs-fMRI, while the corresponding mean diffusivity (MD) was obtained from DTI. Correlations among inter-cortical fc-CC, DTI indices, Cognitive Ability Screening Instrument scores, and laboratory tests were also analyzed. Results showed that gradual reductions of HE-related consciousness levels, from "without HE" or "minimal HE" to "overt HE", correlated with decreased anterior-posterior fc-CC in DMN [F(4.415), p = 0.000)]. The MD values from regions with anterior-posterior fc-CC differences in DMN revealed significant differences between the overt HE group and other groups. Increased MD in this network was inversely associated with decreased fc-CC in DMN and linearly correlated with poor cognitive performance. In conclusion, cerebral edema can be linked to altered cerebral temporal architecture that modifies both within- and between-network connectivity in HE. Reduced fc-CC in DMN is associated with behavior and consciousness deterioration. Through appropriate targets, rs-fMRI technology may provide relevant supplemental information for monitoring HE and serve as a new biomarker for clinical diagnosis.	[Lin, Wei-Che; Chen, Hsiu-Ling; Cheng, Yu-Fan] Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan; [Lin, Wei-Che; Chen, Chao-Long; Lu, Cheng-Hsien; Chen, Hsiu-Ling; Li, Shau-Hsuan; Cheng, Yu-Fan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lin, Wei-Che; Hsu, Tun-Wei; Chen, Hsiu-Ling; Lin, Ching-Po] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Hsu, Tun-Wei] Taipei Vet Gen Hosp, Dept Diagnost Radiol, Taipei, Taiwan; [Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Wu, Changwei W.] Natl Cent Univ, Inst Biomed Engn, Tao Yuan, Taiwan; [Lu, Cheng-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Li, Shau-Hsuan] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Yeh, Pin-Yang] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan 70101, Taiwan; [Yeh, Pin-Yang] Tsyr Huey Mental Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Lab Brain Connect, Taipei 112, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; National Central University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Cheng Kung University; National Yang Ming Chiao Tung University	Lin, WC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan.	cheng.yufan@msa.hinet.net; cplin@ym.edu.tw		Hess, Christopher/0000-0002-5132-5302; Wu, Changwei W./0000-0001-8968-9366; Hsu, Tun-Wei/0000-0002-4614-6449	National Health Research Institute [NHRI-EX100-9813EC]; National Science Council (NSC) [100-2628-E-010-002-MY3, NSC 97-2314-B-182A-104-MY3]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Health Research Institute (NHRI-EX100-9813EC) and National Science Council (NSC 100-2628-E-010-002-MY3 and NSC 97-2314-B-182A-104-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 1999, J NEUROL SCI, V170, P138, DOI 10.1016/S0022-510X(99)00169-0; Amodio P, 2004, METAB BRAIN DIS, V19, P253, DOI 10.1023/B:MEBR.0000043975.01841.de; ATTERBURY CE, 1978, AM J DIG DIS, V23, P398, DOI 10.1007/BF01072921; Bai YM, 2009, SCHIZOPHR RES, V109, P167, DOI 10.1016/j.schres.2009.02.003; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Das A, 2001, J GASTROEN HEPATOL, V16, P531, DOI 10.1046/j.1440-1746.2001.02487.x; Donovan JP, 1998, LANCET, V351, P719, DOI 10.1016/S0140-6736(97)07373-X; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; GUPTA RK, 1993, AM J GASTROENTEROL, V88, P670; Hagemann TL, 2005, HUM MOL GENET, V14, P2443, DOI 10.1093/hmg/ddi248; Haussinger D, 2000, J HEPATOL, V32, P1035, DOI 10.1016/S0168-8278(00)80110-5; Haussinger D., 2002, J GASTROEN HEPATOL, V17, P256; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Jones EA, 1997, J NEUROL NEUROSUR PS, V63, P279, DOI 10.1136/jnnp.63.3.279; Kale RA, 2006, HEPATOLOGY, V43, P698, DOI 10.1002/hep.21114; Lin WC, 2009, AM J NEURORADIOL, V30, P1248, DOI 10.3174/ajnr.A1517; Lin WC, 2012, AM J NEURORADIOL, V33, P239, DOI 10.3174/ajnr.A2769; Lockwood AH, 2002, METAB BRAIN DIS, V17, P29, DOI 10.1023/A:1014000313824; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu CH, 2011, AM J NEURORADIOL, V32, P1333, DOI 10.3174/ajnr.A2489; MCENTEE WJ, 1993, PSYCHOPHARMACOLOGY, V111, P391, DOI 10.1007/BF02253527; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Tanigami H, 2005, NEUROSCIENCE, V131, P437, DOI 10.1016/j.neuroscience.2004.10.045; Tapert SF, 2004, ADDICT BEHAV, V29, P33, DOI 10.1016/j.addbeh.2003.07.003; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Zhang L, 2011, HUM BRAIN MAPP, DOI [10.1002/hbm.21295, DOI 10.1002/HBM.21295]	41	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36986	10.1371/journal.pone.0036986	http://dx.doi.org/10.1371/journal.pone.0036986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623966	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500043
J	Wu, CC; Li, XB; Han, TS; Li, P; Wang, JG; Liu, GW; Wang, Z; Ge, CR; Gao, SZ				Wu, ChenChen; Li, XiaoBing; Han, TieSuo; Li, Peng; Wang, JianGuo; Liu, GuoWen; Wang, Zhe; Ge, ChangRong; Gao, ShiZheng			Dietary Pseudopurpurin Improves Bone Geometry Architecture and Metabolism in Red-Bone Guishan Goats	PLOS ONE			English	Article							OVARIECTOMIZED RATS; TRABECULAR BONE; ALIZARIN RED; STRENGTH; CALCIUM; INVITRO; MINERALIZATION; CALVARIA; MADDER	Red-colored bones were found initially in some Guishan goats in the 1980s, and they were designated red-boned goats. However, it is not understood what causes the red color in the bone, or whether the red material changes the bone geometry, architecture, and metabolism of red-boned goats. Pseudopurpurin was identified in the red-colored material of the bone in red-boned goats by high-performance liquid chromatography-electrospray ionization-mass spetrometry and nuclear magnetic resonance analysis. Pseudopurpurin is one of the main constituents of Rubia cordifolia L, which is eaten by the goats. The assessment of the mechanical properties and micro-computed tomography showed that the red-boned goats displayed an increase in the trabecular volume fraction, trabecular thickness, and the number of trabeculae in the distal femur. The mean thickness, inner perimeter, outer perimeter, and area of the femoral diaphysis were also increased. In addition, the trabecular separation and structure model index of the distal femur were decreased, but the bone mineral density of the whole femur and the mechanical properties of the femoral diaphysis were enhanced in the red-boned goats. Meanwhile, expression of alkaline phosphatase and osteocalcin mRNA was higher, and the ratio of the receptor activator of the nuclear factor kappa B ligand to osteoprotegerin was markedly lower in the bone marrow of the red-boned goats compared with common goats. To confirm further the effect of pseudopurpurin on bone geometry, architecture, and metabolism, Wistar rats were fed diets to which pseudopurpurin was added for 5 months. Similar changes were observed in the femurs of the treated rats. The above results demonstrate that pseudopurpurin has a close affinity with the mineral salts of bone, and consequently a high level of mineral salts in the bone cause an improvement in bone strength and an enhancement in the structure and metabolic functions of the bone.	[Wu, ChenChen; Li, XiaoBing; Han, TieSuo; Wang, JianGuo; Liu, GuoWen; Wang, Zhe] Jilin Univ, Coll Anim Sci & Vet Med, Jilin, Jilin, Peoples R China; [Li, Peng] Shenyang Agr Univ, Coll Anim Sci & Vet Med, Liaoning, Peoples R China; [Ge, ChangRong; Gao, ShiZheng] Yunnan Agr Univ, Coll Anim Food & Sci Technol, Yunnan, Peoples R China	Jilin University; Shenyang Agricultural University; Yunnan Agricultural University	Wu, CC (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Jilin, Jilin, Peoples R China.	liuguowen2008@163.com; wangzhe500518@sohu.com	Li, Xiaobing/B-1267-2019; LI, Xiaobing/AAB-8762-2019	Li, Xiaobing/0000-0001-9105-6365; 	National Nature Science Foundation of China; Foundation of Yunnan Province [U0836601]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Yunnan Province	This work was supported by National Nature Science Foundation of China and the Foundation of Yunnan Province (No. U0836601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YJ, 2010, CALCIFIED TISSUE INT, V87, P365, DOI 10.1007/s00223-010-9410-z; Bagi CM, 2006, BONE, V38, P136, DOI 10.1016/j.bone.2005.07.028; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; Bergh JJ, 2004, ENDOCRINOLOGY, V145, P426, DOI 10.1210/en.2003-0319; BRADBEER JN, 1992, J BONE MINER RES, V7, P905; Fratzl-Zelman N, 1998, BONE, V23, P511, DOI 10.1016/S8756-3282(98)00139-2; Han XL, 2009, BONE, V44, P942, DOI 10.1016/j.bone.2008.12.005; Hott M, 2003, BONE, V33, P115, DOI 10.1016/S8756-3282(03)00115-7; KELLER TS, 1994, J BIOMECH, V27, P1159, DOI 10.1016/0021-9290(94)90056-6; Kiel E. G., 1965, J SOC DYERS COLOUR, V81, P98, DOI [DOI 10.1111/J.1478-4408.1965.TB02647.X, 10.1111/j.1478-4408.1965.tb02647.x]; KIEL EG, 1963, J SOC DYERS COLOUR, V79, P61; Lancianese SL, 2008, BONE, V43, P1039, DOI 10.1016/j.bone.2008.07.247; Macklin CC, 1917, J MED RES, V4, P493; Muller R, 2004, J BONE MINER RES, V19, P1787, DOI 10.1359/JBMR.040809; NEFUSSI JR, 1985, DIFFERENTIATION, V29, P160, DOI 10.1111/j.1432-0436.1985.tb00310.x; Norton SA, 1998, J AM ACAD DERMATOL, V39, P484, DOI 10.1016/S0190-9622(98)70328-7; PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110; RICE JC, 1988, J BIOMECH, V21, P155, DOI 10.1016/0021-9290(88)90008-5; Richter D, 1937, BIOCHEM J, V31, P591, DOI 10.1042/bj0310591; Rico H, 2000, EUR J OBSTET GYN R B, V90, P97, DOI 10.1016/S0301-2115(99)00223-7; SALTMAN PD, 1993, J AM COLL NUTR, V12, P384, DOI 10.1080/07315724.1993.10718327; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Turner CH, 2001, J BONE MINER RES, V16, P1532, DOI 10.1359/jbmr.2001.16.8.1532; Ulrich D, 1999, BONE, V25, P55, DOI 10.1016/S8756-3282(99)00098-8; van der Meulen MCH, 2001, BONE, V29, P101, DOI 10.1016/S8756-3282(01)00491-4	25	4	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37469	10.1371/journal.pone.0037469	http://dx.doi.org/10.1371/journal.pone.0037469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624037	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343500122
J	Xu, XF; Yang, XD; Zhang, P; Chen, XY; Liu, HX; Li, ZZ				Xu, Xiaofeng; Yang, Xiangdong; Zhang, Ping; Chen, Xiuying; Liu, Huaxiang; Li, Zhenzhong			Effects of Exogenous Galanin on Neuropathic Pain State and Change of Galanin and Its Receptors in DRG and SDH after Sciatic Nerve-Pinch Injury in Rat	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; SPINAL-CORD; GROWTH-FACTOR; NEURONS; EXPRESSION; INVOLVEMENT; ACTIVATION; MECHANISMS; HORN; ANTINOCICEPTION	A large number of neuroanatomical, neurophysiologic, and neurochemical mechanisms are thought to contribute to the development and maintenance of neuropathic pain. However, mechanisms responsible for neuropathic pain have not been completely delineated. It has been demonstrated that neuropeptide galanin (Gal) is upregulated after injury in the dorsal root ganglion (DRG) and spinal dorsal horn (SDH) where it plays a predominantly antinociceptive role. In the present study, sciatic nerve-pinch injury rat model was used to determine the effects of exogenous Gal on the expression of the Gal and its receptors (GalR1, GalR2) in DRG and SDH, the alterations of pain behavior, nerve conduction velocity (NCV) and morphology of sciatic nerve. The results showed that exogenous Gal had antinociceptive effects in this nerve-pinch injury induced neuropathic pain animal model. It is very interesting that Gal, GalR1 and GalR2 change their expression greatly in DRG and SDH after nerve injury and intrathecal injection of exougenous Gal. Morphological investigation displays a serious damage after nerve-pinch injury and an amendatory regeneration after exogenous Gal treatment. These findings imply that Gal, via activation of GalR1 and/or GalR2, may have neuroprotective effects in reducing neuropathic pain behaviors and improving nerve regeneration after nerve injury.	[Xu, Xiaofeng; Zhang, Ping; Li, Zhenzhong] Shandong Univ, Sch Med, Dept Anat, Jinan 250100, Peoples R China; [Yang, Xiangdong] Shandong Univ, Qilu Hosp, Dept Nephrol, Jinan 250100, Peoples R China; [Chen, Xiuying] Shandong Univ, Affiliated Shandong Prov Hosp, Dept Electroencephalog, Jinan 250100, Peoples R China; [Liu, Huaxiang] Shandong Univ, Qilu Hosp, Dept Rheumatol, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Xu, XF (corresponding author), Shandong Univ, Sch Med, Dept Anat, Jinan 250100, Peoples R China.	zli@sdu.edu.cn			National Natural Science Foundation of China [81141060]; Science and Technology Development Project of Jinan Municipality of Shandong Province of China [200905041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Project of Jinan Municipality of Shandong Province of China	This work was supported by the National Natural Science Foundation of China (No. 81141060) and the Science and Technology Development Project of Jinan Municipality of Shandong Province of China (No. 200905041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbosh C, 2011, J NEUROCHEM, V117, P425, DOI 10.1111/j.1471-4159.2011.07204.x; Alier KA, 2008, PAIN, V137, P138, DOI 10.1016/j.pain.2007.08.030; An K, 2010, EUR J PAIN, V14, P595, DOI 10.1016/j.ejpain.2009.10.015; Aoyama R, 2011, PAIN, V152, P2085, DOI 10.1016/j.pain.2011.05.014; Atlasi Mohammad Ali, 2009, Iranian Biomedical Journal, V13, P65; Brumovsky P, 2006, BRAIN RES, V1085, P111, DOI 10.1016/j.brainres.2006.02.088; Brumovsky P, 2006, J CHEM NEUROANAT, V31, P243, DOI 10.1016/j.jchemneu.2006.02.001; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Coronel MF, 2008, J CHEM NEUROANAT, V35, P94, DOI 10.1016/j.jchemneu.2007.07.001; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Flatters SJL, 2002, PAIN, V98, P249, DOI 10.1016/S0304-3959(02)00180-X; Gidal B, 2006, AM J MANAG CARE, V12, pS269; Guan Y, 2010, ANESTHESIOLOGY, V113, P1392, DOI 10.1097/ALN.0b013e3181fcd95c; Hirose K, 2010, EUR SPINE J, V19, P1746, DOI 10.1007/s00586-010-1428-4; Hobson SA, 2008, CELL MOL LIFE SCI, V65, P1806, DOI 10.1007/s00018-008-8154-7; Hua XY, 2005, NEUROPEPTIDES, V39, P211, DOI 10.1016/j.npep.2004.12.024; Hua XY, 2004, J PHARMACOL EXP THER, V308, P574, DOI 10.1124/jpet.103.058289; Hulse RP, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-26; Jiang LY, 2010, J FORMOS MED ASSOC, V109, P438, DOI 10.1016/S0929-6646(10)60075-7; Jin WY, 2010, BRAIN RES, V1320, P16, DOI 10.1016/j.brainres.2009.12.060; Kato A, 2002, BRIT J PHARMACOL, V135, P1336, DOI 10.1038/sj.bjp.0704578; Kato R, 2002, J NEUROSCI, V22, P9410; Kerekes N, 2003, EUR J NEUROSCI, V18, P2957, DOI 10.1111/j.1460-9568.2003.03057.x; Landry M, 2006, J COMP NEUROL, V499, P391, DOI 10.1002/cne.21109; Lang R, 2007, PHARMACOL THERAPEUT, V115, P177, DOI 10.1016/j.pharmthera.2007.05.009; Lapirot O, 2011, PAIN, V152, P1821, DOI 10.1016/j.pain.2011.03.030; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016/S0304-3959(00)00251-7; Liu Z, 2008, IN VITRO CELL DEV-AN, V44, P379, DOI 10.1007/s11626-008-9118-9; Liu Z, 2009, PHARM BIOL, V47, P634, DOI 10.1080/13880200902915630; Lu Y, 2007, J PHYSIOL-LONDON, V582, P127, DOI 10.1113/jphysiol.2007.131565; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; O'Meara G, 2000, P NATL ACAD SCI USA, V97, P11569, DOI 10.1073/pnas.210254597; Ohsawa M, 2010, EUR J PHARMACOL, V644, P1, DOI 10.1016/j.ejphar.2010.07.007; Patil SB, 2011, PAIN, V152, P924, DOI 10.1016/j.pain.2011.01.017; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pope RJP, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-67; Quintero L, 2011, PAIN, V152, P1909, DOI 10.1016/j.pain.2011.04.017; Ramos KM, 2007, DIABETES, V56, P1569, DOI 10.2337/db06-1269; Rose K, 2011, PAIN, V152, P742, DOI 10.1016/j.pain.2010.12.028; Shi TJS, 2006, EUR J NEUROSCI, V23, P627, DOI 10.1111/j.1460-9568.2006.04593.x; Shimoshige Y, 2010, BIOL PHARM BULL, V33, P67, DOI 10.1248/bpb.33.67; Vanelderen P, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.09.006; Vivoli E, 2010, NEUROSCIENCE, V167, P1168, DOI 10.1016/j.neuroscience.2010.03.017; Wilson-Gerwing TD, 2006, NEUROSCIENCE, V141, P2075, DOI 10.1016/j.neuroscience.2006.05.056; Wittau N, 2000, ONCOGENE, V19, P4199, DOI 10.1038/sj.onc.1203777; Xiong W, 2005, REGUL PEPTIDES, V132, P85, DOI 10.1016/j.regpep.2005.09.002; Xu XJ, 2010, EXPERIENTIA SUPPL, V102, P39, DOI 10.1007/978-3-0346-0228-0_4; Xu XF, 2012, BRAIN RES BULL, V87, P85, DOI 10.1016/j.brainresbull.2011.10.012; Zhang X, 1998, ANN NY ACAD SCI, V863, P402, DOI 10.1111/j.1749-6632.1998.tb10710.x	49	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37621	10.1371/journal.pone.0037621	http://dx.doi.org/10.1371/journal.pone.0037621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624057	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500146
J	Wander, K; O'Connor, K; Shell-Duncan, B				Wander, Katherine; O'Connor, Kathleen; Shell-Duncan, Bettina			Expanding the Hygiene Hypothesis: Early Exposure to Infectious Agents Predicts Delayed-Type Hypersensitivity to Candida among Children in Kilimanjaro	PLOS ONE			English	Article							DAY-CARE ATTENDANCE; INFLAMMATORY-BOWEL-DISEASE; FAMILY-SIZE; EARLY-LIFE; NUTRITIONAL-STATUS; SEX-DIFFERENCES; PARENTAL AGE; BIRTH-ORDER; SCHOOL-AGE; HAY-FEVER	Background: Multiple lines of evidence suggest that infections in early life prevent the development of pathological immune responses to allergens and autoantigens (the hygiene hypothesis). Early infections may also affect later immune responses to pathogen antigen. Methods: To evaluate an association between early infections and immune responses to pathogen antigen, delayed-type hypersensitivity (DTH) to Candida albicans was evaluated among 283 2- to 7-year-old children in Kilimanjaro, Tanzania. A questionnaire and physical examination were used to characterize variables reflecting early exposure to infectious agents (family size, house construction materials, BCG vaccination, hospitalization history). Logistic regression was used to evaluate the association between early exposure to infectious agents and DTH to C. albicans. Results: Triceps skinfold thickness (OR: 1.11; 95% CI: 1.01, 1.22) and age (OR: 1.27; 95% CI: 1.04, 1.55) were positively associated with DTH to C. albicans. Adjusted for age and sex, large family size (OR: 2.81; 95% CI: 1.04, 7.61), BCG vaccination scar (OR: 3.10; 95% CI: 1.10, 8.71), and hospitalization during infancy with an infectious disease (OR: 4.67; 95% CI: 1.00, 21.74) were positively associated with DTH to C. albicans. Conclusions: Early life infections were positively associated with later DTH to C. albicans. This result supports an expansion of the hygiene hypothesis to explain not only pathological immune responses to allergens, but also appropriate immune responses to pathogens. Immune system development may be responsive to early infections as an adaptive means to tailor reactivity to the local infectious disease ecology.	[Wander, Katherine; O'Connor, Kathleen; Shell-Duncan, Bettina] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [O'Connor, Kathleen] Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wander, K (corresponding author), Univ Washington, Dept Anthropol, Seattle, WA 98195 USA.	kwander@u.washington.edu	Wander, Katherine/AAL-1551-2020	Wander, Katherine/0000-0002-4913-5075	National Science Foundation Doctoral Dissertation Improvement Grant [0968742]; Wenner-Gren Foundation for Anthropological Research Dissertation Fieldwork Grant [8065]; Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant [5R24 HD042828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER	National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); Wenner-Gren Foundation for Anthropological Research Dissertation Fieldwork Grant; Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a National Science Foundation Doctoral Dissertation Improvement Grant [0968742 to KW] and a Wenner-Gren Foundation for Anthropological Research Dissertation Fieldwork Grant [8065 to KW]. Partial support for this research came from a Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant [5R24 HD042828, to the Center for Studies in Demography and Ecology at the University of Washington]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amre DK, 2006, AM J GASTROENTEROL, V101, P1005, DOI 10.1111/j.1572-0241.2006.00526.x; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Black C A, 1999, Dermatol Online J, V5, P7; Brindle E, 2010, J IMMUNOL METHODS, V362, P112, DOI 10.1016/j.jim.2010.09.014; Calvani M, 2002, EUR RESPIR J, V20, P391, DOI 10.1183/09031936.02.00274502; Cardwell CR, 2008, DIABETIC MED, V25, P261, DOI 10.1111/j.1464-5491.2007.02351.x; Cardwell CR, 2005, DIABETIC MED, V22, P200, DOI 10.1111/j.1464-5491.2005.01369.x; Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821; D'Angeli MA, 2010, ARCH PEDIAT ADOL MED, V164, P732, DOI 10.1001/archpediatrics.2010.115; Guilherme Luiza, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S146239940501015X; Haby MM, 2000, PEDIATR PULM, V30, P377, DOI 10.1002/1099-0496(200011)30:5<377::AID-PPUL3>3.3.CO;2-V; Hampe J, 2003, INT J COLORECTAL DIS, V18, P413, DOI 10.1007/s00384-003-0484-1; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Infante-Rivard C, 2001, AM J EPIDEMIOL, V153, P653, DOI 10.1093/aje/153.7.653; Janson C, 2007, J ALLERGY CLIN IMMUN, V120, P673, DOI 10.1016/j.jaci.2007.05.003; Jarvis D, 1997, CLIN EXP ALLERGY, V27, P240; Kaila B, 2001, DIABETES CARE, V24, P1353, DOI 10.2337/diacare.24.8.1353; KNIKER WT, 1985, AM J DIS CHILD, V139, P840, DOI 10.1001/archpedi.1985.02140100102044; Koloski NA, 2008, WORLD J GASTROENTERO, V14, P165, DOI 10.3748/wjg.14.165; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Maizels RM, 2005, CURR OPIN IMMUNOL, V17, P656, DOI 10.1016/j.coi.2005.09.001; Martinez FD, 1999, LANCET, V354, pS12, DOI 10.1016/S0140-6736(99)90437-3; Matricardi PM, 2010, CLIN EXP IMMUNOL, V160, P98, DOI 10.1111/j.1365-2249.2010.04130.x; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Matricardi PM, 1998, J ALLERGY CLIN IMMUN, V101, P439, DOI 10.1016/S0091-6749(98)70350-1; Matricardi PM, 2002, J ALLERGY CLIN IMMUN, V110, P381, DOI 10.1067/mai.2002.126658; Montgomery SM, 2004, EPIDEMIOLOGY, V15, P717, DOI 10.1097/01.ede.0000142138.46167.69; Montgomery SM, 2002, SCAND J GASTROENTERO, V37, P1301, DOI 10.1080/003655202761020588; Nestel P., 2002, ADJUSTING HEMOGLOBIN; NEUMANN CG, 1975, AM J CLIN NUTR, V28, P89, DOI 10.1093/ajcn/28.2.89; Nja F, 2003, ARCH DIS CHILD, V88, P566, DOI 10.1136/adc.88.7.566; Owens IPF, 2002, SCIENCE, V297, P2008, DOI 10.1126/science.1076813; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; Ponsonby AL, 2005, JAMA-J AM MED ASSOC, V293, P463, DOI 10.1001/jama.293.4.463; ShellDuncan B, 1997, J TROP PEDIATRICS, V43, P25, DOI 10.1093/tropej/43.1.25; ShellDuncan B, 1997, AM J HUM BIOL, V9, P381, DOI 10.1002/(SICI)1520-6300(1997)9:3&lt;381::AID-AJHB10&gt;3.0.CO;2-I; Stene LC, 2001, BMJ-BRIT MED J, V323, P1; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; von Mutius E, 1999, EUR RESPIR J, V14, P4, DOI 10.1034/j.1399-3003.1999.14a03.x; von Mutius E, 2001, EUR RESPIR J, V18, P872, DOI 10.1183/09031936.01.00268401; Wander KW, 2012, AM J HUM BI IN PRESS; WASHBURN TC, 1965, PEDIATRICS, V35, P57; Williams LK, 2004, J ALLERGY CLIN IMMUN, V113, P291, DOI 10.1016/j.jaci.2003.11.010; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Zaman K, 1997, ACTA PAEDIATR, V86, P923, DOI 10.1111/j.1651-2227.1997.tb15171.x	46	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37406	10.1371/journal.pone.0037406	http://dx.doi.org/10.1371/journal.pone.0037406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22616000	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341200072
J	Chen, LH; Liu, CD; Ko, FCF; Xu, NN; Ng, IOL; Yam, JWP; Zhu, G				Chen, Lihong; Liu, Changdong; Ko, Frankie Chi Fat; Xu, Naining; Irene Oi-Lin Ng; Yam, Judy Wai Ping; Zhu, Guang			Solution Structure of the Phosphotyrosine Binding (PTB) Domain of Human Tensin2 Protein in Complex with Deleted in Liver Cancer 1 (DLC1) Peptide Reveals a Novel Peptide Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; TUMOR-SUPPRESSOR GENE; CELL-MIGRATION; FAMILY-MEMBER; GROWTH; PROLIFERATION; LOCALIZATION; ASSIGNMENT; PROGRAM; SYSTEM	The protein deleted in liver cancer 1 (DLC1) interacts with the tensin family of focal adhesion proteins to play a role as a tumor suppressor in a wide spectrum of human cancers. This interaction has been proven to be crucial to the oncogenic inhibitory capacity and focal adhesion localization of DLC1. The phosphotyrosine binding (PTB) domain of tensin2 predominantly interacts with a novel site on DLC1, not the canonical NPXY motif. In this study, we characterized this interaction biochemically and determined the complex structure of tensin2 PTB domain with DLC1 peptide by NMR spectroscopy. Our HADDOCK-derived complex structure model elucidates the molecular mechanism by which tensin2 PTB domain recognizes DLC1 peptide and reveals a PTB-peptide binding mode that is unique in that peptide occupies the binding site opposite to the canonical NPXY motif interaction site with the peptide utilizing a non-canonical binding motif to bind in an extended conformation and that the N-terminal helix, which is unique to some Shc- and Dab-like PTB domains, is required for binding. Mutations of crucial residues defined for the PTB-DLC1 interaction affected the co-localization of DLC1 and tensin2 in cells and abolished DLC1-mediated growth suppression of hepatocellular carcinoma cells. This tensin2 PTB-DLC1 peptide complex with a novel binding mode extends the versatile binding repertoire of the PTB domains in mediating diverse cellular signaling pathways as well as provides a molecular and structural basis for better understanding the tumor-suppressive activity of DLC1 and tensin2.	[Irene Oi-Lin Ng; Yam, Judy Wai Ping] Univ Hong Kong, Li Ka Shing Fac Med, StateKey Lab Liver Res, Hong Kong 999077, Hong Kong, Peoples R China; [Ko, Frankie Chi Fat; Irene Oi-Lin Ng; Yam, Judy Wai Ping] Univ Hong Kong, Dept Pathol, Hong Kong 999077, Hong Kong, Peoples R China; [Chen, Lihong; Liu, Changdong; Xu, Naining; Zhu, Guang] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon 999077, Hong Kong, Peoples R China; [Chen, Lihong; Liu, Changdong; Xu, Naining; Zhu, Guang] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon 999077, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Yam, JWP (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, StateKey Lab Liver Res, Hong Kong 999077, Hong Kong, Peoples R China.	judyyam@pathology.hku.hk; gzhu@ust.hk	Ko, Frankie Chi Fat/C-4759-2009; Ko, Frankie Chi Fat/AAZ-8112-2021; Yam, Judy Wai Ping/C-4454-2009	Ko, Frankie Chi Fat/0000-0002-0393-9668; Ko, Frankie Chi Fat/0000-0002-0393-9668; LIU, Changdong/0000-0001-7356-9765; Yam, Judy Wai Ping/0000-0002-5637-121X; Ng, Irene Oi-lin/0000-0001-7532-2029	Hong Kong Research Grants Council [RGC664109, SEG-HKUST06, TUYF10SC03]; University of Hong Kong	Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong)	This work was supported by Hong Kong Research Grants Council Grants RGC664109 (to G. Z. and J. W. P. Y.), SEG-HKUST06, and TUYF10SC03 (to G. Z).; Recipient of the University of Hong Kong Outstanding Young Researcher Award.	BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao X, 2012, P NATL ACAD SCI USA, V109, P1455, DOI 10.1073/pnas.1114368109; Chan LH, 2009, GLOB PUBLIC HEALTH, V4, P1, DOI 10.1080/17441690701524471; Chen HY, 2002, P NATL ACAD SCI USA, V99, P733, DOI 10.1073/pnas.022518699; Chen HY, 2003, BIOCHEM J, V370, P1039, DOI 10.1042/BJ20021308; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cui YM, 2004, MOL CANCER RES, V2, P225; Dai K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021965; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dhalluin C, 2000, MOL CELL, V6, P921, DOI 10.1016/S1097-2765(00)00089-7; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Erlmann P, 2009, MOL BIOL CELL, V20, P4400, DOI 10.1091/mbc.E09-03-0247; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hafizi S, 2010, INT J BIOCHEM CELL B, V42, P52, DOI 10.1016/j.biocel.2009.09.005; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Kawai K, 2010, ADV ENZYME REGUL, V50, P202, DOI 10.1016/j.advenzreg.2009.10.013; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leone M, 2008, BIOPOLYMERS, V89, P86, DOI 10.1002/bip.20862; Li GR, 2011, P NATL ACAD SCI USA, V108, P17129, DOI 10.1073/pnas.1112122108; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Liao YC, 2008, CANCER RES, V68, P7718, DOI 10.1158/0008-5472.CAN-08-2042; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; LO SH, 1994, J CELL BIOL, V125, P1067, DOI 10.1083/jcb.125.5.1067; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; McCleverty CJ, 2007, PROTEIN SCI, V16, P1223, DOI 10.1110/ps.072798707; Ng IOL, 2000, CANCER RES, V60, P6581; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Wong CM, 2003, CANCER RES, V63, P7646; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Yang XY, 2011, CANCER RES, V71, P2916, DOI 10.1158/0008-5472.CAN-10-2158; Yuan BZ, 1998, CANCER RES, V58, P2196; Yuan BZ, 2003, CANCER GENET CYTOGEN, V140, P113, DOI 10.1016/S0165-4608(02)00674-X; Yuan BZ, 2004, ONCOGENE, V23, P1405, DOI 10.1038/sj.onc.1207291; Yuan BZ, 2003, ONCOGENE, V22, P445, DOI 10.1038/sj.onc.1206064; ZHU G, 1992, J MAGN RESON, V100, P202, DOI 10.1016/0022-2364(92)90379-L; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	49	13	13	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26104	26114		10.1074/jbc.M112.360206	http://dx.doi.org/10.1074/jbc.M112.360206			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22645138	Green Published, hybrid			2022-12-25	WOS:000306916300038
J	Irigoyen, N; Caston, JR; Rodriguez, JF				Irigoyen, Nerea; Caston, Jose R.; Rodriguez, Jose F.			Host Proteolytic Activity Is Necessary for Infectious Bursal Disease Virus Capsid Protein Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC NECROSIS VIRUS; STRANDED-RNA VIRUS; CRYSTAL-STRUCTURE; STRUCTURAL POLYMORPHISM; NONENVELOPED VIRUS; MATURATION PROCESS; MOLECULAR SWITCH; CATALYTIC DYAD; INSECT CELLS; VP3	In many viruses, a precursor particle, or procapsid, is assembled and undergoes massive chemical and physical modification to produce the infectious capsid. Capsid assembly and maturation are finely tuned processes in which viral and host factors participate. We show that the precursor of the VP2 capsid protein (pVP2) of the infectious bursal disease virus (IBDV), a double-stranded RNA virus, is processed at the C-terminal domain (CTD) by a host protease, the puromycin-sensitive aminopeptidase (PurSA). The pVP2 CTD (71 residues) has an important role in determining the various conformations of VP2 (441 residues) that build the T = 13 complex capsid. pVP2 CTD activity is controlled by co- and posttranslational proteolytic modifications of different targets by the VP4 viral protease and by VP2 itself to yield the mature VP2-441 species. Puromycin-sensitive aminopeptidase is responsible for the peptidase activity that cleaves the Arg-452-Arg-453 bond to generate the intermediate pVP2-452 polypeptide. A pVP2 R453A substitution abrogates PurSA activity. We used a baculovirus-based system to express the IBDV polyprotein in insect cells and found inefficient formation of virus-like particles similar to IBDV virions, which correlates with the absence of puromycin-sensitive aminopeptidase in these cells. Virus-like particle assembly was nonetheless rescued efficiently by coexpression of chicken PurSA or pVP2-452 protein. Silencing or pharmacological inhibition of puromycin-sensitive aminopeptidase activity in cell lines permissive for IBDV replication caused a major blockade in assembly and/or maturation of infectious IBDV particles, as virus yields were reduced markedly. PurSA activity is thus essential for IBDV replication.	[Caston, Jose R.] CSIC, Ctr Nacl Biotecnol, Dept Struct Macromol, Madrid 28049, Spain; [Irigoyen, Nerea; Rodriguez, Jose F.] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Caston, JR (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Struct Macromol, Madrid 28049, Spain.	jrcaston@cnb.csic.es; jfrodrig@cnb.csic.es	Irigoyen, Nerea/CAJ-2485-2022; Rodríguez, José F/T-8500-2017; Caston, Jose R/L-5896-2014; Irigoyen, Nerea/A-7925-2017; Caston, Jose/AAB-8825-2021	Irigoyen, Nerea/0000-0001-6346-3369; Rodríguez, José F/0000-0001-7944-5341; Caston, Jose R/0000-0003-2350-9048; Irigoyen, Nerea/0000-0001-6346-3369; Caston, Jose/0000-0003-2350-9048	Spanish Ministry of Science and Innovation [BIO2009-12443, AGL2011-24758, BIO2008-02361, BFU2011-25902]; Spanish Ministry of Education and Science (MEC); CSIC Residencia de Estudiantes; Gobierno de Aragon	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education and Science (MEC)(Spanish Government); CSIC Residencia de Estudiantes; Gobierno de Aragon(Gobierno de Aragon)	This work was supported by Spanish Ministry of Science and Innovation Grants BIO2009-12443 and AGL2011-24758 (to J. F. R.) and BIO2008-02361 and BFU2011-25902 (to J. R. C.). This work was also supported by a fellowship from the Spanish Ministry of Education and Science (MEC) with support from the CSIC Residencia de Estudiantes and the Gobierno de Aragon (to N. I.).	Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Bottcher B, 1997, J VIROL, V71, P325; Caldwell RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r6; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Carrere-Kremer S, 2004, J BIOL CHEM, V279, P41384, DOI 10.1074/jbc.M406315200; Casanas A, 2008, STRUCTURE, V16, P29, DOI 10.1016/j.str.2007.10.023; Caston Jose R., 2008, P133; Caston JR, 2001, J VIROL, V75, P10815, DOI 10.1128/JVI.75.22.10815-10828.2001; Chevalier C, 2005, J VIROL, V79, P12253, DOI 10.1128/JVI.79.19.12253-12263.2005; Chevalier C, 2002, J VIROL, V76, P2384, DOI 10.1128/JVI.76.5.2384-2392.2002; Chung HK, 1996, VIROLOGY, V225, P359, DOI 10.1006/viro.1996.0610; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; Da Costa B, 2003, J VIROL, V77, P719, DOI 10.1128/JVI.77.1.719-725.2003; Dokland T, 2000, STRUCTURE, V8, pR157, DOI 10.1016/S0969-2126(00)00181-7; Feldman AR, 2006, J MOL BIOL, V358, P1378, DOI 10.1016/j.jmb.2006.02.045; Fidler I J, 1978, Adv Cancer Res, V28, P149, DOI 10.1016/S0065-230X(08)60648-X; Fischl W, 2008, J VIROL, V82, P8272, DOI 10.1128/JVI.00587-08; Galloux M, 2004, J GEN VIROL, V85, P2231, DOI 10.1099/vir.0.80012-0; Galloux M, 2007, J BIOL CHEM, V282, P20774, DOI 10.1074/jbc.M701048200; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Garriga D, 2006, J VIROL, V80, P6895, DOI 10.1128/JVI.00368-06; Gertsman I, 2009, NATURE, V458, P646, DOI 10.1038/nature07686; Hjalmarsson A, 1999, J VIROL, V73, P3484, DOI 10.1128/JVI.73.4.3484-3490.1999; Irigoyen N, 2009, J BIOL CHEM, V284, P8064, DOI 10.1074/jbc.M808942200; Johnson JE, 2010, CURR OPIN STRUC BIOL, V20, P210, DOI 10.1016/j.sbi.2010.01.004; Lee CC, 2006, J STRUCT BIOL, V155, P74, DOI 10.1016/j.jsb.2006.02.014; Lloyd RE, 2006, VIRUS RES, V119, P76, DOI 10.1016/j.virusres.2005.10.016; Lombardo E, 1999, J VIROL, V73, P6973, DOI 10.1128/JVI.73.8.6973-6983.1999; Luque D, 2007, J VIROL, V81, P6869, DOI 10.1128/JVI.00077-07; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; Luque D, 2009, P NATL ACAD SCI USA, V106, P2148, DOI 10.1073/pnas.0808498106; Maraver A, 2003, J VIROL, V77, P6438, DOI 10.1128/JVI.77.11.6438-6449.2003; Maraver A, 2003, J VIROL, V77, P2459, DOI 10.1128/JVI.77.4.2459-2468.2003; Martinez-Torrecuadrada JL, 2000, VIROLOGY, V278, P322, DOI 10.1006/viro.2000.0559; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; Nobiron I, 2008, VIROLOGY, V371, P350, DOI 10.1016/j.virol.2007.09.022; Ona A, 2004, VIROLOGY, V322, P135, DOI 10.1016/j.virol.2004.01.025; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Sanchez AB, 1999, VIROLOGY, V262, P190, DOI 10.1006/viro.1999.9910; Saugar I, 2005, STRUCTURE, V13, P1007, DOI 10.1016/j.str.2005.04.012; Saugar I, 2010, J BIOL CHEM, V285, P3643, DOI 10.1074/jbc.M109.075994; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; Vakharia VN, 1997, BIOTECHNOL ANN REV, V3, P151, DOI 10.1016/S1387-2656(08)70032-2; Vancini R, 2012, J VIROL, V86, P2390, DOI 10.1128/JVI.06614-11; Villanueva RA, 2004, J VIROL, V78, P13829, DOI 10.1128/JVI.78.24.13829-13838.2004	46	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24473	24482		10.1074/jbc.M112.356113	http://dx.doi.org/10.1074/jbc.M112.356113			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22619177	hybrid, Green Published			2022-12-25	WOS:000306651100040
J	Nakamura, H; Bannai, H; Inoue, T; Michikawa, T; Sano, M; Mikoshiba, K				Nakamura, Hideki; Bannai, Hiroko; Inoue, Takafumi; Michikawa, Takayuki; Sano, Masaki; Mikoshiba, Katsuhiko			Cooperative and Stochastic Calcium Releases from Multiple Calcium Puff Sites Generate Calcium Microdomains in Intact HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENTARY CA2+ SIGNALS; INOSITOL TRISPHOSPHATE; ENDOPLASMIC-RETICULUM; INTRACELLULAR CA2+; LATERAL DIFFUSION; CHANNEL; MICROSCOPY; RESPONSES; DYNAMICS; CLUSTERS	Ca2+ microdomains or locally restricted Ca2+ increases in the cell have recently been reported to regulate many essential physiological events. Ca2+ increases through the inositol 1,4,5-trisphosphate (IP3) receptor (IP3R)/Ca2+ release channels contribute to the formation of a class of such Ca2+ microdomains, which were often observed and referred to as Ca2+ puffs in their isolated states. In this report, we visualized IP3-evoked Ca2+ microdomains in histamine-stimulated intact HeLa cells using a total internal reflection fluorescence microscope, and quantitatively characterized the spatial profile by fitting recorded images to a two-dimensional Gaussian distribution. Ca2+ concentration profiles were marginally spatially anisotropic, with the size increasing linearly even after the amplitude began to decline. We found the event centroid drifted with an apparent diffusion coefficient of 4.20 +/- 0.50 mu m(2)/s, which is significantly larger than those estimated for IP(3)Rs. The sites of maximal Ca2+ increase, rather than initiation or termination sites, were detected repeatedly at the same location. These results indicate that Ca2+ microdomains in intact HeLa cell are generated from spatially distributed multiple IP3R clusters or Ca2+ puff sites, rather than a single IP3R cluster reported in cells loaded with Ca2+ buffers.	[Michikawa, Takayuki] Saitama Univ, Brain Sci Inst, Sakura Ku, Saitama 3388570, Japan; [Nakamura, Hideki; Bannai, Hiroko; Michikawa, Takayuki; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Nakamura, Hideki; Sano, Masaki] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Inoue, Takafumi; Michikawa, Takayuki; Mikoshiba, Katsuhiko] Japan Sci & Technol Corp JST, ICORP, Calcium Oscillat Project, Kawaguchi, Saitama 3320012, Japan; [Nakamura, Hideki; Inoue, Takafumi] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan	Saitama University; RIKEN; University of Tokyo; Japan Science & Technology Agency (JST); Waseda University	Michikawa, T (corresponding author), Saitama Univ, Brain Sci Inst, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	michikawa@mail.saitama-u.ac.jp; mikosiba@brain.riken.jp	Sano, Masaki/E-4434-2012; Mikoshiba, Katsuhiko/N-7943-2015; Bannai, Hiroko/I-7130-2014; Inoue, Takafumi/AAM-9533-2020	Sano, Masaki/0000-0002-6262-9635; Bannai, Hiroko/0000-0002-0951-488X; Inoue, Takafumi/0000-0002-2728-0060; Nakamura, Hideki/0000-0003-2749-8323	Ministry of Education, Science, Sports and Culture of Japan [23650197, 16770124, 14380364, 20370054, 24500476, 2022007]; JST ICORP-SORST; Grants-in-Aid for Scientific Research [23650197, 23300121] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST ICORP-SORST; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan 23650197 (to H. N.), 16770124 (to H. B.), 14380364 (to T. I.), 20370054 and 24500476 (to T. M.) and 2022007 (to K. M.), and from JST ICORP-SORST (to K. M.).	Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bootman M, 1997, J PHYSIOL-LONDON, V499, P307, DOI 10.1113/jphysiol.1997.sp021928; Bootman MD, 1996, CURR BIOL, V6, P855, DOI 10.1016/S0960-9822(02)00609-7; Callamaras N, 2000, EMBO J, V19, P3608, DOI 10.1093/emboj/19.14.3608; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Demuro A, 2008, CELL CALCIUM, V43, P367, DOI 10.1016/j.ceca.2007.07.002; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Ferreri-Jacobia M, 2005, J BIOL CHEM, V280, P3824, DOI 10.1074/jbc.M409462200; Fukatsu K, 2004, J BIOL CHEM, V279, P48976, DOI 10.1074/jbc.M408364200; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; PARKER I, 1990, SCIENCE, V250, P977, DOI 10.1126/science.2237441; PARKER I, 1991, P ROY SOC B-BIOL SCI, V246, P269, DOI 10.1098/rspb.1991.0154; Reber BFX, 1996, PFLUG ARCH EUR J PHY, V432, P893, DOI 10.1007/s004240050213; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Shuai JW, 2005, CELL CALCIUM, V37, P283, DOI 10.1016/j.ceca.2004.10.008; Simkus CRL, 2002, J PHYSIOL-LONDON, V545, P521, DOI 10.1113/jphysiol.2002.022103; Smith GD, 1996, BIOPHYS J, V70, P2527, DOI 10.1016/S0006-3495(96)79824-7; Smith GD, 1998, BIOPHYS J, V75, P15, DOI 10.1016/S0006-3495(98)77491-0; Smith IF, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000466; Smith IF, 2009, P NATL ACAD SCI USA, V106, P6404, DOI 10.1073/pnas.0810799106; Smith IF, 2009, CELL CALCIUM, V45, P65, DOI 10.1016/j.ceca.2008.06.001; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; Thomas D, 1998, J BIOL CHEM, V273, P27130, DOI 10.1074/jbc.273.42.27130; Tovey SC, 2001, J CELL SCI, V114, P3979; WAGNER J, 1994, BIOPHYS J, V67, P447, DOI 10.1016/S0006-3495(94)80500-4; YAO Y, 1995, J PHYSIOL-LONDON, V482, P533, DOI 10.1113/jphysiol.1995.sp020538	35	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24563	24572		10.1074/jbc.M111.311399	http://dx.doi.org/10.1074/jbc.M111.311399			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637479	Green Published, hybrid			2022-12-25	WOS:000306651100049
J	Sizemore, ST; Keri, RA				Sizemore, Steven T.; Keri, Ruth A.			The Forkhead Box Transcription Factor FOXC1 Promotes Breast Cancer Invasion by Inducing Matrix Metalloprotease 7 (MMP7) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-LINES; HELIX GENE; MONOCLONAL-ANTIBODY; CLAUDIN-LOW; IN-VITRO; MATRILYSIN; BASAL; INCREASES; RECEPTOR; PATTERNS	Therapeutic options for treatment of basal-like breast cancers are limited and identification of molecular targets for novel therapies to treat this aggressive cancer is urgently needed. Recently, FOXC1, a forkhead box transcription factor, was identified as a functionally important biomarker of breast cancer aggressiveness and the basal-like breast cancer subtype. However, the mechanism through which FOXC1 controls aggressiveness of basal-like breast cancer remains to be elucidated. Here, we identify matrix metalloprotease 7 (MMP7) as a key downstream effector of FOXC1-mediated invasiveness. Expression of FOXC1 and MMP7 is significantly correlated in breast cancer samples and cell lines at both the mRNA and protein levels. Transient expression of FOXC1 in nontransformed mammary epithelial cell lines resulted in significantly increased expression of MMP7 and an MMP7-dependent increase in invasiveness. In reciprocal experiments, silencing endogenous FOXC1 in basal-like breast cancer cell lines resulted in decreased expression of MMP7 without decreased expression of other matrix metalloproteinases. We also demonstrate that elevated co-expression of FOXC1 and MMP7 is an independent predictor of patient outcome in multivariate analyses of two breast cancer patient cohorts. Together, our findings identify MMP7 as a novel mechanism through which FOXC1 may regulate the basal-like breast cancer invasive phenotype and the propensity of these cancers to metastasize. Furthermore, our findings demonstrate for the first time a correlation between MMP7 expression and basal-like breast cancers, suggesting that MMP7 may be a useful therapeutic target for treatment of this disease.	[Sizemore, Steven T.; Keri, Ruth A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Sch Med, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Keri, RA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	keri@case.edu	Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088	National Institutes of Health [T32CA059366]; Department of Defense [W81XWH-09-1-0696, W81XWH-08-1-0347]; NATIONAL CANCER INSTITUTE [T32CA059366, P30CA043703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Training Grant T32CA059366 (to S. T. S.) and Department of Defense Grants W81XWH-09-1-0696 (to S. T. S.) and W81XWH-08-1-0347 (to R. A. K.).	Berry FB, 2008, HUM MOL GENET, V17, P490, DOI 10.1093/hmg/ddm326; Bertucci F, 2008, INT J CANCER, V123, P236, DOI 10.1002/ijc.23518; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chung TKH, 2012, INT J CANCER, V130, P1036, DOI 10.1002/ijc.26060; Clarke M, 1998, LANCET, V351, P1451; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Du J, 2012, BREAST CANCER RES TR, V131, P65, DOI 10.1007/s10549-011-1396-3; FERNANDEZRESA P, 1995, ANAL BIOCHEM, V224, P434, DOI 10.1006/abio.1995.1063; Fukushima H, 2001, CARCINOGENESIS, V22, P1049, DOI 10.1093/carcin/22.7.1049; Gucalp A, 2011, CHEMOTHER RES PRACT, DOI DOI 10.1155/2011/696208; Hicks DG, 2006, AM J SURG PATHOL, V30, P1097; Jacobsen LB, 2009, BIOTECHNIQUES, V47, P617, DOI 10.2144/000113132; Jiang WG, 2005, CLIN CANCER RES, V11, P6012, DOI 10.1158/1078-0432.CCR-05-0275; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Kidson SH, 1999, DEV BIOL, V211, P306, DOI 10.1006/dbio.1999.9314; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Lynch CC, 2007, CANCER RES, V67, P6760, DOI 10.1158/0008-5472.CAN-07-0026; MATRISIAN LM, 1994, PRINCESS TAKAMATSU S, P152; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakamura H, 2002, ONCOL REP, V9, P751; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Pegram MD, 1998, J CLIN ONCOL, V16, P2659, DOI 10.1200/JCO.1998.16.8.2659; POWELL WC, 1993, CANCER RES, V53, P417; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Ray PS, 2011, ANN SURG ONCOL, V18, P3839, DOI 10.1245/s10434-011-1657-8; Ray PS, 2010, CANCER RES, V70, P3870, DOI 10.1158/0008-5472.CAN-09-4120; Richards TJ, 2012, AM J PHYSIOL-LUNG C, V302, pL746, DOI 10.1152/ajplung.00319.2011; Sato N, 2003, JNCI-J NATL CANCER I, V95, P327, DOI 10.1093/jnci/95.4.327; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tkocz D., 2011, ONCOGENE IN PRESS; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang J., 2012, ONCOGENE IN PRESS; Wang WS, 2006, CARCINOGENESIS, V27, P1113, DOI 10.1093/carcin/bgi351; WITTY JP, 1994, CANCER RES, V54, P4805; YAMAMOTO H, 1995, INT J CANCER, V61, P218, DOI 10.1002/ijc.2910610213	44	68	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24631	24640		10.1074/jbc.M112.375865	http://dx.doi.org/10.1074/jbc.M112.375865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645147	hybrid, Green Published			2022-12-25	WOS:000306651100057
J	Werneburg, NW; Bronk, SF; Guicciardi, ME; Thomas, L; Dikeakos, JD; Thomas, G; Gores, GJ				Werneburg, Nathan W.; Bronk, Steve F.; Guicciardi, Maria Eugenia; Thomas, Laurel; Dikeakos, Jimmy D.; Thomas, Gary; Gores, Gregory J.			Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Protein-induced Lysosomal Translocation of Proapoptotic Effectors Is Mediated by Phosphofurin Acidic Cluster Sorting Protein-2 (PACS-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; MEMBRANE PERMEABILIZATION; HEPATOCYTE APOPTOSIS; GENOTOXIC STRESS; MHC-I; PHOSPHORYLATION; FAMILY; BAX; ACTIVATION; BINDING	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of liver cancer cell lines requires death receptor-5 (DR5)-dependent permeabilization of lysosomal membranes. Ligated DR5 triggers recruitment of the proapoptotic proteins Bim and Bax to lysosomes, releasing cathepsin B into the cytosol where it mediates mitochondria membrane permeabilization and activation of executioner caspases. Despite the requirement for lysosome membrane permeabilization during TRAIL-induced apoptosis, little is known about the mechanism that controls recruitment of Bim and Bax to lysosomal membranes. Here we report that TRAIL induces recruitment of the multifunctional sorting protein phosphofurin acidic cluster sorting protein-2 (PACS-2) to DR5-positive endosomes in Huh-7 cells where it forms an immunoprecipitatable complex with Bim and Bax on lysosomal membranes. shRNA-targeted knockdown of PACS-2 prevents recruitment of Bim or Bax to lysosomes, blunting the TRAIL-induced lysosome membrane permeabilization. Consistent with the reduced lysosome membrane permeabilization, shRNA knockdown of PACS-2 in Huh-7 cells reduced TRAIL-induced apoptosis and increased clonogenic cell survival. The determination that recombinant PACS-2 bound Bim but not Bax in vitro and that shRNA knockdown of Bim blocked Bax recruitment to lysosomes suggests that TRAIL/DR5 triggers endosomal PACS-2 to recruit Bim and Bax to lysosomes to release cathepsin B and induce apoptosis. Together, these findings provide insight into the lysosomal pathway of apoptosis.	[Werneburg, Nathan W.; Bronk, Steve F.; Guicciardi, Maria Eugenia; Gores, Gregory J.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Thomas, Laurel; Dikeakos, Jimmy D.; Thomas, Gary] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Mayo Clinic; Oregon Health & Science University	Gores, GJ (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA.	gores.gregory@mayo.edu			National Institutes of health [DK37274, CA151564, DK 63947]; Canadian Institute of Health Research [HFE-87760]; FRQS [23037]; Collins Medical Trust; NATIONAL CANCER INSTITUTE [R01CA151564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037274, R01DK063947] Funding Source: NIH RePORTER	National Institutes of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); FRQS; Collins Medical Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of health Grants DK37274 and CA151564 (to G. T.) and DK 63947 (to G. J. G.). This work was also supported by Canadian Institute of Health Research fellowship HFE-87760, FRQS fellowship 23037 and the Collins Medical Trust (to J. D. D.).	Akazawa Y, 2009, GASTROENTEROLOGY, V136, P2365, DOI 10.1053/j.gastro.2009.02.071; Aslan JE, 2009, TRAFFIC, V10, P1390, DOI 10.1111/j.1600-0854.2009.00951.x; Aslan JE, 2009, MOL CELL, V34, P497, DOI 10.1016/j.molcel.2009.04.011; Atkins KM, 2008, J BIOL CHEM, V283, P11772, DOI 10.1074/jbc.M707572200; Bouard D, 2007, TRAFFIC, V8, P835, DOI 10.1111/j.1600-0854.2007.00581.x; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Canbay A, 2003, J CLIN INVEST, V112, P152, DOI 10.1172/JCI200317740; Chen JX, 2009, TRAFFIC, V10, P1488, DOI 10.1111/j.1600-0854.2009.00961.x; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; Crump CM, 2003, J VIROL, V77, P11105, DOI 10.1128/JVI.77.20.11105-11113.2003; Dikeakos JD, 2012, MOL BIOL CELL, V23, P2184, DOI 10.1091/mbc.E11-11-0928; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Guicciardi ME, 2005, GASTROENTEROLOGY, V129, P269, DOI 10.1053/j.gastro.2005.05.022; Jenkins PM, 2009, J NEUROSCI, V29, P10541, DOI 10.1523/JNEUROSCI.1590-09.2009; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kahraman A, 2008, HEPATOLOGY, V47, P1317, DOI 10.1002/hep.22136; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Molloy SS, 1998, J CELL BIOL, V142, P1399, DOI 10.1083/jcb.142.6.1399; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takeda K, 2008, P NATL ACAD SCI USA, V105, P10895, DOI 10.1073/pnas.0802702105; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Vogel S, 2012, J BIOL CHEM, V287, P9112, DOI 10.1074/jbc.M111.248906; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Werneburg N, 2004, AM J PHYSIOL-GASTR L, V287, pG436, DOI 10.1152/ajpgi.00019.2004; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; Werneburg NW, 2002, AM J PHYSIOL-GASTR L, V283, pG947, DOI 10.1152/ajpgi.00151.2002; Youker RT, 2009, BIOCHEM J, V421, P1, DOI 10.1042/BJ20081016; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	50	37	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24427	24437		10.1074/jbc.M112.342238	http://dx.doi.org/10.1074/jbc.M112.342238			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645134	Green Published, hybrid			2022-12-25	WOS:000306651100036
J	Hong, SW; Jin, DH; Shin, JS; Moon, JH; Na, YS; Jung, KA; Kim, SM; Kim, JC; Kim, KP; Hong, YS; Lee, JL; Choi, EK; Lee, JS; Kim, TW				Hong, Seung-Woo; Jin, Dong-Hoon; Shin, Jae-Sik; Moon, Jai-Hee; Na, Young-Soon; Jung, Kyung-Ah; Kim, Seung-Mi; Kim, Jin Cheon; Kim, Kyu-pyo; Hong, Yong Sang; Lee, Jae-Lyun; Choi, Eun Kyung; Lee, Jung Shin; Kim, Tae Won			Ring Finger Protein 149 Is an E3 Ubiquitin Ligase Active on Wild-type v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOMA-CELLS; PATHWAY; MUTATIONS; CANCER; PROLIFERATION; INHIBITOR; PLX4032	Members of the RAF family (ARAF, BRAF, and CRAF/RAF-1) are involved in a variety of cellular activities, including growth, survival, differentiation, and transformation. An oncogene encodes BRAF, the function of which is linked to MEK activation. BRAF is the most effective RAF kinase in terms of induction of MEK/ERK activity. However, the mechanisms involved in BRAF regulation remain unclear. In the present work, we used a tandem affinity purification approach to show that RNF149 (RING finger protein 149) interacts with wild-type BRAF. The latter protein is a RING domain-containing E3 ubiquitin ligase involved in control of gene transcription, translation, cytoskeletal organization, cell adhesion, and epithelial development. We showed that RNF149 bound directly to the C-terminal kinase-containing domain of wild-type BRAF and induced ubiquitination, followed by proteasome-dependent degradation, of the latter protein. Functionally, RNF149 attenuated the increase in cell growth induced by wild-type BRAF. However, RNF149 did not bind to mutant BRAF or induce ubiquitination thereof. Thus, we show that RNF149 is an E3 ubiquitin ligase active on wild-type BRAF.	[Hong, Seung-Woo; Jin, Dong-Hoon; Shin, Jae-Sik; Moon, Jai-Hee; Na, Young-Soon; Jung, Kyung-Ah; Kim, Seung-Mi; Kim, Kyu-pyo; Hong, Yong Sang; Lee, Jae-Lyun; Choi, Eun Kyung; Lee, Jung Shin; Kim, Tae Won] Univ Ulsan, Inst Innovat Canc Res, Coll Med, Seoul 138736, South Korea; [Hong, Seung-Woo; Jin, Dong-Hoon; Shin, Jae-Sik; Moon, Jai-Hee; Na, Young-Soon; Jung, Kyung-Ah; Kim, Seung-Mi; Kim, Kyu-pyo; Hong, Yong Sang; Lee, Jae-Lyun; Lee, Jung Shin; Kim, Tae Won] Univ Ulsan, Dept Oncol, Coll Med, Asan Med Ctr, Seoul 138736, South Korea; [Choi, Eun Kyung] Univ Ulsan, Dept Radiat Oncol, Coll Med, Asan Med Ctr, Seoul 138736, South Korea; [Kim, Jin Cheon] Univ Ulsan, Dept Surg, Coll Med, Asan Med Ctr, Seoul 138736, South Korea	University of Ulsan; University of Ulsan; University of Ulsan; University of Ulsan	Kim, TW (corresponding author), Univ Ulsan, Inst Innovat Canc Res, Coll Med, 86 Asanbyeongwon Gil, Seoul 138736, South Korea.	twkimmd@amc.seoul.kr			Korea Health 21 R&D Project, Ministry of Health and Welfare and Family Affairs, Republic of Korea [A102059]; Asan Institute for Life Sciences, Seoul, Republic of Korea [2012-231]	Korea Health 21 R&D Project, Ministry of Health and Welfare and Family Affairs, Republic of Korea; Asan Institute for Life Sciences, Seoul, Republic of Korea	This work was supported by Grant A102059 from the Korea Health 21 R&D Project, Ministry of Health and Welfare and Family Affairs, Republic of Korea and Grant 2012-231 from the Asan Institute for Life Sciences, Seoul, Republic of Korea.	Calipel A, 2003, J BIOL CHEM, V278, P42409, DOI 10.1074/jbc.M308709200; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fransen K, 2004, CARCINOGENESIS, V25, P527, DOI 10.1093/carcin/bgh049; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Lee J, 2011, JNCI-J NATL CANCER I, V103, P674, DOI 10.1093/jnci/djr070; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Ovaa H, 2007, NAT REV CANCER, V7, P613, DOI 10.1038/nrc2128; Packer LM, 2009, PIGM CELL MELANOMA R, V22, P785, DOI 10.1111/j.1755-148X.2009.00618.x; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Sala E, 2008, MOL CANCER RES, V6, P751, DOI 10.1158/1541-7786.MCR-07-2001; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Tsavachidou D, 2004, CANCER RES, V64, P5556, DOI 10.1158/0008-5472.CAN-04-1669; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6	18	22	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					24017	24025		10.1074/jbc.M111.319822	http://dx.doi.org/10.1074/jbc.M111.319822			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22628551	Green Published, hybrid			2022-12-25	WOS:000306511300070
J	Attar, CH; Muller, MM				Attar, Catherine Hindi; Mueller, Matthias M.			Selective Attention to Task-Irrelevant Emotional Distractors Is Unaffected by the Perceptual Load Associated with a Foreground Task	PLOS ONE			English	Article							HUMAN EXTRASTRIATE CORTEX; TIME-COURSE; VISUAL-CORTEX; HUMAN BRAIN; CUED SHIFTS; AUTOMATICITY; PICTURES; FACILITATION; MODULATION; ACTIVATION	A number of studies have shown that emotionally arousing stimuli are preferentially processed in the human brain. Whether or not this preference persists under increased perceptual load associated with a task at hand remains an open question. Here we manipulated two possible determinants of the attentional selection process, perceptual load associated with a foreground task and the emotional valence of concurrently presented task-irrelevant distractors. As a direct measure of sustained attentional resource allocation in early visual cortex we used steady-state visual evoked potentials (SSVEPs) elicited by distinct flicker frequencies of task and distractor stimuli. Subjects either performed a detection (low load) or discrimination (high load) task at a centrally presented symbol stream that flickered at 8.6 Hz while task-irrelevant neutral or unpleasant pictures from the International Affective Picture System (IAPS) flickered at a frequency of 12 Hz in the background of the stream. As reflected in target detection rates and SSVEP amplitudes to both task and distractor stimuli, unpleasant relative to neutral background pictures more strongly withdrew processing resources from the foreground task. Importantly, this finding was unaffected by the factor 'load' which turned out to be a weak modulator of attentional processing in human visual cortex.	[Attar, Catherine Hindi; Mueller, Matthias M.] Univ Leipzig, Inst Psychol, Leipzig, Germany; [Attar, Catherine Hindi] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Attar, CH (corresponding author), Univ Leipzig, Inst Psychol, Leipzig, Germany.	m.mueller@rz.uni-leipzig.de			German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) graduate program "function of attention in cognition''. DFG website: http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SK, 2010, P NATL ACAD SCI USA, V107, P13878, DOI 10.1073/pnas.1002436107; Andersen SK, 2008, CURR BIOL, V18, P1006, DOI 10.1016/j.cub.2008.06.030; Attar CH, 2010, NEUROIMAGE, V53, P1326, DOI 10.1016/j.neuroimage.2010.06.074; Attar CH, 2010, J NEUROSCI, V30, P5204, DOI 10.1523/JNEUROSCI.5029-09.2010; BARGH J A, 1989, P3; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Doallo S, 2006, NEUROREPORT, V17, P1797, DOI 10.1097/01.wnr.0000246325.51191.39; Donderi DC, 2006, PSYCHOL BULL, V132, P73, DOI 10.1037/0033-2909.132.1.73; Duncan J., 1996, ATTENTION PERFORM, P549; Eimer M, 2003, PSYCHOPHYSIOLOGY, V40, P924, DOI 10.1111/1469-8986.00110; Erthal FS, 2005, COGN AFFECT BEHAV NE, V5, P388, DOI 10.3758/CABN.5.4.388; Ferrari V, 2011, PSYCHOPHYSIOLOGY, V48, P515, DOI 10.1111/j.1469-8986.2010.01083.x; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Glascher J, 2007, J NEUROSCI, V27, P4366, DOI 10.1523/JNEUROSCI.3310-06.2007; Hajcak G, 2007, BEHAV NEUROSCI, V121, P1156, DOI 10.1037/0735-7044.121.6.1156; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Holmes A, 2006, NEUROSCI LETT, V394, P48, DOI 10.1016/j.neulet.2005.10.002; Holmes A, 2009, COGN AFFECT BEHAV NE, V9, P323, DOI 10.3758/CABN.9.3.323; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Keil A, 2005, CEREB CORTEX, V15, P1187, DOI 10.1093/cercor/bhi001; Keitel C, 2010, EXP BRAIN RES, V205, P489, DOI 10.1007/s00221-010-2384-2; Lang P. J., 1999, INT AFFECTIVE PICTUR; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Larson CL, 2005, PSYCHOPHYSIOLOGY, V42, P604, DOI 10.1111/j.1469-8986.2005.00345.x; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lipp OV, 2005, EMOTION, V5, P365, DOI 10.1037/1528-3542.5.3.365; Luo Q, 2010, J NEUROSCI, V30, P5825, DOI 10.1523/JNEUROSCI.BC-5668-09.2010; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Muller MM, 2008, CEREB CORTEX, V18, P1892, DOI 10.1093/cercor/bhm215; Muller MM, 2011, J NEUROSCI, V31, P15914, DOI 10.1523/JNEUROSCI.1997-11.2011; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; Muller MM, 2003, NATURE, V424, P309, DOI 10.1038/nature01812; Muller MM, 1998, NAT NEUROSCI, V1, P631, DOI 10.1038/2865; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Okon-Singer H, 2007, EMOTION, V7, P147, DOI 10.1037/1528-3542.7.1.147; Pessoa L, 2005, CURR OPIN NEUROBIOL, V15, P188, DOI 10.1016/j.conb.2005.03.002; Peyk P, 2009, PSYCHOPHYSIOLOGY, V46, P200, DOI 10.1111/j.1469-8986.2008.00755.x; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Rauss KS, 2009, HUM BRAIN MAPP, V30, P1723, DOI 10.1002/hbm.20636; Schupp HT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-16; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2007, PHILOS T R SOC B, V362, P837, DOI 10.1098/rstb.2007.2092; Wieser MJ, 2011, J COGNITIVE NEUROSCI, V23, P1973, DOI 10.1162/jocn.2010.21566	53	32	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37186	10.1371/journal.pone.0037186	http://dx.doi.org/10.1371/journal.pone.0037186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TH	22649513	gold, Green Submitted, Green Published			2022-12-25	WOS:000305335800031
J	Subramanian, L; Blumenfeld, H; Tohn, R; Ly, D; Aguilera, C; Maricic, I; Mansson, JE; Buschard, K; Kumar, V; Delovitch, TL				Subramanian, Lakshmimathy; Blumenfeld, Hartley; Tohn, Robert; Ly, Dalam; Aguilera, Carlos; Maricic, Igor; Mansson, Jan-Eric; Buschard, Karsten; Kumar, Vipin; Delovitch, Terry L.			NKT Cells Stimulated by Long Fatty Acyl Chain Sulfatides Significantly Reduces the Incidence of Type 1 Diabetes in Nonobese Diabetic Mice	PLOS ONE			English	Article							KILLER T-CELLS; DENDRITIC CELLS; INSULIN-SECRETION; CROSS-REGULATION; ACID ISOFORM; BETA-CELLS; GALACTOSYLCERAMIDE; PREVENTS; PROTECTION; INDUCTION	Sulfatide-reactive type II NKT cells have been shown to regulate autoimmunity and anti-tumor immunity. Although, two major isoforms of sulfatide, C16:0 and C24:0, are enriched in the pancreas, their relative role in autoimmune diabetes is not known. Here, we report that sulfatide/CD1d-tetramer(+) cells accumulate in the draining pancreatic lymph nodes, and that treatment of NOD mice with sulfatide or C24:0 was more efficient than C16: 0 in stimulating the NKT cell-mediated transfer of a delay in onset from T1D into NOD. Scid recipients. Using NOD. CD1d(-/-) mice, we show that this delay of T1D is CD1d-dependent. Interestingly, the latter delay or protection from T1D is associated with the enhanced secretion of IL-10 rather than IFN-g by C24:0-treated CD4(+) T cells and the deviation of the islet-reactive diabetogenic T cell response. Both C16:0 and C24:0 sulfatide isoforms are unable to activate and expand type I iNKT cells. Collectively, these data suggest that C24:0 stimulated type II NKT cells may regulate protection from T1D by activating DCs to secrete IL-10 and suppress the activation and expansion of type I iNKT cells and diabetogenic T cells. Our results raise the possibility that C24:0 may be used therapeutically to delay the onset and protect from T1D in humans.	[Subramanian, Lakshmimathy; Blumenfeld, Hartley; Tohn, Robert; Ly, Dalam; Delovitch, Terry L.] Western Univ, Robarts Res Inst, Lab Autoimmune Diabet, London, ON, Canada; [Subramanian, Lakshmimathy; Blumenfeld, Hartley; Tohn, Robert; Ly, Dalam; Delovitch, Terry L.] Western Univ, Dept Microbiol & Immunol, London, ON, Canada; [Ly, Dalam] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Aguilera, Carlos; Maricic, Igor; Kumar, Vipin] Torrey Pines Inst Mol Studies, Lab Autoimmun, San Diego, CA USA; [Mansson, Jan-Eric] Sahlgrens Univ Hosp, Dept Neurosci, Molndal, Sweden; [Buschard, Karsten] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark	Western University (University of Western Ontario); Western University (University of Western Ontario); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Torrey Pines Institute for Molecular Studies, California; Sahlgrenska University Hospital; Rigshospitalet; University of Copenhagen	Subramanian, L (corresponding author), Western Univ, Robarts Res Inst, Lab Autoimmune Diabet, London, ON, Canada.	vkumar@tpims.org; del@robarts.ca	Subramanian, Lakshmimathy/T-4733-2019	Ly, Dalam/0000-0002-1177-0225; Buschard, Karsten/0000-0002-0126-7423	Juvenile Diabetes Research Foundation [24-2007-]; Canadian Institutes of Health Research [MOP 64386]; University of Western Ontario; Schulich Graduate Enhancement Scholarship; Department of Microbiology and Immunology; Ontario Graduate Scholarship; NATIONAL CANCER INSTITUTE [R01CA100660] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Western Ontario; Schulich Graduate Enhancement Scholarship; Department of Microbiology and Immunology; Ontario Graduate Scholarship(Ontario Graduate Scholarship); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Juvenile Diabetes Research Foundation International grant 24-2007- and Canadian Institutes of Health Research grant MOP 64386 to Dr. T.L. Delovitch. L. Subramanian was the recipient of Summer Research Training Program Studentship from the University of Western Ontario, H. Blumenfeld was the recipient of a Schulich Graduate Enhancement Scholarship and Department of Microbiology and Immunology Graduate Entrance Fellowship, and R. Tohn was the recipient of a Schulich Graduate Enhancement Scholarship, Department of Microbiology and Immunology Graduate Entrance Fellowship, and Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosino E, 2007, J IMMUNOL, V179, P5126, DOI 10.4049/jimmunol.179.8.5126; Arrenberg P, 2011, GASTROENTEROLOGY, V140, P646, DOI 10.1053/j.gastro.2010.10.003; Arrenberg P, 2010, P NATL ACAD SCI USA, V107, P10984, DOI 10.1073/pnas.1000576107; Arrenberg P, 2009, J CELL PHYSIOL, V218, P246, DOI 10.1002/jcp.21597; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Blomqvist M, 2005, DIABETES-METAB RES, V21, P158, DOI 10.1002/dmrr.519; Blomqvist M, 2003, APMIS, V111, P867, DOI 10.1034/j.1600-0463.2003.1110905.x; Blomqvist M, 2003, J CELL BIOCHEM, V89, P301, DOI 10.1002/jcb.10513; Blomqvist M, 2009, EUR J IMMUNOL, V39, P1726, DOI 10.1002/eji.200839001; Blumenfeld HJ, 2011, CLIN EXP IMMUNOL, V166, P121, DOI 10.1111/j.1365-2249.2011.04454.x; Buschard K, 2005, DIABETOLOGIA, V48, P1957, DOI 10.1007/s00125-005-1926-9; Buschard K, 2005, DIABETIC MED, V22, P1190, DOI 10.1111/j.1464-5491.2005.01613.x; Buschard K, 2001, AUTOIMMUNITY, V34, P9, DOI 10.3109/08916930108994121; Buschard K, 1999, DIABETOLOGIA, V42, P1212, DOI 10.1007/s001250051294; Buschard K, 2006, DIABETES, V55, P2826, DOI 10.2337/db05-1355; Duarte N, 2004, J IMMUNOL, V173, P3112, DOI 10.4049/jimmunol.173.5.3112; Fredman P, 2000, GLYCOBIOLOGY, V10, P39, DOI 10.1093/glycob/10.1.39; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Goff RD, 2004, J AM CHEM SOC, V126, P13602, DOI 10.1021/ja045385q; Halder RC, 2007, J CLIN INVEST, V117, P2302, DOI 10.1172/JCI31602; Hava DL, 2005, CURR OPIN IMMUNOL, V17, P88, DOI 10.1016/j.coi.2004.12.003; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Hussain S, 2005, IMMUNOL RES, V31, P177, DOI 10.1385/IR:31:3:177; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Jeon SB, 2008, J IMMUNOL, V181, P8077, DOI 10.4049/jimmunol.181.11.8077; Kadri N, 2012, J IMMUNOL, V188, P3138, DOI 10.4049/jimmunol.1101390; Kojo S, 2005, J IMMUNOL, V175, P3648, DOI 10.4049/jimmunol.175.6.3648; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Ly D, 2010, CLIN EXP IMMUNOL, V160, P185, DOI 10.1111/j.1365-2249.2009.04074.x; Ly D, 2006, J IMMUNOL, V177, P3695, DOI 10.4049/jimmunol.177.6.3695; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Mi QS, 2004, DIABETES, V53, P1303, DOI 10.2337/diabetes.53.5.1303; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Naumov YN, 2001, P NATL ACAD SCI USA, V98, P13838, DOI 10.1073/pnas.251531798; Osterbye T, 2001, GLYCOBIOLOGY, V11, P473, DOI 10.1093/glycob/11.6.473; Rauch J, 2003, J BIOL CHEM, V278, P47508, DOI 10.1074/jbc.M308089200; Roeske-Nielsen A, 2004, IMMUNOL LETT, V91, P205, DOI 10.1016/j.imlet.2003.12.010; ROSENGREN B, 1989, J NEUROCHEM, V52, P1035, DOI 10.1111/j.1471-4159.1989.tb01844.x; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Sundell I Birgitta, 2010, J Stem Cells, V5, P33, DOI jsc.2010.5.1.33; Tohn R, 2011, CLIN EXP IMMUNOL, V164, P26, DOI 10.1111/j.1365-2249.2011.04323.x; Wang B, 2001, J EXP MED, V194, P313, DOI 10.1084/jem.194.3.313; Wang J, 2008, J IMMUNOL, V181, P2438, DOI 10.4049/jimmunol.181.4.2438; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Wilson SB, 2003, NAT REV IMMUNOL, V3, P211, DOI 10.1038/nri1028; Yamaura A, 2008, BLOOD, V111, P4254, DOI 10.1182/blood-2007-04-085142; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zajonc DM, 2009, IMMUNOL REV, V230, P188, DOI 10.1111/j.1600-065X.2009.00802.x; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625	50	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37771	10.1371/journal.pone.0037771	http://dx.doi.org/10.1371/journal.pone.0037771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649557	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800077
J	Adams, SM; Aksenova, MV; Aksenov, MY; Mactutus, CF; Booze, RM				Adams, Sheila M.; Aksenova, Marina V.; Aksenov, Michael Y.; Mactutus, Charles F.; Booze, Rosemarie M.			Soy Isoflavones Genistein and Daidzein Exert Anti-Apoptotic Actions via a Selective ER-mediated Mechanism in Neurons following HIV-1 Tat(1-86) Exposure	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; SPATIAL MEMORY; DIETARY PHYTOESTROGENS; BETA IMMUNOREACTIVITY; POSTMENOPAUSAL WOMEN; TAT PROTEIN; RATS; INFECTION; ADULT; NEURODEGENERATION	Background: HIV-1 viral protein Tat partially mediates the neural dysfunction and neuronal cell death associated with HIV-1 induced neurodegeneration and neurocognitive disorders. Soy isoflavones provide protection against various neurotoxic insults to maintain neuronal function and thus help preserve neurocognitive capacity. Methodology/Principal Findings: We demonstrate in primary cortical cell cultures that 17 beta-estradiol or isoflavones (genistein or daidzein) attenuate Tat(1-86)-induced expression of apoptotic proteins and subsequent cell death. Exposure of cultured neurons to the estrogen receptor antagonist ICI 182,780 abolished the anti-apoptotic actions of isoflavones. Use of ER alpha or ER beta specific antagonists determined the involvement of both ER isoforms in genistein and daidzein inhibition of caspase activity; ER beta selectively mediated downregulation of mitochondrial pro-apoptotic protein Bax. The findings suggest soy isoflavones effectively diminished HIV-1 Tat-induced apoptotic signaling. Conclusions/Significance: Collectively, our results suggest that soy isoflavones represent an adjunctive therapeutic option with combination anti-retroviral therapy (cART) to preserve neuronal functioning and sustain neurocognitive abilities of HIV-1 infected persons.	[Adams, Sheila M.; Aksenova, Marina V.; Aksenov, Michael Y.; Mactutus, Charles F.; Booze, Rosemarie M.] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Adams, SM (corresponding author), Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA.	Adamssm4@mailbox.sc.edu	Booze, Rosemarie/F-7543-2014	Booze, Rosemarie/0000-0003-3908-8313	National Institutes of Health [DA013137]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD043680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by National Institutes of Health grant DA013137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SM, 2010, SYNAPSE, V64, P829, DOI 10.1002/syn.20793; Aksenov MY, 2009, EXP NEUROL, V219, P586, DOI 10.1016/j.expneurol.2009.07.005; Aksenov MY, 2003, BRAIN RES, V987, P1, DOI 10.1016/S0006-8993(03)03194-9; Aksenova MV, 2009, EXP NEUROL, V215, P253, DOI 10.1016/j.expneurol.2008.10.006; Aksenova MV, 2006, NEUROSCI LETT, V395, P235, DOI 10.1016/j.neulet.2005.10.095; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bjornstrom L, 2005, MECH ESTROGEN RECEPT; Boisse L, 2008, NEUROL CLIN, V26, P799, DOI 10.1016/j.ncl.2008.04.002; Bonavia R, 2001, BIOCHEM BIOPH RES CO, V288, P301, DOI 10.1006/bbrc.2001.5743; Bryant DN, 2010, NEUROSCIENCE, V170, P1261, DOI 10.1016/j.neuroscience.2010.08.019; Bryant DN, 2006, ENDOCRINE, V29, P199, DOI 10.1385/ENDO:29:2:199; Busby MG, 2002, AM J CLIN NUTR, V75, P126, DOI 10.1093/ajcn/75.1.126; Campbell GR, 2011, AIDS RES HUM RETROV, V27, P647, DOI [10.1089/aid.2010.0192, 10.1089/AID.2010.0192]; Casanova M, 1999, TOXICOL SCI, V51, P236, DOI 10.1093/toxsci/51.2.236; Casini ML, 2006, FERTIL STERIL, V85, P972, DOI 10.1016/j.fertnstert.2005.09.048; Clifford David B, 2008, Top HIV Med, V16, P94; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Elzer JG, 2010, J CEREBR BLOOD F MET, V30, P935, DOI 10.1038/jcbfm.2009.258; Ferris MJ, 2010, J NEUROCHEM, V115, P885, DOI 10.1111/j.1471-4159.2010.06968.x; File SE, 2001, PSYCHOPHARMACOLOGY, V157, P430, DOI 10.1007/s002130100845; Fitting S, 2008, BRAIN RES, V1232, P139, DOI 10.1016/j.brainres.2008.07.032; Fitting S, 2006, PHARMACOL BIOCHEM BE, V84, P189, DOI 10.1016/j.pbb.2006.04.014; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hamilton-Reeves JM, 2010, FERTIL STERIL, V94, P997, DOI 10.1016/j.fertnstert.2009.04.038; Herrick SP, 2006, BRAIN RES, V1121, P46, DOI 10.1016/j.brainres.2006.08.084; Hudson L, 2000, J NEUROVIROL, V6, P145, DOI 10.3109/13550280009013158; Hult B, 2008, INT REV PSYCHIATR, V20, P3, DOI 10.1080/09540260701862086; Jorgensen M, 2000, ENVIRON HEALTH PERSP, V108, P403, DOI 10.2307/3454380; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kaul M, 2006, J NEUROIMMUNE PHARM, V1, P138, DOI 10.1007/s11481-006-9011-9; Kim HJ, 2008, J NEUROSCI, V28, P12604, DOI 10.1523/JNEUROSCI.2958-08.2008; King JE, 2006, MICROBES INFECT, V8, P1347, DOI 10.1016/j.micinf.2005.11.014; King JE, 2010, AM J PATHOL, V176, P2819, DOI 10.2353/ajpath.2010.090642; Kostelac D, 2003, J AGR FOOD CHEM, V51, P7632, DOI 10.1021/jf034427b; Lee YB, 2005, J NUTR BIOCHEM, V16, P641, DOI 10.1016/j.jnutbio.2005.06.010; Li WX, 2009, NEUROTOX RES, V16, P205, DOI 10.1007/s12640-009-9047-8; Lindl KA, 2010, J NEUROIMMUNE PHARM, V5, P294, DOI 10.1007/s11481-010-9205-z; Liner Kevin J 2nd, 2008, Curr HIV/AIDS Rep, V5, P64, DOI 10.1007/s11904-008-0011-7; Luine V, 2006, BRAIN RES, V1126, P183, DOI 10.1016/j.brainres.2006.07.016; Luine VN, 1998, HORM BEHAV, V34, P149, DOI 10.1006/hbeh.1998.1473; Lund TD, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-20; Mediouni Sonia, 2012, Infectious Disorders - Drug Targets, V12, P81; Messina M, 2006, NUTR CANCER, V55, P1, DOI 10.1207/s15327914nc5501_1; Moore DJ, 2006, AIDS, V20, P879, DOI 10.1097/01.aids.0000218552.69834.00; Mortensen A, 2009, MOL NUTR FOOD RES, V53, pS266, DOI 10.1002/mnfr.200800478; Nath A, 2002, J INFECT DIS, V186, pS193, DOI 10.1086/344528; Neese SL, 2010, NEUROTOXICOL TERATOL, V32, P200, DOI 10.1016/j.ntt.2009.11.003; Pan YL, 2000, MENOPAUSE, V7, P230, DOI 10.1097/00042192-200007040-00004; Paruthiyil S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006271; Patisaul HB, 2010, FRONT NEUROENDOCRIN, V31, P400, DOI 10.1016/j.yfrne.2010.03.003; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Reeves GK, 2006, LANCET ONCOL, V7, P910, DOI 10.1016/S1470-2045(06)70911-1; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rumbaugh Jeffrey A, 2008, Futur HIV Ther, V2, P271, DOI 10.2217/17469600.2.3.271; Self RL, 2004, BRAIN RES, V995, P39, DOI 10.1016/j.brainres.2003.09.052; Setchell KDR, 1999, J NUTR, V129, p758S, DOI 10.1093/jn/129.3.758S; Sheldahl LC, 2008, NEUROSCIENCE, V153, P751, DOI 10.1016/j.neuroscience.2008.02.035; Shughrue PJ, 2001, J COMP NEUROL, V436, P64; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Silvers JM, 2007, NEUROTOXICOLOGY, V28, P1184, DOI 10.1016/j.neuro.2007.07.005; Stennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299, DOI 10.1016/S0167-4838(99)00281-2; Tee MK, 2004, MOL BIOL CELL, V15, P1262, DOI 10.1091/mbc.E03-06-0360; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Zeng HY, 2004, FREE RADICAL BIO MED, V36, P180, DOI 10.1016/j.freeradbiomed.2003.10.018; Zhao LQ, 2009, ENDOCRINOLOGY, V150, P770, DOI 10.1210/en.2008-0715; Zhao LQ, 2004, BRAIN RES, V1010, P22, DOI 10.1016/j.brainres.2004.02.066; Zhao LX, 2002, EXP BIOL MED, V227, P509, DOI 10.1177/153537020222700716; Zhu J, 2009, J PHARMACOL EXP THER, V329, P1071, DOI 10.1124/jpet.108.150144	70	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37540	10.1371/journal.pone.0037540	http://dx.doi.org/10.1371/journal.pone.0037540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629415	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345300050
J	Hu, ZH; Ma, XW; Qu, XC; Yang, WD; Liang, JM; Wang, J; Tian, J				Hu, Zhenhua; Ma, Xiaowei; Qu, Xiaochao; Yang, Weidong; Liang, Jimin; Wang, Jing; Tian, Jie			Three-dimensional Noninvasive Monitoring Iodine-131 Uptake in the Thyroid Using a Modified Cerenkov Luminescence Tomography Approach	PLOS ONE			English	Article							POSITRON-EMITTING RADIOTRACERS; BIOLUMINESCENCE TOMOGRAPHY; OPTICAL-PROPERTIES; RECONSTRUCTION; RADIATION; LIGHT; MODEL; MEDIA	Background: Cerenkov luminescence tomography (CLT) provides the three-dimensional (3D) radiopharmaceutical biodistribution in small living animals, which is vital to biomedical imaging. However, existing single-spectral and multispectral methods are not very efficient and effective at reconstructing the distribution of the radionuclide tracer. In this paper, we present a semi-quantitative Cerenkov radiation spectral characteristic-based source reconstruction method named the hybrid spectral CLT, to efficiently reconstruct the radionuclide tracer with both encouraging reconstruction results and less acquisition and image reconstruction time. Methodology/Principal Findings: We constructed the implantation mouse model implanted with a 400 mu Ci (NaI)-I-131 radioactive source and the physiological mouse model received an intravenous tail injection of 400 mu Ci radiopharmaceutical Iodine-131 (I-131) to validate the performance of the hybrid spectral CLT and compared the reconstruction results, acquisition, and image reconstruction time with that of single-spectral and multispectral CLT. Furthermore, we performed 3D noninvasive monitoring of I-131 uptake in the thyroid and quantified I-131 uptake in vivo using hybrid spectral CLT. Results showed that the reconstruction based on the hybrid spectral CLT was more accurate in localization and quantification than using single-spectral CLT, and was more efficient in the in vivo experiment compared with multispectral CLT. Additionally, 3D visualization of longitudinal observations suggested that the reconstructed energy of I-131 uptake in the thyroid increased with acquisition time and there was a robust correlation between the reconstructed energy versus the gamma ray counts of I-131 (r(2) = 0.8240). The ex vivo biodistribution experiment further confirmed the I-131 uptake in the thyroid for hybrid spectral CLT. Conclusions/Significance: Results indicated that hybrid spectral CLT could be potentially used for thyroid imaging to evaluate its function and monitor its treatment for thyroid cancer.	[Hu, Zhenhua; Qu, Xiaochao; Liang, Jimin; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China; [Ma, Xiaowei; Yang, Weidong; Wang, Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Nucl Med, Xian 710032, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Air Force Military Medical University; Chinese Academy of Sciences; Institute of Automation, CAS	Hu, ZH (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China.	wangjin@fmmu.edu.cn; tian@ieee.org	Ma, Xiaowei/AAC-3232-2019; Liang, Jimin/B-5394-2014; Tian, Jie/H-1190-2011; Hu, Zhenhua/E-3375-2016; Wang, Jing/G-5261-2018; Life, MC/M-9554-2013; Hu, Zhenhua/V-1399-2019; Tian, Jie/M-5675-2013	Ma, Xiaowei/0000-0002-3062-4063; Liang, Jimin/0000-0003-1428-5804; Tian, Jie/0000-0003-0498-0432; 	National Basic Research and Development Program of China (973) [2011CB707702]; National Natural Science Foundation of China [81090272, 81101083, 81101084, 81101100, 81000632, 30900334, 30970847]; Shaanxi Provincial Natural Science Foundation Research Project [2009JQ8018]; Fundamental Research Funds for the Central Universities	National Basic Research and Development Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Natural Science Foundation Research Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the National Basic Research and Development Program of China (973) under Grant No. 2011CB707702; the National Natural Science Foundation of China under Grant Nos. 81090272, 81101083, 81101084, 81101100, 81000632, 30900334, 30970847; the Shaanxi Provincial Natural Science Foundation Research Project under Grant No. 2009JQ8018; and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrakis G, 2005, PHYS MED BIOL, V50, P4225, DOI 10.1088/0031-9155/50/17/021; Boschi F, 2011, EUR J NUCL MED MOL I, V38, P120, DOI 10.1007/s00259-010-1630-y; Boschi F, 2009, PHYS MED BIOL, V54, pL57, DOI 10.1088/0031-9155/54/23/L01; Cerenkov PA, 1934, DOKL AKAD NAUK SSSR, V2, P451; Chen XL, 2010, OPT EXPRESS, V18, P19876, DOI 10.1364/OE.18.019876; Dothager RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013300; FARRELL TJ, 1992, MED PHYS, V19, P879, DOI 10.1118/1.596777; Frank I, 1937, CR ACAD SCI URSS, V14, P109; Gill P.E., 1981, PRACTICAL OPTIMIZATI; Gurfinkel M, 2004, J BIOMED OPT, V9, P1336, DOI 10.1117/1.1803549; Han RQ, 2009, OPT EXPRESS, V17, P14481, DOI 10.1364/OE.17.014481; He XW, 2010, OPT EXPRESS, V18, P24825, DOI 10.1364/OE.18.024825; Holland JP, 2011, MOL IMAGING, V10, P177, DOI 10.2310/7290.2010.00047; Hu ZH, 2010, OPT EXPRESS, V18, P24441, DOI 10.1364/OE.18.024441; JELLEY JV, 1955, BRIT J APPL PHYS, V6, P227, DOI 10.1088/0508-3443/6/7/301; Li CQ, 2010, OPT LETT, V35, P1109, DOI 10.1364/OL.35.001109; Liu HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009470; Liu JT, 2010, IEEE T BIO-MED ENG, V57, P2579, DOI 10.1109/TBME.2010.2056370; Mitchell GS, 2011, PHILOS T R SOC A, V369, P4605, DOI 10.1098/rsta.2011.0271; Qin CH, 2011, J BIOPHOTONICS, V4, P824, DOI 10.1002/jbio.201100049; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01; Ruggiero A, 2010, J NUCL MED, V51, P1123, DOI 10.2967/jnumed.110.076521; SCHWEIGER M, 1995, MED PHYS, V22, P1779, DOI 10.1118/1.597634; Spinelli AE, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3653963; Spinelli AE, 2011, OPT EXPRESS, V19, P12605, DOI 10.1364/OE.19.012605; Spinelli AE, 2010, PHYS MED BIOL, V55, P483, DOI 10.1088/0031-9155/55/2/010; Wang G, 2004, MED PHYS, V31, P2289, DOI 10.1118/1.1766420; Welch J., 1995, OPTICAL THERMAL RESP; Yan GR, 2008, J X-RAY SCI TECHNOL, V16, P225	29	28	33	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37623	10.1371/journal.pone.0037623	http://dx.doi.org/10.1371/journal.pone.0037623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629431	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300063
J	Xiao, FX; Hiremath, S; Knoll, G; Zimpelmann, J; Srivaratharajah, K; Jadhav, D; Fergusson, D; Kennedy, CRJ; Burns, KD				Xiao, Fengxia; Hiremath, Swapnil; Knoll, Greg; Zimpelmann, Joseph; Srivaratharajah, Kajenny; Jadhav, Deepak; Fergusson, Dean; Kennedy, Chris R. J.; Burns, Kevin D.			Increased Urinary Angiotensin-Converting Enzyme 2 in Renal Transplant Patients with Diabetes	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME-2; EXPRESSION; ACE2	Angiotensin-converting enzyme 2 (ACE2) is expressed in the kidney and may be a renoprotective enzyme, since it converts angiotensin (Ang) II to Ang-(1-7). ACE2 has been detected in urine from patients with chronic kidney disease. We measured urinary ACE2 activity and protein levels in renal transplant patients (age 54 yrs, 65% male, 38% diabetes, n = 100) and healthy controls (age 45 yrs, 26% male, n = 50), and determined factors associated with elevated urinary ACE2 in the patients. Urine from transplant subjects was also assayed for ACE mRNA and protein. No subjects were taking inhibitors of the renin-angiotensin system. Urinary ACE2 levels were significantly higher in transplant patients compared to controls (p = 0.003 for ACE2 activity, and p <= 0.001 for ACE2 protein by ELISA or western analysis). Transplant patients with diabetes mellitus had significantly increased urinary ACE2 activity and protein levels compared to non-diabetics (p<0.001), while ACE2 mRNA levels did not differ. Urinary ACE activity and protein were significantly increased in diabetic transplant subjects, while ACE mRNA levels did not differ from non-diabetic subjects. After adjusting for confounding variables, diabetes was significantly associated with urinary ACE2 activity (p = 0.003) and protein levels (p<0.001), while female gender was associated with urinary mRNA levels for both ACE2 and ACE. These data indicate that urinary ACE2 is increased in renal transplant recipients with diabetes, possibly due to increased shedding from tubular cells. Urinary ACE2 could be a marker of renal renin-angiotensin system activation in these patients.	[Xiao, Fengxia; Hiremath, Swapnil; Knoll, Greg; Zimpelmann, Joseph; Srivaratharajah, Kajenny; Jadhav, Deepak; Fergusson, Dean; Kennedy, Chris R. J.; Burns, Kevin D.] Univ Ottawa, Div Nephrol, Dept Med, Ottawa Hosp,Res Inst,Kidney Res Ctr, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute	Xiao, FX (corresponding author), Univ Ottawa, Div Nephrol, Dept Med, Ottawa Hosp,Res Inst,Kidney Res Ctr, Ottawa, ON, Canada.	kburns@ottawahospital.on.ca	Hiremath, Swapnil/H-3492-2019	Hiremath, Swapnil/0000-0003-0010-3416; Knoll, Greg/0000-0001-5442-9310; Fergusson, Dean/0000-0002-3389-2485	Canadian Institutes of Health Research [MOP110929]; Kidney Foundation of Canada [KFOC100005]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada	The sources of funding that have supported the work include: Canadian Institutes of Health Research: grant number: MOP110929; http://www.cihr-irsc.gc.ca/; and The Kidney Foundation of Canada: grant number: KFOC100005; http://www.kidney.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casarini DE, 2001, INT J BIOCHEM CELL B, V33, P75, DOI 10.1016/S1357-2725(00)00072-8; Dilauro M, 2010, AM J PHYSIOL-RENAL, V298, pF1523, DOI 10.1152/ajprenal.00426.2009; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; HERMANN K, 1992, CLIN CHEM, V38, P1768; Iwata M, 2009, AM J PHYSIOL-CELL PH, V297, pC1318, DOI 10.1152/ajpcell.00036.2009; Ji H, 2008, EXP PHYSIOL, V93, P648, DOI 10.1113/expphysiol.2007.041392; Jia HP, 2009, AM J PHYSIOL-LUNG C, V297, pL84, DOI 10.1152/ajplung.00071.2009; Koitka A, 2008, CLIN EXP PHARMACOL P, V35, P420, DOI 10.1111/j.1440-1681.2008.04889.x; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Leehey DJ, 2008, TRANSL RES, V151, P208, DOI 10.1016/j.trsl.2008.01.003; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li NJ, 2005, AM J PHYSIOL-RENAL, V288, pF353, DOI 10.1152/ajprenal.00144.2004; Melenhorst WB, 2009, AM J PHYSIOL-RENAL, V297, pF781, DOI 10.1152/ajprenal.90610.2008; MEZZANO S, 2003, KIDNEY INT S, V86, P64; Mizuiri S, 2011, NEPHROLOGY, V16, P567, DOI 10.1111/j.1440-1797.2011.01467.x; Oudit GY, 2006, AM J PATHOL, V168, P1808, DOI 10.2353/ajpath.2006.051091; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Reich HN, 2008, KIDNEY INT, V74, P1610, DOI 10.1038/ki.2008.497; Shaltout HA, 2007, AM J PHYSIOL-RENAL, V292, P82; Su Z, 2006, KIDNEY INT, V69, P2212, DOI 10.1038/sj.ki.5001509; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Wang G, 2008, DIABETOLOGIA, V51, P1062, DOI 10.1007/s00125-008-0988-x; Warner FJ, 2005, J BIOL CHEM, V280, P39353, DOI 10.1074/jbc.M508914200; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Wysocki J, 2010, HYPERTENSION, V55, P90, DOI 10.1161/HYPERTENSIONAHA.109.138420; Ye MH, 2004, HYPERTENSION, V43, P1120, DOI 10.1161/01.HYP.0000126192.27644.76	28	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37649	10.1371/journal.pone.0037649	http://dx.doi.org/10.1371/journal.pone.0037649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629438	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345300066
J	Yao, YF; Bruch, AA; Cheng, YM; Mosbrugger, V; Wang, YF; Li, CS				Yao, Yi-Feng; Bruch, Angela A.; Cheng, Ye-Ming; Mosbrugger, Volker; Wang, Yu-Fei; Li, Cheng-Sen			Monsoon versus Uplift in Southwestern China-Late Pliocene Climate in Yuanmou Basin, Yunnan	PLOS ONE			English	Article							EAST-ASIAN MONSOON; PALEOCLIMATE; SEA; PALEOVEGETATION; RECONSTRUCTION; EVOLUTION; RECORD; MA	Yuanmou Basin of Yunnan, SW China, is a famous locality with hominids, hominoids, mammals and plant fossils. Based on the published megaflora and palynoflora data from Yuanmou Basin, the climate of Late Pliocene is reconstructed using the Coexistence Approach. The results indicate a warm and humid subtropical climate with a mean annual temperature of ca. 16-17 degrees C and a mean annual precipitation of ca. 1500-1600 mm in the Late Pliocene rather than a dry, hot climate today, which may be due to the local tectonic change and gradual intensification of India monsoon. The comparison of Late Pliocene climate in Eryuan, Yangyi, Longling, and Yuanmou Basin of Yunnan Province suggests that the mean annual temperatures generally show a latitudinal gradient and fit well with their geographic position, while the mean annual precipitations seem to be related to the different geometries of the valleys under the same monsoon system.	[Yao, Yi-Feng; Wang, Yu-Fei; Li, Cheng-Sen] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Bruch, Angela A.] Senckenberg Res Inst, Heidelberg Acad Sci & Humanities, Res Ctr Role Culture Early Expans Humans, Frankfurt, Germany; [Cheng, Ye-Ming] Geol Museum China, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Senckenberg Gesellschaft fur Naturforschung (SGN)	Yao, YF (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	lics@ibcas.ac.cn			National Natural Science Foundation of China [30990241, 31170206, 40701191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is financially supported by the National Natural Science Foundation of China (Nos. 30990241, 31170206, 40701191). This work is a contribution to the program "Neogene Climate Evolution in Eurasia-NECLIME". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; *BGMRYP, 1990, GEOL MEM 1; Bien M. N., 1940, Bulletin of the Geological Society of China, V20, P179; Chang ZG, 2010, J ASIAN EARTH SCI, V37, P166, DOI 10.1016/j.jseaes.2009.08.005; Chen ZY, 2001, CLIMATE YUNNAN; Cheng YM, 2007, ACTA PHYTOTAXON SIN, V45, P315, DOI 10.1360/aps050119; Cheng YM, 2006, IAWA J, V27, P145, DOI 10.1163/22941932-90000144; [程业明 Cheng Yeming], 2005, [古地理学报, Journal of palaeogeography], V7, P107; Ciochon RL, 2009, NATURE, V459, P910, DOI 10.1038/459910a; Hess S, 2005, MAR MICROPALEONTOL, V54, P63, DOI 10.1016/j.marmicro.2004.09.004; Hu C., 1973, ACTA GEOL SIN-ENGL, V1, P65; IDBMC, 1984, LAND CLIM DAT CHIN 5, p[4, 86]; Jiang NR, 1989, YUNNAN GEOLOGY S, V8, P96; Kleiven HF, 2002, PALAEOGEOGR PALAEOCL, V184, P213; Kou XY, 2006, CLIMATIC CHANGE, V77, P431, DOI 10.1007/s10584-005-9039-5; Li CS, 2008, VEGETATION SUCCESSIO, V1; Li DY., 1989, YUNNAN GEOLOGY S, P35; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; [刘耕武 Liu Gengwu], 2002, [古生物学报, Acta Palaeontologica Sinica], V41, P1; Mosbrugger V, 1997, PALAEOGEOGR PALAEOCL, V134, P61, DOI 10.1016/S0031-0182(96)00154-X; Mosbrugger V, 2005, P NATL ACAD SCI USA, V102, P14964, DOI 10.1073/pnas.0505267102; Pu Q., 1977, ACTA GEOL SIN-ENGL, V1, P89; Qian F, 1984, YUANMOU MAN, P3; Qian F, 1991, QUATERNARY GEOLOGY P; Song XL, 1989, YUNNAN GEOLOGY S, V8, P32; Song Z-C, 1999, FOSSIL SPORES POLLEN, V1; Tian J, 2004, QUATERNARY SCI REV, V23, P2007, DOI 10.1016/j.quascirev.2004.02.013; Urabe A, 2001, QUATERNARY SCI REV, V20, P1671, DOI 10.1016/S0277-3791(01)00023-3; Walker J. D., 2009, GSA TODAY, V19, P60, DOI DOI 10.1130/2009.CTS004R2C; Wan SM, 2006, PALAEOGEOGR PALAEOCL, V241, P139, DOI 10.1016/j.palaeo.2006.06.013; Wehausen R, 2002, EARTH PLANET SC LETT, V201, P621, DOI 10.1016/S0012-821X(02)00746-X; Willis KJ, 1999, SCIENCE, V285, P568, DOI 10.1126/science.285.5427.568; Writing Group of Cenozoic Plants of China (WGCPC), 1978, CEN PLANTS CHIN FOSS, V3; Writing Group of Yunnan Vegetation (WGYV), 1987, VEG YUNN; Wu X.Z., 1995, HUMAN EVOLUTION CHIN; Yao YF, 2009, CLIMATIC CHANGE, V92, P169, DOI 10.1007/s10584-008-9457-2; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhang Zonghu, 1994, Marine Geology & Quaternary Geology (Beijing), V14, P1; Zhu RX, 2008, J HUM EVOL, V55, P1075, DOI 10.1016/j.jhevol.2008.08.005	39	25	28	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37760	10.1371/journal.pone.0037760	http://dx.doi.org/10.1371/journal.pone.0037760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629452	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300075
J	Fallah, M; Reynolds, JH				Fallah, Mazyar; Reynolds, John H.			Contrast Dependence of Smooth Pursuit Eye Movements following a Saccade to Superimposed Targets	PLOS ONE			English	Article							ATTENTIONAL MODULATION; AREA MT; NORMALIZATION MODEL; SPATIAL SUMMATION; SIMPLE CELLS; VISUAL AREA; SELECTION; INTEGRATION; INITIATION; LUMINANCE	Dorsal stream areas provide motion information used by the oculomotor system to generate pursuit eye movements. Neurons in these areas saturate at low levels of luminance contrast. We therefore hypothesized that during the early phase of pursuit, eye velocity would exhibit an oculomotor gain function that saturates at low luminance contrast. To test this, we recorded eye movements in two macaques trained to saccade to an aperture in which a pattern of dots moved left or right. Shortly after the end of the saccade, the eyes followed the direction of motion with an oculomotor gain that increased with contrast before saturating. The addition of a second pattern of dots, moving in the opposite direction and superimposed on the first, resulted in a rightward shift of the contrast-dependent oculomotor gain function. The magnitude of this shift increased with the contrast of the second pattern of dots. Motion was nulled when the two patterns were equal in contrast. Next, we varied contrast over time. Contrast differences that disappeared before saccade onset biased post-saccadic eye movements at short latency. Changes in contrast occurring during or after saccade termination did not influence eye movements for approximately 150 ms. Earlier studies found that eye movements can be explained by a vector average computation when both targets are equal in contrast. We suggest that this averaging computation may reflect a special case of divisive normalization, yielding saturating contrast response functions that shift to the right with opposed motion, averaging motions when targets are equated in contrast.	[Fallah, Mazyar] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Reynolds, John H.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	York University - Canada; Salk Institute	Fallah, M (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	mfallah@yorku.ca	Fallah, Mazyar/ABH-9906-2020	Fallah, Mazyar/0000-0001-5979-3955	National Institutes of Health [1R01EY13802-01]; Gatsby Charitable Foundation; NATIONAL EYE INSTITUTE [R01EY013802] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grant 1R01EY13802-01 and a grant from the Gatsby Charitable Foundation (http://www.gatsby.org.uk/) to JHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Baldauf D, 2008, J NEUROSCI, V28, P10081, DOI 10.1523/JNEUROSCI.3423-08.2008; Born RT, 2002, PROG BRAIN RES, V140, P225; Britten KH, 1999, J NEUROSCI, V19, P5074; Carandini M, 1997, J NEUROSCI, V17, P8621; Case GR, 2007, J NEUROPHYSIOL, V98, P2206, DOI 10.1152/jn.00021.2007; DURSTELER MR, 1988, J NEUROPHYSIOL, V60, P940, DOI 10.1152/jn.1988.60.3.940; FERRERA VP, 1995, J NEUROSCI, V15, P7472; Gardner JL, 2002, NAT NEUROSCI, V5, P892, DOI 10.1038/nn897; Gegenfurtner KR, 1996, VISION RES, V36, P1281, DOI 10.1016/0042-6989(95)00198-0; GELLMAN RS, 1990, VISUAL NEUROSCI, V5, P107, DOI 10.1017/S0952523800000158; Ghose GM, 2008, J NEUROSCI, V28, P5115, DOI 10.1523/JNEUROSCI.0138-08.2008; Groh JM, 1997, J NEUROSCI, V17, P4312; GROSSBERG S, 1973, STUD APPL MATH, V52, P213; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Heuer HW, 2002, J NEUROPHYSIOL, V88, P3398, DOI 10.1152/jn.00255.2002; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kawano K, 1999, CURR OPIN NEUROBIOL, V9, P467, DOI 10.1016/S0959-4388(99)80070-1; KELLER EL, 1991, NEUROSCI RES, V11, P79, DOI 10.1016/0168-0102(91)90048-4; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Krauzlis RJ, 1996, J NEUROPHYSIOL, V76, P4175, DOI 10.1152/jn.1996.76.6.4175; Krauzlis RJ, 1996, J NEUROPHYSIOL, V76, P2822, DOI 10.1152/jn.1996.76.5.2822; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Lisberger SG, 1997, J NEUROSCI, V17, P7490; LISBERGER SG, 1985, J NEUROSCI, V5, P1662; Lisberger SG, 2010, NEURON, V66, P477, DOI 10.1016/j.neuron.2010.03.027; Liston D, 2003, J NEUROSCI, V23, P11305; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Miles FA, 1986, J NEUROPHYSIOL, V56, P1437; MOULDEN B, 1990, PERCEPTION, V19, P79, DOI 10.1068/p190079; Munoz DP, 2002, PROG BRAIN RES, V140, P89; Niu YQ, 2011, J NEUROPHYSIOL, V106, P741, DOI 10.1152/jn.01025.2010; Nothdurft HC, 2000, VISION RES, V40, P2421, DOI 10.1016/S0042-6989(00)00112-7; Recanzone GH, 1999, J NEUROPHYSIOL, V82, P1710, DOI 10.1152/jn.1999.82.4.1710; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 2003, VISION RES, V43, P59, DOI 10.1016/S0042-6989(02)00403-0; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; RODMAN HR, 1987, VISION RES, V27, P2035, DOI 10.1016/0042-6989(87)90118-0; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; SPERLING G, 1968, J OPT SOC AM, V58, P1133, DOI 10.1364/JOSA.58.001133; STONE LS, 1992, VISION RES, V32, P1535, DOI 10.1016/0042-6989(92)90209-2; Takemura A, 2006, ANN NY ACAD SCI, V956, P456; Tchernikov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009338; Valdes-Sosa M, 2000, J EXP PSYCHOL HUMAN, V26, P488, DOI 10.1037/0096-1523.26.2.488; Wannig A, 2007, NEURON, V54, P639, DOI 10.1016/j.neuron.2007.05.001; Watamaniuk SNJ, 2011, VISION RES, V51, P1129, DOI 10.1016/j.visres.2011.03.003	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37888	10.1371/journal.pone.0037888	http://dx.doi.org/10.1371/journal.pone.0037888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629467	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343100057
J	Koch, AM; Antunes, PM; Klironomos, JN				Koch, Alexander M.; Antunes, Pedro M.; Klironomos, John N.			Diversity Effects on Productivity Are Stronger within than between Trophic Groups in the Arbuscular Mycorrhizal Symbiosis	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; FUNCTIONAL DIVERSITY; GENETIC-VARIABILITY; FUNGAL DIVERSITY; BIODIVERSITY; COLONIZATION; COMMUNITIES; FEEDBACK; POPULATION; STABILITY	Background: The diversity of plants and arbuscular mycorrhizal fungi (AMF) has been experimentally shown to alter plant and AMF productivity. However, little is known about how plant and AMF diversity interact to shape their respective productivity. Methodology/Principal Findings: We co-manipulated the diversity of both AMF and plant communities in two greenhouse studies to determine whether the productivity of each trophic group is mainly influenced by plant or AMF diversity, respectively, and whether there is any interaction between plant and fungal diversity. In both experiments we compared the productivity of three different plant species monocultures, or their respective 3-species mixtures. Similarly, in both studies these plant treatments were crossed with an AMF diversity gradient that ranged from zero (non-mycorrhizal controls) to a maximum of three and five taxonomically distinct AMF taxa, respectively. We found that within both trophic groups productivity was significantly influenced by taxon identity, and increased with taxon richness. These main effects of AMF and plant diversity on their respective productivities did not depend on each other, even though we detected significant individual taxon effects across trophic groups. Conclusions/Significance: Our results indicate that similar ecological processes regulate diversity-productivity relationships within trophic groups. However, productivity-diversity relationships are not necessarily correlated across interacting trophic levels, leading to asymmetries and possible biotic feedbacks. Thus, biotic interactions within and across trophic groups should be considered in predictive models of community assembly.	[Koch, Alexander M.; Antunes, Pedro M.; Klironomos, John N.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Koch, AM (corresponding author), Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada.	akoch13@gmail.com	Madeira Antunes, Pedro/C-2949-2008	Madeira Antunes, Pedro/0000-0003-3596-6983	Swiss National Science Foundation [PBLAA-114210, PAOOA-119519]; Roche Research Foundation; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Natural Resources	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Research Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Natural Resources	AMK was supported by fellowships from the Swiss National Science Foundation (http://www.snf.ch, projects PBLAA-114210 and PAOOA-119519) and the Roche Research Foundation. The authors also thank the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) for financial support through a Discovery grant to JNK and PMA, and the Ontario Ministry of Natural Resources (http://www.mnr.gov.on.ca) for financial support to PMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes PM, 2011, NEW PHYTOL, V189, P507, DOI 10.1111/j.1469-8137.2010.03480.x; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Burrows RL, 2002, CAN J BOT, V80, P120, DOI [10.1139/b01-138, 10.1139/B01-138]; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; De Deyn GB, 2011, BIOL LETTERS, V7, P75, DOI 10.1098/rsbl.2010.0575; DOBSON A, 1994, TRENDS ECOL EVOL, V9, P393, DOI 10.1016/0169-5347(94)90062-0; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Grace JB, 2007, ECOL LETT, V10, P680, DOI 10.1111/j.1461-0248.2007.01058.x; GRIME JP, 1987, NATURE, V328, P420, DOI 10.1038/328420a0; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Hausmann NT, 2009, NEW PHYTOL, V183, P1188, DOI 10.1111/j.1469-8137.2009.02882.x; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Helgason T, 2002, J ECOL, V90, P371, DOI 10.1046/j.1365-2745.2001.00674.x; Helgason T, 2009, J EXP BOT, V60, P2465, DOI 10.1093/jxb/erp144; Hoeksema JD, 2010, NEW PHYTOL, V187, P286, DOI 10.1111/j.1469-8137.2010.03305.x; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jansa J, 2008, NEW PHYTOL, V177, P779, DOI 10.1111/j.1469-8137.2007.02294.x; Johnson D, 2004, NEW PHYTOL, V161, P503, DOI 10.1046/j.1469-8137.2003.00938.x; KLIRONOMOS JN, 1993, CAN J BOT, V71, P1472, DOI 10.1139/b93-178; Klironomos JN, 2000, ECOL LETT, V3, P137, DOI 10.1046/j.1461-0248.2000.00131.x; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Klironomos JN, 2002, MYCORRHIZA, V12, P181, DOI 10.1007/s00572-002-0169-6; Klironomos J, 2011, NEW PHYTOL, V189, P366, DOI 10.1111/j.1469-8137.2010.03550.x; Koch AM, 2011, BIOL INVASIONS, V13, P1627, DOI 10.1007/s10530-010-9920-7; Koch AM, 2006, ECOL LETT, V9, P103, DOI 10.1111/j.1461-0248.2005.00853.x; Koch AM, 2004, P NATL ACAD SCI USA, V101, P2369, DOI 10.1073/pnas.0306441101; Konig S, 2010, APPL ENVIRON MICROB, V76, P3765, DOI 10.1128/AEM.02951-09; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; MILLER MH, 1995, CRIT REV BIOTECHNOL, V15, P241, DOI 10.3109/07388559509147411; Molofsky J, 2002, ECOLOGY, V83, P21; Munkvold L, 2004, NEW PHYTOL, V164, P357, DOI 10.1111/j.1469-8137.2004.01169.x; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Pringle A, 2002, TRENDS MICROBIOL, V10, P474, DOI 10.1016/S0966-842X(02)02447-2; Reich PB, 1997, ECOLOGY, V78, P335, DOI 10.1890/0012-9658(1997)078[0335:NMAPIH]2.0.CO;2; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Sanders IR, 2010, ANNU REV GENET, V44, P271, DOI 10.1146/annurev-genet-102108-134239; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vogelsang KM, 2006, NEW PHYTOL, V172, P554, DOI 10.1111/j.1469-8137.2006.01854.x; Wagg C, 2011, ECOL LETT, V14, P1001, DOI 10.1111/j.1461-0248.2011.01666.x; Wagg C, 2011, ECOLOGY, V92, P1303, DOI 10.1890/10-1915.1; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6	51	17	20	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e36950	10.1371/journal.pone.0036950	http://dx.doi.org/10.1371/journal.pone.0036950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629347	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100009
J	Kim, YC; Kim, BG; Lee, JH				Kim, Young-Chae; Kim, Byoung-Gie; Lee, Je-Ho			Thymosin beta(10) Expression Driven by the Human TERT Promoter Induces Ovarian Cancer-Specific Apoptosis through ROS Production	PLOS ONE			English	Article							MESSENGER-RNA; CELL-DEATH; TELOMERASE ACTIVITY; ACTIN CYTOSKELETON; GENE-EXPRESSION; BETA-10 GENE; BAX GENE; STRESS; OVEREXPRESSION; JASPLAKINOLIDE	Thymosin beta(10) (T beta(10)) regulates actin dynamics as a cytoplasm G-actin sequestering protein. Previously, we have shown that T beta(10) diminishes tumor growth, angiogenesis, and proliferation by disrupting actin and by inhibiting Ras. However, little is known about its mechanism of action and biological function. In the present study, we establish a new gene therapy model using a genetically modified adenovirus, referred to as Ad.TERT.T beta(10), that can overexpress the T beta(10) gene in cancer cells. This was accomplished by replacing the native T beta(10) gene promoter with the human TERT promoter in Ad. TERT. T beta(10). We investigated the cancer suppression activity of T beta(10) and found that Ad.TERT.T beta(10) strikingly induced cancer-specific expression of T beta(10) as well as apoptosis in a co-culture model of human primary ovarian cancer cells and normal fibroblasts. Additionally, Ad.TERT.T beta(10) decreased mitochondrial membrane potential and increased reactive oxygen species (ROS) production. These effects were amplified by co-treatment with anticancer drugs, such as paclitaxel and cisplatin. These findings indicate that the rise in ROS production due to actin disruption by T beta(10) overexpression increases apoptosis of human ovarian cancer cells. Indeed, the cancer-specific overexpression of T beta(10) by Ad.TERT.T beta(10) could be a valuable anticancer therapeutic for the treatment of ovarian cancer without toxicity to normal cells.	[Kim, Young-Chae; Kim, Byoung-Gie; Lee, Je-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol,Mol Therapy Res Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, YC (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol,Mol Therapy Res Ctr, Seoul, South Korea.	bksong.kim@samsung.com; mtrc25@yahoo.com		Kim, Young-Chae/0000-0002-5130-4413	Korean government	Korean government(Korean Government)	The funding source is the Korean government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi KNI, 2004, BLOOD, V103, P1319, DOI 10.1182/blood-2003-04-1015; Alldinger I, 2005, PANCREATOLOGY, V5, P370, DOI 10.1159/000086537; Anadon R, 2001, BRAIN RES, V894, P255, DOI 10.1016/S0006-8993(01)02024-8; Ballweber E, 2002, J MOL BIOL, V315, P613, DOI 10.1006/jmbi.2001.5281; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Bilsland AE, 2003, ONCOGENE, V22, P370, DOI 10.1038/sj.onc.1206168; Caers J, 2010, HAEMATOL-HEMATOL J, V95, P163, DOI 10.3324/haematol.2009.006411; Cha HJ, 2003, J NATL CANCER I, V95, P1674, DOI 10.1093/jnci/djg100; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Davies AH, 2011, BIOCHEM J, V436, P517, DOI 10.1042/BJ20110106; During RL, 2007, EMBO J, V26, P2240, DOI 10.1038/sj.emboj.7601687; Giovanni S, 2002, THYROID, V12, P765; Gourlay CW, 2006, MOL CELL BIOL, V26, P6487, DOI 10.1128/MCB.00117-06; Gourlay CW, 2005, BIOCHEM SOC T, V33, P1260, DOI 10.1042/BST0331260; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Gu J, 2000, CANCER RES, V60, P5359; Gu J, 2002, ONCOGENE, V21, P4757, DOI 10.1038/sj.onc.1205582; HALL AK, 1994, RENAL FAILURE, V16, P243, DOI 10.3109/08860229409044864; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hastings ML, 2001, RNA, V7, P471, DOI 10.1017/S1355838201002552; Kim A, 2008, KOREAN J OBSTET GYNE, V51, P518; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Koutrafouri V, 2001, BBA-GEN SUBJECTS, V1568, P60, DOI 10.1016/S0304-4165(01)00200-8; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lee SH, 2005, FEBS LETT, V579, P1027, DOI 10.1016/j.febslet.2005.01.005; Lee SH, 2005, CANCER RES, V65, P137; Lee SH, 2001, ONCOGENE, V20, P6700, DOI 10.1038/sj.onc.1204683; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Martins NM, 2008, J APPL TOXICOL, V28, P337, DOI 10.1002/jat.1284; Misteli T, 1996, MOL BIOL CELL, V7, P1559, DOI 10.1091/mbc.7.10.1559; Mu H, 2006, CELL MOTIL CYTOSKEL, V63, P222, DOI 10.1002/cm.20117; Odaka C, 2000, CLIN DIAGN LAB IMMUN, V7, P947, DOI 10.1128/CDLI.7.6.947-952.2000; Oh J-M, 2008, CANC LETT IN PRESS; Oien KA, 2003, ONCOGENE, V22, P4287, DOI 10.1038/sj.onc.1206615; Phillips AJ, 2006, P NATL ACAD SCI USA, V103, P726, DOI 10.1073/pnas.0506405103; Plumb JA, 2001, ONCOGENE, V20, P7797, DOI 10.1038/sj.onc.1204954; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Rho SB, 2005, J BIOL CHEM, V280, P34003, DOI 10.1074/jbc.M501629200; Rho SB, 2004, FEBS LETT, V557, P57, DOI 10.1016/S0014-5793(03)01438-8; Ritz JM, 2005, CANCER RES, V65, P1187, DOI 10.1158/0008-5472.CAN-04-3046; Rosado JA, 2000, J PHYSIOL-LONDON, V526, P221, DOI 10.1111/j.1469-7793.2000.t01-2-00221.x; Santelli G, 1999, AM J PATHOL, V155, P799, DOI 10.1016/S0002-9440(10)65178-4; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Selimovic D, 2008, CELL SIGNAL, V20, P311, DOI 10.1016/j.cellsig.2007.10.015; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Siebel CW, 1999, P NATL ACAD SCI USA, V96, P5440, DOI 10.1073/pnas.96.10.5440; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; Tang MC, 2011, CANCER LETT, V308, P162, DOI 10.1016/j.canlet.2011.05.001; Visegrady B, 2004, FEBS LETT, V565, P163, DOI 10.1016/j.febslet.2004.03.096; White SR, 2001, AM J RESP CELL MOL, V24, P282, DOI 10.1165/ajrcmb.24.3.3995; Yeung BHY, 2008, BRIT J CANCER, V99, P283, DOI 10.1038/sj.bjc.6604477; YU FX, 1993, J BIOL CHEM, V268, P502; Zou W, ONCOGENE, V23, P457	56	18	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e35399	10.1371/journal.pone.0035399	http://dx.doi.org/10.1371/journal.pone.0035399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623951	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343500005
J	Liu, JW; Sun, N; Bruce, MA; Wu, JC; Butte, MJ				Liu, Jianwei; Sun, Ning; Bruce, Marc A.; Wu, Joseph C.; Butte, Manish J.			Atomic Force Mechanobiology of Pluripotent Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							CLINICAL-APPLICATIONS; CARDIOMYOPATHIES; GENERATION	We describe a method using atomic force microscopy (AFM) to quantify the mechanobiological properties of pluripotent, stem cell-derived cardiomyocytes, including contraction force, rate, duration, and cellular elasticity. We measured beats from cardiomyocytes derived from induced pluripotent stem cells of healthy subjects and those with dilated cardiomyopathy, and from embryonic stem cell lines. We found that our AFM method could quantitate beat forces of single cells and clusters of cardiomyocytes. We demonstrate the dose-responsive, inotropic effect of norepinephrine and beta-adrenergic blockade of metoprolol. Cardiomyocytes derived from subjects with dilated cardiomyopathy showed decreased force and decreased cellular elasticity compared to controls. This AFM-based method can serve as a screening tool for the development of cardiac-active pharmacological agents, or as a platform for studying cardiomyocyte biology.	[Liu, Jianwei; Bruce, Marc A.; Butte, Manish J.] Stanford Univ, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA; [Sun, Ning; Wu, Joseph C.] Stanford Univ, Dept Med, Div Cardiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Liu, JW (corresponding author), Stanford Univ, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA.	manish.butte@stanford.edu	Butte, Manish/T-8860-2019; Butte, Manish/AAM-8604-2020; Wu, Joseph/H-1067-2013	Butte, Manish/0000-0002-4490-5595; Butte, Manish/0000-0002-4490-5595; Sun, Ning/0000-0002-7861-3646; Bruce, Marc/0000-0003-3328-7231; Wu, Joseph/0000-0002-6068-8041	National Institutes of Health (NIH) [K08 AI079268]; NIH New Innovator Award [DP2OD004437, RC1 HL100490]; Center for Probing the Nanoscale, a National Science Foundation Nanoscale Science and Engineering Center [PHY-0830228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI079268] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004437] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Probing the Nanoscale, a National Science Foundation Nanoscale Science and Engineering Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this work was provided by the National Institutes of Health (NIH) (K08 AI079268) to MJB, NIH New Innovator Award DP2OD004437 and RC1 HL100490 to JCW. This work was partially funded by the Center for Probing the Nanoscale, a National Science Foundation Nanoscale Science and Engineering Center, supported under Grant No. PHY-0830228 (to MJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLIGAND JL, 1993, P NATL ACAD SCI USA, V90, P347, DOI 10.1073/pnas.90.1.347; Domke J, 1999, EUR BIOPHYS J BIOPHY, V28, P179, DOI 10.1007/s002490050198; Hershberger RE, 2009, CIRC-HEART FAIL, V2, P253, DOI 10.1161/CIRCHEARTFAILURE.108.817346; Hockemeyer D, 2010, COLD SH Q B, V75, P201, DOI 10.1101/sqb.2010.75.021; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matsa E, 2011, EUR HEART J, V32, P952, DOI 10.1093/eurheartj/ehr073; Oh YZ, 2012, HEART, V98, P443, DOI 10.1136/heartjnl-2011-301317; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Pelling AE, 2007, J MOL RECOGNIT, V20, P467, DOI 10.1002/jmr.832; Sabri A, 2003, J BIOL CHEM, V278, P23944, DOI 10.1074/jbc.M302718200; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; SHROFF SG, 1995, AM J PHYSIOL-CELL PH, V269, pC286, DOI 10.1152/ajpcell.1995.269.1.C286; STICKLE D, 1989, MOL PHARMACOL, V36, P437; Sun N, 2012, SCI TRANSLA IN PRESS; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Van Acker H, 2010, INT J CARDIOL, V144, P307, DOI 10.1016/j.ijcard.2009.03.003; Wickham H, GGPLOT2 ELEGANT GRAP; Wollert KC, 2005, CIRC RES, V96, P151, DOI 10.1161/01.RES.0000155333.69009.63; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	23	91	91	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37559	10.1371/journal.pone.0037559	http://dx.doi.org/10.1371/journal.pone.0037559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624048	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500135
J	Manera, V; Cavallo, A; Chiavarino, C; Schouten, B; Verfaillie, K; Becchio, C				Manera, Valeria; Cavallo, Andrea; Chiavarino, Claudia; Schouten, Ben; Verfaillie, Karl; Becchio, Cristina			Are You Approaching Me? Motor Execution Influences Perceived Action Orientation	PLOS ONE			English	Article							PERCEPTION; POINT; MODULATION; MECHANISMS; STIMULI; DEPTH	Human observers are especially sensitive to the actions of conspecifics that match their own actions. This has been proposed to be critical for social interaction, providing the basis for empathy and joint action. However, the precise relation between observed and executed actions is still poorly understood. Do ongoing actions change the way observers perceive others' actions? To pursue this question, we exploited the bistability of depth-ambiguous point-light walkers, which can be perceived as facing towards the viewer or as facing away from the viewer. We demonstrate that point-light walkers are perceived more often as facing the viewer when the observer is walking on a treadmill compared to when the observer is performing an action that does not match the observed behavior (e.g., cycling). These findings suggest that motor processes influence the perceived orientation of observed actions: Acting observers tend to perceive similar actions by conspecifics as oriented towards themselves. We discuss these results in light of the possible mechanisms subtending action-induced modulation of perception.	[Manera, Valeria; Cavallo, Andrea; Chiavarino, Claudia; Becchio, Cristina] Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy; [Manera, Valeria; Schouten, Ben; Verfaillie, Karl] Katholieke Univ Leuven, Expt Psychol Lab, Louvain, Belgium	University of Turin; KU Leuven	Manera, V (corresponding author), Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy.	cristina.becchio@unito.it	Chiavarino, Claudia/T-6784-2019; Manera, Valeria/O-3498-2016; Cavallo, Andrea/AAB-9615-2019; Manera, Valeria/H-7551-2012	Chiavarino, Claudia/0000-0001-9475-3764; Manera, Valeria/0000-0003-4490-4485; Cavallo, Andrea/0000-0002-3717-3760; Becchio, Cristina/0000-0002-6845-0521	Regione Piemonte, bando Scienze Umane e Sociali [4/2006]; Research Foundation Flanders (FWO) [FWO G.0621.07]	Regione Piemonte, bando Scienze Umane e Sociali(Regione Piemonte); Research Foundation Flanders (FWO)(FWO)	This research was supported by a grant from the Regione Piemonte, bando Scienze Umane e Sociali 2008, L.R. n. 4/2006, and by a grant from the Research Foundation Flanders (FWO), FWO G.0621.07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castiello U, 2003, J EXP PSYCHOL HUMAN, V29, P416, DOI 10.1037/0096-1523.29.2.416; Cattaneo L, 2011, SOC COGN AFFECT NEUR, V6, P301, DOI 10.1093/scan/nsq099; Christensen A, 2011, J NEUROSCI, V31, P3493, DOI 10.1523/JNEUROSCI.4277-10.2011; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; Dekeyser M, 2002, BEHAV RES METH INS C, V34, P375, DOI 10.3758/BF03195465; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Eder AB, 2008, J EXP PSYCHOL GEN, V137, P262, DOI 10.1037/0096-3445.137.2.262; Eder AB, 2009, J EXP PSYCHOL GEN, V138, P218, DOI 10.1037/a0015220; Grosjean M, 2009, PSYCHOL RES-PSYCH FO, V73, P3, DOI 10.1007/s00426-008-0146-6; Hamilton A, 2004, CURR BIOL, V14, P493, DOI 10.1016/j.cub.2004.03.007; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Jacobs A, 2005, J EXP PSYCHOL HUMAN, V31, P157, DOI 10.1037/0096-1523.31.1.157; Jellema T, 2000, BRAIN COGNITION, V44, P280, DOI 10.1006/brcg.2000.1231; Kilner JM, 2006, SOC COGN AFFECT NEUR, V1, P143, DOI 10.1093/scan/nsl017; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Kilner JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004925; Miall RC, 2006, NEUROPSYCHOLOGIA, V44, P966, DOI 10.1016/j.neuropsychologia.2005.09.006; Nummenmaa L, 2009, TRENDS COGN SCI, V13, P135, DOI 10.1016/j.tics.2008.12.006; Pelphrey KA, 2004, PSYCHOL SCI, V15, P598, DOI 10.1111/j.0956-7976.2004.00726.x; Pierno AC, 2008, SOC NEUROSCI-UK, V3, P51, DOI 10.1080/17470910701563269; Pomianowska I, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00004; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; REED CL, 1995, J EXP PSYCHOL HUMAN, V21, P334, DOI 10.1037/0096-1523.21.2.334; Repp BH, 2007, PSYCHOL SCI, V18, P6, DOI 10.1111/j.1467-9280.2007.01839.x; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Schouten B, 2010, BEHAV RES METHODS, V42, P161, DOI 10.3758/BRM.42.1.161; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Springer A, 2011, BRAIN COGNITION, V76, P26, DOI 10.1016/j.bandc.2011.03.007; Vanrie J, 2004, PERCEPTION, V33, P547, DOI 10.1068/p5004; Vanrie J, 2006, PERCEPT PSYCHOPHYS, V68, P601, DOI 10.3758/BF03208762; Vanrie J, 2011, VIS COGN, V19, P1158, DOI 10.1080/13506285.2011.614381; Wohlschlager A, 2000, VISION RES, V40, P925, DOI 10.1016/S0042-6989(99)00239-4; Zwickel J, 2010, PSYCHOL RES-PSYCH FO, V74, P152, DOI 10.1007/s00426-009-0226-2	33	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37514	10.1371/journal.pone.0037514	http://dx.doi.org/10.1371/journal.pone.0037514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22624042	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343500128
J	Maruska, KP; Ung, US; Fernald, RD				Maruska, Karen P.; Ung, Uyhun S.; Fernald, Russell D.			The African Cichlid Fish Astatotilapia burtoni Uses Acoustic Communication for Reproduction: Sound Production, Hearing, and Behavioral Significance	PLOS ONE			English	Article							AUDITORY-SENSITIVITY; HAPLOCHROMIS-BURTONI; LAKE MALAWI; SEASONAL PLASTICITY; FEMALE PREFERENCE; SIGNAL; EXPRESSION; COURTSHIP; RECOGNITION; POPULATIONS	Sexual reproduction in all animals depends on effective communication between signalers and receivers. Many fish species, especially the African cichlids, are well known for their bright coloration and the importance of visual signaling during courtship and mate choice, but little is known about what role acoustic communication plays during mating and how it contributes to sexual selection in this phenotypically diverse group of vertebrates. Here we examined acoustic communication during reproduction in the social cichlid fish, Astatotilapia burtoni. We characterized the sounds and associated behaviors produced by dominant males during courtship, tested for differences in hearing ability associated with female reproductive state and male social status, and then tested the hypothesis that female mate preference is influenced by male sound production. We show that dominant males produce intentional courtship sounds in close proximity to females, and that sounds are spectrally similar to their hearing abilities. Females were 2-5-fold more sensitive to low frequency sounds in the spectral range of male courtship sounds when they were sexually-receptive compared to during the mouthbrooding parental phase. Hearing thresholds were also negatively correlated with circulating sex-steroid levels in females but positively correlated in males, suggesting a potential role for steroids in reproductive-state auditory plasticity. Behavioral experiments showed that receptive females preferred to affiliate with males that were associated with playback of courtship sounds compared to noise controls, indicating that acoustic information is likely important for female mate choice. These data show for the first time in a Tanganyikan cichlid that acoustic communication is important during reproduction as part of a multimodal signaling repertoire, and that perception of auditory information changes depending on the animal's internal physiological state. Our results highlight the importance of examining non-visual sensory modalities as potential substrates for sexual selection contributing to the incredible phenotypic diversity of African cichlid fishes.	[Maruska, Karen P.; Ung, Uyhun S.; Fernald, Russell D.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Maruska, KP (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	maruska@stanford.edu			Stanford University Undergraduate Research Fund; National Institutes of Health [NIH F32NS061431, NIH NS 034950]; National Science Foundation (NSF) [IOS-0923588]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS034950, R01NS034950, F32NS061431, R37NS034950] Funding Source: NIH RePORTER	Stanford University Undergraduate Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by the Stanford University Undergraduate Research Fund (USU), National Institutes of Health (NIH F32NS061431 to KPM and NIH NS 034950 to RDF), and National Science Foundation (NSF IOS-0923588 to RDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Al-Mana D, 2008, NEUROSCIENCE, V153, P881, DOI 10.1016/j.neuroscience.2008.02.077; Amorim MCP, 2008, J FISH BIOL, V72, P1355, DOI 10.1111/j.1095-8649.2008.01802.x; Amorim Maria Clara P., 2006, P71; Amorim MCP, 2004, J FISH BIOL, V65, P1358, DOI 10.1111/j.0022-1112.2004.00535.x; Amorim MCP, 2003, J FISH BIOL, V62, P658, DOI 10.1046/j.1095-8649.2003.00054.x; Amy M, 2009, ETHOLOGY, V115, P239, DOI 10.1111/j.1439-0310.2008.01579.x; Araya-Ajoy YM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008137; Arch VS, 2009, HEAR RES; Blais J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-53; Bradbury Jack W., 1998, pi; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Canlon B, 2007, HEARING RES, V226, P61, DOI 10.1016/j.heares.2006.05.009; Clement TS, 2005, BEHAV ECOL, V16, P83, DOI 10.1093/beheco/arh134; Coleman SW, 2009, ACTA ETHOL, V12, P45, DOI 10.1007/s10211-008-0050-5; CORWIN JT, 1983, J COMP NEUROL, V217, P345, DOI 10.1002/cne.902170309; Crapon de Crapona M.-D., 1974, Experientia, V30, P1394; CRAPONDECAPRONA MD, 1980, Z TIERPSYCHOL, V52, P113; Danley PD, 2011, ENV BIOL FISH; Davidson J, 2007, AQUACULT ENG, V37, P125, DOI 10.1016/j.aquaeng.2007.03.003; Egger B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025601; Fay Richard R., 1999, Springer Handbook of Auditory Research, V11, P269; FAY RR, 1974, COMP BIOCHEM PHYSIOL, V49, P29, DOI 10.1016/0300-9629(74)90539-8; FAY RR, 1975, J EXP BIOL, V62, P379; Fernald RD, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P683; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; FERNALD RD, 1977, ANIM BEHAV, V25, P643, DOI 10.1016/0003-3472(77)90115-4; Gerhardt HC, 2000, BEHAV ECOL, V11, P663, DOI 10.1093/beheco/11.6.663; GREENWOOD PH, 1984, EVOLUTION FISH SPECI; Hankison SJ, 2003, BEHAV ECOL, V14, P282, DOI 10.1093/beheco/14.2.282; HEILIGENBERG W, 1972, Z VERGL PHYSIOL, V76, P168, DOI 10.1007/BF00455960; HIRATA NR, 1975, EXPERIENTIA, V31, P299, DOI 10.1007/BF01922548; Hofmann CM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000266; Horodysky AZ, 2008, J EXP BIOL, V211, P1504, DOI 10.1242/jeb.016196; Hultcrantz M, 2006, ACTA OTO-LARYNGOL, V126, P10, DOI 10.1080/00016480510038617; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Kustan JM, 2011, P R SOC B; Ladich F, 2003, HEARING RES, V182, P119, DOI 10.1016/S0378-5955(03)00188-6; Lechner W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018511; Lehtonen TK, 2011, P ROY SOC B-BIOL SCI, V278, P2318, DOI 10.1098/rspb.2010.2483; Lobel Phillip S., 2001, Journal of Aquariculture & Aquatic Sciences, V9, P167; Lobel PS, 1998, ENVIRON BIOL FISH, V52, P443, DOI 10.1023/A:1007467818465; Longrie N, 2008, J ZOOL, V275, P413, DOI 10.1111/j.1469-7998.2008.00457.x; Longrie N, 2009, J EXP BIOL, V212, P3395, DOI 10.1242/jeb.032946; Maan ME, 2006, AM NAT, V167, P947, DOI 10.1086/503532; Magrath RD, 2011, P BIOL SCI; Mann DA, 2001, J ACOUST SOC AM, V109, P3048, DOI 10.1121/1.1368406; Maruska KP, 2007, J EXP BIOL, V210, P3990, DOI 10.1242/jeb.004390; Maruska KP, 2011, PHYSIOLOGY, V26, P412, DOI 10.1152/physiol.00032.2011; Maruska KP, 2012, J EXP BIOL, V215, P68, DOI 10.1242/jeb.062794; Maruska KP, 2011, HORM BEHAV, V59, P451, DOI 10.1016/j.yhbeh.2011.01.003; Maruska KP, 2010, BEHAV BRAIN RES, V213, P208, DOI 10.1016/j.bbr.2010.04.058; Maruska KP, 2010, HORM BEHAV, V58, P230, DOI 10.1016/j.yhbeh.2010.03.011; Maruska KP, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-58; Maruska KP, 2009, J COMP PHYSL A; McKibben JR, 1998, J ACOUST SOC AM, V104, P3520, DOI 10.1121/1.423938; Mclennan DA, 2003, BIOL J LINN SOC, V80, P555, DOI 10.1111/j.1095-8312.2003.00254.x; MYRBERG AA, 1965, SCIENCE, V149, P555, DOI 10.1126/science.149.3683.555; MYRBERG AA, 2006, COMMUNICATION FISHES, V1, P149; NELISSEN MHJ, 1978, BEHAVIOUR, V64, P137, DOI 10.1163/156853978X00477; Nelissen MHJ, 1977, ANN SOC R ZOOL BELG, V106, P155; Nosil Patrik, 2009, P127; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Page RA, 2005, P ROY SOC B-BIOL SCI, V272, P841, DOI 10.1098/rspb.2004.2998; Partan S, 1999, SCIENCE, V283, P1272, DOI 10.1126/science.283.5406.1272; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Renn SCP, 2009, INTEGR COMP BIOL, V49, P660, DOI 10.1093/icb/icp085; Rice AN, 2003, REV FISH BIOL FISHER, V13, P433, DOI 10.1007/s11160-004-8794-0; Ripley Jennifer L., 2002, Bioacoustics, V12, P238; Ripley JL, 2004, ENVIRON BIOL FISH, V71, P389, DOI 10.1007/s10641-004-4190-9; Rohmann KN, 2011, J EXP BIOL, V214, P1931, DOI 10.1242/jeb.054114; Salzburger W, 2006, P ROY SOC B-BIOL SCI, V273, P257, DOI 10.1098/rspb.2005.3321; SCHELLART NAM, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P295; Scheuber H, 2004, P ROY SOC B-BIOL SCI, V271, P2453, DOI 10.1098/rspb.2004.2907; Simoes JM, 2008, J ACOUST SOC AM, V124, P1332, DOI 10.1121/1.2945712; Sisneros JA, 2004, SCIENCE, V305, P404, DOI 10.1126/science.1097218; Sisneros JA, 2003, J NEUROSCI, V23, P1049; Smith ME, 2004, J EXP BIOL, V207, P3591, DOI 10.1242/jeb.01188; Sturmbauer C., 2011, BIODIVERSITY HOTSPOT, P333, DOI DOI 10.1007/978-3-642-20992-5_18; TAVOLGA WN, 1974, J ACOUST SOC AM, V55, P1323, DOI 10.1121/1.1914704; Taylor RC, 2011, J EXP BIOL, V214, P815, DOI 10.1242/jeb.043638; Tremere LA, 2011, J NEUROSCI, V31, P3271, DOI 10.1523/JNEUROSCI.4355-10.2011; TURNER GF, 1999, EVOLUTION BIOL DIVER, P217; Van Staaden MJ, 2011, CURR ZOOL, V57, P237, DOI 10.1093/czoolo/57.2.237; Verzijden MN, 2010, BEHAV ECOL, V21, P548, DOI 10.1093/beheco/arq018; WHITE SA, 1993, J NEUROSCI, V13, P434; Wysocki LE, 2009, J ACOUST SOC AM, V126, P2100, DOI 10.1121/1.3203562; Wysocki Lidia Eva, 2006, P177; YAN HY, 1992, J COMP PHYSIOL A, V171, P105	89	79	79	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37612	10.1371/journal.pone.0037612	http://dx.doi.org/10.1371/journal.pone.0037612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624055	Green Published, gold			2022-12-25	WOS:000305343500144
J	Auffret, J; Viengchareun, S; Carre, N; Denis, RGP; Magnan, C; Marie, PY; Muscat, A; Feve, B; Lombes, M; Binart, N				Auffret, Julien; Viengchareun, Say; Carre, Nadege; Denis, Raphael G. P.; Magnan, Christophe; Marie, Pierre-Yves; Muscat, Adeline; Feve, Bruno; Lombes, Marc; Binart, Nadine			Beige differentiation of adipose depots in mice lacking prolactin receptor protects against high-fat-diet-induced obesity	FASEB JOURNAL			English	Article						thermogenesis; adipocyte	BROWN FAT; TRANSCRIPTIONAL CONTROL; GROWTH-HORMONE; BODY-WEIGHT; TISSUE; WHITE; RELEASE; LEPTIN; GENE; METABOLISM	Stimulating conversion of white fat to metabolically active adipocytes (beige fat) constitutes a promising strategy against weight gain and its deleterious associated-disorders. We provide direct evidence that prolactin (PRL), best known for its actions on the mammary gland, plays a pivotal role in energy balance through the control of adipocyte differentiation and fate. Here we show that lack of prolactin receptor (PRLR) causes resistance to high-fat-diet-induced obesity due to enhanced energy expenditure and increased metabolic rate. Mutant mice displayed reduced fat mass associated with appearance of massive brown-like adipocyte foci in perirenal and subcutaneous but not in gonadal fat depots under a high-fat diet. Positron emission tomography imaging further demonstrated the occurrence of these thermogenic brown fat depots in adult mice, providing additional support for recruitable brown-like adipocytes (beigeing) in white fat depots. Consistent with the activation of brown adipose tissue, PRLR inactivation increases expression of master genes controlling brown adipocyte fate (PRDM16) and mitochondrial function (PGC1 alpha, UCP1). Altered pRb/Foxc2 expression suggests that this PRL-regulated pathway may contribute to beige cell commitment. Together, these results provide direct genetic evidence that PRLR affects energy balance and metabolic adaptation in rodents via effects on brown adipose tissue differentiation and function.-Auffret, J., Viengchareun, S., Carre, N., Denis, R. G. P., Magnan, C., Marie, P.-Y., Muscat, A., Feve, B., Lombes, M., Binart, N. Beige differentiation of adipose depots in mice lacking prolactin receptor protects against high-fat-diet-induced obesity. FASEB J. 26, 3728-3737 (2012). www.fasebj.org	[Auffret, Julien; Viengchareun, Say; Carre, Nadege; Lombes, Marc; Binart, Nadine] INSERM, U693, F-94275 Le Kremlin Bicetre, France; [Auffret, Julien; Viengchareun, Say; Carre, Nadege; Lombes, Marc; Binart, Nadine] Univ Paris 11, Fac Med Paris Sud, UMR S693, Le Kremlin Bicetre, France; [Denis, Raphael G. P.; Magnan, Christophe] Univ Paris Diderot, CNRS, EAC 4413, Equipe Homeostasie Energet & Regulat Nerveuses &, Paris, France; [Marie, Pierre-Yves] CHU Nancy, INSERM, U961, Nancy, France; [Muscat, Adeline; Feve, Bruno] UMR S 938, Fac Med Pierre & Marie Curie, Paris, France; [Lombes, Marc; Binart, Nadine] Hop Bictr, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP	Binart, N (corresponding author), INSERM, U693, F-94275 Le Kremlin Bicetre, France.	nadine.binart@inserm.fr	Lombes, Marc/L-5933-2018; Binart, Nadine/F-2949-2013; Marie, pierre-yves/AAY-6971-2020; Viengchareun, Say/M-6612-2017; magnan, christophe/AAJ-7622-2021; Denis, Raphael/ABE-1758-2020; Viengchareun, Say/GOV-6812-2022	Lombes, Marc/0000-0003-3189-023X; Binart, Nadine/0000-0002-5606-3866; magnan, christophe/0000-0002-7044-2571; Denis, Raphael/0000-0002-7677-7460; Feve, Bruno/0000-0001-6577-9009; viengchareun, say/0000-0003-4280-3250	Region Ile-de-France (CODDIM); Ministere de l'Education Nationale, de la Recherche et de la Technologie, France; Agence Nationale de la Recherche [09-BLAN-0246]; Institut National de la Sante et de la Recherche Medicale; Universite Paris-Sud	Region Ile-de-France (CODDIM)(Region Ile-de-France); Ministere de l'Education Nationale, de la Recherche et de la Technologie, France; Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris-Sud	The authors thank Prof. M. Freemark (Duke University Medical Center, Durham, NC, USA) for helpful discussions of the manuscript, P. Letteron (IFR2 Bichat Medical School, Paris, France) for his help with DEXA analysis, and S. Poussier and F. Maskali for the recording and analysis of FDG-PET. The authors are also grateful to Prof. D. Ricquier (Institut Cochin, Paris, France) for UCP1 antibody. Calorimetric studies were performed at the Functional and Physiological Exploration Platform (FPE) of the Unit Biologie Fonctionnelle et Adaptative, Universite Paris Diderot (Sorbonne Paris Cite, Unite de Biologie Fonctionnelle et Adaptative, equipes d'Accueil Conventionnees 4413, Centre National de la Recherche Scientifique). R. G. P. D. received a research fellowship from the Region Ile-de-France (CODDIM). J.A. is the recipient of a doctoral fellowship from the Ministere de l'Education Nationale, de la Recherche et de la Technologie, France. This work was supported by grants from Agence Nationale de la Recherche (09-BLAN-0246), Institut National de la Sante et de la Recherche Medicale, and Universite Paris-Sud.	Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Binart N, 2010, TRENDS ENDOCRIN MET, V21, P362, DOI 10.1016/j.tem.2010.01.008; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Brandebourg TD, 2007, BIOCHEM BIOPH RES CO, V357, P408, DOI 10.1016/j.bbrc.2007.03.168; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carter EA, 2011, LIFE SCI, V89, P78, DOI 10.1016/j.lfs.2011.04.014; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Clevenger CV, 2009, TRENDS ENDOCRIN MET, V20, P223, DOI 10.1016/j.tem.2009.03.001; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Silva CMD, 2011, OBESITY, V19, P800, DOI 10.1038/oby.2010.150; Fleenor D, 2005, ENDOCRINOLOGY, V146, P103, DOI 10.1210/en.2004-0744; Flint DJ, 2006, J ENDOCRINOL, V191, P101, DOI 10.1677/joe.1.06939; Freemark M, 2001, ENDOCRINOLOGY, V142, P532, DOI 10.1210/en.142.2.532; Fueger BJ, 2006, J NUCL MED, V47, P999; Goffin V, 2002, ANNU REV PHYSIOL, V64, P47, DOI 10.1146/annurev.physiol.64.081501.131049; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Hugo ER, 2008, J CLIN ENDOCR METAB, V93, P4006, DOI 10.1210/jc.2008-1172; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kok P, 2004, J CLIN ENDOCR METAB, V89, P4445, DOI 10.1210/jc.2003-032184; Kok P, 2006, AM J PHYSIOL-ENDOC M, V291, pE1038, DOI 10.1152/ajpendo.00567.2005; Lee P, 2011, J CLIN ENDOCR METAB, V96, P2450, DOI 10.1210/jc.2011-0487; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2011, DIABETES, V60, P427, DOI 10.2337/db10-0409; Lisboa PC, 2006, HORM METAB RES, V38, P295, DOI 10.1055/s-2006-925390; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Nanbu-Wakao R, 2000, MOL ENDOCRINOL, V14, P307, DOI 10.1210/me.14.2.307; Nilsson L, 2011, MOL GENET METAB, V102, P78, DOI 10.1016/j.ymgme.2010.08.017; NYBROE O, 1985, GEN COMP ENDOCR, V57, P257, DOI 10.1016/0016-6480(85)90270-9; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Roy AF, 2007, J ENDOCRINOL, V195, P341, DOI 10.1677/JOE-07-0321; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schroeder MD, 2002, MOL ENDOCRINOL, V16, P45, DOI 10.1210/me.16.1.45; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seale P, 2009, DIABETES, V58, P1482, DOI 10.2337/db09-0622; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Viengchareun S, 2004, J MOL ENDOCRINOL, V33, P679, DOI 10.1677/jme.1.01563; Viengchareun S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001535; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949	47	54	57	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3728	3737		10.1096/fj.12-204958	http://dx.doi.org/10.1096/fj.12-204958			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22637534	Green Submitted			2022-12-25	WOS:000308391600014
J	Niki, M; Niki, M; Tateishi, Y; Ozeki, Y; Kirikae, T; Lewin, A; Inoue, Y; Matsumoto, M; Dahl, JL; Ogura, H; Kobayashi, K; Matsumoto, S				Niki, Makoto; Niki, Mamiko; Tateishi, Yoshitaka; Ozeki, Yuriko; Kirikae, Teruo; Lewin, Astrid; Inoue, Yusuke; Matsumoto, Makoto; Dahl, John L.; Ogura, Hisashi; Kobayashi, Kazuo; Matsumoto, Sohkichi			A Novel Mechanism of Growth Phase-dependent Tolerance to Isoniazid in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALASE-PEROXIDASE GENE; HISTONE-LIKE PROTEIN; DNA-BINDING PROTEIN; PENICILLIN TOLERANCE; KATG EXPRESSION; BOVIS BCG; TUBERCULOSIS; RESISTANCE; SMEGMATIS; SUSCEPTIBILITY	Tuberculosis remains one of the most deadly infectious diseases worldwide and is a leading public health problem. Although isoniazid (INH) is a key drug for the treatment of tuberculosis, tolerance to INH necessitates prolonged treatment, which is a concern for effective tuberculosis chemotherapy. INH is a prodrug that is activated by the mycobacterial enzyme, KatG. Here, we show that mycobacterial DNA-binding protein 1 (MDP1), which is a histone-like protein conserved in mycobacteria, negatively regulates katG transcription and leads to phenotypic tolerance to INH in mycobacteria. Mycobacterium smegmatis deficient for MDP1 exhibited increased expression of KatG and showed enhanced INH activation compared with the wild-type strain. Expression of MDP1 was increased in the stationary phase and conferred growth phase-dependent tolerance to INH in M. smegmatis. Regulation of KatG expression is conserved between M. smegmatis and Mycobacterium tuberculosis complex. Artificial reduction of MDP1 in Mycobacterium bovis BCG was shown to lead to increased KatG expression and susceptibility to INH. These data suggest a mechanism by which phenotypic tolerance to INH is acquired in mycobacteria.	[Niki, Makoto; Niki, Mamiko; Tateishi, Yoshitaka; Ozeki, Yuriko; Matsumoto, Sohkichi] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Abeno Ku, Osaka 5458585, Japan; [Ogura, Hisashi] Osaka City Univ, Grad Sch Med, Dept Virol, Abeno Ku, Osaka 5458585, Japan; [Tateishi, Yoshitaka] Toneyama Natl Hosp, Natl Hosp Org, Dept Internal Med, Toyonaka, Osaka 5608552, Japan; [Ozeki, Yuriko] Sonoda Womens Univ, Dept Food & Nutr, Amagasaki, Hyogo 6618520, Japan; [Kirikae, Teruo] Natl Ctr Global Hlth & Med, Shinjuku Ku, Tokyo 1628655, Japan; [Lewin, Astrid] Robert Koch Inst, D-13353 Berlin, Germany; [Inoue, Yusuke; Matsumoto, Makoto] Otsuka Pharmaceut Co Ltd, Microbiol Res Inst, Kawaguchi, Tokushima 7710192, Japan; [Dahl, John L.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA; [Kobayashi, Kazuo] Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan	Osaka Metropolitan University; Osaka Metropolitan University; National Center for Global Health & Medicine - Japan; Robert Koch Institute; Otsuka Pharmaceutical; University of Minnesota System; University of Minnesota Duluth; National Institute of Infectious Diseases (NIID)	Niki, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Bacteriol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	myoshi@med.osaka-cu.ac.jp; sohkichi@med.osaka-cu.ac.jp		Matsumoto, Sohkichi/0000-0002-6106-7538	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare (Research on Emerging and Re-emerging Infectious Diseases, Health Sciences Research Grants); Japan Health Sciences Foundation; United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy; Grants-in-Aid for Scientific Research [24501015] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare (Research on Emerging and Re-emerging Infectious Diseases, Health Sciences Research Grants)(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology, the Ministry of Health, Labor, and Welfare (Research on Emerging and Re-emerging Infectious Diseases, Health Sciences Research Grants), The Japan Health Sciences Foundation, and The United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy.	Ando H, 2011, MOL MICROBIOL, V79, P1615, DOI 10.1111/j.1365-2958.2011.07547.x; Aoki K, 2004, J BIOL CHEM, V279, P39798, DOI 10.1074/jbc.M402677200; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Blasco B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002621; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; BROWN BA, 1992, ANTIMICROB AGENTS CH, V36, P1987, DOI 10.1128/AAC.36.9.1987; Colangeli R, 2007, PLOS PATHOG, V3, P780, DOI 10.1371/journal.ppat.0030087; DESSEN A, 1995, SCIENCE, V267, P1638, DOI 10.1126/science.7886450; Dick T, 1998, FEMS MICROBIOL LETT, V163, P159, DOI 10.1111/j.1574-6968.1998.tb13040.x; GOODELL EW, 1978, ANTIMICROB AGENTS CH, V13, P514, DOI 10.1128/AAC.13.3.514; HANDWERGER S, 1985, REV INFECT DIS, V7, P368; Herbert D, 1996, ANTIMICROB AGENTS CH, V40, P2296, DOI 10.1128/AAC.40.10.2296; HEYM B, 1993, J BACTERIOL, V175, P4255, DOI 10.1128/JB.175.13.4255-4259.1993; HILLAR A, 1995, ARCH BIOCHEM BIOPHYS, V323, P438, DOI 10.1006/abbi.1995.0065; HORNE D, 1981, ANTIMICROB AGENTS CH, V20, P128, DOI 10.1128/AAC.20.1.128; Johnsson K, 1997, J BIOL CHEM, V272, P2834, DOI 10.1074/jbc.272.5.2834; Katsube T, 2007, J BACTERIOL, V189, P8241, DOI 10.1128/JB.00550-07; KIM KS, 1987, J ANTIMICROB CHEMOTH, V19, P475, DOI 10.1093/jac/19.4.475; Larsen MH, 2002, MOL MICROBIOL, V46, P453, DOI 10.1046/j.1365-2958.2002.03162.x; Lewin A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-91; Matsumoto S, 1999, MICROBIOL IMMUNOL, V43, P1027, DOI 10.1111/j.1348-0421.1999.tb01232.x; Matsumoto S, 2000, FEMS MICROBIOL LETT, V182, P297, DOI 10.1016/S0378-1097(99)00606-0; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Miesel L, 1998, J BACTERIOL, V180, P2459, DOI 10.1128/JB.180.9.2459-2467.1998; Milano A, 2001, J BACTERIOL, V183, P6801, DOI 10.1128/JB.183.23.6801-6806.2001; Nachega JB, 2003, CLIN INFECT DIS, V36, pS24, DOI 10.1086/344657; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Ormerod LP, 2008, THORAX, V63, P388, DOI 10.1136/thx.2007.077610; PETTIJOHN DE, 1988, J BIOL CHEM, V263, P12793; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004; Rouse DA, 1996, MOL MICROBIOL, V22, P583, DOI 10.1046/j.1365-2958.1996.00133.x; Sekiguchi J, 2007, J CLIN MICROBIOL, V45, P179, DOI 10.1128/JCM.00750-06; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Smith AL, 2003, CHEST, V123, P1495, DOI 10.1378/chest.123.5.1495; Takatsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020985; Timmins GS, 2004, ANTIMICROB AGENTS CH, V48, P3006, DOI 10.1128/AAC.48.8.3006-3009.2004; TUOMANEN E, 1986, REV INFECT DIS, V8, pS279; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; WALLACE RJ, 1986, J CLIN MICROBIOL, V24, P976, DOI 10.1128/JCM.24.6.976-981.1986; Wallis RS, 1999, ANTIMICROB AGENTS CH, V43, P2600, DOI 10.1128/AAC.43.11.2600; Whiteford DC, 2011, MICROBIOL-SGM, V157, P327, DOI 10.1099/mic.0.045518-0; Wilson TM, 1996, MOL MICROBIOL, V19, P1025, DOI 10.1046/j.1365-2958.1996.449980.x; Yeruva VC, 2006, CLIN VACCINE IMMUNOL, V13, P1137, DOI 10.1128/CVI.00125-06; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x; ZHANG Y, 1991, MOL MICROBIOL, V5, P381, DOI 10.1111/j.1365-2958.1991.tb02120.x; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	50	32	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27743	27752		10.1074/jbc.M111.333385	http://dx.doi.org/10.1074/jbc.M111.333385			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22648414	Green Published, hybrid			2022-12-25	WOS:000307840700048
J	Chakrabarti, A; Gupta, K; Sharma, JP; Yang, JB; Agarwal, A; Glick, A; Zhang, YW; Agarwal, M; Agarwal, MK; Wald, DN				Chakrabarti, Amitabha; Gupta, Kalpana; Sharma, James Prabhakar; Yang, Jinbo; Agarwal, Anju; Glick, Abigail; Zhang, Youwei; Agarwal, Munna; Agarwal, Mukesh K.; Wald, David N.			ATP Depletion Triggers Acute Myeloid Leukemia Differentiation through an ATR/Chk1 Protein-dependent and p53 Protein-independent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINTS; DNA-DAMAGE; K562 CELLS; CANCER; NUCLEOTIDES; NETWORK; POOLS; CHK1	Despite advances in oncology drug development, most commonly used cancer therapeutics exhibit serious adverse effects. Often the toxicities of chemotherapeutics are due to the induction of significant DNA damage that is necessary for their ability to kill cancer cells. In some clinical situations, the direct induction of significant cytotoxicity is not a requirement to meet clinical goals. For example, differentiation, growth arrest, and/or senescence is a valuable outcome in some cases. In fact, in the case of acute myeloid leukemia (AML), the use of the differentiation agent all-trans-retinoic acid (ATRA) has revolutionized the therapy for a subset of leukemia patients and led to a dramatic survival improvement. Remarkably, this therapeutic approach is possible even in many elderly patients, who would not be able to tolerate therapy with traditional cytotoxic chemotherapy. Because of the success of ATRA, there is widespread interest in identifying differentiation strategies that may be effective for the 90-95% of AML patients who do not clinically respond to ATRA. Utilizing an AML differentiation agent that is in development, we found that AML differentiation can be induced through ATP depletion and the subsequent activation of DNA damage signaling through an ATR/Chk1-dependent and p53-independent pathway. This study not only reveals mechanisms of AML differentiation but also suggests that further investigation is warranted to investigate the potential clinical use of low dose chemotherapeutics to induce differentiation instead of cytotoxicity. This therapeutic approach may be of particular benefit to patients, such as elderly AML patients, who often cannot tolerate traditional AML chemotherapy.	[Chakrabarti, Amitabha; Sharma, James Prabhakar; Agarwal, Anju; Agarwal, Munna; Agarwal, Mukesh K.] Invenio Therapeut, Cleveland, OH 44106 USA; [Gupta, Kalpana; Wald, David N.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Glick, Abigail] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Zhang, Youwei] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Glick, Abigail; Wald, David N.] Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Yang, Jinbo] Cleveland Clin Fdn, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Cleveland Clinic Foundation	Agarwal, MK (corresponding author), Invenio Therapeut, 11000 Cedar Ave, Cleveland, OH 44106 USA.	mukeshagarwal@inveniotherapeutics.com; dnw@case.edu			NCI NIH HHS [R00 CA126173, R01 CA163214] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R00CA126173, R01CA163214] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Adam T., 2005, KLIN BIOCH METAB, V12, P177; Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; Agarwal ML, 1998, P NATL ACAD SCI USA, V95, P14775, DOI 10.1073/pnas.95.25.14775; Asada M, 1998, LEUKEMIA, V12, P1944, DOI 10.1038/sj.leu.2401228; BECHER H, 1978, KLIN WOCHENSCHR, V56, P275, DOI 10.1007/BF01489173; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Estey EH, 2006, SEMIN HEMATOL, V43, P89, DOI 10.1053/j.seminhematol.2006.01.002; Hastak K, 2008, P NATL ACAD SCI USA, V105, P6314, DOI 10.1073/pnas.0802080105; Huang M, 2004, LEUKEMIA, V18, P1857, DOI 10.1038/sj.leu.2403490; Huang M, 2002, MOL PHARMACOL, V62, P463, DOI 10.1124/mol.62.3.463; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kell Jonathan, 2004, Expert Opin Emerg Drugs, V9, P55, DOI 10.1517/14728214.9.1.55; Lam MH, 2004, CELL CYCLE, V3, P1355, DOI 10.4161/cc.3.11.1225; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Meyer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007768; Nobili S, 2006, CURR DRUG TARGETS, V7, P861, DOI 10.2174/138945006777709593; Pluciennik A, 2007, P NATL ACAD SCI USA, V104, P12709, DOI 10.1073/pnas.0705129104; Schmitt Estelle, 2007, Journal of Zhejiang University-Science B, V8, P377, DOI 10.1631/jzus.2007.B0377; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; SOKOLOSKI JA, 1987, CANCER RES, V47, P6283; SPERLING O, 1979, BIOMED EXPRESS, V31, P20; Tallmann M. S., 2004, Annals of Hematology, V83, pS81; Wald DN, 2008, CANCER RES, V68, P4369, DOI 10.1158/0008-5472.CAN-07-6559; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030	26	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23635	23643		10.1074/jbc.M111.312801	http://dx.doi.org/10.1074/jbc.M111.312801			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22621920	Green Published, hybrid			2022-12-25	WOS:000306511300034
J	Genton, C; Cristescu, R; Gatti, S; Levrero, F; Bigot, E; Caillaud, D; Pierre, JS; Menard, N				Genton, Celine; Cristescu, Romane; Gatti, Sylvain; Levrero, Florence; Bigot, Elodie; Caillaud, Damien; Pierre, Jean-Sebastien; Menard, Nelly			Recovery Potential of a Western Lowland Gorilla Population following a Major Ebola Outbreak: Results from a Ten Year Study	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; VULTURE GYPS-FULVUS; MBELI-BAI; ECOLOGY; CONGO; WILDLIFE; EXTINCTION; PATTERNS; FEVER; CONSERVATION	Investigating the recovery capacity of wildlife populations following demographic crashes is of great interest to ecologists and conservationists. Opportunities to study these aspects are rare due to the difficulty of monitoring populations both before and after a demographic crash. Ebola outbreaks in central Africa have killed up to 95% of the individuals in affected western lowland gorilla (Gorilla gorilla gorilla) populations. Assessing whether and how fast affected populations recover is essential for the conservation of this critically endangered taxon. The gorilla population visiting Lokoue forest clearing, Odzala-Kokoua National Park, Republic of the Congo, has been monitored before, two years after and six years after Ebola affected it in 2004. This allowed us to describe Ebola's short-term and long-term impacts on the structure of the population. The size of the population, which included around 380 gorillas before the Ebola outbreak, dropped to less than 40 individuals after the outbreak. It then remained stable for six years after the outbreak. However, the demographic structure of this small population has significantly changed. Although several solitary males have disappeared, the immigration of adult females, the formation of new breeding groups, and several birth events suggest that the population is showing potential to recover. During the outbreak, surviving adult and subadult females joined old solitary silverbacks. Those females were subsequently observed joining young silverbacks, forming new breeding groups where they later gave birth. Interestingly, some females were observed joining silverbacks that were unlikely to have sired their infant, but no infanticide was observed. The consequences of the Ebola outbreak on the population structure were different two years and six years after the outbreak. Therefore, our results could be used as demographic indicators to detect and date outbreaks that have happened in other, non-monitored gorilla populations.	[Genton, Celine; Gatti, Sylvain; Bigot, Elodie; Pierre, Jean-Sebastien; Menard, Nelly] Univ Rennes 1, CNRS, ECOBIO, Biol Stn Paimpont,UMR 6553, Paimpont, France; [Cristescu, Romane] Univ New S Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2033, Australia; [Levrero, Florence] Univ St Etienne, ENES CNPS, CNRS, UMR 8195, St Etienne, France; [Levrero, Florence] Ctr Natl Rech Sci, Ctr Neurosci Paris Sud, UMR 8195, Paris, France; [Caillaud, Damien] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; University of New South Wales Sydney; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; University of Texas System; University of Texas Austin	Genton, C (corresponding author), Univ Rennes 1, CNRS, ECOBIO, Biol Stn Paimpont,UMR 6553, Paimpont, France.	celine.genton@yahoo.fr	Caillaud, Damien/AAH-5850-2019; Levrero, Fabrizio/AAH-6833-2019; MENARD, Nelly/L-2214-2018	Caillaud, Damien/0000-0002-8347-6869; Levrero, Florence/0000-0002-6904-1375; MENARD, Nelly/0000-0003-4122-9330	ECOsystemes; Ministere de l'Ecologie et du Developpement Durable, France; La Bourbansais and La Palmyre zoological parks; NSF [DEB-0749097]; Direct For Biological Sciences [0749097] Funding Source: National Science Foundation	ECOsystemes; Ministere de l'Ecologie et du Developpement Durable, France; La Bourbansais and La Palmyre zoological parks; NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the ECOsystemes FORestiers program (http:// www.gip-ecofor.org/; Ministere de l'Ecologie et du Developpement Durable, France) and the Especes-Phares program (DG Environnement, UE, carried out by Reseau des Aires Protegees d'Afrique Centrale; http://www.rapac.org). The authors thank the Rent2Connect firm for their material support, and the La Bourbansais and La Palmyre zoological parks for their financial support. DC was supported by NSF Grant DEB-0749097 to L. A. Meyers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; [Anonymous], 2010, R LANG ENV STAT COMP; Anyamba A, 2010, AM J TROP MED HYG, V83, P43, DOI 10.4269/ajtmh.2010.09-0289; Bermejo M, 2004, AM J PRIMATOL, V64, P223, DOI 10.1002/ajp.20073; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Bijleveld AI, 2010, OIKOS, V119, P277, DOI 10.1111/j.1600-0706.2009.17892.x; Breuer T, 2010, BEHAV ECOL SOCIOBIOL, V64, P515, DOI 10.1007/s00265-009-0867-6; Breuer T, 2009, AM J PRIMATOL, V71, P106, DOI 10.1002/ajp.20628; Caillaud D, 2008, AM J PHYS ANTHROPOL, V135, P379, DOI 10.1002/ajpa.20754; Caillaud D, 2006, CURR BIOL, V16, pR489, DOI 10.1016/j.cub.2006.06.017; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Cipolletta C, 2004, AM J PRIMATOL, V64, P193, DOI 10.1002/ajp.20072; Coulson T, 2004, ECOLOGY, V85, P411, DOI 10.1890/03-0009; CREEL S, 1992, NATURE, V360, P633, DOI 10.1038/360633a0; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 1999, TRENDS ECOL EVOL, V14, P279, DOI 10.1016/S0169-5347(99)01665-1; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Delibes-Mateos M, 2009, MAMMAL REV, V39, P124, DOI 10.1111/j.1365-2907.2009.00140.x; Devos C, 2008, ORYX, V42, P367, DOI 10.1017/S0030605308000161; DONAZAR JA, 1990, BIOL CONSERV, V53, P83, DOI 10.1016/0006-3207(90)90001-6; Doran-Sheehy DM, 2004, AM J PRIMATOL, V64, P207, DOI 10.1002/ajp.20075; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Gatti S, 2004, AM J PRIMATOL, V63, P111, DOI 10.1002/ajp.20045; Grenier MB, 2007, SCIENCE, V317, P779, DOI 10.1126/science.1144648; Hadley GL, 2006, J ANIM ECOL, V75, P1058, DOI 10.1111/j.1365-2656.2006.01118.x; Harcourt AH, 2001, ANIM BEHAV, V62, P905, DOI 10.1006/anbe.2001.1835; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Heard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023150; Herve M, 2011, DIVERSE BASIC STAT G; Holzmann I, 2010, AM J PRIMATOL, V72, P475, DOI 10.1002/ajp.20796; Huijbregts B, 2003, ORYX, V37, P437, DOI 10.1017/S0030605303000802; Jennions MD, 2003, BEHAV ECOL, V14, P438, DOI 10.1093/beheco/14.3.438; JOHNSON KM, 1977, LANCET, V1, P569; Lachish S, 2009, J ANIM ECOL, V78, P427, DOI 10.1111/j.1365-2656.2008.01494.x; Lai LW, 2011, INT J ENVIRON HEAL R, V21, P133, DOI 10.1080/09603123.2010.515670; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Levrero F, 2006, AM J PRIMATOL, V68, P275, DOI 10.1002/ajp.20223; Loison A, 1996, J WILDLIFE MANAGE, V60, P517, DOI 10.2307/3802069; Magliocca F, 2002, AM J PRIMATOL, V57, P67, DOI 10.1002/ajp.10034; Magliocca F, 1999, AM J PRIMATOL, V48, P1, DOI 10.1002/(SICI)1098-2345(1999)48:1<1::AID-AJP1>3.0.CO;2-2; Mateo-Tomas P, 2011, IBIS, V153, P832, DOI 10.1111/j.1474-919X.2011.01154.x; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; Mutze G, 2002, WILDLIFE RES, V29, P577, DOI 10.1071/WR00100; Nunn CL, 2006, INFECT DIS PRIMATES; Parnell RJ, 2002, AM J PRIMATOL, V56, P193, DOI 10.1002/ajp.1074; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; Pistorius PA, 2001, POLAR BIOL, V24, P343, DOI 10.1007/s003000000217; Rogers ME, 2004, AM J PRIMATOL, V64, P173, DOI 10.1002/ajp.20071; Rudran R, 2003, INT J PRIMATOL, V24, P925, DOI 10.1023/A:1026241625910; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Stokes EJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P329, DOI 10.1007/s00265-003-0630-3; THORNE E T, 1988, Conservation Biology, V2, P66, DOI 10.1111/j.1523-1739.1988.tb00336.x; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; WCS, 2009, PROT MON GREAT AP OD; Wobeser G, 2002, CAN VET J, V43, P798; Yamagiwa J, 2009, PRIMATES, V50, P293, DOI 10.1007/s10329-009-0163-0	58	25	26	0	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37106	10.1371/journal.pone.0037106	http://dx.doi.org/10.1371/journal.pone.0037106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649511	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800029
J	Jo, JW; Jee, BC; Suh, CS; Kim, SH				Jo, Jun Woo; Jee, Byung Chul; Suh, Chang Suk; Kim, Seok Hyun			The Beneficial Effects of Antifreeze Proteins in the Vitrification of Immature Mouse Oocytes	PLOS ONE			English	Article							GERMINAL-VESICLE OOCYTES; IN-VITRO MATURATION; EMBRYONIC-DEVELOPMENT; SPINDLE CHECKPOINT; GENE-EXPRESSION; MOTOR PROTEIN; CRYOPRESERVATION; EG5; OVEREXPRESSION; FERTILIZATION	Antifreeze proteins (AFPs) are a class of polypeptides that permit organismal survival in sub-freezing environments. The purpose of this study was to investigate the effect of AFP supplementation on immature mouse oocyte vitrification. Germinal vesicle-stage oocytes were vitrified using a two-step exposure to equilibrium and vitrification solution in the presence or absence of 500 ng/mL of AFP III. After warming, oocyte survival, in vitro maturation, fertilization, and embryonic development up to the blastocyst stage were assessed. Spindle and chromosome morphology, membrane integrity, and the expression levels of several genes were assessed in in vitro matured oocytes. The rate of blastocyst formation was significantly higher and the number of caspase-positive blastomeres was significantly lower in the AFP-treated group compared with the untreated group. The proportion of oocytes with intact spindles/chromosomes and stable membranes was also significantly higher in the AFP group. The AFP group showed increased Mad2, Hook-1, Zar1, Zp1, and Bcl2 expression and lower Eg5, Zp2, Caspase6, and Rbm3 expression compared with the untreated group. Supplementation of the vitrification medium with AFP has a protective effect on immature mouse oocytes, promoting their resistance to chilling injury. AFPs may preserve spindle forming ability and membrane integrity at GV stage. The fertilization and subsequent developmental competence of oocytes may be associated with the modulation of Zar1, Zp1/Zp2, Bcl2, Caspase6, and Rbm3.	[Jo, Jun Woo; Jee, Byung Chul; Suh, Chang Suk] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Songnam, South Korea; [Jo, Jun Woo; Jee, Byung Chul; Suh, Chang Suk; Kim, Seok Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Seok Hyun] Seoul Natl Univ Hosp, Dept Obstet & Gynecol, Seoul 110744, South Korea; [Jo, Jun Woo] Seoul Natl Univ, Inst Reprod Med & Populat, Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Jo, JW (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Songnam, South Korea.	suhcs@snu.ac.kr	Jee, Byung Chul/J-5676-2012; Suh, Chang-Suk/J-5513-2012					ARAV A, 1993, MOL REPROD DEV, V36, P488, DOI 10.1002/mrd.1080360413; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Blomberg LA, 2005, PHYSIOL GENOMICS, V20, P188, DOI 10.1152/physiolgenomics.00157.2004; Castillo A, 2007, CANCER RES, V67, P10138, DOI 10.1158/0008-5472.CAN-07-0326; Castillo A, 2007, BIOCHEM BIOPH RES CO, V357, P694, DOI 10.1016/j.bbrc.2007.04.021; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Cobo A, 2010, FERTIL STERIL, V94, P1903, DOI 10.1016/j.fertnstert.2009.10.042; Cobo A, 2010, HUM REPROD, V25, P2239, DOI 10.1093/humrep/deq146; Cooper A, 1998, HUM REPROD, V13, P971, DOI 10.1093/humrep/13.4.971; Exley GE, 1999, BIOL REPROD, V61, P231, DOI 10.1095/biolreprod61.1.231; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Habibi A, 2010, J ASSIST REPROD GEN, V27, P599, DOI 10.1007/s10815-010-9453-0; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; HANDYSIDE AH, 1984, J EXP ZOOL, V231, P429, DOI 10.1002/jez.1402310317; Hinsch E, 2003, THERIOGENOLOGY, V60, P1331, DOI 10.1016/S0093-691X(03)00169-9; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Huang JYJ, 2007, FERTIL STERIL, V88, P1093, DOI 10.1016/j.fertnstert.2006.12.066; Isachenko E, 2004, REPROD BIOMED ONLINE, V8, P553, DOI 10.1016/S1472-6483(10)61102-9; Isachenko EF, 1999, HUM REPROD, V14, P400, DOI 10.1093/humrep/14.2.400; Izawa M, 1998, FERTIL STERIL, V70, P549, DOI 10.1016/S0015-0282(98)00194-0; Jo JW, 2011, FERTIL STERIL; Madura JD, 2000, J MOL RECOGNIT, V13, P101, DOI 10.1002/(SICI)1099-1352(200003/04)13:2<101::AID-JMR493>3.0.CO;2-9; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nagy ZP, 2009, SEMIN REPROD MED, V27, P450, DOI 10.1055/s-0029-1241054; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; PAYNE SR, 1994, CRYOBIOLOGY, V31, P180, DOI 10.1006/cryo.1994.1021; Rao GD, 2004, LANCET, V363, P1829, DOI 10.1016/S0140-6736(04)16320-4; RUBINSKY B, 1990, BIOCHEM BIOPH RES CO, V173, P1369, DOI 10.1016/S0006-291X(05)80939-8; Simpson F, 2005, TRAFFIC, V6, P442, DOI 10.1111/j.1600-0854.2005.00289.x; Smith GD, 2010, FERTIL STERIL, V94, P2088, DOI 10.1016/j.fertnstert.2009.12.065; Somfai T, 2006, THERIOGENOLOGY, V66, P415, DOI 10.1016/j.theriogenology.2005.11.023; Son WY, 1996, FERTIL STERIL, V66, P995, DOI 10.1016/S0015-0282(16)58696-8; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; TOTH TL, 1994, FERTIL STERIL, V61, P1077; TOTH TL, 1994, FERTIL STERIL, V61, P891; Ubaldi F, 2010, HUM REPROD, V25, P1199, DOI 10.1093/humrep/deq046; Wang JZ, 2009, REPRODUCTION, V137, P181, DOI 10.1530/REP-08-0339; Wang WH, 2006, FRONT BIOSCI-LANDMRK, V11, P620, DOI 10.2741/1822; WASSARMAN PM, 1988, ANNU REV BIOCHEM, V57, P415, DOI 10.1146/annurev.bi.57.070188.002215; WASSARMAN PM, 1988, SCI AM, V259, P78, DOI 10.1038/scientificamerican1288-78; Wrenzycki C, 1999, MOL REPROD DEV, V53, P8, DOI 10.1002/(SICI)1098-2795(199905)53:1&lt;8::AID-MRD2&gt;3.0.CO;2-K; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Yang MY, 2002, ANIM REPROD SCI, V70, P159, DOI 10.1016/S0378-4320(01)00186-5; Yeh Y, 1996, CHEM REV, V96, P601, DOI 10.1021/cr950260c; Zhou KW, 2009, CLIN INVEST MED, V32, pE103	46	40	46	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37043	10.1371/journal.pone.0037043	http://dx.doi.org/10.1371/journal.pone.0037043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649508	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800026
J	Josef, N; Amodio, P; Fiorito, G; Shashar, N				Josef, Noam; Amodio, Piero; Fiorito, Graziano; Shashar, Nadav			Camouflaging in a Complex Environment-Octopuses Use Specific Features of Their Surroundings for Background Matching	PLOS ONE			English	Article							DISRUPTIVE COLORATION; CUTTLEFISH CAMOUFLAGE; VISUAL-PERCEPTION; CONTRAST; SUBSTRATE; STATISTICS; MIMICRY; TEXTURE; CRYPSIS; OBJECTS	Living under intense predation pressure, octopuses evolved an effective and impressive camouflaging ability that exploits features of their surroundings to enable them to "blend in.'' To achieve such background matching, an animal may use general resemblance and reproduce characteristics of its entire surroundings, or it may imitate a specific object in its immediate environment. Using image analysis algorithms, we examined correlations between octopuses and their backgrounds. Field experiments show that when camouflaging, Octopus cyanea and O. vulgaris base their body patterns on selected features of nearby objects rather than attempting to match a large field of view. Such an approach enables the octopus to camouflage in partly occluded environments and to solve the problem of differences in appearance as a function of the viewing inclination of the observer.	[Josef, Noam; Shashar, Nadav] Ben Gurion Univ Negev, Dept Life Sci, Eilat Campus, IL-84105 Beer Sheva, Israel; [Amodio, Piero; Fiorito, Graziano] Stn Zool Anton Dohrn, Naples, Italy	Ben Gurion University; Stazione Zoologica Anton Dohrn di Napoli	Josef, N (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Eilat Campus, IL-84105 Beer Sheva, Israel.	bigblue79@bezeqint.net	Shashar, Nadav/Y-8552-2019; Amodio, Piero/ABH-6513-2020; FIORITO, GRAZIANO/N-2270-2014	Amodio, Piero/0000-0002-9408-2902; FIORITO, GRAZIANO/0000-0003-2926-9479	Ben-Gurion University	Ben-Gurion University	We thank the support of Ben-Gurion University's Marine Biology and Biotechnology program and the Inter University Institute for Marine Sciences in Eilat for logistical support. We are grateful to the cephalopod group in the Stazione Zoologica Anton Dohrn for their warm hospitality. Special thanks to the Israeli Nature and Parks Authority for monitoring the capture, maintenance, and release of the octopus. We are grateful for the contributions of B. Alon, A. Lerner, K. Levi, S. Maccusker, E. Yanowski, P. Amodio, C. Talbot, Y. Schnytzer and O. Polak, who provided constructive suggestions and discussions along the way, and Z. Livnat, who donated high resolution images for our study.	Barbosa A, 2004, BIOL BULL-US, V207, P154, DOI 10.1086/BBLv207n2p154; Barbosa A, 2011, P BIOL SCI; Barbosa A, 2008, VISION RES, V48, P1242, DOI 10.1016/j.visres.2008.02.011; Barbosa A, 2007, J EXP BIOL, V210, P1139, DOI 10.1242/jeb.02741; Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; Borrelli L, CATALOGUE BODY PATTE; BROWN PK, 1958, NATURE, V182, P1288, DOI 10.1038/1821288a0; Chiao CC, 2005, BIOL BULL-US, V208, P7, DOI 10.2307/3593095; Chiao CC, 2001, BIOL BULL, V201, P269, DOI 10.2307/1543359; Chiao CC, 2001, J EXP BIOL, V204, P2119; Chlao CC, 2007, VISION RES, V47, P2223, DOI 10.1016/j.visres.2007.05.001; COGGINS JM, 1985, PATTERN RECOGN LETT, V3, P195, DOI 10.1016/0167-8655(85)90053-4; Cott HB, ADAPTIVE COLORATION; Darwin C., 1859, ORIGIN SPECIES MEANS; Edmunds M, 1990, EVOLUTION CRYPTIC CO, P3; Edmunds M, DEFENCE ANIMALS SURV; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; ENDLER JA, 1981, BIOL J LINN SOC, V16, P25, DOI 10.1111/j.1095-8312.1981.tb01840.x; ENDLER JA, 1984, BIOL J LINN SOC, V22, P187, DOI 10.1111/j.1095-8312.1984.tb01677.x; FISHELSON L, 1983, PLANTS ANIMALS LAND; Forsythe JW, 1997, J EXP MAR BIOL ECOL, V209, P15, DOI 10.1016/S0022-0981(96)00057-3; Guilford T, 1992, PREDATOR PSYCHOL EVO, P375; Hailman JP, OPTICAL SIGNALS ANIM; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hanlon RT, 1999, BIOL J LINN SOC, V66, P1; Hanlon RT, CEPHALOPOD BEHAV; Hanlon RT, 1988, PHILOS T R SOC B, V320, P69; Hinton H.E., 1976, P390; Holmes William., 1940, PROC ZOOL SOC LONDON SER A, V110, P17; Kelman EJ, 2007, P R SOC B, V274, P1369, DOI 10.1098/rspb.2007.0240; Kenneth SN, 1964, ECOLOGY, V45, P16; Kovesi P. D., 2000, MATLAB OCTAVE FUNCTI; Mathger LM, 2007, J EXP BIOL, V210, P2657, DOI 10.1242/jeb.004382; Marshall NJ, 1996, NATURE, V382, P408, DOI 10.1038/382408b0; MATHER JA, 1991, B MAR SCI, V49, P256; Mathger LM, 2006, VISION RES, V46, P1746, DOI 10.1016/j.visres.2005.09.035; Merilaita S, 1998, P ROY SOC B-BIOL SCI, V265, P1059, DOI 10.1098/rspb.1998.0399; Merilaita Sami, 2011, P17; MESSENGER JB, 1977, J EXP BIOL, V70, P49; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Packard A., 1977, Symposia of the Zoological Society of London, P191; Packard A, 1988, MOLLUSCA, V11, P30, DOI [10.1016/B978-0-12-751411-6.50010-2, DOI 10.1016/B978-0-12-751411-6.50010-2]; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Shohet AJ, 2006, J EXP BIOL, V209, P4717, DOI 10.1242/jeb.02580; Stevens Martin, 2011, P1; Thayer AH, 1918, SCI MON, V7, P481; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; Zylinski S, 2011, AM NAT, V177, P10	49	20	20	18	209	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37579	10.1371/journal.pone.0037579	http://dx.doi.org/10.1371/journal.pone.0037579			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649542	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800061
J	Chuang, YC; Su, WH; Lei, HY; Lin, YS; Liu, HS; Chang, CP; Yeh, TM				Chuang, Yung-Chun; Su, Wen-Hong; Lei, Huan-Yao; Lin, Yee-Shin; Liu, Hsiao-Sheng; Chang, Chih-Peng; Yeh, Trai-Ming			Macrophage Migration Inhibitory Factor Induces Autophagy via Reactive Oxygen Species Generation	PLOS ONE			English	Article							REGULATES AUTOPHAGY; OXIDATIVE STRESS; CANCER; INFLAMMATION; ACTIVATION; IMMUNITY; HMGB1; MIF; TUMORIGENESIS; MECHANISMS	Autophagy is an evolutionarily conserved catabolic process that maintains cellular homeostasis under stress conditions such as starvation and pathogen infection. Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine that plays important roles in inflammation and tumorigenesis. Cytokines such as IL-1 beta and TNF-alpha that are induced by MIF have been shown to be involved in the induction of autophagy. However, the actual role of MIF in autophagy remains unclear. Here, we have demonstrated that incubation of human hepatoma cell line HuH-7 cells with recombinant MIF (rMIF) induced reactive oxygen species (ROS) production and autophagy formation, including LC3-II expression, LC3 punctae formation, autophagic flux, and mitochondria membrane potential loss. The autophagy induced by rMIF was inhibited in the presence of MIF inhibitor, ISO-1 as well as ROS scavenger N-acetyl-L-cysteine (NAC). In addition, serum starvation-induced MIF release and autophagy of HuH-7 cells were partly blocked in the presence of NAC. Moreover, diminished MIF expression by shRNA transfection or inhibition of MIF by ISO-1 decreased serum starvation-induced autophagy of HuH-7 cells. Taken together, these data suggest that cell autophagy was induced by MIF under stress conditions such as inflammation and starvation through ROS generation.	[Chuang, Yung-Chun] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chuang, Yung-Chun; Su, Wen-Hong; Lei, Huan-Yao; Lin, Yee-Shin; Liu, Hsiao-Sheng; Chang, Chih-Peng; Yeh, Trai-Ming] Natl Cheng Kung Univ, Coll Med, Res Ctr Infect Dis & Signaling, Tainan 70101, Taiwan; [Lei, Huan-Yao; Lin, Yee-Shin; Liu, Hsiao-Sheng; Chang, Chih-Peng] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Yeh, Trai-Ming] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Chuang, YC (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan.	today@mail.ncku.edu.tw	Chuang, Yung-Chun/J-9075-2014; Yeh, Trai-Ming/C-7193-2011	Yeh, Trai-Ming/0000-0003-3172-7432; Liu, Hsiao-Sheng/0000-0003-0576-7203; Chang, Chih-Peng/0000-0002-0061-3478	National Science Council grants in Taiwan [NSC99-2321-B-006-008, NSC99-2320-B-006-017-MY3]; Center of Infectious Disease and Signaling Research in National Cheng Kung University, Tainan, Taiwan; optic-image core lab, Research Center of Clinical Medicine, National Cheng Kung University Hospital	National Science Council grants in Taiwan; Center of Infectious Disease and Signaling Research in National Cheng Kung University, Tainan, Taiwan; optic-image core lab, Research Center of Clinical Medicine, National Cheng Kung University Hospital	This study was supported by National Science Council grants in Taiwan (NSC99-2321-B-006-008, NSC99-2320-B-006-017-MY3) and Center of Infectious Disease and Signaling Research in National Cheng Kung University, Tainan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the support from the optic-image core lab, Research Center of Clinical Medicine, National Cheng Kung University Hospital. This article is dedicated to Prof. H.Y. Lei who passed away during the preparation of the manuscript.	Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Bach JP, 2008, ONCOLOGY-BASEL, V75, P127, DOI 10.1159/000155223; Bach JP, 2009, CANCER-AM CANCER SOC, V115, P2031, DOI 10.1002/cncr.24245; Baugh JA, 2002, CRIT CARE MED, V30, pS27, DOI 10.1097/00003246-200201001-00004; Bifulco C, 2008, CURR PHARM DESIGN, V14, P3790, DOI 10.2174/138161208786898608; Bucala R, 2005, DRUG NEWS PERSPECT, V18, P417, DOI 10.1358/dnp.2005.18.7.939345; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chuang YC, 2011, CYTOKINE, V54, P222, DOI 10.1016/j.cyto.2011.01.013; Conroy H, 2010, QJM-INT J MED, V103, P831, DOI 10.1093/qjmed/hcq148; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Donnelly SC, 1997, MOL MED TODAY, V3, P502, DOI 10.1016/S1357-4310(97)01133-7; Eskelinen EL, 2008, INT REV CEL MOL BIO, V266, P207, DOI 10.1016/S1937-6448(07)66005-5; Garai J, 2009, CURR MED CHEM, V16, P1091, DOI 10.2174/092986709787581842; Gil J, 2003, FREE RADICAL BIO MED, V35, P1500, DOI 10.1016/j.freeradbiomed.2003.08.022; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Hansen TE, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-39; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Kafri T, 1999, J VIROL, V73, P576, DOI 10.1128/JVI.73.1.576-584.1999; Kang R, 2011, AUTOPHAGY, V7, P904, DOI 10.4161/auto.7.8.15704; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Miller FJ, 2010, ANTIOXID REDOX SIGN, V12, P583, DOI 10.1089/ars.2009.2857; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Park HJ, 2011, MOL IMMUNOL, V48, P720, DOI 10.1016/j.molimm.2010.10.020; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Xie LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016428	37	49	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37613	10.1371/journal.pone.0037613	http://dx.doi.org/10.1371/journal.pone.0037613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629429	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300060
J	Long, YH; Liu, HH; Yu, CH; Tian, X; Yang, YR; Wang, C; Pan, YJ				Long, Yanhua; Liu, Hui-Hui; Yu, Changhong; Tian, Xia; Yang, Yi-Ran; Wang, Cheng; Pan, Yajuan			Pre-Existing Diseases of Patients Increase Susceptibility to Hypoxemia during Gastrointestinal Endoscopy	PLOS ONE			English	Article							MYOCARDIAL-ISCHEMIA; VASCULAR FUNCTION; RISK-FACTORS; HYPOXIA; CONSISTENCY; OXYGEN; SEDATION; COMPLICATIONS; TACHYCARDIA; PROPOFOL	Hypoxemia is the most common adverse event that happened during gastrointestinal endoscopy. To estimate risk of hypoxemia prior to endoscopy, American Society of Anesthesiology (ASA) classification scores were used as a major predictive factor. But the accuracy of ASA scores for predicting hypoxemia incidence was doubted here, considering that the classification system ignores much information about general health status and fitness of patient that may contribute to hypoxemia. In this retrospective review of clinical data collected prospectively, the data on 4904 procedures were analyzed. The Pearson's chi-square test or the Fisher exact test was employed to analyze variance of categorical factors. Continuous variables were statistically evaluated using t-tests or Analysis of variance (ANOVA). As a result, only 245 (5.0%) of the enrolled 4904 patients were found to present hypoxemia during endoscopy. Multivariable logistic regressions revealed that independent risk factors for hypoxemia include high BMI (BMI 30 versus 20, Odd ratio: 1.52, 95% CI: 1.13-2.05; P = 0.0098), hypertension (Odd ratio: 2.28, 95% CI: 1.44-3.60; P = 0.0004), diabetes (Odd ratio: 2.37, 95% CI: 1.30-4.34; P = 0.005), gastrointestinal diseases (Odd ratio: 1.77, 95% CI: 1.21-2.60; P = 0.0033), heart diseases (Odd ratio: 1.97, 95% CI: 1.06-3.68; P = 0.0325) and the procedures that combined esophagogastroduodenoscopy (EGD) and colonoscopy (Odd ratio: 4.84, 95% CI: 1.61-15.51; P = 0.0292; EGD as reference). It is noteworthy that ASA classification scores were not included as an independent predictive factor, and susceptibility of youth to hypoxemia during endoscopy was as high as old subjects. In conclusion, some certain pre-existing diseases of patients were newly identified as independent risk factors for hypoxemia during GI endoscopy. High ASA scores are a confounding predictive factor of pre-existing diseases. We thus recommend that youth (<= 18 yrs), obese patients and those patients with hypertension, diabetes, heart diseases, or GI diseases should be monitored closely during sedation endoscopy.	[Long, Yanhua; Liu, Hui-Hui; Tian, Xia; Yang, Yi-Ran; Wang, Cheng; Pan, Yajuan] Wuhan Univ, Tong Ren Hosp, Hosp Wuhan 3, Dept Gastroenterol, Wuhan 430072, Hubei, Peoples R China; [Liu, Hui-Hui; Yang, Yi-Ran] Cleveland Clin Fdn, Genom Med Inst, Cleveland, OH 44195 USA	Wuhan University; Cleveland Clinic Foundation	Long, YH (corresponding author), Wuhan Univ, Tong Ren Hosp, Hosp Wuhan 3, Dept Gastroenterol, Wuhan 430072, Hubei, Peoples R China.	liuhhchris@gmail.com	LIU, HUI-HUI/F-8584-2012					Bernard Philip A, 2009, Int J Adolesc Med Health, V21, P213, DOI 10.1515/IJAMH.2009.21.2.213; BLOCK R, 1993, ENDOSCOPY, V25, P269, DOI 10.1055/s-2007-1010312; Christe C, 2000, J AM GERIATR SOC, V48, P1398, DOI 10.1111/j.1532-5415.2000.tb02628.x; DHARIWAL A, 1992, GASTROINTEST ENDOSC, V38, P684, DOI 10.1016/S0016-5107(92)70564-1; Eisen GM, 2000, GASTROINTEST ENDOSC, V51, pAB76, DOI 10.1016/S0016-5107(00)14079-9; Fisher L, 2006, GASTROINTEST ENDOSC, V63, P948, DOI 10.1016/j.gie.2005.09.020; Foster GE, 2007, EXP PHYSIOL, V92, P51, DOI 10.1113/expphysiol.2006.035204; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; GRIFFIN SM, 1990, BRIT MED J, V300, P83, DOI 10.1136/bmj.300.6717.83; HARLING DW, 1995, ANAESTHESIA, V50, P659; HAYNES SR, 1995, ANAESTHESIA, V50, P195, DOI 10.1111/j.1365-2044.1995.tb04554.x; Holm C, 1998, SCAND J GASTROENTERO, V33, P769; IBER FL, 1993, GASTROINTEST ENDOSC, V39, P620, DOI 10.1016/S0016-5107(93)70211-4; Johnston SD, 2003, ENDOSCOPY, V35, P1039, DOI 10.1055/s-2003-44597; Lecube A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004692; LITTLE JP, 1995, ANAESTHESIA, V50, P658; Müller Suzana, 2004, Arq. Gastroenterol., V41, P162, DOI 10.1590/S0004-28032004000300005; Murthy Tvsp, 2009, Med J Armed Forces India, V65, P161, DOI 10.1016/S0377-1237(09)80133-0; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; Qadeer MA, 2005, CLIN GASTROENTEROL H, V3, P1049, DOI 10.1016/S1542-3565(05)00742-1; Qadeer MA, 2011, DIGESTION, V84, P37, DOI 10.1159/000321621; Qadeer MA, 2009, DIGEST DIS SCI, V54, P1035, DOI 10.1007/s10620-008-0452-2; ROSTYKUS PS, 1980, GASTROENTEROLOGY, V78, P488; Sharma VK, 2007, GASTROINTEST ENDOSC, V66, P27, DOI 10.1016/j.gie.2006.12.040; Steele Russell J, 2010, Stat Methodol, V7, P351; Thomas BJ, 2003, EUR J PHARMACOL, V477, P153, DOI 10.1016/j.ejphar.2003.08.015; Uday J, 1987, RESISTANCES REVOLUTI, P15; Vargo JJ, 2006, ALIMENT PHARM THER, V24, P955, DOI 10.1111/j.1365-2036.2006.03099.x; Vargo John, 2011, Gastroenterol Hepatol (N Y), V7, P189; Vargo JJ, 2010, CURR OPIN GASTROEN, V26, P421, DOI 10.1097/MOG.0b013e32833d1786; WOODS SDS, 1989, GASTROINTEST ENDOSC, V35, P523, DOI 10.1016/S0016-5107(89)72903-5	31	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37614	10.1371/journal.pone.0037614	http://dx.doi.org/10.1371/journal.pone.0037614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629430	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300061
J	Pincham, HL; Szucs, D				Pincham, Hannah L.; Szucs, Denes			Target Cueing Provides Support for Target- and Resource-Based Models of the Attentional Blink	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; DIRECT PARAMETER SPECIFICATION; EVENT-RELATED POTENTIALS; TIME-COURSE; DEPLETION ACCOUNTS; TEMPORAL ATTENTION; WORKING-MEMORY; PERCEPTION; STIMULUS; MASKING	The attentional blink (AB) describes a time-based deficit in processing the second of two masked targets. The AB is attenuated if successive targets appear between the first and final target, or if a cueing target is positioned before the final target. Using various speeds of stimulus presentation, the current study employed successive targets and cueing targets to confirm and extend an understanding of target-target cueing in the AB. In Experiment 1, three targets were presented sequentially at rates of 30 msec/item or 90 msec/item. Successive targets presented at 90 msec improved performance compared with non-successive targets. However, accuracy was equivalently high for successive and non-successive targets presented at 30 msec/item, suggesting that-regardless of whether they occurred consecutively-those items fell within the temporally defined attentional window initiated by the first target. Using four different presentation speeds, Experiment 2 confirmed the time-based definition of the AB and the success of target-cueing at 30 msec/item. This experiment additionally revealed that cueing was most effective when resources were not devoted to the cue, thereby implicating capacity limitations in the AB. Across both experiments, a novel order-error measure suggested that errors tend to decrease with an increasing duration between the targets, but also revealed that certain stimulus conditions result in stable order accuracy. Overall, the results are best encapsulated by target-based and resource-sharing theories of the AB, which collectively value the contributions of capacity limitations and optimizing transient attention in time.	[Pincham, Hannah L.; Szucs, Denes] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Pincham, HL (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	hlp31@cam.ac.uk; ds377@cam.ac.uk		Szucs, Denes/0000-0002-9477-0801	Gates Cambridge Trust studentship; Medical Research Council [G0900643] Funding Source: researchfish; MRC [G0900643] Funding Source: UKRI	Gates Cambridge Trust studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by a Gates Cambridge Trust studentship to HP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek EG, 2007, PSYCHOPHYSIOLOGY, V44, P383, DOI 10.1111/j.1469-8986.2007.00513.x; Bachmann T, 2005, PSYCHOL SCI, V16, P740, DOI 10.1111/j.1467-9280.2005.01604.x; BACHMANN T, 1988, VISION RES, V28, P1255, DOI 10.1016/0042-6989(88)90041-7; Bachmann T., 1999, COGNITIVE CONTRIBUTI, V129, P173; Bowman H, 2007, PSYCHOL REV, V114, P38, DOI 10.1037/0033-295X.114.1.38; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Craston P, 2009, J COGNITIVE NEUROSCI, V21, P550, DOI 10.1162/jocn.2009.21036; Davenport JL, 2005, MEM COGNITION, V33, P241, DOI 10.3758/BF03195313; Dell'Acqua R, 2012, PSYCHON B REV, V19, P232, DOI 10.3758/s13423-011-0209-3; Dell'Acqua R, 2003, PSYCHOPHYSIOLOGY, V40, P629, DOI 10.1111/1469-8986.00064; Dell'Acqua R, 2009, J EXP PSYCHOL HUMAN, V35, P338, DOI 10.1037/a0013555; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Dux PE, 2008, PSYCHON B REV, V15, P809, DOI 10.3758/PBR.15.4.809; Dux PE, 2009, PSYCHON B REV, V16, P219, DOI 10.3758/PBR.16.1.219; Harris IM, 2010, J EXP PSYCHOL HUMAN, V36, P1595, DOI 10.1037/a0019218; Hilkenmeier F, 2010, EUR J COGN PSYCHOL, V22, P1222, DOI 10.1080/09541440903418924; Hommel B, 2005, Q J EXP PSYCHOL-A, V58, P1415, DOI 10.1080/02724980443000647; Kawahara JI, 2006, PSYCHON B REV, V13, P886, DOI 10.3758/BF03194014; KLOTZ W, 1995, PSYCHOL RES-PSYCH FO, V58, P92, DOI 10.1007/BF00571098; Klotz W, 1999, J EXP PSYCHOL HUMAN, V25, P976, DOI 10.1037/0096-1523.25.4.976; Kranczioch C, 2007, NEUROIMAGE, V37, P947, DOI 10.1016/j.neuroimage.2007.05.044; Livesey EJ, 2011, ATTEN PERCEPT PSYCHO, V73, P2104, DOI 10.3758/s13414-011-0177-8; Martens S, 2006, ACTA PSYCHOL, V123, P204, DOI 10.1016/j.actpsy.2006.01.001; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; NEUMANN O, 1994, ATTENTION PERFORM, V15, P123; Nieuwenhuis S, 2005, J EXP PSYCHOL GEN, V134, P291, DOI 10.1037/0096-3445.134.3.291; Nieuwenstein M, 2009, J VISION, V9, DOI 10.1167/9.9.18; Nieuwenstein MR, 2006, J EXP PSYCHOL HUMAN, V32, P973, DOI 10.1037/0096-1523.32.4.973; Nieuwenstein MR, 2006, PSYCHOL SCI, V17, P471, DOI 10.1111/j.1467-9280.2006.01730.x; Nieuwenstein MR, 2009, J EXP PSYCHOL HUMAN, V35, P159, DOI 10.1037/0096-1523.35.1.159; Nieuwenstein MR, 2005, J EXP PSYCHOL HUMAN, V31, P1463, DOI 10.1037/0096-1523.31.6.1463; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Olivers CNL, 2011, ATTEN PERCEPT PSYCHO, V73, P53, DOI 10.3758/s13414-010-0004-7; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Pincham HL, 2012, CEREB CORTEX, V22, P2346, DOI 10.1093/cercor/bhr314; Popple AV, 2007, VISION RES, V47, P2973, DOI 10.1016/j.visres.2007.06.022; Potter MC, 2008, J MEM LANG, V58, P907, DOI 10.1016/j.jml.2007.12.002; Potter MC, 2005, PSYCHON B REV, V12, P460, DOI 10.3758/BF03193788; Potter MC, 2002, J EXP PSYCHOL HUMAN, V28, P1149, DOI 10.1037//0096-1523.28.5.1149; Potter MC, 2005, COMPETITION ATTENTIO, P207; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Scharlau I, 2003, VISION RES, V43, P1351, DOI 10.1016/S0042-6989(03)00141-X; Spalek TM, 2012, J EXP PSYCHOL HUMAN, V38, P402, DOI 10.1037/a0025050; Spalek TM, 2006, PERCEPTION PSYCHOPHY, P68; Visser TAW, 1999, PSYCHOL BULL, V125, P458, DOI 10.1037/0033-2909.125.4.458; Visser TAW, 1999, PSYCHON B REV, V6, P432, DOI 10.3758/BF03210831; Visser TAW, 2011, J EXP PSYCHOL HUMAN, V37, P1527, DOI 10.1037/a0023508; Wyble B, 2011, J EXP PSYCHOL GEN, V140, P488, DOI 10.1037/a0023612; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P787, DOI 10.1037/a0013902; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P324, DOI 10.1037/a0013903	55	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37596	10.1371/journal.pone.0037596	http://dx.doi.org/10.1371/journal.pone.0037596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VQ	22629426	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345300057
J	Kraus, M; Wang, YX; Aleksandrowicz, D; Bachman, E; Szewczak, AA; Walker, D; Xu, L; Bouthillette, M; Childers, KM; Dolinski, B; Haidle, AM; Kopinja, J; Lee, L; Lim, J; Little, KD; Ma, YH; Mathur, A; Mo, JR; O'Hare, E; Otte, RD; Taoka, BM; Wang, WX; Yin, H; Zabierek, AA; Zhang, WS; Zhao, SX; Zhu, J; Young, JR; Marshall, CG				Kraus, Manfred; Wang, Yuxun; Aleksandrowicz, Dan; Bachman, Eric; Szewczak, Alexander A.; Walker, Deborah; Xu, Lin; Bouthillette, Melaney; Childers, Kaleen M.; Dolinski, Brian; Haidle, Andrew M.; Kopinja, Johnny; Lee, Linda; Lim, Jongwon; Little, Kevin D.; Ma, Yanhong; Mathur, Anjili; Mo, Jan-Rung; O'Hare, Erin; Otte, Ryan D.; Taoka, Brandon M.; Wang, Wenxian; Yin, Hong; Zabierek, Anna A.; Zhang, Weisheng; Zhao, Shuxia; Zhu, Joe; Young, Jonathan R.; Marshall, C. Gary			Efficacious Intermittent Dosing of a Novel JAK2 Inhibitor in Mouse Models of Polycythemia Vera	PLOS ONE			English	Article							TYROSINE KINASE JAK2; MYELOPROLIFERATIVE DISORDERS; ESSENTIAL THROMBOCYTHEMIA; MUTATION; EXPRESSION	A high percentage of patients with the myeloproliferative disorder polycythemia vera (PV) harbor a Val617 -> Phe activating mutation in the Janus kinase 2 (JAK2) gene, and both cell culture and mouse models have established a functional role for this mutation in the development of this disease. We describe the properties of MRLB-11055, a highly potent inhibitor of both the WT and V617F forms of JAK2, that has therapeutic efficacy in erythropoietin (EPO)-driven and JAK2V617F-driven mouse models of PV. In cultured cells, MRLB-11055 blocked proliferation and induced apoptosis in a manner consistent with JAK2 pathway inhibition. MRLB-11055 effectively prevented EPO-induced STAT5 activation in the peripheral blood of acutely dosed mice, and could prevent EPO-induced splenomegaly and erythrocytosis in chronically dosed mice. In a bone marrow reconstituted JAK2V617F-luciferase murine PV model, MRLB-11055 rapidly reduced the burden of JAK2V617F-expressing cells from both the spleen and the bone marrow. Using real-time in vivo imaging, we examined the kinetics of disease regression and resurgence, enabling the development of an intermittent dosing schedule that achieved significant reductions in both erythroid and myeloid populations with minimal impact on lymphoid cells. Our studies provide a rationale for the use of non-continuous treatment to provide optimal therapy for PV patients.	[Kraus, Manfred] Merck Res Labs, Dept DMPK, Boston, MA USA; Merck Res Labs, Dept Vitro Sci, Boston, MA USA; Merck Res Labs, Dept Vivo Sci, Boston, MA USA; Merck Res Labs, Dept Med Chem, Boston, MA USA; Merck Res Labs, Dept Basic Pharmaceut Sci, Boston, MA USA; Merck Res Labs, Dept Oncol, Boston, MA USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Kraus, M (corresponding author), Merck Res Labs, Dept DMPK, Boston, MA USA.	jonathan_young@merck.com; christopher_marshall3@merck.com	MA, YAN/HHN-2912-2022; Walker, Deborah/GSE-2426-2022	Wang, Yuxun/0000-0002-4252-6102	Merck Co., Inc.	Merck Co., Inc.(Merck & Company)	All of the research was funded by Merck & Co., Inc. The funders did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript as the authors are employed by the funder.	Baffert F, 2010, MOL CANCER THER, V9, P1945, DOI 10.1158/1535-7163.MCT-10-0053; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bumm TGP, 2006, CANCER RES, V66, P11156, DOI 10.1158/0008-5472.CAN-06-2210; Campbell PJ, 2006, BLOOD, V108, P3548, DOI 10.1182/blood-2005-12-013748; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Conklyn M, 2004, J LEUKOCYTE BIOL, V76, P1248, DOI 10.1189/jlb.0504282; Cortes J, 2008, BLOOD, V112, P1109; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lim J, 2009, United States patent application, Patent No. [WO 200907, 200907]; Lim J, 2011, J MED CHEM, V54, P7334, DOI 10.1021/jm200909u; Ma XM, 2008, AM J HEMATOL, V83, P359, DOI 10.1002/ajh.21129; Ma YH, 2009, BBA-MOL BASIS DIS, V1792, P1073, DOI 10.1016/j.bbadis.2009.08.011; Marrero MB, 2005, VASC PHARMACOL, V43, P307, DOI 10.1016/j.vph.2005.09.002; Mathur A, 2009, BIOCHEM PHARMACOL, V78, P382, DOI 10.1016/j.bcp.2009.04.025; Mesa RA, 2007, CANCER-AM CANCER SOC, V109, P68, DOI 10.1002/cncr.22365; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Pardanani AD, 2008, BLOOD, V112, P43, DOI 10.1182/blood.V112.11.97.97; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Penninga EI, 2006, DRUGS, V66, P2173, DOI 10.2165/00003495-200666170-00003; Rice L, 2006, ARCH PATHOL LAB MED, V130, P1151; Siu T., 2009, Inhibitors of Janus Kinases, Patent No. [WO 2009035575, 2009035575, WO 2009/ 035575 A1]; VERSTOVSEK S, 2008, BLOOD, V112, P1762; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Zaleskas VM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000018; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	30	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37207	10.1371/journal.pone.0037207	http://dx.doi.org/10.1371/journal.pone.0037207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623993	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500073
J	Martins, AP; Marrone, A; Ciancetta, A; Cobo, AG; Echevarria, M; Moura, TF; Re, N; Casini, A; Soveral, G				Martins, Ana Paula; Marrone, Alessandro; Ciancetta, Antonella; Galan Cobo, Ana; Echevarria, Miriam; Moura, Teresa F.; Re, Nazzareno; Casini, Angela; Soveral, Graca			Targeting Aquaporin Function: Potent Inhibition of Aquaglyceroporin-3 by a Gold-Based Compound	PLOS ONE			English	Article							PROTEIN HOMOLOGY DETECTION; WATER PERMEABILITY; BASOLATERAL MEMBRANE; SOLUTION CHEMISTRY; COLLECTING DUCT; FORCE-FIELD; GLYCEROL; CHANNEL; SELECTIVITY; MECHANISM	Aquaporins (AQPs) are membrane channels that conduct water and small solutes such as glycerol and are involved in many physiological functions. Aquaporin-based modulator drugs are predicted to be of broad potential utility in the treatment of several diseases. Until today few AQP inhibitors have been described as suitable candidates for clinical development. Here we report on the potent inhibition of AQP3 channels by gold(III) complexes screened on human red blood cells (hRBC) and AQP3-transfected PC12 cells by a stopped-flow method. Among the various metal compounds tested, Auphen is the most active on AQP3 (IC50 = 0.86 +/- 0.08 mu M in hRBC). Interestingly, the compound poorly affects the water permeability of AQP1. The mechanism of gold inhibition is related to the ability of Au(III) to interact with sulphydryls groups of proteins such as the thiolates of cysteine residues. Additional DFT and modeling studies on possible gold compound/AQP adducts provide a tentative description of the system at a molecular level. The mapping of the periplasmic surface of an homology model of human AQP3 evidenced the thiol group of Cys40 as a likely candidate for binding to gold(III) complexes. Moreover, the investigation of non-covalent binding of Au complexes by docking approaches revealed their preferential binding to AQP3 with respect to AQP1. The high selectivity and low concentration dependent inhibitory effect of Auphen (in the nanomolar range) together with its high water solubility makes the compound a suitable drug lead for future in vivo studies. These results may present novel metal-based scaffolds for AQP drug development.	[Martins, Ana Paula; Moura, Teresa F.; Soveral, Graca] Univ Nova Lisboa, REQUIMTE, Dept Quim, Fac Ciencias & Tecnol, Caparica, Portugal; [Marrone, Alessandro; Ciancetta, Antonella; Re, Nazzareno] Univ G DAnnunzio, Dipartimento Sci Farmaco, Chieti, Italy; [Galan Cobo, Ana; Echevarria, Miriam] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, IBiS, Seville, Spain; [Casini, Angela] Univ Groningen, Res Inst Pharm, Groningen, Netherlands; [Soveral, Graca] Univ Lisbon, Fac Farm, Dept Bioquim & Biol Humana, P-1699 Lisbon, Portugal	Universidade Nova de Lisboa; G d'Annunzio University of Chieti-Pescara; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of Groningen; Universidade de Lisboa	Martins, AP (corresponding author), Univ Nova Lisboa, REQUIMTE, Dept Quim, Fac Ciencias & Tecnol, Caparica, Portugal.	a.casini@rug.nl; gsoveral@ff.ul.pt	Ciancetta, Antonella/AAS-8478-2020; Casini, Angela/Q-1701-2019; IBIS, TERAPIA CELULA/P-3297-2015; Echevarría, Miriam/E-6682-2010; Moura, Teresa F/E-2485-2014; iMed.ULisboa, MetGen/B-5293-2014; Casini, Angela/E-6731-2014; Martins, Ana Paula/A-5657-2013; Soveral, Graça/L-1550-2013; Ciancetta, Antonella/L-9991-2017	Ciancetta, Antonella/0000-0002-7612-2050; Casini, Angela/0000-0003-1599-9542; Echevarría, Miriam/0000-0002-4758-9428; Casini, Angela/0000-0003-1599-9542; Martins, Ana Paula/0000-0002-5064-6171; Soveral, Graça/0000-0001-8487-110X; Ciancetta, Antonella/0000-0002-7612-2050; Martins, Ana Paula/0000-0002-4706-5456; Marrone, Alessandro/0000-0002-8311-8172; Fonseca de Moura, Teresa Maria/0000-0003-3069-0770; Galan Cobo, Ana/0000-0002-0988-1823	Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/65046/2009]; COST [CM0902]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); COST(European Cooperation in Science and Technology (COST))	This work was supported from Fundacao para a Ciencia e a Tecnologia, Portugal, through a Ph.D. fellowship to APM (SFRH/BD/65046/2009). A. Casini thanks the University of Groningen (Rosalind Franklin fellowship). The authors thank COST CM0902 for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate F, 2000, INORG CHIM ACTA, V311, P1, DOI 10.1016/S0020-1693(00)00299-1; Aldinucci D, 2007, ANTI-CANCER DRUG, V18, P323, DOI 10.1097/CAD.0b013e328011ae98; [Anonymous], 2008, MAESTR 8 5; Bagnasco SM, 2006, J MEMBRANE BIOL, V212, P133, DOI 10.1007/s00232-006-0872-x; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Bergamo A, 2012, J INORG BIOCHEM, V106, P90, DOI 10.1016/j.jinorgbio.2011.09.030; Brooks HL, 2000, MOL PHARMACOL, V57, P1021; Campos E, 2011, BIOCHEM BIOPH RES CO, V408, P477, DOI 10.1016/j.bbrc.2011.04.057; Carbrey Jennifer M, 2009, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-540-79885-9_1; Casini A, 2008, J INORG BIOCHEM, V102, P564, DOI 10.1016/j.jinorgbio.2007.11.003; Casini A, 2012, J INORG BIOCHEM, V109, P97, DOI 10.1016/j.jinorgbio.2011.12.007; Casini A, 2009, J BIOL INORG CHEM, V14, P1139, DOI 10.1007/s00775-009-0558-9; Chen HN, 2007, BIOPHYS J, V92, P46, DOI 10.1529/biophysj.106.091934; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0; DENKER BM, 1988, J BIOL CHEM, V263, P15634; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; Echevarria M, 2007, J BIOL CHEM, V282, P30207, DOI 10.1074/jbc.M702639200; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gao L, 2011, MOL ONCOL; Hara M, 2003, P NATL ACAD SCI USA, V100, P7360, DOI 10.1073/pnas.1230416100; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; HARIHARAN PC, 1972, CHEM PHYS LETT, V16, P217, DOI 10.1016/0009-2614(72)80259-8; HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI [10.1063/1.448800, 10.1063/1.448799]; Hub JS, 2008, P NATL ACAD SCI USA, V105, P1198, DOI 10.1073/pnas.0707662104; Huber VJ, 2007, BIOORG MED CHEM LETT, V17, P1270, DOI 10.1016/j.bmcl.2006.12.010; Igarashi H, 2011, NEUROL SCI, V32, P113, DOI 10.1007/s10072-010-0431-1; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Ishibashi K, 2011, AM J PHYSIOL-REG I, V300, pR566, DOI [10.1152/ajpregu.90464.2008, 10.1007/978-94-024-1057-0_2]; Jelen S, 2011, J BIOL CHEM; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Ma B, 2004, ACTA PHARMACOL SIN, V25, P90; Mendes F, 2011, J MED CHEM, V54, P2196, DOI 10.1021/jm2000135; Messori L, 2000, J MED CHEM, V43, P3541, DOI 10.1021/jm990492u; Messori L, 2004, MET IONS BIOL SYST, V41, P2799; Migliati E, 2009, MOL PHARMACOL, V76, P105, DOI 10.1124/mol.108.053744; Migliati ER, 2010, NEUROCRIT CARE, V13, P123, DOI 10.1007/s12028-010-9376-8; MOURA TF, 1984, J MEMBRANE BIOL, V81, P105, DOI 10.1007/BF01868975; Nakamura Y, 2011, ACS CHEM NEUROSCI, V2, P568, DOI 10.1021/cn2000525; Nielsen RJ, 2004, J AM CHEM SOC, V126, P7967, DOI 10.1021/ja031911m; Niemietz CM, 2002, FEBS LETT, V531, P443, DOI 10.1016/S0014-5793(02)03581-0; Niu SQ, 2000, CHEM REV, V100, P353, DOI 10.1021/cr980404y; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1993, J BIOL CHEM, V268, P17; Reedijk J, 2003, P NATL ACAD SCI USA, V100, P3611, DOI 10.1073/pnas.0737293100; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Roudier N, 1998, J BIOL CHEM, V273, P8407, DOI 10.1074/jbc.273.14.8407; Savage DF, 2007, J MOL BIOL, V368, P607, DOI 10.1016/j.jmb.2007.02.070; Savage DF, 2010, P NATL ACAD SCI USA, V107, P17164, DOI 10.1073/pnas.1009864107; Schrodinger LLC, 2009, JAG 7 7 7 5; Schrodinger LLC, 2008, SIT 2 2; Serratrice M, 2012, DALTON T, V41, P3287, DOI 10.1039/c2dt11913g; Shaw CF, 1989, COMMENTS INORG CHEM, V8, P233, DOI DOI 10.1080/02603598908035798; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sogaard R, 2008, PFLUG ARCH EUR J PHY, V456, P285, DOI 10.1007/s00424-007-0392-2; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Takata K, 2004, PROG HISTOCHEM CYTO, V39, P1, DOI 10.1016/j.proghi.2004.03.001; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; TANNOR DJ, 1994, J AM CHEM SOC, V116, P11875, DOI 10.1021/ja00105a030; TSIPOURAS N, 1995, CLIN CHEM, V41, P87; VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707; VANHOEK AN, 1990, J PHYSIOL-LONDON, V420, pP142; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; Verkman Alan S, 2009, Handb Exp Pharmacol, P359, DOI 10.1007/978-3-540-79885-9_18; Wu B, 2007, CELL MOL LIFE SCI, V64, P2413, DOI 10.1007/s00018-007-7163-2; Yang BX, 2008, BIOORGAN MED CHEM, V16, P7489, DOI 10.1016/j.bmc.2008.06.005; Yang BX, 2006, FEBS LETT, V580, P6679, DOI 10.1016/j.febslet.2006.11.025; Zelenina M, 2004, J BIOL CHEM, V279, P51939, DOI 10.1074/jbc.M407645200; Zelenina M, 2003, J BIOL CHEM, V278, P30037, DOI 10.1074/jbc.M302206200; Zhang X, 2010, J CELL BIOCHEM, V109, P162, DOI 10.1002/jcb.22394	77	96	99	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37435	10.1371/journal.pone.0037435	http://dx.doi.org/10.1371/journal.pone.0037435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624030	gold, Green Published			2022-12-25	WOS:000305343500115
J	O'Grady, EP; Viteri, DF; Sokol, PA				O'Grady, Eoin P.; Viteri, Duber F.; Sokol, Pamela A.			A Unique Regulator Contributes to Quorum Sensing and Virulence in Burkholderia cenocepacia	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CEPACIA COMPLEX; CAENORHABDITIS-ELEGANS; CYSTIC-FIBROSIS; INTERSPECIES COMMUNICATION; TRANSCRIPTIONAL REGULATOR; RHIZOBIUM-LEGUMINOSARUM; COLONY MORPHOLOGY; BIOFILM FORMATION; GENES	Burkholderia cenocepacia causes chronic and life-threatening respiratory infections in immunocompromized people. The B. cenocepacia N-acyl-homoserine lactone (AHL)-dependent quorum sensing system relies on the production of AHLs by the synthases CepI and CciI while CepR, CciR and CepR2 control expression of many genes important for pathogenesis. Downstream from, and co-transcribed with cepI, lies BCAM1871 encoding a hypothetical protein that was uncharacterized prior to this study. Orthologs of B. cenocepacia BCAM1871 are uniquely found in Burkholderia spp and are conserved in their genomic locations in pathogenic Burkholderia. We observed significant effects on AHL activity upon mutation or overexpression of BCAM1871, although these effects were more subtle than those observed for CepI indicating BCAM1871 acts as an enhancer of AHL activity. Transcription of cepI, cepR and cciIR was significantly reduced in the BCAM1871 mutant. Swimming and swarming motilities as well as transcription of fliC, encoding flagellin, were significantly reduced in the BCAM1871 mutant. Protease activity and transcription of zmpA and zmpB, encoding extracellular zinc metalloproteases, were undetectable in the BCAM1871 mutant indicating a more significant effect of mutating BCAM1871 than cepI. Exogenous addition of OHL restored cepI, cepR and fliC transcription but had no effect on motility, protease activity or zmpA or zmpB transcription suggesting AHL-independent effects. The BCAM1871 mutant exhibited significantly reduced virulence in rat chronic respiratory and nematode infection models. Gene expression and phenotypic assays as well as vertebrate and invertebrate infection models showed that BCAM1871 significantly contributes to pathogenesis in B. cenocepacia.	[O'Grady, Eoin P.; Viteri, Duber F.; Sokol, Pamela A.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada	University of Calgary	O'Grady, EP (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.	psokol@ucalgary.ca			Cystic Fibrosis Canada; Canadian Institutes of Health Research [MOP-42510]; Cystic Fibrosis Canada fellowship	Cystic Fibrosis Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada fellowship	These studies were supported by research grants from the Cystic Fibrosis Canada and Canadian Institutes of Health Research (grant MOP-42510) to PAS. EPO was the recipient of a Cystic Fibrosis Canada fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 2003, J BACTERIOL, V185, P6456, DOI 10.1128/JB.185.21.6456-6462.2003; Ausubel F. M., 1988, CURRENT PROTOCOLS MO; Baldwin A, 2004, INFECT IMMUN, V72, P1537, DOI 10.1128/IAI.72.3.1537-1547.2004; Bernier SP, 2003, INFECT IMMUN, V71, P5306, DOI 10.1128/IAI.71.9.5306-5313.2003; Bernier SP, 2008, INFECT IMMUN, V76, P38, DOI 10.1128/IAI.00874-07; Bernier SP, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-59; BRENNER S, 1974, GENETICS, V77, P71; CASH HA, 1979, AM REV RESPIR DIS, V119, P453; Chambers CE, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-104; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Corbett CR, 2003, MICROBIOL-SGM, V149, P2263, DOI 10.1099/mic.0.26243-0; Daniels R, 2006, P NATL ACAD SCI USA, V103, P14965, DOI 10.1073/pnas.0511037103; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Dennis J J, 1995, Methods Mol Biol, V47, P125; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Eberl L, 2004, INT J MED MICROBIOL, V294, P123, DOI 10.1016/j.ijmm.2004.06.022; Edwards A, 2009, J BACTERIOL, V191, P3059, DOI 10.1128/JB.01650-08; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Frederix M, 2011, MOL MICROBIOL, V81, P994, DOI 10.1111/j.1365-2958.2011.07738.x; Gotschlich A, 2001, SYST APPL MICROBIOL, V24, P1, DOI 10.1078/0723-2020-00013; Hedl M, 2004, J BACTERIOL, V186, P1927, DOI 10.1128/JB.186.7.1927-1932.2004; HOLLOWAY BW, 1994, MICROBIOL-UK, V140, P2907, DOI 10.1099/13500872-140-11-2907; Huber B, 2004, INFECT IMMUN, V72, P7220, DOI 10.1128/IAI.72.12.7220-7230.2004; Huber B, 2002, MOL MICROBIOL, V46, P411, DOI 10.1046/j.1365-2958.2002.03182.x; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; Kooi C, 2006, INFECT IMMUN, V74, P4083, DOI 10.1128/IAI.00297-06; Kothe M, 2003, CELL MICROBIOL, V5, P343, DOI 10.1046/j.1462-5822.2003.00280.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lamothe J, 2007, CELL MICROBIOL, V9, P40, DOI 10.1111/j.1462-5822.2006.00766.x; Lewenza S, 2002, CAN J MICROBIOL, V48, P707, DOI 10.1139/W02-068; Lewenza S, 2001, J BACTERIOL, V183, P2212, DOI 10.1128/JB.183.7.2212-2218.2001; Lewenza S, 1999, J BACTERIOL, V181, P748, DOI 10.1128/JB.181.3.748-756.1999; Loutet SA, 2010, INFECT IMMUN, V78, P4088, DOI 10.1128/IAI.00212-10; Magalhaes M, 2003, J HOSP INFECT, V54, P120, DOI 10.1016/S0195-6701(03)00118-X; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P910, DOI 10.1128/JCM.38.2.910-913.2000; Malott RJ, 2009, J BACTERIOL, V191, P2447, DOI 10.1128/JB.01746-08; Malott RJ, 2005, INFECT IMMUN, V73, P4982, DOI 10.1128/IAI.73.8.4982-4992.2005; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McKeon SA, 2011, J INFECT DIS, V203, P383, DOI 10.1093/infdis/jiq054; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; O'Grady EP, 2011, J BACTERIOL, V193, P163, DOI 10.1128/JB.00852-10; O'Grady EP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-441; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; Riedel K, 2003, ELECTROPHORESIS, V24, P740, DOI 10.1002/elps.200390089; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schweizer HP, 1996, MOLECULAR BIOLOGY OF PSEUDOMONADS, P229; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Sokol PA, 2003, MICROBIOL-SGM, V149, P3649, DOI 10.1099/mic.0.26540-0; SOKOL PA, 1979, J CLIN MICROBIOL, V9, P538; Speert David Paul, 2002, Paediatr Respir Rev, V3, P230, DOI 10.1016/S1526-0542(02)00185-9; Subramoni S, 2011, INFECT IMMUN, V79, P2984, DOI 10.1128/IAI.00170-11; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Subsin B, 2007, J BACTERIOL, V189, P968, DOI 10.1128/JB.01201-06; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tomlin KL, 2005, APPL ENVIRON MICROB, V71, P5208, DOI 10.1128/AEM.71.9.5208-5218.2005; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; Venturi V, 2011, MOL MICROBIOL, V82, P1060, DOI 10.1111/j.1365-2958.2011.07890.x; Vergunst AC, 2010, INFECT IMMUN, V78, P1495, DOI 10.1128/IAI.00743-09; Wei YP, 2011, MOL MICROBIOL, V79, P616, DOI 10.1111/j.1365-2958.2010.07469.x; Weingart CL, 2005, MOL MICROBIOL, V57, P452, DOI 10.1111/j.1365-2958.2005.04656.x; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Zhu J, 1998, J BACTERIOL, V180, P5398, DOI 10.1128/JB.180.20.5398-5405.1998	71	19	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37611	10.1371/journal.pone.0037611	http://dx.doi.org/10.1371/journal.pone.0037611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624054	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500143
J	Nguyen, Q; Palfreyman, RW; Chan, LCL; Reid, S; Nielsen, LK				Quan Nguyen; Palfreyman, Robin W.; Chan, Leslie C. L.; Reid, Steven; Nielsen, Lars K.			Transcriptome Sequencing of and Microarray Development for a Helicoverpa zea Cell Line to Investigate In Vitro Insect Cell-Baculovirus Interactions	PLOS ONE			English	Article							FUNCTIONAL ANNOTATION; APOPTOSIS PROTEINS; GENE; RNA; EXPRESSION; MODEL; GENERATION; INHIBITOR; EVOLUTION; VERSATILE	The Heliothine insect complex contains some of the most destructive pests of agricultural crops worldwide, including the closely related Helicoverpa zea and H. armigera. Biological control using baculoviruses is practiced at a moderate level worldwide. In order to enable more wide spread use, a better understanding of cell-virus interactions is required. While many baculoviruses have been sequenced, none of the Heliothine insect genomes have been available. In this study, we sequenced, assembled and functionally annotated 29,586 transcripts from cultured H. zea cells using Illumina 100 bps and paired-end transcriptome sequencing (RNA-seq). The transcript sequences had high assembly coverage (64.5 times). 23,401 sequences had putative protein functions, and over 13,000 sequences had high similarities to available sequences in other insect species. The sequence database was estimated to cover at least 85% of all H. zea genes. The sequences were used to construct a microarray, which was evaluated on the infection of H. zea cells with H. Armigera single-capsid nucleopolyhedrovirus (HearNPV). The analysis revealed that up-regulation of apoptosis genes is the main cellular response in the early infection phase (18 hours post infection), while genes linked to four major immunological signalling pathways (Toll, IMD, Jak-STAT and JNK) were down-regulated. Only small changes (generally downwards) were observed for central carbon metabolism. The transcriptome and microarray platform developed in this study represent a greatly expanded resource base for H. zea insect- HearNPV interaction studies, in which key cellular pathways such as those for metabolism, immune response, transcription and replication have been identified. This resource will be used to develop better cell culture-based virus production processes, and more generally to investigate the molecular basis of host range and susceptibility, virus infectivity and virulence, and the ecology and evolution of baculoviruses.	[Quan Nguyen; Palfreyman, Robin W.; Chan, Leslie C. L.; Reid, Steven; Nielsen, Lars K.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia	University of Queensland	Nguyen, Q (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia.	steven.reid@uq.edu.au	Nielsen, Lars K/A-5519-2011; Palfreyman, Robin W/V-8516-2017; Nguyen, Quan H/D-2026-2017	Nielsen, Lars K/0000-0001-8191-3511; Palfreyman, Robin W/0000-0002-1088-7069; Nguyen, Quan H/0000-0001-7870-5703	Australian Research Council [LP0989824]; University of Queenland; Australian Institute for Bioengineering and Nanotechnology	Australian Research Council(Australian Research Council); University of Queenland; Australian Institute for Bioengineering and Nanotechnology	This work was funded by the Australian Research Council Linkage Grant (no. LP0989824). QN's PhD Scholarship was provided by the University of Queenland and the Australian Institute for Bioengineering and Nanotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carinhas N, 2010, METAB ENG, V12, P39, DOI 10.1016/j.ymben.2009.08.008; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Chen CY, 2011, BIOTECHNOL ADV, V29, P618, DOI 10.1016/j.biotechadv.2011.04.004; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cory JS, 2003, ANNU REV ECOL EVOL S, V34, P239, DOI 10.1146/annurev.ecolsys.34.011802.132402; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Courtiade J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-357; Deng YP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-264; Dong DJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-73; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huang N, 2011, J VIROL, V85, P12547, DOI 10.1128/JVI.05766-11; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jacob NM, 2010, BIOTECHNOL BIOENG, V105, P1002, DOI 10.1002/bit.22588; Jacobson A, 2009, J ECON ENTOMOL, V102, P2289, DOI 10.1603/029.102.0634; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo WY, 2011, CANCER GENE THER, V18, P637, DOI 10.1038/cgt.2011.35; Lyupina YV, 2011, VIROLOGY, V421, P34, DOI 10.1016/j.virol.2011.09.010; MacDonald SJ, 2011, MOL ECOL, V20, P2073, DOI 10.1111/j.1365-294X.2011.05031.x; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; MCINTOSH AH, 1983, APPL ENTOMOL ZOOL, V18, P262, DOI 10.1303/aez.18.262; Mena JA, 2011, EXPERT REV VACCINES, V10, P1063, DOI [10.1586/ERV.11.24, 10.1586/erv.11.24]; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Moscardi F, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P415, DOI 10.1007/978-1-4419-7931-5_16; Nguyen Q, 2011, J VIROL METHODS, V175, P197, DOI 10.1016/j.jviromet.2011.05.011; O'Riordan MXD, 2008, DEV CELL, V15, P497, DOI 10.1016/j.devcel.2008.09.012; Oh S, 2010, APPL ENVIRON MICROB, V76, P2980, DOI 10.1128/AEM.02826-09; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Sagisaka A, 2010, VIRUS RES, V147, P166, DOI 10.1016/j.virusres.2009.10.015; Schultz KLW, 2009, J VIROL, V83, P11123, DOI 10.1128/JVI.01199-09; Shelby KS, 2009, J INVERTEBR PATHOL, V101, P86, DOI 10.1016/j.jip.2009.05.002; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szewczyk B., 2009, Journal of Biopesticides, V2, P209; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; Vandergaast R, 2011, J VIROL, V85, P8348, DOI 10.1128/JVI.00667-11; Vellozo AF, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar008; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Xia Q, 2004, SCIENCE, V306, P1397; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Xue JL, 2010, J VIROL METHODS, V163, P210, DOI 10.1016/j.jviromet.2009.09.019; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang JY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-611	58	26	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36324	10.1371/journal.pone.0036324	http://dx.doi.org/10.1371/journal.pone.0036324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629315	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500013
J	Pimentel, C; Vicente, C; Menezes, RA; Caetano, S; Carreto, L; Rodrigues-Pousada, C				Pimentel, Catarina; Vicente, Cristina; Menezes, Regina Andrade; Caetano, Soraia; Carreto, Laura; Rodrigues-Pousada, Claudina			The Role of the Yap5 Transcription Factor in Remodeling Gene Expression in Response to Fe Bioavailability	PLOS ONE			English	Article							VACUOLAR IRON STORAGE; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; YEAST; DEPRIVATION; ADAPTATION; METABOLISM; AFT1; LOCALIZATION; DEFICIENCY	The budding yeast Saccharomyces cerevisiae has developed several mechanisms to avoid either the drastic consequences of iron deprivation or the toxic effects of iron excess. In this work, we analysed the global gene expression changes occurring in yeast cells undergoing iron overload. Several genes directly or indirectly involved in iron homeostasis showed altered expression and the relevance of these changes are discussed. Microarray analyses were also performed to identify new targets of the iron responsive factor Yap5. Besides the iron vacuolar transporter CCC1, Yap5 also controls the expression of glutaredoxin GRX4, previously known to be involved in the regulation of Aft1 nuclear localization. Consistently, we show that in the absence of Yap5 Aft1 nuclear exclusion is slightly impaired. These studies provide further evidence that cells control iron homeostasis by using multiple pathways.	[Pimentel, Catarina; Vicente, Cristina; Menezes, Regina Andrade; Caetano, Soraia; Rodrigues-Pousada, Claudina] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Carreto, Laura] Univ Aveiro, Dept Biol, Ctr Environm & Marine Studies, P-3800 Aveiro, Portugal	Universidade Nova de Lisboa; Universidade de Aveiro	Pimentel, C (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	claudina@itqb.unl.pt	Echaniz, Regina Menezes/AAE-8041-2020; Menezes Echaniz, Regina/L-3792-2014; Pimentel, Catarina/G-2821-2014; Vicente, Cristina/ABD-3690-2020	Menezes Echaniz, Regina/0000-0003-0552-8480; Teixeira Vicente, Cristina/0000-0002-7882-9543; Caetano, Soraia/0000-0001-7427-5670; Pimentel, Catarina/0000-0002-5158-6414; Rodrigues-Pousada, Claudina/0000-0002-5075-3639	Fundacao Ciencia e Tecnologia (FCT) [PEst-OE/EQB/LA0004/2011, PTDC-BIA-MIC/108747/2008, SFRH/BPD/35052/2007, SFRH/BPD/26506/2006]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-MIC/108747/2008] Funding Source: FCT	Fundacao Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This research was supported by Fundacao Ciencia e Tecnologia (FCT-http://www.fct.pt), through the projects PEst-OE/EQB/LA0004/2011 and PTDC-BIA-MIC/108747/2008 to CRP, and grants SFRH/BPD/35052/2007 (to CP) and SFRH/BPD/26506/2006 (to RAM). The DNA microarrays analyses were supported by the National Facility for DNA Microarrays (NFDM) located at the University of Aveiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertinato J, 2003, J BIOL CHEM, V278, P35071, DOI 10.1074/jbc.M302242200; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Darshan D, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001687; Fardeau V, 2007, J BIOL CHEM, V282, P5063, DOI 10.1074/jbc.M610197200; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Hoffmann B, 2011, ANTIOXID REDOX SIGN, V15, P19, DOI 10.1089/ars.2010.3811; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Ihrig J, 2010, EUKARYOT CELL, V9, P460, DOI 10.1128/EC.00213-09; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Lee A, 2005, MOL CELL, V19, P39, DOI 10.1016/j.molcel.2005.05.021; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2011, J BIOL CHEM, V286, P38488, DOI 10.1074/jbc.M111.286666; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lin HL, 2011, J BIOL CHEM, V286, P3851, DOI 10.1074/jbc.M110.190959; Meneghini R, 1997, FREE RADICAL BIO MED, V23, P783, DOI 10.1016/S0891-5849(97)00016-6; Menezes RA, 2004, FEBS LETT, V566, P141, DOI 10.1016/j.febslet.2004.04.019; Menezes RA, 2008, BIOCHEM J, V414, P301, DOI 10.1042/BJ20071537; Mockli N, 2004, BIOTECHNIQUES, V36, P872; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Nevitt T, 2011, BIOMETALS; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rodrigues-Pousada C, 2010, YEAST, V27, P245, DOI 10.1002/yea.1752; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Simon R, 2007, CANCER INFORM, V3, P11; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslet.2007.07.002; Ueta R, 2007, MOL BIOL CELL, V18, P2980, DOI 10.1091/mbc.E06-11-1054; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; Yun CW, 2000, J BIOL CHEM, V275, P10709, DOI 10.1074/jbc.275.14.10709	49	47	47	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37434	10.1371/journal.pone.0037434	http://dx.doi.org/10.1371/journal.pone.0037434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22616008	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300114
J	Chiaverini, C; Sillard, L; Flori, E; Ito, S; Briganti, S; Wakamatsu, K; Fontas, E; Berard, E; Cailliez, M; Cochat, P; Foulard, M; Guest, G; Niaudet, P; Picardo, M; Bernard, FX; Antignac, C; Ortonne, JP; Ballotti, R				Chiaverini, Christine; Sillard, Laura; Flori, Enrica; Ito, Shosuke; Briganti, Stefania; Wakamatsu, Kazumasa; Fontas, Eric; Berard, Etienne; Cailliez, Mathilde; Cochat, Pierre; Foulard, Michel; Guest, Genevieve; Niaudet, Patrick; Picardo, Mauro; Bernard, Francois-Xavier; Antignac, Corinne; Ortonne, Jean Paul; Ballotti, Robert			Cystinosin is a melanosomal protein that regulates melanin synthesis	FASEB JOURNAL			English	Article						pigmentation; melanocyte; melanogenesis; tyrosinase; cystinosis	HUMAN HAIR MELANINS; NEPHROPATHIC CYSTINOSIS; CYCLIC-AMP; EPITHELIAL-CELLS; CTNS MUTATIONS; TYROSINASE; MELANOGENESIS; PIGMENTATION; TRAFFICKING; PHEOMELANIN	Cystinosis is a rare autosomal recessive disease characterized by cystine crystal accumulation leading to multiorgan dysfunctions and caused by mutation in CTNS. CTNS encodes cystinosin, a cystine/H+ symporter that exports cystine out of the lysosomes. Patients with cystinosis frequently exhibit blond hair and fair complexion, suggesting an alteration in melanogenesis. However, the pigmentation singularities of these patients have not been studied, and the role of cystinosin in melanogenesis has remained unknown. In our study, a clinical evaluation of 27 patients with cystinosis showed that 44% had a cutaneous pigmentation dilution compared to their relatives. Analysis of the hair melanin content in these patients by HPLC demonstrated a 50% decrease in eumelanin (4360 vs. 9360 ng/mg), and a 2-fold increase in pheomelanin (53 vs. 20 ng/mg), the yellow/red pigments. Cystinosin-deficient mice also showed a 4-fold increase in hair pheomelanin content. In vitro studies showed that cystinosin was located at melanosomes. CTNS silencing led to a 75% reduction of melanin synthesis that was caused by a degradation of tyrosinase by lysosomal proteases. Our results objectify the pigmentation defect in patients with cystinosis. We also identify the role of CTNS in melanogenesis and add a new gene to the list of the genes involved in the control of skin and hair pigmentation.-Chiaverini, C., Sillard, L., Flori, E., Ito, S., Briganti, S., Wakamatsu, K., Fontas, E., Berard, E., Cailliez, M., Cochat, P., Foulard, M., Guest, G., Niaudet, P., Picardo, M., Bernard, F.-X., Antignac, C., Ortonne, J. P., Ballotti, R. Cystinosin is a melanosomal protein that regulates melanin synthesis. FASEB J. 26, 3779-3789 (2012). www.fasebj.org	[Chiaverini, Christine; Sillard, Laura; Ortonne, Jean Paul; Ballotti, Robert] CHU NICE, Dept Dermatol, F-06202 Nice 3, France; [Chiaverini, Christine; Flori, Enrica; Ortonne, Jean Paul; Ballotti, Robert] Ctr Mediterraneen Med Mol, INSERM, U1065, Equipe 1, Nice, France; [Berard, Etienne] CHU Nice, Dept Clin Res, Nice, France; [Fontas, Eric; Berard, Etienne] CHU Nice, Dept Paediat Nephrol, Nice, France; [Ortonne, Jean Paul; Ballotti, Robert] Med Univ Nice Sophia Antipolis, Unit Format & Rech, Nice, France; [Flori, Enrica; Briganti, Stefania; Picardo, Mauro] Ist Ricovero Cura Carattere Sci IRCSS, San Gallicano Dermatol Inst, Lab Cutaneous Physiopathol, Rome, Italy; [Briganti, Stefania] Ist Ricovero Cura Carattere Sci IRCSS, San Gallicano Dermatol Inst, Integrated Ctr Metabol Res, Rome, Italy; [Ito, Shosuke; Wakamatsu, Kazumasa] Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Aichi, Japan; [Cailliez, Mathilde] Assistance Publ Hop Marseille, Dept Paediat Nephrol, Marseille, France; [Cochat, Pierre] CHU Lyon, Ctr Reference Malad Renales Rares, Bron, France; [Foulard, Michel] CHU Lille, F-59037 Lille, France; [Guest, Genevieve; Niaudet, Patrick] Univ Paris Descartes Sorbonne Paris Cite, AP HP, Dept Paediat Nephrol, Paris, France; [Antignac, Corinne] Univ Paris Descartes Sorbonne Paris Cite, INSERM, U983, Hop Necker Enfants Malades,Inst Imagine, Paris, France; [Bernard, Francois-Xavier] BIOalternat SAS, Gencay, France	CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Fujita Health University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Lyon; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ballotti, R (corresponding author), CHU NICE, Dept Dermatol, F-06202 Nice 3, France.	ballotti@unice.fr	BALLOTTI, Robert/F-8825-2013; Flori, Enrica/H-4417-2014; Briganti, Stefania/AAY-2136-2021; briganti, stefania/J-3185-2016; Wakamatsu, Kazumasa/AAZ-5877-2020; ANTIGNAC, Corinne/H-8945-2017; Picardo, Mauro/A-6978-2011	Flori, Enrica/0000-0002-9275-1041; Briganti, Stefania/0000-0003-2000-006X; briganti, stefania/0000-0003-2000-006X; Wakamatsu, Kazumasa/0000-0003-1748-9001; ANTIGNAC, Corinne/0000-0002-9934-4940; BALLOTTI, Robert/0000-0002-7322-4908; Ito, Shosuke/0000-0001-9182-5144; Picardo, Mauro/0000-0003-4899-6639	Cystinosin Research Foundation	Cystinosin Research Foundation	This work was supported by the Cystinosin Research Foundation (http://www.natalieswish.org). The authors are also indebted to the patients for their invaluable help in this research program. This work has been possible thanks to the expert technical help of Mansour Djedaini, Patricia Abbe, Karine Bille, Anne Pierron, and Genevieve Gozzerino. Electron microscopy experiments were performed by Sandra Lacas-Gervais (Centre Commun de Microscopie Appliquee, Universite de Nice Sophia-Antipolis). The authors are indebted to Dr Philippe Eckart (Department of Paediatry, Centre Hospitalier Universitaire Caen, Caen, France) for patient inclusion.	Ancans J, 2001, EXP CELL RES, V268, P26, DOI 10.1006/excr.2001.5251; Anikster Y, 1999, HUM MUTAT, V14, P454, DOI 10.1002/(SICI)1098-1004(199912)14:6<454::AID-HUMU2>3.0.CO;2-H; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Cheli Y, 2009, J BIOL CHEM, V284, P18699, DOI 10.1074/jbc.M109.005819; Chen K, 2004, PIGM CELL RES, V17, P36, DOI 10.1046/j.1600-0749.2003.00106.x; Cherqui S, 2002, MOL CELL BIOL, V22, P7622, DOI 10.1128/MCB.22.21.7622-7632.2002; Cherqui S, 2001, J BIOL CHEM, V276, P13314, DOI 10.1074/jbc.M010562200; Chintala S, 2005, P NATL ACAD SCI USA, V102, P10964, DOI 10.1073/pnas.0502856102; Costin GE, 2003, J CELL SCI, V116, P3203, DOI 10.1242/jcs.00598; DIMENT S, 1995, J BIOL CHEM, V270, P4213, DOI 10.1074/jbc.270.9.4213; Forestier L, 1999, AM J HUM GENET, V65, P353, DOI 10.1086/302509; Fujita H, 2009, J INVEST DERMATOL, V129, P1489, DOI 10.1038/jid.2008.376; Gahl WA, 2002, NEW ENGL J MED, V347, P111, DOI 10.1056/NEJMra020552; Guillet G, 1998, LANCET, V352, P1444, DOI 10.1016/S0140-6736(05)61267-6; Halaban R, 2002, J BIOL CHEM, V277, P14821, DOI 10.1074/jbc.M111497200; Haq MR, 2002, J AM SOC NEPHROL, V13, P2046, DOI 10.1097/01.ASN.0000022012.95680.BA; Ito S, 2003, PIGM CELL RES, V16, P230, DOI 10.1034/j.1600-0749.2003.00037.x; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Ito S, 2011, PIGM CELL MELANOMA R, V24, P63, DOI 10.1111/j.1755-148X.2010.00755.x; Kalatzis V, 2004, HUM MOL GENET, V13, P1361, DOI 10.1093/hmg/ddh152; Kalatzis V, 2003, PEDIATR NEPHROL, V18, P207, DOI 10.1007/s00467-003-1077-5; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; Kumar A, 2010, J BIOSCIENCES, V35, P21, DOI 10.1007/s12038-010-0004-8; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Nevo N, 2010, NEPHROL DIAL TRANSPL, V25, P1059, DOI 10.1093/ndt/gfp553; Nordlund J. J., 1998, PIGMENTARY SYSTEM; Park M, 2002, J AM SOC NEPHROL, V13, P2878, DOI 10.1097/01.ASN.0000036867.49866.59; Park MA, 2006, J AM SOC NEPHROL, V17, P3167, DOI 10.1681/ASN.2006050474; Passeron T, 2004, FASEB J, V18, P989, DOI 10.1096/fj.03-1240fje; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; Toyofuku K, 2002, PIGM CELL RES, V15, P217, DOI 10.1034/j.1600-0749.2002.02007.x; Tsilou ET, 2006, OPHTHALMOLOGY, V113, P1002, DOI 10.1016/j.ophtha.2005.12.026; Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x; Watabe H, 2004, J BIOL CHEM, V279, P7971, DOI 10.1074/jbc.M309714200; WONG VG, 1970, INVEST OPHTH VISUAL, V9, P83	38	34	36	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2012	26	9					3779	3789		10.1096/fj.11-201376	http://dx.doi.org/10.1096/fj.11-201376			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22649030				2022-12-25	WOS:000308391600018
J	Lee, E; Sidoryk-Wegrzynowicz, M; Wang, N; Webb, A; Son, DS; Lee, K; Aschner, M				Lee, Eunsook; Sidoryk-Wegrzynowicz, Marta; Wang, Ning; Webb, Anton; Son, Deok-Soo; Lee, Kyuwon; Aschner, Michael			GPR30 Regulates Glutamate Transporter GLT-1 Expression in Rat Primary Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; GROWTH-FACTOR RECEPTOR; AMINO-ACID TRANSPORTER-2; HEAT-SHOCK PROTEINS; NF-KAPPA-B; ESTROGEN-RECEPTOR; NERVOUS-SYSTEM; HYPOTHALAMIC ASTROCYTES; NEUROACTIVE STEROIDS; BCL-2 EXPRESSION	The G protein-coupled estrogen receptor GPR30 contributes to the neuroprotective effects of 17 beta-estradiol (E2); however, the mechanisms associated with this protection have yet to be elucidated. Given that E2 increases astrocytic expression of glutamate transporter-1 (GLT-1), which would prevent excitotoxic-induced neuronal death, we proposed that GPR30 mediates E2 action on GLT-1 expression. To investigate this hypothesis, we examined the effects of G1, a selective agonist of GPR30, and GPR30 siRNA on astrocytic GLT-1 expression, as well as glutamate uptake in rat primary astrocytes, and explored potential signaling pathways linking GPR30 to GLT-1. G1 increased GLT-1 protein and mRNA levels, subject to regulation by both MAPK and PI3K signaling. Inhibition of TGF-alpha receptor suppressed the G1-induced increase in GLT-1 expression. Silencing GPR30 reduced the expression of both GLT-1 and TGF-alpha and abrogated the G1-induced increase in GLT-1 expression. Moreover, the G1-induced increase in GLT-1 protein expression was abolished by a protein kinase A inhibitor and an NF-kappa B inhibitor. G1 also enhanced cAMP response element-binding protein (CREB), as well as both NF-kappa B p50 and NF-kappa B p65 binding to the GLT-1 promoter. Finally, to model dysfunction of glutamate transporters, manganese was used, and G1 was found to attenuate manganese-induced impairment in GLT-1 protein expression and glutamate uptake. Taken together, the present data demonstrate that activation of GPR30 increases GLT-1 expression via multiple pathways, suggesting that GPR30 is worthwhile as a potential target to be explored for developing therapeutics of excitotoxic neuronal injury.	[Lee, Eunsook; Wang, Ning; Webb, Anton; Son, Deok-Soo] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA; [Sidoryk-Wegrzynowicz, Marta; Aschner, Michael] Vanderbilt Univ, Dept Pediat, Nashville, TN 37212 USA; [Lee, Kyuwon] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Meharry Medical College; Vanderbilt University; Harvard University	Lee, E (corresponding author), Meharry Med Coll, Dept Physiol, 1005 DB Todd Jr Blvd, Nashville, TN 37208 USA.	elee@mmc.edu		Sidoryk-Wegrzynowicz, Marta/0000-0003-3916-7660	National Institutes of Health [SC1 089630]; National Institute of Environmental Health Sciences [ES R01 10563]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM089630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants SC1 089630 and National Institute of Environmental Health Sciences ES R01 10563.	Abdelhamid R, 2011, ACS CHEM NEUROSCI, V2, P256, DOI 10.1021/cn100106a; Acs P, 2009, GLIA, V57, P807, DOI 10.1002/glia.20806; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Allritz C, 2010, J NEUROSCI RES, V88, P1234, DOI 10.1002/jnr.22303; Alyea RA, 2008, J NEUROCHEM, V106, P1525, DOI 10.1111/j.1471-4159.2008.05491.x; Amorino GP, 2002, MOL BIOL CELL, V13, P2233, DOI 10.1091/mbc.01-12-0572; BARBEAU A, 1984, NEUROTOXICOLOGY, V5, P13; Barlow CA, 2007, AM J PHYSIOL-LUNG C, V292, pL1361, DOI 10.1152/ajplung.00279.2006; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Blasko E, 2009, J NEUROIMMUNOL, V214, P67, DOI 10.1016/j.jneuroim.2009.06.023; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Buchanan CD, 2000, BIOL REPROD, V62, P1710, DOI 10.1095/biolreprod62.6.1710; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Cimarosti H, 2005, NEUROSCI LETT, V385, P52, DOI 10.1016/j.neulet.2005.05.006; COTZIAS GC, 1968, NEUROLOGY, V18, P376, DOI 10.1212/WNL.18.4.376; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; DonCarlos Lydia L, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS113, DOI 10.1016/j.psyneuen.2009.04.012; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Galbiati M, 2002, J NEUROENDOCRINOL, V14, P829, DOI 10.1046/j.1365-2826.2002.00852.x; Gampe K, 2011, BRAIN RES, V1376, P31, DOI 10.1016/j.brainres.2010.11.040; Garcia-Segura LM, 2004, ENDOCRINOLOGY, V145, P1082, DOI 10.1210/en.2003-1383; Ghosh M, 2011, J NEUROSCI, V31, P9159, DOI 10.1523/JNEUROSCI.0302-11.2011; Gingerich S, 2010, NEUROSCIENCE, V170, P54, DOI 10.1016/j.neuroscience.2010.06.076; Kanda N, 2003, J INVEST DERMATOL, V121, P1500, DOI 10.1111/j.1523-1747.2003.12617.x; Kanda N, 2003, J INVEST DERMATOL, V120, P1058, DOI 10.1046/j.1523-1747.2003.12255.x; Kuo J, 2010, J NEUROSCI, V30, P12950, DOI 10.1523/JNEUROSCI.1158-10.2010; Lebesgue D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008642; Lee ESY, 2009, TOXICOL SCI, V110, P156, DOI 10.1093/toxsci/kfp081; Lee ESY, 2009, J NEUROCHEM, V110, P530, DOI 10.1111/j.1471-4159.2009.06105.x; Lee E, 2012, GLIA, V60, P1024, DOI 10.1002/glia.22329; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Liang Z, 2002, J NEUROCHEM, V80, P807, DOI 10.1046/j.0022-3042.2002.00779.x; Liu SB, 2011, CLIN EXP PHARMACOL P, V38, P577, DOI 10.1111/j.1440-1681.2011.05549.x; Lu AG, 2002, J CEREBR BLOOD F MET, V22, P183, DOI 10.1097/00004647-200202000-00006; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Magnaghi V, 2001, BRAIN RES REV, V37, P360, DOI 10.1016/S0165-0173(01)00140-0; Melcangi RC, 2001, BRAIN RES REV, V37, P223, DOI 10.1016/S0165-0173(01)00120-5; Melcangi RC, 2001, INT REV NEUROBIOL, V46, P145; Mutkus L, 2005, BIOL TRACE ELEM RES, V107, P221, DOI 10.1385/BTER:107:3:221; MYDLARSKI MB, 1995, NEUROBIOL AGING, V16, P977, DOI 10.1016/0197-4580(95)02018-7; Nagai M, 2003, MICROBIOL-SGM, V149, P2455, DOI 10.1099/mic.0.26414-0; Pawlak J, 2005, MOL BRAIN RES, V138, P1, DOI 10.1016/j.molbrainres.2004.10.043; Prossnitz ER, 2007, MOL CELL ENDOCRINOL, V265, P138, DOI 10.1016/j.mce.2006.12.010; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Simpkins James W., 1997, American Journal of Medicine, V103, p19S, DOI 10.1016/S0002-9343(97)00260-X; Sims KD, 1999, CRIT REV NEUROBIOL, V13, P169, DOI 10.1615/CritRevNeurobiol.v13.i2.30; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; Su ZZ, 2003, P NATL ACAD SCI USA, V100, P1955, DOI 10.1073/pnas.0136555100; Thone-Reineke C, 2008, J HYPERTENS, V26, P2426, DOI 10.1097/HJH.0b013e328313e403; TRANQUE PA, 1987, BRAIN RES, V406, P348, DOI 10.1016/0006-8993(87)90805-5; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Xu H, 2009, NEUROSCIENCE, V158, P1599, DOI 10.1016/j.neuroscience.2008.11.028; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Zelenaia O, 2000, MOL PHARMACOL, V57, P667, DOI 10.1124/mol.57.4.667	58	65	69	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26817	26828		10.1074/jbc.M112.341867	http://dx.doi.org/10.1074/jbc.M112.341867			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22645130	Green Published, hybrid			2022-12-25	WOS:000307386000031
J	Couture, LA; Piao, WJ; Ru, LW; Vogel, SN; Toshchakov, VY				Couture, Leah A.; Piao, Wenji; Ru, Lisa W.; Vogel, Stefanie N.; Toshchakov, Vladimir Y.			Targeting Toll-like Receptor (TLR) Signaling by Toll/Interleukin-1 Receptor (TIR) Domain-containing Adapter Protein/MyD88 Adapter-like (TIRAP/Mal)-derived Decoy Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CUTTING EDGE; BB LOOPS; TRANSDUCTION; FAMILY; IDENTIFICATION; RECRUITMENT; ENDOCYTOSIS; PATHWAYS; MOLECULE	Toll/interleukin-1 receptor (TIR) domain-containing adapter protein/MyD88 adapter-like (TIRAP/Mal) is an adapter protein that facilitates recruitment of MyD88 to TLR4 and TLR2 signaling complexes. We previously generated a library of cell-permeating TLR4 TIR-derived decoy peptides fused to the translocating segment of the Drosophila Antennapedia homeodomain and examined each peptide for the ability to inhibit TLR4 signaling (Toshchakov, V. Y., Szmacinski, H., Couture, L. A., Lakowicz, J. R., and Vogel, S. N. (2011) J. Immunol. 186, 4819-4827). We have now expanded this study to test TIRAP decoy peptides. Five TIRAP peptides, TR3 (for TIRAP region 3), TR5, TR6, TR9, and TR11, inhibited LPS-induced cytokine mRNA expression and MAPK activation. Inhibition was confirmed at the protein level; select peptides abolished the LPS-induced cytokine production measured in cell culture 24 h after a single treatment. Two of the TLR4 inhibitory peptides, TR3 and TR6, also inhibited cytokine production induced by a TLR2/TLR1 agonist, S-(2,3-bis(palmitoyloxy)-(2R,2S)-propyl)-N-palmitoyl-(R)-CysSer-Lys(4)-OH; however, a higher peptide concentration was required to achieve comparable inhibition of TLR2 versus TLR4 signaling. Two TLR4 inhibitory peptides, TR5 and TR6, were examined for the ability to inhibit TLR4-driven cytokine induction in mice. Pretreatment with either peptide significantly reduced circulating TNF-alpha and IL-6 in mice following LPS injection. This study has identified novel TLR inhibitory peptides that block cellular signaling at low micromolar concentrations in vitro and in vivo. Comparison of TLR4 inhibition by TLR4 and TIRAP TIR-derived peptides supports the view that structurally diverse regions mediate functional interactions of TIR domains.	[Couture, Leah A.; Piao, Wenji; Ru, Lisa W.; Vogel, Stefanie N.; Toshchakov, Vladimir Y.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Toshchakov, VY (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Rm 380,685 W Baltimore St, Baltimore, MD 21201 USA.	vtoshchakov@som.umaryland.edu	Toshchakov, Vladimir/C-2798-2014	Toshchakov, Vladimir/0000-0002-7942-2294	National Institutes of Health [AI-082299, AI-018797]; Howard Hughes Medical Institute Research Training Fellowship for Medical Students; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018797, R01AI082299, R37AI018797, R56AI018797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Research Training Fellowship for Medical Students; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-082299 (to V. Y. T.) and AI-018797 (to S. N. V.). This work was also supported by the 2010 Howard Hughes Medical Institute Research Training Fellowship for Medical Students (to L. A. C.).	Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Chan SL, 2009, J BIOL CHEM, V284, P21386, DOI 10.1074/jbc.C109.007591; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Knapp S, 2010, WIEN MED WOCHENSCHR, V160, P107, DOI 10.1007/s10354-010-0765-6; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Monie TP, 2009, IMMUNOL REV, V227, P161, DOI 10.1111/j.1600-065X.2008.00735.x; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Toshchakov VY, 2007, EXPERT OPIN BIOL TH, V7, P1035, DOI 10.1517/14712598.7.7.1035; Toshchakov VY, 2007, J IMMUNOL, V178, P2655, DOI 10.4049/jimmunol.178.5.2655; Toshchakov VY, 2011, J IMMUNOL, V186, P4819, DOI 10.4049/jimmunol.1002424; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	33	55	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24641	24648		10.1074/jbc.M112.360925	http://dx.doi.org/10.1074/jbc.M112.360925			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22648407	Green Published, hybrid			2022-12-25	WOS:000306651100058
J	Fu, JR; Jin, J; Cichewicz, RH; Hageman, SA; Ellis, TK; Xiang, L; Peng, Q; Jiang, M; Arbez, N; Hotaling, K; Ross, CA; Duan, WZ				Fu, Jinrong; Jin, Jing; Cichewicz, Robert H.; Hageman, Serena A.; Ellis, Trevor K.; Xiang, Lan; Peng, Qi; Jiang, Mali; Arbez, Nicolas; Hotaling, Katelyn; Ross, Christopher A.; Duan, Wenzhen			trans-(-)-epsilon-Viniferin Increases Mitochondrial Sirtuin 3 (SIRT3), Activates AMP-activated Protein Kinase (AMPK), and Protects Cells in Models of Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESVERATROL PROTECTS; DEACETYLASE SIRT3; NATURAL-PRODUCTS; DYSFUNCTION; DEFECTS; LKB1; PGC-1-ALPHA; APOPTOSIS; CANCER; DAMAGE	Huntington disease (HD) is an inherited neurodegenerative disorder caused by an abnormal polyglutamine expansion in the protein Huntingtin (Htt). Currently, no cure is available for HD. The mechanisms by which mutant Htt causes neuronal dysfunction and degeneration remain to be fully elucidated. Nevertheless, mitochondrial dysfunction has been suggested as a key event mediating mutant Htt-induced neurotoxicity because neurons are energy-demanding and particularly susceptible to energy deficits and oxidative stress. SIRT3, a member of sirtuin family, is localized to mitochondria and has been implicated in energy metabolism. Notably, we found that cells expressing mutant Htt displayed reduced SIRT3 levels. trans-(-)-epsilon-Viniferin (viniferin), a natural product among our 22 collected naturally occurring and semisynthetic stilbenic compounds, significantly attenuated mutant Htt-induced depletion of SIRT3 and protected cells from mutant Htt. We demonstrate that viniferin decreases levels of reactive oxygen species and prevents loss of mitochondrial membrane potential in cells expressing mutant Htt. Expression of mutant Htt results in decreased deacetylase activity of SIRT3 and further leads to reduction in cellular NAD(+) levels and mitochondrial biogenesis in cells. Viniferin activates AMP-activated kinase and enhances mitochondrial biogenesis. Knockdown of SIRT3 significantly inhibited viniferin-mediated AMP-activated kinase activation and diminished the neuroprotective effects of viniferin, suggesting that SIRT3 mediates the neuroprotection of viniferin. In conclusion, we establish a novel role for mitochondrial SIRT3 in HD pathogenesis and discovered a natural product that has potent neuroprotection in HD models. Our results suggest that increasing mitochondrial SIRT3 might be considered as a new therapeutic approach to counteract HD, as well as other neurodegenerative diseases with similar mechanisms.	[Fu, Jinrong; Jin, Jing; Xiang, Lan; Peng, Qi; Jiang, Mali; Arbez, Nicolas; Hotaling, Katelyn; Ross, Christopher A.; Duan, Wenzhen] Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21287 USA; [Ross, Christopher A.; Duan, Wenzhen] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21287 USA; [Cichewicz, Robert H.; Hageman, Serena A.; Ellis, Trevor K.] Univ Oklahoma, Stephenson Life Sci Res Ctr, Dept Chem & Biochem, Nat Prod Discovery Grp, Norman, OK 73019 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Oklahoma System; University of Oklahoma - Norman	Duan, WZ (corresponding author), Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, CMSC 8-121,600 N Wolfe St, Baltimore, MD 21287 USA.	wduan2@jhmi.edu	Cichewicz, Robert H/H-5233-2012; Ross, Christopher A/H-8395-2013		National Institutes of Health [NINDS NS064313, NINDS NS16375]; CHDI Foundation, Inc. [CHDI A2120]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016375, P01NS016375, R21NS064313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Foundation, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NINDS NS064313 (to R. H. C.) and NINDS NS16375 (to C. A. R.). This work was also supported by Grant CHDI A2120 from the CHDI Foundation, Inc. (to W. D.).	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Bell EL, 2011, MOL CELL, V42, P561, DOI 10.1016/j.molcel.2011.05.008; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Gibson GE, 2010, BBA-MOL BASIS DIS, V1802, P122, DOI 10.1016/j.bbadis.2009.08.010; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Harper PS, 1996, J ROY COLL PHYS LOND, V30, P221; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Ho DJ, 2010, EXP NEUROL, V225, P74, DOI 10.1016/j.expneurol.2010.05.006; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Jin YN, 2010, J BIOENERG BIOMEMBR, V42, P199, DOI 10.1007/s10863-010-9286-7; Joyner PM, 2011, NAT PROD REP, V28, P26, DOI 10.1039/c0np00017e; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maher P, 2011, HUM MOL GENET, V20, P261, DOI 10.1093/hmg/ddq460; MANN VM, 1990, LANCET, V336, P749, DOI 10.1016/0140-6736(90)92242-A; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Richard T, 2011, ANN NY ACAD SCI, V1215, P103, DOI 10.1111/j.1749-6632.2010.05865.x; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stack EC, 2008, ANN NY ACAD SCI, V1147, P79, DOI 10.1196/annals.1427.008; STAHL WL, 1974, NEUROLOGY, V24, P813, DOI 10.1212/WNL.24.9.813; Tao R, 2007, BIOCHEM BIOPH RES CO, V363, P257, DOI 10.1016/j.bbrc.2007.08.041; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Wang WF, 2005, NEUROBIOL DIS, V20, P500, DOI 10.1016/j.nbd.2005.03.026; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Yang YJ, 2010, J CELL BIOCHEM, V111, P1051, DOI 10.1002/jcb.22795; Yang YJ, 2010, J BIOL CHEM, V285, P7417, DOI 10.1074/jbc.M109.053421; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9	58	142	147	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24460	24472		10.1074/jbc.M112.382226	http://dx.doi.org/10.1074/jbc.M112.382226			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22648412	hybrid, Green Published			2022-12-25	WOS:000306651100039
J	Hotze, EM; Wilson-Kubalek, E; Farrand, AJ; Bentsen, L; Parker, MW; Johnson, AE; Tweten, RK				Hotze, Eileen M.; Wilson-Kubalek, Elizabeth; Farrand, Allison J.; Bentsen, Lori; Parker, Michael W.; Johnson, Arthur E.; Tweten, Rodney K.			Monomer-Monomer Interactions Propagate Structural Transitions Necessary for Pore Formation by the Cholesterol-dependent Cytolysins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGOLYSIN-O; MEMBRANE INSERTION; MECHANISM; PROTEIN; PREPORE; BINDING; COMPLEX; DOMAIN; SHEET	The assembly of the cholesterol-dependent cytolysin (CDC) oligomeric pore complex requires a complex choreography of secondary and tertiary structural changes in domain 3 (D3) of the CDC monomer structure. A point mutation was identified in the archetype CDC, perfringolysin O, that blocks detectable D3 structural changes and traps the membrane-bound monomers in an early and reversible stage of oligomer assembly. Using this and other mutants we show that specific D3 structural changes are propagated from one membrane-bound monomer to another. Propagation of these structural changes results in the exposure of a beta-strand in D3 that allows it to pair and form edge-on interactions with a second beta-strand of a free membrane-bound monomer. Pairing of these strands establishes the final geometry of the pore complex and is necessary to drive the formation of the beta-barrel pore. These studies provide new insights into how structural information is propagated between membrane-bound monomers of a self-assembling system and the interactions that establish the geometry of the final pore complex.	[Hotze, Eileen M.; Farrand, Allison J.; Bentsen, Lori; Tweten, Rodney K.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Wilson-Kubalek, Elizabeth] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Johnson, Arthur E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Mol & Cellular Med, College Stn, TX 77843 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Scripps Research Institute; St. Vincent's Institute of Medical Research; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Tweten, RK (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, BMSB-1053, 940 Stanton L,Young Blvd, Oklahoma City, OK 73104 USA.	rod-tweten@ouhsc.edu	Johnson, Arthur E/G-3457-2012; Parker, Michael W/F-9069-2013	Parker, Michael W/0000-0002-3101-1138	National Institutes of Health through the NIAID [AI037657]; Robert A. Welch Foundation [BE-0017]; Victorian Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037657] Funding Source: NIH RePORTER	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Robert A. Welch Foundation(The Welch Foundation); Victorian Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI037657 through the NIAID. This work was also supported by the Robert A. Welch Foundation Chair Grant BE-0017 and by the Victorian Government Operational Infrastructure Support Scheme to St. Vincent's Institute.	Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Feil SC, 1996, FEBS LETT, V397, P290, DOI 10.1016/S0014-5793(96)01200-8; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Hotze E, 2002, PERSPECTIVES IN MOLECULAR TOXINOLOGY, P23; Hotze EM, 2012, BBA-BIOMEMBRANES, V1818, P1028, DOI 10.1016/j.bbamem.2011.07.036; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Lovelace LL, 2011, J BIOL CHEM, V286, P17585, DOI 10.1074/jbc.M111.219766; NAKAMURA M, 1995, BIOCHEMISTRY-US, V34, P6513, DOI 10.1021/bi00019a032; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Rossjohn J, 2007, J MOL BIOL, V367, P1227, DOI 10.1016/j.jmb.2007.01.042; Schuerch DW, 2005, P NATL ACAD SCI USA, V102, P12537, DOI 10.1073/pnas.0500558102; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Slade DJ, 2008, J MOL BIOL, V379, P331, DOI 10.1016/j.jmb.2008.03.061; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tweten RK, 2001, CURR TOP MICROBIOL, V257, P15	30	45	45	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24534	24543		10.1074/jbc.M112.380139	http://dx.doi.org/10.1074/jbc.M112.380139			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645132	hybrid, Green Published			2022-12-25	WOS:000306651100046
J	Urresti, S; Albesa-Jove, D; Schaeffer, F; Pham, HT; Kaur, D; Gest, P; van der Woerd, MJ; Carreras-Gonzalez, A; Lopez-Fernandez, S; Alzari, PM; Brennan, PJ; Jackson, M; Guerin, ME				Urresti, Saioa; Albesa-Jove, David; Schaeffer, Francis; Pham, Ha T.; Kaur, Devinder; Gest, Petra; van der Woerd, Mark J.; Carreras-Gonzalez, Ana; Lopez-Fernandez, Sonia; Alzari, Pedro M.; Brennan, Patrick J.; Jackson, Mary; Guerin, Marcelo E.			Mechanistic Insights into the Retaining Glucosyl-3-phosphoglycerate Synthase from Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLGLUCOSE LIPOPOLYSACCHARIDE BIOSYNTHESIS; INDUCED CONFORMATIONAL-CHANGES; ENZYMATIC GLYCOSYL TRANSFER; PALMITOYL-COENZYME-A; CRYSTAL-STRUCTURE; HUMAN GLUCURONOSYLTRANSFERASE; MANNOSYLTRANSFERASE PIMA; NEISSERIA-MENINGITIDIS; SUBSTRATE RECOGNITION; MOLECULAR RECOGNITION	Considerable progress has been made in recent years in our understanding of the structural basis of glycosyl transfer. Yet the nature and relevance of the conformational changes associated with substrate recognition and catalysis remain poorly understood. We have focused on the glucosyl-3-phosphoglycerate synthase (GpgS), a "retaining" enzyme, that initiates the biosynthetic pathway of methylglucose lipopolysaccharides in mycobacteria. Evidence is provided that GpgS displays an unusually broad metal ion specificity for a GT-A enzyme, with Mg2+, Mn2+, Ca2+, Co2+, and Fe2+ assisting catalysis. In the crystal structure of the apo-form of GpgS, we have observed that a flexible loop adopts a double conformation L-A and L-I in the active site of both monomers of the protein dimer. Notably, the L-A loop geometry corresponds to an active conformation and is conserved in two other relevant states of the enzyme, namely the GpgS.metal.nucleotide sugar donor and the GpgS.metal.nucleotide.acceptor-bound complexes, indicating that GpgS is intrinsically in a catalytically active conformation. The crystal structure of GpgS in the presence of Mn2+.UDP.phosphoglyceric acid revealed an alternate conformation for the nucleotide sugar beta-phosphate, which likely occurs upon sugar transfer. Structural, biochemical, and biophysical data point to a crucial role of the beta-phosphate in donor and acceptor substrate binding and catalysis. Altogether, our experimental data suggest a model wherein the catalytic site is essentially preformed, with a few conformational changes of lateral chain residues as the protein proceeds along the catalytic cycle. This model of action may be applicable to a broad range of GT-A glycosyltransferases.	[Pham, Ha T.; Kaur, Devinder; Gest, Petra; Brennan, Patrick J.; Jackson, Mary] Colorado State Univ, Dept Microbiol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Pham, Ha T.; Kaur, Devinder; Gest, Petra; Brennan, Patrick J.; Jackson, Mary] Colorado State Univ, Dept Immunol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Pham, Ha T.; Kaur, Devinder; Gest, Petra; Brennan, Patrick J.; Jackson, Mary] Colorado State Univ, Dept Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Urresti, Saioa; Albesa-Jove, David; Carreras-Gonzalez, Ana; Lopez-Fernandez, Sonia; Guerin, Marcelo E.] Univ Pais Vasco Euskal Herriko Unibertsitatea, Unidad Biofis, Ctr Mixto, Consejo Super Invest Cient, Leioa 48940, Bizkaia, Spain; [Urresti, Saioa; Albesa-Jove, David; Carreras-Gonzalez, Ana; Lopez-Fernandez, Sonia; Guerin, Marcelo E.] Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain; [Guerin, Marcelo E.] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain; [Schaeffer, Francis; Alzari, Pedro M.] Inst Pasteur, Unite Microbiol Struct, F-75724 Paris 15, France; [Schaeffer, Francis; Alzari, Pedro M.] Inst Pasteur, CNRS, URA 2185, F-75724 Paris 15, France; [van der Woerd, Mark J.] Colorado State Univ, Dept Biochem & Mol Biol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Basque Foundation for Science; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Colorado State University	Jackson, M (corresponding author), Colorado State Univ, Dept Microbiol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA.	Mary.Jackson@colostate.edu; mrcguerin@gmail.com	Albesa-Jové, David/F-5683-2016; Brennan, Patrick J/G-6896-2017; Albesa-Jové, David/O-3822-2019; Guerin, Marcelo M/N-7245-2016; Jackson, Mary/D-5345-2017	Albesa-Jové, David/0000-0003-2904-8203; Albesa-Jové, David/0000-0003-2904-8203; Guerin, Marcelo M/0000-0001-9524-3184; Jackson, Mary/0000-0002-9212-0258; Urresti, Saioa/0000-0002-8678-8358; Alzari, Pedro/0000-0002-4233-1903	National Institutes of Health from NIAID [AI064798]; European Commission [LSHP-CT-2005-018923, HEALTH-F3-2011-260872]; Spanish Ministry of Science and Innovation [SAF2010-19096, IKERBASQUE]; Basque Foundation for Science; Fundacion Biofisica Bizkaia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Foundation for Science; Fundacion Biofisica Bizkaia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064798 from NIAID. This work was also supported by European Commission Contract LSHP-CT-2005-018923 (New Medicines for Tuberculosis), More Medicines for Tuberculosis Contract HEALTH-F3-2011-260872, the Spanish Ministry of Science and Innovation Contract SAF2010-19096, IKERBASQUE, the Basque Foundation for Science, and the Fundacion Biofisica Bizkaia.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alfaro JA, 2008, J BIOL CHEM, V283, P10097, DOI 10.1074/jbc.M708669200; Ardevol A, 2011, ANGEW CHEM INT EDIT, V50, P10897, DOI 10.1002/anie.201104623; Pereira PJB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003748; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200; Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Brew K, 2010, J BIOL CHEM, V285, P37121, DOI 10.1074/jbc.R110.176248; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chaikuad A, 2011, P NATL ACAD SCI USA, V108, P21028, DOI 10.1073/pnas.1113921108; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Costa J, 2007, J BACTERIOL, V189, P1648, DOI 10.1128/JB.00841-06; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Empadinhas N, 2011, MOL MICROBIOL, V79, P76, DOI 10.1111/j.1365-2958.2010.07432.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Flint J, 2005, NAT STRUCT MOL BIOL, V12, P608, DOI 10.1038/nsmb950; Frantom PA, 2010, J AM CHEM SOC, V132, P6626, DOI 10.1021/ja101231a; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Fulton Z, 2008, J BIOL CHEM, V283, P27881, DOI 10.1074/jbc.M801853200; Gest P, 2008, ACTA CRYSTALLOGR F, V64, P1121, DOI 10.1107/S1744309108032892; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Gomez H, 2012, J AM CHEM SOC, V134, P4743, DOI 10.1021/ja210490f; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Guerin ME, 2009, J BIOL CHEM, V284, P21613, DOI 10.1074/jbc.M109.003947; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; HINDSGAUL O, 1984, BIOCHEMISTRY-US, V23, P577, DOI 10.1021/bi00298a028; Jackson M, 2009, J BIOL CHEM, V284, P1949, DOI 10.1074/jbc.R800047200; Jamaluddin H, 2007, J MOL BIOL, V369, P1270, DOI 10.1016/j.jmb.2007.04.012; Kakuda S, 2004, J BIOL CHEM, V279, P22693, DOI 10.1074/jbc.M400622200; KAMISANGO K, 1987, J BIOL CHEM, V262, P4580; Kaur D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005447; KELLER JM, 1968, J BIOL CHEM, V243, P2905; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Lobsanov YD, 2004, J BIOL CHEM, V279, P17921, DOI 10.1074/jbc.M312720200; Ly HD, 2002, BIOCHEMISTRY-US, V41, P5075, DOI 10.1021/bi012031s; MACHIDA Y, 1973, P NATL ACAD SCI USA, V70, P1146, DOI 10.1073/pnas.70.4.1146; Marlow MS, 2010, NAT CHEM BIOL, V6, P352, DOI 10.1038/nchembio.347; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MORRISON JF, 1971, J BIOL CHEM, V246, P3977; Nielsen MM, 2011, J BIOL CHEM, V286, P15155, DOI 10.1074/jbc.M110.199844; NISHIKAWA Y, 1988, J BIOL CHEM, V263, P8270; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Rao FV, 2009, NAT STRUCT MOL BIOL, V16, P1186, DOI 10.1038/nsmb.1685; REARICK JI, 1979, J BIOL CHEM, V254, P4444; Rini J, 2009, ESSENTIALS GLYCOBIOL; Schaeffer F, 2002, BIOCHEMISTRY-US, V41, P2106, DOI 10.1021/bi011853m; Schwartz SD, 2009, NAT CHEM BIOL, V5, P552, DOI 10.1038/nchembio.202; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Tuffal G, 1998, GLYCOBIOLOGY, V8, P675, DOI 10.1093/glycob/8.7.675; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; YABUSAKI KK, 1978, P NATL ACAD SCI USA, V75, P691, DOI 10.1073/pnas.75.2.691; YABUSAKI KK, 1979, J BIOL CHEM, V254, P2314	67	15	17	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24649	24661		10.1074/jbc.M112.368191	http://dx.doi.org/10.1074/jbc.M112.368191			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637481	hybrid, Green Published			2022-12-25	WOS:000306651100059
J	Dutka, TL; Verburg, E; Larkins, N; Hortemo, KH; Lunde, PK; Sejersted, OM; Lamb, GD				Dutka, Travis L.; Verburg, Esther; Larkins, Noni; Hortemo, Kristin H.; Lunde, Per K.; Sejersted, Ole M.; Lamb, Graham D.			ROS-Mediated Decline in Maximum Ca2+-Activated Force in Rat Skeletal Muscle Fibers following In Vitro and In Vivo Stimulation	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; NITRIC-OXIDE; CONTRACTILE APPARATUS; HYDROGEN-PEROXIDE; SARCOPLASMIC-RETICULUM; S-NITROSOGLUTATHIONE; CELLULAR MECHANISMS; CALCIUM SENSITIVITY; ISOFORM COMPOSITION; REACTIVE OXYGEN	We hypothesised that normal skeletal muscle stimulated intensely either in vitro or in situ would exhibit reactive oxygen species (ROS)-mediated contractile apparatus changes common to many pathophysiological conditions. Isolated soleus (SOL) and extensor digitorum longus (EDL) muscles of the rat were bubbled with 95% O-2 and stimulated in vitro at 31 degrees C to give isometric tetani (50 Hz for 0.5 s every 2 s) until maximum force declined to <= 30%. Skinned superficial slow-twitch fibers from the SOL muscles displayed a large reduction (similar to 41%) in maximum Ca2+-activated specific force (F-max), with Ca2+-sensitivity unchanged. Fibers from EDL muscles were less affected. The decrease in F-max in SOL fibers was evidently due to oxidation effects on cysteine residues because it was reversed if the reducing agent DTT was applied prior to activating the fiber. The GSH:GSSG ratio was similar to 3-fold lower in the cytoplasm of superficial fibers from stimulated muscle compared to control, confirming increased oxidant levels. The presence of Tempol and L-NAME during in vitro stimulation prevented reduction in F-max. Skinned fibers from SOL muscles stimulated in vivo at 37 degrees C with intact blood supply also displayed reduction in F-max, though to a much smaller extent (similar to 12%). Thus, fibers from muscles stimulated even with putatively adequate O-2 supply display a reversible oxidation-induced decrease in F-max without change in Ca2+-sensitivity, consistent with action of peroxynitrite (or possibly superoxide) on cysteine residues of the contractile apparatus. Significantly, the changes closely resemble the contractile deficits observed in a range of pathophysiological conditions. These findings highlight how readily muscle experiences ROS-related deficits, and also point to potential difficulties when defining muscle performance and fatigue.	[Dutka, Travis L.; Larkins, Noni; Lamb, Graham D.] La Trobe Univ, Dept Zool, Melbourne, Vic, Australia; [Verburg, Esther; Hortemo, Kristin H.; Lunde, Per K.; Sejersted, Ole M.] Univ Oslo, Expt Med Res Inst, Oslo, Norway; [Verburg, Esther; Hortemo, Kristin H.; Lunde, Per K.; Sejersted, Ole M.] Oslo Univ Hosp, Oslo, Norway	La Trobe University; University of Oslo; University of Oslo	Dutka, TL (corresponding author), La Trobe Univ, Dept Zool, Melbourne, Vic, Australia.	t.dutka@latrobe.edu.au	Dutka, Travis/AAD-3644-2020		National Health and Medical Research Council of Australia [541938]; South-Eastern Norway Regional Health Authority; Anders Jahre's Fund for the Promotion of Science	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); South-Eastern Norway Regional Health Authority; Anders Jahre's Fund for the Promotion of Science	This project was supported and funded by the National Health and Medical Research Council of Australia (grant number 541938), the South-Eastern Norway Regional Health Authority and Anders Jahre's Fund for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BW, 2009, J APPL PHYSIOL, V106, P662, DOI 10.1152/japplphysiol.91109.2008; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Andrade FH, 1998, J PHYSIOL-LONDON, V509, P577, DOI 10.1111/j.1469-7793.1998.577bn.x; Andrade FH, 1998, J PHYSIOL-LONDON, V509, P565, DOI 10.1111/j.1469-7793.1998.565bn.x; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Barclay CJ, 2005, J MUSCLE RES CELL M, V26, P225, DOI 10.1007/s10974-005-9013-x; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BIGLANDRITCHIE B, 1983, J PHYSIOL-LONDON, V340, P335, DOI 10.1113/jphysiol.1983.sp014765; Bortolotto SK, 2000, AM J PHYSIOL-CELL PH, V279, pC1564, DOI 10.1152/ajpcell.2000.279.5.C1564; Callahan LA, 2001, J APPL PHYSIOL, V90, P45, DOI 10.1152/jappl.2001.90.1.45; Callahan LA, 2001, AM J RESP CELL MOL, V24, P210, DOI 10.1165/ajrcmb.24.2.4075; Callahan Leigh Ann, 2009, Crit Care Med, V37, pS354, DOI 10.1097/CCM.0b013e3181b6e439; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Dutka TL, 2011, J PHYSIOL-LONDON, V589, P2181, DOI 10.1113/jphysiol.2010.200451; Dutka TL, 2011, J APPL PHYSIOL, V110, P705, DOI 10.1152/japplphysiol.00739.2010; Edwards JN, 2007, AM J PHYSIOL-CELL PH, V293, pC650, DOI 10.1152/ajpcell.00037.2007; Eliasson MJL, 1999, J NEUROSCI, V19, P5910, DOI 10.1523/JNEUROSCI.19-14-05910.1999; Ferreira LF, 2008, J APPL PHYSIOL, V104, P853, DOI 10.1152/japplphysiol.00953.2007; Frueh BR, 2001, J NEUROPHYSIOL, V85, P1027, DOI 10.1152/jn.2001.85.3.1027; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Halliwell B., 2007, FREE RADICALS BIOL M; Hardin BJ, 2008, J APPL PHYSIOL, V104, P694, DOI 10.1152/japplphysiol.00898.2007; Hertelendi Z, 2009, J CELL MOL MED, V13, P2200, DOI 10.1111/j.1582-4934.2008.00445.x; Heunks LMA, 2001, J APPL PHYSIOL, V91, P2233, DOI 10.1152/jappl.2001.91.5.2233; JAMIESON D, 1986, ANNU REV PHYSIOL, V48, P703, DOI 10.1146/annurev.ph.48.030186.003415; JI LL, 1992, J APPL PHYSIOL, V73, P1854, DOI 10.1152/jappl.1992.73.5.1854; Lamb GD, 2003, J PHYSIOL-LONDON, V546, P149, DOI 10.1113/jphysiol.2002.027896; Lanone S, 2000, AM J RESP CRIT CARE, V162, P2308, DOI 10.1164/ajrccm.162.6.2001097; Lunde PK, 2006, CIRC RES, V98, P1514, DOI 10.1161/01.RES.0000226529.66545.e5; MACFARLANE NG, 1992, CIRC RES, V70, P1217, DOI 10.1161/01.RES.70.6.1217; Mihm MJ, 2001, CIRCULATION, V104, P174, DOI 10.1161/01.CIR.104.2.174; Murphy RM, 2008, J PHYSIOL-LONDON, V586, P2203, DOI 10.1113/jphysiol.2007.150516; O'Connell B, 2004, BIOCHEM J, V378, P269, DOI 10.1042/BJ20031170; Ottenheijm CAC, 2006, AM J PHYSIOL-LUNG C, V290, pL127, DOI 10.1152/ajplung.00073.2005; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Place N, 2009, J PHYSL; Plant DR, 2000, J MUSCLE RES CELL M, V21, P747, DOI 10.1023/A:1010344008224; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; REID MB, 1992, J APPL PHYSIOL, V73, P1797, DOI 10.1152/jappl.1992.73.5.1797; Reid MB, 2011, J PHYSIOL-LONDON, V589, P2171, DOI 10.1113/jphysiol.2010.203356; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Spencer T, 2009, AM J PHYSIOL-CELL PH, V296, pC1015, DOI 10.1152/ajpcell.00251.2008; Sun JH, 2003, J BIOL CHEM, V278, P8184, DOI 10.1074/jbc.M211940200; Supinski G, 1999, J APPL PHYSIOL, V87, P783, DOI 10.1152/jappl.1999.87.2.783; Supinski G, 2000, AM J PHYSIOL-REG I, V278, pR891, DOI 10.1152/ajpregu.2000.278.4.R891; SUPINSKI G, 1994, J APPL PHYSIOL, V76, P2707, DOI 10.1152/jappl.1994.76.6.2707; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Szentesi P, 2005, J APPL PHYSIOL, V99, P2189, DOI 10.1152/japplphysiol.00542.2005; Tiago T, 2006, BIOCHEMISTRY-US, V45, P3794, DOI 10.1021/bi0518500; Trinh HH, 2006, CLIN EXP PHARMACOL P, V33, P591, DOI 10.1111/j.1440-1681.2006.04412.x; van der Poel C, 2002, J PHYSIOL-LONDON, V544, P765, DOI 10.1113/jphysiol.2002.024968; Viner RI, 1999, BIOCHEMISTRY-US, V38, P12408, DOI 10.1021/bi9909445; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Yamada T, 2009, ARTHRITIS RHEUM-US, V60, P3280, DOI 10.1002/art.24907; Zhang SJ, 2006, J PHYSIOL-LONDON, V572, P551, DOI 10.1113/jphysiol.2005.104521	57	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e35226	10.1371/journal.pone.0035226	http://dx.doi.org/10.1371/journal.pone.0035226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629297	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300001
J	Ishiyama, K; Nakamura, K; Ikai, H; Kanno, T; Kohno, M; Sasaki, K; Niwano, Y				Ishiyama, Kirika; Nakamura, Keisuke; Ikai, Hiroyo; Kanno, Taro; Kohno, Masahiro; Sasaki, Keiichi; Niwano, Yoshimi			Bactericidal Action of Photogenerated Singlet Oxygen from Photosensitizers Used in Plaque Disclosing Agents	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; INACTIVATION; CANCER; INFECTIONS; GINGIVALIS; BIOFILMS; TUMOR	Background: Photodynamic therapy (PDT) has been suggested as an efficient clinical approach for the treatment of dental plaque in the field of dental care. In PDT, once the photosensitizer is irradiated with light of a specific wavelength, it transfers the excitation energy to molecular oxygen, which gives rise to singlet oxygen. Methodology/Principal Findings: Since plaque disclosing agents usually contain photosensitizers such as rose bengal, erythrosine, and phloxine, they could be used for PTD upon photoactivation. The aim of the present study is to compare the ability of these three photosensitizers to produce singlet oxygen in relation to their bactericidal activity. The generation rates of singlet oxygen determined by applying an electron spin resonance technique were in the order phloxine > erythrosine = rose bengal. On the other hand, rose bengal showed the highest bactericidal activity against Streptococcus mutans, a major causative pathogen of caries, followed by erythrosine and phloxine, both of which showed activity similar to each other. One of the reasons for the discrepancy between the singlet oxygen generating ability and bactericidal activity was the incorporation efficiency of the photosensitizers into the bacterial cells. The incorporation rate of rose bengal was the highest among the three photosensitizers examined in the present study, likely leading to the highest bactericidal activity. Meanwhile, the addition of L-histidine, a singlet oxygen quencher, cancelled the bactericidal activity of any of the three photoactivated photosensitizers, proving that singlet oxygen was responsible for the bactericidal action. Conclusions: It is strongly suggested that rose bengal is a suitable photosensitizer for the plaque disclosing agents as compared to the other two photosensitizers, phloxine and erythrosine, when used for PDT.	[Ishiyama, Kirika; Nakamura, Keisuke; Ikai, Hiroyo; Kanno, Taro; Sasaki, Keiichi; Niwano, Yoshimi] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 980, Japan; [Kohno, Masahiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Tokyo 152, Japan	Tohoku University; Tokyo Institute of Technology	Ishiyama, K (corresponding author), Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 980, Japan.	y.niwano@m.tohoku.ac.jp	Niwnao, Yoshimi/Z-3593-2019		Ministry of Education, Science, Sports and Culture, Japan [21791932]	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Young Scientists (B), 21791932, 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Vera DMA, 2012, PHOTOCHEM PHOTOBIOL, V88, P499, DOI 10.1111/j.1751-1097.2012.01087.x; Bhatti M, 1998, PHOTOCHEM PHOTOBIOL, V68, P370, DOI 10.1111/j.1751-1097.1998.tb09694.x; Clo E, 2007, CHEMBIOCHEM, V8, P475, DOI 10.1002/cbic.200600454; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Garcia VG, 2011, J CLIN PERIODONTOL, V38, P1106, DOI 10.1111/j.1600-051X.2011.01785.x; Gonzales FP, 2012, FUNGAL BIOL-UK, V116, P1, DOI 10.1016/j.funbio.2011.10.001; Herrera David, 2011, Evid Based Dent, V12, P78, DOI 10.1038/sj.ebd.6400810; ilela S F, 2012, ARCH ORAL B IN PRESS, DOI [10.1016/j.archoralbio.2011.12.002, DOI 10.1016/J.ARCHORALBI0.2011.12.002]; IWAMOTO Y, 1985, CHEM PHARM BULL, V33, P5529; Juarranz A, 2008, CLIN TRANSL ONCOL, V10, P148, DOI 10.1007/s12094-008-0172-2; Kharkwal GB, 2011, LASER SURG MED, V43, P755, DOI 10.1002/lsm.21080; Konopka K, 2007, J DENT RES, V86, P694, DOI 10.1177/154405910708600803; Luo J, 2006, ANTIOXID REDOX SIGN, V8, P1307, DOI 10.1089/ars.2006.8.1307; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; Martins J, 2004, PHOTOCHEM PHOTOBIOL, V80, P267, DOI 10.1562/2004-03-26-RA-124.1; Nagata JY, 2012, PHOTODIAGNO IN PRESS, DOI DOI 10.1016/J.PDPDT.2011.11.006; Nakamura K, 2011, J CLIN BIOCHEM NUTR, V49, P87, DOI 10.3164/jcbn.10-125; Niziolek-Kierecka M, 2010, PHOTOCHEM PHOTOBIOL, V86, P681, DOI 10.1111/j.1751-1097.2010.00712.x; Papastamou V, 2011, ARCH ORAL BIOL, V56, P264, DOI 10.1016/j.archoralbio.2010.10.007; Rolim JPML, 2012, J PHOTOCH PHOTOBIO B, V106, P40, DOI 10.1016/j.jphotobiol.2011.10.001; Simone CB, 2012, J THORAC DIS, V4, P63, DOI 10.3978/j.issn.2072-1439.2011.11.05; Soukos NS, 2006, J ENDODONT, V32, P979, DOI 10.1016/j.joen.2006.04.007; Soukos NS, 2011, PERIODONTOL 2000, V55, P143, DOI 10.1111/j.1600-0757.2010.00346.x; THOMAS JP, 1987, CANCER LETT, V35, P295, DOI 10.1016/0304-3835(87)90131-5; WEISHAUPT KR, 1976, CANCER RES, V36, P2326; Yamamoto J, 2006, CLIN CANCER RES, V12, P7132, DOI 10.1158/1078-0432.CCR-06-0786; ZANG LY, 1990, PHOTOCHEM PHOTOBIOL, V52, P677, DOI 10.1111/j.1751-1097.1990.tb08666.x	27	38	38	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37871	10.1371/journal.pone.0037871	http://dx.doi.org/10.1371/journal.pone.0037871			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629466	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345300081
J	Miller, KI; Qing, C; Sze, DMY; Neilan, BA				Miller, Kristin I.; Qing, Chen; Sze, Daniel Man Yuen; Neilan, Brett A.			Investigation of the Biosynthetic Potential of Endophytes in Traditional Chinese Anticancer Herbs	PLOS ONE			English	Article							POLYKETIDE SYNTHASE GENES; NONRIBOSOMAL PEPTIDE SYNTHETASES; PLANT ANTITUMOR AGENTS; FUNGAL ENDOPHYTES; NATURAL-PRODUCTS; ANTIMUTAGENIC ACTIVITY; FUTURE-PROSPECTS; ANTIBIOTICS; NRPS; INHIBITOR	Traditional Chinese medicine encompasses a rich empirical knowledge of the use of plants for the treatment of disease. In addition, the microorganisms associated with medicinal plants are also of interest as the producers of the compounds responsible for the observed plant bioactivity. The present study has pioneered the use of genetic screening to assess the potential of endophytes to synthesize bioactive compounds, as indicated by the presence of non-ribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) genes. The total DNA extracts of 30 traditional Chinese herbs, were screened for functional genes involved in the biosynthesis of bioactive compounds. The four PCR screens were successful in targeting four bacterial PKS, six bacterial NRPS, ten fungal PKS and three fungal NRPS gene fragments. Analysis of the detected endophyte gene fragments afforded consideration of the possible bioactivity of the natural products produced by endophytes in medicinal herbs. This investigation describes a rapid method for the initial screening of medicinal herbs and has highlighted a subset of those plants that host endophytes with biosynthetic potential. These selected plants can be the focus of more comprehensive endophyte isolation and natural product studies.	[Miller, Kristin I.; Sze, Daniel Man Yuen] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Miller, Kristin I.; Neilan, Brett A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Qing, Chen] Kunming Med Univ, Yunnan Key Lab Pharmacol Nat Prod, Sch Pharmaceut Sci, Kunming, Peoples R China; [Sze, Daniel Man Yuen] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hung Hom Kowloon, Hong Kong, Peoples R China; [Neilan, Brett A.] Univ New S Wales, Australian Ctr Astrobiol, Sydney, NSW, Australia	University of Sydney; University of New South Wales Sydney; Kunming Medical University; Hong Kong Polytechnic University; University of New South Wales Sydney	Miller, KI (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	b.neilan@unsw.edu.au	Neilan, Brett A/I-5767-2012	Neilan, Brett A/0000-0001-6113-772X	Australia-China Special Fund for ST Cooperation [CH070067]; National Natural Science Foundation of China [30811120009]; International Cooperation Foundation of Yunnan Province of China [30811120009]; Australian Research Council [FF0883440]	Australia-China Special Fund for ST Cooperation(Australian GovernmentDepartment of Industry, Innovation and Science); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Foundation of Yunnan Province of China; Australian Research Council(Australian Research Council)	KIM and DMYS were supported by the Australia-China Special Fund for S&T Cooperation (CH070067) https://grants.innovation.gov.au/ISL/Pages/Doc. aspx?name = ChinaFund.htm. CQ was financially supported by the National Natural Science Foundation of China (No. 30811120009) and the International Cooperation Foundation of Yunnan Province of China (No. 30811120009). BAN was supported by a grant and fellowship from the Australian Research Council (FF0883440) http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ACTON N, 1985, PLANTA MED, V51, P441, DOI 10.1055/s-2007-969543; [Anonymous], 1998, CHINESE MAT MED CHEM; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Ayuso-Sacido A, 2005, MICROB ECOL, V49, P10, DOI 10.1007/s00248-004-0249-6; Bayman P, 1997, NEW PHYTOL, V135, P143, DOI 10.1046/j.1469-8137.1997.00618.x; BIANCHI C, 1975, J PHARM SCI, V64, P1305, DOI 10.1002/jps.2600640809; Bingle LEH, 1999, FUNGAL GENET BIOL, V26, P209, DOI 10.1006/fgbi.1999.1115; Brimble MA, 1999, NAT PROD REP, V16, P267, DOI 10.1039/a804287j; Burns BP, 2005, FEMS MICROBIOL LETT, V243, P293, DOI 10.1016/j.femsle.2004.12.019; Cankar K, 2005, FEMS MICROBIOL LETT, V244, P341, DOI 10.1016/j.femsle.2005.02.008; Castillo UF, 2002, MICROBIOL-SGM, V148, P2675, DOI 10.1099/00221287-148-9-2675; Chen KK, 1924, J PHARMACOL EXP THER, V24, P339; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Davydov M, 2000, J ETHNOPHARMACOL, V72, P345, DOI 10.1016/S0378-8741(00)00181-1; de Bruijn I, 2008, J BACTERIOL, V190, P2777, DOI 10.1128/JB.01563-07; de Carvalho CCCR, 2005, APPL MICROBIOL BIOT, V67, P715, DOI 10.1007/s00253-005-1932-3; Ehrenreich IM, 2005, APPL ENVIRON MICROB, V71, P7401, DOI 10.1128/AEM.71.11.7401-7413.2005; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Gore ME, 2007, FOREST PATHOL, V37, P281, DOI 10.1111/j.1439-0329.2007.00509.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ho LK, 1996, J NAT PROD, V59, P330, DOI 10.1021/np960200h; Hoessel R, 1999, NAT CELL BIOL, V1, P60, DOI 10.1038/9035; Hoffman MT, 2008, MYCOL RES, V112, P331, DOI 10.1016/j.mycres.2007.10.014; Huang KC, 1999, PHARM CHINESE HERBS; Ishida K, 2009, APPL ENVIRON MICROB, V75, P2017, DOI 10.1128/AEM.02258-08; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Johnson R, 2007, FUNGAL GENET BIOL, V44, P1180, DOI 10.1016/j.fgb.2007.04.009; Kannadan S, 2008, FUNCT ECOL, V22, P706, DOI 10.1111/j.1365-2435.2008.01395.x; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Kodani S, 1998, J NAT PROD, V61, P1046, DOI 10.1021/np980106w; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Kusari S, 2011, NAT PROD REP, V28, P1203, DOI 10.1039/c1np00030f; LEE H, 1988, MUTAT RES, V204, P229, DOI 10.1016/0165-1218(88)90093-6; Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m; LI XW, 1986, J BIOGEOGR, V13, P367, DOI 10.2307/2844964; Liao HL, 2008, MOL PLANT MICROBE IN, V21, P469, DOI 10.1094/MPMI-21-4-0469; LIU J, 1989, J BACTERIOL, V171, P791, DOI 10.1128/jb.171.2.791-798.1989; Lopez-Lazaro M, 2003, PLANTA MED, V69, P701, DOI 10.1055/s-2003-42789; Lu YR, 2002, PHYTOCHEMISTRY, V59, P117, DOI 10.1016/S0031-9422(01)00415-0; Mankelow DP, 2000, EXPERT OPIN THER PAT, V10, P1583, DOI 10.1517/13543776.10.10.1583; Marler TE, 2005, HORTSCIENCE, V40, P1607, DOI 10.21273/HORTSCI.40.6.1607; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Mejia LC, 2008, BIOL CONTROL, V46, P4, DOI 10.1016/j.biocontrol.2008.01.012; Miyazawa M, 1999, J AGR FOOD CHEM, V47, P2163, DOI 10.1021/jf970930a; Moffitt MC, 2001, FEMS MICROBIOL LETT, V196, P207, DOI 10.1111/j.1574-6968.2001.tb10566.x; Moore BS, 2005, ANTON LEEUW INT J G, V87, P49, DOI 10.1007/s10482-004-6541-0; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; MORIKAWA M, 1993, J BACTERIOL, V175, P6459, DOI 10.1128/JB.175.20.6459-6466.1993; Murakami M, 1997, PHYTOCHEMISTRY, V44, P449, DOI 10.1016/S0031-9422(96)00437-2; Namwat W, 2002, GENE, V286, P283, DOI 10.1016/S0378-1119(02)00424-9; Neilan BA, 1999, J BACTERIOL, V181, P4089, DOI 10.1128/JB.181.13.4089-4097.1999; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; NiceData, 2004, TRAD CHIN MED NAT SO; Nicholson TP, 2001, CHEM BIOL, V8, P157, DOI 10.1016/S1074-5521(00)90064-4; OKINO T, 1993, TETRAHEDRON LETT, V34, P501, DOI 10.1016/0040-4039(93)85112-A; PERDUE RE, 1970, AMER HORTICULT MAG, V49, P19; Puri SC, 2005, J NAT PROD, V68, P1717, DOI 10.1021/np0502802; Rajbhandari M, 2009, EVID-BASED COMPL ALT, V6, P517, DOI 10.1093/ecam/nem156; Rascher A, 2003, FEMS MICROBIOL LETT, V218, P223, DOI 10.1016/S0378-1097(02)01148-5; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Rounge TB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-396; Rounge TB, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-141; Sauer M, 2002, MYCOL RES, V106, P460, DOI 10.1017/S095375620200566X; Staunton J, 2001, CURR OPIN CHEM BIOL, V5, P159, DOI 10.1016/S1367-5931(00)00185-X; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Strobel GA, 2003, MICROBES INFECT, V5, P535, DOI 10.1016/S1286-4579(03)00073-X; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van der Bank H, 2001, BIOCHEM SYST ECOL, V29, P241, DOI 10.1016/S0305-1978(00)00064-8; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Wawrik B, 2005, APPL ENVIRON MICROB, V71, P2232, DOI 10.1128/AEM.71.5.2232-2238.2005; Weber T, 2003, J BIOTECHNOL, V106, P221, DOI 10.1016/j.jbiotec.2003.08.004; Wei W., 2002, COMBINATION APPL	79	56	61	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e35953	10.1371/journal.pone.0035953	http://dx.doi.org/10.1371/journal.pone.0035953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629306	gold, Green Published			2022-12-25	WOS:000305345300004
J	Ziegler, A; Schroder, L; Ogurreck, M; Faber, C; Stach, T				Ziegler, Alexander; Schroeder, Leif; Ogurreck, Malte; Faber, Cornelius; Stach, Thomas			Evolution of a Novel Muscle Design in Sea Urchins (Echinodermata: Echinoidea)	PLOS ONE			English	Article							ECHINUS ESCULENTUS L; STYLOCIDARIS-AFFINIS ECHINODERMATA; PARACENTROTUS-LIVIDUS LAMARCK; PERISTOMIAL MEMBRANE; ARISTOTLES LANTERN; COMPARATIVE MORPHOLOGY; FUNCTIONAL-MORPHOLOGY; MECHANICAL-BEHAVIOR; VARIABLE TENSILITY; COMPASS DEPRESSORS	The sea urchin (Echinodermata: Echinoidea) masticatory apparatus, or Aristotle's lantern, is a complex structure composed of numerous hard and soft components. The lantern is powered by various paired and unpaired muscle groups. We describe how one set of these muscles, the lantern protractor muscles, has evolved a specialized morphology. This morphology is characterized by the formation of adaxially-facing lobes perpendicular to the main orientation of the muscle, giving the protractor a frilled aspect in horizontal section. Histological and ultrastructural analyses show that the microstructure of frilled muscles is largely identical to that of conventional, flat muscles. Measurements of muscle dimensions in equally-sized specimens demonstrate that the frilled muscle design, in comparison to that of the flat muscle type, considerably increases muscle volume as well as the muscle's surface directed towards the interradial cavity, a compartment of the peripharyngeal coelom. Scanning electron microscopical observations reveal that the insertions of frilled and flat protractor muscles result in characteristic muscle scars on the stereom, reflecting the shapes of individual muscles. Our comparative study of 49 derived "regular" echinoid species using magnetic resonance imaging (MRI) shows that frilled protractor muscles are found only in taxa belonging to the families Toxopneustidae, Echinometridae, and Strongylocentrotidae. The onset of lobe formation during ontogenesis varies between species of these three families. Because frilled protractor muscles are best observed in situ, the application of a non-invasive imaging technique was crucial for the unequivocal identification of this morphological character on a large scale. Although it is currently possible only to speculate on the functional advantages which the frilled muscle morphology might confer, our study forms the anatomical and evolutionary framework for future analyses of this unusual muscle design among sea urchins.	[Ziegler, Alexander] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Schroeder, Leif] Leibniz Inst Mol Pharmacol, Mol Imaging Grp, Berlin, Germany; [Ogurreck, Malte] Helmholtz Zentrum Geesthacht, Inst Werkstoffforsch, Geesthacht, Germany; [Faber, Cornelius] Univ Klinikum Munster, Inst Klin Radiol, Munster, Germany; [Stach, Thomas] Free Univ Berlin, Inst Biol, Berlin, Germany	Harvard University; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; University of Munster; Free University of Berlin	Ziegler, A (corresponding author), Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA.	aziegler@fas.harvard.edu	Schröder, Leif/H-6036-2011; Faber, Cornelius/Q-2689-2016	Schröder, Leif/0000-0003-4901-0325; Faber, Cornelius/0000-0001-7683-7710; Storm, Malte/0000-0002-1602-781X	Deutsche Forschungsgemeinschaft through a Forschungsstipendium	Deutsche Forschungsgemeinschaft through a Forschungsstipendium	This study was supported by the Deutsche Forschungsgemeinschaft through a Forschungsstipendium to AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIETTI F, 1990, J ZOOL, V220, P345, DOI 10.1111/j.1469-7998.1990.tb04312.x; ANDRIETTI F, 1992, ECHINODERM RESEARCH 1991, P95; Asgaard U, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P279, DOI 10.1007/978-3-540-77598-0_15; Binyon J., 1972, PHYSL ECHINODERMS; BIRENHEIDE R, 1992, ECHINODERM RESEARCH 1991, P67; Birenheide R, 1996, BIOL BULL, V190, P218, DOI 10.2307/1542542; BOLTT RE, 1963, J EXP BIOL, V40, P713; BONASORO F, 1995, B ZOOL, V62, P121, DOI 10.1080/11250009509356060; BUCHANAN JB, 1969, J ZOOL, V159, P51; Candia Carnevali M D, 1988, ECHINODERM BIOL, P663; CARNEVALI MDC, 1993, ZOOMORPHOLOGY, V113, P173; CARNEVALI MDC, 1991, B ZOOL, V58, P1, DOI 10.1080/11250009109355726; CARNEVALI MDC, 1990, ECHINODERM RESEARCH, P207; Cavey Michael J., 1994, P345; COBB JLS, 1966, PROC R SOC SER B-BIO, V164, P651, DOI 10.1098/rspb.1966.0054; COBB JLS, 1977, CELL TISSUE RES, V182, P265; COBB JLS, 1966, PROC R SOC SER B-BIO, V164, P624, DOI 10.1098/rspb.1966.0052; COBB JLS, 1968, COMP BIOCHEM PHYSIOL, V24, P311, DOI 10.1016/0010-406X(68)90982-1; COBB JLS, 1966, PROC R SOC SER B-BIO, V164, P641, DOI 10.1098/rspb.1966.0053; Cuenot L, 1891, ARCH BIOL, VXI; de Ridder C., 1988, P675; de Ridder C., 1982, P57; Dolmatov IY, 2007, CELL TISSUE RES, V327, P371, DOI 10.1007/s00441-006-0314-1; Ellers O, 1997, P ROY SOC B-BIOL SCI, V264, P1525, DOI 10.1098/rspb.1997.0211; Elphick MR, 2001, J EXP BIOL, V204, P875; EMIG C C, 1974, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V12, P128; EMIG CC, 1985, Z ZOOL SYST EVOL, V23, P184; Farmanfarmaian A., 1966, P245; GRUNBAUM H, 1978, B MAR SCI, V28, P181; HAMANN O, 1887, JENA Z NATURWISS, V21, P87; HANSON JL, 1986, MAR BIOL, V92, P125, DOI 10.1007/BF00392754; Hawkins HL, 1934, PHILOS T R SOC LON B, V223, P617, DOI 10.1098/rstb.1934.0014; Hill R.B., 1993, Echinoderm Studies, V4, P81; Hoffmann CK, 1871, NIEDERLANDISCHES ARC, V1, P11; Holland ND, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-39; Hyman LH, 1955, INVERTEBRATES ECHINO, VIV; Jackson R. T., 1912, MEMOIRS BOSTON SOC N, V7, P1, DOI DOI 10.5962/BHL.TITLE.4630; Janies DA, 2011, SYST BIOL, V60, P420, DOI 10.1093/sysbio/syr044; Kier PM, 1974, PALEONTOLOGICAL SOC, V5, P1; Kroh A, 2012, WORLD ECHINOIDEA DAT; Kroh A, 2010, J SYST PALAEONTOL, V8, P147, DOI 10.1080/14772011003603556; Lanzavecchia G., 1988, P649; Lavallard R., 1965, Boletim da Faculdade de Filosofia Ciencias e Letras Universidade de Sao Paulo (Zool), VNo. 25, P133; Lawrence JM, 2001, CAN J ZOOL, V79, P1251, DOI 10.1139/cjz-79-7-1251; Leydig F, 1854, ARCH ANATOM PHYSL, P296; LITTLEWOOD DTJ, 1995, PHILOS T R SOC B, V347, P213, DOI 10.1098/rstb.1995.0023; Littlewood DTJ, 1997, BIOL J LINN SOC, V61, P409, DOI 10.1006/bijl.1996.0131; Loven S, 1892, BIH KONG SVENSK AKAD, V18, P1; MARKEL K, 1990, ZOOMORPHOLOGY, V109, P251, DOI 10.1007/BF00312192; MARKEL K, 1979, ZOOMORPHOLOGIE, V94, P1, DOI 10.1007/BF00994054; McKew M., 1999, P103; Meyer-Rochow VB, 2003, PROTOPLASMA, V220, P227, DOI 10.1007/s00709-002-0048-1; Mortensen T., 1943, MONOGRAPH ECHINOIDEA, VIII; Prouho H, 1888, RECHERCHES DOROCIDAR; Ribeiro AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024822; Saita A., 1969, Rendiconti dell'Istituto Lombardo di Scienze e Lettere, VB103, P297; Schick JM, 1983, ECHINODERM STUDIES, P67; Smith AB., 1980, SPEC PAP PALAEONTOL, V25, P1; SMITH AB, 1990, SKELETAL BIOMINERALI, V1, P413; Smith AB, 2006, MOL BIOL EVOL, V23, P1832, DOI 10.1093/molbev/msl039; STAUBER M, 1988, ZOOMORPHOLOGY, V108, P137, DOI 10.1007/BF00363930; STAUBER M, 1993, ZOOMORPHOLOGY, V113, P137, DOI 10.1007/BF00403091; Strenger A, 1973, GROSSES ZOOLOGISCHES; Telford M, 1997, INVERTEBR BIOL, V116, P255, DOI 10.2307/3226902; Temereva E.N., 2001, RUS J MAR BIOL, V27, P156; Tiedemann F., 1816, ANATOMIE ROHREN HOLO; Valentin G, 1841, MONOGRAPHIES ECHINOD; Wilkie I.C., 1996, Echinoderm Studies, V5, P61; Wilkie IC, 1998, J COMP PHYSIOL B, V168, P204, DOI 10.1007/s003600050138; WILKIE IC, 1994, B ZOOL, V61, P39, DOI 10.1080/11250009409355857; Wilkie IC, 2000, ZOOMORPHOLOGY, V120, P119, DOI 10.1007/s004350000029; Wilkie IC, 1998, ZOOMORPHOLOGY, V118, P87, DOI 10.1007/s004350050060; WILKIE IC, 1992, ZOOMORPHOLOGY, V112, P143, DOI 10.1007/BF01633105; WILKIE IC, 1993, COMP BIOCHEM PHYS A, V105, P493, DOI 10.1016/0300-9629(93)90425-4; Wilkie IC, 2002, J EXP BIOL, V205, P159; Ziegler A, 2013, P 7 EUR C E IN PRESS; Ziegler A, 2011, ZOOMORPHOLOGY, V130, P227, DOI 10.1007/s00435-011-0138-8; Ziegler A, 2011, METHODS MOL BIOL, V771, P633, DOI 10.1007/978-1-61779-219-9_32; Ziegler A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-313; Ziegler A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-45; Ziegler A, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-10; Ziegler A, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-33	82	22	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37520	10.1371/journal.pone.0037520	http://dx.doi.org/10.1371/journal.pone.0037520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624043	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343500130
J	Bledzka, K; Liu, JM; Xu, Z; Perera, HD; Yadav, SP; Bialkowska, K; Qin, J; Ma, YQ; Plow, EF				Bledzka, Kamila; Liu, Jianmin; Xu, Zhen; Perera, H. Dhanuja; Yadav, Satya P.; Bialkowska, Katarzyna; Qin, Jun; Ma, Yan-Qing; Plow, Edward F.			Spatial Coordination of Kindlin-2 with Talin Head Domain in Interaction with Integrin beta Cytoplasmic Tails	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; INSIDE-OUT; LEUKOCYTE ADHESION; POINT MUTATION; ACTIVATION; BINDING; ALPHA(IIB)BETA(3); PROTEIN; SUBUNIT; FILAMIN	Both talin head domain and kindlin-2 interact with integrin beta cytoplasmic tails, and they function in concert to induce integrin activation. Binding of talin head domain to beta cytoplasmic tails has been characterized extensively, but information on the interaction of kindin-2 with this integrin segment is limited. In this study, we systematically examine the interactions of kindlin-2 with integrin beta tails. Kindlin-2 interacted well with beta(1) and beta(3) tails but poorly with the beta(2) cytoplasmic tail. This binding selectivity was determined by the non-conserved residues, primarily the three amino acids at the extreme Cterminus of the beta(3) tail, and the sequence in beta(2) was non-permissive. The region at the C termini of integrin beta(1) and beta(3) tails recognized by kindlin-2 was a binding core of 12 amino acids. Kindlin-2 and talin head do not interact with one another but can bind simultaneously to the integrin beta(3) tail without enhancing or inhibiting the interaction of the other binding partner. Kindlin-2 itself failed to directly unclasp integrin alpha/beta tail complex, indicating that kindlin-2 must cooperate with talin to support the integrin activation mechanism.	[Xu, Zhen; Ma, Yan-Qing] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; [Bledzka, Kamila; Liu, Jianmin; Perera, H. Dhanuja; Bialkowska, Katarzyna; Qin, Jun; Plow, Edward F.] Cleveland Clin, Dept Mol Cardiol, Joseph J Jacobs Ctr Thrombosis & Vasc Biol NB 50, Cleveland, OH 44195 USA; [Yadav, Satya P.] Cleveland Clin, Res Core Serv, Dept Mol Biotechnol, Lerner Res Inst, Cleveland, OH 44195 USA	Versiti Blood Center of Wisconsin; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Ma, YQ (corresponding author), Blood Ctr Wisconsin, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI 53226 USA.	yanqing.ma@bcw.edu; plowe@ccf.org		Qin, Jun/0000-0002-2647-9270	National Institutes of Health from the NHLBI [P01HL073311, R01 HL096062]; American Heart Association [10SDG2610277, POST4310067]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311, R01HL096062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL073311 and R01 HL096062 from the NHLBI. This work was also supported by Scientist Development Grant 10SDG2610277 and a postdoctoral fellowship (Great Rivers Affiliate POST4310067) from the American Heart Association.	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Campbell ID, 2004, TRENDS BIOCHEM SCI, V29, P429, DOI 10.1016/j.tibs.2004.06.005; CHEN YP, 1994, BLOOD, V84, P1857; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dimitriou AA, 2009, PLATELETS, V20, P539, DOI 10.3109/09537100903324219; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hers I., 2000, ARTERIOSCLER THROMB, V20, P1651; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; HOYER D, 1993, TRENDS PHARMACOL SCI, V14, P270, DOI 10.1016/0165-6147(93)90129-8; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kodoyianni V, 2011, BIOTECHNIQUES, V50, P32, DOI 10.2144/000113569; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; PLOW EF, 2001, HEMOSTASIS THROMBOSI, P479; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Vinogradova O, 2012, TOP CURR CHEM, V326, P35, DOI 10.1007/128_2011_216; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Zou ZY, 2007, BLOOD, V109, P3284, DOI 10.1182/blood-2006-10-051664	57	60	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24585	24594		10.1074/jbc.M111.336743	http://dx.doi.org/10.1074/jbc.M111.336743			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22648415	hybrid, Green Published			2022-12-25	WOS:000306651100051
J	Boeglin, WE; Brash, AR				Boeglin, William E.; Brash, Alan R.			Cytochrome P450-type Hydroxylation and Epoxidation in a Tyrosine-liganded Hemoprotein, Catalase-related Allene Oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID METABOLISM; LIPOXYGENASE FUSION PROTEIN; BIS-ALLYLIC HYDROXYLATION; RAT-LIVER MICROSOMES; FATTY-ACID; ELECTROPHILIC OXIDANT; THROMBOXANE SYNTHASE; QM/MM CALCULATIONS; EPOXY ALCOHOLS; P450	The ability of hemoproteins to catalyze epoxidation or hydroxylation reactions is usually associated with a cysteine as the proximal ligand to the heme, as in cytochrome P450 or nitric oxide synthase. Catalase-related allene oxide synthase (cAOS) from the coral Plexaura homomalla, like catalase itself, has tyrosine as the proximal heme ligand. Its natural reaction is to convert 8R-hydroperoxy-eicosatetraenoic acid (8R-HPETE) to an allene epoxide, a reaction activated by the ferric heme, forming product via the Fe-IV-OH intermediate, Compound II. Here we oxidized cAOS to Compound I (Fe-V=O) using the oxygen donor iodosylbenzene and investigated the catalytic competence of the enzyme. 8R-hydroxyeicosatetraenoic acid (8R-HETE), the hydroxy analog of the natural substrate, normally unreactive with cAOS, was thereby epoxidized stereospecifically on the 9,10 double bond to form 8R-hydroxy-9R, 10R-trans-epoxy-eicosa-5Z,11Z,14Z-trienoic acid as the predominant product; the turnover was 1/s using 100 mu M iodosylbenzene. The enantiomer, 8S-HETE, was epoxidized stereospecifically, although with less regiospecificity, and was hydroxylated on the 13- and 16-carbons. Arachidonic acid was converted to two major products, 8R-HETE and 8R,9S-eicosatrienoic acid (8R,9S-EET), plus other chiral monoepoxides and bis-allylic 10S-HETE. Linoleic acid was epoxidized, whereas stearic acid was not metabolized. We conclude that when cAOS is charged with an oxygen donor, it can act as a stereospecific monooxygenase. Our results indicate that in the tyrosine-liganded cAOS, a catalase-related hemoprotein in which a polyunsaturated fatty acid can enter the active site, the enzyme has the potential to mimic the activities of typical P450 epoxygenases and some capabilities of P450 hydroxylases.	[Brash, Alan R.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Brash, AR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, RRB Room 510, Nashville, TN 37232 USA.	alan.brash@vanderbilt.edu			National Institutes of Health [GM 074888]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 074888 (to A. R. B.).	ADACHI S, 1993, BIOCHEMISTRY-US, V32, P241, DOI 10.1021/bi00052a031; Aldag C, 2009, P NATL ACAD SCI USA, V106, P5481, DOI 10.1073/pnas.0810503106; BERNART MW, 1994, PHYTOCHEMISTRY, V36, P1233, DOI 10.1016/S0031-9422(00)89643-0; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; Brash AR, 2009, PHYTOCHEMISTRY, V70, P1522, DOI 10.1016/j.phytochem.2009.08.005; BRASH AR, 1995, ARCH BIOCHEM BIOPHYS, V321, P485, DOI 10.1006/abbi.1995.1421; Bylund J, 1998, J PHARMACOL EXP THER, V284, P51; Cho KB, 2011, ARCH BIOCHEM BIOPHYS, V507, P14, DOI 10.1016/j.abb.2010.07.016; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Franke A, 2008, ANGEW CHEM INT EDIT, V47, P5238, DOI 10.1002/anie.200800907; Gao BL, 2009, J BIOL CHEM, V284, P22087, DOI 10.1074/jbc.M109.013151; GELB MH, 1982, P NATL ACAD SCI-BIOL, V79, P5758, DOI 10.1073/pnas.79.19.5758; Groves JT, 2003, P NATL ACAD SCI USA, V100, P3569, DOI 10.1073/pnas.0830019100; Guengerich FP, 2007, J BIOCHEM MOL TOXIC, V21, P163, DOI 10.1002/jbt.20174; GUSTAFSSON JA, 1979, BIOCHEMISTRY-US, V18, P865, DOI 10.1021/bi00572a020; Hamberg M, 1997, ARCH BIOCHEM BIOPHYS, V344, P194, DOI 10.1006/abbi.1997.0194; HAMBERG M, 1986, BIOCHIM BIOPHYS ACTA, V879, P410, DOI 10.1016/0005-2760(86)90233-X; HECKER M, 1987, EUR J BIOCHEM, V169, P563, DOI 10.1111/j.1432-1033.1987.tb13646.x; Jiang YY, 2009, ANGEW CHEM INT EDIT, V48, P7193, DOI 10.1002/anie.200901485; Jin SX, 2004, J BIOL INORG CHEM, V9, P644, DOI 10.1007/s00775-004-0575-7; LICHTENBERGER F, 1976, BIOCHEM BIOPH RES CO, V70, P939, DOI 10.1016/0006-291X(76)90682-3; Luo G, 1998, ARCH BIOCHEM BIOPHYS, V357, P45, DOI 10.1006/abbi.1998.0806; MERCIER J, 1974, CHEM PHYS LIPIDS, V12, P239, DOI 10.1016/0009-3084(74)90078-4; Nicholls P, 2001, ADV INORG CHEM, V51, P51; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; OLIW EH, 1993, ARCH BIOCHEM BIOPHYS, V300, P434, DOI 10.1006/abbi.1993.1059; Ost TWB, 2000, FEBS LETT, V486, P173, DOI 10.1016/S0014-5793(00)02267-5; PEERS KE, 1983, CHEM PHYS LIPIDS, V32, P49, DOI 10.1016/0009-3084(83)90069-5; Putnam CD, 2000, J MOL BIOL, V296, P295, DOI 10.1006/jmbi.1999.3458; RIFKIND AB, 1995, ARCH BIOCHEM BIOPHYS, V320, P380, DOI 10.1016/0003-9861(95)90023-3; Rossiter B. E., 1979, TETRAHEDRON LETT, V20, P4733; Saltzman H., 1973, ORG SYNTH, P658; Schneider C, 2000, ANAL BIOCHEM, V287, P186, DOI 10.1006/abio.2000.4847; Schneider C, 2007, P NATL ACAD SCI USA, V104, P18941, DOI 10.1073/pnas.0707148104; Shaik S, 2010, CHEM REV, V110, P949, DOI 10.1021/cr900121s; Tijet N, 2002, PROSTAG OTH LIPID M, V68-9, P423, DOI 10.1016/S0090-6980(02)00046-1; ULLRICH V, 1994, ANGEW CHEM INT EDIT, V33, P1911, DOI 10.1002/anie.199419111; Ullrich V, 2003, ARCH BIOCHEM BIOPHYS, V409, P45, DOI 10.1016/S0003-9861(02)00410-1; Vaz ADN, 1998, P NATL ACAD SCI USA, V95, P3555, DOI 10.1073/pnas.95.7.3555; Watanabe Y, 2007, ACCOUNTS CHEM RES, V40, P554, DOI 10.1021/ar600046a; YAMAZAKI H, 1995, BIOCHEMISTRY-US, V34, P8380, DOI 10.1021/bi00026a020; Yu ZY, 2003, P NATL ACAD SCI USA, V100, P9162, DOI 10.1073/pnas.1633612100; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V322, P76, DOI 10.1006/abbi.1995.1438	44	8	8	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24139	24147		10.1074/jbc.M112.364216	http://dx.doi.org/10.1074/jbc.M112.364216			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22628547	Green Published, hybrid			2022-12-25	WOS:000306651100009
J	Yagi, H; Saito, T; Yanagisawa, M; Yu, RK; Kato, K				Yagi, Hirokazu; Saito, Takuya; Yanagisawa, Makoto; Yu, Robert K.; Kato, Koichi			Lewis X-carrying N-Glycans Regulate the Proliferation of Mouse Embryonic Neural Stem Cells via the Notch Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; PROTEIN; ASTROCYTES; OLIGOSACCHARIDES; INVOLVEMENT; GENERATION; DIVISION; THERAPY; NEURONS	Neural stem cells (NSCs) possess high proliferative potential and the capacity for self-renewal with retention of multipotency to differentiate into brain-forming cells. Several signaling pathways have been shown to be involved in the fate determination process of NSCs, but the molecular mechanisms underlying the maintenance of neural cell stemness remain largely unknown. Our previous study showed that human natural killer carbohydrate epitopes expressed specifically by mouse NSCs modulate the Ras-MAPK pathway, raising the possibility of regulatory roles of glycoprotein glycans in the specific signaling pathways involved in NSC fate determination. To address this issue, we performed comparative N-glycosylation profiling of NSCs before and after differentiation in a comprehensive and quantitative manner. We found that Lewis X-carrying N-glycans were specifically displayed on undifferentiated cells, whereas paucimannose-type N-glycans were predominantly expressed on differentiated cells. Furthermore, by knocking down a fucosyltransferase 9 with short interfering RNA, we demonstrated that the Lewis X-carrying N-glycans were actively involved in the proliferation of NSCs via modulation of the expression level of Musashi-1, which is an activator of the Notch signaling pathway. Our findings suggest that Lewis X carbohydrates, which have so far been characterized as undifferentiation markers, actually operate as activators of the Notch signaling pathway for the maintenance of NSC stemness during brain development.	[Yanagisawa, Makoto; Yu, Robert K.] Georgia Hlth Sci Univ, Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Yanagisawa, Makoto; Yu, Robert K.] Georgia Hlth Sci Univ, Med Coll Georgia, Inst Neurosci, Augusta, GA 30912 USA; [Yagi, Hirokazu; Saito, Takuya; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Nagoya City University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	Yu, RK (corresponding author), Georgia Hlth Sci Univ, Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA.	ryu@georgiahealth.edu; kkatonmr@ims.ac.jp	Yagi, Hirokazu/ABH-6151-2020	Yagi, Hirokazu/0000-0001-9296-0225; Kato, Koichi/0000-0001-7187-9612	National Institutes of Health from USPHS [NS11853]; Naito Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [22790076, 23110002]; Japan-United States Brain Research Cooperative Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011853] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; Naito Foundation(Naito Memorial Foundation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan-United States Brain Research Cooperative Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS11853 (to R. Y.) from USPHS. This work was also supported by the Naito Foundation and Grants-in-aid for Young Scientists (B) 22790076 (to H. Y.) and Scientific Research on Innovative Areas (No. 23110002, Deciphering sugar chain-based signals regulating integrative neuronal functions) (to H. Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; Supported by the Japan-United States Brain Research Cooperative Program.	Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Bithell A, 2005, CLIN SCI, V108, P13, DOI 10.1042/CS20040276; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chen J, 2008, STROKE, V39, P220, DOI 10.1161/STROKEAHA.107.490946; de Filippis L, 2011, HISTOL HISTOPATHOL, V26, P1093, DOI 10.14670/HH-26.1093; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; EGGENS I, 1989, J BIOL CHEM, V264, P9476; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garwood J, 1999, J NEUROSCI, V19, P3888; Hennen E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201095; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Kanemura Y, 2002, J NEUROSCI RES, V69, P869, DOI 10.1002/jnr.10377; Klassen H, 2001, NEUROSCI LETT, V312, P180, DOI 10.1016/S0304-3940(01)02215-7; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lieberoth A, 2009, J NEUROSCI, V29, P6677, DOI 10.1523/JNEUROSCI.4361-08.2009; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Moriguchi K, 2007, J BIOCHEM, V142, P213, DOI 10.1093/jb/mvm128; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P130, DOI 10.1006/abio.1995.1200; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakatani Y, 2010, GLYCOBIOLOGY, V20, P78, DOI 10.1093/glycob/cwp149; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Sarafian V, 1998, INT J CANCER, V75, P105, DOI 10.1002/(SICI)1097-0215(19980105)75:1<105::AID-IJC16>3.3.CO;2-L; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shimoda Y, 2002, J BIOL CHEM, V277, P2033, DOI 10.1074/jbc.M108495200; STREIT A, 1990, J NEUROCHEM, V55, P1494, DOI 10.1111/j.1471-4159.1990.tb04931.x; STREIT A, 1993, J CELL BIOL, V120, P799, DOI 10.1083/jcb.120.3.799; Suzuki Y, 2010, J BIOL CHEM, V285, P18443, DOI 10.1074/jbc.M110.114645; Takahashi N, 2003, TRENDS GLYCOSCI GLYC, V15, P235, DOI 10.4052/tigg.15.235; Tanabe K, 2006, ANAL BIOCHEM, V348, P324, DOI 10.1016/j.ab.2005.10.035; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; Tomlinson J, 2000, INT J ONCOL, V16, P347; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Yagi H, 2005, GLYCOBIOLOGY, V15, P1051, DOI 10.1093/glycob/cwi092; Yagi H, 2008, CARBOHYD RES, V343, P1373, DOI 10.1016/j.carres.2008.03.031; Yagi H, 2008, GLYCOBIOLOGY, V18, P145, DOI 10.1093/glycob/cwm128; Yagi H, 2010, J BIOL CHEM, V285, P37293, DOI 10.1074/jbc.M110.157081; Yagi H, 2010, GLYCOBIOLOGY, V20, P976, DOI 10.1093/glycob/cwq054; Yagi H, 2010, CARBOHYD RES, V345, P442, DOI 10.1016/j.carres.2009.12.002; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Yanagisawa M, 2005, J BIOCHEM, V138, P285, DOI 10.1093/jb/mvi129; Yanagisawa M, 1999, MOL BIOCHEM PARASIT, V102, P225, DOI 10.1016/S0166-6851(99)00102-4; Yanagisawa M, 2011, ASN NEURO, V3, DOI 10.1042/AN20110006; Yanagisawa M, 2009, J NEUROSCI RES, V87, P3535, DOI 10.1002/jnr.22170; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhou ZD, 2010, IUBMB LIFE, V62, P618, DOI 10.1002/iub.362	51	43	48	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24356	24364		10.1074/jbc.M112.365643	http://dx.doi.org/10.1074/jbc.M112.365643			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645129	Green Published, hybrid			2022-12-25	WOS:000306651100030
J	Diaz-Albiter, H; Sant'Anna, MRV; Genta, FA; Dillon, RJ				Diaz-Albiter, Hector; Sant'Anna, Mauricio R. V.; Genta, Fernando A.; Dillon, Rod J.			Reactive Oxygen Species-mediated Immunity against Leishmania mexicana and Serratia marcescens in the Phlebotomine Sand Fly Lutzomyia longipalpis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISCERAL LEISHMANIASIS; MIDGUT TRANSCRIPTOME; GENE-EXPRESSION; INFECTION; DIPTERA; PEROXIDOXIN; CHAGASI; VECTOR; VIRUS; FLIES	Phlebotomine sand flies are the vectors of medically important Leishmania. The Leishmania protozoa reside in the sand fly gut, but the nature of the immune response to the presence of Leishmania is unknown. Reactive oxygen species (ROS) are a major component of insect innate immune pathways regulating gut-microbe homeostasis. Here we show that the concentration of ROS increased in sand fly midguts after they fed on the insect pathogen Serratia marcescens but not after feeding on the Leishmania that uses the sand fly as a vector. Moreover, the Leishmania is sensitive to ROS either by oral administration of ROS to the infected fly or by silencing a gene that expresses a sand fly ROS-scavenging enzyme. Finally, the treatment of sand flies with an exogenous ROS scavenger (uric acid) altered the gut microbial homeostasis, led to an increased commensal gut microbiota, and reduced insect survival after oral infection with S. marcescens. Our study demonstrates a differential response of the sand fly ROS system to gut microbiota, an insect pathogen, and the Leishmania that utilize the sand fly as a vehicle for transmission between mammalian hosts.	[Sant'Anna, Mauricio R. V.; Dillon, Rod J.] Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YQ, England; [Diaz-Albiter, Hector] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Genta, Fernando A.] Inst Oswaldo Cruz, Lab Insect Biochem & Physiol, BR-21040360 Rio De Janeiro, Brazil	Lancaster University; Liverpool School of Tropical Medicine; University of Liverpool; Fundacao Oswaldo Cruz	Dillon, RJ (corresponding author), Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YQ, England.	r.dillon@lancaster.ac.uk	Sant'Anna, Mauricio Roberto Via/AAQ-6084-2021; DIAZ-ALBITER, HECTOR/G-4327-2012; Sant'Anna, Mauricio Roberto Viana/AAQ-4093-2021; Genta, Fernando/F-1791-2011	Sant'Anna, Mauricio Roberto Viana/0000-0002-2504-0979; Genta, Fernando/0000-0001-9558-1116; Dillon, Rod/0000-0002-3551-0030; Diaz-Albiter, Hector/0000-0003-2937-0569	Consejo Nacional de Ciencia y Tecnologia Fellow [207646]; Leverhulme Trust [F/00 808/C]	Consejo Nacional de Ciencia y Tecnologia Fellow; Leverhulme Trust(Leverhulme Trust)	This work was supported by the Consejo Nacional de Ciencia y Tecnologia Fellow (Reference 207646) and the Leverhulme Trust (Reference F/00 808/C).	Acestor N, 2006, J INFECT DIS, V194, P1160, DOI 10.1086/507646; ALEXANDER B, 1995, AM J TROP MED HYG, V52, P354, DOI 10.4269/ajtmh.1995.52.354; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barr SD, 2001, J BIOL CHEM, V276, P34279, DOI 10.1074/jbc.M104406200; BATES PA, 1994, PARASITOLOGY, V108, P1, DOI 10.1017/S0031182000078458; Bonekamp NA, 2009, BIOFACTORS, V35, P346, DOI 10.1002/biof.48; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Charrel RN, 2005, EMERG INFECT DIS, V11, P1657, DOI 10.3201/eid1111.050869; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; COMER JA, 1990, AM J TROP MED HYG, V42, P483, DOI 10.4269/ajtmh.1990.42.483; Diaz-Albiter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017486; Dillon RJ, 2006, GENOMICS, V88, P831, DOI 10.1016/j.ygeno.2006.06.011; Dostalova A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-223; FREEMAN BA, 1982, LAB INVEST, V47, P412; Gouveia C, 2008, NEOTROP ENTOMOL, V37, P597, DOI 10.1590/S1519-566X2008000500016; Goyal N, 1996, FREE RADICAL BIO MED, V21, P683, DOI 10.1016/0891-5849(96)00130-X; GRIMALDI G, 1993, CLIN MICROBIOL REV, V6, P230, DOI 10.1128/CMR.6.3.230-250.1993; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Holzer TR, 2006, MOL BIOCHEM PARASIT, V146, P198, DOI 10.1016/j.molbiopara.2005.12.009; Jochim RC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-15; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Levick MP, 1998, MOL BIOCHEM PARASIT, V96, P125, DOI 10.1016/S0166-6851(98)00122-4; Maingon RDC, 2008, TRENDS PARASITOL, V24, P12, DOI 10.1016/j.pt.2007.10.003; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; McGonigle S, 1998, PARASITOL TODAY, V14, P139, DOI 10.1016/S0169-4758(97)01211-8; Miyamoto S, 2007, IUBMB LIFE, V59, P322, DOI 10.1080/15216540701242508; Modi G. B., 1997, The molecular biology of insect disease vectors: a methods manual., P21; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Munks RJL, 2005, INSECT MOL BIOL, V14, P483, DOI 10.1111/j.1365-2583.2005.00579.x; Myskova J, 2007, MICROBES INFECT, V9, P317, DOI 10.1016/j.micinf.2006.12.010; Costa CHN, 2008, CAD SAUDE PUBLICA, V24, P2959, DOI 10.1590/S0102-311X2008001200027; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Owusu-Ansah E., 2008, PROTOC EXCH, DOI [10.1038/nprot.2008.23, DOI 10.1038/NPROT.2008.23]; Pal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011271; Ramalho-Ortigao M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-300; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Sant'Anna MRV, 2008, INSECT BIOCHEM MOLEC, V38, P652, DOI 10.1016/j.ibmb.2008.03.012; Soares RPP, 2003, AN ACAD BRAS CIENC, V75, P301, DOI 10.1590/S0001-37652003000300005; Steenkamp DJ, 2002, ANTIOXID REDOX SIGN, V4, P105, DOI 10.1089/152308602753625906; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Volf P, 2011, J VECTOR ECOL, V36, pS1, DOI 10.1111/j.1948-7134.2011.00106.x; WHO, 2010, WHO TECH REP SER, V949, P1	48	65	70	1	41	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23995	24003		10.1074/jbc.M112.376095	http://dx.doi.org/10.1074/jbc.M112.376095			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22645126	Green Published, hybrid			2022-12-25	WOS:000306511300068
J	Chen, LJ; Liu, KW; Xiao, XJ; Tsai, WC; Hsiao, YY; Huang, J; Liu, ZJ				Chen, Li-Jun; Liu, Ke-Wei; Xiao, Xin-Ju; Tsai, Wen-Chieh; Hsiao, Yu-Yun; Huang, Jie; Liu, Zhong-Jian			The Anther Steps onto the Stigma for Self-Fertilization in a Slipper Orchid	PLOS ONE			English	Article							REPRODUCTIVE ASSURANCE; POLLINATION; EVOLUTION; SYSTEMS; PLANTS	Background: Due to the spatial separation between male and female pollen grains from the anther of most flowering plants, including orchids, pollens are transported by wind or animals and deposited onto the receptive surface of the stigma of a different plant. However, self-pollination is common in pollinating animal-scarce habitats. In such habitats, self-pollinations require the assistance of a pollinating agent (e.g., wind, gravity, or floral assembly) to transport the pollen grains from the anther onto its own stigma. Methodology/Principal Findings: Based on observations on floral morphology and flowering phenology, tests of the breeding system, and a comparison of pollination mechanisms, a new self-pollination process was discovered in the hermaphroditic (i.e., possessing spatially separated male and female organs) flower of a slipper orchid, Paphiopedilum parishii. The anther changes from a solid to a liquid state and directly steps onto the stigma surface without the aid of any pollinating agent or floral assembly. Conclusions: The mode of self-pollination discussed here is a new addition to the broad range of genetic and morphological mechanisms that have evolved in flowering plants to ensure their reproductive success. The present self-contained pollination mechanism is a possible adaptation to the insect-scarce habitat of the orchid.	[Chen, Li-Jun; Liu, Ke-Wei; Xiao, Xin-Ju; Huang, Jie; Liu, Zhong-Jian] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Chen, Li-Jun; Liu, Ke-Wei; Xiao, Xin-Ju; Huang, Jie; Liu, Zhong-Jian] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Liu, Ke-Wei; Liu, Zhong-Jian] Tsinghua Univ, Ctr Biotechnol & BioMed, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China; [Xiao, Xin-Ju] Beijing Forestry Univ, Continuing Educ Coll, Beijing, Peoples R China; [Tsai, Wen-Chieh] Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan 70101, Taiwan; [Tsai, Wen-Chieh] Natl Cheng Kung Univ, Orchid Res Ctr, Tainan 70101, Taiwan; [Hsiao, Yu-Yun] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Liu, Zhong-Jian] S China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Beijing Forestry University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; South China Agricultural University	Chen, LJ (corresponding author), Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China.	aju78@163.com; liuzj@sinicaorchid.org		Liu, Zhong-Jian/0000-0003-4390-3878	State Forestry Administration, People's Republic of China [2005-122]; Science and Technology Project of Shenzhen, China [SYF200646409, SY200704300157A]	State Forestry Administration, People's Republic of China; Science and Technology Project of Shenzhen, China	This work is supported by the State Forestry Administration, People's Republic of China (grant no. 2005-122), and the Science and Technology Project of Shenzhen, China (grant no. SYF200646409, SY200704300157A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON WR, 1980, SCIENCE, V207, P892, DOI 10.1126/science.207.4433.892; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Barrett SCH, 2002, HEREDITY, V88, P154, DOI 10.1038/sj/hdy/6800020; Catling P., 1990, ORCHID BIOL REV PERS, P121; Cribb PJ, 1998, GENUS PAPHIOPEDILUM; Darwin C, 1916, EFFECTS CROSS SELF F; Darwin CR., 1882, VARIOUS CONTRIVANCES, V2; DOLE JA, 1992, AM J BOT, V79, P650, DOI 10.2307/2444881; Fisher RA, 1941, ANN EUGENIC, V11, P53, DOI 10.1111/j.1469-1809.1941.tb02272.x; Gale S, 2007, PLANT SYST EVOL, V268, P59, DOI 10.1007/s00606-007-0570-x; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Holsinger KE, 2000, P NATL ACAD SCI USA, V97, P7037, DOI 10.1073/pnas.97.13.7037; Kalisz S, 2004, NATURE, V430, P884, DOI 10.1038/nature02776; Kalisz S, 2003, ECOLOGY, V84, P2928, DOI 10.1890/02-0519; Kalisz S, 1999, AM J BOT, V86, P1239, DOI 10.2307/2656771; Li QJ, 2001, NATURE, V410, P432, DOI 10.1038/35068635; Liu KW, 2006, NATURE, V441, P945, DOI 10.1038/441945a; Liu ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024864; [刘仲健 LIU ZhongJian], 2008, [生态学报, Acta Ecologica Sinica], V28, P2433; Liu ZJ, 2009, MIX BREEDING STRATEG; Liu ZJ, 2009, GENUS PAPHIOPEDILUM; LLOYD DG, 1992, INT J PLANT SCI, V153, P370, DOI 10.1086/297041; LORD EM, 1981, BOT REV, V47, P421, DOI 10.1007/BF02860538; Micheneau C, 2008, PLANT SYST EVOL, V272, P11, DOI 10.1007/s00606-007-0626-y; Peter CI, 2009, S AFR J BOT, V75, P791, DOI 10.1016/j.sajb.2009.07.007; PETER CI, 2009, THESIS U KWAZULUNATA; Richards A.J, 1997, PLANT BREEDING SYSTE; Schoen DJ, 1996, PHILOS T R SOC B, V351, P1281, DOI 10.1098/rstb.1996.0111; SCHOEN DJ, 1991, EVOLUTION, V45, P1651, DOI [10.1111/j.1558-5646.1991.tb02670.x, 10.2307/2409786]; Shi J, 2007, ACTA PHYTOTAXON SIN, V45, P551, DOI 10.1360/aps07025; Stebbins G. L., 1970, ANNU REV ECOL SYST, V1, P307, DOI DOI 10.1146/ANNUREV.ES.01.110170.001515; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Totland O, 2001, AM J BOT, V88, P1011, DOI 10.2307/2657082; van der Cingel N. A., 2001, ATLAS ORCHID POLLINA; van dersCingel N. A., 1995, ATLAS ORCHID POLLINA; Wang YQ, 2004, NATURE, V431, P39, DOI 10.1038/431039b; WYATT R, 1984, SYST BOT, V9, P432, DOI 10.2307/2418792; Xiao XJ, 2012, PLOS ONE, V7, P125, DOI 10.1371/journal.pone.0029718	39	8	9	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37478	10.1371/journal.pone.0037478	http://dx.doi.org/10.1371/journal.pone.0037478			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649529	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800047
J	Ferreira, SR; Machado, GR; Ferreira, VC; Rodrigues, CFMA; de Moraes, TP; Divino, JC; Olandoski, M; McIntyre, C; Pecoits, R				Ferreira-Filho, Sebastiao R.; Machado, Gilberto R.; Ferreira, Valeria C.; Rodrigues, Carlos F. M. A.; de Moraes, Thyago Proenca; Divino-Filho, Jose C.; Olandoski, Marcia; McIntyre, Christopher; Pecoits-Filho, Roberto		BRAZPD Study Investigators	Back to Basics: Pitting Edema and the Optimization of Hypertension Treatment in Incident Peritoneal Dialysis Patients (BRAZPD)	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; CARDIOVASCULAR-DISEASE; VOLUME; FLUID; LONG; THERAPY	Systemic arterial hypertension is an important risk factor for cardiovascular disease that is frequently observed in populations with declining renal function. Initiation of renal replacement therapy at least partially decreases signs of fluid overload; however, high blood pressure levels persist in the majority of patients after dialysis initiation. Hypervolemia due to water retention predisposes peritoneal dialysis (PD) patients to hypertension and can clinically manifest in several forms, including peripheral edema. The approaches to detect edema, which include methods such as bioimpedance, inferior vena cava diameter and biomarkers, are not always available to physicians worldwide. For clinical examinations, the presence of pitting located in the lower extremities and/or over the sacrum to diagnose the presence of peripheral edema in their patients are frequently utulized. We evaluated the impact of edema on the control of blood pressure of incident PD patients during the first year of dialysis treatment. Patients were recruited from 114 Brazilian dialysis centers that were participating in the BRAZPD study for a total of 1089 incident patients. Peripheral edema was diagnosed by the presence of pitting after finger pressure was applied to the edematous area. Patients were divided into 2 groups: those with and without edema according to the monthly medical evaluation. Blood arterial pressure, body mass index, the number of antihypertensive drugs and comorbidities were analyzed. We observed an initial BP reduction in the first five months and a stabilization of blood pressure levels from five to twelve months. The edematous group exhibited higher blood pressure levels than the group without edema during the follow-up. The results strongly indicate that the presence of a simple and easily detectable clinical sign of peripheral edema is a very relevant tool that could be used to re-evaluate not only the patient's clinical hypertensive status but also the PD prescription and patient compliance.	[Ferreira-Filho, Sebastiao R.; Machado, Gilberto R.; Ferreira, Valeria C.; Rodrigues, Carlos F. M. A.] Nefroclin Uberlandia, Uberlandia, MG, Brazil; [Ferreira-Filho, Sebastiao R.; Machado, Gilberto R.] Univ Fed Uberlandia, Uberlandia, MG, Brazil; [de Moraes, Thyago Proenca; Olandoski, Marcia; Pecoits-Filho, Roberto] Pontificia Univ Catolica Parana, Ctr Hlth & Biol Sci, Curitiba, Parana, Brazil; [Divino-Filho, Jose C.] Karolinska Inst, CLINTEC, Div Baxter Novum & Renal Med, Stockholm, Sweden; [McIntyre, Christopher] Univ Nottingham, Fac Med & Hlth Sci, Nottingham NG7 2RD, England	Universidade Federal de Uberlandia; Pontificia Universidade Catolica do Parana; Karolinska Institutet; University of Nottingham	Ferreira, SR (corresponding author), Nefroclin Uberlandia, Uberlandia, MG, Brazil.	sebahferreira@gmail.com	Ferreira-Filho, S R/G-2354-2012; McIntyre, Christopher W/O-8927-2014; de Moraes, Thyago Proenca/M-9400-2014; Pecoits-Filho, Roberto/K-7986-2013; Divino-Filho, Jose/V-5425-2019	Ferreira-Filho, S R/0000-0003-4176-9572; de Moraes, Thyago Proenca/0000-0002-2983-3968; Pecoits-Filho, Roberto/0000-0002-0255-6710; 	Baxter Healthcare	Baxter Healthcare	Baxter Healthcare sponsored this study. During the data collection and analysis, JCDF was employed by Baxter. RPF received a consulting fee and speaker honorarium from Baxter Healthcare. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ates K, 2001, KIDNEY INT, V60, P767, DOI 10.1046/j.1523-1755.2001.060002767.x; Barri YM, 2008, CURR HYPERTENS REP, V10, P39, DOI 10.1007/s11906-008-0009-y; Basile J, 2009, J CLIN HYPERTENSION, P11; Cocchi R, 1999, NEPHROL DIAL TRANSPL, V14, P1536, DOI 10.1093/ndt/14.6.1536; Fernandes N, 2008, KIDNEY INT, V73, pS145, DOI 10.1038/sj.ki.5002616; Fishbane S, 1996, AM J KIDNEY DIS, V28, P257, DOI 10.1016/S0272-6386(96)90309-1; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Gunal AI, 2001, AM J KIDNEY DIS, V37, P588, DOI 10.1053/ajkd.2001.22085; Katzarski KS, 1999, NEPHROL DIAL TRANSPL, V14, P369, DOI 10.1093/ndt/14.2.369; Lameire N, 1993, Perit Dial Int, V13 Suppl 2, pS394; Lang SM, 1999, PERITON DIALYSIS INT, V19, P143; LEUNISSEN KML, 1993, KIDNEY INT, V43, pS50; Levey AS, 1998, AM J KIDNEY DIS, V32, P853, DOI 10.1016/S0272-6386(98)70145-3; Lynn KL, 2002, KIDNEY INT, V62, P2281, DOI 10.1046/j.1523-1755.2002.00685.x; Mailloux LU, 1998, AM J KIDNEY DIS, V32, P705, DOI 10.1016/S0272-6386(98)70146-5; Menon MK, 2001, NEPHROL DIAL TRANSPL, V16, P2207, DOI 10.1093/ndt/16.11.2207; Rahman M, 1999, AM J KIDNEY DIS, V33, P498, DOI 10.1016/S0272-6386(99)70187-3; SALDANHA LF, 1993, AM J KIDNEY DIS, V21, P184, DOI 10.1016/S0272-6386(12)81091-2; SLINGENEYER A, 1983, NEPHRON, V33, P133, DOI 10.1159/000182927; Tang W, 2009, AM J NEPHROL, V30, P120, DOI 10.1159/000206697; TZAMALOUKAS AH, 1995, J AM SOC NEPHROL, V6, P198; Van Biesen W, 2008, PERITON DIALYSIS INT, V28, P596; van Dijk PCW, 2001, NEPHROL DIAL TRANSPL, V16, P1120, DOI 10.1093/ndt/16.6.1120	23	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36758	10.1371/journal.pone.0036758	http://dx.doi.org/10.1371/journal.pone.0036758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649498	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800015
J	Calderone, NW				Calderone, Nicholas W.			Insect Pollinated Crops, Insect Pollinators and US Agriculture: Trend Analysis of Aggregate Data for the Period 1992-2009	PLOS ONE			English	Article							FACTOR SURVEILLANCE SYSTEM; ALFALFA LEAFCUTTING BEE; HONEY-BEES; APIS-MELLIFERA; ECONOMIC VALUE; UNITED-STATES; VEGETABLE CONSUMPTION; MEGACHILE-ROTUNDATA; FLOWERING PLANTS; NATIVE BEES	In the US, the cultivated area (hectares) and production (tonnes) of crops that require or benefit from insect pollination (directly dependent crops: apples, almonds, blueberries, cucurbits, etc.) increased from 1992, the first year in this study, through 1999 and continued near those levels through 2009; aggregate yield (tonnes/hectare) remained unchanged. The value of directly dependent crops attributed to all insect pollination (2009 USD) decreased from $14.29 billion in 1996, the first year for value data in this study, to $10.69 billion in 2001, but increased thereafter, reaching $15.12 billion by 2009. The values attributed to honey bees and non-Apis pollinators followed similar patterns, reaching $11.68 billion and $3.44 billion, respectively, by 2009. The cultivated area of crops grown from seeds resulting from insect pollination (indirectly dependent crops: legume hays, carrots, onions, etc.) was stable from 1992 through 1999, but has since declined. Production of those crops also declined, albeit not as rapidly as the decline in cultivated area; this asymmetry was due to increases in aggregate yield. The value of indirectly dependent crops attributed to insect pollination declined from $15.45 billion in 1996 to $12.00 billion in 2004, but has since trended upward. The value of indirectly dependent crops attributed to honey bees and non-Apis pollinators, exclusive of alfalfa leafcutter bees, has declined since 1996 to $5.39 billion and $1.15 billion, respectively in 2009. The value of alfalfa hay attributed to alfalfa leafcutter bees ranged between $4.99 and $7.04 billion. Trend analysis demonstrates that US producers have a continued and significant need for insect pollinators and that a diminution in managed or wild pollinator populations could seriously threaten the continued production of insect pollinated crops and crops grown from seeds resulting from insect pollination.	Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	Cornell University	Calderone, NW (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	nwc4@cornell.edu			National Honey Board	National Honey Board	This project was funded in part by a grant from the National Honey Board to NWC. No additional external funding was received or used for this study. The author was obligated to publish the results of the study. The funders had no role in study design, data collection and analysis, decision where to publish or preparation of the manuscript.	Adams JW, 2006, SR0628 ERDCCERL; Adams JW, 2004, SR0424ADA432205 ERDC, VI; Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Allsopp MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003128; American Bee Journal, 1987, American Bee Journal, V127, P745; Batra S.W.T., 1978, MARYLAND AGR EXPT ST, V1, P307; Bauer D. M., 2010, Agricultural and Resource Economics Review, V39, P368; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blanck Heidi Michels, 2008, Prev Chronic Dis, V5, pA35; Bosch J, 1999, BEE WORLD, V80, P163, DOI 10.1080/0005772X.1999.11099452; Bosch J, 2000, ENVIRON ENTOMOL, V29, P8, DOI 10.1603/0046-225X-29.1.8; Bosch J, 2002, B ENTOMOL RES, V92, P3, DOI 10.1079/BER2001139; Brooks N., 2009, J FOOD DISTRIBUTION, V40, P39; Brosi BJ, 2008, J APPL ECOL, V45, P773, DOI 10.1111/j.1365-2664.2007.01412.x; Buchmann SL, 1996, FORGOTTEN POLLINATOR; Burgett M, 2004, AM BEE J, V144, P269; Burgett M, 2009, NATL HONEY REPORT, V29, P10; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Canestri J, 2001, CHALLENGES OF PSYCHOANALYSIS IN THE 21ST CENTURY, P1; Caron D, 2010, E BEEKEEPER POLLINAT; Caron D, 2010, BEE COLONY POLLINATI; Carvalheiro LG, 2010, J APPL ECOL, V47, P810, DOI 10.1111/j.1365-2664.2010.01829.x; Champetier A, 2010, BIOECONOMICS HONEY B; Chen Chi-Tung, 1996, Zhonghua Kunchong, V16, P167; Collins GS, 1982, P INT C PLANT VEG OI; Committee on the Status of Pollinators in North America, 2007, STAT POLL N AM; CORBET SA, 1993, ECOL ENTOMOL, V18, P17, DOI 10.1111/j.1365-2311.1993.tb01075.x; Daberkow S, 2009, J ECON ENTOMOL, V102, P868, DOI 10.1603/029.102.0304; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; DELFINADOBAKER M, 1984, AM BEE J, V124, P805; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dimou M, 2008, J APICULT RES, V47, P99, DOI 10.1080/00218839.2008.11101433; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi Lucas A., 2009, Communicative & Integrative Biology, V2, P37; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P652, DOI 10.1016/j.tree.2005.09.006; Greenleaf SS, 2006, BIOL CONSERV, V133, P81, DOI 10.1016/j.biocon.2006.05.025; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Grimaldi David, 2005, pi; Gunstone FD, 2011, EUR J LIPID SCI TECH, V113, P3, DOI 10.1002/ejlt.201000104; Hendrickson MK, 2008, J AGR ENVIRON ETHIC, V21, P311, DOI 10.1007/s10806-008-9092-y; Ingram M., 1996, TROPINET, V7, P1; Javorek SK, 2002, ANN ENTOMOL SOC AM, V95, P345, DOI 10.1603/0013-8746(2002)095[0345:CPEABH]2.0.CO;2; Kasina JM, 2009, J ECON ENTOMOL, V102, P467, DOI 10.1603/029.102.0201; Kearns CA, 1997, BIOSCIENCE, V47, P297, DOI 10.2307/1313191; Kevan Peter G., 2003, Biodiversity (Ottawa), V4, P3; Kevan PG, 2001, CONSERV ECOL, V5; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kluser S., 2007, GLOBAL POLLINATOR DE; Kralova I, 2010, J DISPER SCI TECHNOL, V31, P409, DOI 10.1080/01932690903119674; Kremen C, 2004, ECOL LETT, V7, P1109, DOI 10.1111/j.1461-0248.2004.00662.x; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kremen C, 2000, CONSERV BIOL, V14, P1226, DOI 10.1046/j.1523-1739.2000.00013.x; Kremen C, INSECTS PROVIDERS EC, P349; Kwon YJ, 2003, APPL ENTOMOL ZOOL, V38, P275, DOI 10.1303/aez.2003.275; Levin M. D., 1983, Bulletin of the Entomological Society of America, V29, P50; Li Ji-Lian, 2006, Acta Entomologica Sinica, V49, P342; Li RW, 2000, AM J PUBLIC HEALTH, V90, P777, DOI 10.2105/AJPH.90.5.777; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; MACKENZIE KE, 1994, APIDOLOGIE, V25, P375, DOI 10.1051/apido:19940404; Matsumoto S, 2009, SCI HORTIC-AMSTERDAM, V121, P73, DOI 10.1016/j.scienta.2009.01.003; Mattson JW, 2005, CHARACTERISTICS DECL; Mburu J, 2006, 12 ANN BIOECON C WEA; McGregor S.E., 1976, AGR HDB, V496; Metcalf CL., 1962, DESTRUCTIVE USEFUL I; Michener CD, 2007, BEES WORLD; Muth M. K., 1995, Choices. The Magazine of Food, Farm, and Resources Issues, P19; NASS, 2011, HON HNY 1 2 11; NASS, 2011, VEG; NASS, 1999, STAT B USDA; NASS, 2004, 2002 CENS AGR AC 02; NASS, 2009, STAT B USDA; NASS, 2008, STAT B USDA; NASS, 2009, LAND VAL CASH RENTS; NASS, 1999, STAT B USDA; NASS, 2008, STAT B USDA A; NASS, 2010, HON HNY 1 2 10; NASS, 2001, AGR LAND VAL SP SY 3; NASS, 2009, FARMS LAND FARMS LIV; NASS, 2011, CROP PROD 2010 SUMM; NASS, 2008, LAND VAL CASH RENTS; NASS, 2008, STAT B USDA; NASS, 2007, LAND VAL CASH RENTS; NASS, 2010, TABLE003 XLS US TOT; NASS, 2005, LAND VAL CASH RENTS; NASS, 2003, AGR LAND VAL CASH RE; NASS, 2011, NONC FRUITS NUTS 201; NASS, 2011, CROP PROD; NASS, 1999, AGR LAND VAL SP SY 3; NASS, 2011, LAND VAL 2011 SUMM; NASS, 2004, STAT B USDA A; NASS, 2004, LAND VAL CASH RENTS; NASS, 2004, VEG FIN EST 1997 200; NASS, 2002, AGR LAND VAL SP SY 3; NASS, 2010, CITR FRUITS 2010 SUM; NASS, 2009, HON HNY 1 2 09; NASS, 1995, FARMS LAND FARMS FIN; NASS, 1997, AGR LAND VAL AGR CAS; NASS, 1999, STAT B USDA; NASS, 1998, STAT B USDA A; NASS, 1999, STAT B USDA; NASS, 2009, STAT B USDA; NASS, 2004, STAT B USDA A; NASS, 2011, CROP VAL 2010 SUMM; NASS, 2000, AGR LAND VAL SP SY 3; NASS, 2009, 2007 CENS AGR AC 07; NASS, 2006, LAND VAL CASH RENTS; NASS, 2010, LAND VAL CASH RENTS; NASS, 1995, STAT B USDA; NASS, 2004, STAT B USDA; NASS, 2011, VEG 2010 SUMM; NASS, 2006, FARMS LAND FARMS LIV; NASS, 1998, AGR LAND VAL; NASS, 1998, STAT B USDA A; NASS, 1999, STAT B USDA C; NASS, 2008, STAT B USDA; NASS, 2004, STAT B USDA; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Nzaku K., 2010, Journal of Agribusiness, V28, P163; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Olschewski R, 2006, ECOL SOC, V11; Packer L, 2001, CONSERV ECOL, V5; Palumbo A. D., 1996, Colture Protette, V25, P61; Pitts-Singer TL, 2011, ANNU REV ENTOMOL, V56, P221, DOI 10.1146/annurev-ento-120709-144836; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pritts M. P., 1999, HortTechnology, V9, P13; Rader R, 2009, J APPL ECOL, V46, P1080, DOI 10.1111/j.1365-2664.2009.01700.x; Raghavan V., 2000, DEV BIOL FLOWERING P; RICHARDS KW, 1993, REV SUISSE ZOOL, V100, P807, DOI 10.5962/bhl.part.79885; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; ROBINSON WS, 1989, AM BEE J, V129, P411; ROBINSON WS, 1989, AM BEE J, V129, P477; Sekita N., 1996, Bulletin of the Aomori Apple Experiment Station, P17; Serdula MK, 2004, AM J PUBLIC HEALTH, V94, P1014, DOI 10.2105/AJPH.94.6.1014; Serdula MK, 1996, EPIDEMIOLOGY, V7, P161, DOI 10.1097/00001648-199603000-00010; SHEPPARD WS, 1989, AM BEE J, V129, P664; SHEPPARD WS, 1989, AM BEE J, V129, P617; SOUTHWICK EE, 1992, J ECON ENTOMOL, V85, P621, DOI 10.1093/jee/85.3.621; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Stephen WP, 1981, STATION B OREGON STA, V653, P10; Stokstad E, 2007, SCIENCE, V316, P970, DOI 10.1126/science.316.5827.970; Stout JC, 2009, APIDOLOGIE, V40, P388, DOI 10.1051/apido/2009023; Stubbs CS, 1997, J KANSAS ENTOMOL SOC, V70, P81; Stubbs CS, 2001, J ECON ENTOMOL, V94, P609, DOI 10.1603/0022-0493-94.3.609; Stubbs CS, 1997, ACTA HORTIC, P189, DOI 10.17660/ActaHortic.1997.446.28; Sumner D, 2006, BEE CONOMICS LEAP PO; Tax, 1960, EVOLUTION DARWIN, P227; Thompson W, 2010, BIOMASS BIOENERG, V34, P883, DOI 10.1016/j.biombioe.2010.01.033; Tuell JK, 2010, J ECON ENTOMOL, V103, P668, DOI 10.1603/EC09314; U.S. Department of Labor BOLS, 2011, CONS PRIC IND; Underwood R., 2007, BEE CULTURE, V35, P13; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Ware G, 1973, BEES AGR THEIR PROBL; Winfree R, 2008, J APPL ECOL, V45, P793, DOI 10.1111/j.1365-2664.2007.01418.x; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Zayed A, 2004, P ROY SOC B-BIOL SCI, V271, pS9, DOI 10.1098/rsbl.2003.0109; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102	164	341	353	8	306	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37235	10.1371/journal.pone.0037235	http://dx.doi.org/10.1371/journal.pone.0037235			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629374	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300028
J	Galuardi, B; Lutcavage, M				Galuardi, Benjamin; Lutcavage, Molly			Dispersal Routes and Habitat Utilization of Juvenile Atlantic Bluefin Tuna, Thunnus thynnus, Tracked with Mini PSAT and Archival Tags	PLOS ONE			English	Article							DEPENDENT ENERGY ALLOCATION; SEA-SURFACE-TEMPERATURE; VERTICAL MOVEMENTS; NORTHEASTERN PACIFIC; POPULATION-STRUCTURE; DIVING BEHAVIOR; NORTH-ATLANTIC; FISH; ORIENTALIS; EASTERN	Between 2005 and 2009, we deployed 58 miniature pop-up satellite archival tags (PSAT) and 132 implanted archival tags on juvenile Atlantic bluefin tuna (age 2-5) in the northwest Atlantic Ocean. Data returned from these efforts (n = 26 PSATs, 1 archival tag) revealed their dispersal routes, horizontal and vertical movements and habitat utilization. All of the tagged bluefin tuna remained in the northwest Atlantic for the duration observed, and in summer months exhibited core-use of coastal seas extending from Maryland to Cape Cod, MA, (USA) out to the shelf break. Their winter distributions were more spatially disaggregated, ranging south to the South Atlantic Bight, northern Bahamas and Gulf Stream. Vertical habitat patterns showed that juvenile bluefin tuna mainly occupied shallow depths (mean = 5-12 m, sd = 15-23.7 m) and relatively warm water masses in summer (mean = 17.9-20.9 degrees C, sd = 4.2-2.6 degrees C) and had deeper and more variable depth patterns in winter (mean = 41-58 m, sd = 48.9-62.2 m). Our tagging results reveal annual dispersal patterns, behavior and oceanographic associations of juvenile Atlantic bluefin tuna that were only surmised in earlier studies. Fishery independent profiling from electronic tagging also provide spatially and temporally explicit information for evaluating dispersals rates, population structure and fisheries catch patterns.	[Galuardi, Benjamin; Lutcavage, Molly] Univ Massachusetts Amherst, Large Pelag Res Ctr, Gloucester, MA USA	University of Massachusetts System; University of Massachusetts Amherst	Galuardi, B (corresponding author), Univ Massachusetts Amherst, Large Pelag Res Ctr, Gloucester, MA USA.	galuardi@eco.umass.edu			National Oceanic and Atmospheric Administration [NA04NMF4550391]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This study was funded by a National Oceanic and Atmospheric Administration Grant # NA04NMF4550391 to M. Lutcavage (www.noaa.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrizabalaga H, 2008, FISH OCEANOGR, V17, P74, DOI 10.1111/j.1365-2419.2008.00464.x; AUER SJ, 1987, J GEOPHYS RES-OCEANS, V92, P11709, DOI 10.1029/JC092iC11p11709; Bestley S, 2008, J ANIM ECOL, V77, P1223, DOI 10.1111/j.1365-2656.2008.01437.x; Block BA, 1998, MAR TECHNOL SOC J, V32, P37; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Brill R, 2002, FISH B-NOAA, V100, P155; Brill RW, 2001, AM FISH S S, V25, P179; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; CAREY FG, 1983, COMP BIOCHEM PHYS A, V74, P333, DOI 10.1016/0300-9629(83)90612-6; CAREY FG, 1971, AM ZOOL, V11, P137; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Chapman EW, 2011, CAN J FISH AQUAT SCI, V68, P1934, DOI 10.1139/F2011-109; Churnside JH, 1998, 287 NOAA ERLETL, P71; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Dickhut RM, 2009, ENVIRON SCI TECHNOL, V43, P8522, DOI 10.1021/es901810e; Domeier ML, 2005, FISH B-NOAA, V103, P292; EGGLESTON DB, 1990, FISH B-NOAA, V88, P389; Estrada JA, 2005, MAR BIOL, V147, P37, DOI 10.1007/s00227-004-1541-1; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Fudge DS, 1998, AM J PHYSIOL, V275; Fudge DS, 1996, GUELPH ICHTHYOLOGY R, V4; Galuardi B, 2010, ANALYZEPSAT; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Goethel DR, 2011, REV FISH SCI, V19, P119, DOI 10.1080/10641262.2011.557451; Gunn JS, 1994, P ICES MIN FISH MIGR, V2-4; Hoolihan JP, 2007, ICES J MAR SCI, V64, P1791, DOI 10.1093/icesjms/fsm148; ICCAT, 2009, ICCAT MAN; ICCAT, 2010, 2010 ATL BLUEF TUN S, P1; Itoh T, 2003, FISH B-NOAA, V101, P514; Jorgensen C, 2006, CAN J FISH AQUAT SCI, V63, P186, DOI 10.1139/F05-209; Juan-Jorda MJ, 2011, P NATL ACAD SCI USA, V108, P20650, DOI 10.1073/pnas.1107743108; Kishino H, 1994, B JAPANESE SOC FISHE, V58; Kitagawa T, 2000, MAR ECOL PROG SER, V206, P251, DOI 10.3354/meps206251; Kitagawa T, 2004, FISH OCEANOGR, V13, P161, DOI 10.1111/j.1365-2419.2004.00282.x; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Lam CH, 2010, MAR ECOL PROG SER, V419, P71, DOI 10.3354/meps08862; Lawson GL, 2010, MAR ECOL PROG SER, V400, P245, DOI 10.3354/meps08394; Logan JM, 2011, MAR BIOL, V158, P73, DOI 10.1007/s00227-010-1543-0; Luo JG, 2006, FISH OCEANOGR, V15, P208, DOI 10.1111/j.1365-2419.2006.00360.x; LUTCAVAGE M, 1995, FISH B-NOAA, V93, P495; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Mather F.J., 1995, NOAA TECHNICAL MEMOR, V370, P1; MEYER TL, 1979, FISH B-NOAA, V77, P243; Musyl MK, 2003, FISH OCEANOGR, V12, P152, DOI 10.1046/j.1365-2419.2003.00229.x; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Nielsen A, 2009, STATE SPACE MODEL LI; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; Porch Clay, 1998, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V50, P591; Porch Clay E., 2001, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V52, P1022; Restrepo VR, 2010, COL VOL SCI PAP ICCA, V160, P1; Roffer MA, 1987, INFLUENCE ENV APPARE; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Royer F, 2009, REV-METHODS TECHNOL, V9, P323, DOI 10.1007/978-1-4020-9640-2_20; Schaefer KM, 2002, FISH B-NOAA, V100, P765; Schaefer KM, 2007, MAR BIOL, V152, P503, DOI 10.1007/s00227-007-0689-x; Schaefer KM, 2011, FISH RES, V112, P22, DOI 10.1016/j.fishres.2011.08.006; Sibert JR, 1999, CAN J FISH AQUAT SCI, V56, P925, DOI 10.1139/cjfas-56-6-925; STEVENS ED, 1984, AM J PHYSIOL, V246, pR487, DOI 10.1152/ajpregu.1984.246.4.R487; Sulikowski JA, 2010, MAR ECOL PROG SER, V418, P249, DOI 10.3354/meps08821; Tiews K, 1963, FAO FISH REP, V6, P422; Tiews K, 1963, INT COUNC EXPLOR SEA, V19, P183; Tolentino R, 2009, DEPL DAT REP CLOS LO; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; Wilson PC, 1967, INVENTORY US EXPLORA; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Wilson Steven G., 2010, Endangered Species Research, V10, P355; Yamashita Hideyuki, 2001, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V52, P809	69	68	68	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37829	10.1371/journal.pone.0037829	http://dx.doi.org/10.1371/journal.pone.0037829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629461	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300079
J	Karimi-Abdolrezaee, S; Schut, D; Wang, J; Fehlings, MG				Karimi-Abdolrezaee, Soheila; Schut, Desiree; Wang, Jian; Fehlings, Michael G.			Chondroitinase and Growth Factors Enhance Activation and Oligodendrocyte Differentiation of Endogenous Neural Precursor Cells after Spinal Cord Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM/PROGENITOR CELLS; FUNCTIONAL RECOVERY; IN-VIVO; STEM-CELLS; ADULT-RAT; INHIBITORY MOLECULES; NG2-POSITIVE CELLS; GENE-EXPRESSION; CNS INJURY	The adult spinal cord harbours a population of multipotent neural precursor cells (NPCs) with the ability to replace oligodendrocytes. However, despite this capacity, proliferation and endogenous remyelination is severely limited after spinal cord injury (SCI). In the post-traumatic microenvironment following SCI, endogenous spinal NPCs mainly differentiate into astrocytes which could contribute to astrogliosis that exacerbate the outcomes of SCI. These findings emphasize a key role for the post-SCI niche in modulating the behaviour of spinal NPCs after SCI. We recently reported that chondroitin sulphate proteoglycans (CSPGs) in the glial scar restrict the outcomes of NPC transplantation in SCI by reducing the survival, migration and integration of engrafted NPCs within the injured spinal cord. These inhibitory effects were attenuated by administration of chondroitinase (ChABC) prior to NPC transplantation. Here, in a rat model of compressive SCI, we show that perturbing CSPGs by ChABC in combination with sustained infusion of growth factors (EGF, bFGF and PDGF-AA) optimize the activation and oligodendroglial differentiation of spinal NPCs after injury. Four days following SCI, we intrathecally delivered ChABC and/or GFs for seven days. We performed BrdU incorporation to label proliferating cells during the treatment period after SCI. This strategy increased the proliferation of spinal NPCs, reduced the generation of new astrocytes and promoted their differentiation along an oligodendroglial lineage, a prerequisite for remyelination. Furthermore, ChABC and GF treatments enhanced the response of non-neural cells by increasing the generation of new vascular endothelial cells and decreasing the number of proliferating macrophages/microglia after SCI. In conclusions, our data strongly suggest that optimization of the behaviour of endogenous spinal NPCs after SCI is critical not only to promote endogenous oligodendrocyte replacement, but also to reverse the otherwise detrimental effects of their activation into astrocytes which could negatively influence the repair process after SCI.	[Karimi-Abdolrezaee, Soheila] Univ Manitoba, Regenerat Med Program, Winnipeg, MB, Canada; [Karimi-Abdolrezaee, Soheila] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Schut, Desiree; Wang, Jian; Fehlings, Michael G.] Toronto Western Res Inst, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Neurosci Program, Toronto, ON, Canada	University of Manitoba; University of Manitoba; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Karimi-Abdolrezaee, S (corresponding author), Univ Manitoba, Regenerat Med Program, Winnipeg, MB, Canada.	karimis@cc.umanitoba.ca		Fehlings, Michael/0000-0002-5722-6364; Karimi-Abdolrezaee, Soheila/0000-0002-0683-2663	Craig H. Neilsen (CHN) Foundation [56927]; Manitoba Health Research Council (MHRC); Krembil Chair in Neural Repair and Regeneration	Craig H. Neilsen (CHN) Foundation; Manitoba Health Research Council (MHRC); Krembil Chair in Neural Repair and Regeneration	This work was supported by grants from the Craig H. Neilsen (CHN) Foundation to SKA and MGF (#56927) and the Manitoba Health Research Council (MHRC) to SKA (http://www.mhrc.mb.ca), and the Krembil Chair in Neural Repair and Regeneration to MGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Butt AM, 1997, J NEUROSCI RES, V48, P588; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Eftekharpour E, 2007, J NEUROSCI, V27, P3416, DOI 10.1523/JNEUROSCI.0273-07.2007; Eftekharpour E, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E18; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; FEHLINGS MG, 1989, ELECTROEN CLIN NEURO, V74, P241, DOI 10.1016/0168-5597(89)90055-5; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Fitch MT, 2007, EXP NEUROL; Frost EE, 2003, J NEUROBIOL, V54, P457, DOI 10.1002/neu.10158; FRYER HJL, 1992, J BIOL CHEM, V267, P9874; Gris P, 2007, GLIA, V55, P1145, DOI 10.1002/glia.20537; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Horky LL, 2006, J COMP NEUROL, V498, P525, DOI 10.1002/cne.21065; Horner PJ, 2000, J NEUROSCI, V20, P2218; Ito Y, 2005, GLYCOBIOLOGY, V15, P593, DOI 10.1093/glycob/cwi036; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; Kojima A, 2000, J NEUROPATH EXP NEUR, V59, P687, DOI 10.1093/jnen/59.8.687; Kojima A, 2002, J NEUROTRAUM, V19, P223, DOI 10.1089/08977150252806974; Lachapelle F, 2002, MOL CELL NEUROSCI, V20, P390, DOI 10.1006/mcne.2002.1124; Lundquist A, 2003, BLOOD, V101, P4070, DOI 10.1182/blood-2002-07-1994; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Mothe AJ, 2005, J HISTOCHEM CYTOCHEM, V53, P1215, DOI 10.1369/jhc.5A6639.2005; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219; Nashmi R, 2001, NEUROSCIENCE, V104, P235, DOI 10.1016/S0306-4522(01)00009-4; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; Nashmi R, 2001, MODULATOR; Ohori Y, 2006, J NEUROSCI, V26, P11948, DOI 10.1523/JNEUROSCI.3127-06.2006; Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Rolls A, 2008, PLOS MED, V5, P1262, DOI 10.1371/journal.pmed.0050171; SILVER J, 1994, J NEUROL, V242, pS22, DOI 10.1007/BF00939236; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sirko S, 2010, METHOD ENZYMOL, V479, P37, DOI 10.1016/S0076-6879(10)79003-0; Smith MB, 2002, AM J BOT, V89, P417, DOI 10.3732/ajb.89.3.417; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Weiss S, 1996, J NEUROSCI, V16, P7599; Zai LJ, 2005, GLIA, V50, P247, DOI 10.1002/glia.20176	55	85	89	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37589	10.1371/journal.pone.0037589	http://dx.doi.org/10.1371/journal.pone.0037589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629425	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345300056
J	Song, J; Lays, C; Vandenesch, F; Benito, Y; Bes, M; Chu, YL; Lina, G; Romby, P; Geissmann, T; Boisset, S				Song, Juan; Lays, Claire; Vandenesch, Francois; Benito, Yvonne; Bes, Michele; Chu, Yonglie; Lina, Gerard; Romby, Pascale; Geissmann, Thomas; Boisset, Sandrine			The Expression of Small Regulatory RNAs in Clinical Samples Reflects the Different Life Styles of Staphylococcus aureus in Colonization vs. Infection	PLOS ONE			English	Article							VIRULENCE FACTORS; GENE-EXPRESSION; NONCODING RNAS; AGR FUNCTION; IN-VITRO; RNAIII; BACTERIA; ROT; TRANSLATION; REVEALS	Small RNAs (sRNAs) are involved in the post-transcriptional regulation of metabolic pathways and in responses to stress and virulence. We analyzed the expression levels of five sRNAs of Staphylococcus aureus during human colonization or infection. Total RNA was isolated from nasal carriers, abscesses and cystic fibrosis patients (20 subjects per condition). The expression levels of the sRNAs were measured in the clinical samples and compared with those of the corresponding strains grown in vitro. Five sRNAs were encoded and expressed in all clinical strains in vitro. In vivo, the global expression of the five sRNAs was extremely variable in the abscessed patients, more homogeneous in the cystic fibrosis patients, and highly uniform in the nasal carrier samples. The expression levels of the sRNAs in vivo resembled those obtained at exponential phase or late exponential phase of growth in vitro, for three and one sRNA respectively; while for one sRNA, the expression was always higher in vivo as compared to in vitro growth. The in vitro conditions do not uniformly mimic the in vivo conditions for sRNA expression. Nasal colonization is associated with a unique expression pattern of sRNA that might reflect the commensalism of S. aureus in this niche.	[Song, Juan; Chu, Yonglie] Xi An Jiao Tong Univ, Dept Immunol & Pathogen Biol, Sch Med, Xian 710049, Shaanxi Provinc, Peoples R China; [Song, Juan; Lays, Claire; Vandenesch, Francois; Lina, Gerard; Geissmann, Thomas; Boisset, Sandrine] Univ Lyon 1, F-69365 Lyon, France; [Song, Juan; Lays, Claire; Vandenesch, Francois; Benito, Yvonne; Bes, Michele; Lina, Gerard; Geissmann, Thomas; Boisset, Sandrine] INSERM, U851, F-69008 Lyon, France; [Vandenesch, Francois; Benito, Yvonne; Bes, Michele; Lina, Gerard; Boisset, Sandrine] Hosp Civils Lyon, Ctr Natl Reference Staphylocoques, Bron, France; [Romby, Pascale] Univ Strasbourg, CNRS UPR 9002, IBMC, Strasbourg, France	Xi'an Jiaotong University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Song, J (corresponding author), Xi An Jiao Tong Univ, Dept Immunol & Pathogen Biol, Sch Med, Xian 710049, Shaanxi Provinc, Peoples R China.	sandrine.boisset@univ-lyon1.fr	Vandenesch, Francois/C-7209-2014; ROMBY, Pascale/AGP-3328-2022; Boisset, Sandrine SB/D-8144-2014; Geissmann, Thomas/L-9432-2014; Lina, Gerard J/L-9352-2014	Vandenesch, Francois/0000-0001-9412-7106; Boisset, Sandrine SB/0000-0001-8717-8749; Geissmann, Thomas/0000-0001-5734-5489; LAYS, Claire/0000-0002-8844-2748; Lina, Gerard/0000-0002-9236-7998	China Scholarship Council (CSC); 'Fondation pour la Recherche Medicale' (FRM); 'Institut National pour la Recherche Medicale' (INSERM); 'Centre National de la Recherche Scientifique' (CNRS); 'Agence Nationale pour la Recherche' [ANR09-BLAN-0024-01, ANR10-Pathogenomics-ARMSA]; European Community (CONCORD) [FP7-EC222718]	China Scholarship Council (CSC)(China Scholarship Council); 'Fondation pour la Recherche Medicale' (FRM)(Fondation pour la Recherche Medicale); 'Institut National pour la Recherche Medicale' (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); 'Centre National de la Recherche Scientifique' (CNRS)(Centre National de la Recherche Scientifique (CNRS)); 'Agence Nationale pour la Recherche'(French National Research Agency (ANR)); European Community (CONCORD)	JS was supported by a generous grant from the China Scholarship Council (CSC) and from the 'Fondation pour la Recherche Medicale' (FRM). This work was supported by the 'Institut National pour la Recherche Medicale' (INSERM; FV & TG), the 'Centre National de la Recherche Scientifique' (CNRS; PR), the 'Agence Nationale pour la Recherche' (ANR09-BLAN-0024-01; ANR10-Pathogenomics-ARMSA; PR, FV & SB) and the European Community (CONCORD, FP7-EC222718; TG & GL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qatouseh LF, 2010, J MOL MED, V88, P565, DOI 10.1007/s00109-010-0597-2; Beaume M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010725; Bohn C, 2010, NUCLEIC ACIDS RES, V38, P6620, DOI 10.1093/nar/gkq462; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Burian M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010040; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Dumitrescu O, 2011, ANTIMICROB AGENTS CH, V55, P3261, DOI 10.1128/AAC.01401-10; Felden B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002006; French Society for Microbiology, 2011, REC COM ANT MIRCR; Geisinger E, 2006, MOL MICROBIOL, V61, P1038, DOI 10.1111/j.1365-2958.2006.05292.x; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Goerke C, 2000, INFECT IMMUN, V68, P1304, DOI 10.1128/IAI.68.3.1304-1311.2000; Goerke C, 2010, INT J MED MICROBIOL, V300, P520, DOI 10.1016/j.ijmm.2010.08.003; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lamers RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016426; Liu JM, 2010, CURR OPIN MICROBIOL, V13, P18, DOI 10.1016/j.mib.2009.11.004; Loughman JA, 2009, J INFECT DIS, V199, P294, DOI 10.1086/595982; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marchais A, 2009, GENOME RES, V19, P1084, DOI 10.1101/gr.089714.108; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1989, CELL, V59, P395, DOI 10.1016/0092-8674(89)90300-0; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Repoila F, 2009, BIOL CELL, V101, P117, DOI 10.1042/BC20070137; Robert J, 2011, ANTIMICROB AGENTS CH, V55, P1734, DOI 10.1128/AAC.01221-10; Romby P, 2010, CELL MOL LIFE SCI, V67, P217, DOI 10.1007/s00018-009-0162-8; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wyatt MA, 2010, SCIENCE, V329, P294, DOI 10.1126/science.1188888	40	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37294	10.1371/journal.pone.0037294	http://dx.doi.org/10.1371/journal.pone.0037294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629378	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345300031
J	Gerber, MM; Hampel, H; Schulz, NP; Fernandez, S; Wei, L; Zhou, XP; de la Chapelle, A; Toland, AE				Gerber, Madelyn M.; Hampel, Heather; Schulz, Nathan P.; Fernandez, Soledad; Wei, Lai; Zhou, Xiao-Ping; de la Chapelle, Albert; Toland, Amanda Ewart			Evaluation of Allele-Specific Somatic Changes of Genome-Wide Association Study Susceptibility Alleles in Human Colorectal Cancers	PLOS ONE			English	Article							LYNCH-SYNDROME; SNP RS6983267; RISK LOCUS; 8Q24; CARCINOMAS; IMBALANCE; SCAN; METAANALYSIS; METHYLATION; MUTATIONS	Background: Tumors frequently exhibit loss of tumor suppressor genes or allelic gains of activated oncogenes. A significant proportion of cancer susceptibility loci in the mouse show somatic losses or gains consistent with the presence of a tumor susceptibility or resistance allele. Thus, allele-specific somatic gains or losses at loci may demarcate the presence of resistance or susceptibility alleles. The goal of this study was to determine if previously mapped susceptibility loci for colorectal cancer show evidence of allele-specific somatic events in colon tumors. Methods: We performed quantitative genotyping of 16 single nucleotide polymorphisms (SNPs) showing statistically significant association with colorectal cancer in published genome-wide association studies (GWAS). We genotyped 194 paired normal and colorectal tumor DNA samples and 296 paired validation samples to investigate these SNPs for allele-specific somatic gains and losses. We combined analysis of our data with published data for seven of these SNPs. Results: No statistically significant evidence for allele-specific somatic selection was observed for the tested polymorphisms in the discovery set. The rs6983267 variant, which has shown preferential loss of the non-risk T allele and relative gain of the risk G allele in previous studies, favored relative gain of the G allele in the combined discovery and validation samples (corrected p-value = 0.03). When we combined our data with published allele-specific imbalance data for this SNP, the G allele of rs6983267 showed statistically significant evidence of relative retention (p-value = 2.06x10(-4)). Conclusions: Our results suggest that the majority of variants identified as colon cancer susceptibility alleles through GWAS do not exhibit somatic allele-specific imbalance in colon tumors. Our data confirm previously published results showing allele-specific imbalance for rs6983267. These results indicate that allele-specific imbalance of cancer susceptibility alleles may not be a common phenomenon in colon cancer.	[Gerber, Madelyn M.] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Hampel, Heather; Schulz, Nathan P.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Hampel, Heather; de la Chapelle, Albert; Toland, Amanda Ewart] Ohio State Univ, Div Human Genet, Dept Internal Med, Columbus, OH 43210 USA; [Hampel, Heather; de la Chapelle, Albert; Toland, Amanda Ewart] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; [Fernandez, Soledad; Wei, Lai] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Zhou, Xiao-Ping] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [de la Chapelle, Albert; Toland, Amanda Ewart] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gerber, MM (corresponding author), Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA.	Amanda.Toland@osumc.edu	Toland, Amanda Ewart/E-4202-2011; Hampel, Heather/AAV-4041-2020	Hampel, Heather/0000-0001-7558-9794	NIH/NCI [CA134461, CA67941]; Ohio State University Comprehensive Cancer Center Core grant [CA16058]; OSU College of Medicine Systems and Integrated Biology training grant; OSU College of Medicine Medical Student Research Scholarship; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA067941, R01CA134461, U01CA067941] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ohio State University Comprehensive Cancer Center Core grant; OSU College of Medicine Systems and Integrated Biology training grant; OSU College of Medicine Medical Student Research Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by the NIH/NCI (CA134461 to AET and CA67941 to AdlC) and the Ohio State University Comprehensive Cancer Center Core grant (CA16058). MMG was funded by an OSU College of Medicine Systems and Integrated Biology training grant. NPS was funded by an OSU College of Medicine Medical Student Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Dworkin AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001136; Dworkin AM, 2009, J INVEST DERMATOL, V129, P2868, DOI 10.1038/jid.2009.183; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Hienonen T, 2006, INT J CANCER, V118, P505, DOI 10.1002/ijc.21344; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kocarnik JD, 2010, CANCER EPIDEM BIOMAR, V19, P3131, DOI 10.1158/1055-9965.EPI-10-0878; LaFramboise T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001086; Micale L, 2011, BLOOD CELL MOL DIS, V47, P259, DOI 10.1016/j.bcmd.2011.09.001; Nagase H, 2003, CANCER RES, V63, P4849; Niittymaki I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-23; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pittman AM, 2008, HUM MOL GENET, V17, P3720, DOI 10.1093/hmg/ddn267; Poynter JN, 2007, CANCER RES, V67, P11128, DOI 10.1158/0008-5472.CAN-07-3239; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tuupanen S, 2008, CANCER RES, V68, P14, DOI 10.1158/0008-5472.CAN-07-5766; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Umetani N, 2004, ONCOGENE, V23, P8292, DOI 10.1038/sj.onc.1208022; VARMUS HE, 1984, ANNU REV GENET, V18, P553; Wang C, 2004, J PATHOL, V202, P215, DOI 10.1002/path.1507; Weber F, 2006, AM J HUM GENET, V78, P961, DOI 10.1086/504090; Xiong F, 2010, CANCER EPIDEM BIOMAR, V19, P1855, DOI 10.1158/1055-9965.EPI-10-0210; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yearsley M, 2006, HUM PATHOL, V37, P831, DOI 10.1016/j.humpath.2006.02.009; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	35	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37672	10.1371/journal.pone.0037672	http://dx.doi.org/10.1371/journal.pone.0037672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629442	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343100045
J	Schmitz, H; Bousack, H				Schmitz, Helmut; Bousack, Herbert			Modelling a Historic Oil-Tank Fire Allows an Estimation of the Sensitivity of the Infrared Receptors in Pyrophilous Melanophila Beetles	PLOS ONE			English	Article							STOCHASTIC RESONANCE; ACUMINATA COLEOPTERA; FOREST-FIRES; POOL FIRES; NOISE; BUPRESTIDAE; RADIATION; SENSILLA; TRANSDUCTION; CRAYFISH	Pyrophilous jewel beetles of the genus Melanophila approach forest fires and there is considerable evidence that these beetles can detect fires from great distances of more than 60 km. Because Melanophila beetles are equipped with infrared receptors and are also attracted by hot surfaces it can be concluded that these infrared receptors are used for fire detection. The sensitivity of the IR receptors is still unknown. The lowest threshold published so far is 0.6 W/m(2) which, however, cannot explain the detection of forest fires by IR radiation from distances larger than approximately 10 km. To investigate the possible sensitivity of the IR receptors we assumed that beetles use IR radiation for remote fire detection and we made use of a historic report about a big oil-tank fire in Coalinga, California, in 1924. IR emission of an oil-tank fire can be calculated by "pool fire" simulations which now are used for fire safety and risk analysis. Assuming that beetles were lured to the fire from the nearest forests 25 and 130 km away, our results show that detection from a distance of 25 km requires a threshold of the IR receptors of at least 3x10(-2) W/m(2). According to our investigations most beetles became aware of the fire from a distance of 130 km. In this case the threshold has to be 1.3 +/- 10(-4) W/m(2). Because such low IR intensities are buried in thermal noise we suggest that the infrared sensory system of Melanophila beetles utilizes stochastic resonance for the detection of weak IR radiation. Our simulations also suggest that the biological IR receptors might be even more sensitive than uncooled technical IR sensors. Thus a closer look into the mode of operation of the Melanophila IR receptors seems promising for the development of novel IR sensors.	[Schmitz, Helmut] Univ Bonn, Inst Zool, Bonn, Germany; [Bousack, Herbert] Forschungszentrum Julich, Peter Grunberg Inst, D-52425 Julich, Germany	University of Bonn; Helmholtz Association; Research Center Julich	Schmitz, H (corresponding author), Univ Bonn, Inst Zool, Bonn, Germany.	h.schmitz@uni-bonn.de	Bousack, Herbert/K-4578-2012		German Ministry of Education and Research (BMBF) [01RB0909A]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was funded by the German Ministry of Education and Research (BMBF): www.bmbf.de Grant No.: 01RB0909A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adali T, 2010, ADAPTIVE SIGNAL PROC, pxv; Apel K. H., 1988, Beitrage fur die Forstwirtschaft, V22, P45; Apel K.-H., 1989, Entomologische Nachrichten und Berichte, V33, P278; Barr W. F., 1947, PAN PACIFIC ENT, V23, P162; Barth FG, 2004, CURR OPIN NEUROBIOL, V14, P415, DOI 10.1016/j.conb.2004.07.005; BEER FRANK M., 1940, PAN PACIFIC ENT, V16, P13; BEJAN A, 1991, J HEAT TRANS-T ASME, V113, P261, DOI 10.1115/1.2910540; Bennett M, 2004, FLUCT NOISE LETT, V4, pL1, DOI 10.1142/S0219477504001604; Beyler C., 2002, SFPE HDB FIRE PROTEC, V3rd; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; Bonsignore CP, 2007, EUR J ENTOMOL, V104, P425, DOI 10.14411/eje.2007.062; Bouchet O, FREE SPACE OPTICS PR; Bousack H, 2008, ACTUATOR, P786; Braxmeier H, MAP LAYERS RELIEF MA; BROECKMANN B, 1995, J LOSS PREVENT PROC, V8, P137, DOI 10.1016/0950-4230(95)00016-T; Budzier H, 2010, THERMAL INFRARED SEN, pxx; Center WRC, 2011, HIST CLIM INF; Center WRC, 2011, AV WIND SPEED; Champion GC, 1918, ENTOMOL MON MAG, V54, P199; CHEN RC, 1984, ACTA ENTOMOL SINICA, V27, P121; Clark B Earth Point, EARTH POINT TOOLS GO; Dean TJ, BOOK INSECT RECORDS; Derby CD, 2001, BIOL BULL, V200, P211, DOI 10.2307/1543318; Dettner K., 1999, LEHRBUCH ENTOMOLOGIE; Duke T, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.158101; Evans HF, 2004, BARK AND WOOD BORING INSECTS IN LIVING TREES IN EUROPE, A SYNTHESIS, P447; Evans WG, 2010, ANN ENTOMOL SOC AM, V103, P823, DOI 10.1603/AN10076; EVANS WG, 1964, NATURE, V202, P211, DOI 10.1038/202211a0; EVANS WG, 1966, ECOLOGY, V47, P1061, DOI 10.2307/1935658; EWELL DM, 1989, J APPL METEOROL, V28, P112, DOI 10.1175/1520-0450(1989)028<0112:ATITSS>2.0.CO;2; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gopfert MC, 2003, P NATL ACAD SCI USA, V100, P5514, DOI 10.1073/pnas.0737564100; Gopfert MC, 1999, J EXP BIOL, V202, P2727; GUELZIM A, 1993, J HEAT TRANS-T ASME, V115, P489, DOI 10.1115/1.2910708; Hammer DX, 2001, J INSECT PHYSIOL, V47, P1441, DOI 10.1016/S0022-1910(01)00134-2; Hammer DX, 2001, COMP BIOCHEM PHYS A, V128, P805, DOI 10.1016/S1095-6433(00)00322-6; Hanggi P, 2002, CHEMPHYSCHEM, V3, P285, DOI 10.1002/1439-7641(20020315)3:3<285::AID-CPHC285>3.0.CO;2-A; HARDIN B, 1992, AGR RES, V40, P20; Heskestad G., 2002, SFPE HDB FIRE PROTEC; Hudspeth AJ, 1997, CURR OPIN NEUROBIOL, V7, P480, DOI 10.1016/S0959-4388(97)80026-8; Humphrey JAC, 2003, SENSORS AND SENSING IN BIOLOGY AND ENGINEERING, P129; Jafari MG, 2003, ADAPTRIVE NOISE CANC, P627; Johnson MT, 2005, PHYSICA D, V201, P306, DOI 10.1016/j.physd.2005.01.011; Keeys RJ, OPTICAL INFRARED DET; Klassen M, 1992, STRUCTURE RAD POOL F; Kruse P. W., 1962, ELEMENTS INFRARED TE; Kunzig R, 2000, DISCOVER, V21, P27; Larson DA, 1982, TIME DEPENDENT MODEL; Lindner JF, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051911; LINSLEY E. G., 1957, COLEOPT BULL, V11, P9; Linsley E. Gorton, 1943, JOUR ECON ENT, V36, P341, DOI 10.1093/jee/36.2.341; Linsley EG, 1933, PAN-PAC ENTOMOL, V9, P138; Lohle F, 1944, PHYS Z, V45, P7; Long B., 2004, GUIDE STORAGE TANKS; McCaffrey BJ, 1984, FIRE PLUME DYNAMICS; McGrattan KB, THERMAL RAD LARGE PO; Middleton W.E.K., 2019, VISION ATMOSPHERE; Munoz M, 2007, J HAZARD MATER, V144, P725, DOI 10.1016/j.jhazmat.2007.01.121; Nadrowski B, 2004, P NATL ACAD SCI USA, V101, P12195, DOI 10.1073/pnas.0403020101; Nicholson GW, 1919, ENTOMOL MON MAG, V55, P156; Paine PM, 1913, OIL PRODUCTION METHO; Palm T., 1955, Entomologisk Tidskrift Stockholm, V76, P40; Parker SP, MCGRAW HILL DICT SCI; Raj PK, 2007, J HAZARD MATER, V140, P280, DOI 10.1016/j.jhazmat.2006.08.057; Raj PK, 2005, PROCESS SAF PROG, V24, P192, DOI 10.1002/prs.10082; Ricksecker LE, 1885, ENTOMOL AM, V1, P96; Russell DF, 1999, NATURE, V402, P291, DOI 10.1038/46279; Ryle G. B., 1923, Entomologist's Monthly Magazine, V59, P1; Salley MH, 2004, ESTIMATING RADIANT H; Salley MH, 2004, FIRE DYNAMICS TOOLS; Schmitz A, 2007, ARTHROPOD STRUCT DEV, V36, P291, DOI 10.1016/j.asd.2007.02.002; Schmitz H, 1998, J COMP PHYSIOL A, V182, P647, DOI 10.1007/s003590050210; Schmitz H, 2000, J COMP PHYSIOL A, V186, P543, DOI 10.1007/s003590000109; Services GGW, CAL MEAN MONTH ANN P; SHARP W.E., 1918, ENTOMOL MON MAG, V54, P244; Shimozawa T, 2003, SENSORS AND SENSING IN BIOLOGY AND ENGINEERING, P145; Siegel R, 2002, THERMAL RAD HEAT TRA; Sloop K. D., 1937, University of California Publications in Entomology, V7, P1; Takahashi N, 1999, FIRE SAFETY J, V33, P1, DOI 10.1016/S0379-7112(99)00009-0; Thomas PH, 1963, S INT COMBUSTION, V9, P844, DOI DOI 10.1016/S0082-0784(63)80091-0; Thurm U, 1982, GRUNDZUGE TRANSDUKTI, P681; Trefethen L. M., 1990, APPL MECH REV, V43, P153, DOI [10.1115/1.3119167, DOI 10.1115/1.3119167]; Trijonis J, TSCPDB6123; Van Dyke E.C., 1926, PAN-PAC ENTOMOL, V3, P41; VanDyke EC, 1928, PAN-PAC ENTOMOL, V4, P113; VanDyke EC, 1926, PAN PACIFIC ENTOMOLO, V3; Vondran T, 1995, TISSUE CELL, V27, P645, DOI 10.1016/S0040-8166(05)80020-5; Walther L, 1983, INFRAROTMESSTECHNIK; WAYNE FD, 1991, J LOSS PREVENT PROC, V4, P86; Wilson CC, 1988, FOREST FIRE LAB RIVE; Womack J, WORK STRATEGIC POSIT; WorldClimate, 2011, CLIM DAT 36 N 120 W; Zhao XH, 2008, CHINESE PHYS LETT, V25, P1490, DOI 10.1088/0256-307X/25/4/088	97	24	26	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37627	10.1371/journal.pone.0037627	http://dx.doi.org/10.1371/journal.pone.0037627			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629433	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343100041
J	Liu, XX; Zhang, J; Liu, YH; Li, YM; Li, Z				Liu, Xinxue; Zhang, Jun; Liu, Yinghui; Li, Yangmei; Li, Zhu			The Association between Cesarean Delivery on Maternal Request and Method of Newborn Feeding in China	PLOS ONE			English	Article							INITIATION; OUTCOMES; SECTION; WOMEN; DURATION; BARRIER	Background: Cesarean delivery has increased significantly during the last decades. This study aimed to investigate the association between planned mode of delivery and method of feeding. Methodology/Principal Findings: A cohort was created retrospectively using data from a population-based maternal and child health surveillance system, which covers 27 study sites in China from 1993 to 2006. The cohort consisted of 431,704 women for analysis, including 22,462 women with planned cesarean delivery on maternal request (CDMR) and 409,242 women with planned vaginal delivery (VD). Logistic regression models were used to examine the association between mode of delivery and method of feeding adjusting for selected covariates. In this cohort, 398,176 (92.2%) women exclusively breastfed their baby, 28,798 (6.7%) women chose mixed feeding, and 4,730 (1.1%) women chose formula feeding before hospital discharge. Women who planned CDMR were less likely to exclusively breastfeed and more likely to formula feed their babies than those who planned VD. After adjusting for covariates, the odds ratios were 0.85 (95% CI: 0.81-0.89) for exclusive breastfeeding and 1.61 (95% CI: 1.45-1.79) for formula feeding. Associations between planned mode of delivery and method of feeding in the south, north, rural and urban areas yielded similar results. Conclusion: This study demonstrated that planned CDMR was associated with a lower rate of exclusive breastfeeding and a higher rate of formula feeding in a low-risk Chinese population.	[Liu, Xinxue; Li, Zhu] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Beijing 100871, Peoples R China; [Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE, Shanghai, Peoples R China; [Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China; [Liu, Yinghui] Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China; [Li, Yangmei] Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England	Peking University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Peking University; University of Cambridge	Liu, XX (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Beijing 100871, Peoples R China.	lizhu3669@gmail.com		Liu, Xinxue/0000-0003-1107-0365	National Institute of Child Health and Human Development, National Institutes of Health, U.S.A.; Agency for Healthcare Research and Quality, U.S.A.	National Institute of Child Health and Human Development, National Institutes of Health, U.S.A.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Agency for Healthcare Research and Quality, U.S.A.(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Data cleaning and analysis for this paper was supported in part by the Intramural Research Program at the National Institute of Child Health and Human Development, National Institutes of Health, U.S.A. and Agency for Healthcare Research and Quality, U.S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Chapman DJ, 1999, J AM DIET ASSOC, V99, P450, DOI 10.1016/S0002-8223(99)00109-1; Chung W, 2008, PUBLIC HEALTH NUTR, V11, P225, DOI 10.1017/S136898000700047X; Fewtrell MS, 2007, AM J CLIN NUTR, V85, p635S, DOI 10.1093/ajcn/85.2.635S; Hamilton Brady E, 2006, Natl Vital Stat Rep, V55, P1; Kottmel A, 2012, ARCH GYNECOL OBSTET; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Leung GM, 2002, OBSTET GYNECOL, V99, P785, DOI 10.1016/S0029-7844(02)01940-3; LI Z, 2000, CHINA US COLLABORATI; Lin CH, 2008, J CLIN NURS, V17, P2838, DOI 10.1111/j.1365-2702.2008.02289.x; Liston FA, 2008, ARCH DIS CHILD-FETAL, V93, pF176, DOI 10.1136/adc.2006.112565; Perez-Rios N, 2008, J HUM LACT, V24, P293, DOI 10.1177/0890334408316078; PerezEscamilla R, 1996, AM J PUBLIC HEALTH, V86, P832, DOI 10.2105/AJPH.86.6.832; Qin C, 2011, MATERN CHILD HLTH J; Qiu Liqian, 2008, Asia Pac J Public Health, V20 Suppl, P220; Rowe-Murray HJ, 2002, BIRTH-ISS PERINAT C, V29, P124, DOI 10.1046/j.1523-536X.2002.00172.x; Stavrou EP, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-8; Stefos T, 2001, ACTA OBSTET GYN SCAN, V80, P34, DOI 10.1080/791201831; Tucker H.A., 1994, PHYSL REPROD, Vsecond, P1065; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Viswanathan Meera, 2006, Evid Rep Technol Assess (Full Rep), P1; Wang Bing-shun, 2006, Zhonghua Fu Chan Ke Za Zhi, V41, P246; World Health Organization, OPT DUR EXCL BREATF; World Health Organization United Nations Children's Fund, 2003, GLOB STRAT INF YOUNG; Xie RH, 2011, J WOMENS HEALTH, V20, P1881, DOI 10.1089/jwh.2011.2842; Xu FL, 2009, INT BREASTFEED J, V4, DOI 10.1186/1746-4358-4-6; Zanardo V, 2010, BIRTH-ISS PERINAT C, V37, P275, DOI 10.1111/j.1523-536X.2010.00421.x; Zhang J, 2008, OBSTET GYNECOL, V111, P1077, DOI 10.1097/AOG.0b013e31816e349e	28	24	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37336	10.1371/journal.pone.0037336	http://dx.doi.org/10.1371/journal.pone.0037336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22624019	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500102
J	Shimma, S; Kubo, A; Satoh, T; Toyoda, M				Shimma, Shuichi; Kubo, Ayumi; Satoh, Takaya; Toyoda, Michisato			Detailed Structural Analysis of Lipids Directly on Tissue Specimens Using a MALDI-SpiralTOF-Reflectron TOF Mass Spectrometer	PLOS ONE			English	Article							CHARGE-REMOTE FRAGMENTATION; DOUBLE-BOND POSITION; INDUCED DISSOCIATION; MATRIX; IDENTIFICATION; BRAIN; BIOMOLECULES; DESIGN; IONS	Direct tissue analysis using a novel tandem time-of-flight (TOF-TOF) mass spectrometer is described. This system consists of a matrix-assisted laser desorption/ionization ion source, a spiral ion trajectory TOF mass spectrometer "SpiralTOF (STOF)'', a collision cell, and an offset parabolic reflectron (RTOF). The features of this system are high precursor ion selectivity due to a 17-m flight path length in STOF and elimination of post-source decay (PSD) ions. The acceleration energy is 20 keV, so that high-energy collision-induced dissociation (HE-CID) is possible. Elimination of PSD ions allows observation of the product ions inherent to the HE-CID process. By using this tandem TOF instrument, the product ion spectrum of lipids provided detailed structural information of fatty acid residues.	[Shimma, Shuichi] Osaka Univ, Venture Business Lab, Suita, Osaka, Japan; [Kubo, Ayumi; Satoh, Takaya] JEOL Ltd, Akishima, Tokyo, Japan; [Toyoda, Michisato] Osaka Univ, Grad Sch Sci, Project Res Ctr Fundamental Sci, Toyonaka, Osaka 560, Japan	Osaka University; Jeol Ltd; JEOL Japan; Osaka University	Shimma, S (corresponding author), Osaka Univ, Venture Business Lab, Suita, Osaka, Japan.	sshimma@ncc.go.jp	Toyoda, Michisato/N-6750-2013; Shimma, Shuichi/L-5975-2019	Toyoda, Michisato/0000-0001-5950-6039; 	Japan Society for the Promotion of Science [11020851]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (11020851, Grant-in-Aid for Young Scientists (B); to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgacem O, 2006, RAPID COMMUN MASS SP, V20, P1653, DOI 10.1002/rcm.2486; Chen LC, 2009, J MASS SPECTROM, V44, P1469, DOI 10.1002/jms.1632; Chen RB, 2010, ANAL BIOANAL CHEM, V397, P3185, DOI 10.1007/s00216-010-3723-7; Chughtai K, 2010, CHEM REV, V110, P3237, DOI 10.1021/cr100012c; Colsch B, 2004, J LIPID RES, V45, P281, DOI 10.1194/jlr.M300331-JLR200; Cornett DS, 2008, ANAL CHEM, V80, P5648, DOI 10.1021/ac800617s; CORNISH TJ, 1994, RAPID COMMUN MASS SP, V8, P781, DOI 10.1002/rcm.1290080924; Dill AL, 2011, CHEM COMMUN, V47, P2741, DOI 10.1039/c0cc03518a; Garrett TJ, 2010, METHODS MOL BIOL, V656, P209, DOI 10.1007/978-1-60761-746-4_12; Goodwin RJA, 2011, RAPID COMMUN MASS SP, V25, P969, DOI 10.1002/rcm.4939; Goodwin RJA, 2010, BIOANALYSIS, V2, P279, DOI 10.4155/BIO.09.180; Griffiths WJ, 1996, RAPID COMMUN MASS SP, V10, P21, DOI 10.1002/(SICI)1097-0231(19960115)10:1<21::AID-RCM428>3.0.CO;2-0; GROSS ML, 1992, INT J MASS SPECTROM, V118, P137, DOI 10.1016/0168-1176(92)85060-D; Han XL, 1995, J AM SOC MASS SPECTR, V6, P1202, DOI 10.1016/1044-0305(95)00568-4; HILL JA, 1989, INT J MASS SPECTROM, V92, P211, DOI 10.1016/0168-1176(89)83029-0; Ho YP, 2002, RAPID COMMUN MASS SP, V16, P1582, DOI 10.1002/rcm.751; Hsu FF, 2003, J AM SOC MASS SPECTR, V14, P352, DOI 10.1016/S1044-0305(03)00064-3; JENSEN NJ, 1985, J AM CHEM SOC, V107, P1863, DOI 10.1021/ja00293a010; KAUFMANN R, 1993, RAPID COMMUN MASS SP, V7, P902, DOI 10.1002/rcm.1290071010; Kolli VSK, 1996, RAPID COMMUN MASS SP, V10, P923, DOI 10.1002/(SICI)1097-0231(19960610)10:8<923::AID-RCM610>3.3.CO;2-5; Manicke NE, 2010, J MASS SPECTROM, V45, P223, DOI 10.1002/jms.1707; Marsching C, 2011, ANAL BIOANAL CHEM, V401, P53, DOI 10.1007/s00216-011-4802-0; Mitchell TW, 2009, J CHROMATOGR B, V877, P2722, DOI 10.1016/j.jchromb.2009.01.017; Satoh T, 2005, J AM SOC MASS SPECTR, V16, P1969, DOI 10.1016/j.jasms.2005.08.005; Satoh T, 2007, J AM SOC MASS SPECTR, V18, P1318, DOI 10.1016/j.jasms.2007.04.010; Satoh T, 2011, J AM SOC MASS SPECTR, V22, P797, DOI 10.1007/s13361-011-0090-3; Schwamborn K, 2010, MOL ONCOL, V4, P529, DOI 10.1016/j.molonc.2010.09.002; Seeley EH, 2011, TRENDS BIOTECHNOL, V29, P136, DOI 10.1016/j.tibtech.2010.12.002; Shimma S, 2008, J MASS SPECTROM, V43, P535, DOI 10.1002/jms.1352; Shimma S, 2008, ANAL CHEM, V80, P878, DOI 10.1021/ac071301v; STOFFYN PJ, 1966, J AM OIL CHEM SOC, V43, P69, DOI 10.1007/BF02641017; Sugiura Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003232; Thomas MC, 2008, ANAL CHEM, V80, P303, DOI 10.1021/ac7017684; Vestal ML, 2005, METHOD ENZYMOL, V402, P79, DOI 10.1016/S0076-6879(05)02003-3; Wang HYJ, 2008, INT J MASS SPECTROM, V278, P143, DOI 10.1016/j.ijms.2008.04.005; WYSOCKI VH, 1991, INT J MASS SPECTROM, V104, P179, DOI 10.1016/0168-1176(91)80009-C; WYSOCKI VH, 1987, INT J MASS SPECTROM, V75, P181, DOI 10.1016/0168-1176(87)83054-9; Yang YH, 2009, ANAL BIOCHEM, V387, P133, DOI 10.1016/j.ab.2009.01.005	38	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37107	10.1371/journal.pone.0037107	http://dx.doi.org/10.1371/journal.pone.0037107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623981	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343500058
J	Xu, DS; Yang, CZ; Proescholdt, M; Brundl, E; Brawanski, A; Fang, XP; Lee, CS; Weil, RJ; Zhuang, ZP; Lonser, RR				Xu, David S.; Yang, Chunzhang; Proescholdt, Martin; Bruendl, Elisabeth; Brawanski, Alexander; Fang, Xueping; Lee, Cheng S.; Weil, Robert J.; Zhuang, Zhengping; Lonser, Russell R.			Neuronatin in a Subset of Glioblastoma Multiforme Tumor Progenitor Cells Is Associated with Increased Cell Proliferation and Shorter Patient Survival	PLOS ONE			English	Article							SECONDARY GLIOBLASTOMAS; GENE; EXPRESSION; CLONING; DIFFERENTIATION; IDENTIFICATION; MUTATIONS; GROWTH; BRAIN; MS	Glioblastoma multiforme is the most common and malignant primary brain tumor. Recent evidence indicates that a subset of glioblastoma tumor cells have a stem cell like phenotype that underlies chemotherapy resistance and tumor recurrence. We utilized a new "multidimensional" capillary isoelectric focusing nano-reversed-phase liquid chromatography platform with tandem mass spectrometry to compare the proteomes of isolated glioblastoma tumor stem cell and differentiated tumor cell populations. This proteomic analysis yielded new candidate proteins that were differentially expressed. Specifically, two isoforms of the membrane proteolipid neuronatin (NNAT) were expressed exclusively within the tumor stem cells. We surveyed the expression of NNAT across 10 WHO grade II and III gliomas and 23 glioblastoma (grade IV) human tumor samples and found NNAT was expressed in a subset of primary glioblastoma tumors. Through additional in vitro studies utilizing the U87 glioma cell line, we found that expression of NNAT is associated with significant increases in cellular proliferation. Paralleling the in vitro results, when NNAT levels were evaluated in tumor specimens from a consecutive cohort of 59 glioblastoma patients, the presence of increased levels of NNAT were found to be a an independent risk factor (P = 0.006) for decreased patient survival through Kaplan-Meier and multivariate analysis. These findings indicate that NNAT may have utility as a prognostic biomarker, as well as a cell-surface target for chemotherapeutic agents.	[Xu, David S.; Yang, Chunzhang; Zhuang, Zhengping; Lonser, Russell R.] Natl Inst Neurol Disorders & Stroke, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Weil, Robert J.] Cleveland Clin Fdn, Brain Tumor & Neurooncol Ctr, Cleveland, OH 44195 USA; [Proescholdt, Martin; Bruendl, Elisabeth; Brawanski, Alexander] Univ Regensburg, Med Ctr, Dept Neurosurg, Regensburg, Germany; [Fang, Xueping; Lee, Cheng S.] Calibrant Biosyst, Gaithersburg, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Cleveland Clinic Foundation; University of Regensburg	Xu, DS (corresponding author), Natl Inst Neurol Disorders & Stroke, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.	zhuangp@ninds.nih.gov; Lonserr@ninds.nih.gov		Yang, Chunzhang/0000-0001-6433-0867; Xu, David/0000-0001-8987-4545	National Institutes of Neurological Disorders and Stroke, National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003052] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All work was funded through the intramural research program at the National Institutes of Neurological Disorders and Stroke as a part of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Chu K, 2005, DIABETES, V54, P1064, DOI 10.2337/diabetes.54.4.1064; Dou DX, 1996, BRAIN RES, V723, P8, DOI 10.1016/0006-8993(96)00167-9; JOSEPH R, 1994, BIOCHEM BIOPH RES CO, V201, P1227, DOI 10.1006/bbrc.1994.1836; Kagitani F, 1997, NUCLEIC ACIDS RES, V25, P3428, DOI 10.1093/nar/25.17.3428; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; Maric D, 2003, J NEUROSCI, V23, P240; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Park DM, 2007, CELL CYCLE, V6, P467, DOI 10.4161/cc.6.4.3856; Revill K, 2009, ENDOCR-RELAT CANCER, V16, P537, DOI 10.1677/ERC-09-0008; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Siu IW, 2008, NEURO-ONCOLOGY, V10, P716, DOI 10.1215/15228517-2008-038; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Tohma Y, 1998, J NEUROPATH EXP NEUR, V57, P684, DOI 10.1097/00005072-199807000-00005; Ueki K, 1996, CANCER RES, V56, P150; Usui H, 1997, J MOL NEUROSCI, V9, P55, DOI 10.1007/BF02789395; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vrang N, 2010, OBESITY, V18, P1289, DOI 10.1038/oby.2009.361; Wang YJ, 2005, ANAL CHEM, V77, P6549, DOI 10.1021/ac050491b; Wang YJ, 2005, J PROTEOME RES, V4, P36, DOI 10.1021/pr049876l; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; WIJNHOLDS J, 1995, DEV BIOL, V171, P73, DOI 10.1006/dbio.1995.1261; Yokota N, 2004, ONCOGENE, V23, P3444, DOI 10.1038/sj.onc.1207475	24	21	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37811	10.1371/journal.pone.0037811	http://dx.doi.org/10.1371/journal.pone.0037811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624064	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343500153
J	Li, LZ; Ben, YY; Yuan, SH; Jiang, SB; Xu, JQ; Zhang, XY				Li, Liangzhu; Ben, Yinyin; Yuan, Songhua; Jiang, Shibo; Xu, Jianqing; Zhang, Xiaoyan			Efficacy, Stability, and Biosafety of Sifuvirtide Gel as a Microbicide Candidate against HIV-1	PLOS ONE			English	Article							IN-VITRO; TOPICAL MICROBICIDES; VAGINAL MICROBICIDE; FUSION INHIBITOR; INFECTION; PREVENTION; SAFETY; MODEL; TOXICITY; PEPTIDE	Sifuvirtide is a proven effective HIV-1 entry inhibitor and its safety profile has been established for systemic administration. The present study evaluated the potential of sifuvirtide formulated in a universal gel for topical use as a microbicide candidate for preventing sexual transmission of HIV. Our data showed that sifuvirtide formulated in HEC gel is effective against HIV-1 B, C subtypes, CRF07_BC and CRF01_AE, the latter two recombinants represents the most prevalent strains in China. In addition, we demonstrated that sifuvirtide in gel is stable for at least 8 weeks even at 40 degrees C, and did not cause the disruption of integrity of mucosal epithelial surface, or the up-regulation of inflammatory cytokines both in vitro or in vivo. These results suggest that sifuvirtide gel is an effective, safe and stable product, and should be further tested as a vaginal or rectal microbicide in pre-clinical model or clinical trial for preventing HIV sexual transmission.	[Li, Liangzhu] Fudan Univ, Shanghai Med Coll, MOH MOE Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Li, LZ (corresponding author), Fudan Univ, Shanghai Med Coll, MOH MOE Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	jianqingxu2008@gmail.com; zhang_xycn2002@yahoo.com.cn	Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135	National Grand Program on Key Infectious Disease Control [2012ZX10001-007-008]; National Ministry of Science and Technology of China [2012CB519000]; Natural Science Foundation of China [81102282, 81171553]	National Grand Program on Key Infectious Disease Control; National Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Grand Program on Key Infectious Disease Control (2012ZX10001-007-008), National Ministry of Science and Technology of China (2012CB519000), and the Natural Science Foundation of China (81102282 and 81171553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buffa V, 2009, J GEN VIROL, V90, P234, DOI 10.1099/vir.0.004358-0; Coggins C, 2000, SEX TRANSM INFECT, V76, P480, DOI 10.1136/sti.76.6.480; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Dai SJ, 2005, ACTA PHARMACOL SIN, V26, P1274, DOI 10.1111/j.1745-7254.2005.00163.x; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dezzutti CS, 2004, ANTIMICROB AGENTS CH, V48, P3834, DOI 10.1128/AAC.48.10.3834-3844.2004; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Galen BT, 2007, J INFECT DIS, V195, P1332, DOI 10.1086/513279; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; Hillier SL, 2005, JAIDS-J ACQ IMM DEF, V39, P1, DOI 10.1097/01.qai.0000159671.25950.74; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Li LZ, 2010, CHINESE MED J-PEKING, V123, P3381, DOI 10.3760/cma.j.issn.0366-6999.2010.23.002; Li L, 2011, JAIDS-J ACQ IMM DEF, V56, P384, DOI 10.1097/QAI.0b013e31820a4a8d; Liu ZH, 2011, J BIOL CHEM, V286, P3277, DOI 10.1074/jbc.M110.199323; McGowan I, 2010, CURR OPIN INFECT DIS, V23, P26, DOI 10.1097/QCO.0b013e328334fe70; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Morris GC, 2010, CURR OPIN INFECT DIS, V23, P57, DOI 10.1097/QCO.0b013e328334de6d; Qiu Chao, 2006, Zhonghua Weishengwuxue He Mianyixue Zazhi, V26, P394; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; UNAIDS, UNAIDS REP GLOB AIDS; Veazey RS, 2010, J INFECT DIS, V202, P739, DOI 10.1086/655661; Wang RR, 2009, BIOCHEM BIOPH RES CO, V382, P540, DOI 10.1016/j.bbrc.2009.03.057	22	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37381	10.1371/journal.pone.0037381	http://dx.doi.org/10.1371/journal.pone.0037381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615996	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300107
J	Svensson, JP; Fry, RC; Wang, EM; Somoza, LA; Samson, LD				Svensson, J. Peter; Fry, Rebecca C.; Wang, Emma; Somoza, Luis A.; Samson, Leona D.			Identification of Novel Human Damage Response Proteins Targeted through Yeast Orthology	PLOS ONE			English	Article							BASE EXCISION-REPAIR; DNA-DAMAGE; SACCHAROMYCES-CEREVISIAE; MALIGNANT GLIOMA; CANCER-CELLS; AUTOPHAGY; GENOME; GENE; RADIATION; PATHWAYS	Studies in Saccharomyces cerevisiae show that many proteins influence cellular survival upon exposure to DNA damaging agents. We hypothesized that human orthologs of these S. cerevisiae proteins would also be required for cellular survival after treatment with DNA damaging agents. For this purpose, human homologs of S. cerevisiae proteins were identified and mapped onto the human protein-protein interaction network. The resulting human network was highly modular and a series of selection rules were implemented to identify 45 candidates for human toxicity-modulating proteins. The corresponding transcripts were targeted by RNA interference in human cells. The cell lines with depleted target expression were challenged with three DNA damaging agents: the alkylating agents MMS and 4-NQO, and the oxidizing agent t-BuOOH. A comparison of the survival revealed that the majority (74%) of proteins conferred either sensitivity or resistance. The identified human toxicity-modulating proteins represent a variety of biological functions: autophagy, chromatin modifications, RNA and protein metabolism, and telomere maintenance. Further studies revealed that MMS-induced autophagy increase the survival of cells treated with DNA damaging agents. In summary, we show that damage recovery proteins in humans can be identified through homology to S. cerevisiae and that many of the same pathways are represented among the toxicity modulators.	[Svensson, J. Peter; Fry, Rebecca C.; Wang, Emma; Somoza, Luis A.; Samson, Leona D.] MIT, Ctr Environm Hlth Sci, Biol Engn Dept, Cambridge, MA 02139 USA; [Samson, Leona D.] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Svensson, JP (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	lsamson@mit.edu	Svensson, J Peter/B-4276-2008	Svensson, J Peter/0000-0002-5863-6250; Fry, Rebecca/0000-0003-0899-9018	National Institute of Environmental Health Sciences (NIEHS) [ES02109]; National Cancer Institutes (NCI) [CA55042, CA112967]; Swedish Research Council; NATIONAL CANCER INSTITUTE [R01CA055042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institutes (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from National Institute of Environmental Health Sciences (NIEHS) (ES02109) and the National Cancer Institutes (NCI) (CA55042 and CA112967). Dr. Svensson was supported by a post-doctoral fellowship from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begley TJ, 2004, MOL CELL, V16, P117, DOI 10.1016/j.molcel.2004.09.005; Begley TJ, 2002, MOL CANCER RES, V1, P103; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012; Chakrama FZ, 2010, AUTOPHAGY, V6, P495, DOI 10.4161/auto.6.4.11819; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Costa RMA, 2003, BIOCHIMIE, V85, P1083, DOI 10.1016/j.biochi.2003.10.017; Ding ZB, 2011, CLIN CANCER RES, V17, P6229, DOI 10.1158/1078-0432.CCR-11-0816; Drahota Z, 2005, PHYSIOL RES, V54, P67, DOI 10.33549/physiolres.930578; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Forand A, 2009, BIOL REPROD, V80, P860, DOI 10.1095/biolreprod.108.072884; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fry RC, 2008, GENE DEV, V22, P2621, DOI 10.1101/gad.1688508; GALIEGUEZOUITINA S, 1985, CANCER RES, V45, P520; GALIEGUEZOUITINA S, 1986, CANCER RES, V46, P1858; Gamper AM, 2009, MOL CELL BIOL, V29, P266, DOI 10.1128/MCB.00315-08; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hanway D, 2002, P NATL ACAD SCI USA, V99, P10605, DOI 10.1073/pnas.152264899; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hong MY, 2005, EXP BIOL MED, V230, P464; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; JONES CJ, 1989, CARCINOGENESIS, V10, P1197, DOI 10.1093/carcin/10.7.1197; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kiss H, 2001, GENOMICS, V73, P10, DOI 10.1006/geno.2000.6498; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lee SJ, 2009, GLIA, V57, P1351, DOI 10.1002/glia.20854; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Li CY, 2009, INT J CANCER, V124, P999, DOI 10.1002/ijc.24126; Liu Y, 2008, MOL BIOL CELL, V19, P3080, DOI 10.1091/mbc.E07-12-1290; Lovejoy CA, 2009, P NATL ACAD SCI USA, V106, P19304, DOI 10.1073/pnas.0909345106; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Meira LB, 2009, P NATL ACAD SCI USA, V106, P888, DOI 10.1073/pnas.0807030106; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Paglin S, 2001, CANCER RES, V61, P439; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Perez RE, 2010, J CELL PHYSIOL, V225, P394, DOI 10.1002/jcp.22285; Prenzel T, 2011, CANCER RES, V71, P5739, DOI 10.1158/0008-5472.CAN-11-1896; Qi D, 2004, MOL CELL BIOL, V24, P8080, DOI 10.1128/MCB.24.18.8080-8089.2004; Ravi D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000527; Rohde HM, 2003, J BIOL CHEM, V278, P52689, DOI 10.1074/jbc.M307983200; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Roth RB, 2002, CANCER RES, V62, P656; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Scharer OD, 2010, CHEM BIOL DNA DAMAGE; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suwaki N, 2010, ARCH BIOCHEM BIOPHYS, V497, P55, DOI 10.1016/j.abb.2010.03.003; Svensson JP, 2011, BMC SYSTEMS IN PRESS; van Haaften G, 2006, CURR BIOL, V16, P1344, DOI 10.1016/j.cub.2006.05.047; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; WADE MH, 1979, MUTAT RES, V59, P49, DOI 10.1016/0027-5107(79)90194-5; WALKER MD, 1980, NEW ENGL J MED, V303, P1323, DOI 10.1056/NEJM198012043032303; Wen HJ, 2010, J VIROL, V84, P7448, DOI 10.1128/JVI.00024-10	62	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37368	10.1371/journal.pone.0037368	http://dx.doi.org/10.1371/journal.pone.0037368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615993	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300106
J	Standish, AJ; Salim, AA; Zhang, H; Capon, RJ; Morona, R				Standish, Alistair J.; Salim, Angela A.; Zhang, Hua; Capon, Robert J.; Morona, Renato			Chemical Inhibition of Bacterial Protein Tyrosine Phosphatase Suppresses Capsule Production	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; KINASE WZC; EXTRACELLULAR POLYSACCHARIDES; MOLECULAR CHARACTERIZATION; STAPHYLOCOCCUS-AUREUS; SEQUENCE-ANALYSIS; BIOSYNTHESIS	Capsule polysaccharide is a major virulence factor for a wide range of bacterial pathogens, including Streptococcus pneumoniae. The biosynthesis of Wzy-dependent capsules in both Gram-negative and -positive bacteria is regulated by a system involving a protein tyrosine phosphatase (PTP) and a protein tyrosine kinase. However, how the system functions is still controversial. In Streptococcus pneumoniae, a major human pathogen, the system is present in all but 2 of the 93 serotypes found to date. In order to study this regulation further, we performed a screen to find inhibitors of the phosphatase, CpsB. This led to the observation that a recently discovered marine sponge metabolite, fascioquinol E, inhibited CpsB phosphatase activity both in vitro and in vivo at concentrations that did not affect the growth of the bacteria. This inhibition resulted in decreased capsule synthesis in D39 and Type 1 S. pneumoniae. Furthermore, concentrations of Fascioquinol E that inhibited capsule also lead to increased attachment of pneumococci to a macrophage cell line, suggesting that this compound would inhibit the virulence of the pathogen. Interestingly, this compound also inhibited the phosphatase activity of the structurally unrelated Gram-negative PTP, Wzb, which belongs to separate family of protein tyrosine phosphatases. Furthermore, incubation with Klebsiella pneumoniae, which contains a homologous phosphatase, resulted in decreased capsule synthesis. Taken together, these data provide evidence that PTPs are critical for Wzy-dependent capsule production across a spectrum of bacteria, and as such represents a valuable new molecular target for the development of anti-virulence antibacterials.	[Standish, Alistair J.; Morona, Renato] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Salim, Angela A.; Zhang, Hua; Capon, Robert J.] Univ Queensland, Div Chem & Struct Biol, Inst Mol Biosci, St Lucia, Qld, Australia	University of Adelaide; University of Queensland	Standish, AJ (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	alistair.standish@adelaide.edu.au	Morona, Renato/B-7746-2013; Capon, Robert/G-9238-2012; Salim, Angela/J-4884-2014	Morona, Renato/0000-0001-7009-7440; Capon, Robert/0000-0002-8341-7754; Salim, Angela/0000-0002-8177-5689	Channel 7 Children's Research Foundation (CRF);  [565526]	Channel 7 Children's Research Foundation (CRF); 	This research was funded by Program Grant 565526 and a Channel 7 Children's Research Foundation (CRF) grant (www.crf.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; Bender MH, 2003, J BACTERIOL, V185, P6057, DOI 10.1128/JB.185.20.6057-6066.2003; Bender MH, 2001, J BIOL CHEM, V276, P47966, DOI 10.1074/jbc.M105448200; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Byrne JP, 2011, J BACTERIOL, V193, P2341, DOI 10.1128/JB.00074-11; Chuang YP, 2006, J INFECT DIS, V193, P645, DOI 10.1086/499968; COOPER JM, 1983, J INFECT DIS, V147, P312, DOI 10.1093/infdis/147.2.312; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; DOMENICO P, 1989, INFECT IMMUN, V57, P3778, DOI 10.1128/IAI.57.12.3778-3782.1989; GLUCKSMANN MA, 1993, J BACTERIOL, V175, P7045, DOI 10.1128/jb.175.21.7045-7055.1993; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Grangeasse C, 2010, BBA-PROTEINS PROTEOM, V1804, P628, DOI 10.1016/j.bbapap.2009.08.018; Guildolin A, 1995, DEV BIOL STAND, V85, P267; Hagelueken G, 2009, J MOL BIOL, V392, P678, DOI 10.1016/j.jmb.2009.07.026; Hanson BR, 2011, J BACTERIOL, V193, P411, DOI 10.1128/JB.01098-10; Harvey RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019650; Henriques MX, 2011, MOL MICROBIOL, V82, P515, DOI 10.1111/j.1365-2958.2011.07828.x; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; LaPointe Gisele, 2008, BMC Biochemistry, V9, P10, DOI 10.1186/1471-2091-9-10; Lescop E, 2006, J BIOL CHEM, V281, P19570, DOI 10.1074/jbc.M601263200; LIN WS, 1994, J BACTERIOL, V176, P7005, DOI 10.1128/JB.176.22.7005-7016.1994; Lysenko ES, 2010, CURR BIOL, V20, P1222, DOI 10.1016/j.cub.2010.05.051; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Morona JK, 2000, MOL MICROBIOL, V35, P1431, DOI 10.1046/j.1365-2958.2000.01808.x; Morona JK, 2003, J BACTERIOL, V185, P3009, DOI 10.1128/JB.185.10.3009-3019.2003; Morona JK, 2002, J BACTERIOL, V184, P577, DOI 10.1128/JB.184.2.577-583.2002; Morona JK, 2006, P NATL ACAD SCI USA, V103, P8505, DOI 10.1073/pnas.0602148103; Morona R, 2000, MICROBIOL-UK, V146, P1, DOI 10.1099/00221287-146-1-1; Morona R, 2009, TRENDS BIOCHEM SCI, V34, P78, DOI 10.1016/j.tibs.2008.11.001; Nelson AL, 2007, INFECT IMMUN, V75, P83, DOI 10.1128/IAI.01475-06; Obadia B, 2007, J MOL BIOL, V367, P42, DOI 10.1016/j.jmb.2006.12.048; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; Paiment A, 2002, J BACTERIOL, V184, P6437, DOI 10.1128/JB.184.23.6437-6447.2002; Preneta R, 2002, COMP BIOCHEM PHYS B, V131, P103, DOI 10.1016/S1096-4959(01)00490-0; Presecan E, 1997, MICROBIOL-SGM, V143, P3313, DOI 10.1099/00221287-143-10-3313; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; RUBENS CE, 1993, MOL MICROBIOL, V8, P843, DOI 10.1111/j.1365-2958.1993.tb01631.x; Soulat D, 2006, J BIOL CHEM, V281, P14048, DOI 10.1074/jbc.M513600200; vanKranenburg R, 1997, MOL MICROBIOL, V24, P387, DOI 10.1046/j.1365-2958.1997.3521720.x; Vincent C, 1999, J BACTERIOL, V181, P3472, DOI 10.1128/JB.181.11.3472-3477.1999; Vincent C, 2000, J MOL BIOL, V304, P311, DOI 10.1006/jmbi.2000.4217; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Whitfield C, 2003, CARBOHYD RES, V338, P2491, DOI 10.1016/j.carres.2003.08.010; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Zhang H, 2011, TETRAHEDRON, V67, P2591, DOI 10.1016/j.tet.2011.02.015; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	54	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36312	10.1371/journal.pone.0036312	http://dx.doi.org/10.1371/journal.pone.0036312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22629313	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300014
J	Bechtel, M; Keller, MV; Bloch, W; Sasaki, T; Boukamp, P; Zaucke, F; Paulsson, M; Nischt, R				Bechtel, Manuela; Keller, Manuel V.; Bloch, Wilhelm; Sasaki, Takako; Boukamp, Petra; Zaucke, Frank; Paulsson, Mats; Nischt, Roswitha			Different domains in nidogen-1 and nidogen-2 drive basement membrane formation in skin organotypic cocultures	FASEB JOURNAL			English	Article						3-dimensional coculture system; laminin-collagen connecting activity	LAMININ GAMMA-1 CHAIN; COLLAGEN TYPE-IV; EPITHELIAL MORPHOGENESIS; MOUSE NIDOGEN-2; BINDING-SITE; KERATINOCYTES; COMPONENTS; PROTEIN; CELLS; MICE	Nidogen-1 and nidogen-2 are homologous proteins found in all basement membranes (BMs). They show comparable binding activities in vitro and partially redundant functions in vivo. Previously, we showed that in skin organotypic cocultures, BM formation was prevented in the absence of nidogens and that either nidogen was able to rescue this failure. We now dissected the two nidogens to identify the domains required for BM deposition. For that purpose, HaCaT cells were grown on collagen matrices containing nidogen-deficient, murine fibroblasts. After addition of nidogen-1 or nidogen-2 protein fragments comprising different binding domains, BM deposition was analyzed by immunofluorescence and electron microscopy. We could demonstrate that the rod-G3 domain of nidogen-2 was sufficient to achieve deposition of BM components at the epidermal-collagen interface. In contrast, for nidogen-1, both the G2 and G3 domains were required. Immunoblot analysis confirmed that all BM components were present in comparable amounts under all culture conditions. This finding demonstrates that nidogens, although homologous proteins, exert their effect on BM assembly through different binding domains, which may in turn result in alterations of BM structure and functions, thus providing an explanation for the phenotypical differences observed between nidogen-1 and -2 deficient mice.-Bechtel, M., Keller, M. V., Bloch, W., Sasaki, T., Boukamp, P., Zaucke, F., Paulsson, M., Nischt, R. Different domains in nidogen-1 and nidogen-2 drive basement membrane formation in skin organotypic cocultures. FASEB J. 26, 3637-3648 (2012). www.fasebj.org	[Bechtel, Manuela; Nischt, Roswitha] Univ Hosp Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Keller, Manuel V.; Zaucke, Frank; Paulsson, Mats] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Zaucke, Frank] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Bloch, Wilhelm] German Sport Univ Cologne, Inst Cardiol & Sport Med, Dept Mol & Cellular Sport Med, Cologne, Germany; [Sasaki, Takako] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Dept Expt Med 1, D-91054 Erlangen, Germany; [Boukamp, Petra] German Canc Res Ctr, Div Genet Skin Carcinogenesis, D-6900 Heidelberg, Germany	University of Cologne; University of Cologne; University of Cologne; German Sport University Cologne; University of Erlangen Nuremberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Nischt, R (corresponding author), Univ Hosp Cologne, Dept Dermatol, KerpenerStr 62, D-50937 Cologne, Germany.	roswitha.nischt@uni-koeln.de	Zaucke, Frank/AAT-2688-2021; Zaucke, Frank/E-2077-2012		Deutsche Forschungsgemeinschaft [SFB 829]; Baden-Wurttemberg Stiftung: Adult Stem Cells [P-LS-ASII/35]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Stiftung: Adult Stem Cells	The authors thank Marion Reibetanz and Isabell Koxholt (Department of Dermatology) for excellent technical assistance. The authors thank all colleagues listed in Materials and Methods for providing antibodies, plasmids, and cells expressing recombinant proteins. This work was supported by the Deutsche Forschungsgemeinschaft through the SFB 829 at the University of Cologne (to R.N. and W. B.) and the Baden-Wurttemberg Stiftung: Adult Stem Cells (P-LS-ASII/35 to P.B.).	AUMAILLEY M, 1993, KIDNEY INT, V43, P7, DOI 10.1038/ki.1993.3; Aumailley M, 1999, MATRIX BIOL, V18, P19, DOI 10.1016/S0945-053X(98)00004-3; Aumailley M, 2003, MATRIX BIOL, V22, P49, DOI 10.1016/S0945-053X(03)00013-1; Bader BL, 2005, MOL CELL BIOL, V25, P6846, DOI 10.1128/MCB.25.15.6846-6856.2005; Baranowsky A, 2010, MATRIX BIOL, V29, P15, DOI 10.1016/j.matbio.2009.09.004; Berthod F, 2001, MATRIX BIOL, V20, P463, DOI 10.1016/S0945-053X(01)00162-7; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Breitkreutz D, 1998, EUR J CELL BIOL, V75, P273, DOI 10.1016/S0171-9335(98)80123-4; BREITKREUTZ D, 1993, DIFFERENTIATION, V54, P201, DOI 10.1111/j.1432-0436.1993.tb01602.x; Breitkreutz D, 2004, J CELL SCI, V117, P2611, DOI 10.1242/jcs.01127; EKBLOM P, 1994, DEVELOPMENT, V120, P2003; El Ghalbzouri A, 2005, J INVEST DERMATOL, V124, P79, DOI 10.1111/j.0022-202X.2004.23549.x; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; Ho MSP, 2008, MICROSC RES TECHNIQ, V71, P387, DOI 10.1002/jemt.20567; Hopf M, 2001, NAT STRUCT BIOL, V8, P634, DOI 10.1038/89683; Kadoya Y, 1997, DEVELOPMENT, V124, P683; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Kvasankul M., 2001, EMBO J, V20, P5342; Li A, 2004, J CLIN INVEST, V113, P390, DOI 10.1172/JCI.200419140; Limat A, 1996, EUR J CELL BIOL, V69, P245; MAYER U, 1993, EMBO J, V12, P1879, DOI 10.1002/j.1460-2075.1993.tb05836.x; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Mokkapati S, 2008, J INVEST DERMATOL, V128, P2259, DOI 10.1038/jid.2008.65; Mokkapati S, 2011, J BIOL CHEM, V286, P1911, DOI 10.1074/jbc.M110.149864; Murshed M, 2000, MOL CELL BIOL, V20, P7007, DOI 10.1128/MCB.20.18.7007-7012.2000; NAKAE H, 1993, EUR J BIOCHEM, V213, P11, DOI 10.1111/j.1432-1033.1993.tb17729.x; Nischt R, 2007, J INVEST DERMATOL, V127, P545, DOI 10.1038/sj.jid.5700562; Poschl E, 1996, EMBO J, V15, P5154, DOI 10.1002/j.1460-2075.1996.tb00899.x; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; REINHARDT D, 1993, J BIOL CHEM, V268, P10881; Ries A, 2001, EUR J BIOCHEM, V268, P5119, DOI 10.1046/j.0014-2956.2001.02437.x; Salmivirta K, 2002, EXP CELL RES, V279, P188, DOI 10.1006/excr.2002.5611; Schymeinsky J, 2002, MOL CELL BIOL, V22, P6820, DOI 10.1128/MCB.22.19.6820-6830.2002; Sher I, 2006, J BIOL CHEM, V281, P5178, DOI 10.1074/jbc.M509500200; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; Stark HJ, 1999, J INVEST DERMATOL, V112, P681, DOI 10.1046/j.1523-1747.1999.00573.x; Takagi J, 2003, NATURE, V424, P969, DOI 10.1038/nature01873; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; Vasudevan A, 2010, HIPPOCAMPUS, V20, P608, DOI 10.1002/hipo.20660; Willem M, 2002, DEVELOPMENT, V129, P2711	42	20	20	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2012	26	9					3637	3648		10.1096/fj.11-194597	http://dx.doi.org/10.1096/fj.11-194597			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22623588				2022-12-25	WOS:000308391600006
J	Chen, ZW; Friedland, GD; Pereira, JH; Reveco, SA; Chan, R; Park, JI; Thelen, MP; Adams, PD; Arkin, AP; Keasling, JD; Blanch, HW; Simmons, BA; Sale, KL; Chivian, D; Chhabra, SR				Chen, Zhiwei; Friedland, Gregory D.; Pereira, Jose H.; Reveco, Sonia A.; Chan, Rosa; Park, Joshua I.; Thelen, Michael P.; Adams, Paul D.; Arkin, Adam P.; Keasling, Jay D.; Blanch, Harvey W.; Simmons, Blake A.; Sale, Kenneth L.; Chivian, Dylan; Chhabra, Swapnil R.			Tracing Determinants of Dual Substrate Specificity in Glycoside Hydrolase Family 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM THERMOTOGA-MARITIMA; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; ENZYME PROMISCUITY; BETA-MANNANASE; SEQUENCE; GENE; ANNOTATION; CELLULASE; ALIGNMENT	Enzymes are traditionally viewed as having exquisite substrate specificity; however, recent evidence supports the notion that many enzymes have evolved activities against a range of substrates. The diversity of activities across glycoside hydrolase family 5(GH5) suggests that this family of enzymes may contain numerous members with activities on multiple substrates. In this study, we combined structure- and sequence-based phylogenetic analysis with biochemical characterization to survey the prevalence of dual specificity for glucan- and mannan-based substrates in the GH5 family. Examination of amino acid profile differences between the subfamilies led to the identification and subsequent experimental confirmation of an active site motif indicative of dual specificity. The motif enabled us to successfully discover several new dually specific members of GH5, and this pattern is present in over 70 other enzymes, strongly suggesting that dual endoglucanase-mannanase activity is widespread in this family. In addition, reinstatement of the conserved motif in a wild type member of GH5 enhanced its catalytic efficiency on glucan and mannan substrates by 175 and 1,600%, respectively. Phylogenetic examination of other GH families further indicates that the prevalence of enzyme multispecificity in GHs may be greater than has been experimentally characterized. Single domain multispecific GHs may be exploited for developing improved enzyme cocktails or facile engineering of microbial hosts for consolidated bioprocessing of lignocellulose.	[Chen, Zhiwei; Friedland, Gregory D.; Pereira, Jose H.; Reveco, Sonia A.; Park, Joshua I.; Thelen, Michael P.; Adams, Paul D.; Arkin, Adam P.; Keasling, Jay D.; Blanch, Harvey W.; Simmons, Blake A.; Sale, Kenneth L.; Chivian, Dylan; Chhabra, Swapnil R.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Chen, Zhiwei; Friedland, Gregory D.; Park, Joshua I.; Simmons, Blake A.; Sale, Kenneth L.] Sandia Natl Labs, Livermore, CA 94551 USA; [Pereira, Jose H.; Reveco, Sonia A.; Adams, Paul D.; Arkin, Adam P.; Keasling, Jay D.; Blanch, Harvey W.; Chhabra, Swapnil R.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Chan, Rosa] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Adams, Paul D.; Arkin, Adam P.; Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Keasling, Jay D.; Blanch, Harvey W.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Thelen, Michael P.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Chivian, D (corresponding author), Joint BioEnergy Inst, 5885 Hollis St, Emeryville, CA 94608 USA.	dcchivian@lbl.gov; schhabra@intrexon.com	Arkin, Adam P/A-6751-2008; Adams, Paul David/A-1977-2013; Thelen, Michael P/G-2032-2014; Thelen, Michael/C-6834-2008; Simmons, Blake/N-6022-2016; Keasling, Jay D/J-9162-2012; Arkin, Adam/M-9941-2019	Arkin, Adam P/0000-0002-4999-2931; Adams, Paul David/0000-0001-9333-8219; Thelen, Michael P/0000-0002-2479-5480; Thelen, Michael/0000-0002-2479-5480; Simmons, Blake/0000-0002-1332-1810; Keasling, Jay D/0000-0003-4170-6088; Arkin, Adam/0000-0002-4999-2931; Chivian, Dylan/0000-0001-8189-8729	Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy [DE-AC02-05CH11231]	Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Anthon GE, 2002, ANAL BIOCHEM, V305, P287, DOI 10.1006/abio.2002.5644; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bourgault R, 2005, PROTEIN SCI, V14, P1233, DOI 10.1110/ps.041260905; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chhabra SR, 2002, APPL ENVIRON MICROB, V68, P545, DOI 10.1128/AEM.68.2.545-554.2002; Chhabra SR, 2003, J BIOL CHEM, V278, P7540, DOI 10.1074/jbc.M211748200; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dominguez R, 1996, J MOL BIOL, V257, P1042, DOI 10.1006/jmbi.1996.0222; DUCROS V, 1995, STRUCTURE, V3, P939, DOI 10.1016/S0969-2126(01)00228-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elifantz H, 2008, FEMS MICROBIOL ECOL, V63, P316, DOI 10.1111/j.1574-6941.2007.00429.x; FOONG F, 1991, J GEN MICROBIOL, V137, P1729, DOI 10.1099/00221287-137-7-1729; Hilge M, 1998, STRUCTURE, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Liang CN, 2011, J BIOTECHNOL, V154, P46, DOI 10.1016/j.jbiotec.2011.03.025; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; Pereira JH, 2010, J STRUCT BIOL, V172, P372, DOI 10.1016/j.jsb.2010.06.018; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plewczynski Dariusz, 2002, Appl Bioinformatics, V1, P223; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Reitinger S, 2010, BIOCHEMISTRY-US, V49, P2464, DOI 10.1021/bi100036f; Sabini E, 2000, ACTA CRYSTALLOGR D, V56, P3, DOI 10.1107/S0907444999013943; Stebbings LA, 2004, NUCLEIC ACIDS RES, V32, pD203, DOI 10.1093/nar/gkh027; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Tyler L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-600; Vlasenko E, 2010, BIORESOURCE TECHNOL, V101, P2405, DOI 10.1016/j.biortech.2009.11.057; Wang YG, 2010, J MOL CATAL B-ENZYM, V66, P294, DOI 10.1016/j.molcatb.2010.06.006; Wen F, 2009, CURR OPIN BIOTECH, V20, P412, DOI 10.1016/j.copbio.2009.07.001; WHITEHEAD TR, 1993, CURR MICROBIOL, V27, P27, DOI 10.1007/BF01576830; Wu TH, 2011, BBA-PROTEINS PROTEOM, V1814, P1832, DOI 10.1016/j.bbapap.2011.07.020; Xiao ZZ, 2005, ANAL BIOCHEM, V342, P176, DOI 10.1016/j.ab.2005.01.052; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	45	33	36	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25335	25343		10.1074/jbc.M112.362640	http://dx.doi.org/10.1074/jbc.M112.362640			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22645145	hybrid, Green Published			2022-12-25	WOS:000306651700041
J	Robbins, GR; Truax, AD; Davis, BK; Zhang, L; Brickey, WJ; Ting, JPY				Robbins, Gregory R.; Truax, Agnieszka D.; Davis, Beckley K.; Zhang, Lu; Brickey, W. June; Ting, Jenny P. -Y.			Regulation of Class I Major Histocompatibility Complex (MHC) by Nucleotide-binding Domain, Leucine-rich Repeat-containing (NLR) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-MEMBER NLRC5; NF-KAPPA-B; GTP-BINDING; ATP BINDING; TRANSACTIVATOR; EXPRESSION; CIITA; DEFICIENCY; ACTIVATION; INDUCTION	Most of the nucleotide-binding domain, leucine-rich repeat (NLR) proteins regulate responses to microbial and damage-associated products. Class II transactivator (CIITA) has a distinct function as the master regulator of class II major histocompatibility complex (MHC-II) transcription. Recently, human NLRC5 was found to regulate MHC-I in cell lines; however, a host of conflicting positive and negative functions has been attributed to this protein. To address the function of NLRC5 in a physiologic setting, we generated an Nlrc5(-/-) strain that contains a deletion in the exon that encodes the nucleotide-binding domain. We have not detected a role for this protein in cytokine induction by pathogen-associated molecular patterns and viruses. However, Nlrc5(-/-) cells showed a dramatic decrease of classical (H-2K) and nonclassical (Tla) MHC-I expression by T/B lymphocytes, natural killer (NK) cells, and myeloid-monocytic lineages. As a comparison, CIITA did not affect mouse MHC-I expression. Nlrc5(-/-) splenocytes and bone marrow-derived macrophages were able to up-regulate MHC-I in response to IFN-gamma; however, the absolute levels of MHC-I expression were significantly lower than WT controls. Chromatin immunoprecipitation of IFN-gamma-treated cells indicates that Nlrc5 reduced the silencing H3K27me3 histone modification, but did not affect the activating AcH3 modification on a MHC-I promoter. In summary, we conclude that Nlrc5 is important in the regulation of MHC-I expression by reducing H3K27me3 on MHC-I promoter and joins CIITA as an NLR subfamily that controls MHC gene transcription.	[Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Inst Inflammatory Dis, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Translat Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Inst Inflammatory Dis, Dept Microbiol & Immunol, CB 7295, Chapel Hill, NC 27599 USA.	jpyting@gmail.com	, UNC Flow Cytometry Core/AGU-9839-2022; Zhang, Lu/P-6929-2015		National Institutes of Health [NIAID R37-AI029564, NCI T32 CA009156, NCI CA131645]; National Institutes of Health Center Core Support Grant through the NCI [P30CA06086]; NATIONAL CANCER INSTITUTE [P30CA016086, T32CA009156, R21CA131645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Center Core Support Grant through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants NIAID R37-AI029564 (to J. P. Y. T.), NCI T32 CA009156 (to G. R. R.), and NCI CA131645 (to B. K. D.).; The University of North Carolina (UNC) Flow Cytometry Core Facility is supported in part by a National Institutes of Health Center Core Support Grant (P30CA06086) through the NCI to the UNC Lineberger Comprehensive Cancer Center.	Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Chin KC, 1997, P NATL ACAD SCI USA, V94, P2501, DOI 10.1073/pnas.94.6.2501; Choi NM, 2011, CURR OPIN IMMUNOL, V23, P81, DOI 10.1016/j.coi.2010.09.007; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Davis BK, 2011, J IMMUNOL, V186, P1333, DOI 10.4049/jimmunol.1003111; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Gobin SJP, 1997, IMMUNITY, V6, P601, DOI 10.1016/S1074-7613(00)80348-9; Harton JA, 1999, SCIENCE, V285, P1402, DOI 10.1126/science.285.5432.1402; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Howcroft TK, 2003, MOL CELL BIOL, V23, P3377, DOI 10.1128/MCB.23.10.3377-3391.2003; Itoh-Lindstrom Y, 1999, J IMMUNOL, V163, P2425; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Krawczyk M, 2006, TISSUE ANTIGENS, V67, P183, DOI 10.1111/j.1399-0039.2006.00557.x; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Kumar H, 2011, J IMMUNOL, V186, P994, DOI 10.4049/jimmunol.1002094; Lu CF, 2005, BIOCHEM BIOPH RES CO, V331, P1114, DOI 10.1016/j.bbrc.2005.04.027; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Martin BK, 1997, IMMUNITY, V6, P591, DOI 10.1016/S1074-7613(00)80347-7; Masternak K, 2000, GENE DEV, V14, P1156; Meissner TB, 2012, J IMMUNOL, V188, P4951, DOI 10.4049/jimmunol.1103160; Meissner TB, 2012, BIOCHEM BIOPH RES CO, V418, P786, DOI 10.1016/j.bbrc.2012.01.104; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Moayeri M, 2012, MICROBES INFECT, V14, P392, DOI 10.1016/j.micinf.2011.12.005; Neerincx A, 2010, J BIOL CHEM, V285, P26223, DOI 10.1074/jbc.M110.109736; Raval A, 2003, J IMMUNOL, V170, P922, DOI 10.4049/jimmunol.170.2.922; Staehli F, 2012, J IMMUNOL, V188, P3820, DOI 10.4049/jimmunol.1102671; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Tong YZ, 2012, CELL RES, V22, P822, DOI 10.1038/cr.2012.53; Truax AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036013; Truax AD, 2012, METHODS MOL BIOL, V809, P175, DOI 10.1007/978-1-61779-376-9_12; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Yao Y, 2012, CELL RES, V22, P836, DOI 10.1038/cr.2012.56; Ye ZM, 2008, MOL CELL BIOL, V28, P1841, DOI 10.1128/MCB.01468-07; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhu XS, 2000, MOL CELL BIOL, V20, P6051, DOI 10.1128/MCB.20.16.6051-6061.2000	38	50	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24294	24303		10.1074/jbc.M112.364604	http://dx.doi.org/10.1074/jbc.M112.364604			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645137	Green Published, hybrid			2022-12-25	WOS:000306651100023
J	Tarrago, L; Kaya, A; Weerapana, E; Marino, SM; Gladyshev, VN				Tarrago, Lionel; Kaya, Alaattin; Weerapana, Eranthie; Marino, Stefano M.; Gladyshev, Vadim N.			Methionine Sulfoxide Reductases Preferentially Reduce Unfolded Oxidized Proteins and Protect Cells from Oxidative Protein Unfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISORDERED REGIONS; PRION PROTEIN; R-SULFOXIDE; PREDICTION; CALMODULIN; EXPRESSION; MEMBRANE; SEQUENCE; AFFINITY; RESIDUES	Reduction of methionine sulfoxide (MetO) residues in proteins is catalyzed by methionine sulfoxide reductases A (MSRA) and B (MSRB), which act in a stereospecific manner. Catalytic properties of these enzymes were previously established mostly using low molecular weight MetO-containing compounds, whereas little is known about the catalysis of MetO reduction in proteins, the physiological substrates of MSRA and MSRB. In this work we exploited an NADPH-dependent thioredoxin system and determined the kinetic parameters of yeast MSRA and MSRB using three different MetO-containing proteins. Both enzymes showed Michaelis-Menten kinetics with the Km lower for protein than for small MetO containing substrates. MSRA reduced both oxidized proteins and low molecular weight MetO-containing compounds with similar catalytic efficiencies, whereas MSRB was specialized for the reduction of MetO in proteins. Using oxidized glutathione S-transferase as a model substrate, we showed that both MSR types were more efficient in reducing MetO in unfolded than in folded proteins and that their activities increased with the unfolding state. Biochemical quantification and identification of MetO reduced in the substrates by mass spectrometry revealed that the increased activity was due to better access to oxidized MetO in unfolded proteins; it also showed that MSRA was intrinsically more active with unfolded proteins regardless of MetO availability. Moreover, MSRs most efficiently protected cells from oxidative stress that was accompanied by protein unfolding. Overall, this study indicates that MSRs serve a critical function in the folding process by repairing oxidatively damaged nascent polypeptides and unfolded proteins.	[Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Tarrago, Lionel; Kaya, Alaattin; Marino, Stefano M.; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Weerapana, Eranthie] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston College	Gladyshev, VN (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/J-6187-2013; Kaya, Alaattin/T-6427-2017; Tarrago, Lionel/CAH-1308-2022; Gladyshev, Vadim N/A-9894-2013; Tarrago, Lionel/N-3534-2016	Kaya, Alaattin/0000-0002-6132-5197; Tarrago, Lionel/0000-0001-7115-8137; Tarrago, Lionel/0000-0001-7115-8137; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [AG021518]; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG021518.	Achilli C, 2008, J LEUKOCYTE BIOL, V83, P181, DOI 10.1189/jlb.0707492; [Anonymous], 2006, CURRENT PROTOCOLS BI, DOI DOI 10.1002/0471250953.BI0506S15; Barnham KJ, 2003, J BIOL CHEM, V278, P42959, DOI 10.1074/jbc.M305494200; Beal JL, 2009, BIOCHEMISTRY-US, V48, P11142, DOI 10.1021/bi901343d; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2001, PROTEIN SCI, V10, P2272, DOI 10.1110/ps.10701; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Breydo L, 2005, BIOCHEMISTRY-US, V44, P15534, DOI 10.1021/bi051369+; Colombo G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004296; CREAMER LK, 1981, ARCH BIOCHEM BIOPHYS, V211, P689, DOI 10.1016/0003-9861(81)90505-1; Dos Santos CV, 2005, PLANT PHYSIOL, V138, P909, DOI 10.1104/pp.105.062430; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Ezraty B, 2004, EMBO J, V23, P1868, DOI 10.1038/sj.emboj.7600172; Gao J, 2001, BIOPHYS J, V80, P1791, DOI 10.1016/S0006-3495(01)76149-8; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Kochanczyk M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-34; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laugier E, 2010, PLANT J, V61, P271, DOI 10.1111/j.1365-313X.2009.04053.x; Le DT, 2008, BIOCHEMISTRY-US, V47, P6685, DOI 10.1021/bi800422s; Le DT, 2009, J BIOL CHEM, V284, P4354, DOI 10.1074/jbc.M805891200; Lee BC, 2008, J BIOL CHEM, V283, P28361, DOI 10.1074/jbc.M805059200; Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; LIM K, 1994, PROTEIN SCI, V3, P2233, DOI 10.1002/pro.5560031209; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Mahawar M, 2011, J BIOL CHEM, V286, P19159, DOI 10.1074/jbc.M111.223677; Marino SM, 2010, J MOL BIOL, V404, P902, DOI 10.1016/j.jmb.2010.09.027; Minniti AN, 2009, AGING CELL, V8, P690, DOI 10.1111/j.1474-9726.2009.00521.x; Mizianty MJ, 2010, BIOINFORMATICS, V26, pi489, DOI 10.1093/bioinformatics/btq373; Mulinacci F, 2011, J PHARM SCI-US, V100, P110, DOI 10.1002/jps.22268; Oien DB, 2008, CURR TOP DEV BIOL, V80, P93, DOI 10.1016/S0070-2153(07)80003-2; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Rouhier N, 2007, J BIOL CHEM, V282, P3367, DOI 10.1074/jbc.M605007200; Shchedrina VA, 2011, J BIOL CHEM, V286, P29449, DOI 10.1074/jbc.M111.257600; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tarrago L, 2012, ANTIOXID REDOX SIGN, V16, P79, DOI 10.1089/ars.2011.4153; Tarrago L, 2009, J BIOL CHEM, V284, P18963, DOI 10.1074/jbc.M109.015487; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Xiong YJ, 2006, BIOCHEMISTRY-US, V45, P14642, DOI 10.1021/bi0612465; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhang T, 2012, J BIOMOL STRUCT DYN, V29, P799, DOI 10.1080/073911012010525022; Zhang XH, 2008, BIOL REV, V83, P249, DOI 10.1111/j.1469-185X.2008.00042.x	45	62	64	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24448	24459		10.1074/jbc.M112.374520	http://dx.doi.org/10.1074/jbc.M112.374520			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22628550	Green Published, hybrid			2022-12-25	WOS:000306651100038
J	Yeom, J; Lee, Y; Park, W				Yeom, Jinki; Lee, Yunho; Park, Woojun			ATP-dependent RecG Helicase Is Required for the Transcriptional Regulator OxyR Function in Pseudomonas species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; SUBSTRATE-SPECIFICITY; DNA; REPLICATION; SUPEROXIDE; STRESS; EXPRESSION; AERUGINOSA; PUTIDA	The oxyR gene appears to reside in an operon with the recG helicase gene in many bacteria, including pathogenic Pseudomonas aeruginosa and Pseudomonas putida. Analysis of P. putida transcriptomes shows that many OxyR-controlled genes are regulated by the ATP-dependent RecG helicase and that RecG alone modulates the expression of many genes. We found that purified RecG binds to the promoters of many OxyR-controlled genes and that expression of these genes was not induced under conditions of oxidative stress in recG mutants of P. aeruginosa, P. putida, and Escherichia coli. In vitro data revealed that promoters containing palindromic sequences are essential for RecG binding and that single-strand binding proteins and ATP are also needed for RecG to promote transcription, whereas a magnesium ion has the opposite effect. The OxyR tetramer preferentially binds to promoters after RecG has generated linear DNA in the presence of ATP; otherwise, the OxyR dimer has higher affinity. This study provides new insights into the mechanism of bacterial transcription by demonstrating that RecG might be required for the induction of the OxyR regulon by unwinding palindromic DNA for transcription. This work describes a novel bacterial transcriptional function by RecG helicase with OxyR and may provide new targets for controlling Pseudomonas species pathogen.	[Park, Woojun] Korea Univ, Div Environm Sci & Ecol Engn, Dept Environm Sci & Ecol Engn, Seoul 136713, South Korea	Korea University	Park, W (corresponding author), Korea Univ, Div Environm Sci & Ecol Engn, Dept Environm Sci & Ecol Engn, Seoul 136713, South Korea.	wpark@korea.ac.kr		Yeom, Jinki/0000-0002-5332-2658	National Research Foundation; Korean government (Ministry of Education, Science and Technology) [2012-0005277]	National Research Foundation; Korean government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation Grant funded by the Korean government (Ministry of Education, Science and Technology) (2012-0005277).	Briggs GS, 2005, J BIOL CHEM, V280, P13921, DOI 10.1074/jbc.M412054200; Brown SD, 2006, MOL CELL PROTEOMICS, V5, P1054, DOI 10.1074/mcp.M500394-MCP200; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Costes A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001238; Dai X, 1998, GENE DEV, V12, P2782, DOI 10.1101/gad.12.17.2782; Gregg AV, 2002, MOL CELL, V9, P241, DOI 10.1016/S1097-2765(02)00455-0; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Hishinuma S, 2008, FEMS MICROBIOL LETT, V289, P138, DOI 10.1111/j.1574-6968.2008.01374.x; Huang YH, 2011, PROTEIN J, V30, P102, DOI 10.1007/s10930-011-9309-1; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Kaan T, 2002, MICROBIOL-SGM, V148, P3441, DOI 10.1099/00221287-148-11-3441; Kang JG, 1997, NUCLEIC ACIDS RES, V25, P2566, DOI 10.1093/nar/25.13.2566; Knapp GS, 2009, PROTEIN SCI, V18, P101, DOI 10.1002/pro.5; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Kurahashi H, 2004, J BIOL CHEM, V279, P35377, DOI 10.1074/jbc.M400354200; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Ohara N, 2006, MICROBIOL-SGM, V152, P955, DOI 10.1099/mic.0.28537-0; Panmanee W, 2009, FEMS MICROBIOL LETT, V295, P238, DOI 10.1111/j.1574-6968.2009.01605.x; Park W, 2006, BIOCHEM BIOPH RES CO, V341, P51, DOI 10.1016/j.bbrc.2005.12.142; Ren B, 2009, J BIOL CHEM, V284, P4829, DOI 10.1074/jbc.M807943200; Rudolph CJ, 2010, DNA REPAIR, V9, P210, DOI 10.1016/j.dnarep.2009.12.014; Rudolph CJ, 2009, MOL MICROBIOL, V73, P352, DOI 10.1111/j.1365-2958.2009.06773.x; Sharples GJ, 1999, J BACTERIOL, V181, P5543, DOI 10.1128/JB.181.18.5543-5550.1999; Shida T, 1996, J BIOL CHEM, V271, P26105, DOI 10.1074/jbc.271.42.26105; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; TAYLOR AF, 1992, P NATL ACAD SCI USA, V89, P5226, DOI 10.1073/pnas.89.12.5226; Vologodskaia MY, 1999, J MOL BIOL, V289, P851, DOI 10.1006/jmbi.1999.2811; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Yeom S, 2010, MICROBIOL-SGM, V156, P1487, DOI 10.1099/mic.0.034181-0; Zaim J, 2003, NUCLEIC ACIDS RES, V31, P1444, DOI 10.1093/nar/gkg234; Zeller T, 2004, MICROBIOL-SGM, V150, P3451, DOI 10.1099/mic.0.27308-0; Zhao JJ, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/126986; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	36	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24492	24504		10.1074/jbc.M112.356964	http://dx.doi.org/10.1074/jbc.M112.356964			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22621928	Green Published, hybrid			2022-12-25	WOS:000306651100042
J	Summa, KC; Vitaterna, MH; Turek, FW				Summa, Keith C.; Vitaterna, Martha Hotz; Turek, Fred W.			Environmental Perturbation of the Circadian Clock Disrupts Pregnancy in the Mouse	PLOS ONE			English	Article							VPAC(2) RECEPTOR; SHIFT WORK; OSCILLATORS; RHYTHMICITY; UTERUS; SLEEP	Background: The circadian clock has been linked to reproduction at many levels in mammals. Epidemiological studies of female shift workers have reported increased rates of reproductive abnormalities and adverse pregnancy outcomes, although whether the cause is circadian disruption or another factor associated with shift work is unknown. Here we test whether environmental disruption of circadian rhythms, using repeated shifts of the light: dark (LD) cycle, adversely affects reproductive success in mice. Methodology/Principal Findings: Young adult female C57BL/6J (B6) mice were paired with B6 males until copulation was verified by visual identification of vaginal plug formation. Females were then randomly assigned to one of three groups: control, phase-delay or phase-advance. Controls remained on a constant 12-hr light:12-hr dark cycle, whereas phase-delayed and phase-advanced mice were subjected to 6-hr delays or advances in the LD cycle every 5-6 days, respectively. The number of copulations resulting in term pregnancies was determined. Control females had a full-term pregnancy success rate of 90% (11/12), which fell to 50% (9/18; p<0.1) in the phase-delay group and 22% (4/18; p<0.01) in the phase-advance group. Conclusions/Significance: Repeated shifting of the LD cycle, which disrupts endogenous circadian timekeeping, dramatically reduces pregnancy success in mice. Advances of the LD cycle have a greater negative impact on pregnancy outcomes and, in non-pregnant female mice, require longer for circadian re-entrainment, suggesting that the magnitude or duration of circadian misalignment may be related to the severity of the adverse impact on pregnancy. These results explicitly link disruptions of circadian entrainment to adverse pregnancy outcomes in mammals, which may have important implications for the reproductive health of female shift workers, women with circadian rhythm sleep disorders and/or women with disturbed circadian rhythms for other reasons.	[Summa, Keith C.; Vitaterna, Martha Hotz; Turek, Fred W.] Northwestern Univ, Dept Neurobiol, Ctr Sleep & Circadian Biol, Evanston, IL 60208 USA; [Summa, Keith C.; Turek, Fred W.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Feinberg School of Medicine	Summa, KC (corresponding author), Northwestern Univ, Dept Neurobiol, Ctr Sleep & Circadian Biol, Evanston, IL 60208 USA.	fturek@northwestern.edu		Summa, Keith/0000-0001-9541-8458	March of Dimes Prematurity Research Initiative [21-FY08-506]; National Institutes of Health (NIH) at the Morehouse School of Medicine [U54 NS060659]; NIH [T32 HL007909]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS060659] Funding Source: NIH RePORTER	March of Dimes Prematurity Research Initiative(March of Dimes); National Institutes of Health (NIH) at the Morehouse School of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research was funded by the March of Dimes Prematurity Research Initiative award 21-FY08-506 (F.W.T. & M.H.V.) (www.marchofdimes.com). In addition, support was provided by the National Institutes of Health (NIH) Cooperative Agreement U54 NS060659 to Peter MacLeish at the Morehouse School of Medicine (F.W.T.) and the NIH T32 HL007909 (K.C.S.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akiyama S, 2010, TOHOKU J EXP MED, V221, P287, DOI 10.1620/tjem.221.287; Aspholm R, 1999, J OCCUP ENVIRON MED, V41, P486, DOI 10.1097/00043764-199906000-00015; Bisanti L, 1996, J OCCUP ENVIRON MED, V38, P352, DOI 10.1097/00043764-199604000-00012; Cone JE, 1998, J OCCUP ENVIRON MED, V40, P210, DOI 10.1097/00043764-199803000-00002; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; CZEISLER CA, 1982, SCIENCE, V217, P460, DOI 10.1126/science.7089576; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; DAVIS FC, 1988, J COMP PHYSIOL A, V162, P601, DOI 10.1007/BF01342635; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; Goodman R, 1999, ENCY REPROD, V4, P341; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Kennaway DJ, 2012, MOL CELL ENDOCRINOL, V349, P56, DOI 10.1016/j.mce.2011.08.013; Kennaway DJ, 2005, HUM REPROD UPDATE, V11, P91, DOI 10.1093/humupd/dmh054; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Labyak Susan, 2002, Health Care Women Int, V23, P703, DOI 10.1080/07399330290107449; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; Okun ML, 2011, SLEEP, V34, P1493, DOI 10.5665/sleep.1384; Ratajczak CK, 2010, REPROD FERT DEVELOP, V22, P743, DOI 10.1071/RD09243; Roizen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000922; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Silver L.M., 1995, MOUSE GENETICS CONCE; SWANN JM, 1985, SCIENCE, V228, P898, DOI 10.1126/science.4001926; Varcoe TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018504; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682	27	64	66	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37668	10.1371/journal.pone.0037668	http://dx.doi.org/10.1371/journal.pone.0037668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649550	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335800069
J	Wang, SQ; Xiao, WM; Shan, SC; Jiang, CS; Chen, M; Zhang, Y; Lu, SQ; Chen, J; Zhang, CM; Chen, Q; Long, M				Wang, Shiqi; Xiao, Weiming; Shan, Sicong; Jiang, Chunsun; Chen, Ming; Zhang, Yan; Lu, Shouqin; Chen, Juan; Zhang, Chuanmao; Chen, Quan; Long, Mian			Multi-Patterned Dynamics of Mitochondrial Fission and Fusion in a Living Cell	PLOS ONE			English	Article							MAMMALIAN-CELLS; YEAST; MICROTUBULES; SEGREGATION; MORPHOLOGY; APOPTOSIS; TRANSPORT; MOVEMENT	Mitochondria are highly-dynamic organelles, but it is challenging to monitor quantitatively their dynamics in a living cell. Here we developed a novel approach to determine the global occurrence of mitochondrial fission and fusion events in living human epithelial cells (Hela) and mouse embryonic fibroblast cells (MEF). Distinct patterns of sequential events including fusion followed by fission (Fu-Fi), the so-called "kiss and run'' model previously described, fission followed by fusion (Fi-Fu), fusion followed by fusion (Fu-Fu), and fission followed by fission (Fi-Fi) were observed concurrently. The paired events appeared in high frequencies with short lifetimes and large sizes of individual mitochondria, as compared to those for unpaired events. The high frequencies of paired events were found to be biologically significant. The presence of membrane uncoupler CCCP enhanced the frequency of paired events (from both Fu-Fi and Fi-Fu patterns) with a reduced mitochondrial size. Knock-out of mitofusin protein Mfn1 increased the frequency of fission with increased lifetime of unpaired events whereas deletion of both Mfn1 and Mfn2 resulted in an instable dynamics. These results indicated that the paired events were dominant but unpaired events were not negligible, which provided a new insight into mitochondrial dynamics. In addition to kiss and run model of action, our data suggest that, from a global visualization over an entire cell, multiple patterns of action appeared in mitochondrial fusion and fission.	[Wang, Shiqi; Shan, Sicong; Zhang, Yan; Lu, Shouqin; Chen, Juan; Long, Mian] Chinese Acad Sci, Natl Micrograv Lab, Key Lab Micrograv, Beijing, Peoples R China; [Wang, Shiqi; Shan, Sicong; Zhang, Yan; Lu, Shouqin; Chen, Juan; Long, Mian] Chinese Acad Sci, Inst Mech, Ctr Biomech & Bioengn, Beijing 100080, Peoples R China; [Xiao, Weiming; Jiang, Chunsun; Chen, Ming; Chen, Quan] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China; [Xiao, Weiming; Zhang, Chuanmao] Peking Univ, Coll Life Sci, Dept Cell Biol & Genet, Beijing 100871, Peoples R China; [Xiao, Weiming; Zhang, Chuanmao] Peking Univ, Natl Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Wang, Shiqi] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Peking University; Peking University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Wang, SQ (corresponding author), Chinese Acad Sci, Natl Micrograv Lab, Key Lab Micrograv, Beijing, Peoples R China.	chenq@ioz.ac.cn; mlong@imech.ac.cn	Shan, Sicong/I-3412-2019	Shan, Sicong/0000-0002-4470-4662; Chen, Quan/0000-0001-7539-8728	Chinese Academy of Sciences [KJCX2-YW-L08]; National Natural Science; Foundation of China [30730032, 30730093]; National Key Basic Research Foundation of China [2006CB910303]; National High Technology Research and Development Program of China [2007AA02Z306]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science(National Natural Science Foundation of China (NSFC)); Foundation of China; National Key Basic Research Foundation of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by Chinese Academy of Sciences grant KJCX2-YW-L08, National Natural Science (http://english.cas.cn/), Foundation of China grants 30730032 and 30730093 (http://www.nsfc.gov.cn/Portal0/default106.htm), National Key Basic Research Foundation of China grant 2006CB910303 (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm), and National High Technology Research and Development Program of China grant 2007AA02Z306 (http://www.most.gov.cn/eng/programmes1/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Gorsich SW, 2004, MOL BIOL CELL, V15, P4369, DOI 10.1091/mbc.E03-12-0875; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Knowles MK, 2002, P NATL ACAD SCI USA, V99, P14772, DOI 10.1073/pnas.232346999; Li DD, 2004, BIOPHYS J, V87, P1991, DOI 10.1529/biophysj.104.043281; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Miller KE, 2006, J CELL BIOL, V173, P373, DOI 10.1083/jcb.200510097; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Rojo M, 2002, J CELL SCI, V115, P1663; SALMEEN I, 1985, BIOPHYS J, V48, P681, DOI 10.1016/S0006-3495(85)83825-X; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Scheffler IE, 2001, ADV DRUG DELIVER REV, V49, P3, DOI 10.1016/S0169-409X(01)00123-5; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; TANG XW, 1994, CHINESE PHYS LETT, V11, P522, DOI 10.1088/0256-307X/11/8/016; TERADA H, 1990, ENVIRON HEALTH PERSP, V87, P213, DOI 10.2307/3431027; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wagner OI, 2003, J NEUROSCI, V23, P9046; Wang SQ, 2010, SCI CHINA PHYS MECH, V53, P680, DOI 10.1007/s11433-010-0163-5; Wang SQ, 2008, CELL MOL BIOENG, V1, P67, DOI 10.1007/s12195-008-0002-1; Yaffe MP, 1996, P NATL ACAD SCI USA, V93, P11664, DOI 10.1073/pnas.93.21.11664; Yaffe MP, 2003, P NATL ACAD SCI USA, V100, P11424, DOI 10.1073/pnas.1534703100; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	30	40	42	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e19879	10.1371/journal.pone.0019879	http://dx.doi.org/10.1371/journal.pone.0019879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649485	gold, Green Published			2022-12-25	WOS:000305335800001
J	Kiburu, IN; LaRonde-LeBlanc, N				Kiburu, Irene N.; LaRonde-LeBlanc, Nicole			Interaction of Rio1 Kinase with Toyocamycin Reveals a Conformational Switch That Controls Oligomeric State and Catalytic Activity	PLOS ONE			English	Article							CYTOPLASMIC MATURATION; CRYSTAL-STRUCTURE; FULGIDUS RIO2; RIBOSOMAL-RNA; FAMILY; INHIBITION; ASSEMBLIES; MECHANISM; SUBSTRATE; SOFTWARE	Rio1 kinase is an essential ribosome-processing factor required for proper maturation of 40 S ribosomal subunit. Although its structure is known, several questions regarding its functional remain to be addressed. We report that both Archaeoglobus fulgidus and human Rio1 bind more tightly to an adenosine analog, toyocamycin, than to ATP. Toyocamycin has antibiotic, antiviral and cytotoxic properties, and is known to inhibit ribosome biogenesis, specifically the maturation of 40 S. We determined the X-ray crystal structure of toyocamycin bound to Rio1 at 2.0 angstrom and demonstrated that toyocamycin binds in the ATP binding pocket of the protein. Despite this, measured steady state kinetics were inconsistent with strict competitive inhibition by toyocamycin. In analyzing this interaction, we discovered that Rio1 is capable of accessing multiple distinct oligomeric states and that toyocamycin may inhibit Rio1 by stabilizing a less catalytically active oligomer. We also present evidence of substrate inhibition by high concentrations of ATP for both archaeal and human Rio1. Oligomeric state studies show both proteins access a higher order oligomeric state in the presence of ATP. The study revealed that autophosphorylation by Rio1 reduces oligomer formation and promotes monomerization, resulting in the most active species. Taken together, these results suggest the activity of Rio1 may be modulated by regulating its oligomerization properties in a conserved mechanism, identifies the first ribosome processing target of toyocamycin and presents the first small molecule inhibitor of Rio1 kinase activity.	[Kiburu, Irene N.] Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA; Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Kiburu, IN (corresponding author), Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA.	nlaronde@umd.edu	LaRonde-LeBlanc, Nicole A/C-3399-2009	LaRonde-LeBlanc, Nicole A/0000-0002-2778-8358	National Institutes of Health National Cancer Institute (NIH/NCI) [K22CA123152]; National Center for Research Resources at the National Institutes of Health [RR-15301]; NATIONAL CANCER INSTITUTE [K22CA123152] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health National Cancer Institute (NIH/NCI), award K22CA123152, and National Center for Research Resources at the National Institutes of Health, award RR-15301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Angermayr M, 2002, FEBS LETT, V524, P31, DOI 10.1016/S0014-5793(02)02993-9; Angermayr M, 2002, MOL MICROBIOL, V44, P309, DOI 10.1046/j.1365-2958.2002.02881.x; Angermayr M, 2007, FEBS J, V274, P4654, DOI 10.1111/j.1742-4658.2007.05993.x; Beillard E, 2005, CELL CYCLE, V4, P434, DOI 10.4161/cc.4.3.1557; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Cohen BM, 1984, MOL PHARM, V27, P308; CONNELLCROWLEY L, 1993, MOL BIOL CELL, V4, P79, DOI 10.1091/mbc.4.1.79; Derenzini M, 2000, J PATHOL, V191, P181, DOI 10.1002/(SICI)1096-9896(200006)191:2<181::AID-PATH607>3.0.CO;2-V; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Guderian G, 2011, J BIOL CHEM, V286, P1976, DOI 10.1074/jbc.M110.148486; Gyenis L, 2011, J PROTEOME RES, V10, P4887, DOI 10.1021/pr2008994; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; HEINE U, 1969, CANCER RES, V29, P1875; Humbard MA, 2010, ARCHAEA, V2010, DOI 10.1155/2010/481725; Jaffe EK, 2012, METHODS MOL BIOL, V796, P217, DOI 10.1007/978-1-61779-334-9_12; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Kokona B, 2008, BIOCHEMISTRY-US, V47, P10649, DOI 10.1021/bi801128d; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LaRonde-LeBlanc N, 2005, J BIOL CHEM, V280, P37297, DOI 10.1074/jbc.R500013200; LaRonde-LeBlanc N, 2005, FEBS J, V272, P3698, DOI 10.1111/j.1742-4658.2005.04796.x; LaRonde-LeBlanc N, 2005, FEBS J, V272, P2800, DOI 10.1111/j.1742-4658.2005.04702.x; LaRonde-LeBlanc N, 2004, STRUCTURE, V12, P1585, DOI 10.1016/j.str.2004.06.016; Long MC, 2006, BIOCHEM PHARMACOL, V71, P1671, DOI 10.1016/j.bcp.2006.03.006; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MANSOUR TE, 1972, J BIOL CHEM, V247, P6059; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISHIOKA H, 1990, J ANTIBIOT, V43, P1586, DOI 10.7164/antibiotics.43.1586; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALCZEWSKI K, 1990, BIOCHEMISTRY-US, V29, P6276, DOI 10.1021/bi00478a024; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; RIMAN J, 1969, CANCER RES, V29, P1707; Selwood T, 2008, BIOCHEMISTRY-US, V47, P3245, DOI 10.1021/bi702113z; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; SU JY, 1994, INT J BIOCHEM, V26, P519, DOI 10.1016/0020-711X(94)90009-4; TAVITIAN A, 1968, BIOCHIM BIOPHYS ACTA, V157, P33, DOI 10.1016/0005-2787(68)90261-X; UYEDA K, 1981, J BIOL CHEM, V256, P8394; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Widmann B, 2012, MOL BIOL CELL, V23, P22, DOI 10.1091/mbc.E11-07-0639; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	54	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37371	10.1371/journal.pone.0037371	http://dx.doi.org/10.1371/journal.pone.0037371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629386	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300035
J	Stonkute, S; Braun, J; Pastukhov, A				Stonkute, Solveiga; Braun, Jochen; Pastukhov, Alexander			The Role of Attention in Ambiguous Reversals of Structure-From-Motion	PLOS ONE			English	Article							VISUAL-ATTENTION; PERCEPTUAL ORGANIZATION; MICROSACCADES; PERFORMANCE; SEGMENTATION; FLUCTUATIONS; ADAPTATION; FORM	Multiple dots moving independently back and forth on a flat screen induce a compelling illusion of a sphere rotating in depth (structure-from-motion). If all dots simultaneously reverse their direction of motion, two perceptual outcomes are possible: either the illusory rotation reverses as well (and the illusory depth of each dot is maintained), or the illusory rotation is maintained (but the illusory depth of each dot reverses). We investigated the role of attention in these ambiguous reversals. Greater availability of attention - as manipulated with a concurrent task or inferred from eye movement statistics - shifted the balance in favor of reversing illusory rotation (rather than depth). On the other hand, volitional control over illusory reversals was limited and did not depend on tracking individual dots during the direction reversal. Finally, display properties strongly influenced ambiguous reversals. Any asymmetries between 'front' and 'back' surfaces - created either on purpose by coloring or accidentally by random dot placement - also shifted the balance in favor of reversing illusory rotation (rather than depth). We conclude that the outcome of ambiguous reversals depends on attention, specifically on attention to the illusory sphere and its surface irregularities, but not on attentive tracking of individual surface dots.	[Stonkute, Solveiga; Braun, Jochen; Pastukhov, Alexander] Otto Von Guericke Univ, Inst Biol, Cognit Biol Lab, Magdeburg, Germany	Otto von Guericke University	Stonkute, S (corresponding author), Otto Von Guericke Univ, Inst Biol, Cognit Biol Lab, Magdeburg, Germany.	Pastukhov.Alexander@gmail.com	Stonkute, Solveiga/C-5572-2013; Braun, Jochen/F-1370-2013; Pastukhov, Alexander/F-1399-2013	Braun, Jochen/0000-0002-8886-078X; Pastukhov, Alexander/0000-0002-8738-8591	Bundesministerium fur Bildung und Forschung Bernstein Network; State of Saxony-Anhalt	Bundesministerium fur Bildung und Forschung Bernstein Network(Federal Ministry of Education & Research (BMBF)); State of Saxony-Anhalt	The authors were supported by the Bundesministerium fur Bildung und Forschung Bernstein Network (http://www.nncn.uni-freiburg.de) and the State of Saxony-Anhalt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, CURR BIOL, V20, P1362, DOI 10.1016/j.cub.2010.06.015; Bauer H-U, 2000, PREPARATIONAL INTELL, P163, DOI 10.1.1.30.5763; BENAV MB, 1992, PERCEPT PSYCHOPHYS, V52, P277, DOI 10.3758/BF03209145; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRIDGEMAN B, 1980, VISION RES, V20, P813, DOI 10.1016/0042-6989(80)90013-9; Brouwer GJ, 2006, VISION RES, V46, P3393, DOI 10.1016/j.visres.2006.03.016; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Chen XC, 2004, CURR BIOL, V14, P1013, DOI 10.1016/j.cub.2004.05.042; Cohen MR, 2011, J NEUROSCI, V31, P15802, DOI 10.1523/JNEUROSCI.3063-11.2011; Cohen MR, 2010, J NEUROSCI, V30, P15241, DOI 10.1523/JNEUROSCI.2171-10.2010; Driver J, 2001, COGNITION, V80, P61, DOI 10.1016/S0010-0277(00)00151-7; Einhauser W, 2008, P NATL ACAD SCI USA, V105, P1704, DOI 10.1073/pnas.0707727105; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Fang F, 2004, CURR BIOL, V14, P247, DOI 10.1016/j.cub.2004.01.031; Helmholtz H., 1866, TREATISE PHYSL OPTIC, VVol. III; Hol K, 2003, J VISION, V3, P486, DOI 10.1167/3.7.3; Hupe JM, 2009, J VISION, V9, DOI 10.1167/9.7.10; Jackson S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003982; Kang MS, 2010, ATTEN PERCEPT PSYCHO, V72, P179, DOI 10.3758/APP.72.1.179; Klink PC, 2008, J VISION, V8, DOI 10.1167/8.5.16; Kourtzi Z, 2008, TRENDS COGN SCI, V12, P230, DOI 10.1016/j.tics.2008.02.013; Lee DK, 1999, PERCEPT PSYCHOPHYS, V61, P1241, DOI 10.3758/BF03206177; Li HCO, 1999, VISION RES, V39, P881, DOI 10.1016/S0042-6989(98)00247-8; MACK A, 1992, COGNITIVE PSYCHOL, V24, P475, DOI 10.1016/0010-0285(92)90016-U; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; NAWROT M, 1989, SCIENCE, V244, P716, DOI 10.1126/science.2717948; Necker L. A., 1832, LONDON EDINBURGH PHI, V1, P329, DOI DOI 10.1080/14786443208647909; Orban GA, 2011, ANNU REV NEUROSCI, V34, P361, DOI 10.1146/annurev-neuro-061010-113819; Pastukhov A, 2012, J VISION, V12, DOI 10.1167/12.1.17; Pastukhov A, 2011, J VISION, V11, DOI 10.1167/11.10.12; Pastukhov A, 2010, VISION RES, V50, P1173, DOI 10.1016/j.visres.2010.04.007; Pastukhov A, 2009, VISION RES, V49, P1166, DOI 10.1016/j.visres.2008.04.011; Petersik JT, 2004, SPATIAL VISION, V17, P201, DOI 10.1163/1568568041866015; RAMACHANDRAN VS, 1983, NATURE, V304, P529, DOI 10.1038/304529a0; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; SCHWARTZ BJ, 1983, B PSYCHONOMIC SOC, V21, P456, DOI 10.3758/BF03330007; Sperling G., 1994, EARLY VISION, P133; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Treder MS, 2010, J VISION, V10, DOI 10.1167/10.4.5; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; TREUE S, 1995, VISION RES, V35, P139, DOI 10.1016/0042-6989(94)E0069-W; van Dam LCJ, 2006, VISION RES, V46, P787, DOI 10.1016/j.visres.2005.10.011; van Dam LCJ, 2006, J VISION, V6, P1172, DOI 10.1167/6.11.3; van Ee R, 2009, J OPT SOC AM A, V26, P2612, DOI 10.1364/JOSAA.26.002612; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; WINTERSON BJ, 1976, VISION RES, V16, P1387, DOI 10.1016/0042-6989(76)90156-5; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936; Zivotofsky AZ, 2007, NEUROSCI LETT, V415, P195, DOI 10.1016/j.neulet.2007.01.016	52	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37734	10.1371/journal.pone.0037734	http://dx.doi.org/10.1371/journal.pone.0037734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629450	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300073
J	Bell, JL; Malyukova, A; Holien, JK; Koach, J; Parker, MW; Kavallaris, M; Marshall, GM; Cheung, BB				Bell, Jessica L.; Malyukova, Alena; Holien, Jessica K.; Koach, Jessica; Parker, Michael W.; Kavallaris, Maria; Marshall, Glenn M.; Cheung, Belamy B.			TRIM16 Acts as an E3 Ubiquitin Ligase and Can Heterodimerize with Other TRIM Family Members	PLOS ONE			English	Article							B BOX PROTEIN; TRIPARTITE MOTIF; DOMAIN; SENSITIVITY; PML	The TRIM family of proteins is distinguished by its tripartite motif (TRIM). Typically, TRIM proteins contain a RING finger domain, one or two B-box domains, a coiled-coil domain and the more variable C-terminal domains. TRIM16 does not have a RING domain but does harbour two B-box domains. Here we showed that TRIM16 homodimerized through its coiled-coil domain and heterodimerized with other TRIM family members; TRIM24, Promyelocytic leukaemia (PML) protein and Midline-1 (MID1). Although, TRIM16 has no classic RING domain, three-dimensional modelling of TRIM16 suggested that its B-box domains adopts RING-like folds leading to the hypothesis that TRIM16 acts as an ubiquitin ligase. Consistent with this hypothesis, we demonstrated that TRIM16, devoid of a classical RING domain had auto-polyubiquitination activity and acted as an E3 ubiquitin ligase in vivo and in vitro assays. Thus via its unique structure, TRIM16 possesses both heterodimerization function with other TRIM proteins and also has E3 ubiquitin ligase activity.	[Bell, Jessica L.; Malyukova, Alena; Koach, Jessica; Kavallaris, Maria; Marshall, Glenn M.; Cheung, Belamy B.] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Randwick, NSW, Australia; [Holien, Jessica K.; Parker, Michael W.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Bio21 Mol Sci & Inst, Parkville, Vic 3052, Australia; [Marshall, Glenn M.] Sydney Childrens Hosp, Ctr Childrens Canc & Blood Disorders, Randwick, NSW, Australia	Children's Cancer Institute; University of New South Wales Sydney; St. Vincent's Institute of Medical Research; University of Melbourne	Bell, JL (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Randwick, NSW, Australia.	g.marshall@unsw.edu.au; bcheung@ccia.unsw.edu.au	Kavallaris, Maria/J-5240-2014; Holien, Jess/V-7005-2019; Parker, Michael W/F-9069-2013	Holien, Jess/0000-0002-8735-2871; Parker, Michael W/0000-0002-3101-1138; Cheung, Belamy/0000-0001-8784-860X; Bell, Jessica/0000-0002-8875-0943	Early Career Development Fellowship, Cancer Institute NSW; National Health & Medical Research Council (NHMRC); Biomedical PhD Scholarship; Victorian State Government Operational Infrastructure Support Program	Early Career Development Fellowship, Cancer Institute NSW; National Health & Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia); Biomedical PhD Scholarship; Victorian State Government Operational Infrastructure Support Program	This work was supported by an Early Career Development Fellowship, Cancer Institute NSW (B. C.); National Health & Medical Research Council (NHMRC) and a Biomedical PhD Scholarship (J.B.). M. W. P. is an Australian Research Council Federation Fellow and an NHMRC Honorary Fellow and thanks the Victorian State Government Operational Infrastructure Support Program for support. M. K. is an NHMRC Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda-Orgilles B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003507; BARLOW PN, 1994, J MOL BIOL, V237, P201, DOI 10.1006/jmbi.1994.1222; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Cao TY, 1998, J CELL SCI, V111, P1319; Cao TY, 1997, J CELL SCI, V110, P1563; Cheung BB, 2006, J BIOL CHEM, V281, P18246, DOI 10.1074/jbc.M600879200; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Han XF, 2011, J MOL BIOL, V407, P505, DOI 10.1016/j.jmb.2011.01.048; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Marshall GM, 2010, ONCOGENE, V29, P6172, DOI 10.1038/onc.2010.340; Massiah MA, 2006, J MOL BIOL, V358, P532, DOI 10.1016/j.jmb.2006.02.009; Massiah MA, 2007, J MOL BIOL, V369, P1, DOI 10.1016/j.jmb.2007.03.017; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Raif A, 2009, CANCER LETT, V277, P82, DOI 10.1016/j.canlet.2008.11.030; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Takahashi H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-39; Tao H, 2008, BIOCHEMISTRY-US, V47, P2450, DOI 10.1021/bi7018496; van der Aa LM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-7; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463	22	76	79	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37470	10.1371/journal.pone.0037470	http://dx.doi.org/10.1371/journal.pone.0037470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629402	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343100032
J	Gharib, SA; Khalyfa, A; Abdelkarim, A; Bhushan, B; Gozal, D				Gharib, Sina A.; Khalyfa, Abdelnaby; Abdelkarim, Amal; Bhushan, Bharat; Gozal, David			Integrative miRNA-mRNA Profiling of Adipose Tissue Unravels Transcriptional Circuits Induced by Sleep Fragmentation	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; ADIPOCYTE DIFFERENTIATION; SUBCUTANEOUS ADIPOSE; EXPRESSION PROFILES; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; GENE-EXPRESSION; HEART HEALTH; RISK-FACTORS; MICRORNAS	Obstructive sleep apnea (OSA) is a prevalent condition and strongly associated with metabolic disorders. Sleep fragmentation (SF) is a major consequence of OSA, but its contribution to OSA-related morbidities is not known. We hypothesized that SF causes specific perturbations in transcriptional networks of visceral fat cells, leading to systemic metabolic disturbances. We simultaneously profiled visceral adipose tissue mRNA and miRNA expression in mice exposed to 6 hours of SF during sleep, and developed a new computational framework based on gene set enrichment and network analyses to merge these data. This approach leverages known gene product interactions and biologic pathways to interrogate large-scale gene expression profiling data. We found that SF induced the activation of several distinct pathways, including those involved in insulin regulation and diabetes. Our integrative methodology identified putative controllers and regulators of the metabolic response during SF. We functionally validated our findings by demonstrating altered glucose and lipid homeostasis in sleep-fragmented mice. This is the first study to link sleep fragmentation with widespread disruptions in visceral adipose tissue transcriptome, and presents a generalizable approach to integrate mRNA-miRNA information for systematic mapping of regulatory networks.	[Gharib, Sina A.] Univ Washington, Dept Med, Ctr Lung Biol, Seattle, WA 98195 USA; [Gharib, Sina A.] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA USA; [Khalyfa, Abdelnaby; Abdelkarim, Amal; Bhushan, Bharat; Gozal, David] Univ Chicago, Dept Pediat, Div Biol Sci, Chicago, IL 60637 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago	Gharib, SA (corresponding author), Univ Washington, Dept Med, Ctr Lung Biol, Seattle, WA 98195 USA.	dgozal@uchicago.edu	Khalyfa, Abdelnaby/M-9498-2017; Bhushan, Bharat/G-3530-2016; Gozal, David/M-9492-2017; Gozal, David/ABH-3805-2020	Bhushan, Bharat/0000-0002-4182-9478; GHARIB, SINA A./0000-0002-2480-4367	National Institutes of Health [HL-065270, HL-086662]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086662, R01HL065270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study is supported by National Institutes of Health grants HL-065270 and HL-086662 to DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam I, 2007, OBES REV, V8, P119, DOI 10.1111/j.1467-789X.2006.00269.x; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bosello O, 2000, Obes Rev, V1, P47, DOI 10.1046/j.1467-789x.2000.00008.x; Botros N, 2009, AM J MED, V122, P1122, DOI 10.1016/j.amjmed.2009.04.026; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gauthier BR, 2006, NAT MED, V12, P36, DOI 10.1038/nm0106-36; Gharib SA, 2011, J MOL MED B IN PRESS; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Gozal D, 2001, Sleep Breath, V5, P35; Gozal D, 1998, PEDIATRICS, V102, P616, DOI 10.1542/peds.102.3.616; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Heikkinen S., 2007, EVALUATION GLUCOSE H; Heneghan HM, 2011, J CLIN ENDOCR METAB, V96, pE846, DOI 10.1210/jc.2010-2701; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jun J, 2009, ILAR J, V50, P289, DOI 10.1093/ilar.50.3.289; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Khalyfa A, 2010, AM J RESP CRIT CARE, V181, P1114, DOI 10.1164/rccm.200909-1398OC; Khalyfa A, 2009, SLEEP MED, V10, P75, DOI 10.1016/j.sleep.2007.11.006; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Nair D, 2011, AM J RESP CRIT CARE, V184, P1305, DOI 10.1164/rccm.201107-1173OC; Nielsen JA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-98; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Peterson CW, 2010, MOL CELL BIOL, V30, P2887, DOI 10.1128/MCB.01613-09; Pohjanvirta R, 2008, TOXICOL APPL PHARM, V230, P41, DOI 10.1016/j.taap.2008.02.002; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Punjabi NM, 2009, AM J RESP CRIT CARE, V179, P235, DOI 10.1164/rccm.200809-1392OC; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; Ramesh V., 2009, SLEEP SCI, V2, P64; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Rosen CL, 2003, J PEDIATR-US, V142, P383, DOI 10.1067/mpd.2003.28; Sans CL, 2006, MOL CELL BIOL, V26, P4863, DOI 10.1128/MCB.00657-05; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sukumaran S, 2010, PHYSIOL GENOMICS, V42A, P141, DOI 10.1152/physiolgenomics.00106.2010; Tasali Esra, 2008, Proc Am Thorac Soc, V5, P207, DOI 10.1513/pats.200708-139MG; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357	63	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37669	10.1371/journal.pone.0037669	http://dx.doi.org/10.1371/journal.pone.0037669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629440	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100044
J	Okazaki, A; Sudo, Y; Takagi, S				Okazaki, Ayako; Sudo, Yuki; Takagi, Shin			Optical Silencing of C. elegans Cells with Arch Proton Pump	PLOS ONE			English	Article							NERVOUS-SYSTEM; INTERROGATION; ACTIVATION; EXPRESSION; MEMBRANE; FAMILY	Background: Optogenetic techniques using light-driven ion channels or ion pumps for controlling excitable cells have greatly facilitated the investigation of nervous systems in vivo. A model organism, C. elegans, with its small transparent body and well-characterized neural circuits, is especially suitable for optogenetic analyses. Methodology/Principal Findings: We describe the application of archaerhodopsin-3 (Arch), a recently reported optical neuronal silencer, to C. elegans. Arch::GFP expressed either in all neurons or body wall muscles of the entire body by means of transgenes were localized, at least partially, to the cell membrane without adverse effects, and caused locomotory paralysis of worms when illuminated by green light (550 nm). Pan-neuronal expression of Arch endowed worms with quick and sustained responsiveness to such light. Worms reliably responded to repeated periods of illumination and non-illumination, and remained paralyzed under continuous illumination for 30 seconds. Worms expressing Arch in different subsets of motor neurons exhibited distinct defects in the locomotory behavior under green light: selective silencing of A-type motor neurons affected backward movement while silencing of B-type motor neurons affected forward movement more severely. Our experiments using a heat-shock-mediated induction system also indicate that Arch becomes fully functional only 12 hours after induction and remains functional for more than 24 hour. Conclusions/Sgnificance: Arch can be used for silencing neurons and muscles, and may be a useful alternative to currently widely used halorhodopsin (NpHR) in optogenetic studies of C. elegans.	[Okazaki, Ayako; Sudo, Yuki; Takagi, Shin] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan	Nagoya University	Okazaki, A (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan.	i45116a@nucc.cc.nagoya-u.ac.jp	Sudo, Yuki/AGY-0493-2022	Sudo, Yuki/0000-0001-8155-9356	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [23657100, 22300126] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (ST), and from Japan Society for the Promotion of Science (AO). AO is a JSPS DC1 Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Booth PJ, 1996, BIOCHEMISTRY-US, V35, P5902, DOI 10.1021/bi960129e; Brenner S, 1974, GENETICS, V77, P41; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chalfie M., 1988, NEMATODE CAENORHABDI, P337; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hart AC, 2006, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.87.1, 10.1895/wormbook.1.87.1]; JONES D, 1989, DNA-J MOLEC CELL BIO, V8, P481, DOI 10.1089/dna.1.1989.8.481; Jorgensen Erik M, 2005, WormBook, P1; Knopfel T, 2010, J NEUROSCI, V30, P14998, DOI 10.1523/JNEUROSCI.4190-10.2010; Kuroyanagi H, 2010, NAT PROTOC, V5, P1495, DOI 10.1038/nprot.2010.107; Liu Q, 2006, J BIOL CHEM, V281, P7881, DOI 10.1074/jbc.M512382200; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; MILLER DM, 1995, DEVELOPMENT, V121, P2877; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nukazuka A, 2008, GENE DEV, V22, P1025, DOI 10.1101/gad.1644008; Rand JB, 2007, ACETYLCHOLINE C ELEG, DOI [doi/10.1895/wormbook.1.14.1, DOI 10.1895/WORMBOOK.1.14.1]; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; STOECKENIUS W, 1979, BIOCHIM BIOPHYS ACTA, V505, P215, DOI 10.1016/0304-4173(79)90006-5; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Winnier AR, 1999, GENE DEV, V13, P2774, DOI 10.1101/gad.13.21.2774; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	30	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e35370	10.1371/journal.pone.0035370	http://dx.doi.org/10.1371/journal.pone.0035370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629299	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343100001
J	Yashiro, E; McManus, PS				Yashiro, Erika; McManus, Patricia S.			Effect of Streptomycin Treatment on Bacterial Community Structure in the Apple Phyllosphere	PLOS ONE			English	Article							RESISTANCE GENES; ANTIBIOTIC-RESISTANCE; PSEUDOMONAS-SYRINGAE; TRANSPOSON TN5393; PHYLLOPLANE; MANAGEMENT; DIVERSITY; PLASMIDS; IMPACT; SPREAD	We studied the effect of many years of streptomycin use in apple orchards on the proportion of phyllosphere bacteria resistant to streptomycin and bacterial community structure. Leaf samples were collected during early July through early September from four orchards that had been sprayed with streptomycin during spring of most years for at least 10 years and four orchards that had not been sprayed. The percentage of cultured phyllosphere bacteria resistant to streptomycin at non-sprayed orchards (mean of 65%) was greater than at sprayed orchards (mean of 50%) (P = 0.0271). For each orchard, a 16S rRNA gene clone library was constructed from leaf samples. Proteobacteria dominated the bacterial communities at all orchards, accounting for 71 of 104 OTUs (determined at 97% sequence similarity) and 93% of all sequences. The genera Massilia, Methylobacterium, Pantoea, Pseudomonas, and Sphingomonas were shared across all sites. Shannon and Simpson's diversity indices and Pielou's evenness index were similar among orchards regardless of streptomycin use. Analysis of Similarity (ANOSIM) indicated that long-term streptomycin treatment did not account for the observed variability in community structure among orchards (R = -0.104, P = 0.655). Other variables, including time of summer, temperature and time at sampling, and relative distance of the orchards from each other, also had no significant effect on bacterial community structure. We conclude that factors other than streptomycin exposure drive both the proportion of streptomycin-resistant bacteria and phylogenetic makeup of bacterial communities in the apple phyllosphere in middle to late summer.	[Yashiro, Erika; McManus, Patricia S.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Yashiro, E (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.	psm@plantpath.wisc.edu	Yashiro, Erika/G-6234-2016	Yashiro, Erika/0000-0002-2364-9908	United States Department of Agriculture Cooperative State Research, Education and Extension Service projects [WIS04828, WIS01425]; Vaughan-Bascom fund of the Department of Plant Pathology, University of Wisconsin-Madison	United States Department of Agriculture Cooperative State Research, Education and Extension Service projects; Vaughan-Bascom fund of the Department of Plant Pathology, University of Wisconsin-Madison	This work was supported by United States Department of Agriculture Cooperative State Research, Education and Extension Service projects WIS04828 and WIS01425 and the Vaughan-Bascom fund of the Department of Plant Pathology, University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Boehme S, 2004, MOL NUTR FOOD RES, V48, P522, DOI 10.1002/mnfr.200400030; Brauer SL, 2006, FEMS MICROBIOL ECOL, V57, P206, DOI 10.1111/j.1574-6941.2006.00107.x; CHIOU CS, 1993, J BACTERIOL, V175, P732, DOI 10.1128/JB.175.3.732-740.1993; Duffy B, 2011, ACTA HORTIC, V896, P483; GOODMAN RN, 1961, AM J CLIN NUTR, V9, P269, DOI 10.1093/ajcn/9.3.269; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Handelsman J, 2003, CURR OPIN MICROBIOL, V6, P271, DOI 10.1016/S1369-5274(03)00062-6; HIRANO SS, 1990, ANNU REV PHYTOPATHOL, V28, P155, DOI 10.1146/annurev.py.28.090190.001103; Huang TC, 1999, J APPL MICROBIOL, V86, P741, DOI 10.1046/j.1365-2672.1999.00719.x; Huddleston AS, 1997, APPL ENVIRON MICROB, V63, P1288, DOI 10.1128/AEM.63.4.1288-1297.1997; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mayerhofer G, 2009, J ANTIMICROB CHEMOTH, V63, P1076, DOI 10.1093/jac/dkp055; McEwen SA, 2002, CLIN INFECT DIS, V34, pS93, DOI 10.1086/340246; McGhee GC, 2011, PHYTOPATHOLOGY, V101, P192, DOI 10.1094/PHYTO-04-10-0128; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; NORELLI JL, 1991, APPL ENVIRON MICROB, V57, P486, DOI 10.1128/AEM.57.2.486-491.1991; O'Brien TF, 2002, CLIN INFECT DIS, V34, pS78, DOI 10.1086/340244; Ottesen AR, 2009, J FOOD PROTECT, V72, P2321, DOI 10.4315/0362-028X-72.11.2321; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pezzella C, 2004, ANTIMICROB AGENTS CH, V48, P903, DOI 10.1128/AAC.48.3.903-908.2004; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pukall R, 1996, FEMS MICROBIOL ECOL, V20, P53, DOI 10.1016/0168-6496(96)00021-9; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Redford AJ, 2009, MICROB ECOL, V58, P189, DOI 10.1007/s00248-009-9495-y; Rezzonico F, 2009, ANTIMICROB AGENTS CH, V53, P3173, DOI 10.1128/AAC.00036-09; Rodriguez C, 2006, APPL ENVIRON MICROB, V72, P5870, DOI 10.1128/AEM.00963-06; Rodriguez-Sanchez C, 2008, BIOL FERT SOILS, V44, P589, DOI 10.1007/s00374-007-0242-6; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schnabel EL, 1999, APPL ENVIRON MICROB, V65, P4898; SOBICZEWSKI P, 1991, PLANT DIS, V75, P1110, DOI 10.1094/PD-75-1110; SUNDIN GW, 1995, CAN J MICROBIOL, V41, P792, DOI 10.1139/m95-109; SUNDIN GW, 1995, APPL ENVIRON MICROB, V61, P2891, DOI 10.1128/AEM.61.8.2891-2897.1995; SUNDIN GW, 1993, APPL ENVIRON MICROB, V59, P1018, DOI 10.1128/AEM.59.4.1018-1024.1993; Sundin GW, 2002, CURR MICROBIOL, V45, P63, DOI 10.1007/s00284-001-0100-y; Sundin GW, 1996, MOL ECOL, V5, P133, DOI 10.1111/j.1365-294X.1996.tb00299.x; Tolba S, 2002, FEMS MICROBIOL ECOL, V42, P269, DOI 10.1111/j.1574-6941.2002.tb01017.x; van Overbeek LS, 2002, FEMS MICROBIOL ECOL, V42, P277, DOI 10.1111/j.1574-6941.2002.tb01018.x; Vanbroekhoven K, 2004, ENVIRON MICROBIOL, V6, P1123, DOI 10.1111/j.1462-2920.2004.00654.x; WAKSMAN SA, 1946, ANN NY ACAD SCI, V48, P73, DOI 10.1111/j.1749-6632.1946.tb31756.x; Wang HH, 2011, APPL ENVIRON MICROB, V77, P7093, DOI 10.1128/AEM.06565-11; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yashiro E, 2008, PHYTOPATHOLOGY, V98, pS177; Yashiro E, 2011, J APPL MICROBIOL, V110, P1284, DOI 10.1111/j.1365-2672.2011.04975.x	47	38	38	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37131	10.1371/journal.pone.0037131	http://dx.doi.org/10.1371/journal.pone.0037131			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629357	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100013
J	Alberti, MO; Roth, JC; Ismail, M; Tsuruta, Y; Abraham, E; Pereboeva, L; Gerson, SL; Curiel, DT				Alberti, Michael O.; Roth, Justin C.; Ismail, Mourad; Tsuruta, Yuko; Abraham, Edward; Pereboeva, Larisa; Gerson, Stanton L.; Curiel, David T.			Derivation of a Myeloid Cell-Binding Adenovirus for Gene Therapy of Inflammation	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODY; FIBER PROTEINS; PHAGE DISPLAY; HI LOOP; VECTOR; DELIVERY; RECEPTOR; TROPISM; GENERATION; STRATEGY	The gene therapy field is currently limited by the lack of vehicles that permit efficient gene delivery to specific cell or tissue subsets. Native viral vector tropisms offer a powerful platform for transgene delivery but remain nonspecific, requiring elevated viral doses to achieve efficacy. In order to improve upon these strategies, our group has focused on genetically engineering targeting domains into viral capsid proteins, particularly those based on adenovirus serotype 5 (Ad5). Our primary strategy is based on deletion of the fiber knob domain, to eliminate broad tissue specificity through the human coxsackie-and-adenovirus receptor (hCAR), with seamless incorporation of ligands to re-direct Ad tropism to cell types that express the cognate receptors. Previously, our group and others have demonstrated successful implementation of this strategy in order to specifically target Ad to a number of surface molecules expressed on immortalized cell lines. Here, we utilized phage biopanning to identify a myeloid cell-binding peptide (MBP), with the sequence WTLDRGY, and demonstrated that MBP can be successfully incorporated into a knob-deleted Ad5. The resulting virus, Ad. MBP, results in specific binding to primary myeloid cell types, as well as significantly higher transduction of these target populations ex vivo, compared to unmodified Ad5. These data are the first step in demonstrating Ad targeting to cell types associated with inflammatory disease.	[Alberti, Michael O.; Roth, Justin C.; Pereboeva, Larisa; Curiel, David T.] Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Alberti, Michael O.; Roth, Justin C.; Pereboeva, Larisa; Curiel, David T.] Univ Alabama Birmingham, Gene Therapy Ctr, Birmingham, AL USA; [Ismail, Mourad; Gerson, Stanton L.] Case Western Reserve Univ, Dept Med, Div Hematol & Oncol, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Ismail, Mourad; Gerson, Stanton L.] Case Western Reserve Univ, Natl Ctr Regenerat Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Case Western Reserve University; Case Western Reserve University	Alberti, MO (corresponding author), Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA.	jroth@peds.uab.edu; dcuriel@radonc.wustl.edu		Alberti, Michael/0000-0003-4269-4701	Gene Therapy Center at the University of Alabama at Birmingham (UAB); National Institutes of Health (NIH) [R42CA114921, R01CA073062]; UAB Medical Scientist Training Program [NIH T32GM008361]; NIH [T32CA059366, T32CA075930]; NATIONAL CANCER INSTITUTE [R01CA073062, T32CA059366, R42CA114921, T32CA075930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER	Gene Therapy Center at the University of Alabama at Birmingham (UAB); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Medical Scientist Training Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Gene Therapy Center at the University of Alabama at Birmingham (UAB) and the National Institutes of Health (NIH) grants R42CA114921 to DTC and R01CA073062 to SLG. MOA was supported in part by the UAB Medical Scientist Training Program (NIH T32GM008361). JCR was supported in part by NIH T32CA059366 and NIH T32CA075930. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belousova N, 2003, J VIROL, V77, P11367, DOI 10.1128/JVI.77.21.11367-11377.2003; Belousova N, 2002, J VIROL, V76, P8621, DOI 10.1128/JVI.76.17.8621-8631.2002; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Douglas JT, 1999, NAT BIOTECHNOL, V17, P470, DOI 10.1038/8647; Douglas JT, 1996, NAT BIOTECHNOL, V14, P1574, DOI 10.1038/nbt1196-1574; Glasgow JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008355; Haisma HJ, 2000, CANCER GENE THER, V7, P901, DOI 10.1038/sj.cgt.7700198; Hedley SJ, 2006, GENE THER, V13, P88, DOI 10.1038/sj.gt.3302603; Korokhov N, 2003, J VIROL, V77, P12931, DOI 10.1128/JVI.77.24.12931-12940.2003; Krasnykh V, 1998, J VIROL, V72, P1844, DOI 10.1128/JVI.72.3.1844-1852.1998; Krasnykh V, 2001, J VIROL, V75, P4176, DOI 10.1128/JVI.75.9.4176-4183.2001; Krasnykh VN, 2000, MOL THER, V1, P391, DOI 10.1006/mthe.2000.0062; Magnusson MK, 2002, J GENE MED, V4, P356, DOI 10.1002/jgm.285; Magnusson MK, 2001, J VIROL, V75, P7280, DOI 10.1128/JVI.75.16.7280-7289.2001; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Mizuguchi H, 2001, GENE THER, V8, P730, DOI 10.1038/sj.gt.3301453; Murakami M, 2010, VIROLOGY, V407, P196, DOI 10.1016/j.virol.2010.08.010; Myhre S, 2007, GENE THER, V14, P376, DOI 10.1038/sj.gt.3302875; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nicklin SA, 2001, MOL THER, V4, P534, DOI 10.1006/mthe.2001.0489; Noureddini SC, 2006, VIRUS RES, V116, P185, DOI 10.1016/j.virusres.2005.10.002; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008; Roelvink PW, 1999, SCIENCE, V286, P1568, DOI 10.1126/science.286.5444.1568; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; Tallone T, 2001, P NATL ACAD SCI USA, V98, P7910, DOI 10.1073/pnas.141223398; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; Ulasov IV, 2007, HUM GENE THER, V18, P118, DOI 10.1089/hum.2006.146; van Beusechem VW, 2000, GENE THER, V7, P1940, DOI 10.1038/sj.gt.3301323; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Watkins SJ, 1997, GENE THER, V4, P1004, DOI 10.1038/sj.gt.3300511; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E	37	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37812	10.1371/journal.pone.0037812	http://dx.doi.org/10.1371/journal.pone.0037812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624065	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500154
J	Cai, HY; Kumar, N; Baudis, M				Cai, Haoyang; Kumar, Nitin; Baudis, Michael			arrayMap: A Reference Resource for Genomic Copy Number Imbalances in Human Malignancies	PLOS ONE			English	Article							GENETIC ALTERATIONS; CANCER GENOME; WIDE ANALYSIS; BREAST; PATTERNS; DATABASE; AMPLIFICATION; EXPRESSION; PLATFORMS; MUTATION	Background: The delineation of genomic copy number abnormalities (CNAs) from cancer samples has been instrumental for identification of tumor suppressor genes and oncogenes and proven useful for clinical marker detection. An increasing number of projects have mapped CNAs using high-resolution microarray based techniques. So far, no single resource does provide a global collection of readily accessible oncogenomic array data. Methodology/Principal Findings: We here present arrayMap, a curated reference database and bioinformatics resource targeting copy number profiling data in human cancer. The arrayMap database provides a platform for meta-analysis and systems level data integration of high-resolution oncogenomic CNA data. To date, the resource incorporates more than 40,000 arrays in 224 cancer types extracted from several resources, including the NCBI's Gene Expression Omnibus (GEO), EBI's ArrayExpress (AE), The Cancer Genome Atlas (TCGA), publication supplements and direct submissions. For the majority of the included datasets, probe level and integrated visualization facilitate gene level and genome wide data review. Results from multi-case selections can be connected to downstream data analysis and visualization tools. Conclusions/Significance: To our knowledge, currently no data source provides an extensive collection of high resolution oncogenomic CNA data which readily could be used for genomic feature mining, across a representative range of cancer entities. arrayMap represents our effort for providing a long term platform for oncogenomic CNA data independent of specific platform considerations or specific project dependence. The online database can be accessed at http//www.arraymap.org.	[Cai, Haoyang; Kumar, Nitin; Baudis, Michael] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich	Cai, HY (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	michael.baudis@imls.uzh.ch	Baudis, Michael/J-4602-2012	Baudis, Michael/0000-0002-9903-4248	China Scholarship Council; Krebsliga Schweiz; University of Zurich	China Scholarship Council(China Scholarship Council); Krebsliga Schweiz; University of Zurich	HC is supported through a personal grant from the China Scholarship Council. NK and MB had received support through the Krebsliga Schweiz and the University of Zurich's Research Priority Program Systems Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloza E, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-37; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Baudis M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-226; Baumbusch LO, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-379; Bengtsson H., 2008, 745 U CAL DEP STAT; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Bengtsson H, 2009, BIOINFORMATICS, V25, P861, DOI 10.1093/bioinformatics/btp074; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Bourdeaut F, 2011, AM J MED GENET A, V155A, P1763, DOI 10.1002/ajmg.a.34066; C F, 2005, 2005 M FED CLIN IMM; Cao QY, 2011, NUCLEIC ACIDS RES, V39, pD968, DOI 10.1093/nar/gkq997; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Climent J, 2007, CANCER RES, V67, P818, DOI 10.1158/0008-5472.CAN-06-3307; Curtis C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-588; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gearhart J, 2007, NEW ENGL J MED, V357, P1469, DOI 10.1056/NEJMp078126; Greshock J, 2007, CANCER RES, V67, P10173, DOI 10.1158/0008-5472.CAN-07-2102; Heinrichs S, 2007, GENOME BIOL, P1; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Jin K, 2011, P NATL ACAD SCI US; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Krasinskas AM, 2010, MODERN PATHOL, V23, P531, DOI 10.1038/modpathol.2009.186; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lubin M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005735; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Myllykangas S, 2006, ONCOGENE, V25, P7324, DOI 10.1038/sj.onc.1209717; Park NI, 2012, MOL ONCOLOGY; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Scheinin I, 2008, NUCLEIC ACIDS RES, V36, pD830, DOI 10.1093/nar/gkm802; Smith JS, 2001, JNCI-J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246; Stallings RL, 2007, TRENDS GENET, V23, P278, DOI 10.1016/j.tig.2007.03.009; Stevens KN, 2012, 19P13 1 IS TRIPLE NE; van der Rhee JI, 2011, J AM ACAD DERMATOLOG; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; Wiltshire RN, 2000, NEURO-ONCOLOGY, V2, P164, DOI 10.1093/neuonc/2.3.164; Zhang W, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-74	48	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36944	10.1371/journal.pone.0036944	http://dx.doi.org/10.1371/journal.pone.0036944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629346	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305343500040
J	Chu, CY; Chen, CF; Rajendran, RS; Shen, CN; Chen, TH; Yen, CC; Chuang, CK; Lin, DS; Hsiao, CD				Chu, Che-Yu; Chen, Chi-Fang; Rajendran, R. Samuel; Shen, Chia-Ning; Chen, Te-Hao; Yen, Chueh-Chuan; Chuang, Chih-Kuang; Lin, Dar-Shong; Hsiao, Chung-Der			Overexpression of Akt1 Enhances Adipogenesis and Leads to Lipoma Formation in Zebrafish	PLOS ONE			English	Article							MATRIX GLA PROTEIN; INSULIN-RESISTANCE; SKELETAL-MUSCLE; TRANSGENIC ZEBRAFISH; ADIPOSE-TISSUE; DANIO-RERIO; OBESE GENE; STEM-CELLS; DIFFERENTIATION; EXPRESSION	Background: Obesity is a complex, multifactorial disorder influenced by the interaction of genetic, epigenetic, and environmental factors. Obesity increases the risk of contracting many chronic diseases or metabolic syndrome. Researchers have established several mammalian models of obesity to study its underlying mechanism. However, a lower vertebrate model for conveniently performing drug screening against obesity remains elusive. The specific aim of this study was to create a zebrafish obesity model by over expressing the insulin signaling hub of the Akt1 gene. Methodology/Principal Findings: Skin oncogenic transformation screening shows that a stable zebrafish transgenic of Tg(krt4Hsa.myrAkt1)(cy18) displays severely obese phenotypes at the adult stage. In Tg(krt4:Hsa.myrAkt1)(cy18), the expression of exogenous human constitutively active Akt1 (myrAkt1) can activate endogenous downstream targets of mTOR, GSK-3 alpha/beta, and 70S6K. During the embryonic to larval transitory phase, the specific over expression of myrAkt1 in skin can promote hypertrophic and hyperplastic growth. From 21 hour post-fertilization (hpf) onwards, myrAkt1 transgene was ectopically expressed in several mesenchymal derived tissues. This may be the result of the integration position effect. Tg(krt4:Hsa.myrAkt1)(cy18) caused a rapid increase of body weight, hyperplastic growth of adipocytes, abnormal accumulation of fat tissues, and blood glucose intolerance at the adult stage. Real-time RT-PCR analysis showed the majority of key genes on regulating adipogenesis, adipocytokine, and inflammation are highly upregulated in Tg(krt4:Hsa.myrAkt1)(cy18). In contrast, the myogenesis-and skeletogenesis-related gene transcripts are significantly downregulated in Tg(krt4:Hsa.myrAkt1)(cy18), suggesting that excess adipocyte differentiation occurs at the expense of other mesenchymal derived tissues. Conclusion/Significance: Collectively, the findings of this study provide direct evidence that Akt1 signaling plays an important role in balancing normal levels of fat tissue in vivo. The obese zebrafish examined in this study could be a new powerful model to screen novel drugs for the treatment of human obesity.	[Chu, Che-Yu; Chen, Chi-Fang; Rajendran, R. Samuel; Hsiao, Chung-Der] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan; [Shen, Chia-Ning] Acad Sinica, Genome Res Ctr, Nankang, Taiwan; [Chen, Te-Hao] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Yen, Chueh-Chuan] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Yen, Chueh-Chuan] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chuang, Chih-Kuang] Mackay Mem Hosp, Div Genet & Metab, Dept Med Res, Taipei, Taiwan; [Lin, Dar-Shong] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Lin, Dar-Shong] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Lin, Dar-Shong] Natl Taipei Univ Technol, Dept Chem Engn & Biotechnol, Taipei, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Ctr Nanotechnol, Chungli, Taiwan	Chung Yuan Christian University; Academia Sinica - Taiwan; National Museum of Marine Biology & Aquarium; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; National Taipei University of Technology; Chung Yuan Christian University	Chu, CY (corresponding author), Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan.	dslin@ms1.mmh.org.tw; cdhsiao@cycu.edu.tw	SHEN, CHIA-NING/C-6878-2011; Hsiao, Chung-Der/W-4535-2019	SHEN, CHIA-NING/0000-0002-0747-217X; Hsiao, Chung-Der/0000-0002-6398-8672; R., Samuel Rajendran/0000-0003-1420-7064	National Science Council [NSC96-2321-B-033-002-MY2, NSC99-2320-B-033-001-MY3]; Mackay Memorial Hospital [MMH-CY-9905]; Center of Excellence for Cancer Research at Taipai Veterans General Hospital [DOH100-TD-C-111-007]; National Research Program for Biopharmaceuticals [DOH100-TD-PB-111-TM026]; Taiwan Clinical Oncology Research Foundation	National Science Council(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital; Center of Excellence for Cancer Research at Taipai Veterans General Hospital; National Research Program for Biopharmaceuticals; Taiwan Clinical Oncology Research Foundation	This work was supported by grants from the National Science Council(NSC96-2321-B-033-002-MY2 and NSC99-2320-B-033-001-MY3) and the Mackay Memorial Hospital (MMH-CY-9905) to CDH and DSL. Grants from the Center of Excellence for Cancer Research at Taipai Veterans General Hospital (DOH100-TD-C-111-007), National Research Program for Biopharmaceuticals (DOH100-TD-PB-111-TM026) and Taiwan Clinical Oncology Research Foundation to CCY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; Bera TK, 2008, P NATL ACAD SCI USA, V105, P270, DOI 10.1073/pnas.0710978105; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Christoffersen CT, 1998, BIOCHEM BIOPH RES CO, V246, P426, DOI 10.1006/bbrc.1998.8637; Chung WK, 1996, GENOME RES, V6, P1192, DOI 10.1101/gr.6.12.1192; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Dani C, 1997, J CELL SCI, V110, P1279; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Despres J P, 2006, J Endocrinol Invest, V29, P77; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Drel VR, 2006, DIABETES, V55, P3335, DOI 10.2337/db06-0885; Elo B, 2007, J MOL ENDOCRINOL, V38, P433, DOI 10.1677/JME-06-0037; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Flynn EJ, 2009, J LIPID RES, V50, P1641, DOI 10.1194/jlr.M800590-JLR200; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Gleeson M, 2007, ACTA DIABETOL, V44, P157, DOI 10.1007/s00592-007-0257-3; Gluckman PD, 2008, INT J OBESITY, V32, pS62, DOI 10.1038/ijo.2008.240; Gong ZY, 2002, DEV DYNAM, V223, P204, DOI 10.1002/dvdy.10051; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Guillou Herve, 2008, V49, P3, DOI 10.1007/978-1-4020-8831-5_1; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HENRIKSO.RC, 1967, EXPERIENTIA, V23, P357, DOI 10.1007/BF02144513; Hinault C, 2006, J NUTR BIOCHEM, V17, P374, DOI 10.1016/j.jnutbio.2006.02.008; Hsieh SC, 2009, MOL CARCINOGEN, V48, P545, DOI 10.1002/mc.20491; Huang DL, 2010, GENE CHROMOSOME CANC, V49, P810, DOI 10.1002/gcc.20788; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Jones KS, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-23; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Ju BS, 1999, DEV GENET, V25, P158, DOI 10.1002/(SICI)1520-6408(1999)25:2&lt;158::AID-DVG10&gt;3.0.CO;2-6; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Magun R, 1996, ENDOCRINOLOGY, V137, P3590, DOI 10.1210/en.137.8.3590; Makky K, 2007, DEV BIOL, V303, P501, DOI 10.1016/j.ydbio.2006.11.030; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin A, 2007, ENDOCRINOLOGY, V148, P3419, DOI 10.1210/en.2006-1541; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Newman B, 2001, J CELL BIOL, V154, P659, DOI 10.1083/jcb.200106040; Nishio SI, 2008, DEV DYNAM, V237, P1682, DOI 10.1002/dvdy.21559; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Ordovas JM, 2011, CURR OPIN LIPIDOL, V22, P129, DOI 10.1097/MOL.0b013e32834477a9; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PAVLOVITCH JH, 1991, AM J PHYSIOL, V261, pC964, DOI 10.1152/ajpcell.1991.261.6.C964; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Petit MMR, 1998, CANCER GENET CYTOGEN, V106, P18, DOI 10.1016/S0165-4608(98)00038-7; Pierron A, 2009, CANCER GENET CYTOGEN, V195, P66, DOI 10.1016/j.cancergencyto.2009.06.009; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sakaue H, 1998, J BIOL CHEM, V273, P28945, DOI 10.1074/jbc.273.44.28945; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Segrelles C, 2002, ONCOGENE, V21, P53, DOI 10.1038/sj.onc.1205032; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Shah A, 2008, JPEN-PARENTER ENTER, V32, P638, DOI 10.1177/0148607108325251; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Song Y, 2007, FASEB J, V21, P2042, DOI 10.1096/fj.06-7503com; Spanier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006279; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; Vereshchagina N, 2006, DEVELOPMENT, V133, P4731, DOI 10.1242/dev.02659; Wang YK, 1997, DEVELOPMENT, V124, P2507; Xia XM, 1999, J CELL PHYSIOL, V178, P9, DOI 10.1002/(SICI)1097-4652(199901)178:1<9::AID-JCP2>3.0.CO;2-#; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zhang GJ, 2006, P NATL ACAD SCI USA, V103, P3180, DOI 10.1073/pnas.0508313103; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	78	47	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36474	10.1371/journal.pone.0036474	http://dx.doi.org/10.1371/journal.pone.0036474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623957	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343500017
J	Fabre, L; Zhang, J; Guigon, G; Le Hello, S; Guibert, V; Accou-Demartin, M; de Romans, S; Lim, C; Roux, C; Passet, V; Diancourt, L; Guibourdenche, M; Issenhuth-Jeanjean, S; Achtman, M; Brisse, S; Sola, C; Weill, FX				Fabre, Laetitia; Zhang, Jian; Guigon, Ghislaine; Le Hello, Simon; Guibert, Veronique; Accou-Demartin, Marie; de Romans, Saiana; Lim, Catherine; Roux, Chrystelle; Passet, Virginie; Diancourt, Laure; Guibourdenche, Martine; Issenhuth-Jeanjean, Sylvie; Achtman, Mark; Brisse, Sylvain; Sola, Christophe; Weill, Francois-Xavier			CRISPR Typing and Subtyping for Improved Laboratory Surveillance of Salmonella Infections	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; VARIABLE-NUMBER; IMMUNE-SYSTEM; REPEATS; BACTERIOPHAGE; TYPHIMURIUM; DNA; RESISTANCE; FRANCE; GENES	Laboratory surveillance systems for salmonellosis should ideally be based on the rapid serotyping and subtyping of isolates. However, current typing methods are limited in both speed and precision. Using 783 strains and isolates belonging to 130 serotypes, we show here that a new family of DNA repeats named CRISPR (clustered regularly interspaced short palindromic repeats) is highly polymorphic in Salmonella. We found that CRISPR polymorphism was strongly correlated with both serotype and multilocus sequence type. Furthermore, spacer microevolution discriminated between subtypes within prevalent serotypes, making it possible to carry out typing and subtyping in a single step. We developed a high-throughput subtyping assay for the most prevalent serotype, Typhimurium. An open web-accessible database was set up, providing a serotype/spacer dictionary and an international tool for strain tracking based on this innovative, powerful typing and subtyping tool.	[Fabre, Laetitia; Le Hello, Simon; Guibert, Veronique; Accou-Demartin, Marie; de Romans, Saiana; Lim, Catherine; Roux, Chrystelle; Guibourdenche, Martine; Issenhuth-Jeanjean, Sylvie; Weill, Francois-Xavier] Inst Pasteur, Unite Bacteries Pathogenes Enter, Paris, France; [Zhang, Jian; Sola, Christophe] Univ Paris 11, CNRS, Inst Genet & Microbiol, UMR8621,IGEPE Team,Universud, Orsay, France; [Achtman, Mark] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University College Cork	Fabre, L (corresponding author), Inst Pasteur, Unite Bacteries Pathogenes Enter, Paris, France.	fxweill@pasteur.fr	Le Hello, Simon/K-6584-2018; Brisse, Sylvain/M-8723-2013; Sola, Christophe/A-7992-2016	Le Hello, Simon/0000-0001-7993-4305; Brisse, Sylvain/0000-0002-2516-2108; Sola, Christophe/0000-0003-4672-2140; Achtman, Mark/0000-0001-6815-0070; DIANCOURT, Laure/0000-0002-9670-3274; Weill, Francois-Xavier/0000-0001-9941-5799	Institut Pasteur [354]; Institut de Veille Sanitaire; Science Foundation of Ireland [05/FE1/B882]	Institut Pasteur(European Commission); Institut de Veille Sanitaire; Science Foundation of Ireland(Science Foundation Ireland)	This work was supported by the Institut Pasteur (permanent support for Research and Programme Transversal de Recherche 354) and by the Institut de Veille Sanitaire. The MLST data are publicly available from http://mlst.ucc.ie, which is currently funded by a grant from the Science Foundation of Ireland (05/FE1/B882). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, PLOS PATHOG IN PRESS; ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bender JB, 2001, NEW ENGL J MED, V344, P189, DOI 10.1056/NEJM200101183440305; Bone A, 2010, EUROSURVEILLANCE, V15, P2; den Bakker HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-425; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Fisher Ian S T, 2004, Euro Surveill, V9, P45; Fitzgerald C, 2007, J CLIN MICROBIOL, V45, P3323, DOI 10.1128/JCM.00025-07; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hedberg CW, 2008, EMERG INFECT DIS, V14, P311, DOI 10.3201/eid1402.070666; Hopkins KL, 2007, J CLIN MICROBIOL, V45, P3058, DOI 10.1128/JCM.00715-07; Hopkins KL, 2011, EURO SURVEILL, V16, ppii; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Larsson JT, 2009, EUROSURVEILLANCE, V14, P6; Lindstedt BA, 2003, J CLIN MICROBIOL, V41, P1469, DOI 10.1128/JCM.41.4.1469-1479.2003; Liu FY, 2011, APPL ENVIRON MICROB, V77, P4520, DOI 10.1128/AEM.00468-11; Liu FY, 2011, APPL ENVIRON MICROB, V77, P1946, DOI 10.1128/AEM.02625-10; McQuiston JR, 2011, J CLIN MICROBIOL, V49, P565, DOI 10.1128/JCM.01323-10; Mokrousov Igor, 2007, Biotechnology Journal, V2, P901, DOI 10.1002/biot.200700035; OLSEN JE, 1994, J MED MICROBIOL, V40, P15, DOI 10.1099/00222615-40-1-15; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Rousseau C, 2009, BIOINFORMATICS, V25, P3317, DOI 10.1093/bioinformatics/btp586; Sangal V, 2010, J BACTERIOL, V192, P6465, DOI 10.1128/JB.00969-10; Schouls LM, 2003, J CLIN MICROBIOL, V41, P15, DOI 10.1128/JCM.41.1.15-26.2003; Torpdahl M, 2007, EMERG INFECT DIS, V13, P388, DOI 10.3201/eid1303.060460; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Wattiau P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11; Weill FX, 2006, J CLIN MICROBIOL, V44, P700, DOI 10.1128/JCM.44.3.700-708.2006; Weill FX, 2007, French Patent Application, Patent No. [FR07/09188, 0709188]; Weill FX, 2007, International Patent Application, Patent No. [PCT/IB2008/004004, 2008004004]; Xia SL, 2009, J CLIN MICROBIOL, V47, P401, DOI 10.1128/JCM.01099-08; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0	44	174	185	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36995	10.1371/journal.pone.0036995	http://dx.doi.org/10.1371/journal.pone.0036995			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623967	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500044
J	Krijt, J; Frydlova, J; Kukackova, L; Fujikura, Y; Prikryl, P; Vokurka, M; Necas, E				Krijt, Jan; Frydlova, Jana; Kukackova, Lenka; Fujikura, Yuzo; Prikryl, Petr; Vokurka, Martin; Necas, Emanuel			Effect of Iron Overload and Iron Deficiency on Liver Hemojuvelin Protein	PLOS ONE			English	Article							HEPCIDIN MESSENGER-RNA; HEREDITARY HEMOCHROMATOSIS; MATRIPTASE-2 TMPRSS6; MOUSE-LIVER; JUVENILE HEMOCHROMATOSIS; EXPRESSION; HOMEOSTASIS; GENE; REGULATOR; BMP6	Introduction: Hemojuvelin (Hjv) is a key component of the signaling cascade that regulates liver hepcidin (Hamp) expression. The purpose of this study was to determine Hjv protein levels in mice and rats subjected to iron overload and iron deficiency. Methods: C57BL/6 mice were injected with iron (200 mg/kg); iron deficiency was induced by feeding of an iron-deficient diet, or by repeated phlebotomies. Erythropoietin (EPO)-treated mice were administered recombinant EPO at 50 U/mouse. Wistar rats were injected with iron (1200 mg/kg), or fed an iron-deficient diet. Hjv protein was determined by immunoblotting, liver samples from Hjv-/- mice were used as negative controls. Mouse plasma Hjv content was determined by a commercial ELISA kit. Results: Liver crude membrane fraction from both mice and rats displayed a major Hjv-specific band at 35 kDa, and a weaker band of 20 kDa. In mice, the intensity of these bands was not changed following iron injection, repeated bleeding, low iron diet or EPO administration. No change in liver crude membrane Hjv protein was observed in iron-treated or iron-deficient rats. ELISA assay for mouse plasma Hjv did not show significant difference between Hjv+/+ and Hjv-/- mice. Liver Hamp mRNA, Bmp6 mRNA and Id1 mRNA displayed the expected response to iron overload and iron deficiency. EPO treatment decreased Id1 mRNA, suggesting possible participation of the bone morphogenetic protein pathway in EPO-mediated downregulation of Hamp mRNA. Discussion: Since no differences between Hjv protein levels were found following various experimental manipulations of body iron status, the results indicate that, in vivo, substantial changes in Hamp mRNA can occur without noticeable changes of membrane hemojuvelin content. Therefore, modulation of hemojuvelin protein content apparently does not represent the limiting step in the control of Hamp gene expression.	[Krijt, Jan; Frydlova, Jana; Kukackova, Lenka; Fujikura, Yuzo; Prikryl, Petr; Vokurka, Martin; Necas, Emanuel] Charles Univ Prague, Fac Med 1, Inst Pathophysiol, Prague, Czech Republic	Charles University Prague	Krijt, J (corresponding author), Charles Univ Prague, Fac Med 1, Inst Pathophysiol, Prague, Czech Republic.	jkri@lf1.cuni.cz	FUJIKURA, YUZO/H-2652-2014; Frydlova, Jana/H-8878-2017; Prikryl, Petr/B-1359-2008; Necas, Emanuel/G-4455-2013; Krijt, Jan/B-2359-2009; Vokurka, Martin/F-7533-2017	Frydlova, Jana/0000-0001-9725-9526; Prikryl, Petr/0000-0001-6167-2853; Necas, Emanuel/0000-0002-6101-4639; Vokurka, Martin/0000-0001-5943-5939	Ministry of Education, Youth and Sports of the Czech Republic [MSM 0021620806, LC06044]; Charles University [PRVOUK-P24/LF1/3, UNCE 204021]; Ministry of Health of the Czech Republic [NS10300-3/2009]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	The work was supported by grants MSM 0021620806 and LC06044 from the Ministry of Education, Youth and Sports of the Czech Republic, PRVOUK-P24/LF1/3 and UNCE 204021 from Charles University, and NS10300-3/2009 from the Ministry of Health of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2011, SEMIN LIVER DIS, V31, P280, DOI 10.1055/s-0031-1286059; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; Chen J, 2011, BIOCH BIOPH IN PRESS; Corradini E, 2009, GASTROENTEROLOGY, V137, P1489, DOI 10.1053/j.gastro.2009.06.057; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Fleming RE, 2000, P NATL ACAD SCI USA, V97, P2214, DOI 10.1073/pnas.040548097; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Huang H, 2009, BLOOD, V113, P3593, DOI 10.1182/blood-2008-08-173641; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Krijt J, 2004, BLOOD, V104, P4308, DOI 10.1182/blood-2004-06-2422; Krijt J, 2011, BLOOD CELL MOL DIS, V47, P133, DOI 10.1016/j.bcmd.2011.04.009; Krijt J, 2010, BLOOD CELL MOL DIS, V44, P257, DOI 10.1016/j.bcmd.2010.02.012; Kuninger D, 2006, J CELL SCI, V119, P3273, DOI 10.1242/jcs.03074; Lakhal S, 2011, J BIOL CHEM, V286, P4090, DOI 10.1074/jbc.M110.173096; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; Nicolas G, 2011, BRIT J HAEMATOL, V152, P498, DOI 10.1111/j.1365-2141.2010.08473.x; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Peng H, 2010, BRIT J HAEMATOL, V151, P106, DOI 10.1111/j.1365-2141.2010.08306.x; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2010, TRANSFUSION, V50, P1532, DOI 10.1111/j.1537-2995.2010.02601.x; Truksa J, 2009, BRIT J HAEMATOL, V147, P571, DOI 10.1111/j.1365-2141.2009.07873.x; Vokurka M, 2006, PHYSIOL RES, V55, P667, DOI 10.33549/physiolres.930841; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200	41	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37391	10.1371/journal.pone.0037391	http://dx.doi.org/10.1371/journal.pone.0037391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629388	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343500108
J	Su, Y; Tang, LY; Chen, LJ; He, JR; Su, FX; Lin, Y; Chen, WQ; Xie, XM; Ren, ZF				Su, Yi; Tang, Lu-Ying; Chen, Li-Juan; He, Jian-Rong; Su, Feng-Xi; Lin, Ying; Chen, Wei-Qing; Xie, Xiao-Ming; Ren, Ze-Fang			Joint Effects of Febrile Acute Infection and an Interferon-gamma Polymorphism on Breast Cancer Risk	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; T-CELL-ACTIVATION; IFN-GAMMA; TUMOR-DEVELOPMENT; FEVER; HYPERTHERMIA; EXPRESSION; MELANOMA; HISTORY; ASSOCIATION	Background: There is an inverse relationship between febrile infection and the risk of malignancies. Interferon gamma (IFN-gamma) plays an important role in fever induction and its expression increases with incubation at fever-range temperatures. Therefore, the genetic polymorphism of IFN-gamma may modify the association of febrile infection with breast cancer risk. Methodology and Principal Findings: Information on potential breast cancer risk factors, history of fever during the last 10 years, and blood specimens were collected from 839 incident breast cancer cases and 863 age-matched controls between October 2008 and June 2010 in Guangzhou, China. IFN-gamma (rs2069705) was genotyped using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry platform. Odds ratios (OR) and 95% confidence intervals (CIs) were calculated using multivariate logistic regression. We found that women who had experienced > 1 fever per year had a decreased risk of breast cancer [ORs and 95% CI: 0.77 (0.61-0.99)] compared to those with less than one fever a year. This association only occurred in women with CT/TT genotypes [0.54 (0.37-0.77)] but not in those with the CC genotype [1.09 (0.77-1.55)]. The association of IFN-gamma rs2069705 with the risk of breast cancer was not significant among all participants, while the CT/TT genotypes were significantly related to an elevated risk of breast cancer [1.32 (1.03-1.70)] among the women with < 1 fever per year and to a reduced risk of breast cancer [0.63 (0.40-0.99)] among women with >= 1 fever per year compared to the CC genotype. A marked interaction between fever frequencies and the IFN-gamma genotypes was observed (P for multiplicative and additive interactions were 0.005 and 0.058, respectively). Conclusions: Our findings indicate a possible link between febrile acute infection and a decreased risk of breast cancer, and this association was modified by IFN-gamma rs2069705.	[Su, Yi; Chen, Li-Juan; He, Jian-Rong; Chen, Wei-Qing; Ren, Ze-Fang] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Lu-Ying] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Su, Feng-Xi] Sun Yat Sen Univ, Affiliated Hosp 2, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Ying] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Xiao-Ming] Sun Yat Sen Univ, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Su, Y (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China.	xiexm@sysucc.org.cn; renzef@mail.sysu.edu.cn		He, Jianrong/0000-0003-3837-5126	National Natural Science Foundation of China [81072383, 81172759]; Laboratory Opening Funds at Sun Yat-Sen University [KF2010440]; Key Program of National Natural Science Foundation of China [31030061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Laboratory Opening Funds at Sun Yat-Sen University; Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81072383 and 81172759), the Laboratory Opening Funds at Sun Yat-Sen University (KF2010440), and the Key Program of National Natural Science Foundation of China (31030061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2011, CLIN VACCINE IMMUNOL, V18, P1150, DOI 10.1128/CVI.00051-11; ABEL U, 1991, J CANCER RES CLIN, V117, P339, DOI 10.1007/BF01630717; Atanackovic D, 2002, CANCER IMMUNOL IMMUN, V51, P603, DOI 10.1007/s00262-002-0327-x; Basu S, 2003, INT IMMUNOL, V15, P1053, DOI 10.1093/intimm/dxg104; Borg A, 2000, J NATL CANCER I, V92, P1260, DOI 10.1093/jnci/92.15.1260; Cann SAH, 2003, POSTGRAD MED J, V79, P672; Cann SAH, 2002, MED HYPOTHESES, V58, P115, DOI 10.1054/mehy.2001.1469; DICKSON JA, 1979, LANCET, V1, P202, DOI 10.1016/S0140-6736(79)90594-4; Dinarello CA, 1999, J INFECT DIS, V179, pS294, DOI 10.1086/513856; DINARELLO CA, 1984, J CLIN INVEST, V74, P906, DOI 10.1172/JCI111508; Erdei E, 2010, CYTOKINE, V51, P18, DOI 10.1016/j.cyto.2010.03.014; Falk MH, 2001, INT J HYPERTHER, V17, P1, DOI 10.1080/02656730150201552; Goggins W, 2004, INT J CANCER, V111, P792, DOI 10.1002/ijc.20322; Gonullu G, 2007, SAUDI MED J, V28, P1728; Gregson AL, 2004, INFECT DIS; GROSSARTHMATICEK R, 1987, J CHRON DIS, V40, P967, DOI 10.1016/0021-9681(87)90147-0; Harigai M, 2008, J IMMUNOL, V181, P2211, DOI 10.4049/jimmunol.181.3.2211; Hasday JD, 2000, MICROBES INFECT, V2, P1891, DOI 10.1016/S1286-4579(00)01337-X; He JR, 2012, J INFECT DIS, V205, P64, DOI 10.1093/infdis/jir710; He JR, 2011, CANCER LETT, V309, P128, DOI 10.1016/j.canlet.2011.05.012; He YF, 2005, CANCER IMMUNOL IMMUN, V54, P891, DOI 10.1007/s00262-004-0654-1; Ho WL, 2011, IRISH J MED SCI, V180, P901, DOI 10.1007/s11845-009-0297-5; Hobohm U, 2005, BRIT J CANCER, V92, P421, DOI 10.1038/sj.bjc.6602386; Hobohm U, 2001, CANCER IMMUNOL IMMUN, V50, P391; Hoption SA, 2006, CANCER DETECT PREV, V30, P83, DOI 10.1016/j.cdp.2005.11.001; Jurek AM, 2005, INT J EPIDEMIOL, V34, P680, DOI 10.1093/ije/dyi060; Kamali-Sarvestani E, 2005, CANCER LETT, V223, P113, DOI 10.1016/j.canlet.2004.09.025; Karakus N, 2011, DNA CELL BIOL, V30, P371, DOI 10.1089/dna.2010.1113; Karalyan Z, 2012, VET IMMUNOL IMMUNOP, V145, P551, DOI 10.1016/j.vetimm.2011.12.013; Kida Y, 2006, CANCER IMMUNOL IMMUN, V55, P1459, DOI 10.1007/s00262-006-0146-6; Kim K, 2010, ANN RHEUM DIS, V69, P1247, DOI 10.1136/ard.2009.117572; Kleef R, 2001, NEUROIMMUNOMODULAT, V9, P55, DOI 10.1159/000049008; KOLMEL KF, 1992, MELANOMA RES, V2, P207; Kolmel KF, 1999, MELANOMA RES, V9, P511; KURZROCK R, 1986, CANCER TREAT REP, V70, P1357; LANE HC, 1985, ANN INTERN MED, V103, P714, DOI 10.7326/0003-4819-103-5-714; Lee HC, 2010, J CLIN IMMUNOL, V30, P68, DOI 10.1007/s10875-009-9330-8; Mastrangelo G, 1998, EUR J EPIDEMIOL, V14, P749, DOI 10.1023/A:1007560709013; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; MORIMOTO A, 1987, J PHYSIOL-LONDON, V391, P209, DOI 10.1113/jphysiol.1987.sp016734; Netea MG, 2000, CLIN INFECT DIS, V31, pS178, DOI 10.1086/317513; Ostberg JR, 2006, CANCER IMMUNOL IMMUN, V55, P292, DOI 10.1007/s00262-005-0689-y; Ren ZF, 2010, CANCER EPIDEMIOL, V34, P419, DOI 10.1016/j.canep.2010.04.011; ROBERTS NJ, 1991, REV INFECT DIS, V13, P462; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; Ruiz-Ruiz C, 2000, CANCER RES, V60, P5673; Schlehofer B, 1999, INT J CANCER, V82, P155, DOI 10.1002/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-P; Scola L, 2006, ANN NY ACAD SCI, V1089, P104, DOI 10.1196/annals.1386.017; TRIEB K, 1994, CANCER LETT, V87, P65, DOI 10.1016/0304-3835(94)90410-3; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Zhang HG, 2008, CANCER LETT, V271, P191, DOI 10.1016/j.canlet.2008.05.026	53	12	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37275	10.1371/journal.pone.0037275	http://dx.doi.org/10.1371/journal.pone.0037275			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624006	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500089
J	Tomita, Y; Ikeo, K; Tamakawa, H; Gojobori, T; Ikushima, S				Tomita, Yasuyuki; Ikeo, Kazuho; Tamakawa, Hideyuki; Gojobori, Takashi; Ikushima, Shigehito			Genome and Transcriptome Analysis of the Food-Yeast Candida utilis	PLOS ONE			English	Article							RIBOSOMAL-RNAS SACCHAROMYCETACEAE; MULTIPLE SEQUENCE ALIGNMENT; GENE ORDER BROWSER; L-LACTIC ACID; KLUYVEROMYCES-LACTIS; EFFICIENT PRODUCTION; GLUCOSE-TRANSPORT; BUDDING YEAST; PROTEIN; CEREVISIAE	The industrially important food-yeast Candida utilis is a Crabtree effect-negative yeast used to produce valuable chemicals and recombinant proteins. In the present study, we conducted whole genome sequencing and phylogenetic analysis of C. utilis, which showed that this yeast diverged long before the formation of the CUG and Saccharomyces/Kluyveromyces clades. In addition, we performed comparative genome and transcriptome analyses using next-generation sequencing, which resulted in the identification of genes important for characteristic phenotypes of C. utilis such as those involved in nitrate assimilation, in addition to the gene encoding the functional hexose transporter. We also found that an antisense transcript of the alcohol dehydrogenase gene, which in silico analysis did not predict to be a functional gene, was transcribed in the stationary-phase, suggesting a novel system of repression of ethanol production. These findings should facilitate the development of more sophisticated systems for the production of useful reagents using C. utilis.	[Tomita, Yasuyuki; Tamakawa, Hideyuki; Ikushima, Shigehito] KIRIN Holdings Co Ltd, Cent Labs Frontier Technol, Yokohama, Kanagawa, Japan; [Tomita, Yasuyuki; Ikeo, Kazuho; Gojobori, Takashi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Tomita, Yasuyuki; Ikeo, Kazuho; Gojobori, Takashi] Natl Inst Genet, DNA Data Bank Japan, Mishima, Shizuoka 411, Japan	Kirin Holdings Co Ltd; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Tomita, Y (corresponding author), KIRIN Holdings Co Ltd, Cent Labs Frontier Technol, Yokohama, Kanagawa, Japan.	Shigehito_Ikushima@kirin.co.jp						Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Billard P, 1996, J BACTERIOL, V178, P5860, DOI 10.1128/jb.178.20.5860-5866.1996; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; BOZE H, 1992, CRIT REV BIOTECHNOL, V12, P65, DOI 10.3109/07388559209069188; BRUINENBERG PM, 1983, J GEN MICROBIOL, V129, P965; Buerth C, 2011, MICROBIOL-SGM, V157, P2493, DOI 10.1099/mic.0.049320-0; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Byrne KP, 2006, NUCLEIC ACIDS RES, V34, pD452, DOI 10.1093/nar/gkj041; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; CHOUDARY PV, 1982, BIOCHEM BIOPH RES CO, V108, P1293, DOI 10.1016/0006-291X(82)92140-4; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Harrison BR, 2009, BIOCHEM CELL BIOL, V87, P767, DOI 10.1139/O09-043; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; ICHII T, 1993, J FERMENT BIOENG, V75, P375, DOI 10.1016/0922-338X(93)90137-W; Ikushima S, 2009, BIOSCI BIOTECH BIOCH, V73, P1818, DOI 10.1271/bbb.90186; Ikushima S, 2009, BIOSCI BIOTECH BIOCH, V73, P879, DOI 10.1271/bbb.80799; Ikushima S, 2009, BIOSCI BIOTECH BIOCH, V73, P152, DOI 10.1271/bbb.80568; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; KONDO K, 1995, J BACTERIOL, V177, P7171, DOI 10.1128/jb.177.24.7171-7177.1995; Kondo K, 1997, NAT BIOTECHNOL, V15, P453, DOI 10.1038/nbt0597-453; Kurtzman CP, 1998, YEAST TAXONOMIC STUD; Li Y, 2004, APPL MICROBIOL BIOT, V66, P233, DOI 10.1007/s00253-004-1751-y; Mable BK, 2001, GENET RES, V77, P9, DOI 10.1017/S0016672300004821; Milkowski C, 2001, J BACTERIOL, V183, P5223, DOI 10.1128/JB.183.18.5223-5229.2001; Miura Y, 1998, BIOTECHNOL BIOENG, V58, P306, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<306::AID-BIT29>3.0.CO;2-8; Miura Yutaka, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P129; Nishi T, 2005, GENE, V346, P115, DOI 10.1016/j.gene.2004.10.018; Perez MD, 1997, BIOCHEM J, V321, P397, DOI 10.1042/bj3210397; Pinheiro M, 2006, METHOD INFORM MED, V45, P163, DOI 10.1055/s-0038-1634061; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Salzberg SL, 1999, GENOMICS, V59, P24, DOI 10.1006/geno.1999.5854; Slot JC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001097; Souciet JL, 2009, GENOME RES, V19, P1696, DOI 10.1101/gr.091546.109; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamakawa H, 2012, J BIOSCI BIOENG, V113, P73, DOI 10.1016/j.jbiosc.2011.09.002; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tuch BB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001070; VANURK H, 1989, J GEN MICROBIOL, V135, P2399; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weinberg DE, 2011, CELL, V146, P262, DOI 10.1016/j.cell.2011.06.021; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; YAMADA Y, 1995, BIOSCI BIOTECH BIOCH, V59, P518, DOI 10.1271/bbb.59.518; YAMADA Y, 1995, BIOSCI BIOTECH BIOCH, V59, P945, DOI 10.1271/bbb.59.945	59	24	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37226	10.1371/journal.pone.0037226	http://dx.doi.org/10.1371/journal.pone.0037226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629373	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500078
J	Zhou, ZX; Zhang, C; Zhang, J; Tian, ZG				Zhou, Zhixia; Zhang, Cai; Zhang, Jian; Tian, Zhigang			Macrophages Help NK Cells to Attack Tumor Cells by Stimulatory NKG2D Ligand but Protect Themselves from NK Killing by Inhibitory Ligand Qa-1	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; POLY I-C; DENDRITIC CELLS; IFN-GAMMA; IMPROVES CYTOTOXICITY; INFECTED MACROPHAGES; VIRUS-INFECTION; CUTTING EDGE; CHAIN-B; EXPRESSION	Natural killer (NK) cells and their crosstalk with other immune cells are important for innate immunity against tumor. To explore the role of the interaction between NK cells and macrophages in the regulation of anti-tumor activities of NK cells, we here demonstrate that poly I:C-treated macrophages increased NK cell-mediated cytotoxicity against target tumor cells in NKG2D-dependent manner. In addition, IL-15, IL-18, and IFN-beta secreted by poly I:C-treated macrophages are also involved in NKG2D expression and NK cell activation. Interestingly, the increase in expression of NKG2D ligands on macrophages induced a highly NK cell-mediated cytotoxicity against tumor cells, but not against macrophages themselves. Notably, a high expression level of Qa-1, a NKG2A ligand, on macrophages may contribute to such protection of macrophages from NK cell-mediated killing. Furthermore, Qa-1 or NKG2A knockdown and Qa-1 antibody blockade caused the macrophages to be sensitive to NK cytolysis. These results suggested that macrophages may activate NK cells to attack tumor by NKG2D recognition whereas macrophages protect themselves from NK lysis via preferential expression of Qa-1.	[Zhou, Zhixia; Zhang, Cai; Zhang, Jian; Tian, Zhigang] Shandong Univ, Inst Immunopharmacol & Immunotherapy, Sch Pharmaceut Sci, Jinan 250100, Shandong, Peoples R China; [Tian, Zhigang] Univ Sci & Technol China, Dept Microbiol & Immunol, Sch Life Sci, Hefei, Anhui, Peoples R China	Shandong University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, ZX (corresponding author), Shandong Univ, Inst Immunopharmacol & Immunotherapy, Sch Pharmaceut Sci, Jinan 250100, Shandong, Peoples R China.	caizhangsd@sdu.edu.cn; tzg@ustc.edu.cn	Tian, Zhigang/J-3512-2013; Zhang, Jian/AAQ-3068-2021	Zhou, Zhixia/0000-0002-4080-5749	Natural Science Foundation of China [90713033, 30901307, 30772497]; National 973 Basic Science Program of China [2007CB815800]; Important National Science & Technology Specific Projects [2008ZX10002-008]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Science Program of China; Important National Science & Technology Specific Projects	This work was supported by grants from the Natural Science Foundation of China (#90713033, #30901307, and #30772497), the National 973 Basic Science Program of China (#2007CB815800) and the Important National Science & Technology Specific Projects (#2008ZX10002-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baratin M, 2005, P NATL ACAD SCI USA, V102, P14747, DOI 10.1073/pnas.0507355102; Bellora F, 2010, P NATL ACAD SCI USA, V107, P21659, DOI 10.1073/pnas.1007654108; Biassoni R, 2003, J CELL MOL MED, V7, P376, DOI 10.1111/j.1582-4934.2003.tb00240.x; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Colmenero P, 2007, J IMMUNOL, V179, P4608, DOI 10.4049/jimmunol.179.7.4608; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Coudert JD, 2005, BLOOD, V106, P1711, DOI 10.1182/blood-2005-03-0918; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Elhaik-Goldman S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023472; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Hamerman JA, 2004, J IMMUNOL, V172, P2001, DOI 10.4049/jimmunol.172.4.2001; Jiang Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-12; Jinushi M, 2003, J IMMUNOL, V171, P5423, DOI 10.4049/jimmunol.171.10.5423; Jinushi M, 2003, J IMMUNOL, V170, P1249, DOI 10.4049/jimmunol.170.3.1249; Klezovich-Benard M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002481; Lapaque N, 2009, J IMMUNOL, V182, P4339, DOI 10.4049/jimmunol.0803329; Lu LR, 2007, IMMUNITY, V26, P593, DOI 10.1016/j.immuni.2007.03.017; McQueen KL, 2002, CURR OPIN IMMUNOL, V14, P615, DOI 10.1016/S0952-7915(02)00380-1; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Nedvetzki S, 2007, BLOOD, V109, P3776, DOI 10.1182/blood-2006-10-052977; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Ota T, 2005, BLOOD, V106, P184, DOI 10.1182/blood-2004-11-4257; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Persson CM, 2008, SCAND J IMMUNOL, V67, P30, DOI 10.1111/j.1365-3083.2007.02034.x; Prajeeth CK, 2011, INFECT IMMUN, V79, P2699, DOI 10.1128/IAI.00079-11; Raulet DH, 2004, NAT IMMUNOL, V5, P996, DOI 10.1038/ni1114; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Reimer T, 2008, J LEUKOCYTE BIOL, V83, P1249, DOI 10.1189/jlb.0607412; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Romo N, 2011, J LEUKOCYTE BIOL, V90, P717, DOI 10.1189/jlb.0311171; Salem ML, 2006, VACCINE, V24, P5119, DOI 10.1016/j.vaccine.2006.04.010; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Tjwa ET, 2012, J VIROL; Vivier E, 2002, SCIENCE, V296, P1248, DOI 10.1126/science.1072447; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Wang HM, 2008, MOL IMMUNOL, V45, P1548, DOI 10.1016/j.molimm.2007.10.007; Wang J, 2006, J HEPATOL, V44, P446, DOI 10.1016/j.jhep.2005.08.015; Wang J, 2005, CELL MOL IMMUNOL, V2, P449; Watzl C, 2003, MICROBES INFECT, V5, P31, DOI 10.1016/S1286-4579(02)00057-6; Whitmore MM, 2004, CANCER RES, V64, P5850, DOI 10.1158/0008-5472.CAN-04-0063; Wu JD, 2004, J CLIN INVEST, V114, P560, DOI 10.1172/JCI200422206; Zhang C, 2005, INT IMMUNOPHARMACOL, V5, P1057, DOI 10.1016/j.intimp.2005.02.003; Zhang C, 2008, HUM IMMUNOL, V69, P490, DOI 10.1016/j.humimm.2008.06.004; Zhang C, 2008, CYTOKINE, V42, P128, DOI 10.1016/j.cyto.2008.01.003; Zwirner NW, 2007, CYTOKINE GROWTH F R, V18, P159, DOI 10.1016/j.cytogfr.2007.01.013	48	34	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36928	10.1371/journal.pone.0036928	http://dx.doi.org/10.1371/journal.pone.0036928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629344	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500039
J	Barton, ER; Park, S; James, JK; Makarewich, CA; Philippou, A; Eletto, D; Lei, HQ; Brisson, B; Ostrovsky, O; Li, ZH; Argon, Y				Barton, Elisabeth R.; Park, SooHyun; James, Jose K.; Makarewich, Catherine A.; Philippou, Anastassios; Eletto, Davide; Lei, Hanqin; Brisson, Becky; Ostrovsky, Olga; Li, Zihai; Argon, Yair			Deletion of muscle GRP94 impairs both muscle and body growth by inhibiting local IGF production	FASEB JOURNAL			English	Article						chaperones; endocrine growth control; glucose homeostasis; glucose regulated protein 94; IGFs	FACTOR-BINDING PROTEIN-1; TOLL-LIKE RECEPTORS; (IGF)-I E-PEPTIDES; FACTOR-I; SKELETAL-MUSCLE; ENDOPLASMIC-RETICULUM; SARCOPLASMIC-RETICULUM; CHAPERONE ACTIVITY; GENE-EXPRESSION; TRANSGENIC MICE	Insulin-like growth factors (IGFs) are critical for development and growth of skeletal muscles, but because several tissues produce IGFs, it is not clear which source is necessary or sufficient for muscle growth. Because it is critical for production of both IGF-I and IGF-II, we ablated glucose-regulated protein 94 (GRP94) in murine striated muscle to test the necessity of local IGFs for normal muscle growth. These mice exhibited smaller skeletal muscles with diminished IGF contents but with normal contractile function and no apparent endoplasmic reticulum stress response. This result shows that muscles rely on GRP94 primarily to support local production of IGFs, a pool that is necessary for normal muscle growth. In addition, body weights were similar to 30% smaller than those of litter-mate controls, and circulating IGF-I also decreased significantly, yet glucose homeostasis was maintained with little disruption to the growth hormone pathway. The growth defect was complemented on administration of recombinant IGF-I. Thus, unlike liver production of IGF-I, muscle IGF-I is necessary not only locally but also globally for whole-body growth.-Barton, E. R., Park, S., James, J. K., Makarewich, C. A., Philippou, A., Eletto, D., Lei, H., Brisson, B., Ostrovsky, O., Li, Z., Argon, Y. Deletion of muscle GRP94 impairs both muscle and body growth by inhibiting local IGF production. FASEB J. 26, 3691-3702 (2012). www.fasebj.org	[Barton, Elisabeth R.; Park, SooHyun; Philippou, Anastassios; Lei, Hanqin; Brisson, Becky] Univ Penn, Dept Anat & Cell Biol, Sch Dent Med, Philadelphia, PA 19104 USA; [James, Jose K.; Makarewich, Catherine A.; Eletto, Davide; Ostrovsky, Olga; Argon, Yair] Univ Penn, Div Cellular Pathol, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Barton, Elisabeth R.; Philippou, Anastassios; Brisson, Becky; Argon, Yair] Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Li, Zihai] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Medical University of South Carolina	Argon, Y (corresponding author), 816B ARC,3615 Civic Ctr Blvd, Philadelphia, PA 19104 USA.	yargon@mail.med.upenn.edu	Philippou, Anastassios/H-2748-2019; Ostrovsky, Olga/AAZ-9351-2021	Philippou, Anastassios/0000-0003-0047-3003; park, soohyun/0000-0001-9847-9985	U.S. National Institutes of Health [AG18001, GM04788, AR057363, AR052646, AI070603, AI077283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077283, R01AI070603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646, R01AR057363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008339, R01GM077480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018001] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to the technical expertise provided by Jalpa Modi in mouse husbandry, Magdalena Sikora and Zuozhen Tian in muscle functional measurements and glucose clearance tests, and Monjir Bakshi in muscle primary cultures. The authors also thank Dr. Yina Dong for help with the quantitation of GRP94 deletion, and Dr. Beth McNally (University of Chicago, Chicago, IL, USA) for the gift of antibodies. IPLEX was provided by David Green (Insmed Inc., Monmouth Junction, NJ, USA). This work was supported by U.S. National Institutes of Health grants AG18001 and GM04788 (Y.A.), AR057363 and AR052646 (E. R. B), and AI070603 and AI077283 (Z.L.). O.O. was a fellow of the Arthritis Foundation. The authors declare no conflicts of interest. Author contributions: Y.A., E. R. B., S. P., and Z.L. conceived or designed the experiments and wrote the manuscript; S. P., J.K.J., C. A. M., A. P., D. E., H. L., B. B., and O.O. performed the experiments; E. R. B., S. P., J.K.J., and Y.A. analyzed the data.	Adams GR, 1998, J APPL PHYSIOL, V84, P1716, DOI 10.1152/jappl.1998.84.5.1716; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Barton ER, 2010, J APPL PHYSIOL, V108, P1069, DOI 10.1152/japplphysiol.01308.2009; Barton ER, 2006, J APPL PHYSIOL, V100, P1778, DOI 10.1152/japplphysiol.01405.2005; BECKERLE MC, 1987, CELL, V51, P569, DOI 10.1016/0092-8674(87)90126-7; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; Biswas C, 2007, BIOCHEM J, V405, P233, DOI 10.1042/BJ20061867; BORGES JLC, 1984, J CLIN ENDOCR METAB, V59, P1; Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279; CALA SE, 1994, J BIOL CHEM, V269, P5926; Chin ER, 2003, J PHYSIOL-LONDON, V547, P649, DOI 10.1113/jphysiol.2002.024760; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Datta K, 2009, J BIOL CHEM, V284, P29666, DOI 10.1074/jbc.M109.034041; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Elis S, 2011, AGING CELL, V10, P547, DOI 10.1111/j.1474-9726.2011.00683.x; Fernandez AM, 2002, J CLIN INVEST, V109, P347, DOI 10.1172/JCI200213503; Govoni KE, 2007, PHYSIOL GENOMICS, V30, P354, DOI 10.1152/physiolgenomics.00022.2007; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang J, 1998, P NATL ACAD SCI USA, V95, P12100, DOI 10.1073/pnas.95.21.12100; JAYNES JB, 1988, MOL CELL BIOL, V8, P62, DOI 10.1128/MCB.8.1.62; Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Marchand A, 2006, J BIOL CHEM, V281, P19124, DOI 10.1074/jbc.M602157200; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Murphy RM, 2009, J PHYSIOL-LONDON, V587, P443, DOI 10.1113/jphysiol.2008.163162; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886; Novosyadlyy R, 2008, CELL DEATH DIFFER, V15, P1304, DOI 10.1038/cdd.2008.52; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Ostrovsky O, 2010, BBA-MOL CELL RES, V1803, P333, DOI 10.1016/j.bbamcr.2009.11.005; Ostrovsky O, 2009, P NATL ACAD SCI USA, V106, P11600, DOI 10.1073/pnas.0902626106; Ostrovsky O, 2009, MOL BIOL CELL, V20, P1855, DOI 10.1091/mbc.E08-04-0346; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; Pfeffer LA, 2009, MOL BIOL CELL, V20, P3810, DOI 10.1091/mbc.E08-12-1202; POWELL DR, 1991, J BIOL CHEM, V266, P18868; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Rosenfeld RG, 1996, HORM RES, V46, P170, DOI 10.1159/000185018; Rotwein P, 2010, PEDIATR NEPHROL, V25, P651, DOI 10.1007/s00467-009-1258-y; Schwaller B, 1999, AM J PHYSIOL-CELL PH, V276, pC395, DOI 10.1152/ajpcell.1999.276.2.C395; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; TURNER JD, 1988, AM J PHYSIOL, V255, pE513, DOI 10.1152/ajpendo.1988.255.4.E513; VAN PN, 1989, J BIOL CHEM, V264, P17494; Vitadello M, 1998, BIOCHEM J, V332, P351, DOI 10.1042/bj3320351; Vitadello M, 2003, FASEB J, V17, P923, DOI 10.1096/fj.02-0644fje; Wallenius K, 2001, ENDOCRINOLOGY, V142, P4762, DOI 10.1210/en.142.11.4762; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Yang CQ, 1996, ENDOCRINOLOGY, V137, P2766, DOI 10.1210/en.137.7.2766; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	54	54	55	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3691	3702		10.1096/fj.11-203026	http://dx.doi.org/10.1096/fj.11-203026			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22649033	Green Published			2022-12-25	WOS:000308391600011
J	Eckert, T; Link, S; Le, DTV; Sobczak, JP; Gieseke, A; Richter, K; Woehlke, G				Eckert, Thomas; Link, Susanne; Doan Tuong-Van Le; Sobczak, Jean-Philippe; Gieseke, Anja; Richter, Klaus; Woehlke, Guenther			Subunit Interactions and Cooperativity in the Microtubule-severing AAA ATPase Spastin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARAPLEGIA PROTEIN SPASTIN; ESCRT-III COMPLEX; EXPRESSION ANALYSIS; STRUCTURAL BASIS; PLUS PROTEINS; MOTOR DOMAIN; MUTATIONS; SYNTHASE; IDENTIFICATION; HYDROLYSIS	Spastin is a hexameric ring AAA ATPase that severs microtubules. To see whether the ring complex funnels the energy of multiple ATP hydrolysis events to the site of mechanical action, we investigate here the cooperativity of spastin. Several lines of evidence indicate that interactions among two subunits dominate the cooperative behavior: (i) the ATPase activity shows a sigmoidal dependence on the ATP concentration; (ii) ATP gamma S displays a mixed-inhibition behavior for normal ATP turnover; and (iii) inactive mutant subunits inhibit the activity of spastin in a hyperbolic dependence, characteristic for two interacting species. A quantitative model based on neighbor interactions fits mutant titration experiments well, suggesting that each subunit is mainly influenced by one of its neighbors. These observations are relevant for patients suffering from SPG4-type hereditary spastic paraplegia and explain why single amino acid exchanges lead to a dominant negative phenotype. In severing assays, wild type spastin is even more sensitive toward the presence of inactive mutants than in enzymatic assays, suggesting a weak coupling of ATPase and severing activity.	[Eckert, Thomas; Link, Susanne; Doan Tuong-Van Le; Gieseke, Anja; Woehlke, Guenther] Tech Univ Munich, Dept Phys Biophys E22, D-85748 Garching, Germany; [Sobczak, Jean-Philippe] Tech Univ Munich, Walter Schottky Inst, Lab Biomol Nanotechnol, D-85748 Garching, Germany; [Richter, Klaus] Tech Univ Munich, Dept Chem, D-85748 Garching, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Woehlke, G (corresponding author), Tech Univ Munich, Dept Phys Biophys E22, James Franck Str 1, D-85748 Garching, Germany.	guenther.woehlke@mytum.de	Richter, Klaus/A-2673-2010	Richter, Klaus/0000-0002-8952-9642; Woehlke, Gunther/0000-0001-8462-9962	Deutsche Forschungsgemeinschaft [Wo614/4-1, SFB 863]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Wo614/4-1 and SFB 863. This work was also scientifically and financially supported by Prof. Matthias Rief, Prof. Johannes Buchner, and Prof. Hendrik Dietz.	Abbondanzieri EA, 2009, NATURE, V457, P392, DOI 10.1038/457392a; Adair GS, 1925, J BIOL CHEM, V63, P529; Adio S, 2006, J BIOL CHEM, V281, P37782, DOI 10.1074/jbc.M605061200; Adio S, 2009, FEBS J, V276, P3641, DOI 10.1111/j.1742-4658.2009.07083.x; Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; CHA S, 1968, MOL PHARMACOL, V4, P621; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Ding CM, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-8; Ebbing B, 2008, HUM MOL GENET, V17, P1245, DOI 10.1093/hmg/ddn014; Errico A, 2004, HUM MOL GENET, V13, P2121, DOI 10.1093/hmg/ddh223; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; Fersht A., 1984, ENZYME STRUCTURE MEC, P98; Fonknechten N, 2000, HUM MOL GENET, V9, P637, DOI 10.1093/hmg/9.4.637; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; HUANG TG, 1994, J BIOL CHEM, V269, P16493; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MANDELKOW EM, 1985, J MOL BIOL, V185, P311, DOI 10.1016/0022-2836(85)90406-1; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Proukakis C, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9108; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Sauter S, 2002, HUM MUTAT, V20, P127, DOI 10.1002/humu.10105; Segel I.H., 1975, ENZYME KINETICS; Svenson IK, 2005, NEUROGENETICS, V6, P135, DOI 10.1007/s10048-005-0219-2; Svenson IK, 2001, AM J HUM GENET, V68, P1077, DOI 10.1086/320111; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Zhang XD, 2008, NAT STRUCT MOL BIOL, V15, P1223, DOI 10.1038/nsmb.1501	48	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26278	26290		10.1074/jbc.M111.291898	http://dx.doi.org/10.1074/jbc.M111.291898			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22637577	Green Published, hybrid			2022-12-25	WOS:000306916300054
J	Cvetesic, N; Perona, JJ; Gruic-Sovulj, I				Cvetesic, Nevena; Perona, John J.; Gruic-Sovulj, Ita			Kinetic Partitioning between Synthetic and Editing Pathways in Class I Aminoacyl-tRNA Synthetases Occurs at Both Pre-transfer and Post-transfer Hydrolytic Steps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; CRYSTAL-STRUCTURE; QUALITY-CONTROL; INDUCED-FIT; SPECIFICITY; MECHANISM; ENZYME; ACIDS; COMPLEX; DOMAIN	Comprehensive steady-state and transient kinetic studies of the synthetic and editing activities of Escherichia coli leucyl-tRNA synthetase (LeuRS) demonstrate that the enzyme depends almost entirely on post-transfer editing to endow the cell with specificity against incorporation of norvaline into protein. Among the three class I tRNA synthetases possessing a dedicated post-transfer editing domain (connective peptide 1; CP1 domain), LeuRS resembles valyl-tRNA synthetase in its reliance on post-transfer editing, whereas isoleucyl-tRNA synthetase differs in retaining a distinct tRNA-dependent synthetic site pre-transfer editing activity to clear noncognate amino acids before misacylation. Further characterization of the post-transfer editing activity in LeuRS by single-turnover kinetics demonstrates that the rate-limiting step is dissociation of deacylated tRNA and/or amino acid product and highlights the critical role of a conserved aspartate residue in mediating the first-order hydrolytic steps on the enzyme. Parallel analyses of adenylate and aminoacyl-tRNA formation reactions by wild-type and mutant LeuRS demonstrate that the efficiency of post-transfer editing is controlled by kinetic partitioning between hydrolysis and dissociation of misacylated tRNA and shows that trans editing after rebinding is a competent kinetic pathway. Together with prior analyses of isoleucyl-tRNA synthetase and valyl-tRNA synthetase, these experiments provide the basis for a comprehensive model of editing by class I tRNA synthetases, in which kinetic partitioning plays an essential role at both pre-transfer and post-transfer steps.	[Cvetesic, Nevena; Gruic-Sovulj, Ita] Univ Zagreb, Dept Chem, Fac Sci, Zagreb 10000, Croatia; [Perona, John J.] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [Perona, John J.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	University of Zagreb; Portland State University; Oregon Health & Science University	Gruic-Sovulj, I (corresponding author), Univ Zagreb, Dept Chem, Fac Sci, Horvatovac 102A, Zagreb 10000, Croatia.	gruic@chem.pmf.hr		Cvetesic, Nevena/0000-0002-1575-5612	National Institutes of Health Grants [1R03TW008024, GM63713]; Ministry of Science, Education, and Sports of the Republic of Croatia Grant [119-0982913-1358]; FOGARTY INTERNATIONAL CENTER [R03TW008024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063713] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science, Education, and Sports of the Republic of Croatia Grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R03TW008024 (to J. J. P. and I. G. S.) and GM63713 (to J. J. P.) This work was also supported by Ministry of Science, Education, and Sports of the Republic of Croatia Grant 119-0982913-1358 (to I. Weygand-Durasevic).	Apostol I, 1997, J BIOL CHEM, V272, P28980, DOI 10.1074/jbc.272.46.28980; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Betha AK, 2007, BIOCHEMISTRY-US, V46, P6258, DOI 10.1021/bi061965j; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; Chen X, 2011, NUCLEIC ACIDS RES, V39, P235, DOI 10.1093/nar/gkq763; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Dulic M, 2011, BIOCHIMIE, V93, P1761, DOI 10.1016/j.biochi.2011.06.013; Dulic M, 2010, J BIOL CHEM, V285, P23799, DOI 10.1074/jbc.M110.133553; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fersht A, 1999, STRUCTURE MECH PROTE, P132; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P1238, DOI 10.1021/bi00574a019; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; Francklyn C, 2002, RNA, V8, P1363, DOI 10.1017/S1355838202021180; Francklyn CS, 2008, BIOCHEMISTRY-US, V47, P11695, DOI 10.1021/bi801500z; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Gruic-Sovulj I, 2011, CROAT CHEM ACTA, V84, P179, DOI 10.5562/cca1823; Gutfreund H, 1995, KINETICS LIFE SCI, P103; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ibba M, 1999, NUCLEIC ACIDS RES, V27, P3631, DOI 10.1093/nar/27.18.3631; JAKUBOWSKI H, 1981, NUCLEIC ACIDS RES, V9, P3105, DOI 10.1093/nar/9.13.3105; Jakubowski H, 2012, WIRES RNA, V3, P295, DOI 10.1002/wrna.122; Johnson AA, 2001, J BIOL CHEM, V276, P38097; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200; Kumar S, 2012, J BIOL CHEM, V287, P3175, DOI 10.1074/jbc.M111.313619; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Levengood J, 2004, J BIOL CHEM, V279, P17707, DOI 10.1074/jbc.M313665200; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling JQ, 2009, MOL CELL, V33, P654, DOI 10.1016/j.molcel.2009.01.031; Lue SW, 2007, BIOCHEMISTRY-US, V46, P4466, DOI 10.1021/bi0618215; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Mascarenhas A. P., 2009, V22, P155; McLaughlin HM, 2012, HUM MUTAT, V33, P244, DOI 10.1002/humu.21635; Minajigi A, 2011, BIOCHEMISTRY-US, V50, P1101, DOI 10.1021/bi101360a; Minajigi A, 2010, J BIOL CHEM, V285, P23810, DOI 10.1074/jbc.M110.105320; Minajigi A, 2008, P NATL ACAD SCI USA, V105, P17748, DOI 10.1073/pnas.0804247105; Mursinna RS, 2004, BIOCHEMISTRY-US, V43, P155, DOI 10.1021/bi034919h; Mursinna RS, 2002, J AM CHEM SOC, V124, P7286, DOI 10.1021/ja025879s; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Pasman Z, 2011, BIOCHEMISTRY-US, V50, P1474, DOI 10.1021/bi1013535; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Soini J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-30; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Tang Y, 2002, BIOCHEMISTRY-US, V41, P10635, DOI 10.1021/bi026130x; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Uter NT, 2004, P NATL ACAD SCI USA, V101, P14396, DOI 10.1073/pnas.0404017101; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Xu MG, 2004, BIOCHEM BIOPH RES CO, V318, P11, DOI 10.1016/j.bbrc.2004.03.180; Yadavalli SS, 2012, ADV PROTEIN CHEM STR, V86, P1, DOI 10.1016/B978-0-12-386497-0.00001-3; Zhang CM, 2006, J MOL BIOL, V361, P300, DOI 10.1016/j.jmb.2006.06.015; Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200	72	44	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25381	25394		10.1074/jbc.M112.372151	http://dx.doi.org/10.1074/jbc.M112.372151			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22648413	Green Published, hybrid			2022-12-25	WOS:000306651700046
J	Karauzum, H; Chen, G; Abaandou, L; Mahmoudieh, M; Boroun, AR; Shulenin, S; Devi, VS; Stavale, E; Warfield, KL; Zeitlin, L; Roy, CJ; Sidhu, SS; Aman, MJ				Karauzum, Hatice; Chen, Gang; Abaandou, Laura; Mahmoudieh, Mahta; Boroun, Atefeh R.; Shulenin, Sergey; Devi, V. Sathya; Stavale, Eric; Warfield, Kelly L.; Zeitlin, Larry; Roy, Chad J.; Sidhu, Sachdev S.; Aman, M. Javad			Synthetic Human Monoclonal Antibodies toward Staphylococcal Enterotoxin B (SEB) Protective against Toxic Shock Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT EXPRESSION; IMMUNOGLOBULIN-G; IMMUNE EVASION; HUMAN-DISEASE; SUPERANTIGENS; BINDING; PLANTS; SPECIFICITIES; GENERATION; LIBRARIES	Staphylococcal enterotoxin B (SEB) is a potent toxin that can cause toxic shock syndrome and act as a lethal and incapacitating agent when used as a bioweapon. There are currently no vaccines or immunotherapeutics available against this toxin. Using phage display technology, human antigen-binding fragments (Fabs) were selected against SEB, and proteins were produced in Escherichia coli cells and characterized for their binding affinity and their toxin neutralizing activity in vitro and in vivo. Highly protective Fabs were converted into full-length IgGs and produced in mammalian cells. Additionally, the production of anti-SEB antibodies was explored in the Nicotiana benthamiana plant expression system. Affinity maturation was performed to produce optimized lead anti-SEB antibody candidates with subnanomolar affinities. IgGs produced in N. benthamiana showed characteristics comparable with those of counterparts produced in mammalian cells. IgGs were tested for their therapeutic efficacy in the mouse toxic shock model using different challenge doses of SEB and a treatment with 200 mu g of IgGs 1 h after SEB challenge. The lead candidates displayed full protection from lethal challenge over a wide range of SEB challenge doses. Furthermore, mice that were treated with anti-SEB IgG had significantly lower IFN gamma and IL-2 levels in serum compared with mock-treated mice. In summary, these anti-SEB monoclonal antibodies represent excellent therapeutic candidates for further preclinical and clinical development.	[Chen, Gang; Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Karauzum, Hatice; Abaandou, Laura; Mahmoudieh, Mahta; Boroun, Atefeh R.; Shulenin, Sergey; Devi, V. Sathya; Stavale, Eric; Warfield, Kelly L.; Aman, M. Javad] Integrated Biotherapeut Inc, Gaithersburg, MD 20878 USA; [Chen, Gang; Sidhu, Sachdev S.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Zeitlin, Larry] Mapp Biopharmaceut, San Diego, CA 92121 USA; [Roy, Chad J.] Tulane Sch Med, Tulane Natl Primate Res Ctr, Covington, LA 70433 USA	University of Toronto; University of Toronto; Tulane University	Sidhu, SS (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Dept Mol Genet, 160 Coll St, Toronto, ON M5S 3E1, Canada.	sachdev.sidhu@utoronto.ca; javad@integratedbiotherapeutics.com	Venkatarmani, Sathyadevi/AAP-1068-2020	Venkatarmani, Sathyadevi/0000-0003-1242-8162; Roy, Chad/0000-0002-1710-6974; Chen, Gang/0000-0002-6304-9173	National Institutes of Health, NIAID [U01 AI078023-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082276, U01AI078023] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant U01 AI078023-05 (to Integrated BioTherapeutics, Inc.).	Almagro JC, 2004, J MOL RECOGNIT, V17, P132, DOI 10.1002/jmr.659; Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; BERTHOLD F, 1981, BLUT, V43, P367, DOI 10.1007/BF00320315; Bostrom J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017887; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Burnett JC, 2005, NAT REV DRUG DISCOV, V4, P281, DOI 10.1038/nrd1694; Coffman JD, 2002, PROTEIN EXPRES PURIF, V24, P302, DOI 10.1006/prep.2001.1556; Darenberg J, 2004, CLIN INFECT DIS, V38, P836, DOI 10.1086/381979; Darenberg J, 2003, CLIN INFECT DIS, V37, P333, DOI 10.1086/376630; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Drozdowski Brian, 2010, J Immune Based Ther Vaccines, V8, P9, DOI 10.1186/1476-8518-8-9; Fellouse F. A., 2006, PHAGE DISPLAY BIOTEC, P709; Fellouse FAS, 2007, MAKING USING ANTIBOD, P157; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fraser John D., 2007, V93, P1, DOI 10.1159/000100851; Hiatt A, 2006, P NATL ACAD SCI USA, V103, P14645, DOI 10.1073/pnas.0607089103; Kabat E. A., 1991, SEQUENCES PROTEINS I; KABAT EA, 1991, J IMMUNOL, V147, P1709; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; Larkin EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013253; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Mazor Y, 2007, J IMMUNOL METHODS, V321, P41, DOI 10.1016/j.jim.2007.01.008; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Pogue GP, 2010, PLANT BIOTECHNOL J, V8, P638, DOI 10.1111/j.1467-7652.2009.00495.x; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; SCHLIEVERT PM, 1993, J INFECT DIS, V167, P997, DOI 10.1093/infdis/167.5.997; SCHLIEVERT PM, 1986, LANCET, V1, P1149; Sidhu SS, 2006, NAT CHEM BIOL, V2, P682, DOI 10.1038/nchembio843; STILES BG, 1993, INFECT IMMUN, V61, P5333, DOI 10.1128/IAI.61.12.5333-5338.1993; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Ulrich RG, 1997, TXB MILITARY MED 1, P621; Vajdos FF, 2002, J MOL BIOL, V320, P415, DOI 10.1016/S0022-2836(02)00264-4; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6	38	51	58	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25203	25215		10.1074/jbc.M112.364075	http://dx.doi.org/10.1074/jbc.M112.364075			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22645125	Green Published, hybrid			2022-12-25	WOS:000306651700030
J	Menssen, R; Schweiggert, J; Schreiner, J; Kusevic, D; Reuther, J; Braun, B; Wolf, DH				Menssen, Ruth; Schweiggert, Joerg; Schreiner, Jens; Kusevic, Denis; Reuther, Julia; Braun, Bernhard; Wolf, Dieter H.			Exploring the Topology of the Gid Complex, the E3 Ubiquitin Ligase Involved in Catabolite-induced Degradation of Gluconeogenic Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEXES; IN-VIVO; FRUCTOSE-1,6-BISPHOSPHATASE; YEAST; INACTIVATION; DIMERIZATION; COMPONENTS; MUSKELIN; MODULES	In the yeast Saccharomyces cerevisiae, key regulatory enzymes of gluconeogenesis such as fructose-1,6-bisphosphatase are degraded via the ubiquitin proteasome system when cells are replenished with glucose. Polyubiquitination is carried out by the Gid complex, a multisubunit ubiquitin ligase that consists of seven different Gid (glucose-induced degradation-deficient) proteins. Under gluconeogenic conditions the E3 ligase is composed of six subunits (Gid1/Vid30, Gid2/Rmd5, Gid5/Vid28, Gid7, Gid8, and Gid9/Fyv10). Upon the addition of glucose the regulatory subunit Gid4/Vid24 appears, binds to the Gid complex, and triggers ubiquitination of fructose-1,6-bisphosphatase. All seven proteins are essential for this process; however, nothing is known about the arrangement of the subunits in the complex. Interestingly, each Gid protein possesses several remarkable motifs (e.g. SPRY, LisH, CTLH domains) that may play a role in protein-protein interaction. We, therefore, generated altered versions of individual Gid proteins by deleting or mutating these domains and performed co-immunoprecipitation experiments to analyze the interaction between distinct subunits. Thus, we were able to create an initial model of the topology of this unusual E3 ubiquitin ligase.	[Menssen, Ruth; Schweiggert, Joerg; Schreiner, Jens; Kusevic, Denis; Reuther, Julia; Braun, Bernhard; Wolf, Dieter H.] Univ Stuttgart, Inst Biochem, D-70569 Stuttgart, Germany	University of Stuttgart	Wolf, DH (corresponding author), Univ Stuttgart, Inst Biochem, Pfaffenwaldring 55, D-70569 Stuttgart, Germany.	dieter.wolf@ibc.uni-stuttgart.de	Schweiggert, Jörg/M-9631-2016	Schweiggert, Jörg/0000-0002-1272-3762	Deutsche Forschungsgemeinschaft, Bonn; Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg within the Schlieben-Lange-Programm	Deutsche Forschungsgemeinschaft, Bonn(German Research Foundation (DFG)); Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg within the Schlieben-Lange-Programm	This work was supported by the Deutsche Forschungsgemeinschaft, Bonn.; Supported by the Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg within the Schlieben-Lange-Programm.	Ahn J, 2011, BIOCHEMISTRY-US, V50, P1359, DOI 10.1021/bi101749s; Atabakhsh E, 2009, MOL CANCER RES, V7, P1962, DOI 10.1158/1541-7786.MCR-09-0098; Ausubel FM, 1992, CURRENT PROTOCOLS MO; Betts S, 1999, STRUCT FOLD DES, V7, pR131, DOI 10.1016/S0969-2126(99)80078-1; Braun B, 2011, FEBS LETT, V585, P3856, DOI 10.1016/j.febslet.2011.10.038; Chang LK, 2008, J MOL BIOL, V379, P231, DOI 10.1016/j.jmb.2008.04.011; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Funakoshi M, 2009, YEAST, V26, P185, DOI 10.1002/yea.1658; GANCEDO C, 1965, BIOCHEM BIOPH RES CO, V20, P15, DOI 10.1016/0006-291X(65)90944-7; Gerlitz G, 2005, CELL CYCLE, V4, P1632, DOI 10.4161/cc.4.11.2151; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Hammerle M, 1998, J BIOL CHEM, V273, P25000, DOI 10.1074/jbc.273.39.25000; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mateja A, 2006, J MOL BIOL, V357, P621, DOI 10.1016/j.jmb.2006.01.002; MAZON MJ, 1982, J BIOL CHEM, V257, P1128; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; MULLER M, 1981, J BIOL CHEM, V256, P723; Murrin LC, 2007, J NEUROIMMUNE PHARM, V2, P290, DOI 10.1007/s11481-007-9079-x; Pitre S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-365; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; SCHORK SM, 1995, J BIOL CHEM, V270, P26446, DOI 10.1074/jbc.270.44.26446; SCHORK SM, 1994, FEBS LETT, V349, P270, DOI 10.1016/0014-5793(94)00668-7; SCHORK SM, 1994, NATURE, V369, P283, DOI 10.1038/369283a0; Snowdon C, 2008, FEMS YEAST RES, V8, P204, DOI 10.1111/j.1567-1364.2007.00327.x; Suzuki T, 2008, BIOCHEM J, V411, P581, DOI 10.1042/BJ20071312; Tomaru Koji, 2010, Open Biochem J, V4, P1, DOI 10.2174/1874091X01004010001; Umeda M, 2003, GENE, V303, P47, DOI 10.1016/S0378-1119(02)01153-8; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; van der Merwe GK, 2001, J BIOL CHEM, V276, P28659, DOI 10.1074/jbc.M102280200; VONHERRATH M, 1988, Z LEBENSM UNTERS FOR, V186, P427; Wolf DH, 2011, FEBS LETT, V585, P2769, DOI 10.1016/j.febslet.2011.08.020; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994	42	71	72	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25602	25614		10.1074/jbc.M112.363762	http://dx.doi.org/10.1074/jbc.M112.363762			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22645139	hybrid, Green Published			2022-12-25	WOS:000306651700068
J	Chen, CH; Thompson, DA; Koutalos, Y				Chen, Chunhe; Thompson, Debra A.; Koutalos, Yiannis			Reduction of All-trans-retinal in Vertebrate Rod Photoreceptors Requires the Combined Action of RDH8 and RDH12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; LIGHT-INDUCED DEGENERATION; VISUAL CYCLE; BINDING PROTEIN; SUBSTRATE-SPECIFICITY; DARK-ADAPTATION; OUTER SEGMENTS; MOUSE; RPE65; MUTATIONS	In vertebrate rod cells, retinoid dehydrogenases/reductases (RDHs) are critical for reducing the reactive aldehyde all-trans-retinal that is released by photoactivated rhodopsin, to all-trans-retinol (vitamin A). Previous studies have shown that RDH8 localizes to photoreceptor outer segments and is a strong candidate for performing this role. However, RDH12 function in the photoreceptor inner segments is also key, because loss of function mutations cause retinal degeneration in some forms of Leber congenital amaurosis. To investigate the in vivo roles of RDH8 and RDH12, we used fluorescence imaging to examine all-trans-retinol production in single isolated rod cells from wild-type mice and knock-out mice lacking either one or both RDHs. Outer segments of rods deficient in Rdh8 failed to reduce all-trans-retinal, but those deficient in Rdh12 were unaffected. Following exposure to light, a leak of retinoids from outer to inner segments was detected in rods from both wild-type and knock-out mice. In cells lacking Rdh8 or Rdh12, this leak was mainly all-trans-retinal. Wild-type rods incubated with all-trans-retinal reduced moderate loads of retinal within the cell interior, but this ability was lost by cells deficient in Rdh8 or Rdh12. Our findings are consistent with localization of RDH8 to the outer segment where it provides most of the activity needed to reduce all-trans-retinal generated by the light response. In contrast, RDH12 in inner segments can protect vital cell organelles against aldehyde toxicity caused by an intracellular leak of all-trans-retinal, as well as other aldehydes originating both inside and outside the cell.	[Chen, Chunhe; Koutalos, Yiannis] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Thompson, Debra A.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Thompson, Debra A.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48105 USA; [Koutalos, Yiannis] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Medical University of South Carolina; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Medical University of South Carolina	Koutalos, Y (corresponding author), Med Univ S Carolina, Dept Ophthalmol, 167 Ashley Ave, Charleston, SC 29425 USA.	koutalo@musc.edu		Thompson, Debra/0000-0003-3485-0794	National Institutes of Health [P30-EY07003, R01-EY014850]; Foundation Fighting Blindness, Research to Prevent Blindness; National Institutes of Health from Extramural Research Facilities Program of the National Center for Research Resources [C06 RR015455]; Research to Prevent Blindness Senior Scientific Investigator Award; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY007003, R01EY014850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness, Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Institutes of Health from Extramural Research Facilities Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Senior Scientific Investigator Award(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants P30-EY07003 and R01-EY014850. This work was also supported by the Foundation Fighting Blindness, Research to Prevent Blindness. This work was conducted in a facility constructed with support from National Institutes of Health Grant C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources.; Recipient of a Research to Prevent Blindness Senior Scientific Investigator Award.	Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; BEAUCHAMP RO, 1985, CRC CR REV TOXICOL, V14, P309, DOI 10.3109/10408448509037461; Belyaeva OV, 2008, FEBS J, V275, P138, DOI 10.1111/j.1742-4658.2007.06184.x; Blakeley LR, 2011, INVEST OPHTH VIS SCI, V52, P3483, DOI 10.1167/iovs.10-6694; Chen CH, 2005, BIOPHYS J, V88, P2278, DOI 10.1529/biophysj.104.054254; Chen CH, 2010, PHOTOCH PHOTOBIO SCI, V9, P1475, DOI 10.1039/c0pp00124d; Chen CH, 2009, INVEST OPHTH VIS SCI, V50, P3589, DOI 10.1167/iovs.08-3336; Danciger M, 2003, INVEST OPHTH VIS SCI, V44, P2442, DOI 10.1167/iovs.02-1252; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500; FUTTERMAN S, 1970, J NEUROCHEM, V17, P149, DOI 10.1111/j.1471-4159.1970.tb02195.x; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; Hargrave PA, 2001, INVEST OPHTH VIS SCI, V42, P3; HUBBARD R., 1971, Methods in Enzymology, V18C, P615, DOI 10.1016/S0076-6879(71)18045-7; Janecke AR, 2004, NAT GENET, V36, P850, DOI 10.1038/ng1394; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kanan Y, 2008, INVEST OPHTH VIS SCI, V49, P1071, DOI 10.1167/iovs.07-1207; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; Kurth I, 2007, MOL CELL BIOL, V27, P1370, DOI 10.1128/MCB.01486-06; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Marchette LD, 2010, FREE RADICAL BIO MED, V48, P16, DOI 10.1016/j.freeradbiomed.2009.08.005; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; OKAJIMA TIL, 1989, EXP EYE RES, V49, P629, DOI 10.1016/S0014-4835(89)80059-4; OKAJIMA TIL, 1990, P NATL ACAD SCI USA, V87, P6907, DOI 10.1073/pnas.87.17.6907; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Perrault I, 2004, AM J HUM GENET, V75, P639, DOI 10.1086/424889; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; SAARI JC, 1993, BIOCHEM J, V291, P697, DOI 10.1042/bj2910697; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Travis G. H., 2011, ARVO M, V52, P3357; Tsina E, 2004, J GEN PHYSIOL, V124, P429, DOI 10.1085/jgp.200409078; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Yamamoto H, 1999, NAT GENET, V22, P188, DOI 10.1038/9707	46	47	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24662	24670		10.1074/jbc.M112.354514	http://dx.doi.org/10.1074/jbc.M112.354514			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22621924	Green Published, hybrid			2022-12-25	WOS:000306651100060
J	Paul, MF; Alushin, GM; Barros, MH; Rak, M; Tzagoloff, A				Paul, Marie-Francoise; Alushin, Gregory M.; Barros, Mario H.; Rak, Malgorzata; Tzagoloff, Alexander			The Putative GTPase Encoded by MTG3 Functions in a Novel Pathway for Regulating Assembly of the Small Subunit of Yeast Mitochondrial Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASES; B MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; BACILLUS-SUBTILIS; GENE ENCODES; PROTEINS; YQEH; DNA; TRANSLATION; STEP	Very little is known about biogenesis of mitochondrial ribosomes. The GTPases encoded by the nuclear MTG1 and MTG2 genes of Saccharomyces cerevisiae have been reported to play a role in assembly of the ribosomal 54 S subunit. In the present study biochemical screens of a collection of respiratory deficient yeast mutants have enabled us to identify a third gene essential for expression of mitochondrial ribosomes. This gene codes for a member of the YqeH family of GTPases, which we have named MTG3 in keeping with the earlier convention. Mutations in MTG3 cause the accumulation of the 15 S rRNA precursor, previously shown to have an 80-nucleotide 5' extension. Sucrose gradient sedimentation of mitochondrial ribosomes from temperature-sensitive mtg3 mutants grown at the permissive and restrictive temperatures, combined with immunobloting with subunit-specific antibodies, indicate that Mtg3p is required for assembly of the 30 S but not 54 S ribosomal subunit. The respiratory deficient growth phenotype of an mtg3 null mutant is partially rescued by overexpression of the Mrpl4p constituent located at the peptide exit site of the 54 S subunit. The rescue is accompanied by an increase in processed 15 S rRNA. This suggests that Mtg3p and Mrpl4p jointly regulate assembly of the small subunit by modulating processing of the 15 S rRNA precursor.	[Paul, Marie-Francoise; Alushin, Gregory M.; Barros, Mario H.; Rak, Malgorzata; Tzagoloff, Alexander] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tzagoloff, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	spud@cubpet2.bio.columbia.edu	Barros, Mario/Q-6358-2019; Barros, Mario H/B-8118-2012	Barros, Mario/0000-0003-2977-9815; Alushin, Gregory/0000-0001-7250-4484	National Institutes of Health [HL02274]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL022174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL02274 (to A. T.) and grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (to M. H. B.).	ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350; Anand B, 2009, BIOCHEM BIOPH RES CO, V386, P602, DOI 10.1016/j.bbrc.2009.06.078; Barrientos A, 2003, MOL BIOL CELL, V14, P2292, DOI 10.1091/mbc.E02-10-0636; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barros MH, 2011, J BIOL CHEM, V286, P32937, DOI 10.1074/jbc.M111.265371; BOERNER P, 1981, NUCLEIC ACIDS RES, V9, P6379, DOI 10.1093/nar/9.23.6379; BONITZ SG, 1980, P NATL ACAD SCI-BIOL, V77, P3167, DOI 10.1073/pnas.77.6.3167; BORST P, 1971, FEBS LETT, V13, P73, DOI 10.1016/0014-5793(71)80204-1; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; CHATTON B, 1988, J BIOL CHEM, V263, P52; Connolly K, 2009, TRENDS BIOCHEM SCI, V34, P256, DOI 10.1016/j.tibs.2009.01.011; Datta K, 2005, MOL BIOL CELL, V16, P954, DOI 10.1091/mbc.E04-07-0622; Ellis TP, 2005, GENETICS, V171, P949, DOI 10.1534/genetics.104.036467; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; FAYE G, 1974, J MOL BIOL, V88, P105, DOI 10.1016/0022-2836(74)90304-0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fekete Z, 2008, J BIOL CHEM, V283, P3767, DOI 10.1074/jbc.M709617200; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glick BS, 1995, METHOD ENZYMOL, V260, P224, DOI 10.1016/0076-6879(95)60140-6; Graack HR, 1998, BIOCHEM J, V329, P433, DOI 10.1042/bj3290433; Gruschke S, 2010, J BIOL CHEM, V285, P19022, DOI 10.1074/jbc.M110.113837; Hage Aziz El, 2004, RNA Biol, V1, P10; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; Karbstein K, 2007, BIOPOLYMERS, V87, P1, DOI 10.1002/bip.20762; Kaur J, 2011, EMBO REP, V12, P950, DOI 10.1038/embor.2011.133; KOERNER TJ, 1991, METHOD ENZYMOL, V194, P477; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI M, 1982, J BIOL CHEM, V257, P5921; Loh PC, 2007, GENES GENET SYST, V82, P281, DOI 10.1266/ggs.82.281; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING LAB MANU; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MORIMOTO R, 1979, J BIOL CHEM, V254, P2461; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; OSINGA KA, 1981, NUCLEIC ACIDS RES, V9, P1351, DOI 10.1093/nar/9.6.1351; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; TERPSTRA P, 1979, J BIOL CHEM, V254, P2653; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; Tzagoloff A, 1990, Prog Nucleic Acid Res Mol Biol, V39, P129, DOI 10.1016/S0079-6603(08)60625-X; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Wiesenberger G., 1997, MOL CELL BIOL, V28, P16	47	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24346	24355		10.1074/jbc.M112.363309	http://dx.doi.org/10.1074/jbc.M112.363309			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22621929	Green Published, hybrid			2022-12-25	WOS:000306651100029
J	Ma, JZL; Lim, SN; Qin, JS; Yang, JP; Enomoto, N; Ruedl, C; Ronchese, F				Ma, Joel Zhi-long; Lim, So Nai; Qin, Jim Shixiang; Yang, Jianping; Enomoto, Noriyuki; Ruedl, Christiane; Ronchese, Franca			Murine CD4(+) T Cell Responses Are Inhibited by Cytotoxic T Cell-Mediated Killing of Dendritic Cells and Are Restored by Antigen Transfer	PLOS ONE			English	Article							LYMPHOCYTES IN-VIVO; CROSS-PRESENTATION; LYMPH-NODES; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; DEPENDENT ELIMINATION; VIRAL-INFECTION; PERFORIN; ACTIVATION; CTL; EXPANSION	Cytotoxic T lymphocytes (CTL) provide protection against pathogens and tumors. In addition, experiments in mouse models have shown that CTL can also kill antigen-presenting dendritic cells (DC), reducing their ability to activate primary and secondary CD8(+) T cell responses. In contrast, the effects of CTL-mediated killing on CD4(+) T cell responses have not been fully investigated. Here we use adoptive transfer of TCR transgenic T cells and DC immunization to show that specific CTL significantly inhibited CD4(+) T cell proliferation induced by DC loaded with peptide or low concentrations of protein antigen. In contrast, CTL had little effect on CD4(+) T cell proliferation induced by DC loaded with high protein concentrations or expressing antigen endogenously, even if these DC were efficiently killed and failed to accumulate in the lymph node (LN). Residual CD4(+) T cell proliferation was due to the transfer of antigen from carrier DC to host APC, and predominantly involved skin DC populations. Importantly, the proliferating CD4(+) T cells also developed into IFN-gamma producing memory cells, a property normally requiring direct presentation by activated DC. Thus, CTL-mediated DC killing can inhibit CD4(+) T cell proliferation, with the extent of inhibition being determined by the form and amount of antigen used to load DC. In the presence of high antigen concentrations, antigen transfer to host DC enables the generation of CD4(+) T cell responses regardless of DC killing, and suggests mechanisms whereby CD4(+) T cell responses can be amplified.	[Ma, Joel Zhi-long; Lim, So Nai; Qin, Jim Shixiang; Yang, Jianping; Enomoto, Noriyuki; Ronchese, Franca] Malaghan Inst Med Res, Wellington, New Zealand; [Ma, Joel Zhi-long; Lim, So Nai; Ronchese, Franca] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Ruedl, Christiane] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Malaghan Institute; Victoria University Wellington; Victoria University Wellington; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ma, JZL (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	fronchese@malaghan.org.nz	Ronchese, Franca/M-9618-2019; Enomoto, Noriyuki/GLS-0691-2022; Ruedl, christiane/A-2219-2011	Ronchese, Franca/0000-0001-5835-8230; Enomoto, Noriyuki/0000-0003-3187-4264; Ruedl, christiane/0000-0002-5599-6541; Ma, Joel/0000-0002-0448-6744; Yang, Jianping/0000-0001-5336-6530	Marsden Fund; Health Research Council of New Zealand; Lottery Health	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand); Lottery Health	This work was funded by research grants from the Marsden Fund (http://www.royalsociety.org.nz/programmes/funds/marsden/) and Health Research Council of New Zealand (http://www.hrc.govt.nz/) to FR. JZM was funded by a Lottery Health (http://www.communitymatters. govt.nz/Funding-and-grants-Lottery- grants-Lottery-Health-Research) PhD Scholarship and the Marsden Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Andrew KA, 2008, J IMMUNOL, V181, P8356, DOI 10.4049/jimmunol.181.12.8356; Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Blair DA, 2011, J IMMUNOL, V187, P2310, DOI 10.4049/jimmunol.1100363; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Brehm MA, 2005, J IMMUNOL, V175, P5043, DOI 10.4049/jimmunol.175.8.5043; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Chen M, 2012, BLOOD, V119, P127, DOI 10.1182/blood-2011-06-363994; Dickgreber N, 2009, J IMMUNOL, V182, P1260, DOI 10.4049/jimmunol.182.3.1260; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Enomoto N, 2012, J IMMUNOL, V188, P1734, DOI 10.4049/jimmunol.1102699; Feldmann J, 2002, BRIT J HAEMATOL, V117, P965, DOI 10.1046/j.1365-2141.2002.03534.x; Garrigan K, 1996, BLOOD, V88, P3508, DOI 10.1182/blood.V88.9.3508.bloodjournal8893508; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Hermans IF, 2000, J IMMUNOL, V164, P3095, DOI 10.4049/jimmunol.164.6.3095; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Jusforgues-Saklani H, 2008, J IMMUNOL, V181, P3067, DOI 10.4049/jimmunol.181.5.3067; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kleindienst P, 2003, J IMMUNOL, V170, P2817, DOI 10.4049/jimmunol.170.6.2817; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Kuipers H, 2009, J LEUKOCYTE BIOL, V85, P64, DOI 10.1189/jlb.0807519; Laffont S, 2008, BLOOD, V112, P661, DOI 10.1182/blood-2007-10-120089; Laffont S, 2006, BLOOD, V108, P2257, DOI 10.1182/blood-2005-10-4059; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Luketic L, 2007, J IMMUNOL, V179, P5024, DOI 10.4049/jimmunol.179.8.5024; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; Medema JP, 2001, J EXP MED, V194, P657, DOI 10.1084/jem.194.5.657; Min L, 2010, J IMMUNOL, V184, P4625, DOI 10.4049/jimmunol.0903873; Mueller SN, 2006, J IMMUNOL, V176, P7379, DOI 10.4049/jimmunol.176.12.7379; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Petersen TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017657; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Ritchie DS, 2000, J IMMUNOL METHODS, V246, P109, DOI 10.1016/S0022-1759(00)00300-8; Robinson MJ, 2010, IMMUNOL CELL BIOL, V88, P291, DOI 10.1038/icb.2009.96; Ronchese F, 2001, J EXP MED, V194, pF23, DOI 10.1084/jem.194.5.F23; Ruedl C, 2008, INT IMMUNOL, V20, P1211, DOI 10.1093/intimm/dxn079; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Wakim LM, 2011, NATURE, V471, P629, DOI 10.1038/nature09863; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Yang JP, 2006, P NATL ACAD SCI USA, V103, P147, DOI 10.1073/pnas.0509054103; Yewdall AW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011144	52	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37481	10.1371/journal.pone.0037481	http://dx.doi.org/10.1371/journal.pone.0037481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649530	Green Published, gold			2022-12-25	WOS:000305335800048
J	Cimini, E; Bonnafous, C; Bordoni, V; Lalle, E; Sicard, H; Sacchi, A; Berno, G; Gioia, C; D'Offizi, G; Comandini, UV; Vlassi, C; Capobianchi, MR; Martini, F; Agrati, C				Cimini, Eleonora; Bonnafous, Cecile; Bordoni, Veronica; Lalle, Eleonora; Sicard, Helene; Sacchi, Alessandra; Berno, Giulia; Gioia, Cristiana; D'Offizi, Gianpiero; Comandini, Ubaldo Visco; Vlassi, Chrysoula; Capobianchi, Maria Rosaria; Martini, Federico; Agrati, Chiara			Interferon-alpha Improves Phosphoantigen-Induced V gamma 9V delta 2 T-Cells Interferon-gamma Production during Chronic HCV Infection	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; NATURAL-KILLER-CELLS; VIRUS REPLICON; MESSENGER-RNA; IFN-GAMMA; IMMUNOTHERAPY; ACTIVATION; ANTIGENS; INTERLEUKIN-2; CYTOTOXICITY	In chronic HCV infection, treatment failure and defective host immune response highly demand improved therapy strategies. V gamma 9V delta 2 T-cells may inhibit HCV replication in vitro through IFN-gamma release after Phosphoantigen (PhAg) stimulation. The aim of our work was to analyze V gamma 9V delta 2 T-cell functionality during chronic HCV infection, studying the role of IFN-alpha on their function capability. IFN-gamma production by Vc gamma V delta 2 T-cells was analyzed in vitro in 24 HCV-infected patients and 35 healthy donors (HD) after PhAg stimulation with or without IFN-alpha. The effect of in vivo PhAg/IFN-alpha administration on plasma IFN-gamma levels was analyzed in M. fascicularis monkeys. A quantitative analysis of IFN-gamma mRNA level and stability in V gamma 9V delta 2 T-cells was also evaluated. During chronic HCV infection, V gamma 9V delta 2 T-cells showed an effector/activated phenotype and were significantly impaired in IFN-gamma production. Interestingly, IFN-alpha was able to improve their IFN-gamma response to PhAg both in vitro in HD and HCV-infected patients, and in vivo in Macaca fascicularis primates. Finally, IFN-alpha increased IFN-gamma-mRNA transcription and stability in PhAg-activated V gamma 9V delta 2 T-cells. Altogether our results show a functional impairment of V gamma 9V delta 2 T-cells during chronic HCV infection that can be partially restored by using IFN-alpha. A study aimed to evaluate the antiviral impact of PhAg/IFN-alpha combination may provide new insight in designing possible combined strategies to improve HCV infection treatment outcome.	[Cimini, Eleonora; Bordoni, Veronica; Sacchi, Alessandra; Berno, Giulia; Gioia, Cristiana; Martini, Federico; Agrati, Chiara] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Cellular Immunol Lab, Rome, Italy; [Lalle, Eleonora; Capobianchi, Maria Rosaria; Agrati, Chiara] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Virol Lab, Rome, Italy; [Bonnafous, Cecile; Sicard, Helene] Innate Pharma, Marseille, France; [D'Offizi, Gianpiero; Comandini, Ubaldo Visco; Vlassi, Chrysoula] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Clin Dept, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Cimini, E (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Cellular Immunol Lab, Rome, Italy.	federico.martini@inmi.it	bordoni, veronica/K-8614-2016; Sacchi, Alessandra/K-7782-2016; Cimini, Eleonora/K-8878-2016; Berno, Giulia/K-1991-2016; Agrati, Chiara/K-8806-2016	bordoni, veronica/0000-0002-1747-2245; Sacchi, Alessandra/0000-0003-4964-386X; Cimini, Eleonora/0000-0002-2659-0868; Berno, Giulia/0000-0003-0331-2627; lalle, eleonora/0000-0002-7063-9905; Capobianchi, Maria Rosaria/0000-0003-3465-0071; Agrati, Chiara/0000-0002-5252-0927	Italian Ministry of Health [Current IRCCS Research Program]	Italian Ministry of Health [Current IRCCS Research Program]	This work was supported by the Italian Ministry of Health [Current IRCCS Research Program]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate I, 2003, J MED VIROL, V70, P581, DOI 10.1002/jmv.10433; Agrati C, 2006, J INFECT DIS, V193, P1606, DOI 10.1086/503438; Agrati C, 2006, INT IMMUNOL, V18, P11, DOI 10.1093/intimm/dxh337; Agrati C, 2009, J IMMUNOL, V182, P522, DOI 10.4049/jimmunol.182.1.522; Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Bonneville M, 2006, CURR OPIN IMMUNOL, V18, P539, DOI 10.1016/j.coi.2006.07.002; Castilletti C, 2005, VIROLOGY, V341, P163, DOI 10.1016/j.virol.2005.07.015; Conti L, 2005, J IMMUNOL, V174, P252, DOI 10.4049/jimmunol.174.1.252; Crotta S, 2002, J EXP MED, V195, P35, DOI 10.1084/jem.20011124; De Francesco R, 2005, NATURE, V436, P953, DOI 10.1038/nature04080; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Farag MMS, 2011, CLIN EXP IMMUNOL, V165, P352, DOI 10.1111/j.1365-2249.2011.04431.x; Gan YH, 2001, MOL MED, V7, P636, DOI 10.1007/BF03401870; Gougeon ML, 2002, VACCINE, V20, P1938, DOI 10.1016/S0264-410X(02)00070-1; Hayashi N, 2006, J GASTROENTEROL, V41, P17, DOI 10.1007/s00535-005-1740-7; Jia YT, 2007, J GASTROEN HEPATOL, V22, P1278, DOI 10.1111/j.1440-1746.2007.04957.x; Kim PS, 2010, CURR OPIN IMMUNOL, V22, P223, DOI 10.1016/j.coi.2010.02.005; Kunzmann V, 1999, NEW ENGL J MED, V340, P737, DOI 10.1056/NEJM199903043400914; Kunzmann V, 2004, IMMUNOLOGY, V112, P369, DOI 10.1111/j.1365-2567.2004.01908.x; Larkin J, 2003, J INTERF CYTOK RES, V23, P247, DOI 10.1089/107999003321829962; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; LEVY DE, 1990, EMBO J, V9, P1105, DOI 10.1002/j.1460-2075.1990.tb08216.x; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Martini F, 2000, IMMUNOLOGY, V100, P481, DOI 10.1046/j.1365-2567.2000.00068.x; Mavropoulos A, 2005, BLOOD, V105, P282, DOI 10.1182/blood-2004-07-2782; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Neumann-Haefelin C, 2005, J CLIN VIROL, V32, P75, DOI 10.1016/j.jcv.2004.05.008; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Par G, 2002, J HEPATOL, V37, P514, DOI 10.1016/S0168-8278(02)00218-0; Poccia F, 1999, J INFECT DIS, V180, P858, DOI 10.1086/314925; Poccia F, 2006, J INFECT DIS, V193, P1244, DOI 10.1086/502975; Poccia F, 2005, IMMUNOL LETT, V100, P14, DOI 10.1016/j.imlet.2005.06.025; Poccia F, 2005, MICROBES INFECT, V7, P518, DOI 10.1016/j.micinf.2004.12.009; Poccia F, 2009, AIDS, V23, P555, DOI 10.1097/QAD.0b013e3283244619; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Rodrigue-Gervais IG, 2010, J IMMUNOL, V184, P3134, DOI 10.4049/jimmunol.0902522; Sacchi A, 2009, J INFECT DIS, V199, P432, DOI 10.1086/596047; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1270, DOI 10.1053/j.gastro.2007.01.041; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Sicard H, 2005, J IMMUNOL, V175, P5471, DOI 10.4049/jimmunol.175.8.5471; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Tseng CTK, 2001, HEPATOLOGY, V33, P1312, DOI 10.1053/jhep.2001.24269; Wiegand J, 2007, ANTIVIR THER, V12, P303; Yoon JC, 2009, HEPATOLOGY, V49, P12, DOI 10.1002/hep.22624	46	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37014	10.1371/journal.pone.0037014	http://dx.doi.org/10.1371/journal.pone.0037014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629350	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300019
J	Berry, DJ; Vimaleswaran, KS; Whittaker, JC; Hingorani, AD; Hypponen, E				Berry, Diane J.; Vimaleswaran, Karani S.; Whittaker, John C.; Hingorani, Aroon D.; Hyppoenen, Elina			Evaluation of Genetic Markers as Instruments for Mendelian Randomization Studies on Vitamin D	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BRITISH BIRTH COHORT; AGE 45 YEARS; DETERMINANTS; POPULATION; RISK; IMPUTATION; DISEASE; ENZYME; ADULTS	Background: Mendelian randomization (MR) studies use genetic variants mimicking the influence of a modifiable exposure to assess and quantify a causal association with an outcome, with an aim to avoid problems with confounding and reverse causality affecting other types of observational studies. Aim: We evaluated genetic markers that index differences in 25-hydroxyvitamin D (25(OH) D) as instruments for MR studies on vitamin D. Methods and Findings: We used data from up-to 6,877 participants in the 1958 British birth cohort with information on genetic markers and 25(OH) D. As potential instruments, we selected 20 single nucleotide polymorphisms (SNP) which are located in the vitamin D metabolism pathway or affect skin pigmentation/tanning, including 4 SNPs from genome-wide association (GWA) meta-analyses on 25(OH) D. We analyzed SNP associations with 25(OH) D and evaluated the use of allele scores dividing genes to those affecting 25(OH) D synthesis (DHCR7, CYP2R1) and metabolism (GC, CYP24A1, CYP27B1). In addition to the GWA SNPs, only two SNPs (CYP27B1, OCA2) showed evidence for association with 25(OH) D, with the OCA2 association abolished after lifestyle adjustment. Per allele differences varied between -0.02 and -0.08 nmol/L (P <= 0.02 for all), with a 6.1 nmol/L and a 10.2 nmol/L difference in 25(OH) D between individuals with highest compared lowest number of risk alleles in synthesis and metabolism allele scores, respectively. Individual SNPs but not allele scores showed associations with lifestyle factors. An exception was geographical region which was associated with synthesis score. Illustrative power calculations (80% power, 5% alpha) suggest that approximately 80,000 participants are required to establish a causal effect of vitamin D on blood pressure using the synthesis allele score. Conclusions: Combining SNPs into allele scores provides a more powerful instrument for MR analysis than a single SNP in isolation. Population stratification and the potential for pleiotropic effects need to be considered in MR studies on vitamin D.	[Berry, Diane J.; Hyppoenen, Elina] UCL Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [Berry, Diane J.; Vimaleswaran, Karani S.; Hyppoenen, Elina] UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England; [Whittaker, John C.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Hingorani, Aroon D.] UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London, England; [Hingorani, Aroon D.] UCL, Ctr Clin Pharmacol, London, England	University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; University College London	Berry, DJ (corresponding author), UCL Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England.	e.hypponen@ucl.ac.uk	Hypponen, Elina/B-2596-2014; Whittaker, John C/B-8609-2012	Hypponen, Elina/0000-0003-3670-9399; Whittaker, John C/0000-0002-3529-2379; Hingorani, Aroon/0000-0001-8365-0081; Karani, Vimal/0000-0002-8485-8930	British Heart Foundation; UK Medical Research Council [G0601653]; MRC [G0000934]; Wellcome Trust [068545/Z/02, 076113]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International (JDRF); MRC;  [U01 DK062418]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER; British Heart Foundation [PG/09/023/26806] Funding Source: researchfish; Medical Research Council [G0400546, G1001799, G0601653, G0000934, G0400546B] Funding Source: researchfish; National Institute for Health Research [PHCS/C4/4/016] Funding Source: researchfish; MRC [G0601653, G1001799, G0400546] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from the British Heart Foundation and the UK Medical Research Council [project grant G0601653, PrevMetSyn/SALVE with Academy of Finland]. EH is a Department of Health (UK) Public Health Career Scientist. The 25-hydroxyvitamin D assay in the 1958 British birth cohort was funded by the BUPA foundation. Genotype data from the 1958 British birth cohort DNA collection was funded by MRC grant G0000934 and Wellcome Trust grant 068545/Z/02. This research used resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, National Institute of Child Health and Human Development, and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418. This study also makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113. The work was undertaken at the Centre for Paediatric Epidemiology and Biostatistics which benefits from funding support from the MRC in its capacity as the MRC Centre of Epidemiology for Child Health. Research at the University College London Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust benefits from R&D funding received from the NHS Executive. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, AM REV RESPIR DIS, V136, P1285; Atherton K, 2008, J EPIDEMIOL COMMUN H, V62, P216, DOI 10.1136/jech.2006.058966; BARRETT JC, 2009, NAT GENET; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Chun RF, 2010, J CLIN ENDOCR METAB, V95, P3368, DOI 10.1210/jc.2010-0195; Cleves M., 1999, STAT TECH B, V48, P34; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; Gibb I, 1999, CLIN CHEM, V45, P1833; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Hypponen E, 2007, J CLIN ENDOCR METAB, V92, P4615, DOI 10.1210/jc.2007-1279; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Hypponen E, 2006, DIABETES CARE, V29, P2244, DOI 10.2337/dc06-0946; Institute of Medicine, 2011, DIETARY REFERENCE IN; Lanham-New S A, 2011, Br J Nutr, V105, P144, DOI 10.1017/S0007114510002576; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lee W, 2010, CURR OPIN INVEST DR, V11, P309; Liu EJ, 2010, AM J CLIN NUTR, V91, P1627, DOI 10.3945/ajcn.2009.28441; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; Nan H, 2009, J INVEST DERMATOL, V129, P2250, DOI 10.1038/jid.2009.62; Nitsch D, 2006, AM J EPIDEMIOL, V163, P397, DOI 10.1093/aje/kwj062; Nolte H, 1997, ANN ALLERG ASTHMA IM, V79, P27, DOI 10.1016/S1081-1206(10)63080-3; Palmer T.M., 2011, STAT METHODS MED RES; Parsons TJ, 2009, EUR J CLIN NUTR, V63, P978, DOI 10.1038/ejcn.2009.6; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Power C, 2007, INT J EPIDEMIOL, V36, P532, DOI 10.1093/ije/dyl310; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Sakaki T, 2005, FRONT BIOSCI, V10, P119; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; StataCorp, 2009, STAT STAT SOFTW REL; Stern PH, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P565; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; [No title captured]	46	71	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37465	10.1371/journal.pone.0037465	http://dx.doi.org/10.1371/journal.pone.0037465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629401	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000305343100031
J	Cote, J; Bovenzi, V; Savard, M; Dubuc, C; Fortier, A; Neugebauer, W; Tremblay, L; Muller-Esterl, W; Tsanaclis, AM; Lepage, M; Fortin, D; Gobeil, F				Cote, Jerome; Bovenzi, Veronica; Savard, Martin; Dubuc, Celena; Fortier, Audrey; Neugebauer, Witold; Tremblay, Luc; Mueller-Esterl, Werner; Tsanaclis, Ana-Maria; Lepage, Martin; Fortin, David; Gobeil, Fernand, Jr.			Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model	PLOS ONE			English	Article							BRAIN-BARRIER; PLASMA EXTRAVASATION; B-1 RECEPTORS; BRADYKININ; EXPRESSION; DELIVERY; CHEMOTHERAPY; SURVIVAL; CNS; TEMOZOLOMIDE	Treatment of malignant glioma with chemotherapy is limited mostly because of delivery impediment related to the blood-brain tumor barrier (BTB). B1 receptors (B1R), inducible prototypical G-protein coupled receptors (GPCR) can regulate permeability of vessels including possibly that of brain tumors. Here, we determine the extent of BTB permeability induced by the natural and synthetic peptide B1R agonists, LysdesArg(9)BK (LDBK) and SarLys[DPhe(8)]desArg(9)BK (NG29), in syngeneic F98 glioma-implanted Fischer rats. Ten days after tumor inoculation, we detected the presence of B1R on tumor cells and associated vasculature. NG29 infusion increased brain distribution volume and uptake profiles of paramagnetic probes (Magnevist and Gadomer) at tumoral sites (T-1-weighted imaging). These effects were blocked by B1R antagonist and nonselective cyclooxygenase inhibitors, but not by B2R antagonist and non-selective nitric oxide synthase inhibitors. Consistent with MRI data, systemic co-administration of NG29 improved brain tumor delivery of Carboplatin chemotherapy (ICP-Mass spectrometry). We also detected elevated B1R expression in clinical samples of high-grade glioma. Our results documented a novel GPCR-signaling mechanism for promoting transient BTB disruption, involving activation of B1R and ensuing production of COX metabolites. They also underlined the potential value of synthetic biostable B1R agonists as selective BTB modulators for local delivery of different sized-therapeutics at (peri) tumoral sites.	[Cote, Jerome; Bovenzi, Veronica; Savard, Martin; Dubuc, Celena; Fortier, Audrey; Neugebauer, Witold; Gobeil, Fernand, Jr.] Univ Hosp, Dept Pharmacol, Frankfurt, Germany; [Cote, Jerome; Tremblay, Luc; Lepage, Martin] Univ Hosp, Dept Nucl Med & Radiobiol, Frankfurt, Germany; [Mueller-Esterl, Werner] Univ Hosp, Inst Biochem 2, Frankfurt, Germany; [Tsanaclis, Ana-Maria] Univ Sherbrooke, Ctr Hosp Univ Sherbrooke, Dept Pathol, Sherbrooke, PQ J1K 2R1, Canada; [Fortin, David] Univ Sherbrooke, Dept Surg, Sherbrooke, PQ J1K 2R1, Canada; [Cote, Jerome; Bovenzi, Veronica; Savard, Martin; Dubuc, Celena; Lepage, Martin; Fortin, David; Gobeil, Fernand, Jr.] Univ Sherbrooke, Fac Med & Hlth Sci, Inst Pharmacol, Sherbrooke, PQ J1K 2R1, Canada	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Cote, J (corresponding author), Univ Hosp, Dept Pharmacol, Frankfurt, Germany.	fernand.gobeil@usherbrooke.ca		Lepage, Martin/0000-0002-5363-9487	Institut de Pharmacologie de Sherbrooke/Tranzyme Pharma Inc; Canadian Institute of Health Research [89832, MOP-81358]; Fonds de la recherche en sante du Quebec (FRSQ); FRSQ; Canada Foundation for Innovation; FRSQ-funded Centre de recherche clinique Etienne-Le Bel; Universite de Sherbrooke; Tranzyme Pharma Inc.	Institut de Pharmacologie de Sherbrooke/Tranzyme Pharma Inc; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); FRSQ-funded Centre de recherche clinique Etienne-Le Bel; Universite de Sherbrooke; Tranzyme Pharma Inc.	This work was funded by competitive grants from the Institut de Pharmacologie de Sherbrooke/Tranzyme Pharma Inc and the Canadian Institute of Health Research #MOP# 89832 (FG), #MOP-81358 (DF, ML, FG). Studentship/fellowship awards were obtained from the Fonds de la recherche en sante du Quebec (FRSQ) (JC, MS). FG is a recipient of a Junior 2 scholarship from the FRSQ and a researcher of the Canada Foundation for Innovation. ML and DF hold a Canada Research Chair in MRI and a Banque Nationale Chair in Brain Cancer, respectively. FG, ML and DF are members of the FRSQ-funded Centre de recherche clinique Etienne-Le Bel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DF, WN and FG from Universite de Sherbrooke hereby declare a duality of interest in view of their holding a patent made available to public in 2006 for the use of peptide kinin B1 receptor agonists in the treatment of brain cancer (Publication No. W0 2006/128293 A1). FG, DF and ML have received research funding from Tranzyme Pharma Inc. This company has no proprietary or financial interest in the outcome of the research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Abdouh M, 2008, BRIT J PHARMACOL, V154, P136, DOI 10.1038/bjp.2008.48; Afra D, 2002, LANCET, V359, P1011; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; Belanger S, 2009, PEPTIDES, V30, P777, DOI 10.1016/j.peptides.2008.12.003; Bellavance MA, 2008, AAPS J, V10, P166, DOI 10.1208/s12248-008-9018-7; Black Keith L, 2004, Cancer Control, V11, P165; BLACK KL, 1992, J NEUROSURG, V77, P120, DOI 10.3171/jns.1992.77.1.0120; Borlongan CV, 2003, BRAIN RES BULL, V60, P297, DOI 10.1016/S0361-9230(03)00043-1; Bovenzi V, 2010, J CELL PHYSIOL, V222, P168, DOI 10.1002/jcp.21933; Cardoso RC, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-38; Chee J, 2008, BIOL CHEM, V389, P1225, DOI 10.1515/BC.2008.139; Chee J, 2007, BIOL CHEM, V388, P1235, DOI 10.1515/BC.2007.139; Cote J, 2010, NEUROPEPTIDES, V44, P177, DOI 10.1016/j.npep.2009.12.009; Cote J, 2009, PEPTIDES, V30, P788, DOI 10.1016/j.peptides.2008.12.018; CRUWYS SC, 1994, BRIT J PHARMACOL, V113, P940, DOI 10.1111/j.1476-5381.1994.tb17083.x; Dean R L, 1999, Neuro Oncol, V1, P268, DOI 10.1093/neuonc/1.4.268; Emerich DF, 2001, CLIN PHARMACOKINET, V40, P105, DOI 10.2165/00003088-200140020-00003; Emerich DF, 1999, BRIT J CANCER, V80, P964, DOI 10.1038/sj.bjc.6690450; Emerich DF, 2000, PHARMACEUT RES, V17, P1212, DOI 10.1023/A:1026462629438; Erdlenbruch B, 2003, BRIT J PHARMACOL, V140, P1201, DOI 10.1038/sj.bjp.0705554; Fortier A, 2006, MED SCI S2, V22, P24; Gilbert MR, 2010, NEURO-ONCOLOGY, V12, P1167, DOI 10.1093/neuonc/noq100; Gobeil F, 1999, HYPERTENSION, V33, P823, DOI 10.1161/01.HYP.33.3.823; Gobeil F, 2006, CAN J PHYSIOL PHARM, V84, P287, DOI 10.1139/Y05-127; Hayashi I, 2002, LIFE SCI, V70, P937, DOI 10.1016/S0024-3205(01)01460-6; Hoffman S, 2006, NEURO-ONCOLOGY, V8, P27, DOI 10.1215/S1522851705000323; Jahnke K, 2009, NEURO-ONCOLOGY, V11, P142, DOI 10.1215/15228517-2008-077; Jean WC, 1997, NEUROSURGERY, V41, P726; Juillerat-Jeanneret L, 2008, DRUG DISCOV TODAY, V13, P1099, DOI 10.1016/j.drudis.2008.09.005; Ksendzovsky A, 2010, OPEN IMMUNOLOGY J, V3, P30; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Liu YH, 2001, NEUROL RES, V23, P379, DOI 10.1179/016164101101198596; Lu DY, 2010, J CELL BIOCHEM, V110, P141, DOI 10.1002/jcb.22520; Maeda H, 1996, IMMUNOPHARMACOLOGY, V33, P222, DOI 10.1016/0162-3109(96)00063-X; MAO Y, 1991, CAN MED ASSOC J, V145, P1583; Marceau F, 1998, PHARMACOL REV, V50, P357; Maroldi R, 2005, EUR RADIOL, V15, P617, DOI 10.1007/s00330-004-2617-5; Mathieu D, 2006, CAN J NEUROL SCI, V33, P127, DOI 10.1017/S0317167100004881; Mathieu D, 2007, CAN J NEUROL SCI, V34, P296, DOI 10.1017/S0317167100006715; Mathieu D, 2007, CURR CLIN PHARMACOL, V2, P197, DOI 10.2174/157488407781668767; McLean PG, 2000, CARDIOVASC RES, V48, P194, DOI 10.1016/S0008-6363(00)00184-X; Misra A, 2000, J NEURO-ONCOL, V48, P1, DOI 10.1023/A:1006435201961; Montana V, 2011, J NEUROSCI, V31, P4858, DOI 10.1523/JNEUROSCI.3825-10.2011; Muldoon LL, 2007, J CLIN ONCOL, V25, P2295, DOI 10.1200/JCO.2006.09.9861; Nakano S, 1997, NEUROL RES, V19, P501, DOI 10.1080/01616412.1997.11740848; Nakano S, 1996, CANCER RES, V56, P4027; Neugebauer W, 2002, CAN J PHYSIOL PHARM, V80, P287, DOI 10.1139/Y02-053; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Nieder C, 2009, CLIN ONCOL-UK, V21, P515, DOI 10.1016/j.clon.2009.05.003; Norman MU, 2003, AM J PHYSIOL-HEART C, V284, pH1942, DOI 10.1152/ajpheart.00948.2002; OHNISHI T, 1990, J NEUROSURG, V72, P245, DOI 10.3171/jns.1990.72.2.0245; Pardridge WM, 2002, DRUG DISCOV TODAY, V7, P5, DOI 10.1016/S1359-6446(01)02082-7; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Prat A, 2000, J NEUROPATH EXP NEUR, V59, P896, DOI 10.1093/jnen/59.10.896; Raidoo DM, 1999, IMMUNOPHARMACOLOGY, V43, P255, DOI 10.1016/S0162-3109(99)00097-1; Rainov Nikolai G, 2006, Neurosurg Focus, V20, pE9; Re RN, 2011, J AM SOC HYPERTENS, V5, P435, DOI 10.1016/j.jash.2011.07.001; Recinos VR, 2010, NEUROSURGERY, V66, P530, DOI 10.1227/01.NEU.0000365263.14725.39; Revankar CM, 2007, ACS CHEM BIOL, V2, P536, DOI 10.1021/cb700072n; Rich JN, 2004, NAT REV DRUG DISCOV, V3, P430, DOI 10.1038/nrd1380; Robben JH, 2009, P NATL ACAD SCI USA, V106, P12195, DOI 10.1073/pnas.0900130106; Ross BD, 1998, P NATL ACAD SCI USA, V95, P7012, DOI 10.1073/pnas.95.12.7012; Sarin H, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-33; Sarker MH, 2000, J PHYSIOL-LONDON, V528, P177, DOI 10.1111/j.1469-7793.2000.00177.x; Sasaki A, 1998, J NEUROPATH EXP NEUR, V57, P653, DOI 10.1097/00005072-199807000-00002; Sathornsumetee S, 2007, CANCER-AM CANCER SOC, V110, P13, DOI 10.1002/cncr.22741; Savard M, 2008, J CELL PHYSIOL, V216, P234, DOI 10.1002/jcp.21398; Simard B, 2002, CAN J PHYSIOL PHARM, V80, P1203, DOI 10.1139/Y02-153; Tanaka S, 2003, J DRUG TARGET, V11, P45, DOI 10.1080/1061186031000086072; Uchida M, 2002, NEUROL RES, V24, P739, DOI 10.1179/016164102101200753; Vianna RMJ, 1998, BRIT J PHARMACOL, V123, P281, DOI 10.1038/sj.bjp.0701590; Wahl M, 1996, IMMUNOPHARMACOLOGY, V33, P257, DOI 10.1016/0162-3109(96)00068-9; Walsh DA, 1997, KININ SYSTEM, P301; WILLIAMS TJ, 1979, BRIT J PHARMACOL, V65, P517, DOI 10.1111/j.1476-5381.1979.tb07860.x; WIRTH K, 1991, BRIT J PHARMACOL, V102, P774, DOI 10.1111/j.1476-5381.1991.tb12249.x; Yang WL, 2011, J NEURO-ONCOL, V101, P379, DOI 10.1007/s11060-010-0272-z; Yang WL, 2005, CLIN CANCER RES, V11, P341; Zuraw BL, 2006, IMMUNOL ALLERGY CLIN, V26, P691, DOI 10.1016/j.iac.2006.09.007	80	39	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37485	10.1371/journal.pone.0037485	http://dx.doi.org/10.1371/journal.pone.0037485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629405	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100035
J	Lee, LL; Lin, L; Bell, DS; Levine, S; Hanson, MR				Lee, Li Ling; Lin, Lin; Bell, David S.; Levine, Susan; Hanson, Maureen R.			Sensitivity of PCR Assays for Murine Gammaretroviruses and Mouse Contamination in Human Blood Samples	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; VIRUS-RELATED VIRUS; PROSTATE-CANCER; XMRV; RETROVIRUS; DNA; ENCEPHALOMYELITIS; SEQUENCES; TISSUE	Gammaretroviruses related to murine leukemia virus (MLV) have variously been reported to be present or absent in blood from chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) patients and healthy controls. Using subjects from New York State, we have investigated by PCR methods whether MLV-related sequences can be identified in nucleic acids isolated from whole blood or from peripheral blood mononuclear cells (PBMCs) or following PBMC culture. We have also passaged the prostate cancer cell line LNCaP following incubation with plasma from patients and controls and assayed nucleic acids for viral sequences. We have used 15 sets of primers that can effectively amplify conserved regions of murine endogenous and exogenous retrovirus sequences. We demonstrate that our PCR assays for MLV-related gag sequences and for mouse DNA contamination are extremely sensitive. While we have identified MLV-like gag sequences following PCR on human DNA preparations, we are unable to conclude that these sequences originated in the blood samples.	[Lee, Li Ling; Lin, Lin; Hanson, Maureen R.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Bell, David S.] SUNY Buffalo, Dept Pediat, Buffalo, NY 14260 USA	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lee, LL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	mrh5@cornell.edu	Hanson, Maureen R/D-3879-2009	Hanson, Maureen R/0000-0001-8141-3058	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) [1R21AI090553]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090553] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) grant 1R21AI090553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacich Dean J, 2011, BMC Res Notes, V4, P457, DOI 10.1186/1756-0500-4-457; BELL KM, 1991, REV INFECT DIS, V13, pS32; Capelli E, 2010, INT J IMMUNOPATH PH, V23, P981, DOI 10.1177/039463201002300402; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; Elfaitouri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024602; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Hooper M, 2007, J CLIN PATHOL, V60, P466, DOI 10.1136/jcp.2006.042408; Jason Leonard A, 2009, Bull IACFS ME, V17, P88; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Johnson Hilary., 1996, OSLERS WEB INSIDE LA; Kearney MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030889; Klimas Nancy G, 2007, Curr Rheumatol Rep, V9, P482, DOI 10.1007/s11926-007-0078-y; Lee K, 2010, 1 INT WORKSH XMRV BE; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Shin CH, 2011, J VIROL, V85, P7195, DOI 10.1128/JVI.00693-11; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Wyller VB, 2007, ACTA NEUROL SCAND, V115, P7, DOI 10.1111/j.1600-0404.2007.00840.x; Zhang YA, 2011, CANCER BIOL THER, V12, P617, DOI 10.4161/cbt.12.7.15955; Zheng HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029050	29	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37482	10.1371/journal.pone.0037482	http://dx.doi.org/10.1371/journal.pone.0037482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629404	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343100034
J	Musunuru, K; Romaine, SPR; Lettre, G; Wilson, JG; Volcik, KA; Tsai, MY; Taylor, HA; Schreiner, PJ; Rotter, JI; Rich, SS; Redline, S; Psaty, BM; Papanicolaou, GJ; Ordovas, JM; Liu, K; Krauss, RM; Glazer, NL; Gabriel, SB; Fornage, M; Cupples, LA; Buxbaum, SG; Boerwinkle, E; Ballantyne, CM; Kathiresan, S; Rader, DJ				Musunuru, Kiran; Romaine, Simon P. R.; Lettre, Guillaume; Wilson, James G.; Volcik, Kelly A.; Tsai, Michael Y.; Taylor, Herman A., Jr.; Schreiner, Pamela J.; Rotter, Jerome I.; Rich, Stephen S.; Redline, Susan; Psaty, Bruce M.; Papanicolaou, George J.; Ordovas, Jose M.; Liu, Kiang; Krauss, Ronald M.; Glazer, Nicole L.; Gabriel, Stacey B.; Fornage, Myriam; Cupples, L. Adrienne; Buxbaum, Sarah G.; Boerwinkle, Eric; Ballantyne, Christie M.; Kathiresan, Sekar; Rader, Daniel J.			Multi-Ethnic Analysis of Lipid-Associated Loci: The NHLBI CARe Project	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; TRIGLYCERIDES; DESIGN; GENES; RISK	Background: Whereas it is well established that plasma lipid levels have substantial heritability within populations, it remains unclear how many of the genetic determinants reported in previous studies (largely performed in European American cohorts) are relevant in different ethnicities. Methodology/Principal Findings: We tested a set of similar to 50,000 polymorphisms from similar to 2,000 candidate genes and genetic loci from genome-wide association studies (GWAS) for association with low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) in 25,000 European Americans and 9,000 African Americans in the National Heart, Lung, and Blood Institute (NHLBI) Candidate Gene Association Resource (CARe). We replicated associations for a number of genes in one or both ethnicities and identified a novel lipid-associated variant in a locus harboring ICAM1. We compared the architecture of genetic loci associated with lipids in both African Americans and European Americans and found that the same genes were relevant across ethnic groups but the specific associated variants at each gene often differed. Conclusions/Significance: We identify or provide further evidence for a number of genetic determinants of plasma lipid levels through population association studies. In many loci the determinants appear to differ substantially between African Americans and European Americans.	[Musunuru, Kiran; Gabriel, Stacey B.] Broad Inst, Cambridge, MA USA; [Musunuru, Kiran; Kathiresan, Sekar] Harvard Univ, Sch Med, Boston, MA USA; [Musunuru, Kiran; Kathiresan, Sekar] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Romaine, Simon P. R.] Univ Leeds, Leeds, W Yorkshire, England; [Lettre, Guillaume] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Wilson, James G.; Taylor, Herman A., Jr.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Volcik, Kelly A.; Fornage, Myriam; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA; [Schreiner, Pamela J.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Taylor, Herman A., Jr.; Buxbaum, Sarah G.] Jackson State Univ, Jackson, MS USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Rich, Stephen S.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Redline, Susan] Univ Hosp, Case Med Ctr, Cleveland, OH USA; [Redline, Susan] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Psaty, Bruce M.] Univ Washington, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Papanicolaou, George J.] NHLBI, NIH, Bethesda, MD 20892 USA; [Ordovas, Jose M.] Tufts Univ, Human Nutr Res Ctr Aging, JM United States Dept Agr, Boston, MA 02111 USA; [Krauss, Ronald M.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Glazer, Nicole L.; Cupples, L. Adrienne] Boston Univ, Boston, MA 02215 USA; [Liu, Kiang] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Cupples, L. Adrienne] NHLBI, Framingham Heart Study, Framingham, MA USA; [Ballantyne, Christie M.] Baylor Coll Med, Houston, TX 77030 USA; [Rader, Daniel J.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Leeds; Universite de Montreal; University of Mississippi; University of Mississippi Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Minnesota System; University of Minnesota Twin Cities; Jackson State University; Cedars Sinai Medical Center; University of Virginia; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; University of Washington; University of Washington Seattle; Group Health Cooperative; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tufts University; United States Department of Agriculture (USDA); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Boston University; Northwestern University; Feinberg School of Medicine; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Baylor College of Medicine; University of Pennsylvania	Musunuru, K (corresponding author), Broad Inst, Cambridge, MA USA.	cmb@bcm.edu; sekar@broadinstitute.org; rader@mail.med.upenn.edu	Ballantyne, Christie/A-6599-2008; Buxbaum, Sarah G./E-1970-2013; Rotter, Jerome/AAY-6598-2021; Ordovas, Jose/B-8727-2013	Buxbaum, Sarah G./0000-0002-4886-3564; Schreiner, Pamela/0000-0002-9920-6257; Rich, Stephen/0000-0003-3872-7793; Ordovas, Jose/0000-0002-7581-5680; Glazer, Nicole/0000-0002-6397-609X; Tsai, Michael/0000-0001-7553-3408; Ballantyne, Christie/0000-0002-6432-1730; Cupples, L. Adrienne/0000-0003-0273-7965	T32 grant in Cell and Molecular Training for Cardiovascular Biology from the National Heart, Lung, and Blood Institute [K99-HL098364]; University of Virginia [R01-HL-071205]; DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB072991, N01HB097060, N01HB073002, N01HB097071, N01HB072998, N01HB097062, N01HB073005, N01HB097072, N01HB073000, N01HB097069, N01HB097051, N01HB072996, N01HB072993, N01HB097068, N01HB073001, N01HB097061, N01HB072997, N01HB097053, N01HB097070, N01HB073004, N01HB073006, N01HB072992, N01HB072994, N01HB097073, N01HB097066, N01HB097058, N01HB097064, N01HB097056, N01HB072982, N01HB097054, N01HB072995, N01HB073003] Funding Source: NIH RePORTER; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095168, N01HC048048, N01HC095163, N01HC035129, N01HC005187, N01HC025195, N01HC095171, N01HC095160, N01HC095166, N01HC085082, N01HC095165, N01HC048047, N01HC095100, N01HC095167, N01HC015103, N01HC095159, N01HC085086, N01HC085085, N01HC055021, N01HC055016, N01HC095169, N01HC085081, N01HC055222, N01HC055020, N01HC055015, N01HC095172, N01HC075150, N01HC085079, N01HC095161, N01HC045134, N01HC055018, N01HC048049, N01HC055022, N01HC055019, N01HC085083, N01HC095164, N01HC095170, N01HC095095, N01HC085084, N01HC085080, N01HC095162, N01HC048050] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL095160, K99HL098364, R01HL065226, U01HL063463, U01HL053938, U01HL053941, U01HL053934, R43HL095161, R01HL085083, R42HL055018, U01HL077813, U01HL053916, R01HL076784, R44HL095169, R01HL048049, U01HL064360, U01HL080295, R29HL048048, R01HL046380, R01HL048050, U01HL063429, R41HL055019, R43HL095169, U01HL053937, R01HL071205, R01HL095163, R41HL055018, R01HL048048, R01HL092577, R21HL095165, R13HL095166, R43HL095167, R41HL095172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028321] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	T32 grant in Cell and Molecular Training for Cardiovascular Biology from the National Heart, Lung, and Blood Institute; University of Virginia; DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The following nine parent studies have contributed parent study data, ancillary study data, and DNA samples through the Broad Institute of Massachusetts Institute of Technology and Harvard (N01-HC-65226): Atherosclerosis Risk in Communities: University of North Carolina at Chapel Hill (N01-HC-55015, N01-HC-55018), Baylor Medical College (N01-HC-55016), University of Mississippi Medical Center (N01-HC-55021), University of Minnesota (N01-HC-55019), Johns Hopkins University (N01-HC-55020), University of Texas, Houston (N01-HC-55022); Cardiovascular Health Study: University of Washington (N01-HC-85079, N01-HC-55222, U01-HL-080295), Wake Forest University (N01-HC-85080), Johns Hopkins University (N01-HC-85081, N01-HC-15103), University of Pittsburgh (N01-HC-85082), University of California, Davis (N01-HC-85083), University of California, Irvine (N01-HC-85084), New England Medical Center (N01-HC-85085), University of Vermont (N01-HC-85086), Georgetown University (N01-HC-35129), University of Wisconsin (N01-HC-75150); Cleveland Family Study: Case Western Reserve University (R01-HL-46380, M01-RR-00080); Cooperative Study of Sickle Cell Disease: University of Illinois (N01-HB-72982, N01-HB-97062), Howard University (N01-HB-72991, N01-HB-97061), University of Miami (N01-HB-72992, N01-HB-97064), Duke University (N01-HB-72993), George Washington University (N01-HB-72994), University of Tennessee (N01-HB-72995, N01-HB-97070), Yale University (N01-HB-72996, N01-HB-97072), Children's Hospital-Philadelphia (N01-HB-72997, N01-HB-97056), University of Chicago (N01-HB-72998, N01-HB-97053), Medical College of Georgia (N01-HB-73000, N01-HB-97060), Washington University (N01-HB-73001, N01-HB-97071), Jewish Hospital and Medical Center of Brooklyn (N01-HB-73002), Trustees of Health and Hospitals of the City of Boston, Inc., (N01-HB-73003), Children's Hospital-Oakland (N01-HB-73004, N01-HB-97054), University of Mississippi (N01-HB-73005), St. Luke's Hospital-New York (N01-HB-73006), Alta Bates-Herrick Hospital (N01-HB-97051), Columbia University (N01-HB-97058), St.; Jude's Children's Research Hospital (N01-HB-97066), Research Foundation, State University of New York-Albany (N01-HB-97068, N01-HB-97069), New England Research Institute (N01-HB-97073), Interfaith Medical Center-Brooklyn (N01-HB-97085); Coronary Artery Risk in Young Adults: University of Alabama at Birmingham (N01-HC-48047, N01-HC-95095), University of Minnesota (N01-HC-48048), Northwestern University (N01-HC-48049), Kaiser Foundation Research Institute (N01-HC-48050), Tufts-New England Medical Center (N01-HC-45204), Wake Forest University (N01-HC-45205), Harbor-University of California Los Angeles Research and Education Institute (N01-HC-05187), University of California, Irvine (N01-HC-45134, N01-HC-95100) ;Framingham Heart Study: Boston University (N01-HC-25195, R01-HL-092577, R01-HL-076784, R01-AG-028321); Jackson Heart Study: Jackson State University (N01-HC-95170), University of Mississippi (N01-HC-95171), Tougaloo College (N01-HC-95172); Multi-Ethnic Study of Atherosclerosis: University of Washington (N01-HC-95159), University of California, Los Angeles (N01-HC-95160), Columbia University (N01-HC-95161), Johns Hopkins University (N01-HC-95162, N01-HC-95168), University of Minnesota (N01-HC-95163), Northwestern University (N01-HC-95164), Wake Forest University (N01-HC-95165), University of Vermont (N01-HC-95166), New England Medical Center (N01-HC-95167), Harbor-University of California Los Angeles Research and Education Institute (N01-HC-95169), Cedars-Sinai Medical Center (R01-HL-071205), University of Virginia (subcontract to R01-HL-071205); Sleep Heart Health Study: Johns Hopkins University (U01-HL-064360), Case Western University (U01-HL-063463), University of California, Davis (U01-HL-053916), University of Arizona (U01-HL-053938, U01-HL-053934), University of Pittsburgh (U01-HL-077813), Boston University (U01-HL-053941), MedStar Research Institute (U01-HL-063429), Johns Hopkins University (U01-HL-053937). This work was also supported in part by a T32 grant in Cell and Molecular Training for Cardiovascular Biology and K99-HL098364 from the National Heart, Lung, and Blood Institute (KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Deo RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000342; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kapur NK, 2008, VASC HEALTH RISK MAN, V4, P39, DOI 10.2147/VHRM.S1653; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; NAMBOODIRI K K, 1985, Genetic Epidemiology, V2, P227, DOI 10.1002/gepi.1370020302; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76	19	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e36473	10.1371/journal.pone.0036473	http://dx.doi.org/10.1371/journal.pone.0036473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629316	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100005
J	Pollari, S; Leivonen, SK; Perala, M; Fey, V; Kakonen, SM; Kallioniemi, O				Pollari, Sirkku; Leivonen, Suvi-Katri; Perala, Merja; Fey, Vidal; Kakonen, Sanna-Maria; Kallioniemi, Olli			Identification of MicroRNAs Inhibiting TGF-beta-Induced IL-11 Production in Bone Metastatic Breast Cancer Cells	PLOS ONE			English	Article							TARGET PREDICTION; GENE-EXPRESSION; LET-7; SITES; INTERLEUKIN-11; PROLIFERATION; RECOGNITION; ACTIVATION; MICROARRAY; CARCINOMA	Development of bone metastases is dependent on the cancer cell-bone cell interactions in the bone microenvironment. Transforming growth factor beta (TGF-beta) is released from bone during osteoclastic bone resorption and induces production of osteolytic factors, such as interleukin 11 (IL-11), in breast cancer cells. IL-11 in turn increases osteolysis by stimulating osteoclast function, launching a vicious cycle of cancer growth and bone destruction. We aimed to identify and functionally characterize microRNAs (miRNAs) that mediate the bone metastatic process, focusing on miRNAs that regulate the TGF-beta induction of IL-11. First, we profiled the expression of 455 miRNAs in a highly bone metastatic MDA-MB-231(SA) variant as compared to the parental MDA-MB-231 breast cancer cell line and found 16 miRNAs (3.5%) having a >3-fold expression difference between the two cell types. We then applied a cell-based overexpression screen with Pre-miRNA constructs to functionally identify miRNAs regulating TGF-beta-induced IL-11 production. This analysis pinpointed miR-204, miR-211, and miR-379 as such key regulators. These miRNAs were shown to directly target IL11 by binding to its 3' UTR. MiR-379 also inhibited Smad2/3/4-mediated transcriptional activity. Gene expression analysis of miR-204 and miR-379-transfected cells indicated that these miRNAs downregulated the expression of several genes involved in TGF-beta signaling, including prostaglandin-endoperoxide synthase 2 (PTGS2). In addition, there was a significant correlation between the genes downregulated by miR-379 and a set of genes upregulated in basal subtype of breast cancer. Taken together, the functional evidence and clinical correlations imply novel mechanistic links between miRNAs and the key steps in the bone metastatic process in breast cancer, with potential clinical relevance.	[Pollari, Sirkku; Leivonen, Suvi-Katri; Perala, Merja; Fey, Vidal; Kallioniemi, Olli] Univ Turku, VTT Tech Res Ctr Finland, Turku, Finland; [Pollari, Sirkku; Leivonen, Suvi-Katri; Perala, Merja; Fey, Vidal; Kallioniemi, Olli] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Kakonen, Sanna-Maria] Univ Turku, Inst Biomed, Turku, Finland; [Kallioniemi, Olli] Univ Helsinki, FIMM, Helsinki, Finland	University of Turku; VTT Technical Research Center Finland; University of Turku; University of Turku; University of Helsinki	Pollari, S (corresponding author), Univ Turku, VTT Tech Res Ctr Finland, Turku, Finland.	sielpo@utu.fi	Kallioniemi, Olli P/H-5111-2011; Leivonen, Suvi-Katri/AAK-3096-2021	Kallioniemi, Olli P/0000-0002-3231-0332; Fey, Vidal/0000-0003-1388-5904; Kakonen, Sanna-Maria/0000-0001-9393-6235; Leivonen, Suvi-Katri/0000-0003-3224-0757	Academy of Finland Centre of Excellence grant (Centre of Excellence in Translational Genome-Scale Biology) [20062011]; Academy of Finland post-doctoral grant; Verein zur Forderung der Krebsforschung (TIME project); Drug Discovery Graduate School; Sigrid Juselius Foundation; Finnish Cultural Foundation; Cancer Society of Southwestern Finland	Academy of Finland Centre of Excellence grant (Centre of Excellence in Translational Genome-Scale Biology); Academy of Finland post-doctoral grant; Verein zur Forderung der Krebsforschung (TIME project); Drug Discovery Graduate School; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Cancer Society of Southwestern Finland	This work was supported by the Academy of Finland Centre of Excellence grant (Centre of Excellence in Translational Genome-Scale Biology 2006-2011) http://tgsb.vtt.fi/, Academy of Finland post-doctoral grant to SKL, Verein zur Forderung der Krebsforschung (TIME project), Drug Discovery Graduate School http://ddgs.utu.fi/, and by grants from the Finnish Cancer Organisations http://www.cancer.fi/, Sigrid Juselius Foundation http://www.sigridjuselius.fi/, Finnish Cultural Foundation http://www.skr.fi/, and Cancer Society of Southwestern Finland http://lssy.fi/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Azuma H, 2005, JNCI-J NATL CANCER I, V97, P1734, DOI 10.1093/jnci/dji399; Blagosklonny MV, 2009, PLOS ONE, V4, pe6896, DOI [10.1371/journal.pone.0006896, DOI 10.1371/JOURNAL.PONE.0006896]; Buijs JT, 2011, CANCER MICROENVIRON, V4, P261, DOI 10.1007/s12307-011-0075-6; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Edlund S, 2004, J CELL SCI, V117, P1835, DOI 10.1242/jcs.01036; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Findlay VJ, 2008, CANCER RES, V68, P8499, DOI 10.1158/0008-5472.CAN-08-0907; Fisher JL, 2000, BREAST CANCER RES TR, V61, P1, DOI 10.1023/A:1006445129195; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Franchimont N, 2000, BONE, V26, P249, DOI 10.1016/S8756-3282(99)00275-6; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIRASOLE G, 1994, J CLIN INVEST, V93, P1516, DOI 10.1172/JCI117130; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hanavadi S, 2006, ANN SURG ONCOL, V13, P802, DOI 10.1245/ASO.2006.05.028; Hiraga T, 2006, CANCER RES, V66, P2067, DOI 10.1158/0008-5472.CAN-05-2012; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Li GR, 2011, INVEST OPHTH VIS SCI, V52, P2999, DOI 10.1167/iovs.10-6708; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Mohammad KS, 2011, CANCER RES, V71, P175, DOI 10.1158/0008-5472.CAN-10-2651; Morgan H, 2004, INT J CANCER, V109, P653, DOI 10.1002/ijc.20056; Morgan H, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-1; Nevins JR, 2007, NAT REV GENET, V8, P601, DOI 10.1038/nrg2137; Pollari S, 2012, MOL CANCER RES, V10, P597, DOI 10.1158/1541-7786.MCR-11-0482; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Singh B, 2006, J SURG RES, V131, P267, DOI 10.1016/j.jss.2005.11.582; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sotiriou C, 2001, CANCER LETT, V169, P87, DOI 10.1016/S0304-3835(01)00524-9; Stasinopoulos I, 2007, MOL CANCER RES, V5, P435, DOI 10.1158/1541-7786.MCR-07-0010; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; Wang L, 2011, ONCOGENE, DOI [10.1038/onc.2011.444:10.1038/onc.2011.444, DOI 10.1038/ONC.2011.444:10.1038/ONC.2011.444]; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; WESTERHAUSEN DR, 1991, J BIOL CHEM, V266, P1092; Woodward JKL, 2007, BONE, V41, P912, DOI 10.1016/j.bone.2007.07.024; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	55	63	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37361	10.1371/journal.pone.0037361	http://dx.doi.org/10.1371/journal.pone.0037361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629385	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100024
J	Tian, H; Wang, J; Zhang, BF; Di, JH; Chen, FF; Li, HZ; Li, LT; Pei, DS; Zheng, JN				Tian, Hui; Wang, Jing; Zhang, BaoFu; Di, JieHui; Chen, FeiFei; Li, HuiZhong; Li, LianTao; Pei, DongSheng; Zheng, JunNian			MDA-7/IL-24 Induces Bcl-2 Denitrosylation and Ubiquitin-Degradation Involved in Cancer Cell Apoptosis	PLOS ONE			English	Article							DIFFERENTIATION-ASSOCIATED GENE-7; PROTEIN S-NITROSYLATION; NITRIC-OXIDE SYNTHASE; MELANOMA DIFFERENTIATION; PANCREATIC-CANCER; FAMILY; GROWTH; MDA-7; INACTIVATION; INHIBITION	MDA-7/IL-24 was involved in the specific cancer apoptosis through suppression of Bcl-2 expression, which is a key apoptosis regulatory protein of the mitochondrial death pathway. However, the underlying mechanisms of this regulation are unclear. We report here that tumor-selective replicating adenovirus ZD55-IL-24 leads to Bcl-2 S-denitrosylation and concomitant ubiquitination, which take part in the 26S proteasome degradation. IL-24-siRNA completely blocks Bcl-2 ubiquitination via reversion of Bcl-2 S-denitrosylation and protects it from proteasomal degradation which confirmed the significant role of MDA-7/IL-24 in regulating posttranslational modification of Bcl-2 in cancer cells. Nitric oxide (NO) is a key regulator of protein S-nitrosylation and denitrosylation. The NO donor, sodium nitroprusside (SNP), down-regulates Bcl-2 S-denitrosylation, attenuates Bcl-2 ubiquitination and subsequently counteracts MDA-7/IL-24 induced cancer cell apoptosis, whereas NO inhibitor 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxy-3-oxide (PTIO) shows the opposite effect. At the same time, these NO modulators fail to affect Bcl-2 phosphorylation, suggesting that NO regulates Bcl-2 stability in a phosphorylation-independent manner. In addition, Bcl-2 S-nitrosylation reduction induced by ZD55-IL-24 was attributed to both iNOS decrease and TrxR1 increase. iNOS-siRNA facilitates Bcl-2 S-denitrosylation and ubiquitin-degradation, whereas the TrxR1 inhibitor auranofin prevents Bcl-2 from denitrosylation and ubiquitination, thus restrains the caspase signal pathway activation and subsequent cancer cell apoptosis. Taken together, our studies reveal that MDA-7/IL-24 induces Bcl-2 S-denitrosylation via regulation of iNOS and TrxR1. Moreover, denitrosylation of Bcl-2 results in its ubiquitination and subsequent caspase protease family activation, as a consequence, apoptosis susceptibility. These findings provide a novel insight into MDA-7/IL-24 induced growth inhibition and carcinoma apoptosis.	[Tian, Hui; Wang, Jing; Zhang, BaoFu; Di, JieHui; Chen, FeiFei; Li, HuiZhong; Li, LianTao; Pei, DongSheng; Zheng, JunNian] Xuzhou Med Coll, Lab Biol Canc Therapy, Xuzhou, Peoples R China	Xuzhou Medical University	Tian, H (corresponding author), Xuzhou Med Coll, Lab Biol Canc Therapy, Xuzhou, Peoples R China.	jnzheng@xzmc.edu.cn		li, liantao/0000-0002-8788-2880	National Natural Science Foundation of China [81071854]; Science and Technology Department of Jiangsu Province [BK2010177, BK2010179]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Jiangsu Province	This project was supported by the National Natural Science Foundation of China (Nos. 81071854) and the Science and Technology Department of Jiangsu Province (BK2010177, BK2010179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Azad N, 2010, AM J RESP CELL MOL, V42, P578, DOI 10.1165/rcmb.2009-0094OC; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Ekmekcioglu S, 2003, MOL CANCER THER, V2, P9; Ekmekcioglu S, 2000, CLIN CANCER RES, V6, P4768; Ekmekcioglu S, 2008, CYTOKINE, V43, P34, DOI 10.1016/j.cyto.2008.04.010; Fickenscher H, 2002, TRENDS IMMUNOL, V23, P89, DOI 10.1016/S1471-4906(01)02149-4; Fisher PB, 2005, CANCER RES, V65, P10128, DOI 10.1158/0008-5472.CAN-05-3127; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Grandgirard D, 1998, EMBO J, V17, P1268, DOI 10.1093/emboj/17.5.1268; Gupta P, 2006, PHARMACOL THERAPEUT, V111, P596, DOI 10.1016/j.pharmthera.2005.11.005; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hoffmann J, 2001, J BIOL CHEM, V276, P41383, DOI 10.1074/jbc.M107566200; Jiang HP, 1995, ONCOGENE, V11, P2477; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P9160, DOI 10.1073/pnas.93.17.9160; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Kutuk O, 2008, CURR MOL MED, V8, P102; Lebedeva IV, 2006, CANCER RES, V66, P2403, DOI 10.1158/0008-5472.CAN-05-3510; Lebedeva IV, 2003, CANCER RES, V63, P8138; Lebedeva IV, 2003, ONCOGENE, V22, P8758, DOI 10.1038/sj.onc.1206891; Lebedeva IV, 2005, MOL THER, V11, P4, DOI 10.1016/j.ymthe.2004.08.012; Liu XY, 2006, CELL RES, V16, P25, DOI 10.1038/sj.cr.7310005; Mannick JB, 2002, ARCH BIOCHEM BIOPHYS, V408, P1, DOI 10.1016/S0003-9861(02)00490-3; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Oxford SME, 2004, CURR MED CHEM, V11, P1031, DOI 10.2174/0929867043455486; Schinzel A, 2004, BBA-MOL CELL RES, V1644, P95, DOI 10.1016/j.bbamcr.2003.09.006; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Su ZZ, 2001, P NATL ACAD SCI USA, V98, P10332, DOI 10.1073/pnas.171315198; Su ZZ, 2003, ONCOGENE, V22, P1164, DOI 10.1038/sj.onc.1206062; Yacoub A, 2003, CANCER BIOL THER, V2, P347, DOI 10.4161/cbt.2.4.422; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200	38	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37200	10.1371/journal.pone.0037200	http://dx.doi.org/10.1371/journal.pone.0037200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629368	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343100017
J	Chu, CP; Bing, YH; Liu, H; Qiu, DL				Chu, Chun-Ping; Bing, Yan-Hua; Liu, Heng; Qiu, De-Lai			Roles of Molecular Layer Interneurons in Sensory Information Processing in Mouse Cerebellar Cortex Crus II In Vivo	PLOS ONE			English	Article							FIBER RECEPTIVE-FIELDS; PURKINJE-CELLS; GRANULE CELL; SYNCHRONIZED ACTIVITY; SYNAPTIC CURRENTS; GABA(A) RECEPTORS; BASKET CELLS; PARALLEL; INHIBITION; RAT	Background: Cerebellar cortical molecular layer interneurons (MLIs) play essential roles in sensory information processing by the cerebellar cortex. However, recent experimental and modeling results are questioning traditional roles for molecular layer inhibition in the cerebellum. Methods and Main Results: Synaptic responses of MLIs and Purkinje cells (PCs), evoked by air-puff stimulation of the ipsilateral whisker pad were recorded from cerebellar cortex Crus II in urethane-anesthetized ICR mice by in vivo whole-cell patch-clamp recording techniques. Under current-clamp (I = 0), air-puff stimuli were found to primarily produce inhibition in PCs. In MLIs, this stimulus evoked spike firing regardless of whether they made basket-type synaptic connections or not. However, MLIs not making basket-type synaptic connections had higher rates of background activity and also generated spontaneous spike-lets. Under voltage-clamp conditions, excitatory postsynaptic currents (EPSCs) were recorded in MLIs, although the predominant response of recorded PCs was an inhibitory postsynaptic potential (IPSP). The latencies of EPSCs were similar for all MLIs, but the time course and amplitude of EPSCs varied with depth in the molecular layer. The highest amplitude, shortest duration EPSCs were recorded from MLIs deep in the molecular layer, which also made basket-type synaptic connections. Comparing MLI to PC responses, time to peak of PC IPSP was significantly slower than MLI recorded EPSCs. Blocking GABA(A) receptors uncovered larger EPSCs in PCs whose time to peak, half-width and 10-90% rising time were also significantly slower than in MLIs. Biocytin labeling indicated that the MLIs (but not PCs) are dye-coupled. Conclusions: These findings indicate that tactile face stimulation evokes rapid excitation in MLIs and inhibition occurring at later latencies in PCs in mouse cerebellar cortex Crus II. These results support previous suggestions that the lack of parallel fiber driven PC activity is due to the effect of MLI inhibition.	[Chu, Chun-Ping; Bing, Yan-Hua; Liu, Heng; Qiu, De-Lai] Yanbian Univ, Cellular Funct Res Ctr, Yanji, Jilin Province, Peoples R China; [Bing, Yan-Hua; Liu, Heng; Qiu, De-Lai] Yanbian Univ, Coll Med, Dept Physiol & Pathophysiol, Yanji, Jilin Province, Peoples R China; [Chu, Chun-Ping] Yanbian Univ, Coll Basic Med, Funct Expt Ctr, Yanji, Jilin Province, Peoples R China	Yanbian University; Yanbian University; Yanbian University	Chu, CP (corresponding author), Yanbian Univ, Cellular Funct Res Ctr, Yanji, Jilin Province, Peoples R China.	dlqiu@ybu.edu.cn			National Natural Science Foundation of China [31060138]; Leading Academic Discipline Program, 211 Project of Yanbian University, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leading Academic Discipline Program, 211 Project of Yanbian University, China	This work was supported by the National Natural Science Foundation of China (31060138) and the Leading Academic Discipline Program, 211 Project of Yanbian University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Bower JM, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00027; BOWER JM, 1983, J NEUROPHYSIOL, V49, P745, DOI 10.1152/jn.1983.49.3.745; Brown ME, 2009, J NEUROPHYSIOL, V101, P474, DOI 10.1152/jn.90766.2008; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Chu CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022752; Chu CP, 2011, NEUROSCI LETT, V487, P182, DOI 10.1016/j.neulet.2010.10.018; Cohen D, 1998, P NATL ACAD SCI USA, V95, P15032, DOI 10.1073/pnas.95.25.15032; Cohen D, 2000, J NEUROPHYSIOL, V83, P1932, DOI 10.1152/jn.2000.83.4.1932; Donato R, 2008, CELL CALCIUM, V44, P521, DOI 10.1016/j.ceca.2008.03.006; ECCLES JC, 1972, EXP BRAIN RES, V15, P261, DOI 10.1007/BF00235911; Eccles JC, 1967, CEREBELLUM NEURONAL; Ekerot CF, 2003, CEREBELLUM, V2, P101, DOI 10.1080/14734220309411; Gao WC, 2006, J NEUROSCI, V26, P8377, DOI 10.1523/JNEUROSCI.2434-06.2006; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hevers W, 2008, J NEUROSCI, V28, P5383, DOI 10.1523/JNEUROSCI.5443-07.2008; Holtzman T, 2006, J PHYSIOL-LONDON, V574, P491, DOI 10.1113/jphysiol.2006.108282; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Jaeger D, 1999, J NEUROSCI, V19, P6090, DOI 10.1523/JNEUROSCI.19-14-06090.1999; Jaeger D, 1997, J NEUROSCI, V17, P91, DOI 10.1523/JNEUROSCI.17-01-00091.1997; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Kolb FP, 1997, NEUROSCIENCE, V81, P1155, DOI 10.1016/S0306-4522(97)00255-8; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Lu H, 2005, J NEUROPHYSIOL, V94, P1849, DOI 10.1152/jn.01275.2004; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Mathers DA, 2007, NEUROPHARMACOLOGY, V52, P1160, DOI 10.1016/j.neuropharm.2006.12.004; MEEK J, 1992, NEUROSCIENCE, V48, P249, DOI 10.1016/0306-4522(92)90489-O; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; ODONOGHUE DL, 1989, J NEUROSCI, V9, P2141; Palay S.L., 1974, CEREBELLAR CORTEX; Sakaba T, 2008, NEURON, V57, P406, DOI 10.1016/j.neuron.2007.11.029; Santamaria F, 2007, J NEUROPHYSIOL, V97, P248, DOI 10.1152/jn.01098.2005; Sceniak MP, 2006, J NEUROPHYSIOL, V95, P3865, DOI 10.1152/jn.01196.2005; SCHULZ DW, 1981, BRAIN RES, V209, P177, DOI 10.1016/0006-8993(81)91179-3; Stell BM, 2007, J NEUROSCI, V27, P9022, DOI 10.1523/JNEUROSCI.1954-07.2007; Sultan F, 1998, J COMP NEUROL, V393, P353; Vincent P, 1996, J PHYSIOL-LONDON, V494, P183, DOI 10.1113/jphysiol.1996.sp021484; Walter JT, 2009, J NEUROSCI, V29, P8462, DOI 10.1523/JNEUROSCI.5718-08.2009	42	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37031	10.1371/journal.pone.0037031	http://dx.doi.org/10.1371/journal.pone.0037031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623975	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500052
J	Liu, WM; Pang, RTK; Cheong, AWY; Ng, EHY; Lao, KQ; Lee, KF; Yeung, WSB				Liu, Wei-Min; Pang, Ronald T. K.; Cheong, Ana W. Y.; Ng, Ernest H. Y.; Lao, Kaiqin; Lee, Kai-Fai; Yeung, William S. B.			Involvement of microRNA Lethal-7a in the Regulation of Embryo Implantation in Mice	PLOS ONE			English	Article							MOUSE PERIIMPLANTATION BLASTOCYSTS; CELL-SPECIFIC MICRORNAS; GROWTH-FACTOR-BETA; DELAYED-IMPLANTATION; PREIMPLANTATION EMBRYOS; MAMMALIAN DEVELOPMENT; SPATIAL REGULATION; EXPRESSION; INTEGRIN; UTERUS	MicroRNAs interact with multiple mRNAs resulting in their degradation and/or translational repression. This report used the delayed implantation model to determine the role of miRNAs in blastocysts. Dormant blastocysts in delayed implanting mice were activated by estradiol. Differential expression of 45 out of 238 miRNAs examined was found between the dormant and the activated blastocysts. Five of the nine members of the microRNA lethal-7 (let-7) family were down-regulated after activation. Human blastocysts also had a low expression of let-7 family. Forced-expression of a family member, let-7a in mouse blastocysts decreased the number of implantation sites (let-7a: 1.1 +/- 0.4; control: 3.8 +/- 0.4) in vivo, and reduced the percentages of blastocyst that attached (let-7a: 42.0 +/- 8.3%; control: 79.0 +/- 5.1%) and spreaded (let-7a: 33.5 +/- 2.9%; control: 67.3 +/- 3.8%) on fibronectin in vitro. Integrin-beta 3, a known implantation-related molecule, was demonstrated to be a target of let-7a by 3'-untranslated region reporter assay in cervical cancer cells HeLa, and Western blotting in mouse blastocysts. The inhibitory effect of forced-expression of let-7a on blastocyst attachment and outgrowth was partially nullified in vitro and in vivo by forced-expression of integrin-beta 3. This study provides the first direct evidence that let-7a is involved in regulating the implantation process partly via modulation of the expression of integrin-beta 3. (200 words).	[Liu, Wei-Min; Pang, Ronald T. K.; Cheong, Ana W. Y.; Ng, Ernest H. Y.; Lee, Kai-Fai; Yeung, William S. B.] Univ Hong Kong, Dept Obstet & Gynaecol, Pokfulam, Hong Kong, Peoples R China; [Pang, Ronald T. K.; Lee, Kai-Fai; Yeung, William S. B.] Univ Hong Kong, Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China; [Lao, Kaiqin] Appl Biosyst Inc, Foster City, CA 94404 USA	University of Hong Kong; University of Hong Kong; Thermo Fisher Scientific; Applied Biosystems	Liu, WM (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, Pokfulam, Hong Kong, Peoples R China.	wsbyeung@hku.hk	Pang, Ronald/B-8039-2013; Lee, Calvin Kai Fai/C-4328-2009	Ng, Ernest/0000-0002-7688-4557; Lee, Calvin Kai Fai/0000-0001-5957-439X	GRF grant from the Research Grant Council, Hong Kong [HKU783910M]	GRF grant from the Research Grant Council, Hong Kong	This work is supported by a GRF grant from the Research Grant Council (HKU783910M), Hong Kong (http://www.ugc.edu.hk/eng/rgc/grf/application/cergia.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aplin AE, 1998, PHARMACOL REV, V50, P197; Aplin John D, 2004, Reprod Biol Endocrinol, V2, P48; Aplin JD, 1996, MOL HUM REPROD, V2, P527, DOI 10.1093/molehr/2.7.527; Bandi N, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-55; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basak S, 2002, BIOL REPROD, V66, P1784, DOI 10.1095/biolreprod66.6.1784; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blakaj A, 2008, J BIOL CHEM, V283, P9505, DOI 10.1074/jbc.R800002200; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; DAMSKY C, 1993, FASEB J, V7, P1320, DOI 10.1096/fasebj.7.14.8224605; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fu TY, 2011, J REPROD DEVELOP, V57, P627, DOI 10.1262/jrd.11-018E; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Hamatani T, 2004, P NATL ACAD SCI USA, V101, P10326, DOI 10.1073/pnas.0402597101; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Illera MJ, 2000, BIOL REPROD, V62, P1285, DOI 10.1095/biolreprod62.5.1285; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kaneko Y, 2011, REPROD FERT DEVELOP, V23, P481, DOI 10.1071/RD10211; Katagiri S, 1998, J VET MED SCI, V60, P791, DOI 10.1292/jvms.60.791; Kemp C, 2005, DEV DYNAM, V233, P1064, DOI 10.1002/dvdy.20408; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lao KQ, 2006, BIOCHEM BIOPH RES CO, V343, P85, DOI 10.1016/j.bbrc.2006.02.106; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Legler DF, 2001, J CELL SCI, V114, P1545; Lichner Z, 2011, DIFFERENTIATION, V81, P11, DOI 10.1016/j.diff.2010.08.002; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Liu WM, 2007, FERTIL STERIL, V87, P664, DOI 10.1016/j.fertnstert.2006.07.1525; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Lykke-Andersen K, 2008, MOL BIOL CELL, V19, P4383, DOI 10.1091/mbc.E08-02-0219; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Mummery CL, 2001, MICROSC RES TECHNIQ, V52, P374, DOI 10.1002/1097-0029(20010215)52:4<374::AID-JEMT1022>3.0.CO;2-8; NIEDER GL, 1984, J EXP ZOOL, V231, P121, DOI 10.1002/jez.1402310116; O'Hara AJ, 2009, BLOOD, V113, P5938, DOI 10.1182/blood-2008-09-179168; Ouellet DL, 2006, J BIOMED BIOTECHNOL, V2006, P69616; Pais H, 2010, RNA, V16, P489, DOI 10.1261/rna.1701210; Pang RTK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027878; PARIA BC, 1992, DEV BIOL, V151, P91, DOI 10.1016/0012-1606(92)90216-4; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P55, DOI 10.1073/pnas.90.1.55; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Rout UK, 2004, DEV BIOL, V268, P135, DOI 10.1016/j.ydbio.2003.12.010; SAKHUJATALWAR D, 1984, J REPROD FERTIL, V70, P185, DOI 10.1530/jrf.0.0700185; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Schultz JF, 1997, DEV GENET, V21, P31, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;31::AID-DVG4&gt;3.0.CO;2-9; SCHULTZ JF, 1995, J BIOL CHEM, V270, P11522, DOI 10.1074/jbc.270.19.11522; Soares ML, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-28; Song Lin, 2006, Birth Defects Research, V78, P140, DOI 10.1002/bdrc.20070; Spindler RE, 1996, J EXP ZOOL, V276, P132, DOI 10.1002/(SICI)1097-010X(19961001)276:2&lt;132::AID-JEZ6&gt;3.0.CO;2-P; Su RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015513; SUTHERLAND AE, 1993, DEVELOPMENT, V119, P1175; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Viswanathan SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006143; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang HH, 2008, DEV BIOL, V318, P112, DOI 10.1016/j.ydbio.2008.03.008; Wang J, 1999, BIOL REPROD, V60, P839, DOI 10.1095/biolreprod60.4.839; Wang J, 2007, DEV BIOL, V302, P143, DOI 10.1016/j.ydbio.2006.09.015; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Xia HF, 2010, J REPROD DEVELOP, V56, P73, DOI 10.1262/jrd.09-088K; Xia HF, 2010, INT J MOL SCI, V11, P719, DOI 10.3390/ijms11020719; Xie HR, 2008, DEVELOPMENT, V135, P717, DOI 10.1242/dev.015339; Yang YH, 2008, DEV DYNAM, V237, P2315, DOI 10.1002/dvdy.21666; Zheng GXY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002054; Zovoilis A, 2009, DIFFERENTIATION, V78, P69, DOI 10.1016/j.diff.2009.06.003	74	60	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37039	10.1371/journal.pone.0037039	http://dx.doi.org/10.1371/journal.pone.0037039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623977	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500054
J	Schlecht, NF; Burk, RD; Nucci-Sack, A; Shankar, V; Peake, K; Lorde-Rollins, E; Porter, R; Linares, LO; Rojas, M; Strickler, HD; Diaz, A				Schlecht, Nicolas F.; Burk, Robert D.; Nucci-Sack, Anne; Shankar, Viswanathan; Peake, Ken; Lorde-Rollins, Elizabeth; Porter, Richard; Linares, Lourdes Oriana; Rojas, Mary; Strickler, Howard D.; Diaz, Angela			Cervical, Anal and Oral HPV in an Adolescent Inner-City Health Clinic Providing Free Vaccinations	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; INTRAEPITHELIAL NEOPLASIA; QUADRIVALENT VACCINE; EFFICACY; INFECTION; TRIAL; CANCER; WOMEN	Objectives: Published human papillomavirus (HPV) vaccine trials indicate efficacy is strongest for those naive to the vaccine-types. However, few high-risk young women have been followed and cervical HPV has been the predominant outcome measure. Methods: We collected cervical and anal swabs, as well as oral rinse specimens from 645 sexually active inner-city young females attending a large adolescent health-clinic in New York City that offers free care and HPV vaccination. Specimens were tested for HPV-DNA using a MY09/MY11-PCR system. Type-specific prevalence of HPV at each anatomic site was compared for individuals by vaccination dose using generalized estimating equation logistic regression models. Results: The majority of subjects reported being of non-Caucasian (92%) and/or Hispanic ethnicity (61%). Median age was 18 years (range: 14-20). All had practiced vaginal sex, a third (33%) practiced anal sex, and most (77%) had also engaged in oral sex. At enrollment, 21% had not received the vaccine and 51% had received three doses. Prevalent HPV infection at enrollment was detected in 54% of cervical, 42% of anal and 20% of oral specimens, with vaccine types present in 7%, 6% and 1% of specimens, respectively. Comparing prevalence for vaccine types, the detection of HPV in the cervix of vaccinated compared to unvaccinated adolescents was significantly reduced: HPV6/11 (odds ratio [OR] = 0.19, 95% CI: 0.06-0.75), HPV16 (OR = 0.31, 95% CI: 0.11-0.88) and HPV18 (OR = 0.14, 95% CI: 0.03-0.75). For anal HPV, the risk of detecting vaccine types HPV6/11 (OR = 0.27, 95% CI: 0.10-0.72) and HPV18(OR = 0.12, 95% CI: 0.01-1.16) were significantly reduced for vaccinated adolescents however, the risk for HPV16 was not significantly decreased (OR = 0.63, 95% CI: 0.18-2.20). Conclusion: HPV Prevalence is extremely high in inner-city female adolescents. Administration of the HPV vaccine reduced the risk for cervical HPV; however continued follow-up is required to assess the protection for HPV at all sites in young women with high exposure.	[Schlecht, Nicolas F.; Burk, Robert D.; Shankar, Viswanathan; Strickler, Howard D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat Microbiol & Immunol, Bronx, NY 10467 USA; [Nucci-Sack, Anne; Peake, Ken; Lorde-Rollins, Elizabeth; Porter, Richard; Linares, Lourdes Oriana; Diaz, Angela] Mt Sinai Sch Med, Mt Sinai Adolescent Hlth Ctr, Dept Pediat, New York, NY USA; [Rojas, Mary] Maimonides Hosp, Dept Pediat, Infants & Childrens Hosp, Brooklyn, NY 11219 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Maimonides Medical Center; Yeshiva University; Albert Einstein College of Medicine	Schlecht, NF (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.	nicolas.schlecht@einstein.yu.edu	Viswanathan, Shankar/AAX-5281-2020	Viswanathan, Shankar/0000-0003-3349-9090; Schlecht, Nicolas/0000-0003-2482-244X; Rojas, Mary/0000-0002-0542-4270	National Institute of Allergy and Infectious Diseases [AI072204]; NIH [AI51519]; Einstein Cancer Research Center from the National Cancer Institute [P30 CA013330]; Einstein-Montefiore Center for AIDS; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072204, P30AI051519, R01AI072204] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein Cancer Research Center from the National Cancer Institute; Einstein-Montefiore Center for AIDS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by the National Institute of Allergy and Infectious Diseases (RO1 grant AI072204). Additional funding was provided in part by the Einstein-Montefiore Center for AIDS funded by the NIH (AI51519), the Einstein Cancer Research Center (P30 CA013330) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, N ENGL J MED, V356, P1915; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Castle PE, 2002, J MED VIROL, V68, P417, DOI 10.1002/jmv.10220; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; GREENLAND S, 1986, INT J EPIDEMIOL, V15, P413, DOI 10.1093/ije/15.3.413; Haupt RM, 2011, INT J CANCER, V129, P2632, DOI 10.1002/ijc.25940; Katki H, 2011, HPV VACCINE EFFICACY; Kemp TJ, 2011, VACCINE, V29, P2011, DOI 10.1016/j.vaccine.2011.01.001; Kovacic MB, 2006, CANCER RES, V66, P10112, DOI 10.1158/0008-5472.CAN-06-1812; Kreimer AR, 2011, JNCI-J NATL CANCER I, V103, P1444, DOI 10.1093/jnci/djr319; Kreimer AR, 2011, LANCET ONCOL, V12, P862, DOI 10.1016/S1470-2045(11)70213-3; Mao C, 2006, OBSTET GYNECOL, V107, P18, DOI 10.1097/01.AOG.0000192397.41191.fb; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Olsson SE, 2009, HUM VACCINES, V5, P696, DOI 10.4161/hv.5.10.9515; Paavonen J, 2008, CURR MED RES OPIN, V24, P1623, DOI 10.1185/03007990802068151; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Villa LL, 2006, VACCINE, V24, P5571, DOI 10.1016/j.vaccine.2006.04.068; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; Xue XN, 2010, CANCER EPIDEM BIOMAR, V19, P159, DOI 10.1158/1055-9965.EPI-09-0546	22	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37419	10.1371/journal.pone.0037419	http://dx.doi.org/10.1371/journal.pone.0037419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624027	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500112
J	Wu, XW; Weng, LH; Li, XJ; Guo, C; Pal, SK; Jin, JM; Li, YP; Nelson, RA; Mu, B; Onami, SH; Wu, JJ; Ruel, NH; Wilczynski, SP; Gao, HL; Covarrubias, M; Figlin, RA; Weiss, LM; Wu, HQ				Wu, Xiwei; Weng, Lihong; Li, Xuejun; Guo, Chao; Pal, Sumanta K.; Jin, Jennifer M.; Li, Yuping; Nelson, Rebecca A.; Mu, Bing; Onami, Susan H.; Wu, Jeffrey J.; Ruel, Nora H.; Wilczynski, Sharon P.; Gao, Hanlin; Covarrubias, Maricela; Figlin, Robert A.; Weiss, Lawrence M.; Wu, Huiqing			Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis	PLOS ONE			English	Article							INTEGRATED STAGING SYSTEM; MICRORNA EXPRESSION LEVELS; DIFFERENTIAL EXPRESSION; CANCER; VALIDATION; SURVIVAL; INVASION	Renal cell carcinoma (RCC) metastasis portends a poor prognosis and cannot be reliably predicted. Early determination of the metastatic potential of RCC may help guide proper treatment. We analyzed microRNA (miRNA) expression in clear cell RCC (ccRCC) for the purpose of developing a miRNA expression signature to determine the risk of metastasis and prognosis. We used the microarray technology to profile miRNA expression of 78 benign kidney and ccRCC samples. Using 28 localized and metastatic ccRCC specimens as the training cohort and the univariate logistic regression and risk score methods, we developed a miRNA signature model in which the expression levels of miR-10b, miR-139-5p, miR-130b and miR-199b-5p were used to determine the status of ccRCC metastasis. We validated the signature in an independent 40-sample testing cohort of different stages of primary ccRCCs using the microarray data. Within the testing cohort patients who had at least 5 years follow-up if no metastasis developed, the signature showed a high sensitivity and specificity. The risk status was proven to be associated with the cancer-specific survival. Using the most stably expressed miRNA among benign and tumorous kidney tissue as the internal reference for normalization, we successfully converted his signature to be a quantitative PCR (qPCR)-based assay, which showed the same high sensitivity and specificity. The 4-miRNA is associated with ccRCC metastasis and prognosis. The signature is ready for and will benefit from further large clinical cohort validation and has the potential for clinical application.	[Wu, Xiwei; Covarrubias, Maricela] City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA 91010 USA; [Wu, Xiwei; Weng, Lihong; Li, Xuejun; Guo, Chao; Pal, Sumanta K.; Jin, Jennifer M.; Li, Yuping; Nelson, Rebecca A.; Mu, Bing; Onami, Susan H.; Wu, Jeffrey J.; Ruel, Nora H.; Wilczynski, Sharon P.; Gao, Hanlin; Covarrubias, Maricela; Figlin, Robert A.; Weiss, Lawrence M.; Wu, Huiqing] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Weng, Lihong; Guo, Chao; Jin, Jennifer M.; Li, Yuping; Wu, Jeffrey J.; Wilczynski, Sharon P.; Weiss, Lawrence M.; Wu, Huiqing] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA 91010 USA; [Li, Xuejun; Nelson, Rebecca A.; Mu, Bing; Ruel, Nora H.] City Hope Natl Med Ctr, Dept Informat Sci, Duarte, CA 91010 USA; [Pal, Sumanta K.; Onami, Susan H.; Figlin, Robert A.] City Hope Natl Med Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA 91010 USA; [Gao, Hanlin] City Hope Natl Med Ctr, Dept Canc Biol, Duarte, CA 91010 USA	City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; City of Hope; City of Hope	Wu, XW (corresponding author), City Hope Natl Med Ctr, Dept Mol Med, 1500 E Duarte Rd, Duarte, CA 91010 USA.	hwu@coh.org	Li, Yuping/J-3138-2018; Guo, Chao/B-2647-2010; Nelson, Rebecca/C-4438-2014	Guo, Chao/0000-0002-6673-0933; Ruel, Nora/0000-0002-4591-3618	City of Hope National Medical Center; Beckman Research Institute of City of Hope; California Cancer Specialists Medical Group	City of Hope National Medical Center; Beckman Research Institute of City of Hope; California Cancer Specialists Medical Group	This work was funded by City of Hope National Medical Center, Beckman Research Institute of City of Hope and California Cancer Specialists Medical Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Garzia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004998; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Han KR, 2003, J UROLOGY, V170, P2221, DOI 10.1097/01.ju.0000096049.64863.a1; Hiroki E, 2010, CANCER SCI, V101, P241, DOI 10.1111/j.1349-7006.2009.01385.x; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Klein CA, 2008, SCIENCE, V321, P1785, DOI 10.1126/science.1164853; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lopez-Romero Pedro, 2010, BMC Res Notes, V3, P18, DOI 10.1186/1756-0500-3-18; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Michael MZ, 2003, MOL CANCER RES, V1, P882; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Patard JJ, 2004, J CLIN ONCOL, V22, P3316, DOI 10.1200/JCO.2004.09.104; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weinberg RA, 2008, CANCER CELL, V14, P283, DOI 10.1016/j.ccr.2008.09.009; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zisman A, 2001, J CLIN ONCOL, V19, P3792, DOI 10.1200/JCO.2001.19.17.3792	38	139	145	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e35661	10.1371/journal.pone.0035661	http://dx.doi.org/10.1371/journal.pone.0035661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623952	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500006
J	Kim, J; Tsien, RW; Alger, BE				Kim, Jimok; Tsien, Richard W.; Alger, Bradley E.			An Improved Test for Detecting Multiplicative Homeostatic Synaptic Scaling	PLOS ONE			English	Article							HIPPOCAMPAL SYNAPSES; GAIN-CONTROL; PLASTICITY; DEPRIVATION; INACTIVITY; CIRCUITS; TRAFFICKING; RECEPTORS; AMPLITUDE; NEURONS	Homeostatic scaling of synaptic strengths is essential for maintenance of network "gain", but also poses a risk of losing the distinctions among relative synaptic weights, which are possibly cellular correlates of memory storage. Multiplicative scaling of all synapses has been proposed as a mechanism that would preserve the relative weights among them, because they would all be proportionately adjusted. It is crucial for this hypothesis that all synapses be affected identically, but whether or not this actually occurs is difficult to determine directly. Mathematical tests for multiplicative synaptic scaling are presently carried out on distributions of miniature synaptic current amplitudes, but the accuracy of the test procedure has not been fully validated. We now show that the existence of an amplitude threshold for empirical detection of miniature synaptic currents limits the use of the most common method for detecting multiplicative changes. Our new method circumvents the problem by discarding the potentially distorting subthreshold values after computational scaling. This new method should be useful in assessing the underlying neurophysiological nature of a homeostatic synaptic scaling transformation, and therefore in evaluating its functional significance.	[Kim, Jimok] Georgia Hlth Sci Univ, Grad Program Neurosci, Inst Mol Med & Genet, Augusta, GA USA; [Kim, Jimok] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA; [Kim, Jimok; Tsien, Richard W.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Kim, Jimok; Alger, Bradley E.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Kim, Jimok; Alger, Bradley E.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Stanford University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Kim, J (corresponding author), Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA USA.	jimkim@georgiahealth.edu			National Institutes of Health [R01AG036794, R37MH071739, R01DA014625]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH071739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants R01AG036794 to J.K., R37MH071739 to R.W.T., and R01DA014625 to B.E.A. from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Bartley AF, 2008, J NEUROPHYSIOL, V100, P1983, DOI 10.1152/jn.90635.2008; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Echegoyen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000700; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Hou QM, 2011, NEURON, V72, P806, DOI 10.1016/j.neuron.2011.10.011; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kim J, 2008, NEURON, V58, P925, DOI 10.1016/j.neuron.2008.05.009; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Mitra A, 2012, NAT NEUROSCI, V15, P250, DOI 10.1038/nn.3004; Moulder KL, 2006, J NEUROSCI, V26, P6618, DOI 10.1523/JNEUROSCI.5498-05.2006; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Rabinowitch I, 2008, TRENDS NEUROSCI, V31, P377, DOI 10.1016/j.tins.2008.05.005; Rabinowitch I, 2006, J NEUROSCI, V26, P13474, DOI 10.1523/JNEUROSCI.4333-06.2006; Rabinowitch I, 2006, J NEUROPHYSIOL, V96, P276, DOI 10.1152/jn.00074.2006; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Tetzlaff C, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00047; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Trasande CA, 2007, J CLIN NEUROPHYSIOL, V24, P154, DOI 10.1097/WNP.0b013e318033787f; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008	32	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37364	10.1371/journal.pone.0037364	http://dx.doi.org/10.1371/journal.pone.0037364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615990	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341200067
J	Zhang, GT; Liu, RJ; Zhong, YF; Plotnikov, AN; Zhang, WJ; Zeng, L; Rusinova, E; Gerona-Nevarro, G; Moshkina, N; Joshua, J; Chuang, PY; Ohlmeyer, M; He, JC; Zhou, MM				Zhang, Guangtao; Liu, Ruijie; Zhong, Yifei; Plotnikov, Alexander N.; Zhang, Weijia; Zeng, Lei; Rusinova, Elena; Gerona-Nevarro, Guillermo; Moshkina, Natasha; Joshua, Jennifer; Chuang, Peter Y.; Ohlmeyer, Michael; He, John Cijiang; Zhou, Ming-Ming			Down-regulation of NF-kappa B Transcriptional Activity in HIV-associated Kidney Disease by BRD4 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULAR EPITHELIAL-CELLS; PROBE LEVEL DATA; DIABETIC-NEPHROPATHY; TRANSGENIC MICE; APOPTOSIS; ACTIVATION; INFECTION; THERAPY; NMR; GLOMERULOSCLEROSIS	NF-kappa B-mediated inflammation is the major pathology in chronic kidney diseases, including HIV-associated nephropathy (HIVAN) that ultimately progresses to end stage renal disease. HIV infection in the kidney induces NF-kappa B activation, leading to the production of proinflammatory chemokines, cytokines, and adhesion molecules. In this study, we explored selective inhibition of NF-kappa B transcriptional activity by small molecule blocking NF-kappa B binding to the transcriptional cofactor BRD4, which is required for the assembly of the productive transcriptional complex comprising positive transcription elongation factor b and RNA polymerase II. We showed that our BET (Bromodomain and Extra-Terminal domain)-specific bromodomain inhibitor MS417, designed to block BRD4 binding to the acetylated NF-kappa B, effectively attenuates NF-kappa B transcriptional activation of proinflammatory genes in kidney cells treated with TNF alpha or infected by HIV. MS417 ameliorates inflammation and kidney injury in HIV-1 transgenic mice, an animal model for HIVAN. Our study suggests that BET bromodomain inhibition, targeting at the proinflammatory activity of NF-kappa B, represents a new therapeutic approach for treating NF-kappa B-mediated inflammation and kidney injury in HIVAN.	[Zhang, Guangtao; Plotnikov, Alexander N.; Zeng, Lei; Rusinova, Elena; Gerona-Nevarro, Guillermo; Moshkina, Natasha; Joshua, Jennifer; Ohlmeyer, Michael; Zhou, Ming-Ming] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Liu, Ruijie; Zhang, Weijia; Chuang, Peter Y.; He, John Cijiang] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Liu, Ruijie; He, John Cijiang] James J Peters Vet Affairs Med Ctr, Dept Med, Bronx, NY 10486 USA; [Zhong, Yifei] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Nephrol, Shanghai 201203, Peoples R China	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Shanghai University of Traditional Chinese Medicine	He, JC (corresponding author), 1425 Madison Ave,Box 1677, New York, NY 10029 USA.	cijiang.he@mssm.edu; ming-ming.zhou@mssm.edu	Zhang, Guangtao/C-7341-2011		National Institutes of Health [HG004508, DK088541]; Veterans Affairs Merit Award [1I01BX000345]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088541] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HG004508 (to M.-M. Z.) and DK088541 (to J. C. H.). This work was also supported by Veterans Affairs Merit Award 1I01BX000345 (to J. C. H.).	Atta MG, 2007, CLIN INFECT DIS, V45, P1625, DOI 10.1086/523728; Bruggeman LA, 2000, J AM SOC NEPHROL, V11, P2079, DOI 10.1681/ASN.V11112079; Bruggeman LA, 1997, J CLIN INVEST, V100, P84, DOI 10.1172/JCI119525; Bruggeman LA, 2001, KIDNEY INT, V59, P2174, DOI 10.1046/j.1523-1755.2001.0590062174.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen P, 2011, J AM SOC NEPHROL, V22, P496, DOI 10.1681/ASN.2010040379; Chiang Cheng-Ming, 2009, F1000 Biol Rep, V1, P98, DOI 10.3410/B1-98; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Criswell LA, 2010, IMMUNOL REV, V233, P55, DOI 10.1111/j.0105-2896.2009.00862.x; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; DAGATI V, 1989, KIDNEY INT, V35, P1358, DOI 10.1038/ki.1989.135; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; KOPP JB, 1992, P NATL ACAD SCI USA, V89, P1577, DOI 10.1073/pnas.89.5.1577; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Lu TC, 2006, CURR OPIN NEPHROL HY, V15, P233, DOI 10.1097/01.mnh.0000222688.69217.8e; Lucas GM, 2004, AIDS, V18, P541, DOI 10.1097/00002030-200402200-00022; Marras D, 2002, NAT MED, V8, P522, DOI 10.1038/nm0502-522; Martinka S, 2006, AM J PHYSIOL-RENAL, V290, pF657, DOI 10.1152/ajprenal.00208.2005; Mikula M, 2004, HEPATOLOGY, V39, P628, DOI 10.1002/hep.20084; Mikulak J, 2010, AM J PHYSIOL-RENAL, V299, pF664, DOI 10.1152/ajprenal.00629.2009; Miyoshi S., 2008, Antitumor agent, Patent No. [US 2010/0286127 A1, 20100286127]; Miyoshi S., 2008, International Patent, Patent No. [PCT/JP2008/073864 (US2010/0286127 A1), 2008073864]; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Rangan G, 2009, FRONT BIOSCI-LANDMRK, V14, P3496, DOI 10.2741/3467; Ratnam KK, 2011, KIDNEY INT, V79, P624, DOI 10.1038/ki.2010.470; Ross MJ, 2006, J AM SOC NEPHROL, V17, P996, DOI 10.1681/ASN.2005070692; Ross MJ, 2006, JAIDS-J ACQ IMM DEF, V42, P1, DOI 10.1097/01.qai.0000218353.60099.4f; Ross MJ, 2005, J AM SOC NEPHROL, V16, P2403, DOI 10.1681/ASN.2004121101; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Snyder A, 2010, AIDS, V24, P1107, DOI 10.1097/QAD.0b013e328337b0ab; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Tanji N, 2006, HISTOL HISTOPATHOL, V21, P393, DOI 10.14670/HH-21.393; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wyatt CM, 2007, CLIN J AM SOC NEPHRO, V2, pS20, DOI 10.2215/CJN.03561006; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zheng L, 2006, HUM PATHOL, V37, P637, DOI 10.1016/j.humpath.2006.01.002	53	151	204	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28840	28851		10.1074/jbc.M112.359505	http://dx.doi.org/10.1074/jbc.M112.359505			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22645123	Green Published, hybrid			2022-12-25	WOS:000308074600056
J	Wu, CH; Tang, SC; Wang, PH; Lee, H; Ko, JL				Wu, Chih-Hsien; Tang, Sheau-Chung; Wang, Po-Hui; Lee, Huei; Ko, Jiunn-Liang			Nickel-induced Epithelial-Mesenchymal Transition by Reactive Oxygen Species Generation and E-cadherin Promoter Hypermethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; MOLECULAR-MECHANISMS; LUNG-CANCER; HYPOXIA; METHYLATION; EXPRESSION; CARCINOGENESIS; GENE; INACTIVATION; GENOTOXICITY	Epithelial-mesenchymal transition (EMT) is considered a critical event in the pathogenesis of lung fibrosis and tumor metastasis. During EMT, the expression of differentiation markers switches from cell-cell junction proteins such as E-cadherin to mesenchymal markers such as fibronectin. Although nickel-containing compounds have been shown to be associated with lung carcinogenesis, the role of nickel in the EMT process in bronchial epithelial cells is not clear. The aim of this study was to examine whether nickel contributes to EMT in human bronchial epithelial cells. We also attempted to clarify the mechanisms involved in NiCl2-induced EMT. Our results showed that NiCl2 induced EMT phenotype marker alterations such as up-regulation of fibronectin and down-regulation of E-cadherin. In addition, the potent antioxidant N-acetylcysteine blocked EMT and expression of HIF-1 alpha induced by NiCl2, whereas the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine restored the down-regulation of E-cadherin induced by NiCl2. Promoter hypermethylation of E-cadherin, determined by quantitative real time methyl-specific PCR and bisulfate sequencing, was also induced by NiCl2. These results shed new light on the contribution of NiCl2 to carcinogenesis. Specifically, NiCl2 induces down-regulation of E-cadherin by reactive oxygen species generation and promoter hypermethylation. This study demonstrates for the first time that nickel induces EMT in bronchial epithelial cells.	[Wu, Chih-Hsien; Tang, Sheau-Chung; Wang, Po-Hui; Lee, Huei; Ko, Jiunn-Liang] Chung Shan Med Univ, Inst Med, Taichung 40203, Taiwan; [Wang, Po-Hui] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung 40203, Taiwan; [Ko, Jiunn-Liang] Chung Shan Med Univ Hosp, Dept Med Oncol & Chest Med, Taichung 40203, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Ko, JL (corresponding author), Chung Shan Med Univ, Inst Med, 110,Sect 1,Chien Kuo N Rd, Taichung 40203, Taiwan.	jlko@csmu.edu.tw		Ko, Jiunn-Liang/0000-0001-6855-9239	National Science Council, Taiwan [NSC-99-2314-B-040-012-MY3]; National Research Program for Genomic Medicine, National Science Council Grant [NSC-97-3112-B-001-016]; National Science Council, Ministry of Education; Chung Shan Medical University	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Research Program for Genomic Medicine, National Science Council Grant; National Science Council, Ministry of Education(Ministry of Science and Technology, Taiwan); Chung Shan Medical University	This work was supported by National Science Council, Taiwan, Grant NSC-99-2314-B-040-012-MY3.; RNAi reagents were obtained from the National RNAi Core Facility (Institute of Molecular Biology/Genomic Research Center, Academia Sinica), which is supported by National Research Program for Genomic Medicine, National Science Council Grant NSC-97-3112-B-001-016. Confocal microscopy was performed by the Instrument Center of Chung Shan Medical University, which is supported in part by the National Science Council, Ministry of Education, and Chung Shan Medical University.	Cameron Keyuna S., 2011, Reviews on Environmental Health, V26, P81, DOI 10.1515/REVEH.2011.012; Chen CY, 2003, TOXICOL APPL PHARM, V189, P153, DOI 10.1016/S0041-008X(03)00086-3; Chen HB, 2010, CARCINOGENESIS, V31, P2136, DOI 10.1093/carcin/bgq197; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Corn PG, 2000, CLIN CANCER RES, V6, P4243; Costa M, 2005, MUTAT RES-FUND MOL M, V592, P79, DOI 10.1016/j.mrfmmm.2005.06.008; Costa M, 2003, J ENVIRON MONITOR, V5, P222, DOI 10.1039/b210260a; Davidson T, 2005, MOL CELL BIOCHEM, V279, P157, DOI 10.1007/s11010-005-8288-y; EDELMAN DA, 1989, ENVIRON HEALTH PERSP, V81, P221, DOI 10.2307/3430832; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Galanis A, 2009, MUTAT RES-GEN TOX EN, V674, P31, DOI 10.1016/j.mrgentox.2008.10.008; Galaris D, 2002, CRIT REV ONCOL HEMAT, V42, P93, DOI 10.1016/S1040-8428(01)00212-8; Gao N, 2004, MOL CELL BIOCHEM, V255, P33, DOI 10.1023/B:MCBI.0000007259.65742.16; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Giannoni E, 2012, ANTIOXID REDOX SIGN, V16, P1248, DOI 10.1089/ars.2011.4280; Guan DY, 2010, MOL CARCINOGEN, V49, P68, DOI 10.1002/mc.20578; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hiraki M, 2010, ANN SURG ONCOL, V17, P1177, DOI 10.1245/s10434-009-0815-8; Hsin IL, 2010, MUTAT RES-FUND MOL M, V688, P72, DOI 10.1016/j.mrfmmm.2010.03.011; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Kim DS, 2007, CANCER-AM CANCER SOC, V110, P2785, DOI 10.1002/cncr.23113; Kogan-Sakin I, 2011, CELL DEATH DIFFER, V18, P271, DOI 10.1038/cdd.2010.94; Law AYS, 2008, EXP CELL RES, V314, P1823, DOI 10.1016/j.yexcr.2008.03.001; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Maeda G, 2007, ODONTOLOGY, V95, P24, DOI 10.1007/s10266-007-0068-6; Nojima D, 2001, MOL CARCINOGEN, V32, P19, DOI 10.1002/mc.1060; Patel E, 2012, TOXICOL APPL PHARM, V258, P367, DOI 10.1016/j.taap.2011.11.019; Salnikow Konstantin, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P307; Strathdee G, 2002, SEMIN CANCER BIOL, V12, P373, DOI 10.1016/S1044-579X(02)00057-3; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Veljkovic E, 2011, TOXICOL IN VITRO, V25, P446, DOI 10.1016/j.tiv.2010.11.011; Vladimirov YA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1545, DOI 10.1134/S0006297909130082; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Xu ZG, 2011, TOXICOLOGY, V285, P25, DOI 10.1016/j.tox.2011.03.016; Yang MH, 2008, CELL CYCLE, V7, P2090, DOI 10.4161/cc.7.14.6324; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yeldandi AV, 2000, MUTAT RES-FUND MOL M, V448, P159, DOI 10.1016/S0027-5107(99)00234-1; Zhang KH, 2009, CANCER RES, V69, P5340, DOI 10.1158/0008-5472.CAN-09-0112; Zhao JH, 2004, TOXICOL APPL PHARM, V194, P60, DOI 10.1016/j.taap.2003.08.011	44	71	73	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25292	25302		10.1074/jbc.M111.291195	http://dx.doi.org/10.1074/jbc.M111.291195			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22648416	Green Published, hybrid			2022-12-25	WOS:000306651700037
J	Iizuka, T; Tamura, T; Sezutsu, H; Mase, K; Okada, E; Asaoka, K				Iizuka, Tetsuya; Tamura, Toshiki; Sezutsu, Hideki; Mase, Keisuke; Okada, Eiji; Asaoka, Kiyoshi			Genetic Analysis of the Electrophysiological Response to Salicin, a Bitter Substance, in a Polyphagous Strain of the Silkworm Bombyx mori	PLOS ONE			English	Article							GUSTATORY SENSITIVITY; TASTE RECEPTOR; DROSOPHILA; CATERPILLARS; LARVAE; CHEMORECEPTORS; PATHWAYS; SENSILLA; CELLS	Sawa-J is a polyphagous silkworm (Bombyx mori L.) strain that eats various plant leaves that normal silkworms do not. The feeding preference behavior of Sawa-J is controlled by one major recessive gene(s) on the polyphagous (pph) locus, and several minor genes; moreover, its deterrent cells possess low sensitivity to some bitter substances including salicin. To clarify whether taste sensitivity is controlled by the pph locus, we conducted a genetic analysis of the electrophysiological characteristics of the taste response using the polyphagous strain Sawa-J.lem, in which pph is linked to the visible larval marker lemon (lem) on the third chromosome, and the normal strain Daiankyo, in which the wild-type gene of pph (+(pph)) is marked with Zebra (Ze). Maxillary taste neurons of the two strains had similar dose-response relationships for sucrose, inositol, and strychnine nitrate, but the deterrent cell of Sawa-J.lem showed a remarkably low sensitivity to salicin. The F-1 generation of the two strains had characteristics similar to the Daiankyo strain, consistent with the idea that pph is recessive. In the BF1 progeny between F-1 females and Sawa-J.lem males where no crossing-over occurs, the lem and Ze phenotypes corresponded to different electrophysiological reactions to 25 mM salicin, indicating that the gene responsible for taste sensitivity to salicin is located on the same chromosome as the lem and Ze genes. The normal and weak reactions to 25 mM salicin were segregated in crossover-type larvae of the BF1 progeny produced by a reciprocal cross, and the recombination frequency agreed well with the theoretical ratio for the loci of lem, pph, and Ze on the standard linkage map. These results indicate that taste sensitivity to salicin is controlled by the gene(s) on the pph locus.	[Iizuka, Tetsuya; Tamura, Toshiki; Sezutsu, Hideki; Okada, Eiji] Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, Tsukuba, Ibaraki, Japan; [Mase, Keisuke] Nihon Univ, Coll Humanities & Sci, Setagaya Ku, Tokyo 156, Japan; [Asaoka, Kiyoshi] Natl Inst Agrobiol Sci, Insect Plant Interact Res Unit, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; Nihon University; National Institute of Agrobiological Sciences - Japan	Iizuka, T (corresponding author), Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, Tsukuba, Ibaraki, Japan.	asaoka@affrc.go.jp		Sezutsu, Hideki/0000-0001-8886-1611	National Institute of Agrobiological Sciences (NIAS)	National Institute of Agrobiological Sciences (NIAS)	This work was funded by National Institute of Agrobiological Sciences (NIAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAOKA K, 1995, ENTOMOL EXP APPL, V77, P167, DOI 10.1007/BF02383030; Asaoka K, 2000, J COMP PHYSIOL A, V186, P1011, DOI 10.1007/s003590000154; Asaoka K, 2010, INT J WILD SILKMOTH, V14, P1; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Dether VG, 1976, HUNGRY FLY; Glendinning JI, 1999, BEHAV NEUROSCI, V113, P840, DOI 10.1037/0735-7044.113.4.840; Glendinning JI, 2002, J NEUROSCI, V22, P7281; Glendinning JI, 1997, J NEUROPHYSIOL, V78, P734, DOI 10.1152/jn.1997.78.2.734; Glendinning JI, 1998, J COMP PHYSIOL A, V183, P35, DOI 10.1007/s003590050232; HAMAMURA Y, 1962, NATURE, V194, P754, DOI 10.1038/194754a0; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Iizuka Tetsuya, 2007, Journal of Insect Biotechnology and Sericology, V76, P107; ISHIKAWA S, 1963, J CELL COMPAR PHYSL, V61, P99, DOI 10.1002/jcp.1030610111; ISHIKAWA S, 1966, J CELL PHYSIOL, V67, P1, DOI 10.1002/jcp.1040670102; Ishikawa S, 1966, B SERICUL EXPET STAT, V20, P291; ITO T, 1960, J INSECT PHYSIOL, V5, P95, DOI 10.1016/0022-1910(60)90035-4; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; KANDA T, 1988, Journal of Sericultural Science of Japan, V57, P489; KANDA T, 1992, B NATL I SERIC ENTOM, V5, P1; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Matsuo T, 2008, GENETICS, V178, P1061, DOI 10.1534/genetics.107.079046; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; MORI M, 1982, J INSECT PHYSIOL, V28, P969, DOI 10.1016/0022-1910(82)90114-7; OHNUMA A, 1996, REP SILK SCI RES I, V44, P1; Ohnuma Akio, 1997, Journal of Sericultural Science of Japan, V66, P431; Ouyang Q, 2009, COMP BIOCHEM PHYS A, V153, P309, DOI 10.1016/j.cbpa.2009.03.004; Schoonhoven LM, 2002, ACTA ZOOL ACAD SCI H, V48, P215; TAZIMA Y, 1989, SERICOLOGIA, V29, P437; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; TORII K, 1948, REP SILK SCI RES I, V2, P3; van Loon JJA, 1999, ENTOMOL EXP APPL, V91, P29, DOI 10.1046/j.1570-7458.1999.00463.x; VANDRONGELEN W, 1980, ENTOMOL EXP APPL, V28, P199, DOI 10.1007/BF00287129; Vermehren-Schmaedick A, 2011, J COMP PHYSIOL A, V197, P717, DOI 10.1007/s00359-011-0634-9; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Yamamoto T, 1983, J SERIC SCI JPN, V52, P330; YAZAWA M, 1991, Journal of Sericultural Science of Japan, V60, P363; YOKOYAMA T, 1975, REP SILK SCI RES I, V24, P27	40	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37549	10.1371/journal.pone.0037549	http://dx.doi.org/10.1371/journal.pone.0037549			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649537	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335800056
J	Mosqueira, M; Willmann, G; Zeiger, U; Khurana, TS				Mosqueira, Matias; Willmann, Gabriel; Zeiger, Ulrike; Khurana, Tejvir S.			Expression Profiling Reveals Novel Hypoxic Biomarkers in Peripheral Blood of Adult Mice Exposed to Chronic Hypoxia	PLOS ONE			English	Article							LEPTIN GENE-EXPRESSION; INDUCIBLE FACTOR-I; PULMONARY-HYPERTENSION; INTERMITTENT HYPOXIA; ERYTHROPOIETIN; SPECTRIN; RATS; CELLS; ALTITUDE; RECEPTOR	Hypoxia induces a myriad of changes including an increase in hematocrit due to erythropoietin (EPO) mediated erythropoiesis. While hypoxia is of importance physiologically and clinically, lacunae exist in our knowledge of the systemic and temporal changes in gene expression occurring in blood during the exposure and recovery from hypoxia. To identify these changes expression profiling was conducted on blood obtained from cohorts of C57Bl-10 wild type mice that were maintained at normoxia (NX), exposed for two weeks to normobaric chronic hypoxia (CH) or two weeks of CH followed by two weeks of normoxic recovery (REC). Using stringent bioinformatic cut-offs (0% FDR, 2 fold change cut-off), 230 genes were identified and separated into four distinct temporal categories. Class I) contained 1 transcript up-regulated in both CH and REC; Class II) contained 202 transcripts up-regulated in CH but down-regulated after REC; Class III) contained 9 transcripts down-regulated both in CH and REC; Class IV) contained 18 transcripts down-regulated after CH exposure but up-regulated after REC. Profiling was independently validated and extended by analyzing expression levels of selected genes as novel biomarkers from our profile (e.g. spectrin alpha-1, ubiquitin domain family-1 and pyrroline-5-carboxylate reductase-1) by performing qPCR at 7 different time points during CH and REC. Our identification and characterization of these genes define transcriptome level changes occurring during chronic hypoxia and normoxic recovery as well as novel blood biomarkers that may be useful in monitoring a variety of physiological and pathological conditions associated with hypoxia.	[Mosqueira, Matias; Willmann, Gabriel; Zeiger, Ulrike; Khurana, Tejvir S.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Mosqueira, Matias; Willmann, Gabriel; Zeiger, Ulrike; Khurana, Tejvir S.] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Mosqueira, Matias] Heidelberg Univ, Med Biophys Grp, Inst Physiol & Pathophysiol, Heidelberg, Germany; [Willmann, Gabriel] Univ Cologne, Dept Vegetat Physiol, D-50931 Cologne, Germany	University of Pennsylvania; University of Pennsylvania; Ruprecht Karls University Heidelberg; University of Cologne	Mosqueira, M (corresponding author), Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	tsk@mail.med.upenn.edu	Mosqueira, Matias/C-5899-2019	Mosqueira, Matias/0000-0001-7744-9138	Muscular Dystrophy of America; World Anti-Doping Agency	Muscular Dystrophy of America; World Anti-Doping Agency	The research was supported by grants from The Muscular Dystrophy of America (TSK) and the World Anti-Doping Agency (TSK and SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 1970, Int Rev Connect Tissue Res, V5, P1; Ahima RS, 2000, FRONT HORM RES, V26, P42; Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Ambrosini G, 2002, J BIOL CHEM, V277, P34601, DOI 10.1074/jbc.M205172200; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Balbir A, 2007, AM J PHYSIOL-LUNG C, V292, pL704, DOI 10.1152/ajplung.00383.2006; Baze MM, 2010, PHYSL GENOMICS; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Chakrabarti A, 2006, BIOSCIENCE REP, V26, P369, DOI 10.1007/s10540-006-9024-x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dill RP, 2001, MECH AGEING DEV, V122, P533, DOI 10.1016/S0047-6374(01)00216-0; Ebert BL, 1999, BLOOD, V94, P1864; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Fenner BJ, 2009, BBA-PROTEINS PROTEOM, V1794, P1010, DOI 10.1016/j.bbapap.2009.02.013; Fisher JW, 2003, EXP BIOL MED, V228, P1; Forbes WH, 1936, AM J PHYSIOL, V116, P309, DOI 10.1152/ajplegacy.1936.116.2.309; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gaber T, 2009, J RHEUMATOL, V36, P2655, DOI 10.3899/jrheum.090255; Gharib SA, 2010, SLEEP, V33, P1439, DOI 10.1093/sleep/33.11.1439; Gheorghe CP, 2007, REPROD SCI, V14, P223, DOI 10.1177/1933719107302860; Gonzalez-Cinca N, 2004, HORM RES, V62, P191, DOI 10.1159/000080897; Grosfeld A, 2002, J BIOL CHEM, V277, P42953, DOI 10.1074/jbc.M206775200; Hammond EM, 2006, MOL CELL BIOL, V26, P3492, DOI 10.1128/MCB.26.9.3492-3504.2006; HARIK SI, 1994, J APPL PHYSIOL, V77, P896, DOI 10.1152/jappl.1994.77.2.896; HILL NS, 1993, RESP PHYSIOL, V91, P261, DOI 10.1016/0034-5687(93)90104-I; Hoggard N, 1997, P NATL ACAD SCI USA, V94, P11073, DOI 10.1073/pnas.94.20.11073; Houwen B, 2002, CLIN LAB MED, V22, P1, DOI 10.1016/S0272-2712(03)00064-7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JELKMANN W, 1986, RESP PHYSIOL, V63, P257, DOI 10.1016/0034-5687(86)90093-9; Juul SE, 2009, PEDIATR RES, V65, P485, DOI 10.1203/PDR.0b013e31819d90c8; KELLOGG RH, 1978, RESP PHYSIOL, V34, P1, DOI 10.1016/0034-5687(78)90046-4; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koistinen PO, 2000, MED SCI SPORT EXER, V32, P800, DOI 10.1097/00005768-200004000-00012; Komor M, 2005, STEM CELLS, V23, P1154, DOI 10.1634/stemcells.2004-0171; Kwapiszewska G, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-109; Lai Y, 2009, ISLETS, V1, P19, DOI 10.4161/isl.1.1.8530; Mense SM, 2006, PHYSIOL GENOMICS, V25, P435, DOI 10.1152/physiolgenomics.00315.2005; MIYAKE T, 1977, J BIOL CHEM, V252, P5558; Morash B, 1999, ENDOCRINOLOGY, V140, P5995, DOI 10.1210/en.140.12.5995; Mwaikambo BR, 2009, J BIOL CHEM, V284, P26695, DOI 10.1074/jbc.M109.033480; OGAWA Y, 1995, J CLIN INVEST, V96, P1647, DOI 10.1172/JCI118204; OU LC, 1980, EXP HEMATOL, V8, P243; Ou LC, 2004, RESP PHYSIOL NEUROBI, V141, P59, DOI 10.1016/j.resp.2004.04.001; Pascual J, 1996, FEBS LETT, V383, P201, DOI 10.1016/0014-5793(96)00251-7; Pfafflin A, 2006, CELL PHYSIOL BIOCHEM, V18, P199, DOI 10.1159/000097667; PISON CM, 1995, AM J PHYSIOL-ENDOC M, V268, pE965, DOI 10.1152/ajpendo.1995.268.5.E965; Pistilli EE, 2010, AM J PHYSIOL-REG I, V298, pR96, DOI 10.1152/ajpregu.00138.2009; Rogers HM, 2008, EXP HEMATOL, V36, P17, DOI 10.1016/j.exphem.2007.08.014; Roiniotis J, 2009, J IMMUNOL, V182, P7974, DOI 10.4049/jimmunol.0804216; Salim A, 2004, J BIOL CHEM, V279, P40007, DOI 10.1074/jbc.M403715200; Savourey G, 2004, EUR J APPL PHYSIOL, V93, P47, DOI 10.1007/s00421-004-1159-5; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Serghides L, 2003, TRENDS PARASITOL, V19, P461, DOI 10.1016/j.pt.2003.08.006; SHOTTON DM, 1979, J MOL BIOL, V131, P303, DOI 10.1016/0022-2836(79)90078-0; Speicher D W, 1984, Prog Clin Biol Res, V165, P441; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Telen MJ, 2005, TRANSFUS MED REV, V19, P32, DOI 10.1016/j.tmrv.2004.09.006; Telen MJ, 2000, SEMIN HEMATOL, V37, P130, DOI 10.1016/S0037-1963(00)90038-6; van den Beucken T, 2011, RADIOTHER ONCOL, V99, P379, DOI 10.1016/j.radonc.2011.05.058; Vishesh A, 2008, DIABETES OBES METAB, V10, P973, DOI 10.1111/j.1463-1326.2008.00852.x; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Wenger RH, 2000, J EXP BIOL, V203, P1253; Windsor JS, 2007, POSTGRAD MED J, V83, P148, DOI 10.1136/pgmj.2006.049734; XIA Y, 1997, AM J PHYSIOL-REG I, V273, pR1734; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Yang YZ, 2006, INTERNAL MED, V45, P941, DOI 10.2169/internalmedicine.45.1733; YEH GC, 1980, BIOCHEM BIOPH RES CO, V94, P450, DOI 10.1016/0006-291X(80)91252-8; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	70	14	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37497	10.1371/journal.pone.0037497	http://dx.doi.org/10.1371/journal.pone.0037497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629407	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300046
J	Pedrino, GR; Freiria-Oliveira, AH; Colombari, DSA; Rosa, DA; Cravo, SL				Pedrino, Gustavo Rodrigues; Freiria-Oliveira, Andre Henrique; Almeida Colombari, Debora Simoes; Rosa, Daniel Alves; Cravo, Sergio Luiz			A2 Noradrenergic Lesions Prevent Renal Sympathoinhibition Induced by Hypernatremia in Rats	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; HYPERTONIC SALINE INFUSION; SYMPATHETIC-NERVE ACTIVITY; MEDULLARY CATECHOLAMINERGIC NEURONS; SPONTANEOUSLY HYPERTENSIVE-RATS; BLOOD-VOLUME EXPANSION; CARDIOVASCULAR-RESPONSES; VENTROLATERAL MEDULLA; SOLITARY TRACT; HYPOTHALAMIC NEUROENDOCRINE	Renal vasodilation and sympathoinhibition are recognized responses induced by hypernatremia, but the central neural pathways underlying such responses are not yet entirely understood. Several findings suggest that A2 noradrenergic neurons, which are found in the nucleus of the solitary tract (NTS), play a role in the pathways that contribute to body fluid homeostasis and cardiovascular regulation. The purpose of this study was to determine the effects of selective lesions of A2 neurons on the renal vasodilation and sympathoinhibition induced by hypertonic saline (HS) infusion. Male Wistar rats (280-350 g) received an injection into the NTS of anti-dopamine-beta-hydroxylase-saporin (A2 lesion; 6.3 ng in 60 nl; n = 6) or free saporin (sham; 1.3 ng in 60 nl; n = 7). Two weeks later, the rats were anesthetized (urethane 1.2 g.kg(-1) b.wt., i.v.) and the blood pressure, renal blood flow (RBF), renal vascular conductance (RVC) and renal sympathetic nerve activity (RSNA) were recorded. In sham rats, the HS infusion (3 M NaCl, 1.8 ml.kg(-1) b.wt., i.v.) induced transient hypertension (peak at 10 min after HS; 9 +/- 2.7 mmHg) and increases in the RBF and RVC (141 +/- 7.9% and 140 +/- 7.9% of baseline at 60 min after HS, respectively). HS infusion also decreased the RSNA (-45 +/- 5.0% at 10 min after HS) throughout the experimental period. In the A2-lesioned rats, the HS infusion induced transient hypertension (6 +/- 1.4 mmHg at 10 min after HS), as well as increased RBF and RVC (133 +/- 5.2% and 134 +/- 6.9% of baseline at 60 min after HS, respectively). However, in these rats, the HS failed to reduce the RSNA (115 +/- 3.1% at 10 min after HS). The extent of the catecholaminergic lesions was confirmed by immunocytochemistry. These results suggest that A2 noradrenergic neurons are components of the neural pathways regulating the composition of the extracellular fluid compartment and are selectively involved in hypernatremia-induced sympathoinhibition.	[Pedrino, Gustavo Rodrigues; Rosa, Daniel Alves] Univ Fed Goias, Dept Physiol Sci, Goiania, Go, Brazil; [Freiria-Oliveira, Andre Henrique; Almeida Colombari, Debora Simoes] Sao Paulo State Univ, Sch Dent, Dept Physiol & Pathol, Sao Paulo, Brazil; [Cravo, Sergio Luiz] Univ Fed Sao Paulo, Escola Paulista Med, Dept Physiol, Sao Paulo, Brazil	Universidade Federal de Goias; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	Pedrino, GR (corresponding author), Univ Fed Goias, Dept Physiol Sci, Goiania, Go, Brazil.	pedrino@pq.cnpq.br	CRAVO, SERGIO L/K-4104-2012; Freiria-Oliveira, Andre/F-2756-2012; Pedrino, Gustavo R/I-5614-2015; Colombari, Débora/H-2916-2012; Colombari, Débora Simões A./AAG-1794-2021; Rosa, Daniel A/E-5429-2018	CRAVO, SERGIO L/0000-0002-3441-5576; Pedrino, Gustavo R/0000-0003-0488-5400; Colombari, Débora/0000-0003-4331-0271; Colombari, Débora Simões A./0000-0003-4331-0271; Rosa, Daniel A/0000-0002-7036-0840; Freiria-Oliveira, Andre Henrique/0000-0002-7511-5035	Coordenadoria de Aperfeicoamento em Pesquisa (CAPES) [BEX1380/07-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [477832/2010-5]; Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG) [200910267000352]	Coordenadoria de Aperfeicoamento em Pesquisa (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG))	This work was supported by Coordenadoria de Aperfeicoamento em Pesquisa (CAPES; #BEX1380/07-9; www.capes.gov.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; #477832/2010-5; www.cnpq.br) and Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG; #200910267000352; www.fapeg.go.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colombari DSA, 2008, BRAIN RES BULL, V76, P572, DOI 10.1016/j.brainresbull.2008.04.001; ANTUNESRODRIGUES J, 1991, P NATL ACAD SCI USA, V88, P2956, DOI 10.1073/pnas.88.7.2956; ANTUNESRODRIGUES J, 1993, P NATL ACAD SCI USA, V90, P10240, DOI 10.1073/pnas.90.21.10240; Appleyard SM, 2007, J NEUROSCI, V27, P13292, DOI 10.1523/JNEUROSCI.3502-07.2007; ARMSTRONG DM, 1982, J COMP NEUROL, V212, P173, DOI 10.1002/cne.902120207; Bealer SL, 1997, AM J PHYSIOL-REG I, V272, pR1283, DOI 10.1152/ajpregu.1997.272.4.R1283; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Buller KM, 1999, BRAIN RES, V834, P42, DOI 10.1016/S0006-8993(99)01539-5; CIRIELLO J, 1984, AM J PHYSIOL, V246, pR968, DOI 10.1152/ajpregu.1984.246.6.R968; Ciriello J, 1996, BRAIN RES, V726, P227, DOI 10.1016/S0006-8993(96)00474-X; Cravo SL, 2011, BRAZ J MED BIOL RES, V44, P877, DOI 10.1590/S0100-879X2011000900008; CUNNINGHAM ET, 1988, J COMP NEUROL, V274, P60, DOI 10.1002/cne.902740107; DAY TA, 1990, NEUROSCI LETT, V113, P156, DOI 10.1016/0304-3940(90)90296-L; DAY TA, 1992, BRAIN RES, V594, P244, DOI 10.1016/0006-8993(92)91131-W; Duale H, 2007, CARDIOVASC RES, V76, P184, DOI 10.1016/j.cardiores.2007.06.018; FERNANDEZGALAZ C, 1994, BRAIN RES, V636, P227, DOI 10.1016/0006-8993(94)91021-9; Geerling JC, 2007, J COMP NEUROL, V504, P379, DOI 10.1002/cne.21452; Godino A, 2005, NEUROSCIENCE, V133, P493, DOI 10.1016/j.neuroscience.2005.02.035; HOCHSTENBACH SL, 1995, BRAIN RES, V674, P46, DOI 10.1016/0006-8993(94)01434-J; HOCHSTENBACH SL, 1994, AM J PHYSIOL, V266, pR1916, DOI 10.1152/ajpregu.1994.266.6.R1916; Howe BM, 2004, EXP NEUROL, V187, P190, DOI 10.1016/j.expneurol.2004.01.020; KALIA M, 1982, J COMP NEUROL, V211, P248, DOI 10.1002/cne.902110304; Kasparov S, 2008, EXP PHYSIOL, V93, P725, DOI 10.1113/expphysiol.2007.041814; Madden CJ, 1999, AM J PHYSIOL-REG I, V277, pR1063, DOI 10.1152/ajpregu.1999.277.4.R1063; Madden CJ, 2003, AM J PHYSIOL-HEART C, V285, pH2734, DOI 10.1152/ajpheart.00155.2003; May CN, 2000, AM J PHYSIOL-REG I, V279, pR1827, DOI 10.1152/ajpregu.2000.279.5.R1827; Mozaffari MS, 1997, AM J MED SCI, V314, P370, DOI 10.1097/00000441-199712000-00003; Nishida Y, 1998, AM J PHYSIOL-REG I, V274, pR97, DOI 10.1152/ajpregu.1998.274.1.R97; Pedrino GR, 2005, AUTON NEUROSCI-BASIC, V117, P9, DOI 10.1016/j.autneu.2004.09.005; Pedrino GR, 2009, CLIN EXP PHARMACOL P, V36, pe83, DOI 10.1111/j.1440-1681.2009.05280.x; Pedrino GR, 2008, AUTON NEUROSCI-BASIC, V142, P55, DOI 10.1016/j.autneu.2008.06.006; Pedrino GR, 2006, EXP PHYSIOL, V91, P995, DOI 10.1113/expphysiol.2006.034611; RAUCH AL, 1990, AM J PHYSIOL, V258, pR531, DOI 10.1152/ajpregu.1990.258.2.R531; Rinaman L, 1997, NEUROSCIENCE, V79, P1165, DOI 10.1016/S0306-4522(97)00022-5; Rinaman L, 2011, AM J PHYSIOL-REG I, V300, pR222, DOI 10.1152/ajpregu.00556.2010; SAPHIER D, 1993, AM J PHYSIOL, V264, pR891, DOI 10.1152/ajpregu.1993.264.5.R891; SAWCHENKO PE, 1981, SCIENCE, V214, P685, DOI 10.1126/science.7292008; Schoorlemmer GHM, 2000, AM J PHYSIOL-REG I, V278, pR917, DOI 10.1152/ajpregu.2000.278.4.R917; Shi P, 2007, AM J PHYSIOL-REG I, V293, pR2279, DOI 10.1152/ajpregu.00160.2007; SMITH DW, 1995, AM J PHYSIOL-REG I, V268, pR1336, DOI 10.1152/ajpregu.1995.268.5.R1336; Spyer K M, 1981, Rev Physiol Biochem Pharmacol, V88, P24, DOI 10.1007/BFb0034536; Tanaka J, 2003, BRAIN RES BULL, V60, P233, DOI 10.1016/S0361-9230(03)00039-X; Tanaka J, 1997, NEUROREPORT, V8, P3147, DOI 10.1097/00001756-199709290-00028; Toney GM, 2003, ACTA PHYSIOL SCAND, V177, P43, DOI 10.1046/j.1365-201X.2003.01046.x; TUCKER DC, 1987, J COMP NEUROL, V259, P591, DOI 10.1002/cne.902590408; Weiss ML, 1996, J AUTONOM NERV SYST, V57, P109, DOI 10.1016/0165-1838(95)00108-5	46	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37587	10.1371/journal.pone.0037587	http://dx.doi.org/10.1371/journal.pone.0037587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629424	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100039
J	Grietens, KP; Toomer, E; Boock, AU; Hausmann-Muela, S; Peeters, H; Kanobana, K; Gryseels, C; Ribera, JM				Grietens, Koen Peeters; Toomer, Elizabeth; Boock, Alphonse Um; Hausmann-Muela, Susanna; Peeters, Hans; Kanobana, Kirezi; Gryseels, Charlotte; Ribera, Joan Muela			What Role Do Traditional Beliefs Play in Treatment Seeking and Delay for Buruli Ulcer Disease?-Insights from a Mixed Methods Study in Cameroon	PLOS ONE			English	Article							BURDEN	Background: Victims of Buruli ulcer disease (BUD) frequently report to specialized units at a late stage of the disease. This delay has been associated with local beliefs and a preference for traditional healing linked to a reportedly mystical origin of the disease. We assessed the role beliefs play in determining BUD sufferers' choice between traditional and biomedical treatments. Methods: Anthropological fieldwork was conducted in community and clinical settings in the region of Ayos and Akonolinga in Central Cameroon. The research design consisted of a mixed methods study, triangulating a qualitative strand based on ethnographic research and quantitative data obtained through a survey presented to all patients at the Ayos and Akonolinga hospitals (N = 79) at the time of study and in four endemic communities (N = 73) belonging to the hospitals' catchment area. Results: The analysis of BUD sufferers' health-seeking behaviour showed extremely complex therapeutic itineraries, including various attempts and failures both in the biomedical and traditional fields. Contrary to expectations, nearly half of all hospital patients attributed their illness to mystical causes, while traditional healers admitted patients they perceived to be infected by natural causes. Moreover, both patients in hospitals and in communities often combined elements of both types of treatments. Ultimately, perceptions regarding the effectiveness of the treatment, the option for local treatment as a cost prevention strategy and the characteristics of the doctor-patient relationship were more determinant for treatment choice than beliefs. Discussion: The ascription of delay and treatment choice to beliefs constitutes an over-simplification of BUD health-seeking behaviour and places the responsibility directly on the shoulders of BUD sufferers while potentially neglecting other structural elements. While more efficacious treatment in the biomedical sector is likely to reduce perceived mystical involvement in the disease, additional decentralization could constitute a key element to reduce delay and increase adherence to biomedical treatment.	[Grietens, Koen Peeters; Gryseels, Charlotte] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Boock, Alphonse Um] Aide Lepreux Emmaus Suisse, Yaounde, Cameroon; [Grietens, Koen Peeters; Toomer, Elizabeth; Hausmann-Muela, Susanna; Peeters, Hans; Ribera, Joan Muela] PASS Int, Tessenderlo, Belgium; [Peeters, Hans] Univ Leuven, Ctr Sociol Res, Louvain, Belgium; [Kanobana, Kirezi] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM); KU Leuven; Institute of Tropical Medicine (ITM)	Grietens, KP (corresponding author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	kpeeters@itg.be	Ribera, JM/B-8181-2009; Peeters Grietens, Koen/G-7028-2019	Ribera, JM/0000-0003-1042-6024; Peeters Grietens, Koen/0000-0001-6570-9887; muela ribera, joan/0000-0003-2111-6275; Gryseels, Charlotte/0000-0002-8963-4469	Aide aux Lepreux Emmaus Suisse	Aide aux Lepreux Emmaus Suisse	This study funded by Aide aux Lepreux Emmaus Suisse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Anthropological Association, 2018, COD ETH AM ANTHR ASS; American Anthropological Association, STAT ETHN I REV BOAR; Asiedu K, 1998, AM J TROP MED HYG, V59, P1015, DOI 10.4269/ajtmh.1998.59.1015; Aujoulat I, 2003, TROP MED INT HEALTH, V8, P750, DOI 10.1046/j.1365-3156.2003.01089.x; Geissler P W, 1998, Anthropol Med, V5, P63, DOI 10.1080/13648470.1998.9964549; Grietens KP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000321; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Jacobsen KH, 2010, INT J INFECT DIS, V14, pE677, DOI 10.1016/j.ijid.2009.11.013; Johnson P, 2005, PLOS MED, V2, P0282; Kibadi K, 2009, TROP MED INT HEALTH, V14, P1110, DOI 10.1111/j.1365-3156.2009.02324.x; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Muela S H, 1998, Anthropol Med, V5, P43, DOI 10.1080/13648470.1998.9964548; Mulder AA, 2008, T ROY SOC TROP MED H, V102, P912, DOI 10.1016/j.trstmh.2008.05.026; Noeske J, 2004, AM J TROP MED HYG, V70, P520, DOI 10.4269/ajtmh.2004.70.520; Porten K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000466; Pouillot R, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000101; Ribera JM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000445; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Stienstra Y, 2002, AM J TROP MED HYG, V67, P207, DOI 10.4269/ajtmh.2002.67.207; Thomas F, 2008, MED ANTHROPOL, V27, P227, DOI 10.1080/01459740802222716; Um Boock A, 2004, LEPRA AID INTERNAL R; WHO, WHO BUR ULC DIS	22	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36954	10.1371/journal.pone.0036954	http://dx.doi.org/10.1371/journal.pone.0036954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623964	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500041
J	Hong, JR; Talapatra, S; Katz, J; Tester, PA; Waggett, RJ; Place, AR				Hong, Jiarong; Talapatra, Siddharth; Katz, Joseph; Tester, Patricia A.; Waggett, Rebecca J.; Place, Allen R.			Algal Toxins Alter Copepod Feeding Behavior	PLOS ONE			English	Article							DINOFLAGELLATE KARLODINIUM-VENEFICUM; KARENIA-BREVIS; CALANOID COPEPODS; PREY-SELECTION; ACARTIA-TONSA; DISTRIBUTIONS; RESISTANCE; CURRENTS; CAPTURE	Using digital holographic cinematography, we quantify and compare the feeding behavior of free-swimming copepods, Acartia tonsa, on nutritional prey (Storeatula major) to that occurring during exposure to toxic and non-toxic strains of Karenia brevis and Karlodinium veneficum. These two harmful algal species produce polyketide toxins with different modes of action and potency. We distinguish between two different beating modes of the copepod's feeding appendages-a "sampling beating" that has short durations (<100 ms) and involves little fluid entrainment and a longer duration "grazing beating" that persists up to 1200 ms and generates feeding currents. The durations of both beating modes have log-normal distributions. Without prey, A. tonsa only samples the environment at low frequency. Upon introduction of non-toxic food, it increases its sampling time moderately and the grazing period substantially. On mono algal diets for either of the toxic dinoflagellates, sampling time fraction is high but the grazing is very limited. A. tonsa demonstrates aversion to both toxic algal species. In mixtures of S. major and the neurotoxin producing K. brevis, sampling and grazing diminish rapidly, presumably due to neurological effects of consuming brevetoxins while trying to feed on S. major. In contrast, on mixtures of cytotoxin producing K. veneficum, both behavioral modes persist, indicating that intake of karlotoxins does not immediately inhibit the copepod's grazing behavior. These findings add critical insight into how these algal toxins may influence the copepod's feeding behavior, and suggest how some harmful algal species may alter top-down control exerted by grazers like copepods.	[Hong, Jiarong; Talapatra, Siddharth; Katz, Joseph] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Tester, Patricia A.] Natl Ocean & Atmospher Adm, Natl Ocean Serv, Beaufort, NC USA; [Waggett, Rebecca J.] Univ Tampa, Dept Biol, Tampa, FL 33606 USA; [Place, Allen R.] Univ Maryland, Ctr Environm Sci, Inst Marine & Environm Technol, Baltimore, MD 21201 USA	Johns Hopkins University; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; University of Tampa; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	Hong, JR (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	katz@jhu.edu	Place, Allen R/F-9267-2013; Katz, Joseph/A-7624-2010	Katz, Joseph/0000-0001-9067-2473; Hong, Jiarong/0000-0001-7860-2181	National Science Foundation; Office of Naval Research; National Research Council (NRC); Center for Coastal Fisheries and Habitat Research (CCFHR); National Centers for Coastal Ocean Science (NCCOS) of the National Oceanographic and Atmospheric Administration (NOAA); Div Of Chem, Bioeng, Env, & Transp Sys [0923391] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021949] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); National Research Council (NRC); Center for Coastal Fisheries and Habitat Research (CCFHR); National Centers for Coastal Ocean Science (NCCOS) of the National Oceanographic and Atmospheric Administration (NOAA); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support for the Johns Hopkins University (JHU) group has been provided in part by National Science Foundation, and in part by the Office of Naval Research, National Oceanographic Partnership Program (NOPP). Support for RJW was from National Research Council (NRC) Research Associateship Program (RAP) funded by the Center for Coastal Fisheries and Habitat Research (CCFHR) and National Centers for Coastal Ocean Science (NCCOS) of the National Oceanographic and Atmospheric Administration (NOAA). This is contribution #4649 from the University of Maryland Center for Environmental Sciences, contribution #12-231 from the Institute of Marine and Environmental Technology and contribution #685 from the Ecology and Oceanography of Harmful Algal Blooms (ECOHAB) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf JE, 2009, J PHYCOL, V45, P176, DOI 10.1111/j.1529-8817.2008.00641.x; Adolf JE, 2008, HARMFUL ALGAE, V8, P119, DOI 10.1016/j.hal.2008.08.003; AMOORE JE, 1991, CHEM SENSES, V3, P331; Ariens EJ, 1966, ADV DRUG RES, P235; Avery DE, 2007, LIMNOL OCEANOGR, V52, P2099, DOI 10.4319/lo.2007.52.5.2099; Breier CF, 2007, J PLANKTON RES, V29, P115, DOI 10.1093/plankt/fbl075; Colin SP, 2004, EVOL ECOL, V18, P355, DOI 10.1007/s10682-004-2369-3; Deeds JR, 2006, AFR J MAR SCI, V28, P421, DOI 10.2989/18142320609504190; DONAGHAY PL, 1979, MAR BIOL, V52, P137, DOI 10.1007/BF00390421; Dur G, 2011, HYDROBIOLOGIA, V666, P197, DOI 10.1007/s10750-010-0586-z; FRIEDMAN MM, 1975, P NATL ACAD SCI USA, V72, P4185, DOI 10.1073/pnas.72.10.4185; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Glibert PM, 2009, AQUAT MICROB ECOL, V55, P17, DOI 10.3354/ame01279; GREENE CH, 1988, HYDROBIOLOGIA, V167, P295, DOI 10.1007/BF00026317; Hall NS, 2008, ESTUAR COAST, V31, P402, DOI 10.1007/s12237-008-9035-x; HUNTLEY M, 1986, MAR ECOL PROG SER, V28, P105, DOI 10.3354/meps028105; Ives J.D., 1985, P413; IVES JD, 1987, J EXP MAR BIOL ECOL, V112, P131, DOI 10.1016/0022-0981(87)90113-4; JONSSON PR, 1990, MAR ECOL PROG SER, V60, P35, DOI 10.3354/meps060035; Kenakin T., 2006, PHARM PRIMER THEORY; Kiorboe T, 1996, MAR ECOL PROG SER, V143, P65, DOI 10.3354/meps143065; Kiorboe T, 1999, MAR ECOL PROG SER, V179, P97, DOI 10.3354/meps179097; KOCH AL, 1969, J THEOR BIOL, V23, P251, DOI 10.1016/0022-5193(69)90040-X; KOEHL MAR, 1981, LIMNOL OCEANOGR, V26, P1062, DOI 10.4319/lo.1981.26.6.1062; LANCET D, 1993, P NATL ACAD SCI USA, V90, P3715, DOI 10.1073/pnas.90.8.3715; Lester KM, 2008, CONT SHELF RES, V28, P99, DOI 10.1016/j.csr.2007.04.009; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Malkiel E, 2003, J EXP BIOL, V206, P3657, DOI 10.1242/jeb.00586; MENINI A, 1995, NATURE, V373, P435, DOI 10.1038/373435a0; Moore PA, 1999, LIMNOL OCEANOGR, V44, P166, DOI 10.4319/lo.1999.44.1.0166; ROSENBERG GG, 1980, LIMNOL OCEANOGR, V25, P738, DOI 10.4319/lo.1980.25.4.0738; SAIZ E, 1995, MAR ECOL PROG SER, V122, P147, DOI 10.3354/meps122147; Schultz M, 2009, J PLANKTON RES, V31, P553, DOI 10.1093/plankt/fbp010; Sheng J, 2007, P NATL ACAD SCI USA, V104, P17512, DOI 10.1073/pnas.0704658104; Sheng J, 2010, P NATL ACAD SCI USA, V107, P2082, DOI 10.1073/pnas.0912254107; Smayda TJ, 1992, FOOD CHAINS MODELS M, P257; Steinke M, 2006, LIMNOL OCEANOGR, V51, P1925, DOI 10.4319/lo.2006.51.4.1925; STRICKLER JR, 1977, LIMNOL OCEANOGR, V22, P165, DOI 10.4319/lo.1977.22.1.0165; STRICKLER JR, 1982, SCIENCE, V218, P158, DOI 10.1126/science.218.4568.158; Strickler V.R., 1984, P187; Stumpf RP, 2008, CONT SHELF RES, V28, P189, DOI 10.1016/j.csr.2007.04.017; Sunda WG, 2006, J PHYCOL, V42, P963, DOI 10.1111/j.1529-8817.2006.00261.x; Svensen C, 2000, J PLANKTON RES, V22, P1155, DOI 10.1093/plankt/22.6.1155; Teegarden GJ, 1999, MAR ECOL PROG SER, V181, P163, DOI 10.3354/meps181163; Teegarden GJ, 1996, J EXP MAR BIOL ECOL, V196, P145, DOI 10.1016/0022-0981(95)00128-X; Turner J.T., 1989, Coastal and Estuarine Studies, P359; Turner Jefferson T., 1998, NATO ASI Series Series G Ecological Sciences, V41, P453; Vanderploeg Henry A., 1994, P205; Waggett RJ, 2008, MAR ECOL PROG SER, V366, P31, DOI 10.3354/meps07518; Waggett RJ, 2012, MAR ECOL PROG SER, V444, P15, DOI 10.3354/meps09401; Xu WB, 2001, P NATL ACAD SCI USA, V98, P11301, DOI 10.1073/pnas.191361398	51	40	43	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36845	10.1371/journal.pone.0036845	http://dx.doi.org/10.1371/journal.pone.0036845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629336	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500031
J	Nale, JY; Shan, JY; Hickenbotham, PT; Fawley, WN; Wilcox, MH; Clokie, MRJ				Nale, Janet Y.; Shan, Jinyu; Hickenbotham, Peter T.; Fawley, Warren N.; Wilcox, Mark H.; Clokie, Martha R. J.			Diverse Temperate Bacteriophage Carriage in Clostridium difficile 027 Strains	PLOS ONE			English	Article							R-TYPE PYOCIN; PSEUDOMONAS-AERUGINOSA; MOLECULAR CHARACTERIZATION; GENOMIC ORGANIZATION; TOXIN PRODUCTION; PHAGE; INDUCTION; PROPHAGES; EVOLUTION; INFECTION	Background: The hypervirulent Clostridium difficile ribotype 027 can be classified into subtypes, but it unknown if these differ in terms of severity of C. difficile infection (CDI). Genomic studies of C. difficile 027 strains have established that they are rich in mobile genetic elements including prophages. This study combined physiological studies, electron microscopy analysis and molecular biology to determine the potential role of temperate bacteriophages in disease and diversity of C. difficile 027. Methodology/Principal Findings: We induced prophages from 91 clinical C. difficile 027 isolates and used transmission electron microscopy and pulsed-field gel electrophoresis to characterise the bacteriophages present. We established a correlation between phage morphology and subtype. Morphologically distinct tailed bacteriophages belonging to Myoviridae and Siphoviridae were identified in 63 and three isolates, respectively. Dual phage carriage was observed in four isolates. In addition, there were inducible phage tail-like particles (PT-LPs) in all isolates. The capacity of two antibiotics mitomycin C and norfloxacin to induce prophages was compared and it was shown that they induced specific prophages from C. difficile isolates. A PCR assay targeting the capsid gene of the myoviruses was designed to examine molecular diversity of C. difficile myoviruses. Phylogenetic analysis of the capsid gene sequences from eight ribotypes showed that all sequences found in the ribotype 027 isolates were identical and distinct from other C. difficile ribotypes and other bacteria species. Conclusion/Significance: A diverse set of temperate bacteriophages are associated with C. difficile 027. The observed correlation between phage carriage and the subtypes suggests that temperate bacteriophages contribute to the diversity of C. difficile 027 and may play a role in severity of disease associated with this ribotype. The capsid gene can be used as a tool to identify C. difficile myoviruses present within bacterial genomes.	[Nale, Janet Y.; Shan, Jinyu; Hickenbotham, Peter T.; Clokie, Martha R. J.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Fawley, Warren N.; Wilcox, Mark H.] Leeds Teaching Hosp Trust, Leeds Gen Infirm, Dept Microbiol, Old Med Sch, Leeds, W Yorkshire, England; [Clokie, Martha R. J.] Univ Leeds, Leeds, W Yorkshire, England	University of Leicester; Leeds General Infirmary; University of Leeds; University of Leeds	Nale, JY (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	mrjc1@le.ac.uk	Nale, Janet/ADL-6092-2022; Nale, Janet/GSN-8421-2022	Nale, Janet/0000-0003-0501-7402; Clokie, Martha/0000-0002-6069-8936	Medical Research Council New Investigator Research Grant [G0700855]; MRC [G0700855] Funding Source: UKRI; Medical Research Council [G0700855] Funding Source: researchfish	Medical Research Council New Investigator Research Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council New Investigator Research Grant (G0700855) to MRJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; BRADLEY DE, 1965, J GEN MICROBIOL, V41, P233, DOI 10.1099/00221287-41-2-233; Brazier JS, 2008, BRIT J BIOMED SCI, V65, P39, DOI 10.1080/09674845.2008.11732796; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Casjens Sherwood, 2005, P39; Dupuy B, 2008, J MED MICROBIOL, V57, P685, DOI 10.1099/jmm.0.47775-0; Fawley WN, 2008, J CLIN MICROBIOL, V46, P954, DOI 10.1128/JCM.01764-07; Fortier LC, 2007, APPL ENVIRON MICROB, V73, P7358, DOI 10.1128/AEM.00582-07; Goh S, 2005, J MED MICROBIOL, V54, P129, DOI 10.1099/jmm.0.45821-0; Goh S, 2005, APPL ENVIRON MICROB, V71, P1079, DOI 10.1128/AEM.71.2.1079-1083.2005; Goh S, 2007, MICROBIOL-SGM, V153, P676, DOI 10.1099/mic.0.2006/002436-0; Govind R, 2006, J BACTERIOL, V188, P2568, DOI 10.1128/JB.188.7.2568-2577.2006; Govind R, 2009, J VIROL, V83, P12037, DOI 10.1128/JVI.01256-09; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Horgan M, 2010, GENE, V462, P34, DOI 10.1016/j.gene.2010.04.010; INOUE K, 1968, J VIROL, V2, P537, DOI 10.1128/JVI.2.5.537-540.1968; Jenkins Lynda, 2004, Nurs Times, V100, P56; Jones DT, 2005, HDB CLOSTRIDIA, P878; KIRBY EP, 1967, P NATL ACAD SCI USA, V58, P1903, DOI 10.1073/pnas.58.5.1903; Kuijper E J, 2008, Euro Surveill, V13; Lee FKN, 1999, INFECT IMMUN, V67, P717, DOI 10.1128/IAI.67.2.717-725.1999; MAHONEY DE, 1985, J CLIN MICROBIOL, V21, P251, DOI 10.1128/JCM.21.2.251-254.1985; Marsh JW, 2006, J CLIN MICROBIOL, V44, P2558, DOI 10.1128/JCM.02364-05; Matsushiro A, 1999, J BACTERIOL, V181, P2257, DOI 10.1128/JB.181.7.2257-2260.1999; Mayer MJ, 2008, J BACTERIOL, V190, P6734, DOI 10.1128/JB.00686-08; NAGY E, 1991, APMIS, V99, P321, DOI 10.1111/j.1699-0463.1991.tb05156.x; Nakayama K, 2000, MOL MICROBIOL, V38, P213, DOI 10.1046/j.1365-2958.2000.02135.x; OKAMOTO K, 1968, J MOL BIOL, V34, P413, DOI 10.1016/0022-2836(68)90169-1; Romero P, 2004, VIROLOGY, V322, P239, DOI 10.1016/j.virol.2004.01.029; Sambrook J, 2001, MOL CLONING LAB MANU; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sekulovic O, 2011, J BACTERIOL, V193, P2726, DOI 10.1128/JB.00787-10; Smarda J, 2005, APPL ENVIRON MICROB, V71, P8970, DOI 10.1128/AEM.71.12.8970-8973.2005; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; TAKEYA K, 1969, J GEN VIROL, V4, P145, DOI 10.1099/0022-1317-4-2-145; URATANI Y, 1984, J BACTERIOL, V157, P632, DOI 10.1128/JB.157.2.632-636.1984; Zimmer M, 2002, J BACTERIOL, V184, P4359, DOI 10.1128/JB.184.16.4359-4368.2002	39	36	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37263	10.1371/journal.pone.0037263	http://dx.doi.org/10.1371/journal.pone.0037263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624004	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500086
J	Herrmann, J; Elnakady, YA; Wiedmann, RM; Ullrich, A; Rohde, M; Kazmaier, U; Vollmar, AM; Muller, R				Herrmann, Jennifer; Elnakady, Yasser A.; Wiedmann, Romina M.; Ullrich, Angelika; Rohde, Manfred; Kazmaier, Uli; Vollmar, Angelika M.; Mueller, Rolf			Pretubulysin: From Hypothetical Biosynthetic Intermediate to Potential Lead in Tumor Therapy	PLOS ONE			English	Article							BAX CONFORMATIONAL CHANGE; NATURAL-PRODUCTS; DRUG DISCOVERY; BIOLOGICAL-PROPERTIES; ANTICANCER AGENTS; TUBULIN POLYMERIZATION; DNA FRAGMENTATION; GLIDING BACTERIA; FLOW-CYTOMETRY; CYTOCHROME-C	Pretubulysin is a natural product that is found in strains of myxobacteria in only minute amounts. It represents the first enzyme-free intermediate in the biosynthesis of tubulysins and undergoes post-assembly acylation and oxidation reactions. Pretubulysin inhibits the growth of cultured mammalian cells, as do tubulysins, which are already in advanced preclinical development as anticancer and antiangiogenic agents. The mechanism of action of this highly potent compound class involves the depolymerization of microtubules, thereby inducing mitotic arrest. Supply issues with naturally occurring derivatives can now be circumvented by the total synthesis of pretubulysin, which, in contrast to tubulysin, is synthetically accessible in gram-scale quantities. We show that the simplified precursor is nearly equally potent to the parent compound. Pretubulysin induces apoptosis and inhibits cancer cell migration and tubulin assembly in vitro. Consequently, pretubulysin appears to be an ideal candidate for future development in preclinical trials and is a very promising early lead structure in cancer therapy.	[Herrmann, Jennifer; Elnakady, Yasser A.; Mueller, Rolf] Univ Saarland, Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res Saarland, D-6600 Saarbrucken, Germany; [Herrmann, Jennifer; Elnakady, Yasser A.; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-6600 Saarbrucken, Germany; [Wiedmann, Romina M.; Vollmar, Angelika M.] Univ Munich, Dept Pharm, Munich, Germany; [Ullrich, Angelika; Kazmaier, Uli] Univ Saarland, Inst Organ Chem, D-6600 Saarbrucken, Germany; [Rohde, Manfred] Helmholtz Ctr Infect Res, Dept Med Microbiol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Saarland University; University of Munich; Saarland University; Helmholtz Association; Helmholtz-Center for Infection Research	Herrmann, J (corresponding author), Univ Saarland, Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res Saarland, D-6600 Saarbrucken, Germany.	rolf.mueller@helmholtz-hzi.de	Müller, Rolf/B-1559-2008; Elnakady, Yasser A./N-6882-2019; Elnakady, Yasser Abbass/GYJ-1602-2022; Kazmaier, Uli/D-2947-2018	Müller, Rolf/0000-0002-1042-5665; Herrmann, Jennifer/0000-0003-3398-9938	Deutsche Forschungsgemeinschaft [FOR1406]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was provided by the Deutsche Forschungsgemeinschaft (FOR1406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; BHALLA K, 1993, LEUKEMIA, V7, P563; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Blagosklonny MV, 2001, LEUKEMIA, V15, P869, DOI 10.1038/sj.leu.2402134; BOLLAG DM, 1995, CANCER RES, V55, P2325; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Burkhart JL, 2011, EUR J ORG CHEM, V2011, P3050, DOI 10.1002/ejoc.201100155; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Conlin A, 2007, NAT REV DRUG DISCOV, V6, P953, DOI 10.1038/nrd2469; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Domling A, 2005, MOL DIVERS, V9, P141, DOI 10.1007/s11030-005-1542-0; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Elnakady YA, 2004, BIOCHEM PHARMACOL, V67, P927, DOI 10.1016/j.bcp.2003.10.029; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Garcia R, 2010, MOL PHYLOGENET EVOL, V57, P878, DOI 10.1016/j.ympev.2010.08.028; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Gerth K, 2003, J BIOTECHNOL, V106, P233, DOI 10.1016/j.jbiotec.2003.07.015; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hofle G., 1996, ANGEW CHEM, V108, P1671, DOI DOI 10.1098/RSPA.2013.0690; Hopkins CD, 2009, NAT PROD REP, V26, P585, DOI 10.1039/b813799b; IRSCHIK H, 1995, J ANTIBIOT, V48, P31, DOI 10.7164/antibiotics.48.31; IRSCHIK H, 1995, J ANTIBIOT, V48, P962, DOI 10.7164/antibiotics.48.962; JANSEN R, 1994, LIEBIGS ANN CHEM, P759; Khalil MW, 2006, CHEMBIOCHEM, V7, P678, DOI 10.1002/cbic.200500421; Kubicek K, 2010, ANGEW CHEM INT EDIT, V49, P4809, DOI 10.1002/anie.200906828; KUNZE B, 1995, J ANTIBIOT, V48, P1262, DOI 10.7164/antibiotics.48.1262; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Neri D, 2006, CHEMMEDCHEM, V1, P175, DOI 10.1002/cmdc.200500043; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Palmer TD, 2011, ADV DRUG DELIVER REV, V63, P568, DOI 10.1016/j.addr.2011.04.008; Peltier HM, 2006, J AM CHEM SOC, V128, P16018, DOI 10.1021/ja067177z; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Sandmann A, 2004, CHEM BIOL, V11, P1071, DOI 10.1016/j.chembiol.2004.05.014; SASSE F, 1993, J ANTIBIOT, V46, P741, DOI 10.7164/antibiotics.46.741; Sasse F, 2000, J ANTIBIOT, V53, P879, DOI 10.7164/antibiotics.53.879; SLOBODA RD, 1976, BIOCHEMISTRY-US, V15, P4497, DOI 10.1021/bi00665a026; Steinmetz H, 2004, ANGEW CHEM INT EDIT, V43, P4888, DOI 10.1002/anie.200460147; Ullrich A, 2009, EUR J ORG CHEM, V2009, P6367, DOI 10.1002/ejoc.200900999; Ullrich A, 2009, ANGEW CHEM INT EDIT, V48, P4422, DOI 10.1002/anie.200900406; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Wang ZY, 2007, CHEM BIOL DRUG DES, V70, P75, DOI 10.1111/j.1747-0285.2007.00541.x; Weiderhold KN, 2006, INT J CANCER, V118, P1032, DOI 10.1002/ijc.21424; Weissman KJ, 2010, NAT PROD REP, V27, P1276, DOI 10.1039/c001260m; Wenzel SC, 2009, CURR OPIN DRUG DISC, V12, P220; Yamaguchi H, 2002, J BIOL CHEM, V277, P41604, DOI 10.1074/jbc.M207516200; Yamaguchi H, 2002, CANCER RES, V62, P466; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	56	34	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37416	10.1371/journal.pone.0037416	http://dx.doi.org/10.1371/journal.pone.0037416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22616003	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341200074
J	Baker, AM; Bird, D; Lang, G; Cox, TR; Erler, JT				Baker, A-M; Bird, D.; Lang, G.; Cox, T. R.; Erler, J. T.			Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK	ONCOGENE			English	Article						colorectal cancer; metastasis; lysyl oxidase; focal adhesion kinase	FOCAL ADHESION KINASE; TUMOR-GROWTH; METASTASIS; TENSION; CELLS; SRC	The extracellular, matrix-modifying enzyme lysyl oxidase (LOX) has recently been linked to colorectal cancer (CRC) progression, in particular to the stages of invasion and metastasis. In this report, we use cell lines expressing a catalytically inactive mutant form of LOX to show that catalytic activity is required for LOX-mediated effects on proliferation and invasion in both in vitro and in vivo models of CRC. Furthermore, we use rheology to measure the relative stiffness of modified collagen matrices and subcutaneous tumors, and show that LOX-induced collagen cross-linking results in stiffening of the matrix both in vitro and in vivo. We observe a strong association between matrix stiffness and activation of the FAK (focal adhesion kinase)/SRC-signaling pathway, with a stiffer environment resulting in increased FAK/SRC phosphorylation and a more proliferative and invasive phenotype. We are the first to show a direct relationship between LOX enzymatic activity and tissue stiffness, and to demonstrate a role for stiffness in driving CRC progression. Our findings provide significant evidence to suggest that therapeutic inhibition of LOX activity may provide a novel effective treatment option for patients with metastatic CRC. Oncogene (2013) 32, 1863-1868; doi: 10.1038/onc.2012.202; published online 28 May 2012	[Baker, A-M; Bird, D.; Lang, G.; Cox, T. R.; Erler, J. T.] Inst Canc Res, Div Canc Biol, Hypoxia & Metastasis Team, London SW3 6JB, England; [Bird, D.; Lang, G.; Cox, T. R.; Erler, J. T.] Inst Canc Res, Div Canc Biol, CRUK Tumour Cell Signalling Unit, London SW3 6JB, England; [Cox, T. R.; Erler, J. T.] Univ Copenhagen, BRIC, DK-2200 Copenhagen N, Denmark	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Copenhagen	Erler, JT (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	janine.erler@bric.ku.dk		Baker, Ann-Marie/0000-0001-8905-9137; Cox, Thomas/0000-0001-9294-1745; Erler, Janine/0000-0001-8675-6527	Medical Research Council [G0800102]; Institute of Cancer Research, Cancer Research UK [C107/A10433]; BRIC; Worldwide Cancer Research [09-0796] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Cancer Research, Cancer Research UK(Cancer Research UK); BRIC; Worldwide Cancer Research	We would like to thank the staff of the BSU and histopathology departments at the Institute of Cancer Research for assistance with in vivo work and processing of tissue samples. Funding was provided by the Medical Research Council (G0800102 to AMB), the Institute of Cancer Research (JTE), Cancer Research UK (C107/A10433 to TRC, DB, GL and JTE) and BRIC (TRC and JTE).	Baker AM, 2011, JNCI-J NATL CANCER I, V103, P407, DOI 10.1093/jnci/djq569; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Colpaert C, 2001, AM J SURG PATHOL, V25, P1557, DOI 10.1097/00000478-200112000-00016; Csiszar K, 2002, INT J CANCER, V97, P636, DOI 10.1002/ijc.10035; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Kim Y, 2009, ONCOL REP, V22, P799, DOI 10.3892/or_00000502; Le QT, 2009, J CLIN ONCOL, V27, P4281, DOI 10.1200/JCO.2008.20.6003; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Pez F, 2011, CANCER RES, V71, P1647, DOI 10.1158/0008-5472.CAN-10-1516; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Sinkus R, 2000, PHYS MED BIOL, V45, P1649, DOI 10.1088/0031-9155/45/6/317; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002	18	198	202	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2013	32	14					1863	1868		10.1038/onc.2012.202	http://dx.doi.org/10.1038/onc.2012.202			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	118RQ	22641216				2022-12-25	WOS:000317043900012
J	Zhang, YY; Li, F; Patterson, AD; Wang, Y; Krausz, KW; Neale, G; Thomas, S; Nachagari, D; Vogel, P; Vore, M; Gonzalez, FJ; Schuetz, JD				Zhang, Yuanyuan; Li, Fei; Patterson, Andrew D.; Wang, Yao; Krausz, Kristopher W.; Neale, Geoffrey; Thomas, Sarah; Nachagari, Deepa; Vogel, Peter; Vore, Mary; Gonzalez, Frank J.; Schuetz, John D.			Abcb11 Deficiency Induces Cholestasis Coupled to Impaired beta-Fatty Acid Oxidation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT EXPORT PUMP; FAMILIAL INTRAHEPATIC CHOLESTASIS; FARNESOID-X-RECEPTOR; P-GLYCOPROTEIN; KNOCKOUT MICE; BILE-ACIDS; MOLECULAR-MECHANISMS; NUCLEAR RECEPTOR; EXPRESSION; LIVER	The bile salt export pump (BSEP) is an ATP-binding cassette transporter that serves as the primary system for removing bile salts from the liver. In humans, deficiency of BSEP, which is encoded by the ABCB11 gene, causes severe progressive cholestatic liver disease from early infancy. In previous studies of Abcb11 deficiency in mice generated on a mixed genetic background, the animals did not recapitulate the human disease. We reasoned that ABCB11 deficiency may cause unique changes in hepatic metabolism that are predictive of liver injury. To test this possibility, we first determined that Abcb11 knock-out (KO) C57BL/6J mice recapitulate human deficiency. Before the onset of cholestasis, Abcb11 KO mice have altered hepatic lipid metabolism coupled with reduced expression of genes important in mitochondrial fatty acid oxidation. This was associated with increased serum free-fatty acids, reduced total white adipose, and marked impairment of long-chain fatty acid beta-oxidation. Importantly, metabolomic analysis confirmed that Abcb11 KO mice have impaired mitochondrial fatty acid beta-oxidation with the elevated fatty acid metabolites phenylpropionylglycine and phenylacetylglycine. These metabolic changes precede cholestasis but may be of relevance to cholestatic disease progression because altered fatty acid metabolism can enhance reactive oxygen species that might exacerbate cholestatic liver damage.	[Zhang, Yuanyuan; Wang, Yao; Thomas, Sarah; Nachagari, Deepa; Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Li, Fei; Patterson, Andrew D.; Krausz, Kristopher W.; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20852 USA; [Vore, Mary] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40506 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Kentucky	Schuetz, JD (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, MS 313,262 Danny Thomas Pl, Memphis, TN 38105 USA.	John.Schuetz@stjude.org	Schuetz, John D/N-2692-2018; Li, Fei/F-6849-2013; zhang, yuanyuan/GYA-4428-2022; Vogel, Peter/N-2490-2018; Patterson, Andrew/G-3852-2012; Patterson, Andrew/ABF-1575-2020	Vogel, Peter/0000-0002-7535-0545; Patterson, Andrew/0000-0003-2073-0070; Patterson, Andrew/0000-0003-2073-0070	National Institutes of Health [2R01-GM60904, R21HL114066, P30 CA21745, CA21865]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [ZIABC005562, ZIABC005708, R01CA194206] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL114066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01-GM60904, R21HL114066, P30 CA21745, and CA21865. This work was also supported by the American Lebanese Syrian Associated Charities.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Chen WM, 2008, J CLIN INVEST, V118, P2620, DOI 10.1172/JCI34566; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Cho HY, 2004, FASEB J, V18, P1258, DOI 10.1096/fj.03-1127fje; Cho JY, 2010, J LIPID RES, V51, P1063, DOI 10.1194/jlr.M002923; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Desvergne B, 2007, BBA-MOL CELL BIOL L, V1771, P913, DOI 10.1016/j.bbalip.2007.07.005; Evason K, 2011, AM J SURG PATHOL, V35, P687, DOI 10.1097/PAS.0b013e318212ec87; FALANY CN, 1994, J BIOL CHEM, V269, P19375; Fromenty B, 1997, J HEPATOL, V26, P43, DOI 10.1016/S0168-8278(97)80496-5; GREGO AV, 1995, CLIN NUTR, V14, P143, DOI 10.1016/S0261-5614(95)80011-5; Hardwick JP, 2009, PPAR RES, V2009, DOI 10.1155/2009/952734; Hayashi H, 2005, HEPATOLOGY, V41, P916, DOI 10.1002/hep.20627; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; HOFMANN AF, 1967, ANNU REV MED, V18, P333, DOI 10.1146/annurev.me.18.020167.002001; Holloway GP, 2011, J PHYSIOL-LONDON, V589, P169, DOI 10.1113/jphysiol.2010.198663; Holloway GP, 2009, AM J PHYSIOL-REG I, V297, pR960, DOI 10.1152/ajpregu.91021.2008; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jansen PLM, 1999, GASTROENTEROLOGY, V117, P1370, DOI 10.1016/S0016-5085(99)70287-8; Kagawa T, 2008, AM J PHYSIOL-GASTR L, V294, pG58, DOI 10.1152/ajpgi.00367.2007; Knisely AS, 2006, HEPATOLOGY, V44, P478, DOI 10.1002/hep.21287; Lam P, 2005, BIOCHEMISTRY-US, V44, P12598, DOI 10.1021/bi050943e; Lam P, 2007, AM J PHYSIOL-CELL PH, V293, pC1709, DOI 10.1152/ajpcell.00327.2007; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lewis D F, 2001, ScientificWorldJournal, V1, P151; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Muhfeld A, 2003, ARCH BIOCHEM BIOPHYS, V413, P32, DOI 10.1016/S0003-9861(03)00098-5; Narayan SB, 2005, CLIN CHEM, V51, P644, DOI 10.1373/clinchem.2004.045005; Noe J, 2005, J HEPATOL, V43, P536, DOI 10.1016/j.jhep.2005.05.020; Perwaiz S, 2003, J LIPID RES, V44, P494, DOI 10.1194/jlr.M200394-JLR200; PETTERSEN JE, 1972, CLIN CHIM ACTA, V38, P17, DOI 10.1016/0009-8981(72)90202-1; PREISS B, 1964, J BIOL CHEM, V239, P85; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; RINALDO P, 1988, NEW ENGL J MED, V319, P1308, DOI 10.1056/NEJM198811173192003; Savkur RS, 2005, BIOCHEM BIOPH RES CO, V329, P391, DOI 10.1016/j.bbrc.2005.01.141; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; Smith BK, 2011, BIOCHEM J, V437, P125, DOI 10.1042/BJ20101861; Stieger B, 2007, PFLUG ARCH EUR J PHY, V453, P611, DOI 10.1007/s00424-006-0152-8; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Talanian JL, 2010, AM J PHYSIOL-ENDOC M, V299, pE180, DOI 10.1152/ajpendo.00073.2010; TIMBRELL JA, 1995, GEN PHARMACOL-VASC S, V26, P453, DOI 10.1016/0306-3623(94)00203-Y; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wang RX, 2003, HEPATOLOGY, V38, P1489, DOI 10.1016/j.hep.2003.09.037; Wang RX, 2001, P NATL ACAD SCI USA, V98, P2011, DOI 10.1073/pnas.031465498; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	55	50	75	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24784	24794		10.1074/jbc.M111.329318	http://dx.doi.org/10.1074/jbc.M111.329318			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22619174	Green Published, hybrid			2022-12-25	WOS:000306651100071
J	Shioda, N; Ishikawa, K; Tagashira, H; Ishizuka, T; Yawo, H; Fukunaga, K				Shioda, Norifumi; Ishikawa, Kiyoshi; Tagashira, Hideaki; Ishizuka, Toru; Yawo, Hiromu; Fukunaga, Kohji			Expression of a Truncated Form of the Endoplasmic Reticulum Chaperone Protein, sigma 1 Receptor, Promotes Mitochondrial Energy Depletion and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL TRISPHOSPHATE RECEPTOR; CELL-DEATH; MOUSE-BRAIN; LIGAND-BINDING; CA2+; AUTOPHAGY; CALCIUM; ISCHEMIA; CHANNELS; CLONING	The sigma 1 receptor (sigma R-1) regulates endoplasmic reticulum (ER)/mitochondrial interorganellar Ca2+ mobilization through the inositol 1,4,5-trisphosphate receptor (IP3R). Here, we observed that expression of a novel splice variant of sigma R-1, termed short form sigma R-1 (sigma 1SR), has a detrimental effect on mitochondrial energy production and cell survival. sigma 1SR mRNA lacks 47 ribo-nucleotides encoding exon 2, resulting in a frameshift and formation of a truncated receptor. sigma 1SR localizes primarily in the ER at perinuclear regions and forms a complex with sigma R-1 but not with IP3R in the mitochondrion-associated ER membrane. Overexpression of both sigma R-1 and the truncated isoform promotes mitochondrial elongation with increased ER mitochondrial contact surface. sigma R-1 overexpression increases the efficiency of mitochondrial Ca2+ uptake in response to IP3R-driven stimuli, whereas sigma 1SR overexpression reduces it. Most importantly, sigma R-1 promotes ATP production via increased mitochondrial Ca2+ uptake, promoting cell survival in the presence of ER stress. By contrast, sigma 1SR suppresses ATP production following ER stress, enhancing cell death. Taken together, the newly identified sigma 1SR isoform interferes with sigma R-1 function relevant to mitochondrial energy production under ER stress conditions, promoting cellular apoptosis.	[Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808577, Japan	Tohoku University; Tohoku University	Fukunaga, K (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Aoba Ku, 6-3 Aramaki Aoba, Sendai, Miyagi 9808578, Japan.	kfukunaga@m.tohoku.ac.jp	Ishizuka, Toru/L-8191-2017; Fukunaga, Kohji/AAI-8811-2021; Yawo, Hiromu/I-4871-2015	Ishizuka, Toru/0000-0003-4405-8792; Yawo, Hiromu/0000-0002-4299-3288; Fukunaga, Kohji/0000-0001-8526-2824; Ishikawa, Kiyoshi/0000-0001-5816-1948	Ministry of Education, Science, Sports and Culture of Japan; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency [22390109, 24659024, 23790072, 23110501]; Smoking Research Foundation; Grants-in-Aid for Scientific Research [24659024] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Smoking Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research on innovative areas (Foundation of Synapse and Neurocircuit Pathology), Grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan and Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, 22390109 and 24659024 (to K. F.) and 23790072 and 23110501 (to N. S.), and from the Smoking Research Foundation (to K. F.).	Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Celsi F, 2009, BBA-BIOENERGETICS, V1787, P335, DOI 10.1016/j.bbabio.2009.02.021; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Criollo A, 2007, AUTOPHAGY, V3, P350, DOI 10.4161/auto.4077; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Decuypere JP, 2011, BBA-MOL CELL RES, V1813, P1003, DOI 10.1016/j.bbamcr.2010.11.023; Ganapathy ME, 1999, J PHARMACOL EXP THER, V289, P251; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hajnoczky G, 2000, J BIOENERG BIOMEMBR, V32, P15, DOI 10.1023/A:1005504210587; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hanson CJ, 2004, CURR BIOL, V14, pR933, DOI 10.1016/j.cub.2004.10.019; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P718, DOI 10.1124/jpet.103.051284; Hayashi T, 2000, J PHARMACOL EXP THER, V293, P788; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; HELLEWELL SB, 1994, EUR J PHARM-MOLEC PH, V268, P9, DOI 10.1016/0922-4106(94)90115-5; Jahani-Asl A, 2007, J BIOL CHEM, V282, P23788, DOI 10.1074/jbc.M703812200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kekuda R, 1996, BIOCHEM BIOPH RES CO, V229, P553, DOI 10.1006/bbrc.1996.1842; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Luty AA, 2010, ANN NEUROL, V68, P639, DOI 10.1002/ana.22274; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Martina M, 2007, J PHYSIOL-LONDON, V578, P143, DOI 10.1113/jphysiol.2006.116178; Maurice T, 1997, PROG NEURO-PSYCHOPH, V21, P69, DOI 10.1016/S0278-5846(96)00160-1; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Schetz JA, 2007, BRAIN RES, V1181, P1, DOI 10.1016/j.brainres.2007.08.068; Seth P, 1997, BIOCHEM BIOPH RES CO, V241, P535, DOI 10.1006/bbrc.1997.7840; Shioda N, 2008, NEUROSCIENCE, V155, P876, DOI 10.1016/j.neuroscience.2008.05.056; Shioda N, 2006, J NEUROCHEM, V98, P310, DOI 10.1111/j.1471-4159.2006.03874.x; Shioda N, 2011, J NEUROSCI, V31, P346, DOI 10.1523/JNEUROSCI.4816-10.2011; Shioda N, 2010, J NEUROSCI, V30, P3146, DOI 10.1523/JNEUROSCI.4140-09.2010; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Tagashira H, 2010, AM J PHYSIOL-HEART C, V299, pH1535, DOI 10.1152/ajpheart.00198.2010; Takebayashi M, 2002, J PHARMACOL EXP THER, V303, P1227, DOI 10.1124/jpet.102.041970; Takeuchi Y, 2003, J NEUROCHEM, V85, P1064, DOI 10.1046/j.1471-4159.2003.01763.x; Tanimura A, 1996, J BIOL CHEM, V271, P30904, DOI 10.1074/jbc.271.48.30904; Urani A, 2004, EUR J PHARMACOL, V486, P151, DOI 10.1016/j.ejphar.2003.12.018; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vicencio JM, 2009, CELL DEATH DIFFER, V16, P1006, DOI 10.1038/cdd.2009.34; Wu ZP, 2008, J BIOL CHEM, V283, P28198, DOI 10.1074/jbc.M802099200	56	61	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23318	23331		10.1074/jbc.M112.349142	http://dx.doi.org/10.1074/jbc.M112.349142			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22619170	hybrid, Green Published			2022-12-25	WOS:000306511300006
J	Gao, Y; Li, YF; Guo, X; Wu, ZG; Zhang, W				Gao, Yan; Li, Yanfeng; Guo, Xing; Wu, Zhenguo; Zhang, Wei			Loss of STAT1 in Bone Marrow-Derived Cells Accelerates Skeletal Muscle Regeneration	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SATELLITE-CELL; MYOGENIC DIFFERENTIATION; TARGETED DISRUPTION; GROWTH-FACTOR; STEM-CELL; TNF-ALPHA; IN-VIVO; MICE; PROLIFERATION	Background: Skeletal muscle regeneration is a complex process which is not yet completely understood. Evidence suggested that the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway may have a role in myogenesis. In this study, we aim to explore the possible role of STAT1 in muscle regeneration. Methods: Wild-type and STAT1 knockout mice were used in this study. Tibialis anterior muscle injury was conducted by cardiotoxin (CTX) injection. Bone marrow transplantation and glucocorticoid treatment were performed to manipulate the immune system of the mice. Results: Muscle regeneration was accelerated in STAT1-/- mice after CTX injury. Bone marrow transplantation experiments showed that the regeneration process relied on the type of donor mice rather than on recipient mice. Levels of pro-inflammatory cytokines, TNF alpha and IL-1 beta, were significantly higher in STAT1-/- mice at 1 day and/ or 2 days post-injury, while levels of anti-inflammatory cytokine, IL-10, were lower in STAT1-/- mice at 2 days and 3 days post-injury. Levels of IGF-1 were significantly higher in the STAT1-/- mice at 1 day and 2 days post-injury. Furthermore, the muscle regeneration process was inhibited in glucocorticoid-treated mice. Conclusions: Loss of STAT1 in bone marrow-derived cells accelerates skeletal muscle regeneration.	[Gao, Yan; Li, Yanfeng; Guo, Xing; Wu, Zhenguo; Zhang, Wei] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Gao, Yan] Capital Med Univ, Dept Anat, Beijing, Peoples R China; [Wu, Zhenguo; Zhang, Wei] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Guangdong, Peoples R China; [Zhang, Wei] Ji Nan Univ, Coll Pharm, Ji Nan Univ Hong Kong Univ Sci & Technol Joint La, Guangzhou, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Capital Medical University; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Hong Kong University of Science & Technology; Jinan University	Gao, Y (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	zhangweisapce@gmail.com; bczgwu@ust.hk	li, yan/GTI-4638-2022	Wu, Zhenguo/0000-0003-3049-8324	Guangdong Natural Science Foundation [10451063201005367]; Shenzhen Science and Technology Project [JC200903180682A]; Beijing Natural Science Foundation [5102008]; Beijing Municipal Commission of Education [KM201010025003]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Shenzhen Science and Technology Project; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education)	The study was supported by the Research Grants of Guangdong Natural Science Foundation (10451063201005367), Shenzhen Science and Technology Project (JC200903180682A), Beijing Natural Science Foundation (5102008) and Scientific Research Common Program of Beijing Municipal Commission of Education (KM201010025003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Belcastro AN, 1996, J APPL PHYSIOL, V80, P1331, DOI 10.1152/jappl.1996.80.4.1331; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Collins RA, 2001, J HISTOCHEM CYTOCHEM, V49, P989, DOI 10.1177/002215540104900807; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FIELDING RA, 1993, AM J PHYSIOL, V265, pR166, DOI 10.1152/ajpregu.1993.265.1.R166; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058; GROUNDS MD, 1987, J PATHOL, V153, P71, DOI 10.1002/path.1711530110; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022; Ivashkiv L B, 2000, Rev Immunogenet, V2, P220; Kami K, 2002, J HISTOCHEM CYTOCHEM, V50, P1579, DOI 10.1177/002215540205001202; Kataoka Y, 2003, J BIOL CHEM, V278, P44178, DOI 10.1074/jbc.M304884200; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Launay T, 2001, J HISTOCHEM CYTOCHEM, V49, P887, DOI 10.1177/002215540104900709; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Menetrey J, 2000, J BONE JOINT SURG BR, V82B, P131, DOI 10.1302/0301-620X.82B1.8954; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Motoda L, 2007, STEM CELLS, V25, P2976, DOI 10.1634/stemcells.2007-0061; Nguyen HX, 2003, J PHYSIOL-LONDON, V547, P125, DOI 10.1113/jphysiol.2002.031450; Philippou A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P208; Ruzek MC, 1999, J IMMUNOL, V162, P3527; Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Spangenburg EE, 2002, AM J PHYSIOL-CELL PH, V283, pC204, DOI 10.1152/ajpcell.00574.2001; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; Teixeira CFP, 2003, MUSCLE NERVE, V28, P449, DOI 10.1002/mus.10453; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Wozniak AC, 2005, MUSCLE NERVE, V31, P283, DOI 10.1002/mus.20263; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Zador E, 2001, MUSCLE NERVE, V24, P1058, DOI 10.1002/mus.1110; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	41	5	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37656	10.1371/journal.pone.0037656	http://dx.doi.org/10.1371/journal.pone.0037656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649549	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335800068
J	Vang, LL; Medvedev, AV; Adler, J				Vang, Lar L.; Medvedev, Alexei V.; Adler, Julius			Simple Ways to Measure Behavioral Responses of Drosophila to Stimuli and Use of These Methods to Characterize a Novel Mutant	PLOS ONE			English	Article							ADULT DROSOPHILA; CENTRAL COMPLEX; GENETIC-ANALYSIS; TRP CHANNELS; TASTE; GRAVITY; PERCEPTION; HYGROSENSATION; IDENTIFICATION; MELANOGASTER	The behavioral responses of adult Drosophila fruit flies to a variety of sensory stimuli - light, volatile and non-volatile chemicals, temperature, humidity, gravity, and sound - have been measured by others previously. Some of those assays are rather complex; a review of them is presented in the Discussion. Our objective here has been to find out how to measure the behavior of adult Drosophila fruit flies by methods that are inexpensive and easy to carry out. These new assays have now been used here to characterize a novel mutant that fails to be attracted or repelled by a variety of sensory stimuli even though it is motile.	[Vang, Lar L.; Medvedev, Alexei V.; Adler, Julius] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Vang, Lar L.; Medvedev, Alexei V.; Adler, Julius] Univ Wisconsin, Dept Genet, Madison, WI 53705 USA; [Medvedev, Alexei V.] Georgetown Univ, Dept Microbiol & Immunol, Washington, DC USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Georgetown University	Vang, LL (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	adler@biochem.wisc.edu			Camille and Henry Dreyfus Foundation	Camille and Henry Dreyfus Foundation	Julius Adler is grateful to The Camille and Henry Dreyfus Foundation for supporting our research by undergraduates the past six years by means of the Senior Scientist Mentor Program. We thank Laura Vanderploeg for the art work.	Adler J, 2011, ANNU REV BIOCHEM, V80, P42, DOI 10.1146/annurev-biochem-121609-100316; Amrein H, 2005, CURR BIOL, V15, pR673, DOI 10.1016/j.cub.2005.08.021; Anholt RRH, 2001, CHEM SENSES, V26, P215, DOI 10.1093/chemse/26.2.215; Armstrong JD, 2006, GENES BRAIN BEHAV, V5, P222, DOI 10.1111/j.1601-183X.2005.00154.x; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Baker DA, 2007, J COMP NEUROL, V501, P756, DOI 10.1002/cne.21257; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BORST A, 1982, J COMP PHYSIOL, V147, P479, DOI 10.1007/BF00612013; Borst A, 2009, CURR BIOL, V19, pR36, DOI 10.1016/j.cub.2008.11.001; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Carpenter FW, 1905, AM NAT, V39, P157, DOI 10.1086/278502; Desroches CE, 2010, GENET RES, V92, P167, DOI 10.1017/S0016672310000194; Devaud JM, 2003, BEHAV PROCESS, V64, P177, DOI 10.1016/S0376-6357(03)00134-7; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; FALK R, 1975, NATURE, V254, P325, DOI 10.1038/254325a0; Frechter S, 2007, J NEUROSCI, V27, P5571, DOI 10.1523/JNEUROSCI.0310-07.2007; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hardie RC, 2012, WILEY INTERDISCIPLIN, V1, P162, DOI [10.1002/wmts.20, DOI 10.1002/WMTS.20]; HEISENBERG M, 1994, FORTS ZOOL, V39, P61; HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143; HEISENBERG M, 1972, J COMP PHYSIOL, V80, P119, DOI 10.1007/BF00696485; HELFAND SL, 1989, P NATL ACAD SCI USA, V86, P2908, DOI 10.1073/pnas.86.8.2908; HIRSCH J, 1959, J COMP PHYSIOL PSYCH, V52, P304, DOI 10.1037/h0043498; Inagaki HK, 2010, NAT PROTOC, V5, P20, DOI 10.1038/nprot.2009.196; Inoshita T, 2006, P NATL ACAD SCI USA, V103, P1094, DOI 10.1073/pnas.0502376103; Ishimoto H, 2004, CELL MOL LIFE SCI, V61, P10, DOI 10.1007/s00018-003-3182-9; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; LEFFELAAR D, 1984, DEV GENET, V4, P211; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Martin JR, 1999, J COMP PHYSIOL A, V184, P73, DOI 10.1007/s003590050307; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; McEwen RS, 1918, J EXP ZOOL, V25, P49, DOI 10.1002/jez.1400250103; McKemy DD, 2007, PFLUG ARCH EUR J PHY, V454, P777, DOI 10.1007/s00424-006-0199-6; MCKENNA M, 1989, P NATL ACAD SCI USA, V86, P8118, DOI 10.1073/pnas.86.20.8118; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Pak WL, 2010, J NEUROGENET, V24, P55, DOI 10.3109/01677061003797302; PAK WL, 1969, NATURE, V222, P351, DOI 10.1038/222351a0; Poeck B, 2008, DEV NEUROBIOL, V68, P1046, DOI 10.1002/dneu.20643; RODRIGUES V, 1978, P INDIAN ACAD SCI B, V87, P147; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; STRAUSS R, 1995, J NEUROGENET, V10, P53; Strauss R, 1955, NERV SYST BEHAV P 4; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; TANIMURA T, 1982, J COMP PHYSIOL, V147, P433, DOI 10.1007/BF00612007; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; WOODARD C, 1989, GENETICS, V123, P315; Xu SY, 2006, GENES BRAIN BEHAV, V5, P602, DOI 10.1111/j.1601-183X.2006.00213.x	60	17	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37495	10.1371/journal.pone.0037495	http://dx.doi.org/10.1371/journal.pone.0037495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649531	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335800049
J	Xu, CG; Fisher, R; Wullschleger, SD; Wilson, CJ; Cai, M; McDowell, NG				Xu, Chonggang; Fisher, Rosie; Wullschleger, Stan D.; Wilson, Cathy J.; Cai, Michael; McDowell, Nate G.			Toward a Mechanistic Modeling of Nitrogen Limitation on Vegetation Dynamics	PLOS ONE			English	Article							ELEVATED CO2; PHOTOSYNTHETIC ACCLIMATION; STOMATAL CONDUCTANCE; GROWTH TEMPERATURE; LIGHT GRADIENTS; SHADE TOLERANCE; LEAF NITROGEN; PLANT-GROWTH; CARBON GAIN; PINUS-TAEDA	Nitrogen is a dominant regulator of vegetation dynamics, net primary production, and terrestrial carbon cycles; however, most ecosystem models use a rather simplistic relationship between leaf nitrogen content and photosynthetic capacity. Such an approach does not consider how patterns of nitrogen allocation may change with differences in light intensity, growing-season temperature and CO2 concentration. To account for this known variability in nitrogen-photosynthesis relationships, we develop a mechanistic nitrogen allocation model based on a trade-off of nitrogen allocated between growth and storage, and an optimization of nitrogen allocated among light capture, electron transport, carboxylation, and respiration. The developed model is able to predict the acclimation of photosynthetic capacity to changes in CO2 concentration, temperature, and radiation when evaluated against published data of V-c,V-max (maximum carboxylation rate) and J(max) (maximum electron transport rate). A sensitivity analysis of the model for herbaceous plants, deciduous and evergreen trees implies that elevated CO2 concentrations lead to lower allocation of nitrogen to carboxylation but higher allocation to storage. Higher growing-season temperatures cause lower allocation of nitrogen to carboxylation, due to higher nitrogen requirements for light capture pigments and for storage. Lower levels of radiation have a much stronger effect on allocation of nitrogen to carboxylation for herbaceous plants than for trees, resulting from higher nitrogen requirements for light capture for herbaceous plants. As far as we know, this is the first model of complete nitrogen allocation that simultaneously considers nitrogen allocation to light capture, electron transport, carboxylation, respiration and storage, and the responses of each to altered environmental conditions. We expect this model could potentially improve our confidence in simulations of carbon-nitrogen interactions and the vegetation feedbacks to climate in Earth system models.	[Xu, Chonggang; Wilson, Cathy J.; McDowell, Nate G.] Los Alamos Natl Lab, Div Earth & Environm Sci, Los Alamos, NM 87545 USA; [Wullschleger, Stan D.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Fisher, Rosie] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Cai, Michael] Los Alamos Natl Lab, Div Intelligence & Space Res, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; National Center Atmospheric Research (NCAR) - USA; United States Department of Energy (DOE); Los Alamos National Laboratory	Xu, CG (corresponding author), Los Alamos Natl Lab, Div Earth & Environm Sci, Los Alamos, NM 87545 USA.	xuchongang@gmail.com	fisher, rosie/Y-4226-2019; Wullschleger, Stan D/B-8297-2012; Fisher, Rosie A/E-7746-2013	fisher, rosie/0000-0003-3260-9227; Wullschleger, Stan D/0000-0002-9869-0446; Xu, Chonggang/0000-0002-0937-5744	Department of Energy, Office of Science, Biological and Environmental Research (BER); Los Alamos National Laboratory (LANL); US Department of Energy [DE-AC05-00OR22725]; National Science Foundation	Department of Energy, Office of Science, Biological and Environmental Research (BER)(United States Department of Energy (DOE)); Los Alamos National Laboratory (LANL)(United States Department of Energy (DOE)Los Alamos National Laboratory); US Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work is funded by Department of Energy, Office of Science, Biological and Environmental Research (BER) and Los Alamos National Laboratory (LANL) Laboratory Directed Research and Development (LDRD) Program. This paper is published under the public release code of LA-UR-11-12108. Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the US Department of Energy under contract DE-AC05-00OR22725. Rosie Fisher is funded by the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber JD, 1997, ECOL MODEL, V101, P61, DOI 10.1016/S0304-3800(97)01953-4; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; [Anonymous], 2000, EARTH INTERACT, DOI DOI 10.1175/1087-3562(2000)004%3C0003:PASAOT%3E2.0.CO;2; BENDALL DS, 1958, BIOCHEM J, V70, P381, DOI 10.1042/bj0700381; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Bonan GB, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001593; CHAPIN FS, 1985, ECOLOGY, V66, P564, DOI 10.2307/1940405; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Crous KY, 2008, TREE PHYSIOL, V28, P607, DOI 10.1093/treephys/28.4.607; Dewar RC, 2009, BIOSCIENCE, V59, P127, DOI 10.1525/bio.2009.59.2.6; EHLERINGER J, 1977, PLANT PHYSIOL, V59, P86, DOI 10.1104/pp.59.1.86; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Fisher JB, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003621; FRIEND AD, 1991, PLANT CELL ENVIRON, V14, P895, DOI 10.1111/j.1365-3040.1991.tb00958.x; Haldimann P, 1998, PLANT CELL ENVIRON, V21, P200, DOI 10.1046/j.1365-3040.1998.00260.x; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hikosaka K, 2005, PLANT CELL PHYSIOL, V46, P1283, DOI 10.1093/pcp/pci137; HIKOSAKA K, 1995, PLANT CELL ENVIRON, V18, P605, DOI 10.1111/j.1365-3040.1995.tb00562.x; Hikosaka K, 1996, FUNCT ECOL, V10, P335, DOI 10.2307/2390281; HOLADAY AS, 1992, PLANT PHYSIOL, V98, P1105, DOI 10.1104/pp.98.3.1105; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kleijn D, 2005, NEW PHYTOL, V166, P565, DOI 10.1111/j.1469-8137.2005.01321.x; Kobayashi T., 1999, PLANT SPEC BIOL, V47, P155; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Leegood R. C., 2004, PHOTOSYNTHESIS ENV, P191; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; MAKINO A, 1991, PLANT PHYSIOL, V96, P355, DOI 10.1104/pp.96.2.355; MAKINO A, 1994, PLANT PHYSIOL, V105, P1231, DOI 10.1104/pp.105.4.1231; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; McCarthy HR, 2010, NEW PHYTOL, V185, P514, DOI 10.1111/j.1469-8137.2009.03078.x; McMurtrie RE, 2011, TREE PHYSIOL, V31, P1007, DOI 10.1093/treephys/tpr037; Medlyn BE, 1999, PLANT CELL ENVIRON, V22, P1475, DOI 10.1046/j.1365-3040.1999.00523.x; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MILLARD P, 1988, PLANT CELL ENVIRON, V11, P1, DOI 10.1111/j.1365-3040.1988.tb01769.x; Niinemets U, 1998, TREE PHYSIOL, V18, P681; Niinemets U, 1998, TREE PHYSIOL, V18, P467; Niinemets U, 1997, PLANT CELL ENVIRON, V20, P845, DOI 10.1046/j.1365-3040.1997.d01-133.x; Niinemets U, 1997, FUNCT ECOL, V11, P518, DOI 10.1046/j.1365-2435.1997.00109.x; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Nordin A, 1997, OECOLOGIA, V110, P487, DOI 10.1007/s004420050184; OAKS A, 1980, PLANTA, V148, P477, DOI [10.1007/BF00552663, 10.1007/BF02395318]; Perez R, 2002, SOL ENERGY, V73, P307, DOI 10.1016/S0038-092X(02)00122-6; POORTER H, 1990, PLANT PHYSIOL, V94, P621, DOI 10.1104/pp.94.2.621; REICH PB, 1995, OECOLOGIA, V104, P24, DOI 10.1007/BF00365558; Reich PB, 2009, OECOLOGIA, V160, P207, DOI 10.1007/s00442-009-1291-3; Ripullone F, 2003, TREE PHYSIOL, V23, P137, DOI 10.1093/treephys/23.2.137; Rogers A, 2002, PLANT CELL ENVIRON, V25, P851, DOI 10.1046/j.1365-3040.2002.00868.x; SEEMANN JR, 1987, PLANT PHYSIOL, V84, P796, DOI 10.1104/pp.84.3.796; Seiwa K, 2007, ANN BOT-LONDON, V99, P537, DOI 10.1093/aob/mcl283; Shaver GR, 2001, ECOLOGY, V82, P3163, DOI 10.1890/0012-9658(2001)082[3163:SCIWFT]2.0.CO;2; Tang JY, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011724; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; Verkroost AWM, 2005, ANN BOT-LONDON, V96, P871, DOI 10.1093/aob/mci239; Warren CR, 2003, TREES-STRUCT FUNCT, V17, P359, DOI 10.1007/s00468-003-0246-2	59	43	44	8	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37914	10.1371/journal.pone.0037914	http://dx.doi.org/10.1371/journal.pone.0037914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649564	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335800084
J	Liu, F; Guo, J; Bai, PF; Duan, YH; Wang, XD; Cheng, YL; Feng, H; Huang, LL; Kang, ZS				Liu, Furong; Guo, Jun; Bai, Pengfei; Duan, Yinhui; Wang, Xiaodong; Cheng, Yulin; Feng, Hao; Huang, Lili; Kang, Zhensheng			Wheat TaRab7 GTPase Is Part of the Signaling Pathway in Responses to Stripe Rust and Abiotic Stimuli	PLOS ONE			English	Article							PUCCINIA-STRIIFORMIS; COMPATIBLE INTERACTION; GENE-EXPRESSION; RAB7; RECRUITMENT; RESISTANCE; RILP; IDENTIFICATION; INHIBITION; MATURATION	Small GTP-binding proteins function as regulators of specific intercellular fundamental biological processes. In this study, a small GTP-binding protein Rab7 gene, designated as TaRab7, was identified and characterized from a cDNA library of wheat leaves infected with Puccinia striiformis f. sp. tritici (Pst) the wheat stripe rust pathogen. The gene was predicted to encode a protein of 206 amino acids, with a molecular mass of 23.13 KDa and an isoeletric point (pI) of 5.13. Further analysis revealed the presence of a conserved signature that is characteristic of Rab7, and phylogenetic analysis demonstrated that TaRab7 has the highest similarity to a small GTP binding protein gene (BdRab7-like) from Brachypodium distachyon. Quantitative real-time PCR assays revealed that the expression of TaRab7 was higher in the early stage of the incompatible interactions between wheat and Pst than in the compatible interaction, and the transcription level of TaRab7 was also highly induced by environmental stress stimuli. Furthermore, knocking down TaRab7 expression by virus induced gene silencing enhanced the susceptibility of wheat cv. Suwon 11 to an avirulent race CYR23. These results imply that TaRab7 plays an important role in the early stage of wheat-stripe rust fungus interaction and in stress tolerance.	[Liu, Furong; Guo, Jun; Bai, Pengfei; Duan, Yinhui; Wang, Xiaodong; Cheng, Yulin; Feng, Hao; Huang, Lili; Kang, Zhensheng] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Liu, Furong; Guo, Jun; Bai, Pengfei; Wang, Xiaodong; Cheng, Yulin; Feng, Hao; Huang, Lili; Kang, Zhensheng] NW A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Duan, Yinhui] NW A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Kang, ZS (corresponding author), NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	Kangzs@nwsuaf.edu.cn	Wang, Xiaodong/AAN-2446-2021; Bai, Pengfei/GVU-7318-2022; Wang, Xiaodong/GVS-5446-2022	Bai, Pengfei/0000-0002-2281-2881; Kang, Zhensheng/0000-0001-5575-0122; Wang, Xiaodong/0000-0002-4304-5482	National Natural Science Foundation of China [30930064, 31171795]; earmarked fund for China Agriculture Research System [CARS-3-1-11]; 111 Project from Ministry of Education of China [B07049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for China Agriculture Research System; 111 Project from Ministry of Education of China(Ministry of Education, China - 111 Project)	This work was financially supported by National Natural Science Foundation of China (No. 30930064 and 31171795), the earmarked fund for China Agriculture Research System (No. CARS-3-1-11) and the 111 Project from Ministry of Education of China (No. B07049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Cao ZhangJun, 2003, Acta Botanica Boreali-Occidentalia Sinica, V23, P64; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Duan YH, 2011, MOL BIOL REP, V38, P301, DOI 10.1007/s11033-010-0108-0; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Feng H, 2011, MOL BIOL REP, V38, P3857, DOI 10.1007/s11033-010-0501-8; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fujiwara M, 2006, PLANT PHYSIOL, V140, P734, DOI 10.1104/pp.105.068395; Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062; Harrison RE, 2004, MOL BIOL CELL, V15, P3146, DOI 10.1091/mbc.E04-02-0092; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hein I, 2005, PLANT PHYSIOL, V138, P2155, DOI 10.1104/pp.105.062810; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Jambunathan N, 2003, PLANT PHYSIOL, V132, P1370, DOI 10.1104/pp.103.022970; Kang Z, 1984, ACTA CLLEGII SEPTENT, V4, P18; Kwon SI, 2009, J PLANT BIOL, V52, P79, DOI 10.1007/s12374-009-9011-4; LAMB CJ, 1989, CELL, V56, P215, DOI 10.1016/0092-8674(89)90894-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Ma JB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-586; Mukhopadhyay A, 1997, J BIOL CHEM, V272, P13055, DOI 10.1074/jbc.272.20.13055; Nahm MY, 2003, PLANT CELL PHYSIOL, V44, P1341, DOI 10.1093/pcp/pcg163; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Peralta ER, 2010, J BIOL CHEM, V285, P16814, DOI 10.1074/jbc.M110.111633; PETTY ITD, 1990, EMBO J, V9, P3453, DOI 10.1002/j.1460-2075.1990.tb07553.x; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pogue G. P., 1998, PLANT MOL BIOL MAN L, P1; Roberts EA, 2006, J CELL BIOL, V174, P923, DOI 10.1083/jcb.200603026; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Scianimanico S, 1999, CELL MICROBIOL, V1, P19, DOI 10.1046/j.1462-5822.1999.00002.x; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Stakman EC, 1962, US AGR RES SERV AR E, VE617, P1; Sun J, 2007, J LEUKOCYTE BIOL, V82, P1437, DOI 10.1189/jlb.0507289; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Wang CF, 2007, PHYSIOL MOL PLANT P, V71, P230, DOI 10.1016/j.pmpp.2008.02.006; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; Wang XJ, 2008, EUR J PLANT PATHOL, V120, P241, DOI 10.1007/s10658-007-9212-y; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	44	19	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37146	10.1371/journal.pone.0037146	http://dx.doi.org/10.1371/journal.pone.0037146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629358	gold, Green Submitted, Green Published			2022-12-25	WOS:000305345300022
J	van de Lavoir, MC; Collarini, EJ; Leighton, PA; Fesler, J; Lu, DR; Harriman, WD; Thiyagasundaram, TS; Etches, RJ				van de lavoir, Marie-Cecile; Collarini, Ellen J.; Leighton, Philip A.; Fesler, Jeffrey; Lu, Daniel R.; Harriman, William D.; Thiyagasundaram, T. S.; Etches, Robert J.			Interspecific Germline Transmission of Cultured Primordial Germ Cells	PLOS ONE			English	Article							CHICKEN; SEX	In birds, the primordial germ cell (PGC) lineage separates from the soma within 24 h following fertilization. Here we show that the endogenous population of about 200 PGCs from a single chicken embryo can be expanded one million fold in culture. When cultured PGCs are injected into a xenogeneic embryo at an equivalent stage of development, they colonize the testis. At sexual maturity, these donor PGCs undergo spermatogenesis in the xenogeneic host and become functional sperm. Insemination of semen from the xenogeneic host into females from the donor species produces normal offspring from the donor species. In our model system, the donor species is chicken (Gallus domesticus) and the recipient species is guinea fowl (Numida meleagris), a member of a different avian family, suggesting that the mechanisms controlling proliferation of the germline are highly conserved within birds. From a pragmatic perspective, these data are the basis of a novel strategy to produce endangered species of birds using domesticated hosts that are both tractable and fecund.	[van de lavoir, Marie-Cecile; Collarini, Ellen J.; Leighton, Philip A.; Fesler, Jeffrey; Lu, Daniel R.; Harriman, William D.; Etches, Robert J.] Crystal Biosci Inc, Emeryville, CA USA; [Thiyagasundaram, T. S.] Management Nat Conservat, Dept Presidents Affairs, Abu Dhabi, U Arab Emirates		van de Lavoir, MC (corresponding author), Crystal Biosci Inc, Emeryville, CA USA.	lavoir@crystalbioscience.com						BLACKLER AW, 1972, DEV BIOL, V27, P385, DOI 10.1016/0012-1606(72)90177-7; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Ishiguro S, 2009, J REPROD DEVELOP, V55, P183, DOI 10.1262/jrd.20107; Kang SJ, 2009, THERIOGENOLOGY, V72, P519, DOI 10.1016/j.theriogenology.2009.04.007; Kang SJ, 2008, BIOL REPROD, V79, P931, DOI 10.1095/biolreprod.108.069989; Leighton PA, 2008, MOL REPROD DEV, V75, P1163, DOI 10.1002/mrd.20859; Li Hai-Chang, 2001, Journal of Poultry Science, V38, P308, DOI 10.2141/jpsa.38.308; Liu CH, 2007, ANIM REPROD SCI, V101, P344, DOI 10.1016/j.anireprosci.2006.12.021; Liu CH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094409; Macdonald J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015518; McCarthy EM, 2006, HDB AVIAN HYBRIDS WO; Oliehoek PA, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-9; Ono Tamao, 1998, Animal Science and Technology, V69, P546; Pardue S, 2002, Methods for gamete production in birds, Patent No. [US 6,354, 242, 6354242]; Pitel F, 2000, GENET SEL EVOL, V32, P73, DOI 10.1051/gse:2000107; REYNAUD G, 1969, J EMBRYOL EXP MORPH, V21, P485; Saito T, 2010, INT J DEV BIOL, V54, P1481, DOI 10.1387/ijdb.103111ts; Takeuchi Y, 2004, NATURE, V430, P629, DOI 10.1038/430629a; Takeuchi Y, 2003, BIOL REPROD, V69, P1142, DOI 10.1095/biolreprod.103.017624; van de Lavoir MC, 2006, METHOD ENZYMOL, V418, P38, DOI 10.1016/S0076-6879(06)18003-9; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Wernery U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015824	22	43	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e35664	10.1371/journal.pone.0035664	http://dx.doi.org/10.1371/journal.pone.0035664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629301	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100002
J	Arikata, M; Itoh, Y; Okamatsu, M; Maeda, T; Shiina, T; Tanaka, K; Suzuki, S; Nakayama, M; Sakoda, Y; Ishigaki, H; Takada, A; Ishida, H; Soda, K; Pham, VL; Tsuchiya, H; Nakamura, S; Torii, R; Shimizu, T; Inoko, H; Ohkubo, I; Kida, H; Ogasawara, K				Arikata, Masahiko; Itoh, Yasushi; Okamatsu, Masatoshi; Maeda, Toshinaga; Shiina, Takashi; Tanaka, Keiko; Suzuki, Shingo; Nakayama, Misako; Sakoda, Yoshihiro; Ishigaki, Hirohito; Takada, Ayato; Ishida, Hideaki; Soda, Kosuke; Van Loi Pham; Tsuchiya, Hideaki; Nakamura, Shinichiro; Torii, Ryuzo; Shimizu, Takeshi; Inoko, Hidetoshi; Ohkubo, Iwao; Kida, Hiroshi; Ogasawara, Kazumasa			Memory Immune Responses against Pandemic (H1N1) 2009 Influenza Virus Induced by a Whole Particle Vaccine in Cynomolgus Monkeys Carrying Mafa-A1*052:02	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; CLASS-I; PROTECTIVE IMMUNITY; ANTIBODY-RESPONSES; DENDRITIC CELLS; IFN-GAMMA; B-CELLS; INFECTION; MACAQUES; IDENTIFICATION	We made an H1N1 vaccine candidate from a virus library consisting of 144 (= 16 HAx9 NA) non-pathogenic influenza A viruses and examined its protective effects against a pandemic (2009) H1N1 strain using immunologically naive cynomolgus macaques to exclude preexisting immunity and to employ a preclinical study since preexisting immunity in humans previously vaccinated or infected with influenza virus might make comparison of vaccine efficacy difficult. Furthermore, macaques carrying a major histocompatibility complex class I molecule, Mafa-A1*052:02, were used to analyze peptide-specific CD8(+) T cell responses. Sera of macaques immunized with an inactivated whole particle formulation without addition of an adjuvant showed higher neutralization titers against the vaccine strain A/Hokkaido/2/1981 (H1N1) than did sera of macaques immunized with a split formulation. Neutralization activities against the pandemic strain A/Narita/1/2009 (H1N1) in sera of macaques immunized twice with the split vaccine reached levels similar to those in sera of macaques immunized once with the whole particle vaccine. After inoculation with the pandemic virus, the virus was detected in nasal samples of unvaccinated macaques for 6 days after infection and for 2.67 days and 5.33 days on average in macaques vaccinated with the whole particle vaccine and the split vaccine, respectively. After the challenge infection, recall neutralizing antibody responses against the pandemic virus and CD8(+) T cell responses specific for nucleoprotein peptide NP262-270 bound to Mafa-A1*052:02 in macaques vaccinated with the whole particle vaccine were observed more promptly or more vigorously than those in macaques vaccinated with the split vaccine. These findings demonstrated that the vaccine derived from our virus library was effective for pandemic virus infection in macaques and that the whole particle vaccine conferred more effective memory and broader cross-reactive immune responses to macaques against pandemic influenza virus infection than did the split vaccine.	[Arikata, Masahiko; Itoh, Yasushi; Nakayama, Misako; Ishigaki, Hirohito; Ishida, Hideaki; Van Loi Pham; Ogasawara, Kazumasa] Shiga Univ Med Sci, Div Pathol & Dis Regulat, Dept Pathol, Otsu, Shiga 52021, Japan; [Arikata, Masahiko; Shimizu, Takeshi] Shiga Univ Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Otsu, Shiga 52021, Japan; [Maeda, Toshinaga; Ohkubo, Iwao] Shiga Univ Med Sci, Div Mol Med Biochem, Otsu, Shiga 52021, Japan; [Tsuchiya, Hideaki; Nakamura, Shinichiro; Torii, Ryuzo] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Otsu, Shiga 52021, Japan; [Okamatsu, Masatoshi; Sakoda, Yoshihiro; Soda, Kosuke; Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Microbiol Lab, Dept Dis Control, Sapporo, Hokkaido, Japan; [Takada, Ayato; Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Shiina, Takashi; Tanaka, Keiko; Suzuki, Shingo; Inoko, Hidetoshi] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, Isehara, Kanagawa 25911, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Hokkaido University; Hokkaido University; Tokai University	Arikata, M (corresponding author), Shiga Univ Med Sci, Div Pathol & Dis Regulat, Dept Pathol, Otsu, Shiga 52021, Japan.	yasushii@belle.shiga-med.ac.jp	Takada, Ayato/A-6679-2012; Ishigaki, Hirohito/AAO-7458-2020; Okamatsu, Masatoshi/F-9124-2012; Kida, Hiroshi/F-7244-2012; Sakoda, Yoshihiro/A-5183-2012	Ishigaki, Hirohito/0000-0002-5249-8598; Shimizu, Takeshi/0000-0002-1344-7210; Itoh, Yasushi/0000-0001-7462-2193; Nakayama, Misako/0000-0001-8611-0662; Suzuki, Shingo/0000-0003-1880-582X; Shiina, Takashi/0000-0002-2067-6708	Regional Research and Development Resources Utilization Program; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan; Research Center for Zoonosis Control, Hokkaido University; Japan Initiative for Global Research Network on Infectious Diseases	Regional Research and Development Resources Utilization Program; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Center for Zoonosis Control, Hokkaido University; Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Regional Research and Development Resources Utilization Program, Japan Science and Technology Agency, the Grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan, for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University and the Japan Initiative for Global Research Network on Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WKLY EPIDEMIOL REC; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Burwitz BJ, 2009, J VIROL, V83, P6011, DOI 10.1128/JVI.00199-09; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Herfst S, 2010, VET PATHOL, V47, P1040, DOI 10.1177/0300985810374836; Hofmann S, 2005, MOL CELL PROTEOMICS, V4, P1888, DOI 10.1074/mcp.M500076-MCP200; Hoft DF, 2011, J INFECT DIS, V204, P845, DOI 10.1093/infdis/jir436; HOSKEN NA, 1990, SCIENCE, V248, P367, DOI 10.1126/science.2326647; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Itoh Y, 2008, VACCINE, V26, P562, DOI 10.1016/j.vaccine.2007.11.031; Itoh Y, 2010, VACCINE, V28, P780, DOI 10.1016/j.vaccine.2009.10.067; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kang SM, 2011, J VIROL, V85, P11391, DOI 10.1128/JVI.00080-11; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; KAWANO Y, 1994, J IMMUNOL, V153, P4948; Keller SA, 2010, EUR J IMMUNOL, V40, P103, DOI 10.1002/eji.200939559; Khurana S, 2011, J VIROL, V85, P10945, DOI 10.1128/JVI.05406-11; Kida H, 2006, DEV BIOLOGICALS, V124, P69; KIDA H, 1983, ARCH VIROL, V76, P91, DOI 10.1007/BF01311693; Kita YF, 2009, IMMUNOGENETICS, V61, P635, DOI 10.1007/s00251-009-0390-y; Kitano M, 2011, ANTIMICROB AGENTS CH, V55, P4961, DOI 10.1128/AAC.00412-11; Kitano M, 2010, VIROLOGY, V407, P178, DOI 10.1016/j.virol.2010.08.006; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; MCMICHAEL AJ, 1981, CLIN EXP IMMUNOL, V43, P276; Moron VG, 2003, J IMMUNOL, V171, P2242, DOI 10.4049/jimmunol.171.5.2242; Nishiura H, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-111; Ohno S, 2006, VIRAL IMMUNOL, V19, P458, DOI 10.1089/vim.2006.19.458; Prieto-Lara E, 2010, VACCINE, V28, P4328, DOI 10.1016/j.vaccine.2010.03.068; Rapin N, 2008, IMMUNOGENETICS, V60, P759, DOI 10.1007/s00251-008-0330-2; Rueda P, 1999, VACCINE, V18, P325, DOI 10.1016/S0264-410X(99)00202-9; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Samad RAA, 2011, JPN J VET RES, V59, P23; Saurwein-Teissl M, 1998, CLIN EXP IMMUNOL, V114, P271; Sawai T, 2008, IMMUNOLOGY, V124, P155, DOI 10.1111/j.1365-2567.2007.02745.x; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; SHIMIZU Y, 1988, P NATL ACAD SCI USA, V85, P227, DOI 10.1073/pnas.85.1.227; Sidney J, 2000, J IMMUNOL, V165, P6387, DOI 10.4049/jimmunol.165.11.6387; Song JM, 2010, VIROLOGY, V405, P165, DOI 10.1016/j.virol.2010.05.034; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; TAKAMIYA Y, 1994, INT IMMUNOL, V6, P255; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Uda A, 2005, IMMUNOGENETICS, V57, P189, DOI 10.1007/s00251-005-0782-6; Valkenburg SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001039; Soto-Abraham MV, 2009, NEW ENGL J MED, V361, P2001, DOI 10.1056/NEJMc0907171; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; Yoshino N, 2000, EXP ANIM TOKYO, V49, P97, DOI 10.1538/expanim.49.97	54	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37220	10.1371/journal.pone.0037220	http://dx.doi.org/10.1371/journal.pone.0037220			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623997	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500077
J	Chen, MJ; Zeng, HM; Qiu, DW; Guo, LH; Yang, XF; Shi, HX; Zhou, TT; Zhao, J				Chen, Mingjia; Zeng, Hongmei; Qiu, Dewen; Guo, Lihua; Yang, Xiufen; Shi, Huaixing; Zhou, Tingting; Zhao, Jing			Purification and Characterization of a Novel Hypersensitive Response-Inducing Elicitor from Magnaporthe oryzae that Triggers Defense Response in Rice	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; DISEASE RESISTANCE; PROTEIN ELICITOR; EARLY EVENTS; CELL-DEATH; OXIDATIVE STRESS; INNATE IMMUNITY; BLAST FUNGUS; ARABIDOPSIS; PLANTS	Background: Magnaporthe oryzae, the rice blast fungus, might secrete certain proteins related to plant-fungal pathogen interactions. Methodology/Principal Findings: In this study, we report the purification, characterization, and gene cloning of a novel hypersensitive response-inducing protein elicitor (MoHrip1) secreted by M. oryzae. The protein fraction was purified and identified by de novo sequencing, and the sequence matched the genomic sequence of a putative protein from M. oryzae strain 70-15 (GenBank accession No. XP_366602.1). The elicitor-encoding gene mohrip1 was isolated; it consisted of a 429 bp cDNA, which encodes a polypeptide of 142 amino acids with a molecular weight of 14.322 kDa and a pI of 4.53. The deduced protein, MoHrip1, was expressed in E. coli. And the expression protein collected from bacterium also forms necrotic lesions in tobacco. MoHrip1 could induce the early events of the defense response, including hydrogen peroxide production, callose deposition, and alkalization of the extracellular medium, in tobacco. Moreover, MoHrip1-treated rice seedlings possessed significantly enhanced systemic resistance to M. oryzae compared to the control seedlings. The real-time PCR results indicated that the expression of some pathogenesis-related genes and genes involved in signal transduction could also be induced by MoHrip1. Conclusion/Significance: The results demonstrate that MoHrip1 triggers defense responses in rice and could be used for controlling rice blast disease.	[Chen, Mingjia; Zeng, Hongmei; Qiu, Dewen; Guo, Lihua; Yang, Xiufen; Shi, Huaixing; Zhou, Tingting; Zhao, Jing] Chinses Acad Agr Sci, Inst Plant Protect, Minist Agr, Key Lab Integrated Pest Management Crops, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Chen, MJ (corresponding author), Chinses Acad Agr Sci, Inst Plant Protect, Minist Agr, Key Lab Integrated Pest Management Crops, Beijing, Peoples R China.	hmzeng@caas.net.cn		Chen, Mingjia/0000-0002-0943-3991	National Basic Research Program of China ("973" Program) [2011CB100700]; National Hi-Tech Research and Development Program of China ("863" Projects) [2011AA10A201]	National Basic Research Program of China ("973" Program)(National Basic Research Program of China); National Hi-Tech Research and Development Program of China ("863" Projects)	This work was supported by a grant from National Basic Research Program of China ("973" Program, 2011CB100700) and the National Hi-Tech Research and Development Program of China ("863" Projects, 2011AA10A201). The URL for both funders is http://www.most.gov.cn/eng/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn IP, 2005, PLANT PHYSIOL, V138, P1505, DOI 10.1104/pp.104.058693; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Boka K, 2007, PLANT SIGNAL BEHAV, V2, P498, DOI 10.4161/psb.2.6.4582; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Brault M, 2004, PLANT PHYSIOL, V135, P231, DOI 10.1104/pp.104.039255; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cui HT, 2009, CELL MICROBIOL, V11, P1453, DOI 10.1111/j.1462-5822.2009.01359.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Davis DA, 1998, PHYSIOL MOL PLANT P, V52, P259, DOI 10.1006/pmpp.1998.0150; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; DIXON RA, 1994, ANNU REV PHYTOPATHOL, V32, P479, DOI 10.1146/annurev.py.32.090194.002403; DSilva I, 1997, J BIOL CHEM, V272, P3924, DOI 10.1074/jbc.272.7.3924; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Ebel J, 1998, PLANTA, V206, P335, DOI 10.1007/s004250050409; Ellis JG, 2009, CURR OPIN PLANT BIOL, V12, P399, DOI 10.1016/j.pbi.2009.05.004; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Gurr SJ, 2005, TRENDS BIOTECHNOL, V23, P275, DOI 10.1016/j.tibtech.2005.04.007; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Hwang SH, 2008, PLANTA, V227, P1141, DOI 10.1007/s00425-007-0687-8; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KANOH H, 1993, J PESTIC SCI, V18, P325; Katagiri F, 2010, MOL PLANT MICROBE IN, V23, P1531, DOI 10.1094/MPMI-04-10-0099; Keller H, 1996, PLANT PHYSIOL, V110, P365, DOI 10.1104/pp.110.2.365; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000757; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Koga J, 1998, J BIOL CHEM, V273, P31985, DOI 10.1074/jbc.273.48.31985; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Liu JL, 2010, MOL PLANT PATHOL, V11, P419, DOI [10.1111/J.1364-3703.2009.00607.X, 10.1111/j.1364-3703.2009.00607.x]; Mao J, 2010, ANN APPL BIOL, V156, P411, DOI 10.1111/j.1744-7348.2010.00398.x; Mishra AK, 2009, MICROBIOL RES, V164, P688, DOI 10.1016/j.micres.2008.09.001; Mitsuhara I, 2008, MOL GENET GENOMICS, V279, P415, DOI 10.1007/s00438-008-0322-9; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Nishizawa Y, 1999, THEOR APPL GENET, V99, P383, DOI 10.1007/s001220051248; Nurnberger T, 1999, CELL MOL LIFE SCI, V55, P167, DOI 10.1007/s000180050283; Nurnberger T, 2002, CURR OPIN PLANT BIOL, V5, P318, DOI 10.1016/S1369-5266(02)00265-0; Osman H, 2001, FEBS LETT, V489, P55, DOI 10.1016/S0014-5793(01)02078-6; Panstruga R, 2009, CELL, V136, P978, DOI 10.1016/j.cell.2009.02.020; Peng DH, 2011, MOL PLANT MICROBE IN, V24, P1239, DOI 10.1094/MPMI-01-11-0003; Pieterse CMJ, 1999, TRENDS PLANT SCI, V4, P52, DOI 10.1016/S1360-1385(98)01364-8; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Pugin A, 1997, PLANT CELL, V9, P2077, DOI 10.1105/tpc.9.11.2077; Qiu DW, 2009, PLANT CELL REP, V28, P925, DOI 10.1007/s00299-009-0698-y; Rep M, 2005, FEMS MICROBIOL LETT, V253, P19, DOI 10.1016/j.femsle.2005.09.014; Repka V, 2006, BIOL PLANTARUM, V50, P94, DOI 10.1007/s10535-005-0080-z; Ribot C, 2008, J PLANT PHYSIOL, V165, P114, DOI 10.1016/j.jplph.2007.06.013; Sauerborn J, 2002, PHYTOPATHOLOGY, V92, P59, DOI 10.1094/PHYTO.2002.92.1.59; SCHAFFRATH U, 1995, PHYSIOL MOL PLANT P, V46, P293, DOI 10.1006/pmpp.1995.1023; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Stuiver MH, 2001, NATURE, V411, P865, DOI 10.1038/35081200; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Veit S, 2001, PLANT PHYSIOL, V127, P832, DOI 10.1104/pp.010350; Wang BN, 2012, APPL MICROBIOL BIOT, V93, P191, DOI 10.1007/s00253-011-3405-1; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Xie XZ, 2011, MOL PLANT, V4, P688, DOI 10.1093/mp/ssr005; Yano A, 1998, MOL PLANT MICROBE IN, V11, P115, DOI 10.1094/MPMI.1998.11.2.115; Zhang W, 2011, MOL BIOL REP, V38, P2549, DOI 10.1007/s11033-010-0393-7; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003	71	51	59	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37654	10.1371/journal.pone.0037654	http://dx.doi.org/10.1371/journal.pone.0037654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624059	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343500148
J	Friar, JL; Goldman, T; Perez-Mercader, J				Friar, James L.; Goldman, Terrance; Perez-Mercader, Juan			Genome Sizes and the Benford Distribution	PLOS ONE			English	Article							PROTEOMES; EVOLUTION; ORIGINS; LIFE; DNA	Background: Data on the number of Open Reading Frames (ORFs) coded by genomes from the 3 domains of Life show the presence of some notable general features. These include essential differences between the Prokaryotes and Eukaryotes, with the number of ORFs growing linearly with total genome size for the former, but only logarithmically for the latter. Results: Simply by assuming that the (protein) coding and non-coding fractions of the genome must have different dynamics and that the non-coding fraction must be particularly versatile and therefore be controlled by a variety of (unspecified) probability distribution functions (pdf's), we are able to predict that the number of ORFs for Eukaryotes follows a Benford distribution and must therefore have a specific logarithmic form. Using the data for the 1000+ genomes available to us in early 2010, we find that the Benford distribution provides excellent fits to the data over several orders of magnitude. Conclusions: In its linear regime the Benford distribution produces excellent fits to the Prokaryote data, while the full non-linear form of the distribution similarly provides an excellent fit to the Eukaryote data. Furthermore, in their region of overlap the salient features are statistically congruent. This allows us to interpret the difference between Prokaryotes and Eukaryotes as the manifestation of the increased demand in the biological functions required for the larger Eukaryotes, to estimate some minimal genome sizes, and to predict a maximal Prokaryote genome size on the order of 8-12 megabasepairs. These results naturally allow a mathematical interpretation in terms of maximal entropy and, therefore, most efficient information transmission.	[Friar, James L.; Goldman, Terrance] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Perez-Mercader, Juan] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Perez-Mercader, Juan] Santa Fe Inst, Santa Fe, NM 87501 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Harvard University; The Santa Fe Institute	Friar, JL (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.	jperezmercader@fas.harvard.edu			National Nuclear Security Administration of the United States Department of Energy at Los Alamos National Laboratory [DE-AC52-06NA25396]; everis Foundation; Repsol S. A.	National Nuclear Security Administration of the United States Department of Energy at Los Alamos National Laboratory; everis Foundation; Repsol S. A.	This work was carried out in part under the auspices of the National Nuclear Security Administration of the United States Department of Energy at Los Alamos National Laboratory under Contract No. DE-AC52-06NA25396. JP-M would like to thank the everis Foundation and Repsol S. A. for support, and the Theoretical Division of Los Alamos National Laboratory for its hospitality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert SE, 2008, J THEOR BIOL, V252, P587, DOI 10.1016/j.jtbi.2008.02.005; Alberts B, 2008, MOL BIOL CELL; Benford F, 1938, P AM PHILOS SOC, V78, P551, DOI DOI 10.2307/984802; Berger A, 2011, MATH INTELL, V33, P85, DOI 10.1007/s00283-010-9182-3; Brown TA, 2007, GENOMES; Cover TM, 1991, ELEMENTS INFORM THEO; Davidson EH, 2006, REG GEN GEN REG; Fernandez A, 2011, NATURE, V474, P502, DOI 10.1038/nature09992; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Goldenfeld N, 2011, ANNU REV CONDEN MA P, V2, P375, DOI 10.1146/annurev-conmatphys-062910-140509; Hamming R. W., 1973, NUMERICAL METHODS SC; HAMMING RW, 1970, AT&T TECH J, V49, P1609, DOI 10.1002/j.1538-7305.1970.tb04281.x; Hartl DL, 2012, GENETICS ANAL GENES; Hill TP, 1995, STAT SCI, V10, P354, DOI 10.1214/ss/1177009869; HILL TP, 1995, P AM MATH SOC, V123, P887, DOI 10.2307/2160815; Losich R., 2008, MOL BIOL GENE; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2007, ORIGINS GENOME ARCHI; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; McCoy MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006456; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Peterson SN, 2001, GENOME BIOL, V2; PETERSON SN, 1993, J BACTERIOL, V175, P7918, DOI 10.1128/JB.175.24.7918-7930.1993; Phillips R., 2008, PHYS BIOL CELL; PINKHAM RS, 1961, ANN MATH STAT, V32, P1223, DOI 10.1214/aoms/1177704862; Renyi A, 1991, FDN PROBABILITY; Shannon C., 1964, MATH THEORY COMMUNIC; Shannon C.E., 1948, BELL SYSTEM TECHNICA, V27; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Wang ML, 2011, P NATL ACAD SCI USA, V108, P11954, DOI 10.1073/pnas.1017361108; Wang ML, 2009, STRUCTURE, V17, P66, DOI 10.1016/j.str.2008.11.008; Yockey H.P., 2005, INFORM THEORY EVOLUT	35	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36624	10.1371/journal.pone.0036624	http://dx.doi.org/10.1371/journal.pone.0036624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629319	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500021
J	Mirza, M; Pang, MF; Zaini, MA; Haiko, P; Tammela, T; Alitalo, K; Philipson, L; Fuxe, J; Sollerbrant, K				Mirza, Momina; Pang, Mei-Fong; Zaini, Mohamad Amr; Haiko, Paula; Tammela, Tuomas; Alitalo, Kari; Philipson, Lennart; Fuxe, Jonas; Sollerbrant, Kerstin			Essential Role of the Coxsackie - and Adenovirus Receptor (CAR) in Development of the Lymphatic System in Mice	PLOS ONE			English	Article							EPITHELIAL TIGHT JUNCTIONS; ENDOTHELIAL-CELLS; VESSELS; FAMILY; DISEASE; LYMPHANGIOGENESIS; VASCULATURE; MATURATION; PLATELETS; ADHESION	The coxsackie- and adenovirus receptor (CAR) is a cell adhesion molecule predominantly associated with epithelial tight junctions in adult tissues. CAR is also expressed in cardiomyocytes and essential for heart development up to embryonic day 11.5, but not thereafter. CAR is not expressed in vascular endothelial cells but was recently detected in neonatal lymphatic vessels, suggesting that CAR could play a role in the development of the lymphatic system. To address this, we generated mice carrying a conditional deletion of the CAR gene (Cxadr) and knocked out CAR in the mouse embryo at different time points during post-cardiac development. Deletion of Cxadr from E12.5, but not from E13.5, resulted in subcutaneous edema, hemorrhage and embryonic death. Subcutaneous lymphatic vessels were dilated and structurally abnormal with gaps and holes present at lymphatic endothelial cell-cell junctions. Furthermore, lymphatic vessels were filled with erythrocytes showing a defect in the separation between the blood and lymphatic systems. Regionally, erythrocytes leaked out into the interstitium from leaky lymphatic vessels explaining the hemorrhage detected in CAR-deficient mouse embryos. The results show that CAR plays an essential role in development of the lymphatic vasculature in the mouse embryo by promoting appropriate formation of lymphatic endothelial cell-cell junctions.	[Mirza, Momina; Zaini, Mohamad Amr; Sollerbrant, Kerstin] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Mirza, Momina; Zaini, Mohamad Amr; Sollerbrant, Kerstin] Univ Hosp, Stockholm, Sweden; [Pang, Mei-Fong; Fuxe, Jonas] Karolinska Inst, Dept Med Biochem & Biophys, Vasc Biol Unit, Stockholm, Sweden; [Haiko, Paula; Tammela, Tuomas; Alitalo, Kari] Univ Helsinki, Mol Canc Biol Lab, Helsinki, Finland; [Philipson, Lennart] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; University of Helsinki; Karolinska Institutet	Mirza, M (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	kerstin.sollerbrant@ki.se	Fuxe, Jonas/T-4433-2017; Pang, Mei-Fong/F-9162-2010; Alitalo, Kari K/J-5013-2014	Fuxe, Jonas/0000-0003-4576-9377; Alitalo, Kari K/0000-0002-7331-0902; /0000-0003-3675-6961; Pang, Mei Fong/0000-0002-3030-1272	Swedish Cancer Society; Samaritstiftelsen; Swedish Research Council; Swedish Childhood Cancer Foundation; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Samaritstiftelsen; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Karolinska Institutet(Karolinska Institutet)	KS was supported by grants from the Swedish Cancer Society and Samaritstiftelsen (to MM); JF was supported by the Swedish Research Council, the Swedish Childhood Cancer Foundation, the Karolinska Institutet and the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Andersson AM, 1998, J VIROL, V72, P9585, DOI 10.1128/JVI.72.12.9585-9596.1998; Asher DR, 2005, GENESIS, V42, P77, DOI 10.1002/gene.20127; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bertozzi CC, 2010, ARTERIOSCL THROM VAS, V30, P2368, DOI 10.1161/ATVBAHA.110.217281; Chen JW, 2006, CIRC RES, V98, P923, DOI 10.1161/01.RES.0000218041.41932.e3; Dorner AA, 2005, J CELL SCI, V118, P3509, DOI 10.1242/jcs.02476; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hirata K, 2001, J BIOL CHEM, V276, P16223, DOI 10.1074/jbc.M100630200; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Mandell KJ, 2005, ADV DRUG DELIVER REV, V57, P857, DOI 10.1016/j.addr.2005.01.005; Norrmen C, 2009, J CELL BIOL, V185, P439, DOI 10.1083/jcb.200901104; Othman M, 2007, BLOOD, V109, P2832, DOI 10.1182/blood-2006-06-032524; Pazirandeh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020203; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Philipson L, 2004, CURR TOP MICROBIOL, V273, P87; Raschperger E, 2004, J BIOL CHEM, V279, P796, DOI 10.1074/jbc.M308249200; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; Vigl B, 2009, EXP CELL RES, V315, P336, DOI 10.1016/j.yexcr.2008.10.020; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910	27	36	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37523	10.1371/journal.pone.0037523	http://dx.doi.org/10.1371/journal.pone.0037523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624044	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500131
J	Papura, D; Burban, C; van Helden, M; Giresse, X; Nusillard, B; Guillemaud, T; Kerdelhue, C				Papura, Daciana; Burban, Christian; van Helden, Maarten; Giresse, Xavier; Nusillard, Benoit; Guillemaud, Thomas; Kerdelhue, Carole			Microsatellite and Mitochondrial Data Provide Evidence for a Single Major Introduction for the Neartic Leafhopper Scaphoideus titanus in Europe	PLOS ONE			English	Article							FLAVESCENCE DOREE PHYTOPLASMA; GENETIC-VARIATION; GRAPEVINE YELLOWS; F-STATISTICS; NULL ALLELES; DIFFERENTIATION; INVASION; VECTOR; CICADELLIDAE; CONSEQUENCES	Scaphoideus titanus, a leafhopper native to North America and invasive in Europe, is the vector of the Flavescence doree phytoplasma, the causal agent of the most important form of grapevine yellows in European vineyards. We studied 10 polymorphic microsatellite loci and a 623 bp fragment of the mitochondrial cytochrome oxidase II gene in native S. titanus from north-eastern America and introduced European populations, to elucidate the colonization scenario. Consistent with their recent history, invasive European populations were less genetically diverse than American populations for both types of markers, suggesting a recent bottleneck. Significant isolation by distance was detected between American populations but not between European populations. None of the European mitochondrial haplotypes was found in the American vineyards, from which they are assumed to have originated. The precise source of the invasive S. titanus populations therefore remains unclear. Nevertheless, the high heterozygosity of North-East American populations (which contained 92% of the observed alleles) suggests that this region is part of the native range of S. titanus. Clustering population genetics analyses with microsatellite and mitochondrial data suggested that European populations originated from a single introduction event. Most of the introduced populations clustered with populations from Long Island, the Atlantic Coast winegrowing region in which Vitis aestivalis occurs.	[Papura, Daciana; van Helden, Maarten; Giresse, Xavier] Univ Bordeaux, ISVV, UMR SAVE 1065, F-33140 Villenave Dornon, France; [Papura, Daciana; Giresse, Xavier] INRA, ISVV, UMR SAVE 1065, F-33140 Villenave Dornon, France; [Burban, Christian; Kerdelhue, Carole] INRA Bordeaux, UMR BIOGECO 1202, Cestas, France; [Nusillard, Benoit] Irstea, UR EFNO, F-45290 Nogent Sur Vernisson, France; [Guillemaud, Thomas] INRA UNSA CNRS, UMR IBSV 1301, F-06903 Sophia Antipolis, France	UDICE-French Research Universities; Universite de Bordeaux; INRAE; INRAE; INRAE; INRAE	Papura, D (corresponding author), Univ Bordeaux, ISVV, UMR SAVE 1065, F-33140 Villenave Dornon, France.	dpapura@bordeaux.inra.fr	Kerdelhue, Carole/GVS-0309-2022; guillemaud, thomas/B-4899-2012	guillemaud, thomas/0000-0003-0451-1644; Papura, Daciana/0000-0002-1147-9200; Kerdelhue, Carole/0000-0001-7667-902X	Institut National de la Recherche Agronomique	Institut National de la Recherche Agronomique	This research was funded by the Institut National de la Recherche Agronomique http://www.inra.fr/. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No permission was required to collect the samples.	Amsellem L, 2000, MOL ECOL, V9, P443, DOI 10.1046/j.1365-294x.2000.00876.x; Angelini E, 2004, EUR J PLANT PATHOL, V110, P193, DOI 10.1023/B:EJPP.0000015361.95661.37; Arnaud G, 2007, APPL ENVIRON MICROB, V73, P4001, DOI 10.1128/AEM.02323-06; Avise J.C., 2000, HIST FORMATION SPECI; Avise J.C., 2004, MOL MARKERS NATURAL; Baggiolini M., 1968, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V40, P270; BALL E. D., 1932, JOUR WASHINGTON ACAD SCI, V22, P9; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Barnett DE, 1977, T AM ENTOMOL SOC, V102, P485; Batlle A, 1997, VITIS, V36, P211; Beanland L, 2006, ENVIRON ENTOMOL, V35, P332, DOI 10.1603/0046-225X-35.2.332; Beaumont MA, 2002, GENETICS, V162, P2025; Beirne B. P., 1956, MEM ENTOMOL SOC CAN, V88, P5; Bertin S, 2007, GENETICA, V131, P275, DOI 10.1007/s10709-006-9137-y; BONFILS J., 1960, Annales des Epiphyties, V11, P325; Boudon-Padieu E, 2002, ATTI GIORN FITOPATOL, V1, P15; Boudon-Padieu Elisabeth, 1996, Comptes Rendus de l'Academie d'Agriculture de France, V82, P5; Burban C, 1999, MOL ECOL, V8, P1593, DOI 10.1046/j.1365-294x.1999.00739.x; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; CAUDWELL A, 1983, AGRONOMIE, V3, P103, DOI 10.1051/agro:19830201; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clerc L., 1997, Revue Suisse de Viticulture, d'Arboriculture et d'Horticulture, V29, P245; Cornuet JM, 1996, GENETICS, V144, P2001; DeLong D. M., 1939, Proceedings of the Entomological Society of Washington, V41, P33; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Der Z, 2007, B INSECTOL, V60, P199; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Estoup A, 2004, EVOLUTION, V58, P2021, DOI 10.1111/j.0014-3820.2004.tb00487.x; Estoup A, 2003, MOL ECOL, V12, P657, DOI 10.1046/j.1365-294X.2003.01761.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Goudet J, 1996, GENETICS, V144, P1933; Hancock J.M., 1997, MICROSATELLITES EVOL, P1; Hill GT, 2000, PLANT DIS, V84, P134, DOI 10.1094/PDIS.2000.84.2.134; Krnjajic S, 2007, B INSECTOL, V60, P197; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Lessio F, 2006, J ECON ENTOMOL, V99, P578, DOI 10.1603/0022-0493-99.2.578; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MAIXNER M, 1993, PLANT DIS, V77, P408, DOI 10.1094/PD-77-0408; Maixner M., 2005, BCPC Symposium Proceedings, V81, P141; Malembic-Maher S, 2007, B INSECTOL, V60, P329; Metcalf ZP, 1967, GEN CATALOGUE HOMOPT, P2129; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Moran NA, 2003, ENVIRON MICROBIOL, V5, P116, DOI 10.1046/j.1462-2920.2003.00391.x; NEI M, 1978, GENETICS, V89, P583; NOVAK SJ, 1993, HEREDITY, V71, P167, DOI 10.1038/hdy.1993.121; Olivier CY, 2009, CAN ENTOMOL, V141, P425, DOI 10.4039/n08-CPA02; Ordish G., 1972, GREAT WINE BLIGHT; Osler R., 2002, Informatore Agrario, V58, P61; Papura D, 2006, MOL ECOL NOTES, V6, P1114, DOI 10.1111/j.1471-8286.2006.01454.x; Papura D, 2009, INFECT GENET EVOL, V9, P867, DOI 10.1016/j.meegid.2009.05.009; Pavan F., 1997, Informatore Agrario, V53, P73; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pons O, 1996, GENETICS, V144, P1237; Pouget R, 1990, HIST LUTTE PYLLOXERA; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Quartau J.A., 2001, IOBC-WPRS Bulletin, V24, P273; R Development Core Team, 2008, LANG ENV STAT COMP; Randi E, 1998, HEREDITY, V80, P429, DOI 10.1038/sj.hdy.6883180; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roderick GK, 2003, NAT REV GENET, V4, P889, DOI 10.1038/nrg1201; Rousset F, 1997, GENETICS, V145, P1219; Russell JR, 1997, THEOR APPL GENET, V95, P714, DOI 10.1007/s001220050617; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schvester D, 1962, REV ZOOL AGR APPL, V91, P118; Seljak G, 2008, B INSECTOL, V61, P201; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Steffek R, 2006, EPPO B, V37, P191; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; VIDANO C., 1964, Italia Agricola, V101, P1031; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0; Zahniser JN, 2008, SYST BIODIVERS, V6, P1, DOI 10.1017/S1477200007002617	83	30	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36882	10.1371/journal.pone.0036882	http://dx.doi.org/10.1371/journal.pone.0036882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629338	Green Published, gold			2022-12-25	WOS:000305343500033
J	Vogelsang, M; Wang, YB; Veber, N; Mwapagha, LM; Parker, MI				Vogelsang, Matjaz; Wang, Yabing; Veber, Nika; Mwapagha, Lamech M.; Parker, M. Iqbal			The Cumulative Effects of Polymorphisms in the DNA Mismatch Repair Genes and Tobacco Smoking in Oesophageal Cancer Risk	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ALLELE-SPECIFIC PCR; MICROSATELLITE INSTABILITY; LUNG-CANCER; HAPLOTYPE RECONSTRUCTION; PROTEIN FUNCTION; SOUTH-AFRICA; HUMAN GENOME; ADENOCARCINOMA; SUSCEPTIBILITY	The DNA mismatch repair (MMR) enzymes repair errors in DNA that occur during normal DNA metabolism or are induced by certain cancer-contributing exposures. We assessed the association between 10 single-nucleotide polymorphisms (SNPs) in 5 MMR genes and oesophageal cancer risk in South Africans. Prior to genotyping, SNPs were selected from the HapMap database, based on their significantly different genotypic distributions between European ancestry populations and four HapMap populations of African origin. In the Mixed Ancestry group, the MSH3 rs26279 G/G versus A/A or A/G genotype was positively associated with cancer (OR = 2.71; 95% CI: 1.34-5.50). Similar associations were observed for PMS1 rs5742938 (GG versus AA or AG: OR = 1.73; 95% CI: 1.07-2.79) and MLH3 rs28756991 (AA or GA versus GG: OR = 2.07; 95% IC: 1.04-4.12). In Black individuals, however, no association between MMR polymorhisms and cancer risk was observed in individual SNP analysis. The interactions between MMR genes were evaluated using the model-based multifactor-dimensionality reduction approach, which showed a significant genetic interaction between SNPs in MSH2, MSH3 and PMS1 genes in Black and Mixed Ancestry subjects, respectively. The data also implies that pathogenesis of common polymorphisms in MMR genes is influenced by exposure to tobacco smoke. In conclusion, our findings suggest that common polymorphisms in MMR genes and/or their combined effects might be involved in the aetiology of oesophageal cancer.	[Vogelsang, Matjaz; Wang, Yabing; Veber, Nika; Mwapagha, Lamech M.; Parker, M. Iqbal] Int Ctr Genet Engn & Biotechnol, Cape Town Component, South Africa; [Vogelsang, Matjaz; Wang, Yabing; Veber, Nika; Mwapagha, Lamech M.; Parker, M. Iqbal] Univ Cape Town, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Vogelsang, Matjaz; Wang, Yabing; Veber, Nika; Mwapagha, Lamech M.; Parker, M. Iqbal] Univ Cape Town, IIDMM, ZA-7925 Cape Town, South Africa; [Vogelsang, Matjaz] Natl Inst Chem, Dept Biosynth & Biotransformat, Ljubljana, Slovenia	University of Cape Town; University of Cape Town; National Institute of Chemistry - Slovenia	Vogelsang, M (corresponding author), Int Ctr Genet Engn & Biotechnol, Cape Town Component, South Africa.	iqbal.parker@uct.ac.za		Mwapagha, Lamech/0000-0003-1048-1787	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; International Centre for Genetic Engineering and Biotechnology (ICGEB); South African MRC; University of Cape Town; ICGEB postdoctoral fellowship	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; International Centre for Genetic Engineering and Biotechnology (ICGEB); South African MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cape Town; ICGEB postdoctoral fellowship	This work was supported by the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation, the International Centre for Genetic Engineering and Biotechnology (ICGEB), the South African MRC and the University of Cape Town. MV is a recipient of an ICGEB postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Bye H, 2011, CARCINOGENESIS, V32, P1855, DOI 10.1093/carcin/bgr211; Calle ML, 2008, STAT MED, V27, P6532, DOI 10.1002/sim.3431; Cheung WY, 2009, GASTROENTEROL CLIN N, V38, P75, DOI 10.1016/j.gtc.2009.01.009; Conde J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-344; Dandara C, 2006, CARCINOGENESIS, V27, P791, DOI 10.1093/carcin/bgi257; Dodd LE, 2006, CANCER EPIDEM BIOMAR, V15, P2216, DOI 10.1158/1055-9965.EPI-06-0455; Doss CGP, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-42; Evans SC, 2004, CANCER LETT, V212, P241, DOI 10.1016/j.canlet.2004.03.011; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gauderman W, QUANTO 1 1 COMPUTER; Germer Soren, 2003, Methods Mol Biol, V212, P197; Gleeson CM, 1996, CANCER RES, V56, P259; Hendricks D, 2002, IUBMB LIFE, V53, P263, DOI 10.1080/15216540212643; Hirao T, 2001, CANCER RES, V61, P612; Hirata H, 2008, J UROLOGY, V179, P2020, DOI 10.1016/j.juro.2008.01.009; Hiyama T, 2007, INT J CANCER, V121, P1643, DOI 10.1002/ijc.23044; Hou YZ, 2007, J BIOL CHEM, V282, P9279, DOI 10.1074/jbc.M608523200; Ikeguchi M, 1999, ONCOLOGY-BASEL, V56, P164, DOI 10.1159/000011959; Jin ZH, 2006, J BIOL CHEM, V281, P14446, DOI 10.1074/jbc.M511914200; JORQUERA R, 1994, CARCINOGENESIS, V15, P389, DOI 10.1093/carcin/15.2.389; Kagawa Y, 2000, ANTICANCER RES, V20, P213; Kulke MH, 2001, CANCER-AM CANCER SOC, V91, P1451, DOI 10.1002/1097-0142(20010415)91:8<1451::AID-CNCR1152>3.0.CO;2-Z; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Layke JC, 2006, AM FAM PHYSICIAN, V73, P2187; Li DP, 2010, BMC GENET, V11, DOI [10.1186/1471-2156-11-47, 10.1186/1471-2164-11-446]; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Liu CY, 2010, CARCINOGENESIS, V31, P1259, DOI 10.1093/carcin/bgq092; Lo YL, 2011, LUNG CANCER, V72, P280, DOI 10.1016/j.lungcan.2010.10.009; Lukanich Jeanne M, 2003, Semin Thorac Cardiovasc Surg, V15, P158; Calle ML, 2010, BIOINFORMATICS, V26, P2198, DOI 10.1093/bioinformatics/btq352; Matejcic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029366; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; MELTZER SJ, 1994, CANCER RES, V54, P3379; Michiels S, 2007, CARCINOGENESIS, V28, P1731, DOI 10.1093/carcin/bgm111; Mijal RS, 2004, CHEM RES TOXICOL, V17, P424, DOI 10.1021/tx0342417; Muzeau F, 1997, BRIT J CANCER, V75, P1336, DOI 10.1038/bjc.1997.226; Naidoo R, 2005, J CLIN PATHOL, V58, P281, DOI 10.1136/jcp.2003.014290; NAKASHIMA H, 1995, INT J CANCER, V64, P286, DOI 10.1002/ijc.2910640413; National Health Laboratory Service National Cancer Registry of South Africa, 2004, INC HIST DIAGN CANC; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; OGASAWARA S, 1995, CANCER RES, V55, P891; Park SH, 2004, INT J CANCER, V112, P678, DOI 10.1002/ijc.20359; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Dutra LA, 2008, ARQ BRAS ENDOCRINOL, V52, P1362, DOI 10.1590/S0004-27302008000800026; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Uchida N, 2001, INT J CANCER, V91, P687, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1106>3.3.CO;2-D; Uehara H, 2005, J SURG ONCOL, V92, P109, DOI 10.1002/jso.20332; Wang L, 1996, ONCOGENE, V12, P699; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wangkumhang P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-275; Wei QY, 1998, CANCER EPIDEM BIOMAR, V7, P309; Yanagi M, 2000, VIRCHOWS ARCH, V437, P605, DOI 10.1007/s004280000322; Yang Chun-xia, 2005, Asian Pac J Cancer Prev, V6, P48	63	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36962	10.1371/journal.pone.0036962	http://dx.doi.org/10.1371/journal.pone.0036962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623965	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500042
J	Alvarado, VY; Odokonyero, D; Duncan, O; Mirkov, TE; Scholthof, HB				Alvarado, Veria Y.; Odokonyero, Denis; Duncan, Olivia; Mirkov, T. Erik; Scholthof, Herman B.			Molecular and Physiological Properties Associated with Zebra Complex Disease in Potatoes and Its Relation with Candidatus Liberibacter Contents in Psyllid Vectors	PLOS ONE			English	Article							POLYPHENOL OXIDASE; DIFFERENTIAL EXPRESSION; BACTERICERA-COCKERELLI; SOLANUM-TUBEROSUM; CHIP; TRANSMISSION; SOLANACEARUM; PLANT; ENDOSYMBIONTS; TRANSCRIPTION	Zebra complex (ZC) disease on potatoes is associated with Candidatus Liberibacter solanacearum (CLs), an alpha-proteobacterium that resides in the plant phloem and is transmitted by the potato psyllid Bactericera cockerelli (Sulc). The name ZC originates from the brown striping in fried chips of infected tubers, but the whole plants also exhibit a variety of morphological features and symptoms for which the physiological or molecular basis are not understood. We determined that compared to healthy plants, stems of ZC-plants accumulate starch and more than three-fold total protein, including gene expression regulatory factors (e. g. cyclophilin) and tuber storage proteins (e. g., patatins), indicating that ZC-affected stems are reprogrammed to exhibit tuber-like physiological properties. Furthermore, the total phenolic content in ZC potato stems was elevated two-fold, and amounts of polyphenol oxidase enzyme were also high, both serving to explain the ZC-hallmark rapid brown discoloration of air-exposed damaged tissue. Newly developed quantitative and/or conventional PCR demonstrated that the percentage of psyllids in laboratory colonies containing detectable levels of CLs and its titer could fluctuate over time with effects on colony prolificacy, but presumed reproduction-associated primary endosymbiont levels remained stable. Potato plants exposed in the laboratory to psyllid populations with relatively low-CLs content survived while exposure of plants to high-CLs psyllids rapidly culminated in a lethal collapse. In conclusion, we identified plant physiological biomarkers associated with the presence of ZC and/or CLs in the vegetative potato plant tissue and determined that the titer of CLs in the psyllid population directly affects the rate of disease development in plants.	[Alvarado, Veria Y.; Odokonyero, Denis; Duncan, Olivia; Mirkov, T. Erik; Scholthof, Herman B.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Mirkov, T. Erik] Texas A&M Syst, Texas AgriLife Res, Weslaco, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Alvarado, VY (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.	valvarado@tamu.edu			Texas Department of Agriculture through The Texas Agrilife Research Zebra Chip Disease Program	Texas Department of Agriculture through The Texas Agrilife Research Zebra Chip Disease Program	Texas Department of Agriculture through The Texas Agrilife Research Zebra Chip Disease Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado VY, 2010, P 10 ANN ZEBR CHIP R, P24; Barakat A, 2001, PLANT PHYSIOL, V127, P398, DOI 10.1104/pp.010265; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Binkley AM, 1929, SCIENCE, V70, P615, DOI 10.1126/science.70.1825.615; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CNAS, 2006, EC IMP ZEBR CHIP TEX; Crosslin JM, 2010, HIST MAKING POTATO Z; Czaninski Y, 1974, ELECT MICROSCOPY ENZ, P66; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Freire MA, 2005, GENE, V345, P271, DOI 10.1016/j.gene.2004.11.030; Goolsby J, 2010, 10 ANN ZEBR CHIP REP, P1; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; HANNAPEL DJ, 1990, PLANT PHYSIOL, V94, P919, DOI 10.1104/pp.94.3.919; HANNAPEL DJ, 1985, PLANT PHYSIOL, V78, P700, DOI 10.1104/pp.78.4.700; Kaur S, 2004, DIS MANAG FRUITS VEG, V1, P233; Kielbowicz-Matuk A, 2007, PHYSIOL PLANTARUM, V131, P387, DOI 10.1111/j.1399-3054.2007.00968.x; Levy J, 2011, PHYTOPATHOLOGY, V101, P1285, DOI 10.1094/PHYTO-04-11-0121; Li L, 2002, PLANTA, V215, P239, DOI 10.1007/s00425-002-0750-4; Li WB, 2009, J MICROBIOL METH, V78, P59, DOI 10.1016/j.mimet.2009.04.009; Liefting LW, 2008, PLANT DIS, V92, P1474, DOI 10.1094/PDIS-92-10-1474A; Lin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; Liu D, 2006, ENTOMOL EXP APPL, V118, P177, DOI 10.1111/j.1570-7458.2006.00383.x; MARQUES L, 1994, PHYTOCHEMISTRY, V36, P1117, DOI 10.1016/S0031-9422(00)89623-5; Marusek CM, 2006, J INORG BIOCHEM, V100, P108, DOI 10.1016/j.jinorgbio.2005.10.008; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Munyaneza JE., 2008, SUBPLANT SCI, V60, P27; Nachappa P, 2011, CURR MICROBIOL, V62, P1510, DOI 10.1007/s00284-011-9885-5; Navarre DA, 2009, AM J POTATO RES, V86, P88, DOI 10.1007/s12230-008-9060-0; Partington JC, 1999, PLANTA, V207, P449, DOI 10.1007/s004250050504; Pitman AR, 2011, EUR J PLANT PATHOL, V129, P389, DOI 10.1007/s10658-010-9702-1; Queiroz C, 2008, FOOD REV INT, V24, P361, DOI 10.1080/87559120802089332; Secor GA, 2009, PLANT DIS, V93, P574, DOI 10.1094/PDIS-93-6-0574; Secor GA, 2006, PLANT DIS, V90, P377, DOI 10.1094/PD-90-0377B; Sengoda VG, 2010, AM J POTATO RES, V87, P41, DOI 10.1007/s12230-009-9115-x; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Stupar RM, 2006, GENETICS, V172, P1263, DOI 10.1534/genetics.105.051219; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Tamborindeguy C, 2010, 10 ANN ZEBR CHIP REP, P164; Thao ML, 2000, CURR MICROBIOL, V41, P300, DOI 10.1007/s002840010138; THYGESEN PW, 1995, PLANT PHYSIOL, V109, P525, DOI 10.1104/pp.109.2.525; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wen A, 2009, PLANT DIS, V93, P1102, DOI 10.1094/PDIS-93-11-1102; WENZLER HC, 1989, PLANT MOL BIOL, V12, P41, DOI 10.1007/BF00017446; Zhang SJ, 2011, MOL PLANT MICROBE IN, V24, P458, DOI 10.1094/MPMI-11-10-0256; ZHENG XM, 1990, NATURE, V344, P556, DOI 10.1038/344556a0; Zourelidou M, 2002, PLANT J, V30, P489, DOI 10.1046/j.1365-313X.2002.01302.x	46	32	33	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37345	10.1371/journal.pone.0037345	http://dx.doi.org/10.1371/journal.pone.0037345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615987	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200065
J	Curriu, M; Carrillo, J; Massanella, M; Garcia, E; Cunyat, F; Pena, R; Wienberg, P; Carrato, C; Areal, J; Bofill, M; Clotet, B; Blanco, J; Cabrera, C				Curriu, Marta; Carrillo, Jorge; Massanella, Marta; Garcia, Elisabet; Cunyat, Francesc; Pena, Ruth; Wienberg, Peter; Carrato, Cristina; Areal, Joan; Bofill, Margarita; Clotet, Bonaventura; Blanco, Julia; Cabrera, Cecilia			Susceptibility of Human Lymphoid Tissue Cultured ex vivo to Xenotropic Murine Leukemia Virus-Related Virus (XMRV) Infection	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; APOBEC3 CYTIDINE DEAMINASES; PROSTATE CARCINOMA-CELLS; RETROVIRUS XMRV; UNITED-STATES; ENDOGENOUS RETROVIRUSES; GAMMARETROVIRUS XMRV; CXCR4-TROPIC HIV-1; INTEGRATION SITES; VIRAL-INFECTIONS	Background: Xenotropic murine leukemia virus-related virus (XMRV) was generated after a recombination event between two endogenous murine leukemia viruses during the production of a prostate cancer cell line. Although the associations of the XMRV infection with human diseases appear unlikely, the XMRV is a retrovirus of undefined pathogenic potential, able to replicate in human cells in vitro. Since recent studies using animal models for infection have yielded conflicting results, we set out an ex vivo model for XMRV infection of human tonsillar tissue to determine whether XMRV produced by 22Rv1 cells is able to replicate in human lymphoid organs. Tonsil blocks were infected and infection kinetics and its pathogenic effects were monitored Results: XMRV, though restricted by APOBEC, enters and integrates into the tissue cells. The infection did not result in changes of T or B-cells, immune activation, nor inflammatory chemokines. Infectious viruses could be recovered from supernatants of infected tonsils by reinfecting DERSE XMRV indicator cell line, although these supernatants could not establish a new infection in fresh tonsil culture, indicating that in our model, the viral replication is controlled by innate antiviral restriction factors. Conclusions: Overall, the replication-competent retrovirus XMRV, present in a high number of laboratories, is able to infect human lymphoid tissue and produce infectious viruses, even though they were unable to establish a new infection in fresh tonsillar tissue. Hereby, laboratories working with cell lines producing XMRV should have knowledge and understanding of the potential biological biohazardous risks of this virus.	[Curriu, Marta; Carrillo, Jorge; Massanella, Marta; Garcia, Elisabet; Cunyat, Francesc; Pena, Ruth; Bofill, Margarita; Clotet, Bonaventura; Blanco, Julia; Cabrera, Cecilia] Univ Autonoma Barcelona, IrsiCaixa HIVACAT, Inst Recerca Ciencies Salut Germans Trias & Pujol, Hosp Germans Trias, E-08193 Barcelona, Spain; [Wienberg, Peter] Hosp Univ St Joan de Deu, Dept Otorhinolaryngol, Barcelona, Spain; [Carrato, Cristina] Hosp Badalona Germans Trias & Pujol, Dept Pathol, Barcelona, Spain; [Areal, Joan] Hosp Badalona Germans Trias & Pujol, Dept Urol, Barcelona, Spain; [Bofill, Margarita] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Clotet, Bonaventura] Univ Autonoma Barcelona, Lluita SIDA Fdn, Inst Recerca Ciencies Salut Germans Trias & Pujol, Hosp Univ Germans Trias & Pujol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; ICREA; Autonomous University of Barcelona; Hospital Germans Trias i Pujol	Curriu, M (corresponding author), Univ Autonoma Barcelona, IrsiCaixa HIVACAT, Inst Recerca Ciencies Salut Germans Trias & Pujol, Hosp Germans Trias, Carretera Canyet S-N, E-08193 Barcelona, Spain.	ccabrera@irsicaixa.es	Cabrera, Cecilia/S-1113-2019; Carrato, Cristina/K-6923-2017; Blanco, Julià/A-5347-2008; Massanella, Marta/P-8619-2016; Carrillo, Jorge/AAL-9481-2021	Cabrera, Cecilia/0000-0002-9941-6828; Carrato, Cristina/0000-0002-1953-8287; Blanco, Julià/0000-0002-2225-0217; Massanella, Marta/0000-0002-3326-151X; Carrillo, Jorge/0000-0003-0221-5948; Cunyat, Francesc/0000-0002-1284-6324	Fundacion para la Investigacion en Urologia; "Rafael Molla y Rodrigo" scholarship; ayuda de investigacion Pedro Cifuentes Diaz; Health Department of the Catalan Government (Generalitat de Catalunya); Spanish AIDS network "Red Tematica Cooperativa de Investigacion en SIDA" contract; Fondo de. Investigacion Sanitaria project [07/0418]; Sara Borrell postdoctoral program; ICREA Funding Source: Custom	Fundacion para la Investigacion en Urologia; "Rafael Molla y Rodrigo" scholarship; ayuda de investigacion Pedro Cifuentes Diaz; Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); Spanish AIDS network "Red Tematica Cooperativa de Investigacion en SIDA" contract; Fondo de. Investigacion Sanitaria project; Sara Borrell postdoctoral program; ICREA(ICREA)	This work was supported by the Fundacion para la Investigacion en Urologia with a "Rafael Molla y Rodrigo" scholarship and the "ayuda de investigacion Pedro Cifuentes Diaz". C. Cabrera and JB are researchers from Fundacio Institut de Recerca en Ciencies de la Salut Germans Trias i Pujol supported by the Health Department of the Catalan Government (Generalitat de Catalunya). MC is supported by a Spanish AIDS network "Red Tematica Cooperativa de Investigacion en SIDA" contract. FC is supported by the Fondo de. Investigacion Sanitaria project 07/0418 and JC by the Sara Borrell postdoctoral program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHONG BG, 1976, BRIT J CANCER, V34, P203, DOI 10.1038/bjc.1976.144; Akgul B, 2011, MED MICROBIOL IMMUNO; Alberts B, 2011, SCIENCE; Alberts B, 2011, SCIENCE, V334, P1636, DOI 10.1126/science.334.6063.1636-a; Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Baliji S, 2010, J VIROL, V84, P12841, DOI 10.1128/JVI.01863-10; Barnes E, 2010, J INFECT DIS, V202, P1482, DOI 10.1086/657167; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; Bogerd HP, 2011, VIROLOGY, V410, P234, DOI 10.1016/j.virol.2010.11.011; Brenu EW, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-81; BURTONBOY G, 1993, ARCH VIROL, V130, P289, DOI 10.1007/BF01309661; Chaipan C, 2011, J VIROL, V85, P4888, DOI 10.1128/JVI.00046-11; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Cool M, 2011, VIROLOGY; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; de Boer EC, 2000, J UROLOGY, V163, P1999, DOI 10.1016/S0022-5347(05)67617-3; Deichmann M, 2005, ARCH DERMATOL RES, V296, P345, DOI 10.1007/s00403-004-0501-4; Del Prete GQ, 2012, J VIROL, V86, P3152, DOI 10.1128/JVI.06886-11; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Dutko JA, 2005, CURR BIOL, V15, P661, DOI 10.1016/j.cub.2005.02.051; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Fischer N, 2010, EMERG INFECT DIS, V16, P1000, DOI 10.3201/eid1606.100066; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; GAUTSCH JW, 1980, P NATL ACAD SCI-BIOL, V77, P2247, DOI 10.1073/pnas.77.4.2247; Glushakova S, 1997, AIDS RES HUM RETROV, V13, P461, DOI 10.1089/aid.1997.13.461; GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320; Grivel JC, 2003, J VIROL, V77, P8280, DOI 10.1128/JVI.77.15.8280-8289.2003; Grivel JC, 2003, AIDS RES HUM RETROV, V19, P211, DOI 10.1089/088922203763315713; Grivel JC, 2007, AIDS, V21, P1263, DOI 10.1097/QAD.0b013e3281864667; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Henrich TJ, 2010, J INFECT DIS, V202, P1478, DOI 10.1086/657168; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Ito Y, 2004, J INFECT DIS, V189, P506, DOI 10.1086/381153; Katzourakis A, 2011, J VIROL; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; KOTLER M, 1977, ISRAEL J MED SCI, V13, P740; KOZAK CA, 1984, J VIROL, V51, P77, DOI 10.1128/JVI.51.1.77-80.1984; Levy JA, 1999, P NATL ACAD SCI USA, V96, P802, DOI 10.1073/pnas.96.3.802; Lo SC, 2012, P NATL ACAD SCI USA, V109, P346, DOI 10.1073/pnas.1119641109; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2011, IN VIVO, V25, P307; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Martinez-Fierro ML, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-326; Mi Z, 2011, TRANSFUSION; Nagabhushan M, 1996, CANCER RES, V56, P3042; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; OIE HK, 1976, J NATL CANCER I, V56, P423, DOI 10.1093/jnci/56.2.423; Onlamoon N, 2011, J VIROL, V85, P4547, DOI 10.1128/JVI.02411-10; Paprotka T, 2011, SCIENCE; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; PRETLOW TG, 1993, J NATL CANCER I, V85, P394, DOI 10.1093/jnci/85.5.394; Raisch KP, 1998, VIROLOGY, V250, P135, DOI 10.1006/viro.1998.9363; Ravichandran V, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-443; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Rodriguez JJ, 2010, J VIROL, V84, P2556, DOI 10.1128/JVI.01969-09; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Rulli SJ, 2008, J VIROL, V82, P6566, DOI 10.1128/JVI.01357-07; Rusmevichientong A, 2011, J VIROL, V85, P12830, DOI 10.1128/JVI.05624-11; Sabunciyan S, 2011, MOL CELL PROBE, V25, P134, DOI 10.1016/j.mcp.2011.01.005; Sakuma R, 2010, VIROLOGY, V397, P1, DOI 10.1016/j.virol.2009.11.013; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Satterfield BC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-12; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sfanos KS, 2008, PROSTATE, V68, P306, DOI 10.1002/pros.20680; Sfanos KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020874; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shin CH, 2011, J VIROL; Silverman RH, 2011, SCIENCE, V334, P176, DOI 10.1126/science.334.6053.176-a; Singh IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009948; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stieler K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025592; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; Stieler K, 2010, VIROLOGY, V399, P23, DOI 10.1016/j.virol.2009.12.028; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; SUZUKI T, 1977, GANN, V68, P99; Switzer WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019065; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; TODARO GJ, 1973, P NATL ACAD SCI USA, V70, P859, DOI 10.1073/pnas.70.3.859; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Verhaegh GW, 2011, PROSTATE, V71, P415, DOI 10.1002/pros.21255; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Wolff D, 2011, CLIN LAB, V57, P631; YANIV A, 1980, INT J CANCER, V25, P205, DOI 10.1002/ijc.2910250207; Zhang YA, 2011, CANCER BIOL THER, V12, P617, DOI 10.4161/cbt.12.7.15955; Zhao CQ, 2004, J IMMUNOL, V172, P3086, DOI 10.4049/jimmunol.172.5.3086	103	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37415	10.1371/journal.pone.0037415	http://dx.doi.org/10.1371/journal.pone.0037415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22616002	Green Published, gold			2022-12-25	WOS:000305341300111
J	Amengual, J; Golczak, M; Palczewski, K; von Lintig, J				Amengual, Jaume; Golczak, Marcin; Palczewski, Krzysztof; von Lintig, Johannes			Lecithin: Retinol Acyltransferase Is Critical for Cellular Uptake of Vitamin A from Serum Retinol-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; MICE LACKING; PLASMA RETINOL; KNOCKOUT MICE; ACID RECEPTOR; VISUAL CYCLE; EXPRESSION; FENRETINIDE; METABOLISM; STRA6	Vitamin A (all-trans-retinol) must be adequately distributed within the mammalian body to produce visual chromophore in the eyes and all-trans-retinoic acid in other tissues. Vitamin A is transported in the blood bound to retinol-binding protein (holo-RBP), and its target cells express an RBP receptor encoded by the Stra6 (stimulated by retinoic acid 6) gene. Here we show in mice that cellular uptake of vitamin A from holo-RBP depends on functional coupling of STRA6 with intracellular lecithin: retinol acyltransferase (LRAT). Thus, vitamin A uptake from recombinant holo-RBP exhibited by wild type mice was impaired in Lrat(-/-) mice. We further provide evidence that vitamin A uptake is regulated by all-trans-retinoic acid in non-ocular tissues of mice. When in excess, vitamin A was rapidly taken up and converted to its inert ester form in peripheral tissues, such as lung, whereas in vitamin A deficiency, ocular retinoid uptake was favored. Finally, we show that the drug fenretinide, used clinically to presumably lower blood RBP levels and thus decrease circulating retinol, targets the functional coupling of STRA6 and LRAT to increase cellular vitamin A uptake in peripheral tissues. These studies provide mechanistic insights into how vitamin A is distributed to peripheral tissues in a regulated manner and identify LRAT as a critical component of this process.	[Amengual, Jaume; Golczak, Marcin; Palczewski, Krzysztof; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	von Lintig, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol W333, 10900 Euclid Ave, Cleveland, OH 44106 USA.	johannes.vonlintig@case.edu		von Lintig, Johannes/0000-0002-2079-2143	National Institutes of Health [EY019641, EY020551]; NATIONAL EYE INSTITUTE [R01EY019641, R01EY020551, R01EY009339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019641 and EY020551.	Abu-Abed SS, 1998, J BIOL CHEM, V273, P2409, DOI 10.1074/jbc.273.4.2409; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BERNI R, 1992, FEBS LETT, V308, P43, DOI 10.1016/0014-5793(92)81046-O; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Blaner WS, 2007, CELL METAB, V5, P164, DOI 10.1016/j.cmet.2007.02.006; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; Cooper JP, 2011, BRIT J PHARMACOL, V163, P1263, DOI 10.1111/j.1476-5381.2011.01310.x; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; DECENSI A, 1994, J NATL CANCER I, V86, P105, DOI 10.1093/jnci/86.2.105; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; Felipe F, 2004, DIABETES, V53, P882, DOI 10.2337/diabetes.53.4.882; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; GOODMAN DS, 1965, J LIPID RES, V6, P390; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; KAISERKUPFER MI, 1986, ARCH OPHTHALMOL-CHIC, V104, P69; KAJI EH, 1993, J BIOL CHEM, V268, P22188; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2011, ACS CHEM BIOL, V6, P1041, DOI 10.1021/cb200178w; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Matsuura T, 1997, J NUTR, V127, P218, DOI 10.1093/jn/127.2.218; Motani A, 2009, J BIOL CHEM, V284, P7673, DOI 10.1074/jbc.M809654200; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Paik J, 2004, J NUTR, V134, p276S, DOI 10.1093/jn/134.1.276S; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Preitner F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1420, DOI 10.1152/ajpendo.00362.2009; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2002, J BIOL CHEM, V277, P30191, DOI 10.1074/jbc.M205046200; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Ribot J, 2001, OBES RES, V9, P500, DOI 10.1038/oby.2001.65; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; Saari JC, 2002, INVEST OPHTH VIS SCI, V43, P1730; van Bennekum AM, 1999, J LIPID RES, V40, P565; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Wu LL, 2010, J LIPID RES, V51, P378, DOI 10.1194/jlr.M001222; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; ZHAO ZR, 1994, NAT IMMUN, V13, P280; Zolfaghari R, 2002, J NUTR, V132, P1160, DOI 10.1093/jn/132.6.1160	42	71	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24216	24227		10.1074/jbc.M112.353979	http://dx.doi.org/10.1074/jbc.M112.353979			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637576	hybrid, Green Published			2022-12-25	WOS:000306651100016
J	Hochstatter, J; Holzel, M; Rohrmoser, M; Schermelleh, L; Leonhardt, H; Keough, R; Gonda, TJ; Imhof, A; Eick, D; Langst, G; Nemeth, A				Hochstatter, Julia; Hoelzel, Michael; Rohrmoser, Michaela; Schermelleh, Lothar; Leonhardt, Heinrich; Keough, Rebecca; Gonda, Thomas J.; Imhof, Axel; Eick, Dirk; Laengst, Gernot; Nemeth, Attila			Myb-binding Protein 1a (Mybbp1a) Regulates Levels and Processing of Pre-ribosomal RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-I TRANSCRIPTION; FACTOR TIF-IA; NUCLEAR ANTIGEN 1; SACCHAROMYCES-CEREVISIAE; NUCLEOLAR PROTEIN; MOLECULAR-CLONING; GENE-EXPRESSION; DEPENDENT TRANSCRIPTION; YEAST; CHROMATIN	Ribosomal RNA gene transcription, co-transcriptional processing, and ribosome biogenesis are highly coordinated processes that are tightly regulated during cell growth. In this study we discovered that Mybbp1a is associated with both the RNA polymerase I complex and the ribosome biogenesis machinery. Using a reporter assay that uncouples transcription and RNA processing, we show that Mybbp1a represses rRNA gene transcription. In addition, overexpression of the protein reduces RNA polymerase I loading on endogenous rRNA genes as revealed by chromatin immunoprecipitation experiments. Accordingly, depletion of Mybbp1a results in an accumulation of the rRNA precursor in vivo but surprisingly also causes growth arrest of the cells. This effect can be explained by the observation that the modulation of Mybbp1a protein levels results in defects in pre-rRNA processing within the cell. Therefore, the protein may play a dual role in the rRNA metabolism, potentially linking and coordinating ribosomal DNA transcription and pre-rRNA processing to allow for the efficient synthesis of ribosomes.	[Hochstatter, Julia; Laengst, Gernot; Nemeth, Attila] Univ Regensburg, Biochem Ctr Regensburg, D-93053 Regensburg, Germany; [Hoelzel, Michael; Rohrmoser, Michaela; Eick, Dirk] Helmholtz Ctr Munich, Dept Mol Epigenet, D-81377 Munich, Germany; [Hoelzel, Michael; Rohrmoser, Michaela; Eick, Dirk] Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany; [Hochstatter, Julia; Imhof, Axel] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Hochstatter, Julia; Imhof, Axel] Univ Munich, Munich Ctr Integrated Prot Sci, D-80336 Munich, Germany; [Keough, Rebecca] Flinders Univ S Australia, Sch Med, Adelaide, SA 5001, Australia; [Gonda, Thomas J.] Univ Queensland Res Wing, Diamantina Inst Canc Immunol & Metab Med, Buranda, Qld 4102, Australia; [Schermelleh, Lothar; Leonhardt, Heinrich] Univ Munich, Dept Biol, D-82152 Martinsried, Germany; [Schermelleh, Lothar; Leonhardt, Heinrich] Univ Munich, Ctr Integrated Prot Sci, D-82152 Martinsried, Germany	University of Regensburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Munich; Flinders University South Australia; University of Queensland; University of Munich; University of Munich	Langst, G (corresponding author), Univ Regensburg, Biochem Ctr Regensburg, Univ Str 31, D-93053 Regensburg, Germany.	gernot.laengst@vkl.uni-regensburg.de; attila.nemeth@vkl.uni-regensburg.de	Leonhardt, Heinrich/B-2791-2014; Imhof, Axel/AAU-5313-2021; Schermelleh, Lothar/H-4588-2019; Längst, Gernot/G-5287-2015	Imhof, Axel/0000-0003-2993-8249; Schermelleh, Lothar/0000-0002-1612-9699; Längst, Gernot/0000-0002-8232-1179; Gonda, Thomas/0000-0002-8792-3021; Groth, Julia/0000-0002-7676-6964	Deutsche Forschungsgemeinschaft; Bayerisches Genomforschungsnetzwerk (BayGene)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayerisches Genomforschungsnetzwerk (BayGene)	This work was supported by Deutsche Forschungsgemeinschaft grants (to G. L., D. E., A. I., and H. L.) and the Bayerisches Genomforschungsnetzwerk (BayGene) (to G. L.).	Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; Bodem J, 2000, EMBO REP, V1, P171, DOI 10.1093/embo-reports/kvd032; BUTTGEREIT D, 1985, NUCLEIC ACIDS RES, V13, P8165, DOI 10.1093/nar/13.22.8165; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; CHRISTENSEN ME, 1992, CELL BIOL INT REP, V16, P1119, DOI 10.1016/S0309-1651(05)80038-4; Diaz VM, 2007, MOL CELL BIOL, V27, P7981, DOI 10.1128/MCB.01290-07; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; EVERS R, 1995, EMBO J, V14, P1248, DOI 10.1002/j.1460-2075.1995.tb07108.x; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Gambe AE, 2009, FEBS LETT, V583, P1951, DOI 10.1016/j.febslet.2009.05.033; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Granneman S, 2005, CURR OPIN CELL BIOL, V17, P281, DOI 10.1016/j.ceb.2005.04.001; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Hara Y, 2009, NUCLEIC ACIDS RES, V37, P1115, DOI 10.1093/nar/gkn1013; Henning D, 2003, J BIOL CHEM, V278, P52307, DOI 10.1074/jbc.M310846200; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Holmstrom TH, 2008, J BIOL CHEM, V283, P7046, DOI 10.1074/jbc.M709613200; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Hong B, 1997, MOL CELL BIOL, V17, P378, DOI 10.1128/MCB.17.1.378; Jones LC, 2002, J BIOL CHEM, V277, P22515, DOI 10.1074/jbc.M200740200; Keough R, 1999, GENOMICS, V62, P483, DOI 10.1006/geno.1999.6035; Keough RA, 2003, EXP CELL RES, V289, P108, DOI 10.1016/S0014-4827(03)00262-3; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Kuroda T, 2011, EMBO J, V30, P1054, DOI 10.1038/emboj.2011.23; Li JW, 2006, EMBO J, V25, P5735, DOI 10.1038/sj.emboj.7601454; MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Melnik S, 2011, NAT METHODS, V8, P963, DOI [10.1038/NMETH.1705, 10.1038/nmeth.1705]; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; MOUGEY EB, 1993, GENE DEV, V7, P1609, DOI 10.1101/gad.7.8.1609; Nadeem FK, 2006, MOL GENET GENOMICS, V276, P391, DOI 10.1007/s00438-006-0144-6; Nemeth A, 2004, NUCLEIC ACIDS RES, V32, P4091, DOI 10.1093/nar/gkh732; Nemeth A, 2008, EPIGENETICS-US, V3, P243, DOI 10.4161/epi.3.5.6913; Nemeth A, 2008, EMBO J, V27, P1255, DOI 10.1038/emboj.2008.57; Nemeth A, 2011, TRENDS GENET, V27, P149, DOI 10.1016/j.tig.2011.01.002; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Owen HR, 2007, J MOL BIOL, V366, P725, DOI 10.1016/j.jmb.2006.11.099; Perrera C, 2010, J BIOL CHEM, V285, P11775, DOI 10.1074/jbc.M109.068312; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; SCHNAPP A, 1990, EMBO J, V9, P2857, DOI 10.1002/j.1460-2075.1990.tb07475.x; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Seither P, 1996, GENOMICS, V37, P135, DOI 10.1006/geno.1996.0531; Seither P, 1997, CHROMOSOMA, V106, P216, DOI 10.1007/s004120050242; Shimizu K, 2002, P NATL ACAD SCI USA, V99, P9133, DOI 10.1073/pnas.142277999; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Tavner FJ, 1998, MOL CELL BIOL, V18, P989, DOI 10.1128/MCB.18.2.989; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Tsujii R, 2000, GENES CELLS, V5, P543, DOI 10.1046/j.1365-2443.2000.00346.x; Tsuno A, 2000, MOL CELL BIOL, V20, P2066, DOI 10.1128/MCB.20.6.2066-2074.2000; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wu H, 2000, EMBO REP, V1, P140, DOI 10.1093/embo-reports/kvd026; Yamauchi T, 2008, GENES CELLS, V13, P27, DOI 10.1111/j.1365-2443.2007.01148.x; Yanagida M, 2004, J BIOL CHEM, V279, P1607, DOI 10.1074/jbc.M305604200; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Zhao J, 2003, MOL CELL, V11, P405, DOI 10.1016/S1097-2765(03)00036-4	69	29	30	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24365	24377		10.1074/jbc.M111.303719	http://dx.doi.org/10.1074/jbc.M111.303719			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645127	hybrid, Green Published			2022-12-25	WOS:000306651100031
J	Sanyal, S; Claessen, JHL; Ploegh, HL				Sanyal, Sumana; Claessen, Jasper H. L.; Ploegh, Hidde L.			A Viral Deubiquitylating Enzyme Restores Dislocation of Substrates from the Endoplasmic Reticulum (ER) in Semi-intact Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I HEAVY-CHAINS; PROTEIN DISLOCATION; RETRO-TRANSLOCATION; DEGRADATION; COMPLEX; CYTOSOL; TRANSPORT; RETROTRANSLOCATION; GLYCOPROTEIN; PROTEASOME	Terminally misfolded glycoproteins are ejected from the endoplasmic reticulum (ER) to the cytosol and are destroyed by the ubiquitin proteasome system. A dominant negative version of the deubiquitylating enzyme Yod1 (Yod1C160S) causes accumulation of dislocation substrates in the ER. Failure to remove ubiquitin from the dislocation substrate might therefore stall the reaction at the exit site from the ER. We hypothesized that addition of a promiscuous deubiquitylase should overcome this blockade and restore dislocation. We monitored ER-to-cytosol transport of misfolded proteins in cells permeabilized at high cell density by perfringolysin O, a pore-forming cytolysin. This method allows ready access of otherwise impermeant reagents to the intracellular milieu with minimal dilution of cytoplasmic components. We show that addition of the purified Epstein-Barr virus deubiquitylase to semi-intact cells indeed initiates dislocation of a stalled substrate intermediate, resulting in stabilization of substrates in the cytosol. Our data provide new mechanistic insight in the dislocation reaction and support a model where failure to deubiquitylate an ER-resident protein occludes the dislocon and causes upstream misfolded intermediates to accumulate.	[Ploegh, Hidde L.] MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Ploegh, HL (corresponding author), MIT, Whitehead Inst Biomed Res, Dept Biol, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	Sanyal, Sumana/AAF-5155-2020; Sanyal, Sumana/I-7975-2013	Sanyal, Sumana/0000-0002-6230-5366	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants (to H. L. P.).	BALCH WE, 1990, TRENDS BIOCHEM SCI, V15, P473, DOI 10.1016/0968-0004(90)90301-Q; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Claessen JHL, 2010, J BIOL CHEM, V285, P20732, DOI 10.1074/jbc.M110.120766; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Flanagan JJ, 2009, BIOCHEMISTRY-US, V48, P3977, DOI 10.1021/bi9002309; Furman MH, 2002, J BIOL CHEM, V277, P3258, DOI 10.1074/jbc.M109765200; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; IKONEN E, 1995, CELL, V81, P571, DOI 10.1016/0092-8674(95)90078-0; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Nelson LD, 2010, BIOPHYS J, V99, P3255, DOI 10.1016/j.bpj.2010.09.028; Olzmann JA, 2011, J BIOL CHEM, V286, P27872, DOI 10.1074/jbc.C111.266452; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Symons M, 2003, CURR BIOL, V13, pR409, DOI 10.1016/S0960-9822(03)00324-5; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800	32	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23594	23603		10.1074/jbc.M112.365312	http://dx.doi.org/10.1074/jbc.M112.365312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22619172	hybrid, Green Published			2022-12-25	WOS:000306511300030
J	Zhao, T; Huang, XH; Han, L; Wang, XH; Cheng, HQ; Zhao, YG; Chen, Q; Chen, J; Cheng, HP; Xiao, RP; Zheng, M				Zhao, Ting; Huang, Xiaohu; Han, Liang; Wang, Xianhua; Cheng, Hongqiang; Zhao, Yungang; Chen, Quan; Chen, Ju; Cheng, Heping; Xiao, Ruiping; Zheng, Ming			Central Role of Mitofusin 2 in Autophagosome-Lysosome Fusion in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL FUSION; ISCHEMIA/REPERFUSION INJURY; ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; PROTEIN; GTPASE; MUSCLE; ACCUMULATION; MEMBRANES; HEART	In the heart, autophagy has been implicated in cardioprotection and ischemia-reperfusion tolerance, and the dysregulation of autophagy is associated with the development of heart failure. Mitochondrial dynamic proteins are profoundly involved in autophagic processes, especially the initiation and formation of autophagosomes, but it is not clear whether they play any role in cardiac autophagy. We previously reported that mitofusin 2 (MFN2), a mitochondrial outer membrane protein, serves as a major determinant of cardiomyocyte apoptosis mediated by oxidative stress. Here, we reveal a novel and essential role of MFN2 in mediating cardiac autophagy. We found that specific deletion of MFN2 in cardiomyocytes caused extensive accumulation of autophagosomes. In particular, the fusion of autophagosomes with lysosomes, a critical step in autophagic degradation, was markedly retarded without altering the formation of autophagosomes and lysosomes in response to ischemia-reperfusion stress. Importantly, MFN2 co-immunoprecipitated with RAB7 in the heart, and starvation further increased it. Knockdown of MFN2 by shRNA prevented, whereas re-expression of MFN2 restored, the autophagosome-lysosome fusion in neonatal cardiomyocytes. Hearts from cardiac-specific MFN2 knockout mice had abnormal mitochondrial and cellular metabolism and were vulnerable to ischemia-reperfusion challenge. Our study defined a novel and essential role of MFN2 in the cardiac autophagic process by mediating the maturation of autophagy at the phase of autophagosome-lysosome fusion; deficiency of MFN2 caused multiple molecular and functional defects that undermined cardiac reserve and gradually led to cardiac vulnerability and dysfunction.	[Zhao, Ting; Huang, Xiaohu; Han, Liang; Wang, Xianhua; Zhao, Yungang; Cheng, Heping; Xiao, Ruiping; Zheng, Ming] Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Cheng, Hongqiang; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Chen, Quan] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China	Peking University; University of California System; University of California San Diego; Chinese Academy of Sciences; Institute of Zoology, CAS	Zheng, M (corresponding author), Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.	zhengm@pku.edu.cn	Chen, Ju/E-5579-2011; Huang, Xiaohu/R-2399-2017; cheng, heping/A-7299-2011; Yimei, Wang/AAE-4083-2019; Xiao, Rui-Ping/AAE-2629-2019; Heping, Cheng/AAE-2680-2019; Huang, Xiaohu/H-6446-2019	Huang, Xiaohu/0000-0003-4580-4582; Heping, Cheng/0000-0002-9604-6702; Huang, Xiaohu/0000-0003-4580-4582; Chen, Quan/0000-0001-7539-8728; Cheng, Hongqiang/0000-0001-9662-1570	National Science Foundation of China [30770870, 30971062]; National Key Basic Research Program of China [2007CB512100]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066100] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Science Foundation of China Grants 30770870 and 30971062 and National Key Basic Research Program of China Grant 2007CB512100.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Amiott EA, 2008, EXP NEUROL, V211, P115, DOI 10.1016/j.expneurol.2008.01.010; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; BING RJ, 1954, AM J MED, V16, P504, DOI 10.1016/0002-9343(54)90365-4; Birkedal R, 2006, AM J PHYSIOL-CELL PH, V291, pC1148, DOI 10.1152/ajpcell.00236.2006; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Guo XM, 2007, CIRC RES, V101, P1113, DOI 10.1161/CIRCRESAHA.107.157644; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Inuzuka Y, 2009, CIRCULATION, V120, P1695, DOI 10.1161/CIRCULATIONAHA.109.871137; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; McEwan DG, 2010, CELL, V141, P564, DOI 10.1016/j.cell.2010.04.030; Minamisawa S, 1999, J BIOL CHEM, V274, P10066, DOI 10.1074/jbc.274.15.10066; Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V302, pH167, DOI 10.1152/ajpheart.00833.2011; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rojo M, 2002, J CELL SCI, V115, P1663; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Sciarretta S, 2011, PEDIATR CARDIOL, V32, P275, DOI 10.1007/s00246-010-9855-x; Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Stroikin Y, 2004, EUR J CELL BIOL, V83, P583, DOI 10.1078/0171-9335-00433; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769; Terman A, 2004, ANN NY ACAD SCI, V1019, P70, DOI 10.1196/annals.1297.015; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zheng M, 2010, J MOL MED, V88, P987, DOI 10.1007/s00109-010-0675-5; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	60	142	150	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23615	23625		10.1074/jbc.M112.379164	http://dx.doi.org/10.1074/jbc.M112.379164			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22619176	Green Published, hybrid			2022-12-25	WOS:000306511300032
J	Bottcher, C; Dennis, EG; Booker, GW; Polyak, SW; Boss, PK; Davies, C				Boettcher, Christine; Dennis, Eric G.; Booker, Grant W.; Polyak, Steven W.; Boss, Paul K.; Davies, Christopher			A Novel Tool for Studying Auxin-Metabolism: The Inhibition of Grapevine Indole-3-Acetic Acid-Amido Synthetases by a Reaction Intermediate Analogue	PLOS ONE			English	Article							VITIS-VINIFERA L.; EVOLUTIONARY HISTORY; CRYSTAL-STRUCTURES; GH3 FAMILY; ARABIDOPSIS; EXPRESSION; ADENYLATE; HYPOCOTYL; GENE; BIOSYNTHESIS	An important process for the regulation of auxin levels in plants is the inactivation of indole-3-acetic acid (IAA) by conjugation to amino acids. The conjugation reaction is catalysed by IAA-amido synthetases belonging to the family of GH3 proteins. Genetic approaches to study the biological significance of these enzymes have been hampered by large gene numbers and a high degree of functional redundancy. To overcome these difficulties a chemical approach based on the reaction mechanism of GH3 proteins was employed to design a small molecule inhibitor of IAA-amido synthetase activity. Adenosine-5'-[2-(1H-indol-3-yl)ethyl]phosphate (AIEP) mimics the adenylated intermediate of the IAA-conjugation reaction and was therefore proposed to compete with the binding of MgATP and IAA in the initial stages of catalysis. Two grapevine IAA-amido synthetases with different catalytic properties were chosen to test the inhibitory effects of AIEP in vitro. GH3-1 has previously been implicated in the grape berry ripening process and is restricted to two amino acid substrates, whereas GH3-6 conjugated IAA to 13 amino acids. AIEP is the most potent inhibitor of GH3 enzymes so far described and was shown to be competitive against MgATP and IAA binding to both enzymes with K-i-values 17-68-fold lower than the respective K-m-values. AIEP also exhibited in vivo activity in an ex planta test system using young grape berries. Exposure to 5-20 mu M of the inhibitor led to decreased levels of the common conjugate IAA-Asp and reduced the accumulation of the corresponding Asp-conjugate upon treatment with a synthetic auxin. AIEP therefore represents a novel chemical probe with which to study IAA-amido synthetase function.	[Boettcher, Christine; Dennis, Eric G.; Boss, Paul K.; Davies, Christopher] CSIRO Plant Ind, Glen Osmond, SA, Australia; [Booker, Grant W.; Polyak, Steven W.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide	Bottcher, C (corresponding author), CSIRO Plant Ind, Glen Osmond, SA, Australia.	christine.bottcher@csiro.au	Boettcher, Christine/AAW-8080-2021; davies, christopher/F-3363-2010; Polyak, Steven W/A-7488-2019; Boss, Paul K/A-1292-2010; Bottcher, Christine/H-3323-2012; Polyak, Steven W./G-3185-2011	Boettcher, Christine/0000-0003-3317-5264; Polyak, Steven W/0000-0002-8458-5194; Boss, Paul K/0000-0003-0356-9342; Bottcher, Christine/0000-0003-3317-5264; Polyak, Steven W./0000-0002-8458-5194	Grape and Wine Research and Development Corporation [CSP 09/05]	Grape and Wine Research and Development Corporation	This work was supported by the Grape and Wine Research and Development Corporation (grant no. CSP 09/05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTYMIUK PJ, 1994, NAT STRUCT BIOL, V1, P758, DOI 10.1038/nsb1194-758; Assmann SM, 2010, PLANT HORMONES BIOSY, P339; Bagautdinov B, 2005, J MOL BIOL, V353, P322, DOI 10.1016/j.jmb.2005.08.032; Bernier S, 2000, BIOORG MED CHEM LETT, V10, P2441, DOI 10.1016/S0960-894X(00)00478-9; Bottcher C, 2011, J EXP BOT, V62, P4267, DOI 10.1093/jxb/err134; Bottcher C, 2010, J EXP BOT, V61, P3615, DOI 10.1093/jxb/erq174; Brown PH, 2004, J MOL BIOL, V337, P857, DOI 10.1016/j.jmb.2004.01.041; Chen Q, 2010, J BIOL CHEM, V285; Cusack S, 1996, EMBO J, V15, P6321, DOI 10.1002/j.1460-2075.1996.tb01022.x; da Costa TPS, 2012, J BIOL CHEM, V287, P17823, DOI 10.1074/jbc.M112.356576; De Rybel B, 2009, ACS CHEM BIOL, V4, P987, DOI 10.1021/cb9001624; Delker C, 2008, PLANTA, V227, P929, DOI 10.1007/s00425-008-0710-8; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Domingo C, 2009, MOL PLANT MICROBE IN, V22, P201, DOI 10.1094/MPMI-22-2-0201; Fan F, 2009, BIOCHEMISTRY-US, V48, P7150, DOI 10.1021/bi900457x; Forrest AK, 2000, BIOORG MED CHEM LETT, V10, P1871, DOI 10.1016/S0960-894X(00)00360-7; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Gottlieb A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020361; HAGEN G, 1984, PLANTA, V162, P147, DOI 10.1007/BF00410211; He WR, 2011, PLANT CELL, V23, P3944, DOI 10.1105/tpc.111.089029; INABA A, 1976, J JPN SOC HORTIC SCI, V45, P245, DOI 10.2503/jjshs.45.245; Khan S, 2007, PLANTA, V226, P21, DOI 10.1007/s00425-006-0462-2; Liu KD, 2005, PLANT MOL BIOL, V58, P447, DOI 10.1007/s11103-005-6505-4; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Nakazawa M, 2001, PLANT J, V25, P213, DOI 10.1046/j.1365-313x.2001.00957.x; Okrent RA, 2011, PLANT MOL BIOL, V76, P489, DOI 10.1007/s11103-011-9776-y; Ostergaard L, 2009, CURR OPIN PLANT BIOL, V12, P36, DOI 10.1016/j.pbi.2008.09.011; Ostin A, 1998, PLANT PHYSIOL, V118, P285, DOI 10.1104/pp.118.1.285; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Simon S, 2011, PLANT SCI, V180, P454, DOI 10.1016/j.plantsci.2010.12.007; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Takase T, 2004, PLANT J, V37, P471, DOI 10.1046/j.1365-313X.2003.01973.x; Tanaka H, 2006, CELL MOL LIFE SCI, V63, P2738, DOI 10.1007/s00018-006-6116-5; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; UEDA H, 1991, BIOCHIM BIOPHYS ACTA, V1080, P126, DOI 10.1016/0167-4838(91)90138-P; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Wang H, 2008, PLANT GROWTH REGUL, V56, P225, DOI 10.1007/s10725-008-9313-4; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zhang SW, 2009, PLANT PHYSIOL, V151, P1889, DOI 10.1104/pp.109.146803; Zhang ZQ, 2007, PLANT PHYSIOL, V145, P450, DOI 10.1104/pp.107.106021; Zhao Y, 2010, ANNU REV PLANT BIOL, V61, P1911	47	26	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37632	10.1371/journal.pone.0037632	http://dx.doi.org/10.1371/journal.pone.0037632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649546	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800065
J	Chatterjee, T; Pal, A; Dey, S; Chatterjee, BK; Chakrabarti, P				Chatterjee, Tanaya; Pal, Aritrika; Dey, Sucharita; Chatterjee, Barun K.; Chakrabarti, Pinak			Interaction of Virstatin with Human Serum Albumin: Spectroscopic Analysis and Molecular Modeling	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; LIGAND-BINDING; SECONDARY STRUCTURE; VIBRIO-CHOLERAE; BOVINE; THERMODYNAMICS; CONFORMATION; TRANSITION; VIRULENCE; PROTEINS	Virstatin is a small molecule that inhibits Vibrio cholerae virulence regulation, the causative agent for cholera. Here we report the interaction of virstatin with human serum albumin (HSA) using various biophysical methods. The drug binding was monitored using different isomeric forms of HSA (N form similar to pH 7.2, B form similar to pH 9.0 and F form similar to pH 3.5) by absorption and fluorescence spectroscopy. There is a considerable quenching of the intrinsic fluorescence of HSA on binding the drug. The distance (r) between donor (Trp214 in HSA) and acceptor (virstatin), obtained from Forster-type fluorescence resonance energy transfer (FRET), was found to be 3.05 nm. The ITC data revealed that the binding was an enthalpy-driven process and the binding constants K-a for N and B isomers were found to be 6.09X10(5) M-1 and 4.47X10(5) M (-1), respectively. The conformational changes of HSA due to the interaction with the drug were investigated from circular dichroism (CD) and Fourier Transform Infrared (FTIR) spectroscopy. For 1:1 molar ratio of the protein and the drug the far-UV CD spectra showed an increase in alpha-helicity for all the conformers of HSA, and the protein is stabilized against urea and thermal unfolding. Molecular docking studies revealed possible residues involved in the protein-drug interaction and indicated that virstatin binds to Site I (subdomain IIA), also known as the warfarin binding site.	[Chatterjee, Tanaya; Pal, Aritrika; Chakrabarti, Pinak] Bose Inst, Dept Biochem, Kolkata, India; [Dey, Sucharita; Chakrabarti, Pinak] Bose Inst, Bioinformat Ctr, Kolkata, India; [Chatterjee, Barun K.] Bose Inst, Dept Phys, Kolkata, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Chatterjee, T (corresponding author), Bose Inst, Dept Biochem, Kolkata, India.	tanaya_chatterjee@yahoo.com; pinak@boseinst.ernet.in		Dey, Sucharita/0000-0003-0605-2576	Department of Science and Technology (India); Council of Scientific and Industrial Research (India); Department of Biotechnology (India)	Department of Science and Technology (India)(Department of Science & Technology (India)); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (India)(Department of Biotechnology (DBT) India)	T. C. is supported by a Fast Track Young Scientist Project from the Department of Science and Technology (India); A.P. and S.D. are recipients of fellowships from the Council of Scientific and Industrial Research (India) and the Department of Biotechnology (India), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Ahmad E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026186; Bagatolli LA, 1996, J PHARM SCI, V85, P1131, DOI 10.1021/js960142k; Bian QQ, 2004, INT J BIOL MACROMOL, V34, P333, DOI 10.1016/j.ijbiomac.2004.09.005; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; CARTER DC, 1989, SCIENCE, V244, P1195, DOI 10.1126/science.2727704; CARTER DC, 1990, SCIENCE, V249, P302, DOI 10.1126/science.2374930; Chatterjee T, 2011, BIOCHEMISTRY-US, V50, P2962, DOI 10.1021/bi101673x; Connelly Patrick R., 1994, Current Opinion in Biotechnology, V5, P381, DOI 10.1016/0958-1669(94)90046-9; Dockal M, 2000, J BIOL CHEM, V275, P3042, DOI 10.1074/jbc.275.5.3042; ERA S, 1990, INT J PEPT PROT RES, V35, P1; FEHSKE KJ, 1982, MOL PHARMACOL, V21, P387; Foster J.F, 1977, ALBUMIN STRUCTURE FU, VFunction and Uses; GEISOW MJ, 1977, BIOCHEM J, V163, P477, DOI 10.1042/bj1630477; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Griffith DC, 2006, AM J TROP MED HYG, V75, P973, DOI 10.4269/ajtmh.2006.75.973; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; HIGGINS DE, 1992, J BACTERIOL, V174, P6974, DOI 10.1128/JB.174.21.6974-6980.1992; Hubbard S., 1992, NACCESS PROGRAM CALC; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kelly SM, 1997, BBA-PROTEIN STRUCT M, V1338, P161, DOI 10.1016/S0167-4838(96)00190-2; KHAN MY, 1986, BIOCHEM J, V236, P307, DOI 10.1042/bj2360307; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LEONARD WJ, 1963, J BIOL CHEM, V238, P1984; Li Y, 2006, BIOORGAN MED CHEM, V14, P1431, DOI 10.1016/j.bmc.2005.09.066; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Muzammil S, 2000, BBA-PROTEIN STRUCT M, V1476, P139, DOI 10.1016/S0167-4838(99)00226-5; Neault JF, 1998, BBA-PROTEIN STRUCT M, V1384, P153, DOI 10.1016/S0167-4838(98)00011-9; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Peters T, ALL ALBUMIN BIOCH GE; Puri AW, 2009, ACS CHEM BIOL, V4, P603, DOI 10.1021/cb9001409; Rahmelow K, 1996, ANAL BIOCHEM, V241, P5, DOI 10.1006/abio.1996.0369; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shakhnovich EA, 2007, P NATL ACAD SCI USA, V104, P2372, DOI 10.1073/pnas.0611643104; Shanmugam G, 2004, BIOPHYS CHEM, V111, P73, DOI 10.1016/j.bpc.2004.04.005; Shaw AK, 2008, J PHOTOCH PHOTOBIO B, V90, P69, DOI 10.1016/j.jphotobiol.2007.11.003; SOGAMI M, 1982, INT J PEPT PROT RES, V19, P263; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Uversky VN, 1997, BIOCHEMISTRY-US, V36; Varshney A, 2011, PLOS ONE, V6; Waldor MK., 1996, ENTERIC INFECT IMMUN, P37, DOI [10.1007/978-1-4899-0313-6_3, DOI 10.1007/978-1-4899-0313-6_3]; Wi S, 1998, BIOSPECTROSCOPY, V4, P93, DOI 10.1002/(SICI)1520-6343(1998)4:2<93::AID-BSPY2>3.0.CO;2-T; WILTING J, 1980, BIOCHIM BIOPHYS ACTA, V626, P291, DOI 10.1016/0005-2795(80)90123-3; Yamasaki K, 1999, BBA-PROTEIN STRUCT M, V1432, P313, DOI 10.1016/S0167-4838(99)00098-9; YAMASAKI M, 1990, INT J BIOL MACROMOL, V12, P263, DOI 10.1016/0141-8130(90)90007-W; Zsila F, 2011, BIOINFORMATICS, V27, P1806, DOI 10.1093/bioinformatics/btr284	53	106	107	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37468	10.1371/journal.pone.0037468	http://dx.doi.org/10.1371/journal.pone.0037468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649528	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335800046
J	Lamb, T; Beamer, DA				Lamb, Trip; Beamer, David A.			Digits Lost or Gained? Evidence for Pedal Evolution in the Dwarf Salamander Complex (Eurycea, Plethodontidae)	PLOS ONE			English	Article							BODY-FORM; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR SYSTEMATICS; BAYESIAN-ESTIMATION; SQUAMATE REPTILES; LIMB EVOLUTION; MIXED MODELS; CONVERGENCE; GENUS; MINIATURIZATION	Change in digit number, particularly digit loss, has occurred repeatedly over the evolutionary history of tetrapods. Although digit loss has been documented among distantly related species of salamanders, it is relatively uncommon in this amphibian order. For example, reduction from five to four toes appears to have evolved just three times in the morphologically and ecologically diverse family Plethodontidae. Here we report a molecular phylogenetic analysis for one of these four-toed lineages - the Eurycea quadridigitata complex (dwarf salamanders) - emphasizing relationships to other species in the genus. A multilocus phylogeny reveals that dwarf salamanders are paraphyletic with respect to a complex of five-toed, paedomorphic Eurycea from the Edwards Plateau in Texas. We use this phylogeny to examine evolution of digit number within the dwarf-Edwards Plateau clade, testing contrasting hypotheses of digit loss (parallelism among dwarf salamanders) versus digit gain (re-evolution in the Edwards Plateau complex). Bayes factors analysis provides statistical support for a five-toed common ancestor at the dwarf-Edwards node, favoring, slightly, the parallelism hypothesis for digit loss. More importantly, our phylogenetic results pinpoint a rare event in the pedal evolution of plethodontid salamanders.	[Lamb, Trip; Beamer, David A.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Beamer, David A.] Nash Community Coll, Dept Math & Sci, Rocky Mount, NC USA	University of North Carolina; East Carolina University	Lamb, T (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	dbeamer@nashcc.edu			East Carolina University Research; South Carolina Department of Natural Resources	East Carolina University Research; South Carolina Department of Natural Resources	This project was supported by an East Carolina University Research/Creative Activity award and a grant from the South Carolina Department of Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERCH P, 1985, EVOLUTION, V39, P8, DOI 10.1111/j.1558-5646.1985.tb04076.x; Ane C, 2007, MOL BIOL EVOL, V24, P412; Bickham JW, 1996, HERPETOLOGICA, V52, P89; Bonett RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005615; Brandley MC, 2008, EVOLUTION, V62, P2042, DOI 10.1111/j.1558-5646.2008.00430.x; Bryson RW, 2010, EVOLUTION, V64, P2315, DOI 10.1111/j.1558-5646.2010.01014.x; Camp CD, 2009, J ZOOL, V279, P86, DOI 10.1111/j.1469-7998.2009.00593.x; Chen W, 2009, MOL ECOL, V18, P2856, DOI 10.1111/j.1365-294X.2009.04258.x; Chippindale PT, 2000, HERPETOL MONOGR, V14, P1, DOI 10.2307/1467045; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Galis F, 2001, TRENDS ECOL EVOL, V16, P637, DOI 10.1016/S0169-5347(01)02289-3; Gompel N, 2009, DEV BIOL, V332, P36, DOI 10.1016/j.ydbio.2009.04.040; HANKEN J, 1983, J MORPHOL, V177, P255, DOI 10.1002/jmor.1051770304; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; Harrison JR, 2003, SOUTHEAST NAT, V2, P159, DOI 10.1656/1528-7092(2003)002[0159:ANSOEC]2.0.CO;2; Hillis DM, 2001, HERPETOLOGICA, V57, P266; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kohlsdorf T, 2006, EVOLUTION, V60, P1896; Kohlsdorf T, 2010, EVOLUTION, V64, P2477, DOI 10.1111/j.1558-5646.2010.01042.x; LANDE R, 1978, EVOLUTION, V32, P73, DOI 10.1111/j.1558-5646.1978.tb01099.x; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Leache AD, 2011, SYST BIOL, V60, P126, DOI 10.1093/sysbio/syq073; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; Masta SE, 2002, MOL PHYLOGENET EVOL, V24, P302, DOI 10.1016/S1055-7903(02)00216-6; Mittleman M.B., 1967, CAT AM AMPHIB REPTIL, V44, P1; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; Nevado B, 2009, MOL ECOL, V18, P4240, DOI 10.1111/j.1365-294X.2009.04348.x; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; ROTH G, 1990, BIOL J LINN SOC, V40, P165, DOI 10.1111/j.1095-8312.1990.tb01974.x; Roy S, 2002, J EXP ZOOL, V293, P186, DOI 10.1002/jez.10110; Shapiro MD, 2003, J EXP ZOOL PART B, V297B, P48, DOI 10.1002/jez.b.00019; Shubin Neil H., 2003, Amphibian Biology, V5, P1782; SHUBIN NH, 1986, EVOL BIOL, V20, P319; Siler CD, 2011, EVOLUTION, V65, P2641, DOI 10.1111/j.1558-5646.2011.01315.x; Stamatakis A, 2007, J VLSI SIG PROC SYST, V48, P271, DOI 10.1007/s11265-007-0067-4; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steiner CC, 2009, MOL BIOL EVOL, V26, P35, DOI 10.1093/molbev/msn218; Stopper GF, 2007, DEV DYNAM, V236, P321, DOI 10.1002/dvdy.21025; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vieites DR, 2011, MOL PHYLOGENET EVOL, V59, P623, DOI 10.1016/j.ympev.2011.03.012; Wagner GP, 1999, AM ZOOL, V39, P686; Wake DB, 2009, ANNU REV ECOL EVOL S, V40, P333, DOI 10.1146/annurev.ecolsys.39.110707.173552; WAKE DB, 1991, AM NAT, V138, P543, DOI 10.1086/285234; Weisrock DW, 2005, MOL ECOL, V14, P1457, DOI 10.1111/j.1365-294X.2005.02524.x; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; Wiens JJ, 2003, SYST BIOL, V52, P501, DOI 10.1080/10635150390218222; Wiens JJ, 2008, EVOL DEV, V10, P449, DOI 10.1111/j.1525-142X.2008.00256.x; Young RL, 2009, EVOL DEV, V11, P647, DOI 10.1111/j.1525-142X.2009.00372.x	57	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37544	10.1371/journal.pone.0037544	http://dx.doi.org/10.1371/journal.pone.0037544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649536	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335800055
J	van Boxtel, JJA; Lu, HJ				van Boxtel, Jeroen J. A.; Lu, Hongjing			Signature Movements Lead to Efficient Search for Threatening Actions	PLOS ONE			English	Article							BIOLOGICAL-MOTION; VISUAL-SEARCH; PERCEPTION; EMOTION; ATTENTION; FACE; FAMILIARITY; STIMULUS; AMYGDALA; GENDER	The ability to find and evade fighting persons in a crowd is potentially life-saving. To investigate how the visual system processes threatening actions, we employed a visual search paradigm with threatening boxer targets among emotionally-neutral walker distractors, and vice versa. We found that a boxer popped out for both intact and scrambled actions, whereas walkers did not. A reverse correlation analysis revealed that observers' responses clustered around the time of the "punch'', a signature movement of boxing actions, but not around specific movements of the walker. These findings support the existence of a detector for signature movements in action perception. This detector helps in rapidly detecting aggressive behavior in a crowd, potentially through an expedited (sub) cortical threat-detection mechanism.	[van Boxtel, Jeroen J. A.; Lu, Hongjing] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Lu, Hongjing] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	van Boxtel, JJA (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA.	j.j.a.vanboxtel@gmail.com; hongjing@ucla.edu	van Boxtel, Jeroen J.A./O-7624-2014	van Boxtel, Jeroen J.A./0000-0003-2643-0474	NSF (National Science Foundation) [BCS-0843880, EIA-0196217]	NSF (National Science Foundation)(National Science Foundation (NSF))	This work was supported by NSF (National Science Foundation) funding to H. Lu (NSF BCS-0843880). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Janice Lau and Michael Finch for their help in data collection. The motion capture data used in this project was obtained from http://mocap.cs. cmu.edu. The database was created with funding from NSF (National Science Foundation) EIA-0196217.	Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Cavanagh P, 2001, COGNITION, V80, P47, DOI 10.1016/S0010-0277(00)00153-0; Chang DHF, 2008, J VISION, V8, DOI 10.1167/8.5.3; Chouchourelou A, 2006, SOC NEUROSCI-UK, V1, P63, DOI 10.1080/17470910600630599; Coelho CM, 2010, J VISION, V10, DOI 10.1167/10.1.7; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; DITTRICH WH, 1993, PERCEPTION, V22, P15, DOI 10.1068/p220015; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Gao T, 2010, PSYCHOL SCI, V21, P1845, DOI 10.1177/0956797610388814; Giese MA, 2002, VISION RES, V42, P1847, DOI 10.1016/S0042-6989(02)00093-7; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Hirai M, 2006, NEUROSCI LETT, V403, P299, DOI 10.1016/j.neulet.2006.05.002; KLEFFNER DA, 1992, PERCEPT PSYCHOPHYS, V52, P18, DOI 10.3758/BF03206757; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; Lobue V, 2008, PSYCHOL SCI, V19, P284, DOI 10.1111/j.1467-9280.2008.02081.x; Ma YL, 2006, BEHAV RES METHODS, V38, P134, DOI 10.3758/BF03192758; Manera V, 2010, BEHAV RES METHODS, V42, P168, DOI 10.3758/BRM.42.1.168; MATHER G, 1994, P ROY SOC B-BIOL SCI, V258, P273, DOI 10.1098/rspb.1994.0173; Norman JF, 2004, PSYCHOL AGING, V19, P219, DOI 10.1037/0882-7974.19.1.219; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2003, CURR DIR PSYCHOL SCI, V12, P5, DOI 10.1111/1467-8721.01211; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; POIZNER H, 1981, J EXP PSYCHOL HUMAN, V7, P430, DOI 10.1037/0096-1523.7.2.430; Purcell DG, 1996, PERCEPTION, V25, P1091, DOI 10.1068/p251091; Roether CL, 2009, J VISION, V9, DOI 10.1167/9.6.15; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Thirkettle M, 2009, J VISION, V9, DOI 10.1167/9.3.28; Thurman SM, 2008, J VISION, V8, DOI 10.1167/8.3.28; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Vangeneugden J, 2009, CEREB CORTEX, V19, P593, DOI 10.1093/cercor/bhn109; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wang L, 2010, PSYCHOL SCI, V21, P1083, DOI 10.1177/0956797610376072; WANG QQ, 1994, PERCEPT PSYCHOPHYS, V56, P495, DOI 10.3758/BF03206946; Wolfe JM, 2001, PERCEPT PSYCHOPHYS, V63, P381, DOI 10.3758/BF03194406	39	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37085	10.1371/journal.pone.0037085	http://dx.doi.org/10.1371/journal.pone.0037085			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TH	22649510	gold, Green Published			2022-12-25	WOS:000305335800028
J	Huang, YH; Lin, KH; Chen, HC; Chang, ML; Hsu, CW; Lai, MW; Chen, TC; Lee, WC; Tseng, YH; Yeh, CT				Huang, Ya-Hui; Lin, Kwang-Huei; Chen, Hua-Chien; Chang, Ming-Ling; Hsu, Chao-Wei; Lai, Ming-Wei; Chen, Tse-Ching; Lee, Wei-Chen; Tseng, Yi-Hsin; Yeh, Chau-Ting			Identification of Postoperative Prognostic MicroRNA Predictors in Hepatocellular Carcinoma	PLOS ONE			English	Article							NON-TUMOROUS TISSUES; EXPRESSION PROFILES; MICROARRAY ANALYSIS; CANCER; HEPATITIS; SURVIVAL; LIVER; DEREGULATION; PROGRESSION; SUPPRESSOR	Comparison of microRNA (miRNA) expression profiles in the noncancerous liver tissues adjacent to hepatocelluar carcinomas (HCCs) was a strategy to identify postoperative prognostic predictors in this study. Expression profiles of 270 miRNAs were determined in the paraneoplastic liver tissues of 12 HCC patients with known postoperative prognosis. A panel of candidate miRNA predictors was identified. The prognostic predictive value of these candidate miRNAs was then verified in 216 postoperative HCC patients. Univariate analysis identified 8 and 3 miRNA predictors for recurrence-free (RFS) and overall (OS) survivals, respectively. Multivariate analysis revealed high expression levels of miR-155 (HR, 2.002 [1.324-3.027]; P = .001), miR-15a (HR, 0.478 [0.248-0.920]; P = .027), miR-432 (HR, 1.816 [1.203-2.740]; P = .015), miR-486-3p (HR, 0.543 [0.330-0.893]; P = .016), miR-15b (HR, 1.074 [1.002-1.152]; P = .043) and miR-30b (HR, 1.102 [1.025-1.185]; P = .009) were significantly associated with RFS. When clinicopathological predictors were included, multivariate analysis revealed that tumor number and miR-432, miR-486-3p, and miR-30b expression levels remained significant as independent predictors for RFS. Additionally, expression knockdown of miR-155 in J7 and Mahlavu hepatoma cells resulted in decreased cell growth and enhanced cell death in xenograft tumors, suggesting an oncogenic effect of miR-155. In conclusion, significant prognostic miRNA predictors were identified through examination of miRNA expression levels in paraneoplastic liver tissues. Functional analysis of a miRNA predictor, miR-155, suggested that the prognostic miRNA predictors identified under this strategy could serve as potential molecular targets for anticancer therapy.	[Huang, Ya-Hui; Chang, Ming-Ling; Hsu, Chao-Wei; Yeh, Chau-Ting] Chang Gung Mem Hosp, Dept Hepatogastroenterol, Liver Res Ctr, Tao Yuan, Taiwan; [Lin, Kwang-Huei; Tseng, Yi-Hsin] Chang Gung Univ, Dept Biochem, Sch Med, Tao Yuan, Taiwan; [Chen, Hua-Chien] Chang Gung Univ, Dept Life Sci, Tao Yuan, Taiwan; [Lai, Ming-Wei] Chang Gung Children Hosp, Dept Pediat Gastroenterol, Tao Yuan, Taiwan; [Chen, Tse-Ching] Chang Gung Mem Hosp, Dept Pathol, Dept Surg, Taipei 10591, Taiwan; [Lee, Wei-Chen] Chang Gung Mem Hosp, Div Gen Surg, Dept Surg, Taipei 10591, Taiwan; [Yeh, Chau-Ting] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Huang, YH (corresponding author), Chang Gung Mem Hosp, Dept Hepatogastroenterol, Liver Res Ctr, Tao Yuan, Taiwan.	chautingy@gmail.com			Chang Gung Medical Research Council [CMRPG381041, CMRPG381042]	Chang Gung Medical Research Council	The study is supported by a grant from Chang Gung Medical Research Council (CMRPG381041 and CMRPG381042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandres E, 2007, DNA CELL BIOL, V26, P273, DOI 10.1089/dna.2006.0544; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Chen HY, 2011, MED ONCOL; Chung GE, 2010, ONCOL REP, V23, P113, DOI 10.3892/or_00000612; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025872; Han ZB, 2012, J CANCER RES CLIN, V138, P153, DOI 10.1007/s00432-011-1076-z; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; HSIEH KH, 1987, GUT, V28, P117, DOI 10.1136/gut.28.2.117; Huang XH, 2009, HEPATOL RES, V39, P786, DOI 10.1111/j.1872-034X.2009.00502.x; Huang YH, 2010, J CELL PHYSIOL, V222, P347, DOI 10.1002/jcp.21959; Huang YS, 2008, J GASTROEN HEPATOL, V23, P87, DOI 10.1111/j.1440-1746.2007.05223.x; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ji JF, 2010, J HEPATOL, V52, P690, DOI 10.1016/j.jhep.2009.12.025; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Khaled HM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-32; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; OEFINGER PE, 1981, J GEN VIROL, V53, P105, DOI 10.1099/0022-1317-53-1-105; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Sato F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016435; Skawran B, 2008, MODERN PATHOL, V21, P1479, DOI 10.1038/modpathol.2008.147; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang CX, 2011, J GASTROEN HEPATOL, V26, P1630, DOI 10.1111/j.1440-1746.2011.06758.x; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Xie Q, 2011, CANCER; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	42	74	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37188	10.1371/journal.pone.0037188	http://dx.doi.org/10.1371/journal.pone.0037188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629365	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300024
J	Liang, J; Li, XH; Dai, L; Zeng, WY; Li, Q; Li, MR; Zhou, R; He, CH; Wang, YP; Zhu, J				Liang, Juan; Li, Xiaohong; Dai, Li; Zeng, Weiyue; Li, Qi; Li, Mingrong; Zhou, Rong; He, Chunhua; Wang, Yanping; Zhu, Jun			The Changes in Maternal Mortality in 1000 Counties in Mid-Western China by a Government-Initiated Intervention	PLOS ONE			English	Article							DEATHS	Background: Since 2000, the Chinese government has implemented an intervention program to reduce maternal mortality and eliminate neonatal tetanus in accordance with the Millennium Development Goals 5. To assess the effectiveness of this intervention program, we analyzed the level, trend and reasons defining the maternal mortality ratio (MMR) in the 1,000 priority counties before and after implementation of the intervention between 1999 and 2007. Methodology/Principal Findings: The data was obtained from the National Maternal and Child Health Routine Reporting System. The intervention included providing basic and emergency obstetric equipment and supplies to local medical hospitals, and also included providing professional training to local obstetric doctors, development of obstetric emergency centers and "green channel" express referral networks, reducing or waiving the cost of hospital delivery, and conducting community health education. Based on the initiation time of the intervention and the level of poverty, 1,000 counties, containing a total population of 300 million, were categorized into three groups. MMR significantly decreased by about 50%, with an average reduction rate of 9.24%, 16.06%, and 18.61% per year in the three county groups, respectively. The hospital delivery rate significantly increased. Obstetric hemorrhage was the leading cause of maternal deaths and significantly declined, with an average decrease in the MMR of 11.25%, 18.03%, and 24.90% per year, respectively. The magnitude of the MMR, the average reduction rate of the MMR, and the occurrence of the leading causes of death were closely associated with the percentage of poverty. Conclusions/Significance: The intervention program implemented by the Chinese government has significantly reduced the MMR in mid-western China, suggesting that well-targeted interventions could be an efficient strategy to reducing MMR in resource-poor areas. Reduction of the MMR not only depends on conducting proven interventions, but also relies on economic development in rural areas with a high burden of maternal death.	[Liang, Juan; Li, Qi; Li, Mingrong; Zhu, Jun] Sichuan Univ, W China Univ Hosp 2, Natl Off Maternal & Child Hlth Surveillance, Chengdu 610064, Sichuan, Peoples R China; [Li, Xiaohong; Dai, Li; He, Chunhua; Wang, Yanping] Sichuan Univ, W China Univ Hosp 2, Natl Ctr Birth Defects Monitoring, Chengdu 610064, Sichuan, Peoples R China; [Zeng, Weiyue; Zhou, Rong] Sichuan Univ, W China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Liang, J (corresponding author), Sichuan Univ, W China Univ Hosp 2, Natl Off Maternal & Child Hlth Surveillance, Chengdu 610064, Sichuan, Peoples R China.	yanpingwang0618@163.com; zzhj3121@163.com		Li, Xiaohong/0000-0003-0336-7302	Chinese Ministry of Health [QT2003-009, 05wsb-02]; UNICEF [YH601-11-1141]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0935]	Chinese Ministry of Health; UNICEF; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Chinese Ministry of Health (grants QT2003-009 and 05wsb-02), UNICEF (grant YH601-11-1141) and Program for Changjiang Scholars and Innovative Research Team in University (IRT0935). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg CJ, 2005, OBSTET GYNECOL, V106, P1228, DOI 10.1097/01.AOG.0000187894.71913.e8; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Campbell C, 2005, B WORLD HEALTH ORGAN, V83, P462; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; Cui FQ, 2007, CHIN J VACCINES IMMU, V13, P1; Department of Maternal and Child Health and Community Health Ministry of Health, 2008, AN 2007 NAT MAT CHIL; Department of Maternal and Child Health and Community Health Ministry of Health, 2002, EXP PROGR DECR MAT M; Department of Maternal and Child Health and Community Health Ministry of Health, 2008, EXP PROGR DECR MAT M; Feng ZC, 2006, MATERN CHILD HLTH J, V21, P2185; Gao YQ, 2009, B WORLD HEALTH ORGAN, V87, P913, DOI 10.2471/BLT.08.060426; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Huang A., 2010, CHIN, V11, P130; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Koblinsky M., 2003, REDUCING MATERNAL MO; Lawn JE, 2006, LANCET, V368, P1474, DOI 10.1016/S0140-6736(06)69387-2; Li XH, 2011, ACTA OBSTET GYN SCAN, V90, P586, DOI 10.1111/j.1600-0412.2011.01110.x; Liang J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-243; Liang JA, 2010, INT J GYNECOL OBSTET, V110, P93, DOI 10.1016/j.ijgo.2010.03.013; Liang Juan, 2004, Sichuan Da Xue Xue Bao Yi Xue Ban, V35, P258; Lu Haixia, 2009, CHINESE HLTH EC, V28, P38; Luo R., 2007, MATERNAL CHILD HLTH, V22, P2313; National Bureau of Statistics of China, 2005, NAT ANN STAT B; PADMANATHAN I, 2003, INVESTING MATERNAL H; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Shah QH, 2007, REPROD HEALTH MATTER, V15, P17, DOI 10.1016/S0968-8080(07)30339-X; The State Council Leading Group Office of Poverty Alleviation and Development, 2006, LIST STAT LEV POV ST; UNICEF, 2007, PROTECTING THE WORLD'S CHILDREN: IMPACT OF THE CONVENTION ON THE RIGHTS OF THE CHILD IN DIVERSE LEGAL SYSTEMS, P1; United Nations, 2001, 56 SESS NEW YORK 16; World Health Organization, 2007, MAT MORT 2005 EST DE; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization, 1992, INT CLASS DIS REL HL; Yadamsuren B, 2009, B WORLD HEALTH ORGAN, V88, P192; Yayla M, 2003, J PERINAT MED, V31, P386, DOI 10.1515/JPM.2003.059; Zhang K, 2002, MED AID POOR THEORIE; 梁娟, 2009, [四川大学学报. 医学版, Journal of Sichuan University. Medical Science Edition], V40, P341	36	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37458	10.1371/journal.pone.0037458	http://dx.doi.org/10.1371/journal.pone.0037458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629398	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100030
J	Tai, MC; Chen, YH; Cheng, JH; Liang, CM; Chen, JT; Chen, CL; Lu, DW				Tai, Ming-Cheng; Chen, Yi-Hao; Cheng, Jen-Hao; Liang, Chang-Min; Chen, Jiann-Torng; Chen, Ching-Long; Lu, Da-Wen			Early Ahmed Glaucoma Valve Implantation after Penetrating Keratoplasty Leads to Better Outcomes in an Asian Population with Preexisting Glaucoma	PLOS ONE			English	Article							MOLTENO IMPLANT; REFRACTORY GLAUCOMA; CLINICAL-EXPERIENCE; GRAFT-SURVIVAL; FOLLOW-UP; EYES; POLYPROPYLENE; SILICONE; SURGERY	Background: To evaluate the efficacy of Ahmed Glaucoma Valve (AGV) surgery and the optimal interval between penetrating keratoplasty (PKP) and AGV implantation in a population of Asian patients with preexisting glaucoma who underwent PKP. Methodology/Principal Findings: In total, 45 eyes of 45 patients were included in this retrospective chart review. The final intraocular pressures (IOPs), graft survival rate, and changes in visual acuity were assessed to evaluate the outcomes of AGV implantations in eyes in which AGV implantation occurred within 1 month of post-PKP IOP elevation (Group 1) and in eyes in which AGV implantation took place more than 1 month after the post-PKP IOP evaluation (Group 2). Factors that were associated with graft failure were analyzed, and the overall patterns of complications were reviewed. By their final follow-up visits, 58% of the patients had been successfully treated for glaucoma. After the operation, there were no statistically significant differences between the groups with respect to graft survival (p = 0.98), but significant differences for IOP control (p = 0.049) and the maintenance of visual acuity (VA) (p<0.05) were observed. One year after surgery, the success rates of IOP control in Group 1 and Group 2 were 80% and 46.7%, respectively, and these rates fell to 70% and 37.3%, respectively, by 2 years. Factors that were associated with a high risk of AGV failure were a diagnosis of preexisting angle-closure glaucoma, a history of previous PKP, and a preoperative IOP that was >21 mm Hg. The most common surgical complication, aside from graft failure, was hyphema. Conclusions/Significance: Early AGV implantation results in a higher probability of AGV survival and a better VA outcome without increasing the risk of corneal graft failure as a result of post-PKP glaucoma drainage tube implantation.	[Tai, Ming-Cheng; Chen, Yi-Hao; Cheng, Jen-Hao; Liang, Chang-Min; Chen, Jiann-Torng; Chen, Ching-Long; Lu, Da-Wen] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan; [Tai, Ming-Cheng; Chen, Yi-Hao; Liang, Chang-Min; Chen, Jiann-Torng; Chen, Ching-Long; Lu, Da-Wen] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Tai, MC (corresponding author), Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan.	p310849@ms23.hinet.net			Tri-Service General Hospital [TSGHC100-008-006-6-S03, TSGH-C100-086]	Tri-Service General Hospital	This study is supported, in part, by grants from the Tri-Service General Hospital (TSGHC100-008-006-6-S03 and TSGH-C100-086). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aswad LA, 2006, AM J OPHTHALMOL, V141, P390, DOI 10.1016/j.ajo.2005.08.036; Al-Torbak A, 2003, CORNEA, V22, P194, DOI 10.1097/00003226-200304000-00002; Al-Torbak AA, 2004, CORNEA, V23, P554, DOI 10.1097/01.ico.0000122704.49054.95; Alvarenga LS, 2004, AM J OPHTHALMOL, V138, P200, DOI 10.1016/j.ajo.2004.02.058; Ayyala RS, 1998, OPHTHALMOLOGY, V105, P1968, DOI 10.1016/S0161-6420(98)91049-1; Ayyala RS, 2000, SURV OPHTHALMOL, V45, P91, DOI 10.1016/S0039-6257(00)00141-7; Babizhayev MA, 2011, CURR MOL MED, V11, P528, DOI 10.2174/156652411800615126; Coleman AL, 1997, AM J OPHTHALMOL, V123, P54, DOI 10.1016/S0002-9394(14)70992-4; Das JC, 2005, EYE, V19, P183, DOI 10.1038/sj.eye.6701447; Doyle J W, 1994, Semin Ophthalmol, V9, P254, DOI 10.3109/08820539409060024; GOLDBERG DB, 1981, AM J OPHTHALMOL, V92, P372, DOI 10.1016/0002-9394(81)90527-4; Ishida K, 2006, OPHTHALMOLOGY, V113, P1320, DOI 10.1016/j.ophtha.2006.04.020; Kook MS, 2000, OPHTHALMIC SURG LAS, V31, P100; Kwon YH, 2001, OPHTHALMOLOGY, V108, P272, DOI 10.1016/S0161-6420(00)00496-6; Lai JSM, 2000, BRIT J OPHTHALMOL, V84, P718, DOI 10.1136/bjo.84.7.718; MCDONNELL PJ, 1988, OPHTHALMOLOGY, V95, P364; MUENZLER WS, 1981, OPHTHALMIC SURG LAS, V12, P210; Brasil MVOM, 2007, J GLAUCOMA, V16, P36, DOI 10.1097/01.ijg.0000243477.82779.31; RAPUANO CJ, 1995, CORNEA, V14, P26; Reinhard T, 1997, GRAEF ARCH CLIN EXP, V235, P553, DOI 10.1007/BF00947083; SHERWOOD MB, 1993, OPHTHALMIC SURG LAS, V24, P185; Sit M, 2001, CORNEA, V20, P129, DOI 10.1097/00003226-200103000-00002; Taglia DP, 2002, J GLAUCOMA, V11, P347, DOI 10.1097/00061198-200208000-00012; Tai MC, 2010, EYE, V24, P547, DOI 10.1038/eye.2009.181; Topouzis F, 1999, AM J OPHTHALMOL, V128, P198, DOI 10.1016/S0002-9394(99)00080-X; Wilson MR, 2003, AM J OPHTHALMOL, V136, P464, DOI 10.1016/S0002-9394(03)00239-3; Yalvac IS, 2007, EYE, V21, P65, DOI 10.1038/sj.eye.6702125; Yamagami S, 1996, ACTA OPHTHALMOL SCAN, V74, P584	28	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37867	10.1371/journal.pone.0037867	http://dx.doi.org/10.1371/journal.pone.0037867			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629464	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343100055
J	Braem, MGM; Onland-Moret, NC; Schouten, LJ; Kruitwagen, RFPM; Lukanova, A; Allen, NE; Wark, PA; Tjonneland, A; Hansen, L; Brauner, CM; Overvad, K; Clavel-Chapelon, F; Chabbert-Buffet, N; Teucher, B; Floegel, A; Boeing, H; Trichopoulou, A; Adarakis, G; Plada, M; Rinaldi, S; Fedirko, V; Romieu, I; Pala, V; Galasso, R; Sacerdote, C; Palli, D; Tumino, R; Bueno-de-Mesquita, HB; Gram, IT; Gavrilyuk, O; Lund, E; Sanchez, MJ; Bonet, C; Chirlaque, MD; Larranaga, N; Gurrea, AB; Quiros, JR; Idahl, A; Ohlson, N; Lundin, E; Jirstrom, K; Butt, S; Tsilidis, KK; Khaw, KT; Wareham, N; Riboli, E; Kaaks, R; Peeters, PHM				Braem, Marieke G. M.; Onland-Moret, N. Charlotte; Schouten, Leo J.; Kruitwagen, Roy F. P. M.; Lukanova, Annekatrin; Allen, Naomi E.; Wark, Petra A.; Tjonneland, Anne; Hansen, Louise; Brauner, Christina Marie; Overvad, Kim; Clavel-Chapelon, Francoise; Chabbert-Buffet, Nathalie; Teucher, Birgit; Floegel, Anna; Boeing, Heiner; Trichopoulou, Antonia; Adarakis, George; Plada, Maria; Rinaldi, Sabina; Fedirko, Veronika; Romieu, Isabelle; Pala, Valeria; Galasso, Rocco; Sacerdote, Carlotta; Palli, Domenico; Tumino, Rosario; Bueno-de-Mesquita, H. Bas; Gram, Inger Torhild; Gavrilyuk, Oxana; Lund, Eiliv; Sanchez, Maria-Jose; Bonet, Catalina; Chirlaque, Maria-Dolores; Larranaga, Nerea; Barricarte Gurrea, Aurelio; Quiros, Jose R.; Idahl, Annika; Ohlson, Nina; Lundin, Eva; Jirstrom, Karin; Butt, Salma; Tsilidis, Konstantinos K.; Khaw, Kay-Tee; Wareham, Nick; Riboli, Elio; Kaaks, Rudolf; Peeters, Petra H. M.			Multiple Miscarriages Are Associated with the Risk of Ovarian Cancer: Results from the European Prospective Investigation into Cancer and Nutrition	PLOS ONE			English	Article							ABORTION; EPIDEMIOLOGY	While the risk of ovarian cancer clearly reduces with each full-term pregnancy, the effect of incomplete pregnancies is unclear. We investigated whether incomplete pregnancies (miscarriages and induced abortions) are associated with risk of epithelial ovarian cancer. This observational study was carried out in female participants of the European Prospective Investigation into Cancer and Nutrition (EPIC). A total of 274,442 women were followed from 1992 until 2010. The baseline questionnaire elicited information on miscarriages and induced abortions, reproductive history, and lifestyle-related factors. During a median follow-up of 11.5 years, 1,035 women were diagnosed with incident epithelial ovarian cancer. Despite the lack of an overall association (ever vs. never), risk of ovarian cancer was higher among women with multiple incomplete pregnancies (HR >= 4vs.0: 1.74, 95% CI: 1.20-2.70; number of cases in this category: n = 23). This association was particularly evident for multiple miscarriages (HR >= 4vs.0: 1.99, 95% CI: 1.06-3.73; number of cases in this category: n = 10), with no significant association for multiple induced abortions (HR >= 4vs.0: 1.46, 95% CI: 0.68-3.14; number of cases in this category: n = 7). Our findings suggest that multiple miscarriages are associated with an increased risk of epithelial ovarian cancer, possibly through a shared cluster of etiological factors or a common underlying pathology. These findings should be interpreted with caution as this is the first study to show this association and given the small number of cases in the highest exposure categories.	[Braem, Marieke G. M.; Onland-Moret, N. Charlotte; Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Schouten, Leo J.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands; [Kruitwagen, Roy F. P. M.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Obstet & Gynaecol, Med Ctr, Maastricht, Netherlands; [Lukanova, Annekatrin; Teucher, Birgit; Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany; [Allen, Naomi E.; Tsilidis, Konstantinos K.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Wark, Petra A.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Tjonneland, Anne; Hansen, Louise] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Brauner, Christina Marie; Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Clavel-Chapelon, Francoise] Inst Gustave Roussy, INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, F-94805 Villejuif, France; [Chabbert-Buffet, Nathalie] Univ Paris 06, Paris, France; [Chabbert-Buffet, Nathalie] Hosp Tenon, AP HP, Dept Gynecol, Paris, France; [Floegel, Anna; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Trichopoulou, Antonia] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, WHO Collaborating Ctr Food & Nutr Policies, GR-11527 Athens, Greece; [Trichopoulou, Antonia; Adarakis, George; Plada, Maria] Hellen Hlth Fdn, Athens, Greece; [Rinaldi, Sabina; Fedirko, Veronika; Romieu, Isabelle] Int Agcy Res Canc, Sect Nutr & Metab, Nutr Epidemiol Grp, F-69372 Lyon, France; [Pala, Valeria] Fdn IRCCS Ist Nazl Tumori, Nutr Epidemiol Unit, Milan, Italy; [Galasso, Rocco] Ist Ricovero & Cura Carattere Sci, Ctr Riferimento Oncol Basilicata, Clin Epidemiol Unit, Biostat & Canc Registry, Rionero In Vulture, Italy; [Sacerdote, Carlotta] CPO Piemonte, Ctr Canc Prevent, Turin, Italy; [Sacerdote, Carlotta] Human Genet Fdn, Turin, Italy; [Palli, Domenico] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Gram, Inger Torhild; Gavrilyuk, Oxana; Lund, Eiliv] Univ Tromso, Fac Hlth Sci, Inst Community Med, N-9001 Tromso, Norway; [Sanchez, Maria-Jose] Escuela Andaluza Salud Publ, Granada, Spain; [Sanchez, Maria-Jose; Chirlaque, Maria-Dolores; Larranaga, Nerea; Barricarte Gurrea, Aurelio] CIBERESP, Consortium Biomed Res Epidemiol & Publ Hlth, Barcelona, Spain; [Bonet, Catalina] Catalan Inst Oncol, Canc Epidemiol Res Programme, Unit Nutr Environm & Canc, Barcelona, Spain; [Chirlaque, Maria-Dolores] Murcia Reg Hlth Author, Dept Epidemiol, Murcia, Spain; [Larranaga, Nerea] Basque Govt, Publ Hlth Dept Gipuzkoa, Madrid, Spain; [Barricarte Gurrea, Aurelio] Navarre Publ Hlth Inst, Pamplona, Spain; [Quiros, Jose R.] Publ Hlth & Hlth Planning Directorate, Asturias, Spain; [Idahl, Annika] Umea Univ, Dept Clin Sci Obstet & Gynecol, Umea, Sweden; [Idahl, Annika] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Ohlson, Nina; Lundin, Eva] Umea Univ, Dept Med Biosci, Umea, Sweden; [Jirstrom, Karin] Lund Univ, Skane Univ Hosp, Div Pathol, Dept Clin Sci, Lund, Sweden; [Butt, Salma] Lund Univ, Skane Univ Hosp, Dept Surg, Malmo, Sweden; [Tsilidis, Konstantinos K.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Khaw, Kay-Tee] Univ Cambridge, Cambridge, England; [Wareham, Nick] MRC, Epidemiol Unit Cambridge, Cambridge, England; [Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England	Utrecht University; Utrecht University Medical Center; Maastricht University; Maastricht University; Helmholtz Association; German Cancer Research Center (DKFZ); University of Oxford; Imperial College London; Danish Cancer Society; Aarhus University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Athens Medical School; National & Kapodistrian University of Athens; World Health Organization; World Health Organization; International Agency for Research on Cancer (IARC); Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS CROB; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; UiT The Arctic University of Tromso; Escuela Andaluza de Salud Publica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Catalan Institute of Oncology; Murcia Regional Health Council; Basque Government; Public Health Institute of Navarra; Umea University; Umea University; Umea University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; University of Ioannina; University of Cambridge; Imperial College London	Braem, MGM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	m.g.m.braem@umcutrecht.nl	Sánchez, Maria-José/D-1087-2011; Pala, Valeria/K-4738-2016; Floegel, Anna/F-4854-2013; Schouten, Leo J/G-3713-2012; Onland-Moret, N. Charlotte/G-9185-2011; Galasso, Rocco/AAL-2150-2020; Teucher, Birgit/J-6380-2015; Schouten, Leo J/AAB-2275-2019; Clavel-Chapelon, Francoise/G-6733-2014; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Khaw, Kay-Tee/AAZ-3209-2021; Wark, Petra/C-1752-2016	Sánchez, Maria-José/0000-0003-4817-0757; Pala, Valeria/0000-0001-5438-970X; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Galasso, Rocco/0000-0003-4831-6437; Schouten, Leo J/0000-0003-3361-7560; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; tumino, rosario/0000-0003-2666-414X; Tjonneland, Anne/0000-0003-4385-2097; Lund, Eiliv/0000-0002-8071-8711; Tsilidis, Konstantinos/0000-0002-8452-8472; Riboli, Elio/0000-0001-6795-6080; Floegel, Anna/0000-0001-9806-4288; Overvad, Kim/0000-0001-6429-7921; Kruitwagen, Roy F.P.M./0000-0002-1305-9541; Sacerdote, Carlotta/0000-0002-8008-5096; Larranaga, Nerea/0000-0002-9993-9880; PALLI, Domenico/0000-0002-5558-2437; Wark, Petra/0000-0003-1020-4640; Bonet, Catalina/0000-0003-0259-2591	Dutch Cancer Society [UU2008-4267]; European Commission (DG-SANCO); International Agency for Research on Cancer; Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); Hellenic Health Foundation; Stavros Niarchos Foundation; Hellenic Ministry of Health and Social Solidarity (Greece); Italian Association for Research on Cancer (AIRC) and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); Health Research Fund (FIS); Regional Governments of Andalucia, Asturias, Basque Country, Murcia [6236]; Navarra, ISCIII RETIC (Spain) [RD06/0020]; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane and Vasterbotten (Sweden); Cancer Research United Kingdom, Medical Research Council (United Kingdom); Medical Research Council [MC_U106179471, G0401527, G1000143] Funding Source: researchfish	Dutch Cancer Society(KWF Kankerbestrijding); European Commission (DG-SANCO)(European CommissionEuropean Commission Joint Research Centre); International Agency for Research on Cancer; Danish Cancer Society (Denmark)(Danish Cancer Society); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany)(Deutsche Krebshilfe); Hellenic Health Foundation; Stavros Niarchos Foundation; Hellenic Ministry of Health and Social Solidarity (Greece); Italian Association for Research on Cancer (AIRC) and National Research Council (Italy)(Fondazione AIRC per la ricerca sul cancro); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland)(Netherlands Organization for Scientific Research (NWO)); World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands)(Netherlands Government); Health Research Fund (FIS)(Instituto de Salud Carlos III); Regional Governments of Andalucia, Asturias, Basque Country, Murcia; Navarra, ISCIII RETIC (Spain); Swedish Cancer Society(Swedish Cancer Society); Swedish Scientific Council; Regional Government of Skane and Vasterbotten (Sweden); Cancer Research United Kingdom, Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was financially supported by the Dutch Cancer Society (UU2008-4267). The coordination of EPIC is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation, the Stavros Niarchos Foundation and the Hellenic Ministry of Health and Social Solidarity (Greece); Italian Association for Research on Cancer (AIRC) and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); Health Research Fund (FIS), Regional Governments of Andalucia, Asturias, Basque Country, Murcia (no. 6236) and Navarra, ISCIII RETIC (RD06/0020) (Spain); Swedish Cancer Society, Swedish Scientific Council and Regional Government of Skane and Vasterbotten (Sweden); Cancer Research United Kingdom, Medical Research Council (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON BA, 1994, DEMOGRAPHY, V31, P115, DOI 10.2307/2061911; Christiansen OB, 1996, HUM REPROD UPDATE, V2, P271, DOI 10.1093/humupd/2.4.271; Dick MLB, 2009, CANCER CAUSE CONTROL, V20, P1571, DOI 10.1007/s10552-009-9402-3; Fu HS, 1998, FAM PLANN PERSPECT, V30, P128, DOI 10.2307/2991627; La Vecchia C, 2001, EUR J CANCER PREV, V10, P125, DOI 10.1097/00008469-200104000-00002; Lukanova A, 2005, CANCER EPIDEM BIOMAR, V14, P98; MILLER H, 1969, FERTIL STERIL, V20, P433; Musil CM, 2002, WESTERN J NURS RES, V24, P815, DOI 10.1177/019394502762477004; Potdar N, 2005, CURR OPIN OBSTET GYN, V17, P424, DOI 10.1097/01.gco.0000175363.20094.bd; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Riman T, 1998, CLIN ENDOCRINOL, V49, P695, DOI 10.1046/j.1365-2265.1998.00577.x; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; Rookus MA, 1996, J NATL CANCER I, V88, P1759, DOI 10.1093/jnci/88.23.1759; Sueblinvong T, 2009, CURR TREAT OPTION ON, V10, P67, DOI 10.1007/s11864-009-0108-2; Tsilidis KK, 2011, BRIT J CANCER, V105, P1436, DOI 10.1038/bjc.2011.371	16	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37141	10.1371/journal.pone.0037141	http://dx.doi.org/10.1371/journal.pone.0037141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623987	Green Published, gold			2022-12-25	WOS:000305343500064
J	Chen, DP; Tseng, CP; Wang, WT; Sun, CF				Chen, Ding-Ping; Tseng, Ching-Ping; Wang, Wei-Ting; Sun, Chien-Feng			Genetic and Mechanistic Evaluation for the Mixed-Field Agglutination in B-3 Blood Type with IVS3+5G > A ABO Gene Mutation	PLOS ONE			English	Article							GROUP-A; TRANSFERASE; PROMOTER; ALLELE; CELL; GLYCOSYLTRANSFERASE; RECOMBINATION; TRANSCRIPTION; POLYMORPHISM; PHENOTYPES	Background: The ABO blood type B-3 is the most common B subtype in the Chinese population with a frequency of 1/900. Although IVS3+5G > A (rs55852701) mutation of B gene has been shown to associate with the development of B-3 blood type, genetic and mechanistic evaluation for the unique mixed-field agglutination phenotype has not yet been completely addressed. Methodology/Principal Findings: In this study, we analyzed 16 cases of confirmed B-3 individuals and found that IVS3+5G > A attributes to all cases of B-3. RT-PCR analyses revealed the presence of at least 7 types of aberrant B-3 splicing transcripts with most of the transcripts causing early termination and producing non-functional protein during translation. The splicing transcript without exon 3 that was predicted to generate functional B-3 glycosyltransferase lacking 19 amino acids at the N-terminal segment constituted only 0.9% of the splicing transcripts. Expression of the B-3 cDNA with exon 3 deletion in the K562 erythroleukemia cells revealed that the B-3 glycosyltransferase had only 40% of B-1 activity in converting H antigen to B antigen. Notably, the typical mixed-field agglutination of B-3-RBCs can be mimicked by adding anti-B antibody to the K562-B-3 cells. Conclusions/Significance: This study thereby demonstrates that both aberrant splicing of B transcripts and the reduced B-3 glycosyltransferase activity contribute to weak B expression and the mixed-field agglutination of B-3, adding to the complexity for the regulatory mechanisms of ABO gene expression.	[Chen, Ding-Ping; Wang, Wei-Ting; Sun, Chien-Feng] Chang Gung Mem Hosp, Dept Lab Med, Kaohsiung, Taoyuan County, Taiwan; [Tseng, Ching-Ping] Chang Gung Univ, Mol Med Res Ctr, Kaohsiung, Taoyuan County, Taiwan; [Sun, Chien-Feng] Chang Gung Univ, Dept Pathol, Sch Med, Kaohsiung, Taoyuan County, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Chen, DP (corresponding author), Chang Gung Mem Hosp, Dept Lab Med, Kaohsiung, Taoyuan County, Taiwan.	suncgj@adm.cgmh.org.tw		TSENG, CHING-PING/0000-0002-2587-210X	National Science Council, Taiwan [NSC 98-2320-B-182A-006]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Grant NSC 98-2320-B-182A-006 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen DP, 2011, ANN CLIN LAB SCI, V41, P346; Chen DP, 2005, VOX SANG, V88, P196, DOI 10.1111/j.1423-0410.2005.00608.x; Chester MA, 2001, TRANSFUS MED REV, V15, P177, DOI 10.1053/tmrv.2001.24591; Hata Y, 2002, VOX SANG, V82, P39, DOI 10.1046/j.0042-9007.2001.00134.x; Hou JW, 2006, ACTA PAEDIATR, V95, P1500, DOI 10.1080/08035250600617131; Hwang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025492; Irshaid NM, 1999, TRANSFUSION MED, V9, P219; Issitt, 1998, APPL BLOOD GROUP SER; Kominato Y, 1997, J BIOL CHEM, V272, P25890, DOI 10.1074/jbc.272.41.25890; Kominato Y, 1999, J BIOL CHEM, V274, P37240, DOI 10.1074/jbc.274.52.37240; Kominato Y, 2002, J BIOL CHEM, V277, P37936, DOI 10.1074/jbc.M204238200; Landsteiner K, 1900, ZENTRALBL BAKTERIOL, V27, P352; LINCHU M, 1986, TRANSFUSION, V26, P428, DOI 10.1046/j.1537-2995.1986.26587020118.x; Ogasawara K, 1996, BLOOD, V88, P2732, DOI 10.1182/blood.V88.7.2732.bloodjournal8872732; Ogasawara K, 1996, HUM GENET, V97, P777; Ogasawara K, 2001, IMMUNOGENETICS, V53, P190, DOI 10.1007/s002510100315; Olsson ML, 2000, TRANSFUSION, V40, p13S; Olsson ML, 2001, TRANSFUSION MED, V11, P295, DOI 10.1046/j.1365-3148.2001.00320.x; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Seltsam A, 2005, TRANSFUSION, V45, P1663, DOI 10.1111/j.1537-2995.2005.00558.x; Sun CF, 2003, VOX SANG, V85, P216, DOI 10.1046/j.1423-0410.2003.00349.x; Sun CF, 2003, TRANSFUSION, V43, P1138, DOI 10.1046/j.1537-2995.2003.00500.x; Symoens S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020121; Wakisaka KT, 2011, BBA-MOL BASIS DIS, V1812, P1452, DOI 10.1016/j.bbadis.2011.07.011; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; YAMAMOTO F, 1990, J BIOL CHEM, V265, P1146; YAMAMOTO F, 1995, GLYCOBIOLOGY, V5, P51, DOI 10.1093/glycob/5.1.51; YAMAMOTO FI, 1993, VOX SANG, V64, P116, DOI 10.1111/j.1423-0410.1993.tb02528.x; Yip SP, 2002, ANN HUM GENET, V66, P1, DOI 10.1017/S0003480001008995; Yu LC, 2000, BIOCHEM BIOPH RES CO, V273, P459, DOI 10.1006/bbrc.2000.2962; Yu LC, 2002, BLOOD, V100, P1490, DOI 10.1182/blood-2002-01-0188; Zhu FM, 2008, TRANSFUSION, V48, P2476, DOI 10.1111/j.1537-2995.2008.01874.x	32	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37272	10.1371/journal.pone.0037272	http://dx.doi.org/10.1371/journal.pone.0037272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624005	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500088
J	Guimond, S; Massrieh, W				Guimond, Sylvain; Massrieh, Wael			Intricate Correlation between Body Posture, Personality Trait and Incidence of Body Pain: A Cross-Referential Study Report	PLOS ONE			English	Article							LOW-BACK-PAIN	Objective: Occupational back pain is a disorder that commonly affects the working population, resulting in disability, health-care utilization, and a heavy socioeconomic burden. Although the etiology of occupational pain remains largely unsolved, anecdotal evidence exists for the contribution of personality and posture to long-term pain management, pointing to a direct contribution of the mind-body axis. In the current study, we have conducted an extensive evaluation into the relationships between posture and personality. Method: We have sampled a random population of 100 subjects (50 men and 50 women) in the age range of 13-82 years based on their personality and biomechanical profiles. All subjects were French-Canadian, living in Canada between the Quebec and Sorel-Tracy areas. The Biotonix analyses and report were used on the subjects being tested in order to distinguish postural deviations. Personality was determined by using the Myers-Briggs Type Indicator questionnaire. Results: We establish a correlation between ideal and kyphosis-lordosis postures and extraverted personalities. Conversely, our studies establish a correlative relationship between flat back and sway-back postures with introverted personalities. Conclusion: Overall, our studies establish a novel correlative relationship between personality, posture and pain.	[Guimond, Sylvain] San Diego Univ Integrat Studies, San Diego, CA USA; [Massrieh, Wael] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada	McGill University	Guimond, S (corresponding author), Biotonix Inc, Quebec City, PQ, Canada.	waelmassrieh@gmail.com			San Diego University for Integrative Studies	San Diego University for Integrative Studies	Funding was provided by the San Diego University for Integrative Studies. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2000, HLTH CARE COMMUNICAT; Andersson Gunnar B. J., 1997, P93; Argyle M, 1999, PSYCHOL INTERPERSONA; Briggs KC, 1998, MYERS BRIGGS TYPE IN; Briggs Myers I, 1980, GIFTS DIFFERING UNDE; Briggs-Myers I., 2003, MBTI MANUAL GUIDE DE, V3rd; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Garofalo JP, 1999, PSYCHOSOCIAL FACTORS, P164; Gori Luigi, 2005, Recenti Prog Med, V96, P89; Harrison DE, 2007, EUR SPINE J, V16, P213, DOI 10.1007/s00586-006-0081-4; HART LG, 1995, SPINE, V20, P11, DOI 10.1097/00007632-199501000-00003; HEILBRUN AB, 1988, J PERS ASSESS, V52, P420, DOI 10.1207/s15327752jpa5203_3; Johnson SM, 1993, TRANSFORMATION CHARA; Jung C.G., 1923, PSYCHOL TYPES; KAPLAN RM, 1994, HEALTH PSYCHOL, V13, P366, DOI 10.1037/0278-6133.13.4.366; Kendall K, 1983, MUSCLES TESTING FUNC; Marras WS, 2000, SPINE, V25, P3045, DOI 10.1097/00007632-200012010-00012; Missaoui B, 2008, NEUROPHYSIOL CLIN, V38, P447, DOI 10.1016/j.neucli.2008.09.004; Normand M, 2005, J MANIP PHYSIOL THER, V25, P246; Ono T, 2000, J DENT RES, V79, P1879, DOI 10.1177/00220345000790111101; Ryckman R. M., 2004, THEORIES PERSONALITY; Smith AJ, 2010, J ORTHOP SPORT PHYS, V40, P517, DOI 10.2519/jospt.2010.3369; Taylor SE, 1999, HLTH PSYCHOL; Wai EK, 2010, SPINE J, V10, P554, DOI 10.1016/j.spinee.2010.03.033	24	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37450	10.1371/journal.pone.0037450	http://dx.doi.org/10.1371/journal.pone.0037450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624034	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343500119
J	Klinck, H; Mellinger, DK; Klinck, K; Bogue, NM; Luby, JC; Jump, WA; Shilling, GB; Litchendorf, T; Wood, AS; Schorr, GS; Baird, RW				Klinck, Holger; Mellinger, David K.; Klinck, Karolin; Bogue, Neil M.; Luby, James C.; Jump, William A.; Shilling, Geoffrey B.; Litchendorf, Trina; Wood, Angela S.; Schorr, Gregory S.; Baird, Robin W.			Near-Real-Time Acoustic Monitoring of Beaked Whales and Other Cetaceans Using a Seaglider (TM)	PLOS ONE			English	Article							CUVIERS ZIPHIUS-CAVIROSTRIS; ECHOLOCATION CLICKS; DIVING BEHAVIOR; CROSS-SEAMOUNT; KILLER WHALES; SITE FIDELITY; HAWAII; PATTERNS; MOVEMENTS; GLIDERS	In most areas, estimating the presence and distribution of cryptic marine mammal species, such as beaked whales, is extremely difficult using traditional observational techniques such as ship-based visual line transect surveys. Because acoustic methods permit detection of animals underwater, at night, and in poor weather conditions, passive acoustic observation has been used increasingly often over the last decade to study marine mammal distribution, abundance, and movements, as well as for mitigation of potentially harmful anthropogenic effects. However, there is demand for new, cost-effective tools that allow scientists to monitor areas of interest autonomously with high temporal and spatial resolution in near-real time. Here we describe an autonomous underwater vehicle - a glider - equipped with an acoustic sensor and onboard data processing capabilities to passively scan an area for marine mammals in near-real time. The glider was tested extensively off the west coast of the Island of Hawai'i, USA. The instrument covered approximately 390 km during three weeks at sea and collected a total of 194 h of acoustic data. Detections of beaked whales were successfully reported to shore in near-real time. Manual analysis of the recorded data revealed a high number of vocalizations of delphinids and sperm whales. Furthermore, the glider collected vocalizations of unknown origin very similar to those made by known species of beaked whales. The instrument developed here can be used to cost-effectively screen areas of interest for marine mammals for several months at a time. The near-real-time detection and reporting capabilities of the glider can help to protect marine mammals during potentially harmful anthropogenic activities such as seismic exploration for sub-sea fossil fuels or naval sonar exercises. Furthermore, the glider is capable of under-ice operation, allowing investigation of otherwise inaccessible polar environments that are critical habitats for many endangered marine mammal species.	[Klinck, Holger; Mellinger, David K.; Klinck, Karolin] Oregon State Univ, Hatfield Marine Sci Ctr, NOAA Pacific Marine Environm Lab, Cooperat Inst Marine Resources Studies, Newport, OR 97365 USA; [Bogue, Neil M.; Luby, James C.; Jump, William A.; Shilling, Geoffrey B.; Litchendorf, Trina; Wood, Angela S.] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Schorr, Gregory S.; Baird, Robin W.] Cascadia Res Collect, Olympia, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University; University of Washington; University of Washington Seattle	Klinck, H (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, NOAA Pacific Marine Environm Lab, Cooperat Inst Marine Resources Studies, Newport, OR 97365 USA.	Holger.Klinck@oregonstate.edu	Klinck, Holger/X-5214-2019; Baird, Robin/Y-8230-2019	Klinck, Holger/0000-0003-1078-7268; Baird, Robin/0000-0002-9419-6336	Naval Postgraduate School (NPS) [N00244-08-1-0029, N00244-09-1-0079, N00244-10-1-0047]; Office of Naval Research (ONR) [N00014-08-1-0309, N00014-08-1-1082, N00014-10-1-0387, N00014-08-1-1198]; U.S. Navy (N45) through the Southwest Fisheries Science Center (NOAA/SWFSC); Wild Whale Research Foundation (WWRF)	Naval Postgraduate School (NPS); Office of Naval Research (ONR)(Office of Naval Research); U.S. Navy (N45) through the Southwest Fisheries Science Center (NOAA/SWFSC); Wild Whale Research Foundation (WWRF)	This work was supported by Naval Postgraduate School (NPS) grants N00244-08-1-0029, N00244-09-1-0079, and N00244-10-1-0047, and Office of Naval Research (ONR) grants N00014-08-1-0309, N00014-08-1-1082, N00014-10-1-0387, and N00014-08-1-1198. Cascadia Research Collective satellite tagging work was supported by the U.S. Navy (N45) through the Southwest Fisheries Science Center (NOAA/SWFSC) and by the Wild Whale Research Foundation (WWRF). NPS: http://www.nps.edu ONR: http://www.onr.navy.mil N45: http://www.navy.mil/local/n45 NOAA/SWFSC: http://swfsc.noaa.gov WWRF: http://www.wildwhaleresearch.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; Aschettino JM, 2012, MAR MAMMAL SCI, V28, P666, DOI 10.1111/j.1748-7692.2011.00517.x; Baird R. W., 2003, P 15 BIENN C BIOL MA; Baird RW, 2008, MAR MAMMAL SCI, V24, P630, DOI 10.1111/j.1748-7692.2008.00211.x; Baird RW, 2006, CAN J ZOOL, V84, P1120, DOI 10.1139/Z06-095; Baird RW, 2001, CAN J ZOOL, V79, P988, DOI 10.1139/cjz-79-6-988; Baumgartner MF, 2008, LIMNOL OCEANOGR, V53, P2197, DOI 10.4319/lo.2008.53.5_part_2.2197; Benoit-Bird KJ, 2003, J ACOUST SOC AM, V114, P1888, DOI 10.1121/1.1612484; Dalebout ML, 2004, J HERED, V95, P459, DOI 10.1093/jhered/esh054; Eriksen CC, 2001, IEEE J OCEANIC ENG, V26, P424, DOI 10.1109/48.972073; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Johnston DW, 2008, BIOL LETTERS, V4, P208, DOI 10.1098/rsbl.2007.0614; Klinck H, 2011, J ACOUST SOC AM, V129, P1807, DOI 10.1121/1.3531924; McDonald MA, 2009, J ACOUST SOC AM, V125, P624, DOI 10.1121/1.3050317; McSweeney DJ, 2007, MAR MAMMAL SCI, V23, P666, DOI 10.1111/j.1748-7692.2007.00135.x; McSweeney DJ, 2009, MAR MAMMAL SCI, V25, P557, DOI 10.1111/j.1748-7692.2008.00267.x; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Mellinger DK, 2010, J ACOUST SOC AM, V128, P2299; Moore SE, 2007, MAR TECHNOL SOC J, V41, P53, DOI 10.4031/002533207787442033; Norris K.S., 1994, HAWAIIAN SPINNER DOL; Rankin S, 2011, J ACOUST SOC AM, V130, pEL339, DOI 10.1121/1.3646026; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Roch MA, 2011, J ACOUST SOC AM, V129, P467, DOI 10.1121/1.3514383; Rosi P, 2009, CURRENTS US NAVY WIN, P6; Rudnick DL, 2004, MAR TECHNOL SOC J, V38, P73, DOI 10.4031/002533204787522703; Schorr Gregory S., 2010, Endangered Species Research, V10, P203, DOI 10.3354/esr00229; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Yack TM, 2010, APPL ACOUST, V71, P1043, DOI 10.1016/j.apacoust.2010.04.010; Zimmer WMX, 2008, J ACOUST SOC AM, V124, P2823, DOI 10.1121/1.2988277	30	69	71	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36128	10.1371/journal.pone.0036128	http://dx.doi.org/10.1371/journal.pone.0036128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629309	Green Published, gold			2022-12-25	WOS:000305343500010
J	Pin, C; Watson, AJM; Carding, SR				Pin, Carmen; Watson, Alastair J. M.; Carding, Simon R.			Modelling the Spatio-Temporal Cell Dynamics Reveals Novel Insights on Cell Differentiation and Proliferation in the Small Intestinal Crypt	PLOS ONE			English	Article							EPITHELIAL STEM-CELL; SELF-RENEWAL; PANETH CELLS; IN-VITRO; MOUSE; COMPACTION; CANCER; NOTCH; ORGANIZATION; HOMEOSTASIS	We developed a slow structural relaxation model to describe cellular dynamics in the crypt of the mouse small intestine. Cells are arranged in a three dimensional spiral the size of which dynamically changes according to cell production demands of adjacent villi. Cell differentiation and proliferation is regulated through Wnt and Notch signals, the strength of which depends on the local cell composition. The highest level of Wnt activity is associated with maintaining equipotent stem cells (SC), Paneth cells and common goblet-Paneth cell progenitors (CGPCPs) intermingling at the crypt bottom. Low levels of Wnt signalling area are associated with stem cells giving rise to secretory cells (CGPCPs, enteroendocrine or Tuft cells) and proliferative absorptive progenitors. Deciding between these two fates, secretory and stem/absorptive cells, depends on Notch signalling. Our model predicts that Notch signalling inhibits secretory fate if more than 50% of cells they are in contact with belong to the secretory lineage. CGPCPs under high Wnt signalling will differentiate into Paneth cells while those migrating out from the crypt bottom differentiate into goblet cells. We have assumed that mature Paneth cells migrating upwards undergo anoikis. Structural relaxation explains the localisation of Paneth cells to the crypt bottom in the absence of active forces. The predicted crypt generation time from one SC is 4-5 days with 10-12 days needed to reach a structural steady state. Our predictions are consistent with experimental observations made under altered Wnt and Notch signalling. Mutations affecting stem cells located at the crypt floor have a 50% chance of being propagated throughout the crypt while mutations in cells above are rarely propagated. The predicted recovery time of an injured crypt losing half of its cells is approximately 2 days.	[Pin, Carmen; Carding, Simon R.] Inst Food Res, Norwich, Norfolk, England; [Watson, Alastair J. M.; Carding, Simon R.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of East Anglia	Pin, C (corresponding author), Inst Food Res, Norwich, Norfolk, England.	carmen.pin@bbsrc.ac.uk	pin, carmen/C-8959-2014	Carding, Simon/0000-0002-2383-9701	Biotechnology and Biological Sciences Research Council (BBSRC) [44446, 44451]; BBSRC [BBS/E/F/00044446, BBS/E/F/00042262, BBS/E/F/00044406] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044406, BBS/E/F/00042262, BBS/E/F/00044446] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work has been supported by the Biotechnology and Biological Sciences Research Council (BBSRC) strategic grants 44446 and 44451. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; Caglioti E, 1997, PHYS REV LETT, V79, P1575, DOI 10.1103/PhysRevLett.79.1575; CHANG WWL, 1971, AM J ANAT, V131, P101, DOI 10.1002/aja.1001310106; CHWALINSKI S, 1989, AM J ANAT, V186, P397, DOI 10.1002/aja.1001860409; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Escobar M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1260; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Galle J, 2009, J MATH BIOL, V58, P261, DOI 10.1007/s00285-008-0172-4; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6; LOEFFLER M, 1988, CELL TISSUE KINET, V21, P247, DOI 10.1111/j.1365-2184.1988.tb00784.x; LOEFFLER M, 1986, CELL TISSUE KINET, V19, P627, DOI 10.1111/j.1365-2184.1986.tb00763.x; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V132, pA381; Nicodemi M, 1997, J PHYS A-MATH GEN, V30, pL379, DOI 10.1088/0305-4470/30/11/006; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; PAULUS U, 1993, J CELL SCI, V106, P473; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Peng GW, 1998, PHYS REV E, V57, P829, DOI 10.1103/PhysRevE.57.829; Piccioni M, 1999, PHYS REV E, V59, P3858, DOI 10.1103/PhysRevE.59.3858; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Potten CS, 1997, STEM CELLS, V15, P82, DOI 10.1002/stem.150082; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Schneider MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014325; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Solanas G, 2011, NAT CELL BIOL, V13, P1100, DOI 10.1038/ncb2298; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stamataki D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024484; Takeda N, 2011, SCIENCE; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Leeuwen IMM, 2009, CELL PROLIFERAT, V42, P617, DOI 10.1111/j.1365-2184.2009.00627.x; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; VanDussen KL, 2010, DEV BIOL, V346, P215, DOI 10.1016/j.ydbio.2010.07.026; Wright N. A., 1984, BIOL EPITHELIAL CELL, V1; WRIGHT NA, 1979, J CLIN PATHOL, V32, P462, DOI 10.1136/jcp.32.5.462; Wright NA, 1984, BIOL EPITHELIAL CELL, V2; Yan K. S., 2011, P NATL ACAD SCI US; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	61	25	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37115	10.1371/journal.pone.0037115	http://dx.doi.org/10.1371/journal.pone.0037115			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623982	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500059
J	Tynan, GA; McNaughton, A; Jarnicki, A; Tsuji, T; Lavelle, EC				Tynan, Graham A.; McNaughton, Anne; Jarnicki, Andrew; Tsuji, Takao; Lavelle, Ed C.			Polymyxin B Inadequately Quenches the Effects of Contaminating Lipopolysaccharide on Murine Dendritic Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; HEAT-SHOCK PROTEINS; GROUP BOX-1 PROTEIN; EPIDERMAL LANGERHANS CELLS; TUMOR-NECROSIS-FACTOR; INNATE IMMUNE-SYSTEM; HUMAN HEAT-SHOCK-PROTEIN-60; ENDOTOXIN CONTAMINATION; INFLAMMATORY RESPONSE; HUMAN NEUTROPHILS	Dendritic cell (DC) activation is commonly used as a measure of the immunomodulatory potential of candidate exogenous and endogenous molecules. Residual lipopolysaccharide (LPS) contamination is a recurring theme and the potency of LPS is not always fully appreciated. To address this, polymyxin B (PmB) is often used to neutralise contaminating LPS. However, the limited capacity of this antibiotic to successfully block these effects is neglected. Therefore, this study aimed to determine the minimum LPS concentration required to induce murine bone marrow-derived dendritic cell (BMDC) maturation and cytokine secretion and to assess the ability of PmB to inhibit these processes. LPS concentrations as low as 10 pg/ml and 20 pg/ml induced secretion of interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha respectively, while a concentration of 50 pg/ml promoted secretion of IL-12p40. A much higher threshold exists for IL-12p70 as an LPS concentration of 500 pg/ml was required to induce secretion of this cytokine. The efficacy of PmB varied substantially for different cytokines but this antibiotic was particularly limited in its ability to inhibit LPS-induced secretion of IL-6 and TNF-alpha. Furthermore, an LPS concentration of 50 pg/ml was sufficient to promote DC expression of costimulatory molecules and PmB was limited in its capacity to reverse this process when LPS concentrations of greater than 20 ng/ml were used. There is a common perception that LPS is heat resistant. However, heat treatment attenuated the ability of low concentrations of LPS to induce secretion of IL-6 and IL-12p40 by BMDCs, thus suggesting that heat-inactivation of protein preparations is also an ineffective control for discounting potential LPS contamination. Finally, LPS concentrations of less than 10 pg/ml were incapable of promoting secretion of IL-6 independently but could synergise with heat-labile enterotoxin (LT) to promote IL-6, indicating that reducing contaminating endotoxin concentrations to low pg/ml concentrations is essential to avoid misleading conclusions regarding candidate immunomodulators.	[Tynan, Graham A.; McNaughton, Anne; Lavelle, Ed C.] Trinity Coll Dublin, Adjuvant Res Grp, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland; [Tynan, Graham A.; Lavelle, Ed C.] Trinity Coll Dublin, Immunol Res Ctr, Trinity Biomed Sci Inst, Dublin, Ireland; [Jarnicki, Andrew] Univ Newcastle, Sch Biomed Sci & Pharm, Fac Hlth, Callaghan, NSW 2308, Australia; [Tsuji, Takao] Fujita Hlth Univ, Dept Microbiol, Sch Med, Toyoake, Aichi, Japan	Trinity College Dublin; Trinity College Dublin; University of Newcastle; Fujita Health University	Tynan, GA (corresponding author), Trinity Coll Dublin, Adjuvant Res Grp, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland.	lavellee@tcd.ie	Lavelle, Ed/A-1716-2008	Lavelle, Ed/0000-0002-3167-1080	Science Foundation Ireland as part of the Immunology Research Centre, SFI Strategic Research Cluster [07/SRC/B1144]; Meningitis Research Foundation [0610.0]	Science Foundation Ireland as part of the Immunology Research Centre, SFI Strategic Research Cluster(Science Foundation Ireland); Meningitis Research Foundation(Meningitis Research Foundation (MRF))	This work was supported by Science Foundation Ireland as part of the Immunology Research Centre, SFI Strategic Research Cluster (07/SRC/B1144), and was also supported by the Meningitis Research Foundation (0610.0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Bethke K, 2002, J IMMUNOL, V169, P6141, DOI 10.4049/jimmunol.169.11.6141; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Campo GM, 2010, BIOCHIMIE, V92, P204, DOI 10.1016/j.biochi.2009.10.006; Chen W, 1999, J IMMUNOL, V162, P3212; Dybdahl B, 2002, CIRCULATION, V105, P685, DOI 10.1161/hc0602.103617; Flohe SB, 2003, J IMMUNOL, V170, P2340, DOI 10.4049/jimmunol.170.5.2340; GALANOS C, 1985, EUR J BIOCHEM, V148, P1, DOI 10.1111/j.1432-1033.1985.tb08798.x; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kodaira Y, 2000, J IMMUNOL, V165, P1599, DOI 10.4049/jimmunol.165.3.1599; Krejcova D, 2009, NEUROENDOCRINOL LETT, V30, P106; Lavelle EC, 2003, J IMMUNOL, V171, P2384, DOI 10.4049/jimmunol.171.5.2384; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MAJDE JA, 1993, PEPTIDES, V14, P629, DOI 10.1016/0196-9781(93)90155-A; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; MOORE RA, 1986, ANTIMICROB AGENTS CH, V29, P496, DOI 10.1128/AAC.29.3.496; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Panjwani NN, 2002, J IMMUNOL, V168, P2997, DOI 10.4049/jimmunol.168.6.2997; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Radsak MP, 2003, BLOOD, V101, P2810, DOI 10.1182/blood-2002-07-2261; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reed RC, 2003, J BIOL CHEM, V278, P31853, DOI 10.1074/jbc.M305480200; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; Rouhiainen A, 2007, J LEUKOCYTE BIOL, V81, P49, DOI 10.1189/jlb.0306200; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Warger T, 2006, J BIOL CHEM, V281, P22545, DOI 10.1074/jbc.M502900200; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067	50	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37261	10.1371/journal.pone.0037261	http://dx.doi.org/10.1371/journal.pone.0037261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624003	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500085
J	Fan, WJ; Zhang, M; Zhang, HX; Zhang, P				Fan, Weijuan; Zhang, Min; Zhang, Hongxia; Zhang, Peng			Improved Tolerance to Various Abiotic Stresses in Transgenic Sweet Potato (Ipomoea batatas) Expressing Spinach Betaine Aldehyde Dehydrogenase	PLOS ONE			English	Article							PHOTOSYSTEM-II; GLYCINE BETAINE; CHOLINE OXIDASE; DROUGHT TOLERANCE; OXIDATIVE STRESS; WATER-STRESS; SALT STRESS; PLANTS; BIOSYNTHESIS; ACCUMULATION	Abiotic stresses are critical delimiters for the increased productivity and cultivation expansion of sweet potato (Ipomoea batatas), a root crop with worldwide importance. The increased production of glycine betaine (GB) improves plant tolerance to various abiotic stresses without strong phenotypic changes, providing a feasible approach to improve stable yield production under unfavorable conditions. The gene encoding betaine aldehyde dehydrogenase (BADH) is involved in the biosynthesis of GB in plants, and the accumulation of GB by the heterologous overexpression of BADH improves abiotic stress tolerance in plants. This study is to improve sweet potato, a GB accumulator, resistant to multiple abiotic stresses by promoted GB biosynthesis. A chloroplastic BADH gene from Spinacia oleracea (SoBADH) was introduced into the sweet potato cultivar Sushu-2 via Agrobacterium-mediated transformation. The overexpression of SoBADH in the transgenic sweet potato improved tolerance to various abiotic stresses, including salt, oxidative stress, and low temperature. The increased BADH activity and GB accumulation in the transgenic plant lines under normal and multiple environmental stresses resulted in increased protection against cell damage through the maintenance of cell membrane integrity, stronger photosynthetic activity, reduced reactive oxygen species (ROS) production, and induction or activation of ROS scavenging by the increased activity of free radical-scavenging enzymes. The increased proline accumulation and systemic upregulation of many ROS-scavenging genes in stress-treated transgenic plants also indicated that GB accumulation might stimulate the ROS-scavenging system and proline biosynthesis via an integrative mechanism. This study demonstrates that the enhancement of GB biosynthesis in sweet potato is an effective and feasible approach to improve its tolerance to multiple abiotic stresses without causing phenotypic defects. This strategy for trait improvement in sweet potato not only stabilizes yield production in normal soils in unpredictable climates but also provides a novel germplasm for sweet potato production on marginal lands.	[Fan, Weijuan; Zhang, Hongxia; Zhang, Peng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Zhang, Min; Zhang, Peng] Chinese Acad Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zhang, Min; Zhang, Peng] Chinese Acad Sci, Shanghai Chenshan Bot Garden, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Fan, WJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.	zhangpeng@sibs.ac.cn	Peng Zhang, Dr./A-6423-2008	Peng Zhang, Dr./0000-0002-4868-1306	National High Technology Research and Development Program of China [2009AA10Z102]; Shanghai Municipal Afforestation & City Appearance and Environmental Sanitation Administration [G102410]; Shanghai Science and Technology Committee [09DZ2271800]; Chinese Academy of Sciences [KSCX2-EW-J-12]; Shanghai Key Laboratory of Bio-Energy Crops	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Municipal Afforestation & City Appearance and Environmental Sanitation Administration; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Key Laboratory of Bio-Energy Crops	This work was supported by grants from the National High Technology Research and Development Program of China (No. 2009AA10Z102), Shanghai Municipal Afforestation & City Appearance and Environmental Sanitation Administration (G102410), Shanghai Science and Technology Committee (No. 09DZ2271800) and the Chinese Academy of Sciences (KSCX2-EW-J-12). The Shanghai Key Laboratory of Bio-Energy Crops also supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Taweel K, 2007, PLANT PHYSIOL, V145, P258, DOI 10.1104/pp.107.101733; Allakhverdiev SI, 2004, BBA-BIOENERGETICS, V1657, P23, DOI 10.1016/j.bbabio.2004.03.003; Allakhverdiev SI, 2002, PLANT PHYSIOL, V130, P1443, DOI 10.1104/pp.011114; [Anonymous], 1992, SWEET POTATO UNTAPPE; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; Bovell-Benjamin AC, 2007, ADV FOOD NUTR RES, V52, P1, DOI 10.1016/S1043-4526(06)52001-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Chen THH, 2008, TRENDS PLANT SCI, V13, P499, DOI 10.1016/j.tplants.2008.06.007; Chen THH, 2011, PLANT CELL ENVIRON, V34, P1, DOI 10.1111/j.1365-3040.2010.02232.x; DHINDSA RS, 1981, J EXP BOT, V32, P79, DOI 10.1093/jxb/32.1.79; Dhir SK, 2009, COMPENDIUM TRANSGENI, P157; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; HANSON AD, 1979, CROP SCI, V19, P489, DOI 10.2135/cropsci1979.0011183X001900040015x; Hayashi H, 1997, PLANT J, V12, P133, DOI 10.1046/j.1365-313X.1997.12010133.x; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang J, 2000, PLANT PHYSIOL, V122, P747, DOI 10.1104/pp.122.3.747; JEFFERSON RA, 1989, NATURE, V342, P837, DOI 10.1038/342837a0; Jewell MC, 2010, TRANSGENIC CROP PLANTS: VOL 2, P67, DOI 10.1007/978-3-642-04812-8_2; Jia GX, 2002, PLANT CELL REP, V21, P141, DOI 10.1007/s00299-002-0489-1; Kathuria H, 2009, PLANT BIOTECHNOL J, V7, P512, DOI 10.1111/j.1467-7652.2009.00420.x; Khan MS, 2009, PLANT BIOTECHNOL-NAR, V26, P125, DOI 10.5511/plantbiotechnology.26.125; Kim SH, 2005, BIOTECHNOL LETT, V27, P1841, DOI 10.1007/s10529-005-3891-2; Kim YH, 2008, PLANTA, V227, P867, DOI 10.1007/s00425-007-0663-3; Kou JianPing, 2008, Kezaisheng Nengyuan / Renewable Energy Resources, V26, P3; Lebot V, 2010, HANDB PLANT BREED, V7, P97, DOI 10.1007/978-0-387-92765-7_3; Makela P, 1996, PLANT SCI, V121, P221, DOI 10.1016/S0168-9452(96)04527-X; Martin F. W., 1982, Sweet potato. Proceedings of the first international symposium, Taiwan, 23-27 March 1981., P275; Mazzucotelli E, 2008, PLANT SCI, V174, P420, DOI 10.1016/j.plantsci.2008.02.005; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; MOHANTY P, 1993, BIOCHIM BIOPHYS ACTA, V1144, P92, DOI 10.1016/0005-2728(93)90035-E; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Murata N, 2012, BBA-BIOENERGETICS, V1817, P1127, DOI 10.1016/j.bbabio.2012.02.020; Nishiyama Y, 2005, PHOTOSYNTH RES, V84, P1, DOI 10.1007/s11120-004-6434-0; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; PAPAGEORGIOU GC, 1991, BIOCHIM BIOPHYS ACTA, V1057, P361, DOI 10.1016/S0005-2728(05)80148-3; Park EJ, 2004, PLANT J, V40, P474, DOI 10.1111/j.1365-313X.2004.02237.x; Park EJ, 2007, PLANT CELL ENVIRON, V30, P994, DOI 10.1111/j.1365-3040.2007.01694.x; Park EJ, 2007, PLANT BIOTECHNOL J, V5, P422, DOI 10.1111/j.1467-7652.2007.00251.x; Park EJ, 2006, J CROP IMPROV, V17, P69, DOI 10.1300/J411v17n01_04; Quan RD, 2004, PLANT BIOTECHNOL J, V2, P477, DOI 10.1111/j.1467-7652.2004.00093.x; RHODES D, 1993, ANNU REV PLANT PHYS, V44, P357, DOI 10.1146/annurev.pp.44.060193.002041; Sairam RK, 2002, PLANT SCI, V162, P897, DOI 10.1016/S0168-9452(02)00037-7; Sakamoto A, 2000, J EXP BOT, V51, P81, DOI 10.1093/jexbot/51.342.81; Sakamoto A, 2002, PLANT CELL ENVIRON, V25, P163, DOI 10.1046/j.0016-8025.2001.00790.x; Sakamoto A, 2001, PLANT PHYSIOL, V125, P180, DOI 10.1104/pp.125.1.180; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; Srisuwan S, 2006, PLANT SCI, V171, P424, DOI 10.1016/j.plantsci.2006.05.007; Su J, 2006, J EXP BOT, V57, P1129, DOI 10.1093/jxb/erj133; Sulpice R, 2003, PLANT J, V36, P165, DOI 10.1046/j.1365-313X.2003.01873.x; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; Tian YS, 2009, APPL ENERG, V86, pS77, DOI 10.1016/j.apenergy.2009.06.007; Tunnacliffe A, 2010, TOP CURR GENET, V21, P91, DOI 10.1007/978-3-642-12422-8_6; Uozumi N, 2010, SIGNAL COMMUN PLANTS, P1, DOI 10.1007/978-3-642-10494-7_1; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; WERETILNYK EA, 1989, ARCH BIOCHEM BIOPHYS, V271, P56, DOI 10.1016/0003-9861(89)90255-5; Wu CZ, 2010, ENERGY, V35, P4445, DOI 10.1016/j.energy.2009.04.006; Yan LiangZheng, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P213; [杨俊 YANG Jun], 2011, [植物生理学报, Plant Physiology Journal], V47, P427; Yang J, 2011, PLANT SCI, V181, P701, DOI 10.1016/j.plantsci.2011.01.005; Yang XH, 2005, PLANT PHYSIOL, V138, P2299, DOI 10.1104/pp.105.063164; Yang XH, 2008, PLANT MOL BIOL, V66, P73, DOI 10.1007/s11103-007-9253-9; Zhang LA, 2011, BIORESOURCE TECHNOL, V102, P4573, DOI 10.1016/j.biortech.2010.12.115; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	72	140	157	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37344	10.1371/journal.pone.0037344	http://dx.doi.org/10.1371/journal.pone.0037344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615986	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300104
J	Tabak, JA; Zayas, V				Tabak, Joshua A.; Zayas, Vivian			The Roles of Featural and Configural Face Processing in Snap Judgments of Sexual Orientation	PLOS ONE			English	Article							UPSIDE-DOWN FACES; INVERTED FACES; PERCEPTION; RECOGNITION; INFORMATION; CATEGORIZATION; INVERSION; ACCURACY	Research has shown that people are able to judge sexual orientation from faces with above-chance accuracy, but little is known about how these judgments are formed. Here, we investigated the importance of well-established face processing mechanisms in such judgments: featural processing (e.g., an eye) and configural processing (e.g., spatial distance between eyes). Participants judged sexual orientation from faces presented for 50 milliseconds either upright, which recruits both configural and featural processing, or upside-down, when configural processing is strongly impaired and featural processing remains relatively intact. Although participants judged women's and men's sexual orientation with above-chance accuracy for upright faces and for upside-down faces, accuracy for upside-down faces was significantly reduced. The reduced judgment accuracy for upside-down faces indicates that configural face processing significantly contributes to accurate snap judgments of sexual orientation.	[Tabak, Joshua A.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Zayas, Vivian] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA	University of Washington; University of Washington Seattle; Cornell University	Tabak, JA (corresponding author), Univ Washington, Dept Psychol, Seattle, WA 98195 USA.	tabak@uw.edu			National Science Foundation [DGE-0718124]; Association for Psychological Science; Cornell University's Einhorn Family Charitable Trust Endowment, Cognitive Science Program, and College of Arts and Sciences	National Science Foundation(National Science Foundation (NSF)); Association for Psychological Science; Cornell University's Einhorn Family Charitable Trust Endowment, Cognitive Science Program, and College of Arts and Sciences	This paper is based upon work supported by a National Science Foundation Graduate Research Fellowship awarded to Joshua A. Tabak under Grant No. DGE-0718124 (http://nsf.gov). This research program was funded in part by grants awarded to Joshua A. Tabak by the Association for Psychological Science (http://psychologicalscience.org) and Cornell University's Einhorn Family Charitable Trust Endowment, Cognitive Science Program, and College of Arts and Sciences (http://cornell.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WE AR TV; Bailey JM, 2003, PSYCHOL PERSPECTIVES, P50; Bailey JM, 2009, CONT PERSPECTIVES LE; Barton JJS, 2001, BRIT J PSYCHOL, V92, P527, DOI 10.1348/000712601162329; Baudouin JY, 2006, PERCEPTION, V35, P531, DOI 10.1068/p3403; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Cellerino A, 2004, BRAIN RES BULL, V63, P443, DOI 10.1016/j.brainresbull.2004.03.010; Cloutier J, 2005, J PERS SOC PSYCHOL, V88, P885, DOI 10.1037/0022-3514.88.6.885; Cloutier J, 2007, EUR J SOC PSYCHOL, V37, P1298, DOI 10.1002/ejsp.433; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Diamond L. M., 2008, SEXUAL FLUIDITY UNDE; Diamond LM, 2004, CURR DIR PSYCHOL SCI, V13, P116, DOI 10.1111/j.0963-7214.2004.00287.x; Draine SC, 2009, INQUISIT 3 0 3 2; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Freeman JB, 2010, PERS SOC PSYCHOL B, V36, P1318, DOI 10.1177/0146167210378755; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; GREENWALD AG, 1980, AM PSYCHOL, V35, P603, DOI 10.1037//0003-066X.35.7.603; Hazan C., 2000, REV GEN PSYCHOL, V4, P186, DOI [10.1037/1089-2680.4.2.186, DOI 10.1037/1089-2680.4.2.186]; HU S, 1995, NAT GENET, V11, P248, DOI 10.1038/ng1195-248; Kinnish KK, 2005, ARCH SEX BEHAV, V34, P173, DOI 10.1007/s10508-005-1795-9; KLAYMAN J, 1995, PSYCHOL LEARN MOTIV, V32, P385, DOI DOI 10.1016/S0079-7421(08)60315-1; Leder H, 2001, PERCEPTION, V30, P73, DOI 10.1068/p2911; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; Macrae CN, 2007, EUR J SOC PSYCHOL, V37, P793, DOI 10.1002/ejsp.406; Macrae CN, 2005, J PERS SOC PSYCHOL, V89, P686, DOI 10.1037/0022-3514.89.5.686; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Murray JE, 2000, PSYCHOL SCI, V11, P492, DOI 10.1111/1467-9280.00294; Prins N, RE PHASE SPECTRUM SC; RAE G, 1976, PERCEPT MOTOR SKILL, V42, P98, DOI 10.2466/pms.1976.42.1.98; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; Rieger G, 2010, ARCH SEX BEHAV, V39, P124, DOI 10.1007/s10508-008-9405-2; Rule NO, 2008, J PERS SOC PSYCHOL, V95, P1019, DOI 10.1037/a0013194; Rule NO, 2008, J EXP SOC PSYCHOL, V44, P1100, DOI 10.1016/j.jesp.2007.12.001; Rule NO, 2011, PERS SOC PSYCHOL B, V37, P1499, DOI 10.1177/0146167211415630; Rule NO, 2011, PSYCHOL SCI, V22, P881, DOI 10.1177/0956797611412394; Rule NO, 2009, J EXP SOC PSYCHOL, V45, P1245, DOI 10.1016/j.jesp.2009.07.010; Rule NO, 2009, PSYCHOL SCI, V20, P441, DOI 10.1111/j.1467-9280.2009.02314.x; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Tabak JA, 2011, GAYDAR SEXUAL ORIENT; Tabak JA, 2010, 11 ANN M SOC PERS SO; Tickle NR, 2003, YOU CAN READ FACE BO; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	44	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36671	10.1371/journal.pone.0036671	http://dx.doi.org/10.1371/journal.pone.0036671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UR	22629321	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300023
J	Xu, JF; Fan, X; Zhang, XW; Xu, D; Mou, SL; Cao, SN; Zheng, Z; Miao, JL; Ye, NH				Xu, Jianfang; Fan, Xiao; Zhang, Xiaowen; Xu, Dong; Mou, Shanli; Cao, Shaona; Zheng, Zhou; Miao, Jinlai; Ye, Naihao			Evidence of Coexistence of C-3 and C-4 Photosynthetic Pathways in a Green-Tide-Forming Alga, Ulva prolifera	PLOS ONE			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE OXYGENASE; MULTIPLE SEQUENCE ALIGNMENT; CARBON ASSIMILATION; PHAEODACTYLUM-TRICORNUTUM; CO2/O2 SPECIFICITY; MARINE DIATOMS; KRANZ ANATOMY; METABOLISM; EVOLUTIONARY; GENOME	Ulva prolifera, a typical green-tide-forming alga, can accumulate a large biomass in a relatively short time period, suggesting that photosynthesis in this organism, particularly its carbon fixation pathway, must be very efficient. Green algae are known to generally perform C-3 photosynthesis, but recent metabolic labeling and genome sequencing data suggest that they may also perform C-4 photosynthesis, so C-4 photosynthesis might be more wide-spread than previously anticipated. Both C-3 and C-4 photosynthesis genes were found in U. prolifera by transcriptome sequencing. We also discovered the key enzymes of C-4 metabolism based on functional analysis, such as pyruvate orthophosphate dikinase (PPDK), phosphoenolpyruvate carboxylase (PEPC), and phosphoenolpyruvate carboxykinase (PCK). To investigate whether the alga operates a C-4-like pathway, the expression of rbcL and PPDK and their enzyme activities were measured under various forms and intensities of stress (differing levels of salinity, light intensity, and temperature). The expression of rbcL and PPDK and their enzyme activities were higher under adverse circumstances. However, under conditions of desiccation, the expression of rbcL and ribulose-1, 5-biphosphate carboxylase (RuBPCase) activity was lower, whereas that of PPDK was higher. These results suggest that elevated PPDK activity may alter carbon metabolism and lead to a partial operation of C-4-type carbon metabolism in U. prolifera, probably contributing to its wide distribution and massive, repeated blooms in the Yellow Sea.	[Xu, Jianfang; Mou, Shanli; Zheng, Zhou; Miao, Jinlai] State Ocean Adm, Inst Oceanog 1, Key Lab Marine Bioact Substance, Qingdao, Peoples R China; [Fan, Xiao; Zhang, Xiaowen; Xu, Dong; Ye, Naihao] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Cao, Shaona] Qingdao Agr Univ, Qingdao, Peoples R China	State Oceanic Administration; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Qingdao Agricultural University	Xu, JF (corresponding author), State Ocean Adm, Inst Oceanog 1, Key Lab Marine Bioact Substance, Qingdao, Peoples R China.	yenh@ysfri.ac.cn			Shandong Science and Technology plan project [2011GHY11528]; Specialized Fund for the Basic Research Operating expenses Program [20603022012004]; National Natural Science Foundation of China [41176153]; Natural Science Foundation of Shandong Province [2009ZRA02075]; Qingdao Municipal Science and Technology plan project [11-3-1-5-hy, 10-3-4-11-1-jch]; National Marine Public Welfare Research Project [200805069]	Shandong Science and Technology plan project; Specialized Fund for the Basic Research Operating expenses Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Qingdao Municipal Science and Technology plan project; National Marine Public Welfare Research Project	This work was supported by Shandong Science and Technology plan project (2011GHY11528), the Specialized Fund for the Basic Research Operating expenses Program (20603022012004), National Natural Science Foundation of China (41176153), Natural Science Foundation of Shandong Province (2009ZRA02075), Qingdao Municipal Science and Technology plan project (11-3-1-5-hy), Qingdao Municipal Science and Technology plan project (10-3-4-11-1-jch), National Marine Public Welfare Research Project (200805069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018862; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; BEER S, 1986, PLANT PHYSIOL, V81, P937, DOI 10.1104/pp.81.3.937; BEER S, 1990, PLANT PHYSIOL, V94, P1542, DOI 10.1104/pp.94.4.1542; Bischof K, 2002, PLANTA, V215, P502, DOI 10.1007/s00425-002-0774-9; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; Brautigam A, 2008, PLANT PHYSIOL, V148, P568, DOI 10.1104/pp.108.121012; Brautigam A, 2011, PLANT PHYSIOL, V155, P142, DOI 10.1104/pp.110.159442; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Casati P, 2000, PLANT PHYSIOL, V123, P1611, DOI 10.1104/pp.123.4.1611; Charlier Roger H., 2007, Environmental Research, Engineering and Management, V41, P52; Chen M, 2012, EUR J LIPID SCI TECH, V114, P205, DOI 10.1002/ejlt.201100120; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Dong MT, 2012, PLANT MOL BIOL REP, V30, P10, DOI 10.1007/s11105-011-0311-8; DRECHSLER Z, 1991, PLANT PHYSIOL, V97, P1439, DOI 10.1104/pp.97.4.1439; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Edwards GE, 2004, ANNU REV PLANT BIOL, V55, P173, DOI 10.1146/annurev.arplant.55.031903.141725; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Fleming ED, 2007, J PHYCOL, V43, P15, DOI 10.1111/j.1529-8817.2006.00297.x; Gerard VA, 1996, J PHYCOL, V32, P880, DOI 10.1111/j.0022-3646.1996.00880.x; Gowik U, 2011, PLANT CELL, V23, P2087, DOI 10.1105/tpc.111.086264; Gowik U, 2011, PLANT PHYSIOL, V155, P56, DOI 10.1104/pp.110.165308; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ishimaru K, 1998, PHYSIOL PLANTARUM, V103, P340, DOI 10.1034/j.1399-3054.1998.1030306.x; JORDAN DB, 1984, PLANTA, V161, P308, DOI 10.1007/BF00398720; JOSHI GV, 1974, PHOTOSYNTHETICA, V8, P51; KAREKAR MD, 1973, BOT MAR, V16, P216, DOI 10.1515/botm.1973.16.4.216; Keeley JE, 1998, OECOLOGIA, V116, P85, DOI 10.1007/s004420050566; Keeley JE, 1999, FUNCT ECOL, V13, P106, DOI 10.1046/j.1365-2435.1999.00294.x; KREMER BP, 1977, PLANTA, V133, P191, DOI 10.1007/BF00391918; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Leliaert F, 2009, PHYCOL RES, V57, P147, DOI 10.1111/j.1440-1835.2009.00532.x; Liu XM, 2010, PLANT MOL BIOL REP, V28, P193, DOI 10.1007/s11105-009-0140-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuda Y, 2011, PHOTOSYNTH RES, V109, P191, DOI 10.1007/s11120-011-9623-7; McGinn PJ, 2008, PLANT PHYSIOL, V146, P300, DOI 10.1104/pp.107.110569; Mercado JM, 2009, ESTUAR COAST SHELF S, V85, P449, DOI 10.1016/j.ecss.2009.09.005; Montsant A, 2005, PLANT PHYSIOL, V137, P500, DOI 10.1104/pp.104.052829; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Osborne CP, 2009, P ROY SOC B-BIOL SCI, V276, P1753, DOI 10.1098/rspb.2008.1762; Parker MS, 2008, ANNU REV GENET, V42, P619, DOI 10.1146/annurev.genet.42.110807.091417; Rao S, 2006, PLANT CELL PHYSIOL, V47, P1206, DOI 10.1093/pcp/pcj091; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Reinfelder JR, 2004, PLANT PHYSIOL, V135, P2106, DOI 10.1104/pp.104.041319; Reiskind JB, 1997, PLANT CELL ENVIRON, V20, P211, DOI 10.1046/j.1365-3040.1997.d01-68.x; REISKIND JB, 1989, PLANT SCI, V61, P43, DOI 10.1016/0168-9452(89)90117-9; Riebesell U, 2000, NATURE, V407, P959, DOI 10.1038/35039665; Roberts K, 2007, PLANT PHYSIOL, V145, P230, DOI 10.1104/pp.107.102616; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; SAYRE RT, 1979, PLANT PHYSIOL, V64, P293, DOI 10.1104/pp.64.2.293; SHARKEY TD, 1988, PHYSIOL PLANTARUM, V73, P147, DOI 10.1111/j.1399-3054.1988.tb09205.x; Tachibana M, 2011, PHOTOSYNTH RES, V109, P205, DOI 10.1007/s11120-011-9634-4; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Troughton J. H., 1974, Carnegie Institution Year Book, P768; Tsuji Y, 2009, PLANT CELL PHYSIOL, V50, P318, DOI 10.1093/pcp/pcn200; Ueno O, 2011, J EXP BOT, P1; von Caemmerer S, 2003, PHOTOSYNTH RES, V77, P191, DOI 10.1023/A:1025830019591; Voznesenskaya EV, 2003, AM J BOT, V90, P1669, DOI 10.3732/ajb.90.12.1669; Voznesenskaya EV, 2002, PLANT J, V31, P649, DOI 10.1046/j.1365-313X.2002.01385.x; Voznesenskaya EV, 2001, NATURE, V414, P543, DOI 10.1038/35107073; Wang WL, 2003, BOT BULL ACAD SINICA, V44, P107; Weber APM, 2010, CURR OPIN PLANT BIOL, V13, P257, DOI 10.1016/j.pbi.2010.01.007; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Ye NH, 2011, ECOL RES, V26, P477, DOI 10.1007/s11284-011-0821-8; Zhang X, 2011, LIMNOL OCEANOGR, V56, DOI [10.4319/lo.2011.56.1.0000, DOI 10.4319/LO.2011.56.1.0000]	73	61	72	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37438	10.1371/journal.pone.0037438	http://dx.doi.org/10.1371/journal.pone.0037438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22616009	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300115
J	Tobin, LA; Robert, C; Rapoport, AP; Gojo, I; Baer, MR; Tomkinson, AE; Rassool, FV				Tobin, L. A.; Robert, C.; Rapoport, A. P.; Gojo, I.; Baer, M. R.; Tomkinson, A. E.; Rassool, F. V.			Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias	ONCOGENE			English	Article						chronic myeloid leukemia; DNA ligase III alpha; PARP1; NHEJ; PARP inhibitors; DNA ligase I and III inhibitors	LIGASE-III; CLINICAL RESISTANCE; DRUG-RESISTANCE; ABL MUTATIONS; BCR/ABL; KU; IMATINIB; PROMOTES; BINDING; STI571	Resistance to imatinib (IM) and other tyrosine kinase inhibitors (TKI)s is an increasing problem in leukemias caused by expression of BCR-ABL1. As chronic myeloid leukemia (CML) cell lines expressing BCR-ABL1 utilize an alternative non-homologous end-joining pathway (ALT NHEJ) to repair DNA double-strand breaks (DSB)s, we asked whether this repair pathway is a novel therapeutic target in TKI-resistant disease. Notably, the steady state levels of two ALT NHEJ proteins, poly-(ADP-ribose) polymerase 1 (PARP1) and DNA ligase III alpha, were increased in the BCR-ABL1-positive CML cell line K562 and, to a greater extent, in its imatinib-resistant (IMR) derivative. Incubation of these cell lines with a combination of DNA ligase and PARP inhibitors inhibited ALT NHEJ and selectively decreased survival with the effect being greater in the IMR derivative. Similar results were obtained with TKI-resistant derivatives of two hematopoietic cell lines that had been engineered to stably express BCR-ABL1. Together our results show that the sensitivity of cell lines expressing BCR-ABL1 to the combination of DNA ligase and PARP inhibitors correlates with the steady state levels of PARP1 and DNA ligase III alpha, and ALT NHEJ activity. Importantly, analysis of clinical samples from CML patients confirmed that the expression levels of PARP1 and DNA ligase III alpha correlated with the sensitivity to the DNA repair inhibitor combination. Thus, the expression levels of PARP1 and DNA ligase III alpha serve as biomarkers to identify a subgroup of CML patients who may be candidates for therapies that target the ALT NHEJ pathway when treatment with TKIs has failed. Oncogene (2013) 32, 1784-1793; doi: 10.1038/onc.2012.203; published online 28 May 2012	[Tobin, L. A.; Robert, C.; Rassool, F. V.] Univ Maryland, Sch Med, Dept Radiat Oncol, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Rapoport, A. P.; Gojo, I.; Baer, M. R.] Univ Maryland, Sch Med, Dept Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Tomkinson, A. E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Tomkinson, A. E.] Univ New Mexico, Univ New Mexico Canc Ctr, Albuquerque, NM 87131 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of New Mexico; University of New Mexico	Rassool, FV (corresponding author), Univ Maryland, Sch Med, Dept Radiat Oncol, Marlene & Stewart Greenebaum Canc Ctr,BRB, 655 West Baltimore St,Room 7-023, Baltimore, MD 21201 USA.	frassool@som.umaryland.edu	Classen, Scott/AAY-8176-2020		Cigarette Restitution Funds of Maryland; Leukemia Lymphoma Society; V Foundation; NIH [ES 012512, CA92584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012512] Funding Source: NIH RePORTER	Cigarette Restitution Funds of Maryland; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); V Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We would like to thank Professor Stephen Baylin (JHU) for insightful comments and careful reading of our manuscript. CML patient samples were collected under IMRB no. H25314. These studies were supported by the Cigarette Restitution Funds of Maryland (FR and LT), the Leukemia Lymphoma Society (FR, CR and LT), the V Foundation (FR, LT and AET) and NIH Grants ES 012512 and CA92584 (AET).	Audebert M, 2006, J MOL BIOL, V356, P257, DOI 10.1016/j.jmb.2005.11.028; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Audebert M, 2008, BIOCHEM BIOPH RES CO, V369, P982, DOI 10.1016/j.bbrc.2007.11.132; Ayene IS, 2002, J BIOL CHEM, V277, P9929, DOI 10.1074/jbc.M111366200; Brady N, 2003, CANCER RES, V63, P1798; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chen X, 2008, CANCER RES, V68, P3169, DOI 10.1158/0008-5472.CAN-07-6636; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; FALZON M, 1993, J BIOL CHEM, V268, P10546; Fan JS, 2010, BLOOD, V116, P5298, DOI 10.1182/blood-2010-03-272591; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Foster SS, 2011, MOL CELL BIOL, V31, P4379, DOI 10.1128/MCB.05854-11; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Gaymes TJ, 2002, CANCER RES, V62, P2791; Gorre M, 2001, SCIENCE, V293, P15; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Hehlmann R, 2011, EXPERT OPIN PHARMACO, V12, P269, DOI 10.1517/14656566.2011.533169; Jabbour E, 2011, CANCER-AM CANCER SOC, V117, P1800, DOI 10.1002/cncr.25717; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Lee-Theilen M, 2011, NAT STRUCT MOL BIOL, V18, P75, DOI 10.1038/nsmb.1942; LOBRICH M, 1994, INT J RADIAT BIOL, V65, P623, DOI 10.1080/09553009414550731; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Majsterek I, 2002, CELL BIOL INT, V26, P363, DOI 10.1006/cbir.2002.0865; MIMORI T, 1986, J BIOL CHEM, V261, P375; Nowell P, 1960, SCIENCE, V132, P3; Nowicki MO, 2004, BLOOD, V104, P3746, DOI 10.1182/blood-2004-05-1941; Nussenzweig A, 2007, CELL, V131, P223, DOI 10.1016/j.cell.2007.10.005; Ohmine K, 2003, STEM CELLS, V21, P315, DOI 10.1634/stemcells.21-3-315; Rowley JA, 1973, NATURE, V243, P4; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; Savage D, 1997, BRIT J HAEMATOL, V96, P7; Shah N, 2002, CANCER CELL, V2, P8; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Skorski T, 2002, ONCOGENE, V21, P8591, DOI 10.1038/sj.onc.1206087; Slupianek A, 2002, MOL CELL BIOL, V22, P4189, DOI 10.1128/MCB.22.12.4189-4201.2002; Soverini S, 2005, J CLIN ONCOL, V23, P4100, DOI 10.1200/JCO.2005.05.531; SPIERS ASD, 1995, SEMIN ONCOL, V22, P380; Tobin LA, 2012, MOL CANCER RES, V10, P96, DOI 10.1158/1541-7786.MCR-11-0255; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; von Bubnoff N, 2002, LANCET, V359, P487, DOI 10.1016/S0140-6736(02)07679-1; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Weisberg E, 2000, BLOOD, V95, P3498, DOI 10.1182/blood.V95.11.3498.011k27_3498_3505; Zhang Y, 2011, NAT STRUCT MOL BIOL, V18, P80, DOI 10.1038/nsmb.1940; Zhong S, 2008, J MED CHEM, V51, P4553, DOI 10.1021/jm8001668	53	67	69	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2013	32	14					1784	1793		10.1038/onc.2012.203	http://dx.doi.org/10.1038/onc.2012.203			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	118RQ	22641215	Green Accepted			2022-12-25	WOS:000317043900005
J	Pehar, M; Lehnus, M; Karst, A; Puglielli, L				Pehar, Mariana; Lehnus, Massimiliano; Karst, Anna; Puglielli, Luigi			Proteomic Assessment Shows That Many Endoplasmic Reticulum (ER)-resident Proteins Are Targeted by N-epsilon-Lysine Acetylation in the Lumen of the Organelle and Predicts Broad Biological Impact	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACE1 LEVELS; ER	In addition to the nucleus, cytosol, and mitochondrial lumen, N-epsilon-lysine acetylation also occurs in the lumen of the endoplasmic reticulum ( ER). However, the impact of such an event on ER functions is still unknown. Here, we analyzed the "ER acetyllysine proteome" by nano-LC-MS/MS and discovered that a large number of ER-resident and -transiting proteins undergo N-epsilon-lysine acetylation in the lumen of the organelle. The list of ER-resident proteins includes chaperones and enzymes involved with post-translational modification and folding. Grouping of all acetylated proteins into major functional categories suggests that the ER-based acetylation machinery regulates very diverse biological events. As such, it is predicted to play a fundamental role in human physiology as well as human pathology.	[Puglielli, Luigi] Univ Wisconsin, Dept Med, VAH GRECC, Madison, WI 53705 USA; [Puglielli, Luigi] Vet Affairs Med Ctr, Geriatr Res Educ Clin Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Puglielli, L (corresponding author), Univ Wisconsin, Dept Med, VAH GRECC, 2500 Overlook Terr, Madison, WI 53705 USA.	lp1@medicine.wisc.edu			National Institutes of Health through NIA [AG028569, AG033514]; NATIONAL INSTITUTE ON AGING [R01AG028569, P50AG033514] Funding Source: NIH RePORTER	National Institutes of Health through NIA; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG028569 and AG033514 (to L.P.) through the NIA.	Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chouquet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017886; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Ding Y, 2012, J BIOL CHEM, V287, P8424, DOI 10.1074/jbc.M111.310136; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; GAUT JR, 1993, J BIOL CHEM, V268, P7248; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Jonas MC, 2010, J CELL SCI, V123, P3378, DOI 10.1242/jcs.068841; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Ko MH, 2009, J BIOL CHEM, V284, P2482, DOI 10.1074/jbc.M804901200; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599	16	37	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22436	22440		10.1074/jbc.C112.362871	http://dx.doi.org/10.1074/jbc.C112.362871			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22628546	Green Published, hybrid			2022-12-25	WOS:000306495000002
J	Arsenijevic, T; Gregoire, F; Delforge, V; Delporte, C; Perret, J				Arsenijevic, Tatjana; Gregoire, Francoise; Delforge, Valerie; Delporte, Christine; Perret, Jason			Murine 3T3-L1 Adipocyte Cell Differentiation Model: Validated Reference Genes for qPCR Gene Expression Analysis	PLOS ONE			English	Article							TRANSCRIPTION-PCR DATA; HOUSEKEEPING GENES; MESSENGER-RNA; NORMALIZATION; SELECTION; QUANTIFICATION; PUBLICATION	Background: Analysis of gene expression at the mRNA level, using real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR), mandatorily requires reference genes (RGs) as internal controls. However, increasing evidences have shown that RG expression may vary considerably under experimental conditions. We sought for an appropriate panel of RGs to be used in the 3T3-L1 cell line model during their terminal differentiation into adipocytes. To this end, the expression levels of a panel of seven widely used RG mRNAs were measured by qRT-PCR. The 7 RGs evaluated were beta-actin (ACTB), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), hypoxanthine phosphoribosyl-transferase I (HPRT), ATP synthase H+ transporting mitochondrial F1 complex beta subunit (ATP-5b), tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (Ywhaz), Non-POU-domain containing octamer binding protein (NoNo), and large ribosomal protein L13a (RPL). Methodology/Principal Findings: Using three Excel applications, GeNorm, NormFinder and BestKeeper, we observed that the number and the stability of potential RGs vary significantly during differentiation of 3T3-L1 cells into adipocytes. mRNA expression analyses using qRT-PCR revealed that during the entire differentiation program, only NoNo expression is relatively stable. Moreover, the RG sets that were acceptably stable were different depending on the phase of the overall differentiation process (i.e. mitotic clonal expansion versus the terminal differentiation phase). RPL, ACTB, and Ywhaz, are suitable for terminal differentiation, whereas ATP-5b and HPRT, are suitable during mitotic clonal expansion. Conclusion: Our results demonstrate that special attention must be given to the choice of suitable RGs during the various well defined phases of adipogenesis to ensure accurate data analysis and that the use of several RGs is absolutely required. Consequently, our data show for the first time, that during mitotic clonal expansion, the most suitable RGs are ATP-5b, NoNo and HPRT, while during terminal differentiation the most suitable RGs are, NoNo, RPL, ACTB and Ywhaz.	[Arsenijevic, Tatjana; Gregoire, Francoise; Delporte, Christine; Perret, Jason] Univ Libre Bruxelles, Lab Pathophysiol & Nutr Biochem, Brussels, Belgium; [Delforge, Valerie] Nutrisub ASBL, Brussels, Belgium	Universite Libre de Bruxelles	Arsenijevic, T (corresponding author), Univ Libre Bruxelles, Lab Pathophysiol & Nutr Biochem, Brussels, Belgium.	jperret@ulb.ac.be	Delporte, Christine/A-5733-2012	Delporte, Christine/0000-0003-0385-5824; Gregoire, Francoise/0000-0003-0452-8868	"Fonds National de la recherche scientifique" - FNRS; FRSM [3.4502.09]	"Fonds National de la recherche scientifique" - FNRS(Fonds de la Recherche Scientifique - FNRS); FRSM(Fonds de la Recherche Scientifique - FNRS)	TA is a recipient of a fellowship from "Fonds National de la recherche scientifique" - FNRS. This work was supported by FRSM grant no 3.4502.09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barroso I, 1999, EUR J ENDOCRINOL, V141, P169, DOI 10.1530/eje.0.1410169; Bruge F, 2011, J BIOTECHNOL, V156, P153, DOI 10.1016/j.jbiotec.2011.09.018; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Catalan V, 2007, HORM METAB RES, V39, P495, DOI 10.1055/s-2007-982502; Cowherd RM, 1999, SEMIN CELL DEV BIOL, V10, P3, DOI 10.1006/scdb.1998.0276; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Gabrielsson BG, 2004, MOL CELL BIOCHEM, V258, P65, DOI 10.1023/B:MCBI.0000012837.11847.c8; Gorzelniak K, 2001, HORM METAB RES, V33, P625, DOI 10.1055/s-2001-17911; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Hendriks-Balk MC, 2007, BASIC RES CARDIOL, V102, P195, DOI 10.1007/s00395-007-0649-0; Jacobs C, 2004, FEBS LETT, V565, P70, DOI 10.1016/j.febslet.2004.03.076; Kim Insook, 2011, BMC Res Notes, V4, P440, DOI 10.1186/1756-0500-4-440; MACDOUGALD OA, 1995, CURR BIOL, V5, P618, DOI 10.1016/S0960-9822(95)00125-4; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Maess MB, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-90; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Samaras K, 2010, OBES SURG, V20, P108, DOI 10.1007/s11695-009-9952-1; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Stern-Straeter J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-66; Sugden K, 2010, J PSYCHOPHARMACOL, V24, P1253, DOI 10.1177/0269881108099690; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859	37	53	56	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37517	10.1371/journal.pone.0037517	http://dx.doi.org/10.1371/journal.pone.0037517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629413	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300048
J	Dematheis, F; Zimmerling, U; Flocco, C; Kurtz, B; Vidal, S; Kropf, S; Smalla, K				Dematheis, Flavia; Zimmerling, Ute; Flocco, Cecilia; Kurtz, Benedikt; Vidal, Stefan; Kropf, Siegfried; Smalla, Kornelia			Multitrophic Interaction in the Rhizosphere of Maize: Root Feeding of Western Corn Rootworm Larvae Alters the Microbial Community Composition	PLOS ONE			English	Article							DIABROTICA-VIRGIFERA-VIRGIFERA; POPULATIONS COLEOPTERA; INDUCED RESISTANCE; PLANT-GROWTH; SOIL; INSECT; INFESTATION; BACTERIA; IMPACT; DIVERSITY	Background: Larvae of the Western Corn Rootworm (WCR) feeding on maize roots cause heavy economical losses in the US and in Europe. New or adapted pest management strategies urgently require a better understanding of the multitrophic interaction in the rhizosphere. This study aimed to investigate the effect of WCR root feeding on the microbial communities colonizing the maize rhizosphere. Methodology/Principal Findings: In a greenhouse experiment, maize lines KWS13, KWS14, KWS15 and MON88017 were grown in three different soil types in presence and in absence of WCR larvae. Bacterial and fungal community structures were analyzed by denaturing gradient gel electrophoresis (DGGE) of the 16S rRNA gene and ITS fragments, PCR amplified from the total rhizosphere community DNA. DGGE bands with increased intensity were excised from the gel, cloned and sequenced in order to identify specific bacteria responding to WCR larval feeding. DGGE fingerprints showed that the soil type and the maize line influenced the fungal and bacterial communities inhabiting the maize rhizosphere. WCR larval feeding affected the rhiyosphere microbial populations in a soil type and maize line dependent manner. DGGE band sequencing revealed an increased abundance of Acinetobacter calcoaceticus in the rhizosphere of several maize lines in all soil types upon WCR larval feeding. Conclusion/Significance: The effects of both rhizosphere and WCR larval feeding seemed to be stronger on bacterial communities than on fungi. Bacterial and fungal community shifts in response to larval feeding were most likely due to changes of root exudation patterns. The increased abundance of A. calcoaceticus suggested that phenolic compounds were released upon WCR wounding.	[Dematheis, Flavia; Zimmerling, Ute; Flocco, Cecilia; Smalla, Kornelia] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants JKI, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany; [Kurtz, Benedikt; Vidal, Stefan] Univ Gottingen, Dept Crop Sci, Gottingen, Germany; [Kropf, Siegfried] Univ Magdeburg, Dept Biometry & Med Informat, D-39106 Magdeburg, Germany	Julius Kuhn-Institut; University of Gottingen; Otto von Guericke University	Dematheis, F (corresponding author), Julius Kuhn Inst, Fed Res Ctr Cultivated Plants JKI, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany.	kornelia.smalla@jki.bund.de	Vidal, Stefan/AAC-3130-2020; Smalla, Kornelia/H-4002-2011; Dematheis, Flavia/GRS-2490-2022	Vidal, Stefan/0000-0002-1673-4055; Flocco, Cecilia/0000-0001-9370-6130	Deutsche Forschungsgemeinschaft (DFG) [SM59/7-1, Vi117/17-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (DFG SM59/7-1; Vi117/17-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Baumgarte S, 2005, MOL ECOL, V14, P2539, DOI 10.1111/j.1365-294X.2005.02592.x; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Brimecombe MJ, 2001, BOOKS SOIL PLANT ENV, P95; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Broekgaarden C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-239; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Clark PL, 2006, J ECON ENTOMOL, V99, P722, DOI 10.1603/0022-0493-99.3.722; Costa R, 2006, ENVIRON MICROBIOL, V8, P2136, DOI 10.1111/j.1462-2920.2006.01096.x; Davis CS, 2000, J ECON ENTOMOL, V93, P989, DOI 10.1603/0022-0493-93.3.989; Dawson LA, 2004, APPL SOIL ECOL, V25, P51, DOI 10.1016/S0929-1393(03)00099-4; Denton CS, 1999, SOIL BIOL BIOCHEM, V31, P155, DOI 10.1016/S0038-0717(98)00118-7; EFSA (European Food Safety Authority), 2009, EFSA J, V1193, P1, DOI DOI 10.2903/j.efsa.2009.1149; Erb M, 2009, PLANT J, V59, P292, DOI 10.1111/j.1365-313X.2009.03868.x; European Commission, 2006, OFF J EUR UNION L, V225, P30; European Commission, 2003, OFFICIAL J EUROPEAN, V275, P49; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Grayston SJ, 2001, EUR J SOIL BIOL, V37, P277, DOI 10.1016/S1164-5563(01)01098-6; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Heuer H, 2001, ENVIRONMENTAL MOLECULAR MICROBIOLOGY : PROTOCOLS AND APPLICATIONS, P177; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Kandeler E, 2002, PLANT SOIL, V238, P301, DOI 10.1023/A:1014479220689; Kavroulakis N, 2010, PLANT SOIL, V333, P233, DOI 10.1007/s11104-010-0338-x; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Kurtz B, 2010, THESIS U GOTTINGEN; Lanoue A, 2010, PLANT SIGNAL BEHAV, V5, P1037, DOI [10.4161/psb.5.8.12337, 10.1111/j.1469-8137.2009.03066.x]; Lanoue A, 2010, NEW PHYTOL, V185, P577, DOI 10.1111/j.1469-8137.2009.03066.x; Levine Eli, 2002, American Entomologist, V48, P94; Meihls LN, 2008, P NATL ACAD SCI USA, V105, P19177, DOI 10.1073/pnas.0805565105; Meinke LJ, 2009, AGR FOREST ENTOMOL, V11, P29, DOI 10.1111/j.1461-9563.2008.00419.x; Miethling-Graff R, 2010, EUR J SOIL BIOL, V46, P41, DOI 10.1016/j.ejsobi.2009.10.003; Nishida T, 2010, POPUL ECOL, V52, P507, DOI 10.1007/s10144-010-0208-7; Onstad DW, 2001, ENTOMOL EXP APPL, V100, P195, DOI 10.1023/A:1019289030248; Parimi S, 2006, CROP PROT, V25, P269, DOI 10.1016/j.cropro.2005.04.017; Pineda A, 2010, TRENDS PLANT SCI, V15, P507, DOI 10.1016/j.tplants.2010.05.007; Poerschmann J, 2008, J AGR FOOD CHEM, V56, P11906, DOI 10.1021/jf8023694; Prischmann DA, 2008, APPL SOIL ECOL, V40, P417, DOI 10.1016/j.apsoil.2008.06.012; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Robert CAM, 2012, ECOL LETT, V15, P55, DOI 10.1111/j.1461-0248.2011.01708.x; Spencer JL, 2009, AGR FOREST ENTOMOL, V11, P9, DOI 10.1111/j.1461-9563.2008.00399.x; SPIKE BP, 1991, J ECON ENTOMOL, V84, P1585, DOI 10.1093/jee/84.5.1585; Szalai M, 2011, J PEST SCI, V84, P133, DOI 10.1007/s10340-010-0336-z; Treonis AM, 2005, APPL SOIL ECOL, V28, P203, DOI 10.1016/j.apsoil.2004.08.004; Urias-Lopez M, 2000, ENVIRON ENTOMOL, V29, P861, DOI 10.1603/0046-225X-29.5.861; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Van Oosten VR, 2008, MOL PLANT MICROBE IN, V21, P919, DOI 10.1094/MPMI-21-7-0919; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Wesseler J, 2010, J APPL ENTOMOL, V134, P385, DOI 10.1111/j.1439-0418.2010.01510.x; Wurst S, 2010, APPL SOIL ECOL, V45, P123, DOI 10.1016/j.apsoil.2010.04.005; Zhan Y, 2011, AM SOC MICROBIOL, DOI [10.1128/JB.00261-11, DOI 10.1128/JB.00261-11]	54	20	22	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37288	10.1371/journal.pone.0037288	http://dx.doi.org/10.1371/journal.pone.0037288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629377	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300030
J	De Burghgraeve, T; Kaptein, SJF; Ayala-Nunez, NV; Mondotte, JA; Pastorino, B; Printsevskaya, SS; de Lamballerie, X; Jacobs, M; Preobrazhenskaya, M; Gamarnik, AV; Smit, JM; Neyts, J				De Burghgraeve, Tine; Kaptein, Suzanne J. F.; Ayala-Nunez, Nilda V.; Mondotte, Juan A.; Pastorino, Boris; Printsevskaya, Svetlana S.; de Lamballerie, Xavier; Jacobs, Michael; Preobrazhenskaya, Maria; Gamarnik, Andrea V.; Smit, Jolanda M.; Neyts, Johan			An Analogue of the Antibiotic Teicoplanin Prevents Flavivirus Entry In Vitro	PLOS ONE			English	Article							YELLOW-FEVER-VIRUS; DENGUE VIRUS; GLYCOPEPTIDE ANTIBIOTICS; SEMISYNTHETIC DERIVATIVES; HEPARAN-SULFATE; INHIBITION; INFECTION; BINDING; REPLICATION; TARGET	There is an urgent need for potent inhibitors of dengue virus (DENV) replication for the treatment and/or prophylaxis of infections with this virus. We here report on an aglycon analogue of the antibiotic teicoplanin (code name LCTA-949) that inhibits DENV-induced cytopathic effect (CPE) in a dose-dependent manner. Virus infection was completely inhibited at concentrations that had no adverse effect on the host cells. These findings were corroborated by quantification of viral RNA levels in culture supernatant. Antiviral activity was also observed against other flaviviruses such as the yellow fever virus and the tick-borne encephalitis virus (TBEV). In particular, potent antiviral activity was observed against TBEV. Time-of-drug-addition experiments indicated that LCTA-949 inhibits an early stage in the DENV replication cycle; however, a virucidal effect was excluded. This observation was corroborated by the fact that LCTA-949 lacks activity on DENV subgenomic replicon (that does not encode structural proteins) replication. Using a microsopy-based binding and fusion assay employing DiD-labeled viruses, it was shown that LCTA-949 targets the early stage (binding/entry) of the infection. Moreover, LCTA-949 efficiently inhibits infectivity of DENV particles pre-opsonized with antibodies, thus potentially also inhibiting antibody-dependent enhancement (ADE). In conclusion, LCTA-949 exerts in vitro activity against several flaviviruses and does so (as shown for DENV) by interfering with an early step in the viral replication cycle.	[De Burghgraeve, Tine; Kaptein, Suzanne J. F.; Neyts, Johan] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium; [Ayala-Nunez, Nilda V.; Smit, Jolanda M.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Mondotte, Juan A.; Gamarnik, Andrea V.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina; [Pastorino, Boris; de Lamballerie, Xavier] Univ Mediterrane, Emergence Pathol Virales UMR190, Marseille, France; [Printsevskaya, Svetlana S.; Preobrazhenskaya, Maria] Russian Acad Med Sci, Gause Inst New Antibiot, Moscow, Russia; [Jacobs, Michael] Royal Free & Univ Coll, Sch Med, Dept Med, London, England	KU Leuven; University of Groningen; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; UDICE-French Research Universities; Aix-Marseille Universite; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); Russian Academy of Medical Sciences; Russian Academy of Sciences; Gause Institute of New Antibiotics; University of London; University College London; UCL Medical School	De Burghgraeve, T (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium.	Johan.Neyts@rega.kuleuven.be	Neyts, Johan/U-8267-2017; Kaptein, Suzanne JF/O-8855-2018; Ayala-Nunez, Vanesa/AAI-3881-2021; Kaptein, Suzanne JF/O-4714-2019	Neyts, Johan/0000-0002-0033-7514; Kaptein, Suzanne JF/0000-0002-7935-0219; Kaptein, Suzanne JF/0000-0002-7935-0219; Preobrazhenskaya, Maria/0000-0001-9782-1101; pastorino, boris/0000-0001-5233-5193; Ayala-Nunez, Nilda Vanesa/0000-0001-8401-8723	EU FP7 project SILVER [260644]; GOA (geconcerteerde onderzoeksactie) [10/014]; Netherlands Organization for Scientific Research-Earth and Life Sciences (NWO-ALW); Erasmus Mundus External Cooperation Window	EU FP7 project SILVER; GOA (geconcerteerde onderzoeksactie); Netherlands Organization for Scientific Research-Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); Erasmus Mundus External Cooperation Window	This work was supported by EU FP7 project SILVER (no260644), GOA (geconcerteerde onderzoeksactie, no10/014), The Netherlands Organization for Scientific Research-Earth and Life Sciences (NWO-ALW), and the Erasmus Mundus External Cooperation Window. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alen MMF, 2009, VIROLOGY, V387, P67, DOI 10.1016/j.virol.2009.01.043; Altmeyer R, 2004, CURR PHARM DESIGN, V10, P3701, DOI 10.2174/1381612043382729; [Anonymous], 2009, WHOHTMNTDDEN20091; [Anonymous], YELL FEV; Balzarini J, 2003, J MED CHEM, V46, P2755, DOI 10.1021/jm0300882; Balzarini J, 2006, ANTIVIR RES, V72, P20, DOI 10.1016/j.antiviral.2006.03.005; Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869; Charlier N, 2004, J VIROL, V78, P7418, DOI 10.1128/JVI.78.14.7418-7426.2004; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Coelmont L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013687; Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638; Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005; Kaptein SJF, 2010, ANTIMICROB AGENTS CH, V54, P5269, DOI 10.1128/AAC.00686-10; Lin YL, 2002, ANTIVIR RES, V56, P93, DOI 10.1016/S0166-3542(02)00095-5; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07; Obeid S, 2011, J ANTIMICROB CHEMOTH, V66, P1287, DOI 10.1093/jac/dkr104; Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004; Preobrazhenskaya MN, 2006, ANTIVIR RES, V71, P227, DOI 10.1016/j.antiviral.2006.04.008; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Shi J, 2011, J VIROL, V85, P542, DOI 10.1128/JVI.01406-10; Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10; van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Yang JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000428; Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0	30	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37244	10.1371/journal.pone.0037244	http://dx.doi.org/10.1371/journal.pone.0037244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624001	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500083
J	Hirsch, BT; Stanton, MA; Maldonado, JE				Hirsch, Ben T.; Stanton, Margaret A.; Maldonado, Jesus E.			Kinship Shapes Affiliative Social Networks but Not Aggression in Ring-Tailed Coatis	PLOS ONE			English	Article							BROWN CAPUCHIN MONKEYS; INDIVIDUAL SPATIAL CHOICE; WHITE-NOSED COATIS; KIN SELECTION; NASUA-NASUA; REPRODUCTIVE SUCCESS; BEHAVIORAL SYNCHRONY; MICROSATELLITE LOCI; FEEDING COMPETITION; VIGILANCE BEHAVIOR	Animal groups typically contain individuals with varying degrees of genetic relatedness, and this variation in kinship has a major influence on patterns of aggression and affiliative behaviors. This link between kinship and social behavior underlies socioecological models which have been developed to explain how and why different types of animal societies evolve. We tested if kinship and age-sex class homophily in two groups of ring-tailed coatis (Nasua nasua) predicted the network structure of three different social behaviors: 1) association, 2) grooming, and 3) aggression. Each group was studied during two consecutive years, resulting in four group-years available for analysis (total of 65 individuals). Association patterns were heavily influenced by agonistic interactions which typically occurred during feeding competition. Grooming networks were shaped by mother-offspring bonds, female-female social relationships, and a strong social attraction to adult males. Mother-offspring pairs were more likely to associate and groom each other, but relatedness had no effect on patterns of aggressive behavior. Additionally, kinship had little to no effect on coalitionary support during agonistic interactions. Adult females commonly came to the aid of juveniles during fights with other group members, but females often supported juveniles who were not their offspring (57% of coalitionary interactions). These patterns did not conform to predictions from socioecological models.	[Hirsch, Ben T.] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA; [Hirsch, Ben T.] Smithsonian Trop Res Inst, Panama City, Panama; [Hirsch, Ben T.; Maldonado, Jesus E.] Smithsonian Conservat Biol Inst, Ctr Conservat & Evolutionary Genet, Natl Zool Pk, Washington, DC USA; [Stanton, Margaret A.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Maldonado, Jesus E.] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA	University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Georgetown University; Smithsonian Institution; Smithsonian National Museum of Natural History	Hirsch, BT (corresponding author), Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA.	hirschb@si.edu	Maldonado, Jesus/AIE-8664-2022	Maldonado, Jesus/0000-0002-4282-1072; hirsch, ben/0000-0003-0142-7340	NSF doctoral dissertation improvement grant [BCS-0314525]; Smithsonian Institution postdoctoral fellowship program; Smithsonian Undersecretary for Science restricted endowment funds; Center for Conservation and Evolutionary Genetics at Smithsonian Conservation Biology Institute	NSF doctoral dissertation improvement grant(National Science Foundation (NSF)); Smithsonian Institution postdoctoral fellowship program(Smithsonian Institution); Smithsonian Undersecretary for Science restricted endowment funds; Center for Conservation and Evolutionary Genetics at Smithsonian Conservation Biology Institute	This study was funded by a NSF doctoral dissertation improvement grant (BCS-0314525), the Smithsonian Institution postdoctoral fellowship program, the Smithsonian Undersecretary for Science restricted endowment funds, and the Center for Conservation and Evolutionary Genetics at Smithsonian Conservation Biology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivaz AN, 2011, BEHAV ECOL, V22, P1353, DOI 10.1093/beheco/arr141; Borgatti S. P., 2006, UCINET WINDOWS SOFTW; BORRIES C, 1991, INT J PRIMATOL, V12, P231, DOI 10.1007/BF02547586; Bourke AFG, 2011, P ROY SOC B-BIOL SCI, V278, P3313, DOI 10.1098/rspb.2011.1465; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Chapais B, 2001, BEHAV ECOL SOCIOBIOL, V49, P493, DOI 10.1007/s002650100335; Chapais B, 2004, SOC ARISE MACAQUE MO; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; Crofoot MC, 2011, AM J PRIMATOL, V73, P821, DOI 10.1002/ajp.20959; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Croft DP, 2005, OECOLOGIA, V143, P211, DOI 10.1007/s00442-004-1796-8; Csardi G, INTERJOURNAL COMPLEX, P1695; DATTA S, 1988, ANIM BEHAV, V36, P754, DOI 10.1016/S0003-3472(88)80159-3; DATTA SB, 1991, AM NAT, V138, P201, DOI 10.1086/285212; Davis CS, 1998, MOL ECOL, V7, P1776, DOI 10.1046/j.1365-294x.1998.00515.x; Dekker D, 2007, PSYCHOMETRIKA, V72, P563, DOI 10.1007/s11336-007-9016-1; Di Blanco Y, 2006, BEHAV ECOL SOCIOBIOL, V61, P173, DOI 10.1007/s00265-006-0248-3; Engh AL, 2000, ANIM BEHAV, V60, P323, DOI 10.1006/anbe.2000.1502; Fike JA, 2007, MOL ECOL NOTES, V7, P525, DOI 10.1111/j.1471-8286.2006.01643.x; Gardner A, 2011, J EVOLUTION BIOL, V24, P1020, DOI 10.1111/j.1420-9101.2011.02236.x; Gompper ME, 1996, BEHAV ECOL, V7, P254, DOI 10.1093/beheco/7.3.254; Gompper ME, 1997, ANIM BEHAV, V53, P781, DOI 10.1006/anbe.1996.0344; Hall CL, 1997, ANIM BEHAV, V53, P1069, DOI 10.1006/anbe.1996.0392; Henzi SP, 2010, P NATL ACAD SCI USA, V107, P2130, DOI 10.1073/pnas.0913294107; Hirsch B.T., 2007, THESIS STONY BROOK U; Hirsch BT, 2007, ETHOLOGY, V113, P446, DOI 10.1111/j.1439-0310.2007.01348.x; Hirsch BT, 2007, Q REV BIOL, V82, P9, DOI 10.1086/511657; Hirsch BT, 2011, MAMMALIA, V75, P301, DOI 10.1515/MAMM.2011.030; Hirsch BT, 2011, BEHAV ECOL SOCIOBIOL, V65, P581, DOI 10.1007/s00265-010-1058-1; Hirsch BT, 2011, BEHAV ECOL SOCIOBIOL, V65, P391, DOI 10.1007/s00265-010-1056-3; Hirsch BT, 2011, MOL ECOL, V20, P409, DOI 10.1111/j.1365-294X.2010.04940.x; Hirsch BT, 2010, ETHOLOGY, V116, P671, DOI 10.1111/j.1439-0310.2010.01783.x; Hirsch BT, 2009, J MAMMAL, V90, P136, DOI 10.1644/08-MAMM-A-050.1; Hirsch BT, 2002, BEHAV ECOL SOCIOBIOL, V52, P458, DOI 10.1007/s00265-002-0536-5; HRDY SB, 1976, SCIENCE, V193, P913, DOI 10.1126/science.193.4256.913; JANSON C, 1985, BEHAV ECOL SOCIOBIOL, V18, P125, DOI 10.1007/BF00299041; JANSON CH, 1990, ANIM BEHAV, V40, P910, DOI 10.1016/S0003-3472(05)80993-5; JANSON CH, 1990, ANIM BEHAV, V40, P922, DOI 10.1016/S0003-3472(05)80994-7; Janson CH, 2006, ECOLOGICAL PHYS BEHA, P285; Janson Charles H., 1992, P95; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kays RW, 2000, MOL ECOL, V9, P743, DOI 10.1046/j.1365-294x.2000.00921.x; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; Koprowski JL, 1996, J MAMMAL, V77, P1006, DOI 10.2307/1382781; KRACKHARDT D, 1988, SOC NETWORKS, V10, P359, DOI 10.1016/0378-8733(88)90004-4; KRAUSE J, 1994, BIOL REV, V69, P187, DOI 10.1111/j.1469-185X.1994.tb01505.x; Krause J, 2000, BIOL REV, V75, P477; Marshall JAR, 2011, TRENDS ECOL EVOL, V26, P325, DOI 10.1016/j.tree.2011.04.008; *MOL EC RES PRIM D, 2010, MOL ECOLOGY RESOURCE, V9, P1460; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Palombit RA, 1997, ANIM BEHAV, V54, P599, DOI 10.1006/anbe.1996.0457; Pravosudova EV, 2001, CONDOR, V103, P821, DOI 10.1650/0010-5422(2001)103[0821:TIOKON]2.0.CO;2; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodel HG, 2009, PHYSIOL BEHAV, V97, P495, DOI 10.1016/j.physbeh.2009.04.005; Romero T, 2008, J COMP PSYCHOL, V122, P19, DOI 10.1037/0735-7036.122.1.19; Romero T, 2007, BEHAVIOUR, V144, P179, DOI 10.1163/156853907779947355; Romey WL, 2008, BEHAV ECOL, V19, P338, DOI 10.1093/beheco/arm138; Romey WL, 2007, BEHAV ECOL, V18, P910, DOI 10.1093/beheco/arm057; ROMEY WL, 1995, BEHAV ECOL SOCIOBIOL, V37, P195, DOI 10.1007/s002650050181; Ruckstuhl KE, 2001, BEHAVIOUR, V138, P1033, DOI 10.1163/156853901753286551; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SCHULMAN SR, 1980, AM NAT, V115, P580, DOI 10.1086/283581; Silk JB, 2004, ANIM BEHAV, V67, P573, DOI 10.1016/j.anbehav.2003.07.001; Silk JB, 2002, INT J PRIMATOL, V23, P849, DOI 10.1023/A:1015581016205; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; SIRIPUNKAW CS, 2007, MOL ECOL NOTES, V8, P199; Smith JE, 2011, ANIM BEHAV, V81, P401, DOI 10.1016/j.anbehav.2010.11.007; Smith JE, 2010, BEHAV ECOL, V21, P284, DOI 10.1093/beheco/arp181; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Toth Z, 2009, BEHAV ECOL SOCIOBIOL, V63, P1189, DOI 10.1007/s00265-009-0768-8; van Noordwijk MA, 1999, PRIMATES, V40, P105, DOI 10.1007/BF02557705; van Schaik C.P., 1989, Special Publication of the British Ecological Society, P195; Wahaj SA, 2004, BEHAV ECOL SOCIOBIOL, V56, P237, DOI 10.1007/s00265-004-0783-8; Wasserman S., 1994, SOCIAL NETWORK ANAL; WATTS DP, 1989, ETHOLOGY, V81, P1; Wey TW, 2010, ANIM BEHAV, V79, P1343, DOI 10.1016/j.anbehav.2010.03.008; Whitehead H., 2008, ANAL ANIMAL SOC; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y	80	37	37	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37301	10.1371/journal.pone.0037301	http://dx.doi.org/10.1371/journal.pone.0037301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624010	Green Published, Green Accepted, gold			2022-12-25	WOS:000305343500093
J	Stobb, M; Peterson, JM; Mazzag, B; Gahtan, E				Stobb, Michael; Peterson, Joshua M.; Mazzag, Borbala; Gahtan, Ethan			Graph Theoretical Model of a Sensorimotor Connectome in Zebrafish	PLOS ONE			English	Article							LATERAL-LINE SYSTEM; RETICULOSPINAL NEURONS; SMALL-WORLD; SCALE-FREE; FUNCTIONAL CONNECTIVITY; SPINAL NEURONS; YOUNG LARVAE; BRAIN; NETWORK; ORGANIZATION	Mapping the detailed connectivity patterns (connectomes) of neural circuits is a central goal of neuroscience. The best quantitative approach to analyzing connectome data is still unclear but graph theory has been used with success. We present a graph theoretical model of the posterior lateral line sensorimotor pathway in zebrafish. The model includes 2,616 neurons and 167,114 synaptic connections. Model neurons represent known cell types in zebrafish larvae, and connections were set stochastically following rules based on biological literature. Thus, our model is a uniquely detailed computational representation of a vertebrate connectome. The connectome has low overall connection density, with 2.45% of all possible connections, a value within the physiological range. We used graph theoretical tools to compare the zebrafish connectome graph to small-world, random and structured random graphs of the same size. For each type of graph, 100 randomly generated instantiations were considered. Degree distribution (the number of connections per neuron) varied more in the zebrafish graph than in same size graphs with less biological detail. There was high local clustering and a short average path length between nodes, implying a small-world structure similar to other neural connectomes and complex networks. The graph was found not to be scale-free, in agreement with some other neural connectomes. An experimental lesion was performed that targeted three model brain neurons, including the Mauthner neuron, known to control fast escape turns. The lesion decreased the number of short paths between sensory and motor neurons analogous to the behavioral effects of the same lesion in zebrafish. This model is expandable and can be used to organize and interpret a growing database of information on the zebrafish connectome.	[Stobb, Michael; Peterson, Joshua M.; Mazzag, Borbala] Humboldt State Univ, Dept Math, Arcata, CA 95521 USA; [Gahtan, Ethan] Humboldt State Univ, Dept Psychol, Arcata, CA 95521 USA; [Gahtan, Ethan] Humboldt State Univ, Dept Biol, Arcata, CA 95521 USA	California State University System; California State Polytechnic University, Humboldt; California State University System; California State Polytechnic University, Humboldt; California State University System; California State Polytechnic University, Humboldt	Stobb, M (corresponding author), Humboldt State Univ, Dept Math, Arcata, CA 95521 USA.	eg51@humboldt.edu			National Science Foundation (NSF) [0823358]; National Science Foundation-Research Experience for Undergraduates (NSF-REU) [0755582]; Direct For Biological Sciences [0823358] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Science Foundation-Research Experience for Undergraduates (NSF-REU)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding provided by National Science Foundation (NSF) Award #0823358 (EG) National Science Foundation-Research Experience for Undergraduates (NSF-REU) #0755582 (JMP and MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alexandre D, 1999, P NATL ACAD SCI USA, V96, P7558, DOI 10.1073/pnas.96.13.7558; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; BERNHARDT RR, 1990, J COMP NEUROL, V302, P603, DOI 10.1002/cne.903020315; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullock TH, 2000, BRAIN BEHAV EVOLUT, V55, P236, DOI 10.1159/000006657; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Costa LD, 2005, EUR PHYS J B, V48, P567, DOI 10.1140/epjb/e2006-00017-1; Dambly-Chaudiere C, 2003, BIOL CELL, V95, P579, DOI 10.1016/j.biolcel.2003.10.005; DeFelipe J, 2010, SCIENCE, V330, P1198, DOI 10.1126/science.1193378; Dimitriadis SI, 2010, J NEUROSCI METH, V193, P145, DOI 10.1016/j.jneumeth.2010.08.027; Faucherre A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004477; Fetcho JR, 2010, ANN NY ACAD SCI, V1198, P94, DOI 10.1111/j.1749-6632.2010.05539.x; Gahtan E, 2003, J COMP NEUROL, V459, P186, DOI 10.1002/cne.10621; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Gompel N, 2001, DEVELOPMENT, V128, P387; Goulet J, 2008, J COMP PHYSIOL A, V194, P1, DOI 10.1007/s00359-007-0275-1; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hale ME, 2001, J COMP NEUROL, V437, P1, DOI 10.1002/cne.1266; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kamali M, 2009, J MICROSC-OXFORD, V233, P114, DOI 10.1111/j.1365-2818.2008.03102.x; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; Kinkhabwala A, 2011, P NATL ACAD SCI USA, V108, P1164, DOI 10.1073/pnas.1012185108; Lee U, 2010, ANESTHESIOLOGY, V113, P1081, DOI 10.1097/ALN.0b013e3181f229b5; Li CG, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.052901; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Ma LH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005944; MENDELSON B, 1986, DEV BIOL, V118, P309, DOI 10.1016/0012-1606(86)90098-9; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; Nagiel A, 2008, J NEUROSCI, V28, P8442, DOI 10.1523/JNEUROSCI.2425-08.2008; Nakayama H, 2004, J NEUROSCI, V24, P3199, DOI 10.1523/JNEUROSCI.4419-03.2004; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Orger MB, 2008, NAT NEUROSCI, V11, P327, DOI 10.1038/nn2048; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Piersa J, 2010, IEEE T NEURAL NETWOR, V21, P1747, DOI 10.1109/TNN.2010.2066989; Portillo IJG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006863; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Sankrithi NS, 2010, NEUROSCIENCE, V166, P970, DOI 10.1016/j.neuroscience.2010.01.003; Sato A, 2010, DEV DYNAM, V239, P2058, DOI 10.1002/dvdy.22324; Sohn Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001139; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2011, BRAIN CONNECTIVITY T; Sporns O., 2003, NEUROSCIENCE DATABAS, P171, DOI DOI 10.1007/978-1-4615-1079-6_12; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Srinivasan R, 2010, BIOINFORMATICS, V26, pi64, DOI 10.1093/bioinformatics/btq179; Stephan KE, 2000, PHILOS T R SOC B, V355, P111, DOI 10.1098/rstb.2000.0552; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Vertes PE, 2010, HFSP J, V4, P153, DOI 10.2976/1.3386761; Walsh T, 1999, P 16 IJCAI ART INT; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yan CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023460	58	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37292	10.1371/journal.pone.0037292	http://dx.doi.org/10.1371/journal.pone.0037292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624008	Green Published, gold			2022-12-25	WOS:000305343500091
J	Jennes, W; Kyongo, JK; Vanhommerig, E; Camara, M; Coppens, S; Seydi, M; Mboup, S; Heyndrickx, L; Kestens, L				Jennes, Wim; Kyongo, Jordan K.; Vanhommerig, Evelyn; Camara, Makhtar; Coppens, Sandra; Seydi, Moussa; Mboup, Souleymane; Heyndrickx, Leo; Kestens, Luc			Molecular Epidemiology of HIV-1 Transmission in a Cohort of HIV-1 Concordant Heterosexual Couples from Dakar, Senegal	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CONCURRENT SEXUAL PARTNERSHIPS; PHYLOGENETIC ANALYSIS; TYPE-1 TRANSMISSION; COHABITING COUPLES; HIGH-PREVALENCE; RURAL UGANDA; SOUTH-AFRICA; RISK-FACTORS; CONDOM USE	Background: A large number of HIV-1 infections in Africa occur in married couples. The predominant direction of intracouple transmission and the principal external origins of infection remain important issues of debate. Methods: We investigated HIV-1 transmission in 46 HIV-1 concordant positive couples from Dakar, Senegal. Intracouple transmission was confirmed by maximum-likelihood phylogenetic analysis and pairwise distance comparisons of HIV-1 env gp41 sequences from both partners. Standardized interview data were used to deduce the direction as well as the external sources of the intracouple transmissions. Results: Conservative molecular analyses showed linked viruses in 34 (74%) couples, unlinked viruses in 6 (13%) couples, and indeterminate results for 6 (13%) couples. The interview data corresponded completely with the molecular analyses: all linked couples reported internal transmission and all unlinked couples reported external sources of infection. The majority of linked couples (93%) reported the husband as internal source of infection. These husbands most frequently (82%) reported an occasional sexual relationship as external source of infection. Pairwise comparisons of the CD4 count, antiretroviral therapy status, and the proportion of gp41 ambiguous base pairs within transmission pairs correlated with the reported order of infection events. Conclusions: In this suburban Senegalese population, a majority of HIV-1 concordant couples showed linked HIV-1 transmission with the husband as likely index partner. Our data emphasize the risk of married women for acquiring HIV-1 as a result of the occasional sexual relationships of their husbands.	[Jennes, Wim; Kyongo, Jordan K.; Vanhommerig, Evelyn; Kestens, Luc] Inst Trop Med, Dept Biomed Sci, Immunol Lab, B-2000 Antwerp, Belgium; [Camara, Makhtar; Mboup, Souleymane] Cheikh Anta Diop Univ, Ctr Hosp Univ Dantec, Dept Bacteriol Virol, Immunol Lab, Dakar, Senegal; [Coppens, Sandra; Heyndrickx, Leo] Inst Trop Med, Dept Biomed Sci, Virol Lab, B-2000 Antwerp, Belgium; [Seydi, Moussa] Cheikh Anta Diop Univ, Ctr Hosp Univ Fann, Dept Infect Dis, Dakar, Senegal	Institute of Tropical Medicine (ITM); University Cheikh Anta Diop Dakar; Institute of Tropical Medicine (ITM); University Cheikh Anta Diop Dakar	Jennes, W (corresponding author), Inst Trop Med, Dept Biomed Sci, Immunol Lab, B-2000 Antwerp, Belgium.	wjennes@itg.be	Jennes, Wim/M-2523-2013	Jennes, Wim/0000-0002-3125-6389	Belgian Fund for Scientific Research (FWO-Vlaanderen) [G.0660.06]; Belgian Development Cooperation	Belgian Fund for Scientific Research (FWO-Vlaanderen)(FWO); Belgian Development Cooperation	This work was supported by the Belgian Fund for Scientific Research (FWO-Vlaanderen, grant number G.0660.06, website: www.fwo.be) and the Belgian Development Cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaschak S, 2000, CLIN INFECT DIS, V31, P1098, DOI 10.1086/318152; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Camara M, 2010, J INFECT DIS, V201, P835, DOI 10.1086/651000; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; CARAEL M, 1988, AIDS, V2, P201; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Eshleman SH, 2011, J INFECT DIS; Ever-Silva WA, 2006, JAIDS-J ACQ IMM DEF, V41, P664, DOI 10.1097/01.qai.0000194736.66322.02; Eyawo O, 2010, LANCET INFECT DIS, V10, P770, DOI 10.1016/S1473-3099(10)70189-4; Fisher M, 2010, AIDS, V24, P1739, DOI 10.1097/QAD.0b013e32833ac9e6; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Glynn JR, 2003, JAIDS-J ACQ IMM DEF, V33, P526, DOI 10.1097/00126334-200308010-00015; Gonzalez-Candelas F, 2005, AIDS, V19, P1552, DOI 10.1097/01.aids.0000180783.18177.98; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Guwatudde D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004145; Hollingsworth TD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000876; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2005, AIDS, V19, P449, DOI 10.1097/01.aids.0000161778.15568.a1; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1455, DOI 10.1093/ije/dyl217; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Maharaj P, 2005, INT FAM PLAN PERSPEC, V31, P24, DOI 10.1363/3102405; Malamba SS, 2005, JAIDS-J ACQ IMM DEF, V39, P576; Mattson CL, 2007, SEX TRANSM DIS, V34, P731, DOI 10.1097/01.olq.0000261335.42480.89; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Metzker ML, 2002, P NATL ACAD SCI USA, V99, P14292, DOI 10.1073/pnas.222522599; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014092; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; Rachinger A, 2011, AIDS, V25, P1035, DOI 10.1097/QAD.0b013e3283467020; Ramakrishnan R, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-42; Reniers G, 2010, AIDS, V24, P299, DOI 10.1097/QAD.0b013e328333af03; Resik S, 2007, AIDS RES HUM RETROV, V23, P347, DOI 10.1089/aid.2006.0158; Scaduto DI, 2010, P NATL ACAD SCI USA, V107, P21242, DOI 10.1073/pnas.1015673107; Smith DJ, 2007, AM J PUBLIC HEALTH, V97, P997, DOI 10.2105/AJPH.2006.088583; Sturmer M, 2004, AIDS, V18, P2109, DOI 10.1097/00002030-200411050-00002; Tamura K, 2011, MOL BIOL EVOL; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; UNAIDS, 2011, 2010 REP GLOB AIDS E; Waters L, 2012, CURR OPIN INFECT DIS, V25, P42, DOI 10.1097/QCO.0b013e32834ef5af; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Yang CF, 1999, J CLIN MICROBIOL, V37, P2581, DOI 10.1128/JCM.37.8.2581-2586.1999	53	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37402	10.1371/journal.pone.0037402	http://dx.doi.org/10.1371/journal.pone.0037402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615999	Green Published, gold			2022-12-25	WOS:000305341200071
J	Morancho, B; Parra-Palau, JL; Ibrahim, YH; Morales, CB; Peg, V; Bech-Serra, JJ; Pandiella, A; Canals, F; Baselga, J; Rubio, I; Arribas, J				Morancho, B.; Parra-Palau, J. L.; Ibrahim, Y. H.; Bernado Morales, C.; Peg, V.; Bech-Serra, J. J.; Pandiella, A.; Canals, F.; Baselga, J.; Rubio, I.; Arribas, J.			A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancers	ONCOGENE			English	Article						HER2; ErbB2; breast cancer	RECEPTOR; CLEAVAGE; ERBB-2; GELDANAMYCIN; IDENTIFICATION; TRASTUZUMAB; DEGRADATION; EFFECTOR; P95HER2; GROWTH	The transmembrane tyrosine kinase HER2 (ErbB2, neu) is a prototypical biomarker for breast cancers and a therapeutic target. Although anti-HER2 therapies are remarkably effective, HER2-positive tumors are heterogeneous and some subtypes do not respond or develop resistance to these therapies. Here we show that H2NTF, a novel N-terminal fragment of HER2, is expressed at variable levels in 60% of the breast cancer samples analyzed. Characterization of H2NTF shows that it is devoid of the tyrosine kinase domain but it readily interacts with full-length HER2 and other HER receptors. As a consequence, H2NTF acts as a dominant-negative, attenuating the signaling triggered by full-length HER receptors. Expression of H2NTF results in resistance to the treatment with low concentrations of trastuzumab in vitro. However, cells expressing H2NTF and non-expressing cells have similar sensitivity to trastuzumab in vivo, indicating that H2NTF/trastuzumab complexes trigger antibody-dependent cell-mediated cytotoxicity. Oncogene (2013) 32, 1452-1459; doi:10.1038/onc.2012.152; published online 28 May 2012	[Morancho, B.; Parra-Palau, J. L.; Ibrahim, Y. H.; Bernado Morales, C.; Bech-Serra, J. J.; Canals, F.; Baselga, J.; Arribas, J.] Vall dHebron Inst Oncol VHIO, Preclin Res Program, Barcelona 08035, Spain; [Peg, V.] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Pathol, Bellaterra, Spain; [Peg, V.] Univ Autonoma Barcelona, Dept Morphol Sci, Bellaterra, Spain; [Pandiella, A.] Univ Salamanca, CSIC, Inst Biol Mol Celular & Celular Canc, E-37008 Salamanca, Spain; [Baselga, J.] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA; [Rubio, I.] Vall dHebron Univ Hosp, Breast Canc Ctr, Barcelona, Spain; [Arribas, J.] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Bellaterra, Spain; [Arribas, J.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; Harvard University; Harvard Medical School; Massachusetts General Hospital; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; ICREA	Arribas, J (corresponding author), Vall dHebron Inst Oncol VHIO, Preclin Res Program, Psg Vall dHebron 119-129, Barcelona 08035, Spain.	jarribas@vhio.net	rubio, isabel/U-4259-2018; Arribas, Joaquin/M-4482-2014; Morancho, Beatriz/AAD-3540-2021; Pandiella, Atanasio/O-5180-2014; Bech-Serra, Joan Josep/AAA-2330-2020; Peg., Vicente/AAC-9447-2020; Peg, Vicente/E-9160-2018	rubio, isabel/0000-0003-0035-0679; Arribas, Joaquin/0000-0002-0504-0664; Morancho, Beatriz/0000-0003-3369-8647; Pandiella, Atanasio/0000-0002-4704-8971; Bech-Serra, Joan Josep/0000-0003-3486-781X; Peg., Vicente/0000-0002-5203-6166; Peg, Vicente/0000-0002-5203-6166; Bernado Morales, Cristina/0000-0003-1376-0407	Instituto de Salud Carlos III (Intrasalud) [PI081154, PI11/02496]; Instituto de Salud Carlos III (network of cooperative cancer research) [RTICC-RD06/0020/0022, RTICC-RD06/0020/0041]; GlaxoSmithKline; Breast Cancer Research Foundation (BCRF); ICREA Funding Source: Custom	Instituto de Salud Carlos III (Intrasalud); Instituto de Salud Carlos III (network of cooperative cancer research); GlaxoSmithKline(GlaxoSmithKline); Breast Cancer Research Foundation (BCRF); ICREA(ICREA)	This work was supported by Instituto de Salud Carlos III (Intrasalud PI081154, PI11/02496 and the network of cooperative cancer research (RTICC-RD06/0020/0022 and RTICC-RD06/0020/0041)), GlaxoSmithKline and the Breast Cancer Research Foundation (BCRF).	Abramson V, 2011, CLIN CANCER RES, V17, P952, DOI 10.1158/1078-0432.CCR-09-1947; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Arribas J, 2011, CANCER RES, V71, P1515, DOI 10.1158/0008-5472.CAN-10-3795; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Benoit V, 2004, CANCER RES, V64, P2684, DOI 10.1158/0008-5472.CAN-03-2914; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Doherty JK, 1999, P NATL ACAD SCI USA, V96, P10869, DOI 10.1073/pnas.96.19.10869; HASUI M, 1989, CELL IMMUNOL, V120, P230, DOI 10.1016/0008-8749(89)90190-1; Kulkarni S, 2010, ONCOGENE, V29, P1339, DOI 10.1038/onc.2009.422; Parra-Palau JL, 2010, CANCER RES, V70, P8537, DOI 10.1158/0008-5472.CAN-10-1701; Pedersen K, 2009, MOL CELL BIOL, V29, P3319, DOI 10.1128/MCB.01803-08; Ryan Q, 2008, ONCOLOGIST, V13, P1114, DOI 10.1634/theoncologist.2008-0816; Sanchez-Martin M, 2012, INT J CANCER, V131, P244, DOI 10.1002/ijc.26358; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Spector NL, 2009, J CLIN ONCOL, V27, P5838, DOI 10.1200/JCO.2009.22.1507; Sperinde J, 2010, CLIN CANCER RES, V16, P4226, DOI 10.1158/1078-0432.CCR-10-0410; Strohecker AM, 2008, J BIOL CHEM, V283, P18269, DOI 10.1074/jbc.M802156200; Tikhomirov O, 2005, ONCOGENE, V24, P3906, DOI 10.1038/sj.onc.1208534; Tikhomirov O, 2003, CANCER RES, V63, P39; Tikhomirov O, 2001, J BIOL CHEM, V276, P33675, DOI 10.1074/jbc.M101394200; Tikhomirov O, 2000, J BIOL CHEM, V275, P26625, DOI 10.1074/jbc.M003114200; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200	23	6	6	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 14	2013	32	11					1452	1459		10.1038/onc.2012.152	http://dx.doi.org/10.1038/onc.2012.152			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OZ	22641219				2022-12-25	WOS:000316455600011
J	Jin, QY; Ding, W; Mulder, KM				Jin, Qunyan; Ding, Wei; Mulder, Kathleen M.			The TGF beta Receptor-interacting Protein km23-1/DYNLRB1 Plays an Adaptor Role in TGF beta 1 Autoinduction via Its Association with Ras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; BREAST-CANCER CELLS; LIGHT-CHAIN KM23-1; EPITHELIAL-CELLS; CYTOPLASMIC DYNEIN; C-JUN; TRANSFORMING GROWTH-FACTOR-BETA-1; CARCINOMA CELLS; COGNATE GAP; ACTIVATION	We have previously elucidated the signaling events that are required for TGF beta 1 autoinduction (Yue, J., and Mulder, K. M. (2000) J. Biol. Chem. 275, 30765-30773). Further, we have reported that the TGF beta receptor (T beta R)-interacting protein km23-1 plays an important role in TGF beta signal transduction (Jin, Q., Ding, W., and Mulder, K. M. (2007) J. Biol. Chem. 282, 19122-19132). Here we examined the role of km23-1 in TGF beta 1 autoinduction in TGF beta-sensitive epithelial cells. siRNA blockade of km23-1 reduced TGF beta 1 mRNA expression, as well as DNA binding and transcriptional activation of the relevant activator protein-1 site in the human TGF beta 1 promoter. Further, knockdown of km23-1 inhibited TGF beta-mediated activation of ERK and JNK, phosphorylation of c-Jun, and transactivation of the c-Jun promoter. Sucrose gradient analyses indicate that km23-1 was present in lipid rafts together with Ras and T beta RII after TGF beta treatment. Immunoprecipitation/blot analyses revealed the formation of a TGF beta-inducible complex between Ras and km23-1 in vivo within minutes of TGF beta addition. Moreover, we demonstrate for the first time that km23-1 is required for Ras activation by TGF beta. Our results indicate that km23-1 is required for TGF beta 1 autoinduction through Smad2-independent Ras/ERK/JNK pathways. More importantly, our findings demonstrate that km23-1 functions as a critical adaptor coupling T beta R activation to activation of Ras effector pathways downstream.	[Jin, Qunyan; Ding, Wei; Mulder, Kathleen M.] Penn State Hershey Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Mulder, KM (corresponding author), Penn State Hershey Coll Med, Dept Biochem & Mol Biol MC H171, 500 Univ Dr, Hershey, PA 17033 USA.	kmm15@psu.edu			National Institutes of Health [CA090765, CA092889, CA100239, CA092889-08S1]; NATIONAL CANCER INSTITUTE [R01CA100239, R01CA090765, R01CA092889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA090765, CA092889, CA100239, and CA092889-08S1 (to K. M. M.).	Campbell IG, 2006, CLIN CANCER RES, V12, P3713, DOI 10.1158/1078-0432.CCR-06-0800; Chapnick DA, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-42; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 1996, CURR BIOL, V6, P1226, DOI 10.1016/S0960-9822(96)00702-6; Ding Wei, 2004, Cancer Treat Res, V119, P315; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Frey RS, 1997, CANCER LETT, V117, P41, DOI 10.1016/S0304-3835(97)00211-5; Frey RS, 1997, CANCER RES, V57, P628; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Hartsough MT, 1997, PHARMACOL THERAPEUT, V75, P21, DOI 10.1016/S0163-7258(97)00020-X; Ilangovan U, 2005, J MOL BIOL, V352, P338, DOI 10.1016/j.jmb.2005.07.002; Jiang JM, 2001, GENE, V281, P103, DOI 10.1016/S0378-1119(01)00787-9; Jin Q, 2007, J BIOL CHEM, V282, P19122, DOI 10.1074/jbc.M609915200; Jin QY, 2009, J CELL PHYSIOL, V221, P707, DOI 10.1002/jcp.21910; Jin QY, 2005, CELL SIGNAL, V17, P1363, DOI 10.1016/j.cellsig.2005.02.004; Kang HC, 2007, CANCER GENET CYTOGEN, V175, P173, DOI 10.1016/j.cancergencyto.2007.02.004; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; KATO M, 1995, J BIOL CHEM, V270, P12373, DOI 10.1074/jbc.270.21.12373; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; KIM SJ, 1989, J BIOL CHEM, V264, P402; Koonin EV, 2000, CURR BIOL, V10, pR774, DOI 10.1016/S0960-9822(00)00774-0; LASSUS P, 2002, SCI STKE; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Leonardy S, 2010, EMBO J, V29, P2276, DOI 10.1038/emboj.2010.114; Lin S, 2011, J BIOL CHEM, V286, P44023, DOI 10.1074/jbc.M111.265397; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Liu GM, 2006, J BIOL CHEM, V281, P29479, DOI 10.1074/jbc.M600579200; Liu GM, 2006, MOL CARCINOGEN, V45, P582, DOI 10.1002/mc.20189; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Miertzschke M, 2011, EMBO J, V30, P4185, DOI 10.1038/emboj.2011.291; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Mulder K. M., 1989, CELL MOL BIOL COLON, P45; MULDER KM, 1993, J CELL PHYSIOL, V154, P162, DOI 10.1002/jcp.1041540120; MULDER KM, 1992, J BIOL CHEM, V267, P5029; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Nikulina K, 2004, CELL MOTIL CYTOSKEL, V57, P233, DOI 10.1002/cm.10172; Pandey MK, 2012, INT J CANCER, V130, P213, DOI 10.1002/ijc.25997; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Pulipati NR, 2011, INT J CANCER, V129, P553, DOI 10.1002/ijc.25954; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Tang Q, 2002, MOL BIOL CELL, V13, P4484, DOI 10.1091/mbc.e02-05-0245; VANOBBERGHENSCHILLING E, 1988, J BIOL CHEM, V263, P7741; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wong C, 1999, MOL CELL BIOL, V19, P1821; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6; Yue J, 2004, J CELL PHYSIOL, V199, P284, DOI 10.1002/jcp.10469; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; Yue JB, 2001, PHARMACOL THERAPEUT, V91, P1, DOI 10.1016/S0163-7258(01)00143-7; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898	60	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26453	26463		10.1074/jbc.M112.344887	http://dx.doi.org/10.1074/jbc.M112.344887			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22637579	hybrid, Green Published			2022-12-25	WOS:000306916300070
J	Nagy, P; Lechte, TP; Das, AB; Winterbourn, CC				Nagy, Peter; Lechte, Thomas P.; Das, Andrew B.; Winterbourn, Christine C.			Conjugation of Glutathione to Oxidized Tyrosine Residues in Peptides and Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLET OXYGEN; CYSTEINE DIOXYGENASE; PHENOXYL RADICALS; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; SUPEROXIDE; MYELOPEROXIDASE; ELECTROPHILE; PEROXIDES; ACID	Tyrosine residues are sensitive to oxidation and can be converted to hydroperoxides either by superoxide reacting with the Tyr radical or by singlet oxygen. These hydroperoxides rearrange to bicyclic derivatives that are readily reduced to more stable hydroxides. The aromatic character of tyrosine is lost, but the product contains an alpha-beta unsaturated carbonyl group and is, therefore, an electrophile. We have generated hydroxide derivatives of several Tyr-containing peptides and shown using liquid chromatography/mass spectrometry that they undergo Michael addition with GSH. For Tyr-Gly, rate constants of 9.2 and 11.8 M(-1)min(-1) were measured for the two chromatographically distinct isomers. Unusual for GSH addition to an electrophile, the reaction is reversible, with a half-life of many hours for the reverse reaction. These kinetics indicate that with a typical cellular concentration of 5 mM GSH, >95% Tyr-Gly hydroxide would become conjugated with a half-life of similar to 15 min. Sperm whale myoglobin forms a hydroperoxide on Tyr-151 in a hydrogen peroxide/superoxide-dependent reaction. We show that its hydroxide derivative reacts with GSH to form a conjugate. Detection of the conjugate required stabilization by reduction; otherwise, the reverse reaction occurred during tryptic digestion and analysis. Our findings represent a novel mechanism for peptide or protein glutathionylation involving a carbon-sulfur cross-link between oxidized Tyr and Cys. As with other electrophiles, the oxidized Tyr should undergo a similar reaction with Cys residues in proteins to give intramolecular or intermolecular protein cross-links. This mechanism could give rise to protein cross-linking in conditions of oxidative stress.	[Nagy, Peter; Lechte, Thomas P.; Das, Andrew B.; Winterbourn, Christine C.] Univ Otago, Dept Pathol, Free Rad Res Grp, Christchurch 8040, New Zealand	University of Otago	Winterbourn, CC (corresponding author), Univ Otago, Dept Pathol, Free Rad Res Grp, POB 4345, Christchurch 8040, New Zealand.	christine.winterbourn@otago.ac.nz	Das, Andrew/I-8352-2018; Nagy, Peter/C-6768-2008	Das, Andrew/0000-0001-6509-4886; Nagy, Peter/0000-0003-3393-235X	New Zealand Marsden Fund	New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by the New Zealand Marsden Fund.	Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Codreanu SG, 2009, MOL CELL PROTEOMICS, V8, P670, DOI 10.1074/mcp.M800070-MCP200; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Das AB, 2010, FREE RADICAL BIO MED, V48, P1540, DOI 10.1016/j.freeradbiomed.2010.02.039; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Espenson J. H., 1995, CHEM KINETICS REACTI, P46; ESTERBAUER H, 1975, Z NATURFORSCH C, V30, P466; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; Gieseg S, 2000, BIOCHEM J, V350, P215, DOI 10.1042/0264-6021:3500215; Heinecke JW, 2002, TOXICOLOGY, V177, P11, DOI 10.1016/S0300-483X(02)00192-0; Higdon A. N., 2012, ANTIOXID REDOX SIGNA; Hill BG, 2012, J MOL CELL CARDIOL, V52, P559, DOI 10.1016/j.yjmcc.2011.07.009; Holland R, 2010, ANTIOXID REDOX SIGN, V13, P1749, DOI 10.1089/ars.2010.3273; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; JIN FM, 1993, J CHEM SOC PERK T 2, P1583, DOI 10.1039/p29930001583; JONSSON M, 1993, J PHYS CHEM-US, V97, P8229, DOI 10.1021/j100133a018; Lardinois OM, 2003, J BIOL CHEM, V278, P36214, DOI 10.1074/jbc.M304726200; Liebler DC, 2008, CHEM RES TOXICOL, V21, P117, DOI 10.1021/tx700235t; Lin D, 2008, CHEM RES TOXICOL, V21, P2361, DOI 10.1021/tx800248x; Morgan PE, 2004, FREE RADICAL BIO MED, V36, P484, DOI 10.1016/j.freeradbiomed.2003.11.021; Morgan PE, 2002, EUR J BIOCHEM, V269, P1916, DOI 10.1046/j.1432-1033.2002.02845.x; Nagy P, 2010, FREE RADICAL BIO MED, V49, P792, DOI 10.1016/j.freeradbiomed.2010.05.033; Nagy P, 2009, J BIOL CHEM, V284, P14723, DOI 10.1074/jbc.M809396200; Peskin AV, 2010, BIOCHEM J, V432, P313, DOI 10.1042/BJ20101156; PICHORNER H, 1995, ARCH BIOCHEM BIOPHYS, V323, P429, DOI 10.1006/abbi.1995.0064; Rahmanto AS, 2010, FREE RADICAL BIO MED, V49, P1505, DOI 10.1016/j.freeradbiomed.2010.08.006; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; SAITO I, 1975, J AM CHEM SOC, V97, P5272, DOI 10.1021/ja00851a042; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; SCHUPPE I, 1992, BIOCHEM PHARMACOL, V44, P1757, DOI 10.1016/0006-2952(92)90069-U; Schwobel JAH, 2010, SAR QSAR ENVIRON RES, V21, P693, DOI 10.1080/1062936X.2010.528943; Siakkou E, 2011, BBA-PROTEINS PROTEOM, V1814, P2003, DOI 10.1016/j.bbapap.2011.07.019; Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200; Winterbourn CC, 1997, ARCH BIOCHEM BIOPHYS, V338, P15, DOI 10.1006/abbi.1996.9773; Winterbourn CC, 2004, BIOCHEM J, V381, P241, DOI 10.1042/BJ20040259; Wright A, 2002, PHOTOCHEM PHOTOBIOL, V76, P35, DOI 10.1562/0031-8655(2002)076<0035:SOMPOE>2.0.CO;2	38	24	24	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26068	26076		10.1074/jbc.M112.371690	http://dx.doi.org/10.1074/jbc.M112.371690			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22648418	Green Published, hybrid			2022-12-25	WOS:000306916300034
J	Ochoa, CD; Alexeyev, M; Pastukh, V; Balczon, R; Stevens, T				Ochoa, Cristhiaan D.; Alexeyev, Mikhail; Pastukh, Viktoriya; Balczon, Ron; Stevens, Troy			Pseudomonas aeruginosa Exotoxin Y Is a Promiscuous Cyclase That Increases Endothelial Tau Phosphorylation and Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; DEPENDENT PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; GLYCOGEN-SYNTHASE KINASE-3-BETA; ALZHEIMERS-DISEASE; BARRIER FUNCTION; CYCLIC-GMP; MICROVASCULAR PERMEABILITY; ADENOSINE-MONOPHOSPHATE; POTENT INHIBITORS	Exotoxin Y (ExoY) is a type III secretion system effector found in similar to 90% of the Pseudomonas aeruginosa isolates. Although it is known that ExoY causes inter-endothelial gaps and vascular leak, the mechanisms by which this occurs are poorly understood. Using both a bacteria-delivered and a codon-optimized conditionally expressed ExoY, we report that this toxin is a dual soluble adenylyl and guanylyl cyclase that results in intracellular cAMP and cGMP accumulation. The enzymatic activity of ExoY caused phosphorylation of endothelial Tau serine 214, accumulation of insoluble Tau, inter-endothelial cell gap formation, and increased macromolecular permeability. To discern whether the cAMP or cGMP signal was responsible for Tau phosphorylation and barrier disruption, pulmonary microvascular endothelial cells were engineered for the conditional expression of either wild-type guanylyl cyclase, which synthesizes cGMP, or a mutated guanylyl cyclase, which synthesizes cAMP. Sodium nitroprusside stimulation of the cGMP-generating cyclase resulted in transient Tau serine 214 phosphorylation and gap formation, whereas stimulation of the cAMP-generating cyclase induced a robust increase in Tau serine 214 phosphorylation, gap formation, and macromolecular permeability. These results indicate that the cAMP signal is the dominant stimulus for Tau phosphorylation. Hence, ExoY is a promiscuous cyclase and edema factor that uses cAMP and, to some extent, cGMP to induce the hyperphosphorylation and insolubility of endothelial Tau. Because hyperphosphorylated and insoluble Tau are hallmarks in neurodegenerative tauopathies such as Alzheimer disease, acute Pseudomonas infections cause a pathophysiological sequela in endothelium previously recognized only in chronic neurodegenerative diseases.	[Ochoa, Cristhiaan D.; Pastukh, Viktoriya; Stevens, Troy] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA; [Stevens, Troy] Univ S Alabama, Coll Med, Dept Med, Mobile, AL 36688 USA; [Alexeyev, Mikhail; Balczon, Ron] Univ S Alabama, Coll Med, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; [Ochoa, Cristhiaan D.; Alexeyev, Mikhail; Pastukh, Viktoriya; Balczon, Ron; Stevens, Troy] Univ S Alabama, Coll Med, Ctr Lung Biol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama	Stevens, T (corresponding author), Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA.	tstevens@jaguar1.usouthal.edu		Ochoa, Cristhiaan/0000-0001-9113-2137	National Institutes of Health Grants [HL-60024, HL-66299, HL-76125, HL-107122, 1RO1RR031286]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR031286] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076125, F31HL107122, P01HL066299, R01HL060024, R37HL060024] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010944] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants HL-60024 and HL-66299 (to T. S.), HL-76125 and HL-107122 (to C. D. O.), and 1RO1RR031286 (to M. A.).	Adamson RH, 2008, AM J PHYSIOL-HEART C, V294, pH1188, DOI 10.1152/ajpheart.00937.2007; Adamson RH, 1998, AM J PHYSIOL-HEART C, V274, pH1885, DOI 10.1152/ajpheart.1998.274.6.H1885; Ahuja N, 2004, CRIT REV MICROBIOL, V30, P187, DOI 10.1080/10408410490468795; Alexeyev MF, 2010, MOL BIOL REP, V37, P1987, DOI 10.1007/s11033-009-9647-7; Baker DA, 2004, MOL MICROBIOL, V52, P1229, DOI 10.1111/j.1365-2958.2004.04067.x; Balin BJ, 2008, J ALZHEIMERS DIS, V13, P371; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bandyopadhyay B, 2007, J BIOL CHEM, V282, P16454, DOI 10.1074/jbc.M700192200; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; BERTHIAUME Y, 1987, J CLIN INVEST, V79, P335, DOI 10.1172/JCI112817; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Bouchard M, 2011, CAN J NEUROL SCI, V38, P547, DOI 10.1017/S0317167100012087; Cheli Y, 2009, J BIOL CHEM, V284, P18699, DOI 10.1074/jbc.M109.005819; Cowell BA, 2005, FEMS MICROBIOL LETT, V250, P71, DOI 10.1016/j.femsle.2005.06.044; Creighton J, 2008, J CELL SCI, V121, P110, DOI 10.1242/jcs.011692; Creighton J, 2011, FASEB J, V25, P3356, DOI 10.1096/fj.10-179218; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Frank S, 2008, ACTA NEUROPATHOL, V115, P39, DOI 10.1007/s00401-007-0291-9; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Gairhe S, 2011, AM J PHYSIOL-LUNG C, V301, pL527, DOI 10.1152/ajplung.00091.2011; GEORGE WJ, 1970, P NATL ACAD SCI USA, V66, P398, DOI 10.1073/pnas.66.2.398; Gottle M, 2010, BIOCHEMISTRY-US, V49, P5494, DOI 10.1021/bi100684g; Goldberg N D, 1975, Adv Cyclic Nucleotide Res, V5, P307; Grimley JS, 2008, BIOORG MED CHEM LETT, V18, P759, DOI 10.1016/j.bmcl.2007.11.044; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Hirata-Fukae C, 2009, NEUROSCI LETT, V450, P51, DOI 10.1016/j.neulet.2008.11.023; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Itzhaki RE, 2004, NEUROBIOL AGING, V25, P619, DOI 10.1016/j.neurobiolaging.2003.12.021; Jacobson J. R., 2010, MURRAY NADELS TXB RE, P1; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Kemp SF, 2008, ALLERGY, V63, P1061, DOI 10.1111/j.1398-9995.2008.01733.x; Khaled M, 2002, J BIOL CHEM, V277, P33690, DOI 10.1074/jbc.M202939200; King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; Kinoshita J, 2004, NEUROBIOL AGING, V25, P639, DOI 10.1016/j.neurobiolaging.2004.02.007; Komalavilas P, 1999, J BIOL CHEM, V274, P34301, DOI 10.1074/jbc.274.48.34301; Kuebler WM, 2011, AM J PHYSIOL-LUNG C, V301, pL157, DOI 10.1152/ajplung.00192.2011; Lampugnani MG, 2004, SPRING LAB MAN, P103; Lorimer D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-36; Lory S, 2004, INT J MED MICROBIOL, V293, P479, DOI 10.1078/1438-4221-00297; Lowe K, 2010, CRIT CARE MED, V38, P1458, DOI 10.1097/CCM.0b013e3181de18f0; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Moldobaeva A, 2006, AM J PHYSIOL-LUNG C, V290, pL919, DOI 10.1152/ajplung.00434.2005; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Ochoa CD, 2011, AM J PHYSIOL-LUNG C, V300, pL132, DOI 10.1152/ajplung.00185.2010; Ofori-Acquah SF, 2008, MICROVASC RES, V75, P391, DOI 10.1016/j.mvr.2007.10.006; Parker JC, 2006, AM J PHYSIOL-LUNG C, V291, pL30, DOI 10.1152/ajplung.00317.2005; Parra-Bonilla G, 2010, AM J PHYSIOL-LUNG C, V299, pL513, DOI 10.1152/ajplung.00274.2009; Prasain N., 2009, THESIS U S ALABAMA M; Prasain N, 2009, AM J PHYSIOL-LUNG C, V297, pL73, DOI 10.1152/ajplung.90577.2008; Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Rentsendorj O, 2008, AM J PHYSIOL-LUNG C, V294, pL686, DOI 10.1152/ajplung.00417.2007; Roelofs J, 2002, MOL BIOL EVOL, V19, P2239, DOI 10.1093/oxfordjournals.molbev.a004047; Roelofs J, 2001, EMBO J, V20, P4341, DOI 10.1093/emboj/20.16.4341; Sato S, 2002, J BIOL CHEM, V277, P42060, DOI 10.1074/jbc.M202241200; Sawa Teiji, 2004, Anesthesiol Clin North Am, V22, P591, DOI 10.1016/j.atc.2004.05.002; Sayner SL, 2011, AM J PHYSIOL-LUNG C, V301, pL117, DOI 10.1152/ajplung.00417.2009; Sayner SL, 2011, AM J PHYSIOL-LUNG C, V300, pL667, DOI 10.1152/ajplung.00433.2010; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; Sayner SL, 2004, CIRC RES, V95, P196, DOI 10.1161/01.RES.0000134922.25721.d9; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Spillantini MG, 1997, P NATL ACAD SCI USA, V94, P4113, DOI 10.1073/pnas.94.8.4113; STELZNER TJ, 1989, J CELL PHYSIOL, V139, P157, DOI 10.1002/jcp.1041390122; Stevens T., 2007, ENDOTHELIAL BIOMEDIC, P1160; Stevens Troy, 2008, Proc Am Thorac Soc, V5, P783, DOI 10.1513/pats.200803-027HR; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Weber DJ, 2007, INFECT CONT HOSP EP, V28, P825, DOI 10.1086/518460; Wei JY, 2002, BRAIN RES, V927, P42, DOI 10.1016/S0006-8993(01)03323-6; White RE, 2000, CIRC RES, V86, P897, DOI 10.1161/01.RES.86.8.897; Williams DR, 2006, INTERN MED J, V36, P652, DOI 10.1111/j.1445-5994.2006.01153.x; Williams S, 2005, NEUROPATH APPL NEURO, V31, P414, DOI 10.1111/j.1365-2990.2005.00663.x; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Zhu B, 2010, AM J PHYSIOL-LUNG C, V299, pL493, DOI 10.1152/ajplung.00431.2009	84	73	74	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25407	25418		10.1074/jbc.M111.301440	http://dx.doi.org/10.1074/jbc.M111.301440			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22637478	Green Published, hybrid			2022-12-25	WOS:000306651700048
J	Gounder, AP; Wiens, ME; Wilson, SS; Lu, WY; Smith, JG				Gounder, Anshu P.; Wiens, Mayim E.; Wilson, Sarah S.; Lu, Wuyuan; Smith, Jason G.			Critical Determinants of Human alpha-Defensin 5 Activity against Non-enveloped Viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; ADENOVIRUS; INFECTION; CELLS; HD5; BINDING; PROTEIN	Human alpha-defensins, such as human alpha-defensin 5 (HD5), block infection of non-enveloped viruses, including human adenoviruses (AdV), papillomaviruses (HPV), and polyomaviruses. Through mutational analysis of HD5, we have identified arginine residues that contribute to antiviral activity against AdV and HPV. Of two arginine residues paired on one face of HD5, Arg-28 is critical for both viruses, while Arg-9 is only important for AdV. Two arginine residues on the opposite face of the molecule (Arg-13 and Arg-32) and unpaired Arg-25 are less important for both. In addition, hydrophobicity at residue 29 is a major determinant of anti-adenoviral activity, and a chemical modification that prevents HD5 self-association was strongly attenuating. Although HD5 binds to the capsid of AdV, the molecular basis for this interaction is undefined. Capsid binding by HD5 is not purely charge-dependent, as substitution of lysine for Arg-9 and Arg-28 was deleterious. Analysis of HD5 analogs that retained varying levels of potency demonstrated that anti-adenoviral activity is directly correlated with HD5 binding to the virus, confirming that the viral capsid rather than the cell is the relevant target. Also, AdV aggregation induced by HD5 binding is not sufficient for neutralization. Rather, these studies confirm that the major mechanism of HD5-mediated neutralization of AdV depends upon specific binding to the viral capsid through interactions mediated in part by critical arginine residues, hydrophobicity at residue 29, and multimerization of HD5, which increases initial binding of virus to the cell but prevents subsequent viral uncoating and genome delivery to the nucleus.	[Gounder, Anshu P.; Wiens, Mayim E.; Wilson, Sarah S.; Smith, Jason G.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA	University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Baltimore	Smith, JG (corresponding author), Univ Washington, Dept Microbiol, Box 357735,1705 NE Pacific St, Seattle, WA 98195 USA.	jgsmith2@uw.edu	Lu, Wuyuan/B-2268-2010; Lu, Wuyuan/J-8452-2017	Lu, Wuyuan/0000-0003-1318-9968; Wilson, Sarah/0000-0002-0838-6847; Smith, Jason/0000-0001-6727-5269	National Institutes of Health [K22 AI081870, T32 AI083203, R01 AI072732]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072732, K22AI081870, T32AI083203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants K22 AI081870 (to J. G. S.), T32 AI083203 (to S. S. W.), and R01 AI072732 (to W. L.).	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; BORDERS CL, 1994, PROTEIN SCI, V3, P541; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Cauet G, 2005, BIOCHEMISTRY-US, V44, P5453, DOI 10.1021/bi047702b; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; de Leeuw E, 2009, FEBS LETT, V583, P2507, DOI 10.1016/j.febslet.2009.06.051; Dugan AS, 2008, J BIOL CHEM, V283, P31125, DOI 10.1074/jbc.M805902200; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Karplus PA, 1997, PROTEIN SCI, V6, P1302; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Llenado RA, 2009, INFECT IMMUN, V77, P5035, DOI 10.1128/IAI.00695-09; Nguyen EK, 2010, J VIROL, V84, P4041, DOI 10.1128/JVI.02471-09; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pazgier M, 2012, J BIOL CHEM, V287, P8944, DOI 10.1074/jbc.M111.332205; Rajabi M, 2008, J BIOL CHEM, V283, P21509, DOI 10.1074/jbc.M801851200; Rajabi M, 2012, J BIOL CHEM, V287, P21615, DOI 10.1074/jbc.M112.367995; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; Smith JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000959; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Wang CHK, 2011, BIOMATERIALS, V32, P9536, DOI 10.1016/j.biomaterials.2011.08.069; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wu Z, 2004, J PEPT RES, V64, P118, DOI 10.1111/j.1399-3011.2004.00179.x; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	28	53	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24554	24562		10.1074/jbc.M112.354068	http://dx.doi.org/10.1074/jbc.M112.354068			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637473	Green Published, hybrid			2022-12-25	WOS:000306651100048
J	Khoufache, K; Bazin, S; Girard, K; Guillemette, J; Roy, MC; Verreault, JP; Al-Abed, Y; Foster, W; Akoum, A				Khoufache, Khaled; Bazin, Sylvie; Girard, Karine; Guillemette, Julie; Roy, Marie-Christine; Verreault, Jean-Pierre; Al-Abed, Yousef; Foster, Warren; Akoum, Ali			Macrophage Migration Inhibitory Factor Antagonist Blocks the Development of Endometriosis In Vivo	PLOS ONE			English	Article							MONOCYTE CHEMOTACTIC PROTEIN-1; PERITONEAL-FLUID MACROPHAGES; ENDOTHELIAL GROWTH-FACTOR; TAUTOMERASE ACTIVE-SITE; FACTOR MIF; SIGNALING PATHWAYS; MATRIX METALLOPROTEINASE-2; INTEGRIN ALPHA(V)BETA(3); STIMULATED SECRETION; MENSTRUAL-CYCLE	Endometriosis, a disease of reproductive age women, is a major cause of infertility, menstrual disorders and pelvic pain. Little is known about its etiopathology, but chronic pelvic inflammation is a common feature in affected women. Beside symptomatic treatment of endometriosis-associated pain, only two main suboptimal therapeutic approaches (hormonal and invasive surgery) are generally recommended to patients and no specific targeted treatment is available. Our studies led to the detection of a marked increase in the expression of macrophage migration inhibitory factor (MIF) in the eutopic endometrium, the peripheral blood and the peritoneal fluid of women with endometriosis, and in early, vascularized and active endometriotic lesions. Herein, we developed a treatment model of endometriosis, where human endometrial tissue was first allowed to implant into the peritoneal cavity of nude mice, to assess in vivo the effect of a specific antagonist of MIF (ISO-1) on the progression of endometriosis and evaluate its efficacy as a potential therapeutic tool. Administration of ISO-1 led to a significant decline of the number, size and in situ dissemination of endometriotic lesions. We further showed that ISO-1 may act by significantly inhibiting cell adhesion, tissue remodeling, angiogenesis and inflammation as well as by altering the balance of pro and anti-apoptotic factors. Actually, mice treatment with ISO-1 significantly reduced the expression of cell adhesion receptors alpha v and beta 3 integrins (P < 0.05), matrix metalloproteinases (MMP) 2 and 9 (P < 0.05), vascular endothelial cell growth factor (VEGF) (P < 0.01), interleukin 8 (IL8) (P < 0.05), cyclooxygenease (COX) 2 (P < 0.001) and the anti-apoptotic protein Bcl2 (P < 0.01), but significantly induced the expression of Bax (P < 0.05), a potent pro-apoptotic protein. These data provide evidence that specific inhibition of MIF alters endometriotic tissue growth and progression in vivo and may represent a promising potential therapeutic avenue.	[Khoufache, Khaled; Akoum, Ali] CHUQ, Ctr Rech, Hop St Francois Assise, Quebec City, PQ, Canada; [Bazin, Sylvie; Girard, Karine; Guillemette, Julie; Roy, Marie-Christine; Verreault, Jean-Pierre; Akoum, Ali] Univ Laval, Fac Med, Dept Obstet & Gynecol, Quebec City, PQ G1K 7P4, Canada; [Al-Abed, Yousef] Feinstein Inst Med Res, Manhasset, NY USA; [Foster, Warren] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada	Laval University; Laval University; Northwell Health; McMaster University	Khoufache, K (corresponding author), CHUQ, Ctr Rech, Hop St Francois Assise, Quebec City, PQ, Canada.	ali.akoum@crsfa.ulaval.ca			Canadian Institutes for Health Research [MOP-93716]; Wyeth-Ayerst CIHR/RD; HSFA research centre	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Wyeth-Ayerst CIHR/RD(Canadian Institutes of Health Research (CIHR)); HSFA research centre	Supported by grant MOP-93716 to AA from the Canadian Institutes for Health Research. AA is "Chercheur National'' of the FRSQ; KK was supported by a Wyeth-Ayerst CIHR/R&D Fellowship and holds a fellowship from HSFA research centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoum A, 1996, FERTIL STERIL, V66, P17; Akoum A, 2002, FERTIL STERIL, V77, P989, DOI 10.1016/S0015-0282(02)03082-0; Akoum A, 2001, MOL HUM REPROD, V7, P859, DOI 10.1093/molehr/7.9.859; Akoum A, 2006, FERTIL STERIL, V85, P1379, DOI 10.1016/j.fertnstert.2005.10.073; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Amin MA, 2003, CIRC RES, V93, P321, DOI 10.1161/01.RES.0000087641.56024.DA; Anger DL, 2008, FRONT BIOSCI-LANDMRK, V13, P1578, DOI 10.2741/2782; Bach JP, 2008, ONCOLOGY-BASEL, V75, P127, DOI 10.1159/000155223; Bach JP, 2009, CANCER-AM CANCER SOC, V115, P2031, DOI 10.1002/cncr.24245; Banu SK, 2008, ENDOCRINOLOGY, V149, P1180, DOI 10.1210/en.2007-1168; Barcza E, 2002, INT J GYNECOL OBSTET, V79, P229, DOI 10.1016/S0020-7292(02)00308-9; Bellehumeur C, 2005, HUM REPROD, V20, P1177, DOI 10.1093/humrep/deh749; BLOOM BR, 1970, ANN NY ACAD SCI, V169, P258, DOI 10.1111/j.1749-6632.1970.tb55994.x; Patrick KBA, 2008, J REPROD IMMUNOL, V77, P142, DOI 10.1016/j.jri.2007.07.004; Bondza Patrick Kibangou, 2009, Front Biosci (Elite Ed), V1, P415; Bondza PK, 2007, FERTIL STERIL; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BUDZYNSKI W, 1994, IMMUNOPHARM IMMUNOT, V16, P319, DOI 10.3109/08923979409007097; Calandra T, 1997, CRIT REV IMMUNOL, V17, P77, DOI 10.1615/CritRevImmunol.v17.i1.30; Carli C, 2009, ENDOCRINOLOGY, V150, P3128, DOI 10.1210/en.2008-1088; Check JH, 2011, CLIN EXP OBSTET GYN, V38, P10; Chen PF, 2010, MOL MED, V16, P400, DOI 10.2119/molmed.2009.00128; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; Chuang PC, 2010, AM J PATHOL, V176, P850, DOI 10.2353/ajpath.2010.090551; Chung HW, 2002, FERTIL STERIL, V78, P787, DOI 10.1016/S0015-0282(02)03322-8; Colette S, 2011, EXPERT OPINION INVES; Dmowski WP, 1998, HUM REPROD UPDATE, V4, P696, DOI 10.1093/humupd/4.5.696; Donnez J, 1998, HUM REPROD, V13, P1686, DOI 10.1093/humrep/13.6.1686; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Gebel HM, 1998, FERTIL STERIL, V69, P1042, DOI 10.1016/S0015-0282(98)00073-9; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Harada T, 2007, FRONT BIOSCI-LANDMRK, V12, P3140, DOI 10.2741/2302; Hii LPP, 1998, HUM REPROD, V13, P1030, DOI 10.1093/humrep/13.4.1030; Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71; Hou XQ, 2009, ACTA VIROL, V53, P225, DOI 10.4149/av_2009_04_225; Kats R, 2002, FERTIL STERIL, V78, P69, DOI 10.1016/S0015-0282(02)03189-8; Kats R, 2002, J CLIN ENDOCR METAB, V87, P883, DOI 10.1210/jc.87.2.883; Khoufache K, 2009, J IMMUNOL, V182, P7795, DOI 10.4049/jimmunol.0803743; Leech M, 2003, ARTHRITIS RHEUM, V48, P1881, DOI 10.1002/art.11165; Lin W, 2010, J OBSTET GYNAECOL RE, V36, P344, DOI 10.1111/j.1447-0756.2009.01123.x; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Mahutte NG, 2004, FERTIL STERIL, V82, P97, DOI 10.1016/j.fertnstert.2003.11.044; McLaren J, 1997, HUM REPROD, V12, P146, DOI 10.1093/humrep/12.1.146; McLaren J, 1996, J CLIN INVEST, V98, P482, DOI 10.1172/JCI118815; Meyer-Siegler K, 2000, CYTOKINE, V12, P914, DOI 10.1006/cyto.2000.0682; Meyer-Siegler KL, 2007, GENES IMMUN, V8, P646, DOI 10.1038/sj.gene.6364427; Meyer-Siegler KL, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-34; Morand EF, 2005, FRONT BIOSCI-LANDMRK, V10, P12, DOI 10.2741/1501; Morin M, 2005, FERTIL STERIL, V83, P865, DOI 10.1016/j.fertnstert.2004.10.039; Murk W, 2008, J CLIN ENDOCR METAB, V93, P3532, DOI 10.1210/jc.2007-2051; Nishihira J, 2003, ANN NY ACAD SCI, V995, P171, DOI 10.1111/j.1749-6632.2003.tb03220.x; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; OLIVE DL, 1991, AM J OBSTET GYNECOL, V164, P953; Onodera S, 2002, J BIOL CHEM, V277, P7865, DOI 10.1074/jbc.M106020200; Osteen KG, 2004, GYNECOL OBSTET INVES, V57, P53; Osuga Y, 2011, AM J REPROD IMMUNOL, V65, P1, DOI 10.1111/j.1600-0897.2010.00887.x; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Petrenko O, 2003, J BIOL CHEM, V278, P11078, DOI 10.1074/jbc.M211985200; Rana N, 1996, FERTIL STERIL, V65, P925, DOI 10.1016/S0015-0282(16)58262-4; Ren Y, 2004, ONCOGENE, V23, P4146, DOI 10.1038/sj.onc.1207490; Roger T, 2003, J ENDOTOXIN RES, V9, P119, DOI 10.1179/096805103125001513; Seeber B, 2008, FERTIL STERIL, V89, P1073, DOI 10.1016/j.fertnstert.2007.05.014; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; SIMPSON JL, 1980, AM J OBSTET GYNECOL, V137, P327, DOI 10.1016/0002-9378(80)90917-5; Stojanovic I, 2011, IMMUNOBIOLOGY; Taylor JA, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-135; Taylor RN, 2004, GYNECOL OBSTET INVES, V57, P54; Veillat V, 2010, J CLIN ENDOCR METAB, V95, pE403, DOI 10.1210/jc.2010-0417; Wenzl RJ, 1998, GYNECOL OBSTET INVES, V45, P253, DOI 10.1159/000009978; Yang YB, 2000, J CLIN ENDOCR METAB, V85, P4721, DOI 10.1210/jc.85.12.4721	70	31	32	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37264	10.1371/journal.pone.0037264	http://dx.doi.org/10.1371/journal.pone.0037264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649515	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800033
J	Liberato, MV; Nascimento, AS; Ayers, SD; Lin, JZ; Cvoro, A; Silveira, RL; Martinez, L; Souza, PCT; Saidemberg, D; Deng, T; Amato, AA; Togashi, M; Hsueh, WA; Phillips, K; Palma, MS; Neves, FAR; Skaf, MS; Webb, P; Polikarpov, I				Liberato, Marcelo Vizona; Nascimento, Alessandro S.; Ayers, Steven D.; Lin, Jean Z.; Cvoro, Aleksandra; Silveira, Rodrigo L.; Martinez, Leandro; Souza, Paulo C. T.; Saidemberg, Daniel; Deng, Tuo; Amato, Angela Angelica; Togashi, Marie; Hsueh, Willa A.; Phillips, Kevin; Palma, Mario Sergio; Neves, Francisco A. R.; Skaf, Munir S.; Webb, Paul; Polikarpov, Igor			Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) gamma Activators and Pan-PPAR Partial Agonists	PLOS ONE			English	Article							LIGAND-BINDING-DOMAIN; MOLECULAR-DYNAMICS; ALPHA; EXPRESSION; COMPLEX; GENES; SF-1	Thiazolidinediones (TZDs) act through peroxisome proliferator activated receptor (PPAR) gamma to increase insulin sensitivity in type 2 diabetes (T2DM), but deleterious effects of these ligands mean that selective modulators with improved clinical profiles are needed. We obtained a crystal structure of PPAR gamma ligand binding domain (LBD) and found that the ligand binding pocket (LBP) is occupied by bacterial medium chain fatty acids (MCFAs). We verified that MCFAs (C8-C10) bind the PPAR gamma LBD in vitro and showed that they are low-potency partial agonists that display assay-specific actions relative to TZDs; they act as very weak partial agonists in transfections with PPAR gamma LBD, stronger partial agonists with full length PPAR gamma and exhibit full blockade of PPAR gamma phosphorylation by cyclin-dependent kinase 5 (cdk5), linked to reversal of adipose tissue insulin resistance. MCFAs that bind PPAR gamma also antagonize TZD-dependent adipogenesis in vitro. X-ray structure B-factor analysis and molecular dynamics (MD) simulations suggest that MCFAs weakly stabilize C-terminal activation helix (H) 12 relative to TZDs and this effect is highly dependent on chain length. By contrast, MCFAs preferentially stabilize the H2-H3/beta-sheet region and the helix (H) 11-H12 loop relative to TZDs and we propose that MCFA assay-specific actions are linked to their unique binding mode and suggest that it may be possible to identify selective PPAR gamma modulators with useful clinical profiles among natural products.	[Liberato, Marcelo Vizona; Nascimento, Alessandro S.; Polikarpov, Igor] Univ Sao Paulo, Sao Carlos Phys Inst, Sao Paulo, Brazil; [Ayers, Steven D.; Lin, Jean Z.; Cvoro, Aleksandra; Deng, Tuo; Hsueh, Willa A.; Phillips, Kevin; Webb, Paul] Methodist Hosp, Houston, TX 77030 USA; [Saidemberg, Daniel; Palma, Mario Sergio] Sao Paulo State Univ, Inst Biosci, Sao Paulo, Brazil; [Amato, Angela Angelica; Togashi, Marie; Neves, Francisco A. R.] Univ Brasilia, Dept Pharmaceut Sci, Brasilia, DF, Brazil; [Silveira, Rodrigo L.; Martinez, Leandro; Souza, Paulo C. T.; Skaf, Munir S.] Univ Estadual Campinas, Inst Chem, Sao Paulo, Brazil	Universidade de Sao Paulo; The Methodist Hospital System; The Methodist Hospital - Houston; Universidade Estadual Paulista; Universidade de Brasilia; Universidade Estadual de Campinas	Liberato, MV (corresponding author), Univ Sao Paulo, Sao Carlos Phys Inst, Sao Paulo, Brazil.	pwebb@tmhs.org; ipolikarpov@if.sc.usp.br	Nascimento, Alessandro/Y-3394-2019; Nascimento, Alessandro S/G-9547-2012; Silveira, Rodrigo L/I-3961-2014; Skaf, Munir S/B-1614-2013; Palma, Mario Sergio/E-7800-2012; Deng, Tuo/M-3176-2015; Liberato, Marcelo V/J-3606-2014; Palma, Mario/N-3903-2019; Amato, Angélica/B-9247-2015; Fapesp, Biota/F-8655-2017; Telles de Souza, Paulo Cesar/E-5072-2013; Polikarpov, Igor/D-2575-2012; Martinez, Leandro/B-3792-2008	Nascimento, Alessandro/0000-0001-6656-5379; Nascimento, Alessandro S/0000-0001-6656-5379; Silveira, Rodrigo L/0000-0001-9515-3082; Skaf, Munir S/0000-0001-7485-1228; Palma, Mario Sergio/0000-0002-7363-8211; Liberato, Marcelo V/0000-0002-7609-7844; Amato, Angélica/0000-0002-8454-5504; Fapesp, Biota/0000-0002-9887-8449; Telles de Souza, Paulo Cesar/0000-0003-0660-1301; Martinez, Leandro/0000-0002-6857-1884; Polikarpov, Igor/0000-0001-9496-4174	National Institutes of Health [41482]; Sao Paulo Research Foundation [04/08070-9, 2006/06831-8, 06/00182-8]; National Council for Scientific and Technological Development	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by National Institutes of Health grant 41482 (PW), Sao Paulo Research Foundation grants 04/08070-9 (ASN), 2006/06831-8 (LM) and 06/00182-8 (IP & MS) and National Council for Scientific and Technological Development (IP & MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ambrosio ALB, 2007, J BIOL CHEM, V282, P18625, DOI 10.1074/jbc.M702538200; Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002-0217; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Burgermeister E, 2006, MOL ENDOCRINOL, V20, P809, DOI 10.1210/me.2005-0171; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fyffe SA, 2006, J MOL BIOL, V356, P1005, DOI 10.1016/j.jmb.2005.12.047; Fyffe SA, 2006, MOL CELL, V21, P1, DOI 10.1016/j.molcel.2005.12.001; Glass CK, 2000, GENE DEV, V14, P121; Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870; Han JR, 2003, OBES RES, V11, P734, DOI 10.1038/oby.2003.103; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kallenberger BC, 2003, NAT STRUCT BIOL, V10, P136, DOI 10.1038/nsb892; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Li Y, 2008, NAT STRUCT MOL BIOL, V15, P865, DOI 10.1038/nsmb.1447; Malapaka RRV, 2012, J BIOL CHEM, V287, P183, DOI 10.1074/jbc.M111.294785; Martinez L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-306; Martinez L, 2009, P NATL ACAD SCI USA, V106, P20717, DOI 10.1073/pnas.0911024106; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Nagao K, 2010, PHARMACOL RES, V61, P208, DOI 10.1016/j.phrs.2009.11.007; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rangwala Shamina M, 2002, Sci STKE, V2002, ppe9, DOI 10.1126/stke.2002.121.pe9; Sablin EP, 2009, MOL ENDOCRINOL, V23, P25, DOI 10.1210/me.2007-0508; Shi GQ, 2005, J MED CHEM, V48, P4457, DOI 10.1021/jm0502135; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Waku T, 2009, FEBS LETT, V583, P320, DOI 10.1016/j.febslet.2008.12.017; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Xu HE, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.148pe52; Yang JY, 2009, J NUTR BIOCHEM, V20, P537, DOI 10.1016/j.jnutbio.2008.05.013	44	127	129	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36297	10.1371/journal.pone.0036297	http://dx.doi.org/10.1371/journal.pone.0036297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649490	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800007
J	Santoro, N; Savoye, M; Kim, G; Marotto, K; Shaw, MM; Pierpont, B; Caprio, S				Santoro, Nicola; Savoye, Mary; Kim, Grace; Marotto, Katie; Shaw, Melissa M.; Pierpont, Bridget; Caprio, Sonia			Hepatic Fat Accumulation Is Modulated by the Interaction between the rs738409 Variant in the PNPLA3 Gene and the Dietary Omega6/Omega3 PUFA Intake	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; LIVER-DISEASE; I148M; QUANTIFICATION; RATIO; MR	Background: A single nucleotide polymorphism (SNP), the rs738409, in the patatin like phospholipase 3 gene (PNPLA3) has been recently associated with increased hepatic steatosis and ALT levels in adults and children. Given the potential role of PNPLA3 in fatty liver development, we aimed to explore whether the influence of PNPLA3 genotype on hepatic fat in obese youth might be modulated by dietary factors such as essential omega polyunsaturated fatty acids (PUFA) intake. Materials and Methods: We studied 127 children and adolescents (56 boys, 71 girls; 58 Caucasians; 30 African Americans and 39 Hispanics; mean age 14.7 +/- 3.3; mean BMI 30.7 +/- 7.2). The dietary composition was assessed by the Nutrition Data System for Research (NDS-R version 2011). The patients underwent a MRI study to assess the liver fat content (HFF%), ALT measurement and the genotyping of the rs738409 SNP by automatic sequencing. Results: As previously observed, HFF% and ALT levels varied according to the genotype in each ethnicity. ALT levels and HFF% were significantly influenced by the interaction between genotype and omega-6/omega-3 PUFA ratio (n-6/n-3), p = 0.003 and p = 0.002, respectively. HFF% and ALT levels were, in fact, related to the n-6/n-3 consumption only in subjects homozygote for the G allele of the rs738409 (r2 = 0.45, p = 0.001 and r2 = 0.40, p = 0.006, respectively). Conclusions: These findings suggest that the association of a high dietary n-6/n-3 PUFA with fatty liver and liver damage in obese youths may be driven by a predisposing genotype.	[Santoro, Nicola; Savoye, Mary; Kim, Grace; Marotto, Katie; Shaw, Melissa M.; Pierpont, Bridget; Caprio, Sonia] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA	Yale University	Santoro, N (corresponding author), Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA.	nicola.santoro@yale.edu; sonia.caprio@yale.edu	Santoro, Nicola/A-4897-2014	Santoro, Nicola/0000-0001-6437-4173	American Heart Association [11CRP5620013]; National Institutes of Health (NIH) [R01-HD-40787, R01-HD-28016, K24-HD-01464]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040787, R01HD028016] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001464] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the American Heart Association (http://www.heart.org/HEARTORG/) (11CRP5620013 to NS) and the National Institutes of Health (NIH) (grants R01-HD-40787, R01-HD-28016, and K24-HD-01464) (http://www.nih.gov/) to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Cali AMG, 2009, HEPATOLOGY, V49, P1896, DOI 10.1002/hep.22858; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; Cortez-Pinto H, 2006, CLIN NUTR, V25, P816, DOI 10.1016/j.clnu.2006.01.027; Davis JN, 2010, AM J CLIN NUTR, V92, P1522, DOI 10.3945/ajcn.2010.30185; del Giudice EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027933; Fishbein MH, 1997, MAGN RESON IMAGING, V15, P287, DOI 10.1016/S0730-725X(96)00224-X; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Huang YC, 2011, J BIOL CHEM, V286, P37085, DOI 10.1074/jbc.M111.290114; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Kim H, 2008, MAGN RESON MED, V59, P521, DOI 10.1002/mrm.21561; Molendi-Coste O, 2011, GASTROENTER IN PRESS; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Pacifico L, 2011, WORLD J GASTROENTERO, V17, P3012, DOI 10.3748/wjg.v17.i25.3012; Parker HM, 2012, J HEPATOL IN PRESS; Perttila J, 2012, AM J PHYSL IN PRESS; Romeo S, 2010, INT J OBESITY, V34, P190, DOI 10.1038/ijo.2009.216; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2010, CURR OPIN LIPIDOL, V21, P247, DOI 10.1097/MOL.0b013e328338ca61; Santoro N, 2012, HEPATOLOGY, V55, P781, DOI 10.1002/hep.24806; Santoro N, 2010, HEPATOLOGY, V52, P1281, DOI 10.1002/hep.23832; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Toshimitsu K, 2007, NUTRITION, V23, P46, DOI 10.1016/j.nut.2006.09.004; Valenti L, 2010, HEPATOLOGY, V52, P1274, DOI 10.1002/hep.23823; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Xu J, 2002, J NUTR, V132, P3333, DOI 10.1093/jn/132.11.3333; Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285	29	75	75	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37827	10.1371/journal.pone.0037827	http://dx.doi.org/10.1371/journal.pone.0037827			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629460	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343100053
J	Friedman, J; Alam, SM; Shen, XY; Xia, SM; Stewart, S; Anasti, K; Pollara, J; Fouda, GG; Yang, G; Kelsoe, G; Ferrari, G; Tomaras, GD; Haynes, BF; Liao, HX; Moody, MA; Permar, SR				Friedman, James; Alam, S. Munir; Shen, Xiaoying; Xia, Shi-Mao; Stewart, Shelley; Anasti, Kara; Pollara, Justin; Fouda, Genevieve G.; Yang, Guang; Kelsoe, Garnett; Ferrari, Guido; Tomaras, Georgia D.; Haynes, Barton F.; Liao, Hua-Xin; Moody, M. Anthony; Permar, Sallie R.			Isolation of HIV-1-Neutralizing Mucosal Monoclonal Antibodies from Human Colostrum	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELLULAR IMMUNE-RESPONSES; CORECEPTOR-BINDING-SITE; BREAST-MILK; NEUTRALIZATION EPITOPES; TYROSINE SULFATION; SUBTYPE-B; HIV-1; GP41; IGA	Background: Generation of potent anti-HIV antibody responses in mucosal compartments is a potential requirement of a transmission-blocking HIV vaccine. HIV-specific, functional antibody responses are present in breast milk, and these mucosal antibody responses may play a role in protection of the majority of HIV-exposed, breastfeeding infants. Therefore, characterization of HIV-specific antibodies produced by B cells in milk could guide the development of vaccines that elicit protective mucosal antibody responses. Methods: We isolated B cells from colostrum of an HIV-infected lactating woman with a detectable neutralization response in milk and recombinantly produced and characterized the resulting HIV-1 Envelope (Env)-specific monoclonal antibodies (mAbs). Results: The identified HIV-1 Env-specific colostrum mAbs, CH07 and CH08, represent two of the first mucosally-derived anti-HIV antibodies yet to be reported. Colostrum mAb CH07 is a highly-autoreactive, weakly-neutralizing gp140-specific mAb that binds to linear epitopes in the gp120 C5 region and gp41 fusion domain. In contrast, colostrum mAb CH08 is a nonpolyreactive CD4-inducible (CD4i) gp120-specific mAb with moderate breadth of neutralization. Conclusions: These novel HIV-neutralizing mAbs isolated from a mucosal compartment provide insight into the ability of mucosal B cell populations to produce functional anti-HIV antibodies that may contribute to protection against virus acquisition at mucosal surfaces.	[Friedman, James; Alam, S. Munir; Shen, Xiaoying; Xia, Shi-Mao; Stewart, Shelley; Anasti, Kara; Pollara, Justin; Fouda, Genevieve G.; Ferrari, Guido; Tomaras, Georgia D.; Haynes, Barton F.; Liao, Hua-Xin; Moody, M. Anthony; Permar, Sallie R.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27705 USA; [Yang, Guang; Kelsoe, Garnett] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Duke University; Duke University	Friedman, J (corresponding author), Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27705 USA.	sallie.permar@duke.edu	Fouda, Genevieve/AAR-9720-2020; Alam, S. Munir/AAC-6711-2019; Fouda, Genevieve/AAY-8099-2020; Moody, M/AAB-6947-2020; Ferrari, Guido/Z-2137-2019; Ferrari, Guido/A-6088-2015; Tomaras, Georgia/J-5041-2016	Moody, M/0000-0002-3890-5855; Ferrari, Guido/0000-0001-7747-3349; 	National Institutes of Health (NIH/NIAID/DAIDS); Center for HIV/AIDS Vaccine Immunology (CHAVI) [AI067854, AI07392, AI087992]; Doris Duke Foundation Clinical Scientist Development Award; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD-VIMC) [38619]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068614, K08AI087992, T32AI007392, R01AI081579, UM1AI068614, U19AI067854, U01AI067854] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NIAID/DAIDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for HIV/AIDS Vaccine Immunology (CHAVI); Doris Duke Foundation Clinical Scientist Development Award; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD-VIMC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH/NIAID/DAIDS) grants: the Center for HIV/AIDS Vaccine Immunology (CHAVI) AI067854, AI07392 (JP), and AI087992 (SRP); and the Doris Duke Foundation Clinical Scientist Development Award (SRP). Additional funding was provided by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD-VIMC grant 38619) (GDT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2004, AIDS RES HUM RETROV, V20, P836, DOI 10.1089/0889222041725181; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Bonsignori M, 2011, J VIROL; Czinn S J, 1987, Adv Exp Med Biol, V216A, P305; Dennison SM, 2011, J VIROL, V85, P1340, DOI 10.1128/JVI.01680-10; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Ferrari G, 2011, J VIROL, V85, P7029, DOI 10.1128/JVI.00171-11; Fouda GG, 2011, J VIROL; FREED EO, 1990, P NATL ACAD SCI USA, V87, P4650, DOI 10.1073/pnas.87.12.4650; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Haynes BF, 2011, TRENDS MOL MED, V17, P108, DOI 10.1016/j.molmed.2010.10.008; Haynes BF, 2010, NAT STRUCT MOL BIOL, V17, P543, DOI 10.1038/nsmb0510-543; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; LOPALCO L, 1993, EUR J IMMUNOL, V23, P2016, DOI 10.1002/eji.1830230844; MCDERMOTT MR, 1979, J IMMUNOL, V122, P1892; Miyazawa M, 2009, AIDS, V23, P161, DOI 10.1097/QAD.0b013e3283196a80; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; Moody MA, 2010, J EXP MED, V207, P763, DOI 10.1084/jem.20091281; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; Nadas A, 2004, AIDS RES HUM RETROV, V20, P55, DOI 10.1089/088922204322749503; Nyambi PN, 2000, J VIROL, V74, P7096, DOI 10.1128/JVI.74.15.7096-7107.2000; PALKER TJ, 1988, P NATL ACAD SCI USA, V85, P1932, DOI 10.1073/pnas.85.6.1932; Permar SR, 2008, J IMMUNOL, V181, P3643, DOI 10.4049/jimmunol.181.5.3643; Permar SR, 2010, J VIROL, V84, P8209, DOI 10.1128/JVI.00656-10; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; ROUX ME, 1977, J EXP MED, V146, P1311, DOI 10.1084/jem.146.5.1311; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Tuaillon E, 2009, J IMMUNOL, V182, P7155, DOI 10.4049/jimmunol.0803107; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; Verkoczy L, 2011, CURR OPIN IMMUNOL, V23, P383, DOI 10.1016/j.coi.2011.04.003; Volpe JM, 2006, BIOINFORMATICS, V22, P438, DOI 10.1093/bioinformatics/btk004; Wilks AB, 2010, J IMMUNOL, V185, P7097, DOI 10.4049/jimmunol.1002751	49	22	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37648	10.1371/journal.pone.0037648	http://dx.doi.org/10.1371/journal.pone.0037648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624058	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343500147
J	Kock, J; Rosler, C; Zhang, JJ; Blum, HE; Nassal, M; Thoma, C				Koeck, Josef; Roesler, Christine; Zhang, Jingjing; Blum, Hubert E.; Nassal, Michael; Thoma, Christian			Human Hepatitis B Virus Production in Avian Cells Is Characterized by Enhanced RNA Splicing and the Presence of Capsids Containing Shortened Genomes	PLOS ONE			English	Article							CLOSED CIRCULAR DNA; ARGININE-RICH DOMAIN; CORE PROTEIN; REVERSE TRANSCRIPTION; PREGENOMIC RNA; TYROSINE RESIDUE; TRANSGENIC MICE; HEPG2 CELLS; HBV-DNA; REPLICATION	Experimental studies on hepatitis B virus (HBV) replication are commonly done with human hepatoma cells to reflect the natural species and tissue tropism of the virus. However, HBV can also replicate, upon transfection of virus coding plasmids, in cells of other species. In such cross-species transfection experiments with chicken LMH hepatoma cells, we previously observed the formation of HBV genomes with aberrant electrophoretic mobility, in addition to the those DNA species commonly seen in human HepG2 hepatoma cells. Here, we report that these aberrant DNA forms are mainly due to excessive splicing of HBV pregenomic RNA and the abundant synthesis of spliced DNA products, equivalent to those also made in human cells, yet at much lower level. Mutation of the common splice acceptor site abolished splicing and in turn enhanced production of DNA from full-length pgRNA in transfected LMH cells. The absence of splicing made other DNA molecules visible, that were shortened due to the lack of sequences in the core protein coding region. Furthermore, there was nearly full-length DNA in the cytoplasm of LMH cells that was not protected in viral capsids. Remarkably, we have previously observed similar shortened genomes and non-protected viral DNA in human HepG2 cells, yet exclusively in the nucleus where uncoating and final release of viral genomes occurs. Hence, two effects reflecting capsid disassembly in the nucleus in human HepG2 cells are seen in the cytoplasm of chicken LMH cells.	[Koeck, Josef; Roesler, Christine; Zhang, Jingjing; Blum, Hubert E.; Nassal, Michael; Thoma, Christian] Univ Hosp Freiburg, Dept Med 2, Freiburg, Germany	University of Freiburg	Kock, J (corresponding author), Univ Hosp Freiburg, Dept Med 2, Freiburg, Germany.	josefkoeck@web.de; christian.thoma@uniklinik-freiburg.de	Zhang, Jing/HII-4294-2022; Nassal, Michael/U-4529-2019	Nassal, Michael/0000-0003-2204-9158	Forschungsmanagement of the Medical Faculty of the University of Freiburg [THO740/09]; Deutsche Forschungsgemeinschaft through FOR 1202 "Mechanisms of persistence of hepatotropic viruses''; Fritz-Thyssen-Stiftung; Deutsche Forschungsgemeinschaft [TH 788/2 1, TH 788/2 2]	Forschungsmanagement of the Medical Faculty of the University of Freiburg; Deutsche Forschungsgemeinschaft through FOR 1202 "Mechanisms of persistence of hepatotropic viruses''; Fritz-Thyssen-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in parts by the Forschungsmanagement of the Medical Faculty of the University of Freiburg (THO740/09), and by the Deutsche Forschungsgemeinschaft through FOR 1202 "Mechanisms of persistence of hepatotropic viruses'' (Na 154/12 1). JJZ was funded by a postdoctoral fellowship from the Fritz-Thyssen-Stiftung. CT is a recipient of a Heisenberg-Fellowship from the Deutsche Forschungsgemeinschaft (TH 788/2 1 and TH 788/2 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The article processing charge was funded by the German Research Foundation and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.	Abraham TM, 2008, VIROLOGY, V379, P30, DOI 10.1016/j.virol.2008.06.021; BARTENSCHLAGER R, 1990, J VIROL, V64, P5324, DOI 10.1128/JVI.64.11.5324-5332.1990; BEAMES B, 1993, VIROLOGY, V194, P597, DOI 10.1006/viro.1993.1299; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; BRANLANT C, 1980, NUCLEIC ACIDS RES, V8, P4143, DOI 10.1093/nar/8.18.4143; CONDREAY LD, 1990, J VIROL, V64, P3249, DOI 10.1128/JVI.64.7.3249-3258.1990; GALIBERT F, 1979, NATURE, V281, P646, DOI 10.1038/281646a0; Gao WF, 2007, J VIROL, V81, P6164, DOI 10.1128/JVI.02721-06; Gunther S, 1997, VIROLOGY, V238, P363, DOI 10.1006/viro.1997.8863; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; Habig JW, 2006, J MOL BIOL, V364, P32, DOI 10.1016/j.jmb.2006.08.095; Halverscheid L, 2008, J MED VIROL, V80, P583, DOI 10.1002/jmv.21115; KAWAGUCHI T, 1987, CANCER RES, V47, P4460; Kock J, 2004, J VIROL, V78, P13812, DOI 10.1128/JVI.78.24.13812-13818.2004; Kock J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001082; Lan YT, 1999, VIROLOGY, V259, P342, DOI 10.1006/viro.1999.9798; Le Pogam S, 2005, J VIROL, V79, P1871, DOI 10.1128/JVI.79.3.1871-1887.2005; Lee GH, 2008, VIRUS RES, V136, P1, DOI 10.1016/j.virusres.2008.05.007; Lewellyn EB, PLOS ONE, V6, pe1; Loeb DD, 2002, J VIROL, V76, P10195, DOI 10.1128/JVI.76.20.10195-10202.2002; MASON WS, 1980, J VIROL, V36, P829, DOI 10.1128/JVI.36.3.829-836.1980; Melegari M, 2005, J VIROL, V79, P9810, DOI 10.1128/JVI.79.15.9810-9820.2005; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Obert S, 1996, EMBO J, V15, P2565, DOI 10.1002/j.1460-2075.1996.tb00614.x; Preiss S, 2008, HEPATOLOGY, V48, P741, DOI 10.1002/hep.22386; Reifenberg K, 2002, J GEN VIROL, V83, P991, DOI 10.1099/0022-1317-83-5-991; ROSMORDUC O, 1995, HEPATOLOGY, V22, P10, DOI 10.1016/0270-9139(95)90346-1; Schultz U, 2004, ADV VIRUS RES, V63, P1, DOI 10.1016/S0065-3527(04)63001-6; STAPRANS S, 1991, J VIROL, V65, P1255, DOI 10.1128/JVI.65.3.1255-1262.1991; SU TS, 1989, J VIROL, V63, P4011, DOI 10.1128/JVI.63.9.4011-4018.1989; SUMMERS J, 1990, J VIROL, V64, P2819, DOI 10.1128/JVI.64.6.2819-2824.1990; SUREAU C, 1986, CELL, V47, P37, DOI 10.1016/0092-8674(86)90364-8; TERRE S, 1991, J VIROL, V65, P5539; WEBER M, 1994, J VIROL, V68, P2994, DOI 10.1128/JVI.68.5.2994-2999.1994; WU HL, 1991, J VIROL, V65, P1680, DOI 10.1128/JVI.65.4.1680-1686.1991; YAGINUMA K, 1987, P NATL ACAD SCI USA, V84, P2678, DOI 10.1073/pnas.84.9.2678; ZOULIM F, 1994, J VIROL, V68, P6, DOI 10.1128/JVI.68.1.6-13.1994	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37248	10.1371/journal.pone.0037248	http://dx.doi.org/10.1371/journal.pone.0037248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624002	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500084
J	Lavaud, J; Materna, AC; Sturm, S; Vugrinec, S; Kroth, PG				Lavaud, Johann; Materna, Arne C.; Sturm, Sabine; Vugrinec, Sascha; Kroth, Peter G.			Silencing of the Violaxanthin De-Epoxidase Gene in the Diatom Phaeodactylum tricornutum Reduces Diatoxanthin Synthesis and Non-Photochemical Quenching	PLOS ONE			English	Article							TRANSTHYLAKOID PROTON GRADIENT; XANTHOPHYLL-CYCLE PIGMENTS; LIGHT-HARVESTING COMPLEX; DIADINOXANTHIN CYCLE; ENERGY-DISSIPATION; MARINE DIATOM; TRANSLATIONAL INHIBITION; PLANKTONIC DIATOMS; HIGHER-PLANTS; POOL SIZE	Diatoms are a major group of primary producers ubiquitous in all aquatic ecosystems. To protect themselves from photooxidative damage in a fluctuating light climate potentially punctuated with regular excess light exposures, diatoms have developed several photoprotective mechanisms. The xanthophyll cycle (XC) dependent non-photochemical chlorophyll fluorescence quenching (NPQ) is one of the most important photoprotective processes that rapidly regulate photosynthesis in diatoms. NPQ depends on the conversion of diadinoxanthin (DD) into diatoxanthin (DT) by the violaxanthin de-epoxidase (VDE), also called DD de-epoxidase (DDE). To study the role of DDE in controlling NPQ, we generated transformants of P. tricornutum in which the gene (Vde/Dde) encoding for DDE was silenced. RNA interference was induced by genetic transformation of the cells with plasmids containing either short (198 bp) or long (523 bp) antisense (AS) fragments or, alternatively, with a plasmid mediating the expression of a self-complementary hairpin-like construct (inverted repeat, IR). The silencing approaches generated diatom transformants with a phenotype clearly distinguishable from wildtype (WT) cells, i.e. a lower degree as well as slower kinetics of both DD de-epoxidation and NPQ induction. Real-time PCR based quantification of Dde transcripts revealed differences in transcript levels between AS transformants and WT cells but also between AS and IR transformants, suggesting the possible presence of two different gene silencing mediating mechanisms. This was confirmed by the differential effect of the light intensity on the respective silencing efficiency of both types of transformants. The characterization of the transformants strengthened some of the specific features of the XC and NPQ and confirmed the most recent mechanistic model of the DT/NPQ relationship in diatoms.	[Lavaud, Johann; Materna, Arne C.; Sturm, Sabine; Vugrinec, Sascha; Kroth, Peter G.] Univ Konstanz, Fachbereich Biol, Constance, Germany; [Lavaud, Johann] Univ La Rochelle, LIENSs UMR7266, CNRS, Inst Coastal & Environm Res, La Rochelle, France	University of Konstanz; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Lavaud, J (corresponding author), Univ Konstanz, Fachbereich Biol, Constance, Germany.	sabine.sturm@uni-konstanz.de	Lavaud, Johann/N-6185-2014; Kroth, Peter G/A-9728-2008	Lavaud, Johann/0000-0002-4704-2502; Kroth, Peter G/0000-0003-4734-8955	Universitat Konstanz; European Commission [QLRT-2001-01226]; Deutsche Forschungsgemeinschaft [LA-2368/2-1]	Universitat Konstanz; European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study has been funded by Universitat Konstanz (www.uni-konstanz.de), European Commission (http://cordis.europa.eu, project QLRT-2001-01226) and Deutsche Forschungsgemeinschaft (http://www.dfg.de, project LA-2368/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; ARSALANE W, 1994, PHOTOCHEM PHOTOBIOL, V60, P237, DOI 10.1111/j.1751-1097.1994.tb05097.x; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Bertrand M, 2010, PHOTOSYNTH RES, V106, P89, DOI 10.1007/s11120-010-9589-x; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brunet C, 2010, J PLANKTON RES, V32, P1609, DOI 10.1093/plankt/fbq104; Bugos RC, 1996, P NATL ACAD SCI USA, V93, P6320, DOI 10.1073/pnas.93.13.6320; CARON L, 1988, J EXP MAR BIOL ECOL, V123, P211, DOI 10.1016/0022-0981(88)90043-3; Casper-Lindley C, 1998, PHOTOSYNTH RES, V56, P277, DOI 10.1023/A:1006037516479; Coesel S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002896; De Martino A, 2007, J PHYCOL, V43, P992, DOI 10.1111/j.1529-8817.2007.00384.x; de Poll WHV, 2011, MAR ECOL PROG SER, V426, P119, DOI 10.3354/meps09000; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Demmig-Adams B, 2006, NEW PHYTOL, V172, P11, DOI 10.1111/j.1469-8137.2006.01835.x; Dimier C, 2007, J PHYCOL, V43, P937, DOI 10.1111/j.1529-8817.2007.00381.x; Dimier C, 2009, PROTIST, V160, P397, DOI 10.1016/j.protis.2009.03.001; Frommolt R, 2008, MOL BIOL EVOL, V25, P2653, DOI 10.1093/molbev/msn206; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gisselsson A, 2004, PHYSIOL PLANTARUM, V122, P337, DOI 10.1111/j.1399-3054.2004.00415.x; Goss R, 2006, J PLANT PHYSIOL, V163, P1008, DOI 10.1016/j.jplph.2005.09.008; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Goss R, 2009, J PLANT PHYSIOL, V166, P1839, DOI 10.1016/j.jplph.2009.05.017; Govindjee, 2002, PLANT CELL, V14, P1663, DOI 10.1105/tpc.140810; Grouneva I, 2006, PHYSIOL PLANTARUM, V126, P205, DOI 10.1111/j.1399-3054.2006.00613.x; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Havir EA, 1997, PLANT SCI, V123, P57, DOI 10.1016/S0168-9452(97)04579-2; Hieber AD, 2002, PLANTA, V214, P476, DOI 10.1007/s00425-001-0704-2; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Jakob T, 2001, J PLANT PHYSIOL, V158, P383, DOI 10.1078/0176-1617-00288; Jakob T, 1999, PLANT BIOLOGY, V1, P76, DOI 10.1055/s-2007-978491; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kalituho L, 2007, PLANTA, V225, P423, DOI 10.1007/s00425-006-0356-3; Kropuenske LR, 2010, J PHYCOL, V46, P1138, DOI 10.1111/j.1529-8817.2010.00922.x; Kroth Peter G., 2007, V390, P257; Lavaud J, 2004, J PHYCOL, V40, P130, DOI 10.1046/j.1529-8817.2004.03026.x; Lavaud J, 2003, BIOCHEMISTRY-US, V42, P5802, DOI 10.1021/bi027112i; Lavaud J, 2002, FEBS LETT, V523, P163, DOI 10.1016/S0014-5793(02)02979-4; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; Lavaud J, 2007, FUNCT PLANT SCI BIOT, V1, P267; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; Lavaud J, 2006, PLANT CELL PHYSIOL, V47, P1010, DOI 10.1093/pcp/pcj058; Lepetit B, 2007, BIOCHEMISTRY-US, V46, P9813, DOI 10.1021/bi7008344; Lepetit B, 2012, PHOTOSYNTH RES, V111, P245, DOI 10.1007/s11120-011-9633-5; Lepetit B, 2010, PLANT PHYSIOL, V154, P1905, DOI 10.1104/pp.110.166454; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Lohr M, 2001, PLANTA, V212, P382, DOI 10.1007/s004250000403; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Materna AC, 2009, J PHYCOL, V45, P838, DOI 10.1111/j.1529-8817.2009.00711.x; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mewes H, 2002, PLANT PHYSIOL, V130, P1527, DOI 10.1104/pp.006775; Mouget JL, 1999, EUR J PHYCOL, V34, P109, DOI 10.1017/S0967026299002073; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; OLAIZOLA M, 1994, PHOTOSYNTH RES, V41, P357, DOI 10.1007/BF00019413; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Oxborough K, 2004, J EXP BOT, V55, P1195, DOI 10.1093/jxb/erh145; Perkins RG, 2010, DEVEL APPL PHYCOL, V4, P237, DOI 10.1007/978-90-481-9268-7_12; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Schumann A, 2007, PHYCOLOGIA, V46, P113, DOI 10.2216/06-30.1; TING CS, 1993, PLANT PHYSIOL, V101, P1323, DOI 10.1104/pp.101.4.1323; Verhoeven AS, 2001, PHOTOSYNTH RES, V67, P27, DOI 10.1023/A:1010684327864; Wilhelm C, 2006, PROTIST, V157, P91, DOI 10.1016/j.protis.2006.02.003; WILLEMOES M, 1991, PHYSIOL PLANTARUM, V83, P449, DOI 10.1034/j.1399-3054.1991.830318.x; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x	70	53	56	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36806	10.1371/journal.pone.0036806	http://dx.doi.org/10.1371/journal.pone.0036806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629333	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500028
J	Moreno-Navarrete, JM; Sabater, M; Ortega, F; Ricart, W; Fernandez-Real, JM				Maria Moreno-Navarrete, Jose; Sabater, Monica; Ortega, Francisco; Ricart, Wifredo; Manuel Fernandez-Real, Jose			Circulating Zonulin, a Marker of Intestinal Permeability, Is Increased in Association with Obesity-Associated Insulin Resistance	PLOS ONE			English	Article							DIET-INDUCED OBESITY; TIGHT JUNCTIONS; GUT MICROBIOTA; MICE; PATHOGENESIS; INFLAMMATION; MODULATOR; DISEASE	Zonulin is the only physiological mediator known to regulate intestinal permeability reversibly by modulating intercellular tight junctions. To investigate the relationship between intestinal permeability and obesity-associated metabolic disturbances in humans, we aimed to study circulating zonulin according to obesity and insulin resistance. Circulating zonulin (ELISA) was measured in 123 caucasian men in association with inflammatory and metabolic parameters ( including minimal model-measured insulin sensitivity). Circulating zonulin increased with body mass index (BMI), waist to hip ratio (WHR), fasting insulin, fasting triglycerides, uric acid and IL-6, and negatively correlated with HDL-cholesterol and insulin sensitivity. In multiple regression analysis, insulin sensitivity (p = 0.002) contributed independently to circulating zonulin variance, after controlling for the effects of BMI, fasting triglycerides and age. When circulating IL-6 was added to this model, only BMI (p = 0.01) contributed independently to circulating zonulin variance. In conclusion, the relationship between insulin sensitivity and circulating zonulin might be mediated through the obesity-related circulating IL-6 increase.	[Maria Moreno-Navarrete, Jose] CIBEROBN CB06 03 010, IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain; Inst Salud Carlos III, Girona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Instituto de Salud Carlos III	Moreno-Navarrete, JM (corresponding author), CIBEROBN CB06 03 010, IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain.	jmfernandezreal.girona.ics@gencat.cat	Sabater-Masdeu, Mònica/G-1168-2016; Moreno-Navarrete, José María/H-9772-2015; Ortega, Francisco José J/F-3883-2016; Fernández-Real, Jose Manuel/AGH-3599-2022; Moreno-Navarrete, José María/ABG-5548-2021	Sabater-Masdeu, Mònica/0000-0001-9636-0921; Moreno-Navarrete, José María/0000-0002-2883-511X; Ortega, Francisco José J/0000-0003-2111-769X; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Moreno-Navarrete, José María/0000-0002-2883-511X; Ricart, Wifredo/0000-0002-3452-9098	Ministerio de Educacion y Ciencia [SAF2008-02073]	Ministerio de Educacion y Ciencia(Spanish Government)	This work was partially supported by research grants from the Ministerio de Educacion y Ciencia (SAF2008-02073). CIBEROBN Fisiopatologia de la Obesidad y Nutricion is an initiative from the Instituto de Salud Carlos III from Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BERGMAN RN, 1987, J CLIN INVEST, V79, P790, DOI 10.1172/JCI112886; Brock M, 2011, J BIOL CHEM, V286, P40142, DOI 10.1074/jbc.M111.251793; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Fasano A, 2000, ANN NY ACAD SCI, V915, P214; FERRARIS RP, 1995, AM J CLIN NUTR, V62, P540, DOI 10.1093/ajcn/62.3.540; Ferraris RP, 1993, DIABETES, V123, P1062; Generoso M, 2003, J CHROMATOGR B, V783, P349, DOI 10.1016/S1570-0232(02)00766-3; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hansen D, 2010, EUR J APPL PHYSIOL, V109, P397, DOI 10.1007/s00421-010-1362-5; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sapone A, 2006, DIABETES, V55, P1443, DOI 10.2337/db05-1593; Smecuol E, 2005, CLIN GASTROENTEROL H, V3, P335, DOI 10.1016/S1542-3565(04)00778-5; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; Wang WL, 2000, J CELL SCI, V113, P4435; Wapenaar MC, 2008, GUT, V57, P463, DOI 10.1136/gut.2007.133132	20	173	177	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37160	10.1371/journal.pone.0037160	http://dx.doi.org/10.1371/journal.pone.0037160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629362	Green Published, gold			2022-12-25	WOS:000305343500067
J	Massaro, D; Savazzi, F; Di Dio, C; Freedberg, D; Gallese, V; Gilli, G; Marchetti, A				Massaro, Davide; Savazzi, Federica; Di Dio, Cinzia; Freedberg, David; Gallese, Vittorio; Gilli, Gabriella; Marchetti, Antonella			When Art Moves the Eyes: A Behavioral and Eye-Tracking Study	PLOS ONE			English	Article							RECOGNITION; JUDGMENTS; ATTENTION; MOTION; CORTEX; LEVEL; MODEL; FMRI	The aim of this study was to investigate, using eye-tracking technique, the influence of bottom-up and top-down processes on visual behavior while subjects, naive to art criticism, were presented with representational paintings. Forty-two subjects viewed color and black and white paintings (Color) categorized as dynamic or static (Dynamism) (bottom-up processes). Half of the images represented natural environments and half human subjects (Content); all stimuli were displayed under aesthetic and movement judgment conditions (Task) (top-down processes). Results on gazing behavior showed that content-related top-down processes prevailed over low-level visually-driven bottom-up processes when a human subject is represented in the painting. On the contrary, bottom-up processes, mediated by low-level visual features, particularly affected gazing behavior when looking at nature-content images. We discuss our results proposing a reconsideration of the definition of content-related top-down processes in accordance with the concept of embodied simulation in art perception.	[Massaro, Davide; Marchetti, Antonella] Univ Cattolica Sacro Cuore, Res Unit Theory Mind, Dept Psychol, I-20123 Milan, Italy; [Savazzi, Federica; Gilli, Gabriella] Univ Cattolica Sacro Cuore, Res Unit Psychol Art, Dept Psychol, I-20123 Milan, Italy; [Di Dio, Cinzia; Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Freedberg, David; Gallese, Vittorio] Columbia Univ, Dept Art Hist & Archaeol, New York, NY USA; [Freedberg, David] Columbia Univ, Italian Acad Adv Studies Amer, New York, NY USA; [Gallese, Vittorio] IIT Italian Inst Technol, Brain Ctr Social & Motor Cognit, Parma, Italy	Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; University of Parma; Columbia University; Columbia University; Istituto Italiano di Tecnologia - IIT	Massaro, D (corresponding author), Univ Cattolica Sacro Cuore, Res Unit Theory Mind, Dept Psychol, I-20123 Milan, Italy.	davide.massaro@unicatt.it	Gallese, Vittorio/ABD-5097-2021; Di Dio, Cinzia/HGB-3168-2022; Li, Mengqi/AAG-6804-2021; Massaro, Davide/K-1233-2019; Marchetti, Antonella/W-2226-2018; MARCHETTI, Antonella/AAL-6051-2020	Gallese, Vittorio/0000-0003-4815-3607; Massaro, Davide/0000-0002-4511-6897; Marchetti, Antonella/0000-0001-9985-0539; MARCHETTI, Antonella/0000-0001-9985-0539	EU [TESIS-264828]; Universita Cattolica del Sacro Cuore [D1-2008]	EU(European Commission); Universita Cattolica del Sacro Cuore	This work was supported by the EU grant TESIS-264828 to VG. This research was also made possible by a D1-2008 research grant from the Universita Cattolica del Sacro Cuore to GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas ZA, 2008, PERCEPTION, V37, P1187, DOI 10.1068/p5984; Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; ANTES JR, 1974, J EXP PSYCHOL, V103, P62, DOI 10.1037/h0036799; Arnheim R., 1992, RESCUE ART 26 ESSAYS; Bell BA, 2010, SAS GLOB FOR 2010; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; BERLYNE DE, 1970, PERCEPT PSYCHOPHYS, V8, P279, DOI 10.3758/BF03212593; BOSELIE F, 1985, AM J PSYCHOL, V98, P1, DOI 10.2307/1422765; Buswell Guy Thomas, 1935, PEOPLE LOOK PICTURES; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2010, EXP BRAIN RES, V204, P447, DOI 10.1007/s00221-010-2283-6; Cinzia D, 2009, CURR OPIN NEUROBIOL, V19, P682, DOI 10.1016/j.conb.2009.09.001; Cupchik GC, 2009, BRAIN COGNITION, V70, P84, DOI 10.1016/j.bandc.2009.01.003; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gallese V, 2012, ENCY HUMAN BEHAV; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; Gallese V, 2011, TRENDS COGN SCI, V15, P512, DOI 10.1016/j.tics.2011.09.003; Gori S, 2008, SPATIAL VISION, V21, P201, DOI 10.1163/156856808784532635; Graham DJ, 2010, VISION RES, V50, P1503, DOI 10.1016/j.visres.2010.05.002; Graham DJ, 2010, SPIE C SERIES, V7527, P36, DOI [10.1016/j.cag.2009.04.003, DOI 10.1016/J.CAG.2009.04.003]; Grundland M, 2007, PATTERN RECOGN, V40, P2891, DOI 10.1016/j.patcog.2006.11.003; Heidenreich SM, 2011, EMPIR STUD ARTS, V29, P51, DOI 10.2190/EM.29.1.d; Hekker P., 2008, PRODUCT EXPERIENCE, P259, DOI [DOI 10.1016/B978-008045089-6.50013-7, 10.1016/B978-008045089-6.50013-7]; Hekkert P, 1996, ACTA PSYCHOL, V94, P117, DOI 10.1016/0001-6918(95)00055-0; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Hox J.J., 2005, METHODOLOGY, V1, P85, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Jacobsen T, 2006, LEONARDO, V39, P155, DOI 10.1162/leon.2006.39.2.155; Jacobsen T, 2002, PERCEPT MOTOR SKILL, V95, P755, DOI 10.2466/PMS.95.7.755-766; Le Meur O, 2010, IEEE T IMAGE PROCESS, V19, P2801, DOI 10.1109/TIP.2010.2052262; Leder H, 2004, BRIT J PSYCHOL, V95, P489, DOI 10.1348/0007126042369811; Livingstone M., 2002, VISION ART BIOL SEEI; LOCHER P, 1993, STUD VIS INFORM PROC, V4, P59; Locher P. J., 2006, PSYCHOL SCI, V48, P106, DOI DOI 10.1198/016214504000000683; Locher P, 2010, DES ISSUES, V26, P70, DOI 10.1162/DESI_a_00017; Locher PJ, 1996, CONTRIBUTION EYE MOV; Loucher P. L., 1995, EMPIR STUD ARTS, V13, P183, DOI DOI 10.2190/GMV3-PPWN-LU41-NQVU; Maas CJM, 2004, STAT NEERL, V58, P127, DOI 10.1046/j.0039-0402.2003.00252.x; MACKWORTH NH, 1967, PERCEPT PSYCHOPHYS, V2, P547, DOI 10.3758/BF03210264; MAGIDSON, 2002, CANADIAN J MARKETING, V20, P36; MARTINDALE C, 1988, J EXP PSYCHOL HUMAN, V14, P661, DOI 10.1037/0096-1523.14.4.661; Nodine C. F., 1982, REV RES VISUAL ARTS, V8, P43; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Ramachandran V.S., 1999, J CONSCIOUSNESS STUD, V6, P15, DOI [10.1179/174327908X392906, DOI 10.1179/174327908X392906]; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rothkopf CA, 2007, J VISION, V7, DOI 10.1167/7.14.16; Santella A., 2004, P EYE TRACKING RES A, P27, DOI DOI 10.1145/968363.968368; Smith K, 2008, COMPUT GRAPH FORUM, V27, P193, DOI 10.1111/j.1467-8659.2008.01116.x; Tatler BW, 2008, SPATIAL VISION, V21, P165, DOI 10.1163/156856808782713807; Tobii, 2008, TOB STUD US MAN; Vermunt J. K., 2000, LATENT GOLD USERS MA; Wallraven C., 2009, COMPUTATIONAL AESTHE, P137; Wolfflin H., 1994, EMPATHY FORM SPACE P, P149; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; ZANGEMEISTER WH, 1995, NEUROPSYCHOLOGIA, V33, P1009, DOI 10.1016/0028-3932(95)00014-T; Zellner DA, 2010, FOOD QUAL PREFER, V21, P575, DOI 10.1016/j.foodqual.2010.02.007	62	103	103	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37285	10.1371/journal.pone.0037285	http://dx.doi.org/10.1371/journal.pone.0037285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22624007	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500090
J	Saias, T; Lerner, E; Greacen, T; Simon-Vernier, E; Emer, A; Pintaux, E; Guedeney, A; Dugravier, R; Tereno, S; Falissard, B; Tubach, F; Revah-Levy, A				Saias, Thomas; Lerner, Emilie; Greacen, Tim; Simon-Vernier, Elodie; Emer, Alessandra; Pintaux, Eleonore; Guedeney, Antoine; Dugravier, Romain; Tereno, Susana; Falissard, Bruno; Tubach, Florence; Revah-Levy, Anne		CAPEDP Study Grp	Evaluating Fidelity in Home-Visiting Programs a Qualitative Analysis of 1058 Home Visit Case Notes from 105 Families	PLOS ONE			English	Article							IMPLEMENTATION FIDELITY; YOUNG-CHILDREN; PREVENTION PROGRAM; INTERVENTION; ABUSE; OUTCOMES; VIOLENCE; NEGLECT	Objective: Implementation fidelity is a key issue in home-visiting programs as it determines a program's effectiveness in accomplishing its original goals. This paper seeks to evaluate fidelity in a 27-month program addressing maternal and child health which took place in France between 2006 and 2011. Method: To evaluate implementation fidelity, home visit case notes were analyzed using thematic qualitative and computer-assisted linguistic analyses. Results: During the prenatal period, home visitors focused on the social components of the program. Visitors discussed the physical changes in pregnancy, and psychological and social environment issues. Discussing immigration, unstable employment and financial related issues, family relationships and dynamics and maternity services, while not expected, were found in case notes. Conversely, health during pregnancy, early child development and postpartum mood changes were not identified as topics within the prenatal case notes. During the postnatal period, most components of the intervention were addressed: home visitors observed the mother's adaptation to the baby; routine themes such as psychological needs and medical-social networks were evaluated; information on the importance of social support and on adapting the home environment was given; home visitors counseled on parental authority, and addressed mothers' self-esteem issues; finally, they helped to find child care, when necessary. Some themes were not addressed or partially addressed: health education, child development, home environment, mother's education plans and personal routine, partner support and play with the child. Other themes were not expected, but found in the case notes: social issues, mother-family relationship, relation with services, couple issues, quality of maternal behavior and child's language development. Conclusions: In this program, home visitors experienced difficulties addressing some of the objectives because they gave precedence to the families" urgent needs. This research stresses the importance of training home visitors to adapt the intervention to the social, psychological and health needs of families.	[Saias, Thomas; Lerner, Emilie; Greacen, Tim; Emer, Alessandra] Etab Publ Sante Maison Blanche, Lab Rech, Paris, France; [Simon-Vernier, Elodie; Pintaux, Eleonore; Guedeney, Antoine; Dugravier, Romain; Tereno, Susana] Hop Bichat Claude Bernard, Serv Pedopsychiat, F-75877 Paris 18, France; [Guedeney, Antoine; Dugravier, Romain; Falissard, Bruno; Revah-Levy, Anne] Inst Natl Sante & Rech Med, PSIGIAM U669, Paris, France; [Tubach, Florence] Hop Bichat Claude Bernard, Unite Rech Clin Paris Nord, F-75877 Paris 18, France; [Saias, Thomas] Inst Natl Prevent & Educ Sante, St Denis, France; [Saias, Thomas] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [Emer, Alessandra] Univ Trent, Labosdif, Rovereto, Italy; [Revah-Levy, Anne] Hop Argenteuil, Ctr Soins Psychotherapeut Transit Adolescents, Argenteuil, France; [Revah-Levy, Anne] Univ Paris 05, Univ Paris 11, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; University of Quebec; University of Quebec Montreal; University of Trento; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Saias, T (corresponding author), Etab Publ Sante Maison Blanche, Lab Rech, Paris, France.	th.saias@gmail.com	; Purper-Ouakil, Diane/AAC-5024-2019	Tereno, Susana/0000-0001-5258-7913; Azria, Elie/0000-0002-6159-6253; Guedeney, Antoine/0000-0002-2346-4495; revah-levy, anne/0000-0003-1805-6275; Purper-Ouakil, Diane/0000-0003-0454-1579	National Ministry of Health Hospital Clinical Research Programme [PHRC AOM 05056]; National Institute for Promotion and Health Education; Clinical Research and Development Department of the APHP	National Ministry of Health Hospital Clinical Research Programme; National Institute for Promotion and Health Education; Clinical Research and Development Department of the APHP	The project was financed with a grant from the National Ministry of Health Hospital Clinical Research Programme (PHRC AOM 05056) and the National Institute for Promotion and Health Education. The sponsor was the Clinical Research and Development Department of the APHP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1969, ATTACHMENT LOSS ATTA; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bilukha O, 2005, AM J PREV MED, V28, P11, DOI 10.1016/j.amepre.2004.10.004; Breitenstein SM, 2010, NURS RES, V59, P158, DOI 10.1097/NNR.0b013e3181dbb2e2; Breitenstein SM, 2010, RES NURS HEALTH, V33, P164, DOI 10.1002/nur.20373; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Center for Early Education and Development, 2009, STEPS EFF ENJ PAR ST; Corbin J., 2015, BASICS QUALITATIVE R; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Eames C, 2008, CHILD CARE HLTH DEV, V34, P391, DOI 10.1111/j.1365-2214.2008.00828.x; Fixsen D., 2005, IMPLEMENTATION RES S; Florida State University Center for Prevention and Early Intervention Policy, 2007, PARTN HLTH BAB HOM V; Geeraert L, 2004, CHILD MALTREATMENT, V9, P277, DOI 10.1177/1077559504264265; Glaser B, 1978, DISCOV GROUNDED THEO; Gomby DS, 2007, CHILD ABUSE NEGLECT, V31, P793, DOI 10.1016/j.chiabu.2007.07.001; Gomby DS, 1999, FUTURE CHILD, V9, P4, DOI 10.2307/1602719; Gross D, 2001, FAM RELAT, V50, P246, DOI 10.1111/j.1741-3729.2001.00246.x; Guedeney A, 2011, CAPEDP RES REPORT; Gurlanick M, 1993, EARLY EDUC DEV, V4, P366; Hebbeler KM, 2002, EARLY CHILD RES Q, V17, P28, DOI 10.1016/S0885-2006(02)00128-X; Hiatt SW, 1997, J COMMUNITY PSYCHOL, V25, P77, DOI 10.1002/(SICI)1520-6629(199701)25:1<77::AID-JCOP6>3.0.CO;2-#; Howard KS, 2009, FUTURE CHILD, V19, P119, DOI 10.1353/foc.0.0032; Kahn J., 2010, WHAT WORKS HOME VISI; Kitzman HJ, 1997, J COMMUNITY PSYCHOL, V25, P95; Knoche LL, 2010, EARLY CHILD RES Q, V25, P299, DOI 10.1016/j.ecresq.2009.05.003; Lee CYS, 2008, PREV SCI, V9, P215, DOI 10.1007/s11121-008-0097-6; Lyons-Ruth K, 2004, J AM ACAD CHILD PSY, V43, P699, DOI 10.1097/01.chi.0000122730.72597.07; Mihalic SF, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-5; Olds D, 1997, J COMMUNITY PSYCHOL, V25, P9; Perepletchikova F, 2007, J CONSULT CLIN PSYCH, V75, P829, DOI 10.1037/0022-006X.75.6.829; Powers S, 1999, HOME VISITING REACHI; Reinert M, 2001, REV FRANCAISE PSYCHI, V5, P32; Spoth R, 2007, J FAM PSYCHOL, V21, P137, DOI 10.1037/0893-3200.21.2.137; Stevens J., 2005, J AGGRESS MALTREAT T, V11, P75, DOI DOI 10.1300/J146V11N04_04; Sweet MA, 2004, CHILD DEV, V75, P1435, DOI 10.1111/j.1467-8624.2004.00750.x; Tandon SD, 2008, EARLY CHILD RES Q, V23, P419, DOI 10.1016/j.ecresq.2008.02.002; Von Klitzing K, 2011, INT PERSPECTIVES CHI; Weatherston D., 2000, ZERO 3, V21, P3; Woolfolk T., 2009, FAM RELAT, V28, P188; Yang S, 2009, INT J LAW PSYCHIAT, V32, P294, DOI 10.1016/j.ijlp.2009.06.003	40	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36915	10.1371/journal.pone.0036915	http://dx.doi.org/10.1371/journal.pone.0036915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22629341	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500037
J	Liedigk, R; Yang, MY; Jablonski, NG; Momberg, F; Geissmann, T; Lwin, N; Hla, TH; Liu, ZJ; Wong, B; Ming, L; Long, YC; Zhang, YP; Nadler, T; Zinner, D; Roos, C				Liedigk, Rasmus; Yang, Mouyu; Jablonski, Nina G.; Momberg, Frank; Geissmann, Thomas; Lwin, Ngwe; Hla, Tony Htin; Liu, Zhijin; Wong, Bruce; Ming, Li; Long Yongcheng; Zhang, Ya-Ping; Nadler, Tilo; Zinner, Dietmar; Roos, Christian			Evolutionary History of the Odd-Nosed Monkeys and the Phylogenetic Position of the Newly Described Myanmar Snub-Nosed Monkey Rhinopithecus strykeri	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; NATURAL HYBRIDIZATION; MITOCHONDRIAL-DNA; ASIAN COLOBINES; UPPER MIOCENE; CYTOCHROME-B; PRIMATES; PLEISTOCENE; CLASSIFICATION; PHYLOGEOGRAPHY	Odd-nosed monkeys represent one of the two major groups of Asian colobines. Our knowledge about this primate group is still limited as it is highlighted by the recent discovery of a new species in Northern Myanmar. Although a common origin of the group is now widely accepted, the phylogenetic relationships among its genera and species, and the biogeographic processes leading to their current distribution are largely unknown. To address these issues, we have analyzed complete mitochondrial genomes and 12 nuclear loci, including one X chromosomal, six Y chromosomal and five autosomal loci, from all ten odd-nosed monkey species. The gene tree topologies and divergence age estimates derived from different markers were highly similar, but differed in placing various species or haplogroups within the genera Rhinopithecus and Pygathrix. Based on our data, Rhinopithecus represent the most basal lineage, and Nasalis and Simias form closely related sister taxa, suggesting a Northern origin of odd-nosed monkeys and a later invasion into Indochina and Sundaland. According to our divergence age estimates, the lineages leading to the genera Rhinopithecus, Pygathrix and Nasalis+Simias originated in the late Miocene, while differentiation events within these genera and also the split between Nasalis and Simias occurred in the Pleistocene. Observed gene tree discordances between mitochondrial and nuclear datasets, and paraphylies in the mitochondrial dataset for some species of the genera Rhinopithecus and Pygathrix suggest secondary gene flow after the taxa initially diverged. Most likely such events were triggered by dramatic changes in geology and climate within the region. Overall, our study provides the most comprehensive view on odd-nosed monkey evolution and emphasizes that data from differentially inherited markers are crucial to better understand evolutionary relationships and to trace secondary gene flow.	[Liedigk, Rasmus; Yang, Mouyu; Liu, Zhijin; Roos, Christian] German Primate Ctr, Primate Genet Lab, Gottingen, Germany; [Yang, Mouyu] Fanjingshan Natl Nat Reserve, Jiangkou, Guizhou Provinc, Peoples R China; [Jablonski, Nina G.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Momberg, Frank] Fauna & Flora Int, Myanmar Programme, Yangon, Myanmar; [Geissmann, Thomas] Univ Zurich Irchel, Inst Anthropol, CH-8057 Zurich, Switzerland; [Lwin, Ngwe; Hla, Tony Htin] BANCA, Yangon, Myanmar; [Liu, Zhijin; Wong, Bruce; Ming, Li] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Long Yongcheng] Nature Conservancy, Kunming, Peoples R China; [Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, Kunming, Peoples R China; [Nadler, Tilo] Endangered Primate Rescue Ctr, Frankfurt Zool Soc, Cuc Phuong National Pk, Ninh Binh Provi, Vietnam; [Zinner, Dietmar] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Roos, Christian] German Primate Ctr, Gene Bank Primates, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Zurich; Chinese Academy of Sciences; Institute of Zoology, CAS; Nature Conservancy; Chinese Academy of Sciences; Kunming Institute of Zoology; Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ)	Liedigk, R (corresponding author), German Primate Ctr, Primate Genet Lab, Gottingen, Germany.	croos@dpz.eu			European Union; Arcus Foundation; Arcadia Fund; Halcyon Land Sea Fund; German Primate Center (DPZ); Biodiversitatspakt of the Wissenschaftsgemeinschaft Gottfried-Wilhelm Leibniz (WGL)	European Union(European Commission); Arcus Foundation; Arcadia Fund; Halcyon Land Sea Fund; German Primate Center (DPZ); Biodiversitatspakt of the Wissenschaftsgemeinschaft Gottfried-Wilhelm Leibniz (WGL)	Field work that led to the discovery of the Myanmar snub-nosed monkey was financially supported by the European Union, Arcus Foundation, Arcadia Fund and the Halcyon Land & Sea Fund, administrated by FFI. Further financial support for this project was obtained from the German Primate Center (DPZ) and the Biodiversitatspakt of the Wissenschaftsgemeinschaft Gottfried-Wilhelm Leibniz (WGL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Arnold ML, 2006, ZOOLOGY, V109, P261, DOI 10.1016/j.zool.2006.03.006; Avise J.C., 2004, MOL MARKERS NATURAL; Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chaplin G., 2005, P CALIFORNIA ACAD SC, V56, P27; Colbert EH, 1953, B MUS NAT HIST, V102, P1024; Delson E., 1980, P10; Delson E., 2000, ENCY HUMAN EVOLUTION, P166; Drummond A.J., 2010, GENEIOUS VERSION 5 4; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FERGUSON DK, 1993, P 3 C EV E AS ENV CT, P145; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Geissmann T, 2011, AM J PRIMATOL, V73, P96, DOI 10.1002/ajp.20894; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Groves CP, 2001, PRIMATE TAXONOMY; Hallet B, 2001, J GEOPHYS RES-SOL EA, V106, P13697, DOI 10.1029/2000JB900335; Harrison T, 2007, AM J PHYS ANTHROPOL, P126; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; IUCN, 2019, IUCN RED LIST THREAT; Jablonski N. G., 1998, NATURAL HIST DOUCS S; Jablonski NG, 2002, CAM S BIO EVOL ANTHR, V33, P255; JABLONSKI NG, 1991, J HUM EVOL, V20, P51, DOI 10.1016/0047-2484(91)90045-W; JABLONSKI NG, 1993, FOLIA PRIMATOL, V60, P36, DOI 10.1159/000156674; JABLONSKI NG, 1993, FOLIA PRIMATOL, V60, P118, DOI 10.1159/000156681; Jablonski NG, 2000, J HUM EVOL, V39, P131, DOI 10.1006/jhev.2000.0405; Jablonski NG, 2011, AM J PHYS ANTHROPOL, V144, P174; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kelley J, 2002, CAM S BIO EVOL ANTHR, V33, P369; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; LEAKEY MG, 1993, THEROPITHECUS, P85, DOI 10.1017/CBO9780511565540.004; Lebatard AE, 2008, P NATL ACAD SCI USA, V105, P3226, DOI 10.1073/pnas.0708015105; Li M, 2004, INT J PRIMATOL, V25, P861, DOI 10.1023/B:IJOP.0000029126.27618.88; Liu Z, 2007, MOL ECOL, V16, P3334, DOI 10.1111/j.1365-294X.2007.03383.x; Liu ZJ, 2009, MOL ECOL, V18, P3831, DOI 10.1111/j.1365-294X.2009.04330.x; Louys J, 2007, PALAEOGEOGR PALAEOCL, V243, P152, DOI 10.1016/j.palaeo.2006.07.011; Maddison W, MESQUITE MODULAR SYS; Meijaard E, 2006, DEV PRIMATOL, P305, DOI 10.1007/0-387-31710-4_11; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Osada N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025549; Osterholz M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-58; PENG YZ, 1993, FOLIA PRIMATOL, V60, P106; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Pozzi L, 2011, J HUM EVOL, V61, P209, DOI 10.1016/j.jhevol.2011.02.008; Rambaut A., 2007, TRACE V1 4; Rambaut A., 2008, FIGTREE TREE FIGURE; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roos Christian, 2007, Vietnamese Journal of Primatology, V1, P41; Roos Christian, 2004, P23; Roos Christian, 2001, Zoologische Garten, V71, P1; Roos C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-77; Sterner KN, 2006, MOL PHYLOGENET EVOL, V40, P1, DOI 10.1016/j.ympev.2006.01.017; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tan C, ODD NOSED M IN PRESS; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74; Ting N, 2008, MOL PHYLOGENET EVOL, V46, P466, DOI 10.1016/j.ympev.2007.11.008; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang MY, 2012, AM J PHYS ANTHROPOL, V147, P1, DOI 10.1002/ajpa.21618; Yu L, 2011, MITOCHONDRION, V11, P497, DOI 10.1016/j.mito.2011.01.004; Zalmout IS, 2010, NATURE, V466, P360, DOI 10.1038/nature09094; Zhang YP, 1998, PRIMATES, V39, P39, DOI 10.1007/BF02557742; Ziegler T, 2007, MOL PHYLOGENET EVOL, V42, P807, DOI 10.1016/j.ympev.2006.11.015; Zinner D, 2011, EVOL ANTHROPOL, V20, P96, DOI 10.1002/evan.20301; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83; Zinner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004859; Zwickl D.J., 2006, THESIS U TEXAS AUSTI	70	44	50	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37418	10.1371/journal.pone.0037418	http://dx.doi.org/10.1371/journal.pone.0037418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22616004	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000305341300112
J	Mayer, S; Roeser, M; Lachmann, P; Ishii, S; Suh, JM; Harlander, S; Desch, M; Brunssen, C; Morawietz, H; Tsai, SY; Tsai, MJ; Hohenstein, B; Hugo, C; Todorov, VT				Mayer, Sandra; Roeser, Marc; Lachmann, Peter; Ishii, Sumiyashi; Suh, Jae Mi; Harlander, Sabine; Desch, Michael; Brunssen, Coy; Morawietz, Henning; Tsai, Sophia Y.; Tsai, Ming-Jer; Hohenstein, Bernd; Hugo, Christian; Todorov, Vladimir T.			Chicken Ovalbumin Upstream Promoter Transcription Factor II Regulates Renin Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR COUP-TFII; RESPONSIVE ELEMENT; NUCLEAR RECEPTORS; ORPHAN; MICE; CAMP; ALPHA; IDENTIFICATION; GAMMA; MECHANISMS	This study aimed to investigate the possible involvement of the orphan nuclear receptor chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) in the regulation of renin gene expression. COUP-TFII colocalized with renin in the juxtaglomerular cells of the kidney, which are the main source of renin in vivo. Protein-DNA binding studies demonstrated that COUP-TFII binds to an imperfect direct repeat COUP-TFII recognition sequence (termed hereafter proxDR) in the proximal renin promoter. Because cAMP signaling plays a central role in the control of the renin gene expression, we suggested that COUP-TFII may modulate this cAMP effect. Accordingly, knockdown of COUP-TFII in the clonal renin-producing cell lines As4.1 and Calu-6 diminished the stimulation of the renin mRNA expression by cAMP agonists. In addition, the mutation of the proxDR element in renin promoter reporter gene constructs abrogated the inducibility by cAMP. The proxDR sequence was found to be necessary for the function of a proximal renin promoter cAMP-response element (CRE). Knockdown of COUP-TFII or cAMP-binding protein (CREB), which is the archetypal transcription factor binding to CRE, decreased the basal renin gene expression. However, the deficiency of COUP-TFII did not further diminish the renin expression when CREB was knocked down. In agreement with the cell culture studies, mutant mice deficient in COUP-TFII have lower renin expression than their control strain. Altogether our data show that COUP-TFII is involved in the control of renin gene expression.	[Lachmann, Peter; Todorov, Vladimir T.] Tech Univ Dresden, Lab Expt Nephrol, D-01307 Dresden, Germany; [Lachmann, Peter; Todorov, Vladimir T.] Tech Univ Dresden, Div Nephrol, D-01307 Dresden, Germany; [Brunssen, Coy; Morawietz, Henning] Tech Univ Dresden, Div Vasc Endothelium & Microcirculat, D-01307 Dresden, Germany; [Brunssen, Coy; Morawietz, Henning] Tech Univ Dresden, Dept Med 3, D-01307 Dresden, Germany; [Mayer, Sandra; Roeser, Marc; Harlander, Sabine; Desch, Michael; Hohenstein, Bernd; Hugo, Christian; Todorov, Vladimir T.] Univ Regensburg, Inst Physiol, D-93040 Regensburg, Germany; [Ishii, Sumiyashi; Suh, Jae Mi; Tsai, Sophia Y.; Tsai, Ming-Jer] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; University of Regensburg; Baylor College of Medicine	Todorov, VT (corresponding author), Tech Univ Dresden, Univ Hosp Dresden, Div Nephrol, Lab Expt Nephrol, Fiedlerstr 42, D-01307 Dresden, Germany.	vladimir.todorov@uniklinikum-dresden.de		Harlander, Sabine/0000-0003-2827-425X; Todorov, Vladimir/0000-0002-7011-8130	National Institutes of Health [DK45641, HL76448, DK59820, DK62434]; Deutsche Forschungsgemeinschaft [SFB 699/B1, TO 679/1-1, MO 1695/4-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045641, U19DK062434, R37DK045641, P01DK059820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK45641 (to M. J. T.), HL76448 (to S. Y. T.), and DK59820 and DK62434 (to M. J. T. and S. Y. T.). This work was also supported by Deutsche Forschungsgemeinschaft Grants SFB 699/B1 and TO 679/1-1 (to V. T. T.) and MO 1695/4-1 (to H. M.).	BURT DW, 1989, J BIOL CHEM, V264, P7357; Castrop H, 2010, PHYSIOL REV, V90, P607, DOI 10.1152/physrev.00011.2009; Chen LM, 2007, AM J PHYSIOL-RENAL, V292, pF27, DOI 10.1152/ajprenal.00193.2006; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Desch M, 2011, PFLUG ARCH EUR J PHY, V461, P567, DOI 10.1007/s00424-011-0956-z; Desch M, 2010, MOL ENDOCRINOL, V24, P2139, DOI 10.1210/me.2010-0134; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; HORIUCHI M, 1993, J CLIN INVEST, V92, P1805, DOI 10.1172/JCI116770; Kim SM, 2007, HYPERTENSION, V50, P103, DOI 10.1161/HYPERTENSIONAHA.107.087577; Klar J, 2002, PFLUG ARCH EUR J PHY, V444, P335, DOI 10.1007/s00424-002-0818-9; Konoshita T, 2004, J CELL BIOCHEM, V93, P327, DOI 10.1002/jcb.20151; Konoshita T, 2007, J CELL BIOCHEM, V102, P1043, DOI 10.1002/jcb.21341; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; Lang JA, 1996, AM J PHYSIOL-RENAL, V271, pF94, DOI 10.1152/ajprenal.1996.271.1.F94; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; Lin FJ, 2011, ENDOCR REV, V32, P404, DOI 10.1210/er.2010-0021; Lin FJ, 2010, J CLIN INVEST, V120, P1694, DOI 10.1172/JCI40101; Liu XB, 2003, CIRC RES, V92, P1033, DOI 10.1161/01.RES.0000071355.82009.43; Mercure C, 2009, HYPERTENSION, V53, P1062, DOI 10.1161/HYPERTENSIONAHA.108.115444; Morris BJ, 2004, ACTA PHYSIOL SCAND, V181, P369, DOI 10.1111/j.1365-201X.2004.01307.x; Neubauer B, 2009, AM J PHYSIOL-RENAL, V296, pF1006, DOI 10.1152/ajprenal.90448.2008; Pan L, 2005, HYPERTENSION, V45, P3, DOI 10.1161/01.HYP.0000149717.55920.45; Pan L, 2001, J BIOL CHEM, V276, P45530, DOI 10.1074/jbc.M103010200; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Qin J, 2010, P NATL ACAD SCI USA, V107, P3687, DOI 10.1073/pnas.0914619107; SAGAMI I, 1986, MOL CELL BIOL, V6, P4259, DOI 10.1128/MCB.6.12.4259; Scott DK, 1996, J BIOL CHEM, V271, P31909, DOI 10.1074/jbc.271.50.31909; Shi Q, 2001, J BIOL CHEM, V276, P3597, DOI 10.1074/jbc.M008361200; SIGMUND CD, 1990, J BIOL CHEM, V265, P19916; Suh JM, 2006, MOL ENDOCRINOL, V20, P3412, DOI 10.1210/me.2006-0312; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; Tamura K, 2000, P NATL ACAD SCI USA, V97, P8513, DOI 10.1073/pnas.100519097; Todorov V, 2002, AM J PHYSIOL-REG I, V283, pR1046, DOI 10.1152/ajpregu.00142.2002; Todorov V, 2001, KIDNEY BLOOD PRESS R, V24, P75, DOI 10.1159/000054210; Todorov VT, 2008, ENDOCRINOLOGY, V149, P4647, DOI 10.1210/en.2008-0127; Todorov VT, 2007, HYPERTENSION, V50, P939, DOI 10.1161/HYPERTENSIONAHA.107.092817; Todorov VT, 2004, J BIOL CHEM, V279, P1458, DOI 10.1074/jbc.M308697200; Wang Lee-Ho, 1991, Gene Expression, V1, P207; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; Weatherford ET, 2012, AM J PHYSIOL-RENAL, V302, pF1025, DOI 10.1152/ajprenal.00362.2011; Yang TX, 2000, AM J PHYSIOL-RENAL, V279, pF819, DOI 10.1152/ajprenal.2000.279.5.F819; Ying LH, 1997, J BIOL CHEM, V272, P2412; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511	45	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24483	24491		10.1074/jbc.M111.329474	http://dx.doi.org/10.1074/jbc.M111.329474			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645148	Green Published, hybrid			2022-12-25	WOS:000306651100041
J	Sears, CR; Turchi, JJ				Sears, Catherine R.; Turchi, John J.			Complex Cisplatin-Double Strand Break (DSB) Lesions Directly Impair Cellular Non-Homologous End-Joining (NHEJ) Independent of Downstream Damage Response (DDR) Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER; IONIZING-RADIATION; DNA; REPAIR; ADDUCTS; CELLS; DRUG; RECOMBINATION; CYTOTOXICITY; INHIBITION	The treatment for advanced stage non-small cell lung cancer (NSCLC) often includes platinum-based chemotherapy and IR. Cisplatin and IR combination therapy display schedule and dose-dependent synergy, the mechanism of which is not completely understood. In a series of in vitro and cell culture assays in a NSCLC model, we investigated both the downstream and direct treatment and damage effects of cisplatin on NHEJ catalyzed repair of a DNA DSB. The results demonstrate that extracts prepared from cisplatin-treated cells are fully capable of NHEJ catalyzed repair of a DSB using a non-cisplatin-damaged DNA substrate in vitro. Similarly, using two different host cell reactivation assays, treatment of cells prior to transfection of a linear, undamaged reporter plasmid revealed no reduction in NHEJ compared with untreated cells. In contrast, transfection of a linear GFP-reporter plasmid containing site-specific, cisplatin lesions 6-bp from the termini revealed a significant impairment in DSB repair of the cisplatin-damaged DNA substrates in the absence of cellular treatment with cisplatin. Together, these data demonstrate that impaired NHEJ in combined cisplatin-IR treated cells is likely the result of a direct effect of cisplatin-DNA lesions near a DSB and that the indirect cellular effects of cisplatin treatment are not significant contributors to the synergistic cytotoxicity observed with combination cisplatin-IR treatment.	[Turchi, John J.] Indiana Univ Sch Med, Dept Med, Div Hematol & Oncol, Indianapolis, IN 46202 USA; [Turchi, John J.] Indiana Univ Sch Med, Dept Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Turchi, JJ (corresponding author), Indiana Univ Sch Med, Dept Med, Div Hematol & Oncol, 980 W Walnut Joseph E Walther Hall,R3 C650, Indianapolis, IN 46202 USA.	jturchi@iupui.edu	Turchi, John J/B-5807-2015	Turchi, John J/0000-0001-5375-2992; Sears, Catherine/0000-0002-5797-3458	National Institutes of Health [CA082741]; NATIONAL CANCER INSTITUTE [R01CA082741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA082741 (to J. J. T.).	America Cancer Society, 2011, CANC FACTS FIG; Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Boboila C, 2010, J EXP MED, V207, P417, DOI 10.1084/jem.20092449; Boeckman HJ, 2005, MOL CANCER RES, V3, P277, DOI 10.1158/1541-7786.MCR-04-0032; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Diggle CP, 2005, NUCLEIC ACIDS RES, V33, P2531, DOI 10.1093/nar/gki528; Dolling JA, 1998, INT J RADIAT BIOL, V74, P61, DOI 10.1080/095530098141735; Gorodetsky R, 1998, INT J CANCER, V75, P635, DOI 10.1002/(SICI)1097-0215(19980209)75:4<635::AID-IJC23>3.0.CO;2-6; GROEN HJM, 1995, BRIT J CANCER, V72, P1406, DOI 10.1038/bjc.1995.522; Henkels KM, 1999, CANCER RES, V59, P3077; Jeggo P, 2009, INT J RADIAT BIOL, V85, P1061, DOI 10.3109/09553000903261263; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jett JR, 2007, CHEST, V132, p266S, DOI 10.1378/chest.07-1380; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Koberle B, 1997, INT J CANCER, V70, P551, DOI 10.1002/(SICI)1097-0215(19970304)70:5<551::AID-IJC10>3.0.CO;2-G; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; LIMOLI CL, 1995, MUTAGENESIS, V10, P453, DOI 10.1093/mutage/10.5.453; MASCHARAK PK, 1983, P NATL ACAD SCI-BIOL, V80, P6795, DOI 10.1073/pnas.80.22.6795; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Myint WK, 2002, INT J RADIAT BIOL, V78, P417, DOI 10.1080/09553000110113047; Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010; O'Rourke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002140.pub3; PARKER RJ, 1991, J CLIN INVEST, V87, P772, DOI 10.1172/JCI115080; Patrick SM, 1999, J BIOL CHEM, V274, P14972, DOI 10.1074/jbc.274.21.14972; Pawelczak KS, 2005, NUCLEIC ACIDS RES, V33, P152, DOI 10.1093/nar/gki157; Raaphorst GP, 1996, INT J RADIAT BIOL, V69, P623, DOI 10.1080/095530096145634; Raaphorst GP, 2005, ANTICANCER RES, V25, P53; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; SORENSON CM, 1988, CANCER RES, V48, P4484; TAYLOR SG, 1994, J CLIN ONCOL, V12, P385, DOI 10.1200/JCO.1994.12.2.385; Tornaletti S, 2003, J BIOL CHEM, V278, P35791, DOI 10.1074/jbc.M305394200; Turchi JJ, 2000, NUCLEIC ACIDS RES, V28, P4634, DOI 10.1093/nar/28.23.4634; Turchi JJ, 1996, J BIOL CHEM, V271, P13861, DOI 10.1074/jbc.271.23.13861; VRANA O, 1986, INT J RADIAT BIOL, V50, P995, DOI 10.1080/09553008614551411; Wahl GM, 1997, CANCER SURV, V29, P183; WOOD RD, 1988, CELL, V53, P97, DOI 10.1016/0092-8674(88)90491-6; Wu XM, 2003, CLIN CANCER RES, V9, P5874; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452	39	39	43	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24263	24272		10.1074/jbc.M112.344911	http://dx.doi.org/10.1074/jbc.M112.344911			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22621925	hybrid, Green Published			2022-12-25	WOS:000306651100020
J	Collak, FK; Yagiz, K; Luthringer, DJ; Erkaya, B; Cinar, B				Collak, Filiz Kisaayak; Yagiz, Kader; Luthringer, Daniel J.; Erkaya, Bahriye; Cinar, Bekir			Threonine-120 Phosphorylation Regulated by Phosphoinositide-3-Kinase/Akt and Mammalian Target of Rapamycin Pathway Signaling Limits the Antitumor Activity of Mammalian Sterile 20-Like Kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STE20-LIKE PROTEIN-KINASE; ORGAN SIZE CONTROL; PROSTATE-CANCER; CELL-PROLIFERATION; NUCLEAR TRANSLOCATION; ANDROGEN RECEPTOR; CASPASE CLEAVAGE; ANTIGEN PROMOTER; MST1; MTOR	Mst1/Stk4, a hippo-like serine-threonine kinase, is implicated in many cancers, including prostate cancer. However, the mechanisms regulating Mst1 remain obscure. Here, we characterized the effects of phospho-Thr-120 on Mst1 in prostate cancer cells. We demonstrated that phospho-Thr-120 did not alter the nuclear localization or cleavage of Mst1 in a LNCaP or castration-resistant C4-2 prostate tumor cell model, as revealed by a mutagenesis approach. Phospho-Thr-120 appeared to be specific to cancer cells and predominantly localized in the nucleus. In contrast, phospho-Thr-183, a critical regulator of Mst1 cell death, was exclusively found in the cytoplasm. As assessed by immunohistochemistry, a similar distribution of phospho-Mst1-Thr-120/Thr-183 was also observed in a prostate cancer specimen. In addition, the blockade of PI3K signaling by a small molecule inhibitor, LY294002, increased cytoplasmic phospho-Mst1-Thr-183 without having a significant effect on nuclear phospho-Mst1-Thr-120. However, the attenuation of mammalian target of rapamycin (mTOR) activity by a selective pharmacologic inhibitor, Ku0063794 or CCI-779, caused the up-regulation of nuclear phospho-Mst1-Thr-120 without affecting cytoplasmic phospho-Mst1-Thr-183. This suggests that PI3K and mTOR pathway signaling differentially regulate phospho-Mst1-Thr-120/Thr-183. Moreover, mutagenesis and RNAi data revealed that phospho-Thr-120 resulted in C4-2 cell resistance to mTOR inhibition and reduced the Mst1 suppression of cell growth and androgen receptor-driven gene expression. Collectively, these findings indicate that phospho-Thr-120 leads to the loss of Mst1 functions, supporting cancer cell growth and survival.	[Collak, Filiz Kisaayak; Yagiz, Kader; Erkaya, Bahriye; Cinar, Bekir] Cedars Sinai Med Ctr, Dept Med & Biomed Sci, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Collak, Filiz Kisaayak; Yagiz, Kader; Erkaya, Bahriye; Cinar, Bekir] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Luthringer, Daniel J.] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center	Cinar, B (corresponding author), Cedars Sinai Med Ctr, Dept Med & Biomed Sci, Samuel Oschin Comprehens Canc Inst, 8750 Beverly Blvd,Atrium 103, Los Angeles, CA 90048 USA.	bekir.cinar@cshs.org	CİNAR, BEKIR MURAT/AAL-4474-2021	CİNAR, BEKIR MURAT/0000-0002-7906-5039; Cinar, Bekir/0000-0003-4028-7600	New York Academy of Medicine; Jesse and Donna Garber Foundation; Cedars-Sinai Medical Center Fellowship Award	New York Academy of Medicine; Jesse and Donna Garber Foundation; Cedars-Sinai Medical Center Fellowship Award	This work was supported by an Edwin Beer Fellowship Award from the New York Academy of Medicine (to B. C.) and a Jesse and Donna Garber Foundation and Cedars-Sinai Medical Center Fellowship Award (to B. C.).	Behbakht K, 2011, GYNECOL ONCOL, V123, P19, DOI 10.1016/j.ygyno.2011.06.022; Bhagwat SV, 2010, CURR OPIN INVEST DR, V11, P638; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Cinar B, 2004, BIOCHEM J, V379, P421, DOI 10.1042/BJ20031661; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Cinar B, 2011, CANCER RES, V71, P4303, DOI 10.1158/0008-5472.CAN-10-4532; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P148, DOI 10.1210/me.11.2.148; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; de Souza PM, 2004, BIOCHEM SOC T, V32, P485, DOI 10.1042/BST0320485; Deocampo N D, 2003, Minerva Endocrinol, V28, P145; Ding ZY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009910; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Ghosh PM, 2005, ENDOCR-RELAT CANCER, V12, P119, DOI 10.1677/erc.1.00835; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hay BA, 2003, DEV CELL, V5, P361, DOI 10.1016/S1534-5807(03)00270-3; Ikenoue T, 2009, METHOD ENZYMOL, V452, P165, DOI 10.1016/S0076-6879(08)03611-2; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Kim D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009616; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu Qingsong, 2009, Drug Discov Today Ther Strateg, V6, P47; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Minoo P, 2007, MODERN PATHOL, V20, P331, DOI 10.1038/modpathol.3800740; Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Seidel C, 2007, MOL CARCINOGEN, V46, P865, DOI 10.1002/mc.20317; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Steinmann K, 2009, ONCOL REP, V22, P1519, DOI 10.3892/or_00000596; Tamburini J, 2008, BLOOD, V111, P379, DOI 10.1182/blood-2007-03-080796; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Werzowa J, 2009, BRIT J DERMATOL, V160, P955, DOI 10.1111/j.1365-2133.2008.08991.x; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026343; Yuan ZQ, 2010, J BIOL CHEM, V285, P3815, DOI 10.1074/jbc.M109.059675; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou HY, 2010, ANTI-CANCER AGENT ME, V10, P571, DOI 10.2174/187152010793498663; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	46	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23698	23709		10.1074/jbc.M112.358713	http://dx.doi.org/10.1074/jbc.M112.358713			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22619175	hybrid, Green Published			2022-12-25	WOS:000306511300040
J	Islam, MN; Paquet, N; Fox, D; Dray, E; Zheng, XF; Klein, H; Sung, P; Wang, WD				Islam, M. Nurul; Paquet, Nicolas; Fox, David, III; Dray, Eloise; Zheng, Xiao-Feng; Klein, Hannah; Sung, Patrick; Wang, Weidong			A Variant of the Breast Cancer Type 2 Susceptibility Protein (BRC) Repeat Is Essential for the RECQL5 Helicase to Interact with RAD51 Recombinase for Genome Stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; HOMOLOGOUS RECOMBINATION; PRESYNAPTIC FILAMENT; PROMOTES; EXCHANGE; REPAIR; BLM; CROSSOVERS; DISRUPTION; MECHANISMS	The BRC repeat is a structural motif in the tumor suppressor BRCA2 (breast cancer type 2 susceptibility protein), which promotes homologous recombination (HR) by regulating RAD51 recombinase activity. To date, the BRC repeat has not been observed in other proteins, so that its role in HR is inferred only in the context of BRCA2. Here, we identified a BRC repeat variant, named BRCv, in the RECQL5 helicase, which possesses anti-recombinase activity in vitro and suppresses HR and promotes cellular resistance to camptothecin-induced replication stress in vivo. RECQL5-BRCv interacted with RAD51 through two conserved motifs similar to those in the BRCA2-BRC repeat. Mutations of either motif compromised functions of RECQL5, including association with RAD51, inhibition of RAD51-mediated D-loop formation, suppression of sister chromatid exchange, and resistance to camptothecin-induced replication stress. Potential BRCvs were also found in other HR regulatory proteins, including Srs2 and Sgs1, which possess anti-recombinase activities similar to that of RECQL5. A point mutation in the predicted Srs2-BRCv disrupted the ability of the protein to bind RAD51 and to inhibit D-loop formation. Thus, BRC is a common RAD51 interaction module that can be utilized by different proteins to either promote HR, as in the case of BRCA2, or to suppress HR, as in RECQL5.	[Islam, M. Nurul; Paquet, Nicolas; Dray, Eloise; Zheng, Xiao-Feng; Sung, Patrick] Yale Univ, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06520 USA; [Islam, M. Nurul; Fox, David, III; Wang, Weidong] NIA, Genet Lab, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Klein, Hannah] NYU, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA	Yale University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); New York University	Sung, P (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, Sch Med, POB 6666, New Haven, CT 06520 USA.	patrick.sung@yale.edu; wangw@grc.nia.nih.gov	Wang, Weidong/AAV-2446-2021; Dray, Eloise/E-3938-2012; Dray, Eloise/AAD-5147-2021	Dray, Eloise/0000-0001-6793-9838; Zheng, Xiao-Feng/0000-0001-8769-4604; Wang, Weidong/0000-0002-0658-7928; Paquet, Nicolas/0000-0001-9140-4673; Klein, Hannah/0000-0003-4228-8535	National Institutes of Health, NIA, Intramural Research Program [Z01:AG000657-09]; National Institutes of Health [ES016532, ES015252]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015632, R01ES015252, R21ES016532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000661, Z01AG000657] Funding Source: NIH RePORTER	National Institutes of Health, NIA, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Intramural Research Program Grant Z01:AG000657-09 (to W. W.) and National Institutes of Health Grants ES016532 and ES015252 (to P. S.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Carreira A, 2011, P NATL ACAD SCI USA, V108, P10448, DOI 10.1073/pnas.1106971108; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Galkin VE, 2005, P NATL ACAD SCI USA, V102, P8537, DOI 10.1073/pnas.0407266102; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Hu YD, 2005, MOL CELL BIOL, V25, P3431, DOI 10.1128/MCB.25.9.3431-3442.2005; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Hu YD, 2009, MOL BIOL CELL, V20, P114, DOI 10.1091/mbc.E08-06-0565; Islam MN, 2010, MOL CELL BIOL, V30, P2460, DOI 10.1128/MCB.01583-09; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kohzaki M, 2007, MOL CELL BIOL, V27, P2812, DOI 10.1128/MCB.02043-06; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Ochiai K, 2011, FEBS LETT, V585, P1771, DOI 10.1016/j.febslet.2011.05.027; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Rajendra E, 2010, NUCLEIC ACIDS RES, V38, P82, DOI 10.1093/nar/gkp873; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Schwendener S, 2010, J BIOL CHEM, V285, P15739, DOI 10.1074/jbc.M110.110478; Shivji MKK, 2006, NUCLEIC ACIDS RES, V34, P4000, DOI 10.1093/nar/gkl505; Shivji MKK, 2009, P NATL ACAD SCI USA, V106, P13254, DOI 10.1073/pnas.0906208106; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Wang WS, 2003, MOL CELL BIOL, V23, P3527, DOI 10.1128/MCB.23.10.3527-3535.2003; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636	40	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23808	23818		10.1074/jbc.M112.375014	http://dx.doi.org/10.1074/jbc.M112.375014			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22645136	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000306511300050
J	Sanz-Garcia, M; Monsalve, DM; Sevilla, A; Lazo, PA				Sanz-Garcia, Marta; Monsalve, Diana M.; Sevilla, Ana; Lazo, Pedro A.			Vaccinia-related Kinase 1 (VRK1) Is an Upstream Nucleosomal Kinase Required for the Assembly of 53BP1 Foci in Response to Ionizing Radiation-induced DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; HUMAN VACCINIA-RELATED-KINASE-1 VRK1; HISTONE H2AX; CELL-CYCLE; DEPENDENT PHOSPHORYLATION; MAMMALIAN-CELLS; BINDING-SITE; P53; ATM; CHECKPOINT	Cellular responses to DNA damage require the formation of protein complexes in a highly organized fashion. The complete molecular components that participate in the sequential signaling response to DNA damage remain unknown. Here we demonstrate that vaccinia-related kinase 1 (VRK1) in resting cells plays an important role in the formation of ionizing radiation-induced foci that assemble on the 53BP1 scaffold protein during the DNA damage response. The kinase VRK1 is activated by DNA double strand breaks induced by ionizing radiation (IR) and specifically phosphorylates 53BP1 in serum-starved cells. VRK1 knockdown resulted in the defective formation of 53BP1 foci in response to IR both in number and size. This observed effect on 53BP1 foci is p53- and ataxia-telangiectasia mutated (ATM)-independent and can be rescued with VRK1 mutants resistant to siRNA. VRK1 knockdown also prevented the activating phosphorylation of ATM, CHK2, and DNA-dependent protein kinase in response to IR. VRK1 activation in response to DNA damage is a novel and early step in the signaling of mammalian DNA damage responses.	[Lazo, Pedro A.] Univ Salamanca, CSIC, Expt Therapeut & Translat Oncol Program, IBMCC,Ctr Invest Canc, E-37007 Salamanca, Spain; [Monsalve, Diana M.; Lazo, Pedro A.] Hosp Univ Salamanca, Inst Invest Biomed Salamanca IBSAL, E-37007 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	Lazo, PA (corresponding author), Univ Salamanca, CSIC, Expt Therapeut & Translat Oncol Program, IBMCC,Ctr Invest Canc, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.	pedro.lazo@csic.es	Sevilla, Ana/N-8579-2017; Lazo, Pedro A./M-6435-2014; Monsalve, Diana M./J-2374-2016	Sevilla, Ana/0000-0002-9251-4759; Lazo, Pedro A./0000-0001-8997-3025; Monsalve, Diana M./0000-0002-1145-1312	Ministerio de Ciencia e Innovacion [SAF2010-14935, CSD2007-0017]; Junta de Castilla y Leon [CSI006A11-2, GR-15]; Kutxa-Fundacion Inbiomed.; Junta para la Ampliacion de Estudios-CSIC-Fondo Social Europeo fellowships	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Kutxa-Fundacion Inbiomed.; Junta para la Ampliacion de Estudios-CSIC-Fondo Social Europeo fellowships	This work was supported in part by Ministerio de Ciencia e Innovacion Grants SAF2010-14935 and CSD2007-0017, Junta de Castilla y Leon Grants CSI006A11-2 and GR-15, and the Kutxa-Fundacion Inbiomed.; Supported by Junta para la Ampliacion de Estudios-CSIC-Fondo Social Europeo fellowships.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Aihara H, 2004, GENE DEV, V18, P877, DOI 10.1101/gad.1184604; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barcia R, 2002, ARCH BIOCHEM BIOPHYS, V399, P1, DOI 10.1006/abbi.2001.2746; Buscemi G, 2004, ONCOGENE, V23, P7691, DOI 10.1038/sj.onc.1207986; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Choi YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015254; Coster G, 2010, NUCLEUS-PHILA, V1, P166, DOI 10.4161/nucl.1.2.11176; CRICK F, 1974, NATURE, V248, P766, DOI 10.1038/248766a0; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Kim W, 2012, J BIOL CHEM, V287, P5278, DOI 10.1074/jbc.M111.281709; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; Lakin ND, 1999, ONCOGENE, V18, P3989, DOI 10.1038/sj.onc.1202973; Lancaster OM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001179; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Lee SE, 1997, MOL CELL BIOL, V17, P1425, DOI 10.1128/MCB.17.3.1425; Lin WC, 2001, GENE DEV, V15, P1833; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Lopez-Sanchez I, 2009, MOL CELL BIOL, V29, P1189, DOI 10.1128/MCB.01341-08; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017; Mochan TA, 2003, CANCER RES, V63, P8586; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Nakamura AJ, 2010, CELL CYCLE, V9, P389, DOI 10.4161/cc.9.2.10475; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; Park CH, 2011, MOL BIOL CELL, V22, P1398, DOI 10.1091/mbc.E10-08-0717; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Renbaum P, 2009, AM J HUM GENET, V85, P281, DOI 10.1016/j.ajhg.2009.07.006; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Sanz-Garcia M, 2008, MOL CELL PROTEOMICS, V7, P2199, DOI 10.1074/mcp.M700586-MCP200; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Schober CS, 2011, MECH DEVELOP, V128, P178, DOI 10.1016/j.mod.2011.01.004; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Shin J, 2011, J BIOL CHEM, V286, P22131, DOI 10.1074/jbc.M110.200162; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Suzuki Y, 2010, J BIOL CHEM, V285, P24032, DOI 10.1074/jbc.M110.116640; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tomimatsu N, 2009, EMBO REP, V10, P629, DOI 10.1038/embor.2009.60; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2007, LUNG CANCER, V58, P303, DOI 10.1016/j.lungcan.2007.06.023; Valbuena A, 2007, ARCH BIOCHEM BIOPHYS, V465, P219, DOI 10.1016/j.abb.2007.06.005; Valbuena A, 2011, CELL SIGNAL, V23, P1267, DOI 10.1016/j.cellsig.2011.04.002; Valbuena A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017320; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002649; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; Vazquez-Cedeira M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023235; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Wiebe MS, 2010, BIOL REPROD, V82, P182, DOI 10.1095/biolreprod.109.079095; Wu JX, 2009, J BIOL CHEM, V284, P18078, DOI 10.1074/jbc.M109.002527	74	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23757	23768		10.1074/jbc.M112.353102	http://dx.doi.org/10.1074/jbc.M112.353102			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22621922	hybrid, Green Published			2022-12-25	WOS:000306511300046
J	Bender, S; Rellum, T; Freitag, C; Resch, F; Rietschel, M; Treutlein, J; Jennen-Steinmetz, C; Brandeis, D; Banaschewski, T; Laucht, M				Bender, Stephan; Rellum, Thomas; Freitag, Christine; Resch, Franz; Rietschel, Marcella; Treutlein, Jens; Jennen-Steinmetz, Christine; Brandeis, Daniel; Banaschewski, Tobias; Laucht, Manfred			Dopamine Inactivation Efficacy Related to Functional DAT1 and COMT Variants Influences Motor Response Evaluation	PLOS ONE			English	Article							CONTINGENT NEGATIVE-VARIATION; CATECHOL-O-METHYLTRANSFERASE; TRANSPORTER GENE; WORKING-MEMORY; REWARD SENSITIVITY; CHILDREN; BRAIN; ATTENTION; POLYMORPHISM; ASSOCIATION	Background: Dopamine plays an important role in orienting, response anticipation and movement evaluation. Thus, we examined the influence of functional variants related to dopamine inactivation in the dopamine transporter (DAT1) and catechol-O-methyltransferase genes (COMT) on the time-course of motor processing in a contingent negative variation (CNV) task. Methods: 64-channel EEG recordings were obtained from 195 healthy adolescents of a community-based sample during a continuous performance task (A-X version). Early and late CNV as well as motor postimperative negative variation were assessed. Adolescents were genotyped for the COMT Val(158) Met and two DAT1 polymorphisms (variable number tandem repeats in the 3'-untranslated region and in intron 8). Results: The results revealed a significant interaction between COMT and DAT1, indicating that COMT exerted stronger effects on lateralized motor post-processing (centro-parietal motor postimperative negative variation) in homozygous carriers of a DAT1 haplotype increasing DAT1 expression. Source analysis showed that the time interval 500-1000 ms after the motor response was specifically affected in contrast to preceding movement anticipation and programming stages, which were not altered. Conclusions: Motor slow negative waves allow the genomic imaging of dopamine inactivation effects on cortical motor post-processing during response evaluation. This is the first report to point towards epistatic effects in the motor system during response evaluation, i.e. during the post-processing of an already executed movement rather than during movement programming.	[Bender, Stephan] Tech Univ Dresden, Child & Adolescent Psychiat Dept, Sect Clin Neurophysiol & Multimodal Neuroimaging, D-01062 Dresden, Germany; [Bender, Stephan; Freitag, Christine] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, Frankfurt, Germany; [Bender, Stephan; Resch, Franz] Univ Heidelberg Hosp, Dept Child & Adolescent Psychiat & Psychotherapy, Heidelberg, Germany; [Rellum, Thomas; Brandeis, Daniel; Banaschewski, Tobias; Laucht, Manfred] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, D-6800 Mannheim, Germany; [Rietschel, Marcella; Treutlein, Jens] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-6800 Mannheim, Germany; [Jennen-Steinmetz, Christine] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Biostat, D-6800 Mannheim, Germany; [Brandeis, Daniel] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Brandeis, Daniel] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Laucht, Manfred] Univ Potsdam, Dept Psychol, Potsdam, Germany	Technische Universitat Dresden; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Potsdam	Bender, S (corresponding author), Tech Univ Dresden, Child & Adolescent Psychiat Dept, Sect Clin Neurophysiol & Multimodal Neuroimaging, D-01062 Dresden, Germany.	Stephan.Bender@uniklinik-dresden.de	Banaschewski, Tobias/ABE-5985-2020; Bender, Stephan/AAT-1266-2021	Banaschewski, Tobias/0000-0003-4595-1144; Freitag, Christine Margarete/0000-0001-9676-4782	Deutsche Forschungsgemeinschaft (DFG); Ministry of Science and Investigation, Baden-Wurttemberg, Germany; Medical Faculty of the Goethe University, Frankfurt, Germany [7601002]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry of Science and Investigation, Baden-Wurttemberg, Germany; Medical Faculty of the Goethe University, Frankfurt, Germany	This study was supported by multiple grants from the Deutsche Forschungsgemeinschaft (DFG), the Ministry of Science and Investigation, Baden-Wurttemberg, Germany, and a grant by the Medical Faculty of the Goethe University, Frankfurt, Germany (7601002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaschewski T, 2003, J CHILD PSYCHOL PSYC, V44, P356, DOI 10.1111/1469-7610.00127; Bender S, 2005, NEUROIMAGE, V27, P737, DOI 10.1016/j.neuroimage.2005.05.020; Bender S, 2005, ANN NEUROL, V58, P58, DOI 10.1002/ana.20521; Bender S, 2004, COGNITIVE BRAIN RES, V21, P49, DOI 10.1016/j.cogbrainres.2004.05.004; Bender S, 2004, CLIN NEUROPHYSIOL, V115, P1836, DOI 10.1016/j.clinph.2004.03.023; Bender S, 2002, CEPHALALGIA, V22, P132, DOI 10.1046/j.1468-2982.2002.00334.x; Bender S, 2007, PAIN, V127, P221, DOI 10.1016/j.pain.2006.08.017; Bender S, 2006, NEUROIMAGE, V32, P333, DOI 10.1016/j.neuroimage.2006.03.009; Bender S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039012; Bender S, 2010, CLIN NEUROPHYSIOL, V121, P2044, DOI 10.1016/j.clinph.2010.05.008; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Brandeis D, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00018; Brookes KJ, 2007, AM J MED GENET B, V144B, P1070, DOI 10.1002/ajmg.b.30572; Bruckmann S, BRAIN IN PRESS; Cattell R.B., 1960, CULTURE FAIR INTELLI; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; de Frias CM, 2010, J COGNITIVE NEUROSCI, V22, P1614, DOI 10.1162/jocn.2009.21318; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Franke B, 2008, AM J MED GENET B, V147B, P1576, DOI 10.1002/ajmg.b.30861; Franke B, 2010, NEUROPSYCHOPHARMACOL, V35, P656, DOI 10.1038/npp.2009.170; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; GAILLARD AWK, 1977, PSYCHOPHYSIOLOGY, V14, P563, DOI 10.1111/j.1469-8986.1977.tb01200.x; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Gomez CM, 2003, NEUROIMAGE, V20, P216, DOI 10.1016/S1053-8119(03)00295-7; GRACE AA, 1995, DRUG ALCOHOL DEPEN, V37, P111, DOI 10.1016/0376-8716(94)01066-T; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Hahn T, 2011, HUM BRAIN MAPP, V32, P1557, DOI 10.1002/hbm.21127; Hallett M, 1994, Electromyogr Clin Neurophysiol, V34, P5; Kahkonen S, 2002, CLIN NEUROPHYSIOL, V113, P1894, DOI 10.1016/S1388-2457(02)00305-X; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; KAROUM F, 1994, BRIT J PHARMACOL, V113, P1391; Kiphardt E., 1974, KORPERKOORDINATIONST; Klein C, 1996, PSYCHOPHYSIOLOGY, V33, P426, DOI 10.1111/j.1469-8986.1996.tb01068.x; Klein C, 1998, PSYCHOPHYSIOLOGY, V35, P272, DOI 10.1017/S0048577298961212; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Laucht M, 1997, J CHILD PSYCHOL PSYC, V38, P843, DOI 10.1111/j.1469-7610.1997.tb01602.x; Laucht M, 2007, ARCH GEN PSYCHIAT, V64, P585, DOI 10.1001/archpsyc.64.5.585; Linssen AM, 2011, PSYCHOPHARMACOLOGY B; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Marklund P, 2009, BRAIN, V132, P336, DOI 10.1093/brain/awn309; Masaki H, 2004, PSYCHOPHYSIOLOGY, V41, P220, DOI 10.1111/j.1469-8986.2004.00150.x; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prata DP, 2009, P NATL ACAD SCI USA, V106, P13600, DOI 10.1073/pnas.0903007106; Rockstroh B., 1989, SLOW CORTICAL POTENT; ROHRBAUGH JW, 1980, SCIENCE, V208, P1165, DOI 10.1126/science.7375925; SANO A, 1993, HUM GENET, V91, P405; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Sesack S R, 1998, Adv Pharmacol, V42, P171; Shumay E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022754; SOMMER W, 1994, PSYCHOPHYSIOLOGY, V31, P503, DOI 10.1111/j.1469-8986.1994.tb01054.x; Ulrich R, 1998, PSYCHOPHYSIOLOGY, V35, P721, DOI 10.1111/1469-8986.3560721; van Leeuwen TH, 1998, BEHAV BRAIN RES, V94, P97, DOI 10.1016/S0166-4328(97)00173-3; Vandenbergh DJ, 2000, AM J MED GENET, V96, P678, DOI 10.1002/1096-8628(20001009)96:5<678::AID-AJMG15>3.0.CO;2-8; VanNess SH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-55; Verleger R, 1999, CLIN NEUROPHYSIOL, V110, P1175, DOI 10.1016/S1388-2457(99)00023-1; Weiss R.H., 1987, GRUNDINTELLIGENZTEST; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Yacubian J, 2007, P NATL ACAD SCI USA, V104, P8125, DOI 10.1073/pnas.0702029104	63	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37814	10.1371/journal.pone.0037814	http://dx.doi.org/10.1371/journal.pone.0037814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649558	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305335800078
J	Jiang, FK; Guo, M; Yang, F; Duncan, K; Jackson, D; Rafalski, A; Wang, SC; Li, BL				Jiang, Fukun; Guo, Mei; Yang, Fang; Duncan, Keith; Jackson, David; Rafalski, Antoni; Wang, Shoucai; Li, Bailin			Mutations in an AP2 Transcription Factor-Like Gene Affect Internode Length and Leaf Shape in Maize	PLOS ONE			English	Article							MERISTEM CELL FATE; GREEN-REVOLUTION; GIBBERELLIN BIOSYNTHESIS; SEX DETERMINATION; ARABIDOPSIS; ENCODES; PROTEIN; RICE; TRANSPORTER; EXPRESSION	Background: Plant height is an important agronomic trait that affects yield and tolerance to certain abiotic stresses. Understanding the genetic control of plant height is important for elucidating the regulation of maize development and has practical implications for trait improvement in plant breeding. Methodology/Principal Findings: In this study, two independent, semi-dwarf maize EMS mutants, referred to as dwarf & irregular leaf (dil1), were isolated and confirmed to be allelic. In comparison to wild type plants, the mutant plants have shorter internodes, shorter, wider and wrinkled leaves, as well as smaller leaf angles. Cytological analysis indicated that the leaf epidermal cells and internode parenchyma cells are irregular in shape and are arranged in a more random fashion, and the mutants have disrupted leaf epidermal patterning. In addition, parenchyma cells in the dil1 mutants are significantly smaller than those in wild-type plants. The dil1 mutation was mapped on the long arm of chromosome 6 and a candidate gene, annotated as an AP2 transcription factor-like, was identified through positional cloning. Point mutations near exonintron junctions were identified in both dil1 alleles, resulting in mis-spliced variants. Conclusion: An AP2 transcription factor-like gene involved in stalk and leaf development in maize has been identified. Mutations near exon-intron junctions of the AP2 gene give mis-spliced transcript variants, which result in shorter internodes and wrinkled leaves.	[Jiang, Fukun; Wang, Shoucai] China Agr Univ, Natl Maize Improvement Ctr China, Coll Agr & Biotechnol, Beijing 100094, Peoples R China; [Jiang, Fukun; Duncan, Keith; Rafalski, Antoni; Li, Bailin] DuPont Agr Biotechnol, Wilmington, DE USA; [Guo, Mei] Pioneer HiBred Int Inc, Johnston, IA USA; [Yang, Fang; Jackson, David] Cold Spring Harbor Labs, Cold Spring Harbor, NY USA	China Agricultural University; DuPont; DuPont; Cold Spring Harbor Laboratory	Jiang, FK (corresponding author), China Agr Univ, Natl Maize Improvement Ctr China, Coll Agr & Biotechnol, Beijing 100094, Peoples R China.	Bailin.Li@cgr.dupont.com	Guo, Mei/AAE-5521-2019; li, bz/GVR-7133-2022	Guo, Mei/0000-0002-3274-9564; 	Chinese Scholarship Council; DuPont Agricultural Biotechnology	Chinese Scholarship Council(China Scholarship Council); DuPont Agricultural Biotechnology	This work was supported by the Chinese Scholarship Council and DuPont Agricultural Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Candela H, 2008, NAT REV GENET, V9, P192, DOI 10.1038/nrg2291; Cassani E, 2009, MOL BREEDING, V24, P375, DOI 10.1007/s11032-009-9298-3; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chuck G, 2002, SCIENCE, V298, P1238, DOI 10.1126/science.1076920; Chuck G, 2008, DEVELOPMENT, V135, P3013, DOI 10.1242/dev.024273; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Duvick DN, 1999, CROP SCI, V39, P1622, DOI 10.2135/cropsci1999.3961622x; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; Egawa C, 2006, GENES GENET SYST, V81, P77, DOI 10.1266/ggs.81.77; Fernandez MGS, 2009, TRENDS PLANT SCI, V14, P454, DOI 10.1016/j.tplants.2009.06.005; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Jackson D, 2002, ARABIDOPSIS LAB MANU, P110; Johal GS, 2008, CROP SCI, V48, P2066, DOI 10.2135/cropsci2008.03.0150; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kirch T, 2003, PLANT CELL, V15, P694, DOI 10.1105/tpc.009480; Klucher KM, 1996, PLANT CELL, V8, P137, DOI 10.1105/tpc.8.2.137; Lawit SJ, 2010, PLANT CELL PHYSIOL, V51, P1854, DOI 10.1093/pcp/pcq153; Maeo K, 2009, PLANT J, V60, P476, DOI 10.1111/j.1365-313X.2009.03967.x; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Mathur J, 2003, DEVELOPMENT, V130, P3137, DOI 10.1242/dev.00549; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Muszynski MG, 2006, PLANT PHYSIOL, V142, P1523, DOI 10.1104/pp.106.088815; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Qin F, 2007, PLANT J, V50, P54, DOI 10.1111/j.1365-313X.2007.03034.x; Qiu JL, 2002, PLANT CELL, V14, P101, DOI 10.1105/tpc.010346; Riechmann JL, 1998, BIOL CHEM, V379, P633; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Shi JR, 2007, NAT BIOTECHNOL, V25, P930, DOI 10.1038/nbt1322; Smith LG, 2001, J CELL BIOL, V152, P231, DOI 10.1083/jcb.152.1.231; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Varkonyi-Gasic E, 2012, PLANT MOL BIOL, V78, P417, DOI 10.1007/s11103-012-9877-2; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Ward JM, 2006, PLANT CELL, V18, P29, DOI 10.1105/tpc.105.036707; WINKLER RG, 1995, PLANT CELL, V7, P1307, DOI 10.1105/tpc.7.8.1307; Xue GP, 2004, PLANT J, V37, P326, DOI 10.1046/j.1365-313X.2003.01963.x; Zhuang J, 2010, PLANT GROWTH REGUL, V62, P51, DOI 10.1007/s10725-010-9484-7	48	50	56	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37040	10.1371/journal.pone.0037040	http://dx.doi.org/10.1371/journal.pone.0037040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649507	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000305335800025
J	Johansen, NB; Vistisen, D; Brunner, EJ; Tabak, AG; Shipley, MJ; Wilkinson, IB; McEniery, CM; Roden, M; Herder, C; Kivimaki, M; Witte, DR				Johansen, Nanna B.; Vistisen, Dorte; Brunner, Eric J.; Tabak, Adam G.; Shipley, Martin J.; Wilkinson, Ian B.; McEniery, Carmel M.; Roden, Michael; Herder, Christian; Kivimaeki, Mika; Witte, Daniel R.			Determinants of Aortic Stiffness: 16-Year Follow-Up of the Whitehall II Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PULSE-WAVE VELOCITY; ALL-CAUSE MORTALITY; ARTERIAL STIFFNESS; MULTIPLE IMPUTATION; CARDIOVASCULAR EVENTS; PREDICTION; ADIPONECTIN; ADIPOSITY; PRESSURE	Background: Aortic stiffness is a strong predictor of cardiovascular disease endpoints. Cross-sectional studies have shown associations of various cardiovascular risk factors with aortic pulse wave velocity, a measure of aortic stiffness, but the long-term impact of these factors on aortic stiffness is unknown. Methods: In 3,769 men and women from the Whitehall II cohort, a wide range of traditional and novel cardiovascular risk factors were determined at baseline (1991-1993) and aortic pulse wave velocity was measured at follow-up (2007-2009). The prospective associations between each baseline risk factor and aortic pulse wave velocity at follow-up were assessed through sex stratified linear regression analysis adjusted for relevant confounders. Missing data on baseline determinants were imputed using the Multivariate Imputation by Chained Equations. Results: Among men, the strongest predictors were waist circumference, waist-hip ratio, heart rate and interleukin 1 receptor antagonist, and among women, adiponectin, triglycerides, pulse pressure and waist-hip ratio. The impact of 10 centimeter increase in waist circumference on aortic pulse wave velocity was twice as large for men compared with women (men: 0.40 m/s (95%-CI: 0.24; 0.56); women: 0.17 m/s (95%-CI: -0.01; 0.35)), whereas the opposite was true for the impact of a two-fold increase in adiponectin (men: -0.30 m/s (95%-CI: -0.51; -0.10); women: 0.61 m/s (95%-CI: -0.86; -0.35)). Conclusion: In this large prospective study, central obesity was a strong predictor of aortic stiffness. Additionally, heart rate in men and adiponectin in women predicted aortic pulse wave velocity suggesting that strategies to prevent aortic stiffening should be focused differently by sex.	[Johansen, Nanna B.; Vistisen, Dorte; Witte, Daniel R.] Steno Diabet Ctr AS, Gentofte, Denmark; [Brunner, Eric J.; Tabak, Adam G.; Shipley, Martin J.; Kivimaeki, Mika; Witte, Daniel R.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Tabak, Adam G.] Semmelweis Univ, Fac Med, Dept Med 1, Budapest, Hungary; [Wilkinson, Ian B.; McEniery, Carmel M.] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Roden, Michael; Herder, Christian] Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, D-40225 Dusseldorf, Germany; [Roden, Michael] Univ Dusseldorf, Dept Metab Dis, D-40225 Dusseldorf, Germany	Steno Diabetes Center; University of London; University College London; Semmelweis University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Johansen, NB (corresponding author), Steno Diabet Ctr AS, Gentofte, Denmark.	nabj@steno.dk	Brunner, Eric/H-2114-2011; Roden, Michael/AAD-3843-2019; Witte, Daniel R/C-1722-2008; Kivimaki, Mika/B-3607-2012; Witte, Daniel/AAF-9535-2019; Tabak, Adam/A-5007-2012; Stefanadis, Christodoulos/ABH-2232-2020	Brunner, Eric/0000-0002-0595-4474; Witte, Daniel R/0000-0002-0769-2922; Kivimaki, Mika/0000-0002-4699-5627; Witte, Daniel/0000-0002-0769-2922; Vistisen, Dorte/0000-0001-5045-5351; Johansen, Nanna Borup/0000-0003-3764-8532; Stefanadis, Christodoulos/0000-0001-5974-6454; wilkinson, ian/0000-0001-6598-9399; Tabak, Adam/0000-0002-6234-3936	Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute, United States, National Institutes of Health (NIH): National Institute on Aging, United States, NIH [R01 HL36310, R01 AG013196, R01 AG034454]; Agency for Health Care Policy Research [HS06516]; John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; Medical Research Council New Investigator Award [G0501184]; Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science, Research and Technology of the state North-Rhine Westphalia (Dusseldorf, Germany); Biomedical Research centre Award; European Foundation for the Study of Diabetes(EFSD)/Pfizer for Research into Cardiovascular Disease risk Reduction in Patients with Diabetes [74550801]; Pfizer; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, R01AG034454] Funding Source: NIH RePORTER; British Heart Foundation [FS/12/8/29377, RG/07/008/23674, PG/11/63/29011] Funding Source: researchfish; Medical Research Council [G0902037, G8802774, G0501184, G19/35, G0100222] Funding Source: researchfish; MRC [G0501184, G0902037] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute, United States, National Institutes of Health (NIH): National Institute on Aging, United States, NIH; Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; Medical Research Council New Investigator Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science, Research and Technology of the state North-Rhine Westphalia (Dusseldorf, Germany); Biomedical Research centre Award; European Foundation for the Study of Diabetes(EFSD)/Pfizer for Research into Cardiovascular Disease risk Reduction in Patients with Diabetes; Pfizer(Pfizer); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Whitehall II study has been supported by grants from the Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute (R01 HL36310), United States, National Institutes of Health (NIH): National Institute on Aging (R01 AG013196; R01 AG034454), United States, NIH; Agency for Health Care Policy Research (HS06516); and the John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. MK is supported by the Academy of Finland and the BUPA Foundation, UK. Measurements of IL-1Ra and adiponectin were funded by a Medical Research Council New Investigator Award (G0501184). CH and MR are supported by the Federal Ministry of Health (Berlin, Germany) and the Ministry of Innovation, Science, Research and Technology of the state North-Rhine Westphalia (Dusseldorf, Germany). IBW is a British Heart Foundation Senior Research Fellow, and CMM an Intermediate Fellow. Both are also supported by the Biomedical Research centre Award. NBJ is funded by an unrestricted grant from the European Foundation for the Study of Diabetes(EFSD)/Pfizer for Research into Cardiovascular Disease risk Reduction in Patients with Diabetes (74550801) (See funding program on www.europeandiabetesfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Pfizer partly funded this study. NBJ, DV and DRW are employed by Steno Diabetes Center A/S, which is a research and teaching hospital collaborating with the Danish National Health Service and owned by Novo Nordisk A/S. NBJ, DV and DRW hold shares in Novo Nordisk A/S. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Benetos A, 2002, CIRCULATION, V105, P1202, DOI 10.1161/hc1002.105135; Boutouyrie P, 2010, HYPERTENSION, V55, P1314, DOI 10.1161/HYPERTENSIONAHA.109.148999; Britton A, 2004, ADDICTION, V99, P109, DOI 10.1111/j.1360-0443.2004.00530.x; Brunner EJ, 2011, HYPERTENSION, V57, P1003, DOI 10.1161/HYPERTENSIONAHA.110.168864; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653; Dengo AL, 2010, HYPERTENSION, V55, P855, DOI 10.1161/HYPERTENSIONAHA.109.147850; Gavin JR, 1997, DIABETES CARE, V20, P1183; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Holewijn S, 2010, J INTERN MED, V267, P588, DOI 10.1111/j.1365-2796.2009.02192.x; Ichihara A, 2005, J HUM HYPERTENS, V19, P103, DOI 10.1038/sj.jhh.1001786; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lieb W, 2009, CIRCULATION, V119, P37, DOI 10.1161/CIRCULATIONAHA.108.816108; London GM, 2010, NEPHROL DIAL TRANSPL, V25, P3815, DOI 10.1093/ndt/gfq614; Maki-Petaja KM, 2006, CIRCULATION, V114, P1185, DOI 10.1161/CIRCULATIONAHA.105.601641; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McEniery CM, 2010, HYPERTENSION, V56, P36, DOI 10.1161/HYPERTENSIONAHA.110.150896; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Rubin DB, 2004, MULTIPLE IMPUTATION; Schnabel R, 2008, HYPERTENSION, V51, P1651, DOI 10.1161/HYPERTENSIONAHA.107.105668; Sie MPS, 2009, J HYPERTENS, V27, P1392, DOI 10.1097/HJH.0b013e32832a95b0; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Sutton-Tyrrell K, 2001, HYPERTENSION, V38, P429, DOI 10.1161/01.HYP.38.3.429; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Virtanen M, 2010, EUR HEART J, V31, P1737, DOI 10.1093/eurheartj/ehq124; Vlachopoulos C, 2005, CIRCULATION, V112, P2193, DOI 10.1161/CIRCULATIONAHA.105.535435; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; Wilkinson IB, 1998, J HYPERTENS, V16, P2079, DOI 10.1097/00004872-199816121-00033; Windham BG, 2010, AM J HYPERTENS, V23, P501, DOI 10.1038/ajh.2010.8; Yasmin, 2004, ARTERIOSCL THROM VAS, V24, P969, DOI 10.1161/01.ATV.zhq0504.0173	37	65	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37165	10.1371/journal.pone.0037165	http://dx.doi.org/10.1371/journal.pone.0037165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629363	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300023
J	Zhu, LN; Zhao, SJ; Wu, B; Li, XZ; Kong, DM				Zhu, Li-Na; Zhao, Shu-Juan; Wu, Bin; Li, Xiao-Zeng; Kong, De-Ming			A New Cationic Porphyrin Derivative (TMPipEOPP) with Large Side Arm Substituents: A Highly Selective G-Quadruplex Optical Probe	PLOS ONE			English	Article							TELOMERIC DNA; BINDING	The discovery of uncommon DNA structures and speculation about their potential functions in genes has brought attention to specific DNA structure recognition. G-quadruplexes are four-stranded nucleic acid structures formed by G-rich DNA (or RNA) sequences. G-rich sequences with a high potential to form G-quadruplexes have been found in many important genomic regions. Porphyrin derivatives with cationic side arm substituents are important G-quadruplex-binding ligands. For example, 5,10,15,20-Tetrakis(N-methylpyridinium-4-yl)-21H, 23H-porphyrin (TMPyP4), interacts strongly with G-quadruplexes, but has poor selectivity for G-quadruplex versus duplex DNA. To increase the G-quadruplex recognition specificity, a new cationic porphyrin derivative, 5,10,15,20-tetra-{4-[2-(1-methyl-1-piperidinyl)ethoxy]phenyl}porphyrin (TMPipEOPP), with large side arm substituents was synthesized, and the interactions between TMPipEOPP and different DNA structures were compared. The results show that G-quadruplexes cause large changes in the UV-Vis absorption and fluorescence spectra of TMPipEOPP, but duplex and single-stranded DNAs do not, indicating that TMPipEOPP can be developed as a highly specific optical probe for discriminating G-quadruplex from duplex and single-stranded DNA. Visual discrimination is also possible. Job plot and Scatchard analysis suggest that a complicated binding interaction occurs between TMPipEOPP and G-quadruplexes. At a low [G-quadruplex]/[TMPipEOPP] ratio, one G-quadruplex binds two TMPipEOPP molecules by end-stacking and outside binding modes. At a high [G-quadruplex]/[TMPipEOPP] ratio, two G-quadruplexes bind to one TMPipEOPP molecule in a sandwich-like end-stacking mode.	[Zhu, Li-Na; Zhao, Shu-Juan; Wu, Bin; Li, Xiao-Zeng] Tianjin Univ, Dept Chem, Tianjin 300072, Peoples R China; [Kong, De-Ming] Nankai Univ, Key Lab Funct Polymer Mat, Minist Educ, Tianjin 300071, Peoples R China	Tianjin University; Nankai University	Zhu, LN (corresponding author), Tianjin Univ, Dept Chem, Tianjin 300072, Peoples R China.	linazhu@tju.edu.cn			Natural Science Foundation of China [20801040]; National Basic Research Program of China [2011CB707703]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the Natural Science Foundation of China (no. 20801040) and by the National Basic Research Program of China (no. 2011CB707703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzeer J, 2009, ANGEW CHEM INT EDIT, V48, P9362, DOI 10.1002/anie.200903685; [Anonymous], SMART CONTR SAINT IN; Arthanari H, 1998, NUCLEIC ACIDS RES, V26, P3724, DOI 10.1093/nar/26.16.3724; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Balasubramanian S, 2009, CURR OPIN CHEM BIOL, V13, P345, DOI 10.1016/j.cbpa.2009.04.637; Bennett M, 2000, P NATL ACAD SCI USA, V97, P9476, DOI 10.1073/pnas.160271897; Bhasikuttan AC, 2007, ANGEW CHEM INT EDIT, V46, P9305, DOI 10.1002/anie.200703251; Cummaro A, 2011, BIOCHIMIE, V93, P1392, DOI 10.1016/j.biochi.2011.04.005; Dixon IM, 2005, CHEMBIOCHEM, V6, P123, DOI 10.1002/cbic.200400113; Dixon IM, 2007, J AM CHEM SOC, V129, P1502, DOI 10.1021/ja065591t; Guo JH, 2009, TALANTA, V80, P607, DOI 10.1016/j.talanta.2009.07.034; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Kong DM, 2009, CHEM-EUR J, V15, P901, DOI 10.1002/chem.200801441; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Leopoldo M, 2009, DRUG DISCOV TODAY, V14, P706, DOI 10.1016/j.drudis.2009.03.015; Lombardo CM, 2010, CHEM COMMUN, V46, P9116, DOI 10.1039/c0cc02917c; Lu YJ, 2011, CHEM COMMUN, V47, P4971, DOI 10.1039/c1cc00020a; Martino L, 2009, J PHYS CHEM B, V113, P14779, DOI 10.1021/jp9066394; Murat P, 2011, CHEM SOC REV, V40, P5293, DOI 10.1039/c1cs15117g; Nielsen MC, 2010, CURR MED CHEM, V17, P3438; Pan JX, 2009, J BIOL INORG CHEM, V14, P401, DOI 10.1007/s00775-008-0457-5; PASTERNACK RF, 1983, BIOCHEMISTRY-US, V22, P2406, DOI 10.1021/bi00279a016; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Tran PLT, 2011, NUCLEIC ACIDS RES, V39, P3282, DOI 10.1093/nar/gkq1292; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; Romera C, 2011, BIOCHIMIE, V93, P1310, DOI 10.1016/j.biochi.2011.06.008; SHELDRICK G, SHELXL 97 PROGRAM RE; Sheldrick G. M., SHELXS 97 PROGRAM SO; Shinohara K, 2010, J AM CHEM SOC, V132, P3778, DOI 10.1021/ja908897j; Teulade-Fichou MP, 2003, J AM CHEM SOC, V125, P4732, DOI 10.1021/ja021299j; Vialas C, 2000, BIOCHEMISTRY-US, V39, P9514, DOI 10.1021/bi000743x; Wei CY, 2006, BIOCHEMISTRY-US, V45, P6681, DOI 10.1021/bi052356z; Wei CY, 2010, BIOPHYS CHEM, V148, P51, DOI 10.1016/j.bpc.2010.02.009; Wei CY, 2009, PHYS CHEM CHEM PHYS, V11, P4025, DOI 10.1039/b901027k; Wei CY, 2009, BIOPHYS CHEM, V143, P79, DOI 10.1016/j.bpc.2009.04.005; Wheelhouse RT, 1998, J AM CHEM SOC, V120, P3261, DOI 10.1021/ja973792e; Yamashita T, 2005, BIOORGAN MED CHEM, V13, P2423, DOI 10.1016/j.bmc.2005.01.041; Yang P, 2009, ANGEW CHEM INT EDIT, V48, P2188, DOI 10.1002/anie.200805613; Yu HQ, 2006, J AM CHEM SOC, V128, P15461, DOI 10.1021/ja064536h	39	47	48	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e35586	10.1371/journal.pone.0035586	http://dx.doi.org/10.1371/journal.pone.0035586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629300	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300002
J	Biskup, CS; Sanchez, CL; Arrant, A; Van Swearingen, AED; Kuhn, C; Zepf, FD				Biskup, Caroline Sarah; Sanchez, Cristina L.; Arrant, Andrew; Van Swearingen, Amanda E. D.; Kuhn, Cynthia; Zepf, Florian Daniel			Effects of Acute Tryptophan Depletion on Brain Serotonin Function and Concentrations of Dopamine and Norepinephrine in C57BL/6J and BALB/cJ Mice	PLOS ONE			English	Article							AMINO-ACID MIXTURES; RAT-BRAIN; BEHAVIORAL-INHIBITION; 5-HYDROXYINDOLE METABOLISM; PLASMA TRYPTOPHAN; REACTION-TIME; ADHD; NORADRENALINE; RELEASE; REGIONS	Acute tryptophan depletion (ATD) is a method of lowering brain serotonin (5-HT). Administration of large neutral amino acids (LNAA) limits the transport of endogenous tryptophan (TRP) across the blood brain barrier by competition with other LNAAs and subsequently decreases serotonergic neurotransmission. A recent discussion on the specificity and efficacy of the ATD paradigm for inhibition of central nervous 5-HT has arisen. Moreover, side effects such as vomiting and nausea after intake of amino acids (AA) still limit its use. ATD Moja-De is a revised mixture of AAs which is less nauseating than conventional protocols. It has been used in preliminary clinical studies but its effects on central 5-HT mechanisms and other neurotransmitter systems have not been validated in an animal model. We tested ATD Moja-De (TRP-) in two strains of mice: C57BL/6J, and BALB/cJ, which are reported to have impaired 5-HT synthesis and a more anxious phenotype relative to other strains of mice. ATD Moja-De lowered brain TRP, significantly decreased 5-HT synthesis as indexed by 5-HTP levels after decarboxlyase inhibition, and lowered 5-HT and 5-HIAA in both strains of mice, however more so in C57BL/6J than in BALB/cJ. Dopamine and its metabolites as well as norepinephrine were not affected. A balanced (TRP+) control mixture did not raise 5-HT or 5-HIAA. The present findings suggest that ATD Moja-De effectively and specifically suppresses central serotonergic function. These results also demonstrate a strain-specific effect of ATD Moja-De on anxiety-like behavior.	[Biskup, Caroline Sarah; Sanchez, Cristina L.; Zepf, Florian Daniel] Rhein Westfal TH Aachen, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-52062 Aachen, Nordrhein Westf, Germany; [Biskup, Caroline Sarah; Sanchez, Cristina L.; Zepf, Florian Daniel] Julich Res Ctr, Inst Neurosci & Med, Julich, Nordrhein Westf, Germany; [Biskup, Caroline Sarah; Sanchez, Cristina L.; Zepf, Florian Daniel] JARA Translat Brain Med, Julich, Nordrhein Westf, Germany; [Biskup, Caroline Sarah; Sanchez, Cristina L.; Zepf, Florian Daniel] JARA Translat Brain Med, Aachen, Nordrhein Westf, Germany; [Arrant, Andrew; Van Swearingen, Amanda E. D.; Kuhn, Cynthia] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	RWTH Aachen University; Helmholtz Association; Research Center Julich; Duke University	Biskup, CS (corresponding author), Rhein Westfal TH Aachen, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-52062 Aachen, Nordrhein Westf, Germany.	fzepf@ukaachen.de	Zepf, Florian D/J-5236-2013; Sanchez, Cristina L/C-7615-2009; Van Swearingen, Amanda/AAS-9742-2020	Van Swearingen, Amanda/0000-0002-4287-9741; Arrant, Andrew/0000-0003-4706-9411; Sanchez, Cristina L./0000-0001-6380-4282	German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, BMWi); American Psychiatric Association (APA); American Psychiatric Institute for Research and Education (APIRE); Astra Zeneca ("Young Minds in Psychiatry Award"); German Society for Social Pediatrics and Adolescent Medicine (Deutsche Gesellschaft fur Sozialpadiatrie und Jugendmedizin, DGSPJ); Paul and Ursula Klein Foundation; GlaxoSmithKline Foundation; Raine Foundation for Medical Research (Raine Visiting Professorship)	German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, BMWi)(Federal Ministry for Economic Affairs and Energy (BMWi)); American Psychiatric Association (APA); American Psychiatric Institute for Research and Education (APIRE); Astra Zeneca ("Young Minds in Psychiatry Award"); German Society for Social Pediatrics and Adolescent Medicine (Deutsche Gesellschaft fur Sozialpadiatrie und Jugendmedizin, DGSPJ); Paul and Ursula Klein Foundation; GlaxoSmithKline Foundation(GlaxoSmithKline); Raine Foundation for Medical Research (Raine Visiting Professorship)	This study was funded by the German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, BMWi) with a grant to the senior author of this paper (FDZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: In the past five years, FDZ was the recipient of an unrestricted award donated by the American Psychiatric Association (APA), the American Psychiatric Institute for Research and Education (APIRE), and Astra Zeneca ("Young Minds in Psychiatry Award"). He has also received research support from the German Society for Social Pediatrics and Adolescent Medicine (Deutsche Gesellschaft fur Sozialpadiatrie und Jugendmedizin, DGSPJ), and from the Paul and Ursula Klein Foundation, which is unrelated to the present investigation. He was the recipient of a travel stipend donated by the GlaxoSmithKline Foundation and an unrestricted educational grant, travel support and speaker honoraria donated by Shire pharmaceuticals. FDZ also received support from the Raine Foundation for Medical Research (Raine Visiting Professorship). The other authors have nothing to disclose.	Ardis TC, 2009, J PSYCHOPHARMACOL, V23, P51, DOI 10.1177/0269881108089597; ASHCROFT GW, 1965, J NEUROCHEM, V12, P483, DOI 10.1111/j.1471-4159.1965.tb06775.x; Bel N, 1996, J NEUROCHEM, V67, P669; BENKELFAT C, 1994, ARCH GEN PSYCHIAT, V51, P687; BIGGIO G, 1974, LIFE SCI, V14, P1321, DOI 10.1016/0024-3205(74)90440-8; Bouwknecht J. Adriaan, 2002, Behavioural Brain Research, V136, P489, DOI 10.1016/S0166-4328(02)00200-0; Brodkin ES, 2007, BEHAV BRAIN RES, V176, P53, DOI 10.1016/j.bbr.2006.06.025; CARLSSON A, 1976, J NEURAL TRANSM, V39, P1, DOI 10.1007/BF01248762; Casanovas JM, 1997, BRIT J PHARMACOL, V122, P733, DOI 10.1038/sj.bjp.0701420; CHASE TN, 1969, J NEUROCHEM, V16, P607, DOI 10.1111/j.1471-4159.1969.tb06860.x; Crockett MJ, 2011, MOL PSYCHIAT; Crockett MJ, 2009, J NEUROSCI, V29, P11993, DOI 10.1523/JNEUROSCI.2513-09.2009; DASZUTA A, 1981, J PHYSIOLOGY PARIS, V77, P315; DASZUTA A, 1982, DEV NEUROSCI-BASEL, V5, P130, DOI 10.1159/000112670; Demisch L, 2002, EUR ARCH PSY CLIN N, V252, P25; Dingerkus V, 2012, J NEURAL TR IN PRESS; Eagle DM, 2009, NEUROPSYCHOPHARMACOL, V34, P1311, DOI 10.1038/npp.2008.202; ECCLESTO.D, 1965, J NEUROCHEM, V12, P493, DOI 10.1111/j.1471-4159.1965.tb06776.x; FRANCESCONI RP, 1972, J NUTR, V102, P597, DOI 10.1093/jn/102.5.597; Invernizzi R, 1997, NEUROPHARMACOLOGY, V36, P467, DOI 10.1016/S0028-3908(97)00060-9; Kim DK, 2005, NEUROPHARMACOLOGY, V49, P798, DOI 10.1016/j.neuropharm.2005.08.010; Kim S, 2002, BEHAV PROCESS, V60, P181, DOI 10.1016/S0376-6357(02)00085-2; Mendelsohn D, 2009, NEUROSCI BIOBEHAV R, V33, P926, DOI 10.1016/j.neubiorev.2009.03.006; MOJA EA, 1989, LIFE SCI, V44, P971, DOI 10.1016/0024-3205(89)90497-9; MOJA EA, 1988, LIFE SCI, V42, P1551, DOI 10.1016/0024-3205(88)90013-6; Moore P, 2000, NEUROPSYCHOPHARMACOL, V23, P601, DOI 10.1016/S0893-133X(00)00161-5; MORGAN WW, 1975, LIFE SCI, V17, P143, DOI 10.1016/0024-3205(75)90250-7; Sakowski SA, 2006, J NEUROCHEM, V96, P758, DOI 10.1111/j.1471-4159.2005.03604.x; SHEARD MH, 1971, BRAIN RES, V26, P455, DOI 10.1016/S0006-8993(71)80026-4; Siesser WB, 2010, NEUROSCI LETT, V481, P6, DOI 10.1016/j.neulet.2010.06.035; Solberg LC, 2006, MAMM GENOME, V17, P129, DOI 10.1007/s00335-005-0112-1; Stadler C, 2007, NEUROPSYCHOBIOLOGY, V56, P104, DOI 10.1159/000112951; Stancampiano R, 1997, AM J PHYSIOL-REG I, V272, pR991, DOI 10.1152/ajpregu.1997.272.3.R991; Toker L, 2010, ISR J PSYCHIATR REL, V47, P46; van der Plasse G, 2007, PSYCHOPHARMACOLOGY, V195, P377, DOI 10.1007/s00213-007-0908-7; van Donkelaar EL, 2011, MOL PSYCHIATR, V16, P695, DOI 10.1038/mp.2011.9; van Donkelaar EL, 2010, NEUROCHEM INT, V56, P21, DOI 10.1016/j.neuint.2009.08.010; WURTMAN RJ, 1980, PHARMACOL REV, V32, P315; YOUNG SN, 1985, PSYCHOPHARMACOLOGY, V87, P173, DOI 10.1007/BF00431803; Zepf FD, 2008, HUM PSYCHOPHARM CLIN, V23, P291, DOI 10.1002/hup.934; Zepf FD, 2008, PHARMACOPSYCHIATRY, V41, P60, DOI 10.1055/s-2007-1004593; Zepf FD, 2008, HUM PSYCHOPHARM CLIN, V23, P43, DOI 10.1002/hup.896; Zepf F, 2009, J NEURAL TRANSM, V116, P105, DOI 10.1007/s00702-008-0146-0; Zepf FD, 2009, MED HYPOTHESES, V72, P47, DOI 10.1016/j.mehy.2008.06.046; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540	45	59	59	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e35916	10.1371/journal.pone.0035916	http://dx.doi.org/10.1371/journal.pone.0035916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629305	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343100004
J	Ma, J; Cui, W; He, SM; Duan, YH; Heng, LJ; Wang, L; Gao, GD				Ma, Jie; Cui, Wei; He, Shi-ming; Duan, Yong-hong; Heng, Li-jun; Wang, Liang; Gao, Guo-dong			Human U87 Astrocytoma Cell Invasion Induced by Interaction of beta ig-h3 with Integrin alpha 5 beta 1 Involves Calpain-2	PLOS ONE			English	Article							INDUCIBLE GENE-H3 BETA-IG-H3; GROWTH-FACTOR-BETA; ALPHA(5)BETA(1) INTEGRIN; ALPHA-3-BETA-1 INTEGRIN; EXTRACELLULAR-MATRIX; IN-VITRO; TGF-BETA; ADHESION; GLIOMA; MIGRATION	It is known that beta ig-h3 is involved in the invasive process of many types of tumors, but its mechanism in glioma cells has not been fully clarified. Using immunofluorescent double-staining and confocal imaging analysis, and co-immunoprecipitation assays, we found that beta ig-h3 co-localized with integrin alpha 5 beta 1 in U87 cells. We sought to elucidate the function of this interaction by performing cell invasion assays and gelatin zymography experiments. We found that siRNA knockdowns of beta ig-h3 and calpain-2 impaired cell invasion and MMP secretion. Moreover, beta ig-h3, integrins and calpain-2 are known to be regulated by Ca2+, and they are also involved in tumor cell invasion. Therefore, we further investigated if calpain-2 was relevant to beta ig-h3-integrin alpha 5 beta 1 interaction to affect U87 cell invasion. Our data showed that beta ig-h3 co-localized with integrin alpha 5 beta 1 to enhance the invasion of U87 cells, and that calpain-2, is involved in this process, acting as a downstream molecule.	[Ma, Jie; He, Shi-ming; Heng, Li-jun; Wang, Liang; Gao, Guo-dong] Forth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Peoples R China; [Cui, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol & Metab, Xian 710032, Peoples R China; [Duan, Yong-hong] Chinese Peoples Liberat Army, Hosp 451, Dept Orthopaed Surg, Xian, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Ma, J (corresponding author), Forth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Peoples R China.	neurogao@163.com	wang, liang/GXH-6755-2022	wang, liang/0000-0002-5247-6727	National Natural Science Foundation of China [31070940]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (31070940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2002, BIOCHEM BIOPH RES CO, V294, P940, DOI 10.1016/S0006-291X(02)00576-4; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Carragher NO, 2002, INT J BIOCHEM CELL B, V34, P1539, DOI 10.1016/S1357-2725(02)00069-9; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; Dai JY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-337; Delamarre E, 2009, AM J PATHOL, V175, P844, DOI 10.2353/ajpath.2009.080920; Farber K, 2008, MOL CELL NEUROSCI, V39, P579, DOI 10.1016/j.mcn.2008.08.005; Fan DG, 2009, CELL BIOL INT, V33, P1263, DOI 10.1016/j.cellbi.2009.08.014; GAO JX, 1995, CELL IMMUNOL, V163, P178, DOI 10.1006/cimm.1995.1114; Gibson RM, 2005, MOL CELL NEUROSCI, V28, P588, DOI 10.1016/j.mcn.2004.11.004; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guo YS, 2011, CELL BIOL INT, V35, P811, DOI 10.1042/CBI20100916; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Jang HS, 2010, NEUROCHEM RES, V35, P1796, DOI 10.1007/s11064-010-0246-8; Kawataki T, 2007, EXP CELL RES, V313, P3819, DOI 10.1016/j.yexcr.2007.07.038; Kim KW, 2009, NEUROCHEM RES, V34, P1479, DOI 10.1007/s11064-009-9935-6; Kim MO, 2003, NEUROSCI LETT, V336, P93, DOI 10.1016/S0304-3940(02)01260-0; Kita D, 2001, CANCER RES, V61, P7985; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Martin S, 2009, BBA-MOL CELL RES, V1793, P354, DOI 10.1016/j.bbamcr.2008.09.019; Meng XB, 2004, J PROTEOME RES, V3, P506, DOI 10.1021/pr0340983; PACHTER JA, 1995, ANAL BIOCHEM, V230, P101, DOI 10.1006/abio.1995.1443; Roumes H, 2010, EXP CELL RES, V316, P1587, DOI 10.1016/j.yexcr.2010.02.017; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; Tang J, 2008, CELL MOL LIFE SCI, V65, P2933, DOI 10.1007/s00018-008-8315-8; Tang J, 2009, EXP BIOL MED, V234, P35, DOI 10.3181/0806-RM-187; Thapa N, 2005, BONE, V36, P232, DOI 10.1016/j.bone.2004.08.007; Thapa N, 2007, INT J BIOCHEM CELL B, V39, P2183, DOI 10.1016/j.biocel.2007.06.004; Tsubokawa T, 2006, STROKE, V37, P1888, DOI 10.1161/01.STR.0000227259.15506.24; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; WAYNER EA, 1988, J CELL BIOL, V107, P1881, DOI 10.1083/jcb.107.5.1881; Wu HY, 2007, ACTA MED OKAYAMA, V61, P123; Yun SJ, 2002, MOL BRAIN RES, V107, P57, DOI 10.1016/S0169-328X(02)00447-3; Zeng BX, 2007, J REPROD IMMUNOL, V73, P1, DOI 10.1016/j.jri.2006.05.007	38	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37297	10.1371/journal.pone.0037297	http://dx.doi.org/10.1371/journal.pone.0037297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629380	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343100021
J	Sharples, RJ; Moss, SE; Patterson, TA; Hammond, PS				Sharples, Ruth J.; Moss, Simon E.; Patterson, Toby A.; Hammond, Philip S.			Spatial Variation in Foraging Behaviour of a Marine Top Predator (Phoca vitulina) Determined by a Large-Scale Satellite Tagging Program	PLOS ONE			English	Article							HARBOR SEALS; MORAY-FIRTH; GRAY SEALS; SEASONAL-VARIATION; GREY SEALS; MOVEMENTS; DIET; TELEMETRY; PATTERNS; SPACE	The harbour seal (Phoca vitulina) is a widespread marine predator in Northern Hemisphere waters. British populations have been subject to rapid declines in recent years. Food supply or inter-specific competition may be implicated but basic ecological data are lacking and there are few studies of harbour seal foraging distribution and habits. In this study, satellite tagging conducted at the major seal haul outs around the British Isles showed both that seal movements were highly variable among individuals and that foraging strategy appears to be specialized within particular regions. We investigated whether these apparent differences could be explained by individual level factors: by modelling measures of trip duration and distance travelled as a function of size, sex and body condition. However, these were not found to be good predictors of foraging trip duration or distance, which instead was best predicted by tagging region, time of year and inter-trip duration. Therefore, we propose that local habitat conditions and the constraints they impose are the major determinants of foraging movements. Specifically the distance to profitable feeding grounds from suitable haul-out locations may dictate foraging strategy and behaviour. Accounting for proximity to productive foraging resources is likely to be an important component of understanding population processes. Despite more extensive offshore movements than expected, there was also marked fidelity to the local haul-out region with limited connectivity between study regions. These empirical observations of regional exchange at short time scales demonstrates the value of large scale electronic tagging programs for robust characterization of at-sea foraging behaviour at a wide spatial scale.	[Sharples, Ruth J.; Moss, Simon E.; Hammond, Philip S.] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Sharples, Ruth J.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Patterson, Toby A.] CSIRO Wealth Oceans Res Flagship, Hobart, Tas, Australia	University of St Andrews; University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Sharples, RJ (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland.	rjsharples@gmail.com	Patterson, Toby/B-3836-2011	Patterson, Toby/0000-0002-7150-9205; Hammond, Philip/0000-0002-2381-8302	Department of Energy and Climate Change through its Strategic Environmental Assessment programme; Natural Environment Research Council [smru10001] Funding Source: researchfish	Department of Energy and Climate Change through its Strategic Environmental Assessment programme; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by the United Kingdom Department of Trade and Industry, now the Department of Energy and Climate Change (http://www.decc.gov.uk/) through its Strategic Environmental Assessment programme (http://www.offshore-sea..uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SM, 2004, CAN J ZOOL, V82, P1230, DOI 10.1139/Z04-093; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; BAKER JR, 1990, VET REC, V126, P75; Baxter JM, 2001, AQUAT CONSERV, V11, P261, DOI 10.1002/aqc.465; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Bolt HE, 2009, AQUAT CONSERV, V19, P671, DOI 10.1002/aqc.1030; Boyd IL, 1996, CAN J ZOOL, V74, P1696, DOI 10.1139/z96-187; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Bryant E, 2007, TR01 WILDTR TEL SYST; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Cunningham L, 2009, AQUATIC CONSERVATION, V19; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Estes JA, 2009, PHILOS T R SOC B, V364, P1647, DOI 10.1098/rstb.2008.0231; Fedak M, 2002, INTEGR COMP BIOL, V42, P3, DOI 10.1093/icb/42.1.3; FEDAK MA, 1983, J ZOOL, V200, P298, DOI 10.1111/j.1469-7998.1983.tb05794.x; Hall AJ, 1998, MAR ECOL PROG SER, V170, P269, DOI 10.3354/meps170269; Hall AJ, 2001, J ANIM ECOL, V70, P138; HARKONEN T, 1987, J ZOOL, V213, P535; Harris CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002710; Heath MR, 2005, ICES J MAR SCI, V62, P847, DOI 10.1016/j.icesjms.2005.01.023; Jeffries Steven J., 1993, Aquatic Mammals, V19, P21; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Lesage W, 2004, CAN J ZOOL, V82, P1070, DOI 10.1139/Z04-084; Lonergan M, 2007, J ZOOL, V271, P261, DOI 10.1111/j.1469-7998.2007.00311.x; Lowry LF, 2001, MAR MAMMAL SCI, V17, P835, DOI 10.1111/j.1748-7692.2001.tb01301.x; Matthiopoulos J, 2003, ECOL MODEL, V159, P239, DOI 10.1016/S0304-3800(02)00293-4; Matthiopoulos J, 2004, J APPL ECOL, V41, P476, DOI 10.1111/j.0021-8901.2004.00911.x; McConnell BJ, 1999, J APPL ECOL, V36, P573, DOI 10.1046/j.1365-2664.1999.00429.x; MCCONNELL BJ, 1992, J ZOOL, V226, P271, DOI 10.1111/j.1469-7998.1992.tb03839.x; OLESIUK PF, 1993, FISH B-NOAA, V91, P491; Patterson TA, 2010, ECOLOGY, V91, P273, DOI 10.1890/08-1480.1; PAYNE PM, 1989, MAR MAMMAL SCI, V5, P173, DOI 10.1111/j.1748-7692.1989.tb00331.x; PIERCE GJ, 1991, J ZOOL, V223, P641, DOI 10.1111/j.1469-7998.1991.tb04393.x; Reder S, 2003, POLAR BIOL, V27, P6, DOI 10.1007/s00300-003-0557-1; Revilla E, 2008, P NATL ACAD SCI USA, V105, P19120, DOI 10.1073/pnas.0801725105; Sharples RJ, 2009, MAR ECOL PROG SER, V390, P265, DOI 10.3354/meps08232; Simpkins MA, 2003, MAR MAMMAL SCI, V19, P791, DOI 10.1111/j.1748-7692.2003.tb01130.x; THOMPSON D, 1991, J ZOOL, V224, P223, DOI 10.1111/j.1469-7998.1991.tb04801.x; THOMPSON PM, 1991, J ANIM ECOL, V60, P283, DOI 10.2307/5460; THOMPSON PM, 1989, J APPL ECOL, V26, P521, DOI 10.2307/2404078; Thompson PM, 1996, J APPL ECOL, V33, P1572, DOI 10.2307/2404795; THOMPSON PM, 1990, J APPL ECOL, V27, P492, DOI 10.2307/2404296; Thompson PM, 1998, CAN J ZOOL, V76, P1044, DOI 10.1139/cjz-76-6-1044; THOMPSON PM, 1994, J ANIM ECOL, V63, P24, DOI 10.2307/5579; Tollit DJ, 1996, CAN J ZOOL, V74, P1110, DOI 10.1139/z96-123; VanParijs SM, 1997, ANIM BEHAV, V54, P35, DOI 10.1006/anbe.1996.0426; Venebles WilliamN., 2002, MODERN APPL STAT S; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Vincent C, NAMMCO SCI PUBLICATI, V8, P285; Wanless S, 2005, MAR ECOL PROG SER, V294, P1, DOI 10.3354/meps294001; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	52	59	59	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37216	10.1371/journal.pone.0037216	http://dx.doi.org/10.1371/journal.pone.0037216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629370	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343100018
J	Wen, Q; Jin, D; Zhou, CY; Zhou, MQ; Luo, W; Ma, L				Wen, Qian; Jin, Dan; Zhou, Chao-Ying; Zhou, Ming-Qian; Luo, Wei; Ma, Li			HGF-Transgenic MSCs Can Improve the Effects of Tissue Self-Repair in a Rabbit Model of Traumatic Osteonecrosis of the Femoral Head	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AVASCULAR NECROSIS; EXPRESSION; ENDOGLIN; PROTEIN; CELLS	Background: Osteonecrosis of the femoral head (ONFH) is generally characterized as an irreversible disease and tends to cause permanent disability. Therefore, understanding the pathogenesis and molecular mechanisms of ONFH and developing effective therapeutic methods is critical for slowing the progress of the disease. Methodology/Principal Findings: In this study, an experimental rabbit model of early stage traumatic ONFH was established, validated, and used for an evaluation of therapy. Computed tomography (CT) and magnetic resonance (MR) imaging confirmed that this model represents clinical Association Research Circulation Osseous (ARCO) phase I or II ONFH, which was also confirmed by the presence of significant tissue damage in osseous tissue and vasculature. Pathological examination detected obvious self-repair of bone tissue up to 2 weeks after trauma, as indicated by revascularization (marked by CD105) and expression of collagen type I (Col I), osteocalcin, and proliferating cell nuclear antigen. Transplantation of hepatocyte growth factor (HGF)-transgenic mesenchymal stem cells (MSCs) 1 week after trauma promoted recovery from ONFH, as evidenced by a reversed pattern of Col I expression compared with animals receiving no therapeutic treatment, as well as increased expression of vascular endothelial growth factor. Conclusions/Significance: These results indicate that the transplantation of HGF-transgenic MSCs is a promising method for the treatment for ONFH and suggest that appropriate interference therapy during the tissue self-repair stage contributes to the positive outcomes. This study also provides a model for the further study of the ONFH etiology and therapeutic interventions.	[Wen, Qian; Zhou, Chao-Ying; Zhou, Ming-Qian; Luo, Wei; Ma, Li] So Med Univ, Inst Mol Immunol, Guangzhou, Guangdong, Peoples R China; [Jin, Dan] So Med Univ, Dept Orthopaed & Traumatol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Wen, Q (corresponding author), So Med Univ, Inst Mol Immunol, Guangzhou, Guangdong, Peoples R China.	maryhmz@126.com		Ma, Li/0000-0001-5847-2375; Zhou, Chao-ying/0000-0002-4188-9630	Cooperation Project in Industry, Education and Research of Guangdong province; Ministry of Education of People's Republic of China [2011B090400013]; Science and Technology Project of Guangzhou [2009Z1-E441]; State 863 Projects [2007AA02Z458]	Cooperation Project in Industry, Education and Research of Guangdong province; Ministry of Education of People's Republic of China(Ministry of Education, China); Science and Technology Project of Guangzhou; State 863 Projects(National High Technology Research and Development Program of China)	This work was supported by the Cooperation Project in Industry, Education and Research of Guangdong province and Ministry of Education of People's Republic of China (2011B090400013), Science and Technology Project of Guangzhou (2009Z1-E441) and State 863 Projects (2007AA02Z458). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, ARCO NEWS; Arabmotlagh M, 2006, J ARTHROPLASTY, V21, P129, DOI 10.1016/j.arth.2005.04.014; Bachiller FGC, 2002, CLIN ORTHOP RELAT R, P87; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Barkalow Fern J., 1996, Microcirculation (Philadelphia), V3, P19, DOI 10.3109/10739689609146779; Dahners L E, 1989, J Orthop Trauma, V3, P309, DOI 10.1097/00005131-198912000-00009; Daltro Gildásio Cerqueira, 2008, Acta ortop. bras., V16, P23, DOI 10.1590/S1413-78522008000100004; Dong G, 2001, CANCER RES, V61, P5911; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; FREEMAN MAR, 1969, P ROY SOC MED, V62, P431, DOI 10.1177/003591576906200508; Gangji V, 2004, J BONE JOINT SURG AM, V86A, P1153, DOI 10.2106/00004623-200406000-00006; Gardeniers J, 1991, ARCO NEWS LETT, P153; Gardeniers JW, 1993, ARCO NEWS LETT, V5, P79; GLIMCHER MJ, 1979, CLIN ORTHOP RELAT R, P283; Huffman KM, 2007, RHEUMATOLOGY, V46, P523, DOI 10.1093/rheumatology/kel302; INOUE A, 1979, J BONE JOINT SURG BR, V61, P138, DOI 10.1302/0301-620X.61B2.438261; Kerachian MA, 2006, ENDOTHELIUM-J ENDOTH, V13, P237, DOI 10.1080/10623320600904211; Kusumi Tomomi, 2004, Nihon Rinsho, V62 Suppl 2, P136; Li CG, 2000, INT J CANCER, V89, P122, DOI 10.1002/(SICI)1097-0215(20000320)89:2<122::AID-IJC4>3.0.CO;2-M; MALIZOS KN, 1993, J ORTHOP RES, V11, P350, DOI 10.1002/jor.1100110306; Minhajat R, 2006, PATHOL INT, V56, P717, DOI 10.1111/j.1440-1827.2006.02037.x; Mont MA, 2001, J BONE JOINT SURG AM, V83A, P1013, DOI 10.2106/00004623-200107000-00006; NADEL SN, 1992, AM J ROENTGENOL, V159, P1255, DOI 10.2214/ajr.159.6.1442396; Nakamura T, 1997, CLIN ORTHOP RELAT R, P68; Nishino M, 1997, ARCH ORTHOP TRAUM SU, V116, P259, DOI 10.1007/BF00390048; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Sengupta S, 2003, CIRCULATION, V107, P2955, DOI 10.1161/01.CIR.0000077501.19266.E5; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Van Belle E, 1998, CIRCULATION, V97, P381; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Wen Q, 2008, GENE THER, V15, P1523, DOI 10.1038/gt.2008.110; Wen Q, 2012, J CELL MOL MED, V16, P1260, DOI 10.1111/j.1582-4934.2011.01407.x; Wojta J, 1999, LAB INVEST, V79, P427; Yin L, 2006, CHINESE MED J-PEKING, V119, P581, DOI 10.1097/00029330-200604010-00012	34	19	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37503	10.1371/journal.pone.0037503	http://dx.doi.org/10.1371/journal.pone.0037503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629409	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100037
J	Chuang, LY; Lin, YD; Chang, HW; Yang, CH				Chuang, Li-Yeh; Lin, Yu-Da; Chang, Hsueh-Wei; Yang, Cheng-Hong			An Improved PSO Algorithm for Generating Protective SNP Barcodes in Breast Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMBINATIONAL POLYMORPHISMS; REPAIR GENES; ESTROGEN; SUSCEPTIBILITY; VARIANTS; ESR1; COMT	Background: Possible single nucleotide polymorphism (SNP) interactions in breast cancer are usually not investigated in genome-wide association studies. Previously, we proposed a particle swarm optimization (PSO) method to compute these kinds of SNP interactions. However, this PSO does not guarantee to find the best result in every implement, especially when high-dimensional data is investigated for SNP-SNP interactions. Methodology/Principal Findings: In this study, we propose IPSO algorithm to improve the reliability of PSO for the identification of the best protective SNP barcodes (SNP combinations and genotypes with maximum difference between cases and controls) associated with breast cancer. SNP barcodes containing different numbers of SNPs were computed. The top five SNP barcode results are retained for computing the next SNP barcode with a one-SNP-increase for each processing step. Based on the simulated data for 23 SNPs of six steroid hormone metabolisms and signalling-related genes, the performance of our proposed IPSO algorithm is evaluated. Among 23 SNPs, 13 SNPs displayed significant odds ratio (OR) values (1.268 to 0.848; p < 0.05) for breast cancer. Based on IPSO algorithm, the jointed effect in terms of SNP barcodes with two to seven SNPs show significantly decreasing OR values (0.84 to 0.57; p < 0.05 to 0.001). Using PSO algorithm, two to four SNPs show significantly decreasing OR values (0.84 to 0.77; p < 0.05 to 0.001). Based on the results of 20 simulations, medians of the maximum differences for each SNP barcode generated by IPSO are higher than by PSO. The interquartile ranges of the boxplot, as well as the upper and lower hinges for each n-SNP barcode (n = 3 similar to 10) are more narrow in IPSO than in PSO, suggesting that IPSO is highly reliable for SNP barcode identification. Conclusions/Significance: Overall, the proposed IPSO algorithm is robust to provide exact identification of the best protective SNP barcodes for breast cancer.	[Chuang, Li-Yeh] I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Inst Biotechnol & Chem Engn, Kaohsiung, Taiwan; [Lin, Yu-Da; Yang, Cheng-Hong] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Ctr Excellence Environm Med, Canc Ctr,Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan	I Shou University; I Shou University; National Kaohsiung University of Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chuang, LY (corresponding author), I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan.	changhw@kmu.edu.tw; chyang@cc.kuas.edu.tw	Lin, Yu-da/M-7946-2013; Chang, Hsueh-Wei/C-9654-2009; Yang, Cheng-Hong/K-2438-2019; Yang, Cheng-Hong/M-7984-2013	Lin, Yu-da/0000-0001-5100-6072; Chang, Hsueh-Wei/0000-0003-0068-2366; Yang, Cheng-Hong/0000-0002-2741-0072	National Science Council in Taiwan [NSC99-2622-E-151-019-CC3, NSC99-2221-E-151-056-, DOH101-TD-C-111-002]; Kaohsiung Medical University Research Foundation [KMUER014, KMU-M110001]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Research Foundation	This work is partly supported by the National Science Council in Taiwan under grants NSC99-2622-E-151-019-CC3, NSC99-2221-E-151-056-, and DOH101-TD-C-111-002, and by the Kaohsiung Medical University Research Foundation (KMUER014 and KMU-M110001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2002, MOL CELL ENDOCRINOL, V193, P121, DOI 10.1016/S0303-7207(02)00105-3; Auricchio F, 2008, STEROIDS, V73, P880, DOI 10.1016/j.steroids.2008.01.023; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Chen L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024495; Chen SH, 2008, GENET EPIDEMIOL, V32, P152, DOI 10.1002/gepi.20272; Chung YJ, 2007, BIOINFORMATICS, V23, P71, DOI 10.1093/bioinformatics/btl557; Conde J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-344; Fanale D, 2012, ONCOGENE, V31, P2121, DOI 10.1038/onc.2011.408; Fortunati N, 2010, MOL CELL ENDOCRINOL, V316, P86, DOI 10.1016/j.mce.2009.09.012; Giovannelli P, 2011, FRONT BIOSCI-LANDMRK, V16, P2224, DOI 10.2741/3849; Han W, 2012, CANCER-AM CANCER SOC, V118, P594, DOI 10.1002/cncr.26220; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kraft P, 2010, NAT GENET, V42, P819, DOI 10.1038/ng1010-819; LaPensee EW, 2010, ENDOCR-RELAT CANCER, V17, pR91, DOI 10.1677/ERC-09-0253; Li JM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2772; Lin G.T., 2008, CHIN J PHYSL, V91, P1; Lin GT, 2009, OMICS, V13, P165, DOI 10.1089/omi.2008.0050; Low YL, 2006, NUTR CANCER, V56, P31, DOI 10.1207/s15327914nc5601_5; Mechanic LE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-146; Meindl A, 2009, BREAST CARE, V4, P93, DOI 10.1159/000211991; Pharoah PDP, 2007, PLOS GENET, V3, P401, DOI 10.1371/journal.pgen.0030042; Ricceri F, 2010, DNA REPAIR, V9, P191, DOI 10.1016/j.dnarep.2009.12.002; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Soto AM, 2001, J NATL CANCER I, V93, P1673, DOI 10.1093/jnci/93.22.1673; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Udler MS, 2009, INT J CANCER, V125, P2687, DOI 10.1002/ijc.24678; Yang CH, 2011, OMICS, V15, P399, DOI 10.1089/omi.2010.0028; Yang CH, 2009, CANCER EPIDEMIOL, V33, P147, DOI 10.1016/j.canep.2009.07.001; Yen CY, 2008, J ORAL PATHOL MED, V37, P271, DOI 10.1111/j.1600-0714.2007.00608.x; Yin JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025559; Yu JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2821; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	32	40	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37018	10.1371/journal.pone.0037018	http://dx.doi.org/10.1371/journal.pone.0037018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623973	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343500050
J	Conlisk, E; Lawson, D; Syphard, AD; Franklin, J; Flint, L; Flint, A; Regan, HM				Conlisk, Erin; Lawson, Dawn; Syphard, Alexandra D.; Franklin, Janet; Flint, Lorraine; Flint, Alan; Regan, Helen M.			The Roles of Dispersal, Fecundity, and Predation in the Population Persistence of an Oak (Quercus engelmannii) under Global Change	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ALTERED FIRE REGIME; CLIMATE-CHANGE; SEEDLING RECRUITMENT; ACORN PREDATION; RANGE SHIFTS; FRAGMENTATION; PATTERNS; PRECIPITATION; PREDICTION	A species' response to climate change depends on the interaction of biotic and abiotic factors that define future habitat suitability and species' ability to migrate or adapt. The interactive effects of processes such as fire, dispersal, and predation have not been thoroughly addressed in the climate change literature. Our objective was to examine how life history traits, short-term global change perturbations, and long-term climate change interact to affect the likely persistence of an oak species - Quercus engelmannii (Engelmann oak). Specifically, we combined dynamic species distribution models, which predict suitable habitat, with stochastic, stage-based metapopulation models, which project population trajectories, to evaluate the effects of three global change factors - climate change, land use change, and altered fire frequency emphasizing the roles of dispersal and seed predation. Our model predicted dramatic reduction in Q. engelmannii abundance, especially under drier climates and increased fire frequency. When masting lowers seed predation rates, decreased masting frequency leads to large abundance decreases. Current rates of dispersal are not likely to prevent these effects, although increased dispersal could mitigate population declines. The results suggest that habitat suitability predictions by themselves may under-estimate the impact of climate change for other species and locations.	[Conlisk, Erin; Regan, Helen M.] Univ Calif Riverside, Dept Biol, Ctr Conservat Biol, Riverside, CA 92521 USA; [Lawson, Dawn] Space & Naval Warfare Syst Ctr Pacific, Environm Sci & Appl Syst Branch, San Diego, CA USA; [Syphard, Alexandra D.] Conservat Biol Inst, La Mesa, CA USA; [Franklin, Janet] Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ USA; [Flint, Lorraine; Flint, Alan] USGS Calif Water Sci Ctr, Sacramento, CA USA	University of California System; University of California Riverside; Naval Information Warfare Center Pacific; Arizona State University; Arizona State University-Tempe; United States Department of the Interior; United States Geological Survey	Conlisk, E (corresponding author), Univ Calif Riverside, Dept Biol, Ctr Conservat Biol, Riverside, CA 92521 USA.	erin.conlisk@gmail.com		Syphard, Alexandra/0000-0003-3070-0596	National Science Foundation 488 [NSF-DEB-0824708]; United States Department of Energy [DE-FC02-06ER64159]	National Science Foundation 488; United States Department of Energy(United States Department of Energy (DOE))	Funding provided by National Science Foundation 488 (NSF-DEB-0824708) and the United States Department of Energy (DE-FC02-06ER64159) grants funded this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson WG, 2002, AM J BOT, V89, P119, DOI 10.3732/ajb.89.1.119; Akcakaya HR, 2005, RAMAS GIS; Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681; [Anonymous], 2005, EC HUM WELL BEING SY; Barbour MG, 1989, N AM TERRESTRIAL VEG; BORCHERT MI, 1989, ECOLOGY, V70, P389, DOI 10.2307/1937544; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Bullock JM, 2012, J ECOL, V100, P104, DOI 10.1111/j.1365-2745.2011.01910.x; CALVEG [ESRI geodatabase of vegetation from 1997-2002 Landsat TM. CA Land Cover Mapping and Monitoring Program], 2004, CALVEG ESRI GEOD VEG; Candau J.T., 2002, THESIS U CALIFORNIA; Carmel Y, 2006, FRONT ECOL ENVIRON, V4, P178; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; DARLEYHILL S, 1981, OECOLOGIA, V50, P231, DOI 10.1007/BF00348043; Davis FW, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00187.1; den Ouden J, 2004, SEED FATE PREDATION; Dixon MD, 1997, OECOLOGIA, V111, P201, DOI 10.1007/s004420050226; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; ESPELTA JM, 1995, J VEG SCI, V6, P465, DOI 10.2307/3236344; Espelta JM, 2009, J ECOL, V97, P1416, DOI 10.1111/j.1365-2745.2009.01564.x; Espelta JM, 2008, ECOLOGY, V89, P805, DOI 10.1890/07-0217.1; FLINT LE, 2012, ECOL PROCESS, V1, pNIL6, DOI DOI 10.1186/2192-1709-1-2; Franklin J, 2009, MAPPING SPECIES DIST; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Germaine HL, 1998, J VEG SCI, V9, P157, DOI 10.2307/3237114; Gomez JM, 2004, PLANT ECOL, V172, P287, DOI 10.1023/B:VEGE.0000026327.60991.f9; Gomez JM, 2003, ECOGRAPHY, V26, P573, DOI 10.1034/j.1600-0587.2003.03586.x; Grivet D, 2005, MOL ECOL, V14, P3585, DOI 10.1111/j.1365-294X.2005.02680.x; Haidinger T. L., 1993, Madrono, V40, P141; IUCN, 2019, IUCN RED LIST THREAT; Iverson LR, 2004, GLOBAL ECOL BIOGEOGR, V13, P209, DOI 10.1111/j.1466-822X.2004.00093.x; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Kelly Maggi, 2005, Madrono, V52, P191, DOI 10.3120/0024-9637(2005)52[191:DOAHDT]2.0.CO;2; KOENIG WD, 1994, CAN J FOREST RES, V24, P2105, DOI 10.1139/x94-270; Kueppers LM, 2005, P NATL ACAD SCI USA, V102, P16281, DOI 10.1073/pnas.0501427102; Lawson D. M., 1993, THESIS SAN DIEGO STA; Lawson DM, 2010, GLOBAL CHANGE BIOL, V16, P2518, DOI 10.1111/j.1365-2486.2009.02143.x; Linacre NA, 2004, CONSERV BIOL, V18, P768, DOI 10.1111/j.1523-1739.2004.00067.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Malcolm JR, 2002, J BIOGEOGR, V29, P835, DOI 10.1046/j.1365-2699.2002.00702.x; McCarthy MA, 2001, ANIM CONSERV, V4, P351, DOI 10.1017/S136794300100141X; Midgley GF, 2006, DIVERS DISTRIB, V12, P555, DOI 10.1111/j.1366-9516.2006.00273.x; Moore JE, 2007, OECOLOGIA, V151, P663, DOI 10.1007/s00442-006-0616-8; Nakamura M, 2010, AGR FOREST METEOROL, V150, P1026, DOI 10.1016/j.agrformet.2010.04.001; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; Perez-Ramos IM, 2010, ECOLOGY, V91, P3057, DOI 10.1890/09-2313.1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pincetl S, 2008, REAL ESTATE REV, V37, P25; Plumb TR, 1986, P S MULT US MAN CAL; POLAKOW D, 1999, C P BUSHF 99 AUSTR B; Principe ZA, 2002, THESIS SAN DIEGO U; Regan HM, 2010, ECOLOGY, V91, P1114, DOI 10.1890/09-0287.1; Scofield DG, 2010, J ECOL, V98, P561, DOI 10.1111/j.1365-2745.2010.01649.x; Snow GE, 1972, THESIS OREGON STATE; SORK VL, 1993, VEGETATIO, V108, P133; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Syphard AD, 2006, ECOL APPL, V16, P1744, DOI 10.1890/1051-0761(2006)016[1744:STEOFF]2.0.CO;2; Syphard AD, 2011, J ENVIRON MANAGE, V92, P1882, DOI 10.1016/j.jenvman.2011.03.014; Syphard AD, 2009, ECOGRAPHY, V32, P907, DOI 10.1111/j.1600-0587.2009.05883.x; Syphard AD, 2009, CONSERV BIOL, V23, P758, DOI 10.1111/j.1523-1739.2009.01223.x; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Vander Wall SB, 2002, ECOLOGY, V83, P3508, DOI 10.2307/3072099; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Wells ML, 2004, LANDSCAPE ECOL, V19, P139, DOI 10.1023/B:LAND.0000021713.81489.a7; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x	78	33	33	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36391	10.1371/journal.pone.0036391	http://dx.doi.org/10.1371/journal.pone.0036391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623955	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500015
J	Dussaubat, C; Brunet, JL; Higes, M; Colbourne, JK; Lopez, J; Choi, JH; Martin-Hernandez, R; Botias, C; Cousin, M; McDonnell, C; Bonnet, M; Belzunces, LP; Moritz, RFA; Le Conte, Y; Alaux, C				Dussaubat, Claudia; Brunet, Jean-Luc; Higes, Mariano; Colbourne, John K.; Lopez, Jacqueline; Choi, Jeong-Hyeon; Martin-Hernandez, Raquel; Botias, Cristina; Cousin, Marianne; McDonnell, Cynthia; Bonnet, Marc; Belzunces, Luc P.; Moritz, Robin F. A.; Le Conte, Yves; Alaux, Cedric			Gut Pathology and Responses to the Microsporidium Nosema ceranae in the Honey Bee Apis mellifera	PLOS ONE			English	Article							INTESTINAL ALKALINE-PHOSPHATASE; COLONY COLLAPSE DISORDER; PICORNA-LIKE VIRUS; COMPLETE GENOME SEQUENCE; DEFORMED WING VIRUS; PARALYSIS VIRUS; MOLECULAR CHARACTERIZATION; HYPOPHARYNGEAL-GLAND; NUCLEOTIDE-SEQUENCE; IMMUNE-RESPONSE	The microsporidium Nosema ceranae is a newly prevalent parasite of the European honey bee (Apis mellifera). Although this parasite is presently spreading across the world into its novel host, the mechanisms by it which affects the bees and how bees respond are not well understood. We therefore performed an extensive characterization of the parasite effects at the molecular level by using genetic and biochemical tools. The transcriptome modifications at the midgut level were characterized seven days post-infection with tiling microarrays. Then we tested the bee midgut response to infection by measuring activity of antioxidant and detoxification enzymes (superoxide dismutases, glutathione peroxidases, glutathione reductase, and glutathione-S-transferase). At the gene-expression level, the bee midgut responded to N. ceranae infection by an increase in oxidative stress concurrent with the generation of antioxidant enzymes, defense and protective response specifically observed in the gut of mammals and insects. However, at the enzymatic level, the protective response was not confirmed, with only glutathione-S-transferase exhibiting a higher activity in infected bees. The oxidative stress was associated with a higher transcription of sugar transporter in the gut. Finally, a dramatic effect of the microsporidia infection was the inhibition of genes involved in the homeostasis and renewal of intestinal tissues (Wnt signaling pathway), a phenomenon that was confirmed at the histological level. This tissue degeneration and prevention of gut epithelium renewal may explain early bee death. In conclusion, our integrated approach not only gives new insights into the pathological effects of N. ceranae and the bee gut response, but also demonstrate that the honey bee gut is an interesting model system for studying host defense responses.	[Dussaubat, Claudia; Brunet, Jean-Luc; Cousin, Marianne; McDonnell, Cynthia; Bonnet, Marc; Belzunces, Luc P.; Le Conte, Yves; Alaux, Cedric] INRA, UR Abeilles & Environm 406, Avignon, France; [Higes, Mariano; Martin-Hernandez, Raquel; Botias, Cristina] JCCM, Bee Pathol Lab, Ctr Apicola Reg, Marchamalo, Spain; [Colbourne, John K.; Lopez, Jacqueline; Choi, Jeong-Hyeon] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN USA; [Moritz, Robin F. A.] Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany	INRAE; Indiana University System; Indiana University Bloomington; Martin Luther University Halle Wittenberg	Dussaubat, C (corresponding author), INRA, UR Abeilles & Environm 406, Site Agroparc, Avignon, France.	cedric.alaux@avignon.inra.fr	Alaux, Cedric/B-4667-2013; Lopez, Jacqueline A/F-9712-2013; Martin-Hernandez, Raquel/J-7507-2013; Botías, Cristina/L-4918-2017; Le Conte, Yves M/B-3246-2016; Colbourne, John K/L-7748-2014; Higes, Mariano/N-9380-2017; BRUNET, Jean-Luc/ABE-9178-2021; Moritz, Robin FA/K-6053-2012; , Belzunces/P-7061-2019; Choi, Justin/F-8792-2014; Le Conte, Yves/AAP-2379-2021; Le Conte, Yves/M-4442-2018	Alaux, Cedric/0000-0002-3045-2599; Martin-Hernandez, Raquel/0000-0002-1730-9368; Botías, Cristina/0000-0002-3891-9931; Le Conte, Yves M/0000-0002-8466-5370; Colbourne, John K/0000-0002-6966-2972; Higes, Mariano/0000-0001-7338-5851; BRUNET, Jean-Luc/0000-0002-3827-1135; Moritz, Robin FA/0000-0003-0791-887X; , Belzunces/0000-0003-1798-9962; Le Conte, Yves/0000-0002-8466-5370; Le Conte, Yves/0000-0002-8466-5370	BEEDOC [RTD REG/E.4(2009)D/561221]; INRA Sante des Plantes et de l'Environnement department (AAP SPE); Junta de Comunidades de Castilla-La Mancha (Consejeria de Agricultura, Medio Rural y Marino, Programa Nacional Apicola); CONICYT/French Embassy of Chile; COLOSS short-term mission (COST Action) [FA0803]; Instituto de Recursos Humanos para la Ciencia y la Tecnologia (Fundacion Parque Cientifico y Tecnologico de Albaceta, Spain); INRA (INRA Sante des Plantes et de l'Environnement department); METACyt Initiative of Indiana University; Lilly Endowment, Inc.	BEEDOC; INRA Sante des Plantes et de l'Environnement department (AAP SPE); Junta de Comunidades de Castilla-La Mancha (Consejeria de Agricultura, Medio Rural y Marino, Programa Nacional Apicola)(Junta de Comunidades de Castilla-La Mancha); CONICYT/French Embassy of Chile; COLOSS short-term mission (COST Action); Instituto de Recursos Humanos para la Ciencia y la Tecnologia (Fundacion Parque Cientifico y Tecnologico de Albaceta, Spain); INRA (INRA Sante des Plantes et de l'Environnement department); METACyt Initiative of Indiana University; Lilly Endowment, Inc.	This work was co-funded by a BEEDOC grant (FP7, RTD REG/E.4(2009)D/561221), grants from INRA Sante des Plantes et de l'Environnement department (AAP SPE 2010) and Junta de Comunidades de Castilla-La Mancha (Consejeria de Agricultura, Medio Rural y Marino, Programa Nacional Apicola 2011-2013). C. Dussaubat was supported by a CONICYT/French Embassy of Chile grant and a COLOSS short-term mission (COST Action FA0803), R. Martin-Hernandez by the Instituto de Recursos Humanos para la Ciencia y la Tecnologia (Fundacion Parque Cientifico y Tecnologico de Albaceta, Spain), CM by the BEEDOC grant (FP7, RTD REG/E.4(2009)D/561221) and C. Alaux by an INRA young researcher position (INRA Sante des Plantes et de l'Environnement department). Work at the Center for Genomics and Bioinformatics was supported in part by the METACyt Initiative of Indiana University, funded in part through a major grant from the Lilly Endowment, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2011, J INVERTEBR PATHOL, V106, P380, DOI 10.1016/j.jip.2010.12.005; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Atwood H. L., 1997, Invertebrate Neuroscience, V3, P81, DOI 10.1007/BF02480362; Becnel James J., 1999, P447; Bodyrev AA, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1157, DOI 10.1023/A:1012441215506; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bounias M, 1996, ECOTOX ENVIRON SAFE, V35, P67, DOI 10.1006/eesa.1996.0082; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; COHN LA, 1994, AM J PHYSIOL, V266, pL397, DOI 10.1152/ajplung.1994.266.4.L397; Copenhaver PF, 2007, DEV DYNAM, V236, P1841, DOI 10.1002/dvdy.21138; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Costa C, 2011, J INVERTEBR PATHOL, V108, P224, DOI 10.1016/j.jip.2011.08.012; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; de Medina FS, 2004, BIOCHEM PHARMACOL, V68, P2317, DOI 10.1016/j.bcp.2004.07.045; de Miranda JR, 2004, J GEN VIROL, V85, P2263, DOI 10.1099/vir.0.79990-0; EGUCHI M, 1995, COMP BIOCHEM PHYS B, V111, P151, DOI 10.1016/0305-0491(94)00248-S; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Fenoy S, 2009, APPL ENVIRON MICROB, V75, P6886, DOI 10.1128/AEM.01025-09; Fergestad T, 2006, GENETICS, V172, P1031, DOI 10.1534/genetics.105.050625; Fischer P, 2008, NATURWISSENSCHAFTEN, V95, P723, DOI 10.1007/s00114-008-0378-8; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; FRIES I, 1988, APIDOLOGIE, V19, P319, DOI 10.1051/apido:19880310; Fries I., 1995, CROSSINFECTIVITY NOS, P151; Fries I., 1997, HONEY BEE PESTS PRED, P59; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Fujiyuki T, 2006, J VIROL, V80, P11528, DOI 10.1128/JVI.00754-06; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh RC, 1999, J GEN VIROL, V80, P1541, DOI 10.1099/0022-1317-80-6-1541; Gill EE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-296; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Gonzalez IL, 1997, GENOME RES, V7, P65, DOI 10.1101/gr.7.1.65; Govan VA, 2000, VIROLOGY, V277, P457, DOI 10.1006/viro.2000.0616; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2010, APIDOLOGIE, V41, P375, DOI 10.1051/apido/2010019; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Q, 2012, J INVERTEBR PATHOL, V109, P297, DOI 10.1016/j.jip.2012.01.004; Huang WF, 2008, J INVERTEBR PATHOL, V97, P9, DOI 10.1016/j.jip.2007.07.001; Huising MO, 2005, ENDOCRINOLOGY, V146, P2165, DOI 10.1210/en.2004-1514; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; KINNULA VL, 1992, AM J PHYSIOL, V262, pL708, DOI 10.1152/ajplung.1992.262.6.L708; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; Kubo T, 1996, J BIOCHEM-TOKYO, V119, P291, DOI 10.1093/oxfordjournals.jbchem.a021237; Kunieda T, 2006, INSECT MOL BIOL, V15, P563, DOI 10.1111/j.1365-2583.2006.00677.x; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Leat N, 2000, J GEN VIROL, V81, P2111, DOI 10.1099/0022-1317-81-8-2111; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Martin-Hernandez R, 2011, PARASITOL RES, V109, P605, DOI 10.1007/s00436-011-2292-9; Martin-Hernandez R, 2009, APPL ENVIRON MICROB, V75, P2554, DOI 10.1128/AEM.02908-08; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Meana A, 2010, J APICULT RES, V49, P212, DOI 10.3896/IBRA.1.49.2.12; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mehta B, 2001, DEVELOPMENT, V128, P3161; Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003; Naug D, 2009, APIDOLOGIE, V40, P595, DOI 10.1051/apido/2009039; Ohashi K, 1996, BIOCHEM BIOPH RES CO, V221, P380, DOI 10.1006/bbrc.1996.0604; Olivier V, 2008, VIRUS RES, V132, P59, DOI 10.1016/j.virusres.2007.10.014; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Paxton RJ, 2010, J APICULT RES, V49, P80, DOI 10.3896/IBRA.1.49.1.11; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Qin X, 2006, INSECT MOL BIOL, V15, P715, DOI 10.1111/j.1365-2583.2006.00694.x; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Scanlon M, 2000, J EUKARYOT MICROBIOL, V47, P525, DOI 10.1111/j.1550-7408.2000.tb00085.x; Scharf ME, 2005, INSECT MOL BIOL, V14, P31, DOI 10.1111/j.1365-2583.2004.00527.x; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; Slomovic S, 2006, CRIT REV PLANT SCI, V25, P65, DOI 10.1080/07352680500391337; Slomovic S, 2006, NUCLEIC ACIDS RES, V34, P2966, DOI 10.1093/nar/gkl357; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stengel A, 2009, ANNU REV PHYSIOL, V71, P219, DOI 10.1146/annurev.physiol.010908.163221; Team RDC, 2009, R LANG ENV STAT COMP; TSAI CC, 1995, DEVELOPMENT, V121, P453; Valanne S, 2010, J IMMUNOL, V184, P6188, DOI 10.4049/jimmunol.1000261; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Wang P, 2010, J CELL PHYSIOL, V222, P33, DOI 10.1002/jcp.21928; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Williams GR, 2008, J INVERTEBR PATHOL, V97, P189, DOI 10.1016/j.jip.2007.08.005; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Zander E., 1909, M NCH BIENENZ, V31, P196, DOI DOI 10.1016/J.BBAGEN.2015.01.008	99	169	178	4	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37017	10.1371/journal.pone.0037017	http://dx.doi.org/10.1371/journal.pone.0037017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623972	Green Published, gold			2022-12-25	WOS:000305343500049
J	Hudson, EP; Nikoshkov, A; Uhlen, M; Rockberg, J				Hudson, Elton P.; Nikoshkov, Andrej; Uhlen, Mathias; Rockberg, Johan			Automated Solid-Phase Subcloning Based on Beads Brought into Proximity by Magnetic Force	PLOS ONE			English	Article							PICHIA-PASTORIS; DNA-MOLECULES; IN-VITRO; CLONING; PCR; EXPRESSION; PRODUCTS; PROTEINS; EMULSION; TARGETS	In the fields of proteomics, metabolic engineering and synthetic biology there is a need for high-throughput and reliable cloning methods to facilitate construction of expression vectors and genetic pathways. Here, we describe a new approach for solid-phase cloning in which both the vector and the gene are immobilized to separate paramagnetic beads and brought into proximity by magnetic force. Ligation events were directly evaluated using fluorescent-based microscopy and flow cytometry. The highest ligation efficiencies were obtained when gene- and vector-coated beads were brought into close contact by application of a magnet during the ligation step. An automated procedure was developed using a laboratory workstation to transfer genes into various expression vectors and more than 95% correct clones were obtained in a number of various applications. The method presented here is suitable for efficient subcloning in an automated manner to rapidly generate a large number of gene constructs in various vectors intended for high throughput applications.	[Hudson, Elton P.; Nikoshkov, Andrej; Uhlen, Mathias; Rockberg, Johan] KTH Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden; [Uhlen, Mathias] KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden; [Uhlen, Mathias] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark	Royal Institute of Technology; Royal Institute of Technology; Technical University of Denmark	Hudson, EP (corresponding author), KTH Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden.	johanr@biotech.kth.se	Hudson, Paul/ABH-8177-2020; Uhlen, Mathias/B-3262-2016; Uhlen, Mathias/AAV-8746-2021	Uhlen, Mathias/0000-0002-4858-8056; Hudson, Elton/0000-0003-1899-7649	Novo Nordisk Foundation; Knut and Alice Wallenberg Foundation; VINNOVA ProNova center; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); VINNOVA ProNova center(Vinnova); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Novo Nordisk Foundation, Knut and Alice Wallenberg Foundation and the VINNOVA ProNova center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Ayra-Pardo Camilo, 1998, Biotecnologia Aplicada, V15, P173; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Castronovo M, 2008, NANO LETT, V8, P4140, DOI 10.1021/nl802370g; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; Gan R, 2008, BIOTECHNOL PROGR, V24, P1107, DOI 10.1002/btpr.43; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Isalan M, 2005, NAT METHODS, V2, P113, DOI 10.1038/NMETH732; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Kojima T, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni143; Larsson M, 2000, J BIOTECHNOL, V80, P143, DOI 10.1016/S0168-1656(00)00258-3; Lee H, 2010, NAT MATER, V9, P745, DOI [10.1038/nmat2815, 10.1038/NMAT2815]; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Naimushin AN, 2001, BIOPOLYMERS, V58, P204, DOI 10.1002/1097-0282(200102)58:2<204::AID-BIP90>3.0.CO;2-1; NILSSON P, 1995, ANAL BIOCHEM, V224, P400, DOI 10.1006/abio.1995.1057; Peterson AW, 2001, NUCLEIC ACIDS RES, V29, P5163, DOI 10.1093/nar/29.24.5163; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Riccelli PV, 2001, NUCLEIC ACIDS RES, V29, P996, DOI 10.1093/nar/29.4.996; Rockberg J, 2008, NAT METHODS, V5, P1039, DOI 10.1038/nmeth.1272; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Roth ME, 2004, NAT BIOTECHNOL, V22, P418, DOI 10.1038/nbt948; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; STAHL S, 1988, NUCLEIC ACIDS RES, V16, P3025, DOI 10.1093/nar/16.7.3025; Steen J, 2006, PROTEIN EXPRES PURIF, V46, P173, DOI 10.1016/j.pep.2005.12.010; UHLEN M, 1989, NATURE, V340, P733, DOI 10.1038/340733a0; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02; Yeung SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl702	35	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37429	10.1371/journal.pone.0037429	http://dx.doi.org/10.1371/journal.pone.0037429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624028	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500113
J	Samonis, G; Karageorgopoulos, DE; Maraki, S; Levis, P; Dimopoulou, D; Spernovasilis, NA; Kofteridis, DP; Falagas, ME				Samonis, George; Karageorgopoulos, Drosos E.; Maraki, Sofia; Levis, Panagiotis; Dimopoulou, Dimitra; Spernovasilis, Nikolaos A.; Kofteridis, Diamantis P.; Falagas, Matthew E.			Stenotrophomonas maltophilia Infections in a General Hospital: Patient Characteristics, Antimicrobial Susceptibility, and Treatment Outcome	PLOS ONE			English	Article							MULTIDRUG-RESISTANT STRAINS; GRAM-NEGATIVE BACILLI; XANTHOMONAS-MALTOPHILIA; AGAR DILUTION; POLYMYXIN-B; PATHOGEN; MORTALITY; CRITERIA; THERAPY; COLONIZATION	Introduction: Stenotrophomonas maltophilia is acquiring increasing importance as a nosocomial pathogen. Methods: We retrospectively studied the characteristics and outcome of patients with any type of S. maltophilia infection at the University Hospital of Heraklion, Crete, Greece, between 1/2005-12/2010. S. maltophilia antimicrobial susceptibility was tested with the agar dilution method. Prognostic factors for all-cause in-hospital mortality were assessed with multivariate logistic regression. Results: Sixty-eight patients (median age: 70.5 years; 64.7% males) with S. maltophilia infection, not related to cystic fibrosis, were included. The 68 patients were hospitalized in medical (29.4%), surgical (26.5%), hematology/oncology departments (23.5%), or the intensive care units (ICU; 20.6%). The most frequent infection types were respiratory tract (54.4%), bloodstream (16.2%), skin/soft tissue (10.3%), and intra-abdominal (8.8%) infection. The S. maltophilia-associated infection was polymicrobial in 33.8% of the cases. In vitro susceptibility was higher to colistin (91.2%), trimethoprim/sulfamethoxazole and netilmicin (85.3% each), and ciprofloxacin (82.4%). The empirical and the targeted treatment regimens were microbiologically appropriate for 47.3% and 63.6% of the 55 patients with data available, respectively. Most patients received targeted therapy with a combination of agents other than trimethoprim/sulfamethoxazole. The crude mortality and the mortality and the S. maltophilia infection-related mortality were 14.7% and 4.4%, respectively. ICU hospitalization was the only independent prognostic factor for mortality. Conclusion: S. maltophilia infection in a general hospital can be associated with a good prognosis, except for the patients hospitalized in the ICU. Combination reigmens with fluoroquinolones, colistin, or tigecycline could be alternative treatment options to trimethoprim/sulfamethoxazole.	[Samonis, George; Dimopoulou, Dimitra; Spernovasilis, Nikolaos A.; Kofteridis, Diamantis P.] Univ Hosp Heraklion, Dept Internal Med, Iraklion, Crete, Greece; [Karageorgopoulos, Drosos E.; Levis, Panagiotis; Falagas, Matthew E.] Alfa Inst Biomed Sci, Athens, Greece; [Karageorgopoulos, Drosos E.] Hellen Ctr Dis Control & Prevent, Athens, Greece; [Maraki, Sofia] Univ Hosp Heraklion, Dept Clin Microbiol, Iraklion, Crete, Greece; [Falagas, Matthew E.] Henry Dunant Hosp, Dept Med, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	University Hospital of Heraklion; Alfa Institute Of Biomedical Sciences; University Hospital of Heraklion; Henry Dunant Hospital; Tufts University	Samonis, G (corresponding author), Univ Hosp Heraklion, Dept Internal Med, Iraklion, Crete, Greece.	m.falagas@aibs.gr	Karageorgopoulos, Drosos/K-9241-2018	Karageorgopoulos, Drosos/0000-0002-9959-9978				Araoka H, 2010, EUR J CLIN MICROBIOL, V29, P605, DOI 10.1007/s10096-010-0882-6; Betriu C, 2002, J ANTIMICROB CHEMOTH, V50, P758, DOI 10.1093/jac/dkf196; Blanquer D, 2008, J CHEMOTHERAPY, V20, P761, DOI 10.1179/joc.2008.20.6.761; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Del Toro MD, 2002, MEDICINE, V81, P228; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Falagas ME, 2008, J ANTIMICROB CHEMOTH, V62, P889, DOI 10.1093/jac/dkn301; Falagas ME, 2009, FUTURE MICROBIOL, V4, P1103, DOI 10.2217/FMB.09.84; Farrell DJ, 2010, ANTIMICROB AGENTS CH, V54, P2735, DOI 10.1128/AAC.01774-09; Gales AC, 2006, CLIN MICROBIOL INFEC, V12, P315, DOI 10.1111/j.1469-0691.2005.01351.x; Gales AC, 2001, J CLIN MICROBIOL, V39, P183, DOI 10.1128/JCM.39.1.183-190.2001; Garrison MW, 1996, ANTIMICROB AGENTS CH, V40, P2859, DOI 10.1128/AAC.40.12.2859; Gulmez D, 2010, J INFECT CHEMOTHER, V16, P322, DOI 10.1007/s10156-010-0068-2; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hu LF, 2011, INT J ANTIMICROB AG, V37, P230, DOI 10.1016/j.ijantimicag.2010.10.025; Kwa ALH, 2008, ANN ACAD MED SINGAP, V37, P826; LAING FPY, 1995, J CLIN MICROBIOL, V33, P513, DOI 10.1128/JCM.33.3.513-518.1995; Lambert T, 1999, ANTIMICROB AGENTS CH, V43, P2366, DOI 10.1128/AAC.43.10.2366; Leclercq R, 2011, CLIN MICROBIOL INFEC; LECSOBORNET M, 1992, ANTIMICROB AGENTS CH, V36, P669, DOI 10.1128/AAC.36.3.669; Li XZ, 2003, J ANTIMICROB CHEMOTH, V51, P803, DOI 10.1093/jac/dkg148; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Nicodemo AC, 2007, EUR J CLIN MICROBIOL, V26, P229, DOI 10.1007/s10096-007-0279-3; Nicodemo AC, 2004, J ANTIMICROB CHEMOTH, V53, P604, DOI 10.1093/jac/dkh128; Penzak SR, 1997, PHARMACOTHERAPY, V17, P293; Safdar A, 2007, CLIN INFECT DIS, V45, P1602, DOI 10.1086/522998; San Gabriel P, 2004, ANTIMICROB AGENTS CH, V48, P168, DOI 10.1128/AAC.48.1.168-171.2004; Toleman MA, 2007, EMERG INFECT DIS, V13, P559, DOI 10.3201/eid1304.061378; Traub WH, 1998, CHEMOTHERAPY, V44, P164, DOI 10.1159/000007111; Valdezate S, 2005, J ANTIMICROB CHEMOTH, V56, P220, DOI 10.1093/jac/dki182; Valdezate S, 2004, J CLIN MICROBIOL, V42, P693, DOI 10.1128/JCM.42.2.693-699.2003; Valdezate S, 2001, ANTIMICROB AGENTS CH, V45, P1581, DOI 10.1128/AAC.45.5.1581-1584.2001; VanCouwenberghe CJ, 1997, INFECT CONT HOSP EP, V18, P316, DOI 10.1086/647618; VARTIVARIAN S, 1994, ANTIMICROB AGENTS CH, V38, P624, DOI 10.1128/AAC.38.3.624; Vila J, 2002, ENFERM INFEC MICR CL, V20, P304, DOI 10.1016/S0213-005X(02)72803-6	38	74	82	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37375	10.1371/journal.pone.0037375	http://dx.doi.org/10.1371/journal.pone.0037375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624022	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500106
J	Badirou, I; Kurdi, M; Legendre, P; Rayes, J; Bryckaert, M; Casari, C; Lenting, PJ; Christophe, OD; Denis, CV				Badirou, Idinath; Kurdi, Mohamad; Legendre, Paulette; Rayes, Julie; Bryckaert, Marijke; Casari, Caterina; Lenting, Peter J.; Christophe, Olivier D.; Denis, Cecile V.			In Vivo Analysis of the Role of O-Glycosylations of Von Willebrand Factor	PLOS ONE			English	Article							N-LINKED GLYCOSYLATION; HUMAN VONWILLEBRAND-FACTOR; FACTOR-DEFICIENT MICE; GLYCOPROTEIN-IB-IX; THROMBUS FORMATION; FACTOR-VIII; A1 DOMAIN; PLASMA; CARBOHYDRATE; MUTATION	The objective of this project was to study the function of O-glycosylations in von Willebrand factor (VWF) life cycle. In total, 14 different murine Vwf cDNAs mutated on one or several O-glycosylations sites were generated: 9 individual mutants, 2 doublets, 2 clusters and 1 mutant with all 9 murine glycosylation sites mutated (Del-O-Gly). We expressed each mutated cDNA in VWF deficient-mice by hydrodynamic injection. An immunosorbent assay with Peanut Agglutinin (PNA) was used to verify the O-glycosylation status. Wild-type (WT) VWF expressed by hepatocytes after hydrodynamic injection was able to bind PNA with slightly higher affinity than endothelial-derived VWF. In contrast, the Del-O-Gly VWF mutant did not bind PNA, demonstrating removal of O-linked glycans. All mutants displayed a normal multimeric pattern. Two mutants, Del-OGly and T1255A/T1256A, led to expression levels 50% lower than those induced by WT VWF and their half-life in vivo was significantly reduced. When testing the capacity of each mutant to correct the bleeding time of VWF-deficient mice, we found that S1486A, T1255A, T1256A and the doublet T1255A/T1256A were unable to do so. In conclusion we have shown that O-glycosylations are dispensable for normal VWF multimerization and biosynthesis. It also appears that some O-glycosylation sites, particularly the T1255 and T1256 residues, are involved in the maintenance of VWF plasma levels and are essential for normal haemostasis. As for the S1486 residue, it seems to be important for platelet binding as demonstrated in vitro using perfusion experiments.	[Badirou, Idinath; Kurdi, Mohamad; Legendre, Paulette; Rayes, Julie; Bryckaert, Marijke; Casari, Caterina; Lenting, Peter J.; Christophe, Olivier D.; Denis, Cecile V.] INSERM, U770, F-94275 Le Kremlin Bicetre, France; [Legendre, Paulette; Bryckaert, Marijke; Lenting, Peter J.; Christophe, Olivier D.; Denis, Cecile V.] Univ Paris Sud, UMR S 770, F-94275 Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Badirou, I (corresponding author), INSERM, U770, F-94275 Le Kremlin Bicetre, France.	cecile.denis@inserm.fr	casari, caterina/GXG-5273-2022; Lenting, Peter/AAH-5663-2019; Denis, Cecile/A-7649-2011; christophe, olivier/W-4268-2017; Casari, Caterina/O-7537-2019; Lenting, Peter/F-8269-2013	Lenting, Peter/0000-0002-7937-3429; Denis, Cecile/0000-0001-5152-9156; christophe, olivier/0000-0002-9080-6336; Casari, Caterina/0000-0002-8271-6795; Lenting, Peter/0000-0002-7937-3429; Bryckaert, Marijke/0000-0003-3398-0976; Rayes, Julie/0000-0003-0499-6880	Institut National de la Sante et de la Recherche Medicale; Laboratoires Francais de Fractionnement et des Biotechnologies (LFB); Agence Nationale de la Recherche [ANR-08-CEXC-018-01]; Groupe d'Etude sur l'Hemostase et la Thrombose; Societe Francaise d'Hematologie	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Laboratoires Francais de Fractionnement et des Biotechnologies (LFB); Agence Nationale de la Recherche(French National Research Agency (ANR)); Groupe d'Etude sur l'Hemostase et la Thrombose; Societe Francaise d'Hematologie	This study was funded by Institut National de la Sante et de la Recherche Medicale, by Laboratoires Francais de Fractionnement et des Biotechnologies (LFB) and by a grant from Agence Nationale de la Recherche (ANR-08-CEXC-018-01) to PJL. IB is a recipient of a Ph.D. grant from the Groupe d'Etude sur l'Hemostase et la Thrombose and from the Societe Francaise d'Hematologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auwerx J, 2008, VIROLOGY, V382, P10, DOI 10.1016/j.virol.2008.09.010; Canis K, 2010, J THROMB HAEMOST, V8, P137, DOI 10.1111/j.1538-7836.2009.03665.x; CAREW JA, 1992, J CLIN INVEST, V90, P2258, DOI 10.1172/JCI116112; Chitta MS, 2007, PLATELETS, V18, P182, DOI 10.1080/09537100600938816; CRUZ MA, 1993, J BIOL CHEM, V268, P21238; Davies JA, 2008, J THROMB HAEMOST, V6, P97; Esch Jan Schulte am II, 2005, British Journal of Haematology, V128, P82, DOI 10.1111/j.1365-2141.2004.05253.x; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kauskot A, 2007, J BIOL CHEM, V282, P31990, DOI 10.1074/jbc.M701596200; Lenting PJ, 2004, J BIOL CHEM, V279, P12102, DOI 10.1074/jbc.M310436200; Martin C, 2007, J THROMB HAEMOST, V5, P1363, DOI 10.1111/j.1538-7836.2007.02536.x; Marx I, 2008, BLOOD, V112, P603, DOI 10.1182/blood-2008-02-142943; Marx I, 2008, ARTERIOSCL THROM VAS, V28, P419, DOI 10.1161/ATVBAHA.107.159442; McKinnon TAJ, 2008, BLOOD, V111, P3042, DOI 10.1182/blood-2007-06-095042; McKinnon TAJ, 2010, BLOOD, V116, P640, DOI 10.1182/blood-2010-02-267450; Mohlke KL, 1999, CELL, V96, P111, DOI 10.1016/S0092-8674(00)80964-2; Obert B, 1999, THROMB HAEMOSTASIS, V82, P1382; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; Plaimauer B, 2006, BLOOD, V107, P118, DOI 10.1182/blood-2005-06-2482; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; Rayes J, 2010, BLOOD, V115, P4870, DOI 10.1182/blood-2009-11-254193; Ruggeri ZM, 2003, CURR OPIN HEMATOL, V10, P142, DOI 10.1097/00062752-200303000-00008; SAKARIASSEN KS, 1979, NATURE, V279, P636, DOI 10.1038/279636a0; SAMOR B, 1989, GLYCOCONJUGATE J, V6, P263, DOI 10.1007/BF01047846; Stoddart JH, 1996, BLOOD, V88, P1692; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; Turecek PL, 2009, HAMOSTASEOLOGIE, V29, pS32; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200; van Schooten CJM, 2007, BLOOD, V109, P2430, DOI 10.1182/blood-2006-06-032706; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A, 2009, CURR PROTOC PROTEIN, P11; WAGNER DD, 1986, J CELL BIOL, V102, P1320, DOI 10.1083/jcb.102.4.1320; WEISS HJ, 1977, J CLIN INVEST, V60, P390, DOI 10.1172/JCI108788; Yang L, 2009, J THROMB HAEMOST, V7, P1696, DOI 10.1111/j.1538-7836.2009.03578.x	34	32	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37508	10.1371/journal.pone.0037508	http://dx.doi.org/10.1371/journal.pone.0037508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22616016	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341200080
J	Freudlsperger, C; Bian, Y; Wise, SC; Burnett, J; Coupar, J; Yang, X; Chen, Z; Van Waes, C				Freudlsperger, C.; Bian, Y.; Wise, S. Contag; Burnett, J.; Coupar, J.; Yang, X.; Chen, Z.; Van Waes, C.			TGF-beta and NF-kappa B signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers	ONCOGENE			English	Article						TGF-beta TAK1; NF-kappa B; SMAD7; celastrol; head and neck cancer	SQUAMOUS-CELL CARCINOMA; INDUCED APOPTOSIS; GENE-EXPRESSION; KINASE TAK1; GROWTH; ACTIVATION; RECEPTOR; PROTEIN; PROLIFERATION; INHIBITOR	Transforming growth factor-beta (TGF-beta) has a dual role in epithelial malignancies, including head and neck squamous cell carcinoma (HNSCC). Attenuation of canonical TGF-beta signaling enhances de novo tumor development, whereas TGF-beta overexpression and signaling paradoxically promotes malignant progression. We recently observed that TGF-beta-induced growth arrest response is attenuated, in association with aberrant activation of nuclear factor-kappa B (NF-kappa B), a transcription factor, which promotes malignant progression in HNSCC. However, what role cross-talk between components of the TGF-beta and NF-kappa B pathways plays in altered activation of these pathways has not been established. Here, we show TGF-beta receptor II and TGF-beta-activated kinase 1 (TAK1) are predominantly expressed in a subset of HNSCC tumors with nuclear activation of NF-kappa B family member RELA (p65). Further, TGF-beta 1 treatment induced sequential phosphorylation of TAK1, IKK, I kappa B alpha and RELA in human HNSCC lines. TAK1 enhances TGF-beta-induced NF-kappa B activation, as TAK1 siRNA knockdown decreased TGF-beta 1-induced phosphorylation of IKK, I kappa B and RELA, degradation of I kappa B alpha, RELA nuclear translocation and DNA binding, and NF-kappa B-induced reporter and target gene transcription. Functionally, TAK1 siRNA inhibited cell proliferation, migration and invasion. Celastrol, a TAK1 inhibitor and anti-inflammatory compound used in traditional Chinese medicine, also decreased TGF-beta 1-induced phosphorylation of TAK1 and RELA, and suppressed basal, TGF-beta 1- and tumor necrosis factor-alpha (TNF-alpha)-induced NF-kappa B reporter gene activity. Celastrol also inhibited cell proliferation, while increasing sub-G0 DNA fragmentation and Annexin V markers of apoptosis. Furthermore, TGF-beta and RELA activation promoted SMAD7 expression. In turn, SMAD7 preferentially suppressed TGF-beta-induced SMAD and NF-kappa B reporters when compared with constitutive or TNF-alpha-induced NF-kappa B reporter gene activation. Thus, cross-talk by TGF-beta via TAK1 and NF-kappa B promotes the malignant phenotype of HNSCC. Moreover, NF-kappa B may contribute to the downstream attenuation of canonical TGF-beta signaling through increased SMAD7 expression. Celastrol highlights the therapeutic potential of agents targeting TAK1 as a key node in this pro-oncogenic TGF-beta-NF-kappa B signal pathway. Oncogene (2013) 32, 1549-1559; doi:10.1038/onc.2012.171; published online 28 May 2012	[Freudlsperger, C.; Bian, Y.; Wise, S. Contag; Burnett, J.; Coupar, J.; Yang, X.; Chen, Z.; Van Waes, C.] Natl Inst Deafness & Other Commun Disorders, Tumor Biol Sect, Head & Neck Surg Branch, NIH, Bethesda, MD 20892 USA; [Freudlsperger, C.] Univ Hosp Tuebingen, Dept Oral & Maxillofacial Surg, Tubingen, Germany	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Chen, Z (corresponding author), Natl Inst Deafness & Other Commun Disorders, Tumor Biol Sect, Head & Neck Surg Branch, NIH, 10 Ctr Dr,MSC 1462,Bldg 10,Rm 4-2732, Bethesda, MD 20892 USA.	chenz@nidcd.nih.gov; vanwaesc@nidcd.nih.gov	Freudlsperger, Christian/ABE-2926-2020	Freudlsperger, Christian/0000-0002-4289-0457	National Institute on Deafness and Other Communication Disorders, NIH [ZIA-DC-000016, ZIA-DC-000073]; Clinical Research Training Program; NIH; Pfizer Inc.; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000073, ZIADC000016] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Clinical Research Training Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Inc.(Pfizer); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by intramural projects ZIA-DC-000016 and ZIA-DC-000073 from the National Institute on Deafness and Other Communication Disorders, NIH. Dr Contag Wise was supported by the Clinical Research Training Program, a public-private partnership supported jointly by the NIH and Pfizer Inc. The authors wish to thank Dr Ning T Yeh (NIDCD/NIH) and Chris Silvin (NHGRI/NIH) for their technical assistance. We would like to thank Drs Adam Glick and Ashok Kulkarni for review of the manuscript and helpful comments.	Arsura M, 1996, IMMUNITY, V5, P31, DOI 10.1016/S1074-7613(00)80307-6; Arsura M, 1997, CELL GROWTH DIFFER, V8, P1049; Arsura M, 2003, HEPATOLOGY, V38, P1540; Attisano L, 2001, GENOME BIOL, V2; Azuma M, 1999, EXP CELL RES, V250, P213, DOI 10.1006/excr.1999.4503; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bian YS, 2009, CANCER RES, V69, P5918, DOI 10.1158/0008-5472.CAN-08-4623; Bitzer M, 2000, GENE DEV, V14, P187; Bornstein S, 2009, J CLIN INVEST, V119, P3408, DOI 10.1172/JCI38854; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P1195; Calixto Joao B., 2004, Planta Medica, V70, P93, DOI 10.1055/s-2004-815483; Chatterjee A, 2010, CANCER RES, V70, P1419, DOI 10.1158/0008-5472.CAN-09-2613; Cohen J, 2009, CANCER RES, V69, P3415, DOI 10.1158/0008-5472.CAN-08-3704; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dowdy SC, 2003, J BIOL CHEM, V278, P44377, DOI 10.1074/jbc.M307202200; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Friedman J, 2007, CLIN CANCER RES, V13, P6568, DOI 10.1158/1078-0432.CCR-07-1591; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hong S, 2007, CANCER RES, V67, P9577, DOI 10.1158/0008-5472.CAN-07-1179; Hong S, 2007, NAT IMMUNOL, V8, P504, DOI 10.1038/ni1451; Irie T, 2000, FEBS LETT, V467, P160, DOI 10.1016/S0014-5793(00)01146-7; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; Jadrich JL, 2003, GENE EXPR PATTERNS, V3, P131, DOI 10.1016/S1567-133X(03)00012-7; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lee TL, 2008, INT J CANCER, V122, P1987, DOI 10.1002/ijc.23324; Li H, 2005, EUR J PHARMACOL, V512, P231, DOI 10.1016/j.ejphar.2005.02.030; Lu SL, 2006, GENE DEV, V20, P1331, DOI 10.1101/gad.1413306; Lu T, 2004, P NATL ACAD SCI USA, V101, P7112, DOI 10.1073/pnas.0402048101; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; REISS M, 1990, CANCER COMMUN, V2, P363, DOI 10.3727/095535490820874029; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Setty AR, 2005, SEMIN ARTHRITIS RHEU, V34, P773, DOI 10.1016/j.semarthrit.2005.01.011; Sheng HM, 1999, ONCOGENE, V18, P855, DOI 10.1038/sj.onc.1202397; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sovak MA, 1999, CELL GROWTH DIFFER, V10, P537; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Tao XL, 2002, ARTHRITIS RHEUM, V46, P1735, DOI 10.1002/art.10411; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; White RA, 2010, ONCOGENE, V29, P5437, DOI 10.1038/onc.2010.306; Wolf JS, 2001, CLIN CANCER RES, V7, P1812; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xie W, 2003, ONCOL RES, V14, P61, DOI 10.3727/000000003108748612; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r78; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yasui T, 2011, J BONE MINER RES, V26, P1447, DOI 10.1002/jbmr.357; Zhang PL, 2005, MODERN PATHOL, V18, P924, DOI 10.1038/modpathol.3800372; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	61	178	185	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 21	2013	32	12					1549	1559		10.1038/onc.2012.171	http://dx.doi.org/10.1038/onc.2012.171			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110PC	22641218	Green Accepted			2022-12-25	WOS:000316456000008
J	Ming-Lum, A; Shojania, S; So, E; McCarrell, E; Shaw, E; Vu, D; Wang, I; McIntosh, LP; Mui, ALF				Ming-Lum, Andrew; Shojania, Shaheen; So, Eva; McCarrell, Erin; Shaw, Eileen; Vu, David; Wang, Ida; McIntosh, Lawrence P.; Mui, Alice L-F			A pleckstrin homology-related domain in SHIP1 mediates membrane localization during Fc gamma receptor-induced phagocytosis	FASEB JOURNAL			English	Article						phosphoinositide-3 ' kinase; macrophage; lipid-binding domain	INOSITOL 5'-PHOSPHATASE SHIP; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; SH2 DOMAIN; IN-VIVO; NMR-SPECTROSCOPY; LARGER PROTEINS; DEFICIENT MICE; C-TERMINUS; CELLS	SH2 domain-containing inositol-5'-phosphatase-1 (SHIP1) inhibits inflammation by hydrolyzing phosphoinositide-3'-kinase generated membrane phosphatidylinositol-3,4,5-trisphosphate (PIP3). Bioinformatic analysis of SHIP1 from multiple species revealed a pleckstrin homololgy-related (PH-R) domain, which we hypothesize mediates SHIP1's association with the membrane, a requirement for its biological function. Recombinant murine SHIP1 PH-R domain was subjected to biophysical and biochemical analysis. Residues K370 and K397 were found to be important for PH-R domain association with membrane PIP3. Wildtype PH-R domain bound PIP3 with 1.9 +/- 0.2 nM affinity, while the affinity of a K370A/K397A substituted mutant was too low to measure. Wild-type ( but not the K370A/K397A substituted) full-length SHIP1 protein, reconstitutes normal inhibition of Fc gamma receptor-mediated phagocytosis when introduced into SHIP1(-/-) murine macrophages, reducing the number of phagocytic events by 2-fold as compared to SHIP1(-/-) cells. In fact, the PH-R-mediated membrane interaction appears to be a major mechanism by which SHIP1 is recruited to the membrane, since the K370A/K397A substitution reduced the recruitment of both full-length SHIP1 and the PH-R domain by >= 2-fold. We have previously shown that SHIP1 enzyme activity can be targeted for therapeutic purposes. The current studies suggest that molecules targeting the PH-R domain can also modulate SHIP1 function.-Ming-Lum, A., Shojania, S., So, E., McCarrell, E., Shaw, E., Vu, D., Wang, I., McIntosh, L. P., Mui, A. L. F. A pleckstrin homology-related domain in SHIP1 mediates membrane localization during Fc gamma receptor-induced phagocytosis. FASEB J. 26, 3163-3177 (2012). www.fasebj.org	[Ming-Lum, Andrew; So, Eva; McCarrell, Erin; Shaw, Eileen; Vu, David; Wang, Ida; Mui, Alice L-F] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada; [Shojania, Shaheen; McIntosh, Lawrence P.; Mui, Alice L-F] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [McIntosh, Lawrence P.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada; [Ming-Lum, Andrew; So, Eva; McCarrell, Erin; Shaw, Eileen; Vu, David; Wang, Ida; Mui, Alice L-F] Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute	Mui, ALF (corresponding author), Jack Bell Res Ctr, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	alice.mui@ubc.ca			Canadian Institutes for Health Research (CIHR) [MOP-84539]; Canadian Cancer Society Research Institute [017308]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	The authors gratefully acknowledge Dr. Gerald Krystal (University of British Columbia) for the SHIP1-deficient cells and his critical reading of the manuscript; Tina Chang (University of British Columbia) for performing experiments; and Raymond J. Andersen and Christopher J. Ong (University of British Columbia) for the reagents and their critical reading of the manuscript. Funding sources include the Canadian Institutes for Health Research (CIHR; MOP-84539 to A.L.F.M.) and the Canadian Cancer Society Research Institute (017308 to L.P.M). A.M.L. held CIHR doctoral research, Michael Smith Foundation for Health Research (MSFHR), and CIHR Transplantation Training Program graduate scholarships. S.S. held a CIHR Transplantation Training Program postdoctoral fellowship. D.V. held a CIHR Translational Research in Infectious Diseases scholarship. Instrument support for the biophysical studies was provided by the CIHR, the Canadian Foundation for Innovation, the British Columbia Knowledge Development Fund, the University of British Columbia Blusson Fund, and the MSFHR. Author contributions: A.M.L, S.S., L.P.M., and A.L.F.M. designed and performed research, analyzed data, and wrote the paper; E. So, E.M., E. Shaw, D.V., and I.W. performed experiments. Conflict of interest declaration: A.L.M., Raymond J. Andersen, Christopher J. Ong, and Gerald Krystal are scientific founders of Aquinox Pharmaceuticals. They do not receive compensation from the company, nor are they involved in day-to-day operations.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ai J, 2006, BLOOD, V107, P813, DOI 10.1182/blood-2005-05-1841; Aman MJ, 2000, MOL CELL BIOL, V20, P3576, DOI 10.1128/MCB.20.10.3576-3589.2000; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; BLASI E, 1989, CANCER BIOCHEM BIOPH, V10, P303; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Brooks R, 2010, J IMMUNOL, V184, P3582, DOI 10.4049/jimmunol.0902844; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Cox D, 2001, J EXP MED, V193, P61, DOI 10.1084/jem.193.1.61; Cozier GE, 2004, CURR TOP MICROBIOL, V282, P49; Damen JE, 2001, BLOOD, V97, P1343, DOI 10.1182/blood.V97.5.1343; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dewitt S, 2006, J CELL SCI, V119, P443, DOI 10.1242/jcs.02756; Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Edlich C, 2005, STRUCTURE, V13, P277, DOI 10.1016/j.str.2004.11.012; Ganesan LP, 2003, J BIOL CHEM, V278, P35710, DOI 10.1074/jbc.M305078200; Godard T., 2008, SPARKY 3 115; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Gupta N, 1999, J BIOL CHEM, V274, P7489, DOI 10.1074/jbc.274.11.7489; Harris SJ, 2011, J IMMUNOL, V186, P4936, DOI 10.4049/jimmunol.1002350; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Huang ZY, 2003, J LEUKOCYTE BIOL, V73, P823, DOI 10.1189/jlb.0902454; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Jaumouille V., CURR OPIN CELL BIOL, V23, P22; Kamen LA, 2007, MOL BIOL CELL, V18, P2463, DOI 10.1091/mbc.e07-01-0061; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KEIGHTLEY DD, 1980, J STEROID BIOCHEM, V13, P1317, DOI 10.1016/0022-4731(80)90092-8; Kennah M, 2009, EXP HEMATOL, V37, P1274, DOI 10.1016/j.exphem.2009.08.001; Kerr WG, 2011, ANN NY ACAD SCI, V1217, P1, DOI 10.1111/j.1749-6632.2010.05869.x; Kerr WG, 2011, GUT, V60, P177, DOI 10.1136/gut.2009.202283; KIENER PA, 1993, J BIOL CHEM, V268, P24442; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehmann AK, 2000, J IMMUNOL METHODS, V243, P229, DOI 10.1016/S0022-1759(00)00237-4; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; MacDonald SM, 2002, MOL IMMUNOL, V38, P1323, DOI 10.1016/S0161-5890(02)00082-2; March ME, 2002, SEMIN IMMUNOL, V14, P37, DOI 10.1006/smim.2001.0340; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; McLarren KW, 2011, AM J PATHOL, V179, P180, DOI 10.1016/j.ajpath.2011.03.018; Mehta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021175; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Ong CJ, 2007, BLOOD, V110, P1942, DOI 10.1182/blood-2007-03-079699; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; Sly LM, 2003, EXP HEMATOL, V31, P1170, DOI 10.1016/j.exphem.2003.09.011; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wada T, 1999, ENDOCRINOLOGY, V140, P4585, DOI 10.1210/en.140.10.4585; Wientjes FB, 2003, CURR OPIN HEMATOL, V10, P2, DOI 10.1097/00062752-200301000-00002; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P6464, DOI 10.1021/ja00093a069; Yogo K, 2006, ENDOCRINOLOGY, V147, P3307, DOI 10.1210/en.2005-1309; Zhang H., 2005, THRIFTY WEB SERVER V; Zhang Y., P NATL ACAD SCI US, V107, P19332	65	20	21	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2012	26	8					3163	3177		10.1096/fj.11-201475	http://dx.doi.org/10.1096/fj.11-201475			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22651931				2022-12-25	WOS:000307162800008
J	Sardar, HS; Gilbert, SP				Sardar, Harjinder S.; Gilbert, Susan P.			Microtubule Capture by Mitotic Kinesin Centromere Protein E (CENP-E)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE KINETOCHORE MOTOR; ATP HYDROLYSIS; DIMERIC EG5; PATHWAY; MITOSIS; ANAPHASE; STEP; PROMETAPHASE; PROCESSIVITY; CHROMOSOMES	Centromere protein E, CENP-E, is a kinetochore-associated kinesin-7 that establishes the microtubule-chromosome linkage and transports monooriented chromosomes to the spindle equator along kinetochore fibers of already bioriented chromosomes. As a processive kinesin, CENP-E uses a hand-over-hand mechanism, yet a number of studies suggest that CENP-E exhibits mechanistic differences from other processive kinesins that may be important for its role in chromosome congression. The results reported here show that association of CENP-E with the microtubule is unusually slow at 0.08 mu M-1 s(-1) followed by slow ADP release at 0.9 s(-1). ATP binding and hydrolysis are fast with motor dissociation from the microtubule at 1.4 s(-1), suggesting that CENP-E head detachment from the microtubule, possibly controlled by phosphate release, determines the rate of stepping during a processive run because the rate of microtubule gliding corresponds to 1.4 steps/s. We hypothesize that the unusually slow CENP-E microtubule association step favors CENP-E binding of stable microtubules over dynamic ones, a mechanism that would bias CENP-E binding to kinetochore fibers.	[Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Dept Biol, 110 8th St, Troy, NY 12180 USA.	sgilbert@rpi.edu			National Institutes of Health [R01 GM54141]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM54141 (to S. P. G.).	Bakhoum SF, 2012, CURR OPIN CELL BIOL, V24, P64, DOI 10.1016/j.ceb.2011.11.012; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Brown KD, 1996, J CELL SCI, V109, P961; BROWN KD, 1994, J CELL BIOL, V125, P1303, DOI 10.1083/jcb.125.6.1303; Chen CJ, 2011, J BIOL CHEM, V286, P29261, DOI 10.1074/jbc.M111.255554; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; Espeut J, 2008, MOL CELL, V29, P637, DOI 10.1016/j.molcel.2008.01.004; Gilbert SP, 2011, COMPREHENSIVE BIOPHYSICS, VOL 4: MOLECULAR MOTORS AND MOTILITY, P321, DOI 10.1016/B978-0-12-374920-8.00421-5; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; GILBERT SP, 1993, BIOCHEMISTRY-US, V32, P4677, DOI 10.1021/bi00068a028; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim ED, 2010, J BIOL CHEM, V285, P18650, DOI 10.1074/jbc.M109.092072; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Klumpp LM, 2003, BIOCHEMISTRY-US, V42, P2595, DOI 10.1021/bi026715r; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Krzysiak TC, 2008, J BIOL CHEM, V283, P2078, DOI 10.1074/jbc.M708354200; Krzysiak TC, 2006, J BIOL CHEM, V281, P39444, DOI 10.1074/jbc.M608056200; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Moyer ML, 1998, BIOCHEMISTRY-US, V37, P800, DOI 10.1021/bi9711184; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Rosenfeld SS, 2002, J BIOL CHEM, V277, P36731, DOI 10.1074/jbc.M205261200; Rosenfeld SS, 2009, J BIOL CHEM, V284, P32858, DOI 10.1074/jbc.M109.041210; Sardar HS, 2010, CURR BIOL, V20, P1648, DOI 10.1016/j.cub.2010.08.001; Shastry S, 2011, P NATL ACAD SCI USA, V108, P16253, DOI 10.1073/pnas.1102628108; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Toprak E, 2009, P NATL ACAD SCI USA, V106, P12717, DOI 10.1073/pnas.0808396106; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Waitzman JS, 2011, BIOPHYS J, V101, P2760, DOI 10.1016/j.bpj.2011.10.032; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Yardimci H, 2008, P NATL ACAD SCI USA, V105, P6016, DOI 10.1073/pnas.0711314105; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	52	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24894	24904		10.1074/jbc.M112.376830	http://dx.doi.org/10.1074/jbc.M112.376830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22637578	hybrid, Green Published			2022-12-25	WOS:000306651700004
J	Depetris, RS; Julien, JP; Khayat, R; Lee, JH; Pejchal, R; Katpally, U; Cocco, N; Kachare, M; Massi, E; David, KB; Cupo, A; Marozsan, AJ; Olson, WC; Ward, AB; Wilson, IA; Sanders, RW; Moore, JP				Depetris, Rafael S.; Julien, Jean-Philippe; Khayat, Reza; Lee, Jeong Hyun; Pejchal, Robert; Katpally, Umesh; Cocco, Nicolette; Kachare, Milind; Massi, Evan; David, Kathryn B.; Cupo, Albert; Marozsan, Andre J.; Olson, William C.; Ward, Andrew B.; Wilson, Ian A.; Sanders, Rogier W.; Moore, John P.			Partial Enzymatic Deglycosylation Preserves the Structure of Cleaved Recombinant HIV-1 Envelope Glycoprotein Trimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; SITE-SPECIFIC ANALYSIS; N-LINKED GLYCANS; GLYCOSYLATION SITES; LIGHT-SCATTERING; TYPE-1 GP120; NEUTRALIZATION SENSITIVITY; BROAD NEUTRALIZATION; CHEMOKINE RECEPTORS	The trimeric envelope glycoprotein complex (Env) is the focus of vaccine development programs aimed at generating protective humoral responses to human immunodeficiency virus type 1 (HIV-1). N-Linked glycans, which constitute almost half of the molecular mass of the external Env domains, produce considerable structural heterogeneity and are a major impediment to crystallization studies. Moreover, by shielding the peptide backbone, glycans can block attempts to generate neutralizing antibodies against a substantial subset of potential epitopes when Env proteins are used as immunogens. Here, we describe the partial deglycosylation of soluble, cleaved recombinant Env trimers by inhibition of the synthesis of complex N-glycans during Env production, followed by treatment with glycosidases under conditions that preserve Env trimer integrity. The partially deglycosylated trimers are stable, and neither abnormally sensitive to proteolytic digestion nor prone to aggregation. Moreover, the deglycosylated trimers retain or increase their ability to bind CD4 and antibodies that are directed to conformational epitopes, including the CD4-binding site and the V3 region. However, as expected, they do not react with glycan-dependent antibodies 2G12 and PGT123, or the C-type lectin receptor DC-SIGN. Electron microscopic analysis shows that partially deglycosylated trimers have a structure similar to fully glycosylated trimers, indicating that removal of glycans does not substantially perturb the structural integrity of the trimer. The gly-can-depleted Env trimers should be useful for structural and immunogenicity studies.	[Depetris, Rafael S.; Cocco, Nicolette; Kachare, Milind; Massi, Evan; David, Kathryn B.; Cupo, Albert; Marozsan, Andre J.; Sanders, Rogier W.; Moore, John P.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Julien, Jean-Philippe; Khayat, Reza; Lee, Jeong Hyun; Pejchal, Robert; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Katpally, Umesh; Olson, William C.] Progen Pharmaceut Inc, Tarrytown, NY 10591 USA; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	Cornell University; Scripps Research Institute; University of Amsterdam; Academic Medical Center Amsterdam	Sanders, RW (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.	rws2002@med.cornell.edu; jpm2003@med.cornell.edu	Ward, Andrew B/F-9203-2014; Ward, Andrew/ABD-7728-2021	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Julien, Jean-Philippe/0000-0001-7602-3995; Lee, Jeong Hyun/0000-0001-7371-845X	National Institutes of Health [P01 AI82362, R01 AI36082]; International AIDS Vaccine Initiative (IAVI); Canadian Institutes of Health Research (CIHR); Vidi from the Netherlands Organization for Scientific Research (NWO); European Research Council [ERC-StG-2011-280829-SHEV]; National Institutes of Health through the National Center for Research Resources' P41 program [RR017573]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI082362, R37AI036082, R01AI084817, R01AI036082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative (IAVI); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Vidi from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); National Institutes of Health through the National Center for Research Resources' P41 program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AI82362 and R01 AI36082 and the International AIDS Vaccine Initiative (IAVI).; Recipient of a Canadian Institutes of Health Research (CIHR) Fellowship.; Recipient of a Vidi grant from the Netherlands Organization for Scientific Research (NWO) and a Starting Investigator Grant from the European Research Council (ERC-StG-2011-280829-SHEV).; We thank James Robinson and Dennis Burton for donating reagents and Kenneth Kang for technical assistance. The electron microscopy data were collected by the authors at the National Resource for Automated Molecular Microscopy (NRAMM), which is supported by the National Institutes of Health through the National Center for Research Resources' P41 program Grant RR017573.	ALLAWAY GP, 1995, AIDS RES HUM RETROV, V11, P533, DOI 10.1089/aid.1995.11.533; Arakawa T, 2001, ANAL BIOCHEM, V299, P158, DOI 10.1006/abio.2001.5432; BACK NKT, 1994, VIROLOGY, V199, P431, DOI 10.1006/viro.1994.1141; Banerjee K, 2012, AIDS RES HUM RETROV, V28, P206, DOI 10.1089/aid.2011.0101; Banerjee K, 2009, VIROLOGY, V389, P108, DOI 10.1016/j.virol.2009.04.001; Beddows S, 2005, J VIROL, V79, P8812, DOI 10.1128/JVI.79.14.8812-8827.2005; Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Beddows S, 2006, AIDS RES HUM RETROV, V22, P569, DOI 10.1089/aid.2006.22.569; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; Dey AK, 2009, VIROLOGY, V385, P275, DOI 10.1016/j.virol.2008.12.009; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; FENOUILLET E, 1990, J VIROL, V64, P2841, DOI 10.1128/JVI.64.6.2841-2848.1990; FENOUILLET E, 1994, TRENDS BIOCHEM SCI, V19, P65, DOI 10.1016/0968-0004(94)90034-5; FENOUILLET E, 1989, J EXP MED, V169, P807, DOI 10.1084/jem.169.3.807; FISCHER E, 1995, GLYCOCONJUGATE J, V12, P707, DOI 10.1007/BF00731268; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Go EP, 2008, J PROTEOME RES, V7, P1660, DOI 10.1021/pr7006957; Go EP, 2007, ANAL CHEM, V79, P1708, DOI 10.1021/ac061548c; Go EP, 2011, INT J MASS SPECTROM, V305, P209, DOI 10.1016/j.ijms.2010.11.009; Go EP, 2009, J PROTEOME RES, V8, P4231, DOI 10.1021/pr9002728; GOJOBORI T, 1990, P NATL ACAD SCI USA, V87, P4108, DOI 10.1073/pnas.87.11.4108; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Iyer SPN, 2007, AIDS RES HUM RETROV, V23, P817, DOI 10.1089/aid.2006.0261; Kang Y, 2009, VACCINE, V27, P5120, DOI 10.1016/j.vaccine.2009.06.037; Kendrick BS, 2001, ANAL BIOCHEM, V299, P136, DOI 10.1006/abio.2001.5411; Kirschner M, 2006, PROTEIN EXPRES PURIF, V48, P61, DOI 10.1016/j.pep.2006.02.017; Klasse PJ, 2012, AIDS RES HUM RETROV, V28, P1, DOI [10.1089/aid.2011.0053, 10.1089/AID.2011.0053]; KORNFELD S, 1978, J BIOL CHEM, V253, P7771; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Losman B, 1999, FEBS LETT, V454, P47, DOI 10.1016/S0014-5793(99)00740-1; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; Malenbaum SE, 2000, J VIROL, V74, P11008, DOI 10.1128/JVI.74.23.11008-11016.2000; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; Marzi A, 2007, VIROLOGY, V368, P322, DOI 10.1016/j.virol.2007.07.004; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Means RE, 2000, J VIROL, V74, P11181, DOI 10.1128/JVI.74.23.11181-11190.2000; Melchers M, 2012, J VIROL, V86, P2488, DOI 10.1128/JVI.06259-11; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MONTEFIORI DC, 1993, J VIROL, V67, P2699, DOI 10.1128/JVI.67.5.2699-2706.1993; MONTEFIORI DC, 1988, P NATL ACAD SCI USA, V85, P9248, DOI 10.1073/pnas.85.23.9248; MOORE JP, 1995, J VIROL, V69, P122, DOI 10.1128/JVI.69.1.122-130.1995; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Perrin C, 1998, VIROLOGY, V242, P338, DOI 10.1006/viro.1997.9016; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Rucker J, 1997, J VIROL, V71, P8999, DOI 10.1128/JVI.71.12.8999-9007.1997; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Sanders RW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-10; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Scanlan CN, 2003, ADV EXP MED BIOL, V535, P205; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; SNAITH SM, 1968, BIOCHEM J, V110, P663, DOI 10.1042/bj1100663; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Stansell E, 2011, J VIROL, V85, P582, DOI 10.1128/JVI.01871-10; Stansell Elizabeth, 2010, Yale Journal of Biology and Medicine, V83, P201; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	84	43	51	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24239	24254		10.1074/jbc.M112.371898	http://dx.doi.org/10.1074/jbc.M112.371898			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645128	Green Published, hybrid			2022-12-25	WOS:000306651100018
J	Grunewald, M; Johnson, S; Lu, DY; Wang, Z; Lomberk, G; Albert, PR; Stockmeier, CA; Meyer, JH; Urrutia, R; Miczek, KA; Austin, MC; Wang, JM; Paul, IA; Woolverton, WL; Seo, S; Sittman, DB; Ou, XM				Grunewald, Matthew; Johnson, Shakevia; Lu, Deyin; Wang, Zhe; Lomberk, Gwen; Albert, Paul R.; Stockmeier, Craig A.; Meyer, Jeffrey H.; Urrutia, Raul; Miczek, Klaus A.; Austin, Mark C.; Wang, Junming; Paul, Ian A.; Woolverton, William L.; Seo, Seungmae; Sittman, Donald B.; Ou, Xiao-Ming			Mechanistic Role for a Novel Glucocorticoid-KLF11 (TIEG2) Protein Pathway in Stress-induced Monoamine Oxidase A Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR DEPRESSIVE DISORDER; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CELL-DEATH; INSULIN-BIOSYNTHESIS; SOCIAL STRESS; BRAIN; GENE; MICE; TRANSCRIPTION; BINDING	Chronic stress is a risk factor for psychiatric illnesses, including depressive disorders, and is characterized by increased blood glucocorticoids and brain monoamine oxidase A (MAO A, which degrades monoamine neurotransmitters). This study elucidates the relationship between stress-induced MAO A and the transcription factor Kruppel-like factor 11 (KLF11, also called TIEG2, a member of the Sp/KLF-family), which inhibits cell growth. We report that 1) a glucocorticoid (dexamethasone) increases KLF11 mRNA and protein levels in cultured neuronal cells; 2) overexpressing KLF11 increases levels of MAO A mRNA and enzymatic activity, which is further enhanced by glucocorticoids; in contrast, siRNA-mediated KLF11 knockdown reduces glucocorticoid-induced MAO A expression in cultured neurons; 3) induction of KLF11 and translocation of KLF11 from the cytoplasm to the nucleus are key regulatory mechanisms leading to increased MAO A catalytic activity and mRNA levels because of direct activation of the MAO A promoter via Sp/KLF-binding sites; 4) KLF11 knockout mice show reduced MAOA mRNA and catalytic activity in the brain cortex compared with wild-type mice; and 5) exposure to chronic social defeat stress induces blood glucocorticoids and activates the KLF11 pathway in the rat brain, which results in increased MAO A mRNA and enzymatic activity. Thus, this study reveals for the first time that KLF11 is an MAO A regulator and is produced in response to neuronal stress, which transcriptionally activates MAOA. The novel glucocorticoid-KLF11-MAOA pathway may play a crucial role in modulating distinct pathophysiological steps in stress-related disorders.	[Grunewald, Matthew; Johnson, Shakevia; Lu, Deyin; Wang, Zhe; Stockmeier, Craig A.; Austin, Mark C.; Paul, Ian A.; Woolverton, William L.; Ou, Xiao-Ming] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA; [Wang, Junming] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Sittman, Donald B.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Lomberk, Gwen; Urrutia, Raul; Seo, Seungmae] Mayo Clin, GI Res Unit, Epigenet & Chromatin Dynam Lab, Rochester, MN 55905 USA; [Albert, Paul R.] Ottawa Hosp, Res Inst Neurosci, Ottawa, ON K1H 8M5, Canada; [Meyer, Jeffrey H.] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada; [Meyer, Jeffrey H.] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; [Miczek, Klaus A.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA; [Stockmeier, Craig A.] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Mayo Clinic; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Tufts University; Case Western Reserve University	Ou, XM (corresponding author), Univ Mississippi, Med Ctr, Div Neurobiol & Behav Res, Dept Psychiat & Human Behav G 109, 2500 N State St, Jackson, MS 39216 USA.	xou@umc.edu	Lomberk, Gwen/AAL-8490-2020; Albert, Paul/E-4804-2010	Lomberk, Gwen/0000-0001-5463-789X; Albert, Paul/0000-0002-1809-3554; Seo, Seungmae/0000-0003-2175-6440	National Institutes of Health [DK 52913]; National Institute on Alcohol Abuse and Alcoholism [R01AA020103]; Public Health Service [P20 RR 017701]; National Alliance for Research on Schizophrenia and Depression; Canadian Institutes of Health Research; University of Mississippi Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, R56DK052913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Alliance for Research on Schizophrenia and Depression(NARSAD); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Mississippi Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 52913 (to R. U.) and by National Institute on Alcohol Abuse and Alcoholism Grant R01AA020103 (to X. O.). This work was also supported by Public Health Service Grant P20 RR 017701 (to C. A. S.), by the National Alliance for Research on Schizophrenia and Depression (to J. H. M. and X. O.), by the Canadian Institutes of Health Research (to P. R. A. and J. H. M.), and by an intramural research support grant from the University of Mississippi Medical Center (to J. W. and X. O.). J. H. M. has applied for a patent to employ MAO measures to diagnose or identify subtypes of major depressive disorder. He has had operating grant support/consultation with GlaxoSmithKline, BristolMyersSquibb, Lundbeck, SK Life Sciences, and Eli-Lilly.	Bonnefond A, 2011, J BIOL CHEM, V286, P28414, DOI 10.1074/jbc.M110.215822; Buttar NS, 2010, J BIOL CHEM, V285, P11433, DOI 10.1074/jbc.M109.077065; Cao S, 2005, J BIOL CHEM, V280, P1901, DOI 10.1074/jbc.M407941200; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chen Y, 2007, PHYTOMEDICINE, V14, P523, DOI 10.1016/j.phymed.2006.09.007; Chen Y, 2012, STRESS, V15, P74, DOI 10.3109/10253890.2011.585188; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Dietz DM, 2011, BIOL PSYCHIAT, V70, P408, DOI 10.1016/j.biopsych.2011.05.005; Doyle A, 1996, LIFE SCI, V59, P1357, DOI 10.1016/0024-3205(96)00461-4; Du LS, 2002, NEUROREPORT, V13, P1195, DOI 10.1097/00001756-200207020-00025; Du LS, 2004, NEUROREPORT, V15, P2097, DOI 10.1097/00001756-200409150-00020; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Filipenko ML, 2002, NEUROSCI LETT, V321, P25, DOI 10.1016/S0304-3940(01)02495-8; Garin I, 2010, P NATL ACAD SCI USA, V107, P3105, DOI 10.1073/pnas.0910533107; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Jahng JW, 2008, EUR J PHARMACOL, V581, P64, DOI 10.1016/j.ejphar.2007.11.029; Janknecht R, 2002, HISTOL HISTOPATHOL, V17, P657, DOI 10.14670/HH-17.657; Johnson S, 2011, NEUROPSYCHOPHARMACOL, V36, P2139, DOI 10.1038/npp.2011.105; Johnson S, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00180; Kieran N, 2010, NEUROSCI LETT, V469, P380, DOI 10.1016/j.neulet.2009.12.032; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Lu DY, 2008, DRUG DISCOV THER, V2, P289; Manoli I, 2005, FASEB J, V19, P1359, DOI 10.1096/fj.04-3660fje; Mao QQ, 2009, J ETHNOPHARMACOL, V124, P316, DOI 10.1016/j.jep.2009.04.019; Meyer JH, 2006, ARCH GEN PSYCHIAT, V63, P1209, DOI 10.1001/archpsyc.63.11.1209; Meyer JH, 2009, ARCH GEN PSYCHIAT, V66, P1304, DOI 10.1001/archgenpsychiatry.2009.156; MICZEK KA, 1982, SCIENCE, V215, P1520, DOI 10.1126/science.7199758; Miczek KA, 2011, J NEUROSCI, V31, P9848, DOI 10.1523/JNEUROSCI.0637-11.2011; Morilak DA, 2004, INT J NEUROPSYCHOPH, V7, P193, DOI 10.1017/S1461145704004080; Ou XM, 2006, J BIOL CHEM, V281, P21512, DOI 10.1074/jbc.M600250200; Ou XM, 2006, P NATL ACAD SCI USA, V103, P10923, DOI 10.1073/pnas.0601515103; Ou XM, 2010, BIOL PSYCHIAT, V67, P855, DOI 10.1016/j.biopsych.2009.10.032; Ou XM, 2009, NEUROTOX RES, V16, P148, DOI 10.1007/s12640-009-9064-7; Ou XM, 2004, J BIOL CHEM, V279, P21021, DOI 10.1074/jbc.M312638200; Ou XM, 2001, J BIOL CHEM, V276, P14299, DOI 10.1074/jbc.M005363200; Sacher J, 2010, ARCH GEN PSYCHIAT, V67, P468, DOI 10.1001/archgenpsychiatry.2010.32; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; SCHILDKRAUT JJ, 1967, SCIENCE, V156, P21, DOI 10.1126/science.156.3771.21; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Song CZ, 2002, J BIOL CHEM, V277, P7029, DOI 10.1074/jbc.M108826200; Thorpe LW, 1987, J HISTOCHEM CYTOCHEM, V35, P23, DOI 10.1177/35.1.3025289; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; Verhoeven WMA, 2010, PSYCHOPATHOLOGY, V43, P63, DOI 10.1159/000260045; Vialou V, 2010, J NEUROSCI, V30, P14585, DOI 10.1523/JNEUROSCI.2496-10.2010; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883	46	70	72	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24195	24206		10.1074/jbc.M112.373936	http://dx.doi.org/10.1074/jbc.M112.373936			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22628545	hybrid, Green Published			2022-12-25	WOS:000306651100014
J	Liu, S; Xie, ZW; Zhao, QW; Pang, H; Turk, J; Calderon, L; Su, W; Zhao, GG; Xu, HF; Gong, MC; Guo, ZH				Liu, Shu; Xie, Zhongwen; Zhao, Qingwei; Pang, Huan; Turk, John; Calderon, Lindsay; Su, Wen; Zhao, Guogang; Xu, Haifei; Gong, Ming C.; Guo, Zhenheng			Smooth Muscle-specific Expression of Calcium-independent Phospholipase A(2)beta (iPLA(2)beta) Participates in the Initiation and Early Progression of Vascular Inflammation and Neointima Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; MECHANISM-BASED DISCRIMINATION; G-PROTEIN SIGNALING-2; DIABETIC DB/DB MICE; UP-REGULATION; 13-HYDROPEROXYOCTADECADIENOIC ACID; RESPONSE ELEMENT; ANGIOTENSIN-II; CAROTID-ARTERY; RHO KINASE	Whether group VIA phospholipase A(2) (iPLA(2)beta) is involved in vascular inflammation and neointima formation is largely unknown. Here, we report that iPLA(2)beta expression increases in the vascular tunica media upon carotid artery ligation and that neointima formation is suppressed by genetic deletion of iPLA(2)beta or by inhibiting its activity or expression via perivascular delivery of bromoenol lactone or of antisense oligonucleotides, respectively. To investigate whether smooth muscle-specific iPLA(2)beta is involved in neointima formation, we generated transgenic mice in which iPLA(2)beta is expressed specifically in smooth muscle cells and demonstrate that smooth muscle-specific expression of iPLA(2)beta exacerbates ligation-induced neointima formation and enhanced both production of proinflammatory cytokines and vascular infiltration by macrophages. With cultured vascular smooth muscle cell, angiotensin II, arachidonic acid, and TNF-alpha markedly induce increased expression of IL-6 and TNF-alpha mRNAs, all of which were suppressed by inhibiting iPLA(2)beta activity or expression with bromoenol lactone, antisense oligonucleotides, and genetic deletion, respectively. Similar suppression also results from genetic deletion of 12/15-lipoxygenase or inhibiting its activity with nordihydroguaiaretic acid or luteolin. Expression of iPLA(2)beta protein in cultured vascular smooth muscle cells was found to depend on the phenotypic state and to rise upon incubation with TNF-alpha. Our studies thus illustrate that smooth muscle cell-specific iPLA(2)beta participates in the initiation and early progression of vascular inflammation and neointima formation and suggest that iPLA(2)beta may represent a novel therapeutic target for preventing cardiovascular diseases.	[Liu, Shu; Su, Wen; Zhao, Guogang; Xu, Haifei; Guo, Zhenheng] Univ Kentucky, Dept Internal Med, Sch Med, Lexington, KY 40536 USA; [Xie, Zhongwen; Zhao, Qingwei; Pang, Huan; Calderon, Lindsay; Gong, Ming C.; Guo, Zhenheng] Univ Kentucky, Dept Physiol, Sch Med, Lexington, KY 40536 USA; [Turk, John] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University of Kentucky; University of Kentucky; Washington University (WUSTL)	Guo, ZH (corresponding author), Univ Kentucky, Dept Internal Med, Sch Med, 515 Wethington Bldg,900 S Limestone, Lexington, KY 40536 USA.	zguo2@uky.edu	xu, haifei/C-9659-2016	Calderon, Lindsay/0000-0003-0919-0077	National Institutes of Health from NCRR [HL088389, HL088389-02S1, HL082791, P20 RR021954]; NIGMS [P20 GM103527]; USPHS [R37-DK34388, P41-RR00954, P60-DK20579, P30-DK56341]; Commonwealth of Kentucky Diabetes Research Trust Fund; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954, P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082791, R01HL088389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, R37DK034388, P30DK056341, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Commonwealth of Kentucky Diabetes Research Trust Fund; American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health HL088389 and HL088389-02S1 (to Z. G.), HL082791 (to M. G.), P20 RR021954 from NCRR and P20 GM103527 from NIGMS, and USPHS Grants R37-DK34388, P41-RR00954, P60-DK20579, and P30-DK56341 (to J. T.). This work was also supported by the Commonwealth of Kentucky Diabetes Research Trust Fund (to Z. G.) and a postdoctoral fellowship from the American Heart Association (to S. L.).	Balsinde J, 1997, J BIOL CHEM, V272, P16069, DOI 10.1074/jbc.272.26.16069; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Dwarakanath RS, 2004, J MOL CELL CARDIOL, V36, P585, DOI 10.1016/j.yjmcc.2004.02.007; Franchi L, 2009, J INNATE IMMUN, V1, P607, DOI 10.1159/000227263; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Guo ZH, 2005, CARDIOVASC RES, V67, P723, DOI 10.1016/j.cardiores.2005.04.008; Guo ZH, 2003, J BIOL CHEM, V278, P1856, DOI 10.1074/jbc.M211075200; Harmon KJ, 2000, AM J PATHOL, V156, P1741, DOI 10.1016/S0002-9440(10)65045-6; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hooks SB, 2008, BIOCHEM PHARMACOL, V76, P1059, DOI 10.1016/j.bcp.2008.07.044; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kallmeier RC, 1995, J BIOL CHEM, V270, P30949, DOI 10.1074/jbc.270.52.30949; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kumar A, 1997, CIRCULATION, V96, P4333; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; LEHMAN JJ, 1993, J BIOL CHEM, V268, P20713; Lei XY, 2010, J BIOL CHEM, V285, P6693, DOI 10.1074/jbc.M109.084293; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu SJ, 1998, AM J PHYSIOL-HEART C, V275, pH1462, DOI 10.1152/ajpheart.1998.275.4.H1462; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Natarajan R, 2004, ARTERIOSCL THROM VAS, V24, P1542, DOI 10.1161/01.ATV.0000133606.69732.4c; Natarajan R, 2001, ARTERIOSCL THROM VAS, V21, P1408, DOI 10.1161/hq0901.095278; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pang H, 2006, AM J PHYSIOL-CELL PH, V290, pC892, DOI 10.1152/ajpcell.00378.2005; Pang HA, 2005, AM J PHYSIOL-CELL PH, V289, pC352, DOI 10.1152/ajpcell.00111.2005; Raines EW, 2005, J LIPID RES, V46, P1081, DOI 10.1194/jlr.R500004-JLR200; Rectenwald JE, 2000, CIRCULATION, V102, P1697, DOI 10.1161/01.CIR.102.14.1697; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Schober A, 2005, ANTIOXID REDOX SIGN, V7, P1249, DOI 10.1089/ars.2005.7.1249; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Seashols SJ, 2004, BBA-MOL CELL BIOL L, V1684, P29, DOI 10.1016/j.bbalip.2004.05.003; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Song HW, 2006, BIOCHEMISTRY-US, V45, P1061, DOI 10.1021/bi052065q; Stec DE, 2001, BIOTECHNIQUES, V31, P256, DOI 10.2144/01312bm03; Su W, 2008, AM J PHYSIOL-HEART C, V295, pH1634, DOI 10.1152/ajpheart.00257.2008; VILLA AE, 1995, CIRC RES, V76, P505, DOI 10.1161/01.RES.76.4.505; Walev I, 2000, J IMMUNOL, V164, P5120, DOI 10.4049/jimmunol.164.10.5120; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; Xie Z, 2007, J BIOL CHEM, V282, P25278, DOI 10.1074/jbc.M611206200; Xie ZW, 2011, J BIOL CHEM, V286, P44646, DOI 10.1074/jbc.M111.265462; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711; Xie ZW, 2006, CARDIOVASC RES, V69, P491, DOI 10.1016/j.cardiores.2005.11.002; Yellaturu CR, 2003, J BIOL CHEM, V278, P43831, DOI 10.1074/jbc.M301472200; Zhou RH, 2008, LIFE SCI, V82, P174, DOI 10.1016/j.lfs.2007.10.025	51	18	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24739	24753		10.1074/jbc.M112.340216	http://dx.doi.org/10.1074/jbc.M112.340216			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637477	hybrid, Green Published			2022-12-25	WOS:000306651100067
J	Vecchio, AJ; Orlando, BJ; Nandagiri, R; Malkowski, MG				Vecchio, Alex J.; Orlando, Benjamin J.; Nandagiri, Ritwik; Malkowski, Michael G.			Investigating Substrate Promiscuity in Cyclooxygenase-2 THE ROLE OF ARG-120 AND RESIDUES LINING THE HYDROPHOBIC GROOVE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEROXIDE-H SYNTHASE-1; ACTIVE-SITE; ARACHIDONIC-ACID; ENDOCANNABINOID OXYGENATION; MOLECULAR-GRAPHICS; STRUCTURAL BASIS; LINOLENIC ACID; ARGININE 120; FATTY-ACIDS; CROSS-TALK	The cyclooxygenases (COX-1 and COX-2) generate prostaglandin H-2 from arachidonic acid (AA). In its catalytically productive conformation, AA binds within the cyclooxygenase channel with its carboxylate near Arg-120 and Tyr-355 and omega-end located within a hydrophobic groove above Ser-530. Although AA is the preferred substrate for both isoforms, COX-2 can oxygenate a broad spectrum of substrates. Mutational analyses have established that an interaction of the carboxylate of AA with Arg-120 is required for high affinity binding by COX-1 but not COX-2, suggesting that hydrophobic interactions between the omega-end of substrates and cyclooxygenase channel residues play a significant role in COX-2-mediated oxygenation. We used structure-function analyses to investigate the role that Arg-120 and residues lining the hydrophobic groove play in the binding and oxygenation of substrates by murine (mu) COX-2. Mutations to individual amino acids within the hydrophobic groove exhibited decreased rates of oxygenation toward AA with little effect on binding. R120A muCOX-2 oxygenated 18-carbon omega-6 and omega-3 substrates albeit at reduced rates, indicating that an interaction with Arg-120 is not required for catalysis. Structural determinations of Co3+-protoporphyrin IX-reconstituted muCOX-2 with alpha-linolenic acid and G533V muCOX-2 with AA indicate that proper bisallylic carbon alignment is the major determinant for efficient substrate oxygenation by COX-2. Overall, these findings implicate Arg-120 and hydrophobic groove residues as determinants that govern proper alignment of the bisallylic carbon below Tyr-385 for catalysis in COX-2 and confirm nuances between COX isoforms that explain substrate promiscuity.	[Malkowski, Michael G.] SUNY Buffalo, Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Malkowski, MG (corresponding author), SUNY Buffalo, Hauptman Woodward Med Res Inst, 700 Ellicott St, Buffalo, NY 14203 USA.	malkowski@hwi.buffalo.edu	Malkowski, Michael G/G-4939-2011	Malkowski, Michael G/0000-0003-1025-0014; Vecchio, Alex/0000-0002-4222-7874; Malkowski, Michael/0000-0002-1203-7463	National Science Foundation [DMR-0225180]; National Institutes of Health [RR-01646, GM077176]; KeyBank; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077176] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KeyBank; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	X-ray diffraction experiments were conducted at the Cornell High Energy Synchrotron Source (CHESS), supported by National Science Foundation Award DMR-0225180, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, supported by National Institutes of Health Award RR-01646.; This work was supported, in whole or in part, by National Institutes of Health Grant GM077176.; Supported by graduate fellowships from KeyBank.	Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Garavito RM, 2002, PROSTAG OTH LIPID M, V68-9, P129; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Marnett LJ, 2009, ANNU REV PHARMACOL, V49, P265, DOI 10.1146/annurev.pharmtox.011008.145638; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Novak EM, 2012, PROSTAG LEUKOTR ESS, V86, P107, DOI 10.1016/j.plefa.2012.01.003; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rieke CJ, 1999, J BIOL CHEM, V274, P17109, DOI 10.1074/jbc.274.24.17109; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Rowlinson SW, 2000, J BIOL CHEM, V275, P6586, DOI 10.1074/jbc.275.9.6586; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; SHIMOKAWA T, 1992, J BIOL CHEM, V267, P12387; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Thuresson ED, 2001, J BIOL CHEM, V276, P10358, DOI 10.1074/jbc.M009378200; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200	39	37	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24619	24630		10.1074/jbc.M112.372243	http://dx.doi.org/10.1074/jbc.M112.372243			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637474	Green Published, hybrid			2022-12-25	WOS:000306651100056
J	Dinamarco, TM; Freitas, FZ; Almeida, RS; Brown, NA; dos Reis, TF; Ramalho, LNZ; Savoldi, M; Goldman, MHS; Bertolini, MC; Goldman, GH				Dinamarco, Taisa Magnani; Freitas, Fernanda Zanolli; Almeida, Ricardo S.; Brown, Neil Andrew; dos Reis, Thaila Fernanda; Zambelli Ramalho, Leandra Naira; Savoldi, Marcela; Goldman, Maria Helena S.; Bertolini, Maria Celia; Goldman, Gustavo Henrique			Functional Characterization of an Aspergillus fumigatus Calcium Transporter (PmcA) that Is Essential for Fungal Infection	PLOS ONE			English	Article							HIGH-EFFICIENCY TRANSFORMATION; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; CALCINEURIN TARGET; CATION HOMEOSTASIS; CA2+; HOMOLOG; CRZ1; IDENTIFICATION	Aspergillus fumigatus is a primary and opportunistic pathogen, as well as a major allergen, of mammals. The Ca+2-calcineurin pathway affects virulence, morphogenesis and antifungal drug action in A. fumigatus. Here, we investigated three components of the A. fumigatus Ca+2-calcineurin pathway, pmcA,-B, and -C, which encode calcium transporters. We demonstrated that CrzA can directly control the mRNA accumulation of the pmcA-C genes by binding to their promoter regions. CrzA-binding experiments suggested that the 5'-CACAGCCAC-3' and 5'-CCCTGCCCC-3' sequences upstream of pmcA and pmcC genes, respectively, are possible calcineurin-dependent response elements (CDREs)-like consensus motifs. Null mutants were constructed for pmcA and -beta and a conditional mutant for pmcC demonstrating pmcC is an essential gene. The Delta pmcA and Delta pmcB mutants were more sensitive to calcium and resistant to manganese and cyclosporin was able to modulate the sensitivity or resistance of these mutants to these salts, supporting the interaction between calcineurin and the function of these transporters. The pmcA-C genes have decreased mRNA abundance into the alveoli in the Delta calA and Delta crzA mutant strains. However, only the A. fumigatus Delta pmcA was avirulent in the murine model of invasive pulmonary aspergillosis.	[Goldman, Gustavo Henrique] Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Sao Paulo, Brazil; [Dinamarco, Taisa Magnani; Brown, Neil Andrew; dos Reis, Thaila Fernanda; Savoldi, Marcela; Goldman, Gustavo Henrique] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Sao Paulo, Brazil; [Goldman, Maria Helena S.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil; [Zambelli Ramalho, Leandra Naira] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Almeida, Ricardo S.] Univ Londrina, Dept Microbiol, Londrina, Parana, Brazil; [Freitas, Fernanda Zanolli; Bertolini, Maria Celia] Univ Estadual Paulista, Inst Quim, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista	Dinamarco, TM (corresponding author), Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Sao Paulo, Brazil.	ggoldman@usp.br	Ramalho, Leandra Náira Zambelli/A-3983-2010; Almeida, Ricardo/AFO-8380-2022; dos Reis, Thaila F/N-6237-2014; Dinamarco, Taisa M/J-8923-2012; Zanolli Freitas, Fernanda/J-9425-2012; Zanolli Freitas, Fernanda/ABB-9297-2021; Dinamarco, Taisa/M-7174-2019; Goldman, Maria Helena S./D-1424-2012; Ramalho, Leandra/AAA-6432-2021; Goldman, Gustavo Henrique/F-1848-2013; Bertolini, Maria Celia/D-3654-2012	Ramalho, Leandra Náira Zambelli/0000-0002-3486-5294; Almeida, Ricardo/0000-0002-1427-936X; dos Reis, Thaila F/0000-0002-7776-977X; Dinamarco, Taisa M/0000-0001-6284-387X; Zanolli Freitas, Fernanda/0000-0002-8810-2970; Zanolli Freitas, Fernanda/0000-0002-8810-2970; Dinamarco, Taisa/0000-0001-6284-387X; Goldman, Maria Helena S./0000-0002-6786-9320; Goldman, Gustavo Henrique/0000-0002-2986-350X; Bertolini, Maria Celia/0000-0001-5319-2710; Brown, Neil/0000-0002-3555-5765	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman BJ, 2011, EUKARYOT CELL, V10, P654, DOI 10.1128/EC.00239-10; Bowman BJ, 2009, EUKARYOT CELL, V8, P1845, DOI 10.1128/EC.00174-09; Cairns T, 2010, FEMS MICROBIOL LETT, V307, P1, DOI 10.1111/j.1574-6968.2010.01961.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; CORNELIUS G, 1987, J GEN MICROBIOL, V133, P2341; CRAMER CL, 1984, J BIOL CHEM, V259, P5152; Cramer RA, 2008, EUKARYOT CELL, V7, P1085, DOI 10.1128/EC.00086-08; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Cunningham KW, 2011, CELL CALCIUM, V50, P129, DOI 10.1016/j.ceca.2011.01.010; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Ferreira MED, 2007, FUNGAL GENET BIOL, V44, P219, DOI 10.1016/j.fgb.2006.08.004; DUNN T, 1994, J BIOL CHEM, V269, P7273; EILAM Y, 1985, J GEN MICROBIOL, V131, P623; Findon H, 2010, FUNGAL GENET BIOL, V47, P647, DOI 10.1016/j.fgb.2010.04.002; Flipphi M, 2002, BIOCHEM J, V364, P25, DOI 10.1042/bj3640025; Fox DS, 2002, BIOESSAYS, V24, P894, DOI 10.1002/bies.10157; Goldman GH, 2003, EUKARYOT CELL, V2, P34, DOI 10.1128/EC.2.1.34-48.2003; Greenberger PA, 2002, J ALLERGY CLIN IMMUN, V110, P685, DOI 10.1067/mai.2002.130179; Hagiwara D, 2008, CURR GENET, V54, P325, DOI 10.1007/s00294-008-0220-z; HALACHMI D, 1989, FEBS LETT, V256, P55, DOI 10.1016/0014-5793(89)81717-X; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; HERRERAESTRELLA A, 1990, MOL MICROBIOL, V4, P839, DOI 10.1111/j.1365-2958.1990.tb00654.x; Hirayama S, 2003, J BIOL CHEM, V20, P18078; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Malavazi I, 2009, FUNGAL GENET BIOL, V46, P791, DOI 10.1016/j.fgb.2009.06.009; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; MILLER AJ, 1990, P NATL ACAD SCI USA, V87, P9348, DOI 10.1073/pnas.87.23.9348; Mota AO, 2008, MOL GENET GENOMICS, V280, P483, DOI 10.1007/s00438-008-0381-y; Olivero I, 2003, FEMS MICROBIOL LETT, V219, P137, DOI 10.1016/S0378-1097(03)00002-8; Onyewu Chiatogu, 2004, Infection and Immunity, V72, P7330, DOI 10.1128/IAI.72.12.7330-7333.2004; Pinchai N, 2010, EUKARYOT CELL, V9, P472, DOI 10.1128/EC.00378-09; Pittman JK, 2011, CELL CALCIUM, V50, P139, DOI 10.1016/j.ceca.2011.01.004; Pozos TC, 1996, MOL CELL BIOL, V16, P3730; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Santos M, 2005, CURR GENET, V48, P88, DOI 10.1007/s00294-005-0003-8; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Semighini CP, 2002, APPL ENVIRON MICROB, V68, P1351, DOI 10.1128/AEM.68.3.1351-1357.2002; Soriani FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-12; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Spielvogel A, 2008, BIOCHEM J, V414, P419, DOI 10.1042/BJ20080344; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Stie J, 2008, EUKARYOT CELL, V7, P177, DOI 10.1128/EC.00326-07; STROOBANT P, 1979, P NATL ACAD SCI USA, V76, P3102, DOI 10.1073/pnas.76.7.3102; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Zakrzewska A, 2005, EUKARYOT CELL, V4, P703, DOI 10.1128/EC.4.4.703-715.2005	51	44	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37591	10.1371/journal.pone.0037591	http://dx.doi.org/10.1371/journal.pone.0037591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649543	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335800062
J	Ssengooba, W; Kiwanuka, N; Kateete, DP; Katamba, A; Joloba, ML				Ssengooba, Willy; Kiwanuka, Noah; Kateete, David P.; Katamba, Achilles; Joloba, Moses L.			Incremental Yield of Serial Sputum Cultures for Diagnosis of Tuberculosis among HIV Infected Smear Negative Pulmonary TB Suspects in Kampala, Uganda	PLOS ONE			English	Article							COST-EFFECTIVENESS	Background: Sputum culture is the gold standard for diagnosis of pulmonary tuberculosis (PTB). Although mostly used for research, culture is recommended by the World Health Organization for TB diagnosis among HIV infected smear negative PTB suspects. Even then, the number of sputum samples required remains unspecified. Here, we determined the Incremental Yield (IY) and number of samples required to diagnose an additional PTB case upon second and third serial sputum culture. Methods/Findings: This was a cross sectional study done between January and March 2011. Serial sputum samples were provided by participants within two days and cultured using Lowenstein Jensen (LJ) and Mycobacteria Growth Indicator Tube (MGIT) methods. A PTB case was defined as a positive culture on either one or both methods. The IY from the second and third serial cultures was determined and the reciprocal of the product of the fractions of IY provided the number of samples required for an additional PTB case. Of the 170 smear negative PTB suspects, 62 (36.5%) met the case definition. The IY of the second sample culture was 12.7%, 23.6% and 12.6% and for the third sample culture was 6.8%, 7.5% and 7.3% with LJ, MGIT and LJ or MGIT, respectively. The number of samples required for an additional PTB case and 95% CI upon the second sample culture were 29.9 (16.6, 156.5), 11.3 (7.6, 21.9) and 20.8 (12.5, 62.7); while for the third sample culture were 55.6 (26.4, 500.4), 35.7 (19.0, 313.8) and 36.1 (19.1, 330.9) by LJ, MGIT and LJ or MGIT respectively. Conclusions/Significance: Among HIV infected smear negative PTB suspects in Kampala, 93% of PTB cases are diagnosed upon the second serial sputum culture. The number of cultures needed to diagnose an additional PTB case, ranges from 11-30 and 35-56 by the second and third sputum samples, respectively.	[Ssengooba, Willy; Kateete, David P.; Joloba, Moses L.] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Kampala, Uganda; [Kiwanuka, Noah] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Katamba, Achilles] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda	Makerere University; Makerere University; Makerere University	Ssengooba, W (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Kampala, Uganda.	akatamba@chs.mak.ac.ug; moses.joloba@case.edu	Ssengooba, Willy/ABE-2168-2020; Kateete, David Patrick/HCH-5603-2022	Ssengooba, Willy/0000-0002-1643-110X; Kateete, David Patrick/0000-0001-8075-3069; Joloba, Moses/0000-0002-0334-9983	Fogarty International Training grant under Clinical Operational and Health Services Research of the JCRC (Joint Research Clinical Center, Kampala, Uganda) [U2RTW006879]; FOGARTY INTERNATIONAL CENTER [U2RTW006879] Funding Source: NIH RePORTER	Fogarty International Training grant under Clinical Operational and Health Services Research of the JCRC (Joint Research Clinical Center, Kampala, Uganda); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by a Fogarty International Training grant to WS under Clinical Operational and Health Services Research of the JCRC (Joint Research Clinical Center, Kampala, Uganda) (award #U2RTW006879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], IMPR DIAGN TREATM SM, DOI DOI 10.1186/s12879-016-1967-3; CDC, 1985, PUBL HLTH MYC GUID L; CDC, 1979, LAB MAN AC FAST MICR; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Crampin AC, 2001, INT J TUBERC LUNG D, V5, P994; Dimairo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011849; Harries AD, 2000, INT J TUBERC LUNG D, V4, P36; Hirano K, 2004, J CLIN MICROBIOL, V42, P390, DOI 10.1128/JCM.42.1.390-392.2004; Ipuge YA, 1996, T R SOC TROP MED HYG, V90, P256; Katamba A, 2007, INT J TUBERC LUNG D, V11, P659; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; Lee JJ, 2003, INT J TUBERC LUNG D, V7, P569; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Muchwa Christopher, 2012, BMC Res Notes, V5, P44, DOI 10.1186/1756-0500-5-44; Mueller DH, 2008, INT J TUBERC LUNG D, V12, P1196; Rieder HL, 2005, INT J TUBERC LUNG D, V9, P384; Siddiqi S H, 2006, MGIT PROC MAN BACTEC; Walker D, 2000, INT J TUBERC LUNG D, V4, P246; WHO, 2009, WHO ROL RESP TB HIV	22	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37650	10.1371/journal.pone.0037650	http://dx.doi.org/10.1371/journal.pone.0037650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629439	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345300067
J	Wang, S; Huang, X; Sun, DN; Xin, XL; Pan, QM; Peng, SY; Liang, ZJ; Luo, C; Yang, YM; Jiang, HL; Huang, M; Chai, WG; Ding, J; Geng, MY				Wang, Shuai; Huang, Xun; Sun, Danni; Xin, Xianliang; Pan, Qiuming; Peng, Shuying; Liang, Zhongjie; Luo, Cheng; Yang, Yiming; Jiang, Hualiang; Huang, Min; Chai, Wengang; Ding, Jian; Geng, Meiyu			Extensive Crosstalk between O-GlcNAcylation and Phosphorylation Regulates Akt Signaling	PLOS ONE			English	Article							BETA-N-ACETYLGLUCOSAMINE; PROTEIN-KINASE B; INSULIN-RESISTANCE; IN-VIVO; GLCNAC; IDENTIFICATION; ACTIVATION; DYNAMICS; GROWTH; SITE	O-linked N-acetylglucosamine glycosylations (O-GlcNAc) and O-linked phosphorylations (O-phosphate), as two important types of post-translational modifications, often occur on the same protein and bear a reciprocal relationship. In addition to the well documented phosphorylations that control Akt activity, Akt also undergoes O-GlcNAcylation, but the interplay between these two modifications and the biological significance remain unclear, largely due to the technique challenges. Here, we applied a two-step analytic approach composed of the O-GlcNAc immunoenrichment and subsequent O-phosphate immunodetection. Such an easy method enabled us to visualize endogenous glycosylated and phosphorylated Akt subpopulations in parallel and observed the inhibitory effect of Akt O-GlcNAcylations on its phosphorylation. Further studies utilizing mass spectrometry and mutagenesis approaches showed that O-GlcNAcylations at Thr 305 and Thr 312 inhibited Akt phosphorylation at Thr 308 via disrupting the interaction between Akt and PDK1. The impaired Akt activation in turn resulted in the compromised biological functions of Akt, as evidenced by suppressed cell proliferation and migration capabilities. Together, this study revealed an extensive crosstalk between O-GlcNAcylations and phosphorylations of Akt and demonstrated O-GlcNAcylation as a new regulatory modification for Akt signaling.	[Wang, Shuai; Huang, Xun; Sun, Danni; Xin, Xianliang; Pan, Qiuming; Huang, Min; Chai, Wengang; Ding, Jian; Geng, Meiyu] Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai 200031, Peoples R China; [Peng, Shuying; Yang, Yiming] Chinese Acad Sci, Shanghai Inst Mat Med, Lab Mass Spectrometry, Shanghai 200031, Peoples R China; [Liang, Zhongjie; Luo, Cheng; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Discovery & Design, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Chai, Wengang] Imperial Coll London, Glycosci Lab, Fac Med, Harrow, Middx, England	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Imperial College London	Wang, S (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai 200031, Peoples R China.	jding@mail.shcnc.ac.cn; mygeng@mail.shcnc.ac.cn	Liang, Zhongjie/F-2108-2019; Huang, xun/AAM-3093-2020	Liang, Zhongjie/0000-0003-0763-5407; 	Natural Science Foundation of China for Distinguished Young Scholars [30725046]; Natural Science Foundation of China for Innovation Research Group [81021062]	Natural Science Foundation of China for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Natural Science Foundation of China for Innovation Research Group(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the Natural Science Foundation of China for Distinguished Young Scholars (No. 30725046), and the Natural Science Foundation of China for Innovation Research Group (No. 81021062). Website: http://www.nsfc.gov.cn/Portal0/default106.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Ball LE, 2006, MOL CELL PROTEOMICS, V5, P313, DOI 10.1074/mcp.M500314-MCP200; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Carr SM, 2011, EMBO J, V30, P317, DOI 10.1038/emboj.2010.311; Chalkley RJ, 2008, COMP ANAL C, V52, P353, DOI 10.1016/S0166-526X(08)00215-8; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Gandy JC, 2006, FEBS LETT, V580, P3051, DOI 10.1016/j.febslet.2006.04.051; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jo M, 2003, J BIOL CHEM, V278, P1642, DOI 10.1074/jbc.M210877200; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Joost HG, 2000, METH MOL B, V155, P77; Kang ES, 2008, EXP CELL RES, V314, P2238, DOI 10.1016/j.yexcr.2008.04.014; Klein AL, 2009, MOL CELL PROTEOMICS, V8, P2733, DOI 10.1074/mcp.M900207-MCP200; Kohler JJ, 2010, NAT CHEM BIOL, V6, P634, DOI 10.1038/nchembio.429; Lippa B, 2008, BIOORG MED CHEM LETT, V18, P3359, DOI 10.1016/j.bmcl.2008.04.034; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Macauley MS, 2010, CHEM BIOL, V17, P937, DOI 10.1016/j.chembiol.2010.07.006; Macauley MS, 2008, J BIOL CHEM, V283, P34687, DOI 10.1074/jbc.M804525200; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matthews JA, 2007, MOL CELL BIOCHEM, V298, P109, DOI 10.1007/s11010-006-9358-5; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Park SY, 2010, EMBO J, V29, P3787, DOI 10.1038/emboj.2010.254; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Walker KS, 1998, BIOCHEM J, V331, P299, DOI 10.1042/bj3310299; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Yang WL, 2010, CELL CYCLE, V9, P486, DOI 10.4161/cc.9.3.10508; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u	47	74	79	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37427	10.1371/journal.pone.0037427	http://dx.doi.org/10.1371/journal.pone.0037427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629392	gold, Green Submitted, Green Published			2022-12-25	WOS:000305345300039
J	Franzen, M; Schweiger, O; Betzholtz, PE				Franzen, Markus; Schweiger, Oliver; Betzholtz, Per-Eric			Species-Area Relationships Are Controlled by Species Traits	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; HABITAT FRAGMENTATION; ISLAND BIOGEOGRAPHY; DISPERSAL ABILITY; LANDSCAPE CONTEXT; BODY-SIZE; PATTERNS; BUTTERFLIES; ABUNDANCE; MOTHS	The species-area relationship (SAR) is one of the most thoroughly investigated empirical relationships in ecology. Two theories have been proposed to explain SARs: classical island biogeography theory and niche theory. Classical island biogeography theory considers the processes of persistence, extinction, and colonization, whereas niche theory focuses on species requirements, such as habitat and resource use. Recent studies have called for the unification of these two theories to better explain the underlying mechanisms that generates SARs. In this context, species traits that can be related to each theory seem promising. Here we analyzed the SARs of butterfly and moth assemblages on islands differing in size and isolation. We tested whether species traits modify the SAR and the response to isolation. In addition to the expected overall effects on the area, traits related to each of the two theories increased the model fit, from 69% up to 90%. Steeper slopes have been shown to have a particularly higher sensitivity to area, which was indicated by species with restricted range (slope = 0.82), narrow dietary niche (slope = 0.59), low abundance (slope = 0.52), and low reproductive potential (slope = 0.51). We concluded that considering species traits by analyzing SARs yields considerable potential for unifying island biogeography theory and niche theory, and that the systematic and predictable effects observed when considering traits can help to guide conservation and management actions.	[Franzen, Markus; Schweiger, Oliver] UFZ Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany; [Franzen, Markus] Lund Univ, Dept Biol, Div Biodivers, Lund, Sweden; [Betzholtz, Per-Eric] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Lund University; Linnaeus University	Franzen, M (corresponding author), UFZ Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany.	markus.franzen@ufz.de	Schweiger, Oliver/B-4909-2008	Schweiger, Oliver/0000-0001-8779-2335	The Royal Physiographic Society in Lund; Krapperupsstiftelsen; FORMAS; European Commission Framework Programme (FP) 7 via the Integrated Project SCALES [226852]; European Commission Framework Programme (FP) 7 via the Collaborative Project STEP [244090]	The Royal Physiographic Society in Lund; Krapperupsstiftelsen; FORMAS(Swedish Research Council Formas); European Commission Framework Programme (FP) 7 via the Integrated Project SCALES; European Commission Framework Programme (FP) 7 via the Collaborative Project STEP	This study was supported by The Royal Physiographic Society in Lund, Krapperupsstiftelsen and FORMAS. The authors also acknowledge the support of the European Commission Framework Programme (FP) 7 via the Integrated Project SCALES [grant 226852] and the Collaborative Project STEP [grant 244090]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersson H., 2002, TEMPERATUR NEDERBORD; Altermatt F, 2010, ECOL LETT, V13, P1475, DOI 10.1111/j.1461-0248.2010.01534.x; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; BAZ A, 1995, J BIOGEOGR, V22, P129, DOI 10.2307/2846077; Beck J, 2006, J BIOGEOGR, V33, P694, DOI 10.1111/j.1365-2699.2005.01418.x; Beck J, 2007, GLOBAL ECOL BIOGEOGR, V16, P341, DOI 10.1111/j.1466-8238.2007.00289.x; Betzholtz PE, 2011, ECOL ENTOMOL, V36, P369, DOI 10.1111/j.1365-2311.2011.01281.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bommarco R, 2010, P ROY SOC B-BIOL SCI, V277, P2075, DOI 10.1098/rspb.2009.2221; Brotons L, 2003, AM NAT, V162, P343, DOI 10.1086/376887; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Cagnolo L, 2009, CONSERV BIOL, V23, P1167, DOI 10.1111/j.1523-1739.2009.01214.x; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; Darlington P. J., 1943, ECOL MONOGR, V13, P37, DOI 10.2307/1943589; Davies N, 1998, GLOBAL ECOL BIOGEOGR, V7, P285; Dennis RLH, 2000, BIODIVERS CONSERV, V9, P343, DOI 10.1023/A:1008924329854; Dennis RLH, 2003, OIKOS, V102, P417, DOI 10.1034/j.1600-0706.2003.12387.x; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Emmet A.M., 1991, P61; Franzen M, 2007, J INSECT CONSERV, V11, P367, DOI 10.1007/s10841-006-9053-6; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; GASTON KJ, 1989, BIOL J LINN SOC, V37, P367, DOI 10.1111/j.1095-8312.1989.tb01912.x; Gelman A., 2007, DATA ANAL USING REGR; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Henriksen H.J., 1982, BUTTERFLIES SCANDINA; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Holt Robert D., 1996, P313; Hortal J, 2009, AM NAT, V174, pE205, DOI 10.1086/645085; Hubbell S.P., 2001, MG POP BIOL, V32; HULDEN L, 2000, ATLAS FINNISH MACROL; Hyden N, 2007, NATIONALNYCKELN SVER; INKINEN P, 1994, ANN ZOOL FENN, V31, P235; Itamies J, 1983, FACTORS CONTRIBUTING; Kadmon R, 2007, AM NAT, V170, P443, DOI 10.1086/519853; Karsholt O., 1998, REVIDERET KATALOG DA; Karsholt Ole, 2008, Entomologiske Meddelelser, V76, P3; Kotiaho JS, 2005, P NATL ACAD SCI USA, V102, P1963, DOI 10.1073/pnas.0406718102; Krauss J, 2003, J BIOGEOGR, V30, P889, DOI 10.1046/j.1365-2699.2003.00878.x; Kreft H, 2008, ECOL LETT, V11, P116, DOI 10.1111/j.1461-0248.2007.01129.x; Lennon JJ, 2004, ECOL LETT, V7, P81, DOI 10.1046/j.1461-0248.2004.00548.x; Lindeborg Mats, 2009, Entomologisk Tidskrift, V130, P11; Loder N, 1998, BIOL J LINN SOC, V63, P121, DOI 10.1111/j.1095-8312.1998.tb01642.x; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Lomolino MV, 2009, Q REV BIOL, V84, P357, DOI 10.1086/648123; MAC ARTHUR ROBERT H., 1967; MACE GM, 1997, BIOL RARITY CAUSES C, P131; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nekola JC, 2007, ECOL LETT, V10, P188, DOI 10.1111/j.1461-0248.2006.01003.x; Nieminen M, 1999, ECOGRAPHY, V22, P697, DOI 10.1111/j.1600-0587.1999.tb00519.x; NILSSON SG, 1988, J ANIM ECOL, V57, P685, DOI 10.2307/4933; Nordstrom F., 1943, Opuscula Entomologica, V8, P59; Ockinger E, 2012, LANDSCAPE ECOL, V27, P121, DOI 10.1007/s10980-011-9686-z; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Palm E, 1986, DANMARKS DYRELIV, V3; Parmesan Camille, 2001, Symposia of the Royal Entomological Society of London, V20, P387, DOI 10.1079/9780851994567.0387; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Powney GD, 2010, OIKOS, V119, P1690, DOI 10.1111/j.1600-0706.2010.18168.x; Poyry J, 2011, GLOBAL ECOL BIOGEOGR, V20, P289, DOI 10.1111/j.1466-8238.2010.00597.x; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; RAZOWSKI, 1996, LEPIDOPTERA EUROPE D; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Schweiger O, 2012, GLOBAL ECOL BIOGEOGR, V21, P88, DOI 10.1111/j.1466-8238.2010.00607.x; Sekar S, 2012, J ANIM ECOL, V81, P174, DOI 10.1111/j.1365-2656.2011.01909.x; SKOU P, 1991, NORDENS UGLER; Skou P., 1984, DANMARKS DYRELIV, V2; Solymos P, 2012, GLOBAL ECOL BIOGEOGR, V21, P109, DOI 10.1111/j.1466-8238.2011.00655.x; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P507, DOI 10.1111/j.1365-2486.2005.00910.x; Stadel Nielsen P, 2008, DATA REGISTERET MED; STEARNS SC, 1983, OIKOS, V41, P173, DOI 10.2307/3544261; Steffan-Dewenter I, 2000, ECOL LETT, V3, P449, DOI 10.1046/j.1461-0248.2000.00175.x; Svensson I., 1994, CATALOGUS LEPIDOPTER; SVENSSON I, 1993, LEPIDOPTERA CALENDER; TAYLOR LR, 1980, J ANIM ECOL, V49, P209, DOI 10.2307/4285; Thomas JA, 2005, PHILOS T R SOC B, V360, P339, DOI 10.1098/rstb.2004.1585; Triantis KA, 2003, J BIOGEOGR, V30, P19, DOI 10.1046/j.1365-2699.2003.00805.x; Triantis KA, 2010, ECOGRAPHY, V33, P285, DOI 10.1111/j.1600-0587.2010.06203.x; Ulrich W, 2003, ECOGRAPHY, V26, P365, DOI 10.1034/j.1600-0587.2003.03441.x; WILCOX BA, 1986, OECOLOGIA, V69, P188, DOI 10.1007/BF00377620	80	61	62	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37359	10.1371/journal.pone.0037359	http://dx.doi.org/10.1371/journal.pone.0037359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629384	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343100023
J	Kuong, KJ; Kuzminov, A				Kuong, Kawai J.; Kuzminov, Andrei			Disintegration of Nascent Replication Bubbles during Thymine Starvation Triggers RecA- and RecBCD-dependent Replication Origin Destruction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CHROMOSOMAL FRAGMENTATION; DEFICIENT MUTANTS; DNA-REPLICATION; DEATH; REPAIR; URACIL; INACTIVATION; MECHANISM; DUTPASE	Thymineless death strikes cells unable to synthesize DNA precursor dTTP, with the nature of chromosomal damage still unclear. Thymine starvation stalls replication forks, whereas accumulating evidence indicates the replication origin is also affected. Using a novel DNA labeling technique, here we show that replication slowly continues in thymine-starved cells, but the newly synthesized DNA becomes fragmented and degraded. This degradation apparently releases enough thymine to sustain initiation of new replication bubbles from the chromosomal origin, which destabilizes the origin in a RecA-dependent manner. Marker frequency analysis with gene arrays 1) reveals destruction of the origin-centered chromosomal segment in RecA(+) cells; 2) confirms origin accumulation in the recA mutants; and 3) identifies the sites around the origin where destruction initiates in the recBCD mutants. We propose that thymineless cells convert persistent single-strand gaps behind replication forks into double-strand breaks, using the released thymine for new initiations, whereas subsequent disintegration of small replication bubbles causes replication origin destruction.	[Kuong, Kawai J.; Kuzminov, Andrei] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Kuzminov, A (corresponding author), B103 C&LSL,601 S Goodwin Ave, Urbana, IL 61801 USA.	kuzminov@life.illinois.edu			National Institutes of Health Grant [GM 073115]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073115] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 073115.	AHMAD SI, 1980, Z NATURFORSCH C, V35, P279; Ahmad SI, 1998, ANNU REV MICROBIOL, V52, P591, DOI 10.1146/annurev.micro.52.1.591; BREITMAN TR, 1972, J BACTERIOL, V112, P646, DOI 10.1128/JB.112.1.646-648.1972; Chernyshev A, 2007, APPL MICROBIOL BIOT, V74, P282, DOI 10.1007/s00253-006-0763-1; CLARK AJ, 1966, J MOL BIOL, V19, P442, DOI 10.1016/S0022-2836(66)80015-3; COHEN SS, 1971, ANN NY ACAD SCI, V186, P292; CUMMINGS DJ, 1967, J BACTERIOL, V93, P1917, DOI 10.1128/JB.93.6.1917-1924.1967; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DRLICA K, 1980, P NATL ACAD SCI-BIOL, V77, P6879, DOI 10.1073/pnas.77.11.6879; Duggin IG, 2008, P NATL ACAD SCI USA, V105, P16737, DOI 10.1073/pnas.0806414105; Fonville NC, 2011, GENETICS, V189, P23, DOI 10.1534/genetics.111.130161; Fonville NC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000865; GALLANT J, 1961, J BACTERIOL, V82, P187, DOI 10.1128/JB.82.2.187-194.1961; Guarino E, 2007, J BACTERIOL, V189, P5782, DOI 10.1128/JB.00411-07; INOUYE M, 1971, J BACTERIOL, V106, P539, DOI 10.1128/JB.106.2.539-542.1971; Khan SR, 2012, J BIOL CHEM, V287, P6250, DOI 10.1074/jbc.M111.322990; KHIDHIR MA, 1985, MOL GEN GENET, V199, P133, DOI 10.1007/BF00327522; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P9419, DOI 10.1073/pnas.97.17.9419; Kouzminova EA, 2006, J MOL BIOL, V355, P20, DOI 10.1016/j.jmb.2005.10.044; Kouzminova EA, 2004, MOL MICROBIOL, V51, P1279, DOI 10.1111/j.1365-2958.2003.03924.x; Kouzminova EA, 2008, MOL MICROBIOL, V68, P202, DOI 10.1111/j.1365-2958.2008.06149.x; Kouzminova EA, 2012, MOL MICROBIOL, V84, P1079, DOI 10.1111/j.1365-2958.2012.08076.x; KUNZ BA, 1982, MUTAT RES, V93, P353, DOI 10.1016/0027-5107(82)90150-6; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kuong KJ, 2010, GENES CELLS, V15, P619, DOI 10.1111/j.1365-2443.2010.01405.x; Kuong KJ, 2009, J MOL BIOL, V390, P845, DOI 10.1016/j.jmb.2009.05.038; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuzminov Andrei, 2005, P349; Ladner RD, 2001, CURR PROTEIN PEPT SC, V2, P361, DOI 10.2174/1389203013380991; Martin CM, 2011, DNA REPAIR, V10, P94, DOI 10.1016/j.dnarep.2010.10.005; Miranda A, 2003, GENETICS, V163, P1255; Morganroth PA, 2006, J BACTERIOL, V188, P5286, DOI 10.1128/JB.00543-06; MUKHERJEE P, 1971, MUTAT RES, V12, P341, DOI 10.1016/0027-5107(71)90084-4; Nakayama H, 2005, MUTAT RES-FUND MOL M, V577, P228, DOI 10.1016/j.mrfmmm.2005.02.015; NAKAYAMA H, 1982, CAN J MICROBIOL, V28, P425, DOI 10.1139/m82-064; NAKAYAMA K, 1994, J MOL BIOL, V243, P611, DOI 10.1016/0022-2836(94)90036-1; NAKAYAMA K, 1988, CAN J MICROBIOL, V34, P905, DOI 10.1139/m88-157; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; PRITCHARD RH, 1964, J MOL BIOL, V9, P288, DOI 10.1016/S0022-2836(64)80208-4; RAMAREDDY G, 1970, J MOL BIOL, V50, P525, DOI 10.1016/0022-2836(70)90209-3; Regamey A, 2000, MOL MICROBIOL, V38, P423, DOI 10.1046/j.1365-2958.2000.02130.x; REITER H, 1970, J MOL BIOL, V50, P533, DOI 10.1016/0022-2836(70)90210-X; RUPP WD, 1971, J MOL BIOL, V61, P25, DOI 10.1016/0022-2836(71)90204-X; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; Sangurdekar DP, 2010, MOL MICROBIOL, V75, P1455, DOI 10.1111/j.1365-2958.2010.07072.x; Seno T, 1985, Basic Life Sci, V31, P241; SHARMA RC, 1987, J BACTERIOL, V169, P4559, DOI 10.1128/jb.169.10.4559-4564.1987; SILVERSTEIN JL, 1976, VIROLOGY, V72, P212, DOI 10.1016/0042-6822(76)90324-X; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; Van Triest B, 1999, ONCOLOGY-BASEL, V57, P179, DOI 10.1159/000012030; WACHSMAN JT, 1964, J BACTERIOL, V87, P1079, DOI 10.1128/JB.87.5.1079-1086.1964; Wang JD, 2007, P NATL ACAD SCI USA, V104, P5608, DOI 10.1073/pnas.0608999104; ZALKIN H, 1996, ESCHERICHIA COLI SAL, P561	53	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23958	23970		10.1074/jbc.M112.359687	http://dx.doi.org/10.1074/jbc.M112.359687			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22621921	Green Published, hybrid			2022-12-25	WOS:000306511300065
J	Lang, I; Fick, A; Schafer, V; Giner, T; Siegmund, D; Wajant, H				Lang, Isabell; Fick, Andrea; Schaefer, Viktoria; Giner, Tina; Siegmund, Daniela; Wajant, Harald			Signaling Active CD95 Receptor Molecules Trigger Co-translocation of Inactive CD95 Molecules into Lipid Rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FAS-MEDIATED APOPTOSIS; DEATH RECEPTOR; CELL-DEATH; DOWN-REGULATION; TYROSINE PHOSPHORYLATION; RESTRICTED ACTIVATION; COMPLEX-FORMATION; GAMMA-INTERFERON; FAMILY-MEMBERS	The capability of soluble CD95L trimers to trigger CD95-associated signaling pathways is drastically increased by oligomerization. The latter can be achieved, for example, by antibodies recognizing a N-terminal epitope tag in recombinant CD95L variants or by genetic engineering-enforced formation of hexamers. Using highly sensitive and accurate binding studies with recombinant CD95L variants equipped with a Gaussia princeps luciferase reporter domain, we found that oligomerization of CD95L has no major effect on CD95 occupancy. This indicates that the higher activity of oligomerized CD95L trimers is not related to an avidity-related increase in apparent affinity and points instead to a crucial role of aggregation of initially formed trimeric CD95L-CD95 complexes in CD95 activation. Furthermore, binding of soluble CD95L trimers was found to be insufficient to increase the association of CD95 with the lipid raft-containing membrane fraction. However, when Gaussia princeps luciferase-CD95L trimers were used as tracers to "mark" inactive CD95 molecules, increased association of these inactive receptors was observed upon activation of the remaining CD95 molecules by help of highly active hexameric Fc-CD95L or membrane CD95L. Moreover, in cells expressing endogenous CD95 and chimeric CD40-CD95 receptors, triggering of CD95 signaling via endogenous CD95 resulted in co-translocation of CD40-CD95 to the lipid raft fraction, whereas vice versa activation of CD95-associated pathways with Fc-CD40L via CD40-CD95 resulted in co-translocation of endogenous CD95. In sum, this shows that signaling-active CD95 molecules not only enhance their own association with the lipid raft-containing membrane fraction but also those of inactive CD95 molecules.	[Lang, Isabell; Fick, Andrea; Schaefer, Viktoria; Siegmund, Daniela; Wajant, Harald] Univ Hosp Wurzburg, Div Mol Internal Med, Dept Internal Med 2, D-97070 Wurzburg, Germany; [Giner, Tina] Univ Hosp Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Wajant, H (corresponding author), Univ Hosp Wurzburg, Div Mol Internal Med, Dept Internal Med 2, Rontgenring 11, D-97070 Wurzburg, Germany.	harald.wajant@mail.uni-wuerzburg.de	Wajant, Harald/A-3020-2017	Wajant, Harald/0000-0002-2005-3949; Lang, Isabell/0000-0002-6369-4973	Deutsche Forschungsgemeinschaft [DFG Wa 1025/21-1, SFB 487, TP B7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants DFG Wa 1025/21-1 and SFB 487, TP B7.	AGGARWAL BB, 1985, NATURE, V318, P665, DOI 10.1038/318665a0; Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Aoki K, 2001, NAT IMMUNOL, V2, P333, DOI 10.1038/86336; BAGLIONI C, 1985, J BIOL CHEM, V260, P3395; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Berg D, 2007, CELL DEATH DIFFER, V14, P2021, DOI 10.1038/sj.cdd.4402213; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bremer E, 2006, BLOOD, V107, P2863, DOI 10.1182/blood-2005-07-2929; Bremer E, 2008, CANCER RES, V68, P597, DOI 10.1158/0008-5472.CAN-07-5171; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; Eramo A, 2004, EUR J IMMUNOL, V34, P1930, DOI 10.1002/eji.200324786; Esposito D, 2010, STRUCTURE, V18, P1378, DOI 10.1016/j.str.2010.08.006; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Fulda S, 2000, CANCER RES, V60, P3947; Fumarola C, 2001, CELL DEATH DIFFER, V8, P1004, DOI 10.1038/sj.cdd.4400902; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; Grassme H, 2001, BIOCHEM BIOPH RES CO, V284, P1016, DOI 10.1006/bbrc.2001.5045; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; HAAKE AR, 1995, CELL DEATH DIFFER, V2, P183; Hao ZY, 2010, J MOL CELL BIOL, V2, P63, DOI 10.1093/jmcb/mjp034; Henkler F, 2005, J CELL BIOL, V168, P1087, DOI 10.1083/jcb.200501048; Herrero R, 2011, J CLIN INVEST, V121, P1174, DOI 10.1172/JCI43004; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Imanishi T, 2000, J VASC RES, V37, P523, DOI 10.1159/000054085; Janssen O, 1996, IMMUNOL LETT, V49, P63, DOI 10.1016/0165-2478(95)02482-4; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Martin DA, 1999, P NATL ACAD SCI USA, V96, P4552, DOI 10.1073/pnas.96.8.4552; Micheau O, 1999, J BIOL CHEM, V274, P7987, DOI 10.1074/jbc.274.12.7987; Papoff G, 1999, J BIOL CHEM, V274, P38241, DOI 10.1074/jbc.274.53.38241; Parlato S, 2000, EMBO J, V19, P5123, DOI 10.1093/emboj/19.19.5123; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Rossin A, 2010, EXP CELL RES, V316, P1513, DOI 10.1016/j.yexcr.2010.03.002; Samel D, 2003, J BIOL CHEM, V278, P32077, DOI 10.1074/jbc.M304866200; Sancho-Martinez I, 2009, CELL CYCLE, V8, P838, DOI 10.4161/cc.8.6.7906; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Siegmund D, 2002, MOL MED, V8, P725, DOI 10.1007/BF03402036; Siegmund D, 2005, MOL CELL BIOL, V25, P6363, DOI 10.1128/MCB.25.15.6363-6379.2005; SMITH RA, 1987, J BIOL CHEM, V262, P6951; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tauzin S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001090; Wajant H, 2003, CYTOKINE GROWTH F R, V14, P53, DOI 10.1016/S1359-6101(02)00072-2; Wajant H., 2011, CANC LETT IN PRESS; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Wyzgol A, 2009, J IMMUNOL, V183, P1851, DOI 10.4049/jimmunol.0802597	64	21	21	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					24026	24042		10.1074/jbc.M111.328211	http://dx.doi.org/10.1074/jbc.M111.328211			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22645131	hybrid, Green Published			2022-12-25	WOS:000306511300071
J	Pan, YW; Zou, JH; Wang, WB; Sakagami, H; Garelick, MG; Abel, G; Kuo, CT; Storm, DR; Xia, ZG				Pan, Yung-Wei; Zou, Junhui; Wang, Wenbin; Sakagami, Hiroyuki; Garelick, Michael G.; Abel, Glen; Kuo, Chay T.; Storm, Daniel R.; Xia, Zhengui			Inducible and Conditional Deletion of Extracellular Signal-regulated Kinase 5 Disrupts Adult Hippocampal Neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; ENHANCED SYNAPTIC PLASTICITY; GENERATED GRANULE CELLS; DENTATE GYRUS; NEUROTROPHIC FACTOR; STEM-CELL; ANTIDEPRESSANT TREATMENT; TARGETED DELETION; CORTICAL-NEURONS; RAT HIPPOCAMPUS	Recent studies have led to the exciting idea that adult-born neurons in the dentate gyrus of the hippocampus may play a role in hippocampus-dependent memory formation. However, signaling mechanisms that regulate adult hippocampal neurogenesis are not well defined. Here we report that extracellular signal-regulated kinase 5 (ERK5), a member of the mitogen-activated protein kinase family, is selectively expressed in the neurogenic regions of the adult mouse brain. We present evidence that shRNA suppression of ERK5 in adult hippocampal neural stem/progenitor cells (aNPCs) reduces the number of neurons while increasing the number of cells expressing markers for stem/progenitor cells or proliferation. Furthermore, shERK5 attenuates both transcription and neuronal differentiation mediated by Neurogenin 2, a transcription factor expressed in adult hippocampal neural progenitor cells. By contrast, ectopic activation of endogenous ERK5 signaling via expression of constitutive active MEK5, an upstream activating kinase for ERK5, promotes neurogenesis in cultured aNPCs and in the dentate gyrus of the mouse brain. Moreover, neurotrophins including NT3 activate ERK5 and stimulate neuronal differentiation in aNPCs in an ERK5-dependent manner. Finally, inducible and conditional deletion of ERK5 specifically in the neurogenic regions of the adult mouse brain delays the normal progression of neuronal differentiation and attenuates adult neurogenesis in vivo. These data suggest ERK5 signaling as a critical regulator of adult hippocampal neurogenesis.	[Zou, Junhui; Wang, Wenbin; Abel, Glen; Xia, Zhengui] Univ Washington, Dept Environm & Occupat Hlth Sci, Toxicol Program, Seattle, WA 98195 USA; [Pan, Yung-Wei; Xia, Zhengui] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Garelick, Michael G.; Storm, Daniel R.; Xia, Zhengui] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Sakagami, Hiroyuki] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 2288555, Japan; [Kuo, Chay T.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Kuo, Chay T.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kitasato University; Duke University; Duke University	Xia, ZG (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Toxicol Program, Box 357234, Seattle, WA 98195 USA.	zxia@u.washington.edu			National Institutes of Health [AG19193, NS20498, T32HD007183, F31DC011216]; NICHD [P30 HD02274]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183, P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498, R01NS078192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC011216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants AG19193 (to Z. X.), NS20498 (to D. R. S.), T32HD007183 and F31DC011216 (to Y. W. P) and Grant P30 HD02274 from the NICHD.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ALVAREZBUYLLA A, 1988, P NATL ACAD SCI USA, V85, P8722, DOI 10.1073/pnas.85.22.8722; Athos J., 2001, CURR PROTOCOLS NEURO; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bruel-Jungerman E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007901; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Chan JP, 2008, MOL CELL NEUROSCI, V39, P372, DOI 10.1016/j.mcn.2008.07.017; Cundiff P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005204; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Di Benedetto B, 2007, J COMP NEUROL, V500, P542, DOI 10.1002/cne.21186; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Epp JR, 2007, NEUROSCIENCE, V149, P273, DOI 10.1016/j.neuroscience.2007.07.046; Finegan KG, 2009, CELL DEATH DIFFER, V16, P674, DOI 10.1038/cdd.2008.193; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jiao J, 2008, STEM CELLS, V26, P1221, DOI 10.1634/stemcells.2007-0513; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Leuner B, 2004, J NEUROSCI, V24, P7477, DOI 10.1523/JNEUROSCI.0204-04.2004; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Liu LD, 2006, P NATL ACAD SCI USA, V103, P9697, DOI 10.1073/pnas.0603373103; Ma DK, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-16; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ozen I, 2007, EUR J NEUROSCI, V25, P2591, DOI 10.1111/j.1460-9568.2007.05541.x; Pan YW, 2012, J NEUROSCI, V32, P6444, DOI 10.1523/JNEUROSCI.6076-11.2012; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Russo-Neustadt AA, 2004, NEUROPSYCHOPHARMACOL, V29, P2189, DOI 10.1038/sj.npp.1300514; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shalizi A, 2003, J NEUROSCI, V23, P7326; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang X, 2005, MOL CELL BIOL, V25, P336, DOI 10.1128/MCB.25.1.336-345.2005; Wang YP, 2006, J BIOL CHEM, V281, P35965, DOI 10.1074/jbc.M605503200; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	67	31	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23306	23317		10.1074/jbc.M112.344762	http://dx.doi.org/10.1074/jbc.M112.344762			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22645146	Green Published, hybrid			2022-12-25	WOS:000306511300005
J	Chen, G; Ghosh, P; O'Farrell, T; Munk, R; Rezanka, LJ; Sasaki, CY; Longo, DL				Chen, Gang; Ghosh, Paritosh; O'Farrell, Thomas; Munk, Rachel; Rezanka, Louis J.; Sasaki, Carl Y.; Longo, Dan L.			Transforming Growth Factor beta 1 (TGF-beta 1) Suppresses Growth of B-cell Lymphoma Cells by p14(ARF)-dependent Regulation of Mutant p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARF TUMOR-SUPPRESSOR; FUNCTION PHENOTYPE; GENE-EXPRESSION; CYCLE ARREST; WILD-TYPE; IN-VIVO; GAIN; P19(ARF); MDM2; PROTEINS	Previously we reported that TGF-beta 1-induced growth suppression was associated with a decrease in mutant p53 levels in B-cell lymphoma cells. The goal of the present study was to understand the mechanism involved in TGF-beta 1-mediated down-regulation of mutant p53. In RL and CA46, two B-cell lymphoma cell lines, TGF-beta 1 treatment caused down-regulation of E2F-1 transcription factor resulting in the down-regulation of both p14(ARF) and mutant p53, leading to growth arrest. Experimental overexpression of E2F-1 increased p14(ARF) level and blocked TGF-beta 1-induced down-regulation of p14(ARF). Overexpression of p14(ARF) blocked the down-regulation of mutant p53 and prevented growth arrest. p14(ARF) also attenuated TGF-beta 1-induced p21(Cip1/WAF1) induction, which was reversible by p53 siRNA, indicating the involvement of mutant p53 in controlling the TGF-beta 1-induced expression of p21(Cip1/WAF1). The interaction observed between phospho-Smad2 and mutant p53 in the nucleus could be the mechanism responsible for blocking the growth-suppressive effects of TGF-beta 1. In RL cells, p14(ARF) is present in a trimer consisting of mutant p53-Mdm2-p14(ARF) and in a dimer consisting of Mdm2-p14(ARF). Because it is known that Mdm2 can degrade p53, it is possible that, in its trimeric form, p14(ARF) is able to stabilize mutant p53 by inhibiting Mdm2. In its dimeric form, p14(ARF) may be sequestering Mdm2, limiting its ability to degrade p53. Collectively, these data demonstrate a unique mechanism in which the inhibition of TGF-beta 1-mediated growth suppression by mutant p53 can be reversed by the down-regulation of its stabilizing protein p14(ARF). This work suggests that the high levels of p14(ARF) often found in tumor cells could be a potential therapeutic target.	[Ghosh, Paritosh] NIA, Lymphocyte Cell Biol Unit, Lab Mol Biol & Immunol, Biomed Res Ctr,Intramural Res Program,NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Ghosh, P (corresponding author), NIA, Lymphocyte Cell Biol Unit, Lab Mol Biol & Immunol, Biomed Res Ctr,Intramural Res Program,NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	ghoshp@grc.nia.nih.gov	Longo, Dan L./F-6022-2011		NIA, National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE ON AGING [ZIAAG000166] Funding Source: NIH RePORTER	NIA, National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the NIA, National Institutes of Health Intramural Research Program.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; BECKWITH M, 1995, BLOOD, V85, P2461, DOI 10.1182/blood.V85.9.2461.bloodjournal8592461; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Cardinali M, 1997, MOL CARCINOGEN, V18, P78, DOI 10.1002/(SICI)1098-2744(199702)18:2<78::AID-MC3>3.0.CO;2-M; Chen G, 2007, BLOOD, V109, P5301, DOI 10.1182/blood-2006-06-032128; Chen G, 2011, MOL CANCER RES, V9, P78, DOI 10.1158/1541-7786.MCR-10-0216; CHEN YM, 1994, MOL CELL BIOL, V14, P6764, DOI 10.1128/MCB.14.10.6764; Cong F, 1999, ONCOGENE, V18, P7731, DOI 10.1038/sj.onc.1203290; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; EWEN ME, 1995, GENE DEV, V9, P204, DOI 10.1101/gad.9.2.204; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Freeman-Anderson NE, 2009, DEVELOPMENT, V136, P2081, DOI 10.1242/dev.033548; GERWIN BI, 1992, P NATL ACAD SCI USA, V89, P2759, DOI 10.1073/pnas.89.7.2759; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hixon ML, 2000, HISTOL HISTOPATHOL, V15, P551, DOI 10.14670/HH-15.551; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; HSIAO M, 1994, AM J PATHOL, V145, P702; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Korgaonkar C, 2002, MOL CELL BIOL, V22, P196, DOI 10.1128/MCB.22.1.196-206.2002; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lanyi A, 1998, ONCOGENE, V16, P3169, DOI 10.1038/sj.onc.1201857; Lenburg ME, 2007, J BIOL CHEM, V282, P4803, DOI 10.1074/jbc.M605870200; LI CCH, 1995, LEUKEMIA, V9, P650; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; O'Farrell TJ, 2004, CANCER RES, V64, P8199, DOI 10.1158/0008-5472.CAN-03-3639; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Quelle DE, 1997, P NATL ACAD SCI USA, V94, P669, DOI 10.1073/pnas.94.2.669; REISS M, 1993, CANCER RES, V53, P899; RENSCHLER MF, 1995, CANCER RES, V55, P5642; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Roussel MF, 1999, ONCOGENE, V18, P5311, DOI 10.1038/sj.onc.1202998; Salmon P, 2000, BLOOD, V96, P3392; Sanchez-Aguilera A, 2002, BLOOD, V99, P1411, DOI 10.1182/blood.V99.4.1411; Sasaki CY, 2007, CANCER RES, V67, P11218, DOI 10.1158/0008-5472.CAN-07-0922; SHAULSKY G, 1991, CANCER RES, V51, P5232; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Spender LC, 2009, J BIOL CHEM, V284, P1435, DOI 10.1074/jbc.M808080200; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Uzzo RG, 1999, J CLIN INVEST, V104, P769, DOI 10.1172/JCI6775; Vijayachandra K, 2009, MOL CARCINOGEN, V48, P181, DOI 10.1002/mc.20472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang XJ, 1998, MOL CARCINOGEN, V23, P185, DOI 10.1002/(SICI)1098-2744(199811)23:3<185::AID-MC7>3.0.CO;2-5; Yarbrough WG, 2002, CANCER RES, V62, P1171; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	57	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23184	23195		10.1074/jbc.M112.351411	http://dx.doi.org/10.1074/jbc.M112.351411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22621932	Green Published, hybrid			2022-12-25	WOS:000306495000073
J	Lever, M; George, PM; Elmslie, JL; Atkinson, W; Slow, S; Molyneux, SL; Troughton, RW; Richards, AM; Frampton, CM; Chambers, ST				Lever, Michael; George, Peter M.; Elmslie, Jane L.; Atkinson, Wendy; Slow, Sandy; Molyneux, Sarah L.; Troughton, Richard W.; Richards, A. Mark; Frampton, Christopher M.; Chambers, Stephen T.			Betaine and Secondary Events in an Acute Coronary Syndrome Cohort	PLOS ONE			English	Article							GLYCINE BETAINE; PLASMA HOMOCYSTEINE; CARDIOVASCULAR EVENTS; NATRIURETIC PEPTIDE; SUPPLEMENTATION; METABOLISM; CHOLINE; RISK; DERIVATIVES; OSMOLYTES	Betaine insufficiency is associated with unfavourable vascular risk profiles in metabolic syndrome patients. We investigated associations between betaine insufficiency and secondary events in acute coronary syndrome patients. Methods: Plasma (531) and urine (415) samples were collected four months after discharge following an acute coronary event. Death (34), secondary acute myocardial infarction (MI) (70) and hospital admission for heart failure (45) events were recorded over a median follow-up of 832 days. Principal Findings: The highest and lowest quintiles of urinary betaine excretion associated with risk of heart failure (p = 0.0046, p = 0.013 compared with middle 60%) but not with subsequent acute MI. The lowest quintile of plasma betaine was associated with subsequent acute MI (p = 0.014), and the top quintile plasma betaine with heart failure (p = 0.043), especially in patients with diabetes (p<0.001). Top quintile plasma concentrations of dimethylglycine (betaine metabolite) and top quintile plasma homocysteine both associated with all three outcomes, acute MI (p = 0.004, <0.001), heart failure (p = 0.027, p<0.001) and survival (p<0.001, p<0.001). High homocysteine was associated with high or low betaine excretion in.60% of these subjects (p = 0.017). Median NT- proBNP concentrations were lowest in the middle quintile of plasma betaine concentration (p = 0.002). Conclusions: Betaine insufficiency indicates increased risk of secondary heart failure and acute MI. Its association with elevated homocysteine may partly explain the disappointing results of folate supplementation. In some patients, especially with diabetes, elevated plasma betaine also indicates increased risk.	[Lever, Michael; George, Peter M.; Elmslie, Jane L.; Atkinson, Wendy; Slow, Sandy; Molyneux, Sarah L.] Canterbury Hlth Labs, Clin Biochem Unit, Christchurch, New Zealand; [Lever, Michael; George, Peter M.; Slow, Sandy; Chambers, Stephen T.] Univ Otago Christchurch, Dept Pathol, Christchurch, New Zealand; [Troughton, Richard W.; Richards, A. Mark; Frampton, Christopher M.] Univ Otago Christchurch, Dept Med, Christchurch Cardioendocrine Res Grp, Christchurch, New Zealand	Canterbury Health Laboratories; University of Otago; University of Otago	Lever, M (corresponding author), Canterbury Hlth Labs, Clin Biochem Unit, Christchurch, New Zealand.	michael.lever@otago.ac.nz	George, Peter M/A-1315-2013	George, Peter M/0000-0001-9100-3466; Molyneux, Sarah/0000-0001-6816-5619; Chambers, Stephen/0000-0002-0698-3285; Troughton, Richard/0000-0001-7484-4036	National Heart Foundation of New Zealand [1090]	National Heart Foundation of New Zealand	National Heart Foundation of New Zealand grant 1090; url: http://www.heartfoundation.org.nz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Armstrong LE, 2008, J STRENGTH COND RES, V22, P851, DOI 10.1519/JSC.0b013e31816a6efb; Atkinson W, 2009, NUTR METAB CARDIOVAS, V19, P767, DOI 10.1016/j.numecd.2009.01.004; Beck FX, 1998, PFLUG ARCH EUR J PHY, V436, P814, DOI 10.1007/s004240050710; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Ellis KL, 2011, J MOL CELL CARDIOL, V50, P695, DOI 10.1016/j.yjmcc.2011.01.010; Hoffman JR, 2009, J INT SOC SPORT NUTR, V6, DOI 10.1186/1550-2783-6-7; Holm PI, 2004, ARTERIOSCL THROM VAS, V24, P301, DOI 10.1161/01.ATV.0000114569.54976.31; Konstantinova SV, 2008, AM J CLIN NUTR, V88, P1663, DOI 10.3945/ajcn.2008.26531; Krupicka J, 2009, PHYSIOL RES, V58, P171, DOI 10.33549/physiolres.931461; Lee EC, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-27; LEVER M, 1994, CLIN CHIM ACTA, V230, P69, DOI 10.1016/0009-8981(94)90090-6; Lever M, 2005, METABOLISM, V54, P1, DOI 10.1016/j.metabol.2004.07.007; Lever M, 2004, CLIN BIOCHEM, V37, P184, DOI 10.1016/j.clinbiochem.2003.11.004; Lever M, 2007, CLIN BIOCHEM, V40, P798, DOI 10.1016/j.clinbiochem.2007.03.009; Lever M, 2007, CLIN BIOCHEM, V40, P447, DOI 10.1016/j.clinbiochem.2006.10.029; Lever M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032460; Lever M, 2012, CLIN BIOCHEM, V45, P154, DOI 10.1016/j.clinbiochem.2011.10.021; Lever M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021666; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Lever M, 2009, CARDIOVASC DRUG THER, V23, P395, DOI 10.1007/s10557-009-6188-1; Lever M, 2009, CLIN BIOCHEM, V42, P706, DOI 10.1016/j.clinbiochem.2009.02.001; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Lv SW, 2009, EUR J NUTR, V48, P205, DOI 10.1007/s00394-009-0003-4; Ratriyanto A, 2009, ASIAN AUSTRAL J ANIM, V22, P1461, DOI 10.5713/ajas.2009.80659; Remme WJ, 2001, EUR HEART J, V22, P1527, DOI 10.1053/euhj.2001.2783; Richards AM, 1999, HEART, V81, P114, DOI 10.1136/hrt.81.2.114; Rodriguez RMG, 2013, INT J CARDIOL, V167, P768, DOI 10.1016/j.ijcard.2012.03.047; Schwab U, 2006, J NUTR, V136, P34, DOI 10.1093/jn/136.1.34; Schwab U, 2011, EUR J CLIN NUTR, V65, P70, DOI 10.1038/ejcn.2010.230; Schwahn BC, 2007, ATHEROSCLEROSIS, V195, pE100, DOI 10.1016/j.atherosclerosis.2007.06.030; Shewan LG, 2010, INT J CARDIOL, V144, P1, DOI 10.1016/j.ijcard.2010.07.030; SIZELAND PCB, 1995, AM J PHYSIOL-RENAL, V268, pF227, DOI 10.1152/ajprenal.1995.268.2.F227; Slow S, 2009, PHYSIOL RES, V58, P403, DOI 10.33549/physiolres.931569; Smulders YM, 2011, J INHERIT METAB DIS, V34, P93, DOI 10.1007/s10545-010-9151-1; Storer MK, 2006, J CHROMATOGR A, V1104, P263, DOI 10.1016/j.chroma.2005.11.123; Storer MK, 2006, ANAL CHIM ACTA, V558, P319, DOI 10.1016/j.aca.2005.10.060; Strakova J, 2010, NUTR RES, V30, P492, DOI 10.1016/j.nutres.2010.06.017; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Ueland PM, 2005, CLIN CHEM LAB MED, V43, P1069, DOI 10.1515/CCLM.2005.187; Wald DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016473; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wettstein M, 2000, AM J PHYSIOL-GASTR L, V278, pG227, DOI 10.1152/ajpgi.2000.278.2.G227	49	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37883	10.1371/journal.pone.0037883	http://dx.doi.org/10.1371/journal.pone.0037883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649561	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800081
J	Lin, Y; Son, H; Min, K; Lee, J; Choi, GJ; Kim, JC; Lee, YW				Lin, Yang; Son, Hokyoung; Min, Kyunghun; Lee, Jungkwan; Choi, Gyung Ja; Kim, Jin-Cheol; Lee, Yin-Won			A Putative Transcription Factor MYT2 Regulates Perithecium Size in the Ascomycete Gibberella zeae	PLOS ONE			English	Article							FUSARIUM-GRAMINEARUM; SEXUAL DEVELOPMENT; FUNCTIONAL ANALYSES; FEMALE FERTILITY; BINDING PROTEIN; C-MYB; GENE; FUNGUS; MORPHOGENESIS; PATHOGENESIS	The homothallic ascomycete fungus Gibberella zeae is a plant pathogen that is found worldwide, causing Fusarium head blight (FHB) in cereal crops and ear rot of maize. Ascospores formed in fruiting bodies (i.e., perithecia) are hypothesized to be the primary inocula for FHB disease. Perithecium development is a complex cellular differentiation process controlled by many developmentally regulated genes. In this study, we selected a previously reported putative transcription factor containing the Myb DNA-binding domain MYT2 for an in-depth study on sexual development. The deletion of MYT2 resulted in a larger perithecium, while its overexpression resulted in a smaller perithecium when compared to the wild-type strain. These data suggest that MYT2 regulates perithecium size differentiation. MYT2 overexpression affected pleiotropic phenotypes including vegetative growth, conidia production, virulence, and mycotoxin production. Nuclear localization of the MYT2 protein supports its role as a transcriptional regulator. Transcriptional analyses of trichothecene synthetic genes suggest that MYT2 additionally functions as a suppressor for trichothecene production. This is the first study characterizing a transcription factor required for perithecium size differentiation in G. zeae, and it provides a novel angle for understanding sexual development in filamentous fungi.	[Lin, Yang; Son, Hokyoung; Min, Kyunghun; Lee, Yin-Won] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Lin, Yang; Son, Hokyoung; Min, Kyunghun; Lee, Yin-Won] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea; [Lee, Jungkwan] Dong A Univ, Dept Appl Biol, Pusan, South Korea; [Choi, Gyung Ja; Kim, Jin-Cheol] Korea Res Inst Chem Technol, Div Convergence Chem, Res Ctr Biobased Chem, Ecofriendly New Mat Res Grp, Taejon 305606, South Korea	Seoul National University (SNU); Seoul National University (SNU); Dong A University; Korea Research Institute of Chemical Technology (KRICT)	Lin, Y (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	lee2443@snu.ac.kr		Son, Hokyoung/0000-0001-5080-7951; Min, Kyunghun/0000-0002-2682-4660	National Research Foundation of Korea (NRF); Korean government (MEST) [2012-0000575]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (2012-0000575). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin TK, 2010, MOL PLANT MICROBE IN, V23, P566, DOI 10.1094/MPMI-23-5-0566; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Bowden RL, 1999, PHYTOPATHOLOGY, V89, P182, DOI 10.1094/PHYTO.1999.89.2.182; Desjardins AE, 2004, APPL ENVIRON MICROB, V70, P2437, DOI 10.1128/AEM.70.4.2437-2444.2004; DESJARDINS AE, 2006, FUSARIUM MYCOTOXINS; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; DUPREY SP, 1985, P NATL ACAD SCI USA, V82, P6937, DOI 10.1073/pnas.82.20.6937; DYER PS, 1992, BIOL REV, V67, P421, DOI 10.1111/j.1469-185X.1992.tb01189.x; Engh I, 2010, EUR J CELL BIOL, V89, P864, DOI 10.1016/j.ejcb.2010.07.002; Gardiner DM, 2009, MOL PLANT MICROBE IN, V22, P1588, DOI 10.1094/MPMI-22-12-1588; Guldener U, 2006, FUNGAL GENET BIOL, V43, P316, DOI 10.1016/j.fgb.2006.01.005; Hallen HE, 2007, FUNGAL GENET BIOL, V44, P1146, DOI 10.1016/j.fgb.2007.04.007; Han YK, 2007, MOL MICROBIOL, V63, P768, DOI 10.1111/j.1365-2958.2006.05557.x; Harris SD, 2005, MYCOLOGIA, V97, P880, DOI 10.3852/mycologia.97.4.880; HOHN TM, 1992, MOL PLANT MICROBE IN, V5, P249, DOI 10.1094/MPMI-5-249; Horwitz BA, 1999, FUNGAL GENET BIOL, V26, P19, DOI 10.1006/fgbi.1998.1094; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Jenczmionka NJ, 2003, CURR GENET, V43, P87, DOI 10.1007/s00294-003-0379-2; Kim JE, 2009, CURR GENET, V55, P449, DOI 10.1007/s00294-009-0258-6; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; Kwon SJ, 2009, VIRUS RES, V144, P96, DOI 10.1016/j.virusres.2009.04.004; Lee J, 2003, MOL MICROBIOL, V50, P145, DOI 10.1046/j.1365-2958.2003.03694.x; Lee J, 2010, BIOCHEM BIOPH RES CO, V401, P48, DOI 10.1016/j.bbrc.2010.09.005; Lee SH, 2009, EUKARYOT CELL, V8, P1155, DOI 10.1128/EC.00335-08; Lee SH, 2009, EUKARYOT CELL, V8, P116, DOI 10.1128/EC.00176-08; Lee S, 2011, EUKARYOT CELL, V10, P1043, DOI 10.1128/EC.05071-11; Lee SH, 2006, FUNGAL GENET BIOL, V43, P295, DOI 10.1016/j.fgb.2005.12.007; Leslie J. F., 2006, FUSARIUM LAB MANUAL, DOI 10.1002/9780470278376; Lin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025586; Lipsick JS, 1996, ONCOGENE, V13, P223; Lord KM, 2011, FUNGAL GENET BIOL, V48, P388, DOI 10.1016/j.fgb.2010.11.009; McDonald WH, 1999, MOL CELL BIOL, V19, P5352; Min K, 2010, EUKARYOT CELL, V9, P1495, DOI 10.1128/EC.00083-10; MIZUGUCHI G, 1990, J BIOL CHEM, V265, P9280; Nowrousian M, 2007, MOL MICROBIOL, V64, P923, DOI 10.1111/j.1365-2958.2007.05694.x; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; OHI R, 1994, EMBO J, V13, P471, DOI 10.1002/j.1460-2075.1994.tb06282.x; Park J, 2008, NUCLEIC ACIDS RES, V36, pD562, DOI 10.1093/nar/gkm758; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Poggeler S., 2018, PHYSL GENETICS, V15, P325, DOI [10.1007/978-3-319-71740-1_1, DOI 10.1007/978-3-319-71740-1_1, DOI 10.1007/3-540-28135-5_16]; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Qi WH, 2006, MOL GENET GENOMICS, V276, P87, DOI 10.1007/s00438-006-0125-9; Raju NB, 2009, J BIOSCIENCES, V34, P139, DOI 10.1007/s12038-009-0015-5; Raju Namboori B., 2008, Fungal Biology Reviews, V22, P26, DOI 10.1016/j.fbr.2008.03.003; RAJU NB, 1992, MYCOL RES, V96, P241, DOI 10.1016/S0953-7562(09)80934-9; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Read ND, 1996, MYCOL RES, V100, P1281, DOI 10.1016/S0953-7562(96)80057-8; Rodriguez-Sanchez L, 2011, J CELL SCI, V124, P25, DOI 10.1242/jcs.070987; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez-Gorostiaga A, 2004, MOL CELL BIOL, V24, P398, DOI 10.1128/MCB.24.1.398-406.2004; Seo JA, 1996, MYCOPATHOLOGIA, V134, P31, DOI 10.1007/BF00437050; Shen WC, 1998, GENETICS, V148, P1031; Shim WB, 2006, MOL PLANT MICROBE IN, V19, P725, DOI 10.1094/MPMI-19-0725; Son H, 2012, FEMS MICROBIOL LETT, V329, P123, DOI 10.1111/j.1574-6968.2012.02511.x; Son H, 2011, FUNGAL BIOL-UK, V115, P1290, DOI 10.1016/j.funbio.2011.09.006; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Son H, 2011, FUNGAL GENET BIOL, V48, P408, DOI 10.1016/j.fgb.2011.01.002; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; TICEBALDWIN K, 1989, SCIENCE, V246, P931, DOI 10.1126/science.2683089; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; Trail F, 2003, FUNGAL GENET BIOL, V38, P187, DOI 10.1016/S1087-1845(02)00529-7; Trail F, 2002, MYCOLOGIA, V94, P181, DOI 10.2307/3761794; Trail F, 2000, MYCOLOGIA, V92, P130, DOI 10.2307/3761457; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Weston K, 1998, CURR OPIN GENET DEV, V8, P76, DOI 10.1016/S0959-437X(98)80065-8; WIESER J, 1995, GENE DEV, V9, P491, DOI 10.1101/gad.9.4.491; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhao A, 1997, NUCLEIC ACIDS RES, V25, P904, DOI 10.1093/nar/25.4.904; Zhou XY, 2010, FUNGAL GENET BIOL, V47, P143, DOI 10.1016/j.fgb.2009.11.001; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6	72	18	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37859	10.1371/journal.pone.0037859	http://dx.doi.org/10.1371/journal.pone.0037859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649560	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335800080
J	Aini, H; Ochi, H; Iwata, M; Okawa, A; Koga, D; Okazaki, M; Sano, A; Asou, Y				Aini, Hailati; Ochi, Hiroki; Iwata, Munetaka; Okawa, Atsushi; Koga, Daisuke; Okazaki, Mutsumi; Sano, Atsushi; Asou, Yoshinori			Procyanidin B3 Prevents Articular Cartilage Degeneration and Heterotopic Cartilage Formation in a Mouse Surgical Osteoarthritis Model	PLOS ONE			English	Article							PROANTHOCYANIDIN-RICH EXTRACT; NITRIC-OXIDE SYNTHASE; APOPTOTIC CHONDROCYTE DEATH; GRAPE SEED EXTRACT; IN-VIVO; HYALURONIC-ACID; METABOLIC ABNORMALITIES; SELECTIVE-INHIBITION; APPLE POLYPHENOLS; EXPRESSION	Osteoarthritis (OA) is a common disease in the elderly due to an imbalance in cartilage degradation and synthesis. Heterotopic ossification (HO) occurs when ectopic masses of endochondral bone form within the soft tissues around the joints and is triggered by inflammation of the soft tissues. Procyanidin B3 (B3) is a procyanidin dimer that is widely studied due to its high abundance in the human diet and antioxidant activity. Here, we evaluated the role of B3 isolated from grape seeds in the maintenance of chondrocytes in vitro and in vivo. We observed that B3 inhibited H2O2-induced apoptosis in primary chondrocytes, suppressed H2O2- or IL-1 beta-induced nitric oxide synthase (iNOS) production, and prevented IL-1 beta-induced suppression of chondrocyte differentiation marker gene expression in primary chondrocytes. Moreover, B3 treatment enhanced the early differentiation of ATDC5 cells. To examine whether B3 prevents cartilage destruction in vivo, OA was surgically induced in C57BL/6J mice followed by oral administration of B3 or vehicle control. Daily oral B3 administration protected articular cartilage from OA and prevented chondrocyte apoptosis in surgically-induced OA joints. Furthermore, B3 administration prevented heterotopic cartilage formation near the surgical region. iNOS protein expression was enhanced in the synovial tissues and the pseudocapsule around the surgical region in OA mice fed a control diet, but was reduced in mice that received B3. Together, these data indicated that in the OA model, B3 prevented OA progression and heterotopic cartilage formation, at least in a part through the suppression of iNOS. These results support the potential therapeutic benefits of B3 for treatment of human OA and heterotopic ossification.	[Aini, Hailati; Okazaki, Mutsumi] Tokyo Med & Dent Univ, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Ochi, Hiroki] Keio Univ, Dept Internal Med, Tokyo, Japan; [Iwata, Munetaka] Nippon Vet & Life Sci Univ, Sch Vet Med, Div Vet Surg, Tokyo, Japan; [Okawa, Atsushi; Koga, Daisuke; Asou, Yoshinori] Tokyo Med & Dent Univ, Dept Orthoped Surg, Tokyo, Japan; [Sano, Atsushi] Kikkoman Foods Inc, Div Res & Dev, Chiba, Japan	Tokyo Medical & Dental University (TMDU); Keio University; Nippon Veterinary & Life Science University; Tokyo Medical & Dental University (TMDU); Kikkoman Corporation	Aini, H (corresponding author), Tokyo Med & Dent Univ, Dept Plast & Reconstruct Surg, Tokyo, Japan.	aso.orth@tmd.ac.jp		Iwata, Munetaka/0000-0002-5561-4996	Japanese Ministry of Education, Culture, Sports, Science and Technology [C21591935]; Kikkoman Corporation	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kikkoman Corporation	This work was supported by Grants-in-Aid for Scientific Research (Grant Number C21591935) from the Japanese Ministry of Education, Culture, Sports, Science and Technology and also by the Kikkoman Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akiyama H, 2000, BIOL PHARM BULL, V23, P1370, DOI 10.1248/bpb.23.1370; Akiyama H, 2005, FEBS LETT, V579, P4485, DOI 10.1016/j.febslet.2005.07.019; Andreutti D, 1999, J SUBMICR CYTOL PATH, V31, P173; Ariga T, 2004, BIOFACTORS, V21, P197, DOI 10.1002/biof.552210140; Asada S, 2001, INFLAMM RES, V50, P19, DOI 10.1007/s000110050719; Bartlett CS, 2006, BONE, V38, P322, DOI 10.1016/j.bone.2005.08.016; Beck KF, 1998, FEBS LETT, V435, P35, DOI 10.1016/S0014-5793(98)01035-7; Blanco FJ, 1998, ARTHRITIS RHEUM, V41, P284, DOI 10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Carando S, 1999, J AGR FOOD CHEM, V47, P4161, DOI 10.1021/jf9810564; Carini M, 2000, LIFE SCI, V67, P1799, DOI 10.1016/S0024-3205(00)00771-2; Cheng AWM, 2011, OSTEOARTHR CARTILAGE, V19, P118, DOI 10.1016/j.joca.2010.10.019; Clancy RM, 1997, J CELL PHYSIOL, V172, P183, DOI 10.1002/(SICI)1097-4652(199708)172:2<183::AID-JCP5>3.0.CO;2-K; Crofford LJ, 1997, ARTHRITIS RHEUM-US, V40, P226, DOI 10.1002/art.1780400207; Deprez S, 2001, ANTIOXID REDOX SIGN, V3, P957, DOI 10.1089/152308601317203503; Diaz-Gallego L, 2005, J ORTHOP RES, V23, P1370, DOI 10.1016/j.orthres.2005.05.003; Eisengart CA, 2000, CELL IMMUNOL, V204, P143, DOI 10.1006/cimm.2000.1686; FUKUDA K, 1995, INFLAMM RES, V44, P434, DOI 10.1007/BF01757700; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; HAKANSSON L, 1980, J CLIN INVEST, V66, P298, DOI 10.1172/JCI109857; Hamid N, 2010, J BONE JOINT SURG AM, V92A, P2032, DOI 10.2106/JBJS.I.01435; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1632, DOI 10.1002/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO;2-A; Hibasami H, 2004, INT J MOL MED, V13, P795; Hosalkar H, 2011, J BONE JOINT SURG AM, V93A, P1367, DOI 10.2106/JBJS.K.00448; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kim HA, 1999, ARTHRITIS RHEUM, V42, P1528, DOI 10.1002/1529-0131(199907)42:7<1528::AID-ANR28>3.0.CO;2-9; Kim HA, 2000, J RHEUMATOL, V27, P455; Kim J, 2010, OSTEOARTHR CARTILAGE, V18, P424, DOI 10.1016/j.joca.2009.09.008; Koga T, 1999, J AGR FOOD CHEM, V47, P1892, DOI 10.1021/jf9810517; Kuhn K, 2004, OSTEOARTHR CARTILAGE, V12, P1, DOI 10.1016/j.joca.2003.09.015; Kuhn K, 2003, J CELL PHYSIOL, V197, P379, DOI 10.1002/jcp.10372; Lotz M, 1999, RHEUM DIS CLIN N AM, V25, P269, DOI 10.1016/S0889-857X(05)70067-3; Maneiro E, 2005, ANN RHEUM DIS, V64, P388, DOI 10.1136/ard.2004.022152; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; MANKIN HJ, 1973, FED PROC, V32, P1478; McInnes LB, 1996, J EXP MED, V184, P1519, DOI 10.1084/jem.184.4.1519; Nizamutdinova IT, 2009, FOOD CHEM TOXICOL, V47, P2806, DOI 10.1016/j.fct.2009.08.016; Oizumi Y, 2010, J ORG CHEM, V75, P4884, DOI 10.1021/jo1009382; Pelletier JP, 2000, ARTHRITIS RHEUM-US, V43, P1290, DOI 10.1002/1529-0131(200006)43:6<1290::AID-ANR11>3.0.CO;2-R; Pelletier JP, 1998, ARTHRITIS RHEUM-US, V41, P1275, DOI 10.1002/1529-0131(199807)41:7<1275::AID-ART19>3.0.CO;2-T; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quinde-Axtell Z, 2006, J AGR FOOD CHEM, V54, P9978, DOI 10.1021/jf060974w; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; Sano A, 2003, BIOSCI BIOTECH BIOCH, V67, P1140, DOI 10.1271/bbb.67.1140; Scher Jose U, 2007, Curr Rheumatol Rep, V9, P9, DOI 10.1007/s11926-007-0016-z; Serra A, 2010, BRIT J NUTR, V103, P944, DOI 10.1017/S0007114509992741; Shah R, 2005, ARTHRITIS RHEUM-US, V52, P2799, DOI 10.1002/art.21239; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Stevens AL, 2008, OSTEOARTHR CARTILAGE, V16, P489, DOI 10.1016/j.joca.2007.07.015; Takahashi T, 1999, J INVEST DERMATOL, V112, P310, DOI 10.1046/j.1523-1747.1999.00532.x; TASKIRAN D, 1994, BIOCHEM BIOPH RES CO, V200, P142, DOI 10.1006/bbrc.1994.1426; Yamaguchi F, 1999, J AGR FOOD CHEM, V47, P2544, DOI 10.1021/jf9806762; Yamakoshi J, 2004, PHYTOTHER RES, V18, P895, DOI 10.1002/ptr.1537; Yamakoshi J, 2003, PIGM CELL RES, V16, P629, DOI 10.1046/j.1600-0749.2003.00093.x; Yamakoshi J, 2002, J AGR FOOD CHEM, V50, P4983, DOI 10.1021/jf0201632; Yanagida A, 2000, J AGR FOOD CHEM, V48, P5666, DOI 10.1021/jf000363i; Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021; Zhao J, 1999, CARCINOGENESIS, V20, P1737, DOI 10.1093/carcin/20.9.1737	58	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37728	10.1371/journal.pone.0037728	http://dx.doi.org/10.1371/journal.pone.0037728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629448	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345300071
J	Hatanaka, K; Lanahan, AA; Murakami, M; Simons, M				Hatanaka, Kunihiko; Lanahan, Anthony A.; Murakami, Masahiro; Simons, Michael			Fibroblast Growth Factor Signaling Potentiates VE-Cadherin Stability at Adherens Junctions by Regulating SHP2	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CADHERIN; TYROSINE PHOSPHORYLATION; BARRIER FUNCTION; DEPENDENT ENDOCYTOSIS; PARACELLULAR PATHWAY; CELLS; PERMEABILITY; P120-CATENIN; ASSOCIATION; ACTIVATION	Background: The fibroblast growth factor (FGF) system plays a critical role in the maintenance of vascular integrity via enhancing the stability of VE-cadherin at adherens junctions. However, the precise molecular mechanism is not well understood. In the present study, we aimed to investigate the detailed mechanism of FGF regulation of VE-cadherin function that leads to endothelial junction stabilization. Methods and Findings: In vitro studies demonstrated that the loss of FGF signaling disrupts the VE-cadherin-catenin complex at adherens junctions by increasing tyrosine phosphorylation levels of VE-cadherin. Among protein tyrosine phosphatases (PTPs) known to be involved in the maintenance of the VE-cadherin complex, suppression of FGF signaling reduces SHP2 expression levels and SHP2/VE-cadherin interaction due to accelerated SHP2 protein degradation. Increased endothelial permeability caused by FGF signaling inhibition was rescued by SHP2 overexpression, indicating the critical role of SHP2 in the maintenance of endothelial junction integrity. Conclusions: These results identify FGF-dependent maintenance of SHP2 as an important new mechanism controlling the extent of VE-cadherin tyrosine phosphorylation, thereby regulating its presence in adherens junctions and endothelial permeability.	[Hatanaka, Kunihiko; Lanahan, Anthony A.; Murakami, Masahiro; Simons, Michael] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Simons, Michael] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Yale University; Yale University	Hatanaka, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan.	Masahiro.Murakami@Yale.edu	Simons, Michael/G-8553-2014	Simons, Michael/0000-0003-0348-7734	NIH [HL053793]; AHA Scientist Development Grant [10SDG4170137]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107205, R01HL053793] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by NIH grant HL053793 (http://www.nhlbi.nih.gov/; MS) and AHA Scientist Development Grant 10SDG4170137 (http://www.americanheart.org/presenter.jhtml?identifier = 3059907; MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Baumeister U, 2005, EMBO J, V24, P1686, DOI 10.1038/sj.emboj.7600647; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Esser S, 1998, J CELL SCI, V111, P1853; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; GRAZIA LM, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Grinnell KL, 2010, AM J PHYSIOL-LUNG C, V298, pL361, DOI 10.1152/ajplung.00374.2009; Ha CH, 2008, J BIOL CHEM, V283, P7261, DOI 10.1074/jbc.M702881200; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Hatanaka K, 2011, AM J PHYSIOL-HEART C, V300, pH162, DOI 10.1152/ajpheart.00650.2010; Hudry-Clergeon H, 2005, FASEB J, V19, P512, DOI 10.1096/fj.04-2202com; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894; Murakami M, 2002, J BIOL CHEM, V277, P20367, DOI 10.1074/jbc.M202501200; Murakami M, 2011, J CLIN INVEST; Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298; Murakami M, 2009, J MOL MED, V87, P571, DOI 10.1007/s00109-009-0463-2; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Pepper MS, 1998, EXP CELL RES, V241, P414, DOI 10.1006/excr.1998.4072; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Shasby DM, 2002, AM J PHYSIOL-LUNG C, V282, pL1330, DOI 10.1152/ajplung.00329.2001; Shaw SK, 2001, J IMMUNOL, V167, P2323, DOI 10.4049/jimmunol.167.4.2323; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Turowski P, 2008, J CELL SCI, V121, P29, DOI 10.1242/jcs.022681; UENO H, 1992, J BIOL CHEM, V267, P1470; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Vestweber D, 2010, CURR OPIN HEMATOL, V17, P230, DOI 10.1097/MOH.0b013e328338664b; Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhao XF, 2010, J CELL BIOL, V189, P955, DOI 10.1083/jcb.200912094	43	47	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37600	10.1371/journal.pone.0037600	http://dx.doi.org/10.1371/journal.pone.0037600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629427	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345300058
J	Hebert, S; Canlon, B; Hasson, D; Hanson, LLM; Westerlund, H; Theorell, T				Hebert, Sylvie; Canlon, Barbara; Hasson, Dan; Hanson, Linda L. Magnusson; Westerlund, Hugo; Theorell, Tores			Tinnitus Severity Is Reduced with Reduction of Depressive Mood - a Prospective Population Study in Sweden	PLOS ONE			English	Article							HEARING-LOSS; D PERSONALITY; PREVALENCE; SYMPTOMS; ADULTS; HEALTH; NOISE	Tinnitus, the perception of sound without external source, is a highly prevalent public health problem with about 8% of the population having frequently occurring tinnitus, and about 1-2% experiencing significant distress from it. Population studies, as well as studies on self-selected samples, have reported poor psychological well-being in individuals with tinnitus. However, no study has examined the long-term co-variation between mood and tinnitus prevalence or tinnitus severity. In this study, the relationship between depression and tinnitus prevalence and severity over a 2-year period was examined in a representative sample of the general Swedish working population. Results show that a decrease in depression is associated with a decrease in tinnitus prevalence, and even more markedly with tinnitus severity. Hearing loss was a more potent predictor than depression for tinnitus prevalence, but was a weaker predictor than depression for tinnitus severity. In addition, there were sex differences for tinnitus prevalence, but not for tinnitus severity. This study shows a direct and long-term association between tinnitus severity and depression.	[Hebert, Sylvie] Univ Montreal, Fac Med, Ecole Orthophonie & Audiol, BRAMS,Int Lab Brain Mus & Sound Res, Montreal, PQ H3C 3J7, Canada; [Hebert, Sylvie] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada; [Hasson, Dan; Hanson, Linda L. Magnusson; Westerlund, Hugo; Theorell, Tores] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Theorell, Tores] Karolinska Inst, Dept Publ Hlth, Stockholm, Sweden; [Canlon, Barbara; Hasson, Dan] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Universite de Montreal; Universite de Montreal; Stockholm University; Karolinska Institutet; Karolinska Institutet	Hebert, S (corresponding author), Univ Montreal, Fac Med, Ecole Orthophonie & Audiol, BRAMS,Int Lab Brain Mus & Sound Res, Montreal, PQ H3C 3J7, Canada.	sylvie.hebert@umontreal.ca	Hasson, Dan/T-9262-2019; Westerlund, Hugo/A-3049-2012; Hanson, Linda L Magnusson/D-2435-2017	Westerlund, Hugo/0000-0002-8806-5698; Hanson, Linda L Magnusson/0000-0002-2908-1903; Canlon, Barbara/0000-0002-4377-5266; Theorell, Tores/0000-0003-1956-7931	FAS Centre for Research on Hearing Problems in Working Life and Tysta Skolan; Swedish Medical Research Council; FAS Centre for Research on Hearing Problems in Working Life; Karolinska Institute; Tysta Skolan; Fondation Caroline-Durand; Swedish Council for Working Life and Social Research (FAS)	FAS Centre for Research on Hearing Problems in Working Life and Tysta Skolan; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); FAS Centre for Research on Hearing Problems in Working Life; Karolinska Institute(Karolinska Institutet); Tysta Skolan; Fondation Caroline-Durand; Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	Swedish Council for Working Life and Social Research (FAS). DH is supported by a grant from FAS Centre for Research on Hearing Problems in Working Life and Tysta Skolan. BC is supported from the Swedish Medical Research Council, FAS Centre for Research on Hearing Problems in Working Life, the Karolinska Institute, and Tysta Skolan. SH is supported by Fondation Caroline-Durand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Bartels H, 2010, OTOL NEUROTOL, V31, P11, DOI 10.1097/MAO.0b013e3181bc3dd1; Bartels H, 2010, PSYCHOSOMATICS, V51, P29, DOI 10.1176/appi.psy.51.1.29; Beck AT, 1996, BDI 2 BECK DEPRESSIO, Vvi, P38; Bulbul SF, 2009, INT J PEDIATR OTORHI, V73, P1124, DOI 10.1016/j.ijporl.2009.04.018; DAVIS AC, 1989, INT J EPIDEMIOL, V18, P911, DOI 10.1093/ije/18.4.911; Gopinath B, 2010, ANN EPIDEMIOL, V20, P129, DOI 10.1016/j.annepidem.2009.09.002; Hanson LLM, 2008, SCAND J PUBLIC HEALT, V36, P737, DOI 10.1177/1403494808090164; Hanson LLM, 2009, INT ARCH OCC ENV HEA, V82, P951, DOI 10.1007/s00420-009-0406-9; Hasson D, 2010, J EPIDEMIOL COMMUN H, V64, P453, DOI 10.1136/jech.2009.095430; Hasson D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-130; Hebert S, PSYCHOTHER IN PRESS; Hesser H, 2011, CLIN PSYCHOL REV, V31, P545, DOI 10.1016/j.cpr.2010.12.006; Holgers KM, 2000, AUDIOLOGY, V39, P284; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Langguth B, 2011, WORLD J BIOL PSYCHIA; Lipman R.S., 1986, ASSESSMENT DEPRESSIO, P232, DOI [DOI 10.1007/978-3-642-70486-4_22, 10.1007/978-3-642-70486-4_22]; Martinez Devesa P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005233.pub2; Ooms E, 2011, OTOLARYNG HEAD NECK, V145, P276, DOI 10.1177/0194599811403381; Palmer KT, 2002, OCCUP ENVIRON MED, V59, P634, DOI 10.1136/oem.59.9.634; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Saunders GH, 2009, NOISE HEALTH, V11, P14, DOI 10.4103/1463-1741.45308; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schlee W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027379; Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Weisz N, 2006, HEARING RES, V222, P108, DOI 10.1016/j.heares.2006.09.003	28	52	57	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37733	10.1371/journal.pone.0037733	http://dx.doi.org/10.1371/journal.pone.0037733			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VQ	22629449	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345300072
J	Inubushi, T; Iijima, K; Koizumi, M; Sakai, KL				Inubushi, Tomoo; Iijima, Kazuki; Koizumi, Masatoshi; Sakai, Kuniyoshi L.			Left Inferior Frontal Activations Depending on the Canonicity Determined by the Argument Structures of Ditransitive Sentences: An MEG Study	PLOS ONE			English	Article							BROCAS AREA; LANGUAGE; FMRI; COMPREHENSION; INFORMATION; EEG	To elucidate the relationships between syntactic and semantic processes, one interesting question is how syntactic structures are constructed by the argument structure of a verb, where each argument corresponds to a semantic role of each noun phrase (NP). Here we examined the effects of possessivity [sentences with or without a possessor] and canonicity [canonical or noncanonical word orders] using Japanese ditransitive sentences. During a syntactic decision task, the syntactic structure of each sentence would be constructed in an incremental manner based on the predicted argument structure of the ditransitive verb in a verb-final construction. Using magnetoencephalography, we found a significant canonicity effect on the current density in the left inferior frontal gyrus (IFG) at 530-550 ms after the verb onset. This effect was selective to canonical sentences, and significant even when the precedent NP was physically identical. We suggest that the predictive effects associated with syntactic processing became larger for canonical sentences, where the NPs and verb were merged with a minimum structural distance, leading to the left IFG activations. For monotransitive and intransitive verbs, in which structural computation of the sentences was simpler than that of ditransitive sentences, we observed a significant effect selective to noncanonical sentences in the temporoparietal regions during 480-670 ms. This effect probably reflects difficulty in semantic processing of noncanonical sentences. These results demonstrate that the left IFG plays a predictive role in syntactic processing, which depends on the canonicity determined by argument structures, whereas other temporoparietal regions would subserve more semantic aspects of sentence processing.	[Inubushi, Tomoo; Iijima, Kazuki; Sakai, Kuniyoshi L.] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo, Japan; [Inubushi, Tomoo; Iijima, Kazuki; Sakai, Kuniyoshi L.] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo, Japan; [Inubushi, Tomoo; Iijima, Kazuki] Japan Soc Promot Sci, Kawaguchi, Saitama, Japan; [Koizumi, Masatoshi] Tohoku Univ, Dept Linguist, Aoba Ku, Sendai, Miyagi 980, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Japan Society for the Promotion of Science; Tohoku University	Inubushi, T (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo, Japan.	sakai@mind.c.u-tokyo.ac.jp	Koizumi, Masatoshi/GNW-4181-2022; Iijima, Kazuki/S-2552-2017	Koizumi, Masatoshi/0000-0003-0719-7128; Iijima, Kazuki/0000-0001-9572-0980	Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of Japan [20220005, 22222001];  [22.10126]	Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by a Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST), by a Grant-in-Aid for Scientific Research (S) (Nos. 20220005 and 22222001) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows (No. 22.10126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlmann J, 2007, HUM BRAIN MAPP, V28, P940, DOI 10.1002/hbm.20318; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Ben-Shachar M, 2004, NEUROIMAGE, V21, P1320, DOI 10.1016/j.neuroimage.2003.11.027; Boland JE, 1995, J MEM LANG, V34, P774, DOI 10.1006/jmla.1995.1034; Bornkessel I, 2005, NEUROIMAGE, V26, P221, DOI 10.1016/j.neuroimage.2005.01.032; Bresnan J, 2010, LANGUAGE, V86, P168; Bruening B, 2010, LINGUIST INQ, V41, P519, DOI 10.1162/LING_a_00012; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Chomsky N, 2011, LANG LEARN DEV, V7, P263, DOI 10.1080/15475441.2011.584041; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; Comrie B., 1989, LANGUAGE UNIVERSALS, V2nd; Corina DP, 2005, HUM BRAIN MAPP, V24, P1, DOI 10.1002/hbm.20063; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; ELMAN JL, 1991, MACH LEARN, V7, P195, DOI 10.1007/BF00114844; Fiebach CJ, 2005, HUM BRAIN MAPP, V24, P79, DOI 10.1002/hbm.20070; FRAZIER L, 1989, J MEM LANG, V28, P331, DOI 10.1016/0749-596X(89)90037-5; Friston KJ, 2006, NEUROIMAGE, V30, P1097, DOI 10.1016/j.neuroimage.2006.02.007; FUKUI N, 1993, LINGUIST INQ, V24, P399; Green Georgia M., 1974, SEMANTICS SYNTACTIC; Grewe T, 2006, NEUROIMAGE, V32, P1395, DOI 10.1016/j.neuroimage.2006.04.213; Grodzinsky Y, 2008, TRENDS COGN SCI, V12, P474, DOI 10.1016/j.tics.2008.09.001; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hoji H, 1986, ISSUES JAPANESE LING, P163; Hovav MR, 2008, J LINGUIST, V44, P129, DOI 10.1017/S0022226707004975; Iijima K, 2009, NEUROIMAGE, V44, P1387, DOI 10.1016/j.neuroimage.2008.10.041; Jaeggli Osvaldo, 1981, TOPICS ROMANCE SYNTA; Kamide Y, 2003, J MEM LANG, V49, P133, DOI 10.1016/S0749-596X(03)00023-8; Karniski Walt, 1994, Brain Topography, V6, P203, DOI 10.1007/BF01187710; Kinno R, 2008, HUM BRAIN MAPP, V29, P1015, DOI 10.1002/hbm.20441; Kinno R, 2009, BRAIN LANG, V110, P71, DOI 10.1016/j.bandl.2009.05.001; Kishimoto H, 2008, J EAST ASIAN LINGUIS, V17, P141, DOI 10.1007/s10831-008-9023-y; Koizumi M, 2010, LINGUIST INQ, V41, P663, DOI 10.1162/LING_a_00016; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; LARSON RK, 1988, LINGUIST INQ, V19, P335; Marantz Alec., 1993, THEORETICAL ASPECTS, P113; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Miyagawa S, 2004, J EAST ASIAN LINGUIS, V13, P1, DOI 10.1023/B:JEAL.0000007345.64336.84; Nakamoto K., 2006, COGNITIVE STUDIES, V13, P334; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pantazis D, 2005, NEUROIMAGE, V25, P383, DOI 10.1016/j.neuroimage.2004.09.040; Pinker Steven., 1991, LEARNABILITY COGNITI; Radford A., 1997, SYNTACTIC THEORY STR; Ralph MAL, 2009, CEREB CORTEX, V19, P832, DOI 10.1093/cercor/bhn131; SADAKANE K, 1995, LINGUISTICS, V33, P5, DOI 10.1515/ling.1995.33.1.5; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; SAITO M, 1992, J EAST ASIAN LINGUIS, V1, P69, DOI 10.1007/BF00129574; Sakai KL, 2005, SCIENCE, V310, P815, DOI 10.1126/science.1113530; Sakai KL, 2004, CEREB CORTEX, V14, P1233, DOI 10.1093/cercor/bhh084; Santi A, 2012, NEUROPSYCHOLOGIA, V50, P821, DOI 10.1016/j.neuropsychologia.2012.01.017; Shetreet E, 2007, CEREB CORTEX, V17, P1958, DOI 10.1093/cercor/bhl105; Stowe Laurie A., 1986, LANG COGNITIVE PROC, V1, P227, DOI DOI 10.1080/01690968608407062; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028; Suzuki K, 2003, CEREB CORTEX, V13, P517, DOI 10.1093/cercor/13.5.517; Takano Y, 1998, NAT LANG LINGUIST TH, V16, P817, DOI 10.1023/A:1006031229239; Talairach J., 1988, COPLANAR STEREOTAXIC; Tamaoka K, 2005, J PSYCHOLINGUIST RES, V34, P281, DOI 10.1007/s10936-005-3641-6; Thompson CK, 2007, J COGNITIVE NEUROSCI, V19, P1753, DOI 10.1162/jocn.2007.19.11.1753; Wildgruber D, 2004, CEREB CORTEX, V14, P1384, DOI 10.1093/cercor/bhh099; Wilson SM, 2010, J NEUROSCI, V30, P16845, DOI 10.1523/JNEUROSCI.2547-10.2010; Yatsushiro K, 2003, J EAST ASIAN LINGUIS, V12, P141, DOI 10.1023/A:1022423427865	62	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37192	10.1371/journal.pone.0037192	http://dx.doi.org/10.1371/journal.pone.0037192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959VQ	22629366	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300025
J	Lagler, H; Grabmeier-Pfistershammer, K; Touzeau-Romer, V; Tobudic, S; Ramharter, M; Wenisch, J; Gualdoni, GA; Redlberger-Fritz, M; Popow-Kraupp, T; Rieger, A; Burgmann, H				Lagler, Heimo; Grabmeier-Pfistershammer, Katharina; Touzeau-Roemer, Veronique; Tobudic, Selma; Ramharter, Michael; Wenisch, Judith; Gualdoni, Guido Andres; Redlberger-Fritz, Monika; Popow-Kraupp, Theresia; Rieger, Armin; Burgmann, Heinz			Immunogenicity and Tolerability after Two Doses of Non-Adjuvanted, Whole-Virion Pandemic Influenza A (H1N1) Vaccine in HIV-Infected Individuals	PLOS ONE			English	Article							HEMAGGLUTINATION-INHIBITING ANTIBODY; HIV-1-INFECTED PATIENTS; SPLIT VIRION; VIRUS; ADULTS; PROTECTION; RESPONSES; SAFETY	Background: During the influenza pandemic of 2009/10, the whole-virion, Vero-cell-derived, inactivated, pandemic influenza A (H1N1) vaccine Celvapan (R) (Baxter) was used in Austria. Celvapan (R) is adjuvant-free and was the only such vaccine at that time in Europe. The objective of this observational, non-interventional, prospective single-center study was to evaluate the immunogenicity and tolerability of two intramuscular doses of this novel vaccine in HIV-positive individuals. Methods and Findings: A standard hemagglutination inhibition (HAI) assay was used for evaluation of the seroconversion rate and seroprotection against the pandemic H1N1 strain. In addition, H1N1-specific IgG antibodies were measured using a recently developed ELISA and compared with the HAI results. Tolerability of vaccination was evaluated up to one month after the second dose. A total of 79 HIV-infected adults with an indication for H1N1 vaccination were evaluated. At baseline, 55 of the 79 participants had an HAI titer >= 1:40 and two patients showed a positive IgG ELISA. The seroconversion rate was 31% after the first vaccination, increasing to 41% after the second; the corresponding seroprotection rates were 92% and 83% respectively. ELISA IgG levels were positive in 25% after the first vaccination and in 37% after the second. Among the participants with baseline HAI titers <1:40, 63% seroconverted. Young age was clearly associated with lower HAI titers at baseline and with higher seroconversion rates, whereas none of the seven patients >60 years of age had a baseline HAI titer <1:40 or seroconverted after vaccination. The vaccine was well tolerated. Conclusion: The non-adjuvanted pandemic influenza A (H1N1) vaccine was well tolerated and induced a measurable immune response in a sample of HIV-infected individuals.	[Lagler, Heimo; Tobudic, Selma; Ramharter, Michael; Wenisch, Judith; Gualdoni, Guido Andres; Burgmann, Heinz] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria; [Grabmeier-Pfistershammer, Katharina; Touzeau-Roemer, Veronique; Rieger, Armin] Med Univ Vienna, Div Immunol Allergy & Infect Dis, Dept Dermatol, Vienna, Austria; [Ramharter, Michael] Univ Tubingen, Dept Trop Med, Tubingen, Germany; [Redlberger-Fritz, Monika; Popow-Kraupp, Theresia] Med Univ Vienna, Dept Virol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Eberhard Karls University of Tubingen; Medical University of Vienna	Lagler, H (corresponding author), Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria.	heinz.burgmann@meduniwien.ac.at	Burgmann, Heinz/N-2409-2013; Ramharter, Michael/C-5273-2013	Gualdoni, Guido/0000-0001-9490-0197; Grabmeier-Pfistershammer, Katharina/0000-0003-0665-5414; Lagler, Heimo/0000-0003-3240-7385; Burgmann, Heinz/0000-0002-2114-0999; Redlberger-Fritz, Monika/0000-0001-6265-557X; Ramharter, Michael/0000-0002-9259-1885				Arguedas A, 2010, NEW ENGL J MED, V362, P370, DOI 10.1056/NEJMc0909988; Barrett PN, 2011, LANCET, V377, P751, DOI 10.1016/S0140-6736(10)62228-3; Bickel M, 2010, AIDS, V24, pF31, DOI 10.1097/QAD.0b013e3283398da1; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Crum-Cianflone NF, 2011, CLIN INFECT DIS, V52, P138, DOI 10.1093/cid/ciq019; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Dikow R, 2011, AM J KIDNEY DIS, V57, P716, DOI 10.1053/j.ajkd.2010.11.031; Esposito S, 2011, VACCINE, V29, P1677, DOI 10.1016/j.vaccine.2010.12.047; European Committee for Proprietary Medicinal Products, 1997, CPMPBWP21496 EUR AG; European Medicines Agency, 2009, EMA8438072009; Evison J, 2009, CLIN INFECT DIS, V48, P1402, DOI 10.1086/598193; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Ho J, 2011, AIDS, V25, P295, DOI 10.1097/QAD.0b013e328342328b; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Johansen K, 2009, EUROSURVEILLANCE, V14, P12; Kajaste-Rudnitski A, 2011, AIDS, V25, P177, DOI 10.1097/QAD.0b013e328341afa8; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kistner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009349; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Lagler H, 2011, VACCINE, V29, P6888, DOI 10.1016/j.vaccine.2011.07.050; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Manuel O, 2011, CLIN INFECT DIS, V52, P248, DOI 10.1093/cid/ciq104; Mayr A, 1977, SEROLOGIE, V2, P207; Meyer S, 2011, TRANSPLANTATION, V91, P1031, DOI 10.1097/TP.0b013e3182115be0; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miraglia JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027214; Nicholson KG, 2011, LANCET INFECT DIS, V11, P91, DOI 10.1016/S1473-3099(10)70296-6; Orlando G, 2010, AIDS, V24, P2142, DOI 10.1097/QAD.0b013e32833cfcb0; PARKMAN PD, 1977, J INFECT DIS, V136, pS722, DOI 10.1093/infdis/136.Supplement_3.S722; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Soonawala D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016496; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Tebas P, 2010, AIDS, V24, P2187, DOI 10.1097/QAD.0b013e32833c6d5c; Waddington CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2649; World Health Organization, 2009, STAT PRESS DIR GEN M	39	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e36773	10.1371/journal.pone.0036773	http://dx.doi.org/10.1371/journal.pone.0036773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629330	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343100008
J	Chen, ZB; Tan, JY; Wen, Y; Niu, SNA; Wong, SM				Chen, Zibo; Tan, Jackie Yen; Wen, Yi; Niu, Shengniao; Wong, Sek-Man			A Game-Theoretic Model of Interactions between Hibiscus Latent Singapore Virus and Tobacco Mosaic Virus	PLOS ONE			English	Article							COINFECTION; ACCUMULATION; SYNERGISM	Mixed virus infections in plants are common in nature and their interactions affecting host plants would depend mainly on plant species, virus strains, the order of infection and initial amount of inoculum. Hence, the prediction of outcome of virus competition in plants is not easy. In this study, we applied evolutionary game theory to model the interactions between Hibiscus latent Singapore virus (HLSV) and Tobacco mosaic virus (TMV) in Nicotiana benthamiana under co-infection in a plant host. The accumulation of viral RNA was quantified using qPCR at 1, 2 and 8 days post infection (dpi), and two different methods were employed to predict the dominating virus. TMV was predicted to dominate the game in the long run and this prediction was confirmed by both qRT-PCR at 8 dpi and the death of co-infected plants after 15 dpi. In addition, we validated our model by using data reported in the literature. Ten out of fourteen reported co-infection outcomes agreed with our predictions. Explanations were given for the four interactions that did not agree with our model. Hence, it serves as a valuable tool in making long term predictions using short term data obtained in virus co-infections.	[Chen, Zibo; Tan, Jackie Yen; Wen, Yi; Niu, Shengniao; Wong, Sek-Man] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Chen, Zibo; Tan, Jackie Yen] Natl Univ Singapore, Undergrad Res Opportun Sci UROPS, Singapore 117548, Singapore; [Tan, Jackie Yen] Natl Univ Singapore, Univ Scholars Programme USP, Singapore 117548, Singapore; [Wong, Sek-Man] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Chen, ZB (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbswsm@nus.edu.sg	Wong, Sek-Man/I-2385-2012	Wong, Sek-Man/0000-0002-4620-3706; Chen, Zibo/0000-0003-2990-2895	National University of Singapore [R-154-000-493-112]	National University of Singapore(National University of Singapore)	This research work is supported by a research grant R-154-000-493-112 from National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves M, 2009, VIROLOGY, V387, P257, DOI 10.1016/j.virol.2009.01.046; [Anonymous], 1995, EVOLUTIONARY GAME TH; Fattouh F. A., 2003, Pakistan Journal of Plant Pathology, V2, P85; GOELET P, 1982, P NATL ACAD SCI-BIOL, V79, P5818, DOI 10.1073/pnas.79.19.5818; Grande-Perez A, 2005, P NATL ACAD SCI USA, V102, P4448, DOI 10.1073/pnas.0408871102; Kaufman PB., 2009, RECENT ADV PLANT BIO, V13, P333, DOI [10.1007/978-1-4419-0194-1_13, DOI 10.1007/978-1-4419-0194-1_13]; Kokkinos CD, 2006, PLANT DIS, V90, P1347, DOI 10.1094/PD-90-1347; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin S, 2009, J GEN VIROL, V90, P2815, DOI 10.1099/vir.0.012351-0; Maynard Smith J., 1982, EVOLUTION THEORY GAM; McKinney HH, 1929, J AGRIC RES, V39, P0557; Mohamed E., 2010, J AM SCI, V6, P311; Murphy John F, 2006, Phytopathology, V96, P240, DOI 10.1094/PHYTO-96-0240; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Nayudu M. V., 2008, PLANT VIRUSES; Nowak MA, 2004, SCIENCE, V303, P793, DOI 10.1126/science.1093411; Scheets K, 1998, VIROLOGY, V242, P28, DOI 10.1006/viro.1997.8989; SEIFERS DL, 1995, PLANT DIS, V79, P1104, DOI 10.1094/PD-79-1104; Srinivasan KG, 2005, ARCH VIROL, V150, P153, DOI 10.1007/s00705-004-0404-x; Straffin P., 1993, GAME THEORY STRATEGY; Tatineni S, 2010, PHYTOPATHOLOGY, V100, P230, DOI 10.1094/PHYTO-100-3-0230; Turner PE, 2003, AM NAT, V161, P497, DOI 10.1086/367880; WADSWORTH GJ, 1988, ANAL BIOCHEM, V172, P279, DOI 10.1016/0003-2697(88)90443-5; Wintermantel WM, 2008, PHYTOPATHOLOGY, V98, P1340, DOI 10.1094/PHYTO-98-12-1340; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088; Xi DH, 2010, J PHYTOPATHOL, V158, P263, DOI 10.1111/j.1439-0434.2009.01607.x; Yang H, 2010, J PHYTOPATHOL, V158, P833, DOI 10.1111/j.1439-0434.2010.01694.x; Zeng R, 2007, ACTA BIOCH BIOPH SIN, V39, P431, DOI 10.1111/j.1745-7270.2007.00292.x	28	7	7	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37007	10.1371/journal.pone.0037007	http://dx.doi.org/10.1371/journal.pone.0037007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623970	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500047
J	Goodyear, A; Bielefeldt-Ohmann, H; Schweizer, H; Dow, S				Goodyear, Andrew; Bielefeldt-Ohmann, Helle; Schweizer, Herbert; Dow, Steven			Persistent Gastric Colonization with Burkholderia pseudomallei and Dissemination from the Gastrointestinal Tract following Mucosal Inoculation of Mice	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; IN-SITU HYBRIDIZATION; PSEUDOMONAS-PSEUDOMALLEI; BACTEREMIC MELIOIDOSIS; GASTRODUODENAL LESIONS; ALCOHOL-CONSUMPTION; DIABETES-MELLITUS; ENTERIC INFECTION; SELECTIVE MEDIA; MURINE MODEL	Melioidosis is a disease of humans caused by opportunistic infection with the soil and water bacterium Burkholderia pseudomallei. Melioidosis can manifest as an acute, overwhelming infection or as a chronic, recurrent infection. At present, it is not clear where B. pseudomallei resides in the mammalian host during the chronic, recurrent phase of infection. To address this question, we developed a mouse low-dose mucosal challenge model of chronic B. pseudomallei infection and investigated sites of bacterial persistence over 60 days. Sensitive culture techniques and selective media were used to quantitate bacterial burden in major organs, including the gastrointestinal (GI) tract. We found that the GI tract was the primary site of bacterial persistence during the chronic infection phase, and was the only site from which the organism could be consistently cultured during a 60-day infection period. The organism could be repeatedly recovered from all levels of the GI tract, and chronic infection was accompanied by sustained low-level fecal shedding. The stomach was identified as the primary site of GI colonization as determined by fluorescent in situ hybridization. Organisms in the stomach were associated with the gastric mucosal surface, and the propensity to colonize the gastric mucosa was observed with 4 different B. pseudomallei isolates. In contrast, B. pseudomallei organisms were present at low numbers within luminal contents in the small and large intestine and cecum relative to the stomach. Notably, inflammatory lesions were not detected in any GI tissue examined in chronically-infected mice. Only low-dose oral or intranasal inoculation led to GI colonization and development of chronic infection of the spleen and liver. Thus, we concluded that in a mouse model of melioidosis B. pseudomallei preferentially colonizes the stomach following oral inoculation, and that the chronically colonized GI tract likely serves as a reservoir for dissemination of infection to extra-intestinal sites.	[Goodyear, Andrew; Schweizer, Herbert; Dow, Steven] Colorado State Univ, Dept Microbiol Immunol & Pathol, Rocky Mt Reg Ctr Excellence Biodef & Emerging Inf, Ft Collins, CO 80523 USA; [Bielefeldt-Ohmann, Helle] Univ Queensland, Sch Vet Sci, Brisbane, Qld 4072, Australia	Colorado State University; University of Queensland	Goodyear, A (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Rocky Mt Reg Ctr Excellence Biodef & Emerging Inf, Ft Collins, CO 80523 USA.	sdow@colostate.edu			National Institutes of Health [R21AI091991, AI065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI091991, U54AI065357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R21AI091991, and grant AI065357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKMAL M, 1994, CLIN NEPHROL, V42, P198; Aldhous P, 2005, NATURE, V434, P692, DOI 10.1038/434692a; ASHDOWN LR, 1979, PATHOLOGY, V11, P293, DOI 10.3109/00313027909061954; Barnes JL, 2005, EMERG INFECT DIS, V11, P638, DOI 10.3201/eid1104.041051; Boehme MWJ, 2007, HEPATO-GASTROENTEROL, V54, P643; BRADFORD WD, 1974, ARCH PATHOL, V98, P17; Breitbach Katrin, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS89, DOI 10.1016/S0035-9203(08)70022-1; Brett PJ, 1997, EPIDEMIOL INFECT, V118, P137, DOI 10.1017/S095026889600739X; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Bujanda L, 2000, AM J GASTROENTEROL, V95, P3374, DOI 10.1111/j.1572-0241.2000.03347.x; Bytzer P, 2002, AM J GASTROENTEROL, V97, P604; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Chang JH, 2009, DIGEST DIS SCI, V54, P578, DOI 10.1007/s10620-008-0399-3; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chou DW, 2007, J FORMOS MED ASSOC, V106, P1013, DOI 10.1016/S0929-6646(08)60077-7; COTTEW G. S., 1952, AUSTRALIAN VET JOUR, V28, P113, DOI 10.1111/j.1751-0813.1952.tb05138.x; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Currie BJ, 2000, ACTA TROP, V74, P121, DOI 10.1016/S0001-706X(99)00060-1; Currie BJ, 2001, AM J TROP MED HYG, V65, P177, DOI 10.4269/ajtmh.2001.65.177; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; Dance DAB, 2005, EMERG INF DIS 21ST C, P99; DEJSIRILERT S, 1991, JPN J MED SCI BIOL, V44, P63, DOI 10.7883/yoken1952.44.63; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Dharakul T, 1996, J CLIN MICROBIOL, V34, P609, DOI 10.1128/JCM.34.3.609-614.1996; Dharakul T, 1999, J CLIN MICROBIOL, V37, P1906, DOI 10.1128/JCM.37.6.1906-1912.1999; Draper ADK, 2010, APPL ENVIRON MICROB, V76, P5305, DOI 10.1128/AEM.00287-10; Drago-Serrano ME, 2010, IMMUNOL LETT, V134, P35, DOI 10.1016/j.imlet.2010.08.007; FELDMAN M, 1991, DIGEST DIS SCI, V36, P866, DOI 10.1007/BF01297133; Finkelstein RA, 1965, SEATO AFRIMS ANN PRO, P228; Franke A, 2005, DIGEST DIS, V23, P204, DOI 10.1159/000090167; GILLIGAN PH, 1985, J CLIN MICROBIOL, V22, P5, DOI 10.1128/JCM.22.1.5-8.1985; Glass MB, 2009, AM J TROP MED HYG, V80, P1023, DOI 10.4269/ajtmh.2009.80.1023; Goodyear A, 2010, J IMMUNOL, V184, P1445, DOI 10.4049/jimmunol.0900411; Goodyear A, 2009, INFECT IMMUN, V77, P1579, DOI 10.1128/IAI.01384-08; Hagen RM, 2011, INT J MED MICROBIOL, V301, P585, DOI 10.1016/j.ijmm.2011.04.017; Heng Bee Hoon, 1998, Annals Academy of Medicine Singapore, V27, P478; Hoppe I, 1999, INFECT IMMUN, V67, P2891, DOI 10.1128/IAI.67.6.2891-2900.1999; Howard K, 2005, WATER RES, V39, P1085, DOI 10.1016/j.watres.2004.12.028; Howard K, 2003, WATER RES, V37, P4425, DOI 10.1016/S0043-1354(03)00440-8; Inglis TJJ, 1998, LANCET, V352, P1600, DOI 10.1016/S0140-6736(05)61047-1; Isaacson RE, 1998, VET QUART, V20, pS68; Jayanetra P, 1974, Southeast Asian J Trop Med Public Health, V5, P487; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Kaestli M, 2012, ENVIRON MICROBIOL, V14, P2058, DOI 10.1111/j.1462-2920.2011.02671.x; KANAPHUN P, 1993, J INFECT DIS, V167, P230, DOI 10.1093/infdis/167.1.230; KAUFMANN A F, 1970, Journal of Wildlife Diseases, V6, P211; KETTERER PJ, 1986, AUST VET J, V63, P146, DOI 10.1111/j.1751-0813.1986.tb02953.x; Khedmat H, 2007, TRANSPL P, V39, P1003, DOI 10.1016/j.transproceed.2007.03.034; Knoll MR, 1998, ENDOSCOPY, V30, P293, DOI 10.1055/s-2007-1001257; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; LEELARASAMEE A, 1989, REV INFECT DIS, V11, P413; LEVINE MM, 1973, J INFECT DIS, V127, P261, DOI 10.1093/infdis/127.3.261; LEVY AJ, 1947, AM J CLIN PATHOL, V17, P290; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; Liu BP, 2002, INFECT IMMUN, V70, P504, DOI 10.1128/IAI.70.2.504-511.2002; LLOYD JM, 1988, AUST VET J, V65, P191, DOI 10.1111/j.1751-0813.1988.tb14300.x; M'Fadyean J, 1904, J COMP PATHOL, V17, P295; Martino MC, 2005, J INFECT DIS, V192, P136, DOI 10.1086/430740; Mayo M, 2011, EMERG INFECT DIS, V17, P1283, DOI 10.3201/eid1707.100614; MAYS EE, 1975, CHEST, V68, P261, DOI 10.1378/chest.68.2.261; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; Mohawk KL, 2010, MICROB PATHOGENESIS, V48, P131, DOI 10.1016/j.micpath.2010.01.003; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Moore Richard A, 2008, BMC Res Notes, V1, P11, DOI 10.1186/1756-0500-1-11; MORRISON RE, 1988, AM J MED, V84, P965, DOI 10.1016/0002-9343(88)90080-0; Mukhopadhyay A, 2004, J INFECTION, V48, P334, DOI 10.1016/j.jinf.2003.10.005; Nandi T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000845; Nardone G, 2005, HELICOBACTER, V10, P53, DOI 10.1111/j.1523-5378.2005.00291.x; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Noyes HE, 1968, SEATO AFRIMS ANN PRO, P83; OLDS R. J., 1955, Australian Veterinary Journal, V31, P273, DOI 10.1111/j.1751-0813.1955.tb05453.x; PATON JPJ, 1947, BRIT MED J, V1, P336, DOI 10.1136/bmj.1.4497.336; Peacock SJ, 2006, CURR OPIN INFECT DIS, V19, P421, DOI 10.1097/01.qco.0000244046.31135.b3; Peacock SJ, 2005, J CLIN MICROBIOL, V43, P5359, DOI 10.1128/JCM.43.10.5359-5361.2005; Phuong Doan Mai, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS30, DOI 10.1016/S0035-9203(08)70009-9; Propst KL, 2010, INFECT IMMUN, V78, P3136, DOI 10.1128/IAI.01313-09; PUTHUCHEARY SD, 1992, T ROY SOC TROP MED H, V86, P683, DOI 10.1016/0035-9203(92)90191-E; PUTHUCHEARY SD, 1981, TROP GEOGR MED, V33, P19; Quatrini M, 2001, J CLIN GASTROENTEROL, V32, P215, DOI 10.1097/00004836-200103000-00006; Rajendram R, 2005, DIGEST DIS, V23, P214, DOI 10.1159/000090168; Ralph A, 2004, PEDIATR INFECT DIS J, V23, P1169, DOI 10.1097/01.inf.0000145548.79395.da; Rammaert B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-126; Reed L.J., 1938, SIMPLE METHOD ESTIMA, V27, P493, DOI [10.1093/oxfordjournals.aje.a118408, DOI 10.1093/OXFORDJOURNALS.AJE.A118408]; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Ryan GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011108; SCHADE C, 1994, GASTROENTEROLOGY, V107, P180, DOI 10.1016/0016-5085(94)90075-2; Shirazian S, 2010, NAT REV NEPHROL, V6, P480, DOI 10.1038/nrneph.2010.84; Smith MD, 1997, INFECT IMMUN, V65, P4319, DOI 10.1128/IAI.65.10.4319-4321.1997; STACYPHIPPS S, 1995, J CLIN MICROBIOL, V33, P1054, DOI 10.1128/JCM.33.5.1054-1059.1995; Stanton AT, 1925, LANCET, V1, P10; Stanton AT, 1932, STUDIES I MED RES FE, P1; Strauss J M, 1969, Med J Malaya, V24, P94; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; Thibault FM, 2004, J ANTIMICROB CHEMOTH, V54, P1134, DOI 10.1093/jac/dkh471; THIN RNT, 1970, Q J MED, V39, P115; THOMAS AD, 1981, AUST VET J, V57, P144, DOI 10.1111/j.1751-0813.1981.tb00492.x; Tischler AD, 2010, CURR OPIN MICROBIOL, V13, P93, DOI 10.1016/j.mib.2009.12.007; Tong SD, 1996, MICROBIOL IMMUNOL, V40, P451, DOI 10.1111/j.1348-0421.1996.tb01092.x; Trcek J, 2010, FEMS MICROBIOL LETT, V307, P201, DOI 10.1111/j.1574-6968.2010.01983.x; VANDERSAR A, 1948, AM J CLIN PATHOL, V18, P509; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Wasse H, 2003, KIDNEY INT, V64, P1455, DOI 10.1046/j.1523-1755.2003.00225.x; West TE, 2010, AM J TROP MED HYG, V83, P1066, DOI 10.4269/ajtmh.2010.10-0306; Whitmore A, 1912, BRIT MED J, V1912, P1306; Whitmore A, 1913, J HYG-CAMBRIDGE, V13, P1, DOI 10.1017/S0022172400005234; WUTHIEKANUN V, 1995, T ROY SOC TROP MED H, V89, P491, DOI 10.1016/0035-9203(95)90080-2; WUTHIEKANUN V, 1995, T ROY SOC TROP MED H, V89, P41, DOI 10.1016/0035-9203(95)90651-7; WUTHIEKANUN V, 1990, J MED MICROBIOL, V33, P121, DOI 10.1099/00222615-33-2-121; Wuthiekanun V, 1996, J MED MICROBIOL, V45, P408, DOI 10.1099/00222615-45-6-408; Wuthiekanun Vanaporn, 2006, Expert Rev Anti Infect Ther, V4, P445, DOI 10.1586/14787210.4.3.445	113	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37324	10.1371/journal.pone.0037324	http://dx.doi.org/10.1371/journal.pone.0037324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624016	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343500099
J	Sanchez-Fernandez, MA; Sbacchi, S; Correa-Tapia, M; Naumann, R; Klemm, J; Chambon, P; Al-Robaiy, S; Blessing, M; Hoflack, B				Sanchez-Fernandez, Maria Arantzazu; Sbacchi, Silvia; Correa-Tapia, Miguel; Naumann, Ronald; Klemm, Jennifer; Chambon, Pierre; Al-Robaiy, Samiya; Blessing, Manfred; Hoflack, Bernard			Transgenic Mice for a Tamoxifen-Induced, Conditional Expression of the Cre Recombinase in Osteoclasts	PLOS ONE			English	Article							CATHEPSIN-K; BONE-RESORPTION; MOUSE; CELLS; DIFFERENTIATION; MUTAGENESIS; ACTIVATION; ARTHRITIS; GENE	Background: Studies on osteoclasts, the bone resorbing cells, have remained limited due to the lack of transgenic mice allowing the conditional knockout of genes in osteoclasts at any time during development or adulthood. Methodology/Principal Finding: We report here on the generation of transgenic mice which specifically express a tamoxifen-inducible Cre recombinase in osteoclasts. These mice, generated on C57BL/6 and FVB background, express a fusion Cre recombinase-ERT2 protein whose expression is driven by the promoter of cathepsin K (CtsK), a gene highly expressed in osteoclasts. We tested the cellular specificity of Cre activity in CtsKCreERT2 strains by breeding with Rosa26LacZ reporter mice. PCR and histological analyses of the CtsKCreERT2LacZ positive adult mice and E17.5 embryos show that Cre activity is restricted largely to bone tissue. In vitro, primary osteoclasts derived from the bone marrow of CtsKCreERT2+/-LacZ+/- adult mice show a Cre-dependent beta-galactosidase activity after tamoxifen stimulation. Conclusions/Significance: We have generated transgenic lines that enable the tamoxifen-induced, conditional deletion of loxP-flanked genes in osteoclasts, thus circumventing embryonic and postnatal gene lethality and avoiding gene deletion in other cell types. Such CtsKCreERT2 mice provide a convenient tool to study in vivo the different facets of osteoclast function in bone physiology during different developmental stages and adulthood of mice.	[Sanchez-Fernandez, Maria Arantzazu; Sbacchi, Silvia; Correa-Tapia, Miguel; Klemm, Jennifer; Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany; [Naumann, Ronald] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Chambon, Pierre] Univ Strasbourg, Coll France, Inst Genet & Biol Mol & Cellulaire, CNRS UMR7104,Inserm U964, Illkirch Graffenstaden, France; [Al-Robaiy, Samiya; Blessing, Manfred] Biotechnologish Biomed Zentrum, Leipzig, Germany	Technische Universitat Dresden; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sanchez-Fernandez, MA (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany.	bernard.hoflack@biotec.tu-dresden.de	HOFLACK, Bernard/AAZ-6668-2020		German Research Foundation [TRR 83/1-2010, HO 2584/1-1, HO 2584/2-1, HO 2584/6-1, HO 2584/8-1, HO 2584/9-1, HO 2584/1-2, HO2584/10-1]; Ministry of Saxony [HWP-EFRE 4212/05-12/02]; TU-Dresden	German Research Foundation(German Research Foundation (DFG)); Ministry of Saxony; TU-Dresden	The authors' research was supported by grants from the German Research Foundation (TRR 83/1-2010, HO 2584/1-1, HO 2584/2-1, HO 2584/6-1, HO 2584/8-1, HO 2584/9-1, HO 2584/1-2, HO2584/10-1), European funds from the Ministry of Saxony (HWP-EFRE 4212/05-12/02) and by TU-Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chiu WSM, 2004, GENESIS, V39, P178, DOI 10.1002/gene.20041; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Friedrichs B, 2003, J CLIN INVEST, V111, P1733, DOI 10.1172/JCI200315990; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Karsdal MA, 2008, BIOCHEM BIOPH RES CO, V366, P483, DOI 10.1016/j.bbrc.2007.11.168; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kopp HG, 2007, HISTOL HISTOPATHOL, V22, P971, DOI 10.14670/HH-22.971; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Odgren PR, 2006, CONNECT TISSUE RES, V47, P229, DOI 10.1080/03008200600860086; Rantakokko J, 1996, FEBS LETT, V393, P307, DOI 10.1016/0014-5793(96)00907-6; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Sanchez-Fernandez MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003537; Schett G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2110; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Udagawa N, 1999, BONE, V25, P517, DOI 10.1016/S8756-3282(99)00210-0; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	22	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37592	10.1371/journal.pone.0037592	http://dx.doi.org/10.1371/journal.pone.0037592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624050	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500139
J	Verbist, KC; Rose, DL; Cole, CJ; Field, MB; Klonowski, KD				Verbist, Katherine C.; Rose, David L.; Cole, Charles J.; Field, Mary B.; Klonowski, Kimberly D.			IL-15 Participates in the Respiratory Innate Immune Response to Influenza Virus Infection	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CD8(+) T-CELLS; HUMAN NK CELLS; IN-VIVO; TRANS-PRESENTATION; DENDRITIC CELLS; GENE-EXPRESSION; A VIRUS; ACTIVATION; RECEPTOR	Following influenza infection, natural killer (NK) cells function as interim effectors by suppressing viral replication until CD8 T cells are activated, proliferate, and are mobilized within the respiratory tract. Thus, NK cells are an important first line of defense against influenza virus. Here, in a murine model of influenza, we show that virally-induced IL-15 facilitates the trafficking of NK cells into the lung airways. Blocking IL-15 delays NK cell entry to the site of infection and results in a disregulated control of early viral replication. By the same principle, viral control by NK cells can be therapeutically enhanced via intranasal administration of exogenous IL-15 in the early days post influenza infection. In addition to controlling early viral replication, this IL-15-induced mobilization of NK cells to the lung airways has important downstream consequences on adaptive responses. Primarily, depletion of responding NK1.1+ NK cells is associated with reduced immigration of influenza-specific CD8 T cells to the site of infection. Together this work suggests that local deposits of IL-15 in the lung airways regulate the coordinated innate and adaptive immune responses to influenza infection and may represent an important point of immune intervention.	[Verbist, Katherine C.; Cole, Charles J.; Field, Mary B.; Klonowski, Kimberly D.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Rose, David L.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Verbist, KC (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	klonowsk@uga.edu		Verbist, Katherine/0000-0002-3511-5639	University of Georgia; National Institutes of Health [AI077038, AI081800]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077038, R01AI081800] Funding Source: NIH RePORTER	University of Georgia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the University of Georgia and the National Institutes of Health (AI077038 and AI081800 to KDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2007, J MOL BIOL, V367, P25, DOI 10.1016/j.jmb.2006.12.060; ALLAN W, 1990, J IMMUNOL, V144, P3980; Allavena P, 1997, J LEUKOCYTE BIOL, V61, P729, DOI 10.1002/jlb.61.6.729; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Assarsson E, 2000, J IMMUNOL, V165, P3673, DOI 10.4049/jimmunol.165.7.3673; Azimi N, 2000, J VIROL, V74, P7338, DOI 10.1128/JVI.74.16.7338-7348.2000; Barlic J, 2004, J BIOL CHEM, V279, P48520, DOI 10.1074/jbc.M406978200; Benton KA, 2001, J IMMUNOL, V166, P7437, DOI 10.4049/jimmunol.166.12.7437; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Castillo EF, 2010, BLOOD, V116, P2494, DOI 10.1182/blood-2010-03-277103; Castillo EF, 2009, J IMMUNOL, V183, P4948, DOI 10.4049/jimmunol.0900719; Caufour P, 2001, MICROBES INFECT, V3, P181, DOI 10.1016/S1286-4579(01)01370-3; Chae DW, 1996, J IMMUNOL, V157, P2813; Crowe JE, 1999, CURR TOP MICROBIOL, V236, P191; Denney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010675; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Doherty TM, 1996, J IMMUNOL, V156, P735; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Elpek KG, 2010, P NATL ACAD SCI USA, V107, P21647, DOI 10.1073/pnas.1012128107; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Fouchier Ron Am, 2005, Curr Opin Infect Dis, V18, P141; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Ho LP, 2008, EUR J IMMUNOL, V38, P1913, DOI 10.1002/eji.200738017; Hocke AC, 2008, HISTOCHEM CELL BIOL, V130, P165, DOI 10.1007/s00418-008-0414-y; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kilbourne ED, 2004, VIRAL IMMUNOL, V17, P350, DOI 10.1089/0882824041857076; Kitaya K, 2005, J CLIN ENDOCR METAB, V90, P2932, DOI 10.1210/jc.2004-2447; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Koka R, 2003, J EXP MED, V197, P977, DOI 10.1084/jem.20021836; Kos FJ, 1996, CELL IMMUNOL, V173, P1, DOI 10.1006/cimm.1996.0245; Kos FJ, 1996, IMMUNOL TODAY, V17, P174, DOI 10.1016/0167-5699(96)80616-5; Kulkarni RR, 2010, J LEUKOCYTE BIOL, V88, P635, DOI 10.1189/jlb.0410191; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Mattei F, 2001, J IMMUNOL, V167, P1179, DOI 10.4049/jimmunol.167.3.1179; McGill J, 2010, J EXP MED, V207, P521, DOI 10.1084/jem.20091711; Meazza R, 1997, EUR J IMMUNOL, V27, P1049, DOI 10.1002/eji.1830270502; Morandi B, 2009, INT IMMUNOL, V21, P599, DOI 10.1093/intimm/dxp029; Muro S, 2001, J ALLERGY CLIN IMMUN, V108, P970, DOI 10.1067/mai.2001.119556; Onu A, 1997, J IMMUNOL, V158, P255; Perera LP, 1999, J IMMUNOL, V162, P2606; Shen CH, 2008, J IMMUNOL, V180, P171, DOI 10.4049/jimmunol.180.1.171; STEINSTREILEIN J, 1986, J IMMUNOL, V136, P1435; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Verbist KC, 2011, J IMMUNOL, V186, P174, DOI 10.4049/jimmunol.1002613; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Walzer T, 2005, EXPERT OPIN BIOL TH, V5, pS49, DOI 10.1517/14712598.5.1.S49; Woodland DL, 2003, CURR OPIN IMMUNOL, V15, P430, DOI 10.1016/S0952-7915(03)00067-0; Yamaji K, 2006, CANCER IMMUNOL IMMUN, V55, P394, DOI 10.1007/s00262-005-0005-x	54	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37539	10.1371/journal.pone.0037539	http://dx.doi.org/10.1371/journal.pone.0037539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624047	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500134
J	Alkjaer, T; Raffalt, P; Petersen, NC; Simonsen, EB				Alkjaer, Tine; Raffalt, Peter; Petersen, Nicolas C.; Simonsen, Erik B.			Movement Behavior of High-Heeled Walking: How Does the Nervous System Control the Ankle Joint during an Unstable Walking Condition?	PLOS ONE			English	Article							RECIPROCAL INHIBITION; KNEE OSTEOARTHRITIS; POSTURAL STABILITY; NONLINEAR DYNAMICS; EMG ACTIVITY; GAIT; VARIABILITY; SHOES; MODULATION; KINEMATICS	The human locomotor system is flexible and enables humans to move without falling even under less than optimal conditions. Walking with high-heeled shoes constitutes an unstable condition and here we ask how the nervous system controls the ankle joint in this situation? We investigated the movement behavior of high-heeled and barefooted walking in eleven female subjects. The movement variability was quantified by calculation of approximate entropy (ApEn) in the ankle joint angle and the standard deviation (SD) of the stride time intervals. Electromyography (EMG) of the soleus (SO) and tibialis anterior (TA) muscles and the soleus Hoffmann (H-) reflex were measured at 4.0 km/h on a motor driven treadmill to reveal the underlying motor strategies in each walking condition. The ApEn of the ankle joint angle was significantly higher (p<0.01) during high-heeled (0.38+/-0.08) than during barefooted walking (0.28+/-0.07). During high-heeled walking, coactivation between the SO and TA muscles increased towards heel strike and the H-reflex was significantly increased in terminal swing by 40% (p<0.01). These observations show that high-heeled walking is characterized by a more complex and less predictable pattern than barefooted walking. Increased coactivation about the ankle joint together with increased excitability of the SO H-reflex in terminal swing phase indicates that the motor strategy was changed during high-heeled walking. Although, the participants were young, healthy and accustomed to high-heeled walking the results demonstrate that that walking on high-heels needs to be controlled differently from barefooted walking. We suggest that the higher variability reflects an adjusted neural strategy of the nervous system to control the ankle joint during high-heeled walking.	[Alkjaer, Tine; Raffalt, Peter; Petersen, Nicolas C.; Simonsen, Erik B.] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Petersen, Nicolas C.] Univ Copenhagen, Dept Exercise & Sport Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Alkjaer, T (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	talkjaer@sund.ku.dk	Petersen, Nicolas Caesar/ABD-2687-2021; Petersen, Nicolas Caesar/AAE-4354-2022; Petersen, Nicolas Caesar/F-7307-2014	Petersen, Nicolas Caesar/0000-0001-6206-8295; Petersen, Nicolas Caesar/0000-0001-6206-8295; Petersen, Nicolas Caesar/0000-0001-6206-8295; Raffalt, Peter/0000-0002-0119-9141; Alkjaer, Tine/0000-0002-9105-3882; Simonsen, Erik Bruun/0000-0002-6378-6595				Arampatzis A, 2006, J BIOMECH, V39, P1891, DOI 10.1016/j.jbiomech.2005.05.010; ARSENAULT AB, 1986, MED BIOL ENG COMPUT, V24, P337, DOI 10.1007/BF02442685; Barbieri E B, 1983, J Gerontol Nurs, V9, P165; Bartletti R, 2007, SPORT BIOMECH, V6, P224, DOI 10.1080/14763140701322994; Bernstein N.A., 1967, COORDINATION REGULAT; Buzzi UH, 2004, MOTOR CONTROL, V8, P241, DOI 10.1123/mcj.8.3.241; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Cignetti F, 2009, J BIOMECH, V42, P1452, DOI 10.1016/j.jbiomech.2009.04.012; Cronin NJ, 2012, J APPL PHYSL; Decker LM, 2011, KNEE SURG SPORT TR A, V19, P1620, DOI 10.1007/s00167-011-1484-2; EBBELING CJ, 1994, J ORTHOP SPORT PHYS, V19, P190, DOI 10.2519/jospt.1994.19.4.190; EDAMURA M, 1991, J NEUROSCI, V11, P420; Esenyel M, 2003, J AM PODIAT MED ASSN, V93, P27, DOI 10.7547/87507315-93-1-27; Ferris DP, 2001, J PHYSIOL-LONDON, V530, P167, DOI 10.1111/j.1469-7793.2001.0167m.x; Finley JM, 2012, EXP BRAIN RES, V217, P53, DOI 10.1007/s00221-011-2972-9; Frey CC, 1995, AAOS INSTR COURS LEC, V44, P385; Georgoulis Anastasios D, 2006, J Clin Monit Comput, V20, P11, DOI 10.1007/s10877-006-1032-7; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hsue BJ, 2009, J ELECTROMYOGR KINES, V19, P1071, DOI 10.1016/j.jelekin.2008.09.005; Joseph J, 1968, Ann Phys Med, V9, P295; KAPLAN DT, 1991, BIOPHYS J, V59, P945, DOI 10.1016/S0006-3495(91)82309-8; Kerrigan DC, 2001, LANCET, V357, P1097, DOI 10.1016/S0140-6736(00)04312-9; Kerrigan DC, 1998, LANCET, V351, P1399, DOI 10.1016/S0140-6736(97)11281-8; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Lavoie BA, 1997, J NEUROPHYSIOL, V78, P429, DOI 10.1152/jn.1997.78.1.429; LEE KH, 1990, ARCH PHYS MED REHAB, V71, P31; Linder M, 1998, INT J HEALTH SERV, V28, P201, DOI 10.2190/GA2M-FLA2-17FB-V5PE; Menz HB, 1999, J AM PODIAT MED ASSN, V89, P346, DOI 10.7547/87507315-89-7-346; Neptune RR, 2001, J BIOMECH, V34, P1387, DOI 10.1016/S0021-9290(01)00105-1; NIELSEN J, 1993, J PHYSIOL-LONDON, V464, P575, DOI 10.1113/jphysiol.1993.sp019652; OPILACORREIA KA, 1990, ARCH PHYS MED REHAB, V71, P304; OPILACORREIA KA, 1990, ARCH PHYS MED REHAB, V71, P905; Perotto A. O., 2009, ANATOMICAL GUIDE ELE; Petersen N, 1999, J PHYSIOL-LONDON, V520, P605, DOI 10.1111/j.1469-7793.1999.00605.x; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Schneider C, 2000, J NEUROPHYSIOL, V83, P2881, DOI 10.1152/jn.2000.83.5.2881; Simonsen EB, 2011, J APPL BIOMECH; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Smith EO, 1999, FOOT ANKLE INT, V20, P55, DOI 10.1177/107110079902000113; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Trimble MH, 2001, MUSCLE NERVE, V24, P1371, DOI 10.1002/mus.1158	44	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37390	10.1371/journal.pone.0037390	http://dx.doi.org/10.1371/journal.pone.0037390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615997	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300109
J	Mendoza-Naranjo, A; Cormie, P; Serrano, AE; Hu, R; O'Neill, S; Wang, CM; Thrasivoulou, C; Power, KT; White, A; Serena, T; Phillips, ARJ; Becker, DL				Mendoza-Naranjo, Ariadna; Cormie, Peter; Serrano, Antonio E.; Hu, Rebecca; O'Neill, Shay; Wang, Chiuhui Mary; Thrasivoulou, Christopher; Power, Kieran T.; White, Alexis; Serena, Thomas; Phillips, Anthony R. J.; Becker, David L.			Targeting Cx43 and N-Cadherin, Which Are Abnormally Upregulated in Venous Leg Ulcers, Influences Migration, Adhesion and Activation of Rho GTPases	PLOS ONE			English	Article							GAP JUNCTIONAL COMMUNICATION; CONNEXIN EXPRESSION; CELL-MIGRATION; INTERCELLULAR COMMUNICATION; HUMAN SKIN; PROTEIN CONNEXIN-43; WOUND REPAIR; MOUSE; ORGANIZATION; ASTROCYTES	Background: Venous leg ulcers can be very hard to heal and represent a significant medical need with no effective therapeutic treatment currently available. Principal Findings: In wound edge biopsies from human venous leg ulcers we found a striking upregulation of dermal N-cadherin, Zonula Occludens-1 and the gap junction protein Connexin43 (Cx43) compared to intact skin, and in stark contrast to the down-regulation of Cx43 expression seen in acute, healing wounds. We targeted the expression of these proteins in 3T3 fibroblasts to evaluate their role in venous leg ulcers healing. Knockdown of Cx43 and N-cadherin, but not Zonula Occludens-1, accelerated cell migration in a scratch wound-healing assay. Reducing Cx43 increased Golgi reorientation, whilst decreasing cell adhesion and proliferation. Furthermore, Connexin43 and N-cadherin knockdown led to profound effects on fibroblast cytoskeletal dynamics after scratch-wounding. The cells exhibited longer lamelipodial protrusions lacking the F-actin belt seen at the leading edge in wounded control cells. This phenotype was accompanied by augmented activation of Rac-1 and RhoA GTPases, as revealed by Forster Resonance Energy Transfer and pull down experiments. Conclusions: Cx43 and N-cadherin are potential therapeutic targets in the promotion of healing of venous leg ulcers, by acting at least in part through distinct contributions of cell adhesion, migration, proliferation and cytoskeletal dynamics.	[Mendoza-Naranjo, Ariadna; Cormie, Peter; Serrano, Antonio E.; Wang, Chiuhui Mary; Thrasivoulou, Christopher; Power, Kieran T.; Becker, David L.] UCL, Dept Cell & Dev Biol, London, England; [Hu, Rebecca; O'Neill, Shay; White, Alexis; Phillips, Anthony R. J.] CoDa Therapeut, Auckland, New Zealand; [Serena, Thomas] Newbridge Med Res Corp, Warren, PA USA	University of London; University College London	Mendoza-Naranjo, A (corresponding author), UCL, Dept Cell & Dev Biol, London, England.	a.mendoza@ucl.ac.uk; d.becker@ucl.ac.uk	Wang, Chiuhui Mary/B-8277-2009; Becker, David Laurence/GZL-4411-2022; Serrano, Antonio/C-1348-2009; Thrasivoulou, Christopher/F-7087-2010	Wang, Chiuhui Mary/0000-0003-1163-0959; Serrano, Antonio/0000-0002-6728-0081; Thrasivoulou, Christopher/0000-0001-9425-8624	Action Medical Research; Henry Smith Charity	Action Medical Research; Henry Smith Charity	This work was supported in part by Action Medical Research, and the Henry Smith Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt-Holland A, 2008, J INVEST DERMATOL, V128, P2498, DOI 10.1038/jid.2008.102; BATTEN BE, 1979, ANAT REC, V194, P125, DOI 10.1002/ar.1091940109; Becker D, 2001, CELL COMMUN ADHES, V8, P355, DOI 10.3109/15419060109080753; BECKER DL, 1995, MICROSC RES TECHNIQ, V31, P364, DOI 10.1002/jemt.1070310506; BECKER DL, 1995, J CELL SCI, V108, P1455; Brandner JM, 2004, J INVEST DERMATOL, V122, P1310, DOI 10.1111/j.0022-202X.2004.22529.x; Butkevich E, 2004, CURR BIOL, V14, P650, DOI 10.1016/j.cub.2004.03.063; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Chakraborty S, 2010, J BIOL CHEM, V285, P10761, DOI 10.1074/jbc.M109.053348; Cotrina ML, 2008, GLIA, V56, P1791, DOI 10.1002/glia.20728; Coutinho P, 2005, BRIT J PLAST SURG, V58, P658, DOI 10.1016/j.bjps.2004.12.022; Coutinho P, 2003, CELL BIOL INT, V27, P525, DOI 10.1016/S1065-6995(03)00077-5; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Elbert M, 2006, MOL BIOL CELL, V17, P3345, DOI 10.1091/mbc.E06-03-0193; Francis R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026379; Ghatnekar GS, 2009, REGEN MED, V4, P205, DOI 10.2217/17460751.4.2.205; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; GOLIGER JA, 1995, MOL BIOL CELL, V6, P1491, DOI 10.1091/mbc.6.11.1491; Gottrup F, 2004, AM J SURG, V187, p38S, DOI 10.1016/S0002-9610(03)00303-9; Gourdie RG, 2006, ANN NY ACAD SCI, V1080, P49, DOI 10.1196/annals.1380.005; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; GUO HM, 1992, J INVEST DERMATOL, V99, P460, DOI 10.1111/1523-1747.ep12616154; Hosokawa K, 2010, BLOOD, V116, P554, DOI 10.1182/blood-2009-05-224857; Huang GY, 1998, J CELL BIOL, V143, P1725, DOI 10.1083/jcb.143.6.1725; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kretz M, 2004, EUR J CELL BIOL, V83, P647, DOI 10.1078/0171-9335-00422; Kretz M, 2003, J CELL SCI, V116, P3443, DOI 10.1242/jcs.00638; Li W, 2005, J BIOL CHEM, V280, P7941, DOI 10.1074/jbc.M410548200; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Magdalena J, 2003, MOL BIOL CELL, V14, P670, DOI 10.1091/mbc.e02-06-0345; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; McDonough WS, 1999, INT J DEV NEUROSCI, V17, P601, DOI 10.1016/S0736-5748(99)00024-6; Mendoza-Naranjo A, 2007, J CELL SCI, V120, P279, DOI 10.1242/jcs.03323; Mori R, 2006, J CELL SCI, V119, P5193, DOI 10.1242/jcs.03320; Nakano Y, 2008, INVEST OPHTH VIS SCI, V49, P93, DOI 10.1167/iovs.07-0255; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pokutta S, 2002, CURR OPIN STRUC BIOL, V12, P255, DOI 10.1016/S0959-440X(02)00318-4; Pollok S, 2010, J CELL MOL MED; Qiu C, 2003, CURR BIOL, V13, P1697, DOI 10.1016/j.cub.2003.09.007; Redfield A, 1997, J CELL BIOL, V138, P1323, DOI 10.1083/jcb.138.6.1323; Rhett JM, 2008, TRENDS BIOTECHNOL, V26, P173, DOI 10.1016/j.tibtech.2007.12.007; Richards TS, 2004, J CELL BIOL, V167, P555, DOI 10.1083/jcb.200404142; Saitoh M, 1997, CARCINOGENESIS, V18, P1319, DOI 10.1093/carcin/18.7.1319; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Taliana L, 2005, INVEST OPHTH VIS SCI, V46, P96, DOI 10.1167/iovs.04-0145; Theiss C, 2002, EXP CELL RES, V281, P197, DOI 10.1006/excr.2002.5652; Underwood JL, 1999, AM J PHYSIOL-CELL PH, V277, pC330, DOI 10.1152/ajpcell.1999.277.2.C330; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; Walmsley S, 2002, ADV WOUND MANAGEMENT; Wang CM, 2007, DIABETES, V56, P2809, DOI 10.2337/db07-0613; Wang HH, 2008, DEV BIOL, V318, P112, DOI 10.1016/j.ydbio.2008.03.008; Wei CJ, 2005, J BIOL CHEM, V280, P19925, DOI 10.1074/jbc.M412921200; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Wilby MJ, 1999, MOL CELL NEUROSCI, V14, P66, DOI 10.1006/mcne.1999.0766; Wright CS, 2009, WOUND REPAIR REGEN, V17, P240, DOI 10.1111/j.1524-475X.2009.00471.x; Xu X, 2006, DEVELOPMENT, V133, P3629, DOI 10.1242/dev.02543; YONEMURA S, 1995, J CELL SCI, V108, P127	62	52	55	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37374	10.1371/journal.pone.0037374	http://dx.doi.org/10.1371/journal.pone.0037374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615994	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300093
J	Tnimov, Z; Guo, Z; Gambin, Y; Nguyen, UTT; Wu, YW; Abankwa, D; Stigter, A; Collins, BM; Waldmann, H; Goody, RS; Alexandrov, K				Tnimov, Zakir; Guo, Zhong; Gambin, Yann; Nguyen, Uyen T. T.; Wu, Yao-Wen; Abankwa, Daniel; Stigter, Anouk; Collins, Brett M.; Waldmann, Herbert; Goody, Roger S.; Alexandrov, Kirill			Quantitative Analysis of Prenylated RhoA Interaction with Its Chaperone, RhoGDI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP DISSOCIATION INHIBITOR; GUANINE-NUCLEOTIDE EXCHANGE; GTP-BINDING PROTEIN; RAB ESCORT PROTEIN; EZRIN/RADIXIN/MOESIN PROTEINS; GERANYLGERANYL TRANSFERASE; MEMBRANE EXTRACTION; MIGRATING CELLS; CDC42; GTPASES	Small GTPases of the Rho family regulate cytoskeleton remodeling, cell polarity, and transcription, as well as the cell cycle, in eukaryotic cells. Membrane delivery and recycling of the Rho GTPases is mediated by Rho GDP dissociation inhibitor (RhoGDI), which forms a stable complex with prenylated Rho GTPases. We analyzed the interaction of RhoGDI with the active and inactive forms of prenylated and unprenylated RhoA. We demonstrate that RhoGDI binds the prenylated form of RhoA center dot GDP with unexpectedly high affinity (K-d = 5 pM). The very long half-life of the complex is reduced 25-fold on RhoA activation, with a concomitant reduction in affinity (K-d = 3 nM). The 2.8-angstrom structure of the RhoA center dot guanosine 5'-[beta,gamma-imido] triphosphate (GMPPNP)center dot RhoGDI complex demonstrated that complex formation forces the activated RhoA into a GDP-bound conformation in the absence of nucleotide hydrolysis. We demonstrate that membrane extraction of Rho GTPase by RhoGDI is a thermodynamically favored passive process that operates through a series of progressively tighter intermediates, much like the one that is mediated by RabGDI.	[Tnimov, Zakir; Guo, Zhong; Gambin, Yann; Collins, Brett M.; Alexandrov, Kirill] Univ Queensland, Inst Mol Biosci, Dept Mol Cell Biol, St Lucia, Qld 4072, Australia; [Nguyen, Uyen T. T.; Wu, Yao-Wen; Goody, Roger S.] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Stigter, Anouk; Waldmann, Herbert] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44227 Dortmund, Germany; [Abankwa, Daniel] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Abankwa, Daniel] Abo Akad Univ, FIN-20520 Turku, Finland	University of Queensland; Max Planck Society; Max Planck Society; University of Turku; Abo Akademi University	Alexandrov, K (corresponding author), Univ Queensland, Inst Mol Biosci, Dept Mol Cell Biol, 306 Carmody Rd, St Lucia, Qld 4072, Australia.	k.alexandrov@uq.edu.au	Goody, Roger S/J-8845-2014; Tnimov, Zakir Tnimov/G-6764-2012; Waldmann, Herbert/B-7406-2017; GUO, Zhong/J-8723-2014; GAMBIN, Yann/AAI-8501-2021; GAMBIN, Yann/M-8799-2014; Tnimov, Zakir/L-3052-2019; Collins, Brett/J-1563-2014; Wu, Yaowen/N-9802-2015; Alexandrov, Kirill/A-5830-2013; GUO, Zhong/J-8723-2014	Goody, Roger S/0000-0002-0772-0444; Tnimov, Zakir Tnimov/0000-0003-2466-2220; Waldmann, Herbert/0000-0002-9606-7247; GUO, Zhong/0000-0003-0285-5021; Tnimov, Zakir/0000-0003-2466-2220; Collins, Brett/0000-0002-6070-3774; Wu, Yaowen/0000-0002-2573-8736; Alexandrov, Kirill/0000-0002-0957-6511; GUO, Zhong/0000-0002-2277-0087; GAMBIN, Yann/0000-0001-7378-8976; Abankwa, Daniel/0000-0003-2769-0745	Australian Research Council DP Grant [DP1094080]; ARC FF Grant [FT0991611]; National Health Research Council project Grant [569652]	Australian Research Council DP Grant(Australian Research Council); ARC FF Grant(Australian Research Council); National Health Research Council project Grant	This work was supported in part by Australian Research Council DP Grant DP1094080, ARC FF Grant FT0991611, and National Health Research Council project Grant 569652 (to K. A.).	Abramovitz A, 2012, BIOCHEMISTRY-US, V51, P715, DOI 10.1021/bi201211v; Alexandrov K, 2001, METHOD ENZYMOL, V329, P14; ARMSTRONG SA, 1995, J BIOL CHEM, V270, P7864, DOI 10.1074/jbc.270.14.7864; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Chiba Y, 2009, AM J PHYSIOL-LUNG C, V297, pL984, DOI 10.1152/ajplung.00178.2009; CHUANG TH, 1993, J BIOL CHEM, V268, P775; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; Dursina B, 2006, J AM CHEM SOC, V128, P2822, DOI 10.1021/ja052196e; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Golovanov AP, 2001, J MOL BIOL, V305, P121, DOI 10.1006/jmbi.2000.4262; HANCOCK JF, 1993, EMBO J, V12, P1915, DOI 10.1002/j.1460-2075.1993.tb05840.x; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Ignatev A, 2008, J BIOL CHEM, V283, P18377, DOI 10.1074/jbc.M709718200; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Johnson JL, 2009, J BIOL CHEM, V284, P23860, DOI 10.1074/jbc.M109.031815; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Maeda M, 1999, ONCOGENE, V18, P4788, DOI 10.1038/sj.onc.1202871; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nomanbhoy TK, 1999, BIOCHEMISTRY-US, V38, P1744, DOI 10.1021/bi982198u; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; Oyama R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl477; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Rak A, 2002, PROTEIN EXPRES PURIF, V25, P23, DOI 10.1006/prep.2001.1605; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rigler R., 1993, DIFFUSION SINGLE MOL, P235; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; SASAKI T, 1993, J BIOL CHEM, V268, P23959; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; Takeda N, 2006, AM J RESP CELL MOL, V35, P722, DOI 10.1165/rcmb.2006-0034OC; Tiedje C, 2008, MOL BIOL CELL, V19, P2885, DOI 10.1091/mbc.E07-11-1152; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Tschantz WR, 1997, J BIOL CHEM, V272, P9989; Ugolev Y, 2008, J BIOL CHEM, V283, P22257, DOI 10.1074/jbc.M800734200; Ugolev Y, 2006, J BIOL CHEM, V281, P19204, DOI 10.1074/jbc.M600042200; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wu YW, 2007, P NATL ACAD SCI USA, V104, P12294, DOI 10.1073/pnas.0701817104; Wu YW, 2010, NAT CHEM BIOL, V6, P534, DOI [10.1038/NCHEMBIO.386, 10.1038/nchembio.386]; Wu YM, 2009, P NATL ACAD SCI USA, V106, P5807, DOI 10.1073/pnas.0810094106; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045	61	33	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26549	26562		10.1074/jbc.M112.371294	http://dx.doi.org/10.1074/jbc.M112.371294			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22628549	Green Published, hybrid			2022-12-25	WOS:000307386000008
J	Amin, A; Nobauer, K; Patzl, M; Berger, E; Hess, M; Bilic, I				Amin, Aziza; Noebauer, Katharina; Patzl, Martina; Berger, Evelyn; Hess, Michael; Bilic, Ivana			Cysteine Peptidases, Secreted by Trichomonas gallinae, Are Involved in the Cytopathogenic Effects on a Permanent Chicken Liver Cell Culture	PLOS ONE			English	Article							TRITRICHOMONAS-FETUS; VAGINALIS; PROTEINASES; PROTEASES; FINCHES; PATHOGENICITY; PURIFICATION; PREVALENCE; MORTALITY; VIRULENCE	Trichomonas gallinae, the aetiological agent of avian trichomonosis, was shown to secrete soluble factors involved in cytopathogenic effect on a permanent chicken liver (LMH) cell culture. The present study focused on the characterization of these molecules. The addition of specific peptidase inhibitors to the cell-free filtrate partially inhibited the monolayer destruction, which implied the presence of peptidases in the filtrate and their involvement in the cytopathogenic effect. One-dimensional substrate (gelatin) SDS-PAGE confirmed the proteolytic character of the filtrate by demonstrating the proteolytic activity within the molecular weight range from 38 to 110 kDa. In addition, the proteolytic activity was specifically inhibited by addition of TLCK and E-64 cysteine peptidase inhibitors implying their cysteine peptidase nature. Furthermore, variations in the intensity and the number of proteolytic bands were observed between cell-free filtrates of low and high passages of the same T. gallinae clonal culture. Two-dimensional substrate gel electrophoresis of concentrated T. gallinae cell-free filtrate identified at least six proteolytic spots. The mass spectrometric analysis of spots from 2-D gels identified the presence of at least two different Clan CA, family C1, cathepsin L-like cysteine peptidases in the cell-free filtrate of T. gallinae. In parallel, a PCR approach using degenerated primers based on the conserved amino acid sequence region of cysteine peptidases from Trichomonas vaginalis identified the coding sequences for four different Clan CA, family C1, cathepsin L-like cysteine peptidases. Finally, this is the first report analyzing molecules secreted by T. gallinae and demonstrating the ubiquity of peptidases secreted by this protozoon.	[Amin, Aziza; Berger, Evelyn; Hess, Michael; Bilic, Ivana] Univ Vet Med, Clin Avian Reptile & Fish Med, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Noebauer, Katharina] Univ Vet Med, VetCore Facil Res, Vienna, Austria; [Patzl, Martina] Univ Vet Med, Dept Pathobiol, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Amin, A (corresponding author), Univ Vet Med, Clin Avian Reptile & Fish Med, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria.	ivana.bilic@vetmeduni.ac.at	Amin, Aziza/AAJ-7038-2020	Amin, Aziza/0000-0002-8490-1863; Hess, Michael/0000-0002-6991-0120; Bilic, Ivana/0000-0003-3296-5117	Egyptian Ministry of Higher Education, Egyptian Government, Egypt; Vetmeduni Vienna	Egyptian Ministry of Higher Education, Egyptian Government, Egypt; Vetmeduni Vienna	AA was supported by a scholarship from the Egyptian Ministry of Higher Education, Egyptian Government, Egypt. Additional funds for consumables were obtained from the Vetmeduni Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERETE JF, 1995, MICROB PATHOGENESIS, V19, P93, DOI 10.1006/mpat.1995.0049; Alvarez-Sanchez ME, 2000, MICROB PATHOGENESIS, V28, P193, DOI 10.1006/mpat.1999.0336; Amin A, 2012, VET PARASITOL, V186, P196, DOI 10.1016/j.vetpar.2011.11.037; Amin A, 2010, EXP PARASITOL, V124, P202, DOI 10.1016/j.exppara.2009.09.014; Anderson NL, 2009, VET PARASITOL, V161, P178, DOI 10.1016/j.vetpar.2009.01.023; Arroyo R, 1995, Arch Med Res, V26, P279; ARROYO R, 1989, INFECT IMMUN, V57, P2991, DOI 10.1128/IAI.57.10.2991-2997.1989; BAKER JR, 1986, VET REC, V118, P447, DOI 10.1136/vr.118.16.447; Bunbury N, 2007, J WILDLIFE DIS, V43, P399, DOI 10.7589/0090-3558-43.3.399; BURGESS DE, 1990, INFECT IMMUN, V58, P3627, DOI 10.1128/IAI.58.11.3627-3632.1990; COOMBS GH, 1983, PARASITOLOGY, V86, P1, DOI 10.1017/S0031182000057103; COOPER JE, 1988, J WILDLIFE DIS, V24, P80, DOI 10.7589/0090-3558-24.1.80; Cuervo P, 2008, J PROTEOMICS, V71, P109, DOI 10.1016/j.jprot.2008.01.010; De Jesus LB, 2009, J PROTEOME RES, V8, P1555, DOI 10.1021/pr8009066; Draper D, 1998, J INFECT DIS, V178, P815, DOI 10.1086/515366; Fiori PL, 1999, MICROBES INFECT, V1, P149, DOI 10.1016/S1286-4579(99)80006-9; Fiori PL, 1996, MICROB PATHOGENESIS, V20, P109, DOI 10.1006/mpat.1996.0010; Forzan MJ, 2010, CAN VET J, V51, P391; GARBER GE, 1989, J CLIN MICROBIOL, V27, P1548, DOI 10.1128/JCM.27.7.1548-1553.1989; GARBER GE, 1989, CAN J MICROBIOL, V35, P903, DOI 10.1139/m89-150; Garner MM, 1992, J ASS AVIAN VET, V6, P18; Gerhold RW, 2008, J PARASITOL, V94, P1335, DOI 10.1645/GE-1585.1; Grabensteiner E, 2010, VET PARASITOL, V172, P53, DOI 10.1016/j.vetpar.2010.04.015; HARMON WM, 1987, J WILDLIFE DIS, V23, P492, DOI 10.7589/0090-3558-23.3.492; Hernandez-Gutierrez R, 2004, EXP PARASITOL, V107, P125, DOI 10.1016/j.exppara.2004.05.004; Hess M, 2008, VACCINE, V26, P4187, DOI 10.1016/j.vaccine.2008.05.071; HONIGBERG BM, 1961, J PARASITOL, V47, P545, DOI 10.2307/3275054; HONIGBERG BM, 1964, J PROTOZOOL, V11, P447, DOI 10.1111/j.1550-7408.1964.tb01779.x; Krone O, 2005, J WILDLIFE DIS, V41, P304, DOI 10.7589/0090-3558-41.2.304; KULDA J, 1967, Folia Parasitologica (Ceske Budejovice), V14, P295; Lehker MW, 1999, SEX TRANSM INFECT, V75, P231, DOI 10.1136/sti.75.4.231; LEMAHIEU P, 1977, VLAAMS DIERGEN TIJDS, V46, P442; LEVINE NORMAN D., 1940, POULTRY SCI, V19, P205, DOI 10.3382/ps.0190205; LOCKE LN, 1962, J PARASITOL, V48, P497, DOI 10.2307/3275231; LOCKWOOD BC, 1987, MOL BIOCHEM PARASIT, V24, P89, DOI 10.1016/0166-6851(87)90119-8; Lubick KJ, 2004, INFECT IMMUN, V72, P1284, DOI 10.1128/IAI.72.3.1284-1290.2004; Mendoza-Lopez MR, 2000, INFECT IMMUN, V68, P4907, DOI 10.1128/IAI.68.9.4907-4912.2000; Murphy J., 1992, Proceedings Annual Conference Association of Avian Veterinarians, V1992, P21; NARCISI EM, 1991, AVIAN DIS, V35, P55, DOI 10.2307/1591295; Neimanis AS, 2010, AVIAN DIS, V54, P136, DOI 10.1637/8952-060509-Case.1; NORTH MJ, 1990, MOL BIOCHEM PARASIT, V39, P183, DOI 10.1016/0166-6851(90)90057-S; Peters M, 2009, KLEINTIERPRAXIS, V54, P433; Petrin D, 1998, CLIN MICROBIOL REV, V11, P300, DOI 10.1128/CMR.11.2.300; PINDAK FF, 1993, GENITOURIN MED, V69, P35; PROVENZANO D, 1995, INFECT IMMUN, V63, P3388, DOI 10.1128/IAI.63.9.3388-3395.1995; Robinson RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012215; Rosset I, 2002, PARASITOL RES, V88, P356, DOI 10.1007/s00436-001-0555-6; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Schwebke JR, 2004, CLIN MICROBIOL REV, V17, P794, DOI 10.1128/CMR.17.4.794-803.2004; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh BN, 2004, INFECT IMMUN, V72, P4151, DOI 10.1128/IAI.72.7.4151-4158.2004; Sommer U, 2005, J BIOL CHEM, V280, P23853, DOI 10.1074/jbc.M501752200; STABLER RM, 1954, EXP PARASITOL, V3, P368, DOI 10.1016/0014-4894(54)90035-1; STABLER RM, 1947, J PARASITOL, V33, P207, DOI 10.2307/3273551; STABLER RM, 1951, J PARASITOL, V37, P473, DOI 10.2307/3273255; Work TM, 1996, J WILDLIFE DIS, V32, P266, DOI 10.7589/0090-3558-32.2.266	56	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37417	10.1371/journal.pone.0037417	http://dx.doi.org/10.1371/journal.pone.0037417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649527	gold, Green Published			2022-12-25	WOS:000305335800045
J	Jerabek, H; Heermann, DW				Jerabek, Hansjoerg; Heermann, Dieter W.			Expression-Dependent Folding of Interphase Chromatin	PLOS ONE			English	Article							X-CHROMOSOME TERRITORIES; NUCLEAR ARCHITECTURE; TRANSCRIPTION SITES; DNA; ORGANIZATION; DYNAMICS; GENES; ORDER; CONFORMATION; MODEL	Multiple studies suggest that chromatin looping might play a crucial role in organizing eukaryotic genomes. To investigate the interplay between the conformation of interphase chromatin and its transcriptional activity, we include information from gene expression profiles into a polymer model for chromatin that incorporates genomic loops. By relating loop formation to transcriptional activity, we are able to generate chromosome conformations whose structural and topological properties are consistent with experimental data. The model particularly allows to reproduce the conformational variations that are known to occur between highly and lowly expressed chromatin regions. As previously observed in experiments, lowly expressed regions of the simulated polymers are much more compact. Due to the changes in loop formation, the distributions of chromatin loops are also expression-dependent and exhibit a steeper decay in highly active regions. As a results of entropic interaction between differently looped parts of the chromosome, we observe topological alterations leading to a preferential positioning of highly transcribed loci closer to the surface of the chromosome territory. Considering the diffusional behavior of the chromatin fibre, the simulations furthermore show that the higher the expression level of specific parts of the chromatin fibre is, the more dynamic they are. The results exhibit that variations of loop formation along the chromatin fibre, and the entropic changes that come along with it, do not only influence the structural parameters on the local scale, but also effect the global chromosome conformation and topology.	[Jerabek, Hansjoerg; Heermann, Dieter W.] Heidelberg Univ, Inst Theoret Phys, Philosophenweg 19, D-6900 Heidelberg, Germany; [Jerabek, Hansjoerg; Heermann, Dieter W.] Interdisciplinary Ctr Sci Comp, Heidelberg, Germany; [Heermann, Dieter W.] Jackson Lab, Bar Harbor, ME 04609 USA; [Heermann, Dieter W.] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Jackson Laboratory; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jerabek, H (corresponding author), Heidelberg Univ, Inst Theoret Phys, Philosophenweg 19, D-6900 Heidelberg, Germany.	jerabek@tphys.uni-heidelberg.de			Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences	Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences	HJ was funded by the Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abranches R, 1998, J CELL BIOL, V143, P5, DOI 10.1083/jcb.143.1.5; Binder K, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-642-03163-2; Bohn M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051805; Bohn M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014428; Bohn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012218; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; CARMESIN I, 1988, MACROMOLECULES, V21, P2819, DOI 10.1021/ma00187a030; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Cook PR, 2009, J CELL BIOL, V186, P825, DOI 10.1083/jcb.200903083; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2004, BIOL CELL, V96, P555, DOI 10.1016/j.biolcel.2004.07.002; de Nooijer S, 2009, NUCLEIC ACIDS RES, V37, P3558, DOI 10.1093/nar/gkp219; Dekker J, 2003, TRENDS BIOCHEM SCI, V28, P277, DOI 10.1016/S0968-0004(03)00089-6; DEUTSCH HP, 1991, J CHEM PHYS, V94, P2294, DOI 10.1063/1.459901; Dietzel S, 1999, EXP CELL RES, V252, P363, DOI 10.1006/excr.1999.4635; Doi M, 1997, INTRO POLYM PHYS; Dorier J, 2009, NUCLEIC ACIDS RES, V37, P6316, DOI 10.1093/nar/gkp702; Eils R, 1996, J CELL BIOL, V135, P1427, DOI 10.1083/jcb.135.6.1427; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Gavrilov A, 2009, METHODS MOL BIOL, V567, P171, DOI 10.1007/978-1-60327-414-2_12; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; GROSBERG AY, 1988, BIOFIZIKA+, V33, P247; Jackson Dean A., 2005, Briefings in Functional Genomics & Proteomics, V4, P143, DOI 10.1093/bfgp/4.2.143; Jones E., 2001, SCIPY OPEN SOURCE SC; Khalil A, 2007, CHROMOSOME RES, V15, P899, DOI 10.1007/s10577-007-1172-8; Kosak ST, 2004, SCIENCE, V306, P644, DOI 10.1126/science.1103864; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Langowski J, 2006, EUR PHYS J E, V19, P241, DOI 10.1140/epje/i2005-10067-9; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Maeshima K, 2010, CURR OPIN CELL BIOL, V22, P291, DOI 10.1016/j.ceb.2010.03.001; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; Mahy NL, 2002, J CELL BIOL, V157, P579, DOI 10.1083/jcb.200111071; Marenduzzo D, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/L09002; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Mirny LA, 2011, CHROMOSOME RES, V19, P37, DOI 10.1007/s10577-010-9177-0; RUDNICK J, 1987, SCIENCE, V237, P384, DOI 10.1126/science.237.4813.384; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; Scheuermann MO, 2004, EXP CELL RES, V301, P266, DOI 10.1016/j.yexcr.2004.08.031; Schiessel H, 2001, BIOPHYS J, V80, P1940, DOI 10.1016/S0006-3495(01)76164-4; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sexton T, 2007, SEMIN CELL DEV BIOL, V18, P691, DOI 10.1016/j.semcdb.2007.08.008; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Valenzuela L, 2008, MOL CELL BIOL, V28, P1924, DOI 10.1128/MCB.01647-07; Verschure PJ, 1999, J CELL BIOL, V147, P13, DOI 10.1083/jcb.147.1.13; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	49	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37525	10.1371/journal.pone.0037525	http://dx.doi.org/10.1371/journal.pone.0037525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649534	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335800053
J	Miller, NLG; Lawson, C; Chen, XL; Lim, ST; Schlaepfer, DD				Miller, Nichol L. G.; Lawson, Christine; Chen, Xiao Lei; Lim, Ssang-Taek; Schlaepfer, David D.			Rgnef (p190RhoGEF) Knockout Inhibits RhoA Activity, Focal Adhesion Establishment, and Cell Motility Downstream of Integrins	PLOS ONE			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; MICE LACKING; T-CELLS; MIGRATION; KINASE; GTPASES; BINDING; PROTEIN; ACTIVATION; POLARITY	Background: Cell migration is a highly regulated process that involves the formation and turnover of cell-matrix contact sites termed focal adhesions. Rho-family GTPases are molecular switches that regulate actin and focal adhesion dynamics in cells. Guanine nucleotide exchange factors (GEFs) activate Rho-family GTPases. Rgnef (p190RhoGEF) is a ubiquitous 190 kDa GEF implicated in the control of colon carcinoma and fibroblast cell motility. Principal Findings: Rgnef exon 24 floxed mice (Rgnef(flox)) were created and crossed with cytomegalovirus (CMV)-driven Cre recombinase transgenic mice to inactivate Rgnef expression in all tissues during early development. Heterozygous Rgnef(WT/flox) (Cre+) crosses yielded normal Mendelian ratios at embryonic day 13.5, but Rgnef(flox/flox) (Cre+) mice numbers at 3 weeks of age were significantly less than expected. Rgnef(flox/flox) (Cre+) (Rgnef-/-) embryos and primary mouse embryo fibroblasts (MEFs) were isolated and verified to lack Rgnef protein expression. When compared to wildtype (WT) littermate MEFs, loss of Rgnef significantly inhibited haptotaxis migration, wound closure motility, focal adhesion number, and RhoA GTPase activation after fibronectin-integrin stimulation. In WT MEFs, Rgnef activation occurs within 60 minutes upon fibronectin plating of cells associated with RhoA activation. Rgnef-/- MEF phenotypes were rescued by epitope-tagged Rgnef re-expression. Conclusions: Rgnef-/- MEF phenotypes were due to Rgnef loss and support an essential role for Rgnef in RhoA regulation downstream of integrins in control of cell migration.	[Miller, Nichol L. G.; Lawson, Christine; Chen, Xiao Lei; Lim, Ssang-Taek; Schlaepfer, David D.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Miller, NLG (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	dschlaepfer@ucsd.edu		Lim, Steve/0000-0003-0323-8607	NIH [GM087400, 1F32CA159558]; CIHR [200810MFE-193594-139144]; NATIONAL CANCER INSTITUTE [F32CA159558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087400] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH GM087400 to D.D.S. N.L.G.M. was partially supported by NIH 1F32CA159558. C.L. was supported by CIHR 200810MFE-193594-139144. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Canete-Soler R, 2001, J BIOL CHEM, V276, P32046, DOI 10.1074/jbc.M104104200; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; EVA A, 1988, P NATL ACAD SCI USA, V85, P2061, DOI 10.1073/pnas.85.7.2061; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Francis SA, 2006, BLOOD, V107, P1627, DOI 10.1182/blood-2005-03-1164; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hirsch E, 2002, MOL CELL BIOL, V22, P3140, DOI 10.1128/MCB.22.9.3140-3148.2002; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Jackson B, 2011, MOL BIOL CELL, V22, P593, DOI 10.1091/mbc.E09-10-0859; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kaartinen V, 2002, DEV DYNAM, V223, P517, DOI 10.1002/dvdy.10071; Kaartinen V, 2001, DEVELOPMENT, V128, P4217; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lim ST, 2010, J BIOL CHEM, V285, P21526, DOI 10.1074/jbc.M110.129999; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Mayers CM, 2010, J BIOL CHEM, V285, P12344, DOI 10.1074/jbc.M110.106856; Melendez J, 2011, J BIOL CHEM, V286, P15132, DOI 10.1074/jbc.C111.229336; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; Nalbant P, 2009, MOL BIOL CELL, V20, P4070, DOI 10.1091/mbc.E09-01-0041; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; O'Brien SP, 2000, P NATL ACAD SCI USA, V97, P12074, DOI 10.1073/pnas.97.22.12074; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Ren XD, 2000, J CELL SCI, V113, P3673; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rubtsov A, 2005, IMMUNITY, V23, P527, DOI 10.1016/j.immuni.2005.09.018; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Su KC, 2011, DEV CELL, V21, P1104, DOI 10.1016/j.devcel.2011.11.003; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Thumkeo D, 2003, MOL CELL BIOL, V23, P5043, DOI 10.1128/MCB.23.14.5043-5055.2003; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Tomar A, 2009, J CELL SCI, V122, P1852, DOI 10.1242/jcs.046870; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang DY, 2000, J CELL SCI, V113, P4221; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Yu HG, 2011, CANCER RES, V71, P360, DOI 10.1158/0008-5472.CAN-10-2894; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200; Zhai JB, 2001, J BIOL CHEM, V276, P41318, DOI 10.1074/jbc.M107709200	56	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37830	10.1371/journal.pone.0037830	http://dx.doi.org/10.1371/journal.pone.0037830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649559	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335800079
J	Suzuki, T; Arai, S; Takeuchi, M; Sakurai, C; Ebana, H; Higashi, T; Hashimoto, H; Hatsuzawa, K; Wada, I				Suzuki, Takahisa; Arai, Seisuke; Takeuchi, Mayumi; Sakurai, Chiye; Ebana, Hideaki; Higashi, Tsunehito; Hashimoto, Hitoshi; Hatsuzawa, Kiyotaka; Wada, Ikuo			Development of Cysteine-Free Fluorescent Proteins for the Oxidative Environment	PLOS ONE			English	Article							PHOTON-COUNTING HISTOGRAM; MONOMERIC RED; SECRETORY PATHWAY; GREEN; GENE; GFP; INNOVATIONS; EXPRESSION; MICROSCOPY; EVOLUTION	Molecular imaging employing fluorescent proteins has been widely used to highlight specific reactions or processes in various fields of the life sciences. Despite extensive improvements of the fluorescent tag, this technology is still limited in the study of molecular events in the extracellular milieu. This is partly due to the presence of cysteine in the fluorescent proteins. These proteins almost cotranslationally form disulfide bonded oligomers when expressed in the endoplasmic reticulum (ER). Although single molecule photobleaching analysis showed that these oligomers were not fluorescent, the fluorescent monomer form often showed aberrant behavior in folding and motion, particularly when fused to cysteine-containing cargo. Therefore we investigated whether it was possible to eliminate the cysteine without losing the brightness. By site-saturated mutagenesis, we found that the cysteine residues in fluorescent proteins could be replaced with specific alternatives while still retaining their brightness. cf(cysteine-free) SGFP2 showed significantly reduced restriction of free diffusion in the ER and marked improvement of maturation when fused to the prion protein. We further applied this approach to TagRFP family proteins and found a set of mutations that obtains the same level of brightness as the cysteine-containing proteins. The approach used in this study to generate new cysteine-free fluorescent tags should expand the application of molecular imaging to the extracellular milieu and facilitate its usage in medicine and biotechnology.	[Suzuki, Takahisa; Arai, Seisuke; Takeuchi, Mayumi; Sakurai, Chiye; Ebana, Hideaki; Higashi, Tsunehito; Hashimoto, Hitoshi; Hatsuzawa, Kiyotaka; Wada, Ikuo] Fukushima Med Univ, Inst Biomed Sci, Dept Cell Sci, Sch Med, Fukushima, Japan	Fukushima Medical University	Suzuki, T (corresponding author), Fukushima Med Univ, Inst Biomed Sci, Dept Cell Sci, Sch Med, Fukushima, Japan.	iwada@fmu.ac.jp	Higashi, Tsunehito/G-1816-2012	Suzuki, Takahisa/0000-0001-6088-028X; Wada, Ikuo/0000-0001-5668-6994	Japan Society for the Promotion of Science [19370044, 22570189]; Ministry of Education, Culture, Sports, Science and Technology of Japan [19370044, 22570189, 08038570]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was in part supported by grants-in-aid (19370044, 22570189) from the Japan Society for the Promotion of Science and a grant-in-aid (08038570) by the Ministry of Education, Culture, Sports, Science and Technology of Japan to IW (19370044, 08038570) and KH (22570189). No additional external funding received for this study. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai S, 2008, CURR BIOL, V18, P987, DOI 10.1016/j.cub.2008.06.028; Aronson DE, 2011, TRAFFIC, V12, P543, DOI 10.1111/j.1600-0854.2011.01168.x; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chalfie M, 2005, GREEN FLUORESENT PRO; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Conrad C, 2010, J CELL BIOL, V188, P453, DOI 10.1083/jcb.200910105; Davidson MW, 2009, NAT METHODS, V6, P713, DOI 10.1038/nmeth1009-713; Fang C, 2009, NATURE, V462, P200, DOI 10.1038/nature08527; Fisher AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002351; Gennerich A, 2000, BIOPHYS J, V79, P3294, DOI 10.1016/S0006-3495(00)76561-1; Hashiguchi T, 2008, PSSJ ARCH, V1, pe017; Hatsuzawa K, 2009, MOL BIOL CELL, V20, P4435, DOI 10.1091/mbc.E09-03-0241; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Holme A, 2003, EUR J NEUROSCI, V18, P571, DOI 10.1046/j.1460-9568.2003.02780.x; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Huang B, 2004, CHEMPHYSCHEM, V5, P1523, DOI 10.1002/cphc.200400176; INOUYE S, 1994, FEBS LETT, V341, P277, DOI 10.1016/0014-5793(94)80472-9; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Jain RK, 2001, BIOCHEM J, V360, P645, DOI 10.1042/0264-6021:3600645; Karim CB, 2001, J BIOL CHEM, V276, P38814, DOI 10.1074/jbc.M104006200; Kremers GJ, 2007, BIOCHEMISTRY-US, V46, P3775, DOI 10.1021/bi0622874; Kremers GJ, 2011, J CELL SCI, V124, P157, DOI 10.1242/jcs.072744; Malchus N, 2010, J FLUORESC, V20, P19, DOI 10.1007/s10895-009-0517-4; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyawaki A, 2005, NEURON, V48, P189, DOI 10.1016/j.neuron.2005.10.003; Nagaya H, 2008, J CELL BIOL, V180, P129, DOI 10.1083/jcb.200704078; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Perroud TD, 2005, CHEMPHYSCHEM, V6, P905, DOI 10.1002/cphc.200400547; Perroud TD, 2003, CHEMPHYSCHEM, V4, P1121, DOI 10.1002/cphc.200300824; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; SAWANO A, 2000, NUCLEIC ACIDS RES, V28, P78, DOI DOI 10.1093/NAR/28.16.E78; Saxton MJ, 2001, BIOPHYS J, V81, P2226, DOI 10.1016/S0006-3495(01)75870-5; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Skakun Victor V, 2011, Front Biosci (Elite Ed), V3, P489, DOI 10.2741/e264; Snapp EL, 2009, TRENDS CELL BIOL, V19, P649, DOI 10.1016/j.tcb.2009.08.002; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Suzuki K, 2009, PHYS CHEM CHEM PHYS, V11, P9850, DOI 10.1039/b912178a; Timpson P, 2011, J CELL SCI, V124, P2877, DOI 10.1242/jcs.085191; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wada I, 1997, EMBO J, V16, P5420, DOI 10.1093/emboj/16.17.5420; Worth DC, 2010, J CELL SCI, V123, P3629, DOI 10.1242/jcs.064485; Wu D, 2010, J CELL BIOCHEM, V111, P627, DOI 10.1002/jcb.22743; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	55	36	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37551	10.1371/journal.pone.0037551	http://dx.doi.org/10.1371/journal.pone.0037551			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649538	Green Published, Green Submitted, gold			2022-12-25	WOS:000305335800057
J	Kumar, B; Yadav, A; Lang, J; Teknos, TN; Kumar, P				Kumar, Bhavna; Yadav, Arti; Lang, James; Teknos, Theodoros N.; Kumar, Pawan			Dysregulation of MicroRNA-34a Expression in Head and Neck Squamous Cell Carcinoma Promotes Tumor Growth and Tumor Angiogenesis	PLOS ONE			English	Article							SEVERITY STAGING SYSTEM; 5-YEAR SURVIVAL RATES; C-MET EXPRESSION; ENDOTHELIAL-CELLS; OROPHARYNGEAL CANCER; SUPPRESSIVE MIR-34A; SIGNALING PATHWAY; GENE-EXPRESSION; DOWN-REGULATION; SMALL RNAS	Background: MicroRNAs (miRs) are small non-coding RNAs that play an important role in cancer development where they can act as oncogenes or as tumor-suppressors. miR-34a is a tumor-suppressor that is frequently downregulated in a number of tumor types. However, little is known about the role of miR-34a in head and neck squamous cell carcinoma (HNSCC). Methods and Results: miR-34a expression in tumor samples, HNSCC cell lines and endothelial cells was examined by real time PCR. Lipofectamine-2000 was used to transfect miR-34a in HNSCC cell lines and human endothelial cells. Cell-proliferation, migration and clonogenic survival was examined by MTT, Xcelligence system, scratch assay and colony formation assay. miR-34a effect on tumor growth and tumor angiogenesis was examined by in vivo SCID mouse xenograft model. Our results demonstrate that miR-34a is significantly downregulated in HNSCC tumors and cell lines. Ectopic expression of miR-34a in HNSCC cell lines significantly inhibited tumor cell proliferation, colony formation and migration. miR-34a overexpression also markedly downregulated E2F3 and survivin levels. Rescue experiments using microRNA resistant E2F3 isoforms suggest that miR-34a-mediated inhibition of cell proliferation and colony formation is predominantly mediated by E2F3a isoform. In addition, tumor samples from HNSCC patients showed an inverse relationship between miR-34a and survivin as well as miR-34a and E2F3 levels. Overexpression of E2F3a completely rescued survivin expression in miR-34a expressing cells, thereby suggesting that miR-34a may be regulating survivin expression via E2F3a. Ectopic expression of miR-34a also significantly inhibited tumor growth and tumor angiogenesis in a SCID mouse xenograft model. Interestingly, miR-34a inhibited tumor angiogenesis by blocking VEGF production by tumor cells as well as directly inhibiting endothelial cell functions. Conclusions: Taken together, these findings suggest that dysregulation of miR-34a expression is common in HNSCC and modulation of miR34a activity might represent a novel therapeutic strategy for the treatment of HNSCC.	[Kumar, Bhavna; Lang, James; Teknos, Theodoros N.; Kumar, Pawan] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA; [Kumar, Bhavna; Yadav, Arti; Lang, James; Teknos, Theodoros N.; Kumar, Pawan] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Kumar, B (corresponding author), Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA.	pawan.kumar@osumc.edu	Kumar, Pawan/H-7777-2013		National Institutes of Health/National Cancer Institute [CA133250]; Joan's Fund Research Grant; NATIONAL CANCER INSTITUTE [K12CA133250] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Joan's Fund Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Institutes of Health/National Cancer Institute grant CA133250 (PK) and Joan's Fund Research Grant (BK and PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2011, CANCER LETT, V300, P197, DOI 10.1016/j.canlet.2010.10.006; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Asp P, 2009, GENE DEV, V23, P37, DOI 10.1101/gad.1727309; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bradford CR, 2003, HEAD NECK-J SCI SPEC, V25, P654, DOI 10.1002/hed.10274; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen CX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000912; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Chong JL, 2009, MOL CELL BIOL, V29, P414, DOI 10.1128/MCB.01161-08; Danielian PS, 2008, ONCOGENE, V27, P6561, DOI 10.1038/onc.2008.253; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Gou D, 2007, PHYSIOL GENOMICS, V31, P554, DOI 10.1152/physiolgenomics.00005.2007; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Izu A, 2011, TOHOKU J EXP MED, V223, P187, DOI 10.1620/tjem.223.187; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Kawasaki H, 2001, CANCER, V91, P2026, DOI 10.1002/1097-0142(20010601)91:11<2026::AID-CNCR1228>3.0.CO;2-E; Kim SJ, 2003, CLIN CANCER RES, V9, P5161; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Kumar P, 2005, LAB INVEST, V85, P756, DOI 10.1038/labinvest.3700272; Kumar P, 2008, LAB INVEST, V88, P740, DOI 10.1038/labinvest.2008.46; Kumar P, 2007, CANCER RES, V67, P1193, DOI 10.1158/0008-5472.CAN-06-2265; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li BH, 2010, INT J GYNECOL CANCER, V20, P597, DOI 10.1111/IGC.0b013e3181d63170; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liping S, 2010, ORAL SURG ORAL MED O, V110, P484; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Mezquita P, 2005, ONCOGENE, V24, P889, DOI 10.1038/sj.onc.1208251; Nor JE, 2001, CANCER RES, V61, P2183; Preuss SF, 2008, BRIT J CANCER, V98, P627, DOI 10.1038/sj.bjc.6604192; Pugliano FA, 1999, OTOLARYNG HEAD NECK, V120, P38, DOI 10.1016/S0194-5998(99)70367-0; Pugliano FA, 1997, ARCH OTOLARYNGOL, V123, P1118; Ramdas L, 2009, HEAD NECK-J SCI SPEC, V31, P642, DOI 10.1002/hed.21017; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reimer D, 2011, ONCOGENE; Reimer D, 2010, CANCER RES, V70, P4613, DOI 10.1158/0008-5472.CAN-09-3551; Richey LM, 2007, OTOLARYNG HEAD NECK, V136, P98, DOI 10.1016/j.otohns.2006.06.1267; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Sotiropoulou G, 2009, RNA, V15, P1443, DOI 10.1261/rna.1534709; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Swana HS, 1999, NEW ENGL J MED, V341, P452, DOI 10.1056/NEJM199908053410614; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wald AI, 2011, HEAD NECK-J SCI SPEC, V33, P504, DOI 10.1002/hed.21475; Walk Elyse L, 2011, Cancers (Basel), V3, P747, DOI 10.3390/cancers3010747; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Worden FP, 2008, J CLIN ONCOL, V26, P3138, DOI 10.1200/JCO.2007.12.7597; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yadav A, 2011, MOL CANCER THER, V10, P1241, DOI 10.1158/1535-7163.MCT-11-0004; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Zygogianni A, 2011, ASIAN PAC J CANCER P, V12, P339	67	110	113	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37601	10.1371/journal.pone.0037601	http://dx.doi.org/10.1371/journal.pone.0037601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629428	Green Submitted, Green Published, gold			2022-12-25	WOS:000305345300059
J	Ovadia-Caro, S; Nir, Y; Soddu, A; Ramot, M; Hesselmann, G; Vanhaudenhuyse, A; Dinstein, I; Tshibanda, JFL; Boly, M; Harel, M; Laureys, S; Malach, R				Ovadia-Caro, Smadar; Nir, Yuval; Soddu, Andrea; Ramot, Michal; Hesselmann, Guido; Vanhaudenhuyse, Audrey; Dinstein, Ilan; Tshibanda, Jean-Flory L.; Boly, Melanie; Harel, Michal; Laureys, Steven; Malach, Rafael			Reduction in Inter-Hemispheric Connectivity in Disorders of Consciousness	PLOS ONE			English	Article							INTERHEMISPHERIC FUNCTIONAL CONNECTIVITY; RESTING-STATE; DEFAULT NETWORK; BRAIN ACTIVITY; BASE-LINE; VEGETATIVE STATE; MOTOR CORTEX; FLUCTUATIONS; SCALE; COMA	Clinical diagnosis of disorders of consciousness (DOC) caused by brain injury poses great challenges since patients are often behaviorally unresponsive. A promising new approach towards objective DOC diagnosis may be offered by the analysis of ultra-slow (<0.1 Hz) spontaneous brain activity fluctuations measured with functional magnetic resonance imaging (fMRI) during the resting-state. Previous work has shown reduced functional connectivity within the "default network", a subset of regions known to be deactivated during engaging tasks, which correlated with the degree of consciousness impairment. However, it remains unclear whether the breakdown of connectivity is restricted to the "default network", and to what degree changes in functional connectivity can be observed at the single subject level. Here, we analyzed resting-state interhemispheric connectivity in three homotopic regions of interest, which could reliably be identified based on distinct anatomical landmarks, and were part of the "Extrinsic" (externally oriented, task positive) network (pre- and postcentral gyrus, and intraparietal sulcus). Resting-state fMRI data were acquired for a group of 11 healthy subjects and 8 DOC patients. At the group level, our results indicate decreased inter-hemispheric functional connectivity in subjects with impaired awareness as compared to subjects with intact awareness. Individual connectivity scores significantly correlated with the degree of consciousness. Furthermore, a single-case statistic indicated a significant deviation from the healthy sample in 5/8 patients. Importantly, of the three patients whose connectivity indices were comparable to the healthy sample, one was diagnosed as locked-in. Taken together, our results further highlight the clinical potential of resting-state connectivity analysis and might guide the way towards a connectivity measure complementing existing DOC diagnosis.	[Ovadia-Caro, Smadar; Ramot, Michal; Hesselmann, Guido; Dinstein, Ilan; Harel, Michal; Malach, Rafael] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Ovadia-Caro, Smadar] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany; [Nir, Yuval] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Soddu, Andrea; Vanhaudenhuyse, Audrey; Tshibanda, Jean-Flory L.; Boly, Melanie; Laureys, Steven] Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, Liege, Belgium; [Soddu, Andrea; Vanhaudenhuyse, Audrey; Tshibanda, Jean-Flory L.; Boly, Melanie; Laureys, Steven] Univ Liege, Dept Neurol, Liege, Belgium; [Hesselmann, Guido] Charite Campus Mitte, Dept Psychiat, Berlin, Germany	Weizmann Institute of Science; Humboldt University of Berlin; University of Wisconsin System; University of Wisconsin Madison; University of Liege; University of Liege; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ovadia-Caro, S (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	rafi.malach@gmail.com	Hesselmann, Guido/I-2880-2016; Soddu, Andrea/K-7087-2014; Laureys, Steven/AAN-2097-2021; Vanhaudenhuyse, Audrey/AAP-2455-2020; Dinstein, Ilan/AAW-4400-2020; Dinstein, Ilan/L-3325-2016; Laureys, Steven/A-3349-2011	Hesselmann, Guido/0000-0002-8873-7212; Soddu, Andrea/0000-0001-6833-745X; Laureys, Steven/0000-0002-3096-3807; Dinstein, Ilan/0000-0001-8106-5209; Dinstein, Ilan/0000-0001-8106-5209; Nir, Yuval/0000-0002-5433-6349; Ramot, Michal/0000-0001-9716-6469; Boly, Melanie/0000-0001-9584-0907	Israel Science Foundation [160/07]; ISF-Bikura; Helen Kimmel Award for Innovative Research; Belgian Funds for Scientific Research (FRS); European Commission (DECODER); McDonnell Foundation; Mind Science Foundation; University Hospital of Liege; University of Liege	Israel Science Foundation(Israel Science Foundation); ISF-Bikura; Helen Kimmel Award for Innovative Research; Belgian Funds for Scientific Research (FRS)(Fonds de la Recherche Scientifique - FNRS); European Commission (DECODER); McDonnell Foundation; Mind Science Foundation; University Hospital of Liege; University of Liege(University of Liege)	This study was supported by the Israel Science Foundation 160/07 and ISF-Bikura. Grants and the Helen Kimmel Award for Innovative Research to Rafael Malach. The study was supported by the Belgian Funds for Scientific Research (FRS) (http://www2.frs-fnrs.be/), European Commission (DECODER) (http://www.decoder.i1.psychologie.uni-wuerzburg.de/?Partners), McDonnell Foundation (http://www.jsmf.org/), Mind Science Foundation (http://www.mindscience.org/), University Hospital of Liege (http://www.chu.ulg.ac.be/jcms/r_127200/internet-accueil) and University of Liege (http://www.ulg.ac.be/cms/c_5000/home) for Steven Laureys. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Clinical Neurophysiology Society, 2006, Am J Electroneurodiagnostic Technol, V46, P211; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Balduzzi D, 2008, P NATL ACAD SCI USA, V105, P15641, DOI 10.1073/pnas.0808310105; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Boly M, 2008, HUM BRAIN MAPP, V29, P868, DOI 10.1002/hbm.20602; Bruno MA, 2011, PROG BRAIN RES, V193, P323, DOI 10.1016/B978-0-444-53839-0.00021-1; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dinstein I, 2008, J NEUROSCI, V28, P11231, DOI 10.1523/JNEUROSCI.3585-08.2008; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gavrilescu M, 2010, PSYCHOL MED, V40, P1149, DOI 10.1017/S0033291709991632; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Goebel R., 1996, NEUROIMAGE, V3, P5604, DOI [10.1016/s1053-8119(96)80606-9, DOI 10.1016/S1053-8119(96)80606-9]; Golland Y, 2007, CEREB CORTEX, V17, P766, DOI 10.1093/cercor/bhk030; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; Innocenti GM., 1986, GEN ORG CALLOSAL CON, P291, DOI [10.1007/978-1-4613-2149-1_9, DOI 10.1007/978-1-4613-2149-1_9]; Jelsone-Swain LM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00158; JENNETT B, 1975, LANCET, V1, P480; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Koch W, 2010, NEUROIMAGE, V51, P280, DOI 10.1016/j.neuroimage.2009.12.008; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Leon-Carrion J, 2002, BRAIN INJURY, V16, P571, DOI 10.1080/02699050110119781; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Nir Y, 2006, NEUROIMAGE, V30, P1313, DOI 10.1016/j.neuroimage.2005.11.018; Nomura EM, 2010, P NATL ACAD SCI USA, V107, P12017, DOI 10.1073/pnas.1002431107; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; Preminger S, 2011, NEUROIMAGE, V54, P1692, DOI 10.1016/j.neuroimage.2010.08.036; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Soddu A, 2012, HUM BRAIN MAPP, V33, P778, DOI 10.1002/hbm.21249; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Talairach J., 1988, COPLANAR STEREOTAXIC; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Uddin LQ, 2008, NEUROREPORT, V19, P703, DOI 10.1097/WNR.0b013e3282fb8203; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	70	41	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37238	10.1371/journal.pone.0037238	http://dx.doi.org/10.1371/journal.pone.0037238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629375	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345300029
J	Roeber, F; Larsen, JWA; Anderson, N; Campbell, AJD; Anderson, GA; Gasser, RB; Jex, AR				Roeber, Florian; Larsen, John W. A.; Anderson, Norman; Campbell, Angus J. D.; Anderson, Garry A.; Gasser, Robin B.; Jex, Aaron R.			A Molecular Diagnostic Tool to Replace Larval Culture in Conventional Faecal Egg Count Reduction Testing in Sheep	PLOS ONE			English	Article							ANTHELMINTIC RESISTANCE; GASTROINTESTINAL NEMATODES; DRUG-RESISTANCE; INFECTIONS; RUMINANTS; EFFICACY; WORMS; BIAS	The accurate diagnosis of parasitic nematode infections in livestock (including sheep and goats) is central to their effective control and the detection of the anthelmintic resistance. Traditionally, the faecal egg count reduction test (FECRT), combined with the technique of larval culture (LC), has been used widely to assess drug-susceptibility/resistance in strongylid nematodes. However, this approach suffers from a lack of specificity, sensitivity and reliability, and is time-consuming and costly to conduct. Here, we critically assessed a specific PCR assay to support FECRT, in a well-controlled experiment on sheep with naturally acquired strongylid infections known to be resistant to benzimidazoles. We showed that the PCR results were in close agreement with those of total worm count (TWC), but not of LC. Importantly, albendazole resistance detected by PCR-coupled FECRT was unequivocally linked to Teladorsagia circumcincta and, to lesser extent, Trichostrongylus colubriformis, a result that was not achievable by LC. The key findings from this study demonstrate that our PCR-coupled FECRT approach has major merit for supporting anthelmintic resistance in nematode populations. The findings also show clearly that our PCR assay can be used as an alternative to LC, and is more time-efficient and less laborious, which has important practical implications for the effective management and control strongylid nematodes of sheep.	[Roeber, Florian; Campbell, Angus J. D.; Anderson, Garry A.; Gasser, Robin B.; Jex, Aaron R.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia; [Larsen, John W. A.; Anderson, Norman; Campbell, Angus J. D.] Univ Melbourne, Mackinnon Project, Werribee, Vic, Australia	University of Melbourne; University of Melbourne	Roeber, F (corresponding author), Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia.	f.roeber@pgrad.unimelb.edu.au; robinbg@unimelb.edu.au	Gasser, Robin/ABH-6185-2020; Larsen, John/AAF-9958-2021; Larsen, John WA/H-5693-2013; Campbell, Angus J D/F-7671-2014; Jex, Aaron/AGZ-7897-2022	Gasser, Robin/0000-0002-4423-1690; Campbell, Angus J D/0000-0002-3907-5048; Jex, Aaron/0000-0002-1285-7947; LARSEN, JOHN/0000-0003-1436-1889	Australian Research Council (RBG)	Australian Research Council (RBG)(Australian Research Council)	This research was supported by the Australian Research Council (RBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON N, 1972, AUST J AGR RES, V23, P1113, DOI 10.1071/AR9721113; [Anonymous], 1948, J COUNCIL SCI IND RE; Beech RN, 2011, PARASITOLOGY, V138, P160, DOI 10.1017/S0031182010001198; Besier RB, 2003, AUST J EXP AGR, V43, P1383, DOI 10.1071/EA02229; BEVERIDGE I, 1983, VET PARASITOL, V13, P55, DOI 10.1016/0304-4017(83)90020-1; Bott NJ, 2009, INT J PARASITOL, V39, P1277, DOI 10.1016/j.ijpara.2009.03.002; Cabaret J, 2004, VET PARASITOL, V121, P105, DOI 10.1016/j.vetpar.2004.01.020; Coles GC, 2006, VET PARASITOL, V136, P167, DOI 10.1016/j.vetpar.2005.11.019; Conraths FJ, 2006, VET PARASITOL, V136, P91, DOI 10.1016/j.vetpar.2005.12.004; DIKMANS G., 1933, TRANS AMER MICROSC SOC, V52, P1, DOI 10.2307/3222221; Dobson RJ, 1996, INT J PARASITOL, V26, P993, DOI 10.1016/S0020-7519(96)80078-6; DOBSON RJ, 1992, INT J PARASITOL, V22, P1005, DOI 10.1016/0020-7519(92)90060-X; GASSER RB, 1993, NUCLEIC ACIDS RES, V21, P2525, DOI 10.1093/nar/21.10.2525; Gasser RB, 2008, BIOTECHNOL ADV, V26, P325, DOI 10.1016/j.biotechadv.2008.03.003; Gasser RB, 2006, NAT PROTOC, V1, P3121, DOI 10.1038/nprot.2006.485; Gibbons, 2010, KEYS NEMATODE PARASI, P83; Gordon HMEpidemiologyofhelminthosisinsheep, 1981, EPIDEMIOLOGY HELMINT, P551; GORDON HUGH McL, 1933, AUSTRALIAN VET JOUR, V9, P223, DOI 10.1111/j.1751-0813.1933.tb06301.x; Hosking BC, 2009, AUST VET J, V87, P455, DOI 10.1111/j.1751-0813.2009.00511.x; Hosking BC, 2010, PARASITOL RES, V106, P529, DOI 10.1007/s00436-009-1636-1; Kaminsky R, 2008, NATURE, V452, P176, DOI 10.1038/nature06722; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Lichtenfels JR, 1997, VET PARASITOL, V72, P225, DOI 10.1016/S0304-4017(97)00099-X; Love SCJ, 2002, VET REC, V150, P87; MAFF, 1986, MAN VET PAR LAB TECH, P20; McMurtry LW, 2000, VET PARASITOL, V90, P73, DOI 10.1016/S0304-4017(00)00230-2; Nielsen MK, 2010, VET PARASITOL, V167, P55, DOI 10.1016/j.vetpar.2009.09.043; Roeber F, 2011, INFECT GENET EVOL, V11, P849, DOI 10.1016/j.meegid.2011.01.013; Sackett D, 2006, ASSESSING EC COST EN; Taylor MA, 2002, VET PARASITOL, V103, P183, DOI 10.1016/S0304-4017(01)00604-5; Thrusfield M, 2007, VET EPIDEMIOLOGY; van Wyk JA, 2004, VET PARASITOL, V119, P277, DOI 10.1016/j.vetpar.2003.11.012; Villanua D, 2006, PARASITOLOGY, V133, P251, DOI 10.1017/S003118200600031X; von Sarnson-Himmelstjerna G, 2006, VET PARASITOL, V136, P99, DOI 10.1016/j.vetpar.2005.12.005; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Zajac AM, 2006, VET CLIN N AM-FOOD A, V22, P529, DOI 10.1016/j.cvfa.2006.07.006	36	41	43	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37327	10.1371/journal.pone.0037327	http://dx.doi.org/10.1371/journal.pone.0037327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629381	Green Published, gold			2022-12-25	WOS:000305345300033
J	Abdullah, Z; Geiger, S; Nino-Castro, A; Bottcher, JP; Muraliv, E; Gaidt, M; Schildberg, FA; Riethausen, K; Flossdorf, J; Krebs, W; Chakraborty, T; Kurts, C; Schultze, JL; Knolle, PA; Klotz, L				Abdullah, Zeinab; Geiger, Sergej; Nino-Castro, Andrea; Boettcher, Jan P.; Muraliv, Eugenia; Gaidt, Moritz; Schildberg, Frank A.; Riethausen, Kati; Flossdorf, Juliane; Krebs, Wolfgang; Chakraborty, Trinad; Kurts, Christian; Schultze, Joachim L.; Knolle, Percy A.; Klotz, Luisa			Lack of PPAR gamma in Myeloid Cells Confers Resistance to Listeria monocytogenes Infection	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; TUMOR-NECROSIS-FACTOR; CD8-ALPHA(+) DENDRITIC CELLS; NATURAL-KILLER-CELLS; BACTERIAL-INFECTION; IMMUNE-RESPONSES; INFLAMMATORY RESPONSE; MICE DEFICIENT; T-CELLS; MACROPHAGES	The peroxisomal proliferator-activated receptor gamma (PPAR gamma) is a nuclear receptor that controls inflammation and immunity. Innate immune defense against bacterial infection appears to be compromised by PPAR gamma. The relevance of PPAR gamma in myeloid cells, that organize anti-bacterial immunity, for the outcome of immune responses against intracellular bacteria such as Listeria monocytogenes in vivo is unknown. We found that Listeria monocytogenes infection of macrophages rapidly led to increased expression of PPAR gamma. This prompted us to investigate whether PPAR gamma in myeloid cells influences innate immunity against Listeria monocytogenes infection by using transgenic mice with myeloid-cell specific ablation of PPAR gamma (LysMCrexPPAR gamma(flox/flox)). Loss of PPAR gamma in myeloid cells results in enhanced innate immune defense against Listeria monocytogenes infection both, in vitro and in vivo. This increased resistance against infection was characterized by augmented levels of bactericidal factors and inflammatory cytokines: ROS, NO, IFN gamma TNF IL-6 and IL-12. Moreover, myeloid cell-specific loss of PPAR gamma enhanced chemokine and adhesion molecule expression leading to improved recruitment of inflammatory Ly6C(hi) monocytes to sites of infection. Importantly, increased resistance against Listeria infection in the absence of PPAR gamma was not accompanied by enhanced immunopathology. Our results elucidate a yet unknown regulatory network in myeloid cells that is governed by PPAR gamma and restrains both listeriocidal activity and recruitment of inflammatory monocytes during Listeria infection, which may contribute to bacterial immune escape. Pharmacological interference with PPAR gamma activity in myeloid cells might represent a novel strategy to overcome intracellular bacterial infection.	[Abdullah, Zeinab; Geiger, Sergej; Boettcher, Jan P.; Muraliv, Eugenia; Gaidt, Moritz; Schildberg, Frank A.; Riethausen, Kati; Flossdorf, Juliane; Kurts, Christian; Knolle, Percy A.; Klotz, Luisa] Univ Bonn, Inst Mol Med, Bonn, Germany; [Abdullah, Zeinab; Geiger, Sergej; Boettcher, Jan P.; Muraliv, Eugenia; Gaidt, Moritz; Schildberg, Frank A.; Riethausen, Kati; Flossdorf, Juliane; Kurts, Christian; Knolle, Percy A.; Klotz, Luisa] Univ Bonn, Inst Expt Immunol, Bonn, Germany; [Chakraborty, Trinad] Univ Giessen, Inst Med Microbiol, Giessen, Germany; [Nino-Castro, Andrea; Krebs, Wolfgang; Schultze, Joachim L.] Univ Bonn, LIMES Inst, Bonn, Germany; [Klotz, Luisa] Univ Munster, Clin Neurol Inflammatory Disorders Nervous Syst &, Munster, Germany	University of Bonn; University of Bonn; Justus Liebig University Giessen; University of Bonn; University of Munster	Abdullah, Z (corresponding author), Univ Bonn, Inst Mol Med, Bonn, Germany.	pknolle@uni-bonn.de	Schultze, Joachim L/D-7794-2011; chakraborty, trinad/D-1812-2014; Schultze, Joachim L./ABA-8176-2020; Abdullah, Zeinab/HII-5346-2022	Schultze, Joachim L/0000-0003-2812-9853; Schultze, Joachim L./0000-0003-2812-9853; Gaidt, Moritz/0000-0002-8009-294X; Bottcher, Jan/0000-0002-8163-8107; Knolle, Percy A./0000-0003-2983-0414; Nino-Castro, Andrea/0000-0002-0895-3637	Deutsche Forschungsgemeinschaft [Sonderforschungsbereiche 670, 704]; BONFOR	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BONFOR	This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereiche 670 and 704) and an institutional grant by BONFOR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Clark RB, 2000, J IMMUNOL, V164, P1364, DOI 10.4049/jimmunol.164.3.1364; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Dong HD, 2004, IMMUNITY, V20, P327, DOI 10.1016/S1074-7613(04)00050-0; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; HAVELL EA, 1987, J IMMUNOL, V139, P4225; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Jia T, 2009, J IMMUNOL, V183, P1271, DOI 10.4049/jimmunol.0900460; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Klotz L, 2005, J IMMUNOL, V175, P4948, DOI 10.4049/jimmunol.175.8.4948; Klotz L, 2007, J IMMUNOL, V178, P2122, DOI 10.4049/jimmunol.178.4.2122; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Malur A, 2009, J IMMUNOL, V182, P5816, DOI 10.4049/jimmunol.0803504; Marx N, 1998, AM J PATHOL, V153, P17, DOI 10.1016/S0002-9440(10)65540-X; Nencioni A, 2002, J IMMUNOL, V169, P1228, DOI 10.4049/jimmunol.169.3.1228; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Popov A, 2008, J IMMUNOL, V181, P4976, DOI 10.4049/jimmunol.181.7.4976; Popov A, 2008, J MOL MED, V86, P145, DOI 10.1007/s00109-007-0262-6; Popov A, 2006, J CLIN INVEST, V116, P3160, DOI 10.1172/JCI28996; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shi C, 2010, J IMMUNOL, V184, P6266, DOI 10.4049/jimmunol.0904160; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Singh S, 2011, THORAX, V66, P383, DOI 10.1136/thx.2010.152777; Stavru F, 2011, IMMUNOL REV, V240, P160, DOI 10.1111/j.1600-065X.2010.00993.x; Stavrum R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026295; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; Verschoor A, 2011, NAT IMMUNOL, V12, P1194, DOI 10.1038/ni.2140; von Oppen N, 2009, HEPATOLOGY, V49, P1664, DOI 10.1002/hep.22795; Wu L, 2011, BLOOD; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008	54	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37349	10.1371/journal.pone.0037349	http://dx.doi.org/10.1371/journal.pone.0037349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629382	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343100022
J	Wani, KA; Catanese, M; Normantowicz, R; Herd, M; Maher, KN; Chase, DL				Wani, Khursheed A.; Catanese, Mary; Normantowicz, Robyn; Herd, Muriel; Maher, Kathryn N.; Chase, Daniel L.			D1 Dopamine Receptor Signaling Is Modulated by the R7 RGS Protein EAT-16 and the R7 Binding Protein RSBP-1 in Caenoerhabditis elegans Motor Neurons	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; COUPLED RECEPTOR; ACETYLCHOLINE-RELEASE; ADENYLYL-CYCLASE; RNA INTERFERENCE; MEMBRANE ANCHOR; GENE-EXPRESSION; DEP DOMAIN; COMPLEXES; REGULATORS	Dopamine signaling modulates voluntary movement and reward-driven behaviors by acting through G protein-coupled receptors in striatal neurons, and defects in dopamine signaling underlie Parkinson's disease and drug addiction. Despite the importance of understanding how dopamine modifies the activity of striatal neurons to control basal ganglia output, the molecular mechanisms that control dopamine signaling remain largely unclear. Dopamine signaling also controls locomotion behavior in Caenorhabditis elegans. To better understand how dopamine acts in the brain we performed a large-scale dsRNA interference screen in C. elegans for genes required for endogenous dopamine signaling and identified six genes (eat-16, rsbp-1, unc-43, flp-1, grk-1, and cat-1) required for dopamine-mediated behavior. We then used a combination of mutant analysis and cell-specific transgenic rescue experiments to investigate the functional interaction between the proteins encoded by two of these genes, eat-16 and rsbp-1, within single cell types and to examine their role in the modulation of dopamine receptor signaling. We found that EAT-16 and RSBP-1 act together to modulate dopamine signaling and that while they are coexpressed with both D1-like and D2-like dopamine receptors, they do not modulate D2 receptor signaling. Instead, EAT-16 and RSBP-1 act together to selectively inhibit D1 dopamine receptor signaling in cholinergic motor neurons to modulate locomotion behavior.	[Catanese, Mary; Normantowicz, Robyn; Herd, Muriel; Chase, Daniel L.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Wani, Khursheed A.; Maher, Kathryn N.; Chase, Daniel L.] Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Wani, KA (corresponding author), Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA.	danchase@biochem.umass.edu	Wani, Khursheed/AAH-9203-2021	Catanese, Mary/0000-0002-0903-1853	Richard and Susan Smith Family Foundation; National Institutes of Health [MH077935-02]; NIH National Center for Research Services; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH077935] Funding Source: NIH RePORTER	Richard and Susan Smith Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Services; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Richard and Susan Smith Family Foundation (http://www.smithfamilyfoundation.net) and the National Institutes of Health (MH077935-02). Some strains were obtained from the Caenorhabditis Genetics Center, which is supported by the NIH National Center for Research Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT PR, 1990, J BIOL CHEM, V265, P2098; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Allen AT, 2011, GENETICS, V188, P579, DOI 10.1534/genetics.111.128512; Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, MOL CELL BIOL, V29, P3033, DOI 10.1128/MCB.01449-08; Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Bouhamdan M, 2006, J NEUROSCI, V26, P2522, DOI 10.1523/JNEUROSCI.4083-05.2006; BRENNER S, 1974, GENETICS, V77, P71; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Eastman C, 1999, J NEUROSCI, V19, P6225; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GIRAULT JA, 1986, NEUROSCIENCE, V19, P1109, DOI 10.1016/0306-4522(86)90127-2; Gold SJ, 1997, J NEUROSCI, V17, P8024; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; Gu ZL, 2006, MOL PHARMACOL, V69, P813, DOI 10.1124/mol.105.018853; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ikarashi Y, 1997, BRAIN RES BULL, V43, P107, DOI 10.1016/S0361-9230(96)00351-6; Jayanthi LD, 1998, MOL PHARMACOL, V54, P601; Jiang MS, 2001, P NATL ACAD SCI USA, V98, P3577, DOI 10.1073/pnas.051632598; KEBABIAN JW, 1972, P NATL ACAD SCI USA, V69, P2145, DOI 10.1073/pnas.69.8.2145; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; KIMURA K, 1995, J BIOL CHEM, V270, P14672, DOI 10.1074/jbc.270.24.14672; Kovoor A, 2000, J BIOL CHEM, V275, P3397, DOI 10.1074/jbc.275.5.3397; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; MADURO M, 1995, GENETICS, V141, P977; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; McDonald PW, 2007, J NEUROSCI, V27, P14216, DOI 10.1523/JNEUROSCI.2992-07.2007; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Narayanan V, 2007, BIOCHEMISTRY-US, V46, P6859, DOI 10.1021/bi700524w; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; Nelson LS, 1998, MOL BRAIN RES, V58, P103, DOI 10.1016/S0169-328X(98)00106-5; Ng J, 2010, NEUROSCIENCE, V165, P535, DOI 10.1016/j.neuroscience.2009.10.017; Obadiah J, 1999, CELL MOL NEUROBIOL, V19, P653, DOI 10.1023/A:1006988603199; OKKEMA PG, 1993, GENETICS, V135, P385; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Porter MY, 2010, MOL BIOL CELL, V21, P232, DOI 10.1091/mbc.E09-07-0642; Posner BA, 1999, J BIOL CHEM, V274, P31087, DOI 10.1074/jbc.274.43.31087; Psigfogeorgou K, 2011, J NEUROSCI, V31, P5617, DOI 10.1523/JNEUROSCI.4146-10.2011; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rankin ML, 2006, MOL PHARMACOL, V69, P759, DOI 10.1124/mol.105.019901; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Shuey DJ, 1998, J NEUROCHEM, V70, P1964; Sidhu A, 2000, INT J DEV NEUROSCI, V18, P669, DOI 10.1016/S0736-5748(00)00033-2; So CH, 2009, MOL PHARMACOL, V75, P843, DOI 10.1124/mol.108.051805; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; SUNAHARA RK, 1991, NATURE, V350, P614, DOI 10.1038/350614a0; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Villar VM, 2009, J BIOL CHEM, V284, P21425, DOI 10.1074/jbc.M109.003665; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wang HY, 1995, MOL PHARMACOL, V48, P988; Wang M, 2004, SCIENCE, V303, P853, DOI 10.1126/science.1091162; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Wintle RF, 2001, PARKINSONISM RELAT D, V7, P177, DOI 10.1016/S1353-8020(00)00055-9; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Witherow DS, 2003, J BIOL CHEM, V278, P21307, DOI 10.1074/jbc.M212884200; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; ZHOU QY, 1990, NATURE, V347, P76, DOI 10.1038/347076a0; Zhuang XX, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-16-j0001.2000	72	14	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37831	10.1371/journal.pone.0037831	http://dx.doi.org/10.1371/journal.pone.0037831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629462	Green Published, gold			2022-12-25	WOS:000305343100054
J	Trnka, A; Prokop, P; Grim, T				Trnka, Alfred; Prokop, Pavol; Grim, Tomas			Uncovering Dangerous Cheats: How Do Avian Hosts Recognize Adult Brood Parasites?	PLOS ONE			English	Article							CUCKOO CUCULUS-CANORUS; GREAT REED WARBLERS; NEST DEFENSE; ACROCEPHALUS-ARUNDINACEUS; HAWK MIMICRY; ENEMY RECOGNITION; EGG EVICTION; RESPONSES; BEHAVIOR; CUES	Background: Co-evolutionary struggles between dangerous enemies (e. g., brood parasites) and their victims (hosts) lead to the emergence of sophisticated adaptations and counter-adaptations. Salient host tricks to reduce parasitism costs include, as front line defence, adult enemy discrimination. In contrast to the well studied egg stage, investigations addressing the specific cues for adult enemy recognition are rare. Previous studies have suggested barred underparts and yellow eyes may provide cues for the recognition of cuckoos Cuculus canorus by their hosts; however, no study to date has examined the role of the two cues simultaneously under a consistent experimental paradigm. Methodology/Principal Findings: We modify and extend previous work using a novel experimental approach - custom-made dummies with various combinations of hypothesized recognition cues. The salient recognition cue turned out to be the yellow eye. Barred underparts, the only trait examined previously, had a statistically significant but small effect on host aggression highlighting the importance of effect size vs. statistical significance. Conclusion: Relative importance of eye vs. underpart phenotypes may reflect ecological context of host-parasite interaction: yellow eyes are conspicuous from the typical direction of host arrival (from above), whereas barred underparts are poorly visible (being visually blocked by the upper part of the cuckoo's body). This visual constraint may reduce usefulness of barred underparts as a reliable recognition cue under a typical situation near host nests. We propose a novel hypothesis that recognition cues for enemy detection can vary in a context-dependent manner (e.g., depending on whether the enemy is approached from below or from above). Further we suggest a particular cue can trigger fear reactions (escape) in some hosts/populations whereas the same cue can trigger aggression (attack) in other hosts/populations depending on presence/absence of dangerous enemies that are phenotypically similar to brood parasites and costs and benefits associated with particular host responses.	[Trnka, Alfred; Prokop, Pavol] Univ Trnava, Dept Biol, Trnava, Slovakia; [Prokop, Pavol] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Grim, Tomas] Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic; [Grim, Tomas] Palacky Univ, Ornithol Lab, CR-77147 Olomouc, Czech Republic	University of Trnava; Slovak Academy of Sciences; Palacky University Olomouc; Palacky University Olomouc	Trnka, A (corresponding author), Univ Trnava, Dept Biol, Trnava, Slovakia.	tomas.grim@upol.cz	Prokop, Pavol/ABD-9546-2020; Grim, Tomas/A-2852-2008	Prokop, Pavol/0000-0003-2016-7468; Grim, Tomas/0000-0002-5775-6269	Slovak Grant Agency for Science [1/0566/09]; Ministry of Education of the Czech Republic [MSM6198959212]; Human Frontier Science Program [RGY69/07]	Slovak Grant Agency for Science(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Human Frontier Science Program(Human Frontier Science Program)	The authors acknowledge financial support from the Slovak Grant Agency for Science grant no. 1/0566/09 (to AT and PP), the Ministry of Education of the Czech Republic grant no. MSM6198959212, and Human Frontier Science Program Award no. RGY69/07 (to TG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez F, 1996, IBIS, V138, P340, DOI 10.1111/j.1474-919X.1996.tb04349.x; Anderson MG, 2009, PLOS ONE, V4, pA67, DOI 10.1371/journal.pone.0007725; Bartol I, 2002, J AVIAN BIOL, V33, P420, DOI 10.1034/j.1600-048X.2002.02945.x; BAZIN RC, 1993, ETHOLOGY, V94, P326; Bos N, 2010, ANIM BEHAV, V80, P839, DOI 10.1016/j.anbehav.2010.08.001; BRISKIE JV, 1989, ETHOLOGY, V82, P61; Brooke MD, 1998, P ROY SOC B-BIOL SCI, V265, P1277, DOI 10.1098/rspb.1998.0430; Campobello D, 2011, ANIM BEHAV, V82, P885, DOI 10.1016/j.anbehav.2011.07.028; Campobello D, 2011, BEHAV ECOL, V22, P422, DOI 10.1093/beheco/arq225; Campobello D, 2010, ETHOLOGY, V116, P498, DOI 10.1111/j.1439-0310.2010.01764.x; Capek M, 2010, CONDOR, V112, P763, DOI 10.1525/cond.2010.100063; Carter J, 2008, P ROY SOC B-BIOL SCI, V275, P1709, DOI 10.1098/rspb.2008.0095; Cassey P, 2008, BIOL LETTERS, V4, P515, DOI 10.1098/rsbl.2008.0279; Davies NB, 2008, P ROY SOC B-BIOL SCI, V275, P1817, DOI 10.1098/rspb.2008.0331; Davies NB, 2011, J ZOOL, V284, P1, DOI 10.1111/j.1469-7998.2011.00810.x; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 2009, SCIENCE, V324, P1318, DOI 10.1126/science.1172227; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Gill SA, 2004, BEHAV ECOL SOCIOBIOL, V56, P71, DOI 10.1007/s00265-003-0736-7; Gill SA, 1997, ANIM BEHAV, V53, P1287, DOI 10.1006/anbe.1996.0362; Glutz von Blotzheim U., 1971, HDB VOGEL MITTELEURO, V4; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grim T, 2005, AUK, V122, P530, DOI 10.1642/0004-8038(2005)122[0530:HROBPI]2.0.CO;2; Grim T, 2001, BIOLOGIA, V56, P549; Grim T, 2008, J ORNITHOL, V149, P169, DOI 10.1007/s10336-007-0257-7; Grim T, 2006, EVOL ECOL RES, V8, P785; Grim T, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-14; Grim T, 2011, J ANIM ECOL, V80, P508, DOI 10.1111/j.1365-2656.2010.01798.x; Grim T, 2009, BEHAV ECOL, V20, P1138, DOI 10.1093/beheco/arp108; Holen OH, 2006, AM NAT, V167, P377, DOI 10.1086/499567; Honza M, 2004, BIRD STUDY, V51, P256, DOI 10.1080/00063650409461361; Honza M, 2006, J ORNITHOL, V147, P629, DOI 10.1007/s10336-006-0088-y; Honza M, 2010, BEHAVIOUR, V147, P741, DOI 10.1163/000579510X491081; KOHDA Y, 1990, ETHOLOGY, V84, P162; Komarek S., 2003, MIMICRY APOSEMATISM; Ligon RA, 2009, ANIM BEHAV, V77, P1267, DOI 10.1016/j.anbehav.2009.01.031; Lindholm AK, 2000, BEHAVIOUR, V137, P25, DOI 10.1163/156853900501854; Lombardi CM, 2009, AUSTRAL ECOL, V34, P447, DOI 10.1111/j.1442-9993.2009.01946.x; Lopez-de-Hierro MDG, 2010, BEHAV ECOL SOCIOBIOL, V64, P317, DOI 10.1007/s00265-009-0811-9; MOKSNES A, 1991, BEHAVIOUR, V116, P64, DOI 10.1163/156853990X00365; Moksnes A, 2000, IBIS, V142, P247, DOI 10.1111/j.1474-919X.2000.tb04864.x; MOKSNES A, 1993, BEHAV ECOL, V4, P120, DOI 10.1093/beheco/4.2.120; Molnar B, 1944, AQUILA, V51, P100; Moskat C, 2005, ANN ZOOL FENN, V42, P579; Polacikova L, 2010, J AVIAN BIOL, V41, P111, DOI 10.1111/j.1600-048X.2010.04983.x; Polacikova L, 2010, BEHAVIOUR, V147, P465, DOI 10.1163/000579509X12584427339575; Pozgayova M, 2009, BEHAV PROCESS, V81, P34, DOI 10.1016/j.beproc.2008.12.019; Roskaft E, 2002, BEHAVIOUR, V139, P613, DOI 10.1163/15685390260136735; Ruxton GD, 2004, AVOIDING ATTACK EVOL; SCHULER W, 1985, BEHAV ECOL SOCIOBIOL, V16, P249, DOI 10.1007/BF00310988; Sealy SG, 1998, OX ORN SER, V9, P194; SMITH S., 1955, BIRDS FIGHTING; Spottiswoode CN, 2012, BIOL LETTERS, V8, P241, DOI 10.1098/rsbl.2011.0739; Spottiswoode CN, 2010, P NATL ACAD SCI USA, V107, P8672, DOI 10.1073/pnas.0910486107; Thompson JN, 1994, COEVOLUTIONARY PROCE; Trnka A, 2012, ANIM BEHAV, V83, P263, DOI 10.1016/j.anbehav.2011.10.036; Trnka A, 2010, ETHOLOGY, V116, P1075, DOI 10.1111/j.1439-0310.2010.01821.x; Weidinger K, 2010, J ORNITHOL, V151, P729, DOI 10.1007/s10336-010-0512-1; Welbergen JA, 2008, ANIM BEHAV, V76, P811, DOI 10.1016/j.anbehav.2008.03.020; Welbergen JA, 2011, BEHAV ECOL, V22, P574, DOI 10.1093/beheco/arr008; Welbergen JA, 2009, CURR BIOL, V19, P235, DOI 10.1016/j.cub.2008.12.041; Westhoff G, 2005, J COMP PHYSIOL A, V191, P873, DOI 10.1007/s00359-005-0010-8; Wisenden BD, 2004, ANIM BEHAV, V67, P59, DOI 10.1016/j.anbehav.2003.02.010; Wyllie I., 1981, CUCKOO; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	65	36	39	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37445	10.1371/journal.pone.0037445	http://dx.doi.org/10.1371/journal.pone.0037445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624031	Green Published, gold			2022-12-25	WOS:000305343500116
J	Welch, MD; Reed, SCO; Lamason, RL; Serio, AW				Welch, Matthew D.; Reed, Shawna C. O.; Lamason, Rebecca L.; Serio, Alisa W.			Expression of an Epitope-Tagged Virulence Protein in Rickettsia parkeri Using Transposon Insertion	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ACTIN-BASED MOTILITY; SPOTTED-FEVER; ARP2/3 COMPLEX; CONORII; PROWAZEKII; CELLS; RICKA; TRANSFORMATION; EVOLUTION	Despite recent advances in our ability to genetically manipulate Rickettsia, little has been done to employ genetic tools to study the expression and localization of Rickettsia virulence proteins. Using a mariner-based Himar1 transposition system, we expressed an epitope-tagged variant of the actin polymerizing protein RickA under the control of its native promoter in Rickettsia parkeri, allowing the detection of RickA using commercially-available antibodies. Native RickA and epitope-tagged RickA exhibited similar levels of expression and were specifically localized to bacteria. To further facilitate protein expression in Rickettsia, we also developed a plasmid for Rickettsia insertion and expression (pRIE), containing a variant Himar1 transposon with enhanced flexibility for gene insertion, and used it to generate R. parkeri strains expressing diverse fluorescent proteins. Expression of epitope-tagged proteins in Rickettsia will expand our ability to assess the regulation and function of important virulence factors.	[Welch, Matthew D.; Lamason, Rebecca L.; Serio, Alisa W.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Welch, Matthew D.; Reed, Shawna C. O.] Univ Calif Berkeley, Microbiol Grad Grp, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Welch, MD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	welch@berkeley.edu		Reed, Shawna/0000-0002-9041-4869; Lamason, Rebecca/0000-0002-2762-7917	Public Health Service grant from the National Institute of Allergy and Infectious Diseases [AI-074760]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074760] Funding Source: NIH RePORTER	Public Health Service grant from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant AI-074760 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANACKER RL, 1987, J CLIN MICROBIOL, V25, P167, DOI 10.1128/JCM.25.1.167-171.1987; Baldridge GD, 2005, APPL ENVIRON MICROB, V71, P2095, DOI 10.1128/AEM.71.4.2095-2105.2005; Baldridge GD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008965; Balraj P, 2008, FEMS MICROBIOL LETT, V286, P257, DOI 10.1111/j.1574-6968.2008.01283.x; Burkhardt NY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029511; Clark TR, 2011, INFECT IMMUN, V79, P1631, DOI 10.1128/IAI.00048-11; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Driskell LO, 2009, INFECT IMMUN, V77, P3244, DOI 10.1128/IAI.00395-09; Ellison DW, 2008, INFECT IMMUN, V76, P542, DOI 10.1128/IAI.00952-07; Firat-Karalar EN, 2011, MOL BIOL CELL, V22, P4563, DOI 10.1091/mbc.E11-06-0585; Gillespie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002018; Gillespie JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000266; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Gouin E, 1999, J CELL SCI, V112, P1697; HACKSTADT T, 1992, INFECT IMMUN, V60, P159, DOI 10.1128/IAI.60.1.159-165.1992; HEINZEN RA, 1993, INFECT IMMUN, V61, P1926, DOI 10.1128/IAI.61.5.1926-1935.1993; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; Liu ZM, 2007, APPL ENVIRON MICROB, V73, P6644, DOI 10.1128/AEM.01727-07; Martinez JJ, 2004, J CELL SCI, V117, P5097, DOI 10.1242/jcs.01382; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Paddock CD, 2004, CLIN INFECT DIS, V38, P805, DOI 10.1086/381894; Paddock CD, 2008, CLIN INFECT DIS, V47, P1188, DOI 10.1086/592254; Policastro PF, 1997, J MED MICROBIOL, V46, P839, DOI 10.1099/00222615-46-10-839; Rachek LI, 1998, J BACTERIOL, V180, P2118, DOI 10.1128/JB.180.8.2118-2124.1998; Rachek LI, 2000, J BACTERIOL, V182, P3289, DOI 10.1128/JB.182.11.3289-3291.2000; Reed SC, 2011, CELL MICROB IN PRESS; SCHAECHTER M, 1957, VIROLOGY, V3, P160, DOI 10.1016/0042-6822(57)90030-2; Serio AW, 2010, CELL HOST MICROBE, V7, P388, DOI 10.1016/j.chom.2010.04.008; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Simser JA, 2005, MOL MICROBIOL, V58, P71, DOI 10.1111/j.1365-2958.2005.04806.x; TEYSSEIRE N, 1992, RES MICROBIOL, V143, P821, DOI 10.1016/0923-2508(92)90069-Z; Troyer JM, 1999, INFECT IMMUN, V67, P3308, DOI 10.1128/IAI.67.7.3308-3311.1999; Vellaiswamy M, 2011, NEW MICROBIOL, V34, P209; WALKER TS, 1984, INFECT IMMUN, V44, P205, DOI 10.1128/IAI.44.2.205-210.1984	39	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37310	10.1371/journal.pone.0037310	http://dx.doi.org/10.1371/journal.pone.0037310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624012	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343500095
J	Holt, LJ; Turner, N; Mokbel, N; Trefely, S; Kanzleiter, T; Kaplan, W; Ormandy, CJ; Daly, RJ; Cooney, GJ				Holt, Lowenna J.; Turner, Nigel; Mokbel, Nancy; Trefely, Sophie; Kanzleiter, Timo; Kaplan, Warren; Ormandy, Christopher J.; Daly, Roger J.; Cooney, Gregory J.			Grb10 regulates the development of fiber number in skeletal muscle	FASEB JOURNAL			English	Article						metabolism; signal transduction; growth factors; proliferation; aging	GROWTH-FACTOR-I; INSULIN-RECEPTOR; TRANSGENIC MICE; SH2 DOMAIN; MOUSE; EXPRESSION; GENE; HYPERTROPHY; DYSFUNCTION; DISRUPTION	Grb10 is an intracellular adaptor protein that acts as a negative regulator of insulin and insulin-like growth factor 1 (IGF1) receptors. Since global deletion of Grb10 in mice causes hypermuscularity, we have characterized the skeletal muscle physiology underlying this phenotype. Compared to wild-type (WT) controls, adult mice deficient in Grb10 have elevated body mass and muscle mass throughout adulthood, up to 12 mo of age. The muscle enlargement is not due to increased myofiber size, but rather an increase in myofiber number (142% of WT, P<0.01). There is no change in myofiber type proportions between WT and Grb 10-deficient muscles, nor are the metabolic properties of the muscles altered on Grb10 deletion. Notably, the weight and cross-sectional area of hindlimbs from neonatal mice are increased in Grb10-deficient animals (198 and 137% of WT, respectively, both P<0.001). Functional gene signatures for myogenic signaling and proliferation are up-regulated in Grb10-deficient neonatal muscle. Our findings indicate that Grb10 plays a previously unrecognized role in regulating the development of fiber number during murine embryonic growth. In addition, Grb10-ablated muscle from adult mice shows coordinate gene changes that oppose those of muscle wasting pathologies, highlighting Grb10 as a potential therapeutic target for these conditions.-Holt, L. J., Turner, N., Mokbel, N., Trefely, S., Kanzleiter, T., Kaplan, W., Ormandy, C. J., Daly, R. J., Cooney, G. J. Grb10 regulates the development of fiber number in skeletal muscle. FASEB J. 26, 3658-3669 (2012). www.fasebj.org	[Holt, Lowenna J.; Turner, Nigel; Mokbel, Nancy; Trefely, Sophie; Kanzleiter, Timo; Cooney, Gregory J.] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW 2010, Australia; [Kaplan, Warren] Garvan Inst Med Res, Peter Wills Bioinformat Ctr, Sydney, NSW 2010, Australia; [Ormandy, Christopher J.; Daly, Roger J.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW 2010, Australia; [Turner, Nigel; Ormandy, Christopher J.; Daly, Roger J.; Cooney, Gregory J.] Univ New S Wales, St Vincents Hosp Clin Sch, Sydney, NSW, Australia	Garvan Institute of Medical Research; Garvan Institute of Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney	Holt, LJ (corresponding author), Garvan Inst Med Res, Diabet & Obes Res Program, 384 Victoria St, Sydney, NSW 2010, Australia.	l.holt@garvan.org.au	Trefely, Sophie/AAL-9434-2020; Turner, Nigel/H-7176-2013; Ormandy, Chris/G-4165-2014	Turner, Nigel/0000-0002-0119-9328; Daly, Roger/0000-0002-5739-8027; Trefely, Sophie/0000-0003-3816-6869; Ormandy, Christopher/0000-0002-2504-7919; Holt, Lowenna/0000-0002-4703-9696	U.S. National Institute for Child Health and Human Development; National Health and Medical Research Council (NHMRC) of Australia [481335]	U.S. National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors are grateful to William E. Hughes, Katarina Mele, and James G. Burchfield at the Garvan Institute of Medical Research for helpful discussions regarding the analysis of myofiber morphometry, and Alice Boulghourjian for assistance with H&E stains for histology. The monoclonal antibodies to MyHC-2A (SC-71) and MyHC-2B (BF-F3), developed by S. Schiaffino, were obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the U.S. National Institute for Child Health and Human Development and maintained by The University of Iowa, Department of Biology (Iowa City, IA, USA). The authors thank Kim Moran-Jones and Tristan J. Iseli at the Garvan Institute for critical reading of the manuscript. The authors also thank the Biological Testing Facility at the Garvan Institute for assistance with animal care. This work was supported by funding from the National Health and Medical Research Council (NHMRC) of Australia (481335). N.T. is supported by a career development award, and C.J.O., G. J. C., and R. J. D. are supported by research fellowships, from the NHMRC of Australia. The authors declare no conflicts of interest.	Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Callahan Leigh Ann, 2009, Crit Care Med, V37, pS354, DOI 10.1097/CCM.0b013e3181b6e439; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; Dougnac A, 2001, REV MED CHILE, V129, P347; Elashry MI, 2009, REJUV RES, V12, P269, DOI 10.1089/rej.2009.0870; Engert JC, 1996, J CELL BIOL, V135, P431, DOI 10.1083/jcb.135.2.431; Evans W, 1997, J NUTR, V127, pS998; Gnocchi VF, 2008, BIOCHEM SOC T, V36, P1344, DOI 10.1042/BST0361344; GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P312, DOI 10.1152/jappl.1972.33.3.312; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; Hansen H, 1996, J BIOL CHEM, V271, P8882, DOI 10.1074/jbc.271.15.8882; He WM, 1998, J BIOL CHEM, V273, P6860, DOI 10.1074/jbc.273.12.6860; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Holt LJ, 2009, MOL ENDOCRINOL, V23, P1406, DOI 10.1210/me.2008-0386; JAMES DE, 1985, AM J PHYSIOL, V248, pE567, DOI 10.1152/ajpendo.1985.248.5.E567; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Kusminski CM, 2009, APOPTOSIS, V14, P1484, DOI 10.1007/s10495-009-0352-8; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Laviola L, 1997, J CLIN INVEST, V99, P830, DOI 10.1172/JCI119246; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lindstedt SL, 2001, J EXP BIOL, V204, P3195; LIU F, 1995, P NATL ACAD SCI USA, V92, P10287, DOI 10.1073/pnas.92.22.10287; Liu Qi, 2009, Yichuan, V31, P732, DOI 10.3724/SP.J.1005.2009.00732; Liu X, 2003, DOMEST ANIM ENDOCRIN, V25, P215, DOI 10.1016/S0739-7240(03)00061-4; MacArthur DG, 2008, HUM MOL GENET, V17, P1076, DOI 10.1093/hmg/ddm380; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Morrione A, 1997, J BIOL CHEM, V272, P26382, DOI 10.1074/jbc.272.42.26382; Morrione A, 1996, CANCER RES, V56, P3165; Moutoussamy S, 1998, J BIOL CHEM, V273, P15906, DOI 10.1074/jbc.273.26.15906; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; ONeill TJ, 1996, J BIOL CHEM, V271, P22506, DOI 10.1074/jbc.271.37.22506; ONTELL M, 1984, AM J ANAT, V171, P149, DOI 10.1002/aja.1001710203; Ruegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Shaw CS, 2010, ANNU REV NUTR, V30, P13, DOI 10.1146/annurev.nutr.012809.104817; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Velleman SG, 2007, POULTRY SCI, V86, P1050, DOI 10.1093/ps/86.5.1050; Wang J, 1999, MOL CELL BIOL, V19, P6217; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Wells GD, 2008, CAN J NEUROL SCI, V35, P31, DOI 10.1017/S0317167100007538	46	27	27	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2012	26	9					3658	3669		10.1096/fj.11-199349	http://dx.doi.org/10.1096/fj.11-199349			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22623587				2022-12-25	WOS:000308391600008
J	Riad, A; Schwabedissen, HMZ; Weitmann, K; Herda, LR; Dorr, M; Empen, K; Kieback, A; Hummel, A; Reinthaler, M; Grube, M; Klingel, K; Nauck, M; Kandolf, R; Hoffmann, W; Kroemer, HK; Felix, SB				Riad, Alexander; Schwabedissen, Henriette Meyer Zu; Weitmann, Kerstin; Herda, Lars R.; Doerr, Marcus; Empen, Klaus; Kieback, Arne; Hummel, Astrid; Reinthaler, Marcus; Grube, Marcus; Klingel, Karin; Nauck, Matthias; Kandolf, Reinhard; Hoffmann, Wolfgang; Kroemer, Heyo K.; Felix, Stephan B.			Variants of Toll-like Receptor 4 Predict Cardiac Recovery in Patients with Dilated Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; TASK-FORCE; HEART-FAILURE; IMMUNOADSORPTION; MYOCARDITIS; TOLL-LIKE-RECEPTOR-4; ASSOCIATION; CARDIOLOGY; MICE; CLASSIFICATION	The clinical course of patients with dilated cardiomyopathy (DCM) varies from cardiac recovery to end stage heart failure. The etiology of this variability is largely unknown. In this study, we investigated the impact of coding polymorphisms of the innate immune protein Toll-like receptor 4 (TLR4) on left ventricular performance in patients with DCM. Two variants of TLR4 (rs4986790, TLR4 c.1187A -> G, p.299D -> G and rs4986791, TLR4c.1487C -> T, p.T399I) were investigated in 158 patients with DCM. Other reasons for heart failure were excluded by coronary angiography, myocardial biopsy, and echocardiography. Risk factors, age, gender, or treatment did not differ among the groups. At the follow-up evaluation (median 4.0-5.4 months), patients carrying the TLR4 wild type gene displayed cardiac recovery under intense medical heart failure therapy indexed by reduced left ventricular dilation, improved left ventricular ejection fraction, and reduced NT-probrain natriuretic peptide blood level when compared with the initial evaluation. In contrast, patients carrying both the rs4986790 and the rs4986791 variant showed significantly reduced improvement of left ventricular ejection fraction (p = 0.006) and left ventricular dilation (p = 0.015) at the follow-up evaluation when compared with carriers of the wild type gene under the same treatment conditions. In addition, NT-probrain natriuretic peptide level in carriers of both TLR4 variants did not change significantly at the follow up when compared with the first evaluation. Among patients with DCM, the presence of the TLR4 variants rs4986790 and rs4986791 predicts impaired cardiac recovery independently of medical treatment or cardiac risk factors.	[Riad, Alexander; Herda, Lars R.; Doerr, Marcus; Empen, Klaus; Kieback, Arne; Hummel, Astrid; Reinthaler, Marcus; Felix, Stephan B.] Univ Med Greifswald, Dept Cardiol & Pulmonol, D-17475 Greifswald, Germany; [Schwabedissen, Henriette Meyer Zu; Grube, Marcus; Kroemer, Heyo K.] Univ Med Greifswald, Dept Clin Pharmacol, D-17489 Greifswald, Germany; [Weitmann, Kerstin; Hoffmann, Wolfgang] Univ Med Greifswald, Dept Community Med, D-17487 Greifswald, Germany; [Nauck, Matthias] Univ Med Greifswald, Dept Lab Med, D-17487 Greifswald, Germany; [Klingel, Karin; Kandolf, Reinhard] Univ Tubingen, Inst Pathol & Neuropathol, Dept Mol Pathol, D-72076 Tubingen, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Riad, A (corresponding author), Univ Med Greifswald, Dept Cardiol & Pulmonol, D-17475 Greifswald, Germany.	alexander.riad@uni-greifswald.de	Dörr, Marcus/F-1919-2010	Dörr, Marcus/0000-0001-7471-475X; Meyer zu Schwabedissen, Henriette/0000-0003-0458-4579	Transregional Collaborative Research Centre of the German Research Foundation [SFB-TR-19]; Deutsche Herzstiftung [F/01/10]; German Centre of Cardiovascular Research from the German Ministry of Education and Science	Transregional Collaborative Research Centre of the German Research Foundation; Deutsche Herzstiftung; German Centre of Cardiovascular Research from the German Ministry of Education and Science	This work was supported by Transregional Collaborative Research Centre of the German Research Foundation Grant SFB-TR-19, Deutsche Herzstiftung Grant F/01/10, and the German Centre of Cardiovascular Research from the German Ministry of Education and Science.	Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; Boekholdt SM, 2003, CIRCULATION, V107, P2416, DOI 10.1161/01.CIR.0000068311.40161.28; Cheitlin MD, 1997, CIRCULATION, V95, P1686; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; De Gennaro L, 2008, HEART VESSELS, V23, P445, DOI 10.1007/s00380-008-1075-4; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Erridge C, 2003, J EXP MED, V197, P1787, DOI 10.1084/jem.20022078; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Garantziotis S, 2008, ANNU REV MED, V59, P343, DOI 10.1146/annurev.med.59.061206.112455; Herda LR, 2010, AM HEART J, V159, P809, DOI 10.1016/j.ahj.2010.01.012; Herda LR, 2009, ATHEROSCLEROSIS SUPP, V10, P126, DOI 10.1016/S1567-5688(09)71826-4; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kim Se-Chan, 2007, BMC Physiology, V7, P5, DOI 10.1186/1472-6793-7-5; Kindermann I, 2008, CIRCULATION, V118, P639, DOI 10.1161/CIRCULATIONAHA.108.769489; Lorenz E, 2001, BIOTECHNIQUES, V31, P22, DOI 10.2144/01311bm01; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; McNamara DM, 2011, J AM COLL CARDIOL, V58, P1112, DOI 10.1016/j.jacc.2011.05.033; Methe H, 2005, CIRCULATION, V111, P2654, DOI 10.1161/CIRCULATIONAHA.104.498865; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Riad A, 2008, J IMMUNOL, V180, P6954, DOI 10.4049/jimmunol.180.10.6954; Riad A, 2008, EUR J HEART FAIL, V10, P233, DOI 10.1016/j.ejheart.2008.01.004; Riad A, 2011, J IMMUNOL, V186, P2561, DOI 10.4049/jimmunol.1002029; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Sheppard R, 2005, J AM COLL CARDIOL, V46, P1036, DOI 10.1016/j.jacc.2005.05.067; Shimamoto A, 2006, CIRCULATION, V114, pI270, DOI 10.1161/CIRCULATIONAHA.105.000901; Stapel H, 2006, EUR J HEART FAIL, V8, P665, DOI 10.1016/j.ejheart.2006.03.005; Staudt A, 2006, THER APHER DIAL, V10, P42, DOI 10.1111/j.1744-9987.2006.00343.x; Staudt A, 2001, CIRCULATION, V103, P2681; Yilmaz A, 2010, CIRCULATION, V122, P900, DOI 10.1161/CIRCULATIONAHA.109.924167	34	20	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27236	27243		10.1074/jbc.M112.369728	http://dx.doi.org/10.1074/jbc.M112.369728			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22645142	hybrid, Green Published			2022-12-25	WOS:000307386000075
J	Muhle-Goll, C; Hoffmann, S; Afonin, S; Grage, SL; Polyansky, AA; Windisch, D; Zeitler, M; Burck, J; Ulrich, AS				Muhle-Goll, Claudia; Hoffmann, Silke; Afonin, Sergii; Grage, Stephan L.; Polyansky, Anton A.; Windisch, Dirk; Zeitler, Marcel; Buerck, Jochen; Ulrich, Anne S.			Hydrophobic Matching Controls the Tilt and Stability of the Dimeric Platelet-derived Growth Factor Receptor (PDGFR) beta Transmembrane Segment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; TYROSINE KINASE; CIRCULAR-DICHROISM; EGF RECEPTOR; SPATIAL STRUCTURE; DOMAIN; MEMBRANE; HELIX; ACTIVATION; ORIENTATION	The platelet-derived growth factor receptor beta is a member of the cell surface receptor tyrosine kinase family and dimerizes upon activation. We determined the structure of the transmembrane segment in dodecylphosphocholine micelles by liquid-state NMR and found that it forms a stable left-handed helical dimer. Solid-state NMR and oriented circular dichroism were used to measure the tilt angle of the helical segments in macroscopically aligned model membranes with different acyl chain lengths. Both methods showed that decreasing bilayer thickness (DEPC-POPC-DMPC) led to an increase in the helix tilt angle from 10 to 30 with respect to the bilayer normal. At the same time, reconstitution of the comparatively long hydrophobic segment became less effective, eventually resulting in complete protein aggregation in the short-chain lipid DLPC. Unrestrained molecular dynamics simulations of the dimer were carried out in explicit lipid bilayers (DEPC, POPC, DMPC, sphingomyelin), confirming the observed dependence of the helix tilt angle on bilayer thickness. Notably, molecular dynamics revealed that the left-handed dimer gets tilted en bloc, whereas conformational transitions to alternative (e. g. right-handed dimeric) states were not supported. The experimental data along with the simulation results demonstrate a pronounced interplay between the platelet-directed growth factor receptor beta transmembrane segment and the bilayer thickness. The effect of hydrophobic mismatch might play a key role in the redistribution and activation of the receptor within different lipid microdomains of the plasma membrane in vivo.	[Muhle-Goll, Claudia; Hoffmann, Silke; Zeitler, Marcel; Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Organ Chem, D-76131 Karlsruhe, Germany; [Muhle-Goll, Claudia; Hoffmann, Silke; Zeitler, Marcel; Ulrich, Anne S.] Karlsruhe Inst Technol, DFG Ctr Funct Nanostruct, D-76131 Karlsruhe, Germany; [Muhle-Goll, Claudia; Afonin, Sergii; Grage, Stephan L.; Windisch, Dirk; Buerck, Jochen; Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Biol Interfaces IBG 2, D-76021 Karlsruhe, Germany; [Polyansky, Anton A.] Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, AT-1030 Vienna, Austria; [Polyansky, Anton A.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia	Helmholtz Association; Karlsruhe Institute of Technology; German Research Foundation (DFG); Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Vienna; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Ulrich, AS (corresponding author), Karlsruhe Inst Technol, Inst Organ Chem, Fritz Haber Weg 6, D-76131 Karlsruhe, Germany.	anne.ulrich@kit.edu	Ulrich, Anne S/H-5519-2013; Afonin, Sergii/T-2737-2019; Muhle-Goll, Claudia/AAM-6070-2021; Polyansky, Anton A/J-2145-2018	Ulrich, Anne S/0000-0001-5571-9483; Afonin, Sergii/0000-0002-2356-4226; Polyansky, Anton A/0000-0002-1011-2706	European Union [026145]; Russian Ministry of Science and Education [MK-8439.2010.4]; Austrian Science Fund FWF START [Y 514-B11]	European Union(European Commission); Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation); Austrian Science Fund FWF START(Austrian Science Fund (FWF))	High-field NOESY spectra were recorded at the Frankfurt Facility for Biomolecular NMR, which is funded by the European Union Project "EU-NMR-European Network of Research Infrastructures for Providing Access and Technological Advancement in Bio-NMR" FP-2005-RII3 Contract 026145. The modeling part of the study was supported by Russian Ministry of Science and Education Grant MK-8439.2010.4 and Austrian Science Fund FWF START Grant Y 514-B11.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Artemenko EO, 2008, BBA-BIOMEMBRANES, V1778, P2361, DOI 10.1016/j.bbamem.2008.06.003; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Bocharov EV, 2008, J BIOL CHEM, V283, P29385, DOI 10.1074/jbc.M803089200; Bocharov EV, 2008, J BIOL CHEM, V283, P6950, DOI 10.1074/jbc.M709202200; Bocharov EV, 2010, BIOPHYS J, V98, P881, DOI 10.1016/j.bpj.2009.11.008; Clayton AHA, 2000, BBA-BIOMEMBRANES, V1467, P124, DOI 10.1016/S0005-2736(00)00208-X; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Fernandes F, 2003, BIOPHYS J, V85, P2430, DOI 10.1016/S0006-3495(03)74666-9; He LJ, 2011, BBA-BIOMEMBRANES, V1808, P253, DOI 10.1016/j.bbamem.2010.08.007; Isozaki K, 2006, CURR GENOMICS, V7, P469, DOI 10.2174/138920206779315755; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Kim T, 2010, BIOPHYS J, V99, P175, DOI 10.1016/j.bpj.2010.04.015; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; LEWIS BA, 1983, J MOL BIOL, V166, P203, DOI 10.1016/S0022-2836(83)80006-0; Lindner R, 2009, EXP CELL RES, V315, P2871, DOI 10.1016/j.yexcr.2009.07.020; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Mathai JC, 2008, J GEN PHYSIOL, V131, P69, DOI 10.1085/jgp.200709848; Matveev SV, 2002, AM J PHYSIOL-CELL PH, V282, pC935, DOI 10.1152/ajpcell.00349.2001; Mineev KS, 2011, BBA-BIOMEMBRANES, V1808, P2081, DOI 10.1016/j.bbamem.2011.04.017; Mineev KS, 2010, J MOL BIOL, V400, P231, DOI 10.1016/j.jmb.2010.05.016; Monticelli L, 2010, BIOPHYS J, V99, P1455, DOI 10.1016/j.bpj.2010.05.039; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Park SH, 2005, J MOL BIOL, V350, P310, DOI 10.1016/j.jmb.2005.05.004; Petti LM, 1998, ONCOGENE, V16, P843, DOI 10.1038/sj.onc.1201590; Petti LM, 1997, J VIROL, V71, P7318, DOI 10.1128/JVI.71.10.7318-7327.1997; Pietras K, 2003, CANCER CELL, V3, P439, DOI 10.1016/S1535-6108(03)00089-8; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P10315, DOI 10.1021/bi025943i; Polyansky AA, 2011, ADV PROTEIN CHEM STR, V83, P129, DOI 10.1016/B978-0-12-381262-9.00004-5; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Shim AHR, 2010, P NATL ACAD SCI USA, V107, P11307, DOI 10.1073/pnas.1000806107; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Smeijers AF, 2006, J PHYS CHEM B, V110, P13614, DOI 10.1021/jp062012y; Strandberg E, 2009, BIOPHYS J, V96, P3223, DOI 10.1016/j.bpj.2009.02.040; Tertoolen LGJ, 2001, BMC CELL BIOL, V2, part. no., DOI 10.1186/1471-2121-2-8; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; VOGEL H, 1987, BIOCHEMISTRY-US, V26, P4562, DOI 10.1021/bi00388a060; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Windisch D, 2010, BIOPHYS J, V99, P1764, DOI 10.1016/j.bpj.2010.06.073; Xu Q, 2008, BIOPHYS J, V95, P2849, DOI 10.1529/biophysj.108.133629; Yang Y, 2008, P NATL ACAD SCI USA, V105, P7681, DOI 10.1073/pnas.0802896105; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055	47	52	53	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26178	26186		10.1074/jbc.M111.325555	http://dx.doi.org/10.1074/jbc.M111.325555			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22619173	Green Published, hybrid			2022-12-25	WOS:000306916300045
J	Apgar, J; Ross, M; Zuo, X; Dohle, S; Sturtevant, D; Shen, BZ; de la Vega, H; Lessard, P; Lazar, G; Raab, RM				Apgar, James; Ross, Mary; Zuo, Xiao; Dohle, Sarah; Sturtevant, Derek; Shen, Binzhang; de la Vega, Humberto; Lessard, Philip; Lazar, Gabor; Raab, R. Michael			A Predictive Model of Intein Insertion Site for Use in the Engineering of Molecular Switches	PLOS ONE			English	Article							PROTEIN SPLICING MECHANISM; YEAST VMA1 PROTOZYME; DNAE INTEIN; AMINO-ACIDS; ENDONUCLEASE; PURIFICATION; INBASE; IDENTIFICATION; MUTAGENESIS; MODULATION	Inteins are intervening protein domains with self-splicing ability that can be used as molecular switches to control activity of their host protein. Successfully engineering an intein into a host protein requires identifying an insertion site that permits intein insertion and splicing while allowing for proper folding of the mature protein post-splicing. By analyzing sequence and structure based properties of native intein insertion sites we have identified four features that showed significant correlation with the location of the intein insertion sites, and therefore may be useful in predicting insertion sites in other proteins that provide native-like intein function. Three of these properties, the distance to the active site and dimer interface site, the SVM score of the splice site cassette, and the sequence conservation of the site showed statistically significant correlation and strong predictive power, with area under the curve (AUC) values of 0.79, 0.76, and 0.73 respectively, while the distance to secondary structure/loop junction showed significance but with less predictive power (AUC of 0.54). In a case study of 20 insertion sites in the XynB xylanase, two features of native insertion sites showed correlation with the splice sites and demonstrated predictive value in selecting non-native splice sites. Structural modeling of intein insertions at two sites highlighted the role that the insertion site location could play on the ability of the intein to modulate activity of the host protein. These findings can be used to enrich the selection of insertion sites capable of supporting intein splicing and hosting an intein switch.	[Apgar, James; Ross, Mary; Zuo, Xiao; Dohle, Sarah; Sturtevant, Derek; Shen, Binzhang; de la Vega, Humberto; Lessard, Philip; Lazar, Gabor; Raab, R. Michael] Agrivida Inc, Medford, MD USA		Apgar, J (corresponding author), Agrivida Inc, Medford, MD USA.	michael.raab@agrivida.com		Apgar, James/0000-0002-4669-0188				Adam E, 2002, J MOL MICROB BIOTECH, V4, P479; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amitai G, 2009, P NATL ACAD SCI USA, V106, P11005, DOI 10.1073/pnas.0904366106; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aroul-Selvam R, 2004, J MOL BIOL, V338, P633, DOI 10.1016/j.jmb.2004.03.039; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berrondo M, 2008, STRUCTURE, V16, P513, DOI 10.1016/j.str.2008.01.012; Chen LX, 2001, GENE, V263, P39, DOI 10.1016/S0378-1119(00)00568-0; Chong SR, 1998, J BIOL CHEM, V273, P10567, DOI 10.1074/jbc.273.17.10567; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Dalgaard JZ, 1997, NUCLEIC ACIDS RES, V25, P4626, DOI 10.1093/nar/25.22.4626; Evans TC, 1999, J BIOL CHEM, V274, P3923, DOI 10.1074/jbc.274.7.3923; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gangopadhyay JP, 2003, BBA-GEN SUBJECTS, V1619, P193, DOI 10.1016/S0304-4165(02)00495-6; Gray BN, 2011, PLANT BIOTECHNOL J, V9, P1100, DOI 10.1111/j.1467-7652.2011.00632.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Joachims T, 2002, METHODS THEORY ALGOR; Joachims T, 1999, LEARNING PRACTICAL A; Kawasaki M, 1997, J BIOL CHEM, V272, P15668, DOI 10.1074/jbc.272.25.15668; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Mathys S, 1999, GENE, V231, P1, DOI 10.1016/S0378-1119(99)00103-1; Mills KV, 2005, PROTEIN PEPTIDE LETT, V12, P751, DOI 10.2174/0929866054864337; Mootz HD, 2002, J AM CHEM SOC, V124, P9044, DOI 10.1021/ja026769o; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; Nogami S, 1997, GENETICS, V147, P73; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Pearl EJ, 2007, BBA-PROTEINS PROTEOM, V1774, P995, DOI 10.1016/j.bbapap.2007.05.015; Pearl EJ, 2007, FEBS LETT, V581, P3000, DOI 10.1016/j.febslet.2007.05.060; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Perler FB, 2000, NUCLEIC ACIDS RES, V28, P344, DOI 10.1093/nar/28.1.344; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Perler FB, 2005, NUCL ACID M, V16, P193; PERLER FB, 1992, P NATL ACAD SCI USA, V89, P5577, DOI 10.1073/pnas.89.12.5577; Perler FB, 1999, NUCLEIC ACIDS RES, V27, P346, DOI 10.1093/nar/27.1.346; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pietrokovski S, 2001, TRENDS GENET, V17, P465, DOI 10.1016/S0168-9525(01)02365-4; Poland BW, 2000, J BIOL CHEM, V275, P16408, DOI 10.1074/jbc.275.22.16408; Saleh L, 2006, CHEM REC, V6, P183, DOI 10.1002/tcr.20082; Saunders CT, 2002, J MOL BIOL, V322, P891, DOI 10.1016/S0022-2836(02)00813-6; Schwartz EC, 2003, CHEM COMMUN, P2087, DOI 10.1039/b304989m; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Skretas G, 2005, PROTEIN SCI, V14, P523, DOI 10.1110/ps.04996905; Southworth MW, 2000, EMBO J, V19, P5019, DOI 10.1093/emboj/19.18.5019; Southworth MW, 1999, BIOTECHNIQUES, V27, P110, DOI 10.2144/99271st04; Swithers KS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-303; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]; Wood DW, 2000, BIOTECHNOL PROGR, V16, P1055, DOI 10.1021/bp0000858; Yahara K, 2009, P NATL ACAD SCI USA, V106, P18861, DOI 10.1073/pnas.0908404106; Yuen CM, 2006, J AM CHEM SOC, V128, P8939, DOI 10.1021/ja062980e; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979	54	10	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37355	10.1371/journal.pone.0037355	http://dx.doi.org/10.1371/journal.pone.0037355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649521	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335800039
J	Dauksa, A; Gulbinas, A; Barauskas, G; Pundzius, J; Oldenburg, J; El-Maarri, O				Dauksa, Albertas; Gulbinas, Antanas; Barauskas, Giedrius; Pundzius, Juozas; Oldenburg, Johannes; El-Maarri, Osman			Whole Blood DNA Aberrant Methylation in Pancreatic Adenocarcinoma Shows Association with the Course of the Disease: A Pilot Study	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; IP-RP-HPLC; PROMOTER METHYLATION; BREAST-CANCER; COLORECTAL-CANCER; BLADDER-CANCER; GASTRIC-CANCER; LEUKOCYTE DNA; CPG SITES; GENE	Pancreatic tumors are usually diagnosed at an advanced stage in the progression of the disease, thus reducing the survival chances of the patients. Non-invasive early detection would greatly enhance therapy and survival rates. Toward this aim, we investigated in a pilot study the power of methylation changes in whole blood as predictive markers for the detection of pancreatic tumors. We investigated methylation levels at selected CpG sites in the CpG rich regions at the promoter regions of p16, RARbeta, TNFRSF10C, APC, ACIN1, DAPK1, 3OST2, BCL2 and CD44 in the blood of 30 pancreatic tumor patients and in the blood of 49 matching controls. In addition, we studied LINE-1 and Alu repeats using degenerate amplification approach as a surrogate marker for genome-wide methylation. The site-specific methylation measurements at selected CpG sites were done by the SIRPH method. Our results show that in the patient's blood, tumor suppressor genes were slightly but significantly higher methylated at several CpG sites, while repeats were slightly less methylated compared to control blood. This was found to be significantly associated with higher risk for pancreatic ductal adenocarcinoma. Additionally, high methylation levels at TNFRSCF10C were associated with positive perineural spread of tumor cells, while higher methylation levels of TNFRSF10C and ACIN1 were significantly associated with shorter survival. This pilot study shows that methylation changes in blood could provide a promising method for early detection of pancreatic tumors. However, larger studies must be carried out to explore the clinical usefulness of a whole blood methylation based test for non-invasive early detection of pancreatic tumors.	[Dauksa, Albertas; Gulbinas, Antanas] Lithuanian Univ Hlth Sci, Inst Digest Res, Kaunas, Lithuania; [Barauskas, Giedrius; Pundzius, Juozas] Lithuanian Univ Hlth Sci, Dept Surg, Kaunas, Lithuania; [Oldenburg, Johannes; El-Maarri, Osman] Univ Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; University of Bonn	Dauksa, A (corresponding author), Lithuanian Univ Hlth Sci, Inst Digest Res, Kaunas, Lithuania.	gulbanta@yahoo.com; osman.elmaarri@ukb.uni-bonn.de	Barauskas, Giedrius/N-1701-2019; Oldenburg, Johannes/ABB-7817-2020	barauskas, giedrius/0000-0002-4321-7280; Gulbinas, Antanas/0000-0002-6683-1339; El-Maarri, Osman/0000-0002-6859-5819; Oldenburg, Johannes/0000-0002-1585-4100				Ahrendt SA, 1999, JNCI-J NATL CANCER I, V91, P332, DOI 10.1093/jnci/91.4.332; Belinsky SA, 2002, CANCER RES, V62, P2370; Bernal C, 2008, CLIN CANCER RES, V14, P6264, DOI 10.1158/1078-0432.CCR-07-4522; Cheng Y, 2009, PROSTATE, V69, P327, DOI 10.1002/pros.20882; Cho NY, 2007, J PATHOL, V211, P269, DOI 10.1002/path.2106; Choi JY, 2009, CARCINOGENESIS, V30, P1889, DOI 10.1093/carcin/bgp143; Dammann R, 2005, HISTOL HISTOPATHOL, V20, P645, DOI 10.14670/HH-20.645; Deng GR, 2004, CANCER RES, V64, P2692, DOI 10.1158/0008-5472.CAN-03-3000; Ehrlich M, 2006, ONCOGENE, V25, P2636, DOI 10.1038/sj.onc.1209145; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; El-Maarri O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e25; El-Maarri Osman, 2004, Methods Mol Biol, V287, P195; Esteller M, 2001, CANCER RES, V61, P3225; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fleisher AS, 2001, ONCOGENE, V20, P329, DOI 10.1038/sj.onc.1204104; Frigola J, 2005, HUM MOL GENET, V14, P319, DOI 10.1093/hmg/ddi028; Fukushima N, 2003, BRIT J CANCER, V89, P338, DOI 10.1038/sj.bjc.6601039; Fukushima N, 2002, AM J PATHOL, V160, P1573, DOI 10.1016/S0002-9440(10)61104-2; Goessl C, 2001, ANN NY ACAD SCI, V945, P51; Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538; Hoebeeck J, 2009, CANCER LETT, V273, P336, DOI 10.1016/j.canlet.2008.08.019; Hou LF, 2010, INT J CANCER, V127, P1866, DOI 10.1002/ijc.25190; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Jahr S, 2001, CANCER RES, V61, P1659; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kanai Y, 2008, PATHOL INT, V58, P544, DOI 10.1111/j.1440-1827.2008.02270.x; Kito H, 2001, PROSTATE, V49, P110, DOI 10.1002/pros.1124; Lee HS, 2009, CLIN CANCER RES, V15, P812, DOI 10.1158/1078-0432.CCR-08-0266; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Lim U, 2008, GASTROENTEROLOGY, V134, P47, DOI 10.1053/j.gastro.2007.10.013; Machado JC, 2001, ONCOGENE, V20, P1525, DOI 10.1038/sj.onc.1204234; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; Mori T, 2005, J CLIN ONCOL, V23, P9351, DOI 10.1200/JCO.2005.02.9876; Muller HM, 2003, CANCER RES, V63, P7641; Muller HM, 2004, LANCET, V363, P1283, DOI 10.1016/S0140-6736(04)16002-9; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Ohka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023332; Pedersen KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018223; Peng DF, 2006, CARCINOGENESIS, V27, P1160, DOI 10.1093/carcin/bgi361; Riall TS, 2006, SURGERY, V140, P764, DOI 10.1016/j.surg.2006.04.006; Shivapurkar N, 2004, INT J CANCER, V109, P786, DOI 10.1002/ijc.20041; Shivapurkar N, 2007, CANCER LETT, V247, P56, DOI 10.1016/j.canlet.2006.03.020; Shu YJ, 2006, J THORAC ONCOL, V1, P160, DOI 10.1097/01243894-200602000-00010; Sobin L, 2002, TNM CLASSIFICATION M, P81; Suzuki M, 2006, CANCER LETT, V242, P222, DOI 10.1016/j.canlet.2005.11.002; Viet CT, 2008, CANCER EPIDEM BIOMAR, V17, P3603, DOI 10.1158/1055-9965.EPI-08-0507; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Widschwendter M, 2001, J MAMMARY GLAND BIOL, V6, P193, DOI 10.1023/A:1011360724350; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1078; Zhu ZZ, 2011, CANCER CAUSE CONTROL, V22, P437, DOI 10.1007/s10552-010-9715-2	52	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37509	10.1371/journal.pone.0037509	http://dx.doi.org/10.1371/journal.pone.0037509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629410	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345300047
J	Estrada-Pena, A; Estrada-Sanchez, A; Estrada-Sanchez, D				Estrada-Pena, Agustin; Estrada-Sanchez, Adrian; Estrada-Sanchez, David			Occurrence Patterns of Afrotropical Ticks (Acari: Ixodidae) in the Climate Space Are Not Correlated with Their Taxonomic Relationships	PLOS ONE			English	Article							COMPARATIVE PHYLOGEOGRAPHY; ENVIRONMENTAL NICHE; SPECIES RANGES; DISTRIBUTIONS; CONSERVATISM; BIODIVERSITY; DIVERSITY; EVOLUTION; AFRICA; MODELS	Foci of tick species occur at large spatial scales. They are intrinsically difficult to detect because the effect of geographical factors affecting conceptual influence of climate gradients. Here we use a large dataset of occurrences of ticks in the Afrotropical region to outline the main associations of those tick species with the climate space. Using a principal components reduction of monthly temperature and rainfall values over the Afrotropical region, we describe and compare the climate spaces of ticks in a gridded climate space. The dendrogram of distances among taxa according to occurrences in the climate niche is used to draw functional groups, or clusters of species with similar occurrences in the climate space, as different from morphologically derived (taxonomical) groups. We aim to further define the drivers of species richness and endemism at such a grid as well as niche similarities (climate space overlap) among species. Groups of species, as defined from morphological traits alone, are uncorrelated with functional clusters. Taxonomically related species occur separately in the climate gradients. Species belonging to the same functional group share more niche among them than with species in other functional groups. However, niche equivalency is also low for species within the same taxonomic cluster. Thus, taxa evolving from the same lineage tend to maximize the occupancy of the climate space and avoid overlaps with other species of the same taxonomic group. Richness values are drawn across the gradient of seasonal variation of temperature, higher values observed in a portion of the climate space with low thermal seasonality. Richness and endemism values are weakly correlated with mean values of temperature and rainfall. The most parsimonious explanation for the different taxonomic groups that exhibit common patterns of climate space subdivision is that they have a shared biogeographic history acting over a group of ancestrally co-distributed organisms.	[Estrada-Pena, Agustin; Estrada-Sanchez, Adrian; Estrada-Sanchez, David] Univ Zaragoza, Fac Vet Med, Dept Parasitol, Zaragoza, Spain	University of Zaragoza	Estrada-Pena, A (corresponding author), Univ Zaragoza, Fac Vet Med, Dept Parasitol, Zaragoza, Spain.	aestrada@unizar.es		Estrada Pena, Agustin/0000-0001-7483-046X	national science funds	national science funds	The study was funded by national science funds. The funder had no role in study desugn, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2010, MAPPING SPECIES DIST; Apanaskevich DA, 2007, ONDERSTEPOORT J VET, V74, P181; Arthur D.R., 1965, TICKS GENUS IXODES A, P348; Batjes N.H., 2005, 200508 ISRIC WORLD S; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; CRACRAFT J, 1994, AM ZOOL, V34, P33; Cumming GS, 1999, B ENTOMOL RES, V89, P303, DOI 10.1017/S0007485399000450; Cumming GS, 2002, ECOLOGY, V83, P255, DOI 10.1890/0012-9658(2002)083[0255:CCAVAL]2.0.CO;2; Cumming GS, 1998, B ENTOMOL RES, V88, P379, DOI 10.1017/S0007485300042139; Cumming GS, 2000, J BIOGEOGR, V27, P425, DOI 10.1046/j.1365-2699.2000.00419.x; Estrada-Pena A, 2008, MED VET ENTOMOL, V22, P248, DOI 10.1111/j.1365-2915.2008.00745.x; Estrada-Pena A, 2006, MED VET ENTOMOL, V20, P189, DOI 10.1111/j.1365-2915.2006.00622.x; Estrada-Pena A, 2003, ONDERSTEPOORT J VET, V70, P79; Estrada-Pena A, 2010, ENTOMOL EXP APPL, V137, P132, DOI 10.1111/j.1570-7458.2010.01050.x; Guglielmone AA, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2528.1.1; Haffer J, 1997, BIODIVERS CONSERV, V6, P451, DOI 10.1023/A:1018320925954; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoogstraal H., 1982, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V55, P5; MINSHULL JI, 1982, S AFR J WILDL RES, V12, P118; NORVAL RAI, 1994, EXP APPL ACAROL, V18, P383, DOI 10.1007/BF00051522; Olwoch JM, 2003, J BIOGEOGR, V30, P1221, DOI 10.1046/j.1365-2699.2003.00913.x; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Riddle BR, 1996, TRENDS ECOL EVOL, V11, P207, DOI 10.1016/0169-5347(96)10032-X; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Sullivan J, 2000, AM NAT, V155, P755, DOI 10.1086/303362; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P19715, DOI 10.1073/pnas.0902956106; Walker J. B., 2000, GENUS RHIPICEPHALUS; Walker J.B., 1974, IXODID TICKS KENYA R; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x	34	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36976	10.1371/journal.pone.0036976	http://dx.doi.org/10.1371/journal.pone.0036976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629349	Green Submitted, gold, Green Published			2022-12-25	WOS:000305345300018
J	Mukhopadhyay, J; Braig, HR; Rowton, ED; Ghosh, K				Mukhopadhyay, Jaba; Braig, Henk R.; Rowton, Edgar D.; Ghosh, Kashinath			Naturally Occurring Culturable Aerobic Gut Flora of Adult Phlebotomus papatasi, Vector of Leishmania major in the Old World	PLOS ONE			English	Article							GLASSY-WINGED SHARPSHOOTER; SP NOV.; BACILLUS-PUMILUS; VISCERAL LEISHMANIASIS; LUTZOMYIA-LONGIPALPIS; WASTE-WATER; GEN. NOV.; BACTERIA; DIPTERA; DIVERSITY	Background: Cutaneous leishmaniasis is a neglected, vector-borne parasitic disease and is responsible for persistent, often disfiguring lesions and other associated complications. Leishmania, causing zoonotic cutaneous leishmaniasis (ZCL) in the Old World are mainly transmitted by the predominant sand fly vector, Phlebotomus papatasi. To date, there is no efficient control measure or vaccine available for this widespread insect-borne infectious disease. Methodology/Principal Findings: A survey was carried out to study the abundance of different natural gut flora in P. papatasi, with the long-term goal of generating a paratransgenic sand fly that can potentially block the development of Leishmania in the sand fly gut, thereby preventing transmission of leishmania in endemic disease foci. Sand flies, in particular, P. papatasi were captured from different habitats of various parts of the world. Gut microbes were cultured and identified using 16S ribosomal DNA analysis and a phylogenetic tree was constructed. We found variation in the species and abundance of gut flora in flies collected from different habitats. However, a few Gram-positive, nonpathogenic bacteria including Bacillus flexus and B. pumilus were common in most of the sites examined. Conclusion/Significance: Our results indicate that there is a wide range of variation of aerobic gut flora inhabiting sand fly guts, which possibly reflect the ecological condition of the habitat where the fly breeds. Also, some species of bacteria (B. pumilus, and B. flexus) were found from most of the habitats. Important from an applied perspective of dissemination, our results support a link between oviposition induction and adult gut flora.	[Mukhopadhyay, Jaba; Rowton, Edgar D.; Ghosh, Kashinath] Walter Reed Army Inst Res, Div Entomol, Silver Spring, MD USA; [Ghosh, Kashinath] Walter Reed Army Inst Res, Div Expt Therapeut, Silver Spring, MD USA; [Braig, Henk R.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Bangor University	Mukhopadhyay, J (corresponding author), Walter Reed Army Inst Res, Div Entomol, Silver Spring, MD USA.	Kashinath.ghosh@us.army.mil	Braig, Henk/I-5477-2013	Braig, Henk/0000-0001-9592-1141	Department of Defense through the In-House Laboratory Independent Research program at the Walter Reed Army Institute of Research	Department of Defense through the In-House Laboratory Independent Research program at the Walter Reed Army Institute of Research	This study was funded by the Department of Defense through the In-House Laboratory Independent Research program at the Walter Reed Army Institute of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER S., 1929, ANN TROP MED & PARASITOL, V23, P1; Ahmed I, 2007, INT J SYST EVOL MICR, V57, P1117, DOI 10.1099/ijs.0.63867-0; Aksoy HM, 2008, J PLANT PATHOL, V90, P449; Aksoy S, 2008, ADV EXP MED BIOL, V627, P35, DOI 10.1007/978-0-387-78225-6_3; Alexander B, 2003, MED VET ENTOMOL, V17, P1, DOI 10.1046/j.1365-2915.2003.00420.x; An SY, 2007, INT J SYST EVOL MICR, V57, P51, DOI 10.1099/ijs.0.64340-0; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011; Behrendt U, 2002, INT J SYST EVOL MICR, V52, P1441, DOI 10.1099/00207713-52-5-1441; Ben-Dov E, 2006, APPL ENVIRON MICROB, V72, P6902, DOI 10.1128/AEM.00849-06; Benardini JN, 2003, ASTROBIOLOGY, V3, P709, DOI 10.1089/153110703322736033; Bextine B, 2004, CURR MICROBIOL, V48, P327, DOI 10.1007/s00284-003-4178-2; Bohme K, 2011, ELECTROPHORESIS, V32, P2951, DOI 10.1002/elps.201100217; Bottone EJ, 2003, J MED MICROBIOL, V52, P69, DOI 10.1099/jmm.0.04935-0; Butler JF, 2010, FLA ENTOMOL, V93, P218, DOI 10.1653/024.093.0211; Caspi-Fluger A, 2010, ISR J PLANT SCI, V58, P113, DOI 10.1560/IJPS.58.2.113; Chakraborty U, 2006, J BASIC MICROB, V46, P186, DOI 10.1002/jobm.200510050; Chandel S, 2010, J PHYTOPATHOL, V158, P470, DOI 10.1111/j.1439-0434.2009.01635.x; Chang EP, 2009, J MICROBIOL IMMUNOL, V42, P329; Chatterjee S, 2010, AFR J BIOTECHNOL, V9, P6983; Chelbi I, 2008, VECTOR-BORNE ZOONOT, V8, P741, DOI 10.1089/vbz.2007.0265; Cousin FJ, 2011, DAIRY SCI TECHNOL, V91, P1, DOI 10.1051/dst/2010032; Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002; Cutting SM, 2011, FOOD MICROBIOL, V28, P214, DOI 10.1016/j.fm.2010.03.007; Darriet F, 2002, J AM MOSQUITO CONTR, V18, P65; Davari B, 2010, IRAN J ARTHROPOD-BOR, V4, P50; de Oliveira Sandra Maria Pereira, 2000, Revista da Sociedade Brasileira de Medicina Tropical, V33, P319, DOI 10.1590/S0037-86822000000300012; deFreitas JR, 1997, BIOL FERT SOILS, V24, P358, DOI 10.1007/s003740050258; DeGheldre Y, 1997, J CLIN MICROBIOL, V35, P152, DOI 10.1128/JCM.35.1.152-160.1997; Depaquit J, 2010, EUROSURVEILLANCE, V15, P40; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DHIMAN RC, 1983, INDIAN J MED RES, V77, P29; Didelot X, 2009, SYST APPL MICROBIOL, V32, P81, DOI 10.1016/j.syapm.2009.01.001; Dillon RJ, 1996, ANN TROP MED PARASIT, V90, P669, DOI 10.1080/00034983.1996.11813102; Doha S, 1980, J EGYPT SOC PARASITO, V20, P747; Doughari HJ, 2011, MICROBES ENVIRON, V26, P101, DOI 10.1264/jsme2.ME10179; Erickson DL, 2009, J MED ENTOMOL, V46, P1532, DOI 10.1603/033.046.0642; Evans JD, 2005, J APICULT RES, V44, P168; Feldmann H, 2011, NEW ENGL J MED, V364, P1561, DOI 10.1056/NEJMe1102671; Feliciangeli MD, 2004, MED VET ENTOMOL, V18, P71, DOI 10.1111/j.0269-283X.2004.0487.x; Fieck A, 2010, EXP PARASITOL, V125, P342, DOI 10.1016/j.exppara.2010.02.016; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Ghosh K, 2003, ISR J AQUACULT-BAMID, V55, P13; Gneiding K, 2008, J CLIN MICROBIOL, V46, P3646, DOI 10.1128/JCM.01202-08; Gouveia C, 2008, NEOTROP ENTOMOL, V37, P597, DOI 10.1590/S1519-566X2008000500016; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Govindasamy V, 2010, MICROBIOL MONOGR, V18, P333, DOI 10.1007/978-3-642-13612-2_15; Guernaoui S, 2011, J VECTOR ECOL, V36, pS144, DOI 10.1111/j.1948-7134.2011.00124.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton JV, 2003, EMERG INFECT DIS, V9, P1355; Healy B, 2010, FOODBORNE PATHOG DIS, V7, P339, DOI 10.1089/fpd.2009.0379; Hillesland H, 2008, AM J TROP MED HYG, V79, P881, DOI 10.4269/ajtmh.2008.79.881; Hogg JC, 2001, PARASITOLOGY, V123, P441, DOI 10.1017/S0031182001008642; Husseneder Claudia, 2009, P361; Indiragandhi P, 2010, J KOREAN SOC APPL BI, V53, P605, DOI 10.3839/jksabc.2010.093; Jappe U, 2003, ACTA DERM-VENEREOL, V83, P241, DOI 10.1080/00015550310016463; Jhingran Anupam, 2008, P1; Kelley ST, 2011, GENETICA, V139, P541, DOI 10.1007/s10709-010-9498-0; Kempf MJ, 2005, ASTROBIOLOGY, V5, P391, DOI 10.1089/ast.2005.5.391; Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2; Killick-Kendrick R, 2002, WORLD CL PARASITES, V4, P33; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Kishore K, 2006, INDIAN J MED RES, V123, P467; Krishnamurthi S, 2009, INT J SYST EVOL MICR, V59, P1054, DOI 10.1099/ijs.0.65742-0; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Lane RP, 1993, MED INSECTS ARACHNID, P79; Lantova L, 2010, J INVERTEBR PATHOL, V105, P182, DOI 10.1016/j.jip.2010.07.001; Lewis D.J., 1978, BULLETIN OF THE BRITISH MUSEUM (NATURAL HISTORY) ENTOMOLOGY SUPPLEMENT, V37, P217; Lin C, 2010, J HAZARD MATER, V182, P771, DOI 10.1016/j.jhazmat.2010.06.101; Mandiki SNM, 2011, AQUAC RES, V42, P693, DOI 10.1111/j.1365-2109.2010.02744.x; Matsuura Y, 2009, ZOOL SCI, V26, P448, DOI 10.2108/zsj.26.448; Modi Govind B., 1999, P109; Molina CA, 2010, APPL ENVIRON MICROB, V76, P1320, DOI 10.1128/AEM.01624-09; Mondal S, 2010, EXPERT REV ANTI-INFE, V8, P919, DOI 10.1586/ERI.10.78; Morsy Tosson A., 1993, Journal of the Egyptian Society of Parasitology, V23, P109; Mramba F, 2007, J VECTOR ECOL, V32, P134, DOI 10.3376/1081-1710(2007)32[134:VCOSFS]2.0.CO;2; Muller GC, 2011, J VECTOR ECOL, V36, pS195, DOI 10.1111/j.1948-7134.2011.00131.x; Nada DV, 2010, ACTA VET-BEOGRAD, V60, P49, DOI 10.2298/AVB1001049D; Nadarasah G, 2011, FEMS MICROBIOL REV, V35, P555, DOI 10.1111/j.1574-6976.2011.00264.x; NAMITA M, 1991, INDIAN J MED RES-A, V93, P328; NARUSE N, 1990, J ANTIBIOT, V43, P267, DOI 10.7164/antibiotics.43.267; Otranto D, 2010, PARASITE VECTOR, V3, DOI [10.1186/1756-3305-3-77, 10.1186/1756-3305-3-2, 10.1186/1756-3305-3-26]; PANDYA AP, 1980, INDIAN J MED RES, V72, P355; Papa A, 2011, CLIN MICROBIOL INFEC, V17, P585, DOI 10.1111/j.1469-0691.2010.03371.x; Parvizi P, 2003, MED VET ENTOMOL, V17, P351, DOI 10.1111/j.1365-2915.2003.00451.x; Patil PB, 2010, FEMS MICROBIOL LETT, V312, P110, DOI 10.1111/j.1574-6968.2010.02104.x; Pavli A, 2010, INT J INFECT DIS, V14, pE1032, DOI 10.1016/j.ijid.2010.06.019; Perotti MA, 2011, J APPL ENTOMOL, V135, P514, DOI 10.1111/j.1439-0418.2011.01639.x; PICHINOTY F, 1984, ANN INST PASTEUR MIC, VB135, P21, DOI 10.1016/S0769-2609(84)80039-3; Pontes MH, 2011, APPL ENVIRON MICROB, V77, P1918, DOI 10.1128/AEM.02166-10; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raats D, 2007, INT J SYST EVOL MICR, V57, P255, DOI 10.1099/ijs.0.64502-0; Radjame K., 1997, Indian Journal of Experimental Biology, V35, P59; Ramirez JL, 2008, J ECON ENTOMOL, V101, P1519, DOI 10.1603/0022-0493(2008)101[1519:FOAGMB]2.0.CO;2; Ren XX, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000135; Reva ON, 2002, INT J SYST EVOL MICR, V52, P101, DOI 10.1099/00207713-52-1-101; REYSENBACH AL, 1994, APPL ENVIRON MICROB, V60, P2113, DOI 10.1128/AEM.60.6.2113-2119.1994; Ricci I, 2011, ANTON LEEUW INT J G, V99, P43, DOI 10.1007/s10482-010-9532-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rutledge LC, 2009, MED VET ENTOMOL, P147; Sanchez-Contreras M, 2008, BIOTECHNOL GENET ENG, V25, P203, DOI 10.5661/bger-25-203; Sanchez-Gonzalez M, 2011, LETT APPL MICROBIOL, V52, P413, DOI 10.1111/j.1472-765X.2011.03021.x; Sanders M E, 2003, Compr Rev Food Sci Food Saf, V2, P101, DOI 10.1111/j.1541-4337.2003.tb00017.x; SCHLEIN Y, 1994, AM J TROP MED HYG, V50, P20, DOI 10.4269/ajtmh.1994.50.1.TM0500010020; SCHLEIN Y, 1985, PARASITOLOGY, V90, P57, DOI 10.1017/S0031182000049015; Schmidt TR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-430; Seo JK, 2010, ASIAN AUSTRAL J ANIM, V23, P1657, DOI 10.5713/ajas.2010.r.08; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Singh R, 2008, ACTA TROP, V107, P117, DOI 10.1016/j.actatropica.2008.04.025; Singh RP, 2011, AQUAT BIOL, V12, P13, DOI 10.3354/ab00312; Sivagnaname N., 1997, Journal of Communicable Diseases, V29, P153; Subhadra B, 2010, J APPL MICROBIOL, V108, P831, DOI 10.1111/j.1365-2672.2009.04479.x; Sundar S, 2004, CLIN INFECT DIS, V38, P377, DOI 10.1086/380971; Swiecicka I, 2008, BIOCONTROL SCI TECHN, V18, P221, DOI 10.1080/09583150801942334; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarallo VD, 2010, ACTA TROP, V116, P227, DOI 10.1016/j.actatropica.2010.08.013; Tay BY, 2010, WORLD J MICROB BIOT, V26, P1015, DOI 10.1007/s11274-009-0264-3; Toledo AV, 2011, J INSECT SCI, V11, P1, DOI 10.1673/031.011.0129; Tozlu E, 2011, FRESEN ENVIRON BULL, V20, P918; Vasilev G.I., 1987, P208; Volf P, 2002, FOLIA PARASIT, V49, P73, DOI 10.14411/fp.2002.014; Votypka J, 2009, J EUKARYOT MICROBIOL, V56, P583, DOI 10.1111/j.1550-7408.2009.00438.x; Wasserberg G, 2011, J VECTOR ECOL, V36, pS138, DOI 10.1111/j.1948-7134.2011.00123.x; Weber DJ, 2007, ANTIMICROB AGENTS CH, V51, P4217, DOI 10.1128/AAC.00138-07; WHO, 2011, LEISHM; Whon TW, 2010, J MICROBIOL, V48, P862, DOI 10.1007/s12275-010-0214-7; Yamada T, 2009, MICROBES ENVIRON, V24, P205, DOI 10.1264/jsme2.ME09151S; Yildirim E, 2011, HORTSCIENCE, V46, P932, DOI 10.21273/HORTSCI.46.6.932; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhao CQ, 2010, J SOC LEATH TECH CH, V94, P21	131	41	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e35748	10.1371/journal.pone.0035748	http://dx.doi.org/10.1371/journal.pone.0035748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629302	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345300003
J	Ussher, JR; Folmes, CDL; Keung, W; Fillmore, N; Jaswal, JS; Cadete, VJ; Beker, DL; Lam, VH; Zhang, LY; Lopaschuk, GD				Ussher, John R.; Folmes, Clifford D. L.; Keung, Wendy; Fillmore, Natasha; Jaswal, Jagdip S.; Cadete, Virgilio J.; Beker, Donna L.; Lam, Victoria H.; Zhang, Liyan; Lopaschuk, Gary D.			Inhibition of Serine Palmitoyl Transferase I Reduces Cardiac Ceramide Levels and Increases Glycolysis Rates following Diet-Induced Insulin Resistance	PLOS ONE			English	Article							PROTEIN-KINASE-C; ACETYL-COA CARBOXYLASE; FATTY-ACID-METABOLISM; CONTRACTILE DYSFUNCTION; GLUCOSE-OXIDATION; CELL-DEATH; HEART; EFFICIENCY; OBESITY; MICE	Objective: Diet-induced obesity (DIO) leads to an accumulation of intra-myocardial lipid metabolites implicated in causing cardiac insulin resistance and contractile dysfunction. One such metabolite is ceramide, and our aim was to determine the effects of inhibiting de novo ceramide synthesis on cardiac function and insulin stimulated glucose utilization in mice subjected to DIO. Materials and Methods: C57BL/6 mice were fed a low fat diet or subjected to DIO for 12 weeks, and then treated for 4 weeks with either vehicle control or the serine palmitoyl transferase I (SPT I) inhibitor, myriocin. In vivo cardiac function was assessed via ultrasound echocardiography, while glucose metabolism was assessed in isolated working hearts. Results: DIO was not associated with an accumulation of intra-myocardial ceramide, but rather, an accumulation of intra-myocardial DAG (2.63 +/- 0.41 vs. 4.80 +/- 0.97 nmol/g dry weight). Nonetheless, treatment of DIO mice with myriocin decreased intra-myocardial ceramide levels (50.3 +/- 7.7 vs. 26.9 +/- 2.7 nmol/g dry weight) and prevented the DIO-associated increase in intra-myocardial DAG levels. Interestingly, although DIO impaired myocardial glycolysis rates (7789 +/- 1267 vs. 2671 +/- 326 nmol/min/g dry weight), hearts from myriocin treated DIO mice exhibited an increase in glycolysis rates. Conclusions: Our data reveal that although intra-myocardial ceramide does not accumulate following DIO, inhibition of de novo ceramide synthesis nonetheless reduces intra-myocardial ceramide levels and prevents the accumulation of intra-myocardial DAG. These effects improved the DIO-associated impairment of cardiac glycolysis rates, suggesting that SPT I inhibition increases cardiac glucose utilization.	[Ussher, John R.; Folmes, Clifford D. L.; Keung, Wendy; Fillmore, Natasha; Jaswal, Jagdip S.; Cadete, Virgilio J.; Beker, Donna L.; Lam, Victoria H.; Zhang, Liyan; Lopaschuk, Gary D.] Univ Alberta, Mazankowski Alberta Heart Inst, Cardiovasc Res Ctr, Edmonton, AB, Canada	University of Alberta	Ussher, JR (corresponding author), Univ Alberta, Mazankowski Alberta Heart Inst, Cardiovasc Res Ctr, Edmonton, AB, Canada.	gary.lopaschuk@ualberta.ca	Zhang, Li/GWM-7501-2022	Folmes, Clifford/0000-0002-3683-9970; Fillmore, Natasha/0000-0002-6723-0869; Keung, Wendy/0000-0002-6827-6754	Heart and Stroke Foundation of Alberta	Heart and Stroke Foundation of Alberta	This study was supported by a grant from the Heart and Stroke Foundation of Alberta to GDL. JRU is a trainee of the AHFMR and Tomorrow's Research Cardiovascular Health Professionals (TORCH). CDLF is a trainee of the AHFMR, the Canadian Institutes of Health Research and TORCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, 2006, DIABETOLOGIA, V49, P2174, DOI 10.1007/s00125-006-0338-9; Atkinson LL, 2003, AM J PHYSIOL-ENDOC M, V284, pE923, DOI 10.1152/ajpendo.00360.2002; Baranowski M, 2010, J LIPID RES, V51, P74, DOI 10.1194/jlr.M900002-JLR200; Bose R, 2000, METHOD ENZYMOL, V322, P373; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; CONSTANTINTEODOSIU D, 1991, ANAL BIOCHEM, V198, P347, DOI 10.1016/0003-2697(91)90437-X; DENNIS SC, 1991, J MOL CELL CARDIOL, V23, P1077, DOI 10.1016/0022-2828(91)91642-5; deVries JE, 1997, J LIPID RES, V38, P1384; Dyck JRB, 2006, CIRCULATION, V114, P1721, DOI 10.1161/CIRCULATIONAHA.106.642009; Farese RV, 2005, EXP BIOL MED, V230, P593; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Folmes CDL, 2006, CIRC RES, V99, P61, DOI 10.1161/01.RES.0000229656.05244.11; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Liu B, 1996, CIRC RES, V79, P940, DOI 10.1161/01.RES.79.5.940; Liu Q, 2002, J AM COLL CARDIOL, V39, P718, DOI 10.1016/S0735-1097(01)01803-4; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; OPIE LH, 1990, CARDIOVASC DRUG THER, V4, P777, DOI 10.1007/BF00051275; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Somoza B, 2007, ENDOCRINOLOGY, V148, P924, DOI 10.1210/en.2006-0914; Standaert ML, 2004, J BIOL CHEM, V279, P24929, DOI 10.1074/jbc.M402440200; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Sung MMY, 2011, J MOL MED, V89, P459, DOI 10.1007/s00109-010-0720-4; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Tessier JP, 2003, CARDIOVASC RES, V60, P119, DOI 10.1016/S0008-6363(03)00320-1; Ussher JR, 2008, CARDIOVASC RES, V79, P259, DOI 10.1093/cvr/cvn130; Ussher JR, 2012, CARDIOVASC RES, V94, P359, DOI 10.1093/cvr/cvs129; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Ussher JR, 2009, DIABETES, V58, P1766, DOI 10.2337/db09-0011; Ussher JR, 2009, AM J PHYSIOL-ENDOC M, V297, pE349, DOI 10.1152/ajpendo.00009.2009; Ussher JR, 2009, BASIC RES CARDIOL, V104, P203, DOI 10.1007/s00395-009-0003-9; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Young ME, 2002, DIABETES, V51, P2587, DOI 10.2337/diabetes.51.8.2587; Young ME, 2002, CIRCULATION, V105, P1861, DOI 10.1161/01.CIR.0000012467.61045.87; Zhang LY, 2011, CARDIOVASC RES, V89, P148, DOI 10.1093/cvr/cvq266	44	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37703	10.1371/journal.pone.0037703	http://dx.doi.org/10.1371/journal.pone.0037703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629445	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300069
J	Fiaschi, T; Giannoni, E; Taddei, ML; Chiarugi, P				Fiaschi, Tania; Giannoni, Elisa; Taddei, Maria Letizia; Chiarugi, Paola			Globular Adiponectin Activates Motility and Regenerative Traits of Muscle Satellite Cells	PLOS ONE			English	Article							FATTY-ACID OXIDATION; SKELETAL-MUSCLE; IN-VIVO; STEM-CELLS; DYSTROPHIN EXPRESSION; PROGENITOR CELLS; MIGRATION; DIFFERENTIATION; IDENTIFICATION; POPULATION	Regeneration of adult injured skeletal muscle is due to activation of satellite cells, a population of stem cells resident beneath the basal lamina. Thus, information on soluble factors affecting satellite cell activation, as well as migration towards injury and fusion into new myofibers are essential. Here, we show that globular adiponectin (gAd), positively affects several features of muscle satellite cells. gAd activates satellite cells to exit quiescence and increases their recruitment towards myotubes. gAd elicits in satellite cells a specific motility program, involving activation of the small GTPase Rac1, as well as expression of Snail and Twist transcription factors driving a proteolytic motility, useful to reach the site of injury. We show that satellite cells produce autocrine full length adiponectin (fAd), which is converted to gAd by activated macrophages. In turns, gAd concurs to attract to the site of injury both satellite cells and macrophages and induces myogenesis in muscle satellite cells. Thus, these findings add a further role for gAd in skeletal muscle, including the hormone among factors participating in muscle regeneration.	[Fiaschi, Tania; Giannoni, Elisa; Taddei, Maria Letizia; Chiarugi, Paola] Univ Florence, Dept Biochem Sci, Florence, Italy	University of Florence	Fiaschi, T (corresponding author), Univ Florence, Dept Biochem Sci, Florence, Italy.	paola.chiarugi@unifi.it	Chiarugi, Paola/CDD-7988-2022; Giannoni, Elisa/AAE-2092-2020	Giannoni, Elisa/0000-0001-7136-1098; Chiarugi, Paola/0000-0001-7655-2969	Association Francaise contre les Myopathies; Italian Association for Cancer Research; Tuscany Tumor Institute; Tuscany Project TUMAR	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Tuscany Tumor Institute; Tuscany Project TUMAR	This work was supported by Association Francaise contre les Myopathies, Italian Association for Cancer Research, The Tuscany Tumor Institute and the Tuscany Project TUMAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Bachrach E, 2004, P NATL ACAD SCI USA, V101, P3581, DOI 10.1073/pnas.0400373101; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Cantini M, 2002, NEUROL SCI, V23, P189, DOI 10.1007/s100720200060; Carmeli E, 2004, MUSCLE NERVE, V29, P191, DOI 10.1002/mus.10529; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Chiarugi P, 2010, EXPERT OPIN THER TAR, V14, P193, DOI 10.1517/14728220903530712; Cornelison DDW, 2000, DEV BIOL, V224, P122, DOI 10.1006/dbio.2000.9682; De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064; Delaigle AM, 2006, DIABETOLOGIA, V49, P1311, DOI 10.1007/s00125-006-0210-y; Delfini MC, 2009, DEV BIOL, V333, P229, DOI 10.1016/j.ydbio.2009.05.544; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; DiMascio L, 2007, J IMMUNOL, V178, P3511, DOI 10.4049/jimmunol.178.6.3511; El Fahime E, 2000, EXP CELL RES, V258, P279, DOI 10.1006/excr.2000.4962; Fiaschi T, 2007, HEPATOLOGY, V46, P130, DOI 10.1002/hep.21643; Fiaschi T, 2010, MOL BIOL CELL, V21, P848, DOI 10.1091/mbc.E09-04-0310; Fiaschi T, 2009, CELL RES, V19, P584, DOI 10.1038/cr.2009.39; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lescaudron L, 1999, NEUROMUSCULAR DISORD, V9, P72, DOI 10.1016/S0960-8966(98)00111-4; Lewis MP, 2000, J MUSCLE RES CELL M, V21, P223, DOI 10.1023/A:1005670507906; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Takino T, 2006, EXP CELL RES, V312, P1381, DOI 10.1016/j.yexcr.2006.01.008; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Wang W, 2009, AM J PATHOL, V174, P541, DOI 10.2353/ajpath.2009.080509; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zimowska M, 2008, INT J DEV BIOL, V52, P307, DOI 10.1387/ijdb.072331mz	40	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e34782	10.1371/journal.pone.0034782	http://dx.doi.org/10.1371/journal.pone.0034782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629295	Green Published, gold			2022-12-25	WOS:000305343500002
J	Meng, XM; Baylink, DJ; Sheng, M; Wang, HJ; Gridley, DS; Lau, KHW; Zhang, XB				Meng, Xianmei; Baylink, David J.; Sheng, Matilda; Wang, Hongjie; Gridley, Daila S.; Lau, K. -H. William; Zhang, Xiao-Bing			Erythroid Promoter Confines FGF2 Expression to the Marrow after Hematopoietic Stem Cell Gene Therapy and Leads to Enhanced Endosteal Bone Formation	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; EX-VIVO EXPANSION; OVARIECTOMIZED RATS; LENTIVIRAL VECTORS; OSTEOPENIC RATS; STROMAL CELLS; FACTOR BFGF; MICE; STRENGTH; MASS	Fibroblast growth factor-2 (FGF2) has been demonstrated to be a promising osteogenic factor for treating osteoporosis. Our earlier study shows that transplantation of mouse Sca-1(+) hematopoietic stem/progenitor cells that are engineered to express a modified FGF2 leads to considerable endosteal/trabecular bone formation, but it also induces adverse effects like hypocalemia and osteomalacia. Here we report that the use of an erythroid specific promoter, beta-globin, leads to a 5-fold decrease in the ratio of serum FGF2 to the FGF2 expression in the marrow cavity when compared to the use of a ubiquitous promoter spleen focus-forming virus (SFFV). The confined FGF2 expression promotes considerable trabeculae bone formation in endosteum and does not yield anemia and osteomalacia. The avoidance of anemia in the mice that received Sca1(+) cells transduced with FGF2 driven by the beta-globin promoter is likely due to attenuation of high-level serum FGF2-mediated stem cell mobilization observed in the SFFV-FGF2 animals. The prevention of osteomalacia is associated with substantially reduced serum Fgf23/hypophosphatemia, and less pronounced secondary hyperparathyroidism. Our improved stem cell gene therapy strategy represents one step closer to FGF2-based clinical therapy for systemic skeletal augmentation.	[Meng, Xianmei; Baylink, David J.; Sheng, Matilda; Zhang, Xiao-Bing] Loma Linda Univ, Dept Med, Div Regenerat Med, Loma Linda, CA 92350 USA; [Wang, Hongjie] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Gridley, Daila S.] Loma Linda Univ, Dept Radiat Med, Loma Linda, CA 92350 USA; [Lau, K. -H. William] Jerry L Pettis Mem Vet Adm Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA 92354 USA	Loma Linda University; University of Washington; University of Washington Seattle; Loma Linda University	Meng, XM (corresponding author), Loma Linda Univ, Dept Med, Div Regenerat Med, Loma Linda, CA 92350 USA.	xzhang@llu.edu	Gridley, Daila S/P-7711-2015	Lau, Kin-Hing/0000-0003-1109-5052	United States Army Medical Research Acquisition Activity (USAMRAA) [W81XWH-08-1-0697]; Loma Linda University GRASP Award; USAMRAA Concept Award [W81XWH-11-1-0607]; Radiation Research Laboratories in the Department of Radiation Medicine at Loma Linda University	United States Army Medical Research Acquisition Activity (USAMRAA); Loma Linda University GRASP Award; USAMRAA Concept Award; Radiation Research Laboratories in the Department of Radiation Medicine at Loma Linda University	This study was funded by United States Army Medical Research Acquisition Activity (USAMRAA) Grant W81XWH-08-1-0697 (DJB), Loma Linda University GRASP Award (XBZ), USAMRAA Concept Award W81XWH-11-1-0607 (XBZ), and Radiation Research Laboratories in the Department of Radiation Medicine at Loma Linda University (DSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Barde I, 2011, GENE THER, V18, P1087, DOI 10.1038/gt.2011.65; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Beyer I, 2011, MOL THER, V19, P479, DOI 10.1038/mt.2010.256; Bianchi G, 2003, EXP CELL RES, V287, P98, DOI 10.1016/S0014-4827(03)00138-1; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; CHADA K, 1985, NATURE, V314, P377, DOI 10.1038/314377a0; Chaffer CL, 2007, DIFFERENTIATION, V75, P831, DOI 10.1111/j.1432-0436.2007.00210.x; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Chen ST, 2007, J CELL BIOCHEM, V100, P1493, DOI 10.1002/jcb.21136; Choi KY, 2005, DEV DYNAM, V233, P115, DOI 10.1002/dvdy.20323; Menezes Filho Hamilton de, 2006, Arq Bras Endocrinol Metab, V50, P802, DOI 10.1590/S0004-27302006000400025; Hall SL, 2007, MOL THER, V15, P1881, DOI 10.1038/sj.mt.6300258; Hall SL, 2009, J GENE MED, V11, P877, DOI 10.1002/jgm.1369; Iwaniec UT, 2003, BONE, V33, P380, DOI 10.1016/S8756-3282(03)00118-2; Iwaniec UT, 2002, ENDOCRINOLOGY, V143, P2515, DOI 10.1210/en.143.7.2515; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Juppner H, 2010, J BONE MINER RES, V25, P2091, DOI 10.1002/jbmr.170; Lane NE, 2003, OSTEOPOROSIS INT, V14, P374, DOI 10.1007/s00198-003-1374-7; Lane NE, 2003, J BONE MINER RES, V18, P2105, DOI 10.1359/jbmr.2003.18.12.2105; Lewiecki EM, 2010, MATURITAS, V66, P182, DOI 10.1016/j.maturitas.2010.02.008; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; MAZUE G, 1992, TOXICOL LETT, V64-5, P329, DOI 10.1016/0378-4274(92)90205-X; Meng X, 2011, MOL THER; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; NAGAI H, 1995, BONE, V16, P367, DOI 10.1016/8756-3282(94)00049-2; Nakamura K, 1997, J ORTHOPAED RES, V15, P307, DOI 10.1002/jor.1100150222; NAKAMURA T, 1995, ENDOCRINOLOGY, V136, P1276, DOI 10.1210/en.136.3.1276; Nakayama T, 2007, BLOOD, V109, P1363, DOI 10.1182/blood-2006-06-028217; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; Pestina TI, 2009, MOL THER, V17, P245, DOI 10.1038/mt.2008.259; Power RA, 2002, BONE, V31, P143, DOI 10.1016/S8756-3282(02)00799-8; Santilli G, 2011, MOL THER, V19, P122, DOI 10.1038/mt.2010.226; Sheng MHC, 2002, BONE, V30, P486, DOI 10.1016/S8756-3282(01)00693-7; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Silver J, 2010, PEDIATR NEPHROL, V25, P2241, DOI 10.1007/s00467-010-1565-3; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Walsh S, 2000, BONE, V27, P185, DOI 10.1016/S8756-3282(00)00319-7; Wang HJ, 2005, J VIROL, V79, P10999, DOI 10.1128/JVI.79.17.10999-11013.2005; Wang JS, 1996, ACTA ORTHOP SCAND, V67, P1; Xiao LP, 2010, J BIOL CHEM, V285, P2834, DOI 10.1074/jbc.M109.030577; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; Yao W, 2005, OSTEOPOROSIS INT, V16, P1939, DOI 10.1007/s00198-005-1969-2; Zhang XB, 2007, STEM CELLS, V25, P2074, DOI 10.1634/stemcells.2006-0742	49	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37569	10.1371/journal.pone.0037569	http://dx.doi.org/10.1371/journal.pone.0037569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629419	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343500138
J	Murata, K; Kitaori, T; Oishi, S; Watanabe, N; Yoshitomi, H; Tanida, S; Ishikawa, M; Kasahara, T; Shibuya, H; Fujii, N; Nagasawa, T; Nakamura, T; Ito, H				Murata, Koichi; Kitaori, Toshiyuki; Oishi, Shinya; Watanabe, Naoki; Yoshitomi, Hiroyuki; Tanida, Shimei; Ishikawa, Masahiro; Kasahara, Takashi; Shibuya, Hideyuki; Fujii, Nobutaka; Nagasawa, Takashi; Nakamura, Takashi; Ito, Hiromu			Stromal Cell-Derived Factor 1 Regulates the Actin Organization of Chondrocytes and Chondrocyte Hypertrophy	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CHEMOKINE RECEPTOR CXCR4; BONE-MARROW; ENDOCHONDRAL OSSIFICATION; MYOCARDIAL-INFARCTION; MULTIPLE-MYELOMA; IN-VITRO; SDF-1; DIFFERENTIATION; MIGRATION	Stromal cell-derived factor 1 (SDF-1/CXCL12/PBSF) plays important roles in the biological and physiological functions of haematopoietic and mesenchymal stem cells. This chemokine regulates the formation of multiple organ systems during embryogenesis. However, its roles in skeletal development remain unclear. Here we investigated the roles of SDF-1 in chondrocyte differentiation. We demonstrated that SDF-1 protein was expressed at pre-hypertrophic and hypertrophic chondrocytes in the newly formed endochondral callus of rib fracture as well as in the growth plate of normal mouse tibia by immunohistochemical analysis. Using SDF-1(-/-) mouse embryo, we histologically showed that the total length of the whole humeri of SDF-1(-/-) mice was significantly shorter than that of wild- type mice, which was contributed mainly by shorter hypertrophic and calcified zones in SDF-1(-/-) mice. Actin cytoskeleton of hypertrophic chondrocytes in SDF-1(-/-) mouse humeri showed less F-actin and rounder shape than that of wild- type mice. Primary chondrocytes from SDF-1(-/-) mice showed the enhanced formation of philopodia and loss of F-actin. The administration of SDF-1 to primary chondrocytes of wild- type mice and SDF-1(-/-) mice promoted the formation of actin stress fibers. Organ culture of embryonic metatarsals from SDF-1(-/-) mice showed the growth delay, which was recovered by an exogenous administration of SDF-1. mRNA expression of type X collagen in metatarsals and in primary chondrocytes of SDF-1(-/-) mouse embryo was down-regulated while the administration of SDF-1 to metatarsals recovered. These data suggests that SDF-1 regulates the actin organization and stimulates bone growth by mediating chondrocyte hypertrophy.	[Murata, Koichi; Kitaori, Toshiyuki; Yoshitomi, Hiroyuki; Tanida, Shimei; Ishikawa, Masahiro; Kasahara, Takashi; Shibuya, Hideyuki; Nakamura, Takashi; Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto, Japan; [Oishi, Shinya; Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Chemogenom, Kyoto, Japan; [Watanabe, Naoki] Tohoku Univ, Grad Sch Life Sci, Lab Single Mol Cell Biol, Aoba Ku, Sendai, Miyagi 980, Japan; [Nagasawa, Takashi] Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Kyoto, Japan; [Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan	Kyoto University; Kyoto University; Tohoku University; Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto, Japan.	hiromu@kuhp.kyoto-u.ac.jp	Oishi, Shinya/C-1350-2011	Oishi, Shinya/0000-0002-2833-2539; Murata, Koichi/0000-0002-7896-3937; Nagasawa, Takashi/0000-0002-1085-0960	Ministry of Education of Japan [19591756, 21591942]; Grants-in-Aid for Scientific Research [22390096] Funding Source: KAKEN	Ministry of Education of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aids from the Ministry of Education of Japan (No. 19591756 and No. 21591942). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Alvarez J, 2002, DEVELOPMENT, V129, P1913; Avniel S, 2006, J INVEST DERMATOL, V126, P468, DOI 10.1038/sj.jid.5700069; Azab AK, 2009, BLOOD, V114, P619, DOI 10.1182/blood-2009-01-199281; Babarina AV, 2001, MATRIX BIOL, V20, P205, DOI 10.1016/S0945-053X(01)00132-9; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Fukai A, 2010, ARTHRITIS RHEUM-US, V62, P826, DOI 10.1002/art.27296; Grassi F, 2004, J CELL PHYSIOL, V199, P244, DOI 10.1002/jcp.10445; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Ito H, 1999, BIOCHEM BIOPH RES CO, V262, P443, DOI 10.1006/bbrc.1999.1197; Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Raz E, 2009, DEVELOPMENT, V136, P1223, DOI 10.1242/dev.022418; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stein CA, 2009, CLIN CANCER RES, V15, P2797, DOI 10.1158/1078-0432.CCR-08-2610; Sun YX, 2005, J BONE MINER RES, V20, P318, DOI 10.1359/JBMR.041109; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tamamura H, 2003, ORG BIOMOL CHEM, V1, P3663, DOI 10.1039/b306613b; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; van Buul JD, 2003, J BIOL CHEM, V278, P30302, DOI 10.1074/jbc.M304764200; Vicente-Manzanares M, 2002, J IMMUNOL, V168, P400, DOI 10.4049/jimmunol.168.1.400; Vicente-Manzanares Miguel, 2004, Methods Mol Biol, V239, P53; VONDERMARK K, 1977, J CELL BIOL, V73, P736, DOI 10.1083/jcb.73.3.736; Wang GY, 2004, J BIOL CHEM, V279, P13205, DOI 10.1074/jbc.M311427200; Watanabe N, 2010, P JPN ACAD B-PHYS, V86, P62, DOI 10.2183/pjab.86.62; Wei L, 2010, DEV BIOL, V341, P236, DOI 10.1016/j.ydbio.2010.02.033; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	50	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37163	10.1371/journal.pone.0037163	http://dx.doi.org/10.1371/journal.pone.0037163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623989	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500068
J	Younes, JA; van der Mei, HC; van den Heuvel, E; Busscher, HJ; Reid, G				Younes, Jessica A.; van der Mei, Henny C.; van den Heuvel, Edwin; Busscher, Henk J.; Reid, Gregor			Adhesion Forces and Coaggregation between Vaginal Staphylococci and Lactobacilli	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; BIOFILMS; MICROSCOPY; CELLS; SPECIFICITY	Urogenital infections are the most common ailments afflicting women. They are treated with dated antimicrobials whose efficacy is diminishing. The process of infection involves pathogen adhesion and displacement of indigenous Lactobacillus crispatus and Lactobacillus jensenii. An alternative therapeutic approach to antimicrobial therapy is to reestablish lactobacilli in this microbiome through probiotic administration. We hypothesized that lactobacilli displaying strong adhesion forces with pathogens would facilitate coaggregation between the two strains, ultimately explaining the elimination of pathogens seen in vivo. Using atomic force microscopy, we found that adhesion forces between lactobacilli and three virulent toxic shock syndrome toxin 1-producing Staphylococcus aureus strains, were significantly stronger (2.2-6.4 nN) than between staphylococcal pairs (2.2-3.4 nN), especially for the probiotic Lactobacillus reuteri RC-14 (4.0-6.4 nN) after 120 s of bond-strengthening. Moreover, stronger adhesion forces resulted in significantly larger coaggregates. Adhesion between the bacteria occurred instantly upon contact and matured within one to two minutes, demonstrating the potential for rapid anti-pathogen effects using a probiotic. Coaggregation is one of the recognized mechanisms through which lactobacilli can exert their probiotic effects to create a hostile micro-environment around a pathogen. With antimicrobial options fading, it therewith becomes increasingly important to identify lactobacilli that bind strongly with pathogens.	[Younes, Jessica A.; Reid, Gregor] Lawson Hlth Res Inst, London, ON, Canada; [Younes, Jessica A.; van der Mei, Henny C.; Busscher, Henk J.] Univ Med Ctr Groningen, Dept Biomed Engn, WJ Kolff Inst, NL-9713 AV Groningen, Netherlands; [Younes, Jessica A.; van der Mei, Henny C.; van den Heuvel, Edwin; Busscher, Henk J.] Univ Groningen, Groningen, Netherlands; [van den Heuvel, Edwin] Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 AV Groningen, Netherlands; [Reid, Gregor] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Reid, Gregor] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada	Western University (University of Western Ontario); University of Groningen; University of Groningen; University of Groningen; Western University (University of Western Ontario); Western University (University of Western Ontario)	Younes, JA (corresponding author), Lawson Hlth Res Inst, London, ON, Canada.	h.c.van.der.mei@umcg.nl	Busscher, Henk/AAU-2113-2020; Van den Heuvel, Edwin/C-5166-2013; Reid, Gregor/ABE-8327-2020	Busscher, Henk/0000-0002-3644-5533; Van den Heuvel, Edwin/0000-0001-9157-7224; Reid, Gregor/0000-0001-9658-5696	Lawson Health Research Institute, London, Ontario, Canada; University Medical Center, Groningen, The Netherlands	Lawson Health Research Institute, London, Ontario, Canada; University Medical Center, Groningen, The Netherlands(Netherlands Government)	This study was funded by the Lawson Health Research Institute, London, Ontario, Canada, and the University Medical Center, Groningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MIXED EFFECTS MODELS; [Anonymous], 2006, SAS MIXED MODELS; Bowen WR, 2001, J COLLOID INTERF SCI, V237, P54, DOI 10.1006/jcis.2001.7437; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Dague E, 2010, LANGMUIR, V26, P11010, DOI 10.1021/la101862n; Doan TLL, 2011, BIOPHYS J, V101, P2843, DOI 10.1016/j.bpj.2011.10.034; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Jones SE, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-35; Liu YT, 2006, BIOTECHNOL BIOENG, V93, P297, DOI 10.1002/bit.20675; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; MacPhee RA, 2010, EXPERT OPIN PHARMACO, V11, P2985, DOI 10.1517/14656566.2010.512004; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; McMillan A, 2011, COLLOID SURFACE B, V86, P58, DOI 10.1016/j.colsurfb.2011.03.016; Muller DJ, 2009, NAT CHEM BIOL, V5, P383, DOI 10.1038/nchembio.181; Muller DJ, 2009, CURR OPIN BIOTECH, V20, P4, DOI 10.1016/j.copbio.2009.02.005; Mumtaz Shamim, 2008, J Ayub Med Coll Abbottabad, V20, P113; Postollec F, 2006, J DENT RES, V85, P231, DOI 10.1177/154405910608500305; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; REID G, 1990, CURR MICROBIOL, V20, P47, DOI 10.1007/BF02094024; Reid G, 2011, NAT REV MICROBIOL, V9, P27, DOI 10.1038/nrmicro2473; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Saunders S, 2007, COLLOID SURFACE B, V55, P138, DOI 10.1016/j.colsurfb.2006.11.040; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Touhami A, 2006, J BACTERIOL, V188, P370, DOI 10.1128/JB.188.2.370-377.2006; van der Mei HC, 2010, COLLOID SURFACE B, V78, P372, DOI 10.1016/j.colsurfb.2010.03.018; Velraeds MMC, 1998, J MED MICROBIOL, V47, P1081, DOI 10.1099/00222615-47-12-1081; Waar K, 2005, MICROBIOL-SGM, V151, P2459, DOI 10.1099/mic.0.27877-0	29	78	84	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36917	10.1371/journal.pone.0036917	http://dx.doi.org/10.1371/journal.pone.0036917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629342	gold, Green Published			2022-12-25	WOS:000305343500038
J	Wang, QQ; Zhao, N; Kennard, S; Lilly, B				Wang, Qingqing; Zhao, Ning; Kennard, Simone; Lilly, Brenda			Notch2 and Notch3 Function Together to Regulate Vascular Smooth Muscle Development	PLOS ONE			English	Article							NOTCH3-DEFICIENT MICE; EXPRESSION; MUTATION; PATHWAY; CELLS; CADASIL; JAGGED1	Notch signaling has been implicated in the regulation of smooth muscle differentiation, but the precise role of Notch receptors is ill defined. Although Notch3 receptor expression is high in smooth muscle, Notch3 mutant mice are viable and display only mild defects in vascular patterning and smooth muscle differentiation. Notch2 is also expressed in smooth muscle and Notch2 mutant mice show cardiovascular abnormalities indicative of smooth muscle defects. Together, these findings infer that Notch2 and Notch3 act together to govern vascular development and smooth muscle differentiation. To address this hypothesis, we characterized the phenotype of mice with a combined deficiency in Notch2 and Notch3. Our results show that when Notch2 and Notch3 genes are simultaneously disrupted, mice die in utero at mid-gestation due to severe vascular abnormalities. Assembly of the vascular network occurs normally as assessed by Pecam1 expression, however smooth muscle cells surrounding the vessels are grossly deficient leading to vascular collapse. In vitro analysis show that both Notch2 and Notch3 robustly activate smooth muscle differentiation genes, and Notch3, but not Notch2 is a target of Notch signaling. These data highlight the combined actions of the Notch receptors in the regulation of vascular development, and suggest that while these receptors exhibit compensatory roles in smooth muscle, their functions are not entirely overlapping.	[Wang, Qingqing; Zhao, Ning; Lilly, Brenda] Nationwide Childrens Hosp, Ctr Cardiovasc & Pulm Res, Columbus, OH USA; [Zhao, Ning; Lilly, Brenda] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Kennard, Simone] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Georgia; Augusta University	Wang, QQ (corresponding author), Nationwide Childrens Hosp, Ctr Cardiovasc & Pulm Res, Columbus, OH USA.	brenda.lilly@nationwidechildrens.org	LILLY, BRENDA/N-6867-2015	LILLY, BRENDA/0000-0002-3125-7496; Kennard, Simone/0000-0002-7564-9192; Zhao, Ning/0000-0001-6514-234X	National Institutes of Health (NIH) [R01 HL076428]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076428] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grant R01 HL076428 to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; de Chantemele EJB, 2008, ARTERIOSCL THROM VAS, V28, P2216, DOI 10.1161/ATVBAHA.108.171751; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Gaengel K, 2009, ARTERIOSCLER THROMB; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Hamada Y, 1999, DEVELOPMENT, V126, P3415; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kitamoto T, 2005, BIOCHEM BIOPH RES CO, V331, P1154, DOI 10.1016/j.bbrc.2005.03.241; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; McCright B, 2001, DEVELOPMENT, V128, P491; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Siekmann AF, 2008, BIOESSAYS, V30, P303, DOI 10.1002/bies.20736; Varadkar P, 2008, DEV DYNAM, V237, P1144, DOI 10.1002/dvdy.21502	23	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37365	10.1371/journal.pone.0037365	http://dx.doi.org/10.1371/journal.pone.0037365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615991	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341200068
J	Alam, A; Haldar, S; Thulasiram, HV; Kumar, R; Goyal, M; Iqbal, MS; Pal, C; Dey, S; Bindu, S; Sarkar, S; Pal, U; Maiti, NC; Bandyopadhyay, U				Alam, Athar; Haldar, Saikat; Thulasiram, Hirekodathakallu V.; Kumar, Rahul; Goyal, Manish; Iqbal, Mohd Shameel; Pal, Chinmay; Dey, Sumanta; Bindu, Samik; Sarkar, Souvik; Pal, Uttam; Maiti, Nakul C.; Bandyopadhyay, Uday			Novel Anti-inflammatory Activity of Epoxyazadiradione against Macrophage Migration Inhibitory Factor INHIBITION OF TAUTOMERASE AND PROINFLAMMATORY ACTIVITIES OF MACROPHAGE MIGRATION INHIBITORY FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDICA BARK EXTRACT; TOLL-LIKE RECEPTOR-4; KAPPA-B ACTIVATION; FACTOR MIF; FUNCTIONAL-CHARACTERIZATION; PLASMODIUM-FALCIPARUM; THERAPEUTIC TARGET; OXIDATIVE STRESS; NITRIC-OXIDE; EXPRESSION	Macrophage migration inhibitory factor (MIF) is responsible for proinflammatory reactions in various infectious and noninfectious diseases. We have investigated the mechanism of anti-inflammatory activity of epoxyazadiradione, a limonoid purified from neem (Azadirachta indica) fruits, against MIF. Epoxyazadiradione inhibited the tautomerase activity of MIF of both human (huMIF) and malaria parasites (Plasmodium falciparum (PfMIF) and Plasmodium yoelii (PyMIF)) non-competitively in a reversible fashion (K-i, 2.11-5.23 mu M). Epoxyazadiradione also significantly inhibited MIF (huMIF, PyMIF, and PfMIF)-mediated proinflammatory activities in RAW 264.7 cells. It prevented MIF-induced macrophage chemotactic migration, NF-kappa B translocation to the nucleus, up-regulation of inducible nitric-oxide synthase, and nitric oxide production in RAW 264.7 cells. Epoxyazadiradione not only exhibited anti-inflammatory activity in vitro but also in vivo. We tested the anti-inflammatory activity of epoxyazadiradione in vivo after co-administering LPS and MIF in mice to mimic the disease state of sepsis or bacterial infection. Epoxyazadiradione prevented the release of proinflammatory cytokines such as IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha when LPS and PyMIF were co-administered to BALB/c mice. The molecular basis of interaction of epoxyazadiradione with MIFs was explored with the help of computational chemistry tools and a biological knowledge base. Docking simulation indicated that the binding was highly specific and allosteric in nature. The well known MIF inhibitor (S, R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1) inhibited huMIF but not MIF of parasitic origin. In contrast, epoxyazadiradione inhibited both huMIF and plasmodial MIF, thus bearing an immense therapeutic potential against proinflammatory reactions induced by MIF of both malaria parasites and human.	[Alam, Athar; Kumar, Rahul; Goyal, Manish; Iqbal, Mohd Shameel; Pal, Chinmay; Dey, Sumanta; Bindu, Samik; Sarkar, Souvik; Bandyopadhyay, Uday] Indian Inst Chem Biol, CSIR, Div Infect Dis & Immunol, Kolkata 700032, W Bengal, India; [Pal, Uttam; Maiti, Nakul C.] Indian Inst Chem Biol, CSIR, Dept Biol Struct, Kolkata 700032, W Bengal, India; [Pal, Uttam; Maiti, Nakul C.] Indian Inst Chem Biol, CSIR, Bioinformat Div, Kolkata 700032, W Bengal, India; [Haldar, Saikat; Thulasiram, Hirekodathakallu V.] CSIR Natl Chem Lab, Div Organ Chem, Chem Biol Unit, Pune 411008, Maharashtra, India; [Thulasiram, Hirekodathakallu V.] CSIR Inst Genom & Integrat Biol, New Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Bandyopadhyay, U (corresponding author), Indian Inst Chem Biol, CSIR, Div Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	ubandyo_1964@yahoo.com	Maiti, Nakul/GLR-3207-2022; Pal, Uttam/A-8544-2013; Goyal, Manish/O-2183-2015; Iqbal, Mohd Shameel/AAD-9641-2021; Alam, Athar/B-3642-2010	Maiti, Nakul/0000-0002-8498-6502; Pal, Uttam/0000-0003-2110-4610; Goyal, Manish/0000-0003-2383-5409; Iqbal, Mohd Shameel/0000-0002-0353-3561; /0000-0002-5945-976X; Bindu, Samik/0000-0003-1416-2003	Council of Scientific and Industrial Research, New Delhi; University Grants Commission, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi(University Grants Commission, India)	This work was supported by the Council of Scientific and Industrial Research, New Delhi and the University Grants Commission, New Delhi.	Akihisa T, 2009, J OLEO SCI, V58, P581, DOI 10.5650/jos.58.581; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Al-Abed Y, 2011, FUTURE MED CHEM, V3, P45, DOI 10.4155/FMC.10.281; Alam A, 2011, BIOORGAN MED CHEM, V19, P7365, DOI 10.1016/j.bmc.2011.10.056; Alam A, 2011, FREE RADICAL BIO MED, V50, P1659, DOI 10.1016/j.freeradbiomed.2011.03.012; Amin MA, 2006, BLOOD, V107, P2252, DOI 10.1182/blood-2005-05-2011; AROCA P, 1991, BIOCHEM J, V277, P393, DOI 10.1042/bj2770393; Augustijn KD, 2007, INFECT IMMUN, V75, P1116, DOI 10.1128/IAI.00902-06; Bandyopadhyay U, 2004, LIFE SCI, V75, P2867, DOI 10.1016/j.lfs.2004.04.050; Bandyopadhyay U, 2002, LIFE SCI, V71, P2845, DOI 10.1016/S0024-3205(02)02143-4; Bandyopadhyay U., 2010, PHYTOCHEMICALS HUMAN, P187; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Beswick EJ, 2006, INFECT IMMUN, V74, P1148, DOI 10.1128/IAI.74.2.1148-1155.2006; Biswas K., 2002, CURR SCI, V82, P10; Bozza Marcelo T, 2012, J Parasitol Res, V2012, P413052, DOI 10.1155/2012/413052; Bucala R, 2005, DRUG NEWS PERSPECT, V18, P417, DOI 10.1358/dnp.2005.18.7.939345; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1; Chattopadhyay Ishita, 2004, Inflammopharmacology, V12, P153, DOI 10.1163/1568560041352257; Cho YS, 2007, J BIOL CHEM, V282, P23447, DOI 10.1074/jbc.M702950200; Chuang YC, 2011, CYTOKINE, V54, P222, DOI 10.1016/j.cyto.2011.01.013; Dagia NM, 2009, EUR J PHARMACOL, V607, P201, DOI 10.1016/j.ejphar.2009.02.031; Denkinger CM, 2004, ARCH IMMUNOL THER EX, V52, P389; Dey S, 2009, FREE RADICAL BIO MED, V46, P271, DOI 10.1016/j.freeradbiomed.2008.10.032; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Doernberg S, 2011, CYTOKINE, V53, P292, DOI 10.1016/j.cyto.2010.12.010; Enomoto A, 2011, AM J PATHOL, V178, P679, DOI 10.1016/j.ajpath.2010.10.021; Fan HP, 2011, J IMMUNOL, V186, P4915, DOI 10.4049/jimmunol.1003713; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; FUJIWARA T, 1982, CHEM PHARM BULL, V30, P4025; Gao XM, 2011, J MOL CELL CARDIOL, V50, P991, DOI 10.1016/j.yjmcc.2010.12.022; Garai J, 2009, CURR MED CHEM, V16, P1091, DOI 10.2174/092986709787581842; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Goyal M, 2012, NUCLEIC ACIDS RES, V40, P1174, DOI 10.1093/nar/gkr821; Guha M, 2006, FASEB J, V20, P1224, DOI 10.1096/fj.05-5338fje; Guo Yong-Shun, 2011, Zhonghua Zhong Liu Za Zhi, V33, P28; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Hawkins O, 2011, J IMMUNOL, V186, P6607, DOI 10.4049/jimmunol.1003995; Huang XR, 2001, GASTROENTEROLOGY, V121, P619, DOI 10.1053/gast.2001.27205; Jain Vidhan, 2009, BMC Res Notes, V2, P36, DOI 10.1186/1756-0500-2-36; Johnson S, 1997, J CHROMATOGR A, V761, P53, DOI 10.1016/S0021-9673(96)00796-0; Jones Edward, 2007, J Inflamm (Lond), V4, P23, DOI 10.1186/1476-9255-4-23; JONES IW, 1994, FEMS MICROBIOL LETT, V120, P267, DOI 10.1111/j.1574-6968.1994.tb07044.x; Juni P, 2005, BMJ-BRIT MED J, V330, P1342, DOI 10.1136/bmj.330.7504.1342; Kamir D, 2008, J IMMUNOL, V180, P8250, DOI 10.4049/jimmunol.180.12.8250; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; Kim HR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3279; KLENK A, 1986, J CHEM SOC CHEM COMM, P523, DOI 10.1039/c39860000523; Kumar S, 2008, ANTIMICROB AGENTS CH, V52, P705, DOI 10.1128/AAC.00898-07; LANGMAN M J S, 1988, American Journal of Medicine, V84, P15, DOI 10.1016/0002-9343(88)90249-5; LAVIE D, 1971, TETRAHEDRON, V27, P3927, DOI 10.1016/S0040-4020(01)98254-7; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Leng L, 2011, J IMMUNOL, V186, P527, DOI 10.4049/jimmunol.1001767; Li C, 2011, NUTR RES PRACT, V5, P101, DOI 10.4162/nrp.2011.5.2.101; Lin JH, 1997, PHARMACOL REV, V49, P403; Liu SF, 1997, J IMMUNOL, V159, P3976; Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5; Maity P, 2009, PHYTOTHER RES, V23, P747, DOI 10.1002/ptr.2721; Martiney JA, 2000, INFECT IMMUN, V68, P2259, DOI 10.1128/IAI.68.4.2259-2267.2000; McCafferty DM, 2000, GUT, V46, P436, DOI 10.1136/gut.46.3.436; McDevitt MA, 2006, J EXP MED, V203, P1185, DOI 10.1084/jem.20052398; Mempel M, 2003, J INVEST DERMATOL, V121, P1389, DOI 10.1111/j.1523-1747.2003.12630.x; Molnar V, 2005, INT IMMUNOPHARMACOL, V5, P849, DOI 10.1016/j.intimp.2004.12.017; Morand EF, 2005, INTERN MED J, V35, P419, DOI 10.1111/j.1445-5994.2005.00853.x; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nicoletti A, 2011, CYTOKINE, V55, P165, DOI 10.1016/j.cyto.2011.03.027; Onodera S, 2004, ARTHRITIS RHEUM-US, V50, P1437, DOI 10.1002/art.20190; PILLAI NR, 1981, PLANTA MED, V43, P59, DOI 10.1055/s-2007-971474; PILLAI NR, 1984, PLANTA MED, V50, P143, DOI 10.1055/s-2007-969654; Reyes JL, 2006, INFECT IMMUN, V74, P3170, DOI 10.1128/IAI.01648-05; Rodriguez-Sosa M, 2003, INFECT IMMUN, V71, P1247, DOI 10.1128/IAI.71.3.1247-1254.2003; Roger T, 2003, J ENDOTOXIN RES, V9, P119, DOI 10.1179/096805103125001513; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SCHROEDER DR, 1987, J NAT PROD, V50, P241, DOI 10.1021/np50050a023; Shao DD, 2010, MOL IMMUNOL, V47, P726, DOI 10.1016/j.molimm.2009.10.037; Sharma V, 2003, J AGR FOOD CHEM, V51, P3966, DOI 10.1021/jf0342167; SIDDIQUI S, 1988, J NAT PROD, V51, P30, DOI 10.1021/np50055a003; Sienel G., 2000, ULLMANNS ENCY IND CH, V13, P140; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Stosic-Grujicic S, 2008, J CELL PHYSIOL, V215, P665, DOI 10.1002/jcp.21346; Suganuma H, 2011, BIOCHEM BIOPH RES CO, V405, P146, DOI 10.1016/j.bbrc.2011.01.025; Thoh M, 2011, J BIOL CHEM, V286, P4690, DOI 10.1074/jbc.M110.169334; Thorat S, 2010, INFECT IMMUN, V78, P5151, DOI 10.1128/IAI.00277-10; VANDERNAT JM, 1991, PLANTA MED, V57, P65, DOI 10.1055/s-2006-960021; Waheed Akbar, 2006, Pak J Pharm Sci, V19, P322; Wu Z, 2003, J PARASITOL, V89, P507, DOI 10.1645/0022-3395(2003)089[0507:MEACOA]2.0.CO;2; Zhang Y, 2011, INT IMMUNOPHARMACOL, V11, P1333, DOI 10.1016/j.intimp.2011.04.017; Zhao YM, 2011, INT J CANCER, V129, P2463, DOI 10.1002/ijc.25918	94	66	70	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24844	24861		10.1074/jbc.M112.341321	http://dx.doi.org/10.1074/jbc.M112.341321			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645149	Green Published, hybrid			2022-12-25	WOS:000306651100077
J	Kogan, GL; Usakin, LA; Ryazansky, SS; Gvozdev, VA				Kogan, Galina L.; Usakin, Lev A.; Ryazansky, Sergei S.; Gvozdev, Vladimir A.			Expansion and Evolution of the X-Linked Testis Specific Multigene Families in the melanogaster Species Subgroup	PLOS ONE			English	Article							PROTEIN-KINASE CK2; TRANSPOSABLE ELEMENTS; HELITRON TRANSPOSONS; REGULATORY SUBUNIT; DROSOPHILA; GENE; AMPLIFICATION; CHROMOSOMES; ABUNDANT; REPEATS	The testis specific X-linked genes whose evolution is traced here in the melanogaster species subgroup are thought to undergo fast rate of diversification. The CK2 beta tes and NAC beta tes gene families encode the diverged regulatory beta-subunits of protein kinase CK2 and the homologs of beta-subunit of nascent peptide associated complex, respectively. We annotated the CK2 beta tes-like genes related to CK2 beta tes family in the D. simulans and D. sechellia genomes. The ancestor CK2 beta tes-like genes preserved in D. simulans and D. sechellia are considered to be intermediates in the emergence of the D. melanogaster specific Stellate genes related to the CK2 beta tes family. The CK2 beta tes-like genes are more similar to the unique autosomal CK2 beta tes gene than to Stellates, taking into account their peculiarities of polymorphism. The formation of a variant the CK2 beta tes gene Stellate in D. melanogaster as a result of illegitimate recombination between a NAC beta tes promoter and a distinct polymorphic variant of CK2 beta tes-like ancestor copy was traced. We found a close nonrandom proximity between the dispersed defective copies of DINE-1 transposons, the members of Helitron family, and the CK2 beta tes and NAC beta tes genes, suggesting an involvement of DINE-1 elements in duplication and amplification of these genes.	[Kogan, Galina L.; Usakin, Lev A.; Ryazansky, Sergei S.; Gvozdev, Vladimir A.] Russian Acad Sci, Inst Mol Genet, Dept Mol Genet Cell, Moscow, Russia	Russian Academy of Sciences	Kogan, GL (corresponding author), Russian Acad Sci, Inst Mol Genet, Dept Mol Genet Cell, Moscow, Russia.	gvozdev@img.ras.ru	Ryazansky, Sergei/K-3692-2016; Gvozdev, Vladimir/AAH-1730-2021	Ryazansky, Sergei/0000-0002-3171-2997; Gvozdev, Vladimir/0000-0003-1694-1473; Kogan, Galina/0000-0003-0892-1771	Russian Academy of Sciences; Russian Foundation for Basic Research [11-04-00017-a]	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the Molecular and Cellular Biology Program of Russian Academy of Sciences and the Russian Foundation for Basic Research grant (No. 11-04-00017-a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; [Anonymous], 2000, MOL EVOLUTION PHYLOG; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Beatrix B, 2000, J BIOL CHEM, V275, P37838, DOI 10.1074/jbc.M006368200; Bibby AC, 2005, INT J BIOL SCI, V1, P67; Chen ST, 2007, PLOS GENET, V3, P1131, DOI 10.1371/journal.pgen.0030107; Cocca E, 2011, MOL PHYLOGENET EVOL, V58, P439, DOI 10.1016/j.ympev.2010.12.020; Ding Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001255; Egorova KS, 2009, J MOL BIOL, V389, P895, DOI 10.1016/j.jmb.2009.04.064; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Filhol O, 2009, CELL MOL LIFE SCI, V66, P1830, DOI 10.1007/s00018-009-9151-1; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; HARDY RW, 1984, GENETICS, V107, P591; Hollister JD, 2007, MOL BIOL EVOL, V24, P2515, DOI 10.1093/molbev/msm197; Jagadeeshan S, 2005, MOL BIOL EVOL, V22, P1793, DOI 10.1093/molbev/msi175; Jagadeeshan S, 2007, MOL BIOL EVOL, V24, P929, DOI 10.1093/molbev/msm009; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kalmykova AI, 1997, P NATL ACAD SCI USA, V94, P6297, DOI 10.1073/pnas.94.12.6297; Kalmykova AI, 2002, EUR J BIOCHEM, V269, P1418, DOI 10.1046/j.1432-1033.2002.02785.x; Kapitonov VV, 2007, TRENDS GENET, V23, P521, DOI 10.1016/j.tig.2007.08.004; Kapitonov VV, 2003, P NATL ACAD SCI USA, V100, P6569, DOI 10.1073/pnas.0732024100; Kogan GL, 2000, MOL BIOL EVOL, V17, P697, DOI 10.1093/oxfordjournals.molbev.a026348; Lai JS, 2005, P NATL ACAD SCI USA, V102, P9068, DOI 10.1073/pnas.0502923102; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; LITCHFIELD DW, 1993, MOL CELL BIOCHEM, V128, P187, DOI 10.1007/BF01076770; Markesich DC, 2000, DEVELOPMENT, V127, P559; PALUMBO G, 1994, GENETICS, V138, P1181; Pritham EJ, 2007, P NATL ACAD SCI USA, V104, P1895, DOI 10.1073/pnas.0609601104; Sneath P. H. A., 1973, Numerical taxonomy. The principles and practice of numerical classification.; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tulin AV, 1997, GENETICS, V146, P253; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Usakin L A, 2009, Mol Biol (Mosk), V43, P400; Usakin LA, 2005, MOL BIOL EVOL, V22, P1555, DOI 10.1093/molbev/msi147; Yang HP, 2006, GENETICS, V173, P189, DOI 10.1534/genetics.105.051714; Yang HP, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r39; Yang SA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040003; Zhang CJ, 2002, ONCOGENE, V21, P3754, DOI 10.1038/sj.onc.1205467; Zhang JM, 2004, P NATL ACAD SCI USA, V101, P16246, DOI 10.1073/pnas.0407066101; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhou QC, 2006, ZEBRAFISH, V3, P39, DOI 10.1089/zeb.2006.3.39	42	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37738	10.1371/journal.pone.0037738	http://dx.doi.org/10.1371/journal.pone.0037738			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649555	Green Published, gold			2022-12-25	WOS:000305335800075
J	Tomillo, PS; Saba, VS; Blanco, GS; Stock, CA; Paladino, FV; Spotila, JR				Tomillo, Pilar Santidrian; Saba, Vincent S.; Blanco, Gabriela S.; Stock, Charles A.; Paladino, Frank V.; Spotila, James R.			Climate Driven Egg and Hatchling Mortality Threatens Survival of Eastern Pacific Leatherback Turtles	PLOS ONE			English	Article							MARINO-LAS-BAULAS; DERMOCHELYS-CORIACEA; EL-NINO; INCUBATION-TEMPERATURE; SAND TEMPERATURE; CARETTA-CARETTA; COSTA-RICA; SEX-RATIOS; FREQUENCY; AGE	Egg-burying reptiles need relatively stable temperature and humidity in the substrate surrounding their eggs for successful development and hatchling emergence. Here we show that egg and hatchling mortality of leatherback turtles (Dermochelys coriacea) in northwest Costa Rica were affected by climatic variability (precipitation and air temperature) driven by the El Nino Southern Oscillation (ENSO). Drier and warmer conditions associated with El Nino increased egg and hatchling mortality. The fourth assessment report of the Intergovernmental Panel on Climate Change (IPCC) projects a warming and drying in Central America and other regions of the World, under the SRES A2 development scenario. Using projections from an ensemble of global climate models contributed to the IPCC report, we project that egg and hatchling survival will rapidly decline in the region over the next 100 years by similar to 50-60%, due to warming and drying in northwestern Costa Rica, threatening the survival of leatherback turtles. Warming and drying trends may also threaten the survival of sea turtles in other areas affected by similar climate changes.	[Tomillo, Pilar Santidrian; Blanco, Gabriela S.; Spotila, James R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Tomillo, Pilar Santidrian] Leatherback Trust, Goldring Marine Biol Stn, Playa Grande, Costa Rica; [Saba, Vincent S.] Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; [Stock, Charles A.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ USA; [Paladino, Frank V.] Indiana Purdue Univ, Dept Biol, Ft Wayne, IN USA	Drexel University; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; National Oceanic Atmospheric Admin (NOAA) - USA; Purdue University System; Indiana University Purdue University Fort Wayne	Tomillo, PS (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	ms454@drexel.edu	Saba, Vincent/A-3799-2010; Stock, Charles A/H-1281-2012; Santidrián Tomillo, Pilar/N-5406-2014	Saba, Vincent/0000-0002-2974-4826; Stock, Charles A/0000-0001-9549-8013; Santidrián Tomillo, Pilar/0000-0002-6895-7218; Blanco, Gabriela S./0000-0001-6794-4207	Leatherback Trust; Betz Chair Endowment of Drexel University; Earthwatch Institute	Leatherback Trust; Betz Chair Endowment of Drexel University; Earthwatch Institute	Financial support was provided by The Leatherback Trust (www.leatherback.org), the Betz Chair Endowment of Drexel University and the Earthwatch Institute (www.earthwatch.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman R.A., 2004, P15; Avens Larisa, 2009, Endangered Species Research, V8, P165, DOI 10.3354/esr00202; Binckley CA, 1998, COPEIA, P291; BUSTARD HR, 1967, NATURE, V214, P317, DOI 10.1038/214317a0; Casale Paolo, 2011, Endangered Species Research, V13, P123, DOI 10.3354/esr00319; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; DiNezio P. N., 2010, EOS T AM GEOPHYS UN, V91, P141, DOI DOI 10.1029/2010EO160001; Drake DL, 2002, J THERM BIOL, V27, P71, DOI 10.1016/S0306-4565(01)00017-1; GIBBS HL, 1987, ECOLOGY, V68, P1735, DOI 10.2307/1939865; Houghton JDR, 2007, J EXP MAR BIOL ECOL, V345, P71, DOI 10.1016/j.jembe.2007.02.001; Kaplan IC, 2005, CAN J FISH AQUAT SCI, V62, P1710, DOI 10.1139/F05-121; Matsuzawa Y, 2002, MAR BIOL, V140, P639, DOI 10.1007/s00227-001-0724-2; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Miller Jeffrey D., 1999, P124; Nakicenovic N, 2000, IPCC SPECIAL REPORTS; Neelin JD, 2006, P NATL ACAD SCI USA, V103, P6110, DOI 10.1073/pnas.0601798103; Nordmoe ED, 2004, ANIM BEHAV, V68, P387, DOI 10.1016/j.anbehav.2003.07.015; Packard G.C., 1988, Biology of Reptilia, V16, P523; PACKARD GC, 1987, ECOLOGY, V68, P983, DOI 10.2307/1938369; Paladino F. V., 1991, GEOL S AM S, V238, P63; Reina RD, 2002, COPEIA, P653; Reina Richard D., 2009, Endangered Species Research, V7, P155, DOI 10.3354/esr00098; Robertson DS, 2004, GEOL SOC AM BULL, V116, P760, DOI 10.1130/B25402.1; Saba VS, 2007, J APPL ECOL, V44, P395, DOI 10.1111/j.1365-2664.2007.01276.x; Tomillo PS, 2007, CHELONIAN CONSERV BI, V6, P54; Sarti Martinez L, 2000, IUCN 2010 2010 RED L; Martinez LS, 2007, CHELONIAN CONSERV BI, V6, P70, DOI 10.2744/1071-8443(2007)6[70:CABOTL]2.0.CO;2; Segura LN, 2010, HERPETOL CONSERV BIO, V5, P196; Sieg AE, 2010, PHYSL CONSTRAINTS EC; Sieg Annette E., 2011, Endangered Species Research, V15, P195, DOI 10.3354/esr00372; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Steyermark Anthony C., 1996, Chelonian Conservation and Biology, V2, P173; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Tomillo PS, 2008, CONSERV BIOL, V22, P1216, DOI 10.1111/j.1523-1739.2008.00987.x; Tomillo PS, 2009, MAR BIOL, V156, P2021, DOI 10.1007/s00227-009-1234-x; TRILLMICH F, 1985, OECOLOGIA, V67, P19, DOI 10.1007/BF00378445; Valverde Roldan A., 2010, Endangered Species Research, V12, P77, DOI 10.3354/esr00296; Waylen PR, 1996, J CLIMATE, V9, P2606, DOI 10.1175/1520-0442(1996)009<2606:IVOMPI>2.0.CO;2; WEBB GJW, 1989, AM ZOOL, V29, P953; Webster PJ, 1997, NATURE, V390, P562, DOI 10.1038/37499; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Wolter K., 2011, MULTIVARIATE ENSO IN; Zug George R., 1996, Chelonian Conservation and Biology, V2, P244; Zug GR, 2002, FISH B-NOAA, V100, P117	45	68	70	3	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37602	10.1371/journal.pone.0037602	http://dx.doi.org/10.1371/journal.pone.0037602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649544	Green Submitted, gold, Green Published			2022-12-25	WOS:000305335800063
J	Yi, H; Cho, KH; Cho, YS; Kim, K; Nierman, WC; Kim, HS				Yi, Hyojeong; Cho, Kwang-Hwi; Cho, Yun Sung; Kim, Karan; Nierman, William C.; Kim, Heenam Stanley			Twelve Positions in a beta-Lactamase That Can Expand Its Substrate Spectrum with a Single Amino Acid Substitution	PLOS ONE			English	Article							BURKHOLDERIA-PSEUDOMALLEI; ANTIMICROBIAL SUSCEPTIBILITY; ANTIBIOTIC-RESISTANCE; CEFTAZIDIME; EVOLUTION; MUTATIONS	The continuous evolution of beta-lactamases resulting in bacterial resistance to beta-lactam antibiotics is a major concern in public health, and yet the underlying molecular basis or the pattern of such evolution is largely unknown. We investigated the mechanics of the substrate fspectrum expansion of the class A beta-lactamase using PenA of Burkholderia thailandensis as a model. By analyzing 516 mutated enzymes that acquired the ceftazidime-hydrolyzing activity, we found twelve positions with single amino acid substitutions (altogether twenty-nine different substitutions), co-localized at the active-site pocket area. The ceftazidime MIC (minimum inhibitory concentration) levels and the relative frequency in the occurrence of substitutions did not correlate well with each other, and the latter appeared be largely influenced by the intrinsic mutational biases present in bacteria. Simulation studies suggested that all substitutions caused a congruent effect, expanding the space in a conserved structure called the omega loop, which in turn increased flexibility at the active site. A second phase of selection, in which the mutants were placed under increased antibiotic pressure, did not result in a second mutation in the coding region, but a mutation that increased gene expression arose in the promoter. This result suggests that the twelve amino acid positions and their specific substitutions in PenA may represent a comprehensive repertoire of the enzyme's adaptability to a new substrate. These mapped substitutions represent a comprehensive set of general mechanical paths to substrate spectrum expansion in class A beta-lactamases that all share a functional evolutionary mechanism using common conserved residues.	[Yi, Hyojeong; Kim, Karan; Kim, Heenam Stanley] Korea Univ, Coll Med, Dept Med, Seoul 136705, South Korea; [Cho, Kwang-Hwi; Cho, Yun Sung] Soongsil Univ, Sch Syst Biomed Sci & Res, Seoul, South Korea; [Cho, Kwang-Hwi; Cho, Yun Sung] Soongsil Univ, Ctr Integrat Basic Sci, Seoul, South Korea; [Nierman, William C.; Kim, Heenam Stanley] J Craig Venter Inst, Rockville, MD USA	Korea University; Korea University Medicine (KU Medicine); Soongsil University; Soongsil University; J. Craig Venter Institute	Yi, H (corresponding author), Korea Univ, Coll Med, Dept Med, Seoul 136705, South Korea.	hstanleykim@korea.ac.kr	Kim, Heenam Stanley/L-2279-2016	Kim, Heenam Stanley/0000-0003-4856-3518; Cho, Yun Sung/0000-0003-4490-8769	Basic Research Program from the Ministry of Education, Science & Technology in the Republic of Korea [20090088364]; Core Research Program from the Ministry of Education, Science & Technology in the Republic of Korea [20110016847]; 21C Frontier Microbial Genomics & Applications Center Program from the Ministry of Education, Science & Technology in the Republic of Korea [2009K000516]; Korea Foundation for International Cooperation of Science & Technology (KICOS) through Korean Ministry of Science & Technology (MOST) [K20903001812-11E0100-01700]	Basic Research Program from the Ministry of Education, Science & Technology in the Republic of Korea; Core Research Program from the Ministry of Education, Science & Technology in the Republic of Korea; 21C Frontier Microbial Genomics & Applications Center Program from the Ministry of Education, Science & Technology in the Republic of Korea; Korea Foundation for International Cooperation of Science & Technology (KICOS) through Korean Ministry of Science & Technology (MOST)	This work was supported by grants 20090088364 from the Basic Research Program, 20110016847 from the Core Research Program, and 2009K000516 from the 21C Frontier Microbial Genomics & Applications Center Program, all of which are from the Ministry of Education, Science & Technology in the Republic of Korea. Additional support was provided by the Korea Foundation for International Cooperation of Science & Technology (KICOS) through a grant provided by the Korean Ministry of Science & Technology (MOST) in K20903001812-11E0100-01700 to HSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Antunes NT, 2011, BIOCHEMISTRY-US, V50, P6387, DOI 10.1021/bi200403e; Bonacorsi S, 1999, ANTIMICROB AGENTS CH, V43, P213, DOI 10.1128/AAC.43.2.213; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Bush K, 2011, ANNU REV MICROBIOL, V65, P455, DOI 10.1146/annurev-micro-090110-102911; Chen Y, 2005, J AM CHEM SOC, V127, P5423, DOI 10.1021/ja042850a; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; Delmas J, 2006, ANTIMICROB AGENTS CH, V50, P731, DOI 10.1128/AAC.50.2.731-738.2006; Delmas J, 2010, J MOL BIOL, V400, P108, DOI 10.1016/j.jmb.2010.04.062; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Ford PJ, 2004, J ANTIMICROB CHEMOTH, V54, P69, DOI 10.1093/jac/dkh251; Friedrichs MS, 2009, J COMPUT CHEM, V30, P864, DOI 10.1002/jcc.21209; Heritage J, 1999, J ANTIMICROB CHEMOTH, V44, P309, DOI 10.1093/jac/44.3.309; Hershberg R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001115; Ho PL, 2002, J ANTIMICROB CHEMOTH, V50, P723, DOI 10.1093/jac/dkf208; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; JOYCE LF, 1992, J CLIN MICROBIOL, V30, P2709, DOI 10.1128/JCM.30.10.2709-2713.1992; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim HS, 2008, J BACTERIOL, V190, P3700, DOI 10.1128/JB.00067-08; Leitao JH, 2010, APPL MICROBIOL BIOT, V87, P31, DOI 10.1007/s00253-010-2528-0; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Ma L, 2005, ANTIMICROB AGENTS CH, V49, P600, DOI 10.1128/AAC.49.2.600-605.2005; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Poirel L, 2009, ANTIMICROB AGENTS CH, V53, P876, DOI 10.1128/AAC.00946-08; RAQUET X, 1994, J MOL BIOL, V244, P625, DOI 10.1006/jmbi.1994.1756; Rholl DA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00139; Saika Takeshi, 2002, Journal of Infection and Chemotherapy, V8, P341, DOI 10.1007/s10156-002-0200-z; Salverda MLM, 2010, FEMS MICROBIOL REV, V34, P1015, DOI 10.1111/j.1574-6976.2010.00222.x; Sam IC, 2009, J CLIN MICROBIOL, V47, P1556, DOI 10.1128/JCM.01657-08; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sarovich DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030789; Simon R, 1983, ECTOR PLASMIDS VIVO; Song H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000922; Thibault FM, 2004, J ANTIMICROB CHEMOTH, V54, P1134, DOI 10.1093/jac/dkh471; Thongdee M, 2008, APPL ENV MICROBIOL; Tribuddharat C, 2003, ANTIMICROB AGENTS CH, V47, P2082, DOI 10.1128/AAC.47.7.2082-2087.2003; Vakulenko SB, 1999, J BIOL CHEM, V274, P23052, DOI 10.1074/jbc.274.33.23052; VAKULENKO SB, 1995, ANTIMICROB AGENTS CH, V39, P1878, DOI 10.1128/AAC.39.8.1878; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wong WT, 2011, J BIOL CHEM, V286, P31771, DOI 10.1074/jbc.M110.198895; Wuthiekanun Vanaporn, 2006, Expert Rev Anti Infect Ther, V4, P445, DOI 10.1586/14787210.4.3.445	48	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37585	10.1371/journal.pone.0037585	http://dx.doi.org/10.1371/journal.pone.0037585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629423	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345300055
J	Adhi, M; Aziz, S; Muhammad, K; Adhi, MI				Adhi, Mehreen; Aziz, Sumbul; Muhammad, Kashif; Adhi, Mohammad I.			Macular Thickness by Age and Gender in Healthy Eyes Using Spectral Domain Optical Coherence Tomography	PLOS ONE			English	Article							FIBER LAYER THICKNESS; RETINAL THICKNESS; QUANTITATIVE ASSESSMENT; ULTRAHIGH-RESOLUTION; AXIAL LENGTH; HIGH-SPEED; REPRODUCIBILITY; REPEATABILITY; OCT	Purpose: To determine normal macular thickness and its variation by age and gender in healthy eyes using spectral-domain optical coherence tomography (SD-OCT). Methods: In this cross-sectional analysis, two hundred and twenty eyes of 220 healthy subjects underwent raster scanning using Topcon SD-OCT system, at the Department of Ophthalmology, Dow University of Health Sciences and Civil Hospital Karachi, Pakistan. Macular thickness from all 9 regions of the ETDRS map was documented for each subject. Variations in macular thickness measurements by age and gender were determined. Results: The 220 subjects had a mean age of 45.3 years (16-80 years). Using the ETDRS map, foveal thickness for all subjects was measured to be 229 +/- 20.46 mu m. Mean macular thickness for all subjects was 262.8 +/- 13.34 mu m. Male gender was associated with greater foveal (p<0.0001) and mean macular (p<0.0001) thickness compared to females. There was no association of mean macular thickness (r(2) = 0.01; p>0.05) and foveal thickness (r(2) = 0.00004; p>0.05) with age. Conclusion: We have provided normative data for macular thickness using Topcon SD-OCT system. Our results are comparable to some and vary from other reports using the similar OCT system. Our results suggest that male gender is associated with greater macular thickness, while macular thickness has no association with age in healthy eyes. This is the first normative data for macular thickness from Pakistan; benchmark for diagnosing and monitoring macular pathologies. The values obtained in this study may be useful for comparison with other populations, other SD-OCT systems and future imaging technologies.	[Adhi, Mehreen; Aziz, Sumbul; Muhammad, Kashif; Adhi, Mohammad I.] Dow Univ Hlth Sci & Civil Hosp, Dept Ophthalmol, Karachi, Pakistan; [Adhi, Mehreen] Tufts Med Ctr, New England Eye Ctr, Boston, MA USA	Dow University of Health Sciences; Tufts Medical Center	Adhi, M (corresponding author), Dow Univ Hlth Sci & Civil Hosp, Dept Ophthalmol, Karachi, Pakistan.	miadhi@hotmail.com	Adhi, Mohammad Idrees/Q-4117-2019; Adhi, Mehreen/AAS-9733-2021	Adhi, Mohammad Idrees/0000-0003-3971-8573; 				Alam S, 2006, OPHTHALMOLOGY, V113, P1425, DOI 10.1016/j.ophtha.2006.03.020; Alamouti B, 2003, BRIT J OPHTHALMOL, V87, P899, DOI 10.1136/bjo.87.7.899; [Anonymous], 1991, Ophthalmology, V98, P786; Asefzadeh B, 2007, OPTOMETRY VISION SCI, V84, P941; Asrani S, 1999, OPHTHALMOLOGY, V106, P269, DOI 10.1016/S0161-6420(99)90057-X; Bruce A, 2009, OPEN OPHTHALMOL J, V3, P10, DOI 10.2174/1874364100903010010; Chan A, 2006, ARCH OPHTHALMOL-CHIC, V124, P193, DOI 10.1001/archopht.124.2.193; Giani A, 2010, AM J OPHTHALMOL, V150, P815, DOI 10.1016/j.ajo.2010.06.025; Grover S, 2009, AM J OPHTHALMOL, V148, P266, DOI 10.1016/j.ajo.2009.03.006; HEE MR, 1995, ARCH OPHTHALMOL-CHIC, V113, P1019, DOI 10.1001/archopht.1995.01100080071031; HEE MR, 1995, ARCH OPHTHALMOL-CHIC, V113, P325, DOI 10.1001/archopht.1995.01100030081025; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huang JJ, 2011, J GLAUCOMA, V20, P118, DOI 10.1097/IJG.0b013e3181d786f8; Kanadani FN, 2006, BRIT J OPHTHALMOL, V90, P1393, DOI 10.1136/bjo.2006.099069; Kashani AH, 2010, AM J OPHTHALMOL, V149, P496, DOI 10.1016/j.ajo.2009.09.025; Koozekanani D, 2000, INVEST OPHTH VIS SCI, V41, P1486; Legarreta JE, 2008, OPHTHAL SURG LAS IM, V39, pS43, DOI 10.3928/15428877-20080715-02; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4893, DOI 10.1167/iovs.07-1326; Menke MN, 2009, AM J OPHTHALMOL, V147, P467, DOI 10.1016/j.ajo.2008.09.005; Muscat S, 2002, INVEST OPHTH VIS SCI, V43, P490; NUSSENBLATT RB, 1987, OPHTHALMOLOGY, V94, P1134; Oshitari T, 2007, CLIN OPHTHALMOL, V1, P133; Paunescu LA, 2004, INVEST OPHTH VIS SCI, V45, P1716, DOI 10.1167/iovs.03-0514; Pierro L, 2010, AM J OPHTHALMOL, V150, P199, DOI 10.1016/j.ajo.2010.03.015; SHAHIDI M, 1991, ARCH OPHTHALMOL-CHIC, V109, P1115, DOI 10.1001/archopht.1991.01080080075032; Song WK, 2010, INVEST OPHTH VIS SCI, V51, P3913, DOI 10.1167/iovs.09-4189; Sull AC, 2010, RETINA-J RET VIT DIS, V30, P235, DOI 10.1097/IAE.0b013e3181bd2c3b; Tewari Hem K., 2004, Indian Journal of Ophthalmology, V52, P199; Wojtkowski M, 2005, OPHTHALMOLOGY, V112, P1734, DOI 10.1016/j.ophtha.2005.05.023; Wojtkowski M, 2004, OPT EXPRESS, V12, P2404, DOI 10.1364/OPEX.12.002404; Wong ACM, 2005, EYE, V19, P292, DOI 10.1038/sj.eye.6701466	31	70	71	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37638	10.1371/journal.pone.0037638	http://dx.doi.org/10.1371/journal.pone.0037638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629435	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343100042
J	Amaral, CRL; Brito, PM				Amaral, Cesar R. L.; Brito, Paulo M.			A New Chanidae (Ostariophysii: Gonorynchiformes) from the Cretaceous of Brazil with Affinities to Laurasian Gonorynchiforms from Spain	PLOS ONE			English	Article							BIOGEOGRAPHY; TELEOSTEI; FOSSIL; BASIN	Based on specimens originally referred to as "Dastilbe minor", a nomem-nudum, we describe a new genus of Chanidae dagger Nanaichthys longipinnus nov. gen. and sp. which exhibits several diagnostic characters such as the absence of orbitosphenoid and basisphenoid, anteriorly displaced quadrate-mandibular articulation, laterally expanded supraneurals, an acute angle between the preopercular limbs, expansion at the angle between the preopercular limbs, and a curved maxillary articular process. Its occurrence and supposed relationship within the Chanidae reinforce the influence of the Mediterranean Tethys over the Gondwanan main rift system prior to the Aptian/Albian highstands.	[Amaral, Cesar R. L.; Brito, Paulo M.] Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Sao Francisco Xavier, Maracana, Brazil	Universidade do Estado do Rio de Janeiro	Amaral, CRL (corresponding author), Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Sao Francisco Xavier, Maracana, Brazil.	pbritopaleo@yahoo.com.br	Brito, Paulo/B-5784-2013; Amaral, Cesar/AAS-6841-2021	Brito, Paulo/0000-0002-4853-8630	Brazilian National Counsel of Technological and Scientific Development; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro	Brazilian National Counsel of Technological and Scientific Development; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by the Brazilian National Counsel of Technological and Scientific Development and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberhan M, 2001, PALAEOGEOGR PALAEOCL, V165, P375, DOI 10.1016/S0031-0182(00)00172-3; Alvarado-Ortega J, 2010, PALAEONTOLOGY, V53, P297, DOI 10.1111/j.1475-4983.2010.00935.x; ARAMBOURG C, 1935, ANN PALEONTOL, V24, P139; Arratia G, 2010, COMPREHENSIVE REV GO, P71; Arratia Gloria, 1995, Bonner Zoologische Monographien, V36, P1; Brito I.M., 1979, BACIAS SEDIMENTARES; Brito PM, 2007, CYBIUM, V31, P139; Brito Paulo M., 2008, P279; Brito PM, 2008, GEOL SOC SPEC PUBL, V295, P145, DOI 10.1144/SP295.9; Davis MP, MESOZOIC FI IN PRESS; Forskal P., 1775, DESCRIPTIONES ANIMAL; Gasparini Z, 2006, SCIENCE, V311, P70, DOI 10.1126/science.1120803; Gasparini Z., 2005, NEUQUEN BASIN ARGENT, V252, P279; Gasparini Zulma, 2007, Asociacion Paleontologica Argentina Publicacion Especial, V11, P125; Grande T, 1999, COPEIA, P453; Grande T, 1999, ZOOL J LINN SOC-LOND, V125, P197; Grande T, 2010, COMPREHENSIVE REV GO, P38; HALLAM A, 1983, PALAEOGEOGR PALAEOCL, V43, P181, DOI 10.1016/0031-0182(83)90010-X; Jordan D.S., 1910, ANALES CARGENIE MUSE, V7, P22; Jordan D. S., 1908, SMITHSONIAN MISCELLA, V52, P1; Poyato-Ariza FJ, 2010, SER TELEOST FISH BIO, P227, DOI 10.1201/b10194-8; KOUTSOUKOS EAM, 1992, PALAEOGEOGR PALAEOCL, V92, P295, DOI 10.1016/0031-0182(92)90089-N; MOODY JM, 1994, J VERTEBR PALEONTOL, V14, P1, DOI 10.1080/02724634.1994.10011534; Poyato F.J., 1990, Acta Salmanticensia Biblioteca de las Ciencias, P299; Poyato-Ariza Francisco Jose, 1994, Occasional Papers of the Museum of Natural History University of Kansas, V164, P1; Poyato-Ariza Francisco Jose, 1996, Palaeo Ichthyologica, V6, P5; Rosen D. E, 1970, Am. Mus. Novit., VNo. 2428, P1; Santos RS, 1972, PEIXES FORMACAO MARI; SANZ JL, 1988, GEOBIOS-LYON, V21, P611, DOI 10.1016/S0016-6995(88)80072-X; Schultze Hans-Peter, 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V199, P395; SMITH PL, 1983, CAN J EARTH SCI, V20, P86, DOI 10.1139/e83-008; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Traquair R. H., 1911, Mem Mus Belgique Bruxelles, V6; Wenz S, 1984, B MUS NAT HIST NAT C, V4, P275	34	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37247	10.1371/journal.pone.0037247	http://dx.doi.org/10.1371/journal.pone.0037247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629376	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343100020
J	Berzigotti, S; Benlafya, K; Sepulchre, J; Amoroso, A; Joris, B				Berzigotti, Stephanie; Benlafya, Kamal; Sepulchre, Jeremy; Amoroso, Ana; Joris, Bernard			Bacillus licheniformis BlaR1 L3 Loop Is a Zinc Metalloprotease Activated by Self-Proteolysis	PLOS ONE			English	Article							BETA-LACTAMASE SYNTHESIS; STAPHYLOCOCCUS-AUREUS; PENICILLIN-RECEPTOR; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; REPRESSOR BLAL; SENSOR DOMAIN; INDUCTION; THERMOLYSIN; RESISTANCE	In Bacillus licheniformis 749/I, BlaP beta-lactamase is induced by the presence of a beta-lactam antibiotic outside the cell. The first step in the induction mechanism is the detection of the antibiotic by the membrane-bound penicillin receptor BlaR1 that is composed of two functional domains: a carboxy-terminal domain exposed outside the cell, which acts as a penicillin sensor, and an amino-terminal domain anchored to the cytoplasmic membrane, which works as a transducer-transmitter. The acylation of BlaR1 sensor domain by the antibiotic generates an intramolecular signal that leads to the activation of the L3 cytoplasmic loop of the transmitter by a single-point cleavage. The exact mechanism of L3 activation and the nature of the secondary cytoplasmic signal launched by the activated transmitter remain unknown. However, these two events seem to be linked to the presence of a HEXXH zinc binding motif of neutral zinc metallopeptidases. By different experimental approaches, we demonstrated that the L3 loop binds zinc ion, belongs to Gluzincin metallopeptidase superfamily and is activated by self-proteolysis.	[Berzigotti, Stephanie; Benlafya, Kamal; Sepulchre, Jeremy; Amoroso, Ana; Joris, Bernard] Univ Liege, Ctr Prot Engn, Dept Life Sci, Liege, Belgium	University of Liege	Berzigotti, S (corresponding author), Univ Liege, Ctr Prot Engn, Dept Life Sci, Liege, Belgium.	bjoris@ulg.ac.be			Belgian Program on Interuniversity Poles of Attraction [P6/19]; Actions de Recherche Concertees [03/08-297]; Fonds de la Recherche Fondamentale Collective [6 2.4511.06, 2.4524.03]; Fonds de la recherche en Sciences Medicales [7 3.4586.05]; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)	Belgian Program on Interuniversity Poles of Attraction(Belgian Federal Science Policy Office); Actions de Recherche Concertees(University of Liege); Fonds de la Recherche Fondamentale Collective(Fonds de la Recherche Scientifique - FNRS); Fonds de la recherche en Sciences Medicales(Fonds de la Recherche Scientifique - FNRS); Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS)	This research was supported in part by Belgian Program on Interuniversity Poles of Attraction initiated by the Belgian State (Grant P6/19), the Actions de Recherche Concertees (Grant 03/08-297), the Fonds de la Recherche Fondamentale Collective (Grant 6 2.4511.06 and 2.4524.03), the Fonds de la recherche en Sciences Medicales (Grant 7 3.4586.05) and the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA). Stephanie Berzigotti is a fellow of FRIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoroso A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002571; Birck C, 2004, J AM CHEM SOC, V126, P13945, DOI 10.1021/ja044742u; Clarke SR, 2001, MICROBIOL-UK, V147, P803, DOI 10.1099/00221287-147-4-803; Del Papa MF, 2007, J BACTERIOL, V189, P8835, DOI 10.1128/JB.01311-07; Demidyuk IV, 2008, PROTEIN J, V27, P343, DOI 10.1007/s10930-008-9143-2; Duval V, 2003, MOL MICROBIOL, V48, P1553, DOI 10.1046/j.1365-2958.2003.03520.x; Filee P, 2002, MOL MICROBIOL, V44, P685, DOI 10.1046/j.1365-2958.2002.02888.x; FRERE JM, 1995, MOL MICROBIOL, V16, P385, DOI 10.1111/j.1365-2958.1995.tb02404.x; Fukasawa K. M., 2011, J AMINO ACIDS; Gao XA, 2010, P NATL ACAD SCI USA, V107, P17569, DOI 10.1073/pnas.1005681107; GONG ZY, 1994, BIOCHEMISTRY-US, V33, P15149, DOI 10.1021/bi00254a026; Gregory PD, 1997, MOL MICROBIOL, V24, P1025, DOI 10.1046/j.1365-2958.1997.4051770.x; Hanique S, 2004, J BIOL CHEM, V279, P14264, DOI 10.1074/jbc.M313488200; Hardt K, 1997, MOL MICROBIOL, V23, P935, DOI 10.1046/j.1365-2958.1997.2761642.x; HAUSRATH AC, 1994, J BIOL CHEM, V269, P18839; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; JORIS B, 1990, FEMS MICROBIOL LETT, V70, P107, DOI 10.1016/0378-1097(90)90111-3; Kerff F, 2003, BIOCHEMISTRY-US, V42, P12835, DOI 10.1021/bi034976a; KOBAYASHI T, 1987, J BACTERIOL, V169, P3873, DOI 10.1128/jb.169.9.3873-3878.1987; LEMOUAL H, 1991, J BIOL CHEM, V266, P15670; Lewis RA, 2000, J ANTIMICROB CHEMOTH, V45, P139, DOI 10.1093/jac/45.2.139; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Llarrull LI, 2011, J BIOL CHEM, V286, P38148, DOI 10.1074/jbc.M111.288985; MATAGNE A, 1990, BIOCHEM J, V265, P131, DOI 10.1042/bj2650131; MAZEN A, 1988, ANAL BIOCHEM, V172, P39, DOI 10.1016/0003-2697(88)90408-3; MCEUEN AR, 1992, BIOCHEM BIOPH RES CO, V189, P813, DOI 10.1016/0006-291X(92)92275-3; McKinney TK, 2001, J BACTERIOL, V183, P6862, DOI 10.1128/JB.183.23.6862-6868.2001; Pelmenschikov V, 2002, J BIOL INORG CHEM, V7, P284, DOI 10.1007/s007750100295; Philippon A, 1998, CELL MOL LIFE SCI, V54, P341, DOI 10.1007/s000180050161; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; SALERNO AJ, 1988, FEBS LETT, V227, P61, DOI 10.1016/0014-5793(88)81414-5; Sambrook J, 2001, MOL CLONING LAB MANU; Sambrook J, 2001, PURIFICATION ANTIBOD, P1811; SHERRATT DJ, 1973, J GEN MICROBIOL, V76, P217, DOI 10.1099/00221287-76-1-217; Stapleton Paul D., 2002, Science Progress, V85, P57, DOI 10.3184/003685002783238870; SULLIVAN MA, 1984, GENE, V29, P21, DOI 10.1016/0378-1119(84)90161-6; Wilke MS, 2004, J BIOL CHEM, V279, P47278, DOI 10.1074/jbc.M407054200; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144; ZHU YF, 1992, J BACTERIOL, V174, P6171, DOI 10.1128/JB.174.19.6171-6178.1992	39	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36400	10.1371/journal.pone.0036400	http://dx.doi.org/10.1371/journal.pone.0036400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623956	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500016
J	Guillaudeau, A; Durand, K; Bessette, B; Chaunavel, A; Pommepuy, I; Projetti, F; Robert, S; Caire, F; Rabinovitch-Chable, H; Labrousse, F				Guillaudeau, Angelique; Durand, Karine; Bessette, Barbara; Chaunavel, Alain; Pommepuy, Isabelle; Projetti, Fabrice; Robert, Sandrine; Caire, Francois; Rabinovitch-Chable, Helene; Labrousse, Francois			EGFR Soluble Isoforms and Their Transcripts Are Expressed in Meningiomas	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR EXPRESSION; DEPENDENT PROBE AMPLIFICATION; CENTRAL-NERVOUS-SYSTEM; IN-SITU-HYBRIDIZATION; CELL LUNG CARCINOMAS; COLORECTAL-CANCER; OVARIAN-CANCER; GENE AMPLIFICATION; PROTEIN EXPRESSION	The EGFR (epidermal growth factor receptor) is involved in the oncogenesis of many tumors. In addition to the full-length EGFR (isoform a), normal and tumor cells produce soluble EGFR isoforms (sEGFR) that lack the intracellular domain. sEGFR isoforms b, c and d are encoded by EGFR variants 2 (v2), 3 (v3) and 4 (v4) mRNA resulting from gene alternative splicing. Accordingly, the results of EGFR protein expression analysis depend on the domain targeted by the antibodies. In meningiomas, EGFR expression investigations mainly focused on EGFR isoform a. sEGFR and EGFRvIII mutant, that encodes a constitutively active truncated receptor, have not been studied. In a 69 meningiomas series, protein expression was analyzed by immunohistochemistry using extracellular domain targeted antibody (ECD-Ab) and intracellular domain targeted antibody (ICD-Ab). EGFRv1 to v4 and EGFRvIII mRNAs were quantified by RT-PCR and EGFR amplification revealed by MLPA. Results were analyzed with respect to clinical data, tumor resection (Simpson grade), histological type, tumor grade, and patient outcome. Immunochemical staining was stronger with ECD-Ab than with ICD-Ab. Meningiomas expressed EGFRv1 to -v4 mRNAs but not EGFRvIII mutant. Intermediate or high ECD-Ab staining and high EGFRv1 to v4 mRNA levels were associated to a better progression free survival (PFS). PFS was also improved in women, when tumor resection was evaluated as Simpson 1 or 2, in grade I vs. grade II and III meningiomas and when Ki67 labeling index was lower than 10%. Our results suggest that, EGFR protein isoforms without ICD and their corresponding mRNA variants are expressed in meningiomas in addition to the whole isoform a. EGFRvIII was not expressed. High expression levels seem to be related to a better prognosis. These results indicate that the oncogenetic mechanisms involving the EGFR pathway in meningiomas could be different from other tumor types.	[Guillaudeau, Angelique; Durand, Karine; Chaunavel, Alain; Pommepuy, Isabelle; Projetti, Fabrice; Robert, Sandrine; Labrousse, Francois] Dupuytren Univ Hosp, Dept Pathol, Limoges, France; [Bessette, Barbara] Dupuytren Univ Hosp, Dept Cellular Homeostasis & Pathol, Limoges, France; [Caire, Francois] Dupuytren Univ Hosp, Dept Neurosurg, Limoges, France; [Rabinovitch-Chable, Helene] Dupuytren Univ Hosp, Dept Biochem & Mol Genet, Limoges, France	CHU Limoges; CHU Limoges; CHU Limoges; CHU Limoges	Guillaudeau, A (corresponding author), Dupuytren Univ Hosp, Dept Pathol, Limoges, France.	labrousse@unilim.fr	Bessette, Barbara/G-2317-2015	Bessette, Barbara/0000-0001-6673-3694; Durand, Karine/0000-0002-9738-3444; CHAUNAVEL, Alain/0000-0003-2419-8974; Projetti, Fabrice/0000-0002-9023-8543; Labrousse, Francois/0000-0002-3185-4856; ROBERT, Sandrine/0000-0003-1908-3144	Comite Departemental de la Ligue contre le Cancer de la Correze	Comite Departemental de la Ligue contre le Cancer de la Correze	This work was supported by grants from the "Comite Departemental de la Ligue contre le Cancer de la Correze'' (www.ligue-cancer.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanell J, 2005, CURR DRUG TARGETS, V6, P259, DOI 10.2174/1389450053765888; Albitar L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-166; Anagnostou VK, 2010, CANCER EPIDEM BIOMAR, V19, P982, DOI 10.1158/1055-9965.EPI-10-0097; Ancot F, 2009, ONCOGENE, V28, P2185, DOI 10.1038/onc.2009.88; Andersson U, 2004, ACTA NEUROPATHOL, V108, P135, DOI 10.1007/s00401-004-0875-6; Arteaga CL, 2001, J CLIN ONCOL, V19, p32S; Baron AT, 2009, CANCER TREAT RES, V149, P189, DOI 10.1007/978-0-387-98094-2_9; Baron AT, 2009, IDRUGS, V12, P302; Baron AT, 2001, CANCER EPIDEM BIOMAR, V10, P1175; BASU A, 1989, MOL CELL BIOL, V9, P671, DOI 10.1128/MCB.9.2.671; CADENA DL, 1993, PROTEIN EXPRES PURIF, V4, P177, DOI 10.1006/prep.1993.1024; Carroll RS, 1997, J NEUROSURG, V87, P315, DOI 10.3171/jns.1997.87.2.0315; CHAFFANET M, 1992, EUR J CANCER, V28A, P11, DOI 10.1016/0959-8049(92)90374-B; DEPALAZZO IEG, 1993, CANCER RES, V53, P3217; Di Fiore F, 2010, BRIT J CANCER, V103, P1765, DOI 10.1038/sj.bjc.6606008; Domingo G, 2010, EXPERT REV ANTICANC, V10, P1577, DOI [10.1586/era.10.141, 10.1586/ERA.10.141]; Estrada-Bernal A, 2011, J NEURO-ONCOL, V102, P353, DOI 10.1007/s11060-010-0345-z; Fiore DC, 2010, AM FAM PHYSICIAN, V82, P69; FLICKINGER TW, 1992, MOL CELL BIOL, V12, P883, DOI 10.1128/MCB.12.2.883; FOX SB, 1994, BREAST CANCER RES TR, V29, P41, DOI 10.1007/BF00666180; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; GREENFIELD C, 1989, EMBO J, V8, P4115, DOI 10.1002/j.1460-2075.1989.tb08596.x; Guillaudeau A, 2012, INT J ONCOL, V40, P1142, DOI 10.3892/ijo.2011.1287; Guillaudeau A, 2009, APPL IMMUNOHISTO M M, V17, P220, DOI 10.1097/PAI.0b013e31818db320; Halle C, 2011, CLIN CANCER RES, V17, P5501, DOI 10.1158/1078-0432.CCR-11-0297; Hanawa M, 2006, INT J CANCER, V118, P1173, DOI 10.1002/ijc.21454; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; HORSFALL DJ, 1989, AUST NZ J SURG, V59, P881, DOI 10.1111/j.1445-2197.1989.tb07033.x; HUNTS JH, 1985, SOMAT CELL MOLEC GEN, V11, P477, DOI 10.1007/BF01534841; ILEKIS JV, 1995, MOL REPROD DEV, V41, P149, DOI 10.1002/mrd.1080410205; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Ionescu DN, 2005, CANCER, V103, P630, DOI 10.1002/cncr.20811; Jeuken J, 2006, J MOL DIAGN, V8, P433, DOI 10.2353/jmoldx.2006.060012; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; JOHNSON MD, 1994, HUM PATHOL, V25, P146, DOI 10.1016/0046-8177(94)90270-4; JONES NR, 1990, CANCER, V66, P152, DOI 10.1002/1097-0142(19900701)66:1<152::AID-CNCR2820660127>3.0.CO;2-5; Kong Yan-guo, 2002, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V24, P427; Koutras AK, 2011, CURR MED CHEM, V18, P1599, DOI 10.2174/092986711795471338; Lafky JM, 2008, BBA-REV CANCER, V1785, P232, DOI 10.1016/j.bbcan.2008.01.001; LINGGOOD RM, 1995, J NEURO-ONCOL, V26, P45, DOI 10.1007/BF01054768; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maramotti S, 2011, LUNG CANC, V15; Markman B, 2010, ADV CLIN CHEM, V51, P71, DOI 10.1016/S0065-2423(10)51004-7; Mathieu A, 2010, LUNG CANCER, V69, P46, DOI 10.1016/j.lungcan.2009.09.003; Maurizi M, 1996, BRIT J CANCER, V74, P1253, DOI 10.1038/bjc.1996.525; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Modjtahedi H, 2005, CANCER METAST REV, V24, P129, DOI 10.1007/s10555-005-5052-4; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Mukasa A, 2010, P NATL ACAD SCI USA, V107, P2616, DOI 10.1073/pnas.0914356107; Muller V, 2006, ANTICANCER RES, V26, P1479; Nagane Motoo, 2001, Cancer Letters, V162, pS17, DOI 10.1016/S0304-3835(00)00648-0; Norden AD, 2010, J NEURO-ONCOL, V96, P211, DOI 10.1007/s11060-009-9948-7; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Oh MJ, 2000, CLIN CANCER RES, V6, P4760; OKUDA K, 2008, J CANC RES CLIN ONCO; Perez-Torres M, 2008, EXP CELL RES, V314, P2907, DOI 10.1016/j.yexcr.2008.07.013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rahimi M, 2011, CANCER LETT, V306, P43, DOI 10.1016/j.canlet.2011.02.024; Reiter JL, 1996, NUCLEIC ACIDS RES, V24, P4050, DOI 10.1093/nar/24.20.4050; Reiter JL, 2001, GENOMICS, V71, P1, DOI 10.1006/geno.2000.6341; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Sanderson MP, 2008, J CELL BIOCHEM, V103, P1783, DOI 10.1002/jcb.21569; SANFILIPPO JS, 1993, SURG GYNECOL OBSTET, V177, P488; Sasaki H, 2007, ONCOL REP, V17, P319; SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22; Smith JS, 2007, J NEUROSURG, V106, P1034, DOI 10.3171/jns.2007.106.6.1034; STEWART CJR, 1992, INT J GYNECOL PATHOL, V11, P266, DOI 10.1097/00004347-199210000-00004; van Dijk MC, 2005, DIAGN MOL PATHOL, V14, P9, DOI 10.1097/01.pas.0000146701.98954.47; Varella-Garcia M, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-19; Villares GJ, 2007, WORLD J UROL, V25, P573, DOI 10.1007/s00345-007-0202-7; WEBER W, 1984, SCIENCE, V224, P294, DOI 10.1126/science.6324343; WEISMAN AS, 1987, CANCER RES, V47, P2172; Wen PY, 2010, J NEURO-ONCOL, V99, P365, DOI 10.1007/s11060-010-0349-8; Wernicke AG, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-46; WESTPHAL M, 1986, ACTA NEUROCHIR, V83, P62, DOI 10.1007/BF01420510; Whittle IR, 2004, LANCET, V363, P1535, DOI 10.1016/S0140-6736(04)16153-9; Wilken JA, 2011, BIOCHEMISTRY-US, V50, P4309, DOI 10.1021/bi200126j; You B, 2011, J CLIN PHARM; Zampino MG, 2008, CANCER CHEMOTH PHARM, V63, P139, DOI 10.1007/s00280-008-0722-x	79	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37204	10.1371/journal.pone.0037204	http://dx.doi.org/10.1371/journal.pone.0037204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623992	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343500072
J	Jia, PL; Zhao, ZM				Jia, Peilin; Zhao, Zhongming			Personalized Pathway Enrichment Map of Putative Cancer Genes from Next Generation Sequencing Data	PLOS ONE			English	Article							SOMATIC MUTATIONS; PATTERNS; GENOME	Background: Pathway analysis of a set of genes represents an important area in large-scale omic data analysis. However, the application of traditional pathway enrichment methods to next-generation sequencing (NGS) data is prone to several potential biases, including genomic/genetic factors (e.g., the particular disease and gene length) and environmental factors (e.g., personal life-style and frequency and dosage of exposure to mutagens). Therefore, novel methods are urgently needed for these new data types, especially for individual-specific genome data. Methodology: In this study, we proposed a novel method for the pathway analysis of NGS mutation data by explicitly taking into account the gene-wise mutation rate. We estimated the gene-wise mutation rate based on the individual-specific background mutation rate along with the gene length. Taking the mutation rate as a weight for each gene, our weighted resampling strategy builds the null distribution for each pathway while matching the gene length patterns. The empirical P value obtained then provides an adjusted statistical evaluation. Principal Findings/Conclusions: We demonstrated our weighted resampling method to a lung adenocarcinomas dataset and a glioblastoma dataset, and compared it to other widely applied methods. By explicitly adjusting gene-length, the weighted resampling method performs as well as the standard methods for significant pathways with strong evidence. Importantly, our method could effectively reject many marginally significant pathways detected by standard methods, including several long-gene-based, cancer-unrelated pathways. We further demonstrated that by reducing such biases, pathway crosstalk for each individual and pathway co-mutation map across multiple individuals can be objectively explored and evaluated. This method performs pathway analysis in a sample-centered fashion, and provides an alternative way for accurate analysis of cancer-personalized genomes. It can be extended to other types of genomic data (genotyping and methylation) that have similar bias problems.	[Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Jia, PL (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	zhongming.zhao@vanderbilt.edu	Jia, Peilin/B-4519-2013		National Institutes of Health; 2009 NARSAD Maltz Investigator Award; 2010 NARSAD Young Investigator Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 2009 NARSAD Maltz Investigator Award; 2010 NARSAD Young Investigator Award	This work was partially supported by grants from the National Institutes of Health, the 2009 NARSAD Maltz Investigator Award to ZZ, and the 2010 NARSAD Young Investigator Award to PJ. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; GOJOBORI T, 1982, J MOL EVOL, V18, P360, DOI 10.1007/BF01733904; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gu YY, 2011, HUM MUTAT, V32, P1028, DOI 10.1002/humu.21541; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Ladanyi M, 2008, MODERN PATHOL, V21, pS16, DOI 10.1038/modpathol.3801018; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Ramanan VK, 2012, TRENDS GENET, V28, P323, DOI 10.1016/j.tig.2012.03.004; Raychaudhuri S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001097; Rubin AF, 2007, SCIENCE, V317, DOI 10.1126/science.1138956; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Wendl MC, 2011, BIOINFORMATICS, V27, P1595, DOI 10.1093/bioinformatics/btr193; Xia JF, 2012, HUM MUTAT, V33, pE2341, DOI 10.1002/humu.22096; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhao ZM, 2003, GENE, V312, P207, DOI 10.1016/S0378-1119(03)00670-X	24	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37595	10.1371/journal.pone.0037595	http://dx.doi.org/10.1371/journal.pone.0037595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624051	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500140
J	Panther, E; Durk, T; Ferrari, D; Di Virgilio, F; Grimm, M; Sorichter, S; Cicko, S; Herouy, Y; Norgauer, J; Idzko, M; Muller, T				Panther, Elisabeth; Duerk, Thorsten; Ferrari, Davide; Di Virgilio, Francesco; Grimm, Melanie; Sorichter, Stephan; Cicko, Sanja; Herouy, Yared; Norgauer, Johannes; Idzko, Marco; Mueller, Tobias			AMP Affects Intracellular Ca2+ Signaling, Migration, Cytokine Secretion and T Cell Priming Capacity of Dendritic Cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ADENOSINE 5'-MONOPHOSPHATE; 5'-ADENOSINE MONOPHOSPHATE; ENDOGENOUS ADENOSINE; RECEPTOR ACTIVATION; CHLORIDE SECRETION; A(2B) RECEPTOR; P2Y RECEPTORS; ASTHMA; INFLAMMATION	The nucleotide adenosine-5'-monophosphate (AMP) can be released by various cell types and has been shown to elicit different cellular responses. In the extracellular space AMP is dephosphorylated to the nucleoside adenosine which can then bind to adenosine receptors. However, it has been shown that AMP can also activate A(1) and A(2a) receptors directly. Here we show that AMP is a potent modulator of mouse and human dendritic cell (DC) function. AMP increased intracellular Ca2+ concentration in a time and dose dependent manner. Furthermore, AMP stimulated actin-polymerization in human DCs and induced migration of immature human and bone marrow derived mouse DCs, both via direct activation of A(1) receptors. AMP strongly inhibited secretion of TNF-alpha and IL-12p70, while it enhanced production of IL-10 both via activation of A(2a) receptors. Consequently, DCs matured in the presence of AMP and co-cultivated with naive CD4(+)CD45RA(+) T cells inhibited IFN-gamma production whereas secretion of IL-5 and IL-13 was up-regulated. An enhancement of Th2-driven immune response could also be observed when OVA-pulsed murine DCs were pretreated with AMP prior to co-culture with OVA-transgenic naive OTII T cells. An effect due to the enzymatic degradation of AMP to adenosine could be ruled out, as AMP still elicited migration and changes in cytokine secretion in bone-marrow derived DCs generated from CD73-deficient animals and in human DCs pretreated with the ecto-nucleotidase inhibitor 5'-(alpha, beta-methylene) diphosphate (APCP). Finally, the influence of contaminating adenosine could be excluded, as AMP admixed with adenosine desaminase (ADA) was still able to influence DC function. In summary our data show that AMP when present during maturation is a potent regulator of dendritic cell function and point out the role for AMP in the pathogenesis of inflammatory disorders.	[Panther, Elisabeth] Univ Med Ctr Freiburg, Dept Gastroenterol, Freiburg, Germany; [Duerk, Thorsten; Grimm, Melanie; Sorichter, Stephan; Cicko, Sanja; Idzko, Marco; Mueller, Tobias] Univ Med Ctr Freiburg, Dept Pneumol, Freiburg, Germany; [Ferrari, Davide; Di Virgilio, Francesco] Univ Ferrara, Sect Gen Pathol, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy; [Ferrari, Davide; Di Virgilio, Francesco] Univ Ferrara, ICSI, I-44100 Ferrara, Italy; [Herouy, Yared] Univ Med Ctr Freiburg, Dept Dermatol, Freiburg, Germany; [Norgauer, Johannes] Univ Med Ctr Jena, Dept Dermatol, Jena, Germany	University of Freiburg; University of Freiburg; University of Ferrara; University of Ferrara; University of Freiburg	Panther, E (corresponding author), Univ Med Ctr Freiburg, Dept Gastroenterol, Freiburg, Germany.	tobias.mueller@uniklinik-freiburg.de	DI VIRGILIO, Francesco/O-4634-2019; Müller, Tobias/ABH-7263-2020; Di Virgilio, Francesco/J-3754-2018; Ferrari, Davide/F-5644-2015	DI VIRGILIO, Francesco/0000-0003-3566-1362; Müller, Tobias/0000-0002-9801-3496; Di Virgilio, Francesco/0000-0003-3566-1362; Ferrari, Davide/0000-0002-5727-9204	German Research Foundation [DFG ID7/4-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by Emmy Noether Grant DFG ID7/4-1 from the German Research Foundation (to M.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2005, TRENDS PHARMACOL SCI, V26, P8, DOI 10.1016/j.tips.2004.10.010; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Ben Addi A, 2008, EUR J IMMUNOL, V38, P1610, DOI 10.1002/eji.200737781; Berchtold S, 1999, FEBS LETT, V458, P424, DOI 10.1016/S0014-5793(99)01197-7; Choi SH, 2007, ALLERGY, V62, P1119, DOI 10.1111/j.1398-9995.2007.01412.x; Ferrari D, 2000, FASEB J, V14, P2466, DOI 10.1096/fj.00-0031com; Fontinha BM, 2008, NEUROPHARMACOLOGY, V54, P924, DOI 10.1016/j.neuropharm.2008.01.011; Fossetta J, 2003, MOL PHARMACOL, V63, P342, DOI 10.1124/mol.63.2.342; Gao N, 2007, AM J PHYSIOL-GASTR L, V292, pG492, DOI 10.1152/ajpgi.00257.2006; Hieffiel W, 2008, CAN J PHYSIOL PHARM, V86, P46, DOI [10.1139/Y07-115, 10.1139/y07-115]; Idzko M, 2004, J IMMUNOL, V172, P6011, DOI 10.4049/jimmunol.172.10.6011; Idzko M, 2002, BLOOD, V100, P925, DOI 10.1182/blood.V100.3.925; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Idzko M, 2007, J CLIN INVEST, V117, P464, DOI 10.1172/JCI28949; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Inbe H, 2004, J BIOL CHEM, V279, P19790, DOI 10.1074/jbc.M400360200; Jarvis GE, 1996, EUR J PHARMACOL, V315, P203, DOI 10.1016/S0014-2999(96)00637-1; la Sala A, 2002, BLOOD, V99, P1715, DOI 10.1182/blood.V99.5.1715; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Lennon PF, 1998, J EXP MED, V188, P1433, DOI 10.1084/jem.188.8.1433; Lewis MD, 1996, J CLIN ENDOCR METAB, V81, P1296, DOI 10.1210/jc.81.3.1296; MADARA JL, 1993, J CLIN INVEST, V91, P2320, DOI 10.1172/JCI116462; Manrique HA, 2008, EUR RESPIR J, V31, P1205, DOI 10.1183/09031936.00116207; Muller T, 2010, ALLERGY, V65, P1545, DOI 10.1111/j.1398-9995.2010.02426.x; MULLER T, 2010, AM J RESP CELL MOL B; Novitskiy SV, 2008, BLOOD, V112, P1822, DOI 10.1182/blood-2008-02-136325; Pacheco R, 2005, P NATL ACAD SCI USA, V102, P9583, DOI 10.1073/pnas.0501050102; Panther E, 2003, BLOOD, V101, P3985, DOI 10.1182/blood-2002-07-2113; Panther E, 2001, FASEB J, V15, P1963, DOI 10.1096/fj.01-0169com; Polosa R, 1997, THORAX, V52, P919, DOI 10.1136/thx.52.10.919; Polosa R, 2009, TRENDS PHARMACOL SCI, V30, P528, DOI 10.1016/j.tips.2009.07.005; RESNICK MB, 1993, J IMMUNOL, V151, P5716; Rittiner JE, J BIOL CHEM; Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153; Theron AJ, 2002, INFLAMM RES, V51, P594, DOI 10.1007/PL00012434; van den Berge M, 2004, J ALLERGY CLIN IMMUN, V114, P737, DOI 10.1016/j.jaci.2004.05.071; van den Berge M, 2002, CLIN EXP ALLERGY, V32, P824, DOI 10.1046/j.1365-2222.2002.01385.x; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Wilson Constance N, 2009, Handb Exp Pharmacol, P329, DOI 10.1007/978-3-540-89615-9_11; Wilson JM, 2009, J IMMUNOL, V182, P4616, DOI 10.4049/jimmunol.0801279; WU SN, 1992, JPN J PHYSIOL, V42, P35, DOI 10.2170/jjphysiol.42.35	41	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37560	10.1371/journal.pone.0037560	http://dx.doi.org/10.1371/journal.pone.0037560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624049	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500136
J	Singh, A; Padmadas, SS; Mishra, US; Pallikadavath, S; Johnson, FA; Matthews, Z				Singh, Abhishek; Padmadas, Sabu S.; Mishra, Udaya S.; Pallikadavath, Saseendran; Johnson, Fiifi A.; Matthews, Zoe			Socio-Economic Inequalities in the Use of Postnatal Care in India	PLOS ONE			English	Article							MATERNAL HEALTH; NEONATAL SURVIVAL; SERVICES; PRADESH; PROGRAM	Objective: First, our objective was to estimate socio-economic inequalities in the use of postnatal care (PNC) compared with those in the use of care at birth and antenatal care. Second, we wanted to compare inequalities in the use of PNC between facility births and home births and to determine inequalities in the use of PNC among mothers with high-risk births. Methods and Findings: Rich-poor ratios and concentration indices for maternity care were estimated using the third round of the District Level Household Survey conducted in India in 2007-08. Binary logistic regression models were used to examine the socio-economic inequalities associated with use of PNC after adjusting for relevant socio-economic and demographic characteristics. PNC for both mothers and newborns was substantially lower than the care received during pregnancy and child birth. Only 44% of mothers in India at the time of survey received any care within 48 hours after birth. Likewise, only 45% of newborns received check-up within 24 hours of birth. Mothers who had home births were significantly less likely to have received PNC than those who had facility births, with significant differences across the socioeconomic strata. Moreover, the rich-poor gap in PNC use was significantly wider for mothers with birth complications. Conclusions: PNC use has been unacceptably low in India given the risks of mortality for mothers and babies shortly after birth. However, there is evidence to suggest that effective use of pregnancy and childbirth care in health facilities led to better PNC. There are also significant socio-economic inequalities in access to PNC even for those accessing facility-based care. The coverage of essential PNC is inadequate, especially for mothers from economically disadvantaged households. The findings suggest the need for strengthening PNC services to keep pace with advances in coverage for care at birth and prenatal services in India through targeted policy interventions.	[Singh, Abhishek] Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Bombay, Maharashtra, India; [Padmadas, Sabu S.; Johnson, Fiifi A.; Matthews, Zoe] Univ Southampton, Ctr Global Hlth Populat Poverty & Policy, Southampton, Hants, England; [Padmadas, Sabu S.; Johnson, Fiifi A.; Matthews, Zoe] Univ Southampton, Div Social Stat & Demog, Southampton, Hants, England; [Mishra, Udaya S.] Ctr Dev Studies, Thiruvananthapuram, India; [Pallikadavath, Saseendran] Univ Portsmouth, Sch Hlth Sci & Social Work, Global Hlth & Social Care Unit, Portsmouth, Hants, England	International Institute for Population Sciences; University of Southampton; University of Southampton; University of Portsmouth	Singh, A (corresponding author), Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Bombay, Maharashtra, India.	abhi_iips@yahoo.co.in	Amoako Johnson, Fiifi/GWC-1466-2022; Matthews, Zoe/HGD-0506-2022; Singh, Abhishek/ABC-7813-2020	Singh, Abhishek/0000-0001-6263-4410; Matthews, Zoe/0000-0003-1533-6618; Padmadas, Sabu/0000-0002-6538-9374; Pallikadavath, Saseendran/0000-0002-2598-9949	ESRC [RES-238-25-0009]; Economic and Social Research Council [ES/H024700/1] Funding Source: researchfish; ESRC [ES/H024700/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was conducted as part of the UK Economic & Social Research Council (ESRC) Brazil-India Pathfinder Programme for Collaborative Analysis of Microdata Resources. The authors gratefully acknowledge the ESRC for facilitating the study and providing financial support (Grant reference: RES-238-25-0009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ANAL HLTH EQUITY USI; Anwar A., 2004, BANGLADESH INEQUALIT; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Bhatia JC., 1995, HLTH TRANSITION REV, V5, P127; Dhakal Sulochana, 2007, BMC Pregnancy Childbirth, V7, P19, DOI 10.1186/1471-2393-7-19; Dilip TR, 2009, INT POP C IUSSP MARR; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Grover A, 2010, SPECIAL RAPPORTEUR R; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Halder Amal Krishna, 2007, World Health Popul, V9, P48; Howe LD, 2009, J EPIDEMIOL COMMUN H, V63, P871, DOI 10.1136/jech.2009.088021; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS SURV; Jat TR, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-59; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; Mavalankar D, 2008, B WORLD HEALTH ORGAN, V86, P243, DOI 10.2471/BLT.07.048454; Mavlankar DV, 1999, IMPLEMENTING REPROD; Mistry R, 2009, SOC SCI MED, V69, P926, DOI 10.1016/j.socscimed.2009.07.008; MoHFW, 1997, REPR CHILD HLTH PROG; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; Pallikadavath S, 2004, SOC SCI MED, V59, P1147, DOI 10.1016/j.socscimed.2003.11.045; Patel V, 2002, AM J PSYCHIAT, V159, P43, DOI 10.1176/appi.ajp.159.1.43; Ram F, 2006, J HLTH DEV, V2, P67; RamaRao S, 2001, HEALTH POLICY PLANN, V16, P256, DOI 10.1093/heapol/16.3.256; Rasaily R, 2008, INDIAN PEDIATR, V45, P991; RGI, 2011, SPEC B MAT MORT IND; RGI, 2010, COMP IND FERT MORT I; Ronsman C, 2006, MATERNAL MORTALITY W, P13; Rutstein SO, 2004, DHS COMP REPORTS, V6; Sines E, 2007, CRITICAL OPPORTUNITY; Sunil TS, 2006, SOC SCI MED, V62, P1943, DOI 10.1016/j.socscimed.2005.09.004; VANDOORSLAER E, 1992, J HEALTH ECON, V11, P389, DOI 10.1016/0167-6296(92)90013-Q; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wagstaff A, 2004, HEALTH ECON, V13, P297, DOI 10.1002/hec.822; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 1998, BAS NEWB RES PRACT G	40	60	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37037	10.1371/journal.pone.0037037	http://dx.doi.org/10.1371/journal.pone.0037037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22623976	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000305343500053
J	Pashover-Schallinger, E; Aswad, M; Schif-Zuck, S; Shapiro, H; Singer, P; Ariel, A				Pashover-Schallinger, Ester; Aswad, Miran; Schif-Zuck, Sagie; Shapiro, Haim; Singer, Pierre; Ariel, Amiram			The atypical chemokine receptor D6 controls macrophage efferocytosis and cytokine secretion during the resolution of inflammation	FASEB JOURNAL			English	Article						chemokine receptors; apoptotic cell clearance; acute immune responses; leukocytes	APOPTOTIC CELLS; ALTERNATIVE ACTIVATION; NEUTROPHILS; PHAGOCYTOSIS; ENGULFMENT; EXPRESSION; CLEARANCE; SIGNALS; IL-10; BETA	The resolution of acute inflammation is hallmarked by the apoptotic death of inflammatory polymorphonuclear (PMN) cells, followed by their clearance by macrophages. In turn, resolution-phase macrophages exert reduced proinflammatory cytokine production, termed immune silencing. In this study, we found that the atypical chemokine receptor D6 plays an important and chemokine scavenging-independent role in promoting macrophage-mediated resolution. D6(-/-) mice displayed increased numbers of macrophages (2.2-fold increase), but not neutrophils, in their peritonea during the resolution of murine zymosan A-initiated peritonitis, in comparison to D6(+/+) animals. Moreover, D6-deficient macrophages engulfed higher numbers of apoptotic PMN cells in vivo (1.6-fold increase), and secreted higher amounts of TNF-alpha, CCL3, and CCL5 ex vivo than their wild-type (WT) counterparts. In addition, D6 was found to be expressed on apoptotic neutrophils from healthy humans and rodents. Moreover, the immune silencing of LPS-stimulated macrophages following their incubation with senescent PMN cells ex vivo (in terms of TNF-alpha, IL-1 beta, and CCL5 secretion) was diminished (50-65% decrease) when D6(-/-) PMN cells were applied. Accordingly, the adhesive responses induced by macrophage interactions with senescent PMN cells were reduced with D6-deficient PMN cells. Thus, our results indicate a novel mode of action for D6 during the resolution of inflammation that is instrumental to the shaping of resolving macrophage phenotypes and the completion of resolution.-Pashover-Schallinger, E., Aswad, M., Schif-Zuck, S., Shapiro, H., Singer, P., Ariel, A. The atypical chemokine receptor D6 controls macrophage efferocytosis and cytokine secretion during the resolution of inflammation. FASEB J. 26, 3891-3900 (2012). www.fasebj.org	[Pashover-Schallinger, Ester; Aswad, Miran; Schif-Zuck, Sagie; Ariel, Amiram] Univ Haifa, Fac Nat Sci, Dept Biol, IL-31905 Haifa, Israel; [Shapiro, Haim; Singer, Pierre] Rabin Med Ctr, Inst Nutr Res, Petah Tiqwa, Israel	University of Haifa; Rabin Medical Center	Ariel, A (corresponding author), Univ Haifa, Fac Nat Sci, Dept Biol, IL-31905 Haifa, Israel.	amiram@research.haifa.ac.il	Shapiro, Haim/E-1854-2018	Shapiro, Haim/0000-0001-9374-4049; Schif-Zuck, Sagie/0000-0001-5415-9488	Israel Science Foundation [534/09]; Nutricia Research Foundation; Marc Rich Foundation; Teva Pharmaceuticals Ltd. (Natania, Israel)	Israel Science Foundation(Israel Science Foundation); Nutricia Research Foundation(Danone Nutricia); Marc Rich Foundation; Teva Pharmaceuticals Ltd. (Natania, Israel)(Teva Pharmaceutical Industries)	The authors thank Profs. Alberto Mantovani and Massimo Locati (Instituto Clinico Humanitas, Milan, Italy) for providing the D6<SUP>-/-</SUP> mice and for their helpful advice and Simaan Assi for technical assistance with animal procedures. This work was supported by grants from the Israel Science Foundation (grant 534/09), the Nutricia Research Foundation, and the Marc Rich Foundation (to A. A.). A. A. is a recipient of the young scientist award from Teva Pharmaceuticals Ltd. (Natania, Israel). The authors declare no conflicts of interest.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Amano H, 2004, J IMMUNOL, V172, P398, DOI 10.4049/jimmunol.172.1.398; Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Bonecchi R, 2008, BLOOD, V112, P493, DOI 10.1182/blood-2007-08-108316; Bordon Y, 2009, J IMMUNOL, V182, P5032, DOI 10.4049/jimmunol.0802802; Byrne A, 2002, J IMMUNOL, V168, P1968, DOI 10.4049/jimmunol.168.4.1968; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; D'Amico G, 2000, NAT IMMUNOL, V1, P387, DOI 10.1038/80819; de la Torre YM, 2007, P NATL ACAD SCI USA, V104, P2319, DOI 10.1073/pnas.0607514104; de la Torre YM, 2005, EUR J IMMUNOL, V35, P1342, DOI 10.1002/eji.200526114; Di Liberto D, 2008, J EXP MED, V205, P2075, DOI 10.1084/jem.20070608; Erwig LP, 2007, AM J PATHOL, V171, P2, DOI 10.2353/ajpath.2007.070135; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hart D, 2008, J IMMUNOL, V181, P8053, DOI 10.4049/jimmunol.181.11.8053; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; KOWOLENKO M, 1990, J IMMUNOL METHODS, V127, P71, DOI 10.1016/0022-1759(90)90342-S; Lee KM, 2011, BLOOD, V118, P6220, DOI 10.1182/blood-2011-03-344044; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Liu LP, 2006, J IMMUNOL, V177, P17, DOI 10.4049/jimmunol.177.1.17; Majno G., 2004, CELLS TISSUES DIS PR; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McKimmie CS, 2008, J IMMUNOL, V181, P8170, DOI 10.4049/jimmunol.181.11.8170-a; Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72; Nibbs RJB, 2009, METHOD ENZYMOL, V460, P245, DOI 10.1016/S0076-6879(09)05212-4; Patel VA, 2006, J BIOL CHEM, V281, P4663, DOI 10.1074/jbc.M508342200; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; ROSSI AG, 1998, LUNG BIOL HEALTH DIS, V112, P9; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Vetrano S, 2010, GUT, V59, P197, DOI 10.1136/gut.2009.183772; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Weigert A, 2009, BIOL CHEM, V390, P379, DOI 10.1515/BC.2009.048; Whitehead GS, 2007, AM J RESP CRIT CARE, V175, P243, DOI 10.1164/rccm.200606-839OC	45	29	30	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3891	3900		10.1096/fj.11-194894	http://dx.doi.org/10.1096/fj.11-194894			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22651933				2022-12-25	WOS:000308391600029
J	Bai, M; Pang, XY; Lou, JZ; Zhou, QJ; Zhang, K; Ma, J; Li, J; Sun, F; Hsu, VW				Bai, Ming; Pang, Xiaoyun; Lou, Jizhong; Zhou, Qiangjun; Zhang, Kai; Ma, Jun; Li, Jian; Sun, Fei; Hsu, Victor W.			Mechanistic Insights into Regulated Cargo Binding by ACAP1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; ALPHA-5-BETA-1 INTEGRIN; 3D MICROENVIRONMENTS; VESICLE FORMATION; ARFGAP1 PROMOTES; COAT; TRAFFICKING; REFINEMENT; TRANSPORT; DYNAMICS	Coat complexes sort protein cargoes into vesicular transport pathways. An emerging class of coat components has been the GTPase-activating proteins (GAPs) that act on the ADP-ribosylation factor (ARF) family of small GTPases. ACAP1 (ArfGAP with coiled-coil, ankyrin repeat, and PH domains protein 1) is an ARF6 GAP that also acts as a key component of a recently defined clathrin complex for endocytic recycling. Phosphorylation by Akt has been shown to enhance cargo binding by ACAP1 in explaining how integrin recycling is an example of regulated transport. We now shed further mechanistic insights into how this regulation is achieved at the level of cargo binding by ACAP1. We initially defined a critical sequence in the cytoplasmic domain of integrin beta 1 recognized by ACAP1 and showed that this sequence acts as a recycling sorting signal. We then pursued a combination of structural, modeling, and functional studies, which suggest that phosphorylation of ACAP1 relieves a localized mechanism of autoinhibition in regulating cargo binding. Thus, we have elucidated a key regulatory juncture that controls integrin recycling and also advanced the understanding of how regulated cargo binding can lead to regulated transport.	[Bai, Ming; Li, Jian; Hsu, Victor W.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Bai, Ming; Li, Jian; Hsu, Victor W.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Pang, Xiaoyun; Lou, Jizhong; Zhou, Qiangjun; Zhang, Kai; Ma, Jun; Sun, Fei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Institute of Biophysics, CAS	Li, J (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	jli@rics.bwh.harvard.edu; feisun@sun5.ibp.ac.cn; vhsu@rics.bwh.harvard.edu	Sun, Fei/C-4190-2015; Sun, Fei/AAR-3186-2020	Sun, Fei/0000-0002-0351-5144; Sun, Fei/0000-0002-0351-5144; Zhou, Qiangjun/0000-0003-1789-9588; Zhou, Qiangjun/0000-0002-7768-0249; Zhang, Kai/0000-0001-8617-2855	National Institutes of Health [GM073016]; National Science Foundation of China [31000635, 31021062, 31070827]; Chinese Ministry of Science and Technology [2011CB910301, 2011CB910900]; Chinese Academy of Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073016. This work was also supported by National Science Foundation of China Grants 31000635 and 31021062 and Chinese Ministry of Science and Technology 973 Project Grants 2011CB910301 and 2011CB910900.; Supported by National Science Foundation of China Grant 31070827 and the Knowledge Innovation Program of the Chinese Academy of Sciences.	Bai M, 2011, NAT CELL BIOL, V13, P559, DOI 10.1038/ncb2221; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hao Q, 2000, J APPL CRYSTALLOGR, V33, P980, DOI 10.1107/S0021889800001424; Hasan N, 2010, EXP CELL RES, V316, P12, DOI 10.1016/j.yexcr.2009.10.007; Ismail SA, 2010, CELL, V141, P812, DOI 10.1016/j.cell.2010.03.051; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mai A, 2011, J CELL BIOL, V194, P291, DOI 10.1083/jcb.201012126; Mandiyan V, 1999, EMBO J, V18, P6890, DOI 10.1093/emboj/18.24.6890; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Oh SJ, 2010, J BIOL CHEM, V285, P14610, DOI 10.1074/jbc.M109.043935; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015	43	20	22	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28675	28685		10.1074/jbc.M112.378810	http://dx.doi.org/10.1074/jbc.M112.378810			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22645133	Green Published, hybrid			2022-12-25	WOS:000308074600041
J	Juarez, O; Neehaul, Y; Turk, E; Chahboun, N; Demicco, JM; Hellwig, P; Barquera, B				Juarez, Oscar; Neehaul, Yashvin; Turk, Erin; Chahboun, Najat; Demicco, Jessica M.; Hellwig, Petra; Barquera, Blanca			The Role of Glycine Residues 140 and 141 of Subunit B in the Functional Ubiquinone Binding Site of the Na+-pumping NADH: quinone Oxidoreductase from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING NADH; NADHQUINONE OXIDOREDUCTASE; RESPIRATORY-CHAIN; CYTOCHROME-C; INFRARED-SPECTROSCOPY; MEMBRANE-PROTEINS; NQRC SUBUNITS; ALGINOLYTICUS; REDUCTASE; KORORMICIN	The Na+-pumping NADH: quinone oxidoreductase (Na+-NQR) is the main entrance for electrons into the respiratory chain of many marine and pathogenic bacteria. The enzyme accepts electrons from NADH and donates them to ubiquinone, and the free energy released by this redox reaction is used to create an electrochemical gradient of sodium across the cell membrane. Here we report the role of glycine 140 and glycine 141 of the NqrB subunit in the functional binding of ubiquinone. Mutations at these residues altered the affinity of the enzyme for ubiquinol. Moreover, mutations in residue NqrB-G140 almost completely abolished the electron transfer to ubiquinone. Thus, NqrB-G140 and -G141 are critical for the binding and reaction of Na+-NQR with its electron acceptor, ubiquinone.	[Juarez, Oscar; Demicco, Jessica M.; Barquera, Blanca] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol, Troy, NY 12180 USA; [Neehaul, Yashvin; Chahboun, Najat; Hellwig, Petra] Univ Strasbourg, CNRS, Inst Chim, Lab Spectroscopie Vibrat & Electrochim Biomol, F-67060 Strasbourg, France; [Turk, Erin] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Rensselaer Polytechnic Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Stanford University	Barquera, B (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol, Rm 2239,110 8th St, Troy, NY 12180 USA.			Juarez, Oscar/0000-0002-2915-8413; hellwig, petra/0000-0001-6294-5163; Piazza, Erin/0000-0002-3263-5946	National Science Foundation Division of Molecular and Cellular Biosciences Grant [1052234]	National Science Foundation Division of Molecular and Cellular Biosciences Grant	This work was supported in part by National Science Foundation Division of Molecular and Cellular Biosciences Grant 1052234.	Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Behr J, 1998, BIOCHEMISTRY-US, V37, P7400, DOI 10.1021/bi9731697; Bertsova YV, 2004, FEBS LETT, V563, P207, DOI 10.1016/S0014-5793(04)00312-6; Casutt MS, 2011, J BIOL CHEM, V286, P40075, DOI 10.1074/jbc.M111.224980; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; Han M, 1996, J BIOL CHEM, V271, P32330, DOI 10.1074/jbc.271.50.32330; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2002, ARCH BIOCHEM BIOPHYS, V401, P173, DOI 10.1016/S0003-9861(02)00007-3; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; HAYASHI M, 1992, BIOCHIM BIOPHYS ACTA, V1099, P145, DOI 10.1016/0005-2728(92)90211-J; Hellwig P, 2000, BIOCHEMISTRY-US, V39, P10884, DOI 10.1021/bi000842a; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2011, J BIOL CHEM, V286, P26383, DOI 10.1074/jbc.M111.257873; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; MOSS D, 1990, EUR J BIOCHEM, V187, P565, DOI 10.1111/j.1432-1033.1990.tb15338.x; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; Neehaul Y, 2012, BIOCHEMISTRY-US, V51, P4072, DOI 10.1021/bi300343u; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Yoshikawa K, 1997, J ANTIBIOT, V50, P949, DOI 10.7164/antibiotics.50.949; Yoshikawa K, 1999, J ANTIBIOT, V52, P182, DOI 10.7164/antibiotics.52.182	37	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25678	25685		10.1074/jbc.M112.366088	http://dx.doi.org/10.1074/jbc.M112.366088			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22645140	hybrid, Green Published			2022-12-25	WOS:000306651700075
J	Gan, SW; Tan, E; Lin, X; Yu, DJ; Wang, JJ; Tan, GMY; Vararattanavech, A; Yeo, CY; Soon, CH; Soong, TW; Pervushin, K; Torres, J				Gan, Siok-Wan; Tan, Edward; Lin, Xin; Yu, Dejie; Wang, Juejin; Tan, Gregory Ming-Yeong; Vararattanavech, Ardcharaporn; Yeo, Chiew Ying; Soon, Cin Huang; Soong, Tuck Wah; Pervushin, Konstantin; Torres, Jaume			The Small Hydrophobic Protein of the Human Respiratory Syncytial Virus Forms Pentameric Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; INTEGRAL MEMBRANE-PROTEIN; INFLUENZA-A VIRUS; TRANSMEMBRANE DOMAIN; SH GENE; HISTIDINE RESIDUE; STRUCTURAL BASIS; PROTON CHANNEL; P7 PROTEIN; SUBGROUP-B	The small hydrophobic (SH) protein is encoded by the human respiratory syncytial virus. Its absence leads to viral attenuation in the context of whole organisms, and it prevents apoptosis in infected cells. Herein, we have examined the structure of SH protein in detergent micelles and in lipid bilayers, by solution NMR and attenuated total reflection-Fourier transform infrared spectroscopy, respectively. We found that SH protein has a single alpha-helical transmembrane domain and forms homopentamers in several detergents. In detergent micelles, the transmembrane domain is flanked N-terminally by an alpha-helix that forms a ring around the lumen of the pore and C-terminally by an extended beta-turn. SH protein was found in the plasma membrane of transiently expressing HEK 293 cells, which showed pH-dependent (acid-activated) channel activity. Channel activity was abolished in mutants lacking both native His residues, His(22) and His(51), but not when either His was present. Herein, we propose that the pentameric model of SH protein presented is a physiologically relevant conformation, albeit probably not the only one, in which SH contributes to RSV infection and replication. Viroporins are short (similar to 100 amino acids) viral membrane proteins that form oligomers of a defined size, act as proton or ion channels, and in general enhance membrane permeability in the host. However, with some exceptions, their precise biological role of their channel activity is not understood. In general, viroporins resemble poorly specialized proteins but are nevertheless critical for viral fitness. In vivo, viruses lacking viroporins usually exhibit an attenuated or weakened phenotype, altered tropism, and diminished pathological effects. We have chosen to study the SH protein, 64 amino acids long, found in the human respiratory syncytial virus because of the effect of RSV on human health and the lack of adequate antivirals. We show that SH protein forms oligomers that behave as ion channels when activated at low pH. This study adds SH protein to a growing group of viroporins that have been structurally characterized. Although the precise biological role of this pentameric channel is still unknown, this report is nevertheless essential to fill some of the many gaps that exist in the understanding of SH protein function.	[Gan, Siok-Wan; Tan, Edward; Lin, Xin; Vararattanavech, Ardcharaporn; Yeo, Chiew Ying; Soon, Cin Huang; Pervushin, Konstantin; Torres, Jaume] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Yu, Dejie; Wang, Juejin; Tan, Gregory Ming-Yeong; Soong, Tuck Wah] Natl Univ Singapore, Ctr Life Sci, Dept Physiol, Singapore 117456, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Pervushin, K (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	kpervushin@ntu.edu.sg; jtorres@ntu.edu.sg	Juejin, Wang/ABA-7017-2020; Tan, Edward/W-8611-2019; Pervushin, Konstantin/AAJ-6580-2020; Wang, Jue/GVU-0480-2022; Torres, Jaume/A-2179-2011; Torres, Jaume/AAJ-4510-2020	Pervushin, Konstantin/0000-0002-6393-4340; Torres, Jaume/0000-0002-1282-9727; , Juejin/0000-0003-4921-5451	National Research Foundation [NRF-CRP4-2008-02]	National Research Foundation	This work was supported by National Research Foundation Grant NRF-CRP4-2008-02 (to J. T.).	ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; Arkin IT, 1997, J AM CHEM SOC, V119, P8973, DOI 10.1021/ja964253x; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Briggs JAG, 2001, PROTEINS, V44, P370, DOI 10.1002/prot.1102; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bukreyev A, 1997, J VIROL, V71, P8973, DOI 10.1128/JVI.71.12.8973-8982.1997; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Campanella M, 2004, J BIOL CHEM, V279, P18440, DOI 10.1074/jbc.M309494200; Carter SD, 2010, FEBS LETT, V584, P2786, DOI 10.1016/j.febslet.2010.05.006; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chanchevalap S, 2000, J BIOL CHEM, V275, P7811, DOI 10.1074/jbc.275.11.7811; Chen MD, 2000, J INFECT DIS, V182, P1228, DOI 10.1086/315829; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; Clarke D, 2006, J BIOL CHEM, V281, P37057, DOI 10.1074/jbc.M602434200; Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345; COLLINS PL, 1990, J GEN VIROL, V71, P1571, DOI 10.1099/0022-1317-71-7-1571; COLLINS PL, 1993, J GEN VIROL, V74, P1445, DOI 10.1099/0022-1317-74-7-1445; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fleming KG, 2002, J MOL BIOL, V323, P563, DOI 10.1016/S0022-2836(02)00920-8; Fuentes S, 2007, J VIROL, V81, P8361, DOI 10.1128/JVI.02717-06; Gan SW, 2008, PROTEIN SCI, V17, P813, DOI 10.1110/ps.073366208; Gan SW, 2011, ANAL BIOCHEM, V416, P100, DOI 10.1016/j.ab.2011.05.007; Gandhi CS, 1999, J BIOL CHEM, V274, P5474, DOI 10.1074/jbc.274.9.5474; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Guntert Peter, 2004, Methods Mol Biol, V278, P353; He B, 2001, J VIROL, V75, P4068, DOI 10.1128/JVI.75.9.4068-4079.2001; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Howard KP, 2002, P NATL ACAD SCI USA, V99, P8568, DOI 10.1073/pnas.132266099; Hu J, 2007, PROTEIN SCI, V16, P2153, DOI 10.1110/ps.072996707; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Krusat T, 1997, ARCH VIROL, V142, P1247, DOI 10.1007/s007050050156; LAMB RA, 1993, VIROLOGY, V197, P1, DOI 10.1006/viro.1993.1561; Lin YA, 2003, J VIROL, V77, P3371, DOI 10.1128/JVI.77.6.3371-3383.2003; Luik P, 2009, P NATL ACAD SCI USA, V106, P12712, DOI 10.1073/pnas.0905966106; Madan V, 2008, CELL MICROBIOL, V10, P437, DOI 10.1111/j.1462-5822.2007.01057.x; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; McGhie EJ, 2002, MOL MICROBIOL, V44, P1309, DOI 10.1046/j.1365-2958.2002.02958.x; MORRIS JA, 1956, P SOC EXP BIOL MED, V92, P544, DOI 10.3181/00379727-92-22538; Neznanov N, 2001, J VIROL, V75, P10409, DOI 10.1128/JVI.75.21.10409-10420.2001; OLMSTED RA, 1989, J VIROL, V63, P2019, DOI 10.1128/JVI.63.5.2019-2029.1989; Parthasarathy K, 2008, BIOPHYS J, V95, pL39, DOI 10.1529/biophysj.108.133041; Perez M, 1997, VIROLOGY, V235, P342, DOI 10.1006/viro.1997.8696; Pervushin K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000511; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; Qin HJ, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-51; Rixon HWM, 2005, J GEN VIROL, V86, P375, DOI 10.1099/vir.0.80563-0; Rixon HWML, 2004, J GEN VIROL, V85, P1153, DOI 10.1099/vir.0.19769-0; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Takeuchi K, 2007, J BIOL CHEM, V282, P15179, DOI 10.1074/jbc.M608264200; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; Techaarpornkul S, 2001, J VIROL, V75, P6825, DOI 10.1128/JVI.75.15.6825-6834.2001; Tolley KP, 1996, VACCINE, V14, P1637, DOI 10.1016/S0264-410X(96)00136-3; Torres J, 2001, BIOPOLYMERS, V59, P396, DOI 10.1002/1097-0282(200111)59:6<396::AID-BIP1044>3.3.CO;2-P; WANG C, 1995, BIOPHYS J, V69, P1363, DOI 10.1016/S0006-3495(95)80003-2; Whitehead SS, 1999, J VIROL, V73, P3438, DOI 10.1128/JVI.73.4.3438-3442.1999; Wilson L, 2004, VIROLOGY, V330, P322, DOI 10.1016/j.virol.2004.09.033; Wilson RL, 2006, J VIROL, V80, P1700, DOI 10.1128/JVI.80.4.1700-1709.2006; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Yuill KH, 2007, PFLUG ARCH EUR J PHY, V455, P333, DOI 10.1007/s00424-007-0282-7	73	85	87	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24671	24689		10.1074/jbc.M111.332791	http://dx.doi.org/10.1074/jbc.M111.332791			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22621926	Green Published, hybrid			2022-12-25	WOS:000306651100061
J	Ji, YW; Sun, SY; Xia, S; Yang, L; Li, XQ; Qi, L				Ji, Yewei; Sun, Shengyi; Xia, Sheng; Yang, Liu; Li, Xiaoqing; Qi, Ling			Short Term High Fat Diet Challenge Promotes Alternative Macrophage Polarization in Adipose Tissue via Natural Killer T Cells and Interleukin-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; INVARIANT NKT CELLS; IN-VIVO; LIVER-DISEASE; ACTIVATION; INFLAMMATION; OBESITY; MECHANISM; SENSITIVITY; PRECURSOR	Inflammation in adipose tissue plays an important role in the pathogenesis of obesity-associated complications. However, the detailed cellular events underlying the inflammatory changes at the onset of obesity have not been characterized. Here we show that an acute HFD challenge is unexpectedly associated with elevated alternative (M2) macrophage polarization in adipose tissue mediated by Natural Killer T (NKT) cells. Upon 4d HFD feeding, NKT cells are activated, promote M2 macrophage polarization and induce arginase 1 expression via interleukin (IL)-4 in adipose tissue, not in the liver. In NKT-deficient CD1d(-/-) mice, M2 macrophage polarization in adipose tissue is reduced while systemic glucose homeostasis and insulin tolerance are impaired upon 4d HFD challenge. Thus, our study demonstrate, for the first time to our knowledge, that acute HFD feeding is associated with remarkably pronounced and dynamic immune responses in adipose tissue, and adipose-resident NKT cells may link acute HFD feeding with inflammation.	[Ji, Yewei; Xia, Sheng; Li, Xiaoqing; Qi, Ling] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Sun, Shengyi; Qi, Ling] Cornell Univ, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Qi, L (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	lq35@cornell.edu	Ji, Yewei/F-5040-2014	Ji, Yewei/0000-0002-4249-6812; Qi, Ling/0000-0001-8229-0184; Sun, Shengyi/0000-0002-1734-3902	National Institutes of Health NIDDK [R01DK082582, R01DK082582-S1]; American Diabetes Association (ADA) [7-08-JF-47, 1-12-CD-04]; Howard Hughes Medical Institute; American Heart Association; ADA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082582] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association (ADA)(American Diabetes Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Heart Association(American Heart Association); ADA(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded, in whole or in part, by National Institutes of Health NIDDK R01DK082582 and R01DK082582-S1 (to L. Q.) and American Diabetes Association (ADA) Grants 7-08-JF-47 and 1-12-CD-04.; Supported by the International Student Research Fellowship from Howard Hughes Medical Institute.; Supported by the Predoctoral Fellowship from American Heart Association.; Recipient of the Junior Faculty and Career Development Awards from ADA. To whom correspondence should be addressed. Tel.: 607-254-8857; Fax: 607-255-6269; E-mail:lq35@cornell.edu.	Bai L, 2012, J IMMUNOL, V188, P3053, DOI 10.4049/jimmunol.1102414; Bai L, 2009, P NATL ACAD SCI USA, V106, P10254, DOI 10.1073/pnas.0901228106; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Bezbradica JS, 2005, J IMMUNOL, V174, P4696, DOI 10.4049/jimmunol.174.8.4696; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Halder RC, 2007, J CLIN INVEST, V117, P2302, DOI 10.1172/JCI31602; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kotas ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025478; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Li JP, 2002, AM J PHYSIOL-ENDOC M, V282, pE1334, DOI 10.1152/ajpendo.00516.2001; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; MACDONALD HR, 1993, IMMUNOL REV, V133, P105, DOI 10.1111/j.1600-065X.1993.tb01512.x; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oki S, 2004, J CLIN INVEST, V113, P1631, DOI 10.1172/JCI200420862; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Satoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030568; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Sun S., 2012, ANN REV NUT IN PRESS; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zhang GQ, 2011, AM J PHYSIOL-LUNG C, V301, pL975, DOI 10.1152/ajplung.00114.2011	49	109	113	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24378	24386		10.1074/jbc.M112.371807	http://dx.doi.org/10.1074/jbc.M112.371807			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645141	Green Published, hybrid			2022-12-25	WOS:000306651100032
J	Chen, ZJ; Vigueira, PA; Chambers, KT; Hall, AM; Mitra, MS; Qi, N; McDonald, WG; Colca, JR; Kletzien, RF; Finck, BN				Chen, Zhouji; Vigueira, Patrick A.; Chambers, Kari T.; Hall, Angela M.; Mitra, Mayurranjan S.; Qi, Nathan; McDonald, William G.; Colca, Jerry R.; Kletzien, Rolf F.; Finck, Brian N.			Insulin Resistance and Metabolic Derangements in Obese Mice Are Ameliorated by a Novel Peroxisome Proliferator-activated Receptor gamma-sparing Thiazolidinedione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; MITOCHONDRIAL-MEMBRANE PROTEIN; PERFUSED-RAT-LIVER; PPAR-GAMMA; FATTY LIVERS; ROSIGLITAZONE; PIOGLITAZONE; ADIPONECTIN; MITONEET; DELETION	Currently approved thiazolidinediones (TZDs) are effective insulin-sensitizing drugs that may have efficacy for treatment of a variety of metabolic and inflammatory diseases, but their use is limited by side effects that are mediated through ectopic activation of the peroxisome proliferator-activated receptor gamma (PPAR gamma). Emerging evidence suggests that the potent anti-diabetic efficacy of TZDs can be separated from the ability to serve as ligands for PPAR gamma. A novel TZD analog (MSDC-0602) with very low affinity for binding and activation of PPAR gamma was evaluated for its effects on insulin resistance in obese mice. MSDC-0602 treatment markedly improved several measures of multiorgan insulin sensitivity, adipose tissue inflammation, and hepatic metabolic derangements, including suppressing hepatic lipogenesis and gluconeogenesis. These beneficial effects were mediated at least in part via direct actions on hepatocytes and were preserved in hepatocytes from liver-specific PPAR gamma(-/-) mice, indicating that PPAR gamma was not required to suppress these pathways. In conclusion, the beneficial pharmacology exhibited by MSDC-0602 on insulin sensitivity suggests that PPAR gamma-sparing TZDs are effective for treatment of type 2 diabetes with reduced risk of PPAR gamma-mediated side effects.	[Chen, Zhouji; Vigueira, Patrick A.; Chambers, Kari T.; Hall, Angela M.; Mitra, Mayurranjan S.; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [McDonald, William G.; Colca, Jerry R.; Kletzien, Rolf F.] Metab Solut Dev Co, Kalamazoo, MI 49007 USA; [Qi, Nathan] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Washington University (WUSTL); University of Michigan System; University of Michigan	Finck, BN (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave,Box 8031, St Louis, MO 63110 USA.	bfinck@wustl.edu		Hall, Angela Marie/0000-0003-0006-7910; Finck, Brian/0000-0001-5411-3674	National Institutes of Health [R41 DK084596, R42 AA021228, T32 DK007296]; core services of the Digestive Diseases Research Core Center [P30 DK52574]; Nutrition Obesity Research Center at Washington University School of Medicine [P30 DK56341]; Barnes Jewish Hospital Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P30DK052574, P30DK020572, P30DK020579, T32DK007296, R41DK084596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R42AA021228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); core services of the Digestive Diseases Research Core Center; Nutrition Obesity Research Center at Washington University School of Medicine; Barnes Jewish Hospital Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R41 DK084596 and R42 AA021228 and the core services of the Digestive Diseases Research Core Center (Grant P30 DK52574) and the Nutrition Obesity Research Center (Grant P30 DK56341) at Washington University School of Medicine. This work was also supported by a grant from the Barnes Jewish Hospital Foundation. We wish to disclose that Drs. McDonald, Colca, and Kletzien are employees and significant stockholders of Metabolic Solutions Development Co. The drugs provided in this study were provided by Metabolic Solutions Development Co.; Diabetes Research Postdoctoral Training Program Fellow (National Institutes of Health Grant T32 DK007296).	Adams MD, 1998, BIOCHEM PHARMACOL, V55, P1915, DOI 10.1016/S0006-2952(98)00052-5; Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188; Balkrishnan R, 2007, CLIN THER, V29, P1306, DOI 10.1016/j.clinthera.2007.06.019; Beysen C, 2008, J LIPID RES, V49, P2657, DOI 10.1194/jlr.M800165-JLR200; Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Chen ZJ, 2000, J BIOL CHEM, V275, P32807, DOI 10.1074/jbc.M004913200; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Cho MC, 2011, MOL CELL BIOCHEM, V358, P75, DOI 10.1007/s11010-011-0923-1; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Colca J. R., 2009, 20 WORLD DIAB C OCT; Colca JR, 2006, EXPERT OPIN INV DRUG, V15, P205, DOI 10.1517/13543784.15.3.205; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; de Vries CS, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3076; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Funk C, 2001, TOXICOLOGY, V167, P83, DOI 10.1016/S0300-483X(01)00460-7; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Irons BK, 2006, PHARMACOTHERAPY, V26, P168, DOI 10.1592/phco.26.2.168; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Juurlink DN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2942; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lin X, 2002, ARTERIOSCL THROM VAS, V22, P476, DOI 10.1161/hq0302.105271; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Malinowski JM, 2000, CLIN THER, V22, P1151, DOI 10.1016/S0149-2918(00)83060-X; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Nishimura Y, 1997, ACTA DIABETOL, V34, P206, DOI 10.1007/s005920050075; Pereira RI, 2008, LIFE SCI, V83, P638, DOI 10.1016/j.lfs.2008.09.002; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Singh S, 2008, EXPERT OPIN DRUG SAF, V7, P579, DOI [10.1517/14740338.7.5.579, 10.1517/14740338.7.5.579 ]; Starner CI, 2008, J MANAGE CARE PHARM, V14, P523, DOI 10.18553/jmcp.2008.14.6.523; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Zhang H, 2005, P NATL ACAD SCI USA, V102, P9406, DOI 10.1073/pnas.0501744102; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	46	86	97	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23537	23548		10.1074/jbc.M112.363960	http://dx.doi.org/10.1074/jbc.M112.363960			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22621923	Green Published, hybrid			2022-12-25	WOS:000306511300025
J	Wu, CS; Nohr, EA; Bech, BH; Vestergaard, M; Olsen, J				Wu, Chun S.; Nohr, Ellen A.; Bech, Bodil H.; Vestergaard, Mogens; Olsen, Jorn			Long-Term Health Outcomes in Children Born to Mothers with Diabetes: A Population-Based Cohort Study	PLOS ONE			English	Article							INTRAUTERINE EXPOSURE; BIRTH-WEIGHT; CONGENITAL-MALFORMATIONS; METABOLIC SYNDROME; INDIAN CHILDREN; BLOOD-PRESSURE; BREAST-CANCER; PREGNANCY; RISK; PREVALENCE	Background: To examine whether prenatal exposure to parental type 1 diabetes, type 2 diabetes, or gestational diabetes is associated with an increased risk of malignant neoplasm or diseases of the circulatory system in the offspring. Methods/Principal Findings: We conducted a population-based cohort study of 1,781,576 singletons born in Denmark from 1977 to 2008. Children were followed for up to 30 years from the day of birth until the onset of the outcomes under study, death, emigration, or December 31, 2009, whichever came first. We used Cox proportional hazards model to estimate hazard ratios (HR)with 95% confidence intervals (95% CI) for the outcomes under study while adjusting for potential confounders. An increased risk of malignant neoplasm was found in children prenatally exposed to maternal type 2 diabetes (HR = 2.2, 95%CI: 1.5-3.2). An increased risk of diseases of the circulatory system was found in children exposed to maternal type 1 diabetes (HR = 2.2, 95%CI: 1.6-3.0), type 2 diabetes (HR = 1.4, 95%CI: 1.1-1.7), and gestational diabetes (HR = 1.3, 95%CI: 1.1-1.6), but results were attenuated after excluding children with congenital malformations. An increased risk of diseases of the circulatory system was also found in children exposed to paternal type 2 diabetes (HR = 1.5, 95%CI: 1.1-2.2) and the elevated risk remained after excluding children with congenital malformations. Conclusions: This study suggests that susceptibility to malignant neoplasm is modified partly by fetal programming. Diseases of the circulatory system may be modified by genetic factors, other time-stable family factors, or fetal programming.	[Wu, Chun S.; Nohr, Ellen A.; Bech, Bodil H.; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Res Unit Gen Practice, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	Aarhus University; Aarhus University; Aarhus University; University of California System; University of California Los Angeles	Wu, CS (corresponding author), Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark.	cw@soci.au.dk	Olsen, Jørn/F-8801-2015; Bech, Bodil Hammer/B-9646-2016; Vestergaard, Mogens/M-9333-2014	Olsen, Jørn/0000-0001-7462-5140; Bech, Bodil Hammer/0000-0002-0287-3687; Vestergaard, Mogens/0000-0001-8830-2174	Danish Cancer Society [DP04127]; Danish Medical Research Council (FSS)	Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council (FSS)(Danish Medical Research Council)	The study was supported by the Danish Cancer Society (grant number DP04127) and the Danish Medical Research Council (FSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg A, 2001, EARLY HUM DEV, V61, P85, DOI 10.1016/S0378-3782(00)00125-0; Aberg A, 2001, ACTA PAEDIATR, V90, P746, DOI 10.1080/080352501750315645; Andersen TF, 1999, DAN MED BULL, V46, P263; Buchanan TA, 2004, DIABETES MELLITUS FU, P1237; Bunt JC, 2005, J CLIN ENDOCR METAB, V90, P3225, DOI 10.1210/jc.2005-0007; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P58, DOI 10.1177/1403494811404278; Caughey RW, 2009, INT J CANCER, V124, P2658, DOI 10.1002/ijc.24225; Chen YW, 2010, PEDIATR NEPHROL, V25, P1319, DOI 10.1007/s00467-010-1506-1; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Clausen TD, 2009, J CLIN ENDOCR METAB, V94, P2464, DOI 10.1210/jc.2009-0305; DAMM P, 1989, AM J OBSTET GYNECOL, V161, P1163, DOI 10.1016/0002-9378(89)90656-X; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; Hawdon JM, 2011, BEST PRACT RES CL OB, V25, P91, DOI 10.1016/j.bpobgyn.2010.10.005; Jorgen Pedersen, 1977, PREGNANT DIABETIC HE; Knudsen LB, 1998, DAN MED BULL, V45, P320; Krishnaveni GV, 2010, DIABETES CARE, V33, P402, DOI 10.2337/dc09-1393; Mellemkjaer L, 2003, CANCER CAUSE CONTROL, V14, P61, DOI 10.1023/A:1022570305704; Moore TR, 2010, AM J OBSTET GYNECOL, V202, P643, DOI 10.1016/j.ajog.2010.02.059; Pedersen CB, 2006, DAN MED BULL, V53, P441; Reece EA, 2007, CLIN OBSTET GYNECOL, V50, P990, DOI 10.1097/GRF.0b013e31815a634b; Reece EA, 2012, CURR DIABETES REP, V12, P24, DOI 10.1007/s11892-011-0251-6; Ross JA, 2006, CANCER EPIDEM BIOMAR, V15, P1, DOI 10.1158/1055-9965.EPI-05-0923; Schwartz R, 2000, SEMIN PERINATOL, V24, P120, DOI 10.1053/sp.2000.6363; SCHWARTZ R, 1990, NEW ENGL J MED, V323, P340, DOI 10.1056/NEJM199008023230512; Silverman BL, 1998, DIABETES CARE, V21, pB142; Simeoni U, 2009, SEMIN FETAL NEONAT M, V14, P119, DOI 10.1016/j.siny.2009.01.002; Song YQ, 2004, AM J HUM GENET, V74, P208, DOI 10.1086/381400; Tam WH, 2010, DIABETES CARE; Westbom L, 2002, BRIT J CANCER, V86, P1078, DOI [10.1038/sj.bjc.6600192, 10.1038/sj/bjc/6600192]; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wright CS, 2009, AM J HYPERTENS, V22, P215, DOI 10.1038/ajh.2008.326; Xue F, 2007, LANCET ONCOL, V8, P1088, DOI 10.1016/S1470-2045(07)70377-7	34	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36727	10.1371/journal.pone.0036727	http://dx.doi.org/10.1371/journal.pone.0036727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649497	Green Submitted, gold, Green Published			2022-12-25	WOS:000305335800014
J	Goodman, CA; Kotecki, JA; Jacobs, BL; Hornberger, TA				Goodman, Craig A.; Kotecki, Jack A.; Jacobs, Brittany L.; Hornberger, Troy A.			Muscle Fiber Type-Dependent Differences in the Regulation of Protein Synthesis	PLOS ONE			English	Article							SKELETAL-MUSCLE; FOOD-DEPRIVATION; INDUCED GROWTH; MESSENGER-RNA; HYPERTROPHY; EXPRESSION; PGC-1-ALPHA; METABOLISM; ACTIVATION; ATROPHY	This study examined fiber type-dependent differences in the regulation of protein synthesis in individual muscle fibers found within the same whole muscle. Specifically, the in vivo SUrface SEnsing of Translation (SUnSET) methodology was used to measure protein synthesis in type 1, 2A, 2X and 2B fibers of the mouse plantaris muscle, in response to food deprivation (FD), and mechanical overload induced by synergist ablation (SA). The results show that 48 h of FD induced a greater decrease in protein synthesis in type 2X and 2B fibers compared to type 1 and 2A fibers. Type 2X and 2B fibers also had the largest FD-induced decrease in total S6 protein and Ser(240/244) S6 phosphorylation, respectively. Moreover, only type 2X and 2B fibers displayed a FD-induced decrease in cross-sectional area (CSA). Ten days of SA also induced fiber type-dependent responses, with type 2B fibers having the smallest SA-induced increases in protein synthesis, CSA and Ser(240/244) S6 phosphorylation, but the largest increase in total S6 protein. Embryonic myosin heavy chain (MHCEmb) positive fibers were also found in SA muscles and the protein synthesis rates, levels of S6 Ser(240/244) phosphorylation, and total S6 protein content, were 3.6-, 6.1- and 2.9-fold greater than that found in fibers from control muscles, respectively. Overall, these results reveal differential responses in the regulation of protein synthesis and fiber size between fiber types found within the same whole muscle. Moreover, these findings demonstrate that changes found at the whole muscle level do not necessarily reflect changes in individual fiber types.	[Goodman, Craig A.; Kotecki, Jack A.; Jacobs, Brittany L.; Hornberger, Troy A.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Goodman, CA (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA.	thornb1@svm.vetmed.wisc.edu	Goodman, Craig/H-8085-2019	Goodman, Craig/0000-0002-5874-7743; Hornberger, Troy/0000-0002-2349-1899; Jacobs, Brittany/0000-0002-1078-2320	U.S. National Institutes of Health [AR057347]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057347] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by U.S. National Institutes of Health grant AR057347 to TAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2010, J APPL PHYSIOL, V109, P692, DOI 10.1152/japplphysiol.00504.2010; ARMSTRONG RB, 1985, J EXP BIOL, V115, P201; BAILLIE AGS, 1991, AM J PHYSIOL, V260, pE891, DOI 10.1152/ajpendo.1991.260.6.E891; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; Csibi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008994; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; FANG CH, 1995, J AM COLL SURGEONS, V180, P33; Favier FB, 2010, AM J PHYSIOL-REG I, V298, pR1659, DOI 10.1152/ajpregu.00550.2009; GOLDBERG AL, 1969, J PHYSIOL-LONDON, V200, P667, DOI 10.1113/jphysiol.1969.sp008715; GOLDBERG AL, 1968, J CELL BIOL, V36, P653, DOI 10.1083/jcb.36.3.653; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; Habets PEMH, 1999, J HISTOCHEM CYTOCHEM, V47, P995, DOI 10.1177/002215549904700803; HARMON CS, 1984, BIOCHEM J, V223, P687, DOI 10.1042/bj2230687; Henneman E, 2010, HDB PHYSL NERVOUS 1, DOI 10.1002/cphy.cp010211; Kramer DK, 2006, ACTA PHYSIOL, V188, P207, DOI 10.1111/j.1748-1716.2006.01620.x; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; Lee-Young RS, 2009, J APPL PHYSIOL, V107, P283, DOI 10.1152/japplphysiol.91208.2008; LI JB, 1976, AM J PHYSIOL, V231, P441, DOI 10.1152/ajplegacy.1976.231.2.441; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lokireddy S, 2011, MOL ENDOCRINOL, V25, P1936, DOI 10.1210/me.2011-1124; Mahoney SJ, 2009, PROG MOL BIOL TRANSL, V90, P53, DOI 10.1016/S1877-1173(09)90002-3; MCALLISTER RM, 1993, J RECONSTR MICROSURG, V9, P313, DOI 10.1055/s-2007-1006673; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685; MILLWARD DJ, 1976, BIOCHEM J, V156, P185, DOI 10.1042/bj1560185; Mittendorfer B, 2005, J PHYSIOL-LONDON, V563, P203, DOI 10.1113/jphysiol.2004.077180; NAKANO K, 1979, BIOCHEM J, V184, P663, DOI 10.1042/bj1840663; Oded M, 2008, INT REV CEL MOL BIO, P1; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; PREEDY VR, 1988, BIOCHEM J, V254, P631, DOI 10.1042/bj2540631; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Savary I, 1998, BRIT J NUTR, V79, P297, DOI 10.1079/BJN19980047; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Stephenson GM, 2001, CLIN EXP PHARMACOL P, V28, P692, DOI 10.1046/j.1440-1681.2001.03505.x; Talmadge RJ, 2000, MUSCLE NERVE, V23, P661, DOI 10.1002/(SICI)1097-4598(200005)23:5<661::AID-MUS3>3.0.CO;2-J; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0	43	55	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37890	10.1371/journal.pone.0037890	http://dx.doi.org/10.1371/journal.pone.0037890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629468	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305345300082
J	Nguyen, TH; Maucort, G; Sullivan, RKP; Schenning, M; Lavidis, NA; McCluskey, A; Robinson, PJ; Meunier, FA				Nguyen, Tam H.; Maucort, Guillaume; Sullivan, Robert K. P.; Schenning, Mitja; Lavidis, Nickolas A.; McCluskey, Adam; Robinson, Phillip J.; Meunier, Frederic A.			Actin- and Dynamin-Dependent Maturation of Bulk Endocytosis Restores Neurotransmission following Synaptic Depletion	PLOS ONE			English	Article							NEUROMUSCULAR-JUNCTION; VESICLE ENDOCYTOSIS; TRANSMITTER RELEASE; BINDING PROTEIN; MEMBRANE; CYTOSKELETON; POOLS; INVAGINATION; LOCALIZATION; CLATHRIN	Bulk endocytosis contributes to the maintenance of neurotransmission at the amphibian neuromuscular junction by regenerating synaptic vesicles. How nerve terminals internalize adequate portions of the presynaptic membrane when bulk endocytosis is initiated before the end of a sustained stimulation is unknown. A maturation process, occurring at the end of the stimulation, is hypothesised to precisely restore the pools of synaptic vesicles. Using confocal time-lapse microscopy of FM1-43-labeled nerve terminals at the amphibian neuromuscular junction, we confirm that bulk endocytosis is initiated during a sustained tetanic stimulation and reveal that shortly after the end of the stimulation, nerve terminals undergo a maturation process. This includes a transient bulging of the plasma membrane, followed by the development of large intraterminal FM1-43-positive donut-like structures comprising large bulk membrane cisternae surrounded by recycling vesicles. The degree of bulging increased with stimulation frequency and the plasmalemma surface retrieved following the transient bulging correlated with the surface membrane internalized in bulk cisternae and recycling vesicles. Dyngo-4a, a potent dynamin inhibitor, did not block the initiation, but prevented the maturation of bulk endocytosis. In contrast, cytochalasin D, an inhibitor of actin polymerization, hindered both the initiation and maturation processes. Both inhibitors hampered the functional recovery of neurotransmission after synaptic depletion. Our data confirm that initiation of bulk endocytosis occurs during stimulation and demonstrates that a delayed maturation process controlled by actin and dynamin underpins the coupling between exocytosis and bulk endocytosis.	[Nguyen, Tam H.; Sullivan, Robert K. P.; Schenning, Mitja; Meunier, Frederic A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Maucort, Guillaume] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia; [Sullivan, Robert K. P.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Schenning, Mitja; Lavidis, Nickolas A.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [McCluskey, Adam] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Robinson, Phillip J.] Univ Sydney, Cell Signalling Unit, Childrens Med Res Inst, Sydney, NSW 2006, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of Newcastle; Children's Medical Research Institute - Australia; University of Sydney	Nguyen, TH (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	f.meunier@uq.edu.au	Meunier, Frederic A/C-8161-2009; Sullivan, Robert KP/A-8639-2012; Robinson, Phillip J/G-4008-2011; McCluskey, Adam/F-1894-2011	Meunier, Frederic A/0000-0001-6400-1107; Sullivan, Robert KP/0000-0003-3414-2448; Robinson, Phillip J/0000-0002-7878-0313; McCluskey, Adam/0000-0001-7125-863X	Australian Research Council [DP0987669]	Australian Research Council(Australian Research Council)	This work was supported by an Australian Research Council Discovery grant (DP0987669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Clayton EL, 2008, J NEUROSCI, V28, P6627, DOI 10.1523/JNEUROSCI.1445-08.2008; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; COUTEAUX R, 1970, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences Serie D Sciences Naturelles, V271, P2346; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Douthitt HL, 2011, NEUROSCIENCE, V172, P187, DOI 10.1016/j.neuroscience.2010.10.002; Dunaevsky A, 2000, J NEUROSCI, V20, P6007, DOI 10.1523/JNEUROSCI.20-16-06007.2000; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Harper CB, 2011, J BIOL CHEM; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Kidokoro Y, 2006, INT REV NEUROBIOL, V75, P145, DOI 10.1016/S0074-7742(06)75007-3; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Laakso JM, 2010, P NATL ACAD SCI USA, V107, P698, DOI 10.1073/pnas.0911426107; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Llobet A, 2003, NEURON, V40, P1075, DOI 10.1016/S0896-6273(03)00765-7; Lu WB, 2009, J BIOL CHEM, V284, P1930, DOI 10.1074/jbc.M803691200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McNiven MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1944, DOI 10.2741/1348; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Meunier FA, 2010, J CELL SCI, V123, P1131, DOI 10.1242/jcs.049296; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Paillart C, 2003, J NEUROSCI, V23, P4092; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pucci AR, 2006, EXP PHYSIOL, V91, P171, DOI 10.1113/expphysiol.2005.032094; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Richards DA, 2004, J PHYSIOL-LONDON, V557, P77, DOI 10.1113/jphysiol.2004.062158; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Teng HB, 2007, J PHYSIOL-LONDON, V582, P243, DOI 10.1113/jphysiol.2007.130989; VANDERKLOOT W, 1994, PHYSIOL REV, V74, P899, DOI 10.1152/physrev.1994.74.4.899; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Wu LG, 1999, CAN J PHYSIOL PHARM, V77, P672, DOI 10.1139/cjpp-77-9-672; Wu W, 2007, P NATL ACAD SCI USA, V104, P10234, DOI 10.1073/pnas.0611512104; Wu XS, 2009, J NEUROSCI, V29, P11038, DOI 10.1523/JNEUROSCI.2367-09.2009	58	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36913	10.1371/journal.pone.0036913	http://dx.doi.org/10.1371/journal.pone.0036913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629340	Green Published, gold			2022-12-25	WOS:000305345300015
J	Theron, G; Peter, J; Lenders, L; van Zyl-Smit, R; Meldau, R; Govender, U; Dheda, K				Theron, Grant; Peter, Jonny; Lenders, Laura; van Zyl-Smit, Richard; Meldau, Richard; Govender, Ureshnie; Dheda, Keertan			Correlation of Mycobacterium Tuberculosis Specific and Non-Specific Quantitative Th1 T-Cell Responses with Bacillary Load in a High Burden Setting	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; PULMONARY TUBERCULOSIS; ANTITUBERCULOSIS TREATMENT; ACTIVE TUBERCULOSIS; IMMUNE-RESPONSES; RECORDING-SYSTEM; INFECTION; DIAGNOSIS; SPOT.TB; METAANALYSIS	Background: Measures of bacillary load in patients with tuberculosis (TB) may be useful for predicting and monitoring response to treatment. The relationship between quantitative T-cell responses and mycobacterial load remains unclear. We hypothesised that, in a HIV-prevalent high burden setting, the magnitude of mycobacterial antigen-specific and nonspecific T-cell IFN-gamma responses would correlate with (a) bacterial load and (b) culture conversion in patients undergoing treatment. Methods: We compared baseline (n = 147), 2 (n = 35) and 6 month (n = 13) purified-protein-derivative (PPD) and RD1-specific (TSPOT.TB and QFT-GIT) blood RD1-specific (TSPOT.TB; QFT-GIT) responses with associates of sputum bacillary load in patients with culture-confirmed TB in Cape Town, South Africa. Results: IFN-gamma responses were not associated with liquid culture time-to-positivity, smear-grade, Xpert MTB/RIF-generated cycle threshold values or the presence of cavities on the chest radiograph in patients with culture-confirmed TB and irrespective of HIV-status. 2-month IGRA conversion rates (positive-to-negative) were negligible [<11% for TSPOT. TB (3/28) and QFT-GIT (1/29)] and lower compared to culture [60% (21/35); p<0.01]. Conclusions: In a high burden HIV-prevalent setting T-cell IFN-gamma responses to M. tuberculosis-specific and non-specific antigens do not correlate with bacillary load, including Xpert MTB/RIF-generated CT values, and are therefore poorly suited for monitoring treatment and prognostication.	[Theron, Grant; Peter, Jonny; Lenders, Laura; van Zyl-Smit, Richard; Meldau, Richard; Govender, Ureshnie; Dheda, Keertan] Univ Cape Town, Lung Infect & Immun Unit, Div Pulmonol, ZA-7925 Cape Town, South Africa; [Theron, Grant; Peter, Jonny; Lenders, Laura; van Zyl-Smit, Richard; Meldau, Richard; Govender, Ureshnie; Dheda, Keertan] Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Theron, G (corresponding author), Univ Cape Town, Lung Infect & Immun Unit, Div Pulmonol, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Theron, Grant/ABB-1167-2020	Theron, Grant/0000-0002-9216-2415; Peter, Jonathan/0000-0002-2658-0723; van Zyl-Smit, Richard/0000-0002-4115-5362	EU-FP7 award (TBSusgent); EDCTP (TB-NEAT); South African National Research Foundation; Claude Leon Foundation; Discovery Foundation Fellowship; Fogarty International Clinical Research Scholars/Fellows Support Centre National Institutes of Health grant [R24TW007988]; SATBAT; EDCTP (TB-NEAT, TESA); SA DST; SA NRF (SARChI); FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	EU-FP7 award (TBSusgent); EDCTP (TB-NEAT); South African National Research Foundation(National Research Foundation - South Africa); Claude Leon Foundation; Discovery Foundation Fellowship; Fogarty International Clinical Research Scholars/Fellows Support Centre National Institutes of Health grant; SATBAT; EDCTP (TB-NEAT, TESA); SA DST; SA NRF (SARChI); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by an EU-FP7 award (TBSusgent). GT and UG are supported by the EDCTP (TB-NEAT), the South African National Research Foundation (GT) and the Claude Leon Foundation (GT). RVZS and JP are supported by a Discovery Foundation Fellowship, the Fogarty International Clinical Research Scholars/Fellows Support Centre National Institutes of Health grant R24TW007988, SATBAT (JP) and the EDCTP (TB-NEAT). KD is supported by the EDCTP (TB-NEAT, TESA), the SA DST and the SA NRF (SARChI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012502; Al-Attiyah R, 2003, FEMS IMMUNOL MED MIC, V38, P249, DOI 10.1016/S0928-8244(03)00166-4; Bark CM, 2012, J CLIN MICROBIOL, V50, P538, DOI 10.1128/JCM.06193-11; Basirudeen K, 2011, BMC INFECT DIS, P11; Bocchino M, 2010, RESP MED, V104, P1551, DOI 10.1016/j.rmed.2010.05.011; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; DANIEL TM, 1981, AM REV RESPIR DIS, V123, P556; Dawson R, 2010, INT J TUBERC LUNG D, V14, P52; Delogu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018315; Den Boon S, 2005, INT J TUBERC LUNG D, V9, P1088; Dheda K, 2007, J INFECTION, V55, P169, DOI 10.1016/j.jinf.2007.02.005; Dheda K, 2009, THORAX, V64, P847, DOI 10.1136/thx.2009.116376; Dheda K, 2010, RESPIROLOGY, V15, P433, DOI 10.1111/j.1440-1843.2010.01739.x; Diacon A., 2010, EUROPEAN J CLIN MICR, P1; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Ferrand RA, 2005, INT J TUBERC LUNG D, V9, P1034; Franken WPJ, 2008, INT J TUBERC LUNG D, V12, P1286; Hesseling AC, 2010, INT J TUBERC LUNG D, V14, P560; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Lalvani A, 2004, CLIN INFECT DIS, V38, P757, DOI 10.1086/381763; Lee SW, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-300; Ling D, 2011, LANCET INFECT DIS; Ling DI, 2011, EUROPEAN RESP J; Moure R, 2011, J CLIN MICROBIOL, V49, P1137, DOI 10.1128/JCM.01831-10; Netea MG, 2011, CLIN DEV IMMUNOLOGY; Oni T, 2010, EUR RESPIR J, V36, P594, DOI 10.1183/09031936.00171509; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Perrin FMR, 2010, INT J TUBERC LUNG D, V14, P1596; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Ribeiro S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-23; Sauzullo I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005187; Schwander S, 2011, AM J RESP CRIT CARE, V183, P696, DOI 10.1164/rccm.201006-0963PP; Sullivan KM, 2009, PUBLIC HEALTH REP, V124, P471, DOI 10.1177/003335490912400320; Theron G, 2011, AM J RESP CRIT CARE; Theron G, 2011, EUROPEAN RESP J; Theron G, 2011, CLIN INFECT DIS; Visser ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029588; World Health Organization, 2011, WHO PUBL; Wu-Hsieh BA, 2001, CLIN INFECT DIS, V33, P1336, DOI 10.1086/323044	46	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37436	10.1371/journal.pone.0037436	http://dx.doi.org/10.1371/journal.pone.0037436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629395	gold, Green Published, Green Submitted			2022-12-25	WOS:000305345300041
J	Huang, HB; Lai, CH; Chen, GW; Lin, YY; Jaakkola, JJK; Liou, SH; Wang, SL				Huang, Han-Bin; Lai, Ching-Huang; Chen, Guan-Wen; Lin, Yong-Yang; Jaakkola, Jouni J. K.; Liou, Saou-Hsing; Wang, Shu-Li			Traffic-Related Air Pollution and DNA Damage: A Longitudinal Study in Taiwanese Traffic Conductors	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; COMET ASSAY; 1-HYDROXYPYRENE GLUCURONIDE; PARTICULATE MATTER; OXIDATIVE DAMAGE; EXPOSURE; WORKERS; URINE; METABOLITES; VALIDATION	Background: There is accumulating epidemiologic evidence that exposure to traffic-related air pollutants, including particulate matter (PM) and polyaromatic hydro carbons (PAHs), plays a role in etiology and prognosis of a large scale of illnesses, although the role of specific causal agents and underlying mechanisms for different health outcomes remains unknown. Objective: Our general objective was to assess the relations between personal exposure to traffic exhausts, in particular ambient PM2.5 and PAHs, and the occurrence of DNA strand breaks by applying personal monitoring of PM and biomarkers of exposure (urinary 1-hydroxypyrene-glucuronide, 1-OHPG) and effect (urinary 8-hydroxydeoxyguanosine, 8-OHdG and DNA strand breaks). Methods: We recruited 91 traffic conductors and 53 indoor office workers between May 2009 and June 2011 in Taipei City, Taiwan. We used PM2.5 personal samplers to collect breathing-zone particulate PAHs samples. Spot urine and blood samples after work shift of 2 consecutive days were analyzed for 1-OHPG, 8-OHdG and DNA strand breaks, respectively. Statistical methods included linear regression and mixed models. Results: Urinary 8-OHdG levels and the occurrence of DNA strand breaks in traffic conductors significantly exceeded those in indoor office workers in mixed models. Particulate PAHs levels showed a positive association with urinary 1-OHPG in the regression model (beta = 0.056, p = 0.01). Urinary 1-OHPG levels were significantly associated with urinary 8-OHdG levels in the mixed model (beta = 0.101, p = 0.023). Our results provide evidence that exposure to fine particulates causes DNA damage. Further, particulate PAHs could be biologically active constituents of PM2.5 with reference to the induction of oxidative DNA damages.	[Huang, Han-Bin; Wang, Shu-Li] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Huang, Han-Bin; Chen, Guan-Wen; Lin, Yong-Yang; Liou, Saou-Hsing; Wang, Shu-Li] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Miaoli, Taiwan; [Lai, Ching-Huang] Natl Def Med Ctr, Dept Publ Hlth, Taipei, Taiwan; [Jaakkola, Jouni J. K.] Univ Oulu, Inst Hlth Sci, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Wang, Shu-Li] China Med Univ & Hosp, Coll Publ Hlth, Inst Environm Med, Taichung, Taiwan	National Defense Medical Center; National Health Research Institutes - Taiwan; National Defense Medical Center; University of Oulu; China Medical University Taiwan; China Medical University Hospital - Taiwan	Huang, HB (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	slwang@nhri.org.tw	Chen, Guan Wen/S-8797-2019; Wang, Shu-Li/C-1367-2010; Jaakkola, Jouni J.K./G-4314-2012; Liou, Saou-Hsing/B-2667-2010; Lai, Ching-Huang/ABF-9274-2021	Jaakkola, Jouni/0000-0003-4168-4683	National Research Program for Genomic Medicine, Taiwan [DOH97-TD-G-111-032, DOH98-TD-G-111-021, DOH99-TD-G-111-018, NSC100-2325-B400-010]; Academy of Finland	National Research Program for Genomic Medicine, Taiwan(Ministry of Science and Technology, Taiwan); Academy of Finland(Academy of Finland)	This study was supported by the National Research Program for Genomic Medicine, Taiwan (grant no.: DOH97-TD-G-111-032, DOH98-TD-G-111-021, DOH99-TD-G-111-018 and NSC100-2325-B400-010). J.J. was supported by a grant from the Academy of Finland (SALVE Research Program). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEK SO, 1991, WATER AIR SOIL POLL, V60, P279, DOI 10.1007/BF00282628; Bell ML, 2009, AM J RESP CRIT CARE, V179, P1115, DOI 10.1164/rccm.200808-1240OC; Bonvallot V, 2001, AM J RESP CELL MOL, V25, P515, DOI 10.1165/ajrcmb.25.4.4515; Chuang CY, 2003, CHEMOSPHERE, V52, P1163, DOI 10.1016/S0045-6535(03)00307-2; Collins A, 1997, ENVIRON MOL MUTAGEN, V30, P139, DOI 10.1002/(SICI)1098-2280(1997)30:2<139::AID-EM6>3.0.CO;2-I; Gonzalez-Flecha Beatriz, 2004, Molecular Aspects of Medicine, V25, P169, DOI 10.1016/j.mam.2004.02.017; Hininger I, 2004, MUTAT RES-GEN TOX EN, V558, P75, DOI 10.1016/j.mrgentox.2003.11.004; Hu CW, 2006, CLIN CHEM, V52, P1381, DOI 10.1373/clinchem.2005.063735; Hwang BF, 2011, ENVIRON HEALTH PERSP, V119, P1345, DOI 10.1289/ehp.1003056; KANG DH, 1995, OCCUP ENVIRON MED, V52, P593, DOI 10.1136/oem.52.9.593; Kim JY, 2004, ENVIRON HEALTH PERSP, V112, P666, DOI 10.1289/ehp.6827; Kure EH, 1996, CARCINOGENESIS, V17, P2201, DOI 10.1093/carcin/17.10.2201; Lai CH, 2004, ARCH ENVIRON HEALTH, V59, P61, DOI 10.3200/AEOH.59.2.61-69; Lai CH, 2005, OCCUP ENVIRON MED, V62, P216, DOI 10.1136/oem.2004.015107; Marczynski B, 2002, CARCINOGENESIS, V23, P273, DOI 10.1093/carcin/23.2.273; Marczynski B, 2009, ARCH TOXICOL, V83, P947, DOI 10.1007/s00204-009-0444-9; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; Merlo F, 1998, CANCER EPIDEM BIOMAR, V7, P147; Moller P, 2006, BASIC CLIN PHARMACOL, V98, P336, DOI 10.1111/j.1742-7843.2006.pto_167.x; Nafstad P, 2003, THORAX, V58, P1071, DOI 10.1136/thorax.58.12.1071; On the Health Effects of Traffic-Related Air Pollution H. E. I, 2010, TRAFF REL AIR POLL C; Peng RD, 2009, ENVIRON HEALTH PERSP, V117, P957, DOI 10.1289/ehp.0800185; Penning TM, 1999, CHEM RES TOXICOL, V12, P1, DOI 10.1021/tx980143n; Risom L, 2005, MUTAT RES-FUND MOL M, V592, P119, DOI 10.1016/j.mrfmmm.2005.06.012; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Scandalios JG, 2002, GENOME BIOL, V3; Sorensen M, 2003, CANCER EPIDEM BIOMAR, V12, P191; Squadrito GL, 2001, FREE RADICAL BIO MED, V31, P1132, DOI 10.1016/S0891-5849(01)00703-1; Strickland P, 1996, ENVIRON HEALTH PERSP, V104, P927, DOI 10.2307/3433012; STRICKLAND PT, 1994, CARCINOGENESIS, V15, P483, DOI 10.1093/carcin/15.3.483; Tovalin H, 2006, OCCUP ENVIRON MED, V63, P230, DOI 10.1136/oem.2005.019802; Tsai PJ, 2004, ENVIRON SCI TECHNOL, V38, P56, DOI 10.1021/es030588k; Tsai PJ, 2001, J OCCUP HEALTH, V43, P118, DOI 10.1539/joh.43.118; TUOMINEN J, 1988, ENVIRON SCI TECHNOL, V22, P1228, DOI 10.1021/es00175a017; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; Wei YJ, 2009, ENVIRON SCI TECHNOL, V43, P4757, DOI 10.1021/es803337c; Xia T, 2004, ENVIRON HEALTH PERSP, V112, P1347, DOI 10.1289/ehp.7167	37	37	38	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37412	10.1371/journal.pone.0037412	http://dx.doi.org/10.1371/journal.pone.0037412			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629390	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343100026
J	Venhoff, N; Effelsberg, NM; Salzer, U; Warnatz, K; Peter, HH; Lebrecht, D; Schlesier, M; Voll, RE; Thiel, J				Venhoff, Nils; Effelsberg, Nora M.; Salzer, Ulrich; Warnatz, Klaus; Peter, Hans Hartmut; Lebrecht, Dirk; Schlesier, Michael; Voll, Reinhard E.; Thiel, Jens			Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides	PLOS ONE			English	Article							ANTIBODY-ASSOCIATED VASCULITIS; RHEUMATOLOGY 1990 CRITERIA; CHURG-STRAUSS-SYNDROME; WEGENERS-GRANULOMATOSIS; STAPHYLOCOCCUS-AUREUS; LYMPHOCYTE DEPLETION; ARTHRITIS; CLASSIFICATION; DISEASE; IMMUNODEFICIENCY	Objective: To assess the impact of immunosuppressive therapy with cyclophosphamide (CYC) and rituximab (RTX) on serum immunoglobulin (Ig) concentrations and B lymphocyte counts in patients with ANCA-associated vasculitides (AAVs). Methods: Retrospective analysis of Ig concentrations and peripheral B cell counts in 55 AAV patients. Results: CYC treatment resulted in a decrease in Ig levels (median; interquartile range IQR) from IgG 12.8 g/L (8.15-15.45) to 9.17 g/L (8.04-9.90) (p = 0.002), IgM 1.05 g/L (0.70-1.41) to 0.83 g/L (0.60-1.17) (p = 0.046) and IgA 2.58 g/L (1.71-3.48) to 1.58 g/L (1-31-2.39) (p = 0.056) at a median follow-up time of 4 months. IgG remained significantly below the initial value at 14.5 months and 30 months analyses. Subsequent RTX treatment in patients that had previously received CYC resulted in a further decline in Ig levels from pre RTX IgG 9.84 g/L (8.71-11.60) to 7.11 g/L (5.75-8.77; p = 0.007), from pre RTX IgM 0.84 g/L (0.63-1.18) to 0.35 g/L (0.23-0.48; p<0.001) and from pre RTX IgA 2.03 g/L (1.37-2.50) to IgA 1.62 g/L (IQR 0.84-2.43; p = 0.365) 14 months after RTX. Treatment with RTX induced a complete depletion of B cells in all patients. After a median observation time of 20 months median B lymphocyte counts remained severely suppressed (4 B-cells/mu l, 1.25-9.5, p<0.001). Seven patients (21%) that had been treated with CYC followed by RTX were started on Ig replacement because of severe bronchopulmonary infections and serum IgG concentrations below 5 g/L. Conclusions: In patients with AAVs, treatment with CYC leads to a decline in immunoglobulin concentrations. A subsequent RTX therapy aggravates the decline in serum immunoglobulin concentrations and results in a profoundly delayed B cell repopulation. Surveying patients with AAVs post CYC and RTX treatment for serum immunoglobulin concentrations and persisting hypogammaglobulinemia is warranted.	[Venhoff, Nils; Effelsberg, Nora M.; Salzer, Ulrich; Warnatz, Klaus; Peter, Hans Hartmut; Lebrecht, Dirk; Schlesier, Michael; Voll, Reinhard E.; Thiel, Jens] Univ Hosp Freiburg, Dept Rheumatol & Clin Immunol, Freiburg, Germany; [Salzer, Ulrich; Warnatz, Klaus; Peter, Hans Hartmut; Schlesier, Michael; Voll, Reinhard E.; Thiel, Jens] Univ Hosp Freiburg, Ctr Chron Immunodeficiency CCI, Freiburg, Germany	University of Freiburg; University of Freiburg	Venhoff, N (corresponding author), Univ Hosp Freiburg, Dept Rheumatol & Clin Immunol, Freiburg, Germany.	jens.thiel@uniklinik-freiburg.de	Warnatz, Klaus/AAD-3464-2022	Salzer, Ulrich/0000-0002-1769-1157				Abdulahad WH, 2011, ARTHRITIS RHEUM-US, V63, P1116, DOI 10.1002/art.30236; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; FAUCI AS, 1971, NEW ENGL J MED, V285, P1493, DOI 10.1056/NEJM197112302852701; Gottenberg JE, 2010, ARTHRITIS RHEUM-US, V62, P2625, DOI 10.1002/art.27555; Guerry MJCJ, 2012, RHEUMATOLOGY, V51, P634, DOI 10.1093/rheumatology/ker150; Hellmich B, 2007, ANN RHEUM DIS, V66, P605, DOI 10.1136/ard.2006.062711; Holle JU, 2012, ANN RHEUM DIS, V71, P327, DOI 10.1136/ard.2011.153601; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1065; Irie E, 2010, INT J HEMATOL, V91, P501, DOI 10.1007/s12185-010-0528-6; Jones RB, 2010, NEW ENGL J MED, V363, P211, DOI 10.1056/NEJMoa0909169; Jones RB, 2009, ARTHRITIS RHEUM, V60, P2156, DOI 10.1002/art.24637; Kallenberg CGM, 2006, NAT CLIN PRACT RHEUM, V2, P661, DOI 10.1038/ncprheum0355; Kallenberg CGM, 2011, CLIN REV ALLERG IMMU, V41, P224, DOI 10.1007/s12016-011-8258-y; Keogh KA, 2006, AM J RESP CRIT CARE, V173, P180, DOI 10.1164/rccm.200507-1144OC; Keogh KA, 2005, ARTHRITIS RHEUM-US, V52, P262, DOI 10.1002/art.20718; Krumbholz M, 2005, J AUTOIMMUN, V25, P298, DOI 10.1016/j.jaut.2005.08.004; LEAVITT RY, 1990, ARTHRITIS RHEUM, V33, P1101, DOI 10.1002/art.1780330807; Mansfield N, 2011, NEPHROL DIAL TRANSPL, V26, P3280, DOI 10.1093/ndt/gfr127; MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806; Pepper RJ, 2008, RHEUMATOLOGY, V47, P1104, DOI 10.1093/rheumatology/ken175; Popa C, 2007, RHEUMATOLOGY, V46, P626, DOI 10.1093/rheumatology/kel393; Popa ER, 2002, ARTHRITIS RES, V4, P77, DOI 10.1186/ar392; Rees F, 2011, CLIN RHEUMATOL, V30, P1241, DOI 10.1007/s10067-011-1756-8; Roll P, 2006, ARTHRITIS RHEUM-US, V54, P2377, DOI 10.1002/art.22019; STEGEMAN CA, 1994, ANN INTERN MED, V120, P12, DOI 10.7326/0003-4819-120-1-199401010-00003; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; van Vollenhoven RF, 2010, J RHEUMATOL, V37, P558, DOI 10.3899/jrheum.090856; Walker AR, 2008, CANCER INVEST, V26, P431, DOI 10.1080/07357900701809068; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Wernette CM, 2003, CLIN DIAGN LAB IMMUN, V10, P514, DOI 10.1128/CDLI.10.4.514-519.2003	30	97	100	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37626	10.1371/journal.pone.0037626	http://dx.doi.org/10.1371/journal.pone.0037626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629432	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343100040
J	Sovrano, VA; Rigosi, E; Vallortigara, G				Sovrano, Valeria Anna; Rigosi, Elisa; Vallortigara, Giorgio			Spatial Reorientation by Geometry in Bumblebees	PLOS ONE			English	Article							NONGEOMETRIC INFORMATION; LANDMARK INFORMATION; METRIC INFORMATION; CHILDRENS USE; BEES; MODULE; MODULARITY; ENVIRONMENTS; OPTIMIZATION; ORIENTATION	Human and non-human animals are capable of using basic geometric information to reorient in an environment. Geometric information includes metric properties associated with spatial surfaces (e.g., short vs. long wall) and left-right directionality or 'sense' (e.g. a long wall to the left of a short wall). However, it remains unclear whether geometric information is encoded by explicitly computing the layout of surface geometry or by matching images of the environment. View-based spatial encoding is generally thought to hold for insect navigation and, very recently, evidence for navigation by geometry has been reported in ants but only in a condition which does not allow the animals to use features located far from the goal. In this study we tested the spatial reorientation abilities of bumblebees (Bombus terrestris). After spatial disorientation, by passive rotation both clockwise and anticlockwise, bumblebees had to find one of the four exit holes located in the corners of a rectangular enclosure. Bumblebees systematically confused geometrically equivalent exit corners (i.e. corners with the same geometric arrangement of metric properties and sense, for example a short wall to the left of a long wall). However, when one wall of the enclosure was a different colour, bumblebees appeared to combine this featural information (either near or far from the goal) with geometric information to find the correct exit corner. Our results show that bumblebees are able to use both geometric and featural information to reorient themselves, even when features are located far from the goal.	[Sovrano, Valeria Anna; Rigosi, Elisa; Vallortigara, Giorgio] Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy; [Rigosi, Elisa] Fdn Edmund Mach, Res & Innovat Ctr, IASMA, Dept Sustainable Agroecosyst, San Michele All Adige, Italy; [Rigosi, Elisa] Fdn Edmund Mach, Res & Innovat Ctr, IASMA, Dept Bioresources, San Michele All Adige, Italy	University of Trento; Fondazione Edmund Mach; Fondazione Edmund Mach	Sovrano, VA (corresponding author), Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy.	valeriaanna.sovrano@unitn.it		Rigosi, Elisa/0000-0002-2283-1257	Provincia Autonoma di Trento; Fondazione Cassa di Risparmio di Trento e Rovereto	Provincia Autonoma di Trento(Autonomous Province of Trento); Fondazione Cassa di Risparmio di Trento e Rovereto(Fondazione Caritro)	This work has been supported by the Provincia Autonoma di Trento and the Fondazione Cassa di Risparmio di Trento e Rovereto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Shai N, 2011, BEHAV ECOL, V22, P317, DOI 10.1093/beheco/arq206; Brown AA, 2007, PSYCHOL SCI, V18, P569, DOI 10.1111/j.1467-9280.2007.01941.x; CARTWRIGHT BA, 1983, J COMP PHYSIOL, V151, P521, DOI 10.1007/BF00605469; CARTWRIGHT BA, 1982, NATURE, V295, P560, DOI 10.1038/295560a0; Cheng K, 2005, PSYCHON B REV, V12, P1, DOI 10.3758/BF03196346; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Cheng K, 2008, TRENDS COGN SCI, V12, P355, DOI 10.1016/j.tics.2008.06.004; Cheung A, 2008, J EXP PSYCHOL ANIM B, V34, P15, DOI 10.1037/0097-7403.34.1.15; Chiandetti C, 2008, ANIM COGN, V11, P139, DOI 10.1007/s10071-007-0099-y; Chiandetti C, 2010, ANIM COGN, V13, P463, DOI 10.1007/s10071-009-0297-x; CHITTKA L, 1995, ANIM BEHAV, V49, P159, DOI 10.1016/0003-3472(95)80163-4; Collett TS, 2006, ADV STUD BEHAV, V36, P123, DOI 10.1016/S0065-3454(06)36003-2; Collett TS, 2002, NAT REV NEUROSCI, V3, P542, DOI 10.1038/nrn872; Dacke M, 2008, ANIM COGN, V11, P683, DOI 10.1007/s10071-008-0159-y; Dawson MRW, 2010, COGNITION, V114, P207, DOI 10.1016/j.cognition.2009.09.006; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5909, DOI 10.1073/pnas.0711433105; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Gould JL, 2002, COGNITIVE ANIMAL, P41; GOULD JL, 1990, COGNITION, V37, P83, DOI 10.1016/0010-0277(90)90019-G; Gouteux S, 2001, J EXP PSYCHOL GEN, V130, P505, DOI 10.1037//0096-3445.130.3.505; Hermer L, 1996, COGNITION, V61, P195, DOI 10.1016/S0010-0277(96)00714-7; HERMER L, 1994, NATURE, V370, P57, DOI 10.1038/370057a0; Kelly DM, 2011, BIOL LETTERS, V7, P372, DOI 10.1098/rsbl.2010.1024; Kelly DM, 1998, J COMP PSYCHOL, V112, P259, DOI 10.1037/0735-7036.112.3.259; Leadbeater E, 2009, BIOL LETTERS, V5, P310, DOI 10.1098/rsbl.2008.0692; Learmonth AE, 2002, PSYCHOL SCI, V13, P337, DOI 10.1111/1467-9280.00461; Learmonth AE, 2001, J EXP CHILD PSYCHOL, V80, P225, DOI 10.1006/jecp.2001.2635; Learmonth AE, 2008, DEVELOPMENTAL SCI, V11, P414, DOI 10.1111/j.1467-7687.2008.00686.x; Lee SA, 2008, DEVELOPMENTAL SCI, V11, P743, DOI 10.1111/j.1467-7687.2008.00724.x; Lee SA, 2006, PSYCHOL SCI, V17, P577, DOI 10.1111/j.1467-9280.2006.01747.x; Lee SA, 2012, BIOL LETTERS, V8, P492, DOI 10.1098/rsbl.2012.0067; Lee SA, 2011, PSYCHON B REV, V18, P192, DOI 10.3758/s13423-010-0035-z; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Lihoreau M, 2012, BIOL LETTERS, V8, P13, DOI 10.1098/rsbl.2011.0661; Lihoreau M, 2011, FUNCT ECOL, V25, P1284, DOI 10.1111/j.1365-2435.2011.01881.x; Lihoreau M, 2010, AM NAT, V176, P744, DOI 10.1086/657042; Maes JHR, 2009, BEHAV BRAIN RES, V201, P285, DOI 10.1016/j.bbr.2009.02.026; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Miglino O, 2001, COGN PROCESS, V3, P22; Pearce JM, 2004, J EXP PSYCHOL ANIM B, V30, P135, DOI 10.1037/0097-7403.30.2.135; Pecchia T, 2010, J EXP BIOL, V213, P2987, DOI 10.1242/jeb.043315; Raine NE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000556; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Sheynikhovich D, 2009, PSYCHOL REV, V116, P540, DOI 10.1037/a0016170; Sovrano VA, 2005, COGNITION, V97, P121, DOI 10.1016/j.cognition.2004.08.003; Sovrano VA, 2003, J EXP PSYCHOL ANIM B, V29, P199, DOI 10.1037/0097-7403.29.3.199; Sovrano VA, 2002, COGNITION, V85, pB51, DOI 10.1016/S0010-0277(02)00110-5; Sovrano VA, 2007, ANIM COGN, V10, P47, DOI 10.1007/s10071-006-0029-4; Sovrano VA, 2006, PSYCHOL SCI, V17, P616, DOI 10.1111/j.1467-9280.2006.01753.x; Sturzl W, 2008, J EXP PSYCHOL ANIM B, V34, P1, DOI 10.1037/0097-7403.34.1.1; VALLORTIGARA G, 1990, J COMP PSYCHOL, V104, P248, DOI 10.1037/0735-7036.104.3.248; Vallortigara G, 2005, DEVELOPMENTAL SCI, V8, P393, DOI 10.1111/j.1467-7687.2005.00427.x; Vallortigara G, 2004, J COGNITIVE NEUROSCI, V16, P390, DOI 10.1162/089892904322926737; Vallortigara G, 2009, VIENNA SER THEOR BIO, P83; Vallortigara G, 2009, CURR OPIN NEUROBIOL, V19, P20, DOI 10.1016/j.conb.2009.02.002; Vargas JP, 2004, J COMP PSYCHOL, V118, P206, DOI 10.1037/0735-7036.118.2.206; Wystrach A, 2011, J EXP PSYCHOL A 0523; Wystrach Antoine, 2009, Communicative & Integrative Biology, V2, P388; Wystrach A, 2009, CURR BIOL, V19, P61, DOI 10.1016/j.cub.2008.11.054	59	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37449	10.1371/journal.pone.0037449	http://dx.doi.org/10.1371/journal.pone.0037449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624033	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343500118
J	Tilghman, RW; Blais, EM; Cowan, CR; Sherman, NE; Grigera, PR; Jeffery, ED; Fox, JW; Blackman, BR; Tschumperlin, DJ; Papin, JA; Parsons, JT				Tilghman, Robert W.; Blais, Edik M.; Cowan, Catharine R.; Sherman, Nicholas E.; Grigera, Pablo R.; Jeffery, Erin D.; Fox, Jay W.; Blackman, Brett R.; Tschumperlin, Daniel J.; Papin, Jason A.; Parsons, J. Thomas			Matrix Rigidity Regulates Cancer Cell Growth by Modulating Cellular Metabolism and Protein Synthesis	PLOS ONE			English	Article							ANCHORAGE-DEPENDENT FIBROBLASTS; BREAST-CANCER; MESSENGER-RNA; METASTATIC GROWTH; TUMOR-CELLS; DORMANCY; PHOSPHOFRUCTOKINASE; TRANSITION; TURNOVER; SURFACE	Background: Tumor cells in vivo encounter diverse types of microenvironments both at the site of the primary tumor and at sites of distant metastases. Understanding how the various mechanical properties of these microenvironments affect the biology of tumor cells during disease progression is critical in identifying molecular targets for cancer therapy. Methodology/Principal Findings: This study uses flexible polyacrylamide gels as substrates for cell growth in conjunction with a novel proteomic approach to identify the properties of rigidity-dependent cancer cell lines that contribute to their differential growth on soft and rigid substrates. Compared to cells growing on more rigid/stiff substrates (> 10,000 Pa), cells on soft substrates (150-300 Pa) exhibited a longer cell cycle, due predominantly to an extension of the G1 phase of the cell cycle, and were metabolically less active, showing decreased levels of intracellular ATP and a marked reduction in protein synthesis. Using stable isotope labeling of amino acids in culture (SILAC) and mass spectrometry, we measured the rates of protein synthesis of over 1200 cellular proteins under growth conditions on soft and rigid/stiff substrates. We identified cellular proteins whose syntheses were either preferentially inhibited or preserved on soft matrices. The former category included proteins that regulate cytoskeletal structures (e.g., tubulins) and glycolysis (e.g., phosphofructokinase-1), whereas the latter category included proteins that regulate key metabolic pathways required for survival, e.g., nicotinamide phosphoribosyltransferase, a regulator of the NAD salvage pathway. Conclusions/Significance: The cellular properties of rigidity-dependent cancer cells growing on soft matrices are reminiscent of the properties of dormant cancer cells, e.g., slow growth rate and reduced metabolism. We suggest that the use of relatively soft gels as cell culture substrates would allow molecular pathways to be studied under conditions that reflect the different mechanical environments encountered by cancer cells upon metastasis to distant sites.	[Tilghman, Robert W.; Cowan, Catharine R.; Sherman, Nicholas E.; Grigera, Pablo R.; Jeffery, Erin D.; Fox, Jay W.; Parsons, J. Thomas] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA; [Blais, Edik M.; Blackman, Brett R.; Papin, Jason A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Tschumperlin, Daniel J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of Virginia; University of Virginia; Harvard University; Harvard T.H. Chan School of Public Health	Tilghman, RW (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.	rt9c@virginia.edu		Papin, Jason/0000-0002-2769-5805; Jeffery, Erin/0000-0001-9511-7719; Sherman, Nicholas/0000-0003-3206-3113	National Institutes of Health (NIH)-National Cancer Institute (NCI) [CA40042]; NIH [1U54 GM64346]; Coulter Foundation Translational Partners Award; NIH-NCI [T32 CA09109]; NATIONAL CANCER INSTITUTE [T32CA009109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health (NIH)-National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coulter Foundation Translational Partners Award; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants National Institutes of Health (NIH)-National Cancer Institute (NCI) CA40042 (JTP) and NIH 1U54 GM64346 (JTP and JWF) (www.nih.gov) and funding from the Coulter Foundation Translational Partners Award (www.whcf.org) (JTP). EMB was supported by NIH-NCI T32 CA09109. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; BENECKE BJ, 1978, CELL, V14, P931, DOI 10.1016/0092-8674(78)90347-1; BENZEEV A, 1980, CELL, V21, P365, DOI 10.1016/0092-8674(80)90473-0; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; DUNAWAY GA, 1978, J BIOL CHEM, V253, P7460; FARMER SR, 1978, CELL, V15, P627, DOI 10.1016/0092-8674(78)90031-4; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; GEHNRICH SC, 1988, J BIOL CHEM, V263, P11755; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; Grigera PR, 2012, J PROTEOMICS, V75, P2153, DOI 10.1016/j.jprot.2012.01.012; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929; Moon JS, 2011, J BIOL CHEM, V286, P23808, DOI 10.1074/jbc.M111.236737; Paez D, 2012, CLIN CANCER RES, V18, P645, DOI 10.1158/1078-0432.CCR-11-2186; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Schardt JA, 2005, CANCER CELL, V8, P227, DOI 10.1016/j.ccr.2005.08.003; Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Soofi SS, 2009, J STRUCT BIOL, V167, P216, DOI 10.1016/j.jsb.2009.05.005; Sunyer R, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025009; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Terry NHA, 2006, NAT PROTOC, V1, P859, DOI 10.1038/nprot.2006.113; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Uhra JW, 2011, P NATL ACAD SCI USA, V108, P12396, DOI 10.1073/pnas.1106613108; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483	40	41	44	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37231	10.1371/journal.pone.0037231	http://dx.doi.org/10.1371/journal.pone.0037231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623999	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500081
J	Tripovich, JS; Hall-Aspland, S; Charrier, I; Arnould, JPY				Tripovich, Joy S.; Hall-Aspland, Sophie; Charrier, Isabelle; Arnould, John P. Y.			The Behavioural Response of Australian Fur Seals to Motor Boat Noise	PLOS ONE			English	Article							VOCAL RATES; AMPLITUDE	Australian fur seals breed on thirteen islands located in the Bass Strait, Australia. Land access to these islands is restricted, minimising human presence but boat access is still permissible with limitations on approach distances. Thirty-two controlled noise exposure experiments were conducted on breeding Australian fur seals to determine their behavioural response to controlled in-air motor boat noise on Kanowna Island (39 degrees 10'S, 146 degrees 18'E). Our results show there were significant differences in the seals' behaviour at low (64-70 dB) versus high (75-85 dB) sound levels, with seals orientating themselves towards or physically moving away from the louder boat noise at three different sound levels. Furthermore, seals responded more aggressively with one another and were more alert when they heard louder boat noise. Australian fur seals demonstrated plasticity in their vocal responses to boat noise with calls being significantly different between the various sound intensities and barks tending to get faster as the boat noise got louder. These results suggest that Australian fur seals on Kanowna Island show behavioural disturbance to high level boat noise. Consequently, it is recommended that an appropriate level of received boat sound emissions at breeding fur seal colonies be below 74 dB and that these findings be taken into account when evaluating appropriate approach distances and speed limits for boats.	[Tripovich, Joy S.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Hall-Aspland, Sophie] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Charrier, Isabelle] Univ Paris 11, Ctr Neurosci, Orsay, France; [Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia	University of Sydney; University of Tasmania; UDICE-French Research Universities; Universite Paris Saclay; Deakin University	Tripovich, JS (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	joytripovich@hotmail.com	Tripovich, Joy/AGJ-9233-2022	Tripovich, Joy/0000-0001-5690-789X; CHARRIER, Isabelle/0000-0003-4873-2342	Winifred Violet Scott Trust	Winifred Violet Scott Trust	This work was supported by the Winifred Violet Scott Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Back J, 2010, BEHAV RESPONSES AUST; Bermudez-Cuamatzin E, 2011, BIOL LETTERS, V7, P36, DOI 10.1098/rsbl.2010.0437; Boydston EE, 2003, ANIM CONSERV, V6, P207, DOI 10.1017/S1367943003003263; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Burleigh A, 2008, TOO CLOSE COMFORT CO; Charrier I, 2011, J COMP PSYCHOL, V125, P385, DOI 10.1037/a0024513; Dobson A., 2001, INTRO GEN LINEAR MOD, DOI 10.1201/9781420057683; Fernandez-Juricic E, 2001, MAR MAMMAL SCI, V17, P387, DOI 10.1111/j.1748-7692.2001.tb01281.x; French SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017686; Fristrup KM, 2003, J ACOUST SOC AM, V113, P3411, DOI 10.1121/1.1573637; Giese M, 1999, J FIELD ORNITHOL, V70, P49; Holst M, 2011, AQUAT MAMM, V37, P139, DOI 10.1578/AM.37.2.2011.139; Johnson B. C., 1977, ENV ASSESSMENT ALASK, V1, P422; Kirkwood R, 2010, MAR FRESHWATER RES, V61, P695, DOI 10.1071/MF09213; Kunc HP, 2008, ETHOLOGY, V114, P381, DOI 10.1111/j.1439-0310.2008.01484.x; Marler P., 2004, NATURES MUSIC SCI BI; Miller E.H., 1991, P128; Miller PJO, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Morisaka T, 2005, J MAMMAL, V86, P541, DOI 10.1644/1545-1542(2005)86[541:EOANOT]2.0.CO;2; Nemeth E, 2009, ANIM BEHAV, V78, P637, DOI 10.1016/j.anbehav.2009.06.016; Parks SE, 2011, BIOL LETTERS, V7, P33, DOI 10.1098/rsbl.2010.0451; Patkin K, 2005, SUSTAINABILITY INTER, P1; Penna M, 2007, ANIM BEHAV, V74, P45, DOI 10.1016/j.anbehav.2006.11.010; Pytte CL, 2003, ANIM BEHAV, V66, P703, DOI 10.1006/anbe.2003.2257; Rode KD, 2007, J WILDLIFE MANAGE, V71, P929, DOI 10.2193/2006-075; SCHUSTERMAN RJ, 1977, BEHAV BIOL, V20, P404, DOI 10.1016/S0091-6773(77)90964-6; Shannon C., 1964, MATH THEORY COMMUNIC; Shaughnessy P. D., 2008, Tourism in Marine Environments, V5, P15, DOI 10.3727/154427308785855260; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Tripovich JS, 2008, MAR MAMMAL SCI, V24, P913, DOI 10.1111/j.1748-7692.2008.00229.x; Tripovich JS, 2005, BIOACOUSTICS, V15, P79, DOI 10.1080/09524622.2005.9753539; Tyack Peter L., 1999, P287; WICKENS PA, 1992, CAN J FISH AQUAT SCI, V49, P1396, DOI 10.1139/f92-155; Wilsons Promontory Marine National Park, 2006, WILS PROM MAR NAT PA	37	16	16	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37228	10.1371/journal.pone.0037228	http://dx.doi.org/10.1371/journal.pone.0037228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623998	gold, Green Published			2022-12-25	WOS:000305343500080
J	Tabone-Eglinger, S; Wehrle-Haller, M; Aebischer, N; Jacquier, MC; Wehrle-Haller, B				Tabone-Eglinger, Severine; Wehrle-Haller, Monique; Aebischer, Nicole; Jacquier, Marie-Claude; Wehrle-Haller, Bernhard			Membrane-bound Kit ligand regulates melanocyte adhesion and survival, providing physical interaction with an intraepithelial niche	FASEB JOURNAL			English	Article						c-kit; stem cells; motility; spreading; integrin; epidermis	RECEPTOR TYROSINE KINASE; C-KIT; STEEL FACTOR; DOMINANT ROLE; IN-VIVO; CELLS; MIGRATION; ROLES; PROLIFERATION; EXPRESSION	Morphogenesis, as illustrated by melanocyte migration and homing to the skin, requires cadherin adhesion, integrin-dependent migration and Kit-ligand growth factor signaling. However, it is not known how Kit ligand regulates integrin or cadherin-dependent intraepidermal melanocyte behavior. To answer this question, we developed specific 2-dimensional (2D) and 3D culture systems analyzing how soluble or immobilized Kit-ligand-regulated melanocyte migration on vitronectin and laminin, or within a monolayer of kidney epithelial cells. In a 2D system, soluble Kit ligand stimulated integrin-dependent melanoblast migration and chemotaxis and accelerated integrin turnover. In contrast, immobilized, but not soluble, Kit ligand, enhanced integrin-dependent melanocyte spreading on suboptimal laminin concentrations. In 3D, membrane-bound Kit ligand induced intraepithelial melanocyte proliferation, survival, and tight adhesion to epithelial cells, while cleavable Kit ligand was less effective. In contrast, melanocyte motility was independent of membrane-bound Kit ligand, but increased in the presence of the cleavable Kit-ligand isoform. Trans-membrane-dimerization or basolateral-targeting mutants of Kit ligand altered intraepithelial melanocyte localization, survival, and adhesion to epithelial cells. These data and the identification of c-kit/Kit-ligand clusters at cell contacts suggest that membrane-bound Kit ligand captures cell surface-expressed c-kit, providing mechanical anchoring and survival signaling within intraepithelial niches, and thereby defining a new mechanism for melanocyte homeostasis and requirement for environmental niches.-Tabone-Eglinger, S., Wehrle-Haller, M., Aebischer, N., Jacquier, M.-C., Wehrle-Haller, B. Membrane-bound Kit ligand regulates melanocyte adhesion and survival, providing physical interaction with an intraepithelial niche. FASEB J. 26, 3738-3753 (2012). www.fasebj.org	[Tabone-Eglinger, Severine; Wehrle-Haller, Monique; Aebischer, Nicole; Jacquier, Marie-Claude; Wehrle-Haller, Bernhard] Univ Geneva, Dept Cell Physiol & Metab, Ctr Med Univ, CH-1211 Geneva 4, Switzerland	University of Geneva	Wehrle-Haller, B (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Ctr Med Univ, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	bernhard.wehrle-haller@unige.ch		TABONE-eglinger, Severine/0000-0003-4247-1321	Nevus Outreach; Swiss National Science foundation [1003A-130742]; Connective Tissue Cancers Network (CONTICANET; University of Lyon, Lyon, France); Dr. Henri Dubois-Ferriere Dinu Lipatti foundation (Geneva, Switzerland)	Nevus Outreach; Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); Connective Tissue Cancers Network (CONTICANET; University of Lyon, Lyon, France); Dr. Henri Dubois-Ferriere Dinu Lipatti foundation (Geneva, Switzerland)	The authors thank Jozsef Kiss for critical reading of the manuscript and Jean-Yves Blay for discussion. This work was supported by research grants from Nevus Outreach and the Swiss National Science foundation (31003A-130742) to B. W. H. S. T. E. was supported by the Connective Tissue Cancers Network (CONTICANET; University of Lyon, Lyon, France) and the Dr. Henri Dubois-Ferriere Dinu Lipatti foundation (Geneva, Switzerland). The authors declare no conflicts of interest.	ADACHI S, 1992, BLOOD, V79, P650; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; BLUMEJENSEN P, 1994, J BIOL CHEM, V269, P21793; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017; Deshpande S, 2010, DEV BIOL, V337, P199, DOI 10.1016/j.ydbio.2009.10.022; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Engler AJ, 2009, SCIENCE, V324, P208, DOI 10.1126/science.1170107; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Gommerman JL, 2000, BLOOD, V96, P3734, DOI 10.1182/blood.V96.12.3734.h8003734_3734_3742; Gu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025984; Gu Y, 2009, DEVELOPMENT, V136, P1295, DOI 10.1242/dev.030619; Haass NK, 2005, PIGM CELL RES, V18, P150, DOI 10.1111/j.1600-0749.2005.00235.x; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; HUANG EJ, 1992, MOL BIOL CELL, V3, P349, DOI 10.1091/mbc.3.3.349; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Jordan SA, 2000, DEV BIOL, V225, P424, DOI 10.1006/dbio.2000.9856; Kimura Y, 2004, P NATL ACAD SCI USA, V101, P6015, DOI 10.1073/pnas.0305363101; KINASHI T, 1994, BLOOD, V83, P1033; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; KOVACH NL, 1995, BLOOD, V85, P159, DOI 10.1182/blood.V85.1.159.bloodjournal851159; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; Legler DF, 2004, FASEB J, V18, P73, DOI 10.1096/fj.03-1338fje; Li A, 2011, DEV CELL, V21, P722, DOI 10.1016/j.devcel.2011.07.008; Luo R, 2003, DEVELOPMENT, V130, P321, DOI 10.1242/dev.00213; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; MAEDA H, 1992, DEVELOPMENT, V116, P369; Martino M. M., 2011, SCI TRANSL MED, V3, P100; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Mierke CT, 2000, J EXP MED, V192, P801, DOI 10.1084/jem.192.6.801; MIYAZAWA K, 1995, BLOOD, V85, P641, DOI 10.1182/blood.V85.3.641.bloodjournal853641; MONTESANO R, 1985, CELL, V42, P469, DOI 10.1016/0092-8674(85)90104-7; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; Nishikawa-Torikai S, 2011, J INVEST DERMATOL, V131, P2358, DOI 10.1038/jid.2011.195; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Papayannopoulou T, 1998, BLOOD, V91, P2231, DOI 10.1182/blood.V91.7.2231.2231_2231_2239; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; Paulhe F, 2004, J BIOL CHEM, V279, P55545, DOI 10.1074/jbc.M407813200; Paulhe F, 2009, FASEB J, V23, P3037, DOI 10.1096/fj.09-129577; ROTTAPEL R, 1991, MOL CELL BIOL, V11, P3043, DOI 10.1128/MCB.11.6.3043; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Saldana-Caboverde A, 2010, PIGM CELL MELANOMA R, V23, P160, DOI 10.1111/j.1755-148X.2010.00678.x; Santiago-Walker A, 2009, SKIN PHARMACOL PHYS, V22, P114, DOI 10.1159/000178870; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; SVIDERSKAYA EV, 1995, DEVELOPMENT, V121, P1547; Tajima Y, 1998, P NATL ACAD SCI USA, V95, P11903, DOI 10.1073/pnas.95.20.11903; Tan BL, 2003, BLOOD, V101, P4725, DOI 10.1182/blood-2002-08-2521; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; TOKSOZ D, 1992, P NATL ACAD SCI USA, V89, P7350, DOI 10.1073/pnas.89.16.7350; Waskow C, 2002, IMMUNITY, V17, P277, DOI 10.1016/S1074-7613(02)00386-2; Waskow C, 2007, BLOOD, V109, P5363, DOI 10.1182/blood-2006-08-039131; Waskow C, 2009, NAT METHODS, V6, P267, DOI [10.1038/nmeth.1309, 10.1038/NMETH.1309]; Wehrle-Haller B, 1999, DEV BIOL, V210, P71, DOI 10.1006/dbio.1999.9260; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; Wehrle-Haller B, 2001, DEV BIOL, V232, P471, DOI 10.1006/dbio.2001.0167; Wehrle-Haller B, 2001, J BIOL CHEM, V276, P12667, DOI 10.1074/jbc.M008357200; Wehrle-Haller Bernhard, 2007, Methods Mol Biol, V370, P173; WEHRLEHALLER B, 1995, DEVELOPMENT, V121, P731; YEE NS, 1994, J BIOL CHEM, V269, P31991; Zicha D, 1997, Methods Mol Biol, V75, P449	68	14	17	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3738	3753		10.1096/fj.12-206045	http://dx.doi.org/10.1096/fj.12-206045			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22637532				2022-12-25	WOS:000308391600015
J	Bu, LT; Nimlos, MR; Shirts, MR; Stahlberg, J; Himmel, ME; Crowley, MF; Beckham, GT				Bu, Lintao; Nimlos, Mark R.; Shirts, Michael R.; Stahlberg, Jerry; Himmel, Michael E.; Crowley, Michael F.; Beckham, Gregg T.			Product Binding Varies Dramatically between Processive and Nonprocessive Cellulase Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; TRICHODERMA-REESEI; HUMICOLA-INSOLENS; ENZYMATIC-HYDROLYSIS; FORCE-FIELDS; SIMULTANEOUS SACCHARIFICATION; CELLOBIOHYDROLASE CEL6A; BIOMASS RECALCITRANCE; FUNGAL CELLULASE; PROTEIN	Cellulases hydrolyze beta-1,4 glycosidic linkages in cellulose, which are among the most prevalent and stable bonds in Nature. Cellulases comprise many glycoside hydrolase families and exist as processive or nonprocessive enzymes. Product inhibition negatively impacts cellulase action, but experimental measurements of product-binding constants vary significantly, and there is little consensus on the importance of this phenomenon. To provide molecular level insights into cellulase product inhibition, we examine the impact of product binding on processive and nonprocessive cellulases by calculating the binding free energy of cellobiose to the product sites of catalytic domains of processive and nonprocessive enzymes from glycoside hydrolase families 6 and 7. The results suggest that cellobiose binds to processive cellulases much more strongly than nonprocessive cellulases. We also predict that the presence of a cellodextrin bound in the reactant site of the catalytic domain, which is present during enzymatic catalysis, has no effect on product binding in nonprocessive cellulases, whereas it significantly increases product binding to processive cellulases. This difference in product binding correlates with hydrogen bonding between the substrate-side ligand and the cellobiose product in processive cellulase tunnels and the additional stabilization from the longer tunnel-forming loops. The hydrogen bonds between the substrate-and product-side ligands are disrupted by water in nonprocessive cellulase clefts, and the lack of long tunnel-forming loops results in lower affinity of the product ligand. These findings provide new insights into the large discrepancies reported for binding constants for cellulases and suggest that product inhibition will vary significantly based on the amount of productive binding for processive cellulases on cellulose.	[Bu, Lintao; Nimlos, Mark R.; Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Himmel, Michael E.; Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA; [Shirts, Michael R.] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22904 USA; [Stahlberg, Jerry] Swedish Univ Agr Sci, Dept Mol Biol, S-75651 Uppsala, Sweden	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines; University of Virginia; Swedish University of Agricultural Sciences	Bu, LT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA.	lintao.bu@nrel.gov; gregg.beckham@nrel.gov	crowley, michael F/A-4852-2013; Stahlberg, Jerry/D-4163-2013	crowley, michael F/0000-0001-5163-9398; Stahlberg, Jerry/0000-0003-4059-8580	Department of Energy Office of the Biomass Program; National Science Foundation through TeraGrid resources [TG-MCB090159]; Department of Energy EERE [DE-AC36-08GO28308]	Department of Energy Office of the Biomass Program(United States Department of Energy (DOE)); National Science Foundation through TeraGrid resources(National Science Foundation (NSF)); Department of Energy EERE(United States Department of Energy (DOE))	This work was supported by the Department of Energy Office of the Biomass Program. Computational time for this research was supported in part by the National Science Foundation through TeraGrid resources under Grant TG-MCB090159 and by the NREL Computational Sciences Center supported by the Department of Energy EERE under Contract DE-AC36-08GO28308.	Andric P, 2010, BIOTECHNOL ADV, V28, P308, DOI 10.1016/j.biotechadv.2010.01.003; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Bezerra RMF, 2005, APPL BIOCHEM BIOTECH, V126, P49, DOI 10.1007/s12010-005-0005-5; Bezerra RMF, 2004, APPL BIOCHEM BIOTECH, V112, P173, DOI 10.1385/ABAB:112:3:173; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Bommarius AS, 2008, METAB ENG, V10, P370, DOI 10.1016/j.ymben.2008.06.008; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHANZY H, 1983, FEBS LETT, V153, P113, DOI 10.1016/0014-5793(83)80129-X; CHANZY H, 1985, FEBS LETT, V184, P285, DOI 10.1016/0014-5793(85)80623-2; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; CLAEYSSENS M, 1989, BIOCHEM J, V261, P819, DOI 10.1042/bj2610819; Crowley MF, 2009, INT J QUANTUM CHEM, V109, P3767, DOI 10.1002/qua.22372; Davies GJ, 2000, BIOCHEM J, V348, P201, DOI 10.1042/0264-6021:3480201; Du F., APPL BIOCH BIOTECHNO, V161, P313; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Gan Q, 2003, PROCESS BIOCHEM, V38, P1003, DOI 10.1016/S0032-9592(02)00220-0; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; GUSAKOV AV, 1987, BIOTECHNOL BIOENG, V29, P906, DOI 10.1002/bit.260290715; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Hummer G, 2001, J CHEM PHYS, V114, P7330, DOI 10.1063/1.1363668; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Oh KK, 2000, APPL BIOCHEM BIOTECH, V89, P15, DOI 10.1385/ABAB:89:1:15; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; Payne CM, 2011, J PHYS CHEM LETT, V2, P1546, DOI 10.1021/jz2005122; PHILIPPIDIS GP, 1993, BIOTECHNOL BIOENG, V41, P846, DOI 10.1002/bit.260410903; Rosgaard L, 2007, BIOTECHNOL PROGR, V23, P1270, DOI 10.1021/bp070329p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schulein M, 1997, J BIOTECHNOL, V57, P71, DOI 10.1016/S0168-1656(97)00090-4; Taylor CB, 2012, J BIOL CHEM, V287, P3147, DOI 10.1074/jbc.M111.270389; Ubhayasekera W, 2005, FEBS J, V272, P1952, DOI 10.1111/j.1742-4658.2005.04625.x; VANTILBEURGH H, 1989, EUR J BIOCHEM, V184, P553; Varrot A, 1999, BIOCHEMISTRY-US, V38, P8884, DOI 10.1021/bi9903998; Varrot A, 2003, STRUCTURE, V11, P855, DOI 10.1016/S0969-2126(03)00124-2; Varrot A, 2003, CHEM COMMUN, P946, DOI 10.1039/b301592k; WALD S, 1984, BIOTECHNOL BIOENG, V26, P221, DOI 10.1002/bit.260260305	56	50	50	2	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24807	24813		10.1074/jbc.M112.365510	http://dx.doi.org/10.1074/jbc.M112.365510			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22648408	Green Published, hybrid			2022-12-25	WOS:000306651100073
J	Sami, H; Maparu, AK; Kumar, A; Sivakumar, S				Sami, Haider; Maparu, Auhin K.; Kumar, Ashok; Sivakumar, Sri			Generic Delivery of Payload of Nanoparticles Intracellularly via Hybrid Polymer Capsules for Bioimaging Applications	PLOS ONE			English	Article							POLYELECTROLYTE; EMULSIONS; SPHERES; SIZE; MICROCONTAINERS; MICROCAPSULES; DEPENDENCE; PARTICLES; NANORODS; SILICA	Towards the goal of development of a generic nanomaterial delivery system and delivery of the 'as prepared' nanoparticles without 'further surface modification' in a generic way, we have fabricated a hybrid polymer capsule as a delivery vehicle in which nanoparticles are loaded within their cavity. To this end, a generic approach to prepare nanomaterials-loaded polyelectrolyte multilayered (PEM) capsules has been reported, where polystyrene sulfonate (PSS)/polyallylamine hydrochloride (PAH) polymer capsules were employed as nano/microreactors to synthesize variety of nanomaterials (metal nanoparticles; lanthanide doped inorganic nanoparticles; gadolinium based nanoparticles, cadmium based nanoparticles; different shapes of nanoparticles; co-loading of two types of nanoparticles) in their hollow cavity. These nanoparticles-loaded capsules were employed to demonstrate generic delivery of payload of nanoparticles intracellularly (HeLa cells), without the need of individual nanoparticle surface modification. Validation of intracellular internalization of nanoparticles-loaded capsules by HeLa cells was ascertained by confocal laser scanning microscopy. The green emission from Tb3+ was observed after internalization of LaF3:Tb3+(5%) nanoparticles-loaded capsules by HeLa cells, which suggests that nanoparticles in hybrid capsules retain their functionality within the cells. In vitro cytotoxicity studies of these nanoparticles-loaded capsules showed less/no cytotoxicity in comparison to blank capsules or untreated cells, thus offering a way of evading direct contact of nanoparticles with cells because of the presence of biocompatible polymeric shell of capsules. The proposed hybrid delivery system can be potentially developed to avoid a series of biological barriers and deliver multiple cargoes (both simultaneous and individual delivery) without the need of individual cargo design/modification.	[Sami, Haider; Kumar, Ashok] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India; [Maparu, Auhin K.; Sivakumar, Sri] Indian Inst Technol, Unit Excellence Soft Nanofabricat, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Sami, H (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	ashokkum@iitk.ac.in; srisiva@iitk.ac.in	Kumar, Ashok/G-8515-2015; KUMAR, ASHOK/AAF-4055-2021; Sivakumar, Sri/F-2053-2013	KUMAR, ASHOK/0000-0002-9244-0622; Sivakumar, Sri/0000-0002-6472-2702; Kumar, Ashok/0000-0002-4910-9440	IIT Kanpur [IIT/CHE/20080352]; Department of Biotechnology [DBT/CHE/20100304]; Department of Science and Technology; India-UK Science Bridge [DST/BSBE/20090218]; DBT Junior Research Fellowship (DBT-JRF) programme	IIT Kanpur; Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); India-UK Science Bridge; DBT Junior Research Fellowship (DBT-JRF) programme	This work is funded by IIT Kanpur (IIT/CHE/20080352), Department of Biotechnology (DBT/CHE/20100304), Department of Science and Technology and India-UK Science Bridge (DST/BSBE/20090218). HS also acknowledges a senior research fellowship under the DBT Junior Research Fellowship (DBT-JRF) programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alric C, 2008, J AM CHEM SOC, V130, P5908, DOI 10.1021/ja078176p; Angelatos AS, 2005, J PHYS CHEM B, V109, P3071, DOI 10.1021/jp045070x; Bedard MF, 2009, SOFT MATTER, V5, P148, DOI 10.1039/b812553h; Buchel G, 1998, ADV MATER, V10, P1036, DOI 10.1002/(SICI)1521-4095(199809)10:13<1036::AID-ADMA1036>3.0.CO;2-Z; Caruso F, 2000, LANGMUIR, V16, P8932, DOI 10.1021/la000401s; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Choi WS, 2005, J AM CHEM SOC, V127, P16136, DOI 10.1021/ja053981u; Cortez C, 2006, ADV MATER, V18, P1998, DOI 10.1002/adma.200600564; Cui JW, 2010, ADV FUNCT MATER, V20, P1625, DOI 10.1002/adfm.201000209; De Geest BG, 2009, SOFT MATTER, V5, P282, DOI 10.1039/b808262f; del Mercato LL, 2010, NANOSCALE, V2, P458, DOI 10.1039/b9nr00341j; Gorin DA, 2008, PHYS CHEM CHEM PHYS, V10, P6899, DOI 10.1039/b809696a; Jana NR, 2001, J PHYS CHEM B, V105, P4065, DOI 10.1021/jp0107964; Javier AM, 2008, ADV MATER, V20, P4281, DOI 10.1002/adma.200703190; Johnston APR, 2006, CURR OPIN COLLOID IN, V11, P203, DOI 10.1016/j.cocis.2006.05.001; Kievit FM, 2011, ADV MATER, V23, pH217, DOI 10.1002/adma.201102313; Koo HY, 2008, SMALL, V4, P742, DOI 10.1002/smll.200800021; Melancon MP, 2009, MRS BULL, V34, P415, DOI 10.1557/mrs2009.117; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pavlov AM, 2011, SOFT MATTER, V7, P4341, DOI 10.1039/c0sm01536a; Riehemann K, 2009, ANGEW CHEM INT EDIT, V48, P872, DOI 10.1002/anie.200802585; Rivera Gil P, 2008, NANO TODAY, V3, P12; Rogach AL, 2000, CHEM MATER, V12, P2676, DOI 10.1021/cm000244i; Sau TK, 2004, LANGMUIR, V20, P6414, DOI 10.1021/la049463z; Shchukin DG, 2004, J PHYS CHEM B, V108, P19109, DOI 10.1021/jp048052o; Shchukin DG, 2003, LANGMUIR, V19, P4427, DOI 10.1021/la0268707; Sivakumar S, 2008, CHEM MATER, V20, P2063, DOI 10.1021/cm703237a; Sivakumar S, 2006, CHEM-EUR J, V12, P5878, DOI 10.1002/chem.200600224; Sivakumar S, 2009, ADV FUNCT MATER, V19, P2260, DOI 10.1002/adfm.200900399; Sivakumar S, 2009, ADV MATER, V21, P1820, DOI 10.1002/adma.200802475; Skirtach AG, 2004, LANGMUIR, V20, P6988, DOI 10.1021/la048873k; Skirtach AG, 2006, ANGEW CHEM INT EDIT, V45, P4612, DOI 10.1002/anie.200504599; Song Y, 2009, ANGEW CHEM INT EDIT, V48, P9143, DOI 10.1002/anie.200904666; Stadler B, 2011, ADV FUNCT MATER, V21, P14, DOI 10.1002/adfm.201001676; Thurn KT, 2007, NANOSCALE RES LETT, V2, P430, DOI 10.1007/s11671-007-9081-5; Wang YJ, 2008, NANO LETT, V8, P1741, DOI 10.1021/nl080877c; Wang YJ, 2006, CHEM MATER, V18, P4089, DOI 10.1021/cm060866p; Xu XL, 2002, J AM CHEM SOC, V124, P13864, DOI 10.1021/ja026901k; YUAN F, 1995, CANCER RES, V55, P3752; Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001	41	18	20	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e36195	10.1371/journal.pone.0036195	http://dx.doi.org/10.1371/journal.pone.0036195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649489	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335800006
J	Xia, TM; Xiao, D; Liu, D; Chai, WT; Gong, QQ; Wang, NN				Xia, Tongmei; Xiao, Dong; Liu, Dong; Chai, Wenting; Gong, Qingqiu; Wang, Ning Ning			Heterologous Expression of ATG8c from Soybean Confers Tolerance to Nitrogen Deficiency and Increases Yield in Arabidopsis	PLOS ONE			English	Article							NITRATE REDUCTASE-ACTIVITY; AUTOPHAGOSOME FORMATION; AMINO-ACIDS; CELL-DEATH; PROTEIN; VACUOLE; REMOBILIZATION; SENESCENCE; CYTOPLASM; PLANTS	Nitrogen is an essential element for plant growth and yield. Improving Nitrogen Use Efficiency (NUE) of crops could potentially reduce the application of chemical fertilizer and alleviate environmental damage. To identify new NUE genes is therefore an important task in molecular breeding. Macroautophagy (autophagy) is an intracellular process in which damaged or obsolete cytoplasmic components are encapsulated in double membraned vesicles termed autophagosomes, then delivered to the vacuole for degradation and nutrient recycling. One of the core components of autophagosome formation, ATG8, has been shown to directly mediate autophagosome expansion, and the transcript of which is highly inducible upon starvation. Therefore, we postulated that certain homologs of Saccharomyces cerevisiae ATG8 (ScATG8) from crop species could have potential for NUE crop breeding. A soybean (Glycine max, cv. Zhonghuang-13) ATG8, GmATG8c, was selected from the 11 family members based on transcript analysis upon nitrogen deprivation. GmATG8c could partially complement the yeast atg8 mutant. Constitutive expression of GmATG8c in soybean callus cells not only enhanced nitrogen starvation tolerance of the cells but accelerated the growth of the calli. Transgenic Arabidopsis over-expressing GmATG8c performed better under extended nitrogen and carbon starvation conditions. Meanwhile, under optimum growth conditions, the transgenic plants grew faster, bolted earlier, produced larger primary and axillary inflorescences, eventually produced more seeds than the wild-type. In average, the yield was improved by 12.9%. We conclude that GmATG8c may serve as an excellent candidate for breeding crops with enhanced NUE and better yield.	[Xia, Tongmei; Xiao, Dong; Liu, Dong; Chai, Wenting; Gong, Qingqiu; Wang, Ning Ning] Nankai Univ, Dept Plant Biol & Ecol, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University	Xia, TM (corresponding author), Nankai Univ, Dept Plant Biol & Ecol, Coll Life Sci, Tianjin 300071, Peoples R China.	gongq@nankai.edu.cn; wangnn@nankai.edu.cn	Gong, Qingqiu/AAU-9486-2021	Xiao, Dong/0000-0002-4968-9019	Major Technological Program on Cultivation of NewVarieties of Genetically Modified Organisms [2011ZX08004005-007, 2009ZX08009-133B, 2009ZX08009-126B, 2011ZX08010-002-004]; Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP) [200800550017]; Tianjin Research Program of Applied Basic and Cutting-edge Technologies [11JCZDJC16400]	Major Technological Program on Cultivation of NewVarieties of Genetically Modified Organisms; Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Tianjin Research Program of Applied Basic and Cutting-edge Technologies	This work was supported by the Major Technological Program on Cultivation of NewVarieties of Genetically Modified Organisms (No. 2011ZX08004005-007 and 2009ZX08009-133B) to NNW, (No. 2009ZX08009-126B and 2011ZX08010-002-004) to QG, Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP) (No. 200800550017) to NNW, and Tianjin Research Program of Applied Basic and Cutting-edge Technologies (11JCZDJC16400) to QG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2012, PLANT CELL ENVIRON, V35, P38, DOI 10.1111/j.1365-3040.2011.02378.x; Bassham DC, 2006, AUTOPHAGY, V2, P2, DOI 10.4161/auto.2092; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brouquisse R, 1998, PLANT PHYSIOL, V117, P1281, DOI 10.1104/pp.117.4.1281; Chang CY, 2007, MOL BIOL CELL, V18, P919, DOI 10.1091/mbc.E06-08-0683; Chung T, 2009, PLANT PHYSIOL, V149, P220, DOI 10.1104/pp.108.126714; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Contento AL, 2005, PLANT J, V42, P598, DOI 10.1111/j.1365-313X.2005.02396.x; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Fujiki Y, 2007, PLANT PHYSIOL, V143, P1132, DOI 10.1104/pp.106.093864; Fujioka Y, 2008, J BIOL CHEM, V283, P1921, DOI 10.1074/jbc.M706214200; Geiger M, 1998, PLANT CELL ENVIRON, V21, P253, DOI 10.1046/j.1365-3040.1998.00277.x; Good AG, 2004, TRENDS PLANT SCI, V9, P597, DOI 10.1016/j.tplants.2004.10.008; Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; He Y, 2009, PLANT CELL TISS ORG, V98, P11, DOI 10.1007/s11240-009-9533-y; Hirel B, 2001, PLANT PHYSIOL, V125, P1258, DOI 10.1104/pp.125.3.1258; Honig A, 2012, PLANT CELL, V24, P288, DOI 10.1105/tpc.111.093112; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Ishida H, 2008, PLANT PHYSIOL, V148, P142, DOI 10.1104/pp.108.122770; Izumi M, 2010, PLANT PHYSIOL, V154, P1196, DOI 10.1104/pp.110.158519; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kichey T, 2007, FIELD CROP RES, V102, P22, DOI 10.1016/j.fcr.2007.01.002; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kjeldahl J, 1883, Z ANAL CHEM, V22, P336; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; Lai Z, 2011, PLANT J; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; Lenz HD, 2011, PLANT J; Liu D, 2010, J EXP BOT, V61, P1655, DOI 10.1093/jxb/erq033; Liu TB, 2010, AUTOPHAGY, V6, P74, DOI 10.4161/auto.6.1.10438; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Masclaux C, 2001, ANN APPL BIOL, V138, P69, DOI 10.1111/j.1744-7348.2001.tb00086.x; Masclaux-Daubresse C, 2008, PLANT BIOLOGY, V10, P23, DOI 10.1111/j.1438-8677.2008.00097.x; Masclaux-Daubresse C, 2011, J EXP BOT, V62, P2131, DOI 10.1093/jxb/erq405; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Matt P, 1998, PLANTA, V207, P27, DOI 10.1007/s004250050452; Mickelson S, 2003, J EXP BOT, V54, P801, DOI 10.1093/jxb/erg084; Mulvaney RL, 2009, J ENVIRON QUAL, V38, P2295, DOI 10.2134/jeq2008.0527; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Pathak RR, 2008, CURRENT, P94; Patrick JW, 2001, J EXP BOT, V52, P551, DOI 10.1093/jexbot/52.356.551; Phillips AR, 2008, GENETICS, V178, P1339, DOI 10.1534/genetics.107.086199; Rose TL, 2006, BIOL CELL, V98, P53, DOI 10.1042/BC20040516; Sakhonwasee SA, 2009, AUTOPHAGY SUSTAINS A; SHIBLES RM, 1998, P 28 N CENTR EXT IND, P5; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Slavikova S, 2005, J EXP BOT, V56, P2839, DOI 10.1093/jxb/eri276; Slavikova S, 2008, J EXP BOT, V59, P4029, DOI 10.1093/jxb/ern244; Suttangkakul A, 2011, PLANT CELL, V23, P3761, DOI 10.1105/tpc.111.090993; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Tewari K, 2004, J AGRON CROP SCI, V190, P46, DOI 10.1046/j.0931-2250.2003.00073.x; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200; Wilkins MR, 1999, METH MOL B, V112, P531; Woods J, 2010, PHILOS T R SOC B, V365, P2991, DOI 10.1098/rstb.2010.0172; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xiong Y, 2005, PLANT J, V42, P535, DOI 10.1111/j.1365-313X.2005.02397.x; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670; Yamaya T, 2002, J EXP BOT, V53, P917, DOI 10.1093/jexbot/53.370.917; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; Yoshimoto K, 2010, FEBS LETT, V584, P1350, DOI 10.1016/j.febslet.2010.01.007; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635; Zhang WH, 2007, FUNCT PLANT BIOL, V34, P314, DOI 10.1071/FP06271	73	67	74	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37217	10.1371/journal.pone.0037217	http://dx.doi.org/10.1371/journal.pone.0037217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629371	Green Published, Green Submitted, gold			2022-12-25	WOS:000305345300027
J	Chen, DB; Feng, L; Lin, XP; Zhang, W; Li, FR; Liang, XL; Li, XH				Chen, Ding-Bang; Feng, Li; Lin, Xiao-Pu; Zhang, Wei; Li, Fu-Rong; Liang, Xiu-Ling; Li, Xun-Hua			Penicillamine Increases Free Copper and Enhances Oxidative Stress in the Brain of Toxic Milk Mice	PLOS ONE			English	Article							WILSONS-DISEASE; NEUROLOGIC SYNDROME; ATPASE ATP7A; EXPRESSION; TRANSPORTER; TRANSITION; DIAGNOSIS; BARRIER; METALS; MOUSE	Wilson disease (WD) is characterized by the accumulation of copper arising from a mutation in the ATP7B gene. Penicillamine (PA) makes 10-50% of the patients with neurologic symptoms neurologically worse at the early stage of administration. The aim of this study was to determine how the copper metabolism changes and whether the change impairs the brain of toxic milk (tx) mice, an animal model of WD, during the PA administration. The free copper and protein-bound copper concentrations in the serum, cortex and basal ganglia of tx mice with PA administration for 3 days, 10 days and 14 days, respectively, were investigated. The expression of copper transporters, ATP7A and CTR1, was analyzed by real-time quantitative PCR, immunofluorescence and Western blot. Then SOD, MDA and GSH/GSSG were detected to determine whether the oxidative stress changed correspondingly. The results revealed the elevated free copper concentrations in the serum and brain, and declined protein-bound copper concentrations in the brain of tx mice during PA administration. Meanwhile, transiently increased expression of ATP7A and CTR1 was observed generally in the brain parenchyma by immunofluorescence, real-time quantitative PCR and Western blot. Additionally, ATP7A and CTR1 were observed to locate mainly at Golgi apparatus and cellular membrane respectively. Intense staining of ATP7A in the choroid plexus was found in tx mice on the 3rd and 10th day of PA treatment, but rare staining of ATP7A and CTR1 in the blood-brain barrier (BBB). Decreased GSH/GSSG and increased MDA concentrations were also viewed in the cortex and basal ganglia. Our results suggested the elevated free copper concentrations in the brain might lead to the enhanced oxidative stress during PA administration. The increased free copper in the brain might come from the copper mobilized from brain parenchyma cells but not from the serum according to the ATP7A and CTR1 expression analysis.	[Chen, Ding-Bang; Feng, Li; Liang, Xiu-Ling; Li, Xun-Hua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Xiao-Pu] So Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Zhang, Wei; Li, Fu-Rong] Sun Yat Sen Univ, Lab Anim Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Southern Medical University - China; Sun Yat Sen University	Chen, DB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	lxunh001@yahoo.com.cn			National Natural Science Foundation of China [30671154]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by grants from the National Natural Science Foundation of China(30671154,http://www.nsfc.gov.cn/Portal0/default106.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KJ, 2006, BIOMETALS, V19, P555, DOI 10.1007/s10534-005-5918-5; Bohrer D, 2004, CLIN CHIM ACTA, V345, P113, DOI 10.1016/j.cccn.2004.03.001; Brewer GJ, 2010, CHEM RES TOXICOL, V23, P319, DOI 10.1021/tx900338d; Brewer GJ, 2009, TRANSL RES, V154, P70, DOI 10.1016/j.trsl.2009.05.002; Brewer GJ, 2006, ARCH NEUROL-CHICAGO, V63, P521, DOI 10.1001/archneur.63.4.521; BREWER GJ, 1987, ARCH NEUROL-CHICAGO, V44, P490, DOI 10.1001/archneur.1987.00520170020016; Britton RS, 1996, SEMIN LIVER DIS, V16, P3, DOI 10.1055/s-2007-1007214; Cheng J, 2011, BIOL TRACE ELEM RES; Choi BS, 2009, BRAIN RES, V1248, P14, DOI 10.1016/j.brainres.2008.10.056; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Lee J, 2000, GENE, V254, P87, DOI 10.1016/S0378-1119(00)00287-0; Lutsenko S, 2010, METALLOMICS, V2, P596, DOI 10.1039/c0mt00006j; Minghetti M, 2011, COMP BIOCHEM PHYS C, V154, P93, DOI 10.1016/j.cbpc.2011.03.010; Monnot AD, 2011, TOXICOL APPL PHARM; Niciu MJ, 2006, NEUROSCIENCE, V139, P947, DOI 10.1016/j.neuroscience.2006.01.044; Ozcelik D, 2003, BIOL TRACE ELEM RES, V96, P209, DOI 10.1385/BTER:96:1-3:209; Ozcelik D, 2009, BIOL TRACE ELEM RES, V127, P45, DOI 10.1007/s12011-008-8219-3; Pase L, 2004, BIOCHEM J, V378, P1031, DOI 10.1042/BJ20031181; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Porzio S, 1997, ARCH NEUROL-CHICAGO, V54, P1166, DOI 10.1001/archneur.1997.00550210092019; RAUCH H, 1983, J HERED, V74, P141, DOI 10.1093/oxfordjournals.jhered.a109751; Reddy PVB, 2008, LAB INVEST, V88, P816, DOI 10.1038/labinvest.2008.49; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; SAKURAI H, 1992, BIOCHEM BIOPH RES CO, V185, P548, DOI 10.1016/0006-291X(92)91659-E; Sansinanea A S, 1998, Acta Physiol Pharmacol Ther Latinoam, V48, P25; Stuerenburg HJ, 2000, J NEURAL TRANSM, V107, P321, DOI 10.1007/s007020050026; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P386, DOI 10.1016/S0753-3322(03)00012-X; Tennant J, 2002, FEBS LETT, V527, P239, DOI 10.1016/S0014-5793(02)03253-2; Zhang SSZ, 2000, VET HUM TOXICOL, V42, P261	31	49	51	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37709	10.1371/journal.pone.0037709	http://dx.doi.org/10.1371/journal.pone.0037709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629446	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343100048
J	Sunshine, JC; Sunshine, SB; Bhutto, I; Handa, JT; Green, JJ				Sunshine, Joel C.; Sunshine, Sarah B.; Bhutto, Imran; Handa, James T.; Green, Jordan J.			Poly(beta-Amino Ester)-Nanoparticle Mediated Transfection of Retinal Pigment Epithelial Cells In Vitro and In Vivo	PLOS ONE			English	Article							NONVIRAL GENE DELIVERY; THERAPY; NANOPARTICLES; EXPRESSION; POLYMERS; ESTERS)	A variety of genetic diseases in the retina, including retinitis pigmentosa and leber congenital amaurosis, might be excellent targets for gene delivery as treatment. A major challenge in non-viral gene delivery remains finding a safe and effective delivery system. Poly(beta-amino ester)s (PBAEs) have shown great potential as gene delivery reagents because they are easily synthesized and they transfect a wide variety of cell types with high efficacy in vitro. We synthesized a combinatorial library of PBAEs and evaluated them for transfection efficacy and toxicity in retinal pigment epithelial (ARPE-19) cells to identify lead polymer structures and transfection formulations. Our optimal polymer (B5-S5-E7 at 60 w/w polymer: DNA ratio) transfected ARPE-19 cells with 44 +/- 5% transfection efficacy, significantly higher than with optimized formulations of leading commercially available reagents Lipofectamine 2000 (26 +/- 7%) and X-tremeGENE HP DNA (22 +/- 6%); (p<0.001 for both). Ten formulations exceeded 30% transfection efficacy. This high non-viral efficacy was achieved with comparable cytotoxicity (23 +/- 6%) to controls; optimized formulations of Lipofectamine 2000 and X-tremeGENE HP DNA showed 15 +/- 3% and 32 +/- 9% toxicity respectively (p>0.05 for both). Our optimal polymer was also significantly better than a gold standard polymeric transfection reagent, branched 25 kDa polyethyleneimine (PEI), which achieved only 8 +/- 1% transfection efficacy with 25 +/- 6% cytotoxicity. Subretinal injections using lyophilized GFP-PBAE nanoparticles resulted in 1.1 +/- 1x10(3)-fold and 1.5 +/- 0.7x10(3)-fold increased GFP expression in the retinal pigment epithelium (RPE)/choroid and neural retina respectively, compared to injection of DNA alone (p = 0.003 for RPE/choroid, p<0.001 for neural retina). The successful transfection of the RPE in vivo suggests that these nanoparticles could be used to study a number of genetic diseases in the laboratory with the potential to treat debilitating eye diseases.	[Sunshine, Joel C.; Sunshine, Sarah B.; Bhutto, Imran; Handa, James T.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Sunshine, JC (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.	green@jhu.edu	Green, Jordan/B-9001-2009	Green, Jordan/0000-0003-4176-3808; Sunshine, Joel/0000-0001-9987-6712	Maryland Technology Development Corporation Maryland Stem Cell Research Fund (TEDCO MSCRF) [2009-MSCRFE-0098-00]; Medical Scientist Training Program; HHMI-Foundation Fighting Blindness Medical Research Fellowship; Thome Foundation; Research to Prevent Blindness; Robert Bond Welch Professorship;  [EY019904];  [EY14005]; NATIONAL EYE INSTITUTE [R01EY014005, R01EY019904] Funding Source: NIH RePORTER	Maryland Technology Development Corporation Maryland Stem Cell Research Fund (TEDCO MSCRF); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI-Foundation Fighting Blindness Medical Research Fellowship; Thome Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Robert Bond Welch Professorship; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank the Maryland Technology Development Corporation Maryland Stem Cell Research Fund (TEDCO MSCRF, 2009-MSCRFE-0098-00), Medical Scientist Training Program (JCS), HHMI-Foundation Fighting Blindness Medical Research Fellowship (SBS), EY019904 (JTH), EY14005 (JTH), Thome Foundation grant (JTH), a Research to Prevent Blindness unrestricted grant (Wilmer), and the Robert Bond Welch Professorship for support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Hassan K, 2000, CURR EYE RES, V20, P361, DOI 10.1076/0271-3683(200005)20:5;1-1;FT361; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Bhise NS, 2011, SMALL; Bhise NS, 2010, BIOMATERIALS, V31, P8088, DOI 10.1016/j.biomaterials.2010.07.023; Bitner H, 2011, INVEST OPHTH VIS SCI, V52, P5332, DOI 10.1167/iovs.11-7174; Briggs CE, 2001, INVEST OPHTH VIS SCI, V42, P2229; Check E, 2002, NATURE, V420, P116, DOI 10.1038/420116a; Check E, 2005, NATURE, V433, P561, DOI 10.1038/433561a; del Pozo-Rodriguez A, 2008, INT J PHARM, V360, P177, DOI 10.1016/j.ijpharm.2008.04.023; Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336; Green JJ, 2007, ADV MATER, V19, P2836, DOI 10.1002/adma.200700371; Handa JT, 1998, EXP EYE RES, V66, P411, DOI 10.1006/exer.1997.0442; Jacobson SG, 2011, ARCH OPHTHALMOL; Koirala A, 2011, BIOMATERIALS, V32, P9483, DOI 10.1016/j.biomaterials.2011.08.062; Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388; Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645; Shmueli RB, 2012, NANOMED-NANOTECHNOL, V8, P1200, DOI 10.1016/j.nano.2012.01.006; Sunshine J, 2009, ADV MATER, V21, P4947, DOI 10.1002/adma.200901718; Sunshine JC, 2011, THER DELIV, V2, P493, DOI 10.4155/TDE.11.14; Sunshine JC, 2011, BIOMACROMOLECULES, V12, P3592, DOI 10.1021/bm200807s; Tzeng SY, 2011, BIOMATERIALS, V32, P5402, DOI 10.1016/j.biomaterials.2011.04.016; Urtti A, 2000, J DRUG TARGET, V7, P413, DOI 10.3109/10611860009102216; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255	23	75	80	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37543	10.1371/journal.pone.0037543	http://dx.doi.org/10.1371/journal.pone.0037543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629417	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343100038
J	Urquidi, V; Kim, J; Chang, MR; Dai, YF; Rosser, CJ; Goodison, S				Urquidi, Virginia; Kim, Jeongsoon; Chang, Myron; Dai, Yunfeng; Rosser, Charles J.; Goodison, Steve			CCL18 in a Multiplex Urine-Based Assay for the Detection of Bladder Cancer	PLOS ONE			English	Article							ACTIVATOR INHIBITOR TYPE-1; IN-SITU HYBRIDIZATION; CLINICAL UTILITY; EXPRESSION; DIAGNOSIS; CELL; CYTOLOGY; MARKERS; CLASSIFICATION; UROKINASE	The early detection of bladder cancer (BCa) is pivotal for successful patient treatment and management. Through genomic and proteomic studies, we have identified a number of bladder cancer-associated biomarkers that have potential clinical utility. In a case-control study, we examined voided urines from 127 subjects: 64 tumor-bearing subjects and 63 controls. The urine concentrations of the following proteins were assessed by enzyme-linked immunosorbent assay (ELISA); C-C motif chemokine 18 (CCL18), Plasminogen Activator Inhibitor 1 (PAI-1) and CD44. Data were compared to a commercial ELISA-based BCa detection assay (BTA-Trak (c)) and voided urinary cytology. We used analysis of the area under the curve of receiver operating characteristic curves to compare the ability of CCL18, PAI-1, CD44, and BTA to detect BCa in voided urine samples. Urinary concentrations of CCL18, PAI-1, and BTA were significantly elevated in subjects with BCa. CCL18 was the most accurate biomarker (AUC; 0.919; 95% confidence interval [CI], 0.8704-0.9674). Multivariate regression analysis highlighted CCL18 (OR; 18.31; 95% CI, 4.95-67.70, p<0.0001) and BTA (OR; 6.43; 95% CI, 1.86-22.21, p = 0.0033) as independent predictors of BCa in voided urine samples. The combination of CCL18, PAI-1 and CD44 improved the area under the curve to0.938. Preliminary results indicate that CCL18 was a highly accurate biomarker for BCa detection in this cohort. Monitoring CCL18 in voided urine samples has the potential to improve non-invasive tests for BCa diagnosis. Furthermore using the combination of CCL18, PAI-1 and CD44 may make the model more robust to errors to detect BCa over the individual biomarkers or BTA.	[Chang, Myron; Dai, Yunfeng] Univ Florida, Dept Biostat, Gainesville, FL 32610 USA; [Rosser, Charles J.] Univ Texas MD Anderson Canc Ctr, Sect Urol Oncol, Orlando, FL USA; [Urquidi, Virginia; Rosser, Charles J.; Goodison, Steve] Nonagen Biosci Corp, Orlando, FL USA	State University System of Florida; University of Florida; University of Texas System; UTMD Anderson Cancer Center		Charles.rosser@orlandohealth.com			National Cancer Institute [RO1 CA116161]; Florida Department of Health James and Esther King Team Science Award [10KT-01]; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE [R01CA116161] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Department of Health James and Esther King Team Science Award; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by research grants from National Cancer Institute RO1 CA116161 (SG), Florida Department of Health James and Esther King Team Science Award 10KT-01 (CJR), Flight Attendant Medical Research Institute (CJR). The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Greene FL, 2002, ACS AJCCCANCERSTAGIN; Banos JLG, 2001, UROLOGY, V57, P685, DOI 10.1016/S0090-4295(00)01090-6; Becker M, 2010, CANCER-AM CANCER SOC, V116, P4502, DOI 10.1002/cncr.25326; Bossuyt PM, 2004, FAM PRACT, V21, P4, DOI 10.1093/fampra/cmh103; CAJULIS RS, 1995, DIAGN CYTOPATHOL, V13, P214, DOI 10.1002/dc.2840130307; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Daniely M, 2007, CANCER CYTOPATHOL, V111, P517, DOI 10.1002/cncr.23119; Duffy MJ, 1996, CLIN CANCER RES, V2, P613; Eissa S, 2008, CLIN BIOCHEM, V41, P1335, DOI 10.1016/j.clinbiochem.2008.08.085; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Golshani R, 2008, CANCER RES, V68, P483, DOI 10.1158/0008-5472.CAN-07-2140; Hudson MA, 1997, J NATL CANCER I, V89, P709, DOI 10.1093/jnci/89.10.709; Hwang EC, 2010, UROLOGY; Klatte T, 2010, J UROLOGY, V183, P2403, DOI 10.1016/j.juro.2010.01.064; Kreunin P, 2007, J PROTEOME RES, V6, P2631, DOI 10.1021/pr0700807; Lokeshwar VB, 2005, UROLOGY, V66, P35, DOI 10.1016/j.urology.2005.08.064; Malinowsky K, 2010, CURR MED CHEM, V17, P4370, DOI 10.2174/092986710793361216; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Miyake H, 2002, J UROLOGY, V167, P1282, DOI 10.1016/S0022-5347(05)65282-2; Montironi R, 2005, INT J SURG PATHOL, V13, P143, DOI 10.1177/106689690501300203; PEDERSEN H, 1994, CANCER RES, V54, P120; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Pu FS, 1992, CHIN PHARM J, V44, P235; Rajkumar T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-80; RIFE CC, 1979, UROL CLIN N AM, V6, P599; Rosser CJ, 2009, CANCER EPIDEM BIOMAR, V18, P444, DOI 10.1158/1055-9965.EPI-08-1002; Schmitt M, 2010, EXPERT REV MOL DIAGN, V10, P1051, DOI [10.1586/erm.10.71, 10.1586/ERM.10.71]; Span PN, 2008, BJU INT, V102, P177, DOI 10.1111/j.1464-410X.2008.07568.x; Wang Q, 2011, INT J BIOL MARKERS; Woodman AC, 2000, CLIN CANCER RES, V6, P2381; Yang N, 2011, CLIN CANCER RES, V17, P3349, DOI 10.1158/1078-0432.CCR-10-3121; Zohny SF, 2010, MED ONCOL, V27, P1246, DOI 10.1007/s12032-009-9366-x	33	66	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37797	10.1371/journal.pone.0037797	http://dx.doi.org/10.1371/journal.pone.0037797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629457	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343100052
J	Dixit, A; Verkhivker, GM				Dixit, Anshuman; Verkhivker, Gennady M.			Probing Molecular Mechanisms of the Hsp90 Chaperone: Biophysical Modeling Identifies Key Regulators of Functional Dynamics	PLOS ONE			English	Article							ESCHERICHIA-COLI HSP90; N-TERMINAL DOMAIN; ATP-BINDING; CONFORMATIONAL DYNAMICS; CRYSTAL-STRUCTURE; EVOLUTIONARY CONSERVATION; ALLOSTERIC REGULATION; PRINCIPAL COMPONENT; STRUCTURAL-ANALYSIS; NOVOBIOCIN ANALOGS	Deciphering functional mechanisms of the Hsp90 chaperone machinery is an important objective in cancer biology aiming to facilitate discovery of targeted anti-cancer therapies. Despite significant advances in understanding structure and function of molecular chaperones, organizing molecular principles that control the relationship between conformational diversity and functional mechanisms of the Hsp90 activity lack a sufficient quantitative characterization. We combined molecular dynamics simulations, principal component analysis, the energy landscape model and structure-functional analysis of Hsp90 regulatory interactions to systematically investigate functional dynamics of the molecular chaperone. This approach has identified a network of conserved regions common to the Hsp90 chaperones that could play a universal role in coordinating functional dynamics, principal collective motions and allosteric signaling of Hsp90. We have found that these functional motifs may be utilized by the molecular chaperone machinery to act collectively as central regulators of Hsp90 dynamics and activity, including the inter-domain communications, control of ATP hydrolysis, and protein client binding. These findings have provided support to a long-standing assertion that allosteric regulation and catalysis may have emerged via common evolutionary routes. The interaction networks regulating functional motions of Hsp90 may be determined by the inherent structural architecture of the molecular chaperone. At the same time, the thermodynamics-based "conformational selection" of functional states is likely to be activated based on the nature of the binding partner. This mechanistic model of Hsp90 dynamics and function is consistent with the notion that allosteric networks orchestrating cooperative protein motions can be formed by evolutionary conserved and sparsely connected residue clusters. Hence, allosteric signaling through a small network of distantly connected residue clusters may be a rather general functional requirement encoded across molecular chaperones. The obtained insights may be useful in guiding discovery of allosteric Hsp90 inhibitors targeting protein interfaces with co-chaperones and protein binding clients.	[Dixit, Anshuman] Univ Kansas, Sch Pharm, Dept Pharmaceut Chem, Lawrence, KS 66045 USA; [Verkhivker, Gennady M.] Chapman Univ, Schmid Coll Sci & Technol, Sch Computat Sci, Orange, CA USA; [Verkhivker, Gennady M.] Chapman Univ, Schmid Coll Sci & Technol, Crean Sch Hlth & Life Sci, Orange, CA USA; [Verkhivker, Gennady M.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of Kansas; Chapman University System; Chapman University; Chapman University System; Chapman University; University of California System; University of California San Diego	Dixit, A (corresponding author), Inst Life Sci, Dept Biotechnol, Bhubaneswar, Orissa, India.	gverkhiv@ucsd.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471	University of Kansas	University of Kansas	This work is partly supported by funding from The University of Kansas. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; Amadei A, 1999, PROTEINS, V36, P419, DOI 10.1002/(SICI)1097-0134(19990901)36:4<419::AID-PROT5>3.3.CO;2-L; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amolins MW, 2009, MINI-REV MED CHEM, V9, P140, DOI 10.2174/138955709787316056; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bahar I, 2007, CURR OPIN STRUC BIOL, V17, P633, DOI 10.1016/j.sbi.2007.09.011; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Beck R, 2011, CURR MED CHEM, V18, P2816, DOI 10.2174/092986711796011256; Bron P, 2008, BIOL CELL, V100, P413, DOI 10.1042/BC20070149; Burlison JA, 2008, J ORG CHEM, V73, P2130, DOI 10.1021/jo702191a; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Colombo G, 2008, P NATL ACAD SCI USA, V105, P7976, DOI 10.1073/pnas.0802879105; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Daily MD, 2008, PROTEINS, V71, P455, DOI 10.1002/prot.21800; Daily MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000293; Darby JF, 2011, NATURE, V478, P334, DOI 10.1038/478334b; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Dixit A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002179; Dixit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026071; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Dollins DE, 2005, J BIOL CHEM, V280, P30438, DOI 10.1074/jbc.M503761200; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Eleuteri AM, 2002, PROTEINS, V48, P169, DOI 10.1002/prot.10101; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Gaiser AM, 2010, J BIOL CHEM, V285, P40921, DOI 10.1074/jbc.M110.131086; Gao ZH, 2010, CURR OPIN DRUG DISC, V13, P193; Garnier C, 2002, J BIOL CHEM, V277, P12208, DOI 10.1074/jbc.M111874200; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Graf C, 2009, EMBO J, V28, P602, DOI 10.1038/emboj.2008.306; Hagn F, 2011, NAT STRUCT MOL BIOL, V18, P1086, DOI 10.1038/nsmb.2114; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hollup SM, 2011, PROTEIN SCI, V20, P197, DOI 10.1002/pro.558; Huai Q, 2005, STRUCTURE, V13, P579, DOI 10.1016/j.str.2004.12.018; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huth JR, 2007, CHEM BIOL DRUG DES, V70, P1, DOI 10.1111/j.1747-0285.2007.00535.x; Immormino RM, 2004, J BIOL CHEM, V279, P46162, DOI 10.1074/jbc.M405253200; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Jiang YQ, 2010, J BIOL CHEM, V285, P21023, DOI 10.1074/jbc.M110.103390; Johnson BD, 2000, J BIOL CHEM, V275, P32499, DOI 10.1074/jbc.M005195200; Johnson JL, 2007, MOL CELL BIOL, V27, P768, DOI 10.1128/MCB.01034-06; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keskin O, 2000, BIOPHYS J, V78, P2093, DOI 10.1016/S0006-3495(00)76756-7; Kidd BA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000484; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Krukenberg KA, 2009, J MOL BIOL, V390, P278, DOI 10.1016/j.jmb.2009.04.080; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Le Bras G, 2007, J MED CHEM, V50, P6189, DOI 10.1021/jm0707774; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Luccioli S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046008; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maguid S, 2005, BIOPHYS J, V89, P3, DOI 10.1529/biophysj.104.053041; Maguid S, 2008, GENE, V422, P7, DOI 10.1016/j.gene.2008.06.002; Maguid S, 2006, J MOL EVOL, V63, P448, DOI 10.1007/s00239-005-0209-x; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Matts RL, 2011, ACS CHEM BIOL, V6, P800, DOI 10.1021/cb200052x; Matts RL, 2011, BIOORGAN MED CHEM, V19, P684, DOI 10.1016/j.bmc.2010.10.029; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; McDonald E, 2006, CURR TOP MED CHEM, V6, P1091, DOI 10.2174/156802606777812004; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Millson SH, 2004, CELL STRESS CHAPERON, V9, P359, DOI 10.1379/CSC-29R1.1; Mollapour M, 2011, MOL CELL, V41, P672, DOI 10.1016/j.molcel.2011.02.011; Mollapour M, 2010, MOL CELL, V37, P333, DOI 10.1016/j.molcel.2010.01.005; Morra G, 2010, J CHEM THEORY COMPUT, V6, P2978, DOI 10.1021/ct100334n; Morra G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000323; Moulick K, 2011, NAT CHEM BIOL, V7, P818, DOI 10.1038/nchembio.670; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Onuoha SC, 2008, J MOL BIOL, V379, P732, DOI 10.1016/j.jmb.2008.02.013; Ota A, 2010, CIRC RES, V106, P1404, DOI 10.1161/CIRCRESAHA.109.213769; Owen BAL, 2002, J BIOL CHEM, V277, P7086, DOI 10.1074/jbc.M111450200; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Phillips JJ, 2007, J MOL BIOL, V372, P1189, DOI 10.1016/j.jmb.2007.04.059; Piazza F, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026001; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Ratzke C, 2010, P NATL ACAD SCI USA, V107, P16101, DOI 10.1073/pnas.1000916107; Retzlaff M, 2009, EMBO REP, V10, P1147, DOI 10.1038/embor.2009.153; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Richter K, 2011, STRUCTURE, V19, P445, DOI 10.1016/j.str.2011.03.007; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Skjaerven L, 2011, PROTEINS, V79, P232, DOI 10.1002/prot.22875; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Soti C, 2002, J BIOL CHEM, V277, P7066, DOI 10.1074/jbc.M105568200; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Tsutsumi S, 2012, P NATL ACAD SCI USA, V109, P2937, DOI 10.1073/pnas.1114414109; Tsutsumi S, 2009, NAT STRUCT MOL BIOL, V16, P1141, DOI 10.1038/nsmb.1682; van Montfort RLM, 2009, TRENDS BIOTECHNOL, V27, P315, DOI 10.1016/j.tibtech.2009.02.003; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Vaughan CK, 2009, FEBS J, V276, P199, DOI 10.1111/j.1742-4658.2008.06773.x; Verkhivker GM, 2009, CURR TOP MED CHEM, V9, P1369, DOI 10.2174/156802609789895700; Wayne N, 2011, METHODS MOL BIOL, V787, P33, DOI 10.1007/978-1-61779-295-3_3; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Workman P, 2003, CURR CANCER DRUG TAR, V3, P297, DOI 10.2174/1568009033481868; Workman P, 2007, NAT MED, V13, P1415, DOI 10.1038/nm1207-1415; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966; Yang LW, 2009, BIOINFORMATICS, V25, P606, DOI 10.1093/bioinformatics/btp023; Yang L, 2009, P NATL ACAD SCI USA, V106, P12347, DOI 10.1073/pnas.0902159106; Yang LW, 2005, BIOINFORMATICS, V21, P2978, DOI 10.1093/bioinformatics/bti469; Yang LW, 2005, STRUCTURE, V13, P893, DOI 10.1016/j.str.2005.03.015; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Yu XM, 2005, J AM CHEM SOC, V127, P12778, DOI 10.1021/ja0535864; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007; Zhao HP, 2011, J MED CHEM, V54, P3839, DOI 10.1021/jm200148p; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2007, ADV EXP MED BIOL, V594, P27; Zheng WJ, 2010, BIOPHYS J, V98, P3025, DOI 10.1016/j.bpj.2010.03.027; Zheng WJ, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-45; Zheng WJ, 2009, CURR PROTEIN PEPT SC, V10, P128, DOI 10.2174/138920309787847608	166	43	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37605	10.1371/journal.pone.0037605	http://dx.doi.org/10.1371/journal.pone.0037605			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624053	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343500142
J	Pereiro, P; Balseiro, P; Romero, A; Dios, S; Forn-Cuni, G; Fuste, B; Planas, JV; Beltran, S; Novoa, B; Figueras, A				Pereiro, Patricia; Balseiro, Pablo; Romero, Alejandro; Dios, Sonia; Forn-Cuni, Gabriel; Fuste, Berta; Planas, Josep V.; Beltran, Sergi; Novoa, Beatriz; Figueras, Antonio			High-Throughput Sequence Analysis of Turbot (Scophthalmus maximus) Transcriptome Using 454-Pyrosequencing for the Discovery of Antiviral Immune Genes	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; DUPLEX-SPECIFIC NUCLEASE; INNATE IMMUNITY; PRIMARY DEFENSE; SNP DETECTION; FISH; EXPRESSION; ANNOTATION; PROTEIN; IDENTIFICATION	Background: Turbot (Scophthalmus maximus L.) is an important aquacultural resource both in Europe and Asia. However, there is little information on gene sequences available in public databases. Currently, one of the main problems affecting the culture of this flatfish is mortality due to several pathogens, especially viral diseases which are not treatable. In order to identify new genes involved in immune defense, we conducted 454-pyrosequencing of the turbot transcriptome after different immune stimulations. Methodology/Principal Findings: Turbot were injected with viral stimuli to increase the expression level of immune-related genes. High-throughput deep sequencing using 454-pyrosequencing technology yielded 915,256 high-quality reads. These sequences were assembled into 55,404 contigs that were subjected to annotation steps. Intriguingly, 55.16% of the deduced protein was not significantly similar to any sequences in the databases used for the annotation and only 0.85% of the BLASTx top-hits matched S. maximus protein sequences. This relatively low level of annotation is possibly due to the limited information for this specie and other flatfish in the database. These results suggest the identification of a large number of new genes in turbot and in fish in general. A more detailed analysis showed the presence of putative members of several innate and specific immune pathways. Conclusions/Significance: To our knowledge, this study is the first transcriptome analysis using 454-pyrosequencing for turbot. Previously, there were only 12,471 EST and less of 1,500 nucleotide sequences for S. maximus in NCBI database. Our results provide a rich source of data (55,404 contigs and 181,845 singletons) for discovering and identifying new genes, which will serve as a basis for microarray construction, gene expression characterization and for identification of genetic markers to be used in several applications. Immune stimulation in turbot was very effective, obtaining an enormous variety of sequences belonging to genes involved in the defense mechanisms.	[Pereiro, Patricia; Balseiro, Pablo; Romero, Alejandro; Dios, Sonia; Forn-Cuni, Gabriel; Novoa, Beatriz; Figueras, Antonio] CSIC, IIM, Vigo, Spain; [Planas, Josep V.] Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona, Spain; [Planas, Josep V.] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Fuste, Berta; Beltran, Sergi] Univ Barcelona, CCiT UB, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Barcelona; University of Barcelona; University of Barcelona	Pereiro, P (corresponding author), CSIC, IIM, Vigo, Spain.	antoniofigueras@iim.csic.es	Dios, Sonia/M-4201-2018; Novoa, Beatriz/K-3785-2014; Forn-Cuní, Gabriel/M-8498-2016; Figueras, Antonio/AAB-8921-2019; Pereiro, Patricia/AAS-9514-2020; Romero, Alejandro/R-4565-2019; Balseiro, Pablo/I-7406-2013; Figueras, Antonio/B-5133-2015; Beltran, Sergi/I-3408-2015	Dios, Sonia/0000-0002-2126-991X; Forn-Cuní, Gabriel/0000-0001-5976-4759; Figueras, Antonio/0000-0002-0617-0030; Pereiro, Patricia/0000-0002-8734-3334; Romero, Alejandro/0000-0002-9343-3352; Figueras, Antonio/0000-0002-0617-0030; Beltran, Sergi/0000-0002-2810-3445; Planas, Josep/0000-0002-6525-9617; Novoa, Beatriz/0000-0003-4888-8419; Balseiro, Pablo/0000-0002-9365-6775	Spanish Ministerio de Ciencia e Innovacion [CSD2007-00002]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work has been supported by the funding from the project CSD2007-00002 "Aquagenomics" of the program Consolider-Ingenio 2010 from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P172, DOI 10.1016/S0167-4838(00)00157-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Pellitero P, 2008, VET IMMUNOL IMMUNOP, V126, P171, DOI 10.1016/j.vetimm.2008.07.013; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Biragyn A, 2005, CURR PROTEIN PEPT SC, V6, P53, DOI 10.2174/1389203053027601; Bolanos-Garcia VM, 2003, PROG BIOPHYS MOL BIO, V83, P47, DOI 10.1016/S0079-6107(03)00028-2; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Chang MX, 2005, PARASITOL RES, V96, P224, DOI 10.1007/s00436-005-1340-8; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Choudhury M, 2009, ACTA BIOCH BIOPH SIN, V41, P370, DOI 10.1093/abbs/gmp015; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; Concha MI, 2004, EUR J BIOCHEM, V271, P2984, DOI 10.1111/j.1432-1033.2004.04228.x; Concha MI, 2003, FISH SHELLFISH IMMUN, V14, P259, DOI 10.1006/fsim.2002.0435; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; Dios S, 2007, MOL IMMUNOL, V44, P2195, DOI 10.1016/j.molimm.2006.11.017; Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ewart K. Vanya, 1993, Molecular Marine Biology and Biotechnology, V2, P20; Federation of European Aquaculture Producers (FEAP), 2008, PROD PRIC REP MEMB A; Feliciani C, 1996, CRIT REV ORAL BIOL M, V7, P300, DOI 10.1177/10454411960070040101; Food and Agriculture Organization of the United Nations (FAO), 2010, STAT WORLD FISH AQ; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grotmol S, 2000, DIS AQUAT ORGAN, V39, P79, DOI 10.3354/dao039079; HALLQUIST NA, 1994, COMP BIOCHEM PHYS B, V108, P375, DOI 10.1016/0305-0491(94)90089-2; Jensen T, 2007, THROMB HAEMOSTASIS, V97, P822, DOI 10.1160/TH07-01-0039; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P187, DOI 10.1016/S0304-4165(02)00308-2; Kornbluth RS, 2006, J LEUKOCYTE BIOL, V80, P1084, DOI 10.1189/jlb.0306147; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Logdberg L, 2000, BBA-PROTEIN STRUCT M, V1482, P284, DOI 10.1016/S0167-4838(00)00164-3; Lu PP, 2011, LIFE SCI, V88, P839, DOI 10.1016/j.lfs.2011.03.003; Maeda K, 2005, PANCREAS, V31, P54, DOI 10.1097/01.mpa.0000163178.37050.0d; Marra MA, 1998, TRENDS GENET, V14, P4, DOI 10.1016/S0168-9525(97)01355-3; Millan A, 2010, MAR BIOTECHNOL, V12, P452, DOI 10.1007/s10126-009-9231-0; MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Motizuki M, 2002, J BIOCHEM, V132, P115, DOI 10.1093/oxfordjournals.jbchem.a003187; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Nicholls EF, 2010, ANN NY ACAD SCI, V1213, P46, DOI 10.1111/j.1749-6632.2010.05787.x; Nielsen JG, 1986, FISHES NE ATLANTIC M, P1287; Office International des Epizooties (OIE), 2009, MAN DIAGN TEST AQ AN; Pardo BG, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-37; Park KC, 2009, FISH SHELLFISH IMMUN, V26, P91, DOI 10.1016/j.fsi.2008.03.010; Poisa-Beiro L, 2008, MOL IMMUNOL, V45, P218, DOI 10.1016/j.molimm.2007.04.016; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Ross K., 1994, Bulletin of the European Association of Fish Pathologists, V14, P213; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Sarmasik Aliye, 2002, Turkish Journal of Biology, V26, P201; Serazin AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007976; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; Smith VJ, 2010, MAR DRUGS, V8, P1213, DOI 10.3390/md8041213; SRINIVAS RV, 1991, J CELL BIOCHEM, V45, P224, DOI 10.1002/jcb.240450214; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; TADA N, 1993, MOL CELL BIOCHEM, V119, P171, DOI 10.1007/BF00926868; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Townsend MJ, 2000, J CELL SCI, V113, P3549; Villarroel F, 2007, FISH SHELLFISH IMMUN, V23, P197, DOI 10.1016/j.fsi.2006.10.008; Walker PJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010022; Wang C, 2008, J FISH DIS, V31, P505, DOI 10.1111/j.1365-2761.2008.00914.x; Wang H., 2003, CYTOKINE HDB, V4th ed., P837; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; Yeh Y, 1996, CHEM REV, V96, P601, DOI 10.1021/cr950260c; Zhang ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018379; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	79	91	99	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e35369	10.1371/journal.pone.0035369	http://dx.doi.org/10.1371/journal.pone.0035369			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629298	Green Published, gold			2022-12-25	WOS:000305343500004
J	Zheng, M; Lv, LL; Cao, YH; Liu, H; Ni, J; Dai, HY; Liu, D; Lei, XD; Liu, BC				Zheng, Min; Lv, Lin-Li; Cao, Yu-Han; Liu, Hong; Ni, Jie; Dai, Hou-Yong; Liu, Dan; Lei, Xiang-Dong; Liu, Bi-Cheng			A Pilot Trial Assessing Urinary Gene Expression Profiling with an mRNA Array for Diabetic Nephropathy	PLOS ONE			English	Article							KIDNEY-DISEASE; PROGRESSION; PODOCYTES	Background: The initiation and progression of diabetic nephropathy (DN) is complex. Quantification of mRNA expression in urinary sediment has emerged as a novel strategy for studying renal diseases. Considering the numerous molecules involved in DN development, a high-throughput platform with parallel detection of multiple mRNAs is needed. In this study, we constructed a self-assembling mRNA array to analyze urinary mRNAs in DN patients with aims to reveal its potential in searching novel biomarkers. Methods: mRNA array containing 88 genes were fabricated and its performance was evaluated. A pilot study with 9 subjects including 6 DN patients and 3 normal controls were studied with the array. DN patients were assigned into two groups according to their estimate glomerular rate (eGFR): DNI group (eGFR > 60 ml/min/1.73 m(2), n = 3) and DNII group (eGFR<60 ml/min/1.73 m(2), n = 3). Urinary cell pellet was collected from each study participant. Relative abundance of these target mRNAs from urinary pellet was quantified with the array. Results: The array we fabricated displayed high sensitivity and specificity. Moreover, the Cts of Positive PCR Controls in our experiments were 24 +/- 0.5 which indicated high repeatability of the array. A total of 29 mRNAs were significantly increased in DN patients compared with controls (p < 0.05). Among these genes, alpha-actinin4, CDH2, ACE, FAT1, synaptopodin, COL4 alpha, twist, NOTCH3 mRNA expression were 15-fold higher than those in normal controls. In contrast, urinary TIMP-1 mRNA was significantly decreased in DN patients (p < 0.05). It was shown that CTGF, MCP-1, PAI-1, ACE, CDH1, CDH2 mRNA varied significantly among the 3 study groups, and their mRNA levels increased with DN progression (p<0.05). Conclusion: Our pilot study demonstrated that mRNA array might serve as a high-throughput and sensitive tool for detecting mRNA expression in urinary sediment. Thus, this primary study indicated that mRNA array probably could be a useful tool for searching new biomarkers for DN.	[Zheng, Min; Lv, Lin-Li; Cao, Yu-Han; Liu, Hong; Ni, Jie; Dai, Hou-Yong; Liu, Dan; Liu, Bi-Cheng] Southeast Univ, Sch Med, Zhong Da Hosp, Inst Nephrol, Nanjing, Jiangsu, Peoples R China; [Lei, Xiang-Dong] CT Biosci, Chang Zhou, Peoples R China	Southeast University - China	Zheng, M (corresponding author), Southeast Univ, Sch Med, Zhong Da Hosp, Inst Nephrol, Nanjing, Jiangsu, Peoples R China.	Liubc64@yahoo.com.cn			national key basic research project [2012CB517700]; China National Natural Scientific Fund [30870953]	national key basic research project(National Basic Research Program of China); China National Natural Scientific Fund(National Natural Science Foundation of China (NSFC))	This study was supported by the national key basic research project grant (2012CB517700) and China National Natural Scientific Fund (No. 30870953) to B-CL as PI.http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins RC, 2010, AM J KIDNEY DIS, V55, P205, DOI 10.1053/j.ajkd.2009.12.001; Chang Shirley S, 2008, Pediatr Endocrinol Rev, V5 Suppl 4, P974; Chawla T, 2010, WORLD J DIABETES, V1, P141, DOI 10.4239/wjd.v1.i5.141; Huang Y, 2008, J AM SOC NEPHROL, V19, P329, DOI 10.1681/ASN.2007040510; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Li MX, 2007, CHINESE MED J-PEKING, V120, P1925, DOI 10.1097/00029330-200711010-00015; Liu Y, 2010, STRUCT CHEM, V21, P21, DOI 10.1007/s11224-009-9519-8; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; MacIsaac RJ, 2011, CURR OPIN NEPHROL HY, V20, P246, DOI 10.1097/MNH.0b013e3283456546; Menzel S, 2011, PEDIATR NEPHROL, V26, P1775, DOI 10.1007/s00467-010-1725-5; Munshi R, 2011, J AM SOC NEPHROL, V22, P165, DOI 10.1681/ASN.2010060641; Muthukumar T, 2005, NEW ENGL J MED, V353, P2342, DOI 10.1056/NEJMoa051907; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Petermann AT, 2003, KIDNEY INT, V64, P1222, DOI 10.1046/j.1523-1755.2003.00217.x; Rodder S, 2011, VIRCHOWS ARCH, V458, P487, DOI 10.1007/s00428-011-1052-7; Roepman P, 2010, BIOANALYSIS, V2, P249, DOI 10.4155/BIO.09.172; Svensson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008360; Tam FWK, 2009, CYTOKINE, V47, P37, DOI 10.1016/j.cyto.2009.04.001; Tesch GH, 2011, AM J PHYSIOL-RENAL, V300, pF301, DOI 10.1152/ajprenal.00607.2010; Vogelmann SU, 2003, AM J PHYSIOL-RENAL, V285, pF40, DOI 10.1152/ajprenal.00404.2002; Wang G, 2008, DIABETOLOGIA, V51, P1062, DOI 10.1007/s00125-008-0988-x; Wu CC, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/581928; Zheng M, 2011, CLIN ENDOCRINOL OXF; Zheng M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020431	24	20	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e34824	10.1371/journal.pone.0034824	http://dx.doi.org/10.1371/journal.pone.0034824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629296	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500003
J	Park, JI; Steen, EJ; Burd, H; Evans, SS; Redding-Johnson, AM; Batth, T; Benke, PI; D'haeseleer, P; Sun, N; Sale, KL; Keasling, JD; Lee, TS; Petzold, CJ; Mukhopadhyay, A; Singer, SW; Simmons, BA; Gladden, JM				Park, Joshua I.; Steen, Eric J.; Burd, Helcio; Evans, Sophia S.; Redding-Johnson, Alyssa M.; Batth, Tanveer; Benke, Peter I.; D'haeseleer, Patrik; Sun, Ning; Sale, Kenneth L.; Keasling, Jay D.; Lee, Taek Soon; Petzold, Christopher J.; Mukhopadhyay, Aindrila; Singer, Steven W.; Simmons, Blake A.; Gladden, John M.			A Thermophilic Ionic Liquid-Tolerant Cellulase Cocktail for the Production of Cellulosic Biofuels	PLOS ONE			English	Article							GLYCOSIDE HYDROLASE ACTIVITIES; ESCHERICHIA-COLI; CLOSTRIDIUM-THERMOCELLUM; BACTERIAL CONSORTIA; SP-NOV.; BIOMASS; PRETREATMENT; ETHANOL; GROWTH; SWITCHGRASS	Generation of biofuels from sugars in lignocellulosic biomass is a promising alternative to liquid fossil fuels, but efficient and inexpensive bioprocessing configurations must be developed to make this technology commercially viable. One of the major barriers to commercialization is the recalcitrance of plant cell wall polysaccharides to enzymatic hydrolysis. Biomass pretreatment with ionic liquids (ILs) enables efficient saccharification of biomass, but residual ILs inhibit both saccharification and microbial fuel production, requiring extensive washing after IL pretreatment. Pretreatment itself can also produce biomass-derived inhibitory compounds that reduce microbial fuel production. Therefore, there are multiple points in the process from biomass to biofuel production that must be interrogated and optimized to maximize fuel production. Here, we report the development of an IL-tolerant cellulase cocktail by combining thermophilic bacterial glycoside hydrolases produced by a mixed consortia with recombinant glycoside hydrolases. This enzymatic cocktail saccharifies IL-pretreated biomass at higher temperatures and in the presence of much higher IL concentrations than commercial fungal cocktails. Sugars obtained from saccharification of IL-pretreated switchgrass using this cocktail can be converted into biodiesel (fatty acid ethyl-esters or FAEEs) by a metabolically engineered strain of E. coli. During these studies, we found that this biodiesel-producing E. coli strain was sensitive to ILs and inhibitors released by saccharification. This cocktail will enable the development of novel biomass to biofuel bioprocessing configurations that may overcome some of the barriers to production of inexpensive cellulosic biofuels.	[Park, Joshua I.; Steen, Eric J.; Burd, Helcio; Evans, Sophia S.; Redding-Johnson, Alyssa M.; Batth, Tanveer; Benke, Peter I.; D'haeseleer, Patrik; Sun, Ning; Sale, Kenneth L.; Keasling, Jay D.; Lee, Taek Soon; Petzold, Christopher J.; Mukhopadhyay, Aindrila; Singer, Steven W.; Simmons, Blake A.; Gladden, John M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Joint BioEnergy Inst JBEI, Biosci Div, Berkeley, CA 94720 USA; [Park, Joshua I.; Sale, Kenneth L.; Simmons, Blake A.; Gladden, John M.] Sandia Natl Labs, Bioengn & Biomass Sci & Convers Technol Dept, Livermore, CA USA; [D'haeseleer, Patrik] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA; [Singer, Steven W.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Geochem, Berkeley, CA 94720 USA; [Singer, Steven W.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Ecol, Div Earth Sci, Berkeley, CA 94720 USA; [Evans, Sophia S.] Univ Calif Berkeley, Coll Chem, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Park, JI (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.	JMGladden@lbl.gov; JMGladden@lbl.gov	Simmons, Blake/N-6022-2016; Mukhopadhyay, Aindrila/AAW-7257-2021; Keasling, Jay D/J-9162-2012; Sun, Ning/D-6709-2012; Sun, Ning/E-4815-2011; Singer, STeven W/I-1851-2014	Simmons, Blake/0000-0002-1332-1810; Keasling, Jay D/0000-0003-4170-6088; Sun, Ning/0000-0002-9689-9430; D'haeseleer, Patrik/0000-0003-0007-8150; Petzold, Christopher/0000-0002-8270-5228; Batth, Tanveer Singh/0000-0001-5346-4544	US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Lawrence Berkeley National Laboratory; US Department of Energy	US Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE))	This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) and the Joint Genome Institute supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the US Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderlei T, 2004, BIOCHEM ENG J, V17, P187, DOI 10.1016/S1369-703X(03)00181-5; Banerjee G, 2010, BIOTECHNOL BIOENG, V106, P707, DOI 10.1002/bit.22741; Bjornsdottir SH, 2006, EXTREMOPHILES, V10, P1, DOI 10.1007/s00792-005-0466-z; Brennan TCR, 2010, BIOENERG RES, V3, P123, DOI 10.1007/s12155-010-9091-5; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Chhabra SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021470; Datta S, 2010, GREEN CHEM, V12, P338, DOI 10.1039/b916564a; DECKER J, 2009, RENEWABLE ENERGY WOR, P11; DOE US, 2010, US FEM CAT MAK FUELS; Fu DB, 2011, BIORESOURCE TECHNOL, V102, P7008, DOI 10.1016/j.biortech.2011.04.049; Ganske F, 2006, BIOTECHNOL LETT, V28, P465, DOI 10.1007/s10529-006-0006-7; Gladden JM, 2012, BIOTECHNOL BIOENG, V109, P1140, DOI 10.1002/bit.24388; Gladden JM, 2011, APPL ENVIRON MICROB, V77, P5804, DOI 10.1128/AEM.00032-11; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Klein-Marcuschamer D, 2011, BIOFUEL BIOPROD BIOR, V5, P562, DOI 10.1002/bbb.303; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; KUNDU S, 1983, BIOTECHNOL BIOENG, V25, P1109, DOI 10.1002/bit.260250418; Laboratory ORN, 2011, US BILL TON UPD BIOM; Lee SM, 2005, KOREAN J CHEM ENG, V22, P687, DOI 10.1007/BF02705783; Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066; Li Q, 2010, APPL MICROBIOL BIOT, V87, P117, DOI 10.1007/s00253-010-2484-8; Lyon PF, 2000, CAN J MICROBIOL, V46, P1029, DOI 10.1139/cjm-46-11-1029; Meyer AS, 2009, J CEREAL SCI, V50, P337, DOI 10.1016/j.jcs.2009.01.010; Nakayama S, 2011, APPL ENVIRON MICROB, V77, P6470, DOI 10.1128/AEM.00706-11; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Ouellet M, 2011, GREEN CHEM; Park JI, 2011, BIORESOURCE TECHNOL, V102, P5988, DOI 10.1016/j.biortech.2011.02.036; Peralta-Yahya PP, 2010, BIOTECHNOL J, V5, P147, DOI 10.1002/biot.200900220; Pimentel D, 2003, NAT RESOUR RES, V12, P127, DOI DOI 10.1023/A:1024214812527; Shaw AJ, 2008, P NATL ACAD SCI USA, V105, P13769, DOI 10.1073/pnas.0801266105; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sluiter B., 2011, NRELTP51042618; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Tadesse H., 2011, ENERGY ENV SCI; Touzel JP, 2000, INT J SYST EVOL MICR, V50, P315, DOI 10.1099/00207713-50-1-315; Turner MB, 2003, GREEN CHEM, V5, P443, DOI 10.1039/b302570e; Wald M.L., 2011, NY TIMES; Wang Y, 2011, BIOTECHNOL BIOENG, V108, P1042, DOI 10.1002/bit.23045; Watanabe K, 2007, INT J SYST EVOL MICR, V57, P1473, DOI 10.1099/ijs.0.64672-0; Zaldivar J, 1999, BIOTECHNOL BIOENG, V65, P24, DOI 10.1002/(SICI)1097-0290(19991005)65:1<24::AID-BIT4>3.0.CO;2-2; Zhang T, 2011, GREEN CHEM, V13, P2083, DOI 10.1039/c1gc15193b; Zhao H, 2009, J BIOTECHNOL, V139, P47, DOI 10.1016/j.jbiotec.2008.08.009	43	143	149	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37010	10.1371/journal.pone.0037010	http://dx.doi.org/10.1371/journal.pone.0037010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	23251512	Green Submitted, Green Published, gold			2022-12-25	WOS:000305335800023
J	Shi, XD; Pan, Y; Wang, ML; Wang, DS; Li, WY; Jiang, T; Zhang, P; Chi, XM; Jiang, YF; Gao, YH; Zhong, J; Sun, B; Xu, DM; Jiang, J; Niu, JQ				Shi, Xiaodong; Pan, Yu; Wang, Moli; Wang, Dongsheng; Li, Wanyu; Jiang, Tao; Zhang, Peng; Chi, Xiumei; Jiang, Yanfang; Gao, Yanhang; Zhong, Jin; Sun, Bing; Xu, Damo; Jiang, Jing; Niu, Junqi			IL28B Genetic Variation Is Associated with Spontaneous Clearance of Hepatitis C Virus, Treatment Response, Serum IL-28B Levels in Chinese Population	PLOS ONE			English	Article							ALPHA-2B PLUS RIBAVIRIN; VIROLOGICAL RESPONSE; IFN-LAMBDA; INFECTION; THERAPY	Background: The interleukin-28B gene (IL28B) locus has been associated with host resistance to hepatitis C virus (HCV) infection and response to PEG-IFN/RBV treatment in western populations. This study was to determine whether this gene variant is also associated with spontaneous clearance of HCV infection, treatment response and IL-28B protein production in Chinese patients. Methods: We genotyped IL28B genetic variations (rs12980275, rs8103142, rs8099917 and rs12979860) by pyrosequencing DNA samples from cohorts consisting of 529 subjects with persistent HCV infection, 196 subjects who cleared the infection, 171 healthy individuals and 235 chronic HCV patients underwent IFN/RBV treatment. The expression of IL-28B were measured by ELISA and RT-PCR. Results: We found that the four IL28B variants were in complete linkage disequilibrium (r2 = 0.97-0.98). The rs12979860 CC genotype was strongly associated with spontaneously HCV clearance and successful IFN/RBV treatment compared to the CT/TT. IL-28B levels in persistent HCV patients were significantly lower than subjects who spontaneously resolved HCV and healthy controls and were also associated with high levels of ALT (alanine aminotransferase) and AST (aspartate aminotransferase). IL-28B levels were also significantly lower in individuals carrying T alleles than CC homozygous. Conclusions: Thus, the rs12979860-CC variant upstream of IL28B gene is associated with spontaneous clearance of HCV, susceptible to IFN/RBV treatment and increased IL-28B levels in this Chinese population.	[Shi, Xiaodong; Pan, Yu; Li, Wanyu; Zhang, Peng; Chi, Xiumei; Jiang, Yanfang; Gao, Yanhang; Niu, Junqi] Jilin Univ, Dept Hepatol, Hosp 1, Changchun 130023, Peoples R China; [Jiang, Jing] Jilin Univ, Dept Clin Epidemiol, Hosp 1, Changchun 130023, Peoples R China; [Zhong, Jin; Sun, Bing] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Wang, Dongsheng; Jiang, Tao] Hosp HepatologyBiliary Jilin Prov, Changchun, Peoples R China; [Xu, Damo] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Wang, Moli] Jilin Univ, Hosp 4, Changchun 130023, Peoples R China	Jilin University; Jilin University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University of Glasgow; Jilin University	Shi, XD (corresponding author), Jilin Univ, Dept Hepatol, Hosp 1, Changchun 130023, Peoples R China.	jiangjing19702000@yahoo.cn; junqiniu@yahoo.cn	Zhong, Jin/J-4613-2019; Wang, Mengqiang/A-1215-2010; zhi, zhouzhi/J-8063-2013; Yue, Feng/S-6565-2017; Zhong, Jin/M-6859-2018	Wang, Mengqiang/0000-0003-4702-3309; Zhong, Jin/0000-0002-3554-1275	Shanghai Pasteur Health Research Foundation [SPHRF2009001]; Eleventh 5-year National Key Programs on Infectious Disease [2008ZX10002-014]; National Natural Science Foundation of China [81001312/H1005, 81072347/H2609]; Jilin University [20101036]	Shanghai Pasteur Health Research Foundation; Eleventh 5-year National Key Programs on Infectious Disease; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin University(Jilin University)	This study was supported by grants from the Shanghai Pasteur Health Research Foundation (SPHRF2009001), the Eleventh 5-year National Key Programs on Infectious Disease (2008ZX10002-014), the National Natural Science Foundation of China under grants No 81001312/H1005 and 81072347/H2609 and the Graduate Innovation Fund of Jilin University (No. 20101036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; [Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; Aparicio E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013771; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Benvegnu L, 2004, GUT, V53, P744, DOI 10.1136/gut.2003.020263; Bruno S, 2008, ANN HEPATOL, V7, P114, DOI 10.1016/S1665-2681(19)31865-4; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hepburn MJ, 2004, AM J MED, V117, P163, DOI 10.1016/j.amjmed.2004.02.043; Huang CF, 2010, J GASTROEN HEPATOL, V25, P758, DOI 10.1111/j.1440-1746.2009.06148.x; Hwang SJ, 2001, J MED VIROL, V65, P505, DOI 10.1002/jmv.2064; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Missiha SB, 2008, GASTROENTEROLOGY, V134, P1699, DOI 10.1053/j.gastro.2008.02.069; Rauch A, 2010, EUR J CLIN INVEST, V40, P950, DOI 10.1111/j.1365-2362.2010.02337.x; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rauch A, 2009, PHARMACOGENOMICS, V10, P1819, DOI 10.2217/PGS.09.121; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shiina M, 2008, HEPATOLOGY, V47, P385, DOI 10.1002/hep.21996; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thio CL, 2000, HEPATOLOGY, V31, P819, DOI 10.1053/he.2000.4316; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; Zechini B, 2004, EUR J GASTROEN HEPAT, V16, P891, DOI 10.1097/00042737-200409000-00013	40	101	108	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37054	10.1371/journal.pone.0037054	http://dx.doi.org/10.1371/journal.pone.0037054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649509	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305335800027
J	Li, XH; Ha, CT; Fu, DD; Xiao, M				Li, Xiang Hong; Ha, Cam T.; Fu, Dadin; Xiao, Mang			REDD1 Protects Osteoblast Cells from Gamma Radiation-Induced Premature Senescence	PLOS ONE			English	Article							HUMAN HEMATOPOIETIC PROGENITORS; MARROW STROMAL CELLS; NF-KAPPA-B; CELLULAR SENESCENCE; IN-VITRO; DNA-DAMAGE; LIFE-SPAN; P53; MTOR; STRESS	Radiotherapy is commonly used for cancer treatment. However, it often results in side effects due to radiation damage in normal tissue, such as bone marrow (BM) failure. Adult hematopoietic stem and progenitor cells (HSPC) reside in BM next to the endosteal bone surface, which is lined primarily by hematopoietic niche osteoblastic cells. Osteoblasts are relatively more radiation-resistant than HSPCs, but the mechanisms are not well understood. In the present study, we demonstrated that the stress response gene REDD1 (regulated in development and DNA damage responses 1) was highly expressed in human osteoblast cell line (hFOB) cells after gamma irradiation. Knockdown of REDD1 with siRNA resulted in a decrease in hFOB cell numbers, whereas transfection of PCMV6-AC-GFP-REDD1 plasmid DNA into hFOB cells inhibited mammalian target of rapamycin (mTOR) and p21 expression and protected these cells from radiation-induced premature senescence (PS). The PS in irradiated hFOB cells were characterized by significant inhibition of clonogenicity, activation of senescence biomarker SA-beta-gal, and the senescence-associated cytokine secretory phenotype (SASP) after 4 or 8 Gy irradiation. Immunoprecipitation assays demonstrated that the stress response proteins p53 and nuclear factor kappa B (NFkB) interacted with REDD1 in hFOB cells. Knockdown of NFkB or p53 gene dramatically suppressed REDD1 protein expression in these cells, indicating that REDD1 was regulated by both factors. Our data demonstrated that REDD1 is a protective factor in radiation-induced osteoblast cell premature senescence.	[Li, Xiang Hong; Ha, Cam T.; Fu, Dadin; Xiao, Mang] Uniformed Serv Univ Hlth Sci, Radiat Countermeasures Program, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Li, XH (corresponding author), Uniformed Serv Univ Hlth Sci, Radiat Countermeasures Program, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA.	xiao@afrri.usuhs.mil			Armed Forces Radiobiology Research Institute [RAB2EI]; American Congressional Grant [G1B2EP]	Armed Forces Radiobiology Research Institute; American Congressional Grant	This study was supported by Armed Forces Radiobiology Research Institute intramural grant (RAB2EI) to MX and an American Congressional Grant (G1B2EP) to MX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Braunstein S, 2009, MOL CELL BIOL, V29, P5645, DOI 10.1128/MCB.00711-09; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107; Demidenko ZN, 2009, AGING-US, V1, P1008, DOI 10.18632/aging.100115; Demidenko ZN, 2009, CELL CYCLE, V8, P1896, DOI 10.4161/cc.8.12.8809; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Drakos E, 2009, LEUKEMIA, V23, P784, DOI 10.1038/leu.2008.348; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Gery S, 2007, EXP HEMATOL, V35, P572, DOI 10.1016/j.exphem.2007.01.049; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Hill R, 2008, CELL CYCLE, V7, P2535; Hotz ME, 2010, HEALTH PHYS, V98, P894, DOI 10.1097/HP.0b013e3181ab3e71; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kim BY, 2005, CARCINOGENESIS, V26, P1395, DOI 10.1093/carcin/bgi081; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Li XH, 2010, HAEMATOL-HEMATOL J, V95, P1996, DOI 10.3324/haematol.2010.026492; Lin L, 2005, BIOCHEM J, V392, P93, DOI 10.1042/BJ20050553; Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016; Salminen A, 2011, CELL SIGNAL, V23, P747, DOI 10.1016/j.cellsig.2010.10.012; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Singh VK, 2010, INT J RADIAT BIOL, V86, P12, DOI 10.3109/09553000903264515; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xiao M, 2007, MOL PHARMACOL, V72, P370, DOI 10.1124/mol.107.035394; Xiao Mang, 2009, Curr Mol Pharmacol, V2, P122; Xiao M, 2009, EXP HEMATOL, V37, P52, DOI 10.1016/j.exphem.2008.09.001; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	40	41	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36604	10.1371/journal.pone.0036604	http://dx.doi.org/10.1371/journal.pone.0036604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22768107	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500020
J	Shi, XW; Zhou, Z; Wang, LL; Yue, F; Wang, MQ; Yang, CY; Song, LS				Shi, Xiaowei; Zhou, Zhi; Wang, Lingling; Yue, Feng; Wang, Mengqiang; Yang, Chuanyan; Song, Linsheng			The Immunomodulation of Acetylcholinesterase in Zhikong Scallop Chlamys farreri	PLOS ONE			English	Article							PERIPHERAL ANIONIC SITE; MOLECULAR CHARACTERIZATION; MUSCLE REGENERATION; INNATE IMMUNITY; NERVOUS-SYSTEM; RAT-BRAIN; EXPRESSION; INHIBITION; HEMOCYTES; RECEPTOR	Background: Acetycholinesterase (AChE; EC 3.1.1.7) is an essential hydrolytic enzyme in the cholinergic nervous system, which plays an important role during immunomodulation in vertebrates. Though AChEs have been identified in most invertebrates, the knowledge about immunomodulation function of AChE is still quite meagre in invertebrates. Methodology: A scallop AChE gene was identified from Chlamys farreri (designed as CfAChE), and its open reading frame encoded a polypeptide of 522 amino acids. A signal peptide, an active site triad, the choline binding site and the peripheral anionic sites (PAS) were identified in CfAChE. The recombinant mature polypeptide of CfAChE (rCfAChE) was expressed in Pichia pastoris GS115, and its activity was 71.3 +/- 1.3 U mg(-1) to catalyze the hydrolysis of acetylthiocholine iodide. The mRNA transcripts of CfAChE were detected in haemocytes, hepatopancreas, adductor muscle, mantle, gill, kidney and gonad, with the highest expression level in hepatopancreas. The relative expression level of CfAChE mRNA in haemocytes was both up-regulated after LPS (0.5 mg mL(-1)) and human TNF-alpha (50 ng mL(-1)) stimulations, and it reached the highest level at 12 h (10.4-fold, P<0.05) and 1 h (3.2-fold, P<0.05), respectively. After Dichlorvos (DDVP) (50 mg L-1) stimulation, the CfAChE activity in the supernatant of haemolymph decreased significantly from 0.16 U mg(-1) at 0 h to 0.03 U mg(-1) at 3 h, while the expression level of lysozyme in the haemocytes was up-regulated and reached the highest level at 6 h, which was 3.0-fold (P<0.05) of that in the blank group. Conclusions:The results collectively indicated that CfAChE had the acetylcholine-hydrolyzing activity, which was in line with the potential roles of AChE in the neuroimmune system of vertebrates which may help to re-balance the immune system after immune response.	[Shi, Xiaowei; Zhou, Zhi; Wang, Lingling; Yue, Feng; Wang, Mengqiang; Yang, Chuanyan; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Shi, Xiaowei; Zhou, Zhi; Yue, Feng; Wang, Mengqiang; Yang, Chuanyan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shi, XW (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	wanglingling@ms.qdio.ac.cn; lshsong@ms.qdio.ac.cn	Zhong, Jin/J-4613-2019; Wang, Mengqiang/A-1215-2010; zhi, zhouzhi/J-8063-2013; Yue, Feng/S-6565-2017; Zhong, Jin/M-6859-2018	Wang, Mengqiang/0000-0003-4702-3309; Zhong, Jin/0000-0002-3554-1275	Chinese Ministry of Science and Technology [2010CB126404]; National Natural Science Foundation of China [30925028, 30730070, 31072192]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Basic Research Program of China (973 program, no. 2010CB126404) from Chinese Ministry of Science and Technology, and grants (No. 30925028 and 30730070 to LS, and 31072192 to LW) from National Natural Science Foundation of China, http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini C, 2004, EUR J HISTOCHEM, V48, P235; Anguiano GA, 2010, ENVIRON TOXICOL, V25, P327, DOI 10.1002/tox.20491; Arpagaus M, 1998, J PHYSIOLOGY-PARIS, V92, P363, DOI 10.1016/S0928-4257(99)80006-0; Askar KA, 2011, APPL BIOCH BIOTECHNO; Azevedo-Pereira HMVS, 2011, ECOTOX ENVIRON SAFE, V74, P1210, DOI 10.1016/j.ecoenv.2011.03.018; Baxter GD, 1999, INT J PARASITOL, V29, P1765, DOI 10.1016/S0020-7519(99)00136-8; BERGMANN F, 1950, BIOCHIM BIOPHYS ACTA, V6, P217, DOI 10.1016/0006-3002(50)90094-1; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Boudinot E, 2009, RESP PHYSIOL NEUROBI, V165, P40, DOI 10.1016/j.resp.2008.10.003; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branduardi D, 2005, J AM CHEM SOC, V127, P9147, DOI 10.1021/ja0512780; BULBRING E, 1953, PROC R SOC SER B-BIO, V141, P445, DOI 10.1098/rspb.1953.0053; Cao A, 2007, INT IMMUNOPHARMACOL, V7, P1395, DOI 10.1016/j.intimp.2007.07.008; Cheng T.C., 1981, INVERTEBRATE BLOOD C, V1, P223; Cheng Thomas C., 1996, P299; Costa MM, 2009, FISH SHELLFISH IMMUN, V26, P515, DOI 10.1016/j.fsi.2009.02.001; CYMBOROWSKI B, 1970, COMP BIOCHEM PHYSIOL, V32, P367, DOI 10.1016/0010-406X(70)90950-3; Das UN, 2007, MED SCI MONITOR, V13, pRA214; De Zoysa M, 2009, FISH SHELLFISH IMMUN, V26, P625, DOI 10.1016/j.fsi.2008.10.004; DEWHURST SA, 1975, COMP BIOCHEM PHYS C, V50, P53; DOUGHERTY DA, 1990, SCIENCE, V250, P1558, DOI 10.1126/science.2274786; Dvir H, 2010, CHEM-BIOL INTERACT, V187, P10, DOI 10.1016/j.cbi.2010.01.042; ELBERMANI AWI, 1978, J EMBRYOL EXP MORPH, V48, P177; HORNSTEIN EP, 1994, VISUAL NEUROSCI, V11, P989, DOI 10.1017/S0952523800003928; Johnson G, 2006, CURR PHARM DESIGN, V12, P217, DOI 10.2174/138161206775193127; Johnson JL, 2003, BIOCHEMISTRY-US, V42, P5438, DOI 10.1021/bi027065u; Jones AK, 2002, FASEB J, V16, P441, DOI 10.1096/fj.01-0683fje; Kang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019063; Karczmar AG, 2010, CHEM-BIOL INTERACT, V187, P34, DOI 10.1016/j.cbi.2010.03.009; Kawli T, 2010, DIS MODEL MECH, V3, P721, DOI 10.1242/dmm.003871; KEYHANI E, 1981, J CELL SCI, V52, P327; KUSSATHE.E, 1967, HISTOCHEMISTRY, V8, P237, DOI 10.1007/BF00306086; Leone P, 2010, CHEM-BIOL INTERACT, V187, P49, DOI 10.1016/j.cbi.2010.01.030; Lin G, 2005, J BIOCHEM MOL TOXIC, V19, P234, DOI 10.1002/jbt.20087; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo CY, 2010, BIOCHEM PHARMACOL, V80, P1427, DOI 10.1016/j.bcp.2010.07.020; MCKENNA OC, 1968, CIRC RES, V23, P645, DOI 10.1161/01.RES.23.5.645; Monnet-Tschudi F, 2000, TOXICOL APPL PHARM, V165, P175, DOI 10.1006/taap.2000.8934; Nizri E, 2006, NEUROPHARMACOLOGY, V50, P540, DOI 10.1016/j.neuropharm.2005.10.013; ORON U, 1984, CELL MOL BIOL, V30, P411; Pegan K, 2010, CHEM-BIOL INTERACT, V187, P96, DOI 10.1016/j.cbi.2010.03.034; PITZURRA L, 1989, INFECT IMMUN, V57, P2452, DOI 10.1128/IAI.57.8.2452-2456.1989; QUAN N, 1994, J NEUROIMMUNOL, V49, P125, DOI 10.1016/0165-5728(94)90188-0; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; Rand James B, 2007, WormBook, P1; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; ROSENBERRY TL, 1975, ADV ENZYMOL RAMB, V43, P103; RYBICKA K, 1967, EXP PARASITOL, V20, P263, DOI 10.1016/0014-4894(67)90048-3; Salzet M, 2001, TRENDS IMMUNOL, V22, P285, DOI 10.1016/S1471-4906(01)01895-6; SCHWARTZ JH, 1975, J GEN PHYSIOL, V65, P255, DOI 10.1085/jgp.65.3.255; SERAVIN LN, 1965, DOKL AKAD NAUK SSSR+, V160, P486; STEITZ TA, 1982, ANNU REV BIOPHYS BIO, V11, P419, DOI 10.1146/annurev.bb.11.060182.002223; Szegletes T, 1998, BIOCHEMISTRY-US, V37, P4206, DOI 10.1021/bi972158a; Talesa V, 1999, J NEUROCHEM, V72, P1250, DOI 10.1046/j.1471-4159.1999.0721250.x; THIEDEMANN KU, 1986, CELL TISSUE RES, V244, P153; Travers MA, 2008, FISH SHELLFISH IMMUN, V24, P400, DOI 10.1016/j.fsi.2007.10.001; Tyagi E, 2010, EUR J PHARMACOL, V640, P206, DOI 10.1016/j.ejphar.2010.04.041; Tyagi E, 2008, J NEUROIMMUNOL, V205, P51, DOI 10.1016/j.jneuroim.2008.08.015; van Nierop P, 2006, J BIOL CHEM, V281, P1680, DOI 10.1074/jbc.M508571200; von Wachtendonk D., 1979, Comparative Biochemistry and Physiology C Comparative Pharmacology, V63, P279, DOI 10.1016/0306-4492(79)90074-1; Wang LL, 2009, FISH SHELLFISH IMMUN, V26, P744, DOI 10.1016/j.fsi.2009.03.002; WATSON JE, 1976, PFLUG ARCH EUR J PHY, V363, P161, DOI 10.1007/BF01062285; WHITTAKER JR, 1980, J EMBRYOL EXP MORPH, V55, P343; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P195, DOI 10.1016/S1050-4648(02)00161-4; Xuereb B, 2009, AQUAT TOXICOL, V94, P114, DOI 10.1016/j.aquatox.2009.06.010; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089; Zaitseva O V, 2008, Morfologiia, V133, P55; Zhang HA, 2010, FISH SHELLFISH IMMUN, V29, P149, DOI 10.1016/j.fsi.2010.02.024; Zhao PC, 2010, J BIOCHEM MOL TOXIC, V24, P51, DOI 10.1002/jbt.20311; Zhou XX, 2011, PROTEIN EXPRES PURIF, V77, P62, DOI 10.1016/j.pep.2010.11.017	72	101	108	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30828	10.1371/journal.pone.0030828	http://dx.doi.org/10.1371/journal.pone.0030828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22649509	gold, Green Published, Green Submitted			2022-12-25	WOS:000301570600085
J	Wang, YX; Zeng, X; Iyer, NJ; Bryant, DW; Mockler, TC; Mahalingam, R				Wang, Yixing; Zeng, Xin; Iyer, Niranjani J.; Bryant, Douglas W.; Mockler, Todd C.; Mahalingam, Ramamurthy			Exploring the Switchgrass Transcriptome Using Second-Generation Sequencing Technology	PLOS ONE			English	Article							MICROSATELLITE MARKERS; COMPARATIVE GENOMICS; MESSENGER-RNA; GENE; ARABIDOPSIS; PLANT; GERMINATION; RICE; IDENTIFICATION; ANNOTATION	Background: Switchgrass (Panicum virgatum L.) is a C4 perennial grass and widely popular as an important bioenergy crop. To accelerate the pace of developing high yielding switchgrass cultivars adapted to diverse environmental niches, the generation of genomic resources for this plant is necessary. The large genome size and polyploid nature of switchgrass makes whole genome sequencing a daunting task even with current technologies. Exploring the transcriptional landscape using next generation sequencing technologies provides a viable alternative to whole genome sequencing in switchgrass. Principal Findings: Switchgrass cDNA libraries from germinating seedlings, emerging tillers, flowers, and dormant seeds were sequenced using Roche 454 GS-FLX Titanium technology, generating 980,000 reads with an average read length of 367 bp. De novo assembly generated 243,600 contigs with an average length of 535 bp. Using the foxtail millet genome as a reference greatly improved the assembly and annotation of switchgrass ESTs. Comparative analysis of the 454-derived switchgrass EST reads with other sequenced monocots including Brachypodium, sorghum, rice and maize indicated a 70-80% overlap. RPKM analysis demonstrated unique transcriptional signatures of the four tissues analyzed in this study. More than 24,000 ESTs were identified in the dormant seed library. In silico analysis indicated that there are more than 2000 EST-SSRs in this collection. Expression of several orphan ESTs was confirmed by RT-PCR. Significance: We estimate that about 90% of the switchgrass gene space has been covered in this analysis. This study nearly doubles the amount of EST information for switchgrass currently in the public domain. The celerity and economical nature of second-generation sequencing technologies provide an in-depth view of the gene space of complex genomes like switchgrass. Sequence analysis of closely related members of the NAD(+)-malic enzyme type C4 grasses such as the model system Setaria viridis can serve as a viable proxy for the switchgrass genome.	[Wang, Yixing; Zeng, Xin; Iyer, Niranjani J.; Mahalingam, Ramamurthy] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Bryant, Douglas W.; Mockler, Todd C.] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Oklahoma State University System; Oklahoma State University - Stillwater; Donald Danforth Plant Science Center	Wang, YX (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	ramamurthy.mahalingam@okstate.edu	Mahalingam, Ramamurthy/AAP-5463-2020; Mockler, Todd C/L-2609-2013	Mockler, Todd C/0000-0002-0462-5775; Sung, Wen-Wei/0000-0002-2375-0029	National Science Foundation [EPS-0814361]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant No. EPS-0814361. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; Barbazuk WB, 2007, SNP MINING MAIZE 454; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; Boe A, 2008, CROP SCI, V48, P1306, DOI 10.2135/cropsci2007.08.0482; Bouton Joe, 2008, P295, DOI 10.1007/978-0-387-70805-8_11; Bouton JH, 2007, CURR OPIN GENET DEV, V17, P553, DOI 10.1016/j.gde.2007.08.012; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chi KR, 2008, NAT METHODS, V5, P11, DOI 10.1038/NMETH1154; Christin PA, 2009, PLANT PHYSIOL, V149, P82, DOI 10.1104/pp.108.128553; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Furumoto T, 2011, NATURE, V476, P472, DOI 10.1038/nature10250; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hopkins AA, 1996, CROP SCI, V36, P1192, DOI 10.2135/cropsci1996.0011183X003600050021x; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Keshwani DR, 2009, BIORESOURCE TECHNOL, V100, P1515, DOI 10.1016/j.biortech.2008.09.035; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mahalingam R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r20; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Masumoto C, 2010, P NATL ACAD SCI USA, V107, P5226, DOI 10.1073/pnas.0913127107; Matts J, 2010, J PLANT PHYSIOL, V167, P896, DOI 10.1016/j.jplph.2010.02.001; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Muthukumar B, 2004, MOL GENET GENOMICS, V271, P308, DOI 10.1007/s00438-004-0980-1; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Palmer NA, 2012, BIOENERG RES, V5, P649, DOI 10.1007/s12155-011-9171-1; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Puckette M, 2009, J PLANT PHYSIOL, V166, P1284, DOI 10.1016/j.jplph.2009.01.009; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; SCHULZESIEBERT D, 1984, PLANT PHYSIOL, V76, P465, DOI 10.1104/pp.76.2.465; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Schwender J, 2004, CURR OPIN PLANT BIOL, V7, P309, DOI 10.1016/j.pbi.2004.03.016; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Tangphatsornruang S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-137; TANIGUCHI M, 1995, ARCH BIOCHEM BIOPHYS, V318, P295, DOI 10.1006/abbi.1995.1233; Tobias CM, 2008, PLANT GENOME-US, V1, P111, DOI 10.3835/plantgenome2008.08.0003; Tobias CM, 2006, MOL ECOL NOTES, V6, P185, DOI 10.1111/j.1471-8286.2006.01187.x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Wall PK, 2008, NUCLEIC ACIDS RES, V36, pD970, DOI 10.1093/nar/gkm972; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang YW, 2011, THEOR APPL GENET, V122, P677, DOI 10.1007/s00122-010-1477-4; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394	67	72	77	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34225	10.1371/journal.pone.0034225	http://dx.doi.org/10.1371/journal.pone.0034225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22848356	Green Submitted, Green Published, gold			2022-12-25	WOS:000304523400061
J	Li, RG; Gao, S; Hernandez, AG; Wechter, WP; Fei, ZJ; Ling, KS				Li, Rugang; Gao, Shan; Hernandez, Alvaro G.; Wechter, W. Patrick; Fei, Zhangjun; Ling, Kai-Shu			Deep Sequencing of Small RNAs in Tomato for Virus and Viroid Identification and Strain Differentiation	PLOS ONE			English	Article							PEPINO-MOSAIC-VIRUS; 1ST REPORT; GREENHOUSE TOMATOES; NATURAL INFECTION; DISCOVERY; ALIGNMENT; EVOLUTION; PATHOGEN; INSIGHTS; REVEALS	Small RNAs (sRNA), including microRNAs (miRNA) and small interfering RNAs (siRNA), are produced abundantly in plants and animals and function in regulating gene expression or in defense against virus or viroid infection. Analysis of siRNA profiles upon virus infection in plant may allow for virus identification, strain differentiation, and de novo assembly of virus genomes. In the present study, four suspected virus-infected tomato samples collected in the U. S. and Mexico were used for sRNA library construction and deep sequencing. Each library generated between 5-7 million sRNA reads, of which more than 90% were from the tomato genome. Upon in-silico subtraction of the tomato sRNAs, the remaining highly enriched, virus-like siRNA pools were assembled with or without reference virus or viroid genomes. A complete genome was assembled for Potato spindle tuber viroid (PSTVd) using siRNA alone. In addition, a near complete virus genome (98%) also was assembled for Pepino mosaic virus (PepMV). A common mixed infection of two strains of PepMV (EU and US1), which shared 82% of genome nucleotide sequence identity, also could be differentially assembled into their respective genomes. Using de novo assembly, a novel potyvirus with less than 60% overall genome nucleotide sequence identity to other known viruses was discovered and its full genome sequence obtained. Taken together, these data suggest that the sRNA deep sequencing technology will likely become an efficient and powerful generic tool for virus identification in plants and animals.	[Li, Rugang; Wechter, W. Patrick; Ling, Kai-Shu] ARS, US Vegetable Lab, USDA, Charleston, SC USA; [Gao, Shan; Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Hernandez, Alvaro G.] Univ Illinois, WM Keck Ctr Comparat & Funct Genom, Urbana, IL USA; [Fei, Zhangjun] USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	United States Department of Agriculture (USDA); Cornell University; Boyce Thompson Institute for Plant Research; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Li, RG (corresponding author), ARS, US Vegetable Lab, USDA, Charleston, SC USA.	zf25@Cornell.edu; kai.ling@ars.usda.gov	Li, Cong-jun/J-8572-2014; Fei, Zhangjun/H-5152-2012; Ling, Kai-Shu/ABE-9461-2020; Li, Weizhong/A-9735-2008; Khafipour, Ehsan/E-4140-2016	Li, Cong-jun/0000-0003-1389-9820; Li, Weizhong/0000-0003-1804-9403; Li, Rugang/0000-0001-6514-496X; Khafipour, Ehsan/0000-0003-4673-7633; Fei, Zhangjun/0000-0001-9684-1450; Li, Ru/0000-0001-7332-7790	U.S. Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative [SCRI-600-25320]; National Science Foundation [IOS-1110080]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025030] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	U.S. Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by a grant from the U.S. Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative (SCRI-600-25320) to KSL and by National Science Foundation (IOS-1110080) to ZF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bao Y, 2008, ENCY VIROLOGY, V5, P342; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Cotillon AC, 2002, ARCH VIROL, V147, P2231, DOI 10.1007/s00705-002-0873-8; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Hagen C, 2011, ARCH VIROL, V156, P1209, DOI 10.1007/s00705-011-0979-y; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hanssen IM, 2010, MOL PLANT MICROBE IN, V23, P539, DOI 10.1094/MPMI-23-5-0539; Hanssen IM, 2010, MOL PLANT PATHOL, V11, P179, DOI 10.1111/j.1364-3703.2009.00600.x; Isakov O, 2011, BIOINFORMATICS, V27, P2027, DOI 10.1093/bioinformatics/btr349; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; JONES RAC, 1980, ANN APPL BIOL, V94, P61, DOI 10.1111/j.1744-7348.1980.tb03896.x; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Ling KS, 2010, PLANT DIS, V94, P1376, DOI 10.1094/PDIS-07-10-0516; Ling KS, 2009, PLANT DIS, V93, P1216, DOI 10.1094/PDIS-93-11-1216A; Ling KS, 2009, PLANT DIS, V93, P1075, DOI 10.1094/PDIS-93-10-1075B; Ling KS, 2009, PLANT DIS, V93, P839, DOI 10.1094/PDIS-93-8-0839B; Ling KS, 2007, VIRUS GENES, V34, P1, DOI 10.1007/s11262-006-0003-x; Ling KS, 2008, PLANT DIS, V92, P1683, DOI 10.1094/PDIS-92-12-1683; Machida S, 2007, J GEN VIROL, V88, P3452, DOI 10.1099/vir.0.83228-0; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Maroon-Lango CJ, 2005, ARCH VIROL, V150, P1187, DOI 10.1007/s00705-005-0495-z; Martin R, 2007, VIROLOGY, V367, P135, DOI 10.1016/j.virol.2007.05.011; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Navarro B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007686; The Tomato Genome Consortium, 2012, NATURE IN PRESS; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Vlugt R A A, 2000, Plant Dis, V84, P103, DOI 10.1094/PDIS.2000.84.1.103C; Vodovar N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wu QF, 2012, P NATL ACAD SCI USA, V109, P3938, DOI 10.1073/pnas.1117815109; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	41	279	296	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37127	10.1371/journal.pone.0037127	http://dx.doi.org/10.1371/journal.pone.0037127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623984	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500061
J	Li, RW; Wu, ST; Baldwin, RL; Li, WZ; Li, CJ				Li, Robert W.; Wu, Sitao; Baldwin, Ransom L.; Li, Weizhong; Li, Congjun			Perturbation Dynamics of the Rumen Microbiota in Response to Exogenous Butyrate	PLOS ONE			English	Article							VOLATILE FATTY-ACIDS; HUMAN GUT; BUTYRIVIBRIO-FIBRISOLVENS; RUMINAL BUTYRATE; RESISTANT STARCH; LARGE-INTESTINE; FAST PROGRAM; DAIRY-COWS; MILK-YIELD; METABOLISM	The capacity of the rumen microbiota to produce volatile fatty acids (VFAs) has important implications in animal well-being and production. We investigated temporal changes of the rumen microbiota in response to butyrate infusion using pyrosequencing of the 16S rRNA gene. Twenty one phyla were identified in the rumen microbiota of dairy cows. The rumen microbiota harbored 54.5 +/- 6.1 genera (mean +/- SD) and 127.3 +/- 4.4 operational taxonomic units (OTUs), respectively. However, the core microbiome comprised of 26 genera and 82 OTUs. Butyrate infusion altered molar percentages of 3 major VFAs. Butyrate perturbation had a profound impact on the rumen microbial composition. A 72 h-infusion led to a significant change in the numbers of sequence reads derived from 4 phyla, including 2 most abundant phyla, Bacteroidetes and Firmicutes. As many as 19 genera and 43 OTUs were significantly impacted by butyrate infusion. Elevated butyrate levels in the rumen seemingly had a stimulating effect on butyrate-producing bacteria populations. The resilience of the rumen microbial ecosystem was evident as the abundance of the microorganisms returned to their pre-disturbed status after infusion withdrawal. Our findings provide insight into perturbation dynamics of the rumen microbial ecosystem and should guide efforts in formulating optimal uses of probiotic bacteria treating human diseases.	[Li, Robert W.; Baldwin, Ransom L.; Li, Congjun] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA; [Wu, Sitao; Li, Weizhong] Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA	United States Department of Agriculture (USDA); University of California System; University of California San Diego	Li, RW (corresponding author), ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA.	robert.li@ars.usda.gov	Li, Cong-jun/J-8572-2014; Fei, Zhangjun/H-5152-2012; Ling, Kai-Shu/ABE-9461-2020; Li, Weizhong/A-9735-2008; Khafipour, Ehsan/E-4140-2016	Li, Cong-jun/0000-0003-1389-9820; Li, Weizhong/0000-0003-1804-9403; Li, Rugang/0000-0001-6514-496X; Khafipour, Ehsan/0000-0003-4673-7633; Fei, Zhangjun/0000-0001-9684-1450; Li, Ru/0000-0001-7332-7790	National Center for Research Resources (NCRR) [R01RR025030]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025030] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	SW and WL are supported by Award Number R01RR025030 from the National Center for Research Resources (NCRR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCRR or the National Institutes of Health. SW and WL are supported by Award Number R01RR025030 from the National Center for Research Resources (NCRR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCRR or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; BUGAUT M, 1987, COMP BIOCHEM PHYS B, V86, P439, DOI 10.1016/0305-0491(87)90433-0; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; HUHTANEN P, 1993, J DAIRY SCI, V76, P1114, DOI 10.3168/jds.S0022-0302(93)77440-8; Kristensen NB, 2004, J ANIM SCI, V82, P2033; Li CJ, 2007, FUNCT INTEGR GENOMIC, V7, P193, DOI 10.1007/s10142-006-0043-2; Li CJ, 2008, GENE REGUL SYST BIO, V2, P113; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Li RW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-234; Li RW, 2012, ENVIRON MICROBIOL, V14, P129, DOI 10.1111/j.1462-2920.2011.02543.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lopez S, 2003, J ANIM SCI, V81, P2609; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Miettinen H, 1996, J DAIRY SCI, V79, P851, DOI 10.3168/jds.S0022-0302(96)76434-2; Mrazek J, 2006, FOLIA MICROBIOL, V51, P294, DOI 10.1007/BF02931817; Niu BF, 2011, BIOINFORMATICS, V27, P1704, DOI 10.1093/bioinformatics/btr252; Ohkawara S, 2005, J NUTR, V135, P2878, DOI 10.1093/jn/135.12.2878; Ohkawara S, 2006, CLIN VACCINE IMMUNOL, V13, P1231, DOI 10.1128/CVI.00267-06; Pitt RE, 1996, J ANIM SCI, V74, P226; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Sato T, 2008, FEMS MICROBIOL ECOL, V66, P528, DOI 10.1111/j.1574-6941.2008.00528.x; Silvi S, 1999, J APPL MICROBIOL, V86, P521, DOI 10.1046/j.1365-2672.1999.00696.x; STORRY JE, 1966, BRIT J NUTR, V20, P217, DOI 10.1079/BJN19660023; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weimer PJ, 2010, J DAIRY SCI, V93, P5902, DOI 10.3168/jds.2010-3500; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015	35	279	296	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29392	10.1371/journal.pone.0029392	http://dx.doi.org/10.1371/journal.pone.0029392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22623984	Green Published, Green Submitted, gold			2022-12-25	WOS:000301357100009
J	Wang, JA; Gao, F; Liu, ZZ; Qiao, M; Niu, XM; Zhang, KQ; Huang, XW				Wang, Ji'ai; Gao, Feng; Liu, Zhongzhong; Qiao, Min; Niu, Xuemei; Zhang, Ke-Qin; Huang, Xiaowei			Pathway and Molecular Mechanisms for Malachite Green Biodegradation in Exiguobacterium sp MG2	PLOS ONE			English	Article							CRYSTAL VIOLET; TRIPHENYLMETHANE; DECOLORIZATION; DYES; DEGRADATION; AZO	Malachite green (MG), N-methylated diaminotriphenylmethane, is one of the most common dyes in textile industry and has also been used as an effective antifungal agent. However, due to its negative impact on the environment and carcinogenic effects to mammalian cells, there is a significant interest in developing microbial agents to degrade this type of recalcitrant molecules. Here, an Exiguobacterium sp. MG2 was isolated from a river in Yunnan Province of China as one of the best malachite green degraders. This strain had a high decolorization capability even at the concentration of 2500 mg/l and maintained its stable activity within the pH range from 5.0 to 9.0. High-pressure liquid chromatography, liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry were employed to detect the catabolic pathway of MG. Six intermediate products were identified and a potential biodegradation pathway was proposed. This pathway involves a series of reactions of N-demethylation, reduction, benzene ring-removal, and oxidation, which eventually converted N-methylated diaminotriphenylmethane into N, N-dimethylaniline that is the key precursor to MG. Furthermore, our molecular biology experiments suggested that both triphenylmethane reductase gene tmr and cytochrome P450 participated in MG degradation, consistent with their roles in the proposed pathway. Collectively, our investigation is the first report on a biodegradation pathway of triphenylmethane dye MG in bacteria. Citation: Wang J, Gao F, Liu Z, Qiao M, Niu X, et al. (2012) Pathway and Molecular Mechanisms for Malachite Green Biodegradation in Exiguobacterium sp. MG2. PLoS ONE 7(12): e51808. doi:10.1371/journal.pone.0051808	[Huang, Xiaowei] Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China; Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan University	Huang, XW (corresponding author), Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China.	xwhuang@ynu.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	National Basic Research Program of China (Program 973) [2010CB134503]; Department of Science and Technology of Yunnan Province, China [2010GA012]	National Basic Research Program of China (Program 973)(National Basic Research Program of China); Department of Science and Technology of Yunnan Province, China	This work was supported by the National Basic Research Program of China (Program 973, grant No. 2010CB134503), and the Department of Science and Technology of Yunnan Province, China (grant No 2010GA012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SY, 2002, BIOTECHNOL LETT, V24, P1037, DOI 10.1023/A:1015610018103; Azmi W, 1998, ENZYME MICROB TECH, V22, P185, DOI 10.1016/S0141-0229(97)00159-2; BUMPUS JA, 1988, APPL ENVIRON MICROB, V54, P1143, DOI 10.1128/AEM.54.5.1143-1150.1988; Cha CJ, 2001, APPL ENVIRON MICROB, V67, P4358, DOI 10.1128/AEM.67.9.4358-4360.2001; COOPER P, 1993, J SOC DYERS COLOUR, V109, P97; Deng DY, 2008, INT BIODETER BIODEGR, V62, P263, DOI 10.1016/j.ibiod.2008.01.017; Doerge DR, 1998, RAPID COMMUN MASS SP, V12, P1625, DOI 10.1002/(SICI)1097-0231(19981115)12:21<1625::AID-RCM373>3.0.CO;2-I; Gao GD, 2008, CHINESE J CATAL, V29, P426, DOI 10.1016/S1872-2067(08)60043-1; GEORGE KL, 1989, CAN J MICROBIOL, V35, P529, DOI 10.1139/m89-084; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; Jang MS, 2005, APPL ENVIRON MICROB, V71, P7955, DOI 10.1128/AEM.71.12.7955-7960.2005; Jones JJ, 2003, ANTIMICROB AGENTS CH, V47, P2323, DOI 10.1128/AAC.47.7.2323-2326.2003; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; Ortega-Calvo JJ, 2010, APPL ENVIRON MICROB, V76, P4430, DOI 10.1128/AEM.00461-10; Ren SZ, 2006, APPL MICROBIOL BIOT, V72, P1316, DOI 10.1007/s00253-006-0418-2; Sani RK, 1999, ENZYME MICROB TECH, V24, P433, DOI 10.1016/S0141-0229(98)00159-8; Wang JA, 2011, J MOL MICROB BIOTECH, V20, P220, DOI 10.1159/000330669; Wu J, 2009, J ENVIRON SCI-CHINA, V21, P960, DOI 10.1016/S1001-0742(08)62368-2; YATOME C, 1993, APPL MICROBIOL BIOT, V38, P565; YATOME C, 1991, J ENVIRON SCI HEAL A, V26, P75, DOI 10.1080/10934529109375621; Yoon JH, 1998, INT J SYST BACTERIOL, V48, P187, DOI 10.1099/00207713-48-1-187	21	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51808	10.1371/journal.pone.0051808	http://dx.doi.org/10.1371/journal.pone.0051808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	22629437	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386800088
J	Wang, J; Hopkins, CJ; Hou, JN; Zou, XX; Wang, CN; Long, Y; Kurup, S; King, GJ; Meng, JL				Wang, Jing; Hopkins, Clare J.; Hou, Jinna; Zou, Xiaoxiao; Wang, Chongnan; Long, Yan; Kurup, Smita; King, Graham J.; Meng, Jinling			Promoter Variation and Transcript Divergence in Brassicaceae Lineages of FLOWERING LOCUS T	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRANSPOSABLE ELEMENTS; FUNCTIONAL DIVERGENCE; COMPARATIVE GENOMICS; FLORAL INDUCTION; GENE-EXPRESSION; EVOLUTION; NAPUS; MECHANISMS; OLERACEA	Brassica napus (AACC, 2n = 38), an oil crop of world-wide importance, originated from interspecific hybridization of B. rapa (AA, 2n = 20) and B. oleracea (CC, 2n = 18), and has six FLOWERING LOCUS T (FT) paralogues. Two located on the homeologous chromosomes A2 and C2 arose from a lineage distinct from four located on A7 and C6. A set of three conserved blocks A, B and C, which were found to be essential for FT activation by CONSTANS (CO) in Arabidopsis, was identified within the FT upstream region in B. napus and its progenitor diploids. However, on chromosome C2, insertion of a DNA transposable element (TE) and a retro-element in FT upstream blocks A and B contributed to significant structural divergence between the A and C genome orthologues. Phylogenetic analysis of upstream block A indicated the conserved evolutionary relationships of distinct FT genes within Brassicaceae. We conclude that the ancient At-a whole genome duplication contributed to distinct ancestral lineages for this key adaptive gene, which co-exist within the same genus. FT-A2 was found to be transcribed in all leaf samples from different developmental stages in both B. rapa and B. napus, whereas FT-C2 was not transcribed in either B. napus or B. oleracea. Silencing of FT-C2 appeared to result from TE insertion and consequent high levels of cytosine methylation in TE sequences within upstream block A. Interestingly, FT-A7/C6 paralogues were specifically silenced in winter type B. napus but abundantly expressed in spring type cultivars under vernalization-free conditions. Motif prediction indicated the presence of two CO protein binding sites within all Brassica block A and additional sites for FT activation in block C. We propose that the ancestral whole genome duplications have contributed to more complex mechanisms of floral regulation and niche adaptation in Brassica compared to Arabidopsis.	[King, Graham J.] So Cross Univ, So Cross Plant Sci, Lismore, NSW 2480, Australia; [Wang, Jing; Hou, Jinna; Zou, Xiaoxiao; Wang, Chongnan; Long, Yan; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Hopkins, Clare J.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Kurup, Smita] Rothamsted Res, Harpenden, Herts, England	Southern Cross University; Huazhong Agricultural University; University of Melbourne; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	King, GJ (corresponding author), So Cross Univ, So Cross Plant Sci, Lismore, NSW 2480, Australia.	graham.king@scu.edu.au; jmeng@mail.hzau.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	Postdoctoral Science Foundation [20100480915]; 111 Project in China [B07041]; UK Biotechnology and Biological Sciences Research Council	Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 111 Project in China(Ministry of Education, China - 111 Project); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Postdoctoral Science Foundation (20100480915) and 111 Project (B07041) in China. Rothamsted Research receives grant-aided funds from the UK Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Alix K, 2008, PLANT J, V56, P1030, DOI 10.1111/j.1365-313X.2008.03660.x; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cardenas PD, 2012, THEOR APPL GENET, V124, P1215, DOI 10.1007/s00122-011-1781-7; Casacuberta JM, 2003, GENE, V311, P1, DOI 10.1016/S0378-1119(03)00557-2; Chen X, 2011, PLANT PHYSIOL, V155, P851, DOI 10.1104/pp.110.169482; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Chopra S, 1999, P NATL ACAD SCI USA, V96, P15330, DOI 10.1073/pnas.96.26.15330; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Fedoroff N, 2000, P NATL ACAD SCI USA, V97, P7002, DOI 10.1073/pnas.97.13.7002; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Henry Y, 2006, TRENDS PLANT SCI, V11, P267, DOI 10.1016/j.tplants.2006.04.002; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Howell EC, 2005, GENOME, V48, P1093, DOI 10.1139/G05-069; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Keller MM, 2011, PLANT J, V67, P195, DOI 10.1111/j.1365-313X.2011.04598.x; Kinoshita T, 2011, CURR BIOL, V21, P1232, DOI 10.1016/j.cub.2011.06.025; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Lagercrantz U, 1998, GENETICS, V150, P1217; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Lukens L, 2003, GENETICS, V164, P359; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lysak MA, 2006, PLANT SYST EVOL, V259, P175, DOI 10.1007/s00606-006-0418-9; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martynov VV, 2005, RUSS J PLANT PHYSL+, V52, P242, DOI 10.1007/s11183-005-0037-2; Moon J, 2005, PLANT CELL PHYSIOL, V46, P292, DOI 10.1093/pcp/pci024; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; PEREIRA A, 1986, EMBO J, V5, P835, DOI 10.1002/j.1460-2075.1986.tb04292.x; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Qiu D, 2009, PLANT CELL REP, V28, P649, DOI 10.1007/s00299-008-0661-3; Rana D, 2004, PLANT J, V40, P725, DOI 10.1111/j.1365-313X.2004.02244.x; Robert LS, 1998, PLANT MOL BIOL, V37, P763, DOI 10.1023/A:1006064514311; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; UN, 1953, JPN J BOT, V7, P389; Wang J, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-39; Wang J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-271; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Whittle CA, 2009, PLANT CELL, V21, P2203, DOI 10.1105/tpc.109.068411; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xu M, 2010, GENETICS, V184, P53, DOI 10.1534/genetics.109.107904; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zabala G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-124; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang XY, 2004, P NATL ACAD SCI USA, V101, P5589, DOI 10.1073/pnas.0401243101	73	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47127	10.1371/journal.pone.0047127	http://dx.doi.org/10.1371/journal.pone.0047127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	22629437	Green Published, gold, Green Submitted			2022-12-25	WOS:000309807700058
J	Wang, JK; Xu, MY; Zhu, K; Li, L; Liu, XQ				Wang, Juke; Xu, Mengyuan; Zhu, Kai; Li, Lei; Liu, Xinqi			The N-terminus of FILIA Forms an Atypical KH Domain with a Unique Extension Involved in Interaction with RNA	PLOS ONE			English	Article							MATERNAL EFFECT GENE; BINDING PROTEIN; STRUCTURAL BASIS; CELLS; EXPRESSION; SEQUENCE; COMPLEX; ANTIGEN; NOVA; RECOGNITION	FILIA is a member of the recently identified oocyte/embryo expressed gene family in eutherian mammals, which is characterized by containing an N-terminal atypical KH domain. Here we report the structure of the N-terminal fragment of FILIA (FILIA-N), which represents the first reported three-dimensional structure of a KH domain in the oocyte/embryo expressed gene family of proteins. The structure of FILIA-N revealed a unique N-terminal extension beyond the canonical KH region, which plays important roles in interaction with RNA. By co-incubation with the lysates of mice ovaries, FILIA and FILIA-N could sequester specific RNA components, supporting the critical roles of FILIA in regulation of RNA transcripts during mouse oogenesis and early embryogenesis.	[Wang, Juke; Xu, Mengyuan; Liu, Xinqi] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Zhu, Kai; Li, Lei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	Nankai University; Chinese Academy of Sciences; Institute of Zoology, CAS	Wang, JK (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	lil@ioz.ac.cn; liu2008@nankai.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	Ministry of Science and Technology, China [2010CB911800]; National Basic Research Program of China [2011CB944501]; Chinese Academy of Sciences [XDA01010103]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	Liu X is supported by National Basic Research Program of China (973 program) (2010CB911800) from Ministry of Science and Technology, China. Li L is funded by National Basic Research Program of China (2011CB944501) and the Chinese Academy of Sciences (XDA01010103 and the Hundred Talents Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amano H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-11; Amarasinghe AK, 2001, RNA, V7, P1239, DOI 10.1017/S1355838201010603; ASTIGIANO S, 1991, DIFFERENTIATION, V46, P61, DOI 10.1111/j.1432-0436.1991.tb00866.x; Braddock DT, 2002, NATURE, V415, P1051, DOI 10.1038/4151051a; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Cai CL, 2010, MOL BIOL CELL, V21, P3137, DOI 10.1091/mbc.E10-03-0255; CLEGG KB, 1983, DEV BIOL, V95, P331, DOI 10.1016/0012-1606(83)90034-9; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; DELEON V, 1983, DEV BIOL, V98, P400, DOI 10.1016/0012-1606(83)90369-X; Diaz-Moreno I, 2009, NAT STRUCT MOL BIOL, V16, P238, DOI 10.1038/nsmb.1558; Du ZH, 2005, J BIOL CHEM, V280, P38823, DOI 10.1074/jbc.M508183200; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Herr JC, 2008, DEV BIOL, V314, P300, DOI 10.1016/j.ydbio.2007.11.027; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JANIN J, 1990, J BIOL CHEM, V265, P16027; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Meyer NH, 2010, J BIOL CHEM, V285, P28893, DOI 10.1074/jbc.M110.126185; MuellerPillasch F, 1997, ONCOGENE, V14, P2729, DOI 10.1038/sj.onc.1201110; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; NEUYILIK G, 1993, EUR J BIOCHEM, V213, P727, DOI 10.1111/j.1432-1033.1993.tb17813.x; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierre A, 2007, GENOMICS, V90, P583, DOI 10.1016/j.ygeno.2007.06.003; Pozdnyakova I, 2005, FEBS J, V272, P872, DOI 10.1111/j.1742-4658.2004.04527.x; Racki WJ, 2006, DEVELOPMENT, V133, P4527, DOI 10.1242/dev.02651; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; Ramos A, 2002, BIOCHEMISTRY-US, V41, P4193, DOI 10.1021/bi011994o; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; SCHMIDT C, 1992, EUR J BIOCHEM, V206, P625, DOI 10.1111/j.1432-1033.1992.tb16967.x; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shain KH, 2002, J IMMUNOL, V168, P2544, DOI 10.4049/jimmunol.168.5.2544; Siomi H, 1997, CURR OPIN GENET DEV, V7, P345, DOI 10.1016/S0959-437X(97)80148-7; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Tanaka TS, 2006, DEV GROWTH DIFFER, V48, P381, DOI 10.1111/j.1440-169x.2006.00875.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 1999, ENDOCRINOLOGY, V140, P3720, DOI 10.1210/en.140.8.3720; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Valverde R, 2007, STRUCTURE, V15, P1090, DOI 10.1016/j.str.2007.06.022; Vitale AM, 2007, MOL REPROD DEV, V74, P608, DOI 10.1002/mrd.20648; Western P, 2005, STEM CELLS, V23, P1436, DOI 10.1634/stemcells.2005-0146; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106; Zhu JH, 2000, MOL CELL BIOL, V20, P5602, DOI 10.1128/MCB.20.15.5602-5618.2000	60	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30209	10.1371/journal.pone.0030209	http://dx.doi.org/10.1371/journal.pone.0030209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22629437	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200043
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	23029330	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	23029330	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	23029330	Green Submitted, Green Published, gold			2022-12-25	WOS:000306362400093
